PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Goozee, J; Murdoch, B; Ozanne, A; Cheng, Y; Hill, A; Gibbon, F				Goozee, Justine; Murdoch, Bruce; Ozanne, Anne; Cheng, Yan; Hill, Anne; Gibbon, Fiona			Lingual kinematics and coordination in speech-disordered children exhibiting differentiated versus undifferentiated lingual gestures	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						children; tongue; kinematics; undifferentiated gestures	TRAUMATIC BRAIN-INJURY; ELECTROMAGNETIC ARTICULOGRAPHY; TONGUE	Background: Electropalatographic investigations have revealed that a proportion of children with articulation/phonological disorders exhibit undifferentiated lingual gestures, whereby the whole of the tongue contacts the palate simultaneously during lingual consonant production. These undifferentiated lingual gestures have been interpreted to reflect a 'motor constraint', with the tongue tip and body incapable of operating independently. Aims: The present study aimed to provide further insight into the speech motor control abilities of children with articulation/phonological disorders by using electromagnetic articulography to track the movements (velocity, acceleration, distance, duration) of, and the coordination between, the tongue tip and tongue body during lingual consonant production. Methods & Procedures: Comparisons were made between two children with persistent articulation/phonological disorders who exhibited differentiated electropalatographic gestures (9.58 and 10 years), one child with persistent articulation/phonological disorder who demonstrated undifferentiated lingual gestures (11 years), and a group of four control children (mean age=10.98 years, standard deviation=0.48). The children were asked to read aloud single-syllable words containing word-initial /t, s, k/ consonants, with tongue tip and tongue body movements recorded using the electromagnetic articulography AG200 system (Carstens Medizinelektronik GmbH, Germany). Outcomes & Results: Kinematic analysis revealed increased kinematic values for /s/ for the two children with articulation/phonological disorders and differentiated electropalatographic gestures compared with the control group. One of these children also exhibited increased /k/ duration. Reduced acceleration was exhibited by one child with differentiated electropalatographic gestures during /t/ production, and by the child with undifferentiated lingual gestures during /k/. Regarding coordination, lag times between the tongue tip and body were variable between and within children. Spatial contribution to consonant production discriminated between the children with differentiated electropalatographic gestures and undifferentiated lingual gestures, with excessive movement of the tongue body exhibited for alveolar consonants by the child with undifferentiated lingual gestures. Conclusions: All three of the children with articulation/phonological disorders demonstrated aberrant lingual kinematics. The child who exhibited undifferentiated lingual gestures further exhibited excess tongue body movement during alveolar consonants, suggestive of poor motor control, an immature or deviant bracing system, and/or a compensatory mechanism to counteract potential disturbances in tongue tip fine motor control. Electromagnetic articulography provided a means of examining speech motor control deficits, including disturbances in tongue movement and coordination, in children with articulation/phonological disorders.	Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia; La Trobe Univ, Sch Human Commun Sci, Bundoora, Vic, Australia; Queen Margaret Univ Coll, Edinburgh, Midlothian, Scotland		Goozee, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	j.goozee@uq.edu.au	Murdoch, Bruce E/C-1397-2012; Gibbon, Fiona E/J-8255-2013; Hill, Anne/F-4106-2010	Hill, Anne/0000-0003-3907-8369			Broomfield J, 2004, INT J LANG COMM DIS, V39, P303, DOI 10.1080/13682820310001625589; Cheng HY, 2005, J MED SPEECH-LANG PA, V13, P15; DODD B, 1995, DIFFERANTIAL DIAGNOS; Farnetani E., 1997, HDB PHONETIC SCI, P371; Fletcher S. G., 1992, ARTICULATION PHYSIOL; Gibbon FE, 2002, PERCEPT MOTOR SKILL, V95, P295, DOI 10.2466/PMS.95.5.295-307; Gibbon FE, 1999, J SPEECH LANG HEAR R, V42, P382, DOI 10.1044/jslhr.4202.382; GIBBON FE, 1999, P ICPHS SAN FRANC CA, P1913; Goozee J V, 2001, Logoped Phoniatr Vocol, V26, P51; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; GRUNWELL P, 1990, DEV SPEECH DISORDERS; HARDCASTLE WJ, 1976, PHYSIOL SPEECH PRODU; HAYDEN D, 1990, VERBAL MOTOR PRODUCT; HOWARD S, 1998, THESIS U SHEFFIELD S; Howard S., 1994, P 3 C INT CLIN PHON P 3 C INT CLIN PHON, P67; Kuehn D. P., 1976, J PHONETICS, V4, P303, DOI 10.1016/S0095-4470(19)31257-4; Law J, 2000, INT J LANG COMM DIS, V35, P165, DOI 10.1080/136828200247133; Logemann J., 1971, FISHER LOGEMANN TEST; Morley M. E., 1957, DEV DISORDERS SPEECH; Murdoch BE, 2003, BRAIN INJURY, V17, P79, DOI 10.1080/0269905021000010203; Nguyen N, 1996, J PHONETICS, V24, P77, DOI 10.1006/jpho.1996.0006; STONE M, 1991, J PHONETICS, V19, P309, DOI 10.1016/S0095-4470(19)30347-X; WEISS CE, 1980, WEISS COMPREHENSIVE; Wilcox K., 1999, CHILDRENS SPEECH INT; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; [No title captured]	26	17	23	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1368-2822			INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	NOV-DEC	2007	42	6					703	724		10.1080/13682820601104960			22	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	239IE	WOS:000251511200005	17852538				2022-02-06	
J	Lim, DH; Kim, TS; Jac, SP; Kim, SH				Lim, Dong-Ho; Kim, Tae-Sun; Jac, Sung-Pil; Kim, Soo Han			Intracerebral hematoma caused by ruptured traumatic pseudoaneurysm of the middle meningeal artery: A case report	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						traumatic pseudoaneurysm; middle meningeal artery (MMA); intracerebral hematoma	FALSE ANEURYSM	Hematomas caused by ruptured traumatic pseudoaneurysms of the middle meningeal artery (MMA) usually present with extradural hematomas, whereas intradural intraparenchymal hematomas are extremely rare. We report a case of traumatic pseudoaneurysm of the MMA giving rise to an intracerebral hematoma after head trauma. A 70-year-old man suffered a massive intracerebral temporoparietal hemorrhage after a head injury. CT angiogram of the brain revealed a large hematoma in the right middle cranial fossa extending to the right sylvian fissure. Cerebral angiogram also revealed a pseudoaneurysm of the MMA, which was successfully treated surgically. Although traumatic MMA pseudoaneurysm producing intracerebral hematoma (ICH) is rare, it should be considered as a possible cause of intracerebral hematoma.	[Lim, Dong-Ho; Kim, Tae-Sun; Jac, Sung-Pil; Kim, Soo Han] Chonnam Natl Univ, Hosp & Med Sch, Dept Neurosurg, Kwangju 501757, South Korea		Kim, TS (corresponding author), Chonnam Natl Univ, Hosp & Med Sch, Dept Neurosurg, 8 Hak Dong, Kwangju 501757, South Korea.	toesun1963@yahoo.co.kr					BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; Bruneau M, 2002, SURG NEUROL, V57, P174, DOI 10.1016/S0090-3019(01)00668-1; GARZAMERCADO R, 1979, NEUROSURGERY, V5, P200; HIGAZI I, 1969, J NEUROSURG, V30, P172, DOI 10.3171/jns.1969.30.2.0172; Kim JH, 2001, J KOREAN NEUROSURG S, V30, P307; KIMORA T, 1995, NO SHINKEI GEKA, V23, P1021; KUHN RA, 1964, J NEUROSURG, V21, P92, DOI 10.3171/jns.1964.21.2.0092; MEDER JF, 1992, J NEURORADIOLOGY, V19, P248; MORARD M, 1991, NEUROSURGERY, V29, P438, DOI 10.1227/00006123-199109000-00018; Okumura H, 1998, NEUROL SURG TOKYO, V26, P929; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; RAMBAUGH CL, 1972, RADIOLOGY, V104, P81; TSUTOMU K, 2002, NEUROL MED CHIR TOKY, V42, P221	13	17	19	0	0	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2007	42	5					416	418		10.3340/jkns.2007.42.5.416			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	279VT	WOS:000254384000014	19096582	Green Published			2022-02-06	
J	Shelton, C; Shryock, M				Shelton, Charity; Shryock, Meg			Effectiveness of communication/interaction strategies with patients who have neurological injuries in a rehabilitation setting	BRAIN INJURY			English	Article						traumatic brain injury; acquired brain injury; interactions; communication strategies	INDIVIDUALS; APHASIA	Primary objective: A correlational research design was used to examine the relationship between use of interaction strategies and success of interactions between patients with neurological injuries and licensed healthcare providers. It was hypothesized that using specific interaction strategies would increase the success of interactions between patients and staff. Methods and procedures: One hundred and two 5-minute interactions between licensed healthcare providers and adults with neurogenic cognitive-linguistic impairments were videotaped. Staff members involved in the interactions completed a questionnaire stating how successful they felt the interaction was and what positively or negatively impacted the interaction. Five speech-language pathologists viewed the interactions, rated the overall success of each, reported which interaction strategies they observed being used and indicated which strategies they felt most positively impacted the interactions. Results: Use of communication strategies aided the interactions. It was found that as more strategies were used success of the interactions increased. Conclusions: Interactions were aided by the use of communication strategies, especially when multiple strategies were used. Some strategies were more beneficial than others. Training staff in the use of communication strategies may help improve patients' satisfaction and success in rehabilitation.	[Shelton, Charity; Shryock, Meg] Missouri Rehabil Ctr, Traumat Brain Injury Program, Mt Vernon, MO 65712 USA		Shelton, C (corresponding author), Missouri Rehabil Ctr, Traumat Brain Injury Program, 600 N Main, Mt Vernon, MO 65712 USA.	sheltoncf@health.missouri.edu					Braunack-Mayer A, 2001, J CLIN ETHIC, V12, P388; Brown S J, 1994, Clin Nurs Res, V3, P43, DOI 10.1177/105477389400300105; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; Elwyn G, 2001, J EVAL CLIN PRACT, V7, P211, DOI 10.1046/j.1365-2753.2001.00286.x; Gorter S, 2002, J RHEUMATOL, V29, P1496; Hafsteinsdottir TB, 1997, J ADV NURS, V26, P580, DOI 10.1046/j.1365-2648.1997.t01-19-00999.x; JENKINS K, 2002, ESTNA ERCA J, V3, P145; Kaakinen J, 2001, J Am Acad Nurse Pract, V13, P325, DOI 10.1111/j.1745-7599.2001.tb00044.x; MARTIN L, 1989, J AM ACAD NURSE PRAC, V3, P77; Murray LL, 1998, J SPEECH LANG HEAR R, V41, P213, DOI 10.1044/jslhr.4101.213; Murray LL, 1997, J SPEECH LANG HEAR R, V40, P792, DOI 10.1044/jslhr.4004.792; PASHEK GV, 1982, J SPEECH HEAR RES, V25, P377, DOI 10.1044/jshr.2503.377; *REUT, 2003, CALLS DOCT IMPR COMM; Small JA, 2003, J SPEECH LANG HEAR R, V46, P353, DOI 10.1044/1092-4388(2003/028); Tang PC, 1998, J AM MED INFORM ASSN, V5, P563, DOI 10.1136/jamia.1998.0050563; TOMPKINS CA, 1994, J SPEECH HEAR RES, V37, P896, DOI 10.1044/jshr.3704.896; *UB FDN ACT INC, 1996, GUID UN DAT SET MED	17	17	17	0	9	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2007	21	12					1259	1266		10.1080/02699050701716935			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	249HP	WOS:000252219200005	18236201				2022-02-06	
J	Czosnyka, M; Smielewski, P; Lavinio, A; Czosnyka, Z; Pickard, JD				Czosnyka, Marek; Smielewski, Peter; Lavinio, Andrea; Czosnyka, Zofia; Pickard, John D.			A synopsis of brain pressures: which? when? are they all useful?	NEUROLOGICAL RESEARCH			English	Article						brain; biomechanics; critical care; head injury; cerebral perfusion pressure; intracranial pressure; monitoring; autoregulation	CRITICAL CLOSING PRESSURE; SEVERE HEAD-INJURY; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; CEREBRAL PERFUSION-PRESSURE; INTRA-CRANICAL PRESSURE; INTRACRANIAL-PRESSURE; BLOOD-FLOW; PULSATILITY INDEX; CEREBROVASCULAR AUTOREGULATION; NONINVASIVE ASSESSMENT	Objective: In addition to intracranial pressure (ICP) and cerebral perfusion pressure (CPP), there are many more brain-related measures defined as 'pressures'. Cerebral intra-tissue pressure, critical closing pressure, 'optimal' CPP, non-invasive CPP (nCPP) and non-invasive ICP (nICP), interhemispherical pressure gradients are the modalities which currently attract more attention in the management of head injured patients. Methods: This review summarizes the most important points related to the 'brain pressures' applied in clinical practice, and it is based both on the literature and the authors' own experience. Results: While ICP and CPP monitoring remains the cornerstone of head injury management, derived pressures are gaining clinical significance. 'Optimization' of CPP provides a rational compromise between the 'Critical Closing Pressure-oriented protocol' and the 'Lund concept', and it allows individualized tailoring of cerebral hemodynamics. Non-invasive ICP and CPP are practical surrogates for invasive monitoring especially in the early stages of trauma management. CCP and pressure gradients are promising prognostication tools. Discussion: Most of the derived brain pressures cannot be assessed at the bedside without a dedicated computer tool. Some practical and theoretical aspects about the measurement, signal analysis, estimation process, accuracy and interpretation need further researching and refinement.	Univ Cambridge, Addenbrookes Hosp, Dept Neurosci, Acad Neurosurg Unit, Cambridge CB2 2QQ, England		Czosnyka, M (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Neurosci, Acad Neurosurg Unit, Box 167, Cambridge CB2 2QQ, England.	MC141@medschl.cam.ac.uk	Lavinio, Andrea/M-1778-2016	Smielewski, Peter/0000-0001-5096-3938	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0001237, G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0600986, G9439390] Funding Source: Medline		Aaslid R, 2003, STROKE, V34, P1645, DOI 10.1161/01.STR.0000077927.63758.B6; Aaslid R, 1986, INTRACRANIAL PRESSUR, P229; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Balestreri M, 2003, J NEUROSURG, V99, P616; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; BURTON AC, 1951, AM J PHYSIOL, V164, P319, DOI 10.1152/ajplegacy.1951.164.2.319; Chambers IR, 1998, ACT NEUR S, V71, P42; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; Czosnyka M, 1999, J NEUROSURG, V90, P752, DOI 10.3171/jns.1999.90.4.0752; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; CZOSNYKA M, 2003, J CEREB BLOOD FLOW M, V23, pS65; DAVSON H, 1970, Brain Behavior and Evolution, V93, P665, DOI 10.1093/brain/93.4.665; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; Eker C, 2000, BRAIN INJURY, V14, P605; EKSTEDT J, 1978, J NEUROL NEUROSUR PS, V41, P345, DOI 10.1136/jnnp.41.4.345; Gooskens I, 2003, ACTA NEUROCHIR, V145, P527, DOI 10.1007/s00701-003-0045-y; Higgins JNP, 2003, J NEUROL NEUROSUR PS, V74, P1662, DOI 10.1136/jnnp.74.12.1662; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; Kumar A, 2005, J NEUROL NEUROSUR PS, V76, P1570, DOI 10.1136/jnnp.2004.059493; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; Miller J D, 1972, Prog Brain Res, V35, P411; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Petkus V, 2002, ULTRASONICS, V40, P829, DOI 10.1016/S0041-624X(02)00216-0; Piechnik S, 1998, ACT NEUR S, V71, P269; Piechnik SK, 2001, NEUROSURGERY, V49, P1214, DOI 10.1097/00006123-200111000-00034; REID A, 1989, J NEUROL NEUROSUR PS, V52, P610, DOI 10.1136/jnnp.52.5.610; Richards HK, 1999, ACTA NEUROCHIR, V141, P1221, DOI 10.1007/s007010050422; Richards HK, 1998, ACT NEUR S, V71, P229; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; Schoser BGH, 1999, J NEUROSURG, V91, P744, DOI 10.3171/jns.1999.91.5.0744; Silverberg GD, 2001, NEUROLOGY, V57, P1763, DOI 10.1212/WNL.57.10.1763; Smielewski P, 2005, ACT NEUR S, V95, P43; Soehle M, 2004, STROKE, V35, P1393, DOI 10.1161/01.STR.0000128411.07036.a9; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stephensen H, 2002, NEUROSURGERY, V50, P763, DOI 10.1097/00006123-200204000-00016; Torikoshi S, 1995, J Gravit Physiol, V2, pP145; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; Wolfla CE, 1997, J NEUROSURG, V86, P505, DOI 10.3171/jns.1997.86.3.0505; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	60	17	17	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	OCT	2007	29	7					672	679		10.1179/016164107X240053			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234MJ	WOS:000251167900008	18173906				2022-02-06	
J	Shirakawa, T; Nakano, K; Hachiya, NS; Kato, N; Kaneko, K				Shirakawa, Takafumi; Nakano, Kenji; Hachiya, Naomi S.; Kato, Nobumasa; Kaneko, Kiyotoshi			Temporospatial patterns of COX-2 expression and pyramidal cell degeneration in the rat hippocampus after trimethyltin administration	NEUROSCIENCE RESEARCH			English	Article						cyclooxygenase-2 (COX-2); trimethyltin (TMT); CA1; CA3; neuronal degeneration; plasma corticosterone concentration	TRAUMATIC BRAIN-INJURY; RECOMBINANT HUMAN INTERLEUKIN-1-BETA; II GLUCOCORTICOID-RECEPTORS; NECROSIS-FACTOR-ALPHA; NEURONAL DEATH; MESSENGER-RNA; CYCLOOXYGENASE-2 EXPRESSION; TIME-COURSE; CORTICOSTERONE; ISCHEMIA	The temporospatial profile of cyclooxygenase-2 (COX-2) expression and neuronal degeneration following trimethyltim (TMT) administration was investigated in the rat hippocampus region. In the CA] region, significant COX-2 expression was detected on day 3 after TMT administration but pyramidal cell degeneration was detected only on day 5 and thereafter. In the CA3 region, on the other hand, the constitutive COX-2 expression remained unchanged, and more severe pyramidal cell degeneration started on day 3. Concomitant with these observations, we observed that the coadministration of a COX-2 inhibitor prevented such neuronal degeneration only in the CAI region and not in the CA3 region. In addition, COX-2 inhibition did not affect the increase in the plasma corticosterone concentration after TMT administration. Furthermore, the COX-2 inhibitor did not alleviate TMT-induced locomotor hyperactivity in rats, for which inhibitors of corticosterone synthesis are known to be effective. These data suggest that the COX-2-dependent pathway appears to assist TMT-induced degeneration of CA] pyramidal cells but not CA3 pyramidal cells in a corticosterone-independent manner. (C) 2007 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	Astellas Pharma Inc, Drug Safety Res Labs, Drug Discovery Res, Itabashi Ku, Tokyo 1748511, Japan; Astellas Res Serv Co Ltd, Dept Pathol, Itabashi Ku, Tokyo 1748511, Japan; Tokyo Med Univ, Dept Physiol, Shinjuku Ku, Tokyo 1608402, Japan; Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138655, Japan		Shirakawa, T (corresponding author), Astellas Pharma Inc, Drug Safety Res Labs, Drug Discovery Res, Itabashi Ku, 1-1-8 Azusawa, Tokyo 1748511, Japan.	takafumi.shirakawa@jp.astellas.com					ARIASNEGRETE S, 1995, BIOCHEM BIOPH RES CO, V208, P582, DOI 10.1006/bbrc.1995.1378; Baik EJ, 1999, BRAIN RES, V843, P118, DOI 10.1016/S0006-8993(99)01797-7; BOULDIN TW, 1981, AM J PATHOL, V104, P237; Candore G, 2006, ANN NY ACAD SCI, V1089, P472, DOI 10.1196/annals.1386.008; Casolini P, 2002, J NEUROSCI RES, V68, P337, DOI 10.1002/jnr.10192; CHANG LW, 1983, NEUROBEH TOXICOL TER, V5, P443; Choi JS, 2006, NEUROSCI LETT, V393, P231, DOI 10.1016/j.neulet.2005.09.074; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Dayton ET, 1996, J NEUROIMMUNOL, V71, P11, DOI 10.1016/S0165-5728(96)00111-7; DYER RS, 1982, NEUROBEH TOXICOL TER, V4, P141; Gobbo OL, 2004, NEUROSCIENCE, V125, P317, DOI 10.1016/j.neuroscience.2004.01.045; Govoni S, 2001, NEUROSCI LETT, V303, P91, DOI 10.1016/S0304-3940(01)01675-5; Harry GJ, 2002, TOXICOL APPL PHARM, V180, P205, DOI 10.1006/taap.2002.9390; Hayley S, 1999, J NEUROSCI, V19, P5654; Ikeda M, 1996, BRAIN RES, V712, P168, DOI 10.1016/0006-8993(95)01530-2; Imai H, 1998, NEUROTOXICOLOGY, V19, P163; Imai H, 2001, EXP NEUROL, V171, P22, DOI 10.1006/exnr.2001.7725; Ishida N, 1997, NEUROSCIENCE, V81, P1183, DOI 10.1016/S0306-4522(97)00220-0; Ishikura N, 2001, NEUROSCI LETT, V306, P157, DOI 10.1016/S0304-3940(01)01887-0; Kawaguchi K, 2005, BRAIN RES, V1050, P130, DOI 10.1016/j.brainres.2005.05.038; Kim DK, 2006, INT J EXP PATHOL, V87, P73, DOI 10.1111/j.0959-9673.2006.00457.x; Kim HC, 2000, BRAIN RES, V874, P15, DOI 10.1016/S0006-8993(00)02560-9; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Koistinaho J, 1999, STROKE, V30, P1900, DOI 10.1161/01.STR.30.9.1900; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Kunz T, 2006, RESTOR NEUROL NEUROS, V24, P55; LINTHORST ACE, 1994, ENDOCRINOLOGY, V135, P520, DOI 10.1210/en.135.2.520; Liu Y, 2004, NEUROSCI RES, V50, P209, DOI 10.1016/j.neures.2004.06.019; Matsuoka Y, 1999, J CEREBR BLOOD F MET, V19, P1247, DOI 10.1097/00004647-199911000-00009; Nishimura T, 2001, MOL BRAIN RES, V97, P1, DOI 10.1016/S0169-328X(01)00278-9; Nogawa S, 1997, J NEUROSCI, V17, P2746; Parsadaniantz SM, 1999, NEUROENDOCRINOLOGY, V69, P77, DOI 10.1159/000054405; ROBERTSON DG, 1987, TOXICOL PATHOL, V15, P7, DOI 10.1177/019262338701500102; RUPPERT PH, 1982, NEUROBEH TOXICOL TER, V4, P135; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Swanson LW, 1992, BRAIN MAPS STRUCTURE; Takemiya T, 2006, NEUROSCI RES, V56, P103, DOI 10.1016/j.neures.2006.06.003; Tsunashima K, 1998, SYNAPSE, V29, P333; Tsutsumi S, 2002, EXP NEUROL, V173, P86, DOI 10.1006/exnr.2001.7824; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; WOODRUFF ML, 1988, EXP NEUROL, V102, P130, DOI 10.1016/0014-4886(88)90086-6; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T	43	17	17	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102			NEUROSCI RES	Neurosci. Res.	OCT	2007	59	2					117	123		10.1016/j.neures.2007.06.1468			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	224VQ	WOS:000250475500001	17651852				2022-02-06	
J	Adjan, VV; Hauser, KF; Bakalkin, G; Yakovleva, T; Gharibyan, A; Scheff, SW; Knapp, PE				Adjan, V. V.; Hauser, K. F.; Bakalkin, G.; Yakovleva, T.; Gharibyan, A.; Scheff, S. W.; Knapp, P. E.			Caspase-3 activity is reduced after spinal cord injury in mice lacking dynorphin: Differential effects on glia and neurons	NEUROSCIENCE			English	Article						apoptosis; astrocyte; excitotoxic cell death; oligodendrocyte; glutamate; traumatic injury	EXCITATORY AMINO-ACIDS; CENTRAL-NERVOUS-SYSTEM; NMDA RECEPTORS; MESSENGER-RNA; BRAIN-INJURY; MATURE OLIGODENDROCYTES; REGIONAL DISTRIBUTION; ANTAGONIST NALMEFENE; NONOPIOID MECHANISMS; CULTURED ASTROCYTES	Dynorphins are endogenous opioid peptide products of the prodynorphin gene. An extensive literature suggests that dynorphins have deleterious effects on CNS injury outcome. We thus examined whether a deficiency of dynorphin would protect against tissue damage after spinal cord injury (SCI), and if individual cell types would be specifically affected. Wild-type and prodynorphin(-/-) mice received a moderate contusion injury at 10th thoracic vertebrae (T10). Caspase-3 activity at the injury site was significantly decreased in tissue homogenates from prodynorphin(-/-) mice after 4 h. We examined frozen sections at 4 h post-injury by immunostaining for active caspase-3. At 3-4 mm rostral or caudal to the injury, > 90% of all neurons, astrocytes and oligodendrocytes expressed active caspase-3 in both wildtype and knockout mice. At 6-7 mm, there were fewer caspase-3(+) oligodendrocytes and astrocytes than at 3-4 mm. Importantly, caspase-3 activation was significantly lower in prodynorphin(-/-) oligodendrocytes and astrocytes, as compared with wild-type mice. In contrast, while caspase-3 expression in neurons also declined with further distance from the injury, there was no effect of genotype. Radioimmunoassay showed that dynorphin A(1-17) was regionally increased in wild-type injured versus sham-injured tissues, although levels of the prodynorphin processing product Arg(6)-Leu-enkephalin were unchanged. Our results indicate that dynorphin peptides affect the extent of post-injury caspase-3 activation, and that glia are especially sensitive to these effects. By promoting caspase-3 activation, dynorphin peptides likely increase the probability of glial apoptosis after SCI. While normally beneficial, our findings suggest that prodynorphin or its peptide products become maladaptive following SCI and contribute to secondary injury. (c) 2007 Published by Elsevier Ltd on behalf of IBRO.	Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; Karolinska Inst, Dept Clin Neurosci, Expt Alcohol & Drug Addict Res Sect, Stockholm, Sweden		Knapp, PE (corresponding author), Virginia Commonwealth Univ, Coll Med, Dept Anat & Neurobiol, 1217 E Marshall St,Herman A Kontos Med Sci Bldg, Richmond, VA 23298 USA.	peknapp@vcu.edu	Gharibyan, Anna L./B-3401-2010; Hauser, Kurt/AAX-8361-2020	Gharibyan, Anna L./0000-0001-9070-6215; Hauser, Kurt/0000-0001-7886-0332; Bakalkin, Georgy/0000-0002-8074-9833	NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA015097] Funding Source: NIH RePORTER; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA15097] Funding Source: Medline		BAKSHI R, 1992, BRAIN RES, V580, P255, DOI 10.1016/0006-8993(92)90952-6; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; BEHRMANN DL, 1993, EXP NEUROL, V119, P258, DOI 10.1006/exnr.1993.1028; Benjamins JA, 2003, NEUROCHEM RES, V28, P143, DOI 10.1023/A:1021612615554; BERMAN YL, 1994, BIOCHIMIE, V76, P245, DOI 10.1016/0300-9084(94)90153-8; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Caudle RM, 2000, PAIN, V87, P235, DOI 10.1016/S0304-3959(00)00360-2; CHEN L, 1995, J PHYSIOL-LONDON, V482, P575, DOI 10.1113/jphysiol.1995.sp020541; Chou JZ, 1996, PEPTIDES, V17, P983; CHRISTENSSONNYLANDER I, 1985, NEUROPEPTIDES, V6, P391, DOI 10.1016/0143-4179(85)90137-4; CHRISTENSSONNYLANDER I, 1985, REGUL PEPTIDES, V11, P65, DOI 10.1016/0167-0115(85)90032-1; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; CONE RI, 1983, J NEUROSCI, V3, P2146; EVANS CJ, 1988, OPIATE RECEPTORS, P23; Faden A I, 1988, Adv Neurol, V47, P531; Faden A I, 1987, Cent Nerv Syst Trauma, V4, P227; Faden A I, 1996, NIDA Res Monogr, V163, P318; FADEN AI, 1984, BRIT J PHARMACOL, V81, P271, DOI 10.1111/j.1476-5381.1984.tb10074.x; FADEN AI, 1992, J NEUROSCI, V12, P425; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; FADEN AI, 1985, ANN NEUROL, V17, P386, DOI 10.1002/ana.410170414; Feldblum S, 2000, J NEUROTRAUM, V17, P1079, DOI 10.1089/neu.2000.17.1079; Garrido C, 2004, CURR OPIN CELL BIOL, V16, P639, DOI 10.1016/j.ceb.2004.09.008; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; Goody RJ, 2003, NEUROSCIENCE, V116, P807, DOI 10.1016/S0306-4522(02)00563-8; Hauser KF, 1999, EXP NEUROL, V160, P361, DOI 10.1006/exnr.1999.7235; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; Hauser KF, 2001, EXP NEUROL, V168, P78, DOI 10.1006/exnr.2000.7580; HEADRICK JP, 1995, NEUROCHEM INT, V26, P489, DOI 10.1016/0197-0186(94)00153-L; HEALY DJ, 1994, NEUROPEPTIDES, V27, P277, DOI 10.1016/0143-4179(94)90108-2; Hu WH, 1996, NEUROSCI LETT, V203, P13, DOI 10.1016/0304-3940(95)12246-X; Jarskog LF, 2007, NEUROPSYCHOPHARMACOL, V32, P95, DOI 10.1038/sj.npp.1301074; Knapp PE, 2001, GLIA, V35, P156, DOI 10.1002/glia.1080; KOLAJ M, 1995, BRAIN RES, V671, P227, DOI 10.1016/0006-8993(94)01333-D; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Leuchtmann EA, 2003, NEUROBIOL DIS, V14, P336, DOI 10.1016/j.nbd.2003.07.004; Long J B, 1986, Cent Nerv Syst Trauma, V3, P295; Long JB, 2005, EUR J PHARMACOL, V508, P115, DOI 10.1016/j.ejphar.2004.12.008; LONG JB, 1994, J PHARMACOL EXP THER, V269, P358; MASSARDIER D, 1989, EUR J PHARMACOL, V170, P125, DOI 10.1016/0014-2999(89)90149-0; McAdoo DJ, 1999, EXP NEUROL, V159, P538, DOI 10.1006/exnr.1999.7166; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; McEwen ML, 2005, J HISTOCHEM CYTOCHEM, V53, P809, DOI 10.1369/jhc.4A6467.2005; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1994, AM J PHYSIOL, V267, pR665, DOI 10.1152/ajpregu.1994.267.3.R665; Merg F, 2006, J NEUROCHEM, V97, P292, DOI 10.1111/j.1471-4159.2006.03732.x; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Mu XJ, 2002, J NEUROTRAUM, V19, P917, DOI 10.1089/089771502320317078; Nottingham S, 2002, EXP NEUROL, V177, P242, DOI 10.1006/exnr.2002.7975; Nottingham SA, 2003, J COMP NEUROL, V464, P463, DOI 10.1002/cne.10806; NYBERG F, 1985, NEUROPEPTIDES, V5, P537, DOI 10.1016/0143-4179(85)90073-3; Oomman S, 2006, BRAIN RES, V1078, P19, DOI 10.1016/j.brainres.2006.01.041; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Ploj K, 1999, NEUROPEPTIDES, V33, P468, DOI 10.1054/npep.1999.0764; PRZEWLOCKI R, 1988, MOL BRAIN RES, V4, P37, DOI 10.1016/0169-328X(88)90016-2; Reed B, 2003, J NEUROCHEM, V86, P815, DOI 10.1046/j.1471-4159.2003.01859.x; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sanchez-Gomez MV, 2003, J NEUROSCI, V23, P9519; SASEK CA, 1984, NEUROSCIENCE, V12, P855, DOI 10.1016/0306-4522(84)90175-1; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Sharifi N, 2001, MOL BRAIN RES, V86, P70, DOI 10.1016/S0169-328X(00)00264-3; SHINODA H, 1989, SCIENCE, V245, P415, DOI 10.1126/science.2569236; Shukla VK, 1997, J PHARMACOL EXP THER, V283, P604; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; SILBERRING J, 1992, LIFE SCI, V50, P839, DOI 10.1016/0024-3205(92)90202-Z; Singh IN, 2003, NEUROSCIENCE, V122, P1013, DOI 10.1016/j.neuroscience.2003.08.033; SKILLING SR, 1992, BRAIN RES, V575, P272, DOI 10.1016/0006-8993(92)90090-V; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Sun BY, 2006, J NEUROIMMUNOL, V174, P52, DOI 10.1016/j.jneuroim.2006.01.006; SWEETNAM PM, 1986, NEUROSCIENCE, V18, P947, DOI 10.1016/0306-4522(86)90110-7; Tachibana T, 1998, J NEUROTRAUM, V15, P485, DOI 10.1089/neu.1998.15.485; Tan-No K, 2001, EXP CELL RES, V269, P54, DOI 10.1006/excr.2001.5309; Tang QB, 1999, J PHARMACOL EXP THER, V291, P760; TanNo K, 1997, NEUROCHEM INT, V31, P27, DOI 10.1016/S0197-0186(96)00137-4; THORNHILL JA, 1989, BRAIN RES, V490, P174, DOI 10.1016/0006-8993(89)90447-2; Vanderah TW, 1996, PAIN, V68, P275, DOI 10.1016/S0304-3959(96)03225-3; VILIJN MH, 1988, P NATL ACAD SCI USA, V85, P6551, DOI 10.1073/pnas.85.17.6551; VINK R, 1990, J NEUROSCI, V10, P3524; WALKER JM, 1982, SCIENCE, V218, P1136, DOI 10.1126/science.6128791; Winkler T, 2002, AMINO ACIDS, V23, P273, DOI 10.1007/s00726-001-0138-y; Woods AS, 2006, J PROTEOME RES, V5, P1017, DOI 10.1021/pr060016+; Xu GY, 2005, NEUROSCI LETT, V384, P271, DOI 10.1016/j.neulet.2005.04.100; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; YOUNG EA, 1987, PEPTIDES, V8, P701, DOI 10.1016/0196-9781(87)90046-5; YUM SW, 1990, ARCH NEUROL-CHICAGO, V47, P277, DOI 10.1001/archneur.1990.00530030043014; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	90	17	26	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 7	2007	148	3					724	736		10.1016/j.neuroscience.2007.05.053			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216LG	WOS:000249878900012	17698296				2022-02-06	
J	Markovchick, VJ; Moore, EE				Markovchick, Vincent J.; Moore, Ernest E.			Optimal trauma outcome: Trauma system design and the trauma team	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article							SURGEON PRESENCE	Trauma is the number one killer of Americans under age 34, and optimal care of trauma patients is best provided when there is a well-functioning, comprehensive system of trauma care. Results of a recent poll indicate that 61% of the American public is unaware that injury is the leading cause of death for those ages 1 to 34. Only eight states currently have fully functioning trauma systems [1]. A recent meta-analysis of 14 published articles evaluating the impact of implementing trauma systems found a 15% reduction in mortality in favor of the presence of a trauma system [2]. Trauma system development in the United States has evolved over the past 35 years, and the organization taking the lead on trauma system development, review, and verification has been the American College of Surgeons Committee on Trauma (ACS/COT). The ACS/COT trauma center classification scheme has assisted communities in trauma system development [3]. The goal of a mature trauma system is to match the needs of the injured patients to the capabilities of the trauma receiving facility, thus maximizing the chances for the best possible outcome. A national survey conducted in 2002 by the United States Department of Health Resources and Services Administration (HRSA) revealed that most the field do not need a surgeon present on the arrival in the ED [8]. In addition, the majority of trauma patients who have a GCS score of less than 8 have either an abnormal mental status secondary to isolated head trauma or metabolic or toxicologic reasons. Therefore, the authors have modified the criteria at Denver Health for trauma activation and have developed the following protocol (Box 1). These protocols are a dynamic document and will be revised in the future based on the critical evaluation of trauma outcome data from the authors' trauma registry and continuous quality improvement (CQI) processes. In summary, optimal trauma care is a team effort from roadside through rehabilitation. Close collegial collaboration between emergency medicine specialists and trauma surgeons is essential. All efforts and protocols for trauma care should be based on objective CQI outcome data. The ultimate goal should be to make the most efficient use of resources that result in the best possible outcome for the trauma patient.	Univ Colorado, Hlth Sci Ctr, Dept Surg, Div Emergency Med, Denver, CO 80204 USA; Surg & Trauma Serv, Denver, CO 80204 USA; Dept Surg, Denver, CO USA		Markovchick, VJ (corresponding author), 777 Bannock St,MC 0108, Denver, CO 80204 USA.	vince.markovchick@dhha.org					Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Champion HR, 2006, J AM COLL SURGEONS, V203, P951, DOI 10.1016/j.jamcollsurg.2006.08.019; Ciesla DJ, 2004, J TRAUMA, V56, P937, DOI 10.1097/01.TA.0000127768.21385.81; *COMM TRAUM, 2006, AM COLL RES OPT CAR, P19; Esposito TJ, 2006, J AM COLL SURGEONS, V202, P655, DOI 10.1016/j.jamcollsurg.2005.12.008; Green SM, 2006, ANN EMERG MED, V47, P405, DOI 10.1016/j.annemergmed.2005.11.032; Jurkovich GJ, 2005, J TRAUMA, V58, P614, DOI 10.1097/01.TA0000159347.03278.E1; Moore EE, 2006, ANN EMERG MED, V47, P413, DOI 10.1016/j.annemergmed.2006.01.017; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; WEST JG, JAMA, V1099, P3597	10	17	18	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	AUG	2007	25	3					643	+		10.1016/j.emc.2007.07.002			13	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	216OF	WOS:000249886900005	17826210				2022-02-06	
J	Talvik, I; Mannamaa, M; Juri, P; Leito, K; Poder, H; Hamarik, M; Kool, P; Talvik, T				Talvik, Inga; Mannamaa, Mairi; Juri, Piret; Leito, Kaja; Poder, Haide; Hamarik, Malle; Kool, Pille; Talvik, Tiina			Outcome of infants with inflicted traumatic brain injury (shaken baby syndrome) in Estonia	ACTA PAEDIATRICA			English	Article						inflicted brain injury; shaken baby syndrome; outcome; child abuse	NONACCIDENTAL HEAD-INJURY; CHILDREN	This is a population-based prospective study to identify the long-term outcome of children with inflicted traumatic brain injury (ITBI). Twenty-two survivors were identified and followed up. Only 2 of 22 had no developmental problems at follow-up, 20 of 22 children were having different developmental problems, among them 3 of 22 were severely handicapped. Psychological tests passed 17 of 22, 5 did not pass due to severe handicap (3 children) or were too young (2 patients). Epilepsy was found in 7 of 22, being intractable in 3 cases. Serious motor problems were identified in 5 of 22. Ophthalmologic problems were found in 4 of 22. The most important predictor of adverse outcome was young age at the time of the insult. Conclusion: the outcome of these potentially healthy children is poor. The key question is prevention. Health care professionals should be more concerned about these problems.	Tartu Univ Hosp, Dept Neurol, Childrens Clin, EE-51014 Tartu, Estonia; Childrens Hosp, Tallinn, Estonia		Talvik, I (corresponding author), Tartu Univ Hosp, Dept Neurol, Childrens Clin, 6 Lunini St, EE-51014 Tartu, Estonia.	inga.talvik@kliinikum.ee					Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 1999, DEV MED CHILD NEUROL, V41, P220, DOI 10.1017/S0012162299000481; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; FISCHER H, 1994, CLIN PEDIATR, V33, P696, DOI 10.1177/000992289403301113; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Han D P, 1990, J Pediatr Ophthalmol Strabismus, V27, P299; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; KAUFMAN AS, 1983, ADM SCORING MANUAL; KAUFMAN AS, 1983, INTERPRETATIVE MANUA; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Lichtenberger EO, 2001, CA CH AD PS, P97; Lucke T, 2005, ACTA PAEDIATR, V94, P1330, DOI 10.1080/08035250510028632; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Prasad MR, 2005, ARCH DIS CHILD, V90, P82, DOI 10.1136/adc.2003.045583; Sabbadini M, 2001, J INTELL DISABIL RES, V45, P169, DOI 10.1046/j.1365-2788.2001.00301.x; Sattler J.M., 2001, ASSESSMENT CHILDREN; Schermann L, 2004, ACTA PAEDIATR, V93, P1619, DOI 10.1080/08035250410023386; Swenson J, 1997, Minn Med, V80, P41; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; Wechsler D, 1989, MANUAL WECHSLER PRES; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037	31	17	17	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	AUG	2007	96	8					1164	1168		10.1111/j.1651-2227.2007.00362.x			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	193OD	WOS:000248282500014	17578492				2022-02-06	
J	Johnson, JB; Malone, SD				Johnson, Jeffrey B.; Malone, Stephen D.			Ground-coupled acoustic airwaves from Mount St. Helens provide constraints on the May 18, 1980 eruption	EARTH AND PLANETARY SCIENCE LETTERS			English	Article						acoustic airwaves; ground-coupled seismicity; Mount St. Helens	WAVES; PROPAGATION; INFRASOUND; ATMOSPHERE; SATELLITE; VOLCANO; MIDDLE; WINDS; MODEL	The May 18, 1980 Mount St. Helens eruption perturbed the atmosphere and generated atmosphere-to-ground coupled airwaves, which were recorded on at least 35 seismometers operated by the Pacific Northwest Seismograph Network (PNSN). From 102 distinct travel time picks we identify coherent airwaves crossing Washington State primarily to the north and east of the volcano. The travel time curves provide evidence for both stratospheric refractions (at 200 to 300 kin from the volcano) as well as probable thermospheric refractions (at 100 to 350 kin). The very few first-hand reports of audible volcano sounds within about 80 kin of the volcano coincide with a general absence of ground-coupled acoustic arrivals registered within about 100 kin and are attributed to upward refraction of sound waves. From the coherent refracted airwave arrivals, we identify at least four distinct sources which we infer to originate 10 s, 114 s, similar to 180 s and 319 s after the onset of an 8:32: 11 PDT landslide. The first of these sources is attributed to resultant depressurization and explosion of the cryptodome. Most of the subsequent arrivals also appear to be coincident with a source located at or near the presumed volcanic conduit, but at least one of the later arrivals suggests an epicenter displaced about 9 km to the northwest of the vent. This dislocation is compatible with the direction of the sector collapse and lateral blast. We speculate that this concussion corresponds to a northern explosion event associated with hot cryptodome entering the Toutle River Valley. (C) 2007 Elsevier B.V. All rights reserved.	New Mexico Inst Min & Technol, Dept Earth & Environm Sci, Socorro, NM 87801 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA		Johnson, JB (corresponding author), New Mexico Inst Min & Technol, Dept Earth & Environm Sci, Socorro, NM 87801 USA.	jeff.johnson@unh.edu; steve@ess.washington.edu					Aki K., 1980, QUANTITATIVE SEISMOL, V1; Baker W.E., 1973, EXPLOSIONS AIR; BANISTER JR, 1984, J GEOPHYS RES-ATMOS, V89, P4895, DOI 10.1029/JD089iD03p04895; BATH M, 1982, EOS T AGU, V63, P193; Bolt B. A., 1981, EOS Transactions of the American Geophysical Union, V62, P529; Brodsky EE, 1999, J GEOPHYS RES-SOL EA, V104, P29387, DOI 10.1029/1999JB900308; DONN WL, 1981, SCIENCE, V213, P539, DOI 10.1126/science.213.4507.539; Drob DP, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003307; FAIRFIELD C, 1980, OREGON GEOL, V42, P200; FLEMING EL, 1988, 100697 NAT AER SPAC; Ford RD, 1970, INTRO ACOUSTICS; Garces M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020696; Garces MA, 1998, GEOPHYS RES LETT, V25, P2293, DOI 10.1029/98GL01511; GEORGES TM, 1977, J ACOUST SOC AM, V61, P28, DOI 10.1121/1.381263; GEORGES TM, 1971, 212WPL16 NAT OC ATM; HEDIN AE, 1987, J GEOPHYS RES, V92, P4649, DOI 10.1029/JA092iA05p04649; HEDIN AE, 1991, J GEOPHYS RES-SPACE, V96, P7657, DOI 10.1029/91JA00251; HEDIN AE, 1991, J GEOPHYS RES-SPACE, V96, P1159, DOI 10.1029/90JA02125; Hoblitt RP, 2000, PHILOS T ROY SOC A, V358, P1639, DOI 10.1098/rsta.2000.0608; HOLASEK RE, 1995, J GEOPHYS RES-SOL EA, V100, P8469, DOI 10.1029/94JB03137; KANAMORI H, 1982, J GEOPHYS RES, V87, P5422, DOI 10.1029/JB087iB07p05422; KANAMORI H, 1984, J GEOPHYS RES, V89; Kitov IO, 1997, B SEISMOL SOC AM, V87, P1553; Le Pichon A, 2002, J ACOUST SOC AM, V111, P629, DOI 10.1121/1.1404434; Lipman P. W., 1981, 1980 ERUPTIONS MOUNT; MALONE SD, 1981, US GEOL SURV PROF PA, V1250, P803; MOORE JG, 1984, CHRONOLOGY CHARACTER, P133; POWER J, 1993, ALASKA VOLCANO OBSER, V5, P14; Raspet R, 1998, HANDBOOK OF ACOUSTICS, P293; REED JW, 1987, J GEOPHYS RES-ATMOS, V92, P11979, DOI 10.1029/JD092iD10p11979; REES DE, 1986, ADV SPACE RES, V8; RITSEMA AR, 1980, EOS T AGU, V61, P1201; ROSENBAUM JG, 1981, US GEOLOGICAL SURVEY, V1250, P53; Rowe CA, 2000, J VOLCANOL GEOTH RES, V101, P105, DOI 10.1016/S0377-0273(00)00170-0; SCOTT E, 2003, EOS T AGU S, V84; SPARKS RSJ, 1986, J VOLCANOL GEOTH RES, V28, P257, DOI 10.1016/0377-0273(86)90026-0; Sutherland LC, 2004, J ACOUST SOC AM, V115, P1012, DOI 10.1121/1.1631937; SYMONS G, 1988, ERUPTION KRAKATAU SU; Tahira M, 1996, FIRE AND MUD, P601; VOIGHT B, 1981, US GEOL SURV PROF PA, V1250, P69	40	17	17	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0012-821X	1385-013X		EARTH PLANET SC LETT	Earth Planet. Sci. Lett.	JUN 15	2007	258	1-2					16	31		10.1016/j.epsl.2007.03.001			16	Geochemistry & Geophysics	Science Citation Index Expanded (SCI-EXPANDED)	Geochemistry & Geophysics	187DR	WOS:000247828000002					2022-02-06	
J	Dhandapani, SS; Manju, D; Sharma, BS; Mahapatra, AK				Dhandapani, S. S.; Manju, D.; Sharma, B. S.; Mahapatra, A. K.			Clinical malnutrition in severe traumatic brain injury: Factors associated and outcome at 6 months	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Brain injury; clinical features; malnutrition; outcome		Traumatic brain injury increases the metabolic response of body, and therefore nutritional demands. This study was undertaken to evaluate various clinical features of malnutrition in TBI and their influence on neurological outcome. Eighty eight adult patients within 24 hours of TBI admitted with GCS 4 to 8 without serious systemic disorder were enrolled for the study. They were monitored serially for various clinical features of malnutrition till 3 weeks and outcome assessed at 6 months. Every week there was a significant increase in number of patients with various clinical features of malnutrition. Pedal edema was the most frequent sign present in 70% of patients at three weeks, followed by skeletal prominence (19%) and cheilosis (12%). Clinical malnutrition showed significant association with poorer GCS ( p=0.03), admission hypoproteinemia (p=0.03), and delayed full enteral feeding (p< 0.001). Unfavorable outcome at 6 months was noted in 30 out of 37 patients who had clinical malnutrition as compared to 3 out of 15 patients who had no clinical features of malnutrition (odds ratio 17.2, p< 0.001). In multivariate analysis, clinical malnutrition was significantly associated with unfavorable outcome independent of GCS (p=0.002). Analysis of individual clinical markers revealed pedal edema as the only single clinical marker with significant influence on unfavorable outcome at 6 months (p=0.01). Clinical malnutrition developed more among patients with poorer GCS, admission hypoproteinemia, delayed full enteral feeding, and was associated with unfavorable outcome at 6 months. Among the various clinical markers, only pedal edema showed independent association with unfavorable outcome.	[Dhandapani, S. S.; Sharma, B. S.; Mahapatra, A. K.] AIIMS, Dept Neurosurg, Ansari Nagar, New Delhi 110029, India; [Manju, D.] AIIMS, Dept Neuronursing, New Delhi, India		Dhandapani, SS (corresponding author), AIIMS, Dept Neurosurg, Ansari Nagar, New Delhi 110029, India.		Dhandapani, Sivashanmugam/I-2395-2013	Dhandapani, Sivashanmugam/0000-0002-3497-4255; Dhandapani, Manju/0000-0003-3351-3841			CHRISTAKIS G, 1979, J FLA MED ASSOC, V66, P349; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; DEUTSCHMAN CS, 1986, J NEUROSURG, V64, P89, DOI 10.3171/jns.1986.64.1.0089; GADISSEUX P, 1984, J NEUROSURG, V60, P219, DOI 10.3171/jns.1984.60.2.0219; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Henry JB, 2001, CLIN DIAGNOSIS MANAG, P249; Hopkins B., 1993, NUTR SUPPORT DIETETI, V2nd ed., P15; JENNETT B, 1975, LANCET, V1, P480; MCCLAIN CJ, 1988, J NEUROSURG, V69, P386, DOI 10.3171/jns.1988.69.3.0386; Mitchell MK, 2003, NUTR LIFE SPAN, P44; PHILLIPS R, 1987, J NEUROSURG, V67, P846, DOI 10.3171/jns.1987.67.6.0846; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; ROBERTSON CS, 1988, J TRAUMA, V28, P1523, DOI 10.1097/00005373-198811000-00002; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; TEASDALE G, 1974, LANCET, V2, P81; Wilson RF, 2001, NEUROL RES, V23, P121, DOI 10.1179/016164101101198451; Yanagawa T, 2002, COCHRANE DB SYST REV, V3, DOI 10.1002/14651858.CD001530; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; Young B, METABOLIC NUTR SEQUE	19	17	17	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2007	4	1					35	39		10.1016/S0973-0508(07)80009-8			5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3L8O	WOS:000218373700008					2022-02-06	
J	Hebb, MO; Clarke, DB; Tallon, JM				Hebb, Matthew O.; Clarke, David B.; Tallon, John M.			Development of a provincial guideline for the acute assessment and management of adult and pediatric patients with head injuries	CANADIAN JOURNAL OF SURGERY			English	Article							ACUTE SUBDURAL-HEMATOMA; GLASGOW COMA SCALE; INTRACRANIAL INJURY; COMPUTED-TOMOGRAPHY; BRAIN-INJURIES; IMPAIRED CONSCIOUSNESS; NEUROLOGIC EXAMINATION; CLINICAL INDICATORS; EPIDURAL HEMATOMAS; SKULL RADIOGRAPHY	Background: Regionalized approaches to trauma care improve patient outcomes. We developed and distributed a clinical reference poster to standardize the emergency department evaluation and management of patients with traumatic head injuries in hospitals throughout Nova Scotia. Methods: We conducted a MEDLINE literature search to identify publications in the fields of prehospital and emergency management of head injuries. We reviewed and collated select studies to define contemporary standards of care. Results: We derived a 3-tiered decision tool that summarizes the indications for resuscitation, radiography, specialty consultation and transfer of adult and pediatric patients with minor and major head injuries. A guideline poster was constructed and distributed to all provincial emergency departments upon approval by local trauma and critical care staff. Conclusions: This report describes the evidence for a population-based, province-wide assessment and early management tool that was developed for health care personnel who treat patients with head traumas. Comparison of outcome data from pre- and postguideline eras will ultimately shed light on the use of regionalized approaches to managing brain injuries.	Dalhousie Univ, Dept Surg, Div Neurosurg, Halifax, NS B3H 3J5, Canada; Dalhousie Univ, Dept Emergency Med, Halifax, NS B3H 3J5, Canada		Clarke, DB (corresponding author), QEII Hlth Sci Ctr, Div Neurosurg, 1796 Summer St,Rm 3807, Halifax, NS B3H 3A7, Canada.	d.clarke@dal.ca					ACKROYDSOLARZ S, 2002, COMPREHENSIVE REPORT; Barss P., 1998, INJURY PREVENTION IN; BAZZOLI GJ, 1995, JAMA-J AM MED ASSOC, V273, P395; Bergman DA, 1999, PEDIATRICS, V104, P1407; BISHOP M, 1991, AM SURGEON, V57, P737; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; BRAAKMAN R, 1977, CLIN NEUROL NEUROSUR, V80, P104; Cheung DS, 1999, EMERG MED CLIN N AM, V17, P9, DOI 10.1016/S0733-8627(05)70044-4; *COLL SURG COMM TR, 1997, ADV TRAUM LIF SUPP D; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dillman DA, 1978, MAIL TELEPHONE SURVE, V19; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Fielding K, 1990, Aust J Adv Nurs, V7, P13; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Gwinnutt CL, 2001, RESUSCITATION, V48, P17, DOI 10.1016/S0300-9572(00)00314-2; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HILLS MW, 1993, J TRAUMA, V34, P549, DOI 10.1097/00005373-199304000-00011; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Iverson GL, 2000, BRAIN INJURY, V14, P1057; JERET JS, 1993, J TRAUMA, V35, P490, DOI 10.1097/00005373-199309000-00030; *JOINT TASK FORC A, 1993, APLS PED EM MED COUR; KLEINMAN PK, 1992, J PEDIATR-US, V121, P737, DOI 10.1016/S0022-3476(05)81904-3; KRAUS JF, 1987, PEDIATRICS, V79, P501; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Lee JS, 2003, ACAD EMERG MED, V10, P1128, DOI 10.1197/S1069-6563(03)00372-5; LEONIDAS JC, 1982, PEDIATRICS, V69, P139; LIU M, 1988, CRIT CARE MED, V16, P1191, DOI 10.1097/00003246-198812000-00004; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Meyer P, 1999, CHILD NERV SYST, V15, P732, DOI 10.1007/s003810050462; MICHAEL D B, 1989, Journal of Neurotrauma, V6, P177; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MORAN SG, 1994, AM SURGEON, V60, P533; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Osmond MH, 2002, J TRAUMA, V52, P8, DOI 10.1097/00005373-200201000-00004; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Pickett W, 2001, CAN MED ASSOC J, V165, P288; PIETRZAK M, 1991, AM J EMERG MED, V9, P153, DOI 10.1016/0735-6757(91)90179-N; Quayle KS, 1999, PEDIATR CLIN N AM, V46, P1189, DOI 10.1016/S0031-3955(05)70182-6; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Rivara FP, 1997, NEW ENGL J MED, V337, P543, DOI 10.1056/NEJM199708213370807; Rivara FP, 1997, NEW ENGL J MED, V337, P613, DOI 10.1056/NEJM199708283370907; ROS SP, 1992, PEDIATR EMERG CARE, V8, P328, DOI 10.1097/00006565-199212000-00005; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; Ruchholtz S, 1998, INJURY, V29, P115, DOI 10.1016/S0020-1383(97)00150-2; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; Savitsky EA, 2000, AM J EMERG MED, V18, P96, DOI 10.1016/S0735-6757(00)90060-3; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; Shane SA, 1997, PEDIATR EMERG CARE, V13, P198, DOI 10.1097/00006565-199706000-00006; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; SNOEY ER, 1994, ANN EMERG MED, V23, P1127, DOI 10.1016/S0196-0644(94)70115-6; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; STEIN SC, 1993, NEUROSURGERY, V33, P339; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; TEASDALE G, 1974, LANCET, V2, P81; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Woolard Deborah J., 1994, Journal of Emergency Medicine, V12, P453, DOI 10.1016/0736-4679(94)90339-5; [No title captured]	91	17	17	0	4	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0008-428X	1488-2310		CAN J SURG	Can. J. Surg.	JUN	2007	50	3					187	194					8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	173AC	WOS:000246844900006	17568490				2022-02-06	
J	Hornero, R; Aboy, M; Abasolo, D				Hornero, Roberto; Aboy, Mateo; Abasolo, Daniel			Analysis of intracranial pressure during acute intracranial hypertension using Lempel-Ziv complexity: further evidence	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						Lempel-Ziv complexity; intracranial hypertension; intracranial pressure irregularity; approximate entropy; traumatic brain injury	WAVE-FORM; APPROXIMATE ENTROPY; HEAD-INJURY; INFORMATION	We analyzed intracranial pressure (ICP) signals during periods of acute intracranial hypertension (ICH) using the Lempel-Ziv (LZ) complexity measure. Our results indicate the LZ complexity of ICP decreases during periods of ICH. The mean LZ complexity before ICH was 0.20 +/- 0.04, while the mean LZ complexity during ICH was 0.16 +/- 0.03 (p < 0.05). The mean decrease of the LZ complexity values during the ICH episodes was 19.5%. Additionally, we present preliminary evidence suggesting that periods of ICH may be detectable from non-invasive signals coupled with ICP, such as pulse oximetry (SpO(2)).	Univ Valladolid, ETS Ingn Telecomun, Biomed Engn Grp, E-47011 Valladolid, Spain; Oregon Inst Technol, Elect Engn Technol Dept, Portland, OR USA		Hornero, R (corresponding author), Univ Valladolid, ETS Ingn Telecomun, Biomed Engn Grp, Camino Cementerio S-N, E-47011 Valladolid, Spain.	robhor@tel.uva.es	Hornero, Roberto/M-5313-2019; Hornero, Roberto/B-5398-2008; Aboy, Mateo/K-4060-2019; Abasolo, Daniel/B-7322-2009	Hornero, Roberto/0000-0001-9915-2570; Hornero, Roberto/0000-0001-9915-2570; Abasolo, Daniel/0000-0002-4268-2885; Aboy, Mateo/0000-0002-5168-4321			Aboy M, 2006, IEEE T BIO-MED ENG, V53, P2282, DOI 10.1109/TBME.2006.883696; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; CONTANT CF, 1995, J NEUROSCI METH, V57, P15, DOI 10.1016/0165-0270(94)00106-Q; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; GOLDSTEIN B, 2004, CURRENT CONCEPTS PED, P201; Hornero R, 2006, CRIT CARE MED, V34, P87, DOI 10.1097/01.CCM.0000190426.44782.F0; Hornero R, 2005, IEEE T BIO-MED ENG, V52, P1671, DOI 10.1109/TBME.2005.855722; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Luerssen T G, 1997, Semin Pediatr Neurol, V4, P146, DOI 10.1016/S1071-9091(97)80033-2; Nagarajan R, 2002, IEEE T BIO-MED ENG, V49, P1371, DOI 10.1109/TBME.2002.804582; PORTNOY HD, 1982, J NEUROSURG, V56, P666, DOI 10.3171/jns.1982.56.5.0666; Radhakrishnan N, 1998, IEEE ENG MED BIOL, V17, P89, DOI 10.1109/51.677174; Wu X., 1991, ACTA BIOPHYS SINICA, V7, P103; Xu JH, 1997, PHYSICA D, V106, P363, DOI 10.1016/S0167-2789(97)00042-0; Zhang XS, 1999, IEEE T BIO-MED ENG, V46, P548, DOI 10.1109/10.759055; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601	17	17	18	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	JUN	2007	45	6					617	620		10.1007/s11517-007-0194-x			4	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	178HN	WOS:000247211900012	17541667				2022-02-06	
J	Kerby, JD; Sainz, JG; Zhang, FY; Hutchings, A; Sprague, S; Farrokhi, FR; Son, M				Kerby, Jeffrey D.; Sainz, Jorge G.; Zhang, Fangyi; Hutchings, Anne; Sprague, Shane; Farrokhi, Farrokh R.; Son, Minnette			Resuscitation from hemorrhagic shock with HBOC-201 in the setting of traumatic brain injury	SHOCK			English	Article; Proceedings Paper	34th Critical Care Congress of the Society-of-Critical-Care-Medicine	2005	Phoenix, AZ	Soc Crit Care Med		hemoglobin-based oxygen carriers; rat model; controlled cortical impact injury	CEREBRAL PERFUSION-PRESSURE; CROSS-LINKED HEMOGLOBIN; CARRYING SOLUTION HBOC-201; LOW-VOLUME RESUSCITATION; HEAD-INJURY; OXYGEN CARRIER; MODEL; EPIDEMIOLOGY; HYPERCAPNIA; DISABILITY	Outcomes after mild or moderate head trauma are worsened with associated hypotension, and secondary brain injury can be reduced with timely resuscitation. This study was performed to investigate HBOC-201 as a resuscitation therapy in a combined hemorrhagic shock and brain injury model. Anesthetized rats sustained moderate brain injury using a controlled cortical impact device, followed by rapid hemorrhage to a mean arterial pressure of 30 mmHg. After 30 min of hypotension, animals were resuscitated with HBOC-201, autologous shed blood (SB), or lactated Ringer solution (LR). Brain injury was assessed by measurements of cerebral blood flow (CBF) and cerebral vasoreactivity to hypercapnia (CVH) using a laser Doppler flowmeter. Contusion volume was evaluated histologically, and cerebral edema was determined by total water content. The HBOC rats required significantly less resuscitation volume versus LR and SB. The CBF was significantly diminished at 60 min after resuscitation with HBOC (70.1% +/- 3.8% baseline) compared with LR (105.8% +/- 10.1% baseline; P < 0.01) and SB (96.8% +/- 5% baseline; P < 0.05). The CVH was preserved in the HBOC and SB groups. The CVH was significantly diminished compared with baseline in the LR group at 30 min after resuscitation and showed a significant loss compared with HBOC at 60 min after resuscitation. The contusion volume for HBOC (45.1 mm(3)) and SB (35.1 mm(3)) was less than LR (63.5 mm(3), P < 0.01). Although CBF was diminished after resuscitation in the HBOC group, HBOC-treated animals maintained CVH and experienced significantly smaller contusion volume than those treated with LR. These results suggest that resuscitation with HBOC-201 protects autoregulatory mechanisms and may reduce secondary brain injury in traumatic brain injury.	Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Surg Crit Care, Birmingham, AL 35294 USA; Univ Texas, Hlth Sci Ctr, Dept Pediat, Div Pediat Crit Care, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Neurol Surg, Houston, TX USA; Virginia Mason Med Ctr, Dept Neurosurg, Seattle, WA 98101 USA		Kerby, JD (corresponding author), Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Surg Crit Care, LHRB 112,701 19th St S, Birmingham, AL 35294 USA.	Jeffrey.Kerby@ccc.uab.edu		Kerby, Jeffrey/0000-0001-7368-1124			Arnoldo B D, 2001, Curr Opin Crit Care, V7, P431, DOI 10.1097/00075198-200112000-00010; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Chappell JE, 1996, J TRAUMA, V41, P781, DOI 10.1097/00005373-199611000-00003; Chappell JE, 1997, J NEUROSURG, V86, P131, DOI 10.3171/jns.1997.86.1.0131; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Fitzpatrick CM, 2004, J AM COLL SURGEONS, V199, P693, DOI 10.1016/j.jamcollsurg.2004.07.025; Iadecola C, 1996, AM J PHYSIOL-REG I, V271, pR990, DOI 10.1152/ajpregu.1996.271.4.R990; King DR, 2005, J TRAUMA, V59, P553, DOI 10.1097/01.ta.0000177711.52191.62; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee SK, 2002, ACAD EMERG MED, V9, P969; McNeil JD, 2001, J TRAUMA, V50, P1063, DOI 10.1097/00005373-200106000-00015; Moore EE, 2005, SHOCK, V24, P197, DOI 10.1097/01.shk.0000180075.76766.fe; Novak L, 1999, J TRAUMA, V47, P834, DOI 10.1097/00005373-199911000-00003; Ortegon DP, 2002, J TRAUMA, V53, P1068, DOI 10.1097/00005373-200212000-00007; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Piper IR, 1998, BRIT J ANAESTH, V80, P639, DOI 10.1093/bja/80.5.639; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sampson JB, 2003, J TRAUMA, V55, P747, DOI 10.1097/01.TA.0000084519.47163.77; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; Spahn DR, 2005, CURR PHARM DESIGN, V11, P4099, DOI 10.2174/138161205774913354; Tremper KK, 1997, J CARDIOTHOR VASC AN, V11, P1, DOI 10.1016/S1053-0770(97)90242-1; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; York GB, 2003, J TRAUMA, V55, P873, DOI 10.1097/01.TA.0000092681.17874.6F; ZHANG FG, 1992, J CEREBR BLOOD F MET, V12, P962, DOI 10.1038/jcbfm.1992.133; Zhang FY, 2002, J NEUROSURG, V97, P963, DOI 10.3171/jns.2002.97.4.0963	31	17	17	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2007	27	6					652	656		10.1097/01.shk.0000248584.10400.dc			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	173FS	WOS:000246859500010	17505305				2022-02-06	
J	Huang, SJ; Hong, WC; Han, YY; Chen, YS; Wen, CS; Tsan, YS; Tu, YK				Huang, Sheng-Jean; Hong, Wei-Chen; Han, Yin-Yi; Chen, Yuan-Sen; Wen, Chung-Shi; Tsan, Yi-Shin; Tu, Yong-Kwang			Clinical outcome of severe head injury in different protocol-driven therapies	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						severe head injury; protocol-driven therapy; intracranial hypertension; cerebral perfusion pressure	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; INTRACRANIAL-PRESSURE; TARGETED THERAPY; PILOT TRIAL; MANAGEMENT; CARE; MORTALITY; ISCHEMIA	In the past 5 years cerebral perfusion pressure (CPP) management has become mainstream in the treatment of severe head injuries. The American Association of Neurological Surgeons guidelines (2000) suggest that CPP should be maintained at least 70 mmHg; however, there is still debate about optimal CPP level. The purpose of this study is to evaluate the effectiveness of three widely used therapies: intracranial pressure (ICP)-targeted therapy, CPP-targeted therapy with CPP > 70 mmHg, and modified CPP-targeted therapy with CPP > 60 mmHg. The clinical procedures, complications, and patient outcomes are compared. Data including patient age, sex, initial Glasgow Coma Score (GCS), ICP, CPP, fluid status, amount of mannitol and vasopressor used, daily intake and output, complications, and clinical results were collected from 213 patients with severe head injuries over a 12-year period. Patients were categorized into three groups (ICP, CPP, modified CPP [mCPP]) according to treatment protocol used. Retrospective data collection was by chart review. The mortality rate was 28.6%, 14.3%, and 13.5% in groups ICP, CPP, and mCPP, respectively. Highest intake/output ratio, amount of vasopressor used, and pulmonary complication rates were seen in group CPP patients. Group mCPP patients showed the best clinical outcome and lowest complication rate. Though CPP-targeted therapy is the most recommended therapeutic protocol, our data showed that the outcome is as good in the mCPP-targeted group with CPP > 60 mmHg as in the CPP-targeted group, but complications are fewer in the mCPP group. (C) 2006 Elsevier Ltd. All rights reserved.	Natl Taiwan Univ, Div Neurosurg, Coll Med & Hosp, Taipei, Taiwan; Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan		Tu, YK (corresponding author), Natl Taiwan Univ, Div Neurosurg, Coll Med & Hosp, 7 Chung Shan S Rd, Taipei, Taiwan.	yktu@ha.mc.iitu.edu.tw		Tu, Yong-kwang/0000-0003-2113-1176; HAN, YIN-YI/0000-0001-8831-7835			*AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P493; *AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P559; BERNARD GR, 1994, J CRIT CARE, V9, P72, DOI 10.1016/0883-9441(94)90033-7; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; JENNETT B, 1975, LANCET, V1, P480; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Klein D G, 1999, Crit Care Nurs Clin North Am, V11, P209; Macmillan CSA, 2001, J NEUROL NEUROSUR PS, V70, P101, DOI 10.1136/jnnp.70.1.101; MAPSTONE TB, 1996, CONT NEUROSURG, V18, P1; Marion DW, 1997, CONT NEUROSURG, V19, P1; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1990, ADV BRAIN RESUSCITAT, P315; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Prabhakaran P, 2004, J NEUROSURG, V100, P454, DOI 10.3171/ped.2004.100.5.0454; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; TEASDALE G, 1974, LANCET, V2, P81; The Brain Trauma Foundation; The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P479	35	17	17	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2007	14	5					449	454		10.1016/j.jocn.2005.12.012			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	165ZR	WOS:000246346900009	17336527				2022-02-06	
J	Llompart-Pou, JA; Perez-Barcena, I; Raurich, JM; Burguera, B; Ayestaran, JI; Abadal, JM; Homar, J; Ibanez, J				Llompart-Pou, J. A.; Perez-Barcena, I.; Raurich, Ji. M.; Burguera, B.; Ayestaran, J. I.; Abadal, J. M.; Homar, J.; Ibanez, J.			Effect of barbiturate coma on adrenal response in patients with traumatic brain injury	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						traumatic brain injury; barbiturate coma; adrenal insufficiency; hypotension; corticosteroids	ADRENOCORTICOTROPIC HORMONE; INTENSIVE-CARE; HEAD-INJURY; HYPOPITUITARISM; CORTISOL; HYDROCORTISONE; INSUFFICIENCY	Introduction: Barbiturate coma is the second tier measure recommended by guidelines to treat post-traumatic refractory intracranial pressure. Systemic hypotension is its most important side effect. Recent evidence suggests that low-dose corticosteroid therapy may be used in a subset of patients with traumatic brain injury (TBI) to avoid hypotension. We evaluated adrenal function in TBI patients undergoing barbiturate coma, as treatment of their refractory intracranial hypertension. Materials and methods: We prospectively studied 40 patients with moderate to severe TBI. Group A (17 patients) were treated with barbiturate coma. Group B (23 patients) presented intracranial hypertension controlled with first tier measures, and acted as a control. Adrenal function was evaluated by using the high-dose corticotropin stimulation test within 24 h after brain injury and after barbiturate coma induction. Results: Within 24 h after TBI, adrenal function was similar in both groups. Once barbiturate coma was induced, patients in group A treated with barbiturate coma presented a higher incidence of adrenal insufficiency compared with the control group B (53% vs 22%, p=0.03). Patients treated with barbiturates, who developed adrenal impairment, required higher doses of norepinephrine to maintain cerebral perfusion pressure than patients treated with barbiturates without adrenal impairment (1.07 +/- 1.04 mu g/kg/min vs 0.31 +/- 0.32 mu g/kg/min, p=0.03). Conclusions: Patients with TBI treated with barbiturate coma are at higher risk of developing adrenal insufficiency. This subset of patients presented higher requirements of vasoactive support to avoid hypotension. In these patients corticosteroid therapy may have potential therapeutic implications to treat hemodynamic instability.	Hosp Univ Son Dureta, Serv Med Intens, Palma de Mallorca, Spain; Autonomous Univ Barcelona, Dept Surg, Barcelona, Spain; Hosp Univ Son Dureta, Serv Endocrinol, Palma de Mallorca, Spain		Llompart-Pou, JA (corresponding author), Hosp Univ Son Dureta, Serv Med Intens, Palma de Mallorca, Spain.	jallompart@hsd.es					Absalom A, 1999, ANAESTHESIA, V54, P861; Agha Amar, 2005, Am J Med, V118, P1416; Annane D, 2005, CRIT CARE MED, V33, P2688, DOI 10.1097/01.CCM.0000186887.21494.4A; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; BESSE JC, 1966, J PHARMACOL EXP THER, V154, P224; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Brain Trauma Foundation The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P527; Broadbear JH, 2005, PSYCHOPHARMACOLOGY, V178, P83, DOI 10.1007/s00213-004-1986-4; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; DeLong WG, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000130840.64528.1e; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Edwards P, 2005, LANCET, V365, P1957; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Illera JC, 2000, J PHYSIOL BIOCHEM, V56, P329, DOI 10.1007/BF03179801; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; LLOMPARTPOU JA, IN PRESS J TRAUMA; Marsden J.E., 1991, NONLINEAR SCI TODAY, V1, P4; Perez-Barcena J, 2005, NEUROCIRUGIA, V16, P5; PEREZBARCENA J, 2002, MED INTENSIVA, V26, P407; Putignano P, 1998, HORM METAB RES, V30, P389, DOI 10.1055/s-2007-978903; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; TEASDALE G, 1974, LANCET, V2, P81; TOSO CFR, 1993, CAN J ANAESTH, V40, P1084, DOI 10.1007/BF03009482; WHITEHOUSE BJ, 1993, J ENDOCRINOL, V136, P75, DOI 10.1677/joe.0.1360075	32	17	17	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1720-8386			J ENDOCRINOL INVEST	J. Endocrinol. Invest.	MAY	2007	30	5					393	398		10.1007/BF03346316			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	190MT	WOS:000248063800008	17598971				2022-02-06	
J	Meffre, D; Delespierre, B; Gouezou, M; Schumacher, M; Stein, DG; Guennoun, R				Meffre, Delphine; Delespierre, Brigitte; Gouezou, Monique; Schumacher, Michael; Stein, Donald G.; Guennoun, Rachida			3 beta-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase mRNA expression in rat brain: Effect of pseudopregnancy and traumatic brain injury	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article; Proceedings Paper	17th International Symposium of the Journal-of-Steroid-Biochemistry-and-Molecular-Biology	MAY 31-JUN 03, 2006	Seefeld, AUSTRIA	Journal Steroid Biochem & Mol Biol		neurosteroids; 3 beta-hydroxysteroid dehydrogenase; brain; in sitiu hybridization; traumatic brain injury; progesterone	TISSUE-SPECIFIC EXPRESSION; CENTRAL-NERVOUS-SYSTEM; BINDING-PROTEIN 25-DX; IN-SITU HYBRIDIZATION; SPINAL-CORD; SCHWANN-CELLS; FEMALE RATS; PROGESTERONE NEUROPROTECTION; CORTICAL CONTUSION; MYELIN FORMATION	Evidence that endogenous progesterone (PROG) is neuroprotective after traumatic brain injury (TBI) is supported by the findings that pseudopregnant female rats present less edema and achieve better functional recovery than do male rats. PROG in the nervous system may originate from steroidogenic glands or can be locally synthesized. 3 beta-Hydroxysteroid dehydrogenase/5-ene-4-ene isomerase (3 beta-HSD) is the key enzyme in the biosynthesis of PROG. In the present study, we investigated the effects of pseudopregnancy and TBI on brain 3 beta-HSD mRNA expression and on PROG levels. Twenty-four hours after bilateral contusion of the medial prefrontal cortex of rats, 3 beta-HSD mRNA expression was analyzed by in situ hybridization while PROG levels were measured by gas chromatography/mass spectrometry. Similar levels of 3 beta-HSD mRNA expression were observed in males and pseudopregnant females in the non-injured groups. At this time point, there was a significant decrease in the 3 beta-HSD mRNA expression in the contusion site within the frontal cortex in both males and pseudopregnant females. In all other regions analyzed, 3 beta-HSD mRNA expression was not affected by TBI and there was no difference between males and pseudopregnant females. The high decrease in the expression of the 3 beta-HSD mRNA in the lesion site 24h after TBI suggests a possible decrease in locally synthesized PROG in lesion site without change in the other brain regions. This decrease has less impact in pseudopregnant females since they have high plasmatic and brain levels of PROG compared to males. (c) 2007 Elsevier Ltd. All rights reserved.	INSERM, UMT788, F-94276 Le Kremlin Bicetre, France; Univ Paris 11, Le Kremlin Bicetre, France; Emory Univ, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA		Guennoun, R (corresponding author), INSERM, UMT788, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France.	guennoun@kb.inserm.fr	Schumacher, Michael/G-3581-2013; Stein, Donald/AAJ-5139-2020; Guennoun, Rachida/F-2420-2011	Schumacher, Michael/0000-0001-6117-5371; Guennoun, Rachida/0000-0002-9219-7300; MEFFRE, Delphine/0000-0002-9204-2245	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [1R01N540825, 1R01N538664] Funding Source: Medline		ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; BAULIEU EE, 1991, BIOL CELL, V71, P3, DOI 10.1016/0248-4900(91)90045-O; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Beaudoin C, 1997, J ENDOCRINOL, V154, P379, DOI 10.1677/joe.0.1540379; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chan JR, 1998, P NATL ACAD SCI USA, V95, P10459, DOI 10.1073/pnas.95.18.10459; Coirini H, 2003, J NEUROCHEM, V84, P119, DOI 10.1046/j.1471-4159.2003.01512.x; Coirini H, 2002, NEUROSCIENCE, V113, P883, DOI 10.1016/S0306-4522(02)00224-5; CORPECHOT C, 1993, ENDOCRINOLOGY, V133, P1003, DOI 10.1210/en.133.3.1003; De Nicola AF, 2003, ANN NY ACAD SCI, V1007, P317, DOI 10.1196/annals.1286.030; Deniselle MCG, 2002, NEUROBIOL DIS, V11, P457, DOI 10.1006/nbdi.2002.0564; Donath J, 1997, J STEROID BIOCHEM, V62, P107, DOI 10.1016/S0960-0760(97)00012-5; DUPONT E, 1994, MOL CELL NEUROSCI, V5, P119, DOI 10.1006/mcne.1994.1014; Furukawa A, 1998, J NEUROCHEM, V71, P2231; GUENNOUN R, 1995, MOL BRAIN RES, V30, P287, DOI 10.1016/0169-328X(95)00016-L; Guennoun R, 1997, EUR J NEUROSCI, V9, P2236, DOI 10.1111/j.1460-9568.1997.tb01642.x; Hashimoto N, 2003, NEUROSCI LETT, V340, P45, DOI 10.1016/S0304-3940(03)00079-X; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; KAYNARD AH, 1992, ENDOCRINOLOGY, V130, P2192, DOI 10.1210/en.130.4.2192; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Labombarda F, 2002, J NEUROTRAUM, V19, P343, DOI 10.1089/089771502753594918; Labombarda F, 2000, J STEROID BIOCHEM, V73, P159, DOI 10.1016/S0960-0760(00)00064-9; LABRIE F, 1992, J STEROID BIOCHEM, V41, P421, DOI 10.1016/0960-0760(92)90368-S; LORENCE MC, 1991, MOL CELL ENDOCRINOL, V80, P21, DOI 10.1016/0303-7207(91)90139-J; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; RAIMONDI SG, 1989, J STEROID BIOCHEM, V32, P413, DOI 10.1016/0022-4731(89)90215-X; Robert F, 2001, EUR J NEUROSCI, V13, P916, DOI 10.1046/j.0953-816x.2001.01463.x; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; SANNE JL, 1995, J NEUROCHEM, V65, P528; Saredi S, 2005, NEUROSCIENCE, V135, P869, DOI 10.1016/j.neuroscience.2005.06.033; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; SIMARD J, 1993, J BIOL CHEM, V268, P19659; Soma KK, 2005, ENDOCRINOLOGY, V146, P4386, DOI 10.1210/en.2005-0569; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Tonetta S A, 1987, Adv Exp Med Biol, V219, P665; Vongher JM, 1999, PHARMACOL BIOCHEM BE, V64, P777, DOI 10.1016/S0091-3057(99)00140-9; Young J, 1996, STEROIDS, V61, P144, DOI 10.1016/0039-128X(95)00220-K; ZHAO HF, 1991, J BIOL CHEM, V266, P583; ZHAO HF, 1990, ENDOCRINOLOGY, V127, P3237, DOI 10.1210/endo-127-6-3237	50	17	17	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	MAY	2007	104	3-5					293	300		10.1016/j.jsbmb.2007.03.003			8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	191DL	WOS:000248110100028	17428656				2022-02-06	
J	Taber, KH; Hurley, RA				Taber, Katherine H.; Hurley, Robin A.			Traumatic axonal injury: Atlas of major pathways	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							BRAIN-INJURY; WHITE-MATTER; CORTICAL CONNECTIONS; STEREOTAXIC SPACE; TRACTOGRAPHY; MR; AFGHANISTAN; DISSECTION; TOPOGRAPHY; ANATOMY		Salisbury Vet Affairs Med Ctr, Vet Affairs Mid Atlantic Mental Illness Res Educ, Salisbury, NC USA; Salisbury Vet Affairs Med Ctr, Mental Hlth Serv Line, Salisbury, NC USA; Virginia VA Sch Osteopath Med, Div Biomed Sci, Blacksburg, VA USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Wake Forest Univ, Dept Psychiat, Winston Salem, NC 27109 USA; Wake Forest Univ, Dept Radiol, Winston Salem, NC 27109 USA; Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA		Hurley, RA (corresponding author), Hefner VA Med Ctr, 1601 Brenner Ave, Salisbury, NC 28144 USA.	Robin.Hurley@med.va.gov	Taber, Katherine H/B-8260-2011	Taber, Katherine H/0000-0001-7382-6151			Amunts K, 2004, NEUROIMAGE, V22, P42, DOI 10.1016/j.neuroimage.2003.12.031; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Aralasmak A, 2006, J COMPUT ASSIST TOMO, V30, P695, DOI 10.1097/01.rct.0000226397.43235.8b; Barkai G, 2004, PSYCHIAT RES-NEUROIM, V132, P279, DOI 10.1016/j.pscychresns.2004.09.004; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Gutierrez-Cadavid JE., 2005, IMAGING NERVOUS SYST, P869; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Kier EL, 2004, AM J NEURORADIOL, V25, P677; KURCA E, 2006, NEURORADIOLOGY  0620; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le TH, 2006, SEMIN ROENTGENOL, V41, P177, DOI 10.1053/j.ro.2006.04.003; MAKRIS N, 1985, CEREB CORTEX, V15, P854; Mori S, 2005, MRI ATLAS HUMAN WHIT; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; NOLTE J, 2002, HUMAN BRAIN; O'Donnell LJ, 2006, AM J NEURORADIOL, V27, P1032; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pavel D, 2006, BRAIN COGNITION, V60, P211; Schmahmann J.D., 2006, FIBER PATHWAYS BRAIN; SCHMAHMANN JD, 2007, BRAIN; Schwab KA, 2006, NEUROLOGY, V66, pA235; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Shin YB, 2006, BRAIN INJURY, V20, P661, DOI 10.1080/02699050600677071; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Uylings HBM, 2005, ANAT EMBRYOL, V210, P423, DOI 10.1007/s00429-005-0042-4; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Zarei M, 2007, J MAGN RESON IMAGING, V25, P48, DOI 10.1002/jmri.20810; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x	38	17	17	0	0	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	MAY	2007	19	2					100	104					5	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	156RH	WOS:000245666300001					2022-02-06	
J	Whelan, BM; Murdoch, BE; Bellamy, N				Whelan, Brooke-Mai; Murdoch, Bruce E.; Bellamy, Nicholas			Delineating communication impairments associated with mild traumatic brain injury: A case report	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						head injury; language deficits	CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; SUBCORTICAL PARTICIPATION; SUBTHALAMIC NUCLEUS; LANGUAGE FUNCTION; CHILDREN; MODELS; LONG; ADOLESCENTS; DOMINANT	Background: Mild traumatic brain injury (mTBI) without frank neurological disturbance has been linked to persistent physical, cognitive, and affective disturbances in some cases. The cognitive sequelae of this syndrome represent the most frequently studied symptoms, yet the legacy of such injuries on communicative functions remains largely undetermined. Methods: A detailed language profile of a 19-year-old woman, 1 year 10 months following mTBI is compared with a matched normative cohort of 10 participants with nonneurological impairment. Results: Deficits in attention, lexical access, complex lexical-semantic manipulation, response monitoring, and organization were revealed as a consequence of mTBI. Conclusions: This profile provides support for hypotheses pertaining to neuronal fallout mechanisms within the frontal lobes as a consequence of mild neurological insult.	Univ Queensland, Motor Speech & Neurogen Language Res Ctr, Div Speech Pathol, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Natl Res Disabil & Rehabil Med, Brisbane, Qld 4072, Australia		Whelan, BM (corresponding author), Univ Queensland, Motor Speech & Neurogen Language Res Ctr, Div Speech Pathol, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	bmw@uq.edu.au	Bellamy, Nicholas/G-3631-2010; Murdoch, Bruce E/C-1397-2012	Whelan, Brooke-Mai/0000-0002-7909-3160			Adamovich B. B., 1992, SCALES COGNITIVE ABI; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Azuma T, 1997, J MEM LANG, V36, P484, DOI 10.1006/jmla.1997.2502; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Copland DA, 2000, J MED SPEECH-LANG PA, V8, P1; CROSSON B, 1998, HDB NEUROLINGUISTICS, P431; Cudmore LJ, 2000, BRAIN COGNITION, V44, P86; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; GENNARELLI TA, 1982, ANN NEUROL, V12, P212; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1989, MILD HEAD INJURY, P153; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P369, DOI 10.1080/026990598122502; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Huisingh R, 1990, WORD TEST REVISED TE; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Kaplan E, 1983, BOSTON NAMING TEST; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Parker RS, 1996, NEUROPSYCHOL REV, V6, P135, DOI 10.1007/BF01874895; Ponsford J L, 1990, Brain Inj, V4, P111, DOI 10.3109/02699059009026156; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RUBENSTEIN H, 1970, VERBAL LEARNING VERB, V9, P484; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Spreen O., 1969, NEUROSENSORY CTR COM; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; VANORDEN GC, 1994, J EXP PSYCHOL HUMAN, V20, P1269, DOI 10.1037/0096-1523.20.6.1269; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Whelan BM, 2005, J NEUROLINGUIST, V18, P361, DOI 10.1016/j.jneuroling.2004.05.002; Whelan BM, 2005, NEUROCASE, V11, P93, DOI 10.1080/13554790590925501; Whelan BM, 2004, NEUROCASE, V10, P345, DOI 10.1080/13554790490893742; Whelan BM, 2004, MOVEMENT DISORD, V19, P1267, DOI 10.1002/mds.20252; Whelan BM, 2003, J NEUROL NEUROSUR PS, V74, P1543, DOI 10.1136/jnnp.74.11.1543; Whelan BM, 2002, APHASIOLOGY, V16, P1213, DOI 10.1080/02687030244000446; WHELAN BM, 2000, ASIA PACIFIC J SPEEC, V5, P93; Wiig E. H., 1989, TEST LANGUAGE COMPET; WIIG EH, 1974, PERCEPT MOTOR SKILL, V38, P171, DOI 10.2466/pms.1974.38.1.171; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YLVASAKER M, 1994, ED DIMENSIONS ACQUIR, P69	51	17	17	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2007	22	3					192	197		10.1097/01.HTR.0000271120.04405.db			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	174OH	WOS:000246951100006	17510595				2022-02-06	
J	Hobbs, CJ; Osman, J				Hobbs, C. J.; Osman, J.			Genital injuries in boys and abuse	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							SEXUAL-ABUSE; PREVALENCE	Aims: To describe a cohort of boys with genital injuries in whom child abuse was suspected. Methods: Boys with genital injury (penile and/or scrotal) and referred to paediatricians in Leeds, population 750 000, with concerns regarding possible abuse from 1983 to 2003 were identified from medical reports. Results: 86 boys (average age 62.7 months, median age 48 months) were referred between 1983 and 2003. The injury was judged inflicted in 63, unexplained, suspicious or inconsistent with the history given in 17 and accidental in six. The number of discrete injuries ranged from one in 57, two in 15, three in 12, to more than three in two cases. Genital injuries included burns in seven boys, bruises in 27, incised wounds, lacerations or scars in 39, and other traumatic lesions in 27. Non-genital findings included anal findings in 28,.10 bruises in 17, fractures in three, burns in 12, mouth injuries in four, brain and retinal haemorrhages in one, and poor nourishment or underweight in 14. The categories of abuse were physical (eight), sexual (19), both physical and sexual (eight), physical and neglect (four), and physical, sexual and neglect (one). The category of abuse was unspecified in 39 children. Conclusions: Genital injury in boys may be the result of abuse which may be physical or sexual in nature.	St James Univ Hosp, Dept Community Paediat, Leeds LS9 7TF, W Yorkshire, England; Hull Royal Infirm, Dept Accident & Emergency Med, Kingston Upon Hull HU3 2JZ, N Humberside, England		Hobbs, CJ (corresponding author), St James Univ Hosp, Dept Community Paediat, Leeds LS9 7TF, W Yorkshire, England.	chris.hobbs@leedsth.nhs.uk					FINKELHOR D, 1990, CHILD ABUSE NEGLECT, V14, P19, DOI 10.1016/0145-2134(90)90077-7; FINKELHOR D, 1995, JAMA-J AM MED ASSOC, V274, P1692, DOI 10.1001/jama.274.21.1692; Finkelhor D., 1984, CHILD SEXUAL ABUSE N, P150; Heger A, 2002, CHILD ABUSE NEGLECT, V26, P645, DOI 10.1016/S0145-2134(02)00339-3; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; HOBBS CJ, 1987, LANCET, V2, P837; HOBBS CJ, 1989, CHILD ABUSE NEGLECT, V13, P195, DOI 10.1016/0145-2134(89)90006-9; HOBBS CJ, 1986, LANCET, V2, P792; Holmes WC, 1998, JAMA-J AM MED ASSOC, V280, P1855, DOI 10.1001/jama.280.21.1855; REINHART MA, 1987, CHILD ABUSE NEGLECT, V11, P229, DOI 10.1016/0145-2134(87)90062-7; Royal College of Physicians, 1997, PHYS SIGNS SEX AB CH; SPENCER MJ, 1986, PEDIATRICS, V78, P133	12	17	17	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888			ARCH DIS CHILD	Arch. Dis. Child.	APR	2007	92	4					328	331		10.1136/adc.2006.111195			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	148VD	WOS:000245103800012	17376938	Green Published			2022-02-06	
J	Kapsalaki, EZ; Machinis, TG; Robinson, JS; Newman, B; Grigorian, AA; Fountas, KN				Kapsalaki, E. Z.; Machinis, T. G.; Robinson, J. S., III; Newman, B.; Grigorian, A. A.; Fountas, K. N.			Spontaneous resolution of acute cranial subdural hematomas	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						acute; redistribution; spontaneous resolution; subdural hematoma; cranial; MRI	RAPID SPONTANEOUS RESOLUTION; HEAD-INJURY; SURGICAL-TREATMENT; REDISTRIBUTION; MINUTES; ADULTS	Acute cranial subdural hematoma (SDH) represents a common consequence of traumatic brain injury. The vast majority of acute SDHs larger than 10 mm in thickness require immediate surgical evacuation. In rare occasions, however, spontaneous resolution may occur. In our current communication, we present four cases of spontaneous resolution of acute cranial SDH. Further more, the proposed theories explaining spontaneous resolution of acute SDH, as well as, clinical parameters and imaging characteristics that might predict such phenomenon, are also reviewed. The possibility of spontaneous resolution of an acute SDH, although remote, may impact the decision making process regarding the management of these patients under certain conditions. (c) 2006 Elsevier B.V. All rights reserved.	Mercer Univ, Sch Med, Med Ctr Cent Georgia, Dept Neuroradiol, Macon, GA 31207 USA; Mercer Univ, Sch Med, Med Ctr Cent Georgia, Dept Neurosurg, Macon, GA 31207 USA		Fountas, KN (corresponding author), 840 Pine St,Suite 880, Macon, GA 31201 USA.	knfountasmd@excite.com					ABE T, 1999, NO SHINKEI GEKA J, V8, P675; Ahn ES, 2005, J NEUROSURG, V103, P175, DOI 10.3171/ped.2005.103.2.0175; ALDRICH EF, 1993, BRAIN SURG COMPLICAT, P1283; AOKI N, 1990, ACTA NEUROCHIR, V103, P76, DOI 10.1007/BF01420196; ARAI H, 1990, SHONI NO NO SHINKEI, V15, P155; Bortolotti C, 2004, J NEUROSURG, V100, P372, DOI 10.3171/spi.2004.100.4.0372; *BRAIN TRAUM FDN A, 2001, MANAGEMENT PROGNOSIS, P47; Cohen JE, 1998, SURG NEUROL, V50, P241, DOI 10.1016/S0090-3019(97)00026-8; Edwards RJ, 2002, BRIT J NEUROSURG, V16, P609; FUJIOKA S, 1990, Neurologia Medico-Chirurgica, V30, P827, DOI 10.2176/nmc.30.827; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; HORIMOTO C, 1993, NIHON KYUKYU IGOKUKO, V17, P854; Inamasu J, 2002, AM J EMERG MED, V20, P376, DOI 10.1053/ajem.2002.33955; Izumihara A, 1997, NEUROL SURG TOKYO, V25, P307; Joki Tatsuhiro, 1992, Neurological Surgery, V20, P915; Kato N, 2001, NEUROL MED-CHIR, V41, P140, DOI 10.2176/nmc.41.140; Kelly DF, 1996, NEUROLOGICAL SURG, P1618; KOBRINE AI, 1977, J NEUROSURG, V46, P256, DOI 10.3171/jns.1977.46.2.0256; Kundra SN, 2005, NEUROL INDIA, V53, P124, DOI 10.4103/0028-3886.15083; KUROIWA T, 1993, J NEUROSURG, V78, P126, DOI 10.3171/jns.1993.78.1.0126; KURTI X, 1982, ACTA NEUROCHIR, V62, P87, DOI 10.1007/BF01402213; LOU XH, 2000, CHIN J TRAUMATOL, V16, P526; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MAKIYAMA Y, 1985, Nihon University Journal of Medicine, V27, P123; MATSUYAMA T, 1997, SURG NEUROL, V50, P289; Miller JD, 1992, NEUROSURG QUART, V2, P28; Mirzai H, 2005, J NEUROL NEUROSUR PS, V76, P1738, DOI 10.1136/jnnp.2005.067579; NAGAO T, 1986, NEUROSURGERY, V19, P465, DOI 10.1227/00006123-198609000-00024; NICHOLAS DS, 1988, J NEUROSURG, V69, P276, DOI 10.3171/jns.1988.69.2.0276; Niikawa S, 1989, Neurol Med Chir (Tokyo), V29, P820, DOI 10.2176/nmc.29.820; POLMAN CH, 1986, NEUROSURGERY, V19, P446, DOI 10.1227/00006123-198609000-00019; Reina MA, 2002, ANESTH ANALG, V94, P991; ROCKSWOLD GL, 1993, ANN EMERG MED, V22, P1004, DOI 10.1016/S0196-0644(05)82742-8; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Suzuki Y, 1998, NEUROL SURG TOKYO, V26, P1025; Tsui EYK, 2000, EUR J RADIOL, V36, P53, DOI 10.1016/S0720-048X(99)00167-9; Voelker JL, 2000, NEUROSURG CLIN N AM, V11, P507, DOI 10.1016/S1042-3680(18)30115-3; WAGA S, 1979, SURG NEUROL, V11, P191; WHALLEY N, 1948, LANCET, V254, P213; Wu Ming-can, 2004, Chin J Traumatol, V7, P96; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830	41	17	19	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	APR	2007	109	3					287	291		10.1016/j.clineuro.2006.11.005			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	146TG	WOS:000244957000013	17182174				2022-02-06	
J	Haelewyn, B; Freret, T; Pacary, E; Schumann-Bard, P; Boulouard, M; Bernaudin, M; Bouet, V				Haelewyn, Benoit; Freret, Thomas; Pacary, Emilie; Schumann-Bard, Pascale; Boulouard, Michel; Bernaudin, Myriam; Bouet, Valentine			Long-term evaluation of sensorimotor and mnesic behaviour following striatal NMDA-induced unilateral excitotoxic lesion in the mouse	BEHAVIOURAL BRAIN RESEARCH			English	Article						excitotoxicity; stereotaxy; behaviour; mice; striatum; NMDA; sham surgery	FOCAL CEREBRAL-ISCHEMIA; CAUDATE-PUTAMEN LESIONS; TRAUMATIC BRAIN-INJURY; QUINOLINIC ACID LESION; CORTICAL CELL-CULTURE; HUNTINGTONS-DISEASE; WATER-MAZE; MITOCHONDRIAL DYSFUNCTION; GLUTAMATE NEUROTOXICITY; SPATIAL NAVIGATION	Excitotoxic lesion of the striatum provides a useful model for evaluating the excitotoxic processes involved in neurological disorders, in particular stroke diseases. The behavioural outcome after Such injury is however poorly described. We have therefore investigated the potential behavioural deficits induced by a NMDA-induced excitotoxic unilateral lesion of the lateral part of the striatum, by comparison with a PBS striatal injection (sham procedure), and non-operated mice behaviour. Three groups of male adult Swiss mice were constituted: unilateral NMDA (20 nmol striatal NMDA injection), sham (striatal PBS injection), and control (healthy non-operated mice). From 14 to 29 days post-surgery, sensorimotor and mnesic tests were performed in all groups. After euthanasia, immunohistochemical stainings (NeuN and GFAP) were performed in order to assess the size of the lesion. Straight runway and passive avoidance performances revealed mild deficits related to the excitotoxic NMDA-induced lesion as compared to the sham procedure. Moreover, accelerated rotarod and Morris water maze acquisition performances also revealed deficits related to the surgery, i.e. observed in sham-operated as compared to control mice. NeuN staining revealed no striatal lesion in the sham and non-operated groups in contrast to the NMDA-injected group in which the volume of infarcted striatum was 2.4 +/- 0.3 mm(3). GFAP staining revealed a glial reaction in the lesioned striatum of NMDA animals and at the PBS injection site in sham animals. These results suggest that NMDA-induced excitotoxic lesion induces subtle long-term behavioural deficits in mice. Moreover, this study shows the importance of the sham group to investigate the behavioural deficits after excitotoxic lesion models in mice. (c) 2007 Elsevier B.V. All rights reserved.	Univ Caen, CNRS, UMR 6185, CYCERON, F-14074 Caen, France; Univ Caen, CERMN, EA3915, Pharmacol Physiol Lab, F-14032 Caen, France		Bouet, V (corresponding author), Univ Caen, CNRS, UMR 6185, CYCERON, BP 5229,Bd H Becquerel, F-14074 Caen, France.	bouet@cyceron.fr	freret, thomas/B-2068-2012; Bernaudin, Myriam/B-7663-2008; freret, thomas/AAA-2491-2019; BOUET, Valentine/N-9593-2015; Pacary, Emilie/N-6994-2017; Michel, Boulouard/N-9028-2015	freret, thomas/0000-0002-4446-4451; Bernaudin, Myriam/0000-0003-0778-3397; freret, thomas/0000-0002-4446-4451; Pacary, Emilie/0000-0002-7316-4546; Michel, Boulouard/0000-0003-3825-8659			Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; Akita H, 2006, BRAIN RES, V1095, P178, DOI 10.1016/j.brainres.2006.04.039; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BLOCK F, 1993, NEUROSCI LETT, V149, P126, DOI 10.1016/0304-3940(93)90752-7; BOISSIER JR, 1965, ARCH INT PHARMACOD T, V158, P212; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; BOUET V, 2006, EXP NEUROL; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Cosi C, 2004, BRAIN RES, V996, P1, DOI 10.1016/j.brainres.2003.09.072; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Francis L, 2000, REV NEUROLOGIA, V30, P1016, DOI 10.33588/rn.3011.99495; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Fricker RA, 1996, BRAIN RES BULL, V41, P409, DOI 10.1016/S0361-9230(96)00083-4; Furtado JCS, 1996, EXP NEUROL, V138, P158, DOI 10.1006/exnr.1996.0054; Garside S, 1996, NEUROSCIENCE, V75, P1065, DOI 10.1016/0306-4522(96)00172-8; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hansson O, 2001, EUR J NEUROSCI, V14, P1492, DOI 10.1046/j.0953-816x.2001.01767.x; Hattori K, 2000, STROKE, V31, P1939, DOI 10.1161/01.STR.31.8.1939; Higgins GA, 2001, NEUROPHARMACOLOGY, V41, P97, DOI 10.1016/S0028-3908(01)00048-X; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Iravani MM, 2004, BRAIN RES, V1029, P103, DOI 10.1016/j.brainres.2004.09.033; Jiang CT, 2005, EXP NEUROL, V191, P154, DOI 10.1016/j.expneurol.2004.08.035; Joel D, 1998, BRAIN RES, V787, P143, DOI 10.1016/S0006-8993(97)01428-5; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Lelong V, 2001, NEUROPHARMACOLOGY, V41, P517, DOI 10.1016/S0028-3908(01)00085-5; Lorenzini CGA, 1999, NEUROBIOL LEARN MEM, V71, P1; Mandir AS, 2000, J NEUROSCI, V20, P8005; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; MITCHELL JA, 1985, BEHAV NEUROSCI, V99, P1074, DOI 10.1037/0735-7044.99.6.1074; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murphy AN, 1999, ANN NY ACAD SCI, V893, P19, DOI 10.1111/j.1749-6632.1999.tb07815.x; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; OGAWA N, 1985, RES COMMUN CHEM PATH, V50, P435; OLNEY JW, 1990, PROG BRAIN RES, V86, P37; PISA M, 1988, BEHAV BRAIN RES, V27, P21, DOI 10.1016/0166-4328(88)90106-4; Reddrop C, 2005, STROKE, V36, P1241, DOI 10.1161/01.STR.0000166050.84056.48; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Scattoni ML, 2004, BEHAV BRAIN RES, V152, P375, DOI 10.1016/j.bbr.2003.10.021; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sedelis M, 2000, NEUROREPORT, V11, P1093, DOI 10.1097/00001756-200004070-00037; Szyndler J, 2006, PHARMACOL REP, V58, P75; Trueman RC, 2005, BEHAV BRAIN RES, V159, P313, DOI 10.1016/j.bbr.2004.11.021; WAGNER GC, 1987, PSYCHOPHARMACOLOGY, V92, P470; WHISHAW IQ, 1987, BEHAV BRAIN RES, V24, P125, DOI 10.1016/0166-4328(87)90250-6; Winter B, 2004, STROKE, V35, P191, DOI 10.1161/01.STR.0000107188.29688.2C; Winter B, 2005, BIOL PSYCHIAT, V57, P1166, DOI 10.1016/j.biopsych.2005.02.010; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	54	17	18	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 28	2007	178	2					235	243		10.1016/j.bbr.2006.12.023			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	154EX	WOS:000245490700008	17250902				2022-02-06	
J	Dickin, DC; Clark, S				Dickin, D. Clark; Clark, Sean			Generalizability of the sensory organization test in college-aged males: Obtaining a reliable performance measure	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						posture; reliability; sensory motor performance; sensory integration	POSTURAL CONTROL; BASKETBALL PLAYERS; FUNCTIONAL INSTABILITY; OLDER ADULTS; ANKLE JOINT; BALANCE; STABILITY; CONCUSSION; RELIABILITY; INJURY	Objective: This Study used generalizability theory to (1) determine the reliability of the six Sensory Organization Test (SOT) conditions, and (2) to determine the most effective testing schedule to obtain reliable posture measurements. Design: Generalizability theory was used to determine the most effecting testing protocol to obtain reliable assessments of postural sway in various sensory environments. Participants: Twenty-five recreationally active college-aged males. Setting: University research laboratory. Interventions: None. Main Outcome Measurements: Postural stability as measured by equilibrium score (a percentage measure indicating amount Of sway, with lower scores indicating a greater amount of postural sway). Scores were obtained for each of the six sensory conditions across multiple trials, tests, and days. Results: This study showed that performing the SOT twice on a single testing day was sufficient to achieve moderate to good reliability across the six conditions of the SOT. Extending SOT testing to twice on 2 days yielded good to excellent reliability estimates across all SOT conditions. Conclusions: Taken together, these results indicate that for the purpose of monitoring changes in the postural control system, an individual needs to experience the full complement of SOT testing conditions at least twice. However, if highly reliable baseline measures of SOT performance are necessary, multiple tests performed on multiple days are warranted.	Univ Idaho, Dept Hlth Phys Educ Recreat & Dance, Moscow, ID 83844 USA; Gordon Coll, Dept Kinesiol, Wenham, MA USA		Dickin, DC (corresponding author), Univ Idaho, Dept Hlth Phys Educ Recreat & Dance, Box 442401, Moscow, ID 83844 USA.	cdickin@uidaho.edu	Dickin, D. Clark/A-8303-2009	Dickin, D. Clark/0000-0002-3104-4167			Brennan R.L., 2001, GEN THEORY; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Clark S, 1997, ARCH PHYS MED REHAB, V78, P1078, DOI 10.1016/S0003-9993(97)90131-3; Cohen H, 1996, AGE AGEING, V25, P39, DOI 10.1093/ageing/25.1.39; COOGLER CE, 1992, POSTURE GAIT CONTROL, P361; Cronbach LJ, 1972, DEPENDABILITY BEHAV; Emery CA, 2005, PHYS THER, V85, P502, DOI 10.1093/ptj/85.6.502; FORDSMITH CD, 1995, ARCH PHYS MED REHAB, V76, P77, DOI 10.1016/S0003-9993(95)80047-6; Fu ASN, 2005, AM J SPORT MED, V33, P1174, DOI 10.1177/0363546504271976; GAUFFIN H, 1988, INT J SPORTS MED, V9, P141, DOI 10.1055/s-2007-1024996; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Henriksson M, 2001, AM J SPORT MED, V29, P359, DOI 10.1177/03635465010290031801; HOFFMAN M, 1995, J ORTHOP SPORT PHYS, V21, P90, DOI 10.2519/jospt.1995.21.2.90; KOLLEGGER H, 1992, EUR NEUROL, V32, P253, DOI 10.1159/000116836; Mangus Brent C, 2004, Sports Biomech, V3, P209, DOI 10.1080/14763140408522841; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; Morrow JR, 1989, MEASUREMENT CONCEPTS, P73; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; *NEUROCOM INT INC, 2001, SMART BAL MAST OP MA; Paterno MV, 2004, J ORTHOP SPORT PHYS, V34, P305, DOI 10.2519/jospt.2004.34.6.305; Perrin PP, 1997, INT J SPORTS MED, V18, P387, DOI 10.1055/s-2007-972651; Peterka R J, 1990, J Vestib Res, V1, P73; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pintsaar A, 1996, BRIT J SPORT MED, V30, P151, DOI 10.1136/bjsm.30.2.151; ROEBROECK ME, 1993, PHYS THER, V73, P386, DOI 10.1093/ptj/73.6.386; Rozzi SL, 1999, J ORTHOP SPORT PHYS, V29, P478, DOI 10.2519/jospt.1999.29.8.478; SHAVELSON RJ, 1991, GEN THEORY PRIMER; Speers RA, 1998, J BIOMECH, V31, P883, DOI 10.1016/S0021-9290(98)00065-7; TROPP H, 1984, MED SCI SPORT EXER, V16, P64; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd	32	17	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2007	17	2					109	115		10.1097/JSM.0b013e31803bf647			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	147GU	WOS:000244992200004	17414478				2022-02-06	
J	Grosjean, MB; Lenzlinger, PM; Stahel, PF; Yatsiv, I; Shohami, E; Trentz, O; Kossmann, T; Morganti-Kossmann, MC				Grosjean, M. B.; Lenzlinger, P. M.; Stahel, P. F.; Yatsiv, I.; Shohami, E.; Trentz, O.; Kossmann, T.; Morganti-Kossmann, M. C.			Immunohistochemical characterization of Fas (CD95) and Fas Ligand (FasL/CD95L) expression in the injured brain: Relationship with neuronal cell death and inflammatory mediators	HISTOLOGY AND HISTOPATHOLOGY			English	Article						apoptosis; Fas; cytokines; closed head injury; TUNEL; neurodegeneration; traumatic brain injury	TUMOR-NECROSIS-FACTOR; CLOSED-HEAD-INJURY; CENTRAL-NERVOUS-SYSTEM; CORTICAL IMPACT INJURY; NF-KAPPA-B; RAT-BRAIN; MULTIPLE-SCLEROSIS; FACTOR-ALPHA; AUTOIMMUNE ENCEPHALOMYELITIS; CEREBROSPINAL-FLUID	Traumatic brain injury causes progressive tissue atrophy and consequent neurological dysfunction, resulting from neuronal cell death in both animal models and patients. Fas ( CD95) and Fas ligand ( FasL/ CD95L) are important mediators of apoptosis. However, little is known about the relationship between Fas and FasL and neuronal cell death in mice lacking the genes for inflammatory cytokines. In the present study, double tumor necrosis factor/ lymphotoxin-alpha knockout (-/-) and interleukin-6-/- mice were subjected to closed head injury ( CHI) and sacrificed at 24 hours or 7 days post-injury. Consecutive brain sections were evaluated for Fas and FasL expression, in situ DNA fragmentation ( terminal deoxynucleotidyl transferase- mediated dUTP-biotin nick end- labeling; TUNEL), morphologic characteristics of apoptotic cell death and leukocyte infiltration. A peak incidence of TUNEL positive cells was found in the injured cortex at 24 hours which remained slightly elevated at 7 days and coincided with maximum Fas expression. FasL was only moderately increased at 24 hours and showed maximum expression at 7 days. A few TUNEL positive cells were also found in the ipsilateral hippocampus at 24 hours. Apoptotic, TUNEL positive cells mostly co- localized with neurons and Fas and FasL immunoreactivity. The amount of accumulated polymorphonuclear leukocytes and CD11b positive cells was maximal in the injured hemispheres at 24 hours. We show strong evidence that Fas and FasL might be involved in neuronal apoptosis after CHI. Furthermore, Fas and FasL upregulation seems to be independent of neuroinflammation since no differences were found between cytokine(-/-) and wild- type mice.	Univ Zurich, Ctr Dent & Oral Med & Cranio Maxillofacial Surg, Zurich, Switzerland; Univ Hosp, Div Surg Res, Zurich, Switzerland; Univ Hosp, Div Trauma Surg, Zurich, Switzerland; Charite, Dept Trauma & Reconstruct Surg, Berlin, Germany; Hadassah Univ Hosp, Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pharmacol, IL-91010 Jerusalem, Israel; Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Dept Trauma Surg, Melbourne, Vic 3181, Australia		Morganti-Kossmann, MC (corresponding author), Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Dept Trauma Surg, Commercial Rd, Melbourne, Vic 3004, Australia.	cristina.morganti-kossmann@med.monash.edu.au	Lenzlinger, Philipp/A-3822-2008	Morganti-Kossmann, Cristina/0000-0002-0807-2063			ADERKA D, 1989, J IMMUNOL, V143, P3517; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Becher B, 1998, TRENDS NEUROSCI, V21, P114, DOI 10.1016/S0166-2236(97)01180-6; Bechmann I, 1999, GLIA, V27, P62, DOI 10.1002/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; Bonetti B, 1997, ANN NEUROL, V42, P74, DOI 10.1002/ana.410420113; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512000-00014; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Choi C, 1999, J IMMUNOL, V162, P1889; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; Dowling P, 1996, J EXP MED, V184, P1513, DOI 10.1084/jem.184.4.1513; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Ertel W, 1997, J NEUROIMMUNOL, V80, P93, DOI 10.1016/S0165-5728(97)00139-2; Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Felderhoff-Mueser U, 2000, BRAIN PATHOL, V10, P17; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; GROSJEAN MB, 2001, J NEUROTRAUM, V18, P1161; HAMA T, 1991, NEUROSCIENCE, V40, P445, DOI 10.1016/0306-4522(91)90132-8; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Kato H, 1997, EXP NEUROL, V148, P464, DOI 10.1006/exnr.1997.6707; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kiener PA, 1997, J IMMUNOL, V159, P1594; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kohji T, 2000, J NEUROIMMUNOL, V106, P165, DOI 10.1016/S0165-5728(00)00238-1; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Lassmann H, 1997, J NEURAL TRANSM-SUPP, P183; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; MartinezLorenzo MJ, 1996, IMMUNOLOGY, V89, P511, DOI 10.1046/j.1365-2567.1996.d01-782.x; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; MROGANTIKOSSMAN.MC, 2000, RECENT RES DEVEL NEU, V3, P257; MROGANTIKOSSMAN.MC, 2002, IMMUNE INFLAMMATORY, P106; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; NAGATA S, 2001, SHOCK, V16, P165; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; Ottonello L, 1999, J IMMUNOL, V162, P3601; Padosch SA, 2003, NEUROSCI LETT, V338, P247, DOI 10.1016/S0304-3940(02)01408-8; Park CH, 1998, BIOCHEM BIOPH RES CO, V252, P623, DOI 10.1006/bbrc.1998.9572; Pender MP, 2001, GLIA, V36, P137, DOI 10.1002/glia.1103; Penkowa M, 1999, GLIA, V25, P343; Phanithi PB, 2000, NEUROPATHOLOGY, V20, P273, DOI 10.1046/j.1440-1789.2000.00346.x; Pollack A, 1990, Methods Cell Biol, V33, P19; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/S0006-8993(96)00222-3; Qiu JH, 2002, J NEUROSCI, V22, P3504; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RINK A, 1995, AM J PATHOL, V147, P1575; Rose S, 2000, AM J GASTROENTEROL, V95, P1; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Saas P, 1997, J CLIN INVEST, V99, P1173, DOI 10.1172/JCI119273; Sabelko KA, 1997, J IMMUNOL, V159, P3096; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SEI Y, 1995, NEUROIMMUNOMODULAT, V2, P121, DOI 10.1159/000096881; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Sherwood ER, 2000, CRIT CARE MED, V28, P1221, DOI 10.1097/00003246-200004000-00054; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; TAUPIN V, 1993, MOL PHARMACOL, V43, P64; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TOMINAGA T, 1992, NEUROSCI LETT, V139, P265, DOI 10.1016/0304-3940(92)90568-R; Venters HD, 2000, TRENDS NEUROSCI, V23, P175, DOI 10.1016/S0166-2236(99)01533-7; Waldner H, 1997, J IMMUNOL, V159, P3100; White CA, 1998, INT IMMUNOL, V10, P935, DOI 10.1093/intimm/10.7.935; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zipp F, 1997, NERVENARZT, V68, P94, DOI 10.1007/s001150050103	95	17	19	0	1	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	MAR	2007	22	3					235	250					16	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	134NZ	WOS:000244091400002	17163398				2022-02-06	
J	Niemeier, J; Arango-Lasprilla, JC				Niemeier, Janet; Arango-Lasprilla, Juan Carlos			Toward improved rehabilitation services for ethnically diverse survivors of traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						disparities; minorities; rehabilitation; TBI	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; MENTAL-HEALTH-SERVICES; AFRICAN-AMERICAN WOMEN; PRIMARY-CARE PATIENTS; MINORITY STATUS; RACE; DISPARITIES; DEPRESSION; ACCULTURATION; OUTCOMES	Traumatic brain injury is an important public health problem in the United States, especially for individuals from racial and ethnic minorities. The first part of this article provides a synthesis of findings and discussions of cultural issues in the rehabilitation, medical, and psychological scientific literature highlighting the needs and challenges of our diverse population of minority traumatic brain injury survivors in the United States. The second part offers practical recommendations for rehabilitation professionals who desire to improve the healthcare and health outcomes of these individuals. Through an examination of research, guidelines, and resources, we justify the importance of cultural sensitivity in everyday provider interactions with minority clients and their families.	Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil & Psychiat, Richmond, VA 23298 USA; Univ Med & Dent New Jersey, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA		Niemeier, J (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil & Psychiat, POB 980661, Richmond, VA 23298 USA.	jniemeier@mcvh-vcu.edu					Alegria M, 2004, INT J METH PSYCH RES, V13, P208, DOI 10.1002/mpr.178; Alston RJ, 2003, INT J REHABIL RES, V26, P289, DOI 10.1097/00004356-200312000-00006; *AM MED ASS, 2004, RES CULT GEND AW INT, P77; American Psychological Association, 2002, ETHICAL PRINCIPLES P; Anderson JTL, 2000, J OCCUP ENVIRON MED, V42, P176, DOI 10.1097/00043764-200002000-00016; Arango JC, 2006, J HEAD TRAUMA REHAB, V21, P422; ARANGOLASPRILLA JC, 2005, ARCH PHYS MED REHAB, V86, P17; Baker DW, 1998, MED CARE, V36, P1461, DOI 10.1097/00005650-199810000-00004; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Beckfield J, 2004, J HEALTH SOC BEHAV, V45, P231, DOI 10.1177/002214650404500301; Betancourt JR, 2006, ACAD MED, V81, P788, DOI 10.1097/00001888-200609000-00004; Bostick N, 2006, J NATL MED ASSOC, V98, P1329; Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; BURNNET M, 2005, ETHN DIS S3, V15; Cardemil EV, 2003, PROF PSYCHOL-RES PR, V34, P278, DOI 10.1037/0735-7028.34.3.278; CARTER RT, 1999, INFLUENCE RACE RACIA; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Cutrona CE, 2005, J ABNORM PSYCHOL, V114, P3, DOI 10.1037/0021-843X.114.1.3; Dana R. H., 2000, HDB CROSS CULTURAL M; DANA RH, 2000, HISP J BEHAV SCI, V18, P317; DANA RH, 1998, MULTICULTURAL ASSESS; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Flores G, 2006, NEW ENGL J MED, V355, P229, DOI 10.1056/NEJMp058316; Gasquoine PG, 2001, CLIN NEUROPSYCHOL, V15, P2, DOI 10.1076/clin.15.1.2.1915; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Jacobs EA, 2001, J GEN INTERN MED, V16, P468, DOI 10.1046/j.1525-1497.2001.016007468.x; JARGER TE, 2000, ACAD EMERG MED, P134; Johnson B L, 1993, Ann Epidemiol, V3, P175; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kaplan SA, 2006, J HEALTH CARE POOR U, V17, P116, DOI 10.1353/hpu.2006.0026; KATZ JH, 1985, COUNS PSYCHOL, V13, P615, DOI 10.1177/0011000085134005; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lee LJ, 2002, J GEN INTERN MED, V17, P640, DOI 10.1046/j.1525-1497.2002.10742.x; Lomay VT, 2006, REHABIL PSYCHOL, V51, P36, DOI 10.1037/0090-5550.51.1.36; Lopez Rebecca A, 2005, J Immigr Health, V7, P23, DOI 10.1007/s10903-005-1387-8; Manly JJ, 2004, APPL NEUROPSYCHOL, V11, P37, DOI 10.1207/s15324826an1101_5; MAX W, J HEAD TRAUMA REHABI, V6, P219; Miranda J, 2003, HEALTH SERV RES, V38, P613, DOI 10.1111/1475-6773.00136; Miranda J, 2004, J GEN INTERN MED, V19, P120, DOI 10.1111/j.1525-1497.2004.30272.x; Niemeier JP, 2003, ARCH PHYS MED REHAB, V84, P1240, DOI 10.1016/S0003-9993(03)00295-8; NIEMEIER JP, 2006, AM PSYCH ASS NAT CON; *NIH CONS DEV PAN, 1999, JAMA-J AM MED ASSOC, V282, P219; OKAZAKI S, 1998, METHODOLOGICAL ISSUE, P265; PONTEROTTO JG, 2001, HDB MULTICULTURAL CO; PONTEROTTO JG, 2006, PREVENTING PREJUDICE; Primm AB, 2005, COMMUNITY MENT HLT J, V41, P557, DOI 10.1007/s10597-005-6361-3; Primm AB, 2002, J NATL MED ASSOC, V94, P1007; RAMIREZ RR, 2002, CURRENT POPULATION R, P520; ROGLER LH, 1987, AM PSYCHOL, V42, P565, DOI 10.1037/0003-066X.42.6.565; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; ROTH C, 1999, MONITORING ADHERENCE; *RW JOHNSON FDN, IMPR HLTH HEALTHC AL; SANDOVAL J, 1999, TEST INTERPRETATION, P31; Satcher D, 2001, MENT HLTH CULT RAC E; Scarinci IC, 2004, ETHNIC DIS, V14, P567; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Sleath B, 2005, J AM GERIATR SOC, V53, P397, DOI 10.1111/j.1532-5415.2005.53155.x; Smedley BD, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Strothers HS, 2005, J AM GERIATR SOC, V53, P456, DOI 10.1111/j.1532-5415.2005.53164.x; Thompson R. H., 1996, ENCY SOCIAL CULTURAL, V1, P112; THURMAN D, 2001, HEAD TRAUMA BASIC PR; Tucker CM, 2003, MED CARE, V41, P859, DOI 10.1097/00005650-200307000-00010; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wang M., 2003, HLTH INSURANCE COVER; Wang VO, 2005, AM PSYCHOL, V60, P37, DOI 10.1037/0003-066X.60.1.37; WELLS KB, 1989, HEALTH SERV RES, V24, P237; Winthrop RobertH., 1991, DICT CONCEPTS CULTUR; XY JT, 2006, SOC SCI MED, V63, P457; Zane N, 2003, ACCULTURATION ADV TH, P39, DOI DOI 10.1037/10472-005; ZEMBECK BS, 2000, J AGING HEALTH, V12, P229; [No title captured]	82	17	17	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2007	22	2					75	84		10.1097/01.HTR.0000265095.06565.7b			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	152NU	WOS:000245369500002	17414309				2022-02-06	
J	Sifringer, M; Stefovska, V; Endesfelder, S; Stahel, PF; Genz, K; Dzietko, M; Ikonomidou, C; Felderhoff-Mueser, U				Sifringer, Marco; Stefovska, Vanya; Endesfelder, Stefanie; Stahel, Philip F.; Genz, Kerstin; Dzietko, Mark; Ikonomidou, Chrysanthy; Felderhoff-Mueser, Ursula			Activation of caspase-1 dependent interleukins in developmental brain trauma	NEUROBIOLOGY OF DISEASE			English	Article						apoptosis; infant brain trauma; interleukin-1 beta; interleukin-18; caspase-1	DEVELOPING RAT-BRAIN; CLOSED-HEAD INJURY; CONVERTING-ENZYME; RECEPTOR ANTAGONIST; CYTOKINE INDUCTION; HYPOXIA-ISCHEMIA; MICE DEFICIENT; NEONATAL-RATS; CELL-DEATH; DAMAGE	Focal mechanical cortical trauma triggers diffuse apoptotic neurodegeneration in the developing rat brain which is associated with invasion of brain tissue with inflammatory mediators. We hypothesized that caspase-1 and the two caspase-l-processed cytokines, interleukin (IL)-1 beta and IL-18, are involved in trauma-induced neuronal cell death in the developing brain. 7-day-old Wistar rats or C57/BL6 mice were subjected to head trauma using a weight drop device. Animals were sacrificed at defined time points following trauma and brains were processed for histology and molecular analyses. Neuronal cell death in the immature brain peaked at 12-24 h and was accompanied by a marked increase of mRNA and protein levels for caspase-1, IL-1 beta and IL-18 within 2 to 12 h following the injury. Caspase-1 levels were elevated for 72 h, whereas IL-1 beta decreased earlier at 48 h. IL-18 remained high over a period of 3 days and decreased to normal levels by day 7 after the injury. Intraperitoneal injection of recombinant human IL-18-binding protein (IL-18BP), a specific inhibitor of IL-18, attenuated traumatic brain injury. Mice deficient in IL-18 (IL-18-/-) were protected against trauma-induced brain damage. These findings indicate that IL-18 is involved in trauma-induced neuronal cell death in the immature rodent brain and might serve as a potential therapeutic target. (c) 2006 Elsevier Inc. All rights reserved.	Univ Med Berlin, Dept Neonatol, Charite, D-13353 Berlin, Germany; Univ Colorado, Sch Med, Dept Orthopaed Surg, Denver Hlth Med Ctr, Denver, CO 80204 USA; Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Pediat Neurol, Childrens Hosp, D-01307 Dresden, Germany		Felderhoff-Mueser, U (corresponding author), Univ Med Berlin, Dept Neonatol, Charite, Campus Virchow Klinikum,Augustenburger Pl 1, D-13353 Berlin, Germany.	ursula.felderhoff@charite.de	Dzietko, Mark/AAH-5996-2019; Endesfelder, Stefanie/AAA-5534-2022; Felderhoff-Muser, Ursula/AAU-9682-2020	Endesfelder, Stefanie/0000-0002-4030-7969; Dzietko, Mark/0000-0002-3035-4841			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Cai ZW, 2000, PEDIATR RES, V47, P64, DOI 10.1203/00006450-200001000-00013; DEOLMOS JS, 1971, BRAIN RES, V33, P523, DOI 10.1016/0006-8993(71)90130-2; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Felderhoff-Mueser U, 2005, TRENDS NEUROSCI, V28, P487, DOI 10.1016/j.tins.2005.06.008; Felderhoff-Mueser U, 2005, ANN NEUROL, V57, P50, DOI 10.1002/ana.20322; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Firsching R, 2001, WORLD J SURG, V25, P1221; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Hagberg H, 1996, PEDIATR RES, V40, P603, DOI 10.1203/00006450-199610000-00015; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Jander S, 2002, J CEREBR BLOOD F MET, V22, P62, DOI 10.1097/00004647-200201000-00008; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lebel-Binay S, 2000, EUR CYTOKINE NETW, V11, P15; Liu XH, 1999, J CEREBR BLOOD F MET, V19, P1099, DOI 10.1097/00004647-199910000-00006; MAHLY WJ, 1983, PEDIATRICS, V71, P756; MARTIN D, 1994, EXP NEUROL, V130, P362, DOI 10.1006/exnr.1994.1215; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Menge T, 2001, J NEUROSCI RES, V65, P332, DOI 10.1002/jnr.1158; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Rabuffetti M, 2000, J NEUROSCI, V20, P4398, DOI 10.1523/JNEUROSCI.20-12-04398.2000; Schmidt OI, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-13; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Silverstein FS, 1997, NEUROCHEM INT, V30, P375, DOI 10.1016/S0197-0186(96)00072-1; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Stahel Philip F, 2006, Expert Rev Clin Immunol, V2, P445, DOI 10.1586/1744666X.2.3.445; Stroemer RP, 1998, J CEREBR BLOOD F MET, V18, P833, DOI 10.1097/00004647-199808000-00003; STROOCK D, 1997, ASIAN J MATH, V1, P17; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Wheeler RD, 2003, J CEREBR BLOOD F MET, V23, P531, DOI 10.1097/01.WCB.0000059587.71206.BA; Xu RY, 2001, MOL BRAIN RES, V90, P57; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008	43	17	19	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	MAR	2007	25	3					614	622		10.1016/j.nbd.2006.11.003			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145NQ	WOS:000244872200017	17188500				2022-02-06	
J	Irdesel, J; Aydiner, SB; Akgoz, S				Irdesel, J.; Aydiner, S. B.; Akgoz, S.			Rehabilitation outcome after traumatic brain injury	NEUROCIRUGIA			English	Article						traumatic brain injury; rehabilitation; complication	INTENSIVE-CARE-UNIT; FUNCTIONAL INDEPENDENCE; HEAD-INJURY; HETEROTOPIC OSSIFICATION; COMA; COMPLICATIONS; SCALE; RECOVERY; LENGTH; STAY	Rehabilitation goals after traumatic brain injury are improving function, increasing the level of independence as high as possible, preventing complications and providing an acceptable environment to the patient. Several complications can be encountered during the rehabilitation period which lead to physical, cognitive and neurobehavioral impairments that cause major delay in functional improvement. This prospective study was designed in order to investigate the complications and their relations with functional recovery in patients that were included in the acute phase of a rehabilitation program. Thirty traumatic brain injured patients admitted to the Intensive Care Units of Uludag University School of Medicine were included in the study. Rehabilitation program consisted in appropriate positioning, range of motion exercises, postural drainage and respiratory exercises. Complications that were encountered during intensive care rehabilitation program were recorded. All patients were evaluated by Functional Independence Measure, Disability Rating Scale and Ranchos Los Amigos Levels of Cognitive Function Scale at admission and discharge. Improvement was observed in patients in terms of functional outcome and disability levels. Pneumonia, athelectasis, anemia and meningitis were the most frequent complications. Deterioration in functional outcome and disability levels was noted as the number of these complications increased. In conclusion, rehabilitation has an important role in the management of traumatic brain injured patients. Reduction of frequency of complications and improvement in functional outcome and disability levels can be achieved through rehabilitation programs. Long-term controlled studies with large number of patients are needed in order to obtain accurate data on factors associated with rehabilitation outcomes.	Uludag Univ, Sch Med, Dept Phys Med & Rehabil, TR-16059 Bursa, Turkey; Uludag Univ, Sch Med, Dept Biostat, TR-16059 Bursa, Turkey		Irdesel, J (corresponding author), Uludag Univ, Sch Med, Dept Phys Med & Rehabil, TR-16059 Bursa, Turkey.						ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Aras MD, 2004, INT J REHABIL RES, V27, P257, DOI 10.1097/00004356-200412000-00001; Boake C, 2000, PHYS MED REHABILITAT, P1073; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Ciesla ND, 1996, PHYS THER, V76, P609, DOI 10.1093/ptj/76.6.609; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Davis CH, 1997, AM J PHYS MED REHAB, V76, P213, DOI 10.1097/00002060-199705000-00011; DEMIR SO, 2001, TURK FIZ TIP REHAB D, V47, P15; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; Edlich Richard F, 2004, J Long Term Eff Med Implants, V14, P285, DOI 10.1615/JLongTermEffMedImplants.v14.i4.20; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Hagen C., 1972, LEVELS COGNITIVE FUN; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HARRISONFELIX C, 1996, J HEAD TRAUMA REHAB, V11, P11; Hoffmann B, 2002, ACTA NEUROCHIR SUPPL, V79, P25; JOHN R, 1999, ARCH PHYS MED REHAB, V80, P1133; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; KAPLAN CP, 1994, ARCH PHYS MED REHAB, V75, P643, DOI 10.1016/0003-9993(94)90186-4; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; Kaya A, 2001, TURK FIZ TIP REHAB D, V47, P7; Lau AFC, 2003, INT J REHABIL RES, V26, P251, DOI 10.1097/00004356-200312000-00001; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; MERAY J, 2000, FIZIKSEL TIP REHABIL, P1951; Nava S, 1998, ARCH PHYS MED REHAB, V79, P849, DOI 10.1016/S0003-9993(98)90369-0; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Prigatano GP, 1997, ARCH PHYS MED REHAB, V78, P621, DOI 10.1016/S0003-9993(97)90428-7; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RANKA V, 1999, ARCH PHYS MED REHAB, V80, P1131; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P510, DOI 10.1097/00001199-200212000-00003; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; SIEGLER EL, 1994, ARCH INTERN MED, V154, P2185, DOI 10.1001/archinte.154.19.2185; TAN J, 2000, NOROREHABILITASYON, P83; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; WHYTE J, 1998, REHABILITATION MED P, P997; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zafonte RD, 2001, ARCH PHYS MED REHAB, V82, P306, DOI 10.1053/apmr.2001.18226	47	17	20	1	7	SOCIEDAD ESPANOLA NEUROCIRUGIA	MURCIA	C/O  DR POZA, GRAN VIA SALZILLO 42, 30005 MURCIA, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	FEB	2007	18	1					5	15					11	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	170MG	WOS:000246666900001	17393041				2022-02-06	
J	Lichtveld, RA; Panhuizen, IF; Smit, RBJ; Holtslag, HR; van der Werken, C				Lichtveld, Rob A.; Panhuizen, Ivo F.; Smit, Ronald B. J.; Holtslag, Hermann R.; van der Werken, Christian			Predictors of death in trauma patients who are alive on arrival at hospital	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						scoring systems; polytrauma; traumatic brain injury; thorax and abdominal trauma; trauma registries; polytrauma managment including prehospital and shockroom; multiple trauma	BASE DEFICIT; DATA-BANK; PEDIATRIC TRAUMA; INJURY SEVERITY; RESUSCITATION; MORTALITY; SCORE; CARE; PH	Objective: To determine which factors predict death occurring in trauma patients who are alive on arrival at hospital Design Prospective cohort study Method Data were collected from 507 trauma patients with multiple injuries, with a Hospital Trauma Index-injury Severity Score of 16 or more, who were initially delivered by the Emergency Medical Services to the Emergency Department of the University Medical Centre Utrecht (UMCU) during the period 1999-2000. Results: Univariate analysis showed that every year of age increase resulted in a 2% greater risk of death. If the patient had been intubated at the scene of the accident, this risk was increased 4.3-fold. Every point of increase in the Triage Revised Trauma Score (T-RTS) reduced the risk of death by 30%. A similar (but inverse) tendency was found for the HTI-ISS score, with every point of increase resulting in a 5% greater risk of death. There was a clear relationship between the base excess (BE) and hemoglobin (Hb) levels and the risk of death, the latter being increased by 8% for each mmol/I drop in BE, and reduced by 22% for each mmol/I increase in Hb. The risk of death occurring was 2.6 times higher in cases with isolated neurotrauma. These associations hardly changed in the multivariate analysis; only the relation with having been intubated at the scene disappeared. Conclusion: The risk of severely injured accident patients dying after arriving in hospital is mainly determined by the T-RTS, age, presence of isolated neurological damage, BE and Hb level. Skull/brain damage and hemorrhage appear to be the most important causes of death in the first 24 h after the accident. The time interval between the accident and arrival at the hospital does not appear to affect the risk of death.	[Lichtveld, Rob A.] RAVU EMS, NL-3601 BE Utrecht, Netherlands; [Panhuizen, Ivo F.] Radboud Univ Nijmegen Med Ctr, Dept Anaesthesiol, Nijmegen, Netherlands; [Smit, Ronald B. J.] Municipal Hlth Author, Forens Med, Amsterdam, Netherlands; [van der Werken, Christian] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands		Lichtveld, RA (corresponding author), RAVU EMS, Nassaustr 127, NL-3601 BE Utrecht, Netherlands.	r.lichtveld@ravu.nl		Lichtveld, Robert/0000-0002-3957-7056			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CALES RH, 1985, JAMA-J AM MED ASSOC, V254, P1059, DOI 10.1001/jama.254.8.1059; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Davis JW, 1998, J TRAUMA, V44, P114, DOI 10.1097/00005373-199801000-00014; Davis JW, 1998, J TRAUMA, V45, P873, DOI 10.1097/00005373-199811000-00005; Davis JW, 1997, J TRAUMA, V43, P507, DOI 10.1097/00005373-199709000-00020; DAVIS JW, 1991, ANN EMERG MED, V20, P842, DOI 10.1016/S0196-0644(05)81423-4; Guzzo JL, 2005, J AM COLL SURGEONS, V201, P891, DOI 10.1016/j.jamcollsurg.2005.07.013; HARTMAN JAM, 2005, LANDELIJK PROTOCOL A; Hopson LR, 2003, J AM COLL SURGEONS, V196, P106, DOI 10.1016/S1072-7515(02)01668-X; Huerta S, 2005, AM SURGEON, V71, P763; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; Kincaid EH, 2001, J TRAUMA, V51, P332, DOI 10.1097/00005373-200108000-00018; Lerner EB, 2003, ACAD EMERG MED, V10, P949, DOI 10.1197/S1069-6563(03)00313-0; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Martin MJ, 2005, AM J SURG, V190, P836, DOI 10.1016/j.amjsurg.2005.05.051; Nirula R, 2004, J TRAUMA, V57, P37, DOI 10.1097/01.TA.0000128236.45043.6A; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Peterson DL, 2004, AM SURGEON, V70, P326; Pickens JJ, 2005, J TRAUMA, V58, P951, DOI 10.1097/01.TA.0000162174.06448.5A; Rixen D, 2001, SHOCK, V15, P83, DOI 10.1097/00024382-200115020-00001; RUTHERFORD EJ, 1992, J TRAUMA, V33, P417, DOI 10.1097/00005373-199209000-00014; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; Stockinger ZT, 2004, J AM COLL SURGEONS, V198, P227, DOI 10.1016/j.jamcollsurg.2003.10.012; TEASDALE G, 1974, LANCET, V2, P81; Tremblay LN, 2003, AM J SURG, V186, P597, DOI 10.1016/j.amjsurg.2003.09.003	26	17	17	0	8	URBAN & VOGEL	MUNICH	NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY	1863-9933			EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2007	33	1					46	51		10.1007/s00068-007-6097-6			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	313HV	WOS:000256732600008	26815974	Green Submitted, Bronze			2022-02-06	
J	Veronesi, MC; Yard, M; Jackson, J; Lahiri, DK; Kubek, MJ				Veronesi, Michael C.; Yard, Michael; Jackson, James; Lahiri, Debomoy K.; Kubek, Michael J.			An analog of thyrotropin-releasing hormone (TRH) is neuroprotective against glutamate-induced toxicity in fetal rat hippocampal neurons in vitro	BRAIN RESEARCH			English	Article						neuroprotection; thyrotropin-releasing hormone; TRH analog; glutamate; hippocampus	PROTEIN-KINASE-C; POTASSIUM-STIMULATED GLUTAMATE; KAINATE-INDUCED SEIZURES; TEMPORAL-LOBE EPILEPSY; SPINAL-CORD INJURY; BRAIN-INJURY; CELL-DEATH; RAPID DESENSITIZATION; RECEPTOR AGONIST; NERVOUS-SYSTEM	TRH has been found to be efficacious in treating certain neurodegenerative disorders such as epilepsy, Alzheimer's disease, neurotrauma and depression, however, its mechanism of action is poorly understood. Since glutamate (Glu) toxicity has been implicated in these disorders, we utilized primary enriched cultures of rat fetal (E 17) hippocampal neurons to test the hypothesis that an analog of TRH, 3-Methyl-Histidine TRH (3Me-H TRH), given concurrently with Glu would protect such neurons against cell damage and cell death. Cell viability was assessed via Trypan Blue exclusion cell counts, and neuronal damage was determined by assaying lactic acid dehydrogenase (LDH) released in the conditioned media. Fetal hippocampal neurons were cultured in neurobasal media for 7 days. On day 7, neurons (10(6)/well) were treated with: control media, 10 mu M 3Me-H TRH, 500 mu M Glu or 500 mu M Glu with either 10, 1, 0.1, 0.01 or 0.001 mu M 3Me-H TRH. Both media and neurons were harvested 16 h after treatment. Prolonged exposure to 10 mu M 3Me-H TRH was not toxic to the cells, whereas neurons exposed to 500 mu M Glu resulted in maximal cell death. Notably, 10, 1 and 0.1 mu M We-H TRH, when co-treated with 500 mu M Glu, protected fetal neurons against cell death in a concentration-dependent manner. These results provide support for an important neuroprotective effect of TRH/analogs against glutamate toxicity in primary hippocampal neuronal culture and implicate a potentially beneficial role of TRH/analogs in neurodegenerative diseases. (c) 2006 Elsevier B.V. All rights reserved.	Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Program Med Neurobiol, Indianapolis, IN 46202 USA		Kubek, MJ (corresponding author), Indiana Univ, Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,Room MSS035, Indianapolis, IN 46202 USA.	mjkubek@iupui.edu			NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG018379, R01AG018884] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG18884, AG18379, R01 AG018884, R01 AG018379] Funding Source: Medline		BLANCHARD L, 1986, DEV BRAIN RES, V24, P85, DOI 10.1016/0165-3806(86)90175-6; Brecht S, 2001, MOL BRAIN RES, V94, P25, DOI 10.1016/S0006-8993(01)02767-6; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; Chen QX, 1997, J NEUROSCI, V17, P4032; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; Faden AI, 1999, AM J PHYSIOL-REG I, V277, pR1196, DOI 10.1152/ajpregu.1999.277.4.R1196; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; FADEN AI, 1981, NEW ENGL J MED, V305, P1063, DOI 10.1056/NEJM198110293051806; Faden AI, 2004, J ALZHEIMERS DIS, V6, pS93; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; FADEN AI, 1988, BRAIN RES, V448, P287, DOI 10.1016/0006-8993(88)91265-6; FADEN AI, 1989, BRAIN RES, V486, P228, DOI 10.1016/0006-8993(89)90509-X; Francesconi A, 2000, P NATL ACAD SCI USA, V97, P6185, DOI 10.1073/pnas.97.11.6185; Gary KA, 2003, J PHARMACOL EXP THER, V305, P410, DOI 10.1124/jpet.102.044040; Gereau RW, 1998, NEURON, V20, P143, DOI 10.1016/S0896-6273(00)80442-0; Gershengorn MC, 1996, PHYSIOL REV, V76, P175, DOI 10.1152/physrev.1996.76.1.175; GREBER S, 1994, BRIT J PHARMACOL, V113, P737, DOI 10.1111/j.1476-5381.1994.tb17055.x; GRIFFITHS EC, 1989, ANN NY ACAD SCI, V553, P217; HERRERO I, 1994, EUR J NEUROSCI, V6, P115, DOI 10.1111/j.1460-9568.1994.tb00253.x; Heuer H, 2000, J COMP NEUROL, V428, P319; HINKLE PM, 1989, ANN NY ACAD SCI, V553, P176; Hrabovszky E, 2005, ENDOCRINOLOGY, V146, P341, DOI 10.1210/en.2004-0856; IWASAKI Y, 1989, NEUROSCI LETT, V101, P316, DOI 10.1016/0304-3940(89)90552-1; Jaworska-Feil L, 1999, J NEURAL TRANSM, V106, P395, DOI 10.1007/s007020050167; Jaworska-Feil L, 2001, EPILEPSY RES, V43, P67, DOI 10.1016/S0920-1211(00)00178-9; Johansen PW, 2001, CELL SIGNAL, V13, P251, DOI 10.1016/S0898-6568(01)00144-9; JOHNSON WA, 1989, ANN NY ACAD SCI, V553, P137; KIM GD, 1994, J BIOL CHEM, V269, P19933; Knoblach SM, 1999, J NEUROCHEM, V72, pS8; Knoblach SM, 1997, NEUROSCIENCE, V76, P97; Knoblach SM, 1997, NEUROSCIENCE, V76, P85; Koenig ML, 1996, BRAIN RES, V730, P143; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KUBEK MJ, 1989, ANN NY ACAD SCI, V553, P286; Kubek MJ, 2002, PEDIATR NEUROL, V26, P9, DOI 10.1016/S0887-8994(01)00321-6; KUBEK MJ, 1977, BRAIN RES, V126, P196, DOI 10.1016/0006-8993(77)90230-X; LUO G, 2006, ABSTR SOC NEUR; Luo LG, 2001, ENDOCRINE, V15, P79, DOI 10.1385/ENDO:15:1:079; Luo LG, 2002, J ALZHEIMERS DIS, V4, P97, DOI 10.3233/JAD-2002-4204; MCDONALD JW, 1992, EUR J PHARMACOL, V215, P353, DOI 10.1016/0014-2999(92)90058-C; MCDONALD JW, 1993, J NEUROSCI, V13, P4445; MILLIGAN G, 1994, REGULATION CELLULAR; Mundell SJ, 2004, BIOCHEMISTRY-US, V43, P7541, DOI 10.1021/bi0359022; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; NELSON EJ, 1994, J BIOL CHEM, V269, P30854; Nicoletti F, 1999, NEUROPHARMACOLOGY, V38, P1477, DOI 10.1016/S0028-3908(99)00102-1; Nie Y, 2005, BRAIN RES, V1054, P45, DOI 10.1016/j.brainres.2005.06.077; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PITTS LH, 1995, J NEUROTRAUM, V12, P235, DOI 10.1089/neu.1995.12.235; Pizzi M, 1999, EUR J PHARMACOL, V370, P133, DOI 10.1016/S0014-2999(99)00139-9; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; RENAUD LP, 1979, SCIENCE, V205, P1275, DOI 10.1126/science.224461; RIVIER J, 1972, J MED CHEM, V15, P479, DOI 10.1021/jm00275a010; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; SHARIF NA, 1991, NEUROCHEM RES, V16, P95, DOI 10.1007/BF00965695; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; Svoboda P, 1996, MOL PHARMACOL, V49, P646; Takeuchi Y, 2001, BRAIN DEV-JPN, V23, P662, DOI 10.1016/S0387-7604(01)00303-5; Urayama A, 2002, LIFE SCI, V72, P601, DOI 10.1016/S0024-3205(02)02268-3; Wan RQ, 1998, NEUROREPORT, V9, P677, DOI 10.1097/00001756-199803090-00021; YARD M, 2002, ABSTR SOC NEUR, V552; YARD M, 2002, ABSTR END SOC, V28	66	17	18	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 12	2007	1128	1					79	85		10.1016/j.brainres.2006.10.047			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135CC	WOS:000244130400009	17125753	Green Accepted			2022-02-06	
J	Acerini, CL; Tasker, RC				Acerini, Carlo L.; Tasker, Robert C.			Endocrine sequelae of traumatic brain injury in childhood	HORMONE RESEARCH			English	Article; Proceedings Paper	39th International Symposium on Growth Hormone and Growth Factors in Endocrinology and Metabolism	MAY 11-12, 2007	Berlin, GERMANY	Pfizer		traumatic brain injury; hypopituitarism; pituitary dysfunction; rehabilitation; endocrine assessment; children and adolescents	ANTERIOR-PITUITARY DYSFUNCTION; GROWTH-FACTOR-I; POSTTRAUMATIC HYPOPITUITARISM; NEUROENDOCRINE DYSFUNCTION; HEAD TRAUMA; ABNORMALITIES; CHILDREN	Background: Anterior pituitary hormone dysfunction may be an important feature of long-term morbidity in survivors of traumatic brain injury (TBI). The hypothalamic-pituitary structures are vulnerable to damage following head injury. Therefore, pituitary dysfunction, which may be detected months or years after injury, is now well recognised as a long-term consequence of TBI in adults. In contrast, little is known about this potential complication in children and adolescents. This article reviews the available paediatric data, which show that hypopituitarism may occur after both mild and severe TBI, although there is little published data on its incidence or prevalence within this age group. A recent analysis of the KIGS (Pfizer International Growth Study database) highlights very few registered cases of TBI-related growth hormone deficiency, suggesting that this may be either an uncommon or an overlooked phenomenon. Prospective studies will be needed to determine the incidence, natural history and response to hormone replacement of post-TBI-induced hypopituitarism in children. Conclusions: Given the critical role of anterior pituitary hormones in the regulation of growth and pubertal and neurocognitive development in childhood, early detection of hormone abnormalities is vital. A multidisciplinary approach to follow-up and endocrine assessment is required for the long-term management and rehabilitation of children and adolescents who survive moderate to severe head injury. Copyright (c) 2007 S. Karger AG, Basel.	[Acerini, Carlo L.; Tasker, Robert C.] Univ Cambridge, Dept Paediat, Cambridge, England		Acerini, CL (corresponding author), Univ Cambridge, Addenbrookes Hosp, Level 8,Box 116, Cambridge CB2 2QQ, England.	cla22@cam.ac.uk	Tasker, Robert C/R-5837-2019	Tasker, Robert/0000-0003-3647-8113; Acerini, Carlo/0000-0003-2121-5871			Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; BARZILAY Z, 1988, J MED, V19, P47; Benvenga S, 2004, AM J MED, V116, P767, DOI 10.1016/j.amjmed.2003.12.038; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Della Corte F, 1998, CRIT CARE MED, V26, P1419; EDWARDS OM, 1986, MEDICINE, V65, P281; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; GROSSMAN WF, 1994, J REPROD MED, V39, P738; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mariani R, 1996, ARCH PEDIATRIE, V3, P796, DOI 10.1016/0929-693X(96)82164-6; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; SHINAR Y, 1995, J NEUROSCI RES, V42, P516, DOI 10.1002/jnr.490420410; SOCKALOSKY JJ, 1987, J PEDIATR-US, V110, P373, DOI 10.1016/S0022-3476(87)80497-3; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; YAMANAKA C, 1993, EUR J PEDIATR, V152, P99, DOI 10.1007/BF02072482; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288	28	17	17	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0301-0163	1663-2826		HORM RES	Horm. Res.		2007	68			5			14	17		10.1159/000110465			4	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism	247OE	WOS:000252088400006	18174697				2022-02-06	
J	Brown, AW; Malec, JF; Diehl, NN; Englander, J; Cifu, DX				Brown, Allen W.; Malec, James F.; Diehl, Nancy N.; Englander, Jeffrey; Cifu, David X.			Impairment at rehabilitation admission and 1 year after moderate-to-severe traumatic brain injury: A prospective multi-centre analysis	BRAIN INJURY			English	Article						closed head injury; recovery of function; physical examination	LENGTH-OF-STAY; FUNCTIONAL OUTCOMES; TBI PATIENTS; BALANCE; RECOVERY; AMBULATION; DEFICITS; IMPACT; 1-YEAR; STATES	Primary objective: Describe physical impairment at rehabilitation admission and 1- year after moderate- to- severe traumatic brain injury. Research design: Prospective longitudinal multi- centre descriptive analysis. Methods and procedures: Physical examination variables were analysed for all subjects in the Traumatic Brain Injury Model Systems database from 1988 - 2002 that had data both at rehabilitation admission and at 1 year. Main results: Standing balance was more commonly and severely impaired at admission ( 82% of sample impaired) and 1 year ( 24% impaired) compared to other examination variables. Sitting balance was impaired in 52% of the sample at admission, largely resolving ( 5% abnormal) by 1 year. The profile of impaired strength, coordination and tone was similar among the four limbs. Impaired limb strength was most common and persistent over the study period compared to coordination and tone, but strength was normal in greater than 80% of subjects at 1 year. Dysphagia present at admission ( 40% of sample) largely resolved by 1 year ( 0.4% unable to swallow). Impairment in audition and vision was uncommon and changed little during the study period. Conclusions: Acute impairment was present in all variables. A minority of the sample had detectable impairment at 1 year. Standing balance was most severely and persistently impaired.	Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Rochester, MN USA; Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL USA; Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, San Jose, CA 95128 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Brown, AW (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA.	brown.allen@mayo.edu		Brown, Allen W./0000-0001-7228-3351; Cifu, David/0000-0003-1600-9387			Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; BOHANNON RW, 1995, ARCH PHYS MED REHAB, V76, P994, DOI 10.1016/S0003-9993(95)81035-8; Brown AW, 2005, J NEUROTRAUM, V22, P1503; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Hawkins ML, 2005, AM SURGEON, V71, P920; Hillier SL, 1997, BRAIN INJURY, V11, P661; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; McNaughton HK, 2005, ARCH PHYS MED REHAB, V86, P2184, DOI 10.1016/j.apmr.2005.06.010; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Saffle JR, 2005, AM SURGEON, V71, P929; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; *TBIMS, 2002, TRAUM BRAIN INJ MOD; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; WITYK RJ, 1994, STROKE, V25, P362, DOI 10.1161/01.STR.25.2.362; World Health Organization, 2007, INT CLASS FUNCT DIS; Zafonte RD, 1997, BRAIN INJURY, V11, P403	30	17	17	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	7					673	680		10.1080/02699050701468925			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	192LX	WOS:000248204400003	17653941				2022-02-06	
S	Davenport, A		Ronco, C; Bellomo, R; Kellum, JA		Davenport, Andrew			Renal replacement therapy for the patient with acute traumatic brain injury and severe acute kidney injury	ACUTE KIDNEY INJURY	Contributions to Nephrology		English	Article							CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; HEPATIC-ENCEPHALOPATHY; HEMOFILTRATION; MANAGEMENT; DIALYSIS; GUIDE	Fortunately with improvements in initial medical resuscitation, such as the avoidance of nephrotoxins, the incidence of acute kidney injury requiring renal support in patients with acute traumatic brain injury remains low. However the incidence of cerebral hemorrhage in patients on chronic dialysis programs appears to be increasing. By carefully adapting renal replacement to minimize cardiovascular instability and reduce the rate of change of serum osmolality, patient survival in this group of critically ill patients is increasing and starting to approach that of patients with traumatic brain injury without kidney injury. Copyright (C) 2007 S. Karger AG, Basel.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Div Med, Ctr Nephrol, London NW3 2PF, England		Davenport, A (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Div Med, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	andrew.davenport@royalfree.nhs.uk					Andrews PJD, 2006, INTENS CARE MED, V32, P1461, DOI 10.1007/s00134-006-0295-2; BLEI AT, 1993, LANCET, V341, P157, DOI 10.1016/0140-6736(93)90016-A; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P561; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; DAVENPORT A, 1987, BRIT MED J, V295, P1028, DOI 10.1136/bmj.295.6605.1028; Davenport A, 1999, KIDNEY INT, V56, pS62, DOI 10.1046/j.1523-1755.56.s.72.3.x; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; DAVENPORT A, 1991, CLIN NEPHROL, V35, P151; DAVENPORT A, 1990, NEPHROL DIAL TRANSPL, V5, P192, DOI 10.1093/ndt/5.3.192; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Gondo G, 1989, Neurol Med Chir (Tokyo), V29, P1125, DOI 10.2176/nmc.29.1125; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Lo DS, 2006, THROMB RES, V118, P385, DOI 10.1016/j.thromres.2005.03.031; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Pai MF, 2004, RENAL FAILURE, V26, P165, DOI 10.1081/JDI-120038504; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Selby NM, 2006, PERITON DIALYSIS INT, V26, P328	19	17	21	0	1	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0302-5144	1662-2782	978-3-8055-8271-1	CONTRIB NEPHROL	Contrib.Nephrol.		2007	156						333	339		10.1159/000102124			7	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	BGI03	WOS:000247085200036	17464144				2022-02-06	
J	Egeland, J; Langfjaeran, T				Egeland, Jens; Langfjaeran, Tone			Differentiating malingering from genuine cognitive dysfunction using the trail making test-ratio and stroop interference scores	APPLIED NEUROPSYCHOLOGY			English	Article						malingering; stroop; trail making test	TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TEST; DETECTING EXAGGERATION; SUSPECT EFFORT; PERFORMANCE; DEPRESSION; ATTENTION; UTILITY; RATES	Patterns of test performance that are inconsistent with knowledge of brain dysfunction can potentially diffrentiate between malingering and true impairment among litigants with low scores on neuropsychological tests. In this study possible malingerers (11 = 41), impaired (30) or cognitively normal (17) litigants were compared on the Trail Making Test B.-A ratio score and Stroop Interference. The majority of possible malingerers had a low TMT-ratio (< 2.5) and an inverted Stroop effect, whereas the majority of impaired subjects had a high TMT-ratio and specific Stroop interference. Sensitivity to malingering was 61 and 68 percent, and specificity was 57 and 59 percent. This is too low for valid classification of individuals. However, the combination of both measures increases predictability. The clinician is advised to look for other evidence of malingering in cases of simultaneous low TMT-ratio and inverted Stroop. Patients with high TMT-ratio and Stroop interference, should be thoroughly; examined for indications of brain disease.	Vestfold Mental Hlth Care Trust, Dept Res, N-3103 Tonsberg, Norway; Vestfold Mental Hlth Care Trust, No Vestfold Dist Psychiat Ctr, Tonsberg, Norway		Egeland, J (corresponding author), Vestfold Mental Hlth Care Trust, Dept Res, Box 2267, N-3103 Tonsberg, Norway.	jens.egeland@piv.no					Bianchini KJ, 2003, CLIN NEUROPSYCHOL, V17, P574, DOI 10.1076/clin.17.4.574.27946; DELIS D, 1987, CALIFORNIA VERBAL LE; Egeland J, 2003, ACTA PSYCHIAT SCAND, V108, P276, DOI 10.1034/j.1600-0447.2003.00146.x; Egeland J., 2005, TIDSSKRIFT NORSK PSY, V42, P99; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; Golden CJ, 1978, STROOP COLOR WORD TE; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Lemelin S, 1997, J NERV MENT DIS, V185, P542, DOI 10.1097/00005053-199709000-00002; Lu PH, 2004, J CLIN EXP NEUROPSYC, V26, P180, DOI 10.1076/jcen.26.2.180.28082; Martin TA, 2003, APPL NEUROPSYCHOL, V10, P163, DOI 10.1207/S15324826AN1003_05; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morrow L. A., 2001, MED NEUROPSYCHOLOGY; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Osimani A, 1997, J NEUROL NEUROSUR PS, V62, P617, DOI 10.1136/jnnp.62.6.617; Reitan R. M., 1997, DETECTION MALINGERIN; Reitan RM, 1985, HALSTEADREITAN NEURO; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 2003, CLIN NEUROPSYCHOL, V17, P390, DOI 10.1076/clin.17.3.390.18090; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Tedstone D, 2004, DRUG ALCOHOL DEPEN, V75, P277, DOI 10.1016/j.drugalcdep.2004.03.005	24	17	18	1	7	LAWRENCE ERLBAUM ASSOC INC-TAYLOR & FRANCIS	PHILADELPHIA	325 CHESTNUT STREET, STE 800, PHILADELPHIA, PA 19106 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2007	14	2					113	119		10.1080/09084280701319953			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	187ZG	WOS:000247887400006	17523885				2022-02-06	
B	Godefroy, O; Stuss, D		Godefroy, O; Bogousslavsky, J		Godefroy, Olivier; Stuss, Donald			Dysexecutive syndromes	BEHAVIORAL AND COGNITIVE NEUROLOGY OF STROKE			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; WHITE-MATTER LESIONS; FRONTAL-LOBE LESIONS; SUSTAINED ATTENTION DEFICITS; SORTING TEST-PERFORMANCE; DUAL-TASK PERFORMANCE; CLOSED-HEAD INJURY; PREFRONTAL CORTEX; WORKING-MEMORY; EXECUTIVE DYSFUNCTION		[Godefroy, Olivier] Univ Hosp, Dept Neurol, F-80054 Amiens, France; [Stuss, Donald] Rotman Res Inst, Toronto, ON, Canada; [Stuss, Donald] Univ Toronto, Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Godefroy, Olivier] Univ Hosp, Lab Neurosci Fonct & Pathol, CNRE FRE 2726, F-80054 Amiens, France		Godefroy, O (corresponding author), Univ Hosp, Dept Neurol, F-80054 Amiens, France.			Godefroy, Olivier/0000-0001-6789-6620			ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexander MP, 2005, NEUROLOGY, V65, P572, DOI 10.1212/01.wnl.0000172912.07640.92; Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A.D., 1986, WORKING MEMORY; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P119, DOI 10.1080/14640746608400019; Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Benson D.F., 1986, FRONTAL LOBES; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Berger A, 2000, NEUROSCI BIOBEHAV R, V24, P3, DOI 10.1016/S0149-7634(99)00046-9; Beversdorf DQ, 1998, NEUROLOGY, V51, P968, DOI 10.1212/WNL.51.4.968; BOGOUSSLAVSKY J, 1991, ACTA NEUROL SCAND, V83, P309, DOI 10.1111/j.1600-0404.1991.tb04708.x; BOGOUSSLAVSKY J, 1986, STROKE, V17, P434, DOI 10.1161/01.STR.17.3.434; BOGOUSSLAVSKY J, 1988, NEUROLOGY, V38, P837, DOI 10.1212/WNL.38.6.837; BOGOUSSLAVSKY J, 1994, EUR NEUROL, V34, P306, DOI 10.1159/000117068; Buccino G, 2003, ACTA NEUROL SCAND, V107, P330, DOI 10.1034/j.1600-0404.2003.00031.x; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1996, CORTEX, V32, P241, DOI 10.1016/S0010-9452(96)80049-9; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 1996, MEMORY, V4, P359, DOI 10.1080/096582196388906; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; BURGESS PW, 2005, MEASURING MIND SPEED, P215; Burgess PW., 1996, BEHAV ASSESSMENT DYS; CAPLAN LR, 1990, ARCH NEUROL-CHICAGO, V47, P133, DOI 10.1001/archneur.1990.00530020029011; Cowey CM, 1996, MEMORY, V4, P19, DOI 10.1080/741940668; Cramer SC, 1997, STROKE, V28, P2162, DOI 10.1161/01.STR.28.11.2162; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; DALLABARBA G, 1993, CORTEX, V29, P567, DOI 10.1016/S0010-9452(13)80281-X; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; de Bruijn SFTM, 2000, NEUROLOGY, V54, P1687, DOI 10.1212/WNL.54.8.1687; DELIS DC, 1992, NEUROPSYCHOLOGIA, V30, P683, DOI 10.1016/0028-3932(92)90039-O; DELLAROCCHETTA AI, 1993, NEUROPSYCHOLOGIA, V31, P503; Desrosiers J, 1996, STROKE, V27, P1564, DOI 10.1161/01.STR.27.9.1564; DEUTSCH G, 1987, INT J NEUROSCI, V36, P23, DOI 10.3109/00207458709002136; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1997, J NEUROSCI, V17, P9285; DREWE E A, 1975, Cortex, V11, P8; Du AT, 2002, NEUROLOGY, V58, P1635, DOI 10.1212/WNL.58.11.1635; Engstad T, 2003, NEUROEPIDEMIOLOGY, V22, P326, DOI 10.1159/000072921; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fisher C M, 1983, Clin Neurosurg, V31, P9; FLEMINGER S, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003299; Forsyth R., 2003, COCHRANE DB SYST REV, V1; FRITH U, 1989, BRIT J DISORD COMMUN, V24, P123; Fuster, 2015, PREFRONTAL CORTEX; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; Ghika-Schmid F, 2000, ANN NEUROL, V48, P220, DOI 10.1002/1531-8249(200008)48:2<220::AID-ANA12>3.0.CO;2-M; Ghika-Schmid F, 1999, NEUROLOGY, V52, P22, DOI 10.1212/WNL.52.1.22; GLOSSER G, 1990, J CLIN EXP NEUROPSYC, V12, P485, DOI 10.1080/01688639008400995; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; Godefroy O, 1999, CORTEX, V35, P1, DOI 10.1016/S0010-9452(08)70782-2; Godefroy O, 2004, REV NEUROL-FRANCE, V160, P899; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Godefroy O, 2002, NEUROPSYCHOLOGIA, V40, P2234, DOI 10.1016/S0028-3932(02)00109-4; GODEFROY O, 1994, NEUROPSYCHOLOGIA, V32, P983, DOI 10.1016/0028-3932(94)90047-7; Godefroy O, 1998, BRAIN, V121, P1545, DOI 10.1093/brain/121.8.1545; GODEFROY O, 1992, ARCH NEUROL-CHICAGO, V49, P1285, DOI 10.1001/archneur.1992.00530360087023; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; Goel V, 2001, NAT NEUROSCI, V4, P237, DOI 10.1038/85076; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grigsby J, 1998, J AM GERIATR SOC, V46, P590, DOI 10.1111/j.1532-5415.1998.tb01075.x; HABIB M, 1988, REV NEUROL, V144, P571; Harlow J.M., 1993, PUBLICATIONS MASSACH, V4, P274, DOI [DOI 10.1177/0957154X9300401407, https://doi.org/10.1177/0957154X9300401407]; Hecaen H, 1956, TROUBLES MENTAUX COU; Henon H, 1997, STROKE, V28, P2429, DOI 10.1161/01.STR.28.12.2429; Hillis AE, 2000, J NEUROL NEUROSUR PS, V69, P608, DOI 10.1136/jnnp.69.5.608; Hochstenbach J, 1998, J CLIN EXP NEUROPSYC, V20, P503, DOI 10.1076/jcen.20.4.503.1471; Hochstenbach JB, 2003, ARCH PHYS MED REHAB, V84, P1499, DOI 10.1016/S0003-9993(03)00370-8; Hutter B, 2000, NEUROPSYCHOLOGICAL S; HUTTER BO, 1993, NEUROSURGERY, V33, P999; ISHII N, 1986, NEUROLOGY, V36, P340, DOI 10.1212/WNL.36.3.340; Jacobsen CF., 1936, COMP PSYCHOL, V13, P1, DOI DOI 10.1001/ARCHNEURPSYC.1935.02250150108009; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; JASON GW, 1985, NEUROPSYCHOLOGIA, V23, P483, DOI 10.1016/0028-3932(85)90003-X; JETTER W, 1986, CORTEX, V22, P229, DOI 10.1016/S0010-9452(86)80047-8; Kant R, 1998, BRAIN INJURY, V12, P661, DOI 10.1080/026990598122223; Kramer JH, 2002, J NEUROL NEUROSUR PS, V72, P217, DOI 10.1136/jnnp.72.2.217; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Krolak-Salmon P, 2000, EUR NEUROL, V44, P216, DOI 10.1159/000008239; Kumral E, 2002, EUR J NEUROL, V9, P615, DOI 10.1046/j.1468-1331.2002.00452.x; LAPLANE D, 1981, REV NEUROL, V137, P269; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Leskela M, 1999, EUR J NEUROL, V6, P653, DOI 10.1046/j.1468-1331.1999.660653.x; LEVINE B, 1995, J CLIN EXP NEUROPSYC, V17, P740, DOI 10.1080/01688639508405164; Levine B, 1997, NEUROPSYCHOLOGY, V11, P367, DOI 10.1037/0894-4105.11.3.367; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; LJUNGGREN B, 1985, J NEUROSURG, V62, P673, DOI 10.3171/jns.1985.62.5.0673; Loetscher T., COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002842, DOI 10.1002/14651858.CD002842]; Luria A.R., 1966, HIGHER CORTICAL FUNC; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; MAHALICK DM, 1993, NEUROSURGERY, V33, P563, DOI 10.1227/00006123-199310000-00003; MALLOY PF, 1994, J NEUROPSYCH CLIN N, V6, P399; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; Martin Claudine, 2002, Appl Neuropsychol, V9, P148, DOI 10.1207/S15324826AN0903_3; Mayer SA, 2002, NEUROLOGY, V59, P1750, DOI 10.1212/01.WNL.0000035748.91128.C2; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MENDEZ MF, 1989, NEUROLOGY, V39, P349, DOI 10.1212/WNL.39.3.349; MESSERLI P, 1979, SCHWEIZ ARCH NEUROL, V125, P23; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; MISHKIN M, 1964, FRONTAL GRANULAR COR, P219; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Mungas D, 2001, NEUROLOGY, V57, P2229, DOI 10.1212/WNL.57.12.2229; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; O'Brien JT, 2002, ANN NY ACAD SCI, V977, P436, DOI 10.1111/j.1749-6632.2002.tb04849.x; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Pandya DN, 1996, PHILOS T ROY SOC B, V351, P1423, DOI 10.1098/rstb.1996.0127; PEDRAZZI P, 1990, REV NEUROL, V146, P726; PERCHERON G, 1976, REV NEUROL, V132, P297; PERCHERON G, 1976, REV NEUROL, V132, P309; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; PILLON B, 1993, ARCH NEUROL-CHICAGO, V50, P374, DOI 10.1001/archneur.1993.00540040036010; Pohjasvaara T, 2000, ARCH NEUROL-CHICAGO, V57, P1295, DOI 10.1001/archneur.57.9.1295; Pohjasvaara T, 2002, EUR J NEUROL, V9, P269, DOI 10.1046/j.1468-1331.2002.00396.x; Pohjasvaara T, 2003, ALZ DIS ASSOC DIS, V17, P236, DOI 10.1097/00002093-200310000-00007; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; RAMIER AM, 1970, REV NEUROL, V123, P17; Rasquin SMC, 2004, DEMENT GERIATR COGN, V18, P138, DOI 10.1159/000079193; Rasquin SMC, 2002, J NEUROL SCI, V203, P115, DOI 10.1016/S0022-510X(02)00264-2; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; Roberts AC, 1996, PHILOS T R SOC B, V351, P1389, DOI 10.1098/rstb.1996.0122; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rolls ET, 2000, ANNU REV PSYCHOL, V51, P599, DOI 10.1146/annurev.psych.51.1.599; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Rousseaux M, 1996, REV NEUROL-FRANCE, V152, P678; Roussel-Pieronne M., REV NEUROPS IN PRESS; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Rueckert L, 1998, NEUROPSYCHOLOGIA, V36, P653, DOI 10.1016/S0028-3932(97)00150-4; Rylander G., 1939, ACTA PSYCHIAT NE S20, V113, P3; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Saint-Cyr JA, 2003, J INT NEUROPSYCH SOC, V9, P103, DOI 10.1017/S1355617703910125; SANIDES F, 1970, Zeitschrift fuer Mikroskopisch-Anatomische Forschung (Leipzig), V82, P570; Sarazin M, 2003, J NEUROL, V250, P827, DOI 10.1007/s00415-003-1087-z; Schmahmann JD, 2003, STROKE, V34, P2264, DOI 10.1161/01.STR.0000087786.38997.9E; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Schnider A, 2000, NEUROLOGY, V55, P74, DOI 10.1212/WNL.55.1.74; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; SHALLICE T, 1989, BRAIN, V112, P1587, DOI 10.1093/brain/112.6.1587; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1990, NEUROPSYCHOLOGICAL I, P11, DOI DOI 10.1017/CBO9780511665547.003; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; Shankle WR, 1995, ALZ DIS ASSOC DIS, V9, P233, DOI 10.1097/00002093-199509040-00010; Showalter PEC, 2000, J NEUROPSYCH CLIN N, V12, P395; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; STARKSTEIN SE, 1988, BRAIN, V111, P375, DOI 10.1093/brain/111.2.375; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [https://doi.org/10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355]; Stuss D. T., 1987, J NEUROLOGICAL REHAB, V1, P19, DOI DOI 10.1177/136140968700100105; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2002, NEUROPSYCHOLOGY, V16, P500, DOI 10.1037//0894-4105.16.4.500; Stuss DT, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P215; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Sunderland A, 1999, STROKE, V30, P949, DOI 10.1161/01.STR.30.5.949; Tariot PN, 1999, J CLIN PSYCHIAT, V60, P684, DOI 10.4088/JCP.v60n1007; Tariot PN, 1998, AM J PSYCHIAT, V155, P54, DOI 10.1176/ajp.155.1.54; TATEMICHI TK, 1993, ANN NEUROL, V33, P568, DOI 10.1002/ana.410330603; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; TIDSWELL P, 1995, NEUROLOGY, V45, P875; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; TRUELLE JL, 1995, NEUROPSY NEUROPSY BE, V8, P14; Tullberg M, 2004, NEUROLOGY, V63, P246, DOI 10.1212/01.WNL.0000130530.55104.B5; UMILTA C, 1992, EUR J COGN PSYCHOL, V4, P21, DOI 10.1080/09541449208406241; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Vataja R, 2003, EUR J NEUROL, V10, P625, DOI 10.1046/j.1468-1331.2003.00676.x; WEILLER C, 1990, ARCH NEUROL-CHICAGO, V47, P1085, DOI 10.1001/archneur.1990.00530100051013; Wheeler M A, 1995, J Int Neuropsychol Soc, V1, P525; Wheeler MA, 2003, CORTEX, V39, P827, DOI 10.1016/S0010-9452(08)70866-9; WIEGERSMA S, 1990, NEUROPSYCHOLOGIA, V28, P95, DOI 10.1016/0028-3932(90)90089-7; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; WINOCUR G, 1990, BEHAV NEUROSCI, V104, P544, DOI 10.1037/0735-7044.104.4.544; WOLFE N, 1990, ARCH NEUROL-CHICAGO, V47, P129, DOI 10.1001/archneur.1990.00530020025010; [No title captured]	204	17	17	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-52184-261-7				2007							369	406		10.1017/CBO9780511544880.020	10.1017/CBO9780511544880		38	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BYC38	WOS:000297924800020					2022-02-06	
J	Marsh, NV; Kersel, DA				Marsh, Nigel V.; Kersel, Denyse A.			Frequency of behavioural problems at one year following traumatic brain injury: Correspondence between patient and caregiver reports	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							CLOSED-HEAD-INJURY; PSYCHOSOCIAL RECOVERY; ADJUSTMENT; RELATIVES; DISORDER; FAMILY; IMPACT	A group of 62 adults with significant (i.e., ventilation required for > 24 hours) traumatic brain injury (TBI) were assessed approximately one year following their injury. The people with TBI and their primary caregivers completed the patient and relative/friend versions respectively, of the 20-item Head Injury Behaviour Rating Scale (HIBS). Responses by the patient and caregiver groups were compared for the total number of problems reported and the frequency of specific problem behaviours. The caregiver group reported a greater total number of problem behaviours and a higher frequency for 19 of the 20 specific behaviours. These differences between the patients' and caregivers' reports were statistically significant for seven of the 19 problem behaviours. The majority (86%) of these significant differences were on items from the Behavioural Regulation, rather than the Emotional Regulation, subscale of the HIBS. The implications of these findings for the practice of neuropsychological rehabilitation are presented.	Univ New England, Sch Psychol, Armidale, NSW 2351, Australia; Community Treatment Ctr Brain Injury, Glasgow, Lanark, Scotland		Marsh, NV (corresponding author), Univ New England, Sch Psychol, Armidale, NSW 2351, Australia.	nigel.marsh@une.edu.au	Marsh, Nigel V./F-5433-2019; Marsh, Nigel/ABA-3609-2021	Marsh, Nigel V./0000-0002-4060-6432; Marsh, Nigel/0000-0002-4060-6432			Brooks D N, 1979, Int Rehabil Med, V1, P160; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Cohen J., 2013, STAT POWER ANAL BEHA; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Havill JH, 1998, NEW ZEAL MED J, V111, P161; JENNETT B, 1975, LANCET, V1, P480; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Marsh NV, 1990, NEUROPSYCHOLOGY, V4, P13, DOI 10.1037/0894-4105.4.1.13; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; MARSH NV, 1999, BRAIN DAM B, P175; MCKINLAY W, 1999, REHABILITATION ADULT, P74; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Smith LM, 1995, FAMILY SUPPORT PROGR; TEASDALE G, 1974, LANCET, V2, P81; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742	34	17	18	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	DEC	2006	16	6					684	694		10.1080/09602010500220290			11	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	118JY	WOS:000242939800006	17127573				2022-02-06	
J	Pero, S; Incoccia, C; Caracciolo, B; Zoccolotti, P; Formisano, R				Pero, Sergio; Incoccia, Chiara; Caracciolo, Barbara; Zoccolotti, Pierluigi; Formisano, Rita			Rehabilitation of attention in two patients with traumatic brain injury by means of 'attention process training'	BRAIN INJURY			English	Article						brain injury; attention; rehabilitation	CLOSED-HEAD-INJURY; SUSTAINED ATTENTION; DEFICITS; PROGRAM; TASK; PERFORMANCE; MEMORY	Primary objective: This case study aims to evaluate the effectiveness of the Solhberg and Mateer's Attention Process Training ( APT) using a comprehensive evaluation of various attentional processes. Methods and procedures: Two patients with severe traumatic brain injury were given the APT in a chronic phase. Attentional processes were evaluated at various stages before, during and after treatment, using the Testbatterie zur Aufmerksamkeitsprufung and the Test of everyday attention. Main outcomes and results: Both patients showed some degree of recovery, particularly in attentional tasks with a selective component. Lesser improvement was present in the case of tasks mapping on the intensity dimension of attention ( alertness, vigilance). Training achievements were confirmed by the use of a functional scale evaluating attention, pointing to the generality of improvements. Conclusion: The results indicate selective training effects of APT on the attentional disturbances of TBI patients.	Fdn Santa Lucia, IRCCS, Ctr Ric Neuropsicol, I-00179 Rome, Italy; Karolinska Inst, Div Geriatr Epidemiol, Stockholm, Sweden; Univ Roma La Sapienza, Dept Psychol, Rome, Italy		Pero, S (corresponding author), Fdn Santa Lucia, IRCCS, Ctr Ric Neuropsicol, Via Ardeatina 306, I-00179 Rome, Italy.	s.pero@hsantalucia.it	Zoccolotti, Pierluigi/H-4437-2019	Zoccolotti, Pierluigi/0000-0002-6351-2455; Incoccia, Chiara/0000-0003-4068-6548			Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Ben-Yishay Y., 1987, NEUROPSYCHOLOGICAL R, P165; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; CANTAGALLO A, 1998, RASSEGNA PSICOLOGIA, V15, P137; CAPITANI E, 1999, HDB CLIN EXPT NEUROP, P57; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; FEINSTEIN A, 1994, J CLIN EXP NEUROPSYC, V16, P436, DOI 10.1080/01688639408402654; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI DOI 10.1080/09602019208401399; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P89; LEVIN HS, 1988, SCAND J REHABIL MED, P33; Lienert G.A., 1969, TESTAUFBAU TESTANALY; MACCIOCCHI SN, 1990, J CLIN PSYCHOL, V46, P628, DOI 10.1002/1097-4679(199009)46:5<628::AID-JCLP2270460514>3.0.CO;2-V; Miceli G, 1994, BATTERIA ANAL DEFICI; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Park NW, 1999, NEUROPSYCHOL REHABIL, V9, P135, DOI 10.1080/713755595; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; Robertson I., 1994, TEST EVERYDAY ATTENT; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; SAMPSON H, 1961, AUST J PSYCHOL, V13, P185, DOI 10.1080/00049536108256002; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spinnler H, 1987, ITAL J NEUROL SCI, V6, P5; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Sturm W, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P365; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Whyte J, 1997, NEUROPSYCHOLOGIA, V35, P313, DOI 10.1016/S0028-3932(96)00092-9; Zimmermann P., 1992, TESTBATTERIE AUFMERK; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	43	17	18	0	21	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2006	20	11					1207	1219		10.1080/02699050600983271			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	110DD	WOS:000242357600011	17123937				2022-02-06	
J	Prigozen, JM; Horswell, BB; Flaherty, SK; Henderson, JM; Graham, DA; Armistead, LM; Habib, JH; Lukowski, DE				Prigozen, Jason M.; Horswell, Bruce B.; Flaherty, Sarah K.; Henderson, James M.; Graham, David A.; Armistead, Lauren M.; Habib, Joseph H.; Lukowski, David E.			All-terrain vehicle-related maxillofacial trauma in the pediatric population	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							INJURIES; CHILDREN; COLLISIONS; ACCIDENTS	Purpose: Nearly 40% of ati-terrain vehicle (ATV) crash-related fatalities involve pediatric patients, with many of these patients dying from head and neck injuries. West Virginia is in a unique position to examine these injuries because of its high rate of ATV use. This study examines craniofacial ATV-related trauma in children. Patients and Methods: We conducted a single-center, retrospective, descriptive study of 26 children presenting with a craniofacial injury(ies) resulting from an ATV crash from January 2001 to December 2004. Results: Twenty-six children (65% boys) with a mean age of 13.1 years presented with craniofacial injuries during the study period. Two patients were helmeted. Mortality was 3.8% (n = 1, head injury related, postinjury day 3). Patients were most often drivers of the ATV (65%), although girls were more likely to be passengers (P = .03). Facial contusions, lacerations, and abrasions were highly prevalent (62%, 69%, 65%, respectively), as were fractures of the facial bones and skull (77%). Thirty-five percent sustained closed head injuries, which were significantly associated with mandible fractures (odds ratio 12.8%; 95% CI, 1.15-143). Mean length of hospital stay was 4.6 +/- 5 days, and 36% required an ICU stay (mean, 5.1 +/- 3 days). Twenty-four percent required ventilator support (mean, 107 +/- 43 hours; range, 48 to 168 hours). Operative intervention was required in 72% of patients (n = 18). Conclusion: Maxillofacial injury patterns from ATV-related crashes in children suggest a high percentage of significant facial injuries and closed head injuries. As new ATV legislation that addresses operator use is enacted, a decrease in the number and severity of craniofacial injuries may be seen. (c) 2006 American Association of Oral and Maxillofacial Surgeons.	CAMC Inst, Charleston, WV 25304 USA; W Virginia Univ, Sch Med, Charleston Div, Dept Surg, Charleston, WV 25304 USA; Charleston Area Med Ctr, Dept Surg, Sect Maxillofacial Surg, Charleston, WV 25304 USA; Charleston Area Med Ctr, Hlth Educ & Res Inst, Charleston, WV 25304 USA; Charleston Area Med Ctr, Dept Surg, Sect Maxillofacial Surg, Charleston, WV USA		Flaherty, SK (corresponding author), CAMC Inst, 3211 MacCorkle Ave SE, Charleston, WV 25304 USA.	sarah.flaherty@camc.org					Bhutta ST, 2004, PEDIATR RADIOL, V34, P130, DOI 10.1007/s00247-003-1085-4; Brown RL, 2002, J PEDIATR SURG, V37, P375, DOI 10.1053/jpsu.2002.30826; Carlin C B, 1998, J Craniomaxillofac Trauma, V4, P44; DEMAS PN, 1992, J ORAL MAXIL SURG, V50, P1280, DOI 10.1016/0278-2391(92)90227-Q; Fischer K, 2001, PLAST RECONSTR SURG, V108, P328, DOI 10.1097/00006534-200108000-00006; FRIEDMAN R, 1988, LARYNGOSCOPE, V98, P1251; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; Helmkamp JC, 2001, AM J PUBLIC HEALTH, V91, P1792, DOI 10.2105/AJPH.91.11.1792; Holmes PJ, 2004, J ORAL MAXIL SURG, V62, P697, DOI 10.1016/j.joms.2003.12.011; Keenan HT, 2004, PEDIATRICS, V113, pE330, DOI 10.1542/peds.113.4.e330; Marciani RD, 1999, J ORAL MAXIL SURG, V57, P119, DOI 10.1016/S0278-2391(99)90221-5; MCCORMICK G, 2004, PRIVATE PROPERTY CON; Moore EE, 2003, TRAUMA; *NSKC, 2004, INJ FACTS CHILDR RIS; Rodgers GB, 2002, INJ PREV, V8, P42, DOI 10.1136/ip.8.1.42; Touma BJ, 1999, OTOLARYNG HEAD NECK, V121, P736, DOI 10.1053/hn.1999.v121.a98198; U.S. Consumer Product Safety Commission, 1998, ALL TERR VEH EXP INJ; *W VIRG U CTR RUR, 2003, CURR ATV FACTS W VIR; 2003, ALL TERRAIN VEHICLE; 2002, ALL TERRAIN VEHICLE	21	17	19	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	SEP	2006	64	9					1333	1337		10.1016/j.joms.2006.05.014			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	078OW	WOS:000240114100002	16916665				2022-02-06	
J	Bittner, RM; Crowe, SF				Bittner, Robyn M.; Crowe, Simon F.			The relationship between naming difficulty and FAS performance following traumatic brain injury	BRAIN INJURY			English	Article						verbal fluency; word fluency; naming difficulty; FAS language; TBI	CLOSED-HEAD-INJURY; VERBAL FLUENCY; WORD-FLUENCY; FRONTAL-LOBE; DISSOCIATION; IMPAIRMENT; APHASIA; LESIONS; MEMORY; ADULTS	Primary objective: To investigate the relationship between naming difficulty (ND) and FAS performance in traumatic brain injury (TBI). Methods and procedure: Sixty-three patients with a TBI were divided into two groups based on the presence of a ND and were compared with a control group on FAS performance. Results: Whilst the group with a TBI performed more poorly than the control group on the FAS task, there was no difference between those participants who featured a ND and those who did not. The TBIs produced fewer words than the control group in the first time slice of the task, but there was no difference between the group with a ND and the non-ND group on this measure. Conclusion: The results indicate that the effect of word finding deficits is not the principal cause of the diminution of phonemic verbal fluency performance in TBI, which is probably more likely due to compromise in speed of information processing associated with the injury.	La Trobe Univ, Fac Sci Technol & Engn, Sch Psychol Sci, Bundoora, Vic 3086, Australia		Crowe, SF (corresponding author), La Trobe Univ, Fac Sci Technol & Engn, Sch Psychol Sci, Bundoora, Vic 3086, Australia.	s.crowe@latrobe.edu.au		Crowe, Simon/0000-0002-4407-8542			Au R, 1995, AGING COGNITION, V2, P300, DOI 10.1080/13825589508256605; BITTNER RM, 1998, THESIS U SO QUEENSLA; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BUNN T, 1995, ED CHILD PSYCHOL, V12, P46; Capitani E, 1998, CORTEX, V34, P779, DOI 10.1016/S0010-9452(08)70781-0; CROWE SF, 1992, J CLIN EXP NEUROPSYC, V14, P327, DOI 10.1080/01688639208402832; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; CROWE SF, 1996, PSYCHIAT PSYCHOL LAW, V3, P39, DOI DOI 10.1080/13218719609524873; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; Fernaeus SE, 2001, DEMENT GERIATR COGN, V12, P52, DOI 10.1159/000051235; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HOLLAND AL, 1982, P C CLIN APH JUN 6 1, P345; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kaplan E, 1983, BOSTON NAMING TEST; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Killgore WDS, 1999, PERCEPT MOTOR SKILL, V89, P327, DOI 10.2466/PMS.89.5.327-337; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Morse P, 1992, CLIN SYNDROMES ADULT, P85; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Randolph C, 1999, ARCH CLIN NEUROPSYCH, V14, P489, DOI 10.1016/S0887-6177(98)00023-7; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Thompson LI, 1989, CLIN NEUROPSYCHOL, V3, P184, DOI [DOI 10.1080/13854048908403291, 10.1080/13854048908403291]; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, J CLIN EXP NEUROPSYC, V19, P922, DOI 10.1080/01688639708403773; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Wechsler D., 1997, WECHSLER INTELLIGENC	38	17	17	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2006	20	9					971	980		10.1080/02699050600909763			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	094ZN	WOS:000241278100009	17062428				2022-02-06	
J	Javouhey, E; Guerin, AC; Amoros, E; Haddak, M; Ndiaye, A; Floret, D; Chiron, M				Javouhey, Etienne; Guerin, Anne-Celine; Amoros, Emmanuele; Haddak, Mouloud; Ndiaye, Amina; Floret, Daniel; Chiron, Mireille			Severe outcome of children following trauma resulting from road accidents	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						outcome prediction; paediatric; registry; road accident; traumatic brain injury	SEVERE HEAD-INJURY; BRAIN-INJURY; EARLY INTERVENTION; MULTIPLE INJURIES; PEDIATRIC TRAUMA; EPIDEMIOLOGY; ADOLESCENTS; DISABILITY; SURVIVAL; CARE	Objective: The aim of the study was to determine the risk factors of a severe outcome for children severely injured [killed or with an Injury Severity Score (ISS) >= N16] in a road accident. Materials and methods: Casualties that occurred between 1996 and 2001 which involved children under 14 years of age were assessed in a population-based study based on data included in a French road trauma Registry. A severe traumatic brain injury (TBI) was defined as a head injury with an Abbreviated Injury Scale (AIS) severity score >= 3. A multivariate logistic regression was performed to quantify the risk of a "severe outcome" defined as death or an expected serious impairment 1 year later. Results: The annual incidence of an ISS of 16+ was 7.7 per 100,000 children. Among the 126 severely injured children included in this study, 40 died (including 16 immediate deaths), and a severe outcome was expected for 54 of the 86 survivors. Children with an "isolated severe TBI" and those with "multiple injuries including TBI" were more likely to have a severe outcome than those who had an "isolated severe injury without TBI" (OR: 7.91; 95%CI: 1.43-43.77 and OR: 8.37; 95%CI: 1.52-46.13, respectively). Age was inversely linked to a severe outcome. The unprotected motor vehicle occupants (MVO) had an odds ratio of 7.56 (95%CI: 1.07-53.56) compared to the protected MVO. Only 30% of children who survived a severe TBI were admitted to rehabilitation. Conclusions: The mechanism of the injury, an injury pattern involving the head and a young age were associated with a severe outcome following a road accident. A majority of children severely injured were not referred to inpatient rehabilitation.	Hosp Civils Lyon, Hop Edouard Herriot, Pediat Intens Care Unit, F-69437 Lyon 03, France; Univ Lyon 1, UMRESTTE, Joint Unit Inrets, French Natl Inst Transport & Safety Res, Bron, France; Natl Inst Publ Hlth Surveillance, InVS, Bron, France		Javouhey, E (corresponding author), Hosp Civils Lyon, Hop Edouard Herriot, Pediat Intens Care Unit, Pl Arsonval, F-69437 Lyon 03, France.	etienne.javouhey@chu-lyon.fr	Haddak, Mouloud/AAC-4942-2019; Javouhey, Etienne/G-3651-2013; Amoros, Emmanuelle/G-4334-2013	Haddak, Mouloud/0000-0003-0633-3167; 			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS56; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; [Anonymous], 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; Calkins CM, 2002, J TRAUMA, V53, P1058, DOI 10.1097/00005373-200212000-00005; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; HU XH, 1994, J TRAUMA, V37, P209, DOI 10.1097/00005373-199408000-00010; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Laumon B, 2002, REV EPIDEMIOL SANTE, V50, P277; Laumon B, 1997, 41 ANN P ASS ADV AUT, P127; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Macpherson AK, 2003, J TRAUMA, V55, P454, DOI 10.1097/01.TA.0000042158.79688.51; Masson F, 1996, ARCH PEDIATRIE, V3, P651, DOI 10.1016/0929-693X(96)87085-0; MAZUREK AJ, 1994, J ACCID EMERG MED, V11, P9; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Nybo T, 1999, BRAIN INJURY, V13, P759; OSBERG JS, 1990, AM J PHYS MED REHAB, V69, P67, DOI 10.1097/00002060-199004000-00004; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Robertson Charlene M T, 2002, Pediatr Crit Care Med, V3, P345, DOI 10.1097/00130478-200210000-00003; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Suominen P, 1998, INJURY, V29, P425; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tomlin P, 2002, DEV MED CHILD NEUROL, V44, P828; Valadka S, 2000, J PEDIATR SURG, V35, P684, DOI 10.1053/jpsu.2000.5943; VANDERSLUIS CK, 1995, J TRAUMA, V38, P681, DOI 10.1097/00005373-199505000-00001; WALLER JA, 1995, J TRAUMA, V39, P949, DOI 10.1097/00005373-199511000-00021; WESSON DE, 1992, J TRAUMA, V33, P252, DOI 10.1097/00005373-199208000-00015	39	17	17	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	AUG	2006	165	8					519	525		10.1007/s00431-006-0118-z			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	058SH	WOS:000238684400003	16649025				2022-02-06	
J	Noppens, RR; Christ, M; Brambrink, AM; Koerner, IP; Heimann, A; Kempski, O				Noppens, Ruediger R.; Christ, Michael; Brambrink, Ansgar M.; Koerner, Ines P.; Heimann, Axel; Kempski, Oliver			An early bolus of hypertonic saline hydroxyethyl starch improves long-term outcome after global cerebral ischemia	CRITICAL CARE MEDICINE			English	Article						rats; cerebral ischemia; cerebral resuscitation; hypertonic saline; hydroxyethyl starch; histopathology; neurological deficit; survival	7.5-PERCENT SODIUM-CHLORIDE; SMALL-VOLUME RESUSCITATION; NO-REFLOW PHENOMENON; BLOOD-FLOW; HYPOBARIC HYPOTENSION; HEMORRHAGIC-SHOCK; BRAIN; RATS; MECHANISMS; OCCLUSION	Objective: The beneficial effect of hypertonic saline solutions in the emergency treatment of shock and traumatic brain injury is well described. The present study determines effects of a single bolus of hypertonic saline on long-term survival, neurologic function, and neuronal survival 10 days after global cerebral ischemia. In addition, we evaluated the therapeutic window for hypertonic saline treatment (early vs. delayed application). Design: Laboratory experiment. Setting: University laboratory. Subjects. Male Wistar rats weighing 240-330 g. Interventions. Rats were submitted to temporal global cerebral ischemia using temporary bilateral carotid occlusion combined with hypobaric hypotension. Animals received 7.5% saline/6% hydroxyethyl starch (HHS) or vehicle (NaCl 0.9%) at either 1.5 mins (early treatment) or 31.5 mins (delayed treatment) of reperfusion. Regional cerebral blood flow (rCBF) and physiologic variables were measured during insult and early reperfusion. Animal survival and neurologic function were evaluated throughout the 10-day observation period. Quantification of brain injury was performed on day 10. Measurements and Main Results., Early treatment with HHS resulted in a robust restoration of rCBF after ischemia, reduced postischemic mortality by 77% (9% vs. 39% in vehicle-treated controls), ameliorated neurologic performance (Neuro-Deficit-Score 10 days after insult, 96 +/- 0.7 vs. 85 +/- 1.4, mean +/- SE), and almost blunted neuronal cell death (hippocampal CA1, 2150 +/- 191 vs. 884 +/- 141 neurons/mm(2); cortex, 1746 +/- 91 vs. 1060 +/- 112). In contrast, delayed treatment resulted in no sustained effects. Conclusions. Timing of HHS treatment is critical after experimental global cerebral ischemia to reduce mortality, improve neurologic function, and neuronal survival. Our results suggest that early application of HHS may be a potential neuroprotective strategy after global cerebral ischemia.	Johannes Gutenberg Univ Mainz, Dept Anesthesiol, D-6500 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, D-6500 Mainz, Germany		Noppens, RR (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, D-6500 Mainz, Germany.		Christ, Michael/AAQ-8121-2020	Christ, Michael/0000-0001-7977-0195; Heimann, Axel/0000-0003-2510-3228			AMES A, 1968, AM J PATHOL, V52, P437; AYUS JC, 1985, AM J PHYSIOL, V248, pF711, DOI 10.1152/ajprenal.1985.248.5.F711; BEHRMAN SW, 1991, J TRAUMA, V31, P589, DOI 10.1097/00005373-199105000-00001; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Bentsen G, 2004, ACTA ANAESTH SCAND, V48, P1089, DOI 10.1111/j.1399-6576.2004.00497.x; Bhardwaj A, 2000, STROKE, V31, P1694, DOI 10.1161/01.STR.31.7.1694; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Brambrink AM, 1999, J NEUROSCI METH, V92, P111, DOI 10.1016/S0165-0270(99)00100-4; Brambrink AM, 2000, J CEREBR BLOOD F MET, V20, P1425, DOI 10.1097/00004647-200010000-00004; Breil M, 2003, RESUSCITATION, V56, P307, DOI 10.1016/S0300-9572(02)00377-5; Ciesla DJ, 2001, SURGERY, V129, P567, DOI 10.1067/msy.2001.113286; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; DEFELIPPE J, 1980, LANCET, V2, P1002; DIRNAGL U, 1993, NEUROL RES, V15, P128; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; FISCHER EG, 1977, STROKE, V8, P36, DOI 10.1161/01.STR.8.1.36; Fischer M, 2002, RESUSCITATION, V54, P269, DOI 10.1016/S0300-9572(02)00151-X; Fischer M, 1996, RESUSCITATION, V32, P227, DOI 10.1016/0300-9572(96)00953-7; FISHER M, 1995, INTENS CARE MED, V21, P132, DOI 10.1007/BF01726536; GINSBERG MD, 1972, NEUROLOGY, V22, P998, DOI 10.1212/WNL.22.9.998; Hamaguchi S, 2002, CAN J ANAESTH, V49, P745, DOI 10.1007/BF03017456; Hauck EF, 2004, J CEREBR BLOOD F MET, V24, P383, DOI 10.1097/00004647-200404000-00003; Heimann A, 2003, CRIT CARE MED, V31, P2495, DOI 10.1097/01.CCM.0000084893.44650.CB; HEIMANN A, 1994, J CEREBR BLOOD F MET, V14, P1100, DOI 10.1038/jcbfm.1994.144; HURN PD, 1995, J CEREBR BLOOD F MET, V15, P666, DOI 10.1038/jcbfm.1995.82; Jonas J, 2000, SHOCK, V14, P24, DOI 10.1097/00024382-200014010-00005; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kempski O, 1996, ACT NEUR S, V66, P114; Kolsen-Petersen JA, 2004, ACTA ANAESTH SCAND, V48, P667, DOI 10.1111/j.1399-6576.2004.00396.x; Kreimeier U, 2002, ACTA ANAESTH SCAND, V46, P625, DOI 10.1034/j.1399-6576.2002.460601.x; MANINGAS PA, 1987, CRIT CARE MED, V15, P1121, DOI 10.1097/00003246-198712000-00009; Mazzoni MC, 1995, INT J MICROCIRC, V15, P265, DOI 10.1159/000179028; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; Orlic T, 2002, AM J PHYSIOL-CELL PH, V282, pC1261, DOI 10.1152/ajpcell.00479.2001; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Soehle M, 2001, J NEUROSCI METH, V110, P91, DOI 10.1016/S0165-0270(01)00422-8; Soehle M, 1998, STROKE, V29, P1240, DOI 10.1161/01.STR.29.6.1240; Soupart A, 1996, J NEUROPATH EXP NEUR, V55, P106, DOI 10.1097/00005072-199601000-00011; STRECKER U, 1993, INT CONGR SER, V1031, P63; Uhl E, 2000, J CEREBR BLOOD F MET, V20, P979, DOI 10.1097/00004647-200006000-00010; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664, DOI 10.1152/ajpheart.1980.239.5.H664	43	17	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2006	34	8					2194	2200		10.1097/01.CCM.0000228915.94169.B1			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067WU	WOS:000239334100024	16775566				2022-02-06	
J	Axelsson, V; Holback, S; Sjogren, M; Gustafsson, H; Forsby, A				Axelsson, V.; Holback, S.; Sjogren, M.; Gustafsson, H.; Forsby, A.			Gliotoxin induces caspase-dependent neurite degeneration and calpain-mediated general cytotoxicity in differentiated human neuroblastoma SH-SY5Y cells	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						gliotoxin; mycotoxin; caspase; calpain; neurite degeneration; cytotoxicity; SH-SY5Y cells	ACID-INDUCED DIFFERENTIATION; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; ASPERGILLUS-FUMIGATUS; BLASTOMA CELLS; II-SPECTRIN; APOPTOSIS; ACTIVATION; MYCOTOXINS; CLEAVAGE	In this study, a significant increase by 50% in intracellular free calcium concentration ([Ca2+](i)) was observed in differentiated human neuroblastoma (SH-SY5Y) cells after exposure to 0.25 mu M of the fungal metabolite gliotoxin for 72 h. Further, the involvement of caspases and calpains was demonstrated to underlie the gliotoxin-induced cytotoxic and neurite degenerative effects. The caspase inhibitor Z-VAD-fmk almost completely reduced the neurite degeneration from 40% degeneration of neurites to 5% as compared to control. Inhibition of calpains with calpeptin significantly attenuated gliotoxin-induced cytotoxicity, determined as reduction in total cellular protein content, from 43% to 14% as compared to control cells. Western blot analyses of alpha II-spectrin breakdown fragments confirmed activity of the proteases, and that all-spectrin was cleaved by caspases in gliotoxin-exposed cells. These results show that calpains and caspases have a role in the toxicity of gliotoxin in differentiated SH-SY5Y cells and that the process may be Ca2+-mediated. (c) 2006 Elsevier Inc. All rights reserved.	Stockholm Univ, Arrhenius Labs Nat Sci, Dept Neurochem, S-10691 Stockholm, Sweden		Axelsson, V (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Neurochem, S-10691 Stockholm, Sweden.	viktoria@neurochem.su.se		Forsby, Anna/0000-0001-6298-201X			Axelsson V, 2006, CELL BIOL TOXICOL, V22, P127, DOI 10.1007/s10565-006-0048-6; Banik NL, 1997, ANN NY ACAD SCI, V825, P120, DOI 10.1111/j.1749-6632.1997.tb48421.x; BAUER J, 1989, J MED VET MYCOL, V27, P45; BIEDLER JL, 1973, CANCER RES, V33, P2643; Bizat N, 2003, J BIOL CHEM, V278, P43245, DOI 10.1074/jbc.M305057200; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; CICCARONE V, 1989, CANCER RES, V49, P219; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Forsby A, 1995, ATLA-ALTERN LAB ANIM, V23, P800; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GORDON KE, 1993, CAN J NEUROL SCI, V20, P237, DOI 10.1017/S0317167100048010; Green D, 2000, J MEMBRANE BIOL, V175, P223, DOI 10.1007/s002320001070; Grynspan F, 1997, J NEUROSCI RES, V48, P181; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hurne AM, 2002, J BIOL CHEM, V277, P31631, DOI 10.1074/jbc.M201699200; Ivins KJ, 1998, NEUROBIOL DIS, V5, P365, DOI 10.1006/nbdi.1998.0228; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kweon YO, 2003, J HEPATOL, V39, P38, DOI 10.1016/S0168-8278(03)00178-8; LAMBERT DG, 1990, BIOCHEM J, V265, P555, DOI 10.1042/bj2650555; LAND CJ, 1987, APPL ENVIRON MICROB, V53, P787, DOI 10.1128/AEM.53.4.787-790.1987; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LOPACHIN RM, 1994, NEUROTOXICOLOGY, V15, P247; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McGinnis KM, 1999, J NEUROCHEM, V72, P1853, DOI 10.1046/j.1471-4159.1999.0721853.x; MULLBACHER A, 1986, MOL IMMUNOL, V23, P231, DOI 10.1016/0161-5890(86)90047-7; Murray SS, 1997, EXP CELL RES, V233, P297, DOI 10.1006/excr.1997.3550; Nordin-Andersson M, 2003, CELL BIOL TOXICOL, V19, P43, DOI 10.1023/A:1022017731328; Nordin-Andersson M, 1998, TOXICOL IN VITRO, V12, P557, DOI 10.1016/S0887-2333(98)00035-6; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Rami A, 1997, NEUROSCI RES, V27, P93, DOI 10.1016/S0168-0102(96)01123-6; Richard JL, 1996, MYCOPATHOLOGIA, V134, P167, DOI 10.1007/BF00436725; RICHARD JL, 1994, J MED VET MYCOL, V32, P169; Rotter B, 2004, BIOCHEM J, V378, P161, DOI 10.1042/BJ20030955; Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x; SCHWEIZER M, 1994, BIOCHEMISTRY-US, V33, P13401, DOI 10.1021/bi00249a028; Scudamore KA, 1998, J SCI FOOD AGR, V77, P1, DOI 10.1002/(SICI)1097-0010(199805)77:1&lt;1::AID-JSFA9&gt;3.0.CO;2-4; Suen YK, 2001, FREE RADICAL RES, V35, P1, DOI 10.1080/10715760100300541; SUTTON P, 1994, INFECT IMMUN, V62, P1192, DOI 10.1128/IAI.62.4.1192-1198.1994; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang MS, 2004, BRAIN, V127, P671, DOI 10.1093/brain/awh078; WARING P, 1988, J BIOL CHEM, V263, P18493; Waring P, 1996, GEN PHARMACOL, V27, P1311, DOI 10.1016/S0306-3623(96)00083-3; Wenehed V, 2003, FOOD CHEM TOXICOL, V41, P395, DOI 10.1016/S0278-6915(02)00250-8; Zhou XM, 2000, TOXICOL SCI, V54, P194, DOI 10.1093/toxsci/54.1.194	50	17	17	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JUL 7	2006	345	3					1068	1074		10.1016/j.bbrc.2006.05.019			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	054AA	WOS:000238346500025	16712786				2022-02-06	
J	Barrow, IM; Hough, M; Rastatter, MP; Walker, M; Holbert, D; Rotondo, MF				Barrow, Irene M.; Hough, Monica; Rastatter, Michael P.; Walker, Marianna; Holbert, Donald; Rotondo, Michael F.			The effects of mild traumatic brain injury on confrontation naming in adults	BRAIN INJURY			English	Article						mild traumatic brain injury; naming; reaction time	HEAD-INJURY; PERCEPTUAL DIFFERENTIATION; REACTION-TIME; CATEGORY; OBJECT; DEFICITS; INFORMATION; MEMORY; ACQUISITION; ERRORS	Primary objective: To compare confrontation-naming in adults with MTBI to a group of normal adults under increased processing load conditions. Research design: A randomized block, repeated measures design was used to examine confrontation-naming response latency and accuracy using a computerized experimental program. Methods and procedures: Twenty-four adults having sustained a MTBI (aged 18-53) and 24 age-matched controls named pictures from three levels of vocabulary as quickly and accurately as possible. All MTBI participants were assessed with the Scales of Cognitive Ability for Traumatic Brain Injury (SCATBI) for later comparison. Main outcomes and results: The results revealed a main effect of group (p <= 0.001) for the latency data and a group by vocabulary level interaction (p=0.043) for the accuracy data. No significant correlations were found between response latency and accuracy with performance on the SCATBI. Reaction time measures may reveal inefficiencies not tapped by traditional measures.	Hampton Univ, Dept Communicat Sci & Disorders, Hampton, VA 23668 USA; E Carolina Univ, Brody Sch Med, Dept Commun Sci & Disorders, Greenville, NC USA; E Carolina Univ, Brody Sch Med, Dept Stat, Greenville, NC USA; E Carolina Univ, Brody Sch Med, Dept Surg, Greenville, NC USA		Barrow, IM (corresponding author), Hampton Univ, Dept Communicat Sci & Disorders, 201 Sci & Technol, Hampton, VA 23668 USA.	irene.barrow@hamptonu.edu		Walker, Marianna/0000-0002-6342-9088			ABBOUD H, 2000, SUPERLAB PRO EXPT LA; Adamovich B. B., 1992, SCALES COGNITIVE ABI; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Barrow IM, 2003, J TRAUMA, V54, P888, DOI 10.1097/01.TA.0000057150.60668.7C; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bird H, 2000, BRAIN LANG, V72, P246, DOI 10.1006/brln.2000.2292; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; DELL GS, 1992, COGNITION, V42, P287, DOI 10.1016/0010-0277(92)90046-K; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1; Ellis AW, 1998, J EXP PSYCHOL LEARN, V24, P515, DOI 10.1037/0278-7393.24.2.515; ELVELT WJ, 1989, SPEAKING INTENTION A; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Garofeanu C, 2004, EXP BRAIN RES, V159, P55, DOI 10.1007/s00221-004-1932-z; Gerlach C, 1999, BRAIN, V122, P2159, DOI 10.1093/brain/122.11.2159; GLASER WR, 1992, COGNITION, V42, P61, DOI 10.1016/0010-0277(92)90040-O; Goodglass H, 1999, BRAIN LANG, V66, P294, DOI 10.1006/brln.1998.2014; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Hayden M E, 1997, AAOHN J, V45, P635; Heimer L., 1995, HUMAN BRAIN SPINAL C; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hughes AD, 2003, MEM COGNITION, V31, P401, DOI 10.3758/BF03194398; Humphreys G. W., 1987, VISUAL OBJECT PROCES; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JENKINS A, 1986, LANCET, V2, P445; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Laws KR, 2000, BRAIN LANG, V75, P123, DOI 10.1006/brln.2000.2348; Laws KR, 2002, CORTEX, V38, P137, DOI 10.1016/S0010-9452(08)70646-4; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LloydJones T, 1997, MEM COGNITION, V25, P606, DOI 10.3758/BF03211303; LloydJones TJ, 1997, MEM COGNITION, V25, P18, DOI 10.3758/BF03197282; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; Malt BC, 2004, MEM COGNITION, V32, P1346, DOI 10.3758/BF03206325; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MARTIN N, 1989, J MEM LANG, V28, P462, DOI 10.1016/0749-596X(89)90022-3; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MORRISON CM, 1992, MEM COGNITION, V20, P705, DOI 10.3758/BF03202720; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Paivio A., 1971, IMAGERY VERBAL PROCE; Perani D, 1999, NEUROPSYCHOLOGIA, V37, P293, DOI 10.1016/S0028-3932(98)00073-6; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; SALMELIN R, 1994, NATURE, V368, P463, DOI 10.1038/368463a0; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Snodgrass JG, 1996, BEHAV RES METH INSTR, V28, P516, DOI 10.3758/BF03200540; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; THEIOS J, 1989, PSYCHOL REV, V96, P5, DOI 10.1037/0033-295X.96.1.5; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; VITKOVITCH M, 1993, J EXP PSYCHOL LEARN, V19, P243; VITKOVITCH M, 1991, J EXP PSYCHOL LEARN, V17, P664, DOI 10.1037/0278-7393.17.4.664; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005	63	17	17	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2006	20	8					845	855		10.1080/02699050600832445			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	081ZO	WOS:000240356300007	17060151				2022-02-06	
J	Korfias, S; Stranjalis, G; Psachoulia, C; Vasiliadis, C; Pitaridis, M; Boviatsis, E; Sakas, DE				Korfias, Stefanos; Stranjalis, George; Psachoulia, Christina; Vasiliadis, Constantinos; Pitaridis, Marinos; Boviatsis, Efstathios; Sakas, Damianos E.			Slight and short-lasting increase of serum S-100B protein in extra-cranial trauma	BRAIN INJURY			English	Article						extra-cranial trauma; multi-trauma; S-100B protein; surgical trauma; traumatic brain injury	MINOR HEAD-INJURY; CARDIOPULMONARY BYPASS; BRAIN-INJURY; S100B LEVELS; CARDIAC-SURGERY; CEREBRAL INJURY; MARKER; RELEASE; S100-BETA; EMERGENCY	Objective: Serum S-100B protein is an established biochemical marker of traumatic brain injury. At the same time, the question of extra-cranial S-100B release has been raised. This study evaluates the post-traumatic and post-operative release kinetics of S-100B in 45 trauma victims without head injury. Method: Serum S-100B protein was measured on admission and every 24 hours for 4 consecutive days. Results: Initial S-100B was slightly increased (median: 0.54 mu g L-1) and correlated with the severity of extra-cranial trauma (p=0.0004, Mann-Whitney test). Both severely (abdominal or chest trauma with or without bone fractures) and mildly (long bone fractures) injured showed a rapid decline of S-100B (< 0.2 mu g L-1) around 72 hours post-trauma. Extra-cranial surgery caused a secondary increase of S-100B, especially in the mildly injured group (p=0.004, Wilcoxon signed rank test). Conclusions: Extra-cranial injury results in a mild elevation of serum S-100B protein that declines rapidly (1-3 days after injury).	Univ Athens, Evangelismos Hosp, Dept Neurosurg, Athens, Greece; Univ Athens, Evangelismos Hosp, Dept Biochem, Athens, Greece; Univ Athens, Evangelismos Hosp, Dept Intens Care Med, Athens, Greece		Korfias, S (corresponding author), Grove Hotel,134 Brighton Grove Rd, Newcastle Upon Tyne NE4 5NT, Tyne & Wear, England.	skorfias@mail.gr					Anderson RE, 2000, ANN THORAC SURG, V69, P847, DOI 10.1016/S0003-4975(99)01526-X; Anderson RE, 1999, ANN THORAC SURG, V67, P1721, DOI 10.1016/S0003-4975(99)00318-5; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Johnsson P, 1996, J CARDIOTHOR VASC AN, V10, P120, DOI 10.1016/S1053-0770(96)80187-X; Jonsson H, 1999, ANN THORAC SURG, V68, P2202, DOI 10.1016/S0003-4975(99)00851-6; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; SCHAFER BW, 1995, GENOMICS, V25, P638, DOI 10.1016/0888-7543(95)80005-7; SHAABAN M, 2000, BRIT J ANAESTH, V85, P287; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; TEASDALE G, 1975, LANCET, V1, P480; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976	25	17	17	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2006	20	8					867	872		10.1080/02699050600832395			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	081ZO	WOS:000240356300009	17060153				2022-02-06	
J	Pasco, A; Ter Minassian, A; Chapon, C; Lemaire, L; Franconi, F; Darabi, D; Caron, C; Benoit, JP; Le Jeune, JJ				Pasco, A; Ter Minassian, A; Chapon, C; Lemaire, L; Franconi, F; Darabi, D; Caron, C; Benoit, JP; Le Jeune, JJ			Dynamics of cerebral edema and the apparent diffusion coefficient of water changes in patients with severe traumatic brain injury. A prospective MRI study	EUROPEAN RADIOLOGY			English	Article						traumatic brain injury; edema; magnetic resonance imaging; diffusion; apparent diffusion coefficient	INTRACEREBRAL HEMORRHAGE; TIME-COURSE; ISCHEMIA; STROKE; BARRIER; MECHANISMS; MODELS; RATS	The distinction between intracellular (ICE) and extracellular edema (ECE) has a crucial prognostic and therapeutic importance in patients with severe traumatic brain injury (STBI). Indeed, ICE usually leads to cellular death, and maintenance of a cerebral perfusion pressure (CPP) above 70 mmHg is still under debate since this practice may increase ECE. The purpose of this study was to describe the ECE and ICE kinetics associated with STBI using quantitative diffusion MRI. Twelve patients were prospectively studied. The initial ADC in ICE measured on day 1.3 +/- 0.7 is significantly reduced compared to normal-appearing parenchyma (0.51 +/- 0.12 * 10(-3) mm(2)/s vs. 0.76 +/- 0.03 * 10(-3) mm(2)/s, n=12, P < 0.0001) and reaches normality on MRI 3 performed on day 14.2 +/- 3.3. In patients presenting an extension of ICE on MRI 2 performed on day 6.7 +/- 1.4 (ADC(MRI2)=0.40 +/- 0.11 * 10(-3) mm(2)/s), ADC values in the extension area at the first MRI were slightly, but not significantly reduced compared to normal parenchyma (0.69 +/- 0.05 * 10(-3) mm(2)/s, P=0.29). Normalization occurred equally by day 14. ADC in ECE (1.34 +/- 0.22 * 10(-3) mm(2)/s) was elevated and stable with time under CPP therapy. Therefore, ECE is not worsened by CCP therapy, and ICE appears more relevant than ECE in STBI.	Univ Angers, Larrey Hosp, Dept Radiol, F-49033 Angers, France; Univ Angers, Larrey Hosp, Dept Anaesthesiol, F-49033 Angers, France; INSERM, U646, F-49100 Angers, France; Univ Angers, F-49100 Angers, France; Univ Angers, SCAS, F-49045 Angers, France		Pasco, A (corresponding author), Univ Angers, Larrey Hosp, Dept Radiol, F-49033 Angers, France.	anpasco@chu-angers.fr	FRANCONI, Florence/K-4258-2015; Benoit, Jean-Pierre/K-4387-2015; LEMAIRE, Laurent/A-3100-2011	FRANCONI, Florence/0000-0001-6725-0803; LEMAIRE, Laurent/0000-0002-1308-9345; BENOIT, Jean-Pierre/0000-0002-6178-7199			Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Baird AE, 1997, ANN NEUROL, V41, P581, DOI 10.1002/ana.410410506; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beaumont A, 2000, ACT NEUR S, V76, P147; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carhuapoma JR, 2002, AM J NEURORADIOL, V23, P1322; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2000, ACT NEUR S, V76, P349; MILLER JD, 1994, INTENS CARE MED, V20, P249, DOI 10.1007/BF01708957; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Portella G, 2000, ACT NEUR S, V76, P273; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sansing LH, 2003, J NEUROSURG, V98, P985, DOI 10.3171/jns.2003.98.5.0985; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Sorensen AG, 2002, AM J NEURORADIOL, V23, P177; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Warach S, 1996, STROKE, V27, P1254; Witte OW, 2000, J CEREBR BLOOD F MET, V20, P1149, DOI 10.1097/00004647-200008000-00001; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005	35	17	19	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0938-7994			EUR RADIOL	Eur. Radiol.	JUL	2006	16	7					1501	1508		10.1007/s00330-005-0086-0			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	052YP	WOS:000238270300012	16485132				2022-02-06	
J	Segal, ME; Goodman, PH; Goldstein, R; Hauck, W; Whyte, J; Graham, JW; Polansky, M; Hammond, FM				Segal, Mary E.; Goodman, Philip H.; Goldstein, Richard; Hauck, Walter; Whyte, John; Graham, John W.; Polansky, Marcia; Hammond, Flora M.			The accuracy of artificial neural networks in predicting long-term outcome after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						classification and regression trees; multiple regression; neural networks; outcomes; traumatic brain injury	LOGISTIC-REGRESSION; COMMUNITY INTEGRATION; MISSING-DATA; REHABILITATION; TREE; CLASSIFICATION; DISABILITY; VARIABLES; RECOVERY	Objective: This study compared the accuracy of artificial neural networks to multiple regression and classification and regression trees in predicting outcomes of 1644 patients in the Traumatic Brain Injury Model Systems database 1 year after injury. Methods: Data from rehabilitation admission were used to predict discharge scores on the Functional Independence Measure, the Disability Rating Scale, and the Community Integration Questionnaire. Results: Artificial neural networks did not demonstrate greater accuracy in predicting outcomes than did the more widely used method of multiple regression. Both of these methods outperformed classification and regression trees. Conclusion: Because of the sophisticated form of multiple regression with splines that was used, firm conclusions are limited about the relative accuracy of artificial neural networks compared to more widely used forms of multiple regression.	Res Ctr Hlth Care Decis Making Inc, Wyndmoor, PA 19038 USA; Univ Nevada, Reno, NV 89557 USA; Harvard Univ, Sch Med, Boston, MA USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; MossRehab Hosp, Moss Rehabil Res Inst, Philadelphia, PA USA; Penn State Univ, University Pk, PA 16802 USA; Drexel Sch Publ Hlth, Philadelphia, PA USA; Carolinas Rehabil, Charlotte, NC USA		Segal, ME (corresponding author), Res Ctr Hlth Care Decis Making Inc, 8200 Flourtown Ave,Suite 1-C, Wyndmoor, PA 19038 USA.	msegal@healthcaredecisions.org		Whyte, John/0000-0002-4381-1474			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 1984, CLASSIFICATION REGRE; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Burke HB, 1997, CANCER, V79, P857, DOI 10.1002/(SICI)1097-0142(19970215)79:4<857::AID-CNCR24>3.0.CO;2-Y; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1996, NEUROTRAUMA, P779; CODE C, 1994, CORTEX, V30, P527, DOI 10.1016/S0010-9452(13)80348-6; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; EFTEKHAR B, 2005, BMC MED INFORM DECIS, P1; El-Solh AA, 2000, ARCH PHYS MED REHAB, V81, P1388, DOI 10.1053/apmr.2000.16348; Fleming J, 1999, BRAIN INJURY, V13, P417; GOODMAN P, 1999, P BIOM SECT JOINT ST; Graham J. W., 2003, HDB PSYCHOL, V2, P87, DOI DOI 10.1002/0471264385.WEI0204; GRIGSBY J, 1994, ARCH PHYS MED REHAB, V75, P1077, DOI 10.1016/0003-9993(94)90081-7; Harrell FE Jr, 2017, REGRESSION MODELING; HART A, 1990, MED INFORM, V15, P229, DOI 10.3109/14639239009025270; Iezzoni LI, 2004, AM J PHYS MED REHAB, V83, P316, DOI 10.1097/01.PHM.0000118041.17739.BB; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; Oczkowski WJ, 1997, ARCH PHYS MED REHAB, V78, P340, DOI 10.1016/S0003-9993(97)90222-7; Ohno-Machado L, 1999, AM J PHYS MED REHAB, V78, P392, DOI 10.1097/00002060-199907000-00022; Ottenbacher KJ, 2001, J CLIN EPIDEMIOL, V54, P1159, DOI 10.1016/S0895-4356(01)00395-X; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reker DM, 1998, ARCH PHYS MED REHAB, V79, P751, DOI 10.1016/S0003-9993(98)90351-3; Rubin D.B., 1987, MULTIPLE IMPUTATION; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Schafer JL, 1997, ANAL INCOMPLETE MULT; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; *UDS, 1997, GUID UN DAT SET MED; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103	35	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2006	21	4					298	314		10.1097/00001199-200607000-00003			17	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	064SJ	WOS:000239109100003	16915007				2022-02-06	
J	Yates, JR; Heyes, MP; Blight, AR				Yates, Jennifer R.; Heyes, Melvyn P.; Blight, Andrew R.			4-Chloro-3-hydroxyanthranilate reduces local quinolinic acid synthesis, improves functional recovery, and preserves white matter after spinal cord injury	JOURNAL OF NEUROTRAUMA			English	Article						guinea pig; inflammation; kynurenine pathway; macrophage; neurotoxin; spinal cord trauma	SYSTEMIC IMMUNE ACTIVATION; KYNURENINE PATHWAY METABOLISM; TRANSIENT CEREBRAL-ISCHEMIA; RECEPTOR-MEDIATED TOXICITY; TRAUMATIC BRAIN-INJURY; CONVERT L-TRYPTOPHAN; CEREBROSPINAL-FLUID; GLIAL-CELLS; 3-HYDROXYANTHRANILIC ACID; MORPHOMETRIC ANALYSIS	Inflammatory processes within the central nervous system (CNS) contribute significantly to the pathogenesis of a broad range of neurologic diseases, including spinal cord injury (SCI). One mechanism by which immune activation causes neurologic symptoms and tissue injury is via the production of neurotoxins by activated macrophages and microglia. In the present study, the role of the endogenous tryptophan metabolite and neurotoxin quinolinic acid (QUIN) in secondary pathology following traumatic SCI was investigated. Adult Hartley guinea pigs were injured by lateral compression of the spinal cord at the 12th thoracic segment (T12). QUIN had accumulated at the site of injury on day 12 post-injury in proportion to the severity of functional neurologic deficits (as assessed by the cutaneus trunci muscle reflex and motor function score at 5 h post-injury). Systemic administration of the 3-hydroxyanthranilate-3,4-dioxygenase (3-HAD) inhibitor, 4-chloro-3-hydroxyanthranilate (4Cl-3HAA; approximately 100 mg/kg every 12 h, beginning 5 h after injury) attenuated local QUIN production and reduced QUIN accumulation at the site of injury by approximately 50% at day 12, without enhanced accumulations of the neuroprotective metabolite kynurenic acid (KYNA). The severity of secondary functional deficits was also reduced by 4Cl-3HAA. In toluidine blue-stained spinal cord sections, the area of surviving intact white matter at the injury site was increased by approximately 100% in the 4Cl-3HAA-treated group. Sparing of both axons and myelin contributed to this increase. These results support the conclusion that QUIN accumulations at the site of injury contribute to secondary functional deficits and tissue damage following SCI.	Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; Univ N Carolina, Div Neurosurg, Chapel Hill, NC USA; NIMH, Lab Neurotoxicol, Bethesda, MD 20892 USA		Yates, JR (corresponding author), Colby Coll, Dept Psychol, 5550 Mayflower Hill Dr, Waterville, ME 04901 USA.	jryates@colby.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021122] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21122] Funding Source: Medline		BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beagles KE, 1998, J NEUROCHEM, V70, P281; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; BLIGHT AR, 1994, NEUROSCIENCE, V60, P263, DOI 10.1016/0306-4522(94)90220-8; BLIGHT AR, 1995, BRAIN, V118, P735, DOI 10.1093/brain/118.3.735; BLIGHT AR, 1991, J NEUROL SCI, V103, P156, DOI 10.1016/0022-510X(91)90159-5; BLIGHT AR, 1990, J COMP NEUROL, V296, P614, DOI 10.1002/cne.902960408; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; BLIGHT AR, 1993, BRAIN RES, V632, P314, DOI 10.1016/0006-8993(93)91167-Q; Blight AR, 1997, J NEUROTRAUM, V14, P89, DOI 10.1089/neu.1997.14.89; BLIGHT AR, 1992, J NEUROTRAUMA, V9, P83; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BUTT AM, 1992, NEUROSCI LETT, V146, P108, DOI 10.1016/0304-3940(92)90184-9; Cammer W, 2002, NEUROSCI LETT, V327, P123, DOI 10.1016/S0304-3940(02)00392-0; Cammer W, 2001, BRAIN RES, V896, P157, DOI 10.1016/S0006-8993(01)02017-0; Espey MG, 1997, NEUROREPORT, V8, P431, DOI 10.1097/00001756-199701200-00011; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; GALLO V, 1994, GLIA, V11, P94, DOI 10.1002/glia.440110204; Grant RS, 1998, J NEUROCHEM, V70, P1759; GUILIAN D, 1990, SCIENCE, V250, P1593; HEYES MP, 1990, J CHROMATOGR-BIOMED, V530, P108, DOI 10.1016/S0378-4347(00)82308-7; Heyes MP, 1996, BIOCHEM J, V320, P595, DOI 10.1042/bj3200595; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; Heyes MP, 1997, J NEUROCHEM, V68, P280; HEYES MP, 1988, ANAL BIOCHEM, V174, P349, DOI 10.1016/0003-2697(88)90556-8; Heyes MP, 1997, J NEUROCHEM, V69, P1519; HEYES MP, 1992, BIOCHEM J, V283, P633, DOI 10.1042/bj2830633; Heyes MP, 2001, BRAIN, V124, P1033, DOI 10.1093/brain/124.5.1033; Heyes MP, 1998, FASEB J, V12, P881, DOI 10.1096/fasebj.12.10.881; IGNATOWICZ E, 1991, NEUROREPORT, V2, P651, DOI 10.1097/00001756-199111000-00004; Jaeger CB, 1997, EXP NEUROL, V144, P381, DOI 10.1006/exnr.1996.6405; Kerr SJ, 1998, AIDS, V12, P355, DOI 10.1097/00002030-199804000-00003; KETTENMANN H, 1984, NEUROSCI LETT, V47, P271, DOI 10.1016/0304-3940(84)90525-1; LEKIEFFRE D, 1990, NEUROSCI LETT, V120, P31, DOI 10.1016/0304-3940(90)90160-B; LEVY DI, 1990, NEUROSCI LETT, V110, P291, DOI 10.1016/0304-3940(90)90862-4; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; MORONI F, 1988, J NEUROCHEM, V51, P177, DOI 10.1111/j.1471-4159.1988.tb04852.x; Morrison PF, 1999, J NEUROCHEM, V72, P2135, DOI 10.1046/j.1471-4159.1999.0722135.x; MURRAY HW, 1992, J INFECT DIS, V165, P513, DOI 10.1093/infdis/165.3.513; MURRAY HW, 1989, INFECT IMMUN, V57, P845, DOI 10.1128/IAI.57.3.845-849.1989; NEFF NH, 1967, J PHARMACOL EXP THER, V158, P214; Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021; PARLI CJ, 1980, ARCH BIOCHEM BIOPHYS, V203, P161, DOI 10.1016/0003-9861(80)90164-2; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Pemberton LA, 1997, J INTERF CYTOK RES, V17, P589, DOI 10.1089/jir.1997.17.589; Platenik J, 2001, FREE RADICAL RES, V34, P445, DOI 10.1080/10715760100300391; SAITO K, 1993, BIOCHEM J, V291, P11, DOI 10.1042/bj2910011; SAITO K, 1993, J NEUROCHEM, V60, P180, DOI 10.1111/j.1471-4159.1993.tb05836.x; Saito K, 1996, ADV EXP MED BIOL, V398, P407; SAITO K, 1993, J NEUROCHEM, V61, P2061, DOI 10.1111/j.1471-4159.1993.tb07443.x; SAITO K, 1994, NEUROSCI LETT, V178, P211, DOI 10.1016/0304-3940(94)90761-7; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Speciale C, 1996, ADV EXP MED BIOL, V398, P221; Steinhauser C, 1996, TRENDS NEUROSCI, V19, P339, DOI 10.1016/0166-2236(96)10043-6; Thomas SR, 1996, J BIOL CHEM, V271, P32714, DOI 10.1074/jbc.271.51.32714; WHETSELL WO, 1989, NEUROSCI LETT, V97, P271, DOI 10.1016/0304-3940(89)90609-5; Wiley CA, 1995, J NEUROVIROL, V1, P328, DOI 10.3109/13550289509111021; WIRSCHING BA, 1989, BEHAV NEUROSCI, V103, P90, DOI 10.1037/0735-7044.103.1.90; Yoshioka A, 1996, J NEUROSCI RES, V46, P427	60	17	18	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2006	23	6					866	881		10.1089/neu.2006.23.866			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	056TW	WOS:000238549000004	16774472				2022-02-06	
J	Kreipke, CW; Morgan, NC; Petrov, T; Rafols, JA				Kreipke, Christian W.; Morgan, Noah C.; Petrov, Theodor; Rafols, Jose A.			RETRACTED: Calponin and caldesmon cellular domains in reacting microvessels following traumatic brain injury(Retracted article. See vol. 110, pg. 64, 2017)	MICROVASCULAR RESEARCH			English	Article; Retracted Publication						microvascular tone; neurotrauma; contractile proteins	VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL GROWTH-FACTOR; PORCINE CORONARY-ARTERY; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; CONTRACTILE PROTEINS; MESSENGER-RNA; EXPRESSION; PHOSPHORYLATION; MYOSIN	Calponin (Cp) and caldesmon (Cd) are actin-binding proteins involved in the regulation of smooth muscle (SM) tone during blood vessel contraction. While in vitro studies have reported modifications of these proteins during vessel contractility, their role in vivo remains unclear. Traumatic brain injury (TBI) causes disruption of cerebral microvascular tone, leading to sustained contractility in reacting microvessels and cerebral hypoperfusion. This study aimed to determine the spatial and temporal expressions of Cp and Cd in rat cerebral cortical and hippocampal microvessels post-TBI. Reacting microvessels were analyzed in control, 4, 24, and 48 h post-injury. Single and double immunocytochemical techniques together with semiquantitative analyses revealed a Cp upregulation in SM at all time frames post-TBI; with the protein migrating from SM cytosol to the vicinity of the cell membrane. Similarly, Cd immunoreactivity significantly increased in both SM and endothelial cells (En). However, while Cp and Cd in SM remained elevated, their levels in En returned to normal at 48 h post-TBI. The results suggest that Cp and Cd levels increase while compartmentalizing to specific subcellular domains. These changes are temporally associated with modifications in the cytoskeleton and contractile apparatus of SM and En during blood vessel contractility. Furthermore, these changes may underlie the state of sustained contractility and hypoperfusion observed in reacting microvessels after TBI. (c) 2006 Elsevier Inc. All rights reserved.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Rafols, JA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Cranfield, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS039860] Funding Source: Medline		Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; ARBUSTINI E, 1993, AM J CARDIOL, V71, P1382, DOI 10.1016/0002-9149(93)90597-6; Armstead WM, 2004, J NEUROTRAUM, V21, P1204, DOI 10.1089/neu.2004.21.1204; Bandopadhyay R, 2001, J NEUROCYTOL, V30, P35, DOI 10.1023/A:1011965307612; BARANY K, 1992, BIOCHEM BIOPH RES CO, V187, P847, DOI 10.1016/0006-291X(92)91274-T; BIRUKOV KG, 1991, CELL TISSUE RES, V266, P579, DOI 10.1007/BF00318599; Borovikov YS, 1999, INT REV CYTOL, V189, P267, DOI 10.1016/S0074-7696(08)61389-3; CHALOVICH JM, 1990, ANN NY ACAD SCI, V599, P85; Fee DB, 2004, BRAIN RES, V1012, P52, DOI 10.1016/j.brainres.2004.03.028; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Foster DB, 2004, J BIOL CHEM, V279, P53387, DOI 10.1074/jbc.M410109200; FURST DO, 1986, EMBO J, V5, P251, DOI 10.1002/j.1460-2075.1986.tb04206.x; Gimona M, 1996, BIOCH SMOOTH MUSCLE, P91; Graceffa P, 1996, J BIOL CHEM, V271, P30336, DOI 10.1074/jbc.271.48.30336; KAMM KE, 1985, AM J PHYSIOL, V249, pC238, DOI 10.1152/ajpcell.1985.249.3.C238; KATSUYAMA H, 1992, J BIOL CHEM, V267, P14555; Lee YH, 2000, J BIOL CHEM, V275, P3213, DOI 10.1074/jbc.275.5.3213; LEHMAN W, 1987, BIOCHIM BIOPHYS ACTA, V914, P35, DOI 10.1016/0167-4838(87)90158-0; LIN Y, 1993, J BIOCHEM-TOKYO, V113, P643, DOI 10.1093/oxfordjournals.jbchem.a124096; Mabuchi K, 1996, J MUSCLE RES CELL M, V17, P243, DOI 10.1007/BF00124246; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSTON SB, 1991, BIOCHEM J, V279, P1; McBeth BD, 2005, ACAD EMERG MED, V12, P483, DOI 10.1197/j.aem.2004.11.028; MINO T, 1995, BIOCHEM BIOPH RES CO, V208, P397, DOI 10.1006/bbrc.1995.1351; Mirzapoiazova T, 2005, J CELL PHYSIOL, V203, P520, DOI 10.1002/jcp.20244; Nag S, 2002, J NEUROPATH EXP NEUR, V61, P778, DOI 10.1093/jnen/61.9.778; NORTH AJ, 1994, J CELL SCI, V107, P437; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Rafols D, 2004, NEUROSCI LETT, V362, P154, DOI 10.1016/j.neulet.2004.03.021; Sakihara C, 1996, BIOCHEM BIOPH RES CO, V222, P195, DOI 10.1006/bbrc.1996.0721; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; SOBUE K, 1991, J BIOL CHEM, V266, P12115; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Suzuki R, 2003, ACTA NEUROCHIR SUPPL, V86, P277; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Walsh MP, 1996, BIOCHEM CELL BIOL, V74, P485, DOI 10.1139/o96-053; Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027; Yang JX, 2004, ACTA BIOCH BIOPH SIN, V36, P529, DOI 10.1093/abbs/36.8.529; Yuasa U, 1999, J MOL CELL CARDIOL, V31, P1281, DOI 10.1006/jmcc.1999.0960	43	17	18	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0026-2862	1095-9319		MICROVASC RES	Microvasc. Res.	MAY	2006	71	3					197	204		10.1016/j.mvr.2006.02.002			8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	056FP	WOS:000238507300006	16635497				2022-02-06	
J	Holmes, JF; Hendey, GW; Oman, JA; Norton, VC; Lazarenko, G; Ross, SE; Hoffman, JR; Mower, WR				Holmes, JF; Hendey, GW; Oman, JA; Norton, VC; Lazarenko, G; Ross, SE; Hoffman, JR; Mower, WR		NEXUS Grp	Epidemiology of blunt head injury victims undergoing ED cranial computed tomographic scanning	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; UNITED-STATES; PREINJURY WARFARIN; POPULATION; FALLS; MILD; SURVEILLANCE; PREDICTOR; MECHANISM; SEVERITY	Study Objective: We sought to describe the epidemiology of emergency department (ED) patients with blunt head injury undergoing cranial computed tomography (CT) scanning for the evaluation of possible traumatic brain injury (TBI). Methods: Prospective, multicenter, observational Study of ED patients undergoing cranial CT after blunt head injury. Patient's date of birth, sex, and race/ethnicity were documented before CT scanning, Individual patients were considered to have "significant" TBI if the official radiographic interpretation at the end of all imaging studies associated with the trauma was consistent with any of a set of predefined diagnoses. The relative prevalence of TBI among various prespecified groups from those undergoing cranial CT scanning was also calculated. Results: Of 13 728 patients who were enrolled, 8988 (65%) were men and 1193 (8.7%) had a significant acute TBI. Demographic findings associated with increased risk of TBI, among patients selected for scanning, included the following: age below 10 years (relative risk [RR] = 1.44, 95% confidence interval [CI], 1.19-1.77); age above 65 years (RR = 1.59; 95% Cl, 1.40-1.80), and male sex (RR = 1.27; 95% Cl, 1.30-1.43). Conclusion: Among patients selected for cranial CT scanning after blunt head injury, men, patients younger than 10 years, and those older than 65 years have an increased likelihood of significant TBI. (c) 2006 Elsevier Inc. All rights reserved.	Univ Calif Davis, Med Ctr, Div Emergency Med, Sacramento, CA 95817 USA; Univ Calif San Francisco, Fresno Med Educ Program, Dept Emergency Med, Fresno, CA 93702 USA; Univ Calif Irvine, Coll Med, Dept Emergency Med, Irvine, CA 92868 USA; Vanderbilt Univ, Sch Med, Dept Emergency Med, Nashville, TN 37232 USA; Univ Calgary, Foothills Med Ctr, Dept Emergency Med, Calgary, AB T2N 2T9, Canada; Cooper Hlth Syst, Dept Surg, Div Trauma, Camden, NJ 08103 USA; Univ Calif Los Angeles, Sch Med, Div Emergency Med, Los Angeles, CA 90024 USA		Holmes, JF (corresponding author), Univ Calif Davis, Med Ctr, Div Emergency Med, PSSB 2100, Sacramento, CA 95817 USA.	jfholmes@ucdavis.edu		Hendey, Gregory/0000-0002-0170-8743	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [1 R01] Funding Source: Medline		Adekoya N, 2004, PUBLIC HEALTH REP, V119, P486, DOI 10.1016/j.phr.2004.07.006; AMACHER AL, 1987, NEUROSURGERY, V20, P954; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; DEMAREST GB, 1990, GERIATRICS, V45, P36; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Helling TS, 1999, J TRAUMA, V46, P453, DOI 10.1097/00005373-199903000-00019; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jindal A, 2002, WORLD J SURG, V26, P13; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; KRAUS JF, 1987, PEDIATRICS, V79, P501; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lowery DW, 2001, ANN EMERG MED, V38, P12, DOI 10.1067/mem.2001.116149; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; Murray JA, 2000, AM SURGEON, V66, P863; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; ROZYCKI GS, 1991, ARCH EMERG MED, V8, P245; Sallee D, 2000, Alaska Med, V42, P37; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; STEIN J, 1995, ARCH PHYS MED REHAB, V76, P840, DOI 10.1016/S0003-9993(95)80549-4; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1996, WESTERN J MED, V165, P192; Velmahos GC, 2001, J AM COLL SURGEONS, V192, P147, DOI 10.1016/S1072-7515(00)00790-0; Wang MY, 2001, J PEDIATR SURG, V36, P1528, DOI 10.1053/jpsu.2001.27037; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	41	17	17	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAR	2006	24	2					167	173		10.1016/j.ajem.2005.08.009			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	021FJ	WOS:000235968800006	16490645				2022-02-06	
J	Lunemann, A; Ullrich, O; Diestel, A; Jons, T; Ninnemann, O; Kovac, A; Pohl, EE; Hass, R; Nitsch, R; Hendrix, S				Lunemann, A; Ullrich, O; Diestel, A; Jons, T; Ninnemann, O; Kovac, A; Pohl, EE; Hass, R; Nitsch, R; Hendrix, S			Macrophage/microglia activation factor expression is restricted to lesion-associated microglial cells after brain trauma	GLIA			English	Article						entorhinal cortex lesion; deafferentiation; CD11b; 1B4	ENTORHINAL CORTEX LESION; DENTATE GYRUS; MULTIPLE-SCLEROSIS; ATHYMIC MICE; INJURY; CNS; IDENTIFICATION; MACROPHAGES; ASTROCYTES; CLONING	After traumatic brain lesion, microglial cells are rapidly activated, migrate toward the sites of injury, and cause secondary damage that accounts for most of the loss of brain function. In the present study, we have characterized a new macrophage/microglia activation factor (MA-F). Using the monocytic cell line U937, we were able to demonstrate that MAF is upregulated after TPA-induced differentiation into macrophages. We have generated a specific antibody against MAY In BV-2 microglial cells, MAF is partially co-localized with 1134, a classical microglial marker. In addition, we have analyzed the in vivo expression patterns of MAF after entorhinal cortex lesion. We were able to show a substantial upregulation of MAF on selected CD11b(+) and IB4(+) macrophages/microglial cells in the deafferented hippocampus and in the perilesional region, while no MAF expression was detectable on the contralateral side. Confocal microscopy revealed a lysosome-like expression pattern in BV-2 cells, as well as in ECL-associated macrophages/microglial cells in vivo. Furthermore, we were able to demonstrate that U937 cells with downregulated MAF converted slower and to a significantly reduced extent to the macrophageal phenotype after TPA treatment. In addition, MAF downregulation in BV-2 microglial cells substantially reduced the phagocytotic uptake of dextran beads. Our data indicate that MAF is expressed in selected macrophages/microglial cells around the lesion and in the degenerating hippocampus after ECL. Furthermore, MAF expression in monocytic cells seems to play a functional role in the differentiation to a phagocytosing phenotype and may be, at least partially, required for phagocytotic activity, specifically in lesioned tissue after brain trauma. (c) 2005 Wiley-Liss, Inc.	Humboldt Univ, Charite Univ Med Berlin, Inst Cell Biol & Neurobiol, Ctr Anat, D-10098 Berlin, Germany; Otto Von Guericke Univ, Inst Immunol, Dept Mol Immunol & Neuroimmunol, Magdeburg, Germany; Humboldt Univ, Charite Univ Med Berlin, Ctr Anat, Inst Electron Microscope & Mol Neuroanat, D-10098 Berlin, Germany; Hannover Med Sch, Dept Biochem & Tumor Biol, Clin Obstet & Gynecol, D-3000 Hannover, Germany		Nitsch, R (corresponding author), Humboldt Univ, Charite Univ Med Berlin, Inst Cell Biol & Neurobiol, Ctr Anat, Schumannstr 20-21, D-10098 Berlin, Germany.	robert.nitsch@charite.de	Nitsch, Robert/AAI-9129-2021; Hass, Ralf/F-3197-2012; Pohl, Elena E./A-4025-2009; Hendrix, Sven/F-4059-2010	Hass, Ralf/0000-0002-2481-7547; Pohl, Elena E./0000-0002-0604-5950; Hendrix, Sven/0000-0003-2344-7369			BAIDA GE, 1995, BBA-GENE STRUCT EXPR, V1264, P151, DOI 10.1016/0167-4781(95)00150-F; Bechmann I, 1997, GLIA, V20, P145, DOI 10.1002/(SICI)1098-1136(199706)20:2<145::AID-GLIA6>3.0.CO;2-8; Bechmann I, 2000, ANN NY ACAD SCI, V911, P192; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Brauer AU, 2004, FEBS LETT, V563, P41, DOI 10.1016/S0014-5793(04)00244-3; DRENCKHAHN D, 1993, METHOD CELL BIOL, V37, P7, DOI 10.1016/S0091-679X(08)60242-3; Eyupoglu IY, 2003, FASEB J, V17, P1110, DOI 10.1096/fj.02-0825fje; Frotscher M, 1997, TRENDS NEUROSCI, V20, P218, DOI 10.1016/S0166-2236(96)01018-1; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hailer NP, 1999, EUR J NEUROSCI, V11, P3359, DOI 10.1046/j.1460-9568.1999.00808.x; HASS R, 1989, EUR J CELL BIOL, V48, P282; HTAIN WW, 1994, GLIA, V12, P44, DOI 10.1002/glia.440120106; Htain WW, 1997, BRAIN RES, V755, P63, DOI 10.1016/S0006-8993(97)00108-X; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kwidzinski E, 2003, J NEURAL TRANSM-SUPP, P29, DOI 10.1007/978-3-7091-0643-3_2; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; LYNCH G, 1974, BRAIN RES, V69, P1, DOI 10.1016/0006-8993(74)90365-5; Mabuchi T, 2000, STROKE, V31, P1735, DOI 10.1161/01.STR.31.7.1735; Prudovsky I, 2002, EUR J CELL BIOL, V81, P36, DOI 10.1078/0171-9335-00219; Raivich G, 2004, BRAIN RES REV, V46, P261, DOI 10.1016/j.brainresrev.2004.06.006; Rehli M, 1995, BIOCHEM BIOPH RES CO, V217, P661, DOI 10.1006/bbrc.1995.2825; SCHOEN SW, 1994, EXP NEUROL, V127, P106, DOI 10.1006/exnr.1994.1084; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; VARTANIAN T, 1995, MOL MED, V1, P732, DOI 10.1007/BF03401888	28	17	18	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	MAR	2006	53	4					412	419		10.1002/glia.20301			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	020CV	WOS:000235886400009	16342171				2022-02-06	
J	Kim, H; Colantonio, A; Deber, R; Vernich, L				Kim, H; Colantonio, A; Deber, R; Vernich, L			Discharge destination from acute care after traumatic brain injury	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article								Objective: To identify the impact of private insurance coverage on discharge disposition after a traumatic brain injury (TBI) using injury in a motor vehicle accident (MVA) as a proxy for private insurance, controlling for age and severity of injury. Method. Cross-sectional study. Patients: Patients with TBI discharged between 1993-1994 and 2000-2001 (n = 9,703). Main Outcome Measure: Discharge destination from acute care; controlled odds ratio (OR) and confidence interval (CI) for type of injury. Results: Type of injury, age, and length of stay are significantly associated with discharge destination. However, the motor vehicle accident patients are 56% more likely to be discharged to home with support services than patients with similar injuries from falls. Conclusion: Even in a system with universal coverage, availability of private insurance type is a potential independent determinant of postacute care services. More research is required to determine the effect this relationship has on the cost and outcomes of care for TBI patients.	Univ Toronto, Dept Occupat Therapy, Toronto Rehabil Inst, Toronto, ON M5G 1V7, Canada; Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; Univ Toronto, Dept Hlth Policy Management & Evalut, Toronto, ON M5G 1V7, Canada; Univ Toronto, Dept Publ Hlth, Toronto, ON M5G 1V7, Canada		Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Therapy, Toronto Rehabil Inst, 500 Univ Ave, Toronto, ON M5G 1V7, Canada.			Colantonio, Angela/0000-0003-2094-4765; Deber, Raisa/0000-0003-0598-3926			*CAN I HLTH INF, 2001, ONT TRAUM REG 2001A; Canadian Institute for Health Information, 1975, NAT HLTH EXP TRENDS; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Commission on the Future of Health Care in Canada, 2002, BUILD VAL FUT HLTH C; DEBER R, 2004, DELIVERING HLTH CARE, P233; Deber RB, 2003, AM J PUBLIC HEALTH, V93, P20, DOI 10.2105/AJPH.93.1.20; Hoppe E, 1996, PHYSIOTHER CAN, V48, P106; LANDRY M, 2004, MARKET FAILURE ONTAR; LANDRY M, 2005, THESIS U TORONTO TOR; *STAND SEN COMM SO, 2001, HLTH CAN FED ROL STO, V1; *STAND SEN COMM SO, 2002, HLTH CAN FED ROL REC, V6	11	17	17	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	FEB	2006	33	1					48	52		10.1017/S0317167100004686			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	020HC	WOS:000235898300008	16583721	Bronze			2022-02-06	
J	Lye, TC; Grayson, DA; Creasey, H; Piguet, O; Bennett, HP; Ridley, LJ; Kril, JJ; Broe, GA				Lye, TC; Grayson, DA; Creasey, H; Piguet, O; Bennett, HP; Ridley, LJ; Kril, JJ; Broe, GA			Predicting memory performance in normal ageing using different measures of hippocampal size	NEURORADIOLOGY			English	Article						memory; normal; aging; hippocampus; magnetic resonance imaging	TEMPORAL-LOBE EPILEPSY; PROBABLE ALZHEIMERS-DISEASE; SYDNEY OLDER PERSONS; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; VOLUMETRIC MRI; DIAGNOSTIC-VALUE; VERBAL MEMORY; ATROPHY; AMYGDALA	A number of different methods have been employed to correct hippocampal volumes for individual variation in head size. Researchers have previously used qualitative visual inspection to gauge hippocampal atrophy. The purpose of this study was to determine the best measure(s) of hippocampal size for predicting memory functioning in 102 community-dwelling individuals over 80 years of age. Hippocampal size was estimated using magnetic resonance imaging (MRI) volumetry and qualitative visual assessment. Right and left hippocampal volumes were adjusted by three different estimates of head size: total intracranial volume (TICV), whole-brain volume including ventricles (WB+V) and a more refined measure of whole-brain volume with ventricles extracted (WB). We compared the relative efficacy of these three volumetric adjustment methods and visual ratings of hippocampal size in predicting memory performance using linear regression. All four measures of hippocampal size were significant predictors of memory performance. TICV-adjusted volumes performed most poorly in accounting for variance in memory scores. Hippocampal volumes adjusted by either measure of whole-brain volume performed equally well, although qualitative visual ratings of the hippocampus were at least as effective as the volumetric measures in predicting memory performance in community-dwelling individuals in the ninth or tenth decade of life.	Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia; Concord Hosp, Dept Radiol, Sydney, NSW, Australia; Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; Prince Wales Med Res Inst, Sydney, NSW, Australia; Univ New S Wales, Sydney, NSW, Australia; Prince Wales Hosp, Sydney, NSW, Australia		Lye, TC (corresponding author), Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia.	tlye@medicine.usyd.edu.au	Piguet, Olivier/C-9658-2011; Ridley, Lloyd/AAU-5554-2021	Piguet, Olivier/0000-0002-6696-1440; Kril, Jillian/0000-0001-9407-8674			BHATIA S, 1993, NEUROLOGY, V43, P2006, DOI 10.1212/WNL.43.10.2006; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bilir E, 1998, NEURORADIOLOGY, V40, P138, DOI 10.1007/s002340050554; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Cahn DA, 1998, J INT NEUROPSYCH SOC, V4, P106, DOI 10.1017/S1355617798001064; CENDES F, 1993, J COMPUT ASSIST TOMO, V17, P206, DOI 10.1097/00004728-199303000-00008; Cheon JE, 1998, AM J NEURORADIOL, V19, P465; COOK MJ, 1992, BRAIN, V115, P1001, DOI 10.1093/brain/115.4.1001; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; deLeon MJ, 1997, NEUROBIOL AGING, V18, P1, DOI 10.1016/S0197-4580(96)00213-8; DELIS D, 1987, CALIFORNIA VERBAL LE; DESMOND PM, 1994, AUST NZ J MED, V24, P547, DOI 10.1111/j.1445-5994.1994.tb01756.x; DEWEER B, 1995, J NEUROL NEUROSUR PS, V58, P590, DOI 10.1136/jnnp.58.5.590; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Free SL, 1996, EPILEPSIA, V37, P400, DOI 10.1111/j.1528-1157.1996.tb00578.x; Fujioka M, 2000, CEREBROVASC DIS, V10, P2, DOI 10.1159/000016018; GOLOMB J, 1994, LEARN MEMORY, V1, P45; GOLOMB J, 1993, ARCH NEUROL-CHICAGO, V50, P967, DOI 10.1001/archneur.1993.00540090066012; Golomb J, 1996, NEUROLOGY, V47, P810, DOI 10.1212/WNL.47.3.810; Grundman M, 2003, J MOL NEUROSCI, V20, P241, DOI 10.1385/JMN:20:3:241; Grundman M, 2002, J MOL NEUROSCI, V19, P23, DOI 10.1007/s12031-002-0006-6; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Hashimoto M, 2001, NEUROLOGY, V57, P1461, DOI 10.1212/WNL.57.8.1461; Horn R, 1996, DEMENTIA, V7, P182, DOI 10.1159/000106876; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Jackson GD, 1998, NEUROLOGY, V51, P78, DOI 10.1212/WNL.51.1.78; Kopelman MD, 2001, J NEUROL NEUROSUR PS, V71, P23, DOI 10.1136/jnnp.71.1.23; Kurl, 1992, CLIN NEUROPSYCHOL, V6, P49, DOI [10.1080/13854049208401879, DOI 10.1080/13854049208401879]; Kuzniecky RI, 1997, NEUROLOGY, V49, P774, DOI 10.1212/WNL.49.3.774; Laakso MP, 2000, NEUROPSYCHOLOGIA, V38, P579, DOI 10.1016/S0028-3932(99)00111-6; LAAKSO MP, 1995, J NEURAL TRANSM-PARK, V9, P73, DOI 10.1007/BF02252964; Laakso MP, 1998, NEUROBIOL AGING, V19, P23, DOI 10.1016/S0197-4580(98)00006-2; LEHTOVIRTA M, 1995, NEUROSCIENCE, V67, P65, DOI 10.1016/0306-4522(95)00014-A; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; LINN RT, 1995, ARCH NEUROL-CHICAGO, V52, P485, DOI 10.1001/archneur.1995.00540290075020; Lye TC, 2004, J NEUROL NEUROSUR PS, V75, P548, DOI 10.1136/jnnp.2003.010223; Martin RC, 2001, NEUROLOGY, V57, P597, DOI 10.1212/WNL.57.4.597; Martin RC, 1999, J INT NEUROPSYCH SOC, V5, P540, DOI 10.1017/S1355617799566083; Mervaala E, 2000, PSYCHOL MED, V30, P117, DOI 10.1017/S0033291799001567; Mori E, 1997, J NEUROL NEUROSUR PS, V63, P214, DOI 10.1136/jnnp.63.2.214; Pantel J, 1997, PSYCHOL MED, V27, P221, DOI 10.1017/S003329179600431X; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Pihlajamaki M, 2003, HIPPOCAMPUS, V13, P67, DOI 10.1002/hipo.10049; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Rosen AC, 2003, BEHAV NEUROSCI, V117, P1150, DOI 10.1037/0735-7044.117.6.1150; ROSSI A, 1994, PSYCHIAT RES, V52, P43, DOI 10.1016/0165-1781(94)90119-8; Scheltens P, 1997, ALZ DIS ASSOC DIS, V11, P63, DOI 10.1097/00002093-199706000-00002; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SOININEN HS, 1994, NEUROLOGY, V44, P1660, DOI 10.1212/WNL.44.9.1660; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; TROSTER AI, 1993, J CLIN EXP NEUROPSYC, V15, P773, DOI 10.1080/01688639308402595; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Visser PJ, 2002, J NEUROL NEUROSUR PS, V72, P491; Wahlund LO, 2000, J NEUROL NEUROSUR PS, V69, P630, DOI 10.1136/jnnp.69.5.630; Waite LM, 2001, J NEUROL NEUROSUR PS, V71, P296, DOI 10.1136/jnnp.71.3.296; Waite LM, 2001, INT J GERIATR PSYCH, V16, P680, DOI 10.1002/gps.404; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P1521, DOI 10.1001/archneur.1997.00550240071015; Wechsler D, 1987, WMS R MANUAL; WILSON BA, 1995, J CLIN EXP NEUROPSYC, V17, P668, DOI 10.1080/01688639508405157; Wood AG, 2000, J INT NEUROPSYCH SOC, V6, P529, DOI 10.1017/S1355617700655029; Wu CC, 2002, NEUROLOGY, V59, P383, DOI 10.1212/WNL.59.3.383; ZIPURSKY RB, 1994, BIOL PSYCHIAT, V35, P501, DOI 10.1016/0006-3223(94)90097-3; [No title captured]	69	17	19	1	5	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0028-3940			NEURORADIOLOGY	Neuroradiology	FEB	2006	48	2					90	99		10.1007/s00234-005-0032-5			10	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	010SV	WOS:000235219100004	16365740				2022-02-06	
J	Sabri, F; Granath, F; Hjalmarsson, A; Aurelius, E; Skoldenberg, B				Sabri, F; Granath, F; Hjalmarsson, A; Aurelius, E; Skoldenberg, B			Modulation of sFas indicates apoptosis in human herpes simplex encephalitis	JOURNAL OF NEUROIMMUNOLOGY			English	Article						herpes simplex encephalitis; apoptosis; cerebrospinal fluid; soluble Fas	TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; SOLUBLE FAS; MULTIPLE-SCLEROSIS; CD95 APO-1/FAS; VIRUS; EXPRESSION; ACTIVATION; FAS/APO-1	Herpes simplex encephalitis (HSE) is the most common cause of non-epidemic, acute and fatal viral encephalitis. A pronounced mortality and morbidity remains in HSE despite antiviral treatment. There is evidence of a vigorous intrathecal immune activity in acute phases of HSE and of persistently increased activity at follow-ups after years. The role of apoptosis of neuronal cells in HSE patients',as a mechanism of damage has been brought up lately. We hypothesize that the severity and the progression of the cerebral injury resulting from HSE can be evaluated by quantitative measurement of a compartment of immune activation molecules i.e. soluble Fas (sFas) involved in apoptosis through the Fas/Fas Ligand pathway. Consecutive cerebrospinal fluid (CSF) samples from a prospectively followed cohort, included in an antiviral treatment trial in HSE, were enrolled for quantitative measurement of sFas using commercial capture ELISA. In total, CSF samples:from 49 patients with HSE, 63 patients with non-HSE encephalitis and 18 healthy individuals were studied. High levels of sFas were expressed in CSF samples collected between days 0-45 after neurological onset in 41/49 (84%) HSE patients, whereas only 21/63 (33%) of non-HSE patients and none of 18 healthy controls demonstrated measurable levels of sFas. Following the consecutive CSF sFas levels over the time and considering the clinical state of patients at admission, their neurological or lethal outcome at 12 months, and antiviral treatment, we observed that HSE patients with severe neurological sequels revealed an increase in changes of CSF sFas as compared to patients with mild or moderate neurological outcome (57.6 +/- 55.6 pg/ml, n=10 versus 26.3 +/- 97.5 pg/ml, n=14; P=0.008). Also HSE patients undergoing vidarabine treatment expressed significantly higher levels of changes of CSF sFas when compared to acyclovir-treated patients (63.7 +/- 52.8 pg/ml, n = 9 versus 26.1 +/- 98.4 pg/ml, n=14; P = 0.003). Interestingly, regardless of the clinical state at admission, and subsequent disease progression of the HSE patients, we could not observe any significant differences in the CSF sFas levels during the first 7 days of neurological symptoms. These observations underline the role of immunological response throughout the course of HSV infection in the brain and the role of the Fas/FasL pathway in particular in disease progression of HSE. The findings further enforce the need of expanding the knowledge of the pathogenesis of HSE to direct to more effective, in particular not only antiviral but also anti-apoptotic or anti-inflammatory treatment. (c) 2005 Published by Elsevier B.V.	Karolinska Univ Hosp, Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden; Karolinska Univ Hosp, Dept Med, Div Clin Epidemiol, Stockholm, Sweden		Sabri, F (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden.	farideh.sabri@karolinska.se					AURELIUS E, 1994, J INFECT DIS, V170, P678, DOI 10.1093/infdis/170.3.678; AURELIUS E, 1993, J INFECT DIS, V168, P1248, DOI 10.1093/infdis/168.5.1248; AURELIUS E, 1991, LANCET, V337, P189, DOI 10.1016/0140-6736(91)92155-U; BOOSS J, 1984, YALE J BIOL MED, V57, P751; CASCINO I, 1995, J IMMUNOL, V154, P2706; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; De Milito A, 2000, AIDS RES HUM RETROV, V16, P1379, DOI 10.1089/08892220050140928; DeBiasi RL, 2002, J INFECT DIS, V186, P1547, DOI 10.1086/345375; Dowling P, 1996, J EXP MED, V184, P1513, DOI 10.1084/jem.184.4.1513; Elovaara I, 1999, ACTA NEUROPATHOL, V98, P355, DOI 10.1007/s004010051094; Felderhoff-Mueser U, 2001, ARCH DIS CHILD, V84, P369, DOI 10.1136/adc.84.4.369; FISCHER U, 2005, CELL DEATH DIFFER; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Kamiyama H, 2004, CANCER SCI, V95, P990, DOI 10.1111/j.1349-7006.2004.tb03188.x; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Martinez-Torres FJ, 2004, NEUROSCI LETT, V368, P274, DOI 10.1016/j.neulet.2004.06.064; MATSUYAMA T, 1994, BRAIN RES, V657, P342, DOI 10.1016/0006-8993(94)90989-X; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Mogi M, 1996, NEUROSCI LETT, V220, P195, DOI 10.1016/S0304-3940(96)13257-2; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; OWENSCHAUB LB, 1995, CANCER LETT, V94, P1, DOI 10.1016/0304-3835(95)03834-J; Papoff G, 1996, J IMMUNOL, V156, P4622; Perkins D, 2003, J NEUROVIROL, V9, P101, DOI 10.1080/13550280390173427; Sabri F, 2001, J NEUROIMMUNOL, V114, P197, DOI 10.1016/S0165-5728(00)00424-0; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sellner J, 2005, NEUROSCI LETT, V374, P197, DOI 10.1016/j.neulet.2004.10.054; SKOLDENBERG B, 1984, LANCET, V2, P707; SKOLDENBERG B, 1991, SCAND J INFECT DIS, P40; SKOLDENBERG B, IN PRESS J NEUROL; Studahl M, 2000, J NEUROL, V247, P636, DOI 10.1007/s004150070134; TACHIBANA O, 1995, CANCER RES, V55, P5528; Thompson KA, 2000, J NEUROVIROL, V6, P25, DOI 10.3109/13550280009006379; Towfighi A, 2004, NEUROLOGY, V62, P654, DOI 10.1212/01.WNL.0000110188.37546.51; WHITLEY RJ, 1991, DRUGS, V42, P406, DOI 10.2165/00003495-199142030-00005; WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; Zipp F, 1998, ANN NEUROL, V43, P116, DOI 10.1002/ana.410430120	40	17	17	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	FEB	2006	171	1-2					171	176		10.1016/j.jneuroim.2005.10.003			6	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	009LW	WOS:000235114500017	16325272				2022-02-06	
J	Gamboa, AM; Holland, GH; Tierney, JP; Gibson, DS				Gamboa, A. M., Jr.; Holland, Gwendolyn H.; Tierney, John P.; Gibson, David S.			American Community Survey: Earnings and employment for persons with traumatic brain injury	NEUROREHABILITATION			English	Article; Proceedings Paper	1st International Conference on Vocational Outcomes in Traumatic Brain Injury	APR 14-16, 2005	Vancouver, CANADA			disability; brain injury; earnings; employment; American Community Survey		In 2000, the United States Census Bureau began the annual American Community Survey (ACS), which collects data on earnings and employment for persons with various types of impairment. One of the impairments is cognitive disability, defined as existing when a person has a condition lasting six months or more that results in difficulty learning, remembering, or concentrating. Individuals with such limitations are often defined as having mild traumatic brain injury (TBI). Persons with mild TBI often retain the ability to work competitively. Such individuals, however, typically earn less when employed year-round, full-time than do persons without disability and have lower levels of employment, resulting in reduced worklife expectancy. This article focuses on the effects of cognitive disability on earnings and employment. The ACS data are reported by gender and education level for those without disability or with cognitive disability. Employment levels are translated into worklife expectancies and the method of conversion through use of a joint probability of life, participation, and employment is examined.	Vocat Econ Inc, Louisville, KY 40243 USA		Holland, GH (corresponding author), Vocat Econ Inc, 11933 Brinley Ave, Louisville, KY 40243 USA.	gwenh@vocecon.com					ARIAS E, 2004, US LIFE LIFE TABLES; BRODWIN MG, 2002, MED PSYCHOSOCIAL VOC; BROOKSHIRE ML, 2006, TRIAL; BROOKSHIRE ML, 1983, DEFENSE, P20; *CORN U, 2005, REH RES TRAIN CTR DI; GAMBOA AM, 2006, NEW WORKLIFE EXPECTA; STAPLETON DC, 1997, EXPLORATORY STUDY HL; *US CTR DIS CONTR, TRAUM BRAIN INJ FACT; VOGENTHALER DR, 1987, BRAIN INJURY, P113	9	17	17	1	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2006	21	4					327	333					7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	145VU	WOS:000244894700007	17361049				2022-02-06	
J	Rooker, S; Jander, S; Van Reempts, J; Stoll, G; Jorens, PG; Borgers, M; Verlooy, J				Rooker, Servan; Jander, Sebastian; Van Reempts, Jos; Stoll, Guido; Jorens, Philippe G.; Borgers, Marcel; Verlooy, Jan			Spatiotemporal pattern of neuroinflammation after impact-acceleration closed head injury in the rat	MEDIATORS OF INFLAMMATION			English	Article							MODIFIED EXPERIMENTAL-MODEL; INTRACRANIAL-PRESSURE; MESSENGER-RNA; GENE-EXPRESSION; TNF-ALPHA; BRAIN; CYTOKINES; IL-6; INTERLEUKIN-18; INDUCTION	Inflammatory processes have been implicated in the pathogenesis of traumatic brain damage. We analyzed the spatiotemporal expression pattern of the proinflammatory key molecules: interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and inducible nitric oxide synthase in a rat closed head injury ( CHI) paradigm. 51 rats were used for RT- PCR analysis after CHI, and 18 for immunocytochemistry. We found an early upregulation of IL-1 beta, IL-6, and TNF-alpha mRNA between 1 h and 7 h after injury; the expression of iNOS mRNA only revealed a significant increase at 4 h. After 24 h, the expression decreased towards baseline levels, and remained low until 7 d after injury. Immunocytochemically, IL-1 beta induction was localized to ramified microglia in areas surrounding the primary impact place as well as deeper brain structures. Our study shows rapid induction of inflammatory gene expression that exceeds by far the primary impact site and might therefore contribute to tissue damage at remote sites. Copyright (c) 2006 Servan Rooker et al.	Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; Janssen Res Fdn, Dept Life Sci, B-2340 Beerse, Belgium; Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; Univ Antwerp Hosp, Dept Intens Care Med, B-2650 Edegem, Belgium		Rooker, S (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium.		Rooker, Servan/AAD-4316-2020				ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; BULLOCK R, 2000, EUROPEAN J EMERGENCY, V3, P109; Davies CA, 1999, J CEREBR BLOOD F MET, V19, P87, DOI 10.1097/00004647-199901000-00010; De Mulder G, 2000, ACT NEUR S, V76, P409; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Engelborghs K, 1997, ACT NEUR S, V70, P123; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Gillen C, 1998, J NEUROSCI RES, V51, P489, DOI 10.1002/(SICI)1097-4547(19980215)51:4<489::AID-JNR8>3.3.CO;2-5; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Jander S, 2000, J NEUROIMMUNOL, V109, P181, DOI 10.1016/S0165-5728(00)00317-9; Jander S, 1998, J NEUROIMMUNOL, V91, P93, DOI 10.1016/S0165-5728(98)00162-3; Jander S, 2002, J CEREBR BLOOD F MET, V22, P62, DOI 10.1097/00004647-200201000-00008; Jander S, 2001, J CEREBR BLOOD F MET, V21, P218, DOI 10.1097/00004647-200103000-00005; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Rooker S, 2002, J NEUROSCI METH, V119, P83, DOI 10.1016/S0165-0270(02)00183-8; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; van Rossem K, 1999, ADV EXP MED BIOL, V471, P209; VANROSSEM K, 1999, J CEREB BLOOD FLOW M, V19, pS391; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131	29	17	17	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.		2006	2006								90123	10.1155/MI/2006/90123			6	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	080DN	WOS:000240227300001	16864909	Green Published, Green Submitted, gold			2022-02-06	
J	Donnelly, JP; Donnelly, K; Grohman, KK				Donnelly, JP; Donnelly, K; Grohman, KK			A multi-perspective concept mapping study of problems associated with traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; concept mapping; quality of life	QUALITY-OF-LIFE; PROBLEM-SOLVING THERAPY; SELF-AWARENESS; HEAD-INJURY; REHABILITATION; DYSFUNCTION; DEPRESSION; BEHAVIOR; ADULTS; MODEL	Objective: To develop a model of the problems of persons with traumatic brain injury that includes multiple perspectives as well as the multi-dimensional nature of the phenomena. Design: Concept mapping, a multi-variate modelling strategy, was employed to produce an exhaustive inventory and concept map of TBI-related problems based on input from patients, family caregivers and professional providers. Results: The eight-cluster concept map included the following dimensions: social competence, intimacy, behavioural, maturity/ independence, neurophysiological, mood, executive functions and non-executive functions. Conclusions: An underlying two-dimensional conceptual model of TBI problems is proposed with relevance for theory, practice and further research.	SUNY Buffalo, Sch & Educ Psychol, Dept Counseling, Buffalo, NY 14260 USA; SUNY Buffalo, Res Inst Addict, Amherst, NY USA		Donnelly, JP (corresponding author), SUNY Buffalo, Sch & Educ Psychol, Dept Counseling, 401 Baldy Hall, Buffalo, NY 14260 USA.	jpd1@buffalo.edu	Donnelly, James/AAI-4840-2020				Alexopoulos GS, 2003, AM J GERIAT PSYCHIAT, V11, P46, DOI 10.1176/appi.ajgp.11.1.46; Bezeau SC, 2004, BRAIN INJURY, V18, P299, DOI 10.1080/02699050310001617398; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Christ SE, 2003, NEUROPSYCHOLOGY, V17, P171, DOI 10.1037/0894-4105.17.1.171; Cock J, 2003, BRAIN INJURY, V17, P561, DOI 10.1080/0269905031000088306; Day SX, 1998, AM PSYCHOL, V53, P728, DOI 10.1037/0003-066X.53.7.728; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Everitt B. S., 1980, CLUSTER ANAL; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Florio G A, 1998, J Occup Health Psychol, V3, P227; GATI I, 1991, PSYCHOL BULL, V109, P309, DOI 10.1037/0033-2909.109.2.309; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; Golden Z, 2003, INT J NEUROSCI, V113, P733, DOI 10.1080/00207450390200044; Gotay CC, 2002, PSYCHOL ASSESSMENT, V14, P439, DOI 10.1037//1040-3590.14.4.439; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; Kendall E, 2003, J VOCAT REHABIL, V19, P31; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Man DWK, 2003, BRAIN INJURY, V17, P775, DOI 10.1080/0269905031000088577; Man DWK, 2003, BRAIN INJURY, V17, P437, DOI 10.1080/0269905031000070152; Marshall RC, 2003, AM J SPEECH-LANG PAT, V12, P333, DOI 10.1044/1058-0360(2003/079); McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Nezu AM, 1999, J PSYCHOSOC ONCOL, V16, P5, DOI 10.1300/J077v16n03_02; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Power PW, 2003, BRAIN INJURY, V17, P1021, DOI 10.1080/0269905031000110526; PREDIGER DJ, 1982, J VOCAT BEHAV, V21, P259, DOI 10.1016/0001-8791(82)90036-7; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Ruttan LA, 2003, J CLIN EXP NEUROPSYC, V25, P407, DOI 10.1076/jcen.25.3.407.13812; Sahler OJZ, 2002, J DEV BEHAV PEDIATR, V23, P77, DOI 10.1097/00004703-200204000-00003; Simpson G, 2003, J HEAD TRAUMA REHAB, V18, P445, DOI 10.1097/00001199-200309000-00006; Simpson G, 2003, BRAIN INJURY, V17, P723, DOI 10.1080/0269905031000110481; Tasker SL., 2003, ILLN CRISES LOSS, V11, P337, DOI DOI 10.1177/1054137303256585; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Trochim WMK, 2003, TOB CONTROL, V12, P140, DOI 10.1136/tc.12.2.140; TROCHIM WMK, 1989, EVAL PROGRAM PLANN, V12, P1, DOI 10.1016/0149-7189(89)90016-5; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Vandiver VL, 2003, J HEAD TRAUMA REHAB, V18, P457, DOI 10.1097/00001199-200309000-00007; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Zasler ND, 2003, NEUROPSYCHOL REHABIL, V13, P31, DOI 10.1080/09602010	45	17	17	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2005	19	13					1077	1085		10.1080/02699050500110728			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	983ZD	WOS:000233270000002	16286321				2022-02-06	
J	Shafi, S; Gentilello, L				Shafi, S; Gentilello, L			Hypotension does not increase mortality in brain-injured patients more than it does in non-brain-injured patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	18th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 11-15, 2005	Ft Lauderdale, FL	Eastern Assoc Surg Trauma		hypotension; brain injury; mortality; risk factor; traumatic brain injury	UNCONTROLLED HEMORRHAGIC-SHOCK; DELAYED FLUID RESUSCITATION; MULTIPLE ORGAN FAILURE; HEAD-INJURY; HYPOXIA; IMMEDIATE; DURATION; TRAUMA; MODEL; RATS	Objectives: Hypotension increases mortality after all types of injuries. Prior studies comparing mortality of hypotensive traumatic brain injury (TBI) patients to normotensive TBI patients have implied that hypotension is particularly detrimental after TBI. It is unknown whether hypotension affects TBI patients more severely than it affects other types of patients. We hypothesized that hypotension does not increase mortality in TBI patients more than it does in non-TBI patients. Methods: National Trauma Data Bank (1994-2002) patients aged 18 to 45 years with blunt mechanisms of injury treated at Level I and Level II centers were included. Deaths occurring before 24 hours were excluded. Logistic regression was used to measure the association between hypotension (<= 90 mm Hg) and death after adjusting for confounding variables of age, gender, comorbidities, complications, Glasgow Coma Scale score, and severity of associated injuries. Odds ratios (95% confidence interval) indicate the risk of death in hypotensive patients in each group compared with normotensive patients in the same group. Results: The study population consisted of 79,478 patients (TBI, 30,742; no TBI, 48,736). Hypotension independently quadrupled the risk of death after adjusting for confounding variables (odds ratio [OR], 4.8; 95% confidence interval [CI], 4.1-5.6). However, increase in this risk associated with hypotension was the same in TBI (OR, 4.1; 95% CI, 3.5-4.9) and non-TBI patients (OR, 4.6; 95% CI, 3.4-6.0). Furthermore, the relationship between hypotension and TBI did not change with increasing head Abbreviated Injury Scale score severity. Conclusion: Hypotension is an independent risk factor for mortality. However, it does not increase mortality in TBI patients more than it does for non-TBI patients.	Univ Texas, SW Med Ctr, Div Burn Trauma & Surg Crit Care, Dept Surg, Dallas, TX 75390 USA		Shafi, S (corresponding author), Univ Texas, SW Med Ctr, Div Burn Trauma & Surg Crit Care, Dept Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	shahid.shafi@utsouthwestern.edu		holcomb, john/0000-0001-8312-9157			Beaumont A, 2002, ACT NEUR S, V81, P217; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bourguignon PR, 1998, ARCH SURG-CHICAGO, V133, P390, DOI 10.1001/archsurg.133.4.390; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; Cairns C B, 2001, Curr Opin Crit Care, V7, P437, DOI 10.1097/00075198-200112000-00011; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; Holtzer S, 2001, CRIT CARE MED, V29, P1609, DOI 10.1097/00003246-200108000-00018; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Sakles JC, 1997, ANN EMERG MED, V29, P392, DOI 10.1016/S0196-0644(97)70352-4; Sauaia A, 1996, WORLD J SURG, V20, P392, DOI 10.1007/s002689900062; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; Solomonov E, 2000, CRIT CARE MED, V28, P749, DOI 10.1097/00003246-200003000-00024; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533	21	17	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2005	59	4					830	834		10.1097/01.ta.0000188147.36232.c0			5	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	001DN	WOS:000234513900006	16374269				2022-02-06	
J	Stoller, KP				Stoller, KP			Quantification of neurocognitive changes before, during, and after hyperbaric oxygen therapy in a case of fetal alcohol syndrome	PEDIATRICS			English	Article						hyperbaric oxygen therapy; fetal alcohol syndrome	DELAYED-ONSET DYSTONIA; BRAIN-INJURED PATIENTS; ACUTE ISCHEMIC STROKE; CEREBRAL-PALSY; CONCUSSION; HYPOXIA; HYPEROXIA; CHILDREN; TRIAL	Fetal alcohol syndrome (FAS) is the most common nonhereditary cause of mental retardation, with deficits in general intellectual functioning, learning, memory, attention, and problem-solving. Presented here is the first case in which measured neurocognitive abilities were determined before, during, and after hyperbaric oxygen therapy in a case of FAS involving a teenage male patient. Memory, reaction time, and visual motor speed assessments were compared. After 40 hyperbaric treatments with 100% oxygen at 1.5 atmospheres absolute, the patient's performance in 6 of 6 categories of the computer-administered test battery improved. Word composite (verbal) scores improved from 55% to 73%, memory composite (visual) scores improved from 38% to 55%, reaction time composites improved from 1.03 to 0.53 seconds, impulse control composite scores improved from 8 to 5, and visual motor speed scores improved from 18.6 to 19.03. The patient's subjective symptoms diminished 94%. Six months after these treatments, the patient's verbal memory was maintained at 73% without any other interventions; impulsivity continued to improve, whereas other indices did not. Thirty-three additional treatments continued to improve test performance, with verbal memory at 95%, visual memory at 57%, and a 100% reduction of subjective symptoms. This patient, with 15-year-matured FAS, benefited from a short course of low-pressure hyperbaric oxygen therapy, sustained durable cognitive improvements, and continued to exhibit improvement with another short course of treatments.	Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA		Stoller, KP (corresponding author), 404 Brunn Sch Rd D, Santa Fe, NM 87505 USA.	hbotnm@netzero.net					BURKE RE, 1980, J NEUROL NEUROSUR PS, V43, P789, DOI 10.1136/jnnp.43.9.789; Calvert JW, 2004, EXP NEUROL, V189, P150, DOI 10.1016/j.expneurol.2004.05.030; Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Collet JP, 2001, LANCET, V357, P582, DOI 10.1016/S0140-6736(00)04054-X; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Ersanli D, 2004, SWISS MED WKLY, V134, P650; HARCH PG, 1994, UNDERSEA HYPERB ME S, V21, P22; HARCH PG, 1994, UNDERSEA HYPERB ME S, V21, P15; HARCH PG, 1994, UNDERSEA HYPERB ME S, V21, P30; Hardy P, 2002, DEV MED CHILD NEUROL, V44, P436; HARIK SI, 1994, J APPL PHYSIOL, V77, P896, DOI 10.1152/jappl.1994.77.2.896; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Marois P, 2003, DEV MED CHILD NEUROL, V45, P646, DOI 10.1017/S001216220321191; May PA, 2001, ALCOHOL RES HEALTH, V25, P159; Montgomery D, 1999, UNDERSEA HYPERBAR M, V26, P235; Nakajima M, 1994, Rinsho Shinkeigaku, V34, P48; NEUBAUER RA, 1992, CLIN NUCL MED, V17, P477, DOI 10.1097/00003072-199206000-00010; NEUBAUER RA, 1990, LANCET, V335, P542, DOI 10.1016/0140-6736(90)90777-3; NEUBAUER RA, 1990, P 15 INT C NEUR OCC, P10; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; Nighoghossian N, 1997, J NEUROL SCI, V150, P27, DOI 10.1016/S0022-510X(97)05398-7; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; SAINTHILAIRE MH, 1991, NEUROLOGY, V41, P216; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Steindler DA, 2002, LANCET, V359, P1047, DOI 10.1016/S0140-6736(02)08096-0; STOLLER KP, 2004, UND HYP MED SOC GULF; ZISER A, 1984, BRIT MED J, V289, P960, DOI 10.1136/bmj.289.6450.960	31	17	17	1	7	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	OCT	2005	116	4					E586	E591		10.1542/peds.2004-2851			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	970FD	WOS:000232289700070	16166387				2022-02-06	
J	Giles, GM; Wager, J; Fong, L; Waraich, BS				Giles, GM; Wager, J; Fong, L; Waraich, BS			Twenty-month effectiveness of a non-aversive, long-term, low-cost programme for persons with persisting neurobehavioural disability	BRAIN INJURY			English	Article						brain injury; aggression; non-aversive treatment; outcome	TRAUMATIC BRAIN-INJURY; CLOSED HEAD-INJURY; AGGRESSIVE-BEHAVIOR; PSYCHIATRIC-DISORDERS; PAST BEHAVIOR; MEMORY; STAFF; REHABILITATION; ADOLESCENTS; MANAGEMENT	Primary objective: To examine the effectiveness of a programme developed for persons with persisting neurobehavioural/ neuropsychiatric disorders. Research design: Descriptive study of a programme that has a philosophy of normalization, respect, non-confrontation, positive engagement, support and functional and behavioural skill development. Methods and procedures: Participants were the 40 clients admitted during the initial 20 months of operation. Prior to admission clients had recurrent placement failures secondary to behavioural disregulation and typically were housed at County or State Hospitals. An expanded version of the Overt Aggression Scale Modified for Neurorehabilitation was used to provide detailed descriptions of assaults. Main outcomes and results: Over the 20-month period, 49 incidents of client-to-client aggression occurred representing a rate of 0.11 incidents per client month. Thirty-five of 40 clients remained at the end of 20 months, with only three discharges due to behaviour. Conclusions: A long-term, stable living environment has been provided for individuals who had been intractable management problems elsewhere.	Samuel Merritt Coll, Oakland, CA 94609 USA; Crestwood Treatment Ctr, Fremont, CA USA; Univ Calif Davis, Dept Psychiat, Davis, CA 95616 USA		Giles, GM (corresponding author), Samuel Merritt Coll, 450 30th St, Oakland, CA 94609 USA.	ggiles@samuelmerritt.edu					Ackerman SJ, 2003, CLIN PSYCHOL REV, V23, P1, DOI 10.1016/S0272-7358(02)00146-0; Albarracin D, 2000, J PERS SOC PSYCHOL, V79, P5, DOI 10.1037//0022-3514.79.1.5; Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Alderman N, 1999, BRAIN INJURY, V13, P669; ANDREWES D, 1989, J BEHAV THER EXP PSY, V20, P261, DOI 10.1016/0005-7916(89)90032-3; Bardenhagen FJ, 1999, NEUROCASE, V5, P325; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bordin ES, 1979, PSYCHOTHER THEORY RE, V16, P252, DOI DOI 10.1037/H0085885; BRAILSFORD DS, 1973, FACTORS RELATED VIOL, P9; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CHEUNG P, 1997, AUSTR NZ J PSYCHIAT, P31; Deb S, 1999, AM J PSYCHIAT, V156, P374; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; FLEMINGER S, 2003, COCHRANE LIB; Fluharty G, 2001, BRAIN INJURY, V15, P995, DOI 10.1080/02699050010025795; Giles G. M., 1999, REHABILITATION SEVER, P81; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; Giles GM, 2001, BRAIN DAM B, P231; GILES GM, 1988, AM J OCCUP THER, V42, P658, DOI 10.5014/ajot.42.10.658; GILES GM, 1993, BRAIN INJURY REHABIL; GILES GM, 1999, REHABILITATION SEVER; Greve KW, 2001, BRAIN INJURY, V15, P255; HALLER RM, 1988, BRIT J PSYCHIAT, V152, P174, DOI 10.1192/bjp.152.2.174; Hayes SC, 1997, PSYCHOL SCI, V8, P170, DOI 10.1111/j.1467-9280.1997.tb00405.x; Heflin L. J., 2001, FOCUS AUTISM OTHER D, V16, P93, DOI DOI 10.1177/108835760101600205; HODGKINSON PE, 1985, MED SCI LAW, V25, P288, DOI 10.1177/002580248502500411; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KELLY JP, 1997, PATIENT CARE, V31, P48; KELLY JP, 1997, PATIENT CARE, V31; KELLY JP, 1997, PATIENT CARE, V31, P46; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kim E, 2002, NEUROREHABILITATION, V17, P297; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LISHMAN WA, 1998, ORGANIC PSYCHIAT PSY; Luiselli J, 2003, BRAIN INJURY, V17, P255, DOI 10.1080/0269905021000030832; Manchester D, 1997, BRAIN INJURY, V11, P271; Manchester D, 2001, BRAIN DAM B, P157; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; MCDOWELL JJ, 1982, AM PSYCHOL, V37, P771, DOI 10.1037/0003-066X.37.7.771; McMillan TM, 2001, BRAIN DAM B, P257; MONAHAN J, 1992, AM PSYCHOL, V47, P511, DOI 10.1037/0003-066X.47.4.511; Murre JMJ, 1997, MEMORY, V5, P213, DOI 10.1080/741941155; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; PETERS M D, 1992, Brain Injury, V6, P299, DOI 10.3109/02699059209034944; Rabinowitz J, 1999, ACTA PSYCHIAT SCAND, V99, P341, DOI 10.1111/j.1600-0447.1999.tb07239.x; RUBEN I, 1980, J NERV MENT DIS, V168, P243, DOI 10.1097/00005053-198004000-00010; Safran J. D., 2000, NEGOTIATING THERAPEU; SATEL SL, 1991, AM J PSYCHIAT, V148, P1708; SILVER JM, 1991, J NEUROPSYCHIAT, V3, P22; Smith RG, 1997, J APPL BEHAV ANAL, V30, P343, DOI 10.1901/jaba.1997.30-343; SOLOFF PH, 1985, HOSP COMMUNITY PSYCH, V36, P652; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; TANKE ED, 1985, AM J PSYCHIAT, V142, P1409; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; TERRACE HS, 1963, J EXP ANAL BEHAV, V6, P1, DOI 10.1901/jeab.1963.6-1; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Triandis H., 1977, INTERPERSONAL BEHAV; VOLLMER TR, 1993, J APPL BEHAV ANAL, V26, P9, DOI 10.1901/jaba.1993.26-9; Waddington L, 2002, BEHAV COGN PSYCHOTH, V30, P179, DOI 10.1017/S1352465802002059; Watson C, 2001, BRAIN INJURY, V15, P1003, DOI 10.1080/02699050010022662; Whittington R, 1996, BRIT J CLIN PSYCHOL, V35, P11, DOI 10.1111/j.2044-8260.1996.tb01158.x; Zencius A H, 1989, Brain Inj, V3, P199, DOI 10.3109/02699058909004553	70	17	17	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2005	19	10					753	764		10.1080/02699050500110108			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	945EI	WOS:000230484800002	16175836				2022-02-06	
J	Stephenson, S; Langley, J; Cryer, C				Stephenson, S; Langley, J; Cryer, C			Effects of service delivery versus changes in incidence on trends in injury: A demonstration using hospitalised traumatic brain injury	ACCIDENT ANALYSIS AND PREVENTION			English	Article						severity; inpatients; TBI; ICISS; ICD; AIS; trends	SEVERITY; MORTALITY	Though injury incidence and hospitalisations are likely to be correlated, a range of factors other than incidence of injury in a population may influence trends in hospitalised injuries. These include technical changes in the hospital data's coverage, and real changes in the incidence of hospitalisations independent of the population incidence. This paper addresses the latter using the example of traumatic brain injury (TBI) hospitalisations in New Zealand. Data were New Zealand public hospitals inpatient discharges. Five measures of TBI severity were used. The relative rate of minor to serious TBI hospitalisations declined by approximately 2-6% per year from 1988 to 1998. This decline is observed across different mechanisms and the two severity measures used in the detailed analysis. The relative decline in minor to serious TBI is likely to be related to a change in the probability of admission rather than a change in the population TBI incidence. As most TBI hospitalisations are minor this suggests the trend in TBI hospitalisations was significantly influenced by factors other than changes in population incidence. Any analysis of routinely collected secondary injury data needs to consider case selection carefully, especially if trends are being examined. Applying a severity threshold should give more reliable trends. (c) 2005 Elsevier Ltd. All rights reserved.	Univ Otago, Dunedin Sch Med, Injury Prevent Res Unit, Dunedin 9001, Otago, New Zealand		Langley, J (corresponding author), Univ Otago, Dunedin Sch Med, Injury Prevent Res Unit, POB 913, Dunedin 9001, Otago, New Zealand.	shaun.stephenson@ipru.otago.ac.nz; john.langley@ipru.otago.ac.nz; colin.cryer@ipru.otago.ac.nz					Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; *CDCP NAT CTR INJ, 1999, TRAUM BRAIN INJ US R, P1; Cryer PC, 1999, INT J CONS PROD SAFE, V6, P183; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Langley J, 2002, INJ PREV, V8, P332, DOI 10.1136/ip.8.4.332; Langley J, 2000, AUSTR EPIDEMIOLOGIST, V7, P5; MACKENZIE E, 1997, ICDMAP 90 SOFTWARE U; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; *NAT COD CTR, 1996, AUSTR COD STAND ICD; OCONNOR P, 2001, HOSPITALISATION DUE, P1; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Stephenson SCR, 2002, J TRAUMA, V53, P326, DOI 10.1097/00005373-200208000-00023; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; *US NAT CTR HLTH S, 1979, INT CLASS DIS ICD 9, V1; WALSH SS, 1992, J EPIDEMIOL COMMUN H, V46, P26, DOI 10.1136/jech.46.1.26; World Health Organisation (WHO), 1977, MAN INT STAT CLASS D; Zee CS, 1998, NEUROIMAG CLIN N AM, V8, P525	21	17	17	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	SEP	2005	37	5					825	832		10.1016/j.aap.2005.03.024			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	961HP	WOS:000231652900003	15916746				2022-02-06	
J	Wedekind, C; Lippert-Gruner, M				Wedekind, C; Lippert-Gruner, M			Long-term outcome in severe traumatic brain injury is significantly influenced by brainstem involvement	BRAIN INJURY			English	Article						traumatic brain injury; long-term outcome; brainstem lesions	HEAD; LESIONS	Primary objective: To study the 1-year-outcome of 32 survivors of severe traumatic brain injury with respect to the impact of brainstem injury. Research design: Retrospective clinical study performed in a university hospital. Methods and procedures: Thirty-two 1-year-survivors ( 15 with brainstem injury present) of severe traumatic brain injury were investigated for neurological function, activities of daily living, need for care and professional ability. Main outcomes and results: Visual impairment, spasticity, co-ordination deficits and organic psychosis were more frequent in the group harbouring brainstem lesions. Professional ability was worse among these patients. Conclusion: Brainstem involvement in survivors of severe traumatic brain injury conveys a negative impact on long-term outcome.	Univ Cologne, Dept Neurosurg, D-50924 Cologne, Germany		Wedekind, C (corresponding author), Univ Cologne, Dept Neurosurg, D-50924 Cologne, Germany.	drchrwedekind@web.de					Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CONSTANT C, 1996, NEUROLOGICAL SURG, P1792; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Gruner ML, 2000, BRAIN INJURY, V14, P585; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; Keith R A, 1987, Adv Clin Rehabil, V1, P6; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; MAHONEY F I, 1965, Md State Med J, V14, P61; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RHODES M, 1988, J TRAUMA, V28, P931, DOI 10.1097/00005373-198807000-00005; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842	16	17	19	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2005	19	9					681	684		10.1080/02699050400025182			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	945EH	WOS:000230484600005	16195181				2022-02-06	
J	Maeda, T; Lee, SM; Hovda, DA				Maeda, T; Lee, SM; Hovda, DA			Restoration of cerebral vasoreactivity by an L-type calcium channel blocker following fluid percussion brain injury	JOURNAL OF NEUROTRAUMA			English	Article						hemodynamic depression; traumatic brain injury; vasoreactivity; verapamil	CORTICAL IMPACT INJURY; SMOOTH-MUSCLE-CELLS; BLOOD-FLOW; GLUCOSE-UTILIZATION; SUBARACHNOID HEMORRHAGE; INTRAVASCULAR PRESSURE; HEMODYNAMIC DEPRESSION; PIAL ARTERY; RAT; MICROCIRCULATION	Traumatic brain injury (TBI) results in significant acute reductions in regional cerebral blood flow (rCBF). However, the mechanisms by which TBI impairs CBF and cerebral vascular reactivity have remained elusive. In the present study, the effect of verapamil, an L-type calcium (Ca2+) channel blocker, on post-traumatic vascular reactivity was evaluated following a lateral fluid percussion injury (FPI) in rats. rCBF was measured by [C-14]-iodoantipyrine autoradiography 1 h after FPI. Following FPI, significant rCBF reductions were documented in all examined cortical areas. These reductions were the most prominent (72.0%) at the primary injury site. Intravenous infusion of verapamil (VE; 200 mu g/kg/min), and norepinephrine (NE; 20 mu g/mL/min) to maintain normal blood pressure, increased rCBF by 141.5% at the primary injury site when compared to untreated, FP-injured animals. Under stimulated conditions, both the ipsilateral and contralateral hemispheres failed to show any increases in rCBF at I h following FPI. In direct contrast, following VE+NE treatment all cortical areas measured showed near normal vascular reactivity to direct cortical stimulation (normal reactivity = 45% increase in rCBF vs. 47% increase in FPI+VE+NE cases). These findings suggest that the majority of post-traumatic hemodynamic depressions are closely related to mechanisms involving vasoconstriction. Furthermore, Ca2+ may play a causative role in this vasoconstriction and the loss of vasoreactivity.	Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg Neurosurg, Los Angeles, CA USA		Hovda, DA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Div Neurosurg, 10833 Le Conte Ave,Box 957039, Los Angeles, CA 90095 USA.	dhovda@mednet.ucla.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27544, NS37363, NS30308] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030308, R01NS037363, R01NS027544] Funding Source: NIH RePORTER		Alagarsamy S, 1998, J NEUROTRAUM, V15, P627, DOI 10.1089/neu.1998.15.627; Alder VA, 1996, EXP EYE RES, V63, P557, DOI 10.1006/exer.1996.0146; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BRAYDEN JE, 1989, J CEREBR BLOOD F MET, V9, P256, DOI 10.1038/jcbfm.1989.42; Bryan RM, 2001, AM J PHYSIOL-HEART C, V280, pH2011, DOI 10.1152/ajpheart.2001.280.5.H2011; Bukoski RD, 1997, AM J PHYSIOL-HEART C, V272, pH1406; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DAVIS MJ, 1992, AM J PHYSIOL, V262, pC1083, DOI 10.1152/ajpcell.1992.262.4.C1083; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1988, AM J PHYSIOL, V255, pH397, DOI 10.1152/ajpheart.1988.255.2.H397; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Golding EA, 2003, J CEREBR BLOOD F MET, V23, P210, DOI 10.1097/01.WCB.0000044739.64940.B5; HAGBERG H, 1984, J CEREBR BLOOD F MET, V4, P297, DOI 10.1038/jcbfm.1984.41; HARDER DR, 1987, AM J PHYSIOL, V269, pF778; Hong KW, 2001, AM J PHYSIOL-HEART C, V281, pH308, DOI 10.1152/ajpheart.2001.281.1.H308; IIJIMA T, 1992, J CEREBR BLOOD F MET, V12, P727, DOI 10.1038/jcbfm.1992.103; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kawanabe Y, 2003, J NEUROSURG, V98, P561, DOI 10.3171/jns.2003.98.3.0561; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LO EH, 1991, NEUROSCI LETT, V131, P17, DOI 10.1016/0304-3940(91)90327-P; LO EH, 1991, J CEREBR BLOOD F MET, V11, P803, DOI 10.1038/jcbfm.1991.138; Maeda T, 1997, ACT NEUR S, V70, P102; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; MCINTOSH TK, 1992, J CEREBR BLOOD F MET, V12, P697, DOI 10.1038/jcbfm.1992.95; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P607, DOI 10.1038/jcbfm.1986.108; OKIYAMA K, 1994, J NEUROTRAUM, V11, P83, DOI 10.1089/neu.1994.11.83; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8; Schmoker JD, 1996, J NEUROTRAUM, V13, P67, DOI 10.1089/neu.1996.13.67; Setoguchi M, 1997, J PHYSIOL-LONDON, V501, P343, DOI 10.1111/j.1469-7793.1997.343bn.x; SHAH KR, 1983, NEUROSCI LETT, V40, P287, DOI 10.1016/0304-3940(83)90053-8; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Thomale UW, 2001, J NEUROSCI METH, V108, P85, DOI 10.1016/S0165-0270(01)00375-2; WALSH MP, 1994, CAN J PHYSIOL PHARM, V72, P919, DOI 10.1139/y94-130; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Welsh DG, 2000, J PHYSIOL-LONDON, V527, P139, DOI 10.1111/j.1469-7793.2000.t01-1-00139.x; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yang J, 2003, MED ENG PHYS, V25, P691, DOI 10.1016/S1350-4533(03)00100-0; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zou H, 2000, J VASC RES, V37, P556, DOI 10.1159/000054089	72	17	17	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2005	22	7					763	771		10.1089/neu.2005.22.763			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	945VQ	WOS:000230530800004	16004579				2022-02-06	
J	Mottram, L; Donders, J				Mottram, L; Donders, J			Construct validity of the California Verbal Learning Test - Children's Version (CVLT-C) after pediatric traumatic brain injury	PSYCHOLOGICAL ASSESSMENT			English	Article						brain injury; memory; children; CVLT-C	STRUCTURAL EQUATION ANALYSIS; WIDE-RANGE ASSESSMENT; HEAD-INJURY; MEMORY; PERFORMANCE	The purpose of this study was to determine the latent structure of the California Verbal Learning Test-Children's Version (CVLT-C; D. Delis, J. Kramer, E. Kaplan, & B. Ober, 1994) in a sample of 175 children with traumatic brain injury (TBI). Maximum-likelihood confirmatory factor analyses were performed to test 6 competing hypothetical models for fit and parsimony. A 4-factor model consisting of Attention Span, Learning Efficiency, Delayed Recall, and Inaccurate Recall provided the best fit to the data. The results support the construct validity of the CVLT-C in children with TBI and suggest that a multifactorial interpretation of quantitative indexes from this instrument is appropriate for clinical practice.	Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					*AM ED RES ASS AM, 1999, STAND ED PSYCH TESTS; Arnau RC, 2000, ASSESSMENT, V7, P237, DOI 10.1177/107319110000700304; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; Burton DB, 1999, CHILD NEUROPSYCHOL, V5, P34, DOI 10.1076/chin.5.1.34.7077; Burton DB, 1996, CHILD NEUROPSYCHOL, V2, P39, DOI 10.1080/09297049608401349; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Delis DC., 1994, CALIFORNIA VERBAL LE; Donders J, 1999, DEV NEUROPSYCHOL, V15, P395, DOI 10.1080/87565649909540757; Donders J, 1999, DEV NEUROPSYCHOL, V16, P163, DOI 10.1207/S15326942DN1602_2; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; DONDERS J, 1998, HDB PEDIAT PSYCHOL P, V2, P166; EWINGCOBBS L, 1998, TRAUMATIC BRAIN INJU, P11; Farmer JE, 1999, DEV NEUROPSYCHOL, V15, P269, DOI 10.1080/87565649909540749; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Levin HS, 2000, J CLIN EXP NEUROPSYC, V22, P1, DOI 10.1076/1380-3395(200002)22:1;1-8;FT001; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; NETEMEYER RG, 1990, J APPL PSYCHOL, V75, P148, DOI 10.1037/0021-9010.75.2.148; Precourt S, 2002, DEV NEUROPSYCHOL, V21, P173, DOI 10.1207/S15326942DN2102_4; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; SAS Institute Inc, 1990, SAS STAT US GUID VER; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; White DA, 2001, NEUROPSYCHOLOGY, V15, P221, DOI 10.1037/0894-4105.15.2.221; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williams J, 2001, CHILD NEUROPSYCHOL, V7, P15, DOI 10.1076/chin.7.1.15.3148; Woodward H, 1998, APPL NEUROPSYCHOL, V5, P113, DOI 10.1207/s15324826an0503_1; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	31	17	17	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2005	17	2					212	217		10.1037/1040-3590.17.2.212			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	948TE	WOS:000230737800010	16029108				2022-02-06	
J	de Guise, E; Feyz, M; LeBlanc, J; Richard, SL; Lamoureux, J				de Guise, E; Feyz, M; LeBlanc, J; Richard, SL; Lamoureux, J			Overview of traumatic brain injury patients at a tertiary trauma centre	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							SEVERE HEAD-INJURY; COGNITIVE STATUS; CLASSIFICATION; RECOVERY; SCALE; REHABILITATION; HETEROGENEITY; PREDICTION; SPECTRUM; DEFICITS	Objective: The goal of this study was to provide a general descriptive and cognitive portrait of a population with traumatic brain injury (TBI) at the time of their acute care stay. Material and methods: Three hundred and forty-eight TBI patients were assessed. The following data were collected for each patient: age, level of education, duration of post-traumatic amnesia, Galveston Orientation Amnesia Test score, Glasgow Coma Scale score, results of cerebral imaging, Neurobehavioral Rating Scale score, the Functional Independence Measure cognitive score and the Glasgow Outcome Scale score. Results: The clinical profile of the population revealed a mean age of 40.2 (18.7) and a mean of 11.5 (+/- 3.6) years of education. Most patients presented with frontal (57.6%) and temporal (40%) lesions. Sixty-two percent had post-traumatic amnesia of less than 24 hours. Seventy percent presented with mild TBI, 14% with moderate and 15% with severe TBI. The cognitive deficits most frequently observed on the Neurobehavioral Rating Scale were in the areas of attention, memory and mental flexibility as well as slowness and mental fatigability. Most patients had good cognitive outcome on the Functional Independence Measure and scores of 2 and 3 were frequent on the GOS. Forty-five percent of the patients returned home after discharge, 51.7% were referred to in or out patient rehabilitation and 3.2% were transferred to long-term care facilities. Conclusion: Because of the specialized mandate of acute care institutions, the information provided here concerning characteristics of our TBI population is essential for more efficient decision-making and planning/programming with regards to care and service delivery.	McGill Univ, Ctr Hlth, Montreal Gen Hosp, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada		de Guise, E (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp, Traumat Brain Injury Program, Local D13-124,1650 Ave Cedar, Montreal, PQ H3G 1A4, Canada.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ALVES WM, 1985, CENTRAL NERVOUS SYST, P255; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; BERROL S, 1989, TRAUMATIC BRAIN INJU, P31; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Caille S, 2000, BRAIN COGNITION, V44, P30; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GERVAIS M, 1999, PUBLICATION U LAVAL; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Khan S, 2002, BRAIN INJURY, V16, P537, DOI 10.1080/02699050110119862; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LONG CJ, 1988, NEUROPSYCHOLOGICAL S, P132; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; *MED DIS SOC, 1988, MAN TRAUM BRAIN INJ; Milner B, 1975, Adv Neurol, V8, P299; PARKINSON D, 1985, CAN J SURG, V28, P79; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; RILEY E, 1999, REGIONNALISATION SER, P1; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; *U NEW YORK RES FD, 1990, GUID US UN SET MED R; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILSON B, 1992, J NEUROL NEUROSUR PS, V55, P177, DOI 10.1136/jnnp.55.3.177	41	17	17	0	4	CANADIAN J NEUROL SCI INC	CALGARY	PO BOX 4220, STATION C EDITORIAL & SUBSCRIPTION SERV, CALGARY, AB T2T 5N1, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2005	32	2					186	193		10.1017/S0317167100003954			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	930GF	WOS:000229403100007	16018153	Bronze			2022-02-06	
J	Bianco, A; Trani, F; Santoro, G; Angelillo, IF				Bianco, A; Trani, F; Santoro, G; Angelillo, IF			Adolescents' attitudes and behaviour towards motorcycle helmet use in Italy	EUROPEAN JOURNAL OF PEDIATRICS			English	Article; Proceedings Paper	3rd International Conference on Traffic and Transport Psychology	SEP 05-09, 2004	Nottingham, ENGLAND			adolescents; attitudes; behaviour; helmet use; motorcycle	INJURIES; RIDERS; SEVERITY	The study investigated the use of, attitudes towards, and adherence to motorcycle helmets in a group of adolescents. A random sample of 412 adolescents (14-19 years old) attending randomly selected public secondary classes in Catanzaro (Italy) received a questionnaire consisting of questions on socio-demographics, patterns of motorcycle use, frequency of helmet use, helmet use by adult family members and close friends who are motorcyclists, attitudes towards helmet use and number of traffic-related motorcycle accidents in the last year. A total of 387 adolescents participated. The frequency of self-reported helmet use as a driver of the motorcycle or as the passenger was 34.7% and 33.7% respectively. Routine helmet use was greater for adolescents from households in which at least one family member wore a helmet, for youths who agreed that helmet use should be mandatory, and for those who did not experience an accident in the past year. Regression analysis of the attitude models indicated that the younger the age, the more willing an adolescent would be to believe that helmet use reduced the risk of head injuries and the positive attitude that helmet use should be mandatory was higher in younger adolescents and in those who bad no road accident within the past year. A total of 17% reported that they had an accident during the last 12 months of the study period and 30 of them presented motorcycle-related injuries. Conclusion: The development of programmes on helmet use starting as early as primary school is strongly needed.	Univ Catanzaro Magna Graecia, Sch Med, Chair Hyg, I-88100 Catanzaro, Italy		Angelillo, IF (corresponding author), Univ Catanzaro Magna Graecia, Sch Med, Chair Hyg, Via Tommaso Campanella, I-88100 Catanzaro, Italy.	angelillo@unicz.it	Angelillo, Italo Francesco/AAK-1301-2021; Bianco, Aida/R-6612-2016	Angelillo, Italo Francesco/0000-0003-1213-6602; BIANCO, Aida/0000-0003-4674-0306			Brandt MM, 2002, J TRAUMA, V53, P469, DOI 10.1097/00005373-200209000-00012; Chapman S, 2001, J PAEDIATR CHILD H, V37, P567, DOI 10.1046/j.1440-1754.2001.00763.x; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; GRIMA FG, 1995, EUR J EPIDEMIOL, V11, P87, DOI 10.1007/BF01719951; Hennekens CH, 1987, EPIDEMIOLOGY MED, P101; *ISTAT, 2001, STAT INC STRAD ANN 2; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; LaTorre G, 2002, EUR J PUBLIC HEALTH, V12, P99, DOI 10.1093/eurpub/12.2.99; *LEGGE, 1999, 22016121999 CASC OBB; Lin MR, 2003, ANN EMERG MED, V41, P783, DOI 10.1067/mem.2003.186; Lin MR, 2001, J TRAUMA, V50, P24, DOI 10.1097/00005373-200101000-00004; Rothman KJ., 2002, EPIDEMIOLOGY INTRO, P57; Rowland J, 1996, AM J PUBLIC HEALTH, V86, P41, DOI 10.2105/AJPH.86.1.41; *STAT CORP, 2003, STAT REF MAN REL 8 1; Waller PF, 2002, ANNU REV PUBL HEALTH, V23, P93, DOI 10.1146/annurev.publhealth.23.100901.140522	15	17	17	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	APR	2005	164	4					207	211		10.1007/s00431-004-1604-9			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics	918EN	WOS:000228525200003	15633049				2022-02-06	
J	Hanlon, RE; Demery, JA; Kuczen, C; Kelly, JP				Hanlon, RE; Demery, JA; Kuczen, C; Kelly, JP			Effect of traumatic subarachnoid haemorrhage on neuropsychological profiles and vocational outcome following moderate or severe traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; outcome; subarachnoid haemorrhage	SEVERE HEAD-INJURY; IMPACT; SCAN	Objective: Traumatic subarachnoid haemorrhage (tSAH) frequently occurs in moderate or severe traumatic brain injury (TBI) and is related to worse outcome at time of discharge from the acute hospitalization. The current study compared neuropsychological impairment and vocational outcome at 1-year post-injury in patients with and without tSAH. Design: Acute injury, neuroradiological, neuropsychological and vocational data were collected for 100 patients admitted for neurorehabilitation following TBI. Results: Patients with tSAH had significantly worse vocational outcome than patients without tSAH. On neuropsychological measures, patients with tSAH generally performed worse than patients without tSAH across most neurocognitive domains. However, differences in neuropsychological test performance between patients with and without tSAH reached statistical significance on measures of visuospatial processing, verbal reasoning and mood only. Conclusion: The presence of tSAH appears to be associated with worse vocational outcome in survivors of moderate or severe TBI. As such, the presence of tSAH appears to have predictive value with respect to outcome following TBI.	Northwestern Univ, Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; Univ Florida, Gainesville, FL USA; Univ Colorado, Sch Med, Boulder, CO 80309 USA		Hanlon, RE (corresponding author), Northwestern Univ, Sch Med, Dept Psychiat & Behav Sci, 446 E Ontario St,Ste 7-100, Chicago, IL 60611 USA.	r-hanlon@northwestern.edu					BRAAKMAN R, 1994, J NEUROSURG, V80, P797; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; GROLIMUND P, 1988, LANCET, V1, P1173; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Kakarieka A, 1997, NEUROL RES, V19, P230, DOI 10.1080/01616412.1997.11740804; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006	13	17	21	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2005	19	4					257	262		10.1080/02699050400004955			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	917MN	WOS:000228466400003	15832871				2022-02-06	
J	Mortensen, L				Mortensen, L			Written discourse and acquired brain impairment: Evaluation of structural and semantic features of personal letters from a Systemic Functional Linguistic perspective	CLINICAL LINGUISTICS & PHONETICS			English	Article						acquired brain impairment; aphasia; cognitive-language disorder; written discourse; sociolinguistics		This qualitative study investigated written discourse in the form of personal letters written by ten people with aphasia following stroke and ten people with cognitive-language disorder as a consequence of traumatic brain injury, and compared their performance with 15 non brain-damaged writers. Personal letters perform the dual function of providing information and maintaining social relationships. Using the Systemic Functional Linguistics framework for investigation, letters were examined in terms of their dual functions, and at two different strata of language-generic structure and semantic organisation. A small quantum of research suggests that the dissociation between different strata of language (i.e., macro and micro linguistic abilities), identified in the spoken discourse of people with aphasia and people with cognitive-language disorder is mirrored in written discourse. Aphasic writers largely maintain coherent text structure while writers with cognitive-language impairment demonstrate problems with global text coherence and the episodic structure of texts. Results of the generic structure analysis did not support the hypothesis. However, the semantic Move analysis revealed how diminished linguistic resources, most evident in the letters written by the subjects with aphasia, impacted upon the semantic diversity of the text, as well as the interpersonal function of the personal letter. Variable performance as a feature pathology and normality is highlighted and clinical implications discussed.	Macquarie Univ, Dept Linguist, Sydney, NSW 2109, Australia		Mortensen, L (corresponding author), Macquarie Univ, Dept Linguist, Sydney, NSW 2109, Australia.	lmortensen@ozemail.com.au					Barton D., 1999, LETT WRITING SOCIAL; BARTON D, 1991, WRITING COMMUNITY, P59; BEUKELMAN DR, 1991, COMMUNICATION DISORD; Biber D., 1988, VARIATION SPEECH WRI; BLOOM RL, 1993, J SPEECH HEAR RES, V36, P1227, DOI 10.1044/jshr.3606.1227; Brookshire R. H, 1978, CLIN APHASIOLOGY, P223; BUTT DG, 2000, UNPUB MEANING POTENT, P228; CHAPMAN SB, 1997, M TEX SPEECH LANG HE; CHAPMAN SB, 1999, BRAIN DAM B, P235; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; COELHO CA, 1994, CLIN APHASIOLOGY, V21, P183; Davis GA, 2000, APHASIOLOGY DISORDER; FREEDMANSTERN R, 1984, BRAIN LANG, V22, P181, DOI 10.1016/0093-934X(84)90089-0; Goodglass H., 1983, BOSTON DIAGNOSTIC EX; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Halliday M., 2004, INTRO FUNCTIONAL GRA; Halliday M.A.K., 1996, FUNCTIONAL DESCRIPTI, P1; Halliday M.A.K., 1985, SPOKEN WRITTEN LANGU; HALLIDAY M. A. K., 1999, CONSTRUING EXPERIENC; Halliday M. A. K., 1978, LANGUAGE SOCIAL SEMI; Halliday Michael Alexander Kirkwood, 1989, LANGUAGE CONTEXT TEX; Hartley L. L, 1995, COGNITIVE COMMUNICAT; HASAN R, 1996, WAYS F SAYING WAYS F, P51; HASAN R, 1994, PERSPECTIVES PEDAGOG; Hasan R., 1978, CURRENT TRENDS TEXTL, P228; Holland A., 1982, CLIN APH P C, P345; IVASK I, 1990, WORLD LITERATURE TOD, V64, P213, DOI 10.2307/40146397; Matthiessen C. M. I. M., 1997, SYSTEMIC FUNCTIONAL; MORTENSEN L, 2003, THESIS MACQUARIE U S; PARR S, 1995, APHASIOLOGY, V9, P223, DOI 10.1080/02687039508248197; Prigatano G. P., 1985, LANG SCI, V7, P217, DOI [10.1016/S0388-0001(85)80020-6, DOI 10.1016/S0388-0001(85)80020-6]; Searle J. R., 1969, SPEECH ACTS ESSAY PH; Simmons-Mackie N, 2002, APHASIOLOGY, V16, P837, DOI 10.1080/02687030244000185; ULATOWSKA H, 1988, J NEUROLINGUIST, V3, P77; ULATOWSKA HK, 1981, BRAIN LANG, V13, P345, DOI 10.1016/0093-934X(81)90100-0; ULATOWSKA HK, 1983, BRAIN LANG, V19, P317, DOI 10.1016/0093-934X(83)90074-3; ULATOWSKA HK, 1979, STUDIES NEUROLINGUIS, P241; Wilson BM, 2002, BRAIN INJURY, V16, P1011, DOI 10.1080/02699050210147248	38	17	17	2	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.	APR-MAY	2005	19	3					227	247		10.1080/02699200410001698652			21	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	913VC	WOS:000228182300008	15823958				2022-02-06	
J	Brooks, N; Hawley, CA				Brooks, N; Hawley, CA			Return to driving after traumatic brain injury: a British perspective	BRAIN INJURY			English	Article						brain injury; driving; rehabilitation; mobility; community; assessment	SEVERE HEAD-INJURY; FITNESS; KNOWLEDGE; DAMAGE	Primary objective: To identify the current legal situation and professional practice in assisting persons with traumatic brain injury ( TBI) to return to safe driving after injury. Methods and procedures: A brief review of relevant literature, a description of the current statutory and quasi- statutory authorities regulating return to driving after TBI in the UK and a description of the nature and resolution of clinical and practical dilemmas facing professionals helping return to safe driving after TBI. Each of the 15 UK mobility centres was contacted and literature requested; in addition a representative of each centre responded to a structured telephone survey. Main outcome and results: The current situation in the UK is described, with a brief analysis of the strengths and weaknesses both of the current statutory situation, and also the practical situation ( driving centres), with suggestions for improvements in practice. Conclusion: Although brain injury may cause serious limitations in driving ability, previous drivers are not routinely assessed or advised regarding return to driving after TBI.	Univ Warwick, Ctr Hlth Serv Studies, Coventry CV4 7AL, W Midlands, England; Rehab Walls, Milton Keynes, Bucks, England		Hawley, CA (corresponding author), Univ Warwick, Ctr Hlth Serv Studies, Coventry CV4 7AL, W Midlands, England.	c.a.hawley@warwick.ac.uk	Hawley, Carol/AAG-3830-2019				Akinwuntan AE, 2002, ARCH PHYS MED REHAB, V83, P334, DOI 10.1053/apmr.2002.29662; BROOKS N, 2002, EUROPA MEDICOPHYSICA, V38, P25; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; CAMPBELL GH, 2003, DRIVING NEUROLOGICAL; Daigneault G, 2002, J CLIN EXP NEUROPSYC, V24, P221, DOI 10.1076/jcen.24.2.221.993; DEBELLEIX X, 2001, EUROPA MEDICOPHYSICA, V37, P201; *DRIV MED GROUP DR, 2003, MED PRACT GLANC GUID; Galski T, 2000, J HEAD TRAUMA REHAB, V15, P895, DOI 10.1097/00001199-200006000-00004; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; HAWLEY CA, 2000, BRIT J THERAPY REHAB, V7, P116; KING D, 1992, POSTGRAD MED J, V68, P624, DOI 10.1136/pgmj.68.802.624; Kivioja A, 2003, PREDICTION IN FORENSIC AND NEUROPSYCHOLOGY, P209; LUNDQUIST A, 2001, EUROPA MEDICOPHYSICA, V37, P235; Marshall SC, 1999, CAN MED ASSOC J, V161, P687; Morgan JF, 1998, MED SCI LAW, V38, P28, DOI 10.1177/002580249803800105; NEUWIRTH W, 2001, EUROPA MEDICOPHYSICA, V37, P209; Newby G, 1999, BRIT J GEN PRACT, V49, P301; PRIDDY D A, 1990, Brain Injury, V4, P267, DOI 10.3109/02699059009026176; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; [No title captured]; 2002, EUROPA MEDICOPHYSICA, V38; 2001, EUROPA MEDICOPHYSICA, V37	26	17	18	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2005	19	3					165	175		10.1080/02699050410001720004			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	906WJ	WOS:000227675000003	15832891	Green Submitted			2022-02-06	
J	Perez-Barcena, J; Barcelo, B; Homar, J; Abadal, JM; Molina, FJ; de la Pena, A; Sahuquillo, J; Ibanez, J				Perez-Barcena, J; Barcelo, B; Homar, J; Abadal, JM; Molina, FJ; de la Pena, A; Sahuquillo, J; Ibanez, J			Comparison of the effectiveness of pentobarbital and thiopental in patients with refractory intracranial hypertension. Preliminary report of 20 patients	NEUROCIRUGIA			Spanish	Article						head injury; intracranial hypertension; pentobarbital; thiopental	HEAD-INJURED PATIENTS; CEREBRAL PROTECTION; BARBITURATE THERAPY; LIPID-PEROXIDATION; PRESSURE; SODIUM; CARE	Objective. To assess the effectiveness of pentobarbital and thiopental to control raised intracranial pressure (ICP), refractory to first level measures, in patients with severe traumatic brain injury. Material and methods. Prospective, randomized study to compare the effectiveness between two treatments: pentobarbital and thiopental. The patients will be selected from those admitted to the Intensive Care Unit with a severe traumatic brain injury (postresuscitation Glasgow Coma Scale equal or less than 8 points) and raised ICP (ICP > 20 mmHg) refractory to first level measures according to the Brain Trauma Foundation guidelines. The adverse effects of both treatments were also collected. Results. We present the results of the first 20 patients included. Ten received pentobarbital and the other ten thiopental. There were no statistically significance differences in patients' characteristics (age, sex, severity of the trauma at admission and comorbilities). There were no differences between both groups neither in the Glasgow Coma Scale at admission (thiopental six points; pentobarbital seven points; P = 0,26) nor in the admission Cranial Tomography, according to the Traumatic Coma Data Bank classification. Thiopental treatment controlled raised ICP in five cases and pentobarbital in two cases (P = 0,16). Five patients in the thiopental group died and eight in the pentobarbital group (P = 0,16). There were no statistically differences between both groups regarding to the presence of hypotension (P = 1) or infectious complications. Conclusions. These preliminary results indicate that thiopental could be more effective than pentobarbital in patients with refractory intracranial hypertension. These results support previous experimental findings that show that both treatments are not equal and justify to continue this study.	Univ Autonoma Barcelona, Serv Med Intens, Hosp Dureta, Dept Cirurgia, E-08193 Barcelona, Spain; Hosp Son Dureta, Serv Anal Clin, Palma de Mallorca, Spain; Hosp Son Dureta, Serv Neurol, Palma de Mallorca, Spain; Hosp Son LLatzer, Med Interna Serv, Palma de Mallorca, Spain; Hosp Gen Valle Hebron, Serv Neurocirugia, Barcelona, Spain; Univ Autonoma Barcelona, Dept Cirurgia, E-08193 Barcelona, Spain		Perez-Barcena, J (corresponding author), Univ Autonoma Barcelona, Serv Med Intens, Hosp Dureta, Dept Cirurgia, E-08193 Barcelona, Spain.		Poca, Maria A./B-8475-2008; Sahuquillo, Juan/B-3577-2008; Barcelo Martin, Bernardino/H-2806-2017	Poca, Maria A./0000-0002-3831-0536; Sahuquillo, Juan/0000-0003-0713-5875; Ibanez, Javier/0000-0003-3735-8332; Barcelo Martin, Bernardino/0000-0002-6952-5994			Almaas R, 2000, ANESTHESIOLOGY, V92, P764, DOI 10.1097/00000542-200003000-00020; Brain Trauma Foundation The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P527; Cole DJ, 2001, CAN J ANAESTH, V48, P807, DOI 10.1007/BF03016699; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; Drummond JC, 1996, ANESTHESIOLOGY, V85, P1504, DOI 10.1097/00000542-199612000-00050; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; HATANO Y, 1989, ANESTHESIOLOGY, V71, P80, DOI 10.1097/00000542-198907000-00015; Horsley JS, 1937, LANCET, V1, P141; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; MARSHALL LF, 1977, J NEUROSURG, V47, P481; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1977, ACTA NEUROL SCAND, V56, P156; Perez-Barcena J, 2005, NEUROCIRUGIA, V16, P5; ROCKOFF MA, 1979, ANN NEUROL, V6, P194, DOI 10.1002/ana.410060303; Shibuta S, 1998, BRIT J PHARMACOL, V124, P804, DOI 10.1038/sj.bjp.0701884; SMITH DS, 1980, ANESTHESIOLOGY, V53, P186, DOI 10.1097/00000542-198009000-00002; STEEN PA, 1978, STROKE, V9, P140, DOI 10.1161/01.STR.9.2.140; STEEN PA, 1980, ANESTHESIOLOGY, V53, P183; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P537	22	17	17	0	4	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	FEB	2005	16	1					5	12					8	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	917JJ	WOS:000228456700001	15756405				2022-02-06	
J	Urbahns, K; Goldmann, S; Kruger, J; Horvath, E; Schuhmacher, J; Grosser, R; Hinz, V; Mauler, F				Urbahns, K; Goldmann, S; Kruger, J; Horvath, E; Schuhmacher, J; Grosser, R; Hinz, V; Mauler, F			IKCa-channel blockers. Part 2: Discovery of cyclohexadienes	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						IKCa channel; potassium channel; cyclohexadiene; brain edema; water content; cerebral infarction; subdural hematoma; rat	CANNABINOID RECEPTOR AGONIST; K+ CHANNELS	Novel cyclohexadienes have been identified as potent and specific IKCa-channel blockers. In this communication we describe their synthesis as well as their chemical and biological properties. A selected derivative is being enriched in rat brain and reduces the infarct volume, intracranial pressure as well as the water content in a rat subdural hematoma model of traumatic brain injury after iv administration. (C) 2004 Elsevier Ltd. All rights reserved.	Bayer Hlth Care, Pharma Res Ctr, Inst Med Chem, D-42096 Wuppertal, Germany; Bayer Hlth Care, Pharma Res Ctr, Inst Res, CNS, D-42096 Wuppertal, Germany; Bayer Hlth Care, Pharma Res Ctr, Inst Pharmakokinet, D-42096 Wuppertal, Germany		Urbahns, K (corresponding author), AstraZeneca, R&D, Lund, Sweden.	klaus.urbahns@astrazeneca.com					[Anonymous], 1997, [No title captured], Patent No. 19612645; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; ELLORY JC, 1994, BRIT J PHARMACOL, V111, P903, DOI 10.1111/j.1476-5381.1994.tb14823.x; GARDOS G, 1958, BIOCHIM BIOPHYS ACTA, V30, P147; GOLDMANN S, 1985, Patent No. 3416293; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Mauler F, 2003, BRAIN RES, V989, P99, DOI 10.1016/S0006-8993(03)03376-6; Mauler F, 2002, J PHARMACOL EXP THER, V302, P359, DOI 10.1124/jpet.302.1.359; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; SCHWAB A, 1998, CURR RES ION CHANNEL, V3, P126; Urbahns K, 1998, SYNTHESIS-STUTTGART, P1807; Urbahns K, 2003, BIOORG MED CHEM LETT, V13, P2637, DOI 10.1016/S0960-894X(03)00560-2; URBAHNS K, 1996, Patent No. 698597	15	17	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X			BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JAN 17	2005	15	2					401	404		10.1016/j.bmcl.2004.10.063			4	Chemistry, Medicinal; Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Chemistry	887ZU	WOS:000226344800030	15603962				2022-02-06	
J	Bowen, JM				Bowen, Julie M.			Classroom Interventions for Students With Traumatic Brain Injuries	PREVENTING SCHOOL FAILURE			English	Article						behavioral and instructional interventions; learning strategies; traumatic brain injury (TBI)		Students who have sustained a traumatic brain injury (TBI) return to the school setting with a range of cognitive, psychosocial, and physical deficits that can significantly affect their academic functioning. Successful educational reintegration for students with TBI requires careful assessment of each child's unique needs and abilities and the selection of classroom interventions designed to meet those needs. In this article, the author presents information about the range of services that are available in the school setting and discusses typical environmental and classroom accommodations that have proven effective. The author discusses a variety of specific research-based learning strategies, behavioral interventions, and instructional interventions available to educators who work with TBI students.	[Bowen, Julie M.] Jordan Sch Dist, Salt Lake City, UT 84084 USA		Bowen, JM (corresponding author), Jordan Sch Dist, Salt Lake City, UT 84084 USA.						Bowen J., 2004, SCH BASED INTERVENTI, DOI 10.1007/978-1-4419-9102-7; Carnine D, 1982, THEORY INSTRUCTION; Clark E, 1999, SCHOOL PSYCHOL REV, V28, P242; COHEN SB, 1991, J HEAD TRAUMA REHAB, V6, P56; Ducharme JM, 1999, BRAIN INJURY, V13, P645, DOI 10.1080/026990599121232; Ewing-Cobbs L, 1990, TRAUMATIC BRAIN INJU, P107; FARMER JE, 1995, SCHOOL PSYCHOL REV, V24, P230; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; Gardner RM, 2003, J HEAD TRAUMA REHAB, V18, P52, DOI 10.1097/00001199-200301000-00007; GLANG A, 1992, J HEAD TRAUMA REHAB, V7, P93; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Jordan FM, 1996, BRAIN INJURY, V10, P91, DOI 10.1080/026990596124575; Mateer C., 1997, CHILDHOOD TRAUMATIC, P153; Paris R., 1974, CLIN NEUROPSYCHOLOGY, P179; RHODE G, 1993, TOUGH KID BOOK; Rosen CD, 1986, HEAD TRAUMA ED REINT; Slifer KJ, 1997, BRAIN INJURY, V11, P877; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; Wilkening G. N., 1997, CHILDHOOD TRAUMATIC, P79; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; Wiseman-Hakes C, 1998, J HEAD TRAUMA REHAB, V13, P23, DOI 10.1097/00001199-199812000-00005; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Yody BB, 2000, J HEAD TRAUMA REHAB, V15, P1041, DOI 10.1097/00001199-200008000-00006	26	17	17	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1045-988X	1940-4387		PREV SCH FAIL	Prev. Sch. Fail.		2005	49	4					34	41		10.3200/PSFL.49.4.34-41			8	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	V2Y9C	WOS:000218037100006					2022-02-06	
J	Schneider, JJ; Gouvier, WD				Schneider, JJ; Gouvier, WD			Utility of the UFOV test with mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY			English	Article						UFOV; driving; mild head injury; rehabilitation	MOTOR-VEHICLE CRASH; DRIVING PERFORMANCE; SELF-REPORT; FITNESS; INVOLVEMENT; IMPAIRMENT; CHALLENGE; DRIVER; DAMAGE	Driving skills are socially important, easily disrupted by brain injury, and potentially risky and difficult to evaluate afterward. The Useful Field of View test has seen successful use with severe traumatic brain injury (TBI), but its use with mild TBI victims has not been examined. This study shows its ecological insensitivity among persons with mild TBI or no impairment and suggests its use be limited to more severely impaired persons.	Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA		Gouvier, WD (corresponding author), Louisiana State Univ, Dept Psychol, 236 Audubon Hall, Baton Rouge, LA 70803 USA.	wgouvie@lsu.edu					Arthur W, 2001, HUM FACTORS, V43, P1, DOI 10.1518/001872001775992507; BALL KK, 1998, UFOV USEFUL FIELD VI; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; De Raedt R, 2001, CLIN NEUROPSYCHOL, V15, P329, DOI 10.1076/clin.15.3.329.10277; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; GOUVIER WD, 1989, ARCH PHYS MED REHAB, V70, P745; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LUCAS JA, 1998, CLIN NEUROPSYCHOLOGY, P243; NOVACK T, 2003, J INT NEUROPSYCH SOC, V9, P235; NOVACK TA, 2005, UFOV RISK LEVEL DRIV; OJILE J, 1998, UNPUB PREDICTING DRI; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; PIDIKITI RD, 1991, ARCH PHYS MED REHAB, V72, P109; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; SCHULTHEIS MT, 2000, M NAT AC NEUR ORL FL; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; SMITH A, 1961, DIS NERV SYST, V22, P69; Smith A., 1982, SYMBOL DIGIT MODALIT; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WEST R, 1993, ERGONOMICS, V36, P557, DOI 10.1080/00140139308967912	30	17	18	0	5	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2005	12	3					138	142		10.1207/S15324826AN1203_3			5	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	965OR	WOS:000231960500003	16131340				2022-02-06	
J	Barrett, KF; Masel, B; Patterson, J; Scheibel, RS; Corson, KP; Mader, JT				Barrett, KF; Masel, B; Patterson, J; Scheibel, RS; Corson, KP; Mader, JT			Regional CBF in chronic stable TBI treated with hyperbaric oxygen.	UNDERSEA & HYPERBARIC MEDICINE			English	Article							CEREBRAL BLOOD-FLOW; CLOSED-HEAD-INJURY; ISCHEMIC PENUMBRA; BRAIN SPECT; STROKE; RECOVERY; THERAPY; TECHNETIUM-99M-HMPAO; PERFUSION	To investigate whether Hyperbaric Oxygen Therapy (HBO2) could improve neurologic deficits and regional cerebral blood flow (rCBF) in chronic traumatic brain injuries (TBI), the authors employed a nonrandomized control pilot trial. Five subjects, at least three years post head injury, received HBO2. Five head injured controls (HIC) were matched for age, sex, and type of injury. Five healthy subjects served as normal controls. Sixty-eight normal volunteers comprised a reference data bank against which to compare SPECT brain scans. HBO2 subjects received 120 HBO2 in blocks of 80 and 40 treatments with an interval five-month break. Normal controls underwent a single SPECT brain scan, HBO2, and repeat SPECT battery. TBI subjects were evaluated by neurologic, neuropsychometric, exercise testing, and pre and post study MRIs, or CT scans if MRI was contraindicated. Statistical Parametric Mapping was applied to SPECT scans for rCBF analysis. There were no significant objective changes in neurologic, neuropsychometric, exercise testing, MRIs, or rCBF. In this small pilot study, HBO2 did not effect clinical or regional cerebral blood flow improvement in TBI subjects.	Transit Learning Ctr, Galveston, TX USA; Univ Texas, Med Branch, Dept Psychiat, Galveston, TX 77550 USA; Univ Texas, Med Branch, Inst Marine Biomed, Galveston, TX 77550 USA; Univ Texas, Med Branch, Div Hyperbar Med, Galveston, TX 77550 USA		Barrett, KF (corresponding author), Transit Learning Ctr, Galveston, TX USA.						ARTRU F, 1976, EUR NEUROL, V14, P351, DOI 10.1159/000114759; Berrouschot J, 2000, STROKE, V31, P1545, DOI 10.1161/01.STR.31.7.1545; DIPIERO V, 1992, J NEUROL NEUROSUR PS, V55, P990, DOI 10.1136/jnnp.55.11.990; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; GRAHAM GD, 1992, STROKE, V23, P333, DOI 10.1161/01.STR.23.3.333; GRIM PS, 1990, JAMA-J AM MED ASSOC, V263, P2216; HAKIM AM, 1987, CAN J NEUROL SCI, V14, P557; HARCH PG, 1994, UNDERSEA HYPERB ME S, V21, P30; HARCH PG, 1992, UNDERSEA BIOMED RES, V19, P42; HARRIS HS, 1997, ARCH PHYS MED REHAB, V78, P546; Havelius U, 1997, NEUROLOGY, V49, P1360, DOI 10.1212/WNL.49.5.1360; HOLMAN BL, 1992, J NUCL MED, V33, P1888; Jacobs A, 1996, J NUCL MED, V37, P1605; JAIN KK, 1999, TXB HYPERBARIC MED, P261; Laatsch L, 1997, BRAIN INJURY, V11, P851; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; NEUBAUER RA, 1992, CLIN NUCL MED, V17, P477, DOI 10.1097/00003072-199206000-00010; Neubauer RA, 1998, NEUROL RES, V20, pS33; NEUBAUER RA, 1990, LANCET, V335, P542, DOI 10.1016/0140-6736(90)90777-3; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Patterson JC, 1997, J NUCL MED, V38, P1721; Shimosegawa E, 1997, J NUCL MED, V38, P791; Stamatakis EA, 1999, NEUROIMAGE, V10, P397, DOI 10.1006/nimg.1999.0477; Stockbridge HL, 2002, NUCL MED COMMUN, V23, P537, DOI 10.1097/00006231-200206000-00005; TALAIRACH J, 1988, PLANAR STEREOTACTIC; TERYAMA Y, 1991, SURG NEUROL, V36, P335; Umile EM, 1998, BRAIN INJURY, V12, P577; VOSTRUP S, 1986, ACTA NEUROL SCAND, V74, P439; [No title captured]	31	17	18	1	5	UNDERSEA & HYPERBARIC MEDICAL SOC INC	KENSINGTON	10531 METROPOLITAN AVE, KENSINGTON, MD 20895 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	WIN	2004	31	4					395	406					12	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	884IA	WOS:000226076900003	15686271				2022-02-06	
J	Bergeson, AG; Lundin, R; Parkinson, RB; Tate, DF; Victoroff, J; Hopkins, RO; Bigler, ED				Bergeson, AG; Lundin, R; Parkinson, RB; Tate, DF; Victoroff, J; Hopkins, RO; Bigler, ED			Clinical rating of cortical atrophy and cognitive correlates following traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	14th Annual Meeting of the American-Neuropsychiatric-Association	FEB 01-04, 2003	Honolulu, HI	Amer Neuropsychopharmacol Assoc			HEAD-INJURY; MEMORY; DEMENTIA; SEQUELAE; LESIONS; MR	We report on the utility of using a rapid, easy-to-use, visually based semi-quantitative neuroimaging atrophy rating scale in individuals with traumatic brain injury (TBI) and normal control subjects. Magnetic resonance (MR) scans were rated using a standardized semi-quantitative MR rating method. A four-point scale was used to rate each scan for atrophy in frontal, temporal, and parietal areas. Seventy-five TBI subjects (50 males, 25 females) and 75 age- and gender-matched control subjects were compared for atrophy ratings. Clinical atrophy ratings were also compared to a quantitative measure of atrophy, the ventricle-to-brain ratio, and with the TBI subjects' scores on standard neuropsychological tests. TBI patients had significantly higher clinical atrophy ratings in frontal and temporal lobe areas compared to controls. The clinical atrophy ratings significantly correlated with the ventricle-to-brain ratio, a quantitative measure of atrophy in the same TBI subjects. Higher clinical ratings of frontal and temporal atrophy correlated with deficits in memory and executive function. These findings indicate that clinical ratings of trauma-induced atrophy can be reliably performed and are associated with neuropsychological outcome and quantitative measures of cerebral atrophy.	Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90089 USA; LDS Hosp, Dept Med, Div Pulm, Salt Lake City, UT USA; LDS Hosp, Dept Med, Crit Care Div, Salt Lake City, UT USA; Univ Utah, Dept Radiol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1082 SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu	Tate, David/G-5166-2011	Tate, David/0000-0003-0213-1920; Lundin, Rebecca/0000-0002-8380-4834			Beck AT, 1990, BECK ANXIETY INVENTO; Beck AT, 1987, BECK DEPRESSION INVE; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 2002, ALZ DIS ASSOC DIS, V16, P161, DOI 10.1097/00002093-200207000-00006; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; BIGLER ED, 2004, NEUROREHABILITATION; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Delis DC, 1987, CALIFORNIA VERBAL LE; Heaton RK, 1991, COMPREHENSIVE NORMS; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; Kounios J, 2001, NEURON, V29, P297, DOI 10.1016/S0896-6273(01)00199-4; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; Mann K, 2001, ALCOHOL CLIN EXP RES, V25, p104S, DOI 10.1111/j.1530-0277.2001.tb02383.x; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Primus EA, 1997, BRAIN INJURY, V11, P577; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROBB R, 1995, ANALYZE 3 DIMENSIONA; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; VICTOROFF J, 1994, NEUROLOGY, V44, P2267, DOI 10.1212/WNL.44.12.2267; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Wolfson, 1993, HALSTEAD REITAN NEUR; Yoneoka Y, 2002, J NEUROIMAGING, V12, P231, DOI 10.1177/10528402012003004	36	17	18	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2004	18	4					509	520		10.1080/1385404049052414			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology; Neurosciences & Neurology	895BH	WOS:000226835400003	15841954				2022-02-06	
J	Bell, KR; Hoffman, JM; Doctor, JN; Powell, JM; Esselman, P; Bombardier, C; Fraser, R; Dikmen, S				Bell, KR; Hoffman, JM; Doctor, JN; Powell, JM; Esselman, P; Bombardier, C; Fraser, R; Dikmen, S			Development of a telephone follow-up program for individuals following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						rehabilitation; traumatic brain injury	CONTROLLED-TRIAL; NEEDS; EDUCATION; FAMILIES; SUPPORT	Objective: To describe the development of a telephone follow-up program that addresses the needs of survivors of traumatic brain injury (TBI) and their families in the year following injury. The process of developing the program is reviewed from the initial steps of identifying needs through final implementation of the program. Participants: Eighty-four TBI survivors with moderate to severe injuries and their families. Results: Descriptive statistics are presented including number of contacts, areas of concern for participants, and the types of interventions conducted. Case examples are provided to illustrate the impact of the telephone follow-up program. Conclusion: This project demonstrated the feasibility of using the telephone as a means of providing information and support during the first year after moderate to severe traumatic brain injury. Telephone follow-up may enhance service provision for persons with TBI, especially those with a lack of transportation or geographic isolation.	Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Bell, KR (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA.	krbell@u.washington.edu	Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283; Bell, Kathleen/0000-0002-0928-2046			*AM EL ASS, 2003, WASH TECH JOB GROWTH; Austin JS, 1996, ARTHRIT CARE RES, V9, P391, DOI 10.1002/1529-0131(199610)9:5<391::AID-ANR1790090508>3.0.CO;2-V; BANDURA A, 1986, SOCIAL FDN THOUGHT A; Bell KR, 2003, J HEAD TRAUMA REHAB, V18, P504, DOI 10.1097/00001199-200311000-00004; Bostrom J, 1996, APPL NURS RES, V9, P47, DOI 10.1016/S0897-1897(96)80402-2; Broadstock MJ, 1997, PATIENT EDUC COUNS, V32, P141, DOI 10.1016/S0738-3991(97)00036-0; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Campbell C H, 1988, Rehabil Nurs, V13, P320; Engli M, 1993, J Neurosci Nurs, V25, P78; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Karlik B A, 1990, J Cardiovasc Nurs, V4, P70; McPherson KM, 2000, INT J REHABIL RES, V23, P295, DOI 10.1097/00004356-200023040-00005; Miller WR, 1991, MOTIVATIONAL INTERVI; Newton K M, 1988, Prog Cardiovasc Nurs, V3, P62; O'Connell JM, 2002, MED DECIS MAKING, V22, P309, DOI 10.1177/027298902400448876; Paterson B, 2001, Rehabil Nurs, V26, P48; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; *US CENS BUR, 2001, SEL HOUS CHAR; VANELDERENVANKEMENADE T, 1994, BRIT J CLIN PSYCHOL, V33, P367, DOI 10.1111/j.2044-8260.1994.tb01133.x; vanVeenendaal H, 1996, PATIENT EDUC COUNS, V28, P265, DOI 10.1016/0738-3991(95)00853-5; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WEINBERGER M, 1993, ARTHRITIS RHEUM, V36, P243, DOI 10.1002/art.1780360216; [No title captured]	24	17	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2004	19	6					502	512		10.1097/00001199-200411000-00007			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	873LZ	WOS:000225283100007	15602312				2022-02-06	
J	Castejon, OJ; De Castejon, HV				Castejon, OJ; De Castejon, HV			Structural patterns of injured mitochondnia in human oedematous cerebral cortex	BRAIN INJURY			English	Article							CYTOCHROME-C; BRAIN; ISCHEMIA; ANOXIA; NEURONS; DEATH	Primary objective: Cerebral cortical biopsies of 37 patients with clinical diagnosis of congenital malformations, brain trauma and tumours were studied to establish mitochondrial morphological alterations. Methods and procedures: Cortical biopsies obtained in the surgical room were immediately processed by conventional technique for transmission electron microscopy. Results: Three injured mitochondrial morphological patterns were found: swollen clear, (SCM), swollen dense (SDM) and dark degenerated (DDM) mitochondria. SCM were predominantly found in traumatic brain oedema. SDM and DDM were frequently observed in sustained permanent ischaemia induced by brain tumours, vascular anomaly and congenital hydrocephalus. SCM exhibited low electron dense mitochondrial matrix, enlarged intracristal space and continuity of outer and inner mitochondrial membranes. SDM showed high electron dense matrix and swollen intact or fragmented cristae. DDM displayed overall high electron density of matrix and mitochondrial membranes. Conclusion: The injured mitochondrial patterns are related with nerve cell death and considered markers of lethal nerve cell injury.	Univ Zulia, Fac Med, Inst Invest Biol, Maracaibo 4003A, Venezuela		Castejon, OJ (corresponding author), Univ Zulia, Fac Med, Inst Invest Biol, Apartado 526, Maracaibo 4003A, Venezuela.	ocastejo@cantv.net					Anderson MF, 1999, J NEUROCHEM, V73, P1189, DOI 10.1046/j.1471-4159.1999.0731189.x; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; BONDY SC, 1996, PARADIGMS NERVE INJU, P243; BROWN AW, 1973, ACTA NEUROPATHOL, V23, P9, DOI 10.1007/BF00689000; Brown GC, 1999, BIOCHEM SOC SYMP, V66, P17, DOI 10.1042/bss0660017; Castejon O J, 1995, J Neurosurg Sci, V39, P47; CASTEJON OJ, 1980, J NEUROPATH EXP NEUR, V39, P296, DOI 10.1097/00005072-198005000-00006; CASTEJON OJ, 1988, J SUBMICR CYTOL PATH, V20, P519; Castejon OJ, 1999, J SUBMICR CYTOL PATH, V31, P203; CASTEJON OJ, 1994, J SUBMICR CYTOL PATH, V26, P29; Castejon OJ, 1997, BRAIN INJURY, V11, P363, DOI 10.1080/026990597123520; CASTEJON OJ, 1985, J SUBMICR CYTOL PATH, V17, P703; Castejon OJ, 2000, BRAIN INJURY, V14, P303; CASTEJON OJ, BRAIN INJURY, V4, P291; Chen DX, 2003, J CEREBR BLOOD F MET, V23, P88, DOI 10.1097/01.WCB.0000039286.37737.19; Chen H, 2001, STROKE, V32, P2382, DOI 10.1161/hs1001.097099; CLENDENON NR, 1979, SEMINAR NEUROLOGICAL, P115; Du G, 1998, FREE RADICAL BIO MED, V25, P1066, DOI 10.1016/S0891-5849(98)00148-8; Dubinsky JM, 1999, BIOCHEM SOC SYMP, V66, P75, DOI 10.1042/bss0660075; DZHAFAROV AI, 1989, EKSPERIMENTALNOI BIO, V107, P305; GINSBERG MD, 1988, NEUROCHEM PATHOL, V9, P171; GNAIGER E, 2000, TRANSPLANT INT S, V1, pS555; GUTIERREZDIAZ JA, 1985, SURG NEUROL, V24, P67, DOI 10.1016/0090-3019(85)90067-9; HAYES RL, 1996, CATASTROPHIC BRAIN I, P183; HILLERED L, 1989, J NEUROSCI RES, V24, P247, DOI 10.1002/jnr.490240216; HOSSMANN KA, 1985, ACTA NEUROPATHOL, V68, P230, DOI 10.1007/BF00690200; Ikrenyi K, 1976, Adv Exp Med Biol, V75, P159; KOIZUMI J, 1970, Archivum Histologicum Japonicum, V32, P241; KRISTIAN T, J NEUROCHEMISTRY, V83, P1297; KYKENS JA, 1994, J NEUROCHEM, V63, P584; LEHNINGER AL, 1971, BIOENERGETICS, P73; Lemasters JJ, 1997, MOL CELL BIOCHEM, V174, P159, DOI 10.1023/A:1006827601337; Martin LJ, 2000, NEUROBIOL DIS, V7, P169, DOI 10.1006/nbdi.2000.0282; MAYEVSKY A, 1991, Neurological Research, V13, P39; MCCLURE MJ, 1996, PARADIGMS NERVE INJU, P178; Morley P, 1999, CONT NEUROS, P69; Muizelaar JP, 1996, CATASTROPHIC BRAIN I, P233; Newcomb R, 1998, BRAIN RES, V813, P103, DOI 10.1016/S0006-8993(98)01006-3; Nicholls DG, 1999, BIOCHEM SOC SYMP, V66, P55, DOI 10.1042/bss0660055; NOVIKOF VE, FARMAKOLOGIIA TOKSIK, V54, P44; Novikov V. E., 1994, Eksperimental'naya i Klinicheskaya Farmakologiya, V57, P13; Perez-Pinzon MA, 1999, J CEREBR BLOOD F MET, V19, P39, DOI 10.1097/00004647-199901000-00004; ROMANSKY K, 1995, ZBL NEUROCHIR, V56, P111; Rosenthal M, 1997, ADV EXP MED BIOL, V428, P189; Solenski NJ, 2002, STROKE, V33, P816, DOI 10.1161/hs0302.104541; WAGNER KR, 1990, J NEUROL SCI, V100, P142, DOI 10.1016/0022-510X(90)90025-I; Wullner U, 1999, BRAIN RES, V826, P53, DOI 10.1016/S0006-8993(99)01228-7	47	17	18	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2004	18	11					1107	1126		10.1080/02699050410001672332			20	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	863JW	WOS:000224558900004	15545208				2022-02-06	
J	Engberg, AW; Teasdale, TW				Engberg, AW; Teasdale, TW			A population-based study of survival and discharge status for survivors after head injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						traumatic brain injury; head injury; epidemiology; survival; sequelae; rehabilitation planning	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; DISABILITY	Objectives - Creation of a basis for the planning of rehabilitation after head injury in Denmark. Materials and methods - Patients with cranial fractures or traumatic cerebral lesions occurring in Denmark in 1979-93 were identified by computerized searches in the national hospital register. Kaplan-Meier survival functions were calculated for these two categories. Hospital records for a random sample of 389 survivors in 1997 after cranial fracture, acute brain lesion or chronical subdural haematoma, which occurred in 1982, 1987 and 1992 in patients aged 15 years or more at injury, were reviewed. Survivors were characterized by age, gender, place and severity of injury, as well as neurophysical, speech and mental deficits at discharge from hospital. Results - Acute/subacute mortality of hospitalized patients was 27% for cerebral lesions and 4% after cranial fracture. As attrition by death outweighed the decreasing incidence with time, the point prevalence of survivors in 1997 after brain lesions occurring in 1982, 1987 or 1992 was nearly the same, averaging 8.4 per 100 000 of the population above age 14. Half of them were severe, as defined by initial Glasgow Coma Score <9 for more than 6 h. There was no tendency with time of injury with regard to percentage occurrence of neurophysical, speech or mental deficits at discharge. The calculated number of candidates for rehabilitation of personal activities of daily life briefly after injury was 9.8 per 100 000 with cerebral lesion and 1.2 per 100 000 with cranial fracture. The severest 1.5 per 100 000 per year were candidates for early intensive centralized rehabilitation in special centres. Five years after injury, <0.13 per 100 000 population survived in the vegetative state. Conclusion - In this population-based study, survival after cranial fracture and cerebral lesion was described quantitatively through Kaplan-Meier survival distributions. Besides, patterns of severity, neurophysical and mental sequelae among survivors 5, 10 and 15 years post-injury were described. It was shown by examples how the study has been useful already for the planning of rehabilitation according to a national strategy from 1997 in Denmark. Besides, the results may serve as a reference for comparison with future studies.	Copenhagen Univ Hosp, Hvidovre Hosp, Dept Neurol Rehabil, DK-2650 Hvidovre, Denmark; Univ Copenhagen, Dept Psychol, Copenhagen, Denmark		Engberg, AW (corresponding author), Copenhagen Univ Hosp, Hvidovre Hosp, Dept Neurol Rehabil, DK-2650 Hvidovre, Denmark.	aase.engberg@hh.hosp.dk					Andersen TF, 1999, DAN MED BULL, V46, P263; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Baguley I, 2000, BRAIN INJURY, V14, P505; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Hillier SL, 1997, BRAIN INJURY, V11, P661; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; MCKENZIE EJ, 1989, MARYLAND MED J, V38, P725; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; *OECD, 1994, INT ROAD TRAFF ACC D; *SUNDH DAN NAT BOA, 1997, BEH TRAUM HJ TILGR L; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; [No title captured]	21	17	18	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	NOV	2004	110	5					281	290		10.1111/j.1600-0404.2004.00323.x			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	861RC	WOS:000224434900002	15476456				2022-02-06	
J	Lobello, SG; Underhill, AT; Fine, PR				Lobello, SG; Underhill, AT; Fine, PR			The reliability and validity of the Life Satisfaction Index-A with survivors of traumatic brain injury	BRAIN INJURY			English	Article							SPINAL-CORD-INJURY; COMMUNITY	Primary objective: To investigate the internal consistency, long-term stability and validity of the Life Satisfaction Index-A (LSI-A) in a sample of survivors of traumatic brain injury (TBI). Research design: Cohort study. Methods and procedures: LSI-A was administered to survivors of TBI at 12, 24, 48 and 60 months post-injury during telephone interviews. Participants rated their quality of life, independence and participation in activities as well as health status at 24 months. Internal consistency was evaluated with Coefficient alpha. Pearson's r was used to investigate score stability. Test validity was explored with Pearson's r and Analysis of Covariance with age and sex as covariates. Experimental interventions: None. Main outcomes and results: Coefficient alphas ranged from 0.85-0.92. Test re-test coefficients ranged from 0.42-0.77. The LSI-A was positively correlated with self-reported quality of life, independence, activity level and health status. Conclusions: The LSI-A is a reliable and valid measure of the construct of life satisfaction among survivors of TBI.	Auburn Univ, Dept Psychol, Montgomery, AL 36124 USA; Univ Alabama, Sch Med, Injury Control Res Ctr, Birmingham, AL USA		Lobello, SG (corresponding author), Auburn Univ, Dept Psychol, POB 244023, Montgomery, AL 36124 USA.	slobello@mail.aum.edu			ODCDC CDC HHS [R49/CCR403641] Funding Source: Medline		ADAMS DL, 1969, J GERONTOL, V24, P470, DOI 10.1093/geronj/24.4.470; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; COHEN RJ, 1999, PSYCHOL TESTING ASSE, P151; *COMM INJ SCAL AM, 1985, ABBR INJ SCAL 1985 R; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; KAPLAN RM, 1989, PSYCHOL TESTING PRIN, P110; Kemp BJ, 1999, DISABIL REHABIL, V21, P241; LOBELLO SG, J REHABILITATION RES, V40, P293; LOHMANN N, 1977, J GERONTOL, V32, P73, DOI 10.1093/geronj/32.1.73; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; RAO V N, 1981, International Journal of Aging and Human Development, V14, P55, DOI 10.2190/DWM4-E05K-CNTD-XNAA; UNDERHILL AT, IN PRESS BRAIN INJUR; Wallace KA, 2002, EDUC PSYCHOL MEAS, V62, P674, DOI 10.1177/001316402128775085; Warren L, 1996, J REHABIL RES DEV, V33, P404; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9	17	17	19	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2004	18	11					1127	1134		10.1080/02699050410001672378			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	863JW	WOS:000224558900005	15545209				2022-02-06	
J	Louin, G; Besson, VC; Royo, NC; Bonnefont-Rousselot, D; Marchand-Verrecchia, C; Plotkine, M; Jafarian-Tehrani, M				Louin, G; Besson, VC; Royo, NC; Bonnefont-Rousselot, D; Marchand-Verrecchia, C; Plotkine, M; Jafarian-Tehrani, M			Cortical calcium increase following traumatic brain injury represents a pitfall in the evaluation of Ca2+-independent NOS activity	JOURNAL OF NEUROSCIENCE METHODS			English	Article						nitric oxide synthases; inducible nitric oxide inhibitor; 1400W; calcium; traumatic brain injury; rat	NITRIC-OXIDE SYNTHASE; FOCAL CEREBRAL-ISCHEMIA; RATS; ACTIVATION; PHOSPHORYLATION; EXPRESSION; INDUCTION; BINDING; MICE; NEUROPROTECTION	In this report, our findings highlighted the presence of a high level of calcium in the cortex following traumatic brain injury (TBI) in a rat model of fluid percussion-induced brain injury. This calcium increase represents a pitfall in the assessment of Ca2+-independent nitric oxide synthase (NOS) activity supposed to play a role in the secondary brain lesion following TBI. The so-called Ca2+-independent NOS activity measured in the injured cortex 72 h after TBI had the pharmacological profile of a Ca2+-dependent NOS and was therefore inhibited with a supplement of calcium chelator. The remaining activity was very low and iNOS protein was hardly immumodetected on the same sample used for NOS activity assay. The concentration of calcium chelator used in the assay should be revised and adjusted consequently to make sure that the calcium-free condition is achieved for the assay. Otherwise, the findings tend towards an overestimation of Ca2+-independent and underestimation of Ca2+-dependent NOS activities. The revised Ca2+-independent NOS activity assay was then tested, in relation with the amount of iNOS protein, in a model of LPS-induced neuroinflammation. Taken together, precautions should be taken when assessing the Ca2+-independent enzymatic activity in cerebral tissue after a brain insult. (C) 2004 Elsevier B.V. All rights reserved.	Univ Paris 05, UPRES, EA 2510, Pharmacol Lab, F-75270 Paris 06, France; Univ Paris 05, UPRES, EA 3617, Lab Biochim Metab & Clin, F-75270 Paris 06, France		Jafarian-Tehrani, M (corresponding author), Univ Paris 05, UPRES, EA 2510, Pharmacol Lab, 4 Ave Observ, F-75270 Paris 06, France.	mehmaz.jafarian@univ-paris5.fr	besson, valerie C/L-7388-2017; MARCHAND-LEROUX, Catherine/L-7453-2017; BESSON, VALERIE/AAZ-9989-2020; Rousselot, Bonnefont/U-7434-2019	besson, valerie C/0000-0002-1491-2380; MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; BESSON, VALERIE/0000-0002-1491-2380; Bonnefont-Rousselot, Dominique/0000-0003-4689-9202; Jafarian-Tehrani, Mehrnaz/0000-0001-6895-5856			Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; CaulinGlaser T, 1997, CIRC RES, V81, P885; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Corson MA, 1996, CIRC RES, V79, P984, DOI 10.1161/01.RES.79.5.984; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 1999, P NATL ACAD SCI USA, V96, P1123, DOI 10.1073/pnas.96.3.1123; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Grandati M, 1997, BRIT J PHARMACOL, V122, P625, DOI 10.1038/sj.bjp.0701427; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Igarashi J, 1999, P NATL ACAD SCI USA, V96, P12583, DOI 10.1073/pnas.96.22.12583; KNOWLES RG, 1990, BIOCHEM J, V270, P833, DOI 10.1042/bj2700833; Kristof AS, 1998, AM J RESP CRIT CARE, V158, P1883, DOI 10.1164/ajrccm.158.6.9802100; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Parmentier S, 1999, BRIT J PHARMACOL, V127, P546, DOI 10.1038/sj.bjp.0702549; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; SMITH FS, 1998, DETECTION NOS ISOFOR, P171; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Yamada K, 1999, NEUROSCIENCE, V88, P281, DOI 10.1016/S0306-4522(98)00237-1; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781	32	17	18	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2004	138	1-2					73	79		10.1016/j.jneumeth.2004.03.010			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	853CT	WOS:000223804600010	15325114				2022-02-06	
J	Bazarian, JJ; Fisher, SG; Flesher, W; Lillis, R; Knox, KL; Pearson, TA				Bazarian, JJ; Fisher, SG; Flesher, W; Lillis, R; Knox, KL; Pearson, TA			Lateral automobile impacts and the risk of traumatic brain injury	ANNALS OF EMERGENCY MEDICINE			English	Article							MOTOR-VEHICLE COLLISIONS; CAR SIDE IMPACTS; PATTERNS; SEVERITY; CRASHES; HEAD	Study objectives: We determine the relative risk and severity of traumatic brain injury among occupants of lateral impacts compared with occupants of nonlateral impacts. Methods: This was a secondary analysis of the National Highway Traffic Safety Administration's National Automotive Sampling System, Crashworthiness Data Systems for 2000. Analysis was restricted to occupants of vehicles in which at least 1 person experienced an injury with Abbreviated Injury Scale score greater than 2. Traumatic brain injury was defined as an injury to the head or skull with an Abbreviated Injury Scale score greater than 2. Outcomes were analyzed using the chi(2) test and multivariate logistic regression, with adjustment of variance to account for weighted probability sampling. Results: Of the 1,115 occupants available for analysis, impact direction was lateral for 230 (18.42%) occupants and nonlateral for 885 (81.58%) occupants. One hundred eighty-seven (16.07%) occupants experienced a traumatic brain injury, 14.63% after lateral and 16.39% after nonlateral impact. The unadjusted relative risk of traumatic brain injury after lateral impact was 0.89 (95% confidence interval [CI] 0.51 to 1.56). After adjusting for several important crash-related variables, the relative risk of traumatic brain injury was 2.60 (95% CI 1.1 to 6.0). Traumatic brain injuries were more severe after lateral impact according to Abbreviated Injury Scale and Glasgow Coma Scale scores. The proportion of fatal or critical crash-related traumatic brain injuries attributable to lateral impact was 23.5%. Conclusion: Lateral impact is an important independent risk factor for the development of traumatic brain injury after a serious motor vehicle crash. Traumatic brain injuries incurred after lateral impact are more severe than those resulting from nonlateral impact. Vehicle modifications that increase head protection could reduce crash-related severe traumatic brain injuries by up to 61% and prevent up to 2,230 fatal or critical traumatic brain injuries each year in the United States.	Univ Rochester, Med Ctr, Dept Emergency Med, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Community & Prevent Med, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Res Accid Invest Team, Rochester, NY 14642 USA		Bazarian, JJ (corresponding author), Univ Rochester, Med Ctr, Dept Emergency Med, Box 655,601 Elmwood Ave, Rochester, NY 14642 USA.	jeff_bazarian@urmc.rochester.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1 K23 NS 41952-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS041952] Funding Source: NIH RePORTER		ARAJARVI E, 1988, ACCIDENT ANAL PREV, V20, P251, DOI 10.1016/0001-4575(88)90053-X; *ARCNETWORK, HEAD INJ AR NOT CRAS; ARGAN P, 1989, AM J DIS CHILD, V143, P1317; ARGOGAST KB, 2001, J TRAUMA, V51, P469; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; *AUTOLIV, SID IMP AIRB; Bring G, 1996, ACCIDENT ANAL PREV, V28, P359, DOI 10.1016/0001-4575(96)00002-4; DISCHINGER PC, 1993, J TRAUMA, V35, P454, DOI 10.1097/00005373-199309000-00020; Dischinger PC, 1998, ACCIDENT ANAL PREV, V30, P831, DOI 10.1016/S0001-4575(98)00036-0; FRAME P, 1998, NHTSAS NEW HEAD PROT; GABLER HC, AGGRESSIVITY LIGHT T; HALAND Y, 1993, ACCIDENT ANAL PREV, V25, P199, DOI 10.1016/0001-4575(93)90060-A; *INS I HIGHW SAF, SPEC ISS HEAD PROT I; *INS I HIGHW SAF, 2001 2002 MOD SID AI; JENNINGS B, DRIVE MAGAZINE; KAHANE CJ, 809004 NHTSA DOT HS; KANG AI, 2001, STAPP CAR CRASH J, V45, P369; McLellan BA, 1996, J TRAUMA, V41, P708, DOI 10.1097/00005373-199610000-00019; MILTNER E, 1995, ACCIDENT ANAL PREV, V27, P105, DOI 10.1016/0001-4575(94)E0019-H; Morris A, 1995, ACCIDENT ANAL PREV, V27, P749, DOI 10.1016/0001-4575(95)00020-8; *NAT HIGHW TRAFF S, 1999, MOT VEH CRASH DAT FA, P72; *NAT HIGHW TRAFF S, 1992, NAT AUT SAMPL SYST C; *NAT HIGHW TRAFF S, 2000, NAT AUT SAMPL SYST C; *NAT HIGHW TRAFF S, 1993, NAT AUT SAMPL SYST C; *NAT HIGHW TRAFF S, 1994, NAT AUT SAMPL SYST C; *NAT HIGHW TRAFF S, 1991, NAT AUT SAMPL SYST C; *NAT HIGHW TRAFF S, 1988, NAT AUT SAMPL SYST C; ORSAY EM, 1990, ANN EMERG MED, V19, P258; Reiff DA, 2001, J TRAUMA, V51, P340, DOI 10.1097/00005373-200108000-00020; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ., 1995, GUIDELINES SURVEILLA	31	17	18	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	AUG	2004	44	2					142	152		10.1016/j.annemergmed.2004.03.029			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	842AY	WOS:000222975900009	15278087				2022-02-06	
J	De Monte, VE; Geffen, GM; May, CR; McFarland, K				De Monte, VE; Geffen, GM; May, CR; McFarland, K			RETRACTED: Double cross-validation and improved sensitivity of the rapid screen of mild traumatic brain injury (Retracted Article. See vol 29, pg 904, 2007)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Retracted Publication							MINOR HEAD-INJURY; NEUROPSYCHOLOGICAL SEQUELAE; STANDARDIZED ASSESSMENT; POSTTRAUMATIC AMNESIA; AUSTRALIAN RULES; FOOTBALL PLAYERS; CONCUSSION; RECOVERY	This study aimed to replicate and cross-validate the Rapid Screen of Concussion (RSC) for diagnosing mild TBI (mTBI). One hundred (81 male, 19 female) cases of mTBI and 35 (23 male and 12 female) cases of orthopaedic injuries were tested within 24 hr of injury. Double cross-validation was used to examine whether total RSC scores obtained in the cur-rent sample, generalised to one previously reported. In the new sample, mTBI patients answered fewer orientation questions, recalled fewer words on the learning trial and after a delay, judged fewer sentences in 2 min, and completed fewer symbols in the Digit Symbol Substitution Test than orthopaedic controls. The formulae and cut-offs developed on the original and new samples produced similar sensitivity and overall correct classification rates. Inclusion of the Digit Symbol Substitution Test performance of the new sample improved the sensitivity (80.2%) and specificity (82.6%) in males. It did not improve the correct classification rate in females, which was 89.5% sensitivity and 91.7% specificity before the inclusion of the Digit Symbol Substitution Test. Taken together, these results indicate that a combined score on this 12-min screen yields a measure of level of brain impairment up to 24 hr after mTBI.	Univ Queensland, Cognit Psychophysiol Lab, St Lucia, Qld 4067, Australia; Royal Brisbane Hosp, Dept Emergency Med, Brisbane, Qld 4029, Australia; Univ Queensland, Sch Psychol, Brisbane, Qld, Australia		De Monte, VE (corresponding author), Sch Med, Cognit Psychophysiol Lab, Edith Cavell Bldg,Herston Rd, Brisbane, Qld 4006, Australia.	comerf@psy.uq.edu.au					ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Baddeley A., 1992, SPEED CAPACITY LANGU; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; FORRESTER G, 1995, J FARR SERVICES POST; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hillier SL, 1997, BRAIN INJURY, V11, P649; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KRAUS JF, 1989, MILD HEAD INJURY, P8; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1991, J CLIN EXP NEUROPSYC, V13, P439; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Wechsler, 1997, WECHSLER ADULT INTEL; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774	25	17	17	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	2004	26	5					628	644		10.1080/13803390490504443			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	862HE	WOS:000224480800005	15370385				2022-02-06	
J	Dziurdzik, P; Krawczyk, L; Jalowiecki, P; Kondera-Anasz, Z; Menon, L				Dziurdzik, P; Krawczyk, L; Jalowiecki, P; Kondera-Anasz, Z; Menon, L			Serum interleukin-10 in ICU patients with severe acute central nervous system injuries	INFLAMMATION RESEARCH			English	Article						interleukin-10; central nervous system; brain injury; intensive care	TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL ENDOTOXEMIA; CEREBROSPINAL-FLUID; PLASMA-LEVELS; HEAD-INJURY; RELEASE; IL-10; CHILDREN; BLOOD	Rationale:IL-10, the main anti-inflammatory cytokine, may play a pivotal role in cerebral inflammation implicated in the development of brain edema and secondary brain damage after injury. Aim of the study:1) Determining absolute IL-10 serum level and its pattern in critically ill patients with traumatic and non-traumatic acute brain injury. 2) Assessment of prognostic value of serum IL-10 in those patients. Materials and methods:Serum IL-10 levels in 46 adults (multi-profile ICU, teaching hospital) with traumatic brain injury (TBI, N = 18), nontraumatic intracranial hemorrhage (SAH, N = 11) and polytrauma with concomitant brain injury (POL, N = 17) were measured using ELISA. Relationship of IL-10 and initial diagnosis, clinical state, outcome and risk of infection development was evaluated. Results:IL-10 was detectable in the serum of all but one patient on ICU admission (56.6 +/- 91.9 pg/ml; mean +/- SD). No statistically significant differences in IL-10 between TBI, SAH and POL groups as well as between survivors and non-survivors on any day were found. No correlation between IL-10 and GCS or SAPS II was seen. Significant fall in serum IL-10 during the first 4 days of injury in patients of all subgroups was observed. Patients with initial serum IL-10 below 77pg/ml were at significantly higher risk of development of any infection within the first week of injury. Conclusions:After acute brain injury, serum IL-10 in adults is detectable independent of CNS lesion type. Its systemic release is strongly individualized. Serum IL-10 on ICU admission may have some prognostic value to predict development of infection in patients with CNS lesions.	Med Univ Silesia, Chair Anesthesiol Intens Therapy & Emergency Med, Clin Dept Anesthesiol & Intens Care, Katowice, Poland; Med Univ Silesia, Chair & Dept Immunol & Serol, PL-40074 Katowice, Poland		Dziurdzik, P (corresponding author), Wojewodzki Szpital Specjalisty 5, Oddzial Klin Anestezjol & Intensywnej Terapii SAM, Plac Medykow 1, PL-41200 Sosnowiec, Poland.	anestitsos@slam.katowice.pl	Jalowiecki, Przemyslaw/V-8504-2018	Jalowiecki, Przemyslaw/0000-0002-2956-7890; Krawczyk, Lech/0000-0002-6433-2683; Kondera-Anasz, Zdzislawa/0000-0002-4137-0580			Bell MJ, 1997, ACT NEUR S, V70, P96; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DOCKE WD, 1997, SHOCK S, V8, P115; *END INC, HUM ELISA IL 10 KIT; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; GOLDMAN M, 1996, YB INTENSIVE CARE EM, P105; Heesen M, 1996, ACTA NEUROCHIR, V138, P77, DOI 10.1007/BF01411728; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Hensler T, 2000, INFLAMM RES, V49, P524, DOI 10.1007/s000110050626; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Lyons A, 1997, ANN SURG, V226, P450, DOI 10.1097/00000658-199710000-00006; Majetschak M, 2000, CRIT CARE MED, V28, P1847, DOI 10.1097/00003246-200006000-00027; MARCHANT A, 1994, EUR J IMMUNOL, V24, P1167, DOI 10.1002/eji.1830240524; Maskin B, 2001, MEDICINA-BUENOS AIRE, V61, P573; MEERT KL, 1995, CRIT CARE MED, V23, P822, DOI 10.1097/00003246-199505000-00008; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Neidhardt R, 1997, J TRAUMA, V42, P863, DOI 10.1097/00005373-199705000-00017; Partrick DA, 1999, AM J SURG, V178, P564, DOI 10.1016/S0002-9610(99)00240-8; Pelidou SH, 1999, EUR J NEUROL, V6, P437, DOI 10.1046/j.1468-1331.1999.640437.x; Platzer C, 2000, J NEUROIMMUNOL, V105, P31, DOI 10.1016/S0165-5728(00)00205-8; Sherry RM, 1996, J TRAUMA, V40, P613, DOI 10.1097/00005373-199604000-00016; Shimonkevitz R, 1999, SHOCK, V12, P10, DOI 10.1097/00024382-199907000-00002; SPERA PA, 1998, NEUROSCI LETT, V51, P89; Taniguchi T, 1999, CRIT CARE MED, V27, P1262, DOI 10.1097/00003246-199907000-00005; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Woiciechowsky C, 1999, J MOL MED-JMM, V77, P769, DOI 10.1007/s001099900051	29	17	19	0	4	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	AUG	2004	53	8					338	343		10.1007/s00011-004-1265-1			6	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	846EH	WOS:000223297500001	15316663				2022-02-06	
J	Walter, B; Brust, P; Fuchtner, F; Muller, M; Hinz, R; Kuwabara, H; Fritz, H; Zwiener, U; Bauer, R				Walter, B; Brust, P; Fuchtner, F; Muller, M; Hinz, R; Kuwabara, H; Fritz, H; Zwiener, U; Bauer, R			Age-dependent effects of severe traumatic brain injury on cerebral dopaminergic activity in newborn and juvenile pigs	JOURNAL OF NEUROTRAUMA			English	Article						colored microspheres; dopamine metabolism; fluid-percussion; juvenile pig; newborn piglets; pediatric brain injury; positron emission tomography	AMINO-ACID DECARBOXYLASE; DEFICIT HYPERACTIVITY DISORDER; COLORED MICROSPHERE TECHNIQUE; PEDIATRIC HEAD-INJURY; MONOAMINE OXIDASE-B; BLOOD-FLOW; STRIATAL DOPAMINE; RAT-BRAIN; TYROSINE-HYDROXYLASE; CHILDREN	There is evidence that the dopaminergic system is sensitive to traumatic brain injury (TBI). However, the age-dependency of this sensitivity has not been studied together with brain oxidative metabolism. We postulate that the acute effects of severe TBI on brain dopamine turnover are age-dependent. Therefore F-18-labelled 6-fuoro-L-3,4-dihydroxyphenylalanine (FDOPA) together with Positron-Emission-Tomography (PET) was used to estimate the activity of the aromatic amino acid decarboxylase (AADC) in the brain of Ill newborn piglets (7-10 days old) and nine juvenile pigs (6-7 weeks old). Six newborn and five juvenile animals were subjected to a severe fluid-percussion (FP) induced TBI. The remaining animals were used as sham operated untreated control groups. Simultaneously, the regional cerebral blood flow (CBF) was measured with colored microspheres and the cerebral metabolic rates of oxygen and glucose were determined. At 1 h after FP-TBI, [F-18]FDOPA was infused and PET scanning was performed for 2 h. At 2 h after FP-TBI administration, a second series of measurements of physiological values including CBF and brain oxidative metabolism data had been obtained. Severe FP-TBI elicited a marked increase in the rate constant for fluorodopamine production (k(3)(FDOPA)) in all brain regions of newborn piglets studied by between 97% (mesencephalon) and 143% (frontal cortex) (p < 0.05). In contrast, brain hemodynamics and cerebral oxidative metabolism remained unaltered after TBI. Furthermore, the permeability-surface area product of FDOPA (PSFDOPA) was unchanged. In addition, regional blood flow differences between corresponding ipsi- and contralateral brain regions did not occur after TBI. Thus, it is suggested that severe FP-TBI induces an upregulation off AADC activity of newborn piglets that is not related to alterations in brain oxidative metabolism.	Univ Jena, Univ Klinikum Jena, Inst Pathophysiol, D-07740 Jena, Germany; Univ Jena, Inst Pathophysiol & Pathobiochem, D-6900 Jena, Germany; Univ Jena, Dept Neurosurg, D-6900 Jena, Germany; Univ Jena, Dept Anesthesiol & Intens Care, D-6900 Jena, Germany; Inst Interdisciplinary Isotope Res, Leipzig, Germany; Res Ctr Rossendorf, Inst Bioinorgan & Radiopharmaceut Chem, Dresden, Germany; Johns Hopkins Univ, Dept Radiol & Radiol Sci, Baltimore, MD USA		Bauer, R (corresponding author), Univ Jena, Univ Klinikum Jena, Inst Pathophysiol, D-07740 Jena, Germany.	Reinhard.Bauer@mti.uni-jena.de		, Peter/0000-0001-5555-7058; Hinz, Rainer/0000-0002-7808-9207			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Bauer R, 1999, PEDIATR NEUROSURG, V30, P62, DOI 10.1159/000028765; Bauer R, 2002, BRAIN RES, V934, P23, DOI 10.1016/S0006-8993(02)02315-6; Bauer R, 1996, EXP TOXICOL PATHOL, V48, P415; Berry MD, 1996, NEUROCHEM RES, V21, P1075, DOI 10.1007/BF02532418; BERRY MD, 1994, BRIT J PHARMACOL, V113, P1159, DOI 10.1111/j.1476-5381.1994.tb17119.x; Brix G, 1997, J NUCL MED, V38, P1614; Brust P, 1998, INT J DEV NEUROSCI, V16, P353, DOI 10.1016/S0736-5748(98)00017-3; Brust P, 2003, SYNAPSE, V47, P143, DOI 10.1002/syn.10163; BRUST P, 2003, 5 INT C CER VASC BIO; Cho S, 1997, EUR J PHARMACOL, V323, P149, DOI 10.1016/S0014-2999(97)00037-X; COYLE MG, 1993, AM J PHYSIOL, V264, pH141, DOI 10.1152/ajpheart.1993.264.1.H141; CUMMING P, 1995, J NEUROCHEM, V65, P1381; Cumming P, 1998, SYNAPSE, V29, P37, DOI 10.1002/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO;2-C; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1; Ernst M, 1999, AM J PSYCHIAT, V156, P1209; Fisher A, 2000, NEUROSCIENCE, V95, P97; Fisher A, 1998, BRAIN RES, V792, P126, DOI 10.1016/S0006-8993(98)00129-2; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; Graham DI, 2001, BRAIN, V124, P1261, DOI 10.1093/brain/124.7.1261; HADJICONSTANTINOU M, 1995, EUR J PHARM-MOLEC PH, V289, P97, DOI 10.1016/0922-4106(95)90173-6; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; Henry JM, 1997, J INVEST SURG, V10, P281, DOI 10.3109/08941939709032167; HUANG CC, 1994, NEUROCHEM RES, V19, P649, DOI 10.1007/BF00967702; HUANG SC, 1991, J CEREBR BLOOD F MET, V11, P898, DOI 10.1038/jcbfm.1991.155; JOCHUM T, 2000, PFLUG ARCH EUR J P S, V439, pR287; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Konrad KN, 2000, BRAIN INJURY, V14, P859; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAKER HS, 1981, J NEUROCHEM, V36, P589, DOI 10.1111/j.1471-4159.1981.tb01631.x; MAKOWSKI EL, 1968, CIRC RES, V23, P623, DOI 10.1161/01.RES.23.5.623; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; NAMAVARI M, 1992, APPL RADIAT ISOTOPES, V43, P989; PATERSON IA, 1991, J PHARMACOL EXP THER, V258, P1019; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; ROSENBERG PA, 1988, J NEUROSCI, V8, P2887, DOI 10.1523/jneurosci.08-08-02887.1988; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; SLIVKA A, 1985, J BIOL CHEM, V260, P5466; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; THOMPSON RF, 2000, EYEBLINK CLASSICAL C, V2, P17; Vargo JM, 1999, J TRAUMA, V47, P265, DOI 10.1097/00005373-199908000-00008; Vles JSH, 2003, NEUROPEDIATRICS, V34, P77; Vorwieger G, 1998, QUANTITATIVE FUNCTIONAL BRAIN IMAGING WITH POSITRON EMISSION TOMOGRAPHY, P285, DOI 10.1016/B978-012161340-2/50045-7; Walter B, 1997, BASIC RES CARDIOL, V92, P191, DOI 10.1007/s003950050037; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; ZHU MY, 1995, GEN PHARMACOL-VASC S, V26, P681, DOI 10.1016/0306-3623(94)00223-A; ZHU MY, 1992, J NEUROCHEM, V58, P636, DOI 10.1111/j.1471-4159.1992.tb09765.x; ZHU MY, 1994, BRIT J PHARMACOL, V112, P23, DOI 10.1111/j.1476-5381.1994.tb13023.x; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	62	17	17	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2004	21	8					1076	1089		10.1089/0897715041651024			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	846AK	WOS:000223286800010	15319007				2022-02-06	
J	Butterworth, P; Anstey, K; Jorm, AF; Rodgers, B				Butterworth, P; Anstey, K; Jorm, AF; Rodgers, B			A community survey demonstrated cohort differences in the lifetime prevalence of self-reported head injury	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						head injury; brain injury; lifetime prevalence; community survey; cohort effect	TRAUMATIC BRAIN-INJURY; CONSECUTIVE SERIES; DIMINISHED RECALL; COLLEGE-STUDENTS; SECULAR TRENDS; BIRTH-COHORT; DEPRESSION; SYMPTOMS; RISK; EPIDEMIOLOGY	Objective: The objective of the study was to assess the lifetime prevalence and validity of self-reported head injury. Study Design and Setting: Analysis of a cross-sectional community survey, stratified by birth cohort. Seven thousand four hundred eighty-eight residents of Canberra and Queanbeyan, 3,678 males and 3,810 females, representing three cohorts aged in their 20s, 40s and 60s at the time of the survey, were randomly selected from the Australian Electoral Roll. Results: The lifetime prevalence of head injury with at least 15 min loss of consciousness ranged from 5.6 to 6.0% across the three cohorts. Self-reported head injury was associated with symptoms of traumatic brain injury or postconcussion syndrome. Reported head injury did not differ across the birth cohorts, contrary to expectations that prevalence rates would increase with age. Analysis of age at first head injury showed significant differences between cohorts in the reported prevalence at age 20, with estimates considerably higher for the youngest cohort. Conclusion: Although the data may reflect real increases in the risk of head injury, it may be that self-reported measures of lifetime prevalence of head injury underestimate prevalence in older cohorts. (C) 2004 Elsevier Inc. All rights reserved.	Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT 0200, Australia		Butterworth, P (corresponding author), Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT 0200, Australia.	Peter.Butterworth@anu.edu.au	Anstey, Kaarin/A-3852-2008; Jorm, Anthony F/B-5555-2009; Rodgers, Bryan/B-2090-2013	Anstey, Kaarin/0000-0002-9706-9316; Jorm, Anthony F/0000-0002-1424-4116; Rodgers, Bryan/0000-0002-2863-3737; Butterworth, Peter/0000-0002-1531-3881			ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annoni J M, 1992, Disabil Rehabil, V14, P23; [Anonymous], 2000, Bull World Health Organ, V78, P413; Baguley I, 2000, BRAIN INJURY, V14, P505; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Cattelani R, 1996, BRAIN INJURY, V10, P187, DOI 10.1080/026990596124502; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; FORTUNE N, 1999, DEFINITIION INCIDENC; GIUFFRA LA, 1994, PSYCHOL MED, V24, P375, DOI 10.1017/S0033291700027355; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; HOLMES CB, 1991, PERCEPT MOTOR SKILL, V73, P497, DOI 10.2466/PMS.73.5.497-498; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Jennett B, 1989, MILD HEAD INJURY, P23; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; LASCH K, 1990, PSYCHIAT RES, V33, P31, DOI 10.1016/0165-1781(90)90146-V; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; OTTMAN R, 1995, AM J EPIDEMIOL, V141, P235, DOI 10.1093/oxfordjournals.aje.a117425; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; POWELL BD, 1995, PERCEPT MOTOR SKILL, V81, P227, DOI 10.2466/pms.1995.81.1.227; RICE JP, 1992, ARCH GEN PSYCHIAT, V49, P824; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Ryan L M, 1996, Appl Neuropsychol, V3, P49, DOI 10.1207/s15324826an0302_1; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Santa Maria MP, 2001, ARCH CLIN NEUROPSYCH, V16, P133; SEGALOWITZ SJ, 1993, J CLIN EXP NEUROPSYC, V15, P104; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; SIMON GE, 1995, J CLIN EPIDEMIOL, V48, P1109, DOI 10.1016/0895-4356(95)00010-2; SIMON GE, 1992, AM J EPIDEMIOL, V135, P1411, DOI 10.1093/oxfordjournals.aje.a116252; SIMON GE, 1995, EPIDEMIOL REV, V17, P221, DOI 10.1093/oxfordjournals.epirev.a036180; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; Triplett G, 1996, PERCEPT MOTOR SKILL, V83, P1344, DOI 10.2466/pms.1996.83.3f.1344; Vastag B, 2002, JAMA-J AM MED ASSOC, V287, P437, DOI 10.1001/jama.287.4.437; Walker A E, 1971, Zentralbl Neurochir, V32, P3; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WEISSMAN MM, 1991, PSYCHIAT DISORDERS A; Willer B, 1996, NEUROREHABILITATION, V6, P219, DOI 10.3233/NRE-1996-6308; Yoshihama M, 2002, J FAM VIOLENCE, V17, P199, DOI 10.1023/A:1016001211182; [No title captured]; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	56	17	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	JUL	2004	57	7					742	748		10.1016/j.jclinepi.2003.10.015			7	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	856VB	WOS:000224072200011	15358403				2022-02-06	
J	Stover, JF; Sakowitz, OW; Kroppenstedt, SN; Thomale, UW; Kempski, OS; Flugge, G; Unterberg, AW				Stover, JF; Sakowitz, OW; Kroppenstedt, SN; Thomale, UW; Kempski, OS; Flugge, G; Unterberg, AW			Differential effects of prolonged isoflurane anesthesia on plasma, extracellular, and CSF glutamate, neuronal activity, I-125-Mk801 NMDA receptor binding, and brain edema in traumatic brain-injured rats	ACTA NEUROCHIRURGICA			English	Article						electroencephalography; excitotoxicity; in vitro receptor autoradiography; microdialysis; traumatic brain injury	EXCITATORY SYNAPTIC-TRANSMISSION; DEPOLARIZATION-EVOKED GLUTAMATE; CEREBRAL-BLOOD-FLOW; AMINO-ACID RELEASE; VOLATILE ANESTHETICS; CORTICAL PERFUSION; GATED CURRENTS; EEG ACTIVITY; METABOLISM; TRANSPORTERS	Background. Volatile anesthetics reduce neuronal excitation and cerebral metabolism but can also increase intracellular water accumulation in normal and injured brains. While attenuation of neuronal excitation and glutamate release are beneficial under pathological conditions, any increase in edema formation should be avoided. In the present study we investigated duration-dependent effects of the commonly used isoflurane/nitrous oxide (N2O) anesthesia on EEG activity, specific NMDA receptor binding, extracellular, CSF, and plasma glutamate, and cerebral water content in brain-injured rats subjected to short (30 minutes) or prolonged (4 hours) anesthesia. Methods. Before controlled cortical impact injury (CCI), during prolonged (4-8 hours) or short anesthesia (7.5-8 hours after CCI), and before brain removal, changes in neuronal activity were determined by quantitative EEG analysis and glutamate was measured in arterial plasma. Brains were processed to determine acute and persisting changes in cerebral water content and I-125-Mk801 NMDA receptor binding at 8 and 32 hours after CCI, i.e., immediately or 24 hours after short or prolonged anesthesia. During prolonged anesthesia glutamate was measured via microdialysis within the cortical contusion. CSF was sampled before brain removal. Findings. Prolonged isoflurane (1.8 vol%) anesthesia significantly increased EEG activity, plasma, cortical extracellular, and CSF glutamate, cortical and hippocampal I-125-Mk801 NMDA receptor binding, and cerebral water content in brain-injured rats. These changes were partially reversible within 24 hours after prolonged anesthesia. At 24 hours, CSF glutamate was significantly reduced following long isoflurane anesthesia compared to rats previously subjected to short anesthesia despite an earlier significant increase. Conclusions. The partially reversible increases in EEG activity, I-125-Mk801 NMDA receptor binding, cerebral water content, plasma and CSF glutamate appear important for physiological, pathophysiological, and pharmacological studies requiring prolonged anesthesia with isoflurane. Increases in extracellular cortical and plasma glutamate could contribute to acute aggravation of underlying tissue damage.	Univ Zurich Hosp, Div Surg Intens Care Med, CH-8006 Zurich, Switzerland; Charite Dept Neurosurg, Berlin, Germany; Inst Neurosurg Pathophysiol, Mainz, Germany; German Primate Ctr, Gottingen, Germany; Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany		Stover, JF (corresponding author), Univ Zurich Hosp, Div Surg Intens Care Med, Turnerstr 12, CH-8006 Zurich, Switzerland.	stoverfam@bluewin.ch		Sakowitz, Oliver/0000-0003-3248-6335			Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Belelli D, 1999, TRENDS PHARMACOL SCI, V20, P496, DOI 10.1016/S0165-6147(99)01405-4; BERGJOHNSEN J, 1992, ACTA ANAESTH SCAND, V36, P350, DOI 10.1111/j.1399-6576.1992.tb03480.x; CARLI F, 1993, ACTA ANAESTH SCAND, V37, P672, DOI 10.1111/j.1399-6576.1993.tb03787.x; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Detsch O, 2002, NEUROSCI LETT, V317, P9, DOI 10.1016/S0304-3940(01)02419-3; Do SH, 2002, ANESTHESIOLOGY, V96, P1492, DOI 10.1097/00000542-200206000-00032; Duch DS, 1998, TOXICOL LETT, V101, P255, DOI 10.1016/S0378-4274(98)00193-3; Eilers H, 1999, ANESTH ANALG, V88, P1168, DOI 10.1097/00000539-199905000-00037; Harada H, 1999, ANESTH ANALG, V89, P1442, DOI 10.1097/00000539-199912000-00022; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; HORBER FF, 1988, ANESTHESIOLOGY, V69, P319, DOI 10.1097/00000542-198809000-00006; Hudetz AG, 2002, BRAIN RES, V954, P123, DOI 10.1016/S0006-8993(02)03358-9; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; Kindler CH, 1999, ANESTHESIOLOGY, V90, P1137, DOI 10.1097/00000542-199904000-00029; KOCHS E, 1993, ANESTH ANALG, V76, P1222, DOI 10.1213/00000539-199376060-00007; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; KURODA Y, 1993, ANESTH ANALG, V77, P795; Larsen M, 1998, J NEUROSURG ANESTH, V10, P166, DOI 10.1097/00008506-199807000-00007; Larsen M, 1998, EUR J ANAESTH, V15, P224; Lenz C, 1999, ANESTHESIOLOGY, V91, P1720, DOI 10.1097/00000542-199912000-00025; Liachenko S, 1999, BRIT J PHARMACOL, V127, P131, DOI 10.1038/sj.bjp.0702543; Lu XW, 1997, NEUROCHEM RES, V22, P705, DOI 10.1023/A:1027354110563; MacIver MB, 1996, ANESTHESIOLOGY, V85, P823, DOI 10.1097/00000542-199610000-00018; MARTIN DC, 1995, BIOCHEM PHARMACOL, V49, P809, DOI 10.1016/0006-2952(94)00519-R; MCDONALD JW, 1990, NEUROSCIENCE, V38, P103, DOI 10.1016/0306-4522(90)90377-G; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Mills CD, 1997, J NEUROTRAUM, V14, P943, DOI 10.1089/neu.1997.14.943; Ming Z, 2002, ANESTHESIOLOGY, V97, P856, DOI 10.1097/00000542-200210000-00017; Ming Z, 2001, BRAIN RES, V920, P117, DOI 10.1016/S0006-8993(01)03044-X; Miyazaki H, 1997, ANESTHESIOLOGY, V86, P1359, DOI 10.1097/00000542-199706000-00018; Nakashima K, 1996, ANESTHESIOLOGY, V85, P161, DOI 10.1097/00000542-199607000-00022; Nishikawa K, 2000, ANESTHESIOLOGY, V92, P228, DOI 10.1097/00000542-200001000-00035; Nishimaki H, 2002, RESUSCITATION, V54, P207, DOI 10.1016/S0300-9572(02)00120-X; Oh S, 1997, NEUROCHEM RES, V22, P767, DOI 10.1023/A:1022019423197; Paas Y, 1998, TRENDS NEUROSCI, V21, P117, DOI 10.1016/S0166-2236(97)01184-3; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PATEL PM, 1995, ANESTHESIOLOGY, V82, P996, DOI 10.1097/00000542-199504000-00024; RAMPIL IJ, 1992, ANESTHESIOLOGY, V77, P920, DOI 10.1097/00000542-199211000-00014; SCHETTINI A, 1979, BRIT J ANAESTH, V51, P1117, DOI 10.1093/bja/51.12.1117; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P51, DOI 10.1097/00008506-199701000-00012; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; SMITH AL, 1976, ANESTHESIOLOGY, V45, P64, DOI 10.1097/00000542-197607000-00012; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Stover JF, 2003, J NEUROTRAUM, V20, P315, DOI 10.1089/089771503765172273; Stover JF, 2000, ACT NEUR S, V76, P375; Stover JF, 1997, EUR J CLIN INVEST, V27, P1038, DOI 10.1046/j.1365-2362.1997.2250774.x; Takahashi M, 1997, J EXP BIOL, V200, P401; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Weiss HR, 1996, BRAIN RES, V730, P193; WENTHOLD RJ, 2003, ANN REV PHARM TOXICO, V143, P335; Wilson MA, 1998, DEV BRAIN RES, V109, P211, DOI 10.1016/S0165-3806(98)00084-4; Yu XM, 1999, P NATL ACAD SCI USA, V96, P7697, DOI 10.1073/pnas.96.14.7697; Zuo ZY, 2001, NEUROREPORT, V12, P1077, DOI 10.1097/00001756-200104170-00042	55	17	17	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2004	146	8					819	830		10.1007/s00701-004-0281-9			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	837NT	WOS:000222642900020	15254804				2022-02-06	
J	Ucar, T; Baykal, A; Akyuz, M; Dosemeci, L; Toptas, B				Ucar, T; Baykal, A; Akyuz, M; Dosemeci, L; Toptas, B			Comparison of serum and cerebrospinal fluid protein S-100b levels after severe head injury and their prognostic importance	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						severe head injury; S-100b; outcome	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-DAMAGE; SERIAL S-100; MARKERS; PREDICTION	Background. This study aimed to compare serum and cerebrospinal fluid (CSF) S-100b protein levels after a severe head injury. The changes in serum S-100b and CSF S-100b concentrations were investigated as indicators of brain damage for patients suffering from severe head injuries. Methods. The sample included 48 patients with Glasgow Coma Scale scores of 8 or below who had been admitted to the authors' emergency service soon after their severe head injury occurred. Both blood and CSF samples were taken within 1 to 11 hours after admission, then 24, 48, and 72 hours after the injury. Samples of CSF were taken using a ventricular catheter. The outcome was evaluated 6 to 9 months after hospital discharge using the Glasgow Outcome Scale. Results. The overall mean serum S-100b concentration was 3.5 +/- 6.4 among the patients with unfavorable outcomes and 1.3 +/- 2.5 among those with favorable outcomes. These results were not statistically significant (p > 0.05). The overall mean CSF S-100b concentration was 62.2 +/- 21.8 among the patients with unfavorable outcomes and 21.8 +/- 17.7 among those with favorable outcomes. These results, however, were statistically significant (p < 0.05). Conclusion. The results show that CSF S-100b levels clearly are superior to serum S-100b levels for predicting outcome after severe head injury.	Univ Akdeniz, Sch Med, Dept Neurosurg, TR-07070 Antalya, Turkey; Univ Akdeniz, Sch Med, Dept Biochem, Antalya, Turkey; Univ Akdeniz, Sch Med, Dept Anesthesiol & Reanimat, Antalya, Turkey		Ucar, T (corresponding author), Univ Akdeniz, Sch Med, Dept Neurosurg, TR-07070 Antalya, Turkey.	tucar@superonline.com	BAYKAL, ASLI/G-1304-2016	baykal, asli/0000-0002-3935-1591			Ali MS, 2000, BRIT J ANAESTH, V85, P287, DOI 10.1093/bja/85.2.287; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Beaudeux JL, 1999, ANN BIOL CLIN-PARIS, V57, P261; Connolly ES, 2001, NEUROSURGERY, V49, P1076, DOI 10.1097/00006123-200111000-00010; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 2000, NEUROSURG REV, V23, P136, DOI 10.1007/PL00011944; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, J NEUROSURG, V91, P875, DOI 10.3171/jns.1999.91.5.0875; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothoerl RD, 1999, BRAIN INJURY, V13, P387; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026	28	17	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2004	57	1					95	98		10.1097/01.TA.0000071352.95491.75			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	844TR	WOS:000223183800021	15284555				2022-02-06	
J	Mendez, DR; Cherian, L; Moore, N; Arora, T; Liu, PK; Robertson, CS				Mendez, DR; Cherian, L; Moore, N; Arora, T; Liu, PK; Robertson, CS			Oxidative DNA lesions in a rodent model of traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						oxidative DNA damage; oxidative DNA lesions; traumatic brain injury	CORTICAL IMPACT INJURY; NITRIC-OXIDE SYNTHASE; FOREBRAIN ISCHEMIA-REPERFUSION; ALZHEIMERS-DISEASE; CELL-DEATH; RAT-BRAIN; STRAND BREAKS; MOUSE-BRAIN; IN-VIVO; DAMAGE	Background: Oxidative DNA lesions have not been well studied in traumatic brain injury (TBI). Methods: TBI was induced with a controlled cortical impact injury in rats. Brain tissue was examined for 8-hydroxy-2'-deoxyguanosine (oh8dG) using monoclonal antibodies at different time frames; 15 minutes (n = 4), 30 minutes (n = 7), 60 minutes (n = 6), and 240 minutes (n = 5). The control group consisted of sham-operated animals undergoing the same surgery without the controlled cortical impact injury (n = 5). Results: An elevation of oh8dG was detected in the nuclear and perinuclear (mitochondrial) regions of the ipsilateral cortex, but seldom in those of the contralateral cortex. The amount of oh8dG in those animals with TBI was significant in all time frames when compared with sham-operated controls (p < 0.001). The oh8dG levels were more prominent at 15 minutes (p < 0.0001) when compared with controls. Conclusion: Oxidative DNA lesions occurred in this model of TBI maximally early after TBI. This suggests that oh8dGs may affect genetic material of the brain and that oh8dGs may adversely affect gene expression that occurs early after head injury.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Emergency Med, Houston, TX 77030 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Neuroradiol,Dept Radiol, Charlestown, MA USA		Mendez, DR (corresponding author), Baylor Coll Med, Dept Pediat, 6621 Fannin St,Room A210, Houston, TX 77030 USA.	drmendez@texaschildrenshospital.org			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS034810-04S1, NS045845, NS34810, R01 NS045845-01, NS38660, R01 NS034810-04, R01 NS045845] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045845, P01NS038660, R01NS034810] Funding Source: NIH RePORTER		ALTHAUS JS, 1993, MOL CHEM NEUROPATHOL, V20, P147, DOI 10.1007/BF02815368; Bogdanov M, 2000, FREE RADICAL BIO MED, V29, P652, DOI 10.1016/S0891-5849(00)00349-X; BREEN AP, 1995, BIOL MED, V118, P1033; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Cameron P, 1995, AUST NZ J SURG, V65, P848, DOI 10.1111/j.1445-2197.1995.tb00574.x; *CDC, 1988, INJ CONTR, P244; *CDC, 1982, MMWR-MORBID MORTAL W, V31, P599; Chen J, 1997, J NEUROCHEM, V69, P232; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Clark RSB, 1997, J NEUROSCI, V17, P9172; Conti AC, 1998, J NEUROSCI, V18, P5663; Cui JK, 2000, FASEB J, V14, P955; Cui JK, 1999, J NEUROCHEM, V73, P1164, DOI 10.1046/j.1471-4159.1999.0731164.x; DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O; Doder M, 1999, J NEUROL NEUROSUR PS, V66, P380, DOI 10.1136/jnnp.66.3.380; Fabian RH, 1998, J NEUROTRAUM, V15, P433, DOI 10.1089/neu.1998.15.433; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hayashi T, 1999, BRAIN RES, V832, P159, DOI 10.1016/S0006-8993(99)01409-2; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Huang DY, 2000, FASEB J, V14, P407, DOI 10.1096/fasebj.14.2.407; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Lin LH, 2000, J NEUROCHEM, V74, P1098; Liu PK, 2001, TRENDS NEUROSCI, V24, P581, DOI 10.1016/S0166-2236(00)01918-4; Liu PK, 1996, J NEUROSCI, V16, P6795; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Mesenge C, 1996, J NEUROTRAUM, V13, P11, DOI 10.1089/neu.1996.13.11; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Nunomura A, 1999, J NEUROSCI, V19, P1959; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; PARK EM, 1992, P NATL ACAD SCI USA, V89, P3375, DOI 10.1073/pnas.89.8.3375; RINK A, 1995, AM J PATHOL, V147, P1575; Schulz JB, 1995, J NEUROSCI, V15, P8419; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Won MH, 1999, BRAIN RES, V836, P70, DOI 10.1016/S0006-8993(99)01611-X; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5; Zink Brian J., 1996, Emergency Medicine Clinics of North America, V14, P115	48	17	18	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2004	56	6					1235	1240		10.1097/01.TA.0000130759.62286.0E			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	839UT	WOS:000222811100013	15211131				2022-02-06	
J	Sanus, GZ; Tanriverdi, T; Alver, I; Aydin, S; Uzan, M				Sanus, GZ; Tanriverdi, T; Alver, I; Aydin, S; Uzan, M			Evolving traumatic brain lesions - Predictors and results of ninety-eight head-injured patients	NEUROSURGERY QUARTERLY			English	Article						predictors; progressive hemorrhagic injury; traumatic brain injury	INTRAVASCULAR COAGULATION; COMPUTERIZED-TOMOGRAPHY; INTRACEREBRAL HEMATOMA; HEMORRHAGE; FIBRINOLYSIS; PROGESTERONE; MANAGEMENT; FAILURE; COMA	Progression in intracranial lesion(s) caused by traumatic brain injuries may be determined by a serial computerized tomography (CT) scan in the early period, but its significance is still controversial. In this study, the records of 98 head-injured patients in whom 2 consecutive CT scans were performed within 48 hours of injury were analyzed, and the predictors and clinical significance of progressive hemorrhagic injury (PHI) were determined. From June 1, 1998 through July 13, 2002, a cohort of 98 head-injured patients (65 male and 33 female, mean age of 34.8 years, and median Glasgow Come Scale [GCS] score of 11) was evaluated in this retrospective clinical study. The patients were divided into 2 groups: groups 1 and 2 included 51 and 47 patients without and with PHI, respectively. Progression in traumatic lesion(s) was determined by comparing the initial and repeated CT scans. Logistic regression analysis was used to identify physiologic parameters (P = 0.02), Injury Severity Score (P = 0.01), increased intracranial pressure (P = 0.005), and initial diagnosis (P = 0.01) as the best predictors of PHI. The 6-month postinjury outcome was favorable in group 1. PHI occurs mostly in intracerebral hematomas, which are associated with an increase in ICP. Age, increase in ICP, type of initial lesion(s), ISS, anemia, hypoxia, hyperglycemia, coagulopathy, and timing of the first CT scan relative to injury seem to be predictors of PHI.	Univ Istanbul, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey		Uzan, M (corresponding author), POB 5,Cerrahpasa, TR-34301 Istanbul, Turkey.	tanerato2000@yahoo.com	Uzan, Mustafa/D-6571-2019; Tanriverdi, Taner/C-9003-2019; Sanus, Galip Zihni/D-6715-2019				*ASS ADV AUT MED, 1990, ABBR INJ SCAL 1990 R, P15; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; Firsching R, 1997, NEUROL RES, V19, P257, DOI 10.1080/01616412.1997.11740810; FRENCH BN, 1977, SURG NEUROL, V7, P171; FROWEIN R A, 1989, Neurosurgical Review, V12, P184, DOI 10.1007/BF01790644; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Huttunen P, 1998, ALCOHOL, V15, P315, DOI 10.1016/S0741-8329(97)00136-5; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENNETT B, 1975, LANCET, V1, P480; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; LINDENBAUM J, 1969, NEW ENGL J MED, V281, P228; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MILLER JD, 1987, ACTA NEUROCHIR, V85, P80, DOI 10.1007/BF01456102; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; PONDAAG W, 1978, ADV NEUROSURG, V6, P159; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROSES AD, 1995, NAT MED, V1, P603, DOI 10.1038/nm0795-603; SAWADA Y, 1984, J NEUROL NEUROSUR PS, V47, P1125, DOI 10.1136/jnnp.47.10.1125; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021	36	17	30	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-6438	1534-4916		NEUROSURG QUART	Neurosurg. Q.	JUN	2004	14	2					97	104		10.1097/01.wnq.0000127718.06183.12			8	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	843UZ	WOS:000223113400005					2022-02-06	
J	Vega, RS; Adams, VI				Vega, RS; Adams, VI			Suffocation in motor vehicle crashes	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						accidents; traffic; suffocation; asphyxia; autopsy	ACCIDENTAL STRANGULATION; ASPHYXIA; WINDOW; DEATHS	Because death from suffocation in traffic fatalities has not been well described, we delineated the clinical, circumstantial, and autopsy findings associated with suffocation in a series of motor vehicle crashes. Medical examiner case files from a 5-year period were reviewed. Scene investigation, autopsy, toxicology, and first-responder reports were examined. Crash descriptions were reviewed, including vehicle type, mechanism of crash, response time, restraint use, occupant ejection, and victim position in cabins of vehicles. Mechanisms of suffocation, including torso compression, inversion, neck flexion, facial occlusion, and blood aspiration, were determined for each case. The files were searched for factors relevant to the diagnosis of suffocation, namely, cerebral concussion, alcohol intoxication, obesity, petechiae, lung weights as a proxy for livor, natural disease, and impact wounds. Twenty-nine traffic fatality cases were identified in which suffocation caused death. In 26, suffocation mechanisms were solely responsible for death. In 3, death was caused by suffocation in combination with other mechanisms. Twenty-five subjects were occupants of vehicles with cabins and 4 were motorcycle riders. The most common mechanism of suffocation was torso compression. Most subjects had either multiple mechanisms of suffocation or a single mechanism acting in concert with concussion or alcohol intoxication. Concussion and intoxication were common, with one or both present in 20 subjects, including all of those with blood aspiration. Petechiae were frequent but were found consistently only among those with inversion. Cutaneous c est petechiae were associated with inversion and torso compression. Lung weights were highest among those with blood aspiration and lowest among those with inversion. Body mass index was highest among those with inversion, suggesting that obesity could be a risk factor for this mechanism.	Univ S Florida, Dept Pathol, Tampa, FL USA		Vega, RS (corresponding author), James A Haley VA Hosp, Pathol & Lab Med Serv, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	russell.vega@med.va.gov					Aggarwal NK, 1998, MED SCI LAW, V38, P263, DOI 10.1177/002580249803800315; BELL MD, 1992, AM J FOREN MED PATH, V13, P101, DOI 10.1097/00000433-199206000-00004; CALVET R, 1992, J FORENSIC SCI, V37, P1697; DURSO S, 1995, AM J FOREN MED PATH, V16, P352, DOI 10.1097/00000433-199512000-00012; FLIER JS, 2001, HARRISONS PRINCIPLES, P479; FLOBECKER P, 1993, AM J FOREN MED PATH, V14, P74; HABAL MB, 1972, JAMA-J AM MED ASSOC, V22, P1269; Hossack D W, 1972, Med J Aust, V2, P193; KHOLI A, 1996, FORENSIC SCI INT, V78, P7; KOHR RM, 1992, J FORENSIC SCI, V37, P1693; MOORE L, 1993, AM J FOREN MED PATH, V14, P296, DOI 10.1097/00000433-199312000-00005; REAY DT, 1992, AM J FOREN MED PATH, V13, P90, DOI 10.1097/00000433-199206000-00002; SEVITT S, 1968, BRIT J SURG, V55, P481, DOI 10.1002/bjs.1800550702; SIMMONS GT, 1992, AM J FOREN MED PATH, V13, P112, DOI 10.1097/00000433-199206000-00006; SKLAR DP, 1988, AM J EMERG MED, V6, P219; SPITZ WU, 1993, MEDICOLEGAL INVESTIG, P529; Strauss RH, 1997, PEDIATR EMERG CARE, V13, P345, DOI 10.1097/00006565-199710000-00013; TAFF ML, 1991, AM J FOREN MED PATH, V12, P359, DOI 10.1097/00000433-199112000-00058	18	17	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	JUN	2004	25	2					101	107		10.1097/01.paf.0000114136.84700.f5			7	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	824IW	WOS:000221681000002	15166758				2022-02-06	
J	Tombaugh, TN; Rees, L; Baird, B; Kost, J				Tombaugh, TN; Rees, L; Baird, B; Kost, J			The effects of list difficulty and modality of presentation on a computerized version of the Paced Serial Addition Test (PSAT)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							PROCESSING SPEED DEFICITS; MINOR HEAD-INJURY; MULTIPLE-SCLEROSIS; PASAT; RECOVERY; VALIDITY; TASK	The Paced Serial Addition Test (PSAT) presents a series of digits at different speeds with the requirement that the two most recent numbers be added together. Although the PSAT is a relatively difficult test, its level of difficulty may be decreased by changing the number list to make the answers simpler and by presenting the digits visually rather than aurally. In view of this, the present experiment varied both task difficulty (easy vs. hard) and mode of presentation (visual vs. auditory). Task difficulty was manipulated by using two different lists composed of single digits whose answers ranged between 2 and 10 (easy) or 2 and 18 (hard). All stimuli were presented by computer which permitted measurement of response latencies, as well as correctness of responding. The results showed that mode of presentation, but not task difficulty, produced highly significant effects. Additional evidence showed that the ability to compute answers to simple addition problems must be considered as a modulator variable. However, an individual's basic arithmetic ability is not as critical as the modality in which a stimulus is presented. The lower performance associated with the auditory version (i.e., PASAT) was interpreted as an interference effect caused by both the stimulus and the response occurring in a single auditory information processing channel. This interpretation suggests that the PASAT's well documented sensitivity to traumatic brain injury (TBI) may be due, at least in part, to an increased susceptibility to interference effects rather than attributable solely to a decreased rate of information processing.	Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada; Ottawa Concuss Clin, Ottawa, ON, Canada; Rehabil Ctr, Ottawa, ON, Canada		Tombaugh, TN (corresponding author), Carleton Univ, Dept Psychol, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada.	tom_tombaugh@carleton.ca					BATEMAN GD, 1997, DISS ABSTR INT, V57, P5315; Chronicle EP, 1998, NEUROPSYCHOL REHABIL, V8, P273; Crawford JR, 1998, NEUROPSYCHOL REHABIL, V8, P255, DOI 10.1080/713755575; DEARY IJ, 1991, PERS INDIV DIFFER, V12, P983, DOI 10.1016/0191-8869(91)90027-9; Diamond BJ, 1997, J CLIN EXP NEUROPSYC, V19, P34, DOI 10.1080/01688639708403834; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; EGAN V, 1988, PERS INDIV DIFFER, V9, P179, DOI 10.1016/0191-8869(88)90046-3; FEINSTEIN A, 1994, J CLIN EXP NEUROPSYC, V16, P436, DOI 10.1080/01688639408402654; Fos L A, 2000, Appl Neuropsychol, V7, P140, DOI 10.1207/S15324826AN0703_4; French J. W., 1963, KIT REFERENCE TESTS; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL D, 1998, COMMUNICATION; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hiscock M, 1998, J CLIN EXP NEUROPSYC, V20, P463, DOI 10.1076/jcen.20.4.463.1466; JOHNSON DA, 1988, J CHILD PSYCHOL PSYC, V29, P199, DOI 10.1111/j.1469-7610.1988.tb00704.x; Kewman D G, 1988, Brain Inj, V2, P131, DOI 10.3109/02699058809150937; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; SAMPSON H, 1960, AUST J PSYCHOL, V12, P70, DOI 10.1080/00049536008255188; SAMPSON H, 1958, CAN J PSYCHOLOGY, V12, P179, DOI 10.1037/h0083750; Sherman EMS, 1997, CLIN NEUROPSYCHOL, V11, P34, DOI 10.1080/13854049708407027; SNYDER PJ, 1993, J CLIN EXP NEUROPSYC, V15, P18; Snyder PJ, 2001, BRAIN COGNITION, V46, P279, DOI 10.1016/S0278-2626(01)80084-1; Snyder PJ, 2001, NEUROPSYCHOLOGY, V15, P617, DOI 10.1037//0894-4105.15.4.617; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; VANZOMERAN AH, 1994, CLIN NEUROPSYCHOLOGY; VANZOMERAN AH, 1987, NEUROBEHAVIORAL RECO; WEBER MA, 1986, THESIS U VICTORIA BR	30	17	17	0	4	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	2004	26	2					257	265		10.1076/jcen.26.2.257.28080			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	810QW	WOS:000220719800011	15202545				2022-02-06	
J	Tsai, YJ; Leong, SM; Day, AS; Wen, CY; Shieh, JY; Lue, JH				Tsai, YJ; Leong, SM; Day, AS; Wen, CY; Shieh, JY; Lue, JH			A time course analysis of the changes in neuropeptide Y immunoreactivity in the rat cuneate nucleus following median nerve transection	NEUROSCIENCE RESEARCH			English	Article						calcitonin gene-related peptide; galanin; median nerve transection injury; neuropeptide Y; substance P; vasoactive intestinal peptide	C-FOS EXPRESSION; CHRONIC CONSTRICTION INJURY; PRIMARY SENSORY NEURONS; SPINAL-CORD NEURONS; SCIATIC-NERVE; GRACILE NUCLEUS; DORSAL-HORN; ELECTRICAL-STIMULATION; TRANSSYNAPTIC DEGENERATION; TRANSGANGLIONIC TRANSPORT	Using median nerve injury and immunocytochemical methods, we examined the temporal changes in neuropeptide Y (NPY) expression in the cuneate nucleus (CN) in rats following median nerve transection. Under normal circumstances, neuropeptide Y-immunoreactive (NPY-IR) fibers was not detectable in the CN. A few NPY-IR fibers were observed in the ipsilateral CN 5 days after the median nerve transection, and peaked at 4 weeks. Thereafter, they were gradually returned to nearly control level after 16 weeks. Quantitative evaluation showed that the mean percentage of area occupied by NPY-IR fibers in entire and three subregions of the CN at 4 weeks were significantly higher than that at other post-operated time points, respectively. The present ultrastructural observations in the middle region of CN showed that the significantly increased NPY immunoreactivity was confined only in the myelinated axons and terminals but not detected in the dendrites, somata, and glial cells. The NPY-IR terminals made axodendritic synaptic contacts with unlabeled elements. The present results indicate that the time course of the increase of NPY immunoreactivity is similar to c-Fos expression as described in a previous study [J. Neurotrauma 19 (2002) 897]. It is speculated that the increased NPY in the CN after axotomy may affect the excitability of postsynaptic cuneate neurons, however, the functional interaction between NPY and c-Fos-IR neurons needs to be further studied. (C) 2003 Elsevier Ireland Ltd and The Japan Neuroscience Society. All rights reserved.	Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, 1-1,Jen Ai Rd, Taipei 10018, Taiwan; Kiang Wu Nursing, Coll Med, Macau, Peoples R China; Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan		Lue, JH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, 1-1,Jen Ai Rd, Taipei 10018, Taiwan.	thomas@ha.mc.ntu.edu.tw		LUE, JUNE-HORNG/0000-0002-1087-1382			Abdulla FA, 1999, NEUROSCIENCE, V89, P43, DOI 10.1016/S0306-4522(98)00443-6; ANDERSEN P, 1963, NATURE, V199, P655, DOI 10.1038/199655a0; CODERRE TJ, 1986, PAIN, V26, P61, DOI 10.1016/0304-3959(86)90174-0; Day AS, 2001, BRAIN RES, V895, P194, DOI 10.1016/S0006-8993(01)02095-9; DEVOR M, 1978, NATURE, V276, P75, DOI 10.1038/276075a0; HOEFLINGER BF, 1993, J COMP NEUROL, V332, P378, DOI 10.1002/cne.903320309; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; Lue JH, 2000, SYNAPSE, V37, P222, DOI 10.1002/1098-2396(20000901)37:3<222::AID-SYN6>3.3.CO;2-2; Lue JH, 2002, J NEUROTRAUM, V19, P897, DOI 10.1089/08977150260190483; Ma W, 1999, NEUROSCIENCE, V93, P335, DOI 10.1016/S0306-4522(99)00145-1; Ma W, 1998, NEUROSCIENCE, V86, P1217, DOI 10.1016/S0306-4522(98)00068-2; Ma W, 1997, NEUROSCIENCE, V79, P1183, DOI 10.1016/S0306-4522(97)00088-2; Ma WY, 2000, J NEUROSCI RES, V60, P520, DOI 10.1002/(SICI)1097-4547(20000515)60:4<520::AID-JNR11>3.3.CO;2-4; MASLANY S, 1992, NEUROSCI LETT, V139, P130, DOI 10.1016/0304-3940(92)90874-7; Miki K, 1998, NEUROSCIENCE, V82, P1243; MOLANDER C, 1994, BRAIN RES, V644, P74, DOI 10.1016/0006-8993(94)90349-2; MOLANDER C, 1992, NEUROSCIENCE, V50, P223, DOI 10.1016/0306-4522(92)90394-H; NOGUCHI K, 1995, J NEUROSCI, V15, P7633; NYBERG G, 1982, BRAIN RES, V248, P209, DOI 10.1016/0006-8993(82)90579-0; OHARA S, 1994, J NEUROPATH EXP NEUR, V53, P646, DOI 10.1097/00005072-199411000-00012; PERSSON JKE, 1995, EXP BRAIN RES, V105, P331; PERSSON JKE, 1993, SOMATOSENS MOT RES, V10, P475, DOI 10.3109/08990229309028852; Shortland P, 1998, BRAIN RES, V810, P288, DOI 10.1016/S0006-8993(98)00940-8; SUGIMOTO T, 1986, PAIN, V27, P91, DOI 10.1016/0304-3959(86)90226-5; SUGIMOTO T, 1990, PAIN, V42, P205, DOI 10.1016/0304-3959(90)91164-E; TAMATANI M, 1989, BRAIN RES, V495, P122, DOI 10.1016/0006-8993(89)91225-0; TRACEY DJ, 1995, BRAIN RES, V669, P245, DOI 10.1016/0006-8993(94)01265-J; UCHIZONO K, 1965, NATURE, V207, P642, DOI 10.1038/207642a0; XU XJ, 1994, NEUROSCIENCE, V63, P817, DOI 10.1016/0306-4522(94)90526-6; YANG SN, 1995, NEUROREPORT, V6, P384, DOI 10.1097/00001756-199501000-00038; ZHANG X, 1993, EUR J NEUROSCI, V5, P1510, DOI 10.1111/j.1460-9568.1993.tb00219.x	32	17	17	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2004	48	4					369	377		10.1016/j.neures.2003.12.003			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808OW	WOS:000220579400003	15041190				2022-02-06	
J	Burger, R; Bendszus, M; Vince, GH; Solymosi, L; Roosen, K				Burger, R; Bendszus, M; Vince, GH; Solymosi, L; Roosen, K			Neurophysiological monitoring, magnetic resonance imaging, and histological assays confirm the beneficial effects of moderate hypothermia after epidural focal mass lesion development in rodents	NEUROSURGERY			English	Article						hypothermia; ischemia-reperfusion; magnetic resonance imaging; mass lesion; neuromonitoring; trauma	CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; MILD INTRAISCHEMIC HYPOTHERMIA; LASER-DOPPLER FLOWMETRY; FOREBRAIN ISCHEMIA; ARTERY OCCLUSION; TISSUE OXYGEN; POSTTRAUMATIC HYPOTHERMIA; REPRODUCIBLE MODEL; BARRIER DISRUPTION	OBJECTIVE: To assess the effects of moderate intraischemic hypothermia on neurophysiological parameters in an epidural balloon compression model in rats and to correlate the results with magnetic resonance imaging and histological findings. METHODS: Neurophysiological monitoring included laser Doppler flow, tissue partial oxygen pressure, and intracranial pressure measurements and electroencephalographic assessments during balloon expansion, sustained inflation, and reperfusion. Moderate intraischemic cooling of animals was extended throughout the reperfusion period, and results were compared with those for normothermic animals. Moreover, histological morphometric and magnetic resonance imaging volumetric analyses of the lesions were performed. RESULTS: Laser Doppler flow decreased slightly during ischemia (P < 0.05) in animals treated with hypothermia, and flow values demonstrated complete reperfusion, compared with incomplete flow restoration in untreated animals (P < 0.05). During ischemia, the tissue partial oxygen pressure was less than 4.3 mm Hg in both groups. After reperfusion, values returned to the normal range in both groups, but the tissue partial oxygen pressure in hypothermic animals was significantly higher (P = 0.042) and demonstrated 19% higher values, compared with normothermic animals, before rewarming. Moderate hypothermia attenuated a secondary increase in intracranial pressure (P < 0.05), and electroencephalographic findings indicated a trend toward faster recovery (P > 0.05) after reperfusion. Lesion size was reduced by 35% in magnetic resonance imaging volumetric evaluations and by 24.5% in histological morphometric analyses. CONCLUSION: Intraischemic hypothermia improves cerebral microcirculation, attenuates a secondary increase in intracranial pressure, facilitates electroencephalographic recovery, and reduces the lesion size.	Univ Regensburg, Dept Neurosurg, D-93053 Regensburg, Germany; Univ Wurzburg, Dept Neuroradiol, D-97070 Wurzburg, Germany; Univ Wurzburg, Dept Neurosurg, D-97070 Wurzburg, Germany		Burger, R (corresponding author), Univ Regensburg, Dept Neurosurg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	RBurger@t-online.de	Solymosi, Laszlo/E-6449-2018	Solymosi, Laszlo/0000-0001-9647-8647; Vince, Giles/0000-0002-0222-8733			ASTRUP J, 1981, ANESTHESIOLOGY, V55, P263, DOI 10.1097/00000542-198109000-00013; BAKER CJ, 1992, J NEUROSURG, V77, P438, DOI 10.3171/jns.1992.77.3.0438; BAKER CJ, 1995, NEUROSURGERY, V36, P994, DOI 10.1227/00006123-199505000-00016; BALDWIN WA, 1991, AM J PHYSIOL, V261, pH774, DOI 10.1152/ajpheart.1991.261.3.H774; Bendszus M, 2002, J NEUROSURG, V97, P1419, DOI 10.3171/jns.2002.97.6.1419; BENVENISTE H, 1991, STROKE, V22, P259, DOI 10.1161/01.STR.22.2.259; BONNER R, 1981, APPL OPTICS, V20, P2097, DOI 10.1364/AO.20.002097; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Burger R, 2003, J NEUROTRAUM, V20, P543, DOI 10.1089/089771503767168474; Burger R, 2002, J NEUROSURG, V97, P1410, DOI 10.3171/jns.2002.97.6.1410; Burger R, 1999, J NEUROTRAUM, V16, P1149, DOI 10.1089/neu.1999.16.1149; BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHOPP M, 1989, J CEREBR BLOOD F MET, V9, P141, DOI 10.1038/jcbfm.1989.21; CHOPP M, 1991, STROKE, V22, P37, DOI 10.1161/01.STR.22.1.37; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Colbourne F, 1999, J CEREBR BLOOD F MET, V19, P742, DOI 10.1097/00004647-199907000-00003; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; Ebmeyer U, 1998, J NEUROTRAUM, V15, P323, DOI 10.1089/neu.1998.15.323; EYRE JA, 1988, CLIN PHYS PHYSIOL M, V9, P65, DOI 10.1088/0143-0815/9/1/006; FITCH W, 1977, J NEUROL NEUROSUR PS, V40, P843, DOI 10.1136/jnnp.40.9.843; GOTO Y, 1993, NEUROSURGERY, V32, P980, DOI 10.1227/00006123-199306000-00017; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247, DOI 10.1152/ajpheart.1989.256.4.H1247; Herguido MJ, 1999, NEUROSCIENCE, V93, P71, DOI 10.1016/S0306-4522(99)00163-3; Hoffman WE, 1996, NEUROL RES, V18, P185; JAKOBSSON A, 1993, MED BIOL ENG COMPUT, V31, P301, DOI 10.1007/BF02458050; JAKOBSSON K E, 1990, Neurological Research, V12, P153; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; KARIBE H, 1995, J NEUROSURG, V83, P93, DOI 10.3171/jns.1995.83.1.0093; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; KUROIWA T, 1990, J CEREB BLOOD FLOW M, V10, P365; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; LO EH, 1992, STROKE, V23, P889, DOI 10.1161/01.STR.23.6.889; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Markarian GZ, 1996, NEUROSURGERY, V38, P542; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MELLERGARD P, 1991, NEUROSURGERY, V28, P709, DOI 10.1227/00006123-199105000-00012; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; MIYAZAWA T, 1993, ACTA NEUROPATHOL, V85, P488; MORIKAWA E, 1992, J CEREBR BLOOD F MET, V12, P380, DOI 10.1038/jcbfm.1992.55; Nagai S, 1999, NEUROL RES, V21, P204, DOI 10.1080/01616412.1999.11740919; Nakamura T, 1999, J NEUROSURG, V91, P114, DOI 10.3171/jns.1999.91.1.0114; PALMER C, 1989, ANESTHESIOLOGY, V71, P730, DOI 10.1097/00000542-198911000-00017; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SKARPHEDINSSON JO, 1988, ACTA PHYSIOL SCAND, V134, P133, DOI 10.1111/j.1748-1716.1988.tb08469.x; Toyoda T, 1996, NEUROSURGERY, V39, P1200, DOI 10.1097/00006123-199612000-00024; Uranishi R, 1999, J VASC RES, V36, P100, DOI 10.1159/000025631; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; WEINSTEI.JD, 1968, J NEUROSURG, V28, P513, DOI 10.3171/jns.1968.28.6.0513; WELSH FA, 1991, J CEREBR BLOOD F MET, V11, P617, DOI 10.1038/jcbfm.1991.112; WIDMANN R, 1993, J NEUROCHEM, V61, P200, DOI 10.1111/j.1471-4159.1993.tb03556.x; XU BN, 1993, NEUROSURGERY, V32, P289, DOI 10.1227/00006123-199302000-00019; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	72	17	18	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2004	54	3					701	711		10.1227/01.NEU.0000108784.80585.EE			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	802FN	WOS:000220149500051	15028147				2022-02-06	
J	Keenan, MAE; Mehta, S				Keenan, MAE; Mehta, S			Neuro-orthopedic management of shoulder deformity and dysfunction in brain-injured patients - A novel approach	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adhesive capsulitis; brain injury; heterotopic ossification; inferior shoulder subluxation; shoulder contracture; shoulder surgery; spasticity; spastic shoulder	HETEROTOPIC OSSIFICATION; ADULTS; STROKE; PAIN; SPASTICITY; HEMIPLEGIA	Shoulder problems are common in patients with traumatic brain injury. Very little has been written about the evaluation and neuro-orthopedic management of these problems. This is largely because there have not been surgical treatments available other than release of contracted, nonfunctional shoulders. Shoulder problems can be classified and evaluated using several different strategies: bony versus soft tissue restrictions; static versus dynamic deformities; traumatic injuries versus impairments secondary to weakness and spasticity; or problems of active function versus problems of passive function. Regardless of the classification system employed a systematic approach to evaluation and treatment is essential. Shoulder impairments can be corrected leading to significant improvement in functional outcomes. In this paper we report on the novel evaluation and surgical management options developed in our program for the most common shoulder problems encountered in patients with traumatic brain injury.	Univ Penn, Dept Orthopaed Surg, Neuoorthopaed Program, Philadelphia, PA 19104 USA		Keenan, MAE (corresponding author), Univ Penn, Dept Orthopaed Surg, Neuoorthopaed Program, 3400 Spruce St,2 Silverstein, Philadelphia, PA 19104 USA.	maryann.keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				Aldwell C B, 1969, Clin Orthop Relat Res, V63, P69; Bhakta BB, 1996, J NEUROL NEUROSUR PS, V61, P30, DOI 10.1136/jnnp.61.1.30; BRAUN RM, 1971, J BONE JOINT SURG AM, VA 53, P1307, DOI 10.2106/00004623-197153070-00006; Braun RM, 1999, CLIN ORTHOP RELAT R, P54; Fuller DA, 2002, FOOT ANKLE INT, V23, P738, DOI 10.1177/107110070202300810; GARLAND DE, 1978, CLIN ORTHOP RELAT R, P111; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; GARLAND DE, 1981, CLIN ORTHOP RELAT R, V155, P162; Ikai T, 1998, AM J PHYS MED REHAB, V77, P421, DOI 10.1097/00002060-199809000-00012; Keenan MA, 2003, ARCH PHYS MED REHAB, V84, P291, DOI 10.1053/apmr.2003.50099; Kolessar DJ, 1996, J HEAD TRAUMA REHAB, V11, P78, DOI 10.1097/00001199-199608000-00010; MCDAID P, 2001, CHAPMANS ORTHOPAEDIC, P1809; OGILVIEHARRIS DJ, 1995, CLIN ORTHOP RELAT R, P238; Turner-Stokes L, 2002, CLIN REHABIL, V16, P276, DOI 10.1191/0269215502cr491oa; Vuagnat H, 2003, J REHABIL MED, V35, P49, DOI 10.1080/16501970306111	16	17	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2004	19	2					143	154		10.1097/00001199-200403000-00006			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	809NR	WOS:000220643900006	15247824				2022-02-06	
J	Mayer, NH				Mayer, NH			Choosing upper limb muscles for focal intervention after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						arms; chemodenervation; dynamic EMG; upper motoneuron	UPPER MOTONEURON DYSFUNCTION; BOTULINUM TOXIN; SPASTICITY; ELBOW; PATIENT; REFLEX	The upper motoneuron syndrome (UMNS) resulting from lesions of corticospinal pathways is an important source of disability after traumatic brain injury (TBI). Classic expressions of motor behavior in UMNS are of 2 kinds: (1) manifestation of muscle underactivity, termed negative signs, and (2) manifestation of a variety of forms of muscle overactivity, termed positive signs. Combinations of negative and positive signs give rise to clinical patterns of movement dysfunction such as the flexed elbow, the clenched fist, and the thumb-in-palm deformity. These clinical patterns can be viewed as reflecting a net balance of muscle forces acting across the joints of a limb. Individual muscles are amenable to a variety of focal interventions such as neurolysis, chemodenervation, or surgery. Since more than one muscle acts across most joints, choices among muscles for focal intervention are many. This article will focus on focal interventions of upper limb muscles of patients with TBI who have UMNS and will explore the theme of choosing upper limb muscles for focal interventions after TBI.	Drucker Brain Injury Ctr, Philadelphia, PA 19141 USA; Temple Univ, Hlth Sci Ctr, Dept Phys Med & Rehabil, Philadelphia, PA 19141 USA; Albert Einstein Healthcare Network, Motor Control Anal Lab, Jefferson Hlth Syst, Philadelphia, PA 19141 USA		Mayer, NH (corresponding author), Drucker Brain Injury Ctr, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.	nmayer@einstein.edu					Ada L, 1996, HUM MOVEMENT SCI, V15, P671, DOI 10.1016/0167-9457(96)00015-2; BODINEFOWLER SC, 1992, ORTHOPAEDIC REHABILI; Damiano Diane L., 1993, Physical and Occupational Therapy in Pediatrics, V12, P3, DOI 10.1080/J006v12n04_02; DELWAIDE PJ, 1987, MOTOR DISTURBANCES, V1; DIETZ V, 1991, ANN NEUROL, V30, P767, DOI 10.1002/ana.410300605; FELLOWS SJ, 1994, ELECTROEN CLIN NEURO, V93, P106, DOI 10.1016/0168-5597(94)90073-6; Francisco GE, 2002, AM J PHYS MED REHAB, V81, P355, DOI 10.1097/00002060-200205000-00007; Gracies JM, 1997, ANN NEUROL, V42, pT183; HERMAN R, 1970, BRAIN, V93, P273, DOI 10.1093/brain/93.2.273; HUMPHREY DR, 1983, MOTOR CONTROL MECH H; Keenan MA, 1996, J HEAD TRAUMA REHAB, V11, P57, DOI 10.1097/00001199-199608000-00008; Keenan MA, 2003, ARCH PHYS MED REHAB, V84, P291, DOI 10.1053/apmr.2003.50099; Keenan MA, 1999, NEUROREHABILITATION, V12, P119; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P607, DOI 10.1016/S0363-5023(09)90023-5; Mayer NH, 1996, J HEAD TRAUMA REHAB, V11, P37, DOI 10.1097/00001199-199608000-00007; Mayer NH, 1997, MUSCLE NERVE, pS21; Mayer NH, 1997, MUSCLE NERVE, pS1; MAYER NH, 1996, MED REHABILITATION T; MEALS RA, 1988, J BONE JOINT SURG AM, V70A, P1081, DOI 10.2106/00004623-198870070-00017; Okuma Y, 1996, CAN J NEUROL SCI, V23, P15, DOI 10.1017/S0317167100039135; Pierson SH, 1996, ARCH PHYS MED REHAB, V77, P717, DOI 10.1016/S0003-9993(96)90015-5; [No title captured]	22	17	17	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2004	19	2					119	142		10.1097/00001199-200403000-00005			24	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	809NR	WOS:000220643900005	15247823				2022-02-06	
J	Zuckerbraun, BS; Morrison, K; Gaines, B; Ford, HR; Hackam, DJ				Zuckerbraun, BS; Morrison, K; Gaines, B; Ford, HR; Hackam, DJ			Effect of age on cervical spine injuries in children after motor vehicle collisions: Effectiveness of restraint devices	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	34th Annual Meeting of the American-Pediatric-Surgical-Association	MAY 25-30, 2003	Ft Lauderdale, FL	Amer Pediat Surg Assoc		cervical spine; trauma; motor vehicle crash; car safety seats; child restraint devices		Purpose: Despite the devastating consequences of cervical spine (C-spine) injury in children after motor vehicle collisions (MVC), the factors leading to the injury and the appropriateness of protective restraints remain undefined. The authors hypothesized that age-related anatomic factors contribute to inadequate restraints and therefore increase injury severity after MVC. Methods: Data on children (<18 years, 1997 to 2002) admitted to a level 1 pediatric trauma center were prospectively collected and retrospectively reviewed. Those with C-spine injuries caused by MVC were extracted and divided into 2 groups: young (0 to 8 years) and old (9 to 18 years). Statistical comparison was by Student's t test or Z-test, with P less than .05 accepted as significant. Results: Of 5,117 trauma admissions, 94 had C-spine injuries with a mean age of 11 +/- 5 years, 66% of which were boys. Among 1,124 patients who had sustained MVC there were 27 C-spine injuries (2.4% incidence), of which, 12 were less than 8 and 15 were older than 8 years. Restraint devices were utilized at least as frequently in younger children (young, 58% v. old, 43%; not significant). However, younger children had an increased incidence of permanent cord deficit (young, 57% v. old, 13%; P < .05) and closed head injury (young, 50% v. old, 7%; P < .05) even while wearing restraint devices, suggesting that restraint devices are inadequate or improperly used in younger patients. This is supported by the increased injury severity scores of the younger group (young, 37.7 +/- 8.5 v. old, 16.5 +/- 4.6; P < .05). Conclusions: Younger children suffer more sever cervical spine injuries after motor vehicle collisions than their older counterparts, in part because of the inadequacy of currently existing restraint devices. Design modifications to current restraints, including the use of head straps, might improve outcome after MVC in younger patients.	Childrens Hosp Pittsburgh, Dept Surg, Div Pediat Surg, Pittsburgh, PA 15213 USA		Hackam, DJ (corresponding author), Childrens Hosp Pittsburgh, Dept Surg, Div Pediat Surg, 4A 486 Desoto,3705 5th Ave, Pittsburgh, PA 15213 USA.			Hackam, David/0000-0001-5195-8807			Baker C, 1999, AM J EMERG MED, V17, P230, DOI 10.1016/S0735-6757(99)90111-0; BOHN D, 1990, J TRAUMA, V30, P463, DOI 10.1097/00005373-199030040-00017; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Bull MJ, 2002, PEDIATRICS, V109, P550; Durbin DR, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.6.e109; Eleraky MA, 2000, J NEUROSURG, V92, P12, DOI 10.3171/spi.2000.92.1.0012; Givens TG, 1996, J TRAUMA, V41, P310, DOI 10.1097/00005373-199608000-00019; HILL SA, 1984, J NEUROSURG, V60, P700, DOI 10.3171/jns.1984.60.4.0700; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; ORENSTEIN JB, 1994, PEDIATR EMERG CARE, V10, P132, DOI 10.1097/00006565-199406000-00003; Patel JC, 2001, J PEDIATR SURG, V36, P373, DOI 10.1053/jpsu.2001.20720; RUGE JR, 1988, J NEUROSURG, V68, P25, DOI 10.3171/jns.1988.68.1.0025; Winston F K, 2000, LDI Issue Brief, V5, P1	13	17	17	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAR	2004	39	3					483	486		10.1016/j.jpedsurg.2003.11.046			4	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics; Surgery	807ZN	WOS:000220539500073	15017574				2022-02-06	
J	Federman, DG; Kravetz, JD; Ruser, CB; Judson, PH; Kirsner, RS				Federman, DG; Kravetz, JD; Ruser, CB; Judson, PH; Kirsner, RS			Vogt-Koyanagi-Harada syndrome and ulcerative colitis	SOUTHERN MEDICAL JOURNAL			English	Article						brain injury; ulcerative colitis; Vogt-Koyanagi-Harada syndrome	HODGKINS-DISEASE; ASSOCIATION	The Vogt-Koyanagi-Harada (VKH) syndrome is an uncommon disorder characterized by uveitis and neurologic and cutaneous abnormalities, including tinnitus, vertigo, headache, meningoencephalitis, vitiligo, alopecia, and poliosis. The VKH syndrome has been reported to occur in association with other autoimmune disorders. We report a case of a patient with severe ulcerative colitis who developed VKH syndrome. We postulate that the patient's history of a traumatic brain injury might have been responsible for an abnormal "immunologic milieu" and the occurrence of ulcerative colitis, VKH syndrome, and severe reactive arthritis.	VA Connecticut HCS, West Haven, CT 06516 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Retina Consultants PC, Hartford, CT USA; Univ Miami, Sch Med, Dept Dermatol, Miami, FL 33152 USA		Federman, DG (corresponding author), VA Connecticut HCS, 11ACSL,950 Campbell Ave, West Haven, CT 06516 USA.	daniel.federman@med.va.gov					BENIZ J, 1991, RETINA-J RET VIT DIS, V11, P275, DOI 10.1097/00006982-199111030-00001; Chi Hyung-In, 1994, Journal of Dermatology (Tokyo), V21, P683; CHUAH SY, 1991, POSTGRAD MED J, V67, P476, DOI 10.1136/pgmj.67.787.476; CIPRIANI D, 1989, J NEUROL, V236, P303, DOI 10.1007/BF00314462; HAMMER H, 1974, BRIT J OPHTHALMOL, V58, P773, DOI 10.1136/bjo.58.9.773; Hettler D L, 1992, J Am Optom Assoc, V63, P90; IVERSEN TH, 1986, ACTA OPHTHALMOL, V64, P235; JAGGARAO N, 1989, POSTGRAD MED J, V65, P587, DOI 10.1136/pgmj.65.766.587; Jovic NS, 1996, POSTGRAD MED J, V72, P495, DOI 10.1136/pgmj.72.850.495; Lisianyi M I, 1997, Fiziol Zh, V43, P3; MAEZAWA N, 1982, OPHTHALMOLOGICA, V185, P179, DOI 10.1159/000309240; Matsuda H, 1970, Nippon Ganka Gakkai Zasshi, V74, P1107; MOORTHY RS, 1995, SURV OPHTHALMOL, V39, P265, DOI 10.1016/S0039-6257(05)80105-5; ORMANTAEV KS, 1998, ZH VOPR NEIROKHIR IM, V4, P27; Rathinam SR, 1999, OPHTHALMOLOGY, V106, P635, DOI 10.1016/S0161-6420(99)90129-X; Read R W, 2000, Curr Opin Ophthalmol, V11, P437, DOI 10.1097/00055735-200012000-00009; Wong SS, 1999, DERMATOLOGY, V198, P65, DOI 10.1159/000018067	17	17	18	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0038-4348			SOUTH MED J	South.Med.J.	FEB	2004	97	2					169	171		10.1097/01.SMJ.0000100263.99708.10			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831CY	WOS:000222171700014	14982267				2022-02-06	
J	Diaz-Arrastia, R; Gong, YH; Kelly, CJ; Gelman, BB				Diaz-Arrastia, R; Gong, YH; Kelly, CJ; Gelman, BB			Host genetic polymorphisms in human immunodeficiency virus-related neurologic disease	JOURNAL OF NEUROVIROLOGY			English	Article; Proceedings Paper	Joint Symposium on Viral and Host Genetic Factors Regulating HIV/CNS Disease	NOV 20-22, 2002	WASHINGTON, DC	Natl Inst Mental Hlth, Natl Inst Neurol Disorders & Stroke		apolipoprotein E; interleukin-1; tumor necrosis factor	INTERLEUKIN-1 RECEPTOR ANTAGONIST; HIV-ASSOCIATED DEMENTIA; TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; PROMOTER REGION; ALPHA PROMOTER; ALLELE; GENOTYPE; AIDS	The objective of this study was to determine whether host genetic polymorphisms influence the risk of developing human immunodeficiency virus (HIV) encephalitis and vacuolar myelopathy. Allelic association studies were carried out with common polymorphisms in candidate genes that are postulated to play a role in the pathogenesis of HIV-related neurologic complications. The authors studied brains and spinal cords from 270 patients who died of acquired immunodeficiency syndrome (AIDS) from 1989 to 1996. All had complete gross and microscopic pathologic evaluations, and the presence of microglial nodules, multinucleated giant cells, myelin pallor, and vacuolar myelopathy was assessed by an experienced neuropathologist who was blinded to the genotype. DNA was extracted from frozen brain samples, and determination of the presence of the APOE4, TNF-2, IL-1B*2, ILIRN*2 polymorphisms was determined by polymerase chain reaction (PCR) and restricted fragment length polymorphism (RFLP) mapping. The authors did not detect a consistent association between inheritance of candidate polymorphic alleles and the pathologic findings of HIV encephalitis or vacuolar myelopathy. Allelic association studies with candidate genes are powerful techniques that have the potential to contribute to understanding the pathophysiology of HIV-related neurodegeneration. This preliminary study, although including a substantial number of patients, was not sufficiently powered to exclude a modest but clinically significant effects. Future studies will require much larger sample sizes and technical advances to allow screening at larger number of candidate loci.	Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA; Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77550 USA		Diaz-Arrastia, R (corresponding author), Univ Texas, SW Med Ctr, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Ramon.Diaz-Arrastia@UTSouthwestern.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U01 AI46373] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG17861] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R24 MH59656, R03 MH64889] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R24 NS45491] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03MH064889, R24MH059656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R24NS045491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG017861] Funding Source: NIH RePORTER		BIOQUE G, 1995, CLIN EXP IMMUNOL, V102, P379; BLAKEMORE AIF, 1994, ARTHRITIS RHEUM, V37, P1380, DOI 10.1002/art.1780370917; Chapman J, 1996, NEUROLOGY, V46, P1484, DOI 10.1212/WNL.46.5.1484-a; Chapman J, 2001, NEUROLOGY, V56, P312, DOI 10.1212/WNL.56.3.312; Cherner M, 2002, NEUROLOGY, V59, P1563, DOI 10.1212/01.WNL.0000034175.11956.79; Childs EA, 1999, NEUROLOGY, V52, P607, DOI 10.1212/WNL.52.3.607; Corder EH, 1998, NAT MED, V4, P1182, DOI 10.1038/2677; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRUCIUS JBA, 1995, LANCET, V346, P979; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; delaConcha EG, 1997, J NEUROIMMUNOL, V80, P172, DOI 10.1016/S0165-5728(97)00153-7; Dunlop O, 1997, ACTA NEUROL SCAND, V95, P315, DOI 10.1111/j.1600-0404.1997.tb00217.x; Emahazion T, 1999, GENE, V238, P315, DOI 10.1016/S0378-1119(99)00330-3; Fazekas F, 2001, NEUROLOGY, V57, P853, DOI 10.1212/WNL.57.5.853; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gelman BB, 1996, ARCH PATHOL LAB MED, V120, P866; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Griffin DE, 1997, J CLIN INVEST, V100, P2948, DOI 10.1172/JCI119847; Huang SL, 1997, AM J RESP CRIT CARE, V156, P1436, DOI 10.1164/ajrccm.156.5.9609138; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lipton SA, 1998, ANNU REV PHARMACOL, V38, P159, DOI 10.1146/annurev.pharmtox.38.1.159; Lucotte G, 1997, HUM BIOL, V69, P253; MANSFIELD JC, 1994, GASTROENTEROLOGY, V106, P637, DOI 10.1016/0016-5085(94)90696-3; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; Monforte AD, 2000, NEUROLOGY, V54, P1856; Mrak RE, 1997, J NEUROVIROL, V3, P241, DOI 10.3109/13550289709029465; Nadel S, 1996, J INFECT DIS, V174, P878, DOI 10.1093/infdis/174.4.878; PERRUT M, 1998, P 5 M SUP FLUIDS NIC, V1, P1; PLOMIN R, 1994, BEHAV GENET, V24, P107, DOI 10.1007/BF01067815; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Quasney MW, 2001, ANN NEUROL, V50, P157, DOI 10.1002/ana.1284.abs; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Sato-Matsumura KC, 1998, J NEUROIMMUNOL, V91, P89, DOI 10.1016/S0165-5728(98)00161-1; Simpson DM, 1999, CLIN INFECT DIS, V29, P19, DOI 10.1086/520150; Swindells S, 1999, AIDS PATIENT CARE ST, V13, P153, DOI 10.1089/apc.1999.13.153; Tang MX, 1996, AM J HUM GENET, V58, P574; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Zink WE, 1999, FEMS IMMUNOL MED MIC, V26, P233, DOI 10.1111/j.1574-695X.1999.tb01394.x	42	17	17	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1355-0284			J NEUROVIROL	J. Neurovirol.		2004	10			1			67	73		10.1080/13550280490270770			7	Neurosciences; Virology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Virology	801SC	WOS:000220114600011	14982742				2022-02-06	
J	Drummond, SS; Boss, MR				Drummond, SS; Boss, MR			Functional communication screening in individuals with traumatic brain injury	BRAIN INJURY			English	Article							DISCOURSE; ADULTS	The feasibility of a novel instrument, the Functional Communication Scale (FCS), was determined for individuals with moderate-to-mild cognitive-communication deficits secondary to traumatic brain injury (TBI). A group design including 30 adults with confirmed diagnosis and communication problems was utilized. Conversational samples with each participant were videotaped and rated for 13 FCS items. Three raters with diverse clinical experiences rated the elicited samples. Results identified significant and positive relationships between the cognitive-communication severities and the total FCS scores. Significant inter- and intra-rater reliability scores were found for the three raters. The FCS also determined significant differences between individuals with and without concurrent aphasia or dysarthria. No obvious differences were found between males and females nor between individuals with the primary diagnosis of TBI vs other neurological aetiologies. These findings have implications for assessing the adequacy of functional communication of individuals who are candidates for community re-entry.	SE Missouri State Univ, Dept Commun Disorders, Cape Girardeau, MO 63701 USA		Drummond, SS (corresponding author), SE Missouri State Univ, Dept Commun Disorders, MS 2600,1 Univ Plaza, Cape Girardeau, MO 63701 USA.						Adamovich Brenda B., 1998, Seminars in Speech and Language, V19, P281, DOI 10.1055/s-2008-1064050; [Anonymous], 1988, ASHA, V30, P79; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; ELLIOTHOLLAND L, 1999, ANN M AM SPEECH LANG; ENRLICH J, 1989, BRAIN INJURY, V3, P193; Frank EM, 1996, J MED SPEECH-LANG PA, V4, P81; Freund J, 1994, COGNITIVE COMMUNICAT; Hagen C, 1979, REHABILITATION HEAD; HARTLAGE LC, 1992, PREVENTABLE BRAIN DA, P3; Hartley Leila L., 1992, Seminars in Speech and Language, V13, P264, DOI 10.1055/s-2008-1064202; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; ROSS D, 1986, ROSS INFORMATION PRO; Schwartz R, 1989, ASHA, V31, P91; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow P, 1997, BRAIN INJURY, V11, P409; WILLER B, 1992, COMMUNITY INTEGRATIO, V2; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P308, DOI 10.1055/s-2008-1064205	20	17	17	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2004	18	1					41	56		10.1080/0269905031000149461			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	749PB	WOS:000186928200003	14660235				2022-02-06	
J	Schmitter-Edgecombe, M; Marks, W; Wright, MJ; Ventura, M				Schmitter-Edgecombe, M; Marks, W; Wright, MJ; Ventura, M			Retrieval inhibition in directed forgetting following severe closed-head injury	NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; POSTHYPNOTIC AMNESIA; SELECTIVE ATTENTION; STIMULUS MODALITY; DIVIDED ATTENTION; EXPLICIT MEMORY; LIST METHODS; PERFORMANCE; IMPLICIT; TASKS	A variant of the list method directed forgetting procedure was used to examine the role of inhibition in memory performance following severe closed-head injury (CHI). Twenty-four participants with severe CHI and 24 controls studied picture and word stimuli in both forget and remember conditions. Memory testing for the to-be-forgotten and to-be-remembered items consisted of a free-recall test followed by a source-monitoring task. Despite poorer recall performance, the participants with CHI exhibited a directed forgetting effect similar to that in controls. Item recognition scores indicated that the inhibited items were not forgotten but rather were items whose accessibility had been lowered. These findings suggest that residual memory deficits in patients with severe CHI are unlikely to reflect inefficient retrieval inhibition.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA; Univ Memphis, Dept Psychol, Memphis, TN 38152 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 644820, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD35838] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER		Anderson Michael C., 1994, P265; [Anonymous], 1999, SUP PRO BET VERS EXP; Basden BH, 1996, MEMORY, V4, P633, DOI 10.1080/741941000; BASDEN BH, 1993, J EXP PSYCHOL LEARN, V19, P603, DOI 10.1037/0278-7393.19.3.603; Basden BH, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P139; BATCHELDER WH, 1990, PSYCHOL REV, V97, P548, DOI 10.1037/0033-295X.97.4.548; Bjork EL, 1996, CONSCIOUS COGN, V5, P176, DOI 10.1006/ccog.1996.0011; Bjork EL, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P103; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; BJORK RA, 1978, J EXP PSYCHOL-HUM L, V4, P347; BJORKLUND DF, 1990, DEV REV, V10, P48, DOI 10.1016/0273-2297(90)90004-N; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; Constantinidou F, 1999, J MED SPEECH-LANG PA, V7, P283; Constantinidou F, 1996, J GEN PSYCHOL, V123, P173, DOI 10.1080/00221309.1996.9921270; CONSTANTINIDOU F, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199508000-00009; Conway MA, 2000, J MEM LANG, V43, P409, DOI 10.1006/jmla.2000.2706; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; David D, 2000, INT J CLIN EXP HYP, V48, P267, DOI 10.1080/00207140008415246; DELIS D, 1987, CALIFORNIA VERBAL LE; DYWAN J, 1993, BRAIN COGNITION, V21, P20, DOI 10.1006/brcg.1993.1002; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; Fleck DE, 2001, PSYCHOL REC, V51, P207, DOI 10.1007/BF03395395; GEISELMAN RE, 1983, J EXP PSYCHOL GEN, V112, P58, DOI 10.1037/0096-3445.112.1.58; GEISELMAN RE, 1985, MEM COGNITION, V13, P57, DOI 10.3758/BF03198444; Golden J. C., 1978, STROOP COLOR WORD TE; Golding JM, 1996, Q J EXP PSYCHOL-A, V49, P326, DOI 10.1080/027249896392667; Harnishfeger KK, 1996, J EXP CHILD PSYCHOL, V62, P292, DOI 10.1006/jecp.1996.0032; Heaton RK, 1981, MANUAL WISCONSIN CAR; JOHNSON HM, 1994, PSYCHOL BULL, V116, P274, DOI 10.1037/0033-2909.116.2.274; Kuera H., 1967, COMPUTATIONAL ANAL P; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; MacLeod CM, 1999, PSYCHON B REV, V6, P123, DOI 10.3758/BF03210819; Marks W, 2001, J EXP PSYCHOL LEARN, V27, P1464, DOI 10.1037//0278-7393.27.6.1464; Mattis S, 1988, DEMENTIA RATING SCAL; Murnane K, 1996, MEM COGNITION, V24, P417, DOI 10.3758/BF03200931; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RIEFER DM, 1994, J EXP PSYCHOL LEARN, V20, P680, DOI 10.1037/0278-7393.20.3.680; Sattler J. M., 1988, ASSESSMENT CHILDREN; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; Simpson A, 2000, NEUROPSYCHOLOGY, V14, P310, DOI 10.1037//0894-4105.14.2.310; Smith A., 1982, SYMBOL DIGIT MODALIT; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; Vakil E, 1996, NEUROPSY NEUROPSY BE, V9, P176; Vakil E, 1997, NEUROPSYCHOLOGY, V11, P545, DOI 10.1037/0894-4105.11.4.545; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Van Zomeren A. H., 1981, REACTION TIME ATTENT; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1981, WECHSLER ADULT INTEL; Whetstone T, 1996, CONSCIOUS COGN, V5, P395, DOI 10.1006/ccog.1996.0025; Wilson SP, 1998, DEV REV, V18, P86, DOI 10.1006/drev.1997.0445; Zacks RT, 1996, J EXP PSYCHOL LEARN, V22, P143, DOI 10.1037/0278-7393.22.1.143	65	17	17	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	JAN	2004	18	1					104	114		10.1037/0894-4105.18.1.104			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	766WJ	WOS:000188398100011	14744193				2022-02-06	
S	Toth, A; Arz, G; Fazekas, G; Bratanov, D; Zlatov, N		Bien, ZZ; Stefanov, D		Toth, A; Arz, G; Fazekas, G; Bratanov, D; Zlatov, N			Post stroke shoulder-elbow physiotherapy with industrial robots	ADVANCES IN REHABILITATION ROBOTICS: HUMAN-FRIENDLY TECHNOLOGIES ON MOVEMENT ASSISTANCE AND RESTORATION FOR PEOPLE WITH DISABILITIES	Lecture Notes in Control and Information Sciences		English	Article; Proceedings Paper	8th International Conference on Rehabilitation Robotics (ICORR 2003)	APR 22-25, 2003	Korea Adv Inst Sci & Technol, Daejeon, SOUTH KOREA		Korea Adv Inst Sci & Technol			Robotic motor rehabilitation is a promising approach to rehabilitation of post stroke, traumatic brain injury, and spinal cord injury neuromotor impairments. We have observed that manual physiotherapy of spastic hemiparetic patients include 45 different types of three-dimensional repetitive shoulder-elbow motion exercises. The physical capabilities as well as the availability of the physiotherapist limit the realization of effective physiotherapy in daily routine. The paper describes the REHAROB Therapeutic System that uses two industrial robot arms for exercising the patient's upper limb. Special devices and measures make the system safe both for the patient and for the physiotherapist. The current REHAROB system performs individual, three-dimensional, anti-spastic passive motion therapy in the full range of concerted shoulder girdle (5) and elbow (2) motions but due to its versatility it is going to be expanded towards active assisted and active against resistance therapy, and for the physiotherapy of spastic hemiparetic lower limbs. The REHAROB Therapeutic System was designed to integrate commercially available robot, safety, control, and sensor components.	Budapest Unit Technol & Econ, Dept Mfg Engn, H-1111 Budapest, Hungary; Natl Inst Med Rehabil, H-1528 Budapest, Hungary; Univ Rousse, Dept Mfg Engn, Automat & Robot Lab, Rousse 7017, Bulgaria; Cardiff Univ, Mfg Engn Ctr, Cardiff CF24 0YF, S Glam, Wales		Toth, A (corresponding author), Budapest Unit Technol & Econ, Dept Mfg Engn, Egry J 1, H-1111 Budapest, Hungary.	toth@manuf.bme.hu; arz@manuf.bme.hu; kassai@alarmix.net; dany@manuf.ru.acad.bg; zlatovnb@cf.ac.uk					AMIRABDOLLAHIAN F, 2001, INTEGRATION ASSIVE T, P109; Burgar CG, 2000, J REHABIL RES DEV, V37, P663; *EN, 1993, 540 EN; FAZEKAS G, 2002, CLIN NEUROSCI IDEGGY, V55, P268; FEHER M, 1999, NEUROREHABILITAITON; JOHNSON GR, 1998, P 9 WORLD C INT SOC, P639; KOVACS LL, 2001, ADV MANUFACTURING TE, V15, P479; Krebs H I, 2002, Top Stroke Rehabil, V8, P54; Lum Peter, 2002, Top Stroke Rehabil, V8, P40; MLADENOV M, 2002, P 4 INT C TECHN AUT, P173; ROTH A, 2001, INTEGRATION ASSISTIV, P109; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; TOTH A, 2003, P 8 INT C INT C REH, P68; [No title captured]	14	17	17	1	14	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	0170-8643		3-540-21986-2	LECT NOTES CONTR INF			2004	306						391	411					21	Automation & Control Systems; Computer Science, Artificial Intelligence; Computer Science, Information Systems; Robotics; Rehabilitation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Automation & Control Systems; Computer Science; Robotics; Rehabilitation	BAN10	WOS:000222920300025					2022-02-06	
J	Haga, KK; Gregory, LJ; Hicks, CA; Ward, MA; Beech, JS; Bath, PW; Williams, SCR; O'Neill, MJ				Haga, KK; Gregory, LJ; Hicks, CA; Ward, MA; Beech, JS; Bath, PW; Williams, SCR; O'Neill, MJ			The neuronal nitric oxide synthase inhibitor, TRIM, as a neuroprotective agent: effects in models of cerebral ischaemia using histological and magnetic resonance imaging techniques	BRAIN RESEARCH			English	Article						cerebral ischaemia; TRIM; nitric oxide (NO); histology; magnetic resonance spectroscopy; Mongolian gerbil; rat; neuroprotection	TRAUMATIC BRAIN-INJURY; 1-(2-TRIFLUOROMETHYLPHENYL) IMIDAZOLE TRIM; ARTERY OCCLUSION; ANTIOXIDANT LY231617; RECEPTOR ANTAGONIST; 7-NITRO INDAZOLE; FOCAL ISCHEMIA; INFARCT VOLUME; NOS INHIBITOR; ARL 17477	Most neuroprotective compounds that appear promising in the pre-clinical phase of testing are subsequently dismissed as relatively ineffective when entered into large-scale clinical trials. Many pre-clinical studies of potential neuroprotective candidates evaluate efficacy in only one or possibly two different models of ischaemia. In this study we examined the effects of 1,2-trifluoromethylphenyl imidazole (TRIM), a novel neuronal nitric oxide synthase (nNOS) inhibitor, in three models of cerebral ischaemia (global gerbil, global rat and focal rat). In addition, to follow the progression of the pathology, we also compared traditional histology methods with more advanced magnetic resonance imaging (MRI) as endpoint measures for neurological damage and neuroprotection. TRIM (50 mg/kg i.p.) prevented ischaemia-induced hippocampal damage following global ischaemia in gerbils when administered before or immediately post-occlusion, but failed to protect when administration was delayed until 30 min post-occlusion. Further studies indicated that the compound (administered at 50 mg/kg, i.p., immediately after occlusion) also protected in a rat four-vessel occlusion (4-VO) model using both histological and diffusion-weighted (DW) imaging techniques. In a final study, TRIM (50 mg/kg i.p. 30 min after occlusion) provided a significant reduction in infarct volume at 4 and 24 h as measured using diffusion-weighted (DW) and proton density (PD)weighted magnetic resonance imaging (MRI). This was confirmed using histological techniques. These studies confirm that nNOS inhibitors may have utility in stroke and provide evidence that combined magnetic resonance and histological methods can provide a powerful method of assessing neuronal damage in rodent models of cerebral ischaemia. (C) 2003 Elsevier B.V. All rights reserved.	Eli Lilly & Co, Lilly Res Ctr Ltd, Dept Histopathol, Windlesham GU20 6PH, Surrey, England; Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; Kings Coll London, Inst Psychiat, Dept Neurol, Neuroimaging Res Grp, London SE5 8AF, England; Univ Manchester, Hope Hosp, Salford M6 8HD, Lancs, England; Cambridge Ctr Brain Repair, Cambridge, England; Univ Nottingham, Div Stroke Med, Nottingham NG5 1PB, England		O'Neill, MJ (corresponding author), Eli Lilly & Co, Lilly Res Ctr Ltd, Dept Histopathol, Erl Wood Manor, Windlesham GU20 6PH, Surrey, England.	ONEILL_MICHAEL-J@Lilly.Com	Williams, Steve C/D-6979-2011; Bath, Philip/F-9020-2011	Williams, Steve C/0000-0003-4299-1941; opoku, anita/0000-0001-7243-8157; Bath, Philip/0000-0003-2734-5132			BABBEDGE RC, 1993, BRIT J PHARMACOL, V110, P225, DOI 10.1111/j.1476-5381.1993.tb13796.x; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; BLOCK F, 1995, BRAIN RES, V694, P308, DOI 10.1016/0006-8993(95)00821-7; BUISSON A, 1993, J NEUROCHEM, V61, P690; CALDWELL M, 1995, EUR J PHARMACOL, V285, P203, DOI 10.1016/0014-2999(95)00502-C; Cash D, 2001, BRAIN RES, V905, P91, DOI 10.1016/S0006-8993(01)02508-2; Chabrier PE, 1999, CELL MOL LIFE SCI, V55, P1029, DOI 10.1007/s000180050353; CHOI DW, 1993, P NATL ACAD SCI USA, V90, P9741, DOI 10.1073/pnas.90.21.9741; CLEMENS JA, 1993, STROKE, V24, P716, DOI 10.1161/01.STR.24.5.716; Coert BA, 1999, J NEUROSURG, V90, P332, DOI 10.3171/jns.1999.90.2.0332; DAWSON DA, 1994, BRIT J PHARMACOL, V113, P247, DOI 10.1111/j.1476-5381.1994.tb16201.x; DAWSON DA, 1994, CEREBROVAS BRAIN MET, V6, P299; Dawson VL, 1996, J NEUROSCI, V16, P2479; Escott KJ, 1998, J CEREBR BLOOD F MET, V18, P281, DOI 10.1097/00004647-199803000-00006; GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413, DOI 10.1016/0922-4106(89)90023-0; Green IC, 1999, DRUG DISCOV TODAY, V4, P47, DOI 10.1016/S1359-6446(98)01296-3; Gregory LJ, 2001, J MAGN RESON IMAGING, V14, P207, DOI 10.1002/jmri.1175; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HANDY RLC, 1995, BRIT J PHARMACOL, V116, P2349, DOI 10.1111/j.1476-5381.1995.tb15078.x; Handy RLC, 1996, BRIT J PHARMACOL, V119, P423, DOI 10.1111/j.1476-5381.1996.tb16003.x; Harukuni I, 1999, CRIT CARE MED, V27, P2508, DOI 10.1097/00003246-199911000-00030; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Lei BP, 1999, STROKE, V30, P669, DOI 10.1161/01.STR.30.3.669; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moore PK, 1997, TRENDS PHARMACOL SCI, V18, P204, DOI 10.1016/S0165-6147(97)01064-X; NAGAFUJI T, 1995, MOL CHEM NEUROPATHOL, V26, P107, DOI 10.1007/BF02815009; NOWICKI JP, 1991, EUR J PHARMACOL, V204, P339, DOI 10.1016/0014-2999(91)90862-K; O'Neill MJ, 2000, NEUROPHARMACOLOGY, V39, P1575, DOI 10.1016/S0028-3908(99)00250-6; O'Neill MJ, 2000, BRAIN RES, V871, P234, DOI 10.1016/S0006-8993(00)02471-9; Olesen SP, 1997, ACTA NEUROL SCAND, V95, P219, DOI 10.1111/j.1600-0404.1997.tb00102.x; ONeill MJ, 1996, EUR J PHARMACOL, V310, P115, DOI 10.1016/0014-2999(96)00387-1; ONeill MJ, 1997, BRAIN RES, V760, P170, DOI 10.1016/S0006-8993(97)00293-X; Panahian N, 1996, NEUROSCIENCE, V72, P343, DOI 10.1016/0306-4522(95)00563-3; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Schulz JB, 1996, J NEUROCHEM, V67, P430; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Togashi H, 1998, NEUROSCI LETT, V240, P53, DOI 10.1016/S0304-3940(97)00918-X; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wei G, 1999, BBA-MOL BASIS DIS, V1455, P23, DOI 10.1016/S0925-4439(99)00051-4; YOSHIDA T, 1994, J CEREBR BLOOD F MET, V14, P924, DOI 10.1038/jcbfm.1994.123; YOSHIDA T, 1995, NEUROSCI LETT, V194, P214, DOI 10.1016/0304-3940(95)11752-I; Zhang FY, 1996, STROKE, V27, P317, DOI 10.1161/01.STR.27.2.317; Zhang ZG, 1996, J CEREBR BLOOD F MET, V16, P599, DOI 10.1097/00004647-199607000-00009	52	17	19	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 12	2003	993	1-2					42	53		10.1016/j.brainres.2003.08.063			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	753UR	WOS:000187249400005	14642829				2022-02-06	
J	Kennedy, MRT; Carney, E; Peters, SM				Kennedy, MRT; Carney, E; Peters, SM			Predictions of recall and study strategy decisions after diffuse brain injury	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; SELF-AWARENESS; LEARNING JOLS; VERBAL MEMORY; FRONTAL LOBES; JUDGMENTS; METAMEMORY; ACCURACY; DEFICITS; LESIONS	Objective: To investigate relationships between self-monitoring operationalized by predicting recall and study strategy decisions made by adults with diffuse, acquired brain injury (ABI) and adults without ABI. Research design and methods: Eighteen adults with ABI and 16 without ABI studied two lists of unrelated noun-pairs, made item-by-item immediate and delayed recall predictions and selected items ( after predictions) to restudy again. The computer selected items for restudy based on the lowest prediction rating (i.e. unlikely to recall). A mixed list design was used to balance item selection ( self or computer, within-lists) by type of prediction ( immediate or delayed, between-lists). Recall was tested prior to and after restudying. Hypotheses: Delayed recall predictions would be more accurate than immediate recall predictions; participants would select items for restudy that corresponded with 'lower' delayed predictions (i.e. less likely to recall) and 'higher' immediate predictions (i.e. more likely to recall); for adults with ABI, recall would improve the most from restudying items selected after delayed predictions; and that recall predictive accuracy and study selection decisions are independent processes. Results: Delayed recall predictions were more accurate than immediate recall predictions, though adults with ABI tended to be less accurate than controls. Both groups selected items for restudy that had relatively low prediction ratings irrespective of prediction timing. Of adults with ABI, those with low recall prior to restudy selected items that had 'high' immediate predictions (i.e. likely to recall). However, there was no greater benefit to recall using this strategy. For adults with ABI, recall improved the most from restudying items that were self-selected after delayed predictions, whereas controls' recall improved, irrespective of prediction and selection timing. Between-person correlations revealed no relationship between recall predictive accuracy and study selection strategies. Conclusions: These findings imply that adults with ABI should base strategy decisions on delayed predictions rather than on ` in the moment' immediate ones, selecting items that they have predicted will be difficult to recall. Continued efforts to disambiguate self-monitoring from strategy decisions are required before direct clinical applications can be made.	Univ Minnesota, Dept Commun Disorders, Ctr Cognit Sci, Minneapolis, MN 55455 USA		Kennedy, MRT (corresponding author), Univ Minnesota, Dept Commun Disorders, Ctr Cognit Sci, 115 Shevlin Hall,164 Pillsbury Dr SE, Minneapolis, MN 55455 USA.			Carney, Edward/0000-0003-4518-3560			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; AMMONS RB, 1979, PSYCHOL REP, V45, P943, DOI 10.2466/pr0.1979.45.3.943; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cohen J., 2013, STAT POWER ANAL BEHA; COURVILLE CB, 1937, PATHOLOGY CENTRAL NE; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; DUNLOSKY J, 1994, J MEM LANG, V33, P545, DOI 10.1006/jmla.1994.1026; Dunlosky J, 2001, J EXP PSYCHOL LEARN, V27, P1180, DOI 10.1037//0278-7393.27.5.1180; Dunlosky J, 1998, ACTA PSYCHOL, V98, P37, DOI 10.1016/S0001-6918(97)00051-6; DUNLOSKY J, 1997, J GERONTOL B-PSYCHOL, V552, pP178; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Gonzalez R, 1996, PSYCHOL BULL, V119, P159, DOI 10.1037/0033-2909.119.1.159; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; HACKER D, 1998, METACOGNITION ED THE; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kertesz A., 1982, W APHASIA BATTERY; LAWSON MJ, 1989, J CLIN EXP NEUROPSYC, V11, P842, DOI 10.1080/01688638908400939; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; NELSON TO, 1991, PSYCHOL SCI, V2, P267, DOI 10.1111/j.1467-9280.1991.tb00147.x; NELSON TO, 1994, PSYCHOL SCI, V5, P207, DOI 10.1111/j.1467-9280.1994.tb00502.x; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Newman AC, 2000, BRAIN INJURY, V14, P333; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; PARKER SA, 1976, ACTA NEUROCHIR, V34, P71, DOI 10.1007/BF01405864; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Reder LM., 1996, IMPLICIT MEMORY META, V1, P45, DOI DOI 10.1037/A0034030; REITAN RM, 1985, HALSTAD REITAN NEURO; Schlund MW, 2002, BRAIN INJURY, V16, P347, DOI 10.1080/02699050110103977; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Selznick L, 2000, BEHAV INTERVENT, V15, P243, DOI 10.1002/1099-078X(200007/09)15:3<243::AID-BIN59>3.3.CO;2-T; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Sohlberg M., 2001, COGNITIVE REHABILITA; Son LK, 2000, J EXP PSYCHOL LEARN, V26, P204, DOI 10.1037/0278-7393.26.1.204; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; TEASDALE G, 1974, LANCET, V2, P81; Thiede KW, 1999, J EXP PSYCHOL LEARN, V25, P1024, DOI 10.1037/0278-7393.25.4.1024; WEAVER CA, 1995, MEM COGNITION, V23, P12, DOI 10.3758/BF03210553; Wechsler D., 1997, WECHSLER MEMORY SCAL	60	17	17	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2003	17	12					1043	1064		10.1080/0269905031000110436			22	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731WR	WOS:000185909900004	14555364				2022-02-06	
J	Gillon, RS; Cui, Q; Dunlop, SA; Harvey, AR				Gillon, RS; Cui, Q; Dunlop, SA; Harvey, AR			Effects of immunosuppression on regrowth of adult rat retinal ganglion cell axons into peripheral nerve allografts	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						axonal regeneration; cyclosporin-A; FK506; optic nerve, neurotrauma	SPINAL-CORD-INJURY; CYCLOSPORINE-A; NEURONAL SURVIVAL; FK506 INCREASES; MONOCLONAL-ANTIBODY; SCHWANN-CELLS; REGENERATION; GRAFTS; EXPRESSION; TRANSPLANTATION	Analysis of the effectiveness of allografts and immunosuppression in the repair of nerve defects in the adult peripheral nervous system (PNS) has a long experimental and clinical history. There is little information, however, on the use of allografts in peripheral nerve (PN) transplantation into the injured central nervous system (CNS). We assessed the ability of PN allografts (from Dark-Agouti rats) to support regeneration of adult rat retinal ganglion cell (RGC) axons in immunosuppressed host Lewis rats. PN allografts were sutured onto intraorbitally transected optic nerves. Three weeks after grafting, regenerating RGC axon numbers were determined using retrograde fluorescent labelling, and total axons within PN grafts were assessed using pan-neurofilament immunohistochemistry. In the absence of immunosuppression, PN allografts contained few axons and there were very few labelled RGC. These degenerate grafts contained many T cells and macrophages. Systemic (intraperitoneal) application of the immunosuppressants cyclosporin-A or FK506 reduced cellular infiltration into allografts and resulted in extensive axonal regrowth from surviving RGCs. The average number of RGCs regenerating axons into immunosuppressed allografts was not significantly different from that seen in PN autografts in rats sham-injected with saline. Many pan-neurofilament-positive axons, a proportion of which were myelinated, were seen in immunosuppressed allografts, particularly in proximal regions of the grafts toward the optic nerve-PN interface. This study demonstrates that PN allografts can support axonal regrowth in immunosuppressed adult hosts, and points to possible clinical use in CNS repair. (C) 2003 Wiley-Liss, Inc.	Univ Western Australia, Sch Anat & Human Biol, Inst Med Res, Perth, WA 6009, Australia; Univ Western Australia, Sch Anim Biol, Inst Med Res, Perth, WA 6009, Australia		Harvey, AR (corresponding author), Univ Western Australia, Sch Anat & Human Biol, Inst Med Res, 35 Stirling Highway, Perth, WA 6009, Australia.	arharvey@anhb.uwa.edu.au	Dunlop, Sarah A/G-9357-2013; Harvey, Alan R/A-4911-2008	, Alan/0000-0002-2590-831X; Dunlop, Sarah/0000-0002-1306-3962			ANTHONY JP, 1999, TIS ENGN INTELL UNIT, V2, P239; BAHR M, 1992, EXP NEUROL, V116, P13, DOI 10.1016/0014-4886(92)90172-M; Bain JR, 1998, TRANSPL P, V30, P2762, DOI 10.1016/S0041-1345(98)00804-5; Bavetta S, 1999, EXP NEUROL, V158, P382, DOI 10.1006/exnr.1999.7119; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; BRAY GM, 1987, J EXP BIOL, V132, P5; Bregman BS, 1998, CURR OPIN NEUROBIOL, V8, P800, DOI 10.1016/S0959-4388(98)80124-4; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Campbell G, 1999, NEUROREPORT, V10, P3955, DOI 10.1097/00001756-199912160-00042; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; CHO EYP, 1987, BRAIN RES, V419, P369, DOI 10.1016/0006-8993(87)90610-X; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Cui Q, 1999, INVEST OPHTH VIS SCI, V40, P760; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dezawa M, 2000, PROG RETIN EYE RES, V19, P171, DOI 10.1016/S1350-9462(99)00010-5; Freeman EE, 2000, INVEST OPHTH VIS SCI, V41, P1111; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gold BG, 1999, DRUG METAB REV, V31, P649, DOI 10.1081/DMR-100101940; Gold BG, 1998, NEUROSCI LETT, V241, P25, DOI 10.1016/S0304-3940(97)00960-9; GOLD BG, 1995, J NEUROSCI, V15, P7509; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Golka B, 2001, EXP NEUROL, V167, P118, DOI 10.1006/exnr.2000.7540; Guo X, 2001, EUR J NEUROSCI, V13, P1683, DOI 10.1046/j.0953-816x.2001.01542.x; HARVEY AR, 1995, CLIN EXP PHARMACOL P, V22, P569, DOI 10.1111/j.1440-1681.1995.tb02068.x; HUNIG T, 1989, J EXP MED, V169, P73, DOI 10.1084/jem.169.1.73; Ide C, 1996, NEUROSCI RES, V25, P101; Inoue T, 2002, J NEUROSCI, V22, P4468, DOI 10.1523/JNEUROSCI.22-11-04468.2002; Jost SC, 2000, RESTOR NEUROL NEUROS, V17, P39; Keirstead HS, 1999, EXP NEUROL, V159, P225, DOI 10.1006/exnr.1999.7100; Klettner A, 2003, BRIT J PHARMACOL, V138, P1004, DOI 10.1038/sj.bjp.0705132; Klettner A, 2001, MOL BRAIN RES, V97, P21, DOI 10.1016/S0169-328X(01)00286-8; Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692; LYONS WE, 1995, J NEUROSCI, V15, P2985; Madsen JR, 1998, EXP NEUROL, V154, P673, DOI 10.1006/exnr.1998.6974; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; Midha R, 1997, J NEUROPATH EXP NEUR, V56, P421, DOI 10.1097/00005072-199704000-00011; Mirsky R, 1999, BRAIN PATHOL, V9, P293; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; MURAMATSU K, 1995, MICROSURG, V16, P496, DOI 10.1002/micr.1920160712; NG TF, 1995, J NEUROCYTOL, V24, P487, DOI 10.1007/BF01179974; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Sauve Y, 2001, J NEUROSCI, V21, P951, DOI 10.1523/JNEUROSCI.21-03-00951.2001; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; Sensenbrenner M, 1997, J MOL MED-JMM, V75, P653, DOI 10.1007/s001090050149; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; SO KF, 1985, BRAIN RES, V328, P349, DOI 10.1016/0006-8993(85)91047-9; Steiner JP, 1997, NAT MED, V3, P421, DOI 10.1038/nm0497-421; Sugawara T, 1999, NEUROREPORT, V10, P3949, DOI 10.1097/00001756-199912160-00041; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Symons NA, 2001, EUR J NEUROSCI, V14, P522, DOI 10.1046/j.0953-816x.2001.01681.x; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang M S, 1999, J Spinal Cord Med, V22, P287; Wang MS, 1997, J PHARMACOL EXP THER, V282, P1084; Winter C, 2000, NEUROSCIENCE, V95, P753; Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; Ye JH, 1997, EXP NEUROL, V143, P70, DOI 10.1006/exnr.1996.6353; Yin YQ, 2003, J NEUROSCI, V23, P2284	61	17	18	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV 15	2003	74	4					524	532		10.1002/jnr.10788			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739LW	WOS:000186348900006	14598296				2022-02-06	
J	Greiffenstein, MF; Baker, WJ				Greiffenstein, MF; Baker, WJ			Premorbid clues? Preinjury scholastic performance and present neuropsychological functioning in late postconcussion syndrome	CLINICAL NEUROPSYCHOLOGIST			English	Article							MILD HEAD-INJURY; RELIABLE DIGITS; CATEGORY TEST; TEST BATTERY; EDUCATION; REITAN; AGE; DYSFUNCTION; VALIDATION; GENDER	Neuropsychologists rely on demographic variables to form assumptions about premorbid status, and most use years of education as the main variable. School records are a more objective basis for such estimation, particularly in litigated cases. In the present study, final cumulative grade point average (GPA) was regressed on to Halstead-Reitan Battery (HRB), IQ and other neuropsychological test scores in 60 nonmalingering postconcussive litigants and 17 litigants with moderate-severe closed head injury. Results indicated significant correlations between GPA, HRB core tests, commonly used neuropsychological measures, and intelligence. A regression formula indicated litigants with poor grade point average were likely to perform in the impaired range. The present findings suggest the quality of premorbid academic performance also provides an important context in which to view present neuropsychological performance. Marginal premorbid achievement may be a risk factor for late developing postconcussion syndrome and litigation.	Psychol Syst Inc, Royal Oak, MI USA		Greiffenstein, MF (corresponding author), ABPP CN, 26862 Woodward,Suite 103, Royal Oak, MI 48067 USA.	mfgreiff@comcast.net					ADAMS KM, 1975, J PSYCHEDEL DRUG, V7, P151, DOI 10.1080/02791072.1975.10471994; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM PSYCH ASS, 2002, PSYCHINFO; Arnold B. R., 1994, ASSESSMENT, V1, P239, DOI DOI 10.1177/107319119400100303; BINDER LM, 1991, J CLIN CONSULTING PS, V3, P171; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; BRADFORD DT, 1992, INTERPRETIVE REASONI; Choca JP, 1997, NEUROPSYCHOL REV, V7, P61, DOI 10.1023/B:NERV.0000005944.98635.16; CUTLAN SL, 2000, DISS ABSTR INT B, V60, P4213; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1; Dodrill CB, 1997, CLIN NEUROPSYCHOL, V11, P1, DOI 10.1080/13854049708407025; Duncan SA, 2002, ASSESSMENT, V9, P56, DOI 10.1177/1073191102009001007; Elias MF, 1997, EXP AGING RES, V23, P201, DOI 10.1080/03610739708254281; FAUST G, 1991, BRAIN DAMAGE CLAIM C; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; GOETHE KE, 1984, PSYCHIAT ANN, V14, P540, DOI 10.3928/0048-5713-19840701-11; Green P, 2001, CLIN NEUROPSYCHOL, V15, P492, DOI 10.1076/clin.15.4.492.1887; Green P, 2001, NEUROREHABILITATION, V16, P237; Greiffenstein M. F., 2000, BRAIN INJ SOURCE, V4, P26; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; Greiffenstein MF, 2002, PSYCHOL ASSESSMENT, V14, P202, DOI 10.1037//1040-3590.14.2.202; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Halstead WC, 1947, BRAIN INTELLIGENCE Q; Heaton R.K., 1981, WISCONSIN CARD SORTI; HEATON RK, 1978, J NERV MENT DIS, V166, P408, DOI 10.1097/00005053-197806000-00004; HEATON RK, 1994, PSYCHOSOM MED, V56, P8, DOI 10.1097/00006842-199401000-00001; Heaton RK, 1991, COMPREHENSIVE NORMS; HEATON RK, 1996, NEUROPSYCHOLOGICAL A; JARVIS PE, 1984, HALSTEAD REITAN BATT; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KUPKE T, 1979, J CONSULT CLIN PSYCH, V47, P1128, DOI 10.1037/0022-006X.47.6.1128; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; Leckliter Ingrid N, 1992, Clin Neuropsychol, V6, P201, DOI 10.1080/13854049208401856; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Matarazzo JD, 1972, WECHSLERS MEASUREMEN; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Megargee EI, 1999, PSYCHOL ASSESSMENT, V11, P177, DOI 10.1037/1040-3590.11.2.177; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; MILTON SB, 1988, J HEAD TRAUMA REHAB, V3, P1; Mitrushina MN, 1999, HDB NORMATIVE DATA N; NEWNAN OS, 1978, PERCEPT MOTOR SKILL, V46, P635, DOI 10.2466/pms.1978.46.2.635; Putnam SH, 1999, STUD NEUROPSYCHOL DE, P39; Rankin EJ, 1999, STUD NEUROPSYCHOL DE, P85; Reis A, 2001, BRAIN COGNITION, V47, P397, DOI 10.1006/brcg.2001.1316; Reitan R, 1985, HALSTEAD REITAN NEUR; Reitan R M, 1990, Arch Clin Neuropsychol, V5, P265; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P151, DOI 10.1080/13854049508401597; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruff R. M., 1989, MILD HEAD INJURY, P176; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Rutter M, 1996, J DEV BEHAV PEDIATR, V17, P183; RYAN CM, 1987, J CLIN EXP NEUROPSYC, V9, P665, DOI 10.1080/01688638708405209; SCHMIDT M, 1994, ARCH CLIN NEUROPSYCH, V9, P383, DOI 10.1016/0887-6177(94)90002-7; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; SHERER M, 1991, J CLIN EXP NEUROPSYC, V13, P741, DOI 10.1080/01688639108401087; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Sternberg RJ, 1997, AM PSYCHOL, V52, P1144; STERNBERG RJ, 1986, AM SCI, V74, P137; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Sweet JJ, 1996, CLIN NEUROPSYCHOL, V10, P202, DOI 10.1080/13854049608406681; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Vanderploeg RD, 1997, CLIN NEUROPSYCHOL, V11, P210, DOI 10.1080/13854049708407054; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL; WILLIS L, 1988, DEV NEUROPSYCHOL, V4, P23, DOI 10.1080/87565648809540387; [No title captured]	73	17	17	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	2003	17	4					561	573		10.1076/clin.17.4.561.27937			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	776XV	WOS:000189145400012	15168920				2022-02-06	
J	Dimopoulou, I; Anthi, A; Lignos, M; Boukouvalas, E; Evangelou, E; Routsi, C; Mandragos, K; Roussos, C				Dimopoulou, I; Anthi, A; Lignos, M; Boukouvalas, E; Evangelou, E; Routsi, C; Mandragos, K; Roussos, C			Prediction of prolonged ventilatory support in blunt thoracic trauma patients	INTENSIVE CARE MEDICINE			English	Article						thoracic trauma; mechanical ventilation; duration; prediction; bilateral chest injuries; severe head trauma; aging	INJURY SEVERITY SCORE; INTENSIVE-CARE UNIT; MECHANICAL VENTILATION; CHEST TRAUMA; PULMONARY CONTUSION; CONSENSUS CONFERENCE; EARLY TRACHEOSTOMY; STAY; INTUBATION; MORTALITY	Objective. To identify predictors of prolonged (>7 days) mechanical ventilation (MV) in patients with blunt thoracic trauma. Design. Prospective analysis of consecutive patients. Setting. Adult intensive care unit (ICU) in a teaching, tertiary-care hospital. Patients and participants. Sixty-nine patients (53 men, 16 women) with thoracic trauma having a median age of 35 (range 17-85) years and a median injury severity score (ISS) of 29 (range 14-41) were enrolled in the present study. Associated injuries included head-neck (77%), extremities (72%), external (67%), abdomen-pelvis (67%), and face (55%). Interventions. Patient surveillance and data collection. Measurements and results. Thirty-three (48%) of the 69 patients required prolonged ventilatory support, ranging in duration from 8 to 38 (median 18) days. Logistic regression analysis revealed that advancing age (odds ratio=1.04, p=0.04), severity of head injury (odds ratio=1.92, p=0.008), and bilateral thoracic injuries (odds ratio=12.80, p<0.0001) were significant and independent predictors of long-lasting MV. In contrast, gender, injuries affecting the other body regions (face, abdomen-pelvis, extremities, and external), laparotomy in patients with abdominal injury, or PaO2/FIO2 on admission in the ICU, were unrelated to prolonged MV. Conclusions. In thoracic trauma patients admitted in the ICU, prolonged mechanical ventilation was primarily determined by presence of bilateral chest injuries, age, and degree of neurotrauma. This information may help in planning the long-term care of such patients.	Evangelismos Med Ctr, Dept Crit Care Med, Athens, Greece; Natl & Kapodistrian Univ, Intens Care Unit, Hellen Red Cross Hosp, Sch Med, Athens, Greece		Dimopoulou, I (corresponding author), 2 Pesmazoglou St, Athens 14561, Greece.		Evangelou, Evangelos/C-3033-2013	Evangelou, Evangelos/0000-0002-5488-2999			Artigas A, 1998, INTENS CARE MED, V24, P378, DOI 10.1007/s001340050585; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CLARK GC, 1988, J TRAUMA, V28, P298, DOI 10.1097/00005373-198803000-00004; GAILLARD M, 1990, J TRAUMA, V30, P93, DOI 10.1097/00005373-199001000-00015; GAYNOR EB, 1985, LARYNGOSCOPE, V95, P1461; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Guerrero-Lopez F, 2000, CRIT CARE MED, V28, P1370, DOI 10.1097/00003246-200005000-00018; JOHNSON JA, 1986, J TRAUMA, V26, P695, DOI 10.1097/00005373-198608000-00002; JOHNSON SB, 1992, J TRAUMA, V33, P95, DOI 10.1097/00005373-199207000-00018; LESNIK I, 1992, AM SURGEON, V58, P346; LEWIS FR, 1982, SURG CLIN N AM, V62, P97; Lipsett PA, 2000, ANN SURG, V231, P262, DOI 10.1097/00000658-200002000-00016; MACKENZIE EJ, 1989, J TRAUMA, V29, P757, DOI 10.1097/00005373-198906000-00011; Miller RS, 2000, J TRAUMA, V48, P229, DOI 10.1097/00005373-200002000-00006; Pape HC, 2000, J TRAUMA, V49, P496, DOI 10.1097/00005373-200009000-00018; PINILLA JC, 1982, J TRAUMA, V22, P221, DOI 10.1097/00005373-198203000-00008; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; Rashid MA, 2000, EUR J SURG, V166, P22; RODRIGUEZ JL, 1990, SURGERY, V108, P655; Ross BJ, 1996, AM SURGEON, V62, P19; SCHULPEN TMJ, 1986, INJURY, V17, P305, DOI 10.1016/0020-1383(86)90151-8; SPICHER JE, 1987, ARCH INTERN MED, V147, P421, DOI 10.1001/archinte.147.3.421; STELLIN G, 1991, AM SURGEON, V57, P780; Troche G, 1997, CHEST, V112, P745, DOI 10.1378/chest.112.3.745; Velmahos GC, 1997, AM SURGEON, V63, P811; WHITED RE, 1984, LARYNGOSCOPE, V94, P367; WISNER DH, 1990, J TRAUMA, V30, P799, DOI 10.1097/00005373-199007000-00006	27	17	18	0	3	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	JUL	2003	29	7					1101	1105		10.1007/s00134-003-1813-0			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	698ZD	WOS:000184030000012	12802485				2022-02-06	
J	Glassmire, DM; Bierley, RA; Wisniewski, AM; Greene, RL; Kennedy, JE; Date, E				Glassmire, DM; Bierley, RA; Wisniewski, AM; Greene, RL; Kennedy, JE; Date, E			Using the WMS-III faces subtest to detect malingered memory impairment	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							MIXED GROUP VALIDATION; BELIEVABLE DEFICITS; VALIDITY; PERFORMANCE; MMPI-2; TESTS; DYSFUNCTION; PROSPECTS; SYMPTOMS; CAPACITY	The current study evaluated the utility of the WMS-III Faces I subtest (Faces) for the assessment of malingering. Thirty nonlitigating traumatic brain injury patients and 30 control participants were administered Faces under standard administration and instructed malingering conditions. Although the two groups obtained similar scores when taking the test under standard instructions, both groups produced significantly lower performances when instructed to malinger, indicating that Faces is sensitive to malingering, but less sensitive to traumatic brain injury. The total raw score provided stronger classification accuracy than an empirically weighted combination of the five easiest items (i.e., floor effect items). A raw score cutoff of 31 yielded the maximum classification accuracy with 93.3% sensitivity and 80.0% specificity.	Pacific Grad Sch Psychol, Palo Alto, CA USA; Permanente Med Grp Inc, Redwood City, CA USA; Wilford Hall USAF Med Ctr, Def & Vet Head Injury Program, Lackland AFB, TX 78236 USA; Wilford Hall USAF Med Ctr, Dept Neurol, Lackland AFB, TX 78236 USA; VA Palo Alto Healthcare Syst, Palo Alto, CA USA; Def & Vet Head Injury Program, Palo Alto, CA USA		Glassmire, DM (corresponding author), Patton State Hosp, Dept Psychol, AX-234,31202 E Highland Ave, Patton, CA 92369 USA.	davidglassmire@hotmail.com	Glassmire, David/AAO-7344-2021; Glassmire, David/AAX-9268-2020				American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; BERNARD LC, 1993, ARCH CLIN NEUROPSYCH, V8, P539, DOI 10.1016/0887-6177(93)90054-5; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Bierley RA, 2001, BRAIN INJURY, V15, P697, DOI 10.1080/02699050010013671; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BORUM R, 1995, PROF PSYCHOL-RES PR, V26, P465, DOI 10.1037/0735-7028.26.5.465; BRANDT J, 1991, CLIN ASSESSMENT MALI, P65; Butcher JN, 1995, PSYCHOL ASSESSMENT, V7, P320, DOI 10.1037/1040-3590.7.3.320; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cullum C, 1991, FORENSIC NEUROPSYCHO, P141; DAWES RM, 1966, PSYCHOL BULL, V66, P63, DOI 10.1037/h0023584; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; Faust D, 1998, CRIT ISS NE, P1; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; FREDERICK RI, 1995, B AM ACAD PSYCH LAW, V23, P231; Frederick RI, 2000, ARCH CLIN NEUROPSYCH, V15, P281, DOI 10.1016/S0887-6177(99)00002-5; Frederick RI, 2000, BEHAV SCI LAW, V18, P693, DOI 10.1002/bsl.432; FREED DM, 1989, NEUROPSYCHOLOGIA, V27, P325, DOI 10.1016/0028-3932(89)90022-5; GLASS LS, 1991, FORENSIC NEUROPSYCHO, P3; Gouvier WD, 1998, CRIT ISS NE, P55; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Griffin GAE, 1996, PSYCHOL ASSESSMENT, V8, P383; Griffin GAE, 1996, J CONSULT CLIN PSYCH, V64, P1425, DOI 10.1037/0022-006X.64.6.1425; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Hagen C, 1979, REHABILITATION HEAD; HART RP, 1993, J CLIN EXP NEUROPSYC, V15, P245, DOI 10.1080/01688639308402561; HAYS JR, 1993, PERCEPT MOTOR SKILL, V76, P1331, DOI 10.2466/pms.1993.76.3c.1331; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Kaplan E, 1991, WAIS R NI USE WAIS R; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Orey SA, 2000, ARCH CLIN NEUROPSYCH, V15, P335, DOI 10.1016/S0887-6177(99)00024-4; Pankratz L., 1988, CLIN ASSESSMENT MALI, P169; Pankratz L., 1997, CLIN ASSESSMENT MALI, P223; PRIGATANO GP, 1993, J CLIN EXP NEUROPSYC, V15, P537, DOI 10.1080/01688639308402577; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; REY A, 1964, XAMEN CLIN PSYCHOL; Rogers R, 1990, Bull Am Acad Psychiatry Law, V18, P323; Rogers R, 1998, LAW HUMAN BEHAV, V22, P353, DOI 10.1023/A:1025714808591; ROGERS R, 1994, LAW HUMAN BEHAV, V18, P543, DOI 10.1007/BF01499173; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Rosenfeld B, 2000, ARCH CLIN NEUROPSYCH, V15, P349, DOI 10.1016/S0887-6177(99)00025-6; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; SLICK D, 1996, THESIS U VICTORIA; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Wechsler D, 1987, MEMORY SCALE REVISED; Williams JM, 1998, CRIT ISS NE, P105; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3; [No title captured]	71	17	17	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN	2003	25	4					465	481		10.1076/jcen.25.4.465.13875			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	683GY	WOS:000183141300003	12911101				2022-02-06	
J	Pemberton, PL; Dinsmore, J				Pemberton, PL; Dinsmore, J			The use of hypothermia as a method of neuroprotection during neurosurgical procedures and after traumatic brain injury: A survey of clinical practice in Great Britain and Ireland	ANAESTHESIA			English	Article						hypothermia, induced; craniocerebral trauma; neurosurgery; anaesthesia	LOW INTRACRANIAL-PRESSURE; MILD HYPOTHERMIA; TRIAL; THERAPY	Hypothermia has been employed as a method of neuroprotection for many decades. The evidence base for its use is limited, and the balance between benefit and risk is unclear. We felt that in light of this confusion it would be interesting to canvas the opinion of the members of The Neuroanaesthesia Society of Great Britain and Ireland. A questionnaire was sent to all 274 members enquiring into their use of hypothermia during a variety of different neurosurgical procedures and in the management of the head-injured patient. A 75% response rate was achieved. The results showed that over half (58%) of those who replied attempted to cool the patient during cerebral aneurysm surgery. Forty-one per cent of respondents attempt to induce hypothermia in the head-injured patient. However, for other neurosurgical procedures most felt that the disadvantages of cooling the patient outweigh the advantages. The use of hypothermia remains a contentious issue, and as yet there is no clear answer as to whether it should be employed as a method of neuroprotection.	Atkinson Morleys Hosp, London SW20 0NE, England		Pemberton, PL (corresponding author), Atkinson Morleys Hosp, Copse Hill, London SW20 0NE, England.						Berti M, 1998, ANAESTHESIA, V53, P46; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; GADKARY CS, 2002, COCHRANE LIB; Hindman BJ, 1999, NEUROSURGERY, V44, P23, DOI 10.1097/00006123-199901000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Sessler DI, 1997, NEW ENGL J MED, V336, P1730, DOI 10.1056/NEJM199706123362407; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; TODD MM, 1992, ANESTHESIOLOGY, V76, P161	10	17	18	1	3	BLACKWELL PUBLISHING LTD	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	0003-2409			ANAESTHESIA	Anaesthesia	APR	2003	58	4					370	373					4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	656WR	WOS:000181634500012	12688273				2022-02-06	
J	Statler, KD; Alexander, HL; Vagni, VA; Nemoto, EM; Tofovic, SP; Dixon, CE; Jenkins, LW; Marion, DW; Kochanek, PM				Statler, KD; Alexander, HL; Vagni, VA; Nemoto, EM; Tofovic, SP; Dixon, CE; Jenkins, LW; Marion, DW; Kochanek, PM			Moderate hypothermia may be detrimental after traumatic brain injury in fentanyl-anesthetized rats	CRITICAL CARE MEDICINE			English	Article						brain injury; sedation; analgesia; narcotics; excitotoxicity	CONTROLLED CORTICAL IMPACT; CEREBRAL BLOOD-FLOW; LOW INTRACRANIAL-PRESSURE; TOXICITY IN-VIVO; SPIN-LABELED MRI; MILD HYPOTHERMIA; POSTTRAUMATIC HYPOTHERMIA; GLUCOSE-METABOLISM; GLUTAMATE RELEASE; GLOBAL-ISCHEMIA	Objectives: To determine whether transient, moderate hypothermia is beneficial after traumatic brain injury in fentanyl-anesthetized rats. Design: Prospective, randomized study. Setting: University-based animal research facility. Subjects: Adult male Sprague-Dawley rats. Interventions: All rats were intubated, mechanically ventilated, and anesthetized with fentanyl (10 mug/kg intravenous bolus and then 50 mug.kg(-1).hr(-1) infusion). Controlled cortical impact was performed to the left parietal cortex, followed immediately by 1 hr of either normothermia (brain temperature 37+/-0.5degreesC) or hypothermia (brain temperature 32+/-0.5degreesC). Hypothermic rats were rewarmed gradually over 1 hr. Fentanyl anesthesia and mechanical ventilation were continued in both groups until the end of rewarming (2 hrs after traumatic brain injury). Measurements and Main Results: Histologic assessment performed 72 hrs after traumatic brain injury was the primary outcome variable. Secondary outcome variables were physiologic variables monitored during the first 2 hrs after traumatic brain injury and plasma catecholamine and serum fentanyl concentrations measured at the end of both hypothermia and rewarming (1 and 2 hrs after traumatic brain injury). Contusion volume was larger in hypothermic vs. normothermic rats (44.3+/-4.2 vs. 28.6+/-4.0 mm, p<.05), but hippocampal neuronal survival did not differ between groups. Physiologic variables did not differ between groups. Plasma dopamine and norepinephrine concentrations were increased at the end of hypothermia in hypothermic (vs. normothermic) rats (p<.05), indicating that hypothermia augmented the systemic stress response. Similarly, serum fentanyl concentrations were higher in hypothermic (vs. normothermic) rats at the end of both hypothermia and rewarming (p<.05), demonstrating that hypothermia reduced the clearance and/or metabolism of fentanyl. Conclusions: Moderate hypothermia was detrimental after experimental traumatic brain injury in fentanyl-anesthetized rats. Since treatment with hypothermia has provided reliable benefit in experimental traumatic brain injury with inhalational anesthetics, these results indicate that the choice of anesthesia/analgesia after traumatic brain injury may dramatically influence response to other therapeutic interventions, such as hypothermia. Given that narcotics commonly are administered to patients after severe traumatic brain injury, this study may have clinical implications.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15260 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.		Marion, Donald/AAR-5749-2021; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD40686] Funding Source: Medline		ALCARAZ C, 1989, CLIN EXP PHARMACOL P, V16, P367, DOI 10.1111/j.1440-1681.1989.tb01573.x; Beaumont A, 2001, J NEUROTRAUM, V18, P1359, DOI 10.1089/08977150152725650; Beaumont A, 2000, ACT NEUR S, V76, P147; BICKLER PE, 1994, ANESTHESIOLOGY, V81, P1461, DOI 10.1097/00000542-199412000-00022; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Dunn-Meynell AA, 1998, BRAIN RES, V800, P245, DOI 10.1016/S0006-8993(98)00524-1; Eilers H, 1996, ANESTHESIOLOGY, V85, P600, DOI 10.1097/00000542-199609000-00020; Frank SM, 1997, AM J PHYSIOL-REG I, V272, pR557, DOI 10.1152/ajpregu.1997.272.2.R557; Fujisawa H, 1999, J NEUROTRAUM, V16, P1083, DOI 10.1089/neu.1999.16.1083; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GREEN EJ, 1995, BRAIN RES, V702, P145, DOI 10.1016/0006-8993(95)01034-1; HANSEN TD, 1989, BRIT J ANAESTH, V63, P290, DOI 10.1093/bja/63.3.290; Harada H, 1999, ANESTH ANALG, V89, P1442, DOI 10.1097/00000539-199912000-00022; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; KEARSE LA, 1993, ELECTROEN CLIN NEURO, V87, P374, DOI 10.1016/0013-4694(93)90150-T; Kimbro JR, 2000, ANESTHESIOLOGY, V92, P806, DOI 10.1097/00000542-200003000-00024; KISSIN I, 1983, CAN ANAESTH SOC J, V30, P623, DOI 10.1007/BF03015233; KOREN G, 1987, EUR J CLIN PHARMACOL, V32, P373, DOI 10.1007/BF00543972; Lenz C, 1999, ANESTHESIOLOGY, V91, P1720, DOI 10.1097/00000542-199912000-00025; MACHENSEN GB, 1999, ANESTHESIOLOGY, V90, P1; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Miura Y, 1999, ANESTH ANALG, V88, P787, DOI 10.1097/00000539-199904000-00020; Miura Y, 1998, ANESTHESIOLOGY, V89, P391, DOI 10.1097/00000542-199808000-00016; Mori K, 1999, NEUROL RES, V21, P585, DOI 10.1080/01616412.1999.11740981; Mueller E, 2000, ACTA NEUROCHIR SUPPL, V76, P551; Nakashima K, 1996, STROKE, V27, P913, DOI 10.1161/01.STR.27.5.913; Nemoto EM, 1996, ANESTH ANALG, V83, P1262, DOI 10.1097/00000539-199612000-00023; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Popovic R, 2000, ANESTHESIOLOGY, V92, P1343, DOI 10.1097/00000542-200005000-00024; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SAFO Y, 1985, ACTA ANAESTH SCAND, V29, P594, DOI 10.1111/j.1399-6576.1985.tb02261.x; Schmid-Elsaesser R, 1999, STROKE, V30, P1891, DOI 10.1161/01.STR.30.9.1891; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Soonthon-Brant V, 1999, ANESTH ANALG, V88, P49, DOI 10.1097/00000539-199901000-00010; Statler KD, 2000, CRIT CARE MED, V28, pA210; Statler KD, 2000, CRIT CARE MED, V28, pA53; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; TEMPELHOFF R, 1992, J NEUROSURG, V77, P201, DOI 10.3171/jns.1992.77.2.0201; Tofovic SP, 1996, J CARDIOVASC PHARM, V28, P302, DOI 10.1097/00005344-199608000-00018; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	62	17	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2003	31	4					1134	1139		10.1097/01.CCM.0000054864.43122.52			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670MF	WOS:000182411900022	12682484				2022-02-06	
J	Stover, JF; Sakowitz, OW; Beyer, TF; Dohse, NK; Kroppenstedt, SN; Thomale, UW; Schaser, KD; Unterberg, AW				Stover, JF; Sakowitz, OW; Beyer, TF; Dohse, NK; Kroppenstedt, SN; Thomale, UW; Schaser, KD; Unterberg, AW			Effects of LY379268, a selective group II metabotropic glutamate receptor agonist on EEG activity, cortical perfusion, tissue damage, and cortical glutamate, glucose, and lactate levels in brain-injured rats	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; contusion; cortical impact; excitotoxicity; microdialysis; neuroprotection	CEREBROSPINAL-FLUID GLUTAMATE; CEREBRAL BLOOD-FLOW; LASER-DOPPLER FLOWMETRY; EXCITATORY AMINO-ACIDS; IMPACT INJURY; EXTRACELLULAR GLUTAMATE; TRANSPORTER GLT-1; TRAUMATIC INJURY; TEMPORAL PROFILE; IN-VIVO	Activating presynaptic group II metabotropic glutamate (mGlu II) receptors reduces synaptic glutamate release. Attenuating glutamatergic transmission without blocking ionotropic glutamate receptors, thus avoiding unfavorable psychomimetic side effects, makes mGlu II receptor agonists a promising target in treating brain-injured patients. Neuroprotective effects of LY379268 were investigated in rats following controlled cortical impact injury (CCI). At 30 min after CCI, rats received a single intraperitoneal injection of LY379268 (10 mg/kg/body weight) or NaCl. Changes in EEG activity and pericontusional cortical perfusion were determined before trauma, at 4, 24, and 48 h, and 7 days after CCI. Brain edema and contusion volume were determined at 24 h and 7 days after CCI, respectively. Before brain removal pericontusional cortical glutamate, glucose, and lactate were measured via microdialysis. During the early period following CCI, EEG activity and cortical perfusion were significantly reduced in rats receiving LY379268. At 7 days, cortical perfusion was significantly increased in rats treated with LY379268, while EEG activity was depressed as in control rats. While brain edema remained unchanged at 24 h, cortical contusion was significantly decreased by 56% at 7 days after CCI. Cortical glutamate, glucose, and lactate were not influenced. Significant reductions in EEG activity and contusion volume by LY379268 do not appear mediated by attenuated excitotoxicity and energetic impairment. Overall, an additional decrease in cortical perfusion seems to interfere with the anti-edematous potential of LY379268 during the early period following CCI, while an increase in perfusion in LY379268-treated rats at 7 days might contribute to tissue protection.	Humboldt Univ, Charite, Virchow Med Ctr, Dept Neurosurg, D-13353 Berlin, Germany; Humboldt Univ, Charite, Virchow Med Ctr, Dept Trauma & Reconstruct Surg, D-13353 Berlin, Germany		Stover, JF (corresponding author), Humboldt Univ, Charite, Virchow Med Ctr, Dept Neurosurg, Augustenburger Pl 1, D-13353 Berlin, Germany.			Sakowitz, Oliver/0000-0003-3248-6335			Allen JW, 1999, J PHARMACOL EXP THER, V290, P112; Battaglia G, 1997, NEUROSCI LETT, V229, P161, DOI 10.1016/S0304-3940(97)00442-4; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; Bond A, 2000, J PHARMACOL EXP THER, V294, P800; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Bruno V, 1998, J NEUROSCI, V18, P9594; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; BUISSON A, 1995, NEUROPHARMACOLOGY, V34, P1081, DOI 10.1016/0028-3908(95)00073-F; Cai ZW, 1999, NEUROREPORT, V10, P3927, DOI 10.1097/00001756-199912160-00037; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; CHAVIS P, 1995, J NEUROSCI, V15, P135; Colwell CS, 1999, BRAIN RES, V833, P234, DOI 10.1016/S0006-8993(99)01545-0; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; FADEN AI, 1989, SCIENCE, V4, P800; Feinberg I, 2002, PHARMACOL BIOCHEM BE, V73, P467, DOI 10.1016/S0091-3057(02)00843-2; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Gu WG, 1999, J NEUROSCI METH, V90, P23, DOI 10.1016/S0165-0270(99)00041-2; Helton DR, 1997, NEUROPHARMACOLOGY, V36, P1511, DOI 10.1016/S0028-3908(97)00170-6; Helton DR, 1998, J PHARMACOL EXP THER, V284, P651; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kilbride J, 1998, EUR J PHARMACOL, V356, P149, DOI 10.1016/S0014-2999(98)00526-3; Kingston AE, 1999, EUR J PHARMACOL, V377, P155, DOI 10.1016/S0014-2999(99)00397-0; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; LOVINGER DM, 1995, J NEUROPHYSIOL, V73, P1076, DOI 10.1152/jn.1995.73.3.1076; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; McIntosh TK, 1996, LAB INVEST, V74, P315; Meir A, 1999, PHYSIOL REV, V79, P1019, DOI 10.1152/physrev.1999.79.3.1019; Monn JA, 1997, J MED CHEM, V40, P528, DOI 10.1021/jm9606756; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; Murray TK, 2002, PHARMACOL BIOCHEM BE, V73, P455, DOI 10.1016/S0091-3057(02)00842-0; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; NILLSON P, 1990, J CEREB BLOOD FLOW M, V10, P631; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Stoffel M, 2002, J NEUROTRAUM, V19, P467, DOI 10.1089/08977150252932415; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Stover JF, 2002, INTENS CARE MED, V28, P1491, DOI 10.1007/s00134-002-1431-2; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; Stover JF, 2000, BRAIN RES, V875, P51, DOI 10.1016/S0006-8993(00)02597-X; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Thomas JM, 2001, TOP CATAL, V15, P85, DOI 10.1023/A:1016697525123; Unterberg AW, 1997, ACT NEUR S, V70, P106; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Xi ZX, 2002, J PHARMACOL EXP THER, V300, P162, DOI 10.1124/jpet.300.1.162	54	17	17	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2003	20	4					315	326		10.1089/089771503765172273			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	673YY	WOS:000182609900001	12866811				2022-02-06	
J	Kennedy, MRT; Nawrocki, MD				Kennedy, MRT; Nawrocki, MD			Delayed predictive accuracy of narrative recall after traumatic brain injury: Salience and explicitness	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						narrative; brain injury; memory; learning; metamemory; self-monitoring; metacognition; metacomprehension	LEARNING JOLS; JUDGMENTS; MEMORY; METAMEMORY; COMPREHENSION; PERFORMANCE; AWARENESS; TEXT; CUE; ADOLESCENTS	Fifteen adults with traumatic brain injury (TBI) and 15 adults without brain injury listened to narratives, made delayed predictions of recall, and took a delayed recall test. Narrative questions differed by salience (main ideas, details) and explicitness (implied, stated) (R. H. Brookshire & L. E. Nicholas, 1993). TBI survivors recalled less than control participants regardless of question type. All participants recalled main ideas and implied information with greater accuracy than details and stated information. Predictive accuracy for recalling stated information was strong regardless of group. Participants were unable to predict recall for implied information. The materials-appropriate-processing (MAP) hypothesis proposes that predictive accuracy is biased by text type (i.e., predictive accuracy for recalling main ideas should be higher than for details when learning narratives). However, there were no differences in predictive accuracy for recalling main ideas and details, with both groups predicting recall modestly well. Controlling for explicitness appears to be an important variable for future metamemory text studies.	Univ Minnesota, Dept Commun Disorders, Minneapolis, MN 55455 USA		Kennedy, MRT (corresponding author), Univ Minnesota, Dept Commun Disorders, 115 Shevlin Hall,164 Pillbury Dr SE, Minneapolis, MN 55455 USA.	kenne047@tc.umn.edu					AGRESTI AA, 1989, J CLIN PSYCHOL, V45, P270, DOI 10.1002/1097-4679(198903)45:2<270::AID-JCLP2270450215>3.0.CO;2-9; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; AMMONS RB, 1979, PSYCHOL REP, V45, P943, DOI 10.2466/pr0.1979.45.3.943; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Brookshire R. H., 1993, DISCOURSE COMPREHENS; Cohen J., 2013, STAT POWER ANAL BEHA; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; Darley F. L., 1978, DIAGNOSTIC METHODS S; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; DUNLOSKY J, 1992, MEM COGNITION, V20, P374, DOI 10.3758/BF03210921; DUNLOSKY J, 1994, J MEM LANG, V33, P545, DOI 10.1006/jmla.1994.1026; Dunlosky J, 1997, J MEM LANG, V36, P34, DOI 10.1006/jmla.1996.2476; Dunlosky J, 2000, PSYCHOL AGING, V15, P462, DOI 10.1037//0882-7974.15.3.462; GLENBERG AM, 1987, J EXP PSYCHOL GEN, V116, P119, DOI 10.1037/0096-3445.116.2.119; Gonzalez R, 1996, PSYCHOL BULL, V119, P159, DOI 10.1037/0033-2909.119.1.159; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; HAUT M W, 1990, Brain Injury, V4, P281, DOI 10.3109/02699059009026178; JOHNSON RE, 1970, J VERB LEARN VERB BE, V9, P12, DOI 10.1016/S0022-5371(70)80003-2; JOHNSONALIRD PN, 1983, MENTAL MODELS; JOHNSONALIRD PN, 1991, DEDUCTION; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; KENNEDY MRT, 2002, UNPUB SELF MONITORIN; Kertesz A., 1982, W APHASIA BATTERY; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MAKI RH, 1987, MEM COGNITION, V15, P72, DOI 10.3758/BF03197713; Maki RH, 1998, MEM COGNITION, V26, P959, DOI 10.3758/BF03201176; MAKI RH, 1995, AM J PSYCHOL, V108, P327, DOI 10.2307/1422893; Maki RH, 1998, EDUC PSYCHO, P117; MCDANIEL MA, 1986, J MEM LANG, V25, P645, DOI 10.1016/0749-596X(86)90041-0; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McGuire MJ, 2001, J EXP PSYCHOL LEARN, V27, P1172, DOI 10.1037//0278-7393.27.5.1172; McNeil M. R., 1986, SEMINARS SPEECH LANG, V7, P123, DOI DOI 10.1055/s-0028-1085226; METCALFE J, 1994, METACOGNITION KNOWIN, P137; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; NELSON TO, 1991, PSYCHOL SCI, V2, P267, DOI 10.1111/j.1467-9280.1991.tb00147.x; NELSON TO, 1994, PSYCHOL SCI, V5, P207, DOI 10.1111/j.1467-9280.1994.tb00502.x; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Newman AC, 2000, BRAIN INJURY, V14, P333; Nicholas L.E., 1995, AM J SPEECH LANGUAGE, V4, P69, DOI [DOI 10.1044/1058-0360.0403.69, 10.1044/1058-0360.0403.69]; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; REITAN RM, 1985, HALSTADREITAN NEUROS; Schreiber TA, 1998, MEM COGNITION, V26, P553, DOI 10.3758/BF03201162; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; VAKIL E, 1992, J CONSULT CLIN PSYCH, V60, P802, DOI 10.1037/0022-006X.60.5.802; Wallsten TS, 1996, ORGAN BEHAV HUM DEC, V65, P220, DOI 10.1006/obhd.1996.0022; Weaver CA, 1997, PSYCHOL SCI, V8, P318, DOI 10.1111/j.1467-9280.1997.tb00445.x; WEAVER CA, 1995, MEM COGNITION, V23, P12, DOI 10.3758/BF03210553; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL	64	17	17	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	FEB	2003	46	1					98	112		10.1044/1092-4388(2003/008)			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	651ZQ	WOS:000181354300008	12647891				2022-02-06	
J	Mayer, NH; Pelensky, J; Whyte, J; Fidler-Sheppard, R				Mayer, NH; Pelensky, J; Whyte, J; Fidler-Sheppard, R			Characterization and correlates of medical and rehabilitation charges for traumatic brain injury during acute rehabilitation hospitalization	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; hospital charges; inpatients; rehabilitation	STAY; LENGTH; IMPACT	Objective: To identify factors associated with specific categories of charges during acute inpatient rehabilitation treatment after traumatic brain injury (TBI). Design: Prospective observational study. Setting: A single Traumatic Brain Injury Model Systems (TBIMS) center. Participants: Eighty-four consecutive TBIMS patients. One exploratory analysis also included all 350 patients with TBI admitted during 1999. Interventions: Not applicable. Main Outcome Measures: Average daily charges for specific categories of resource use (eg, room and board, rehabilitation therapies, functional labs). Results: Room and board and rehabilitation therapy accounted for almost 90% of average daily charges. There was no linear component of change in average daily charges, but certain categories of charges were significantly higher during the first week than thereafter. Functional status at rehabilitation admission correlated with charges for respiratory, medical, and surgical supplies and with pharmacy and radiology, but not the other categories. Specific medical variables also correlated with specific charge categories. Focused chart reviews of patients with low and high charges in specific categories led to the formulation of additional predictive hypotheses. Conclusion: Certain categories of charges correlated with functional scores and acute medical variables that are known before admission to acute inpatient rehabilitation, allowing for better inpatient admission planning under prospective payment. Further research is needed to identify and correlate resource use that is bundled within the room and board category.	Albert Einstein Healthcare Network, MossRehab, Drucker Brain Injury Ctr, Jefferson Hlth Syst, Philadelphia, PA 19141 USA; Temple Univ, Sch Med, Dept Rehabil Med, Philadelphia, PA 19122 USA; Thomas Jefferson Univ, Dept Rehabil Med, Philadelphia, PA 19107 USA; Moss Rehabil Res Inst, Philadelphia, PA USA		Mayer, NH (corresponding author), Albert Einstein Healthcare Network, MossRehab, Drucker Brain Injury Ctr, Jefferson Hlth Syst, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.			Whyte, John/0000-0002-4381-1474			COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; *CTR MED MED SERV, 2001, FED REGISTER, V66, P152; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; Foster J, 1996, AACN Clin Issues, V7, P168, DOI 10.1097/00044067-199602000-00016; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Haas JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199702000-00003; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; 1998, REHABILITATION TRAUM	11	17	17	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2003	84	2					242	248		10.1053/apmr.2003.50101			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	643QV	WOS:000180872700014	12601656				2022-02-06	
J	Man, DWK; Lam, CS; Bard, CC				Man, DWK; Lam, CS; Bard, CC			Development and application of the Family Empowerment Questionnaire in brain injury	BRAIN INJURY			English	Article							SOCIAL SUPPORT; CAREGIVER; REHABILITATION; DISTRESS; MEMBER; BURDEN; NEEDS	Background: The present study was an ongoing development of a previous study of the Family Empowerment Questionnaire, which had already indicated a four-factor solution ( Skill, Knowledge, Support and Aspiration) empowerment process among family caretakers for their family members with traumatic brain injury (TBI). Objective: The Family Empowerment Questionnaire was used to further explore its applicability to rehabilitation professionals through investigating differences between rehabilitation professionals' and family members' perceptions of empowerment in the rehabilitation process of persons with TBI. Method and procedures: The present study compared the 52-item Family Empowerment Questionnaire scores between 65 rehabilitation professionals with the results obtained from 211 family caretakers. Main outcome: Statistical analyses using the factor-based scores of the four sub-scales revealed that professionals and family members differ significantly in their perceptions regarding family empowerment in TBI rehabilitation in any of the four empowerment factors and within individual items of each factor. Conclusions: Specific activities in which families and professionals' perceptions differed significantly should be explored further and clinical implications of the study are discussed.	Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; IIT, Chicago, IL 60616 USA		Man, DWK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China.						ALLAN K, 1994, REHABIL PSYCHOL, V39, P29; BRUCE BW, 1988, FAMILY RELATIONS J A, V37, P12; DELEHANTY R, 1998, J COGNITIVE REHABILI, V16, P14; DURGIN CJ, 1993, STAFF DEV CLIN INTER, P3; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Jones TM, 1996, REDEFINING FAMILY SU, P87; Junque C, 1997, BRAIN INJURY, V11, P251, DOI 10.1080/026990597123557; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kosciulek JF, 1999, INT J REHABIL RES, V22, P269, DOI 10.1097/00004356-199912000-00003; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LARK CS, 2001, DISS ABSTR INT A, V61, P3785; Leathem J, 1996, BRAIN INJURY, V10, P27; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Man D, 1999, BRAIN INJURY, V13, P433, DOI 10.1080/026990599121485; Man DWK, 1998, BRAIN INJURY, V12, P245, DOI 10.1080/026990598122728; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; MAZZUCCHI A, 2000, INT HDB NEUROPSYCHOL, P299; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Shaw LR, 1997, BRAIN INJURY, V11, P219; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Smith J E, 2000, Care Manag J, V2, P27; Sohlberg MM, 2001, J HEAD TRAUMA REHAB, V16, P498, DOI 10.1097/00001199-200110000-00008; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; WATANABE Y, 1996, JAPANESE J REHABILIT, V36, P180	25	17	18	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2003	17	5					437	450		10.1080/0269905031000070152			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	660MQ	WOS:000181837300007	12745715				2022-02-06	
J	Mukherjee, D; Reis, JP; Heller, W				Mukherjee, D; Reis, JP; Heller, W			Women living with traumatic brain injury: Social isolation, emotional functioning and implications for psychotherapy	WOMEN & THERAPY			English	Article						women; psychotherapy; traumatic brain injury; social functioning; emotional functioning		Women living with Traumatic Brain Injury (TBI) typically experience social and emotional sequelae that can be effectively addressed in the context of a psychotherapeutic relationship. Traumatic Brain Injuries can affect the full range of human functioning, from activities of daily living to experiencing a coherent sense of self. In this article, we focus on two issues, social isolation and emotional functioning, that encompass a number of key challenges facing women with TBI and are common and fruitful foci of psychotherapy. Social isolation includes marginalization in multiple communities, the invisibility of cognitive disabilities, difficulties in interpersonal relationships, and difficulties in employment and access to transportation. Emotional functioning includes posttraumatic stress symptoms, loss of self-esteem, anxiety, depression, anger, and shame. Two exemplary cases are used to illustrate the themes and underscore the complexities and realities of adjusting to TBI. Recommendations for therapists and consumers are woven throughout the paper.	Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; Rehabil Inst Chicago, Hlth Resource Ctr Women Disabil, Chicago, IL USA; Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; Univ Illinois, Beckman Inst, Champaign, IL 61820 USA		Mukherjee, D (corresponding author), Univ Chicago, MacLean Ctr Clin Med Eth, AMB W732,MC 6098,5841 S Maryland Ave, Chicago, IL 60637 USA.			Mukherjee, Debjani/0000-0002-8233-8608; Heller, Wendy/0000-0002-6854-558X			Bergquist TF, 1994, J HEAD TRAUMA REHAB, V9, P50, DOI 10.1097/00001199-199412000-00007; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Gill C. J., 1994, REFRAMING WOMENS HLT, P357; HELLER W, 1997, NEUROPSYCHOLOGY NEUR, P398; LANGER KG, 1992, AM J PSYCHOTHER, V46, P620, DOI 10.1176/appi.psychotherapy.1992.46.4.620; Lewis L., 1991, AWARENESS DEFICIT BR, P223; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Mukherjee D, 2001, REHABIL PSYCHOL, V46, P82, DOI 10.1037/0090-5550.46.1.82; MUKHERJEE D, 2000, THESIS U ILLINOIS UR; *NIH, 1998, REH PERS TRAUM BRAIN, V16, P1; PENNEBAKER JW, 1995, EMOTION DISCLOSURE H, P671; Pollack Irwin W., 1994, P671; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 1994, BRAIN INJURY NEUROPS, P173; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; STEWART JE, 2000, THESIS U ILLINOIS UR; *US GAO, 1998, GAOHEHS9855; WORTMAN CB, 1989, J CONSULT CLIN PSYCH, V57, P349, DOI 10.1037/0022-006X.57.3.349; [No title captured]	22	17	17	0	11	HAWORTH PRESS INC	BINGHAMTON	10 ALICE ST, BINGHAMTON, NY 13904-1580 USA	0270-3149			WOMEN THER	Women Ther.		2003	26	1-2					3	26		10.1300/J015v26n01_01			24	Psychology, Multidisciplinary; Women's Studies	Social Science Citation Index (SSCI)	Psychology; Women's Studies	689YK	WOS:000183520400003					2022-02-06	
J	Murdoch, BE; Goozee, JV				Murdoch, BE; Goozee, JV			EMA analysis of tongue function in children with dysarthria following traumatic brain injury	BRAIN INJURY			English	Article							CLOSED-HEAD INJURY; ELECTROMAGNETIC ARTICULOGRAPHY; SPEECH DISORDERS; MOVEMENTS	Primary objective : To investigate the speed and accuracy of tongue movements exhibited by a sample of children with dysarthria following severe traumatic brain injury (TBI) during speech using electromagnetic articulography (EMA). Methods and procedures : Four children, aged between 12.75-17.17 years with dysarthria following TBI, were assessed using the AG-100 electromagnetic articulography system (Carstens Medizinelektronik). The movement trajectories of receiver coils affixed to each child's tongue were examined during consonant productions, together with a range of quantitative kinematic parameters. The children's results were individually compared against the mean values obtained by a group of eight control children (mean age of 14.67 years, SD 1.60). Main outcomes and results : All four TBI children were perceived to exhibit reduced rates of speech and increased word durations. Objective EMA analysis revealed that two of the TBI children exhibited significantly longer consonant durations compared to the control group, resulting from different underlying mechanisms relating to speed generation capabilities and distances travelled. The other two TBI children did not exhibit increased initial consonant movement durations, suggesting that the vowels and/or final consonants may have been contributing to the increased word durations. Conclusions and clinical implications : The finding of different underlying articulatory kinematic profiles has important implications for the treatment of speech rate disturbances in children with dysarthria following TBI.	Univ Queensland, Dept Speech Pathol & Audiol, Motor Speech Res Unit, Brisbane, Qld, Australia		Murdoch, BE (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, St Lucia, Qld 4072, Australia.		Murdoch, Bruce E/C-1397-2012				Brown J.R., 1975, MOTOR SPEECH DISORDE; CAHILL LM, 2001, TRAUMATIC BRAIN INJU, P121; FISHER HB, 1971, FISHER LONGEMANN TES; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; Hardcastle W.J., 1976, PHYSL SPEECH PRODUCT; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HIROSE H, 1986, FOLIA PHONIATR, V38, P61, DOI 10.1159/000265824; Kuehn D. P., 1976, J PHONETICS, V4, P303, DOI 10.1016/S0095-4470(19)31257-4; Murdoch B. E., 1990, ACQUIRED SPEECH LANG; MURDOCH BE, 1998, DYSARTHRIA PHYSL APP, P373; PERKELL JS, 1992, J ACOUST SOC AM, V92, P3078, DOI 10.1121/1.404204; Rosenbek J.C., 1985, CLIN MANAGEMENT NEUR, V2nd ed., P97; SCHONLE PW, 1987, BRAIN LANG, V31, P26, DOI 10.1016/0093-934X(87)90058-7; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; TULLER B, 1990, J ACOUST SOC AM, V88, P674, DOI 10.1121/1.399771; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; [No title captured]	18	17	17	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2003	17	1					79	93		10.1080/0269905021000010203			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	633LK	WOS:000180284600007	12519650				2022-02-06	
J	Yang, KH; King, AI				Yang, KH; King, AI			A limited review of finite element models developed for brain injury biomechanics research	INTERNATIONAL JOURNAL OF VEHICLE DESIGN			English	Article; Proceedings Paper	Impact Biomechanics Australia Conference	2001	SYDNEY, AUSTRALIA	Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control		finite element model; injury tolerance; intracranial pressure; traumatic brain injury	ACUTE SUBDURAL-HEMATOMA; DIFFUSE AXONAL INJURY; HUMAN HEAD; DYNAMIC-RESPONSE; IMPACT; CONTUSION; TISSUE	In this paper, finite element models developed at Wayne State University to study impact injury biomechanics of the human brain were reviewed. The complexity of these models has been augmented significantly over the years in order to allow each new version of the model to address additional clinical phenomena or to make site-specific correlation between the computer model and biological data. Even though all available data have been used for validation of the latest model, it can only be considered partially validated because there is a lack of quantitative data for a complete validation. Nevertheless, useful information has been derived from model predictions. New and higher quality experimental or real world data are needed for making continued improvement to computer models so that they can accurately predict the risk of brain injury in a given impact.	Wayne State Univ, Ctr Bioengn, Detroit, MI 48202 USA		Yang, KH (corresponding author), Wayne State Univ, Ctr Bioengn, Detroit, MI 48202 USA.	king.yang@wayne.edu					Al-Bsharat A. S., 2000, THESIS WAYNE STATE U; ALBSHARAT AS, 1999, P 43 STAPP CRASH C; Allsop D, 1988, P 32 STAPP CAR CRASH; Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; BAE J, 2001, P 6 US NAT C COMP ME; BANDAK FA, 2001, P 17 ESV C AMST TH N; Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; DIMASI FP, 1995, P 39 STAPP CRASH C; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; HARDY WN, 2001, STAPP CAR CRASH J, P45; HARDY WN, 1997, P CRASHW OCC PROT BI, V225, P241; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; KING AI, 1999, P 1999 BIOENG C ASME, P269; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; MCGRATH P, 1984, ATLAS SECTIONAL ANAT; MCLEAN AJ, 1995, J NEUROTRAUM, V12, P621, DOI 10.1089/neu.1995.12.621; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; MILLER RT, 1998, P 42 STAPP CRASH C; NAGASHIMA T, 1990, Neurologia Medico-Chirurgica, V30, P1, DOI 10.2176/nmc.30.1; Nahum AM, 1977, P 21 STAPP CRASH C; Newman J.A., 1999, P INT RES C BIOM I 1, P17; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; NUSHOLTZ GS, 1984, P 28 STAPP CAR CRASH; Nyquist G. W., 1986, P 30 STAPP CAR CRASH; OMORI K, 2000, P 9 ASME S CRASHW OC, V46, P167; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; RUAN JS, 1995, J NEUROTRAUM, V12, P725, DOI 10.1089/neu.1995.12.725; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; RUAN JS, 1993, P 37 STAPP CAR C; Shreiber D. I., 1997, P 41 STAPP CAR CRASH; SHUGAR TA, 1975, P 19 STAPP CAR CRASH; TONG P, 1989, P 12 INT TECHN C EXP, P617; Trosseille X., 1992, P 36 STAPP CAR CRASH; TURQUIER F, 1996, P 40 STAPP CAR CRASH; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; UENO K, 1996, AGARD AMP HEAD INJ S; VOO K, 1989, MED BIOL ENG COMPUT, V34, P375; WILLIAMS TG, 1995, J CONSUM MARK, V12, P4, DOI DOI 10.1108/07363769510147218; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Zhang L, 2001, STAPP CAR CRASH J; Zhang L.Y., 2001, THESIS WAYNE STATE U; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P 39 STAPP CAR CRASH; ZHOU C, 1994, P 38 STAPP CAR CRASH	48	17	17	0	8	INDERSCIENCE ENTERPRISES LTD	GENEVA	WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 856, CH-1215 GENEVA, SWITZERLAND	0143-3369	1741-5314		INT J VEHICLE DES	Int. J. Veh. Des.		2003	32	1-2					116	129		10.1504/IJVD.2003.003240			14	Engineering, Mechanical; Transportation Science & Technology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Engineering; Transportation	691PK	WOS:000183614500009					2022-02-06	
J	Black, KL; Hanks, RA; Wood, DL; Zafonte, RD; Cullen, N; Cifu, DX; Englander, J; Francisco, GE				Black, KL; Hanks, RA; Wood, DL; Zafonte, RD; Cullen, N; Cifu, DX; Englander, J; Francisco, GE			Blunt versus penetrating violent traumatic brain injury: Frequency and factors associated with secondary conditions and complications	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blunt injury; complications; conditions; penetrating injury; traumatic brain injury; violence	HEAD-INJURY; GUNSHOT WOUNDS; COMA; SCALE	To compare types and frequency of medical complications and comorbidities associated with violence-related penetrating traumatic brain injury (TBI) as compared to violence-related blunt TBI. Method: Data were collected prospectively at four medical centers participating in the TBI Model Systems (TBIMS) of Care project. A total of 317 individuals met the inclusion criteria for the TBIMS (i.e., showed evidence of a TBI, were age 16 or older, presented to the TBIMS emergency department within 24 hours of injury, and received acute and rehabilitation services within the model system). Main Outcome Measures : Frequency of medical complications and comorbid diseases. Results: Patients with penetrating injuries suffered significantly higher rates of respiratory failure (P = .004), pneumonitis/pneumonia, (P = .002), skull fracture (P = .001), cerebrospinal fluid leak (P = .0005), and hypotonia (P = .001) than did patients with blunt injuries. Prediction of complications and comorbidities via multiple regression revealed that a penetrating violent injury and the severity of injury were independent predictors of a higher rate of medical complications, whereas age and gender did not account for unique variance in the equation. Conclusions: Penetrating injuries are associated with higher rates of certain medical complications, especially to the pulmonary and central nervous systems. Acute care physicians and physiatrists must be prepared to treat these complications more often in patients with penetrating injuries.	Inst Rehabil, Dept Phys Med & Rehabil, Detroit, MI 48201 USA; Univ Pittsburgh, Med Ctr Hlth Syst, Pittsburgh, PA USA; Toronto Rehabil Inst, Toronto, ON, Canada; Virginia Commonwealth Univ Med Coll Virginia, Richmond, VA USA; Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; Inst Rehabil & Res, Brain Injury Program, Houston, TX USA		Black, KL (corresponding author), Inst Rehabil, Dept Phys Med & Rehabil, 261 Mack Blvd, Detroit, MI 48201 USA.			Cullen, Nora/0000-0001-6359-9418; Cifu, David/0000-0003-1600-9387			AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Andrews BT, 1992, PHYS MED REHAB CLIN, V3, P249; ANDREWS BT, 1990, PHYS MED REHAB STATE, V4, P495; Ansari SA, 1998, BRIT J NEUROSURG, V12, P340; BLACK K, 1999, TOP SPINAL CORD INJ, V5, P47; JENNETT B, LANCET, V1, P480; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Zafonte RD, 1997, BRAIN INJURY, V11, P403; Zafonte RD, 1998, ARCH PHYS MED REHAB, V79, P1469, DOI 10.1016/S0003-9993(98)90246-5	13	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2002	17	6					489	496		10.1097/00001199-200212000-00001			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	617NN	WOS:000179367900001	12802240				2022-02-06	
J	Simpson, A; Schmitter-Edgecombe, M				Simpson, A; Schmitter-Edgecombe, M			Prediction of employment status following traumatic brain injury using a behavioural measure of frontal lobe functioning	BRAIN INJURY			English	Article							ECOLOGICAL VALIDITY; REHABILITATION; ACTIVATION; RETURN; WORK	Objective: To examine whether a behavioural measure of frontal lobe functioning, the Brock Adaptive Functioning Questionnaire (BAFQ), could predict employment status following traumatic brain injury (TBI). Design: A discriminant function analysis was conducted to determine the ability of the BAFQ, along with other factors, to predict occupational status post-injury. Methods: Sixty-one TBI survivors completed a background information questionnaire, the BAFQ, and an employment status rating scale. Results: A factor analysis of the BAFQ sub-scales revealed two factors, one related to functioning in the orbitofrontal area, and one related to dorsolateral frontal lobe functioning. These two factors, along with background information, were entered into a discriminant function analysis, revealing a 77.4% accuracy rate in predicting occupational status post-injury. Conclusions: Demographic variables were found to differentiate employed from unemployed survivors. The BAFQ appeared useful in differentiating survivors who may return to their pre-injury employment level from those who may require modified employment.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Simpson, A (corresponding author), Oregon Hlth & Sci Univ, Child Dev & Rehabil Ctr, POB 574, Portland, OR 97207 USA.	simpso-na@ohsu.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD35838] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER		Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; BUTLER RW, 1989, CLIN NEUROPSYCHOL, V3, P235; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; CHANG SW, 1999, DISS ABSTR INT B, V59, P3684; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cornette L, 2001, CEREB CORTEX, V11, P59, DOI 10.1093/cercor/11.1.59; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008; DYWAN J, 1995, J INT NEUROPSYCH SOC, V1, P121; FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037/0090-5550.40.3.223; FISHBEIN D, 2000, SCI TREATMENT PREVEN; Fleming J, 1999, BRAIN INJURY, V13, P417; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Johnson SC, 2001, J INT NEUROPSYCH SOC, V7, P55, DOI 10.1017/S135561770171106X; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; KOLB B, 1996, FUNDAMENTALS HUMAN N; LAM CS, 1991, REHABIL COUNS BULL, V35, P68; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; NEWNAN OS, 1978, PERCEPT MOTOR SKILL, V46, P635, DOI 10.2466/pms.1978.46.2.635; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Pietrini P, 2000, AM J PSYCHIAT, V157, P1772, DOI 10.1176/appi.ajp.157.11.1772; Possl O, 2001, BRAIN INJURY, V15, P15; RAY JJ, 1987, PERS INDIV DIFFER, V8, P571, DOI 10.1016/0191-8869(87)90220-0; ROSS P, 2000, DISS ABSTR INT B, V61, P3319; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sarazin M, 1998, NEUROLOGY, V51, P142, DOI 10.1212/WNL.51.1.142; SEIDMAN LJ, 1995, NEUROPSYCHOLOGY, V9, P481; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; STUSS DT, 1987, FRONTAL LOBES REVIS; Thomas DF, 1997, J HEAD TRAUMA REHAB, V12, P72, DOI 10.1097/00001199-199710000-00007; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955	37	17	17	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2002	16	12					1075	1091		10.1080/02699050210155249			17	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	617KK	WOS:000179360700006	12487722				2022-02-06	
J	Eng, N; Obler, LK				Eng, N; Obler, LK			Acquired dyslexia in a biscript reader following traumatic brain injury: A second case	TOPICS IN LANGUAGE DISORDERS			English	Article						alexia; biscriptal; character; logographic; orthographic	CHINESE; PERCEPTION; TONE	This case study examines the reading disruptions in a bilingual/biscriptal (Cantonese/English) reader following traumatic brain injury. Reading disruptions following brain injury are termed acquired dyslexia and alexia. Because of their unique ability to read in two different scripts, biscript readers with acquired dyslexia pose unique questions to neurolinguists and psychologists. These readers possess two orthographic systems and thus allow the opportunity to explore the biscriptal lexicon. Additionally, when particular readers' two scripts are marked differently, as in the case of an alphabetic script and a logographic script, questions regarding word-recognition processes can be explored.	St Johns Univ, Dept Speech Commun Sci & Theatre, Jamaica, NY 11439 USA; CUNY, Grad Sch & Univ Ctr, New York, NY 10021 USA		Eng, N (corresponding author), St Johns Univ, Dept Speech Commun Sci & Theatre, Jamaica, NY 11439 USA.						Albert M.L., 1978, BILINGUAL BRAIN NEUR; Chao Y.R., 1968, GRAMMAR SPOKEN CHINE; COLTHEART M, 1984, ORTHOGRAPHIES READIN; Coltheart M., 1980, DEEP DYSLEXIA; EHRLICH J, 1988, AM SPEECH HEAR ASS A; Eng N, 1996, APHASIOLOGY, V10, P649, DOI 10.1080/02687039608248441; ENG N, 1998, ADV STUD I NEUR COGN; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Francis W.N., 1982, FREQUENCY ANAL ENGLI; GANDOUR J, 1988, BRAIN LANG, V35, P201, DOI 10.1016/0093-934X(88)90109-5; GORAL M, 2001, J NEUROLINGUIST, V14, P321; Kaplan E, 1983, BOSTON NAMING TEST; KARANTH P, 1992, READ WRIT, V4, P87; Kroll J.F., 2001, ONE MIND 2 LANGUAGES, P49; LIM V, 1998, 1 AS PAC COMM DIS C; LYMAN R. S., 1938, CHINESE MED JOUR, V54, P491; McNeil MR, 1978, REVISED TOKEN TEST; OBLER LK, 1984, NEUROPSYCHOLOGIA, V22, P235, DOI 10.1016/0028-3932(84)90066-6; Perfetti CA, 1998, J EXP PSYCHOL LEARN, V24, P101, DOI 10.1037/0278-7393.24.1.101; Sasanuma S, 1972, Cortex, V8, P265; Sasanuma S., 1980, DEEP DYSLEXIA, P48; SUEN YS, 1986, MOST FREQUENT CHINES; Tzeng OJL, 1992, LANGUAGE PROCESSING, P3, DOI 10.1016/s0166-4115(08)61885-3; Weekes BS, 1998, APHASIOLOGY, V12, P77, DOI 10.1080/02687039808249445; Weekes BS, 1997, NEUROCASE, V3, P51, DOI 10.1080/13554799708404034; YIN WG, 1992, LANGUAGE PROCESSING, P349	26	17	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-8294			TOP LANG DISORD	Top. Lang. Disord.	NOV	2002	22	5					5	19		10.1097/00011363-200211000-00005			15	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	612HR	WOS:000179068800005					2022-02-06	
J	Harris, CH; Smith, RS; Helmer, SD; Gorecki, JP; Rody, RB				Harris, CH; Smith, RS; Helmer, SD; Gorecki, JP; Rody, RB			Placement of intracranial pressure monitors by non-neurosurgeons	AMERICAN SURGEON			English	Article							SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; AGGRESSIVE TREATMENT; MANAGEMENT; EXPERIENCE; MANNITOL	Maintaining adequate cerebral perfusion is important in the treatment of patients with closed head injury. Placement of an intracranial pressure (ICP) monitor is necessary to determine both ICP and the cerebral perfusion pressure and serves as a guide to the contemporary management of traumatic brain injury. Insertion of such monitoring devices historically has been performed by neurosurgeons, but others including general (trauma) surgeons have successfully inserted simple ICP monitors. The purpose of this study was to assess the efficacy of ICP monitor placement and to compare the complication rates for ICP monitor placement by general surgery residents, trauma surgeons, and staff neurosurgeons. We retrospectively reviewed the medical records of trauma patients with cerebral injury who required insertion of parenchymal ICP monitors from January 1994 to January 1999. Monitor placement was performed by staff neurosurgeons, general surgical residents, and trauma surgeons. Surgical residents received appropriate training in the placement of ICP monitors from attending trauma surgeons and neurosurgeons. Records were examined for demographic variables such as age, gender, mechanism of injury, admission Glasgow Coma Score, and Injury Severity Score. Records were also reviewed for duration of ICP monitoring and for complications (i.e., intracranial hemorrhage after monitor placement, monitor-related infection, monitor malfunction, and monitor displacement). One hundred fifty-seven monitors were placed in 146 patients with intracranial injury. Surgical residents placed 87 ICP monitors without neurosurgical or trauma attending surgeons at the bedside and 43 with immediate supervision by general surgeons or neurosurgeons. Neurosurgeons placed 26 monitors without the participation of residents, and an attending trauma surgeon placed one monitor without the involvement of a resident or a neurosurgeon. There were no major technical complications, no episodes of catheter-induced intracranial hemorrhage, and no infectious complications. These data suggest that simple ICP monitors may be inserted by non-neurosurgeons without significant problems or complications. The low complication rate associated with this procedure was similar for neurosurgeons and non-neurosurgeons. We believe that insertion of simple parenchymal ICP monitors should be considered a core skill for trauma surgeons and should be included in surgical residency training. Insertion of ICP monitors by non-neurosurgeons is a potential method of improving the care of patients with brain injury in geographic areas that are underserved by neurosurgeons.	Univ Kansas, Sch Med, Dept Surg, Wichita, KS 67214 USA; Via Christi Reg Med Ctr, Dept Emergency Med, Wichita, KS USA; Via Christi Reg Med Ctr, Dept Neurosurg, Wichita, KS USA; Via Christi Reg Med Ctr, Dept Med Educ, Wichita, KS USA; Via Christi Reg Med Ctr, Dept Surg, Wichita, KS USA		Smith, RS (corresponding author), Univ Kansas, Sch Med, Dept Surg, 929 N St Francis, Wichita, KS 67214 USA.			Helmer, Stephen/0000-0002-8760-7950			BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; EDDY VA, 1995, AM SURGEON, V61, P24; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; TASKER RC, 1991, NEUROPEDIATRICS, V22, P47, DOI 10.1055/s-2008-1071416	13	17	17	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2002	68	9					787	790					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	661YA	WOS:000181916500012	12356151				2022-02-06	
J	Fraisse, A; Piechaud, JF; Avierinos, JF; Aubert, F; Colavolpe, C; Habib, G; Bonnet, JL				Fraisse, A; Piechaud, JF; Avierinos, JF; Aubert, F; Colavolpe, C; Habib, G; Bonnet, JL			Transcatheter closure of traumatic ventricular septal defect: An alternative to surgical repair?	ANNALS OF THORACIC SURGERY			English	Article								A 19-year-old-man with multiple-system injuries including a serious head injury and two poorly tolerated traumatic ventricular septal defects, was admitted to our hospital. Transcatheter closure of the cardiac defects was attempted instead of surgical repair because the required anticoagulation for cardiopulmonary bypass could precipitate intracranial bleeding. The two ventricular septal defects were successfully closed with Amplatzer devices, but the patient remained in hemodynamically unstable condition and subsequently died. Transcatheter closure of traumatic ventricular septal defect is an alternative to surgical repair, although it remains a hazardous procedure and requires experienced anesthesia management.	Hop Enfants La Timone, Serv Cardiol A, F-13005 Marseille, France; Hop Enfants La Timone, Serv Reanimat Polyvalente, F-13005 Marseille, France; Hop Enfants La Timone, Serv Chirurg Thorac & Cardiovasc, Marseille, France; Inst Hosp Jacques Cartier, Massy, France		Fraisse, A (corresponding author), Hop Enfants La Timone, Serv Cardiol A, 264 Rue St Pierre, F-13005 Marseille, France.	afraisse@mail.ap-hm.fr	miaoyue, chen/A-6575-2012				LAUSSEN PC, 1995, ANESTH ANALG, V80, P1076, DOI 10.1097/00000539-199506000-00002; LOCK JE, 1988, CIRCULATION, V78, P361, DOI 10.1161/01.CIR.78.2.361; Pretre R, 1997, NEW ENGL J MED, V336, P626, DOI 10.1056/NEJM199702273360906; Schaffer RB, 1999, ANN THORAC SURG, V67, P843, DOI 10.1016/S0003-4975(99)00044-2; Thanopoulos BD, 1999, J AM COLL CARDIOL, V33, P1395, DOI 10.1016/S0735-1097(99)00011-X	5	17	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	AUG	2002	74	2					582	584	PII S0003-4975(02)03607-X	10.1016/S0003-4975(02)03607-X			3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	581XR	WOS:000177320600071	12173854				2022-02-06	
J	Korinth, MC; Ince, A; Banghard, W; Huffmann, BC; Gilsbach, JM				Korinth, MC; Ince, A; Banghard, W; Huffmann, BC; Gilsbach, JM			Pterional orbita decompression in orbital hemorrhage and trauma	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						orbital trauma; retrobulbar hemorrhage; retrobulbar hematoma; trauma; visual loss; orbital decompression	RETROBULBAR HEMORRHAGE; IMMEDIATE DECOMPRESSION; OPTIC-NERVE; ORBITOPATHY; DIAGNOSIS; BLINDNESS; HEMATOMA	Background: This article presents a series of patients with traumatic retrobulbar hematoma and orbital trauma, treated with extended pterional orbital decompression. Methods: Fifteen patients, showing symptomatic retrobulbar hematoma or symptoms of orbital injury after various trauma mechanisms, were treated with deep lateral orbital decompression and removal of orbital blood/bone fragments via this approach. Preoperative and postoperative course, neuroradiologic findings, additional brain or facial injuries, and outcome of eye function are analyzed in detail. Results: Mean delay between trauma and decompression was 70 hours (3 days), with a range from 2 hours to 15 days. Proptosis decreased in all patients and visual acuity improved or remained normal in nine patients and stayed defective in four. Impaired extraocular movements and pupillary changes recovered in 10 patients. Apart from one case of permanent deficit of the frontal branch of the facial nerve, no severe complications were seen. Conclusion The presented pterional orbital decompression represents an effective alternative approach for patients with sight-threatening retrobulbar hematoma or orbital trauma, especially in cases that require direct access to damaged structures and maximal decompression of the orbit. Immediate detection and treatment of orbital hematomas is mandatory for acceptable outcome of eye function.	Univ Hosp, Rhein Westfal TH Aachen, Dept Neurosurg, D-52057 Aachen, Germany; Univ Hosp, Rhein Westfal TH Aachen, Dept Ophthalmol, D-52057 Aachen, Germany		Korinth, MC (corresponding author), Univ Hosp, Rhein Westfal TH Aachen, Dept Neurosurg, D-52057 Aachen, Germany.						Amagasaki K, 1998, NEUROL MED-CHIR, V38, P221, DOI 10.2176/nmc.38.221; BAILEY WK, 1993, J ORAL MAXIL SURG, V51, P780, DOI 10.1016/S0278-2391(10)80422-7; CIONNI RJ, 1991, OPHTHALMOLOGY, V98, P1153; Ghufoor K, 1998, INJURY, V29, P139, DOI 10.1016/S0020-1383(97)00129-0; GILSBACH JM, 1988, NEUROSURG REV, V11, P167, DOI 10.1007/BF01794683; GILSBACH JM, 1994, SKULL BASE SURG, V4, P72, DOI 10.1055/s-2008-1058973; Gocer AI, 1996, NEUROSURG REV, V19, P169, DOI 10.1007/BF00512047; Goldberg RA, 1995, OPHTHALMIC PLAST REC, V11, P245, DOI 10.1097/00002341-199512000-00004; Goodall KL, 1999, INJURY, V30, P485, DOI 10.1016/S0020-1383(99)00137-0; Hislop WS, 1996, BRIT J ORAL MAX SURG, V34, P289, DOI 10.1016/S0266-4356(96)90004-2; HISLOP WS, 1994, INJURY, V25, P663, DOI 10.1016/0020-1383(94)90009-4; LIU D, 1993, AM J OPHTHALMOL, V116, P34, DOI 10.1016/S0002-9394(14)71740-4; MORRIS TA, 1985, J MAXILLOFAC SURG, V13, P129, DOI 10.1016/S0301-0503(85)80032-1; ORD RA, 1981, BRIT J ORAL SURG, V19, P202, DOI 10.1016/0007-117X(81)90005-6; Rosdeutscher JD, 1998, ANN PLAS SURG, V41, P618, DOI 10.1097/00000637-199812000-00006; Saussez Sven, 1998, Rhinology (Utrecht), V36, P37; STOLL W, 1994, HNO, V42, P685; STOLL W, 1988, J CRANIO MAXILL SURG, V16, P308, DOI 10.1016/S1010-5182(88)80068-4; THYNE G M, 1992, New Zealand Dental Journal, V88, P60; Wen HT., 2001, OPER TECH NEUROSURG, V4, P60, DOI [10.1053/otns.2001.25567, DOI 10.1053/OTNS.2001.25567]; WOOD GD, 1986, BRIT J ORAL MAX SURG, V24, P12, DOI 10.1016/0266-4356(86)90033-1; YOUNG CW, 1994, OPHTHALMIC PLAST REC, V10, P137	22	17	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2002	53	1					73	78		10.1097/00005373-200207000-00015			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	573BR	WOS:000176809900020	12131393				2022-02-06	
J	Greiffenstein, MF; Baker, WJ; Johnson-Greene, D				Greiffenstein, MF; Baker, WJ; Johnson-Greene, D			Actual versus self-reported scholastic achievement of litigating postconcussion and severe closed head injury claimants	PSYCHOLOGICAL ASSESSMENT			English	Article							RESPONSE BIAS; MMPI-2; RECALL; SCALE; INDEX	Psychologists typically rely on patients' self-report of premorbid status in litigated settings, The authors examined the fidelity between self-reported and actual scholastic performance in litigating head injury claimants. The data indicated late postconcussion syndrome (LPCS) and severe closed head injury litigants retrospectively inflated scholastic performance to a greater degree than nonlitigating control groups. The LPCS group showed the highest magnitude of grade inflation, but discrepancy scores did not significantly correlate with a battery of malingering measures or with objective cerebral dysfunction. These findings support previous studies, which showed self-report is not a reliable basis for estimation of preinjury cognitive status. Retrospective inflation may represent a response shift bias shaped by an adversarial context rather than a form of malingering.	Psychol Syst Inc, Royal Oak, MI 48067 USA; Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA		Greiffenstein, MF (corresponding author), Psychol Syst Inc, 26862 Woodward,Suite 103, Royal Oak, MI 48067 USA.	mfg@neuro-psychology.com					Arbisi PA, 1997, PSYCHOL ASSESSMENT, V9, P102, DOI 10.1037/1040-3590.9.2.102; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037/0033-2909.113.1.82; BUTCHER JN, 1992, ESSENTIALS MMPI2 MMP; BUTCHER JN, 1989, MMPI2 MANUAL ADM SCO; COLLINS LM, 1985, APPL PSYCH MEAS, V9, P301, DOI 10.1177/014662168500900308; DALTON JE, 1989, PSYCHOL ASSESSMENT, V1, P56, DOI DOI 10.1037/1040-3590.1.1.56; Gosling SD, 1998, J PERS SOC PSYCHOL, V74, P1337, DOI 10.1037/0022-3514.74.5.1337; GREENE R, 1991, MMPI MMPI2 INTERPRET; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; GREIFFENSTEIN MF, 2001, J INT NEUROPSYCH SOC, V7, P181; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HARRISON DA, 1994, J APPL PSYCHOL, V79, P240, DOI 10.1037/0021-9010.79.2.240; Haynes R, 1997, J EPIDEMIOL COMMUN H, V51, P283, DOI 10.1136/jech.51.3.283; Heaton RK, 1991, COMPREHENSIVE NORMS; Henry B., 1994, PSYCHOL ASSESSMENT, V6, P92, DOI [10.1037/1040-3590.6.2.92, DOI 10.1037/1040-3590.6.2.92]; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; HOFFMAN BF, 1986, AM J PSYCHIAT, V143, P1488; HYER L, 1989, J CLIN PSYCHOL, V45, P250, DOI 10.1002/1097-4679(198903)45:2<250::AID-JCLP2270450211>3.0.CO;2-N; JOHNSONGREENE D, 1995, ARCH CLIN NEUROPSYCH, V10, P251, DOI 10.1016/0887-6177(94)00043-P; JohnsonGreene D, 1997, ARCH CLIN NEUROPSYCH, V12, P635, DOI 10.1016/S0887-6177(96)00046-7; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P221, DOI 10.1037/0022-3514.77.2.221; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LeesHaley PR, 1996, PSYCHOL REP, V79, P811, DOI 10.2466/pr0.1996.79.3.811; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; *NAT CTR ED STAT, 2001, COMM COR DAT INF PUB; Rogers R, 1998, LAW HUMAN BEHAV, V22, P273, DOI 10.1023/A:1025702405865; ROGERS R, 1990, PROF PSYCHOL-RES PR, V21, P182; Rogers R., 1997, CLIN ASSESSMENT MALI; SHEPPARD BH, 1980, J PERS SOC PSYCHOL, V39, P320; SPREEN O, 1998, COMPENDIUM NEUORPSYC; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; van den Brink M, 2001, HEADACHE, V41, P11, DOI 10.1046/j.1526-4610.2001.111006011.x; WELTE JW, 1993, ALCOHOL CLIN EXP RES, V17, P758, DOI 10.1111/j.1530-0277.1993.tb00836.x; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	42	17	17	1	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2002	14	2					202	208		10.1037//1040-3590.14.2.202			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	555JL	WOS:000175790900009	12056082				2022-02-06	
J	Subramanian, SK; Roszler, MH; Gaudy, B; Michael, DB				Subramanian, SK; Roszler, MH; Gaudy, B; Michael, DB			Significance of computed tomography mixed density in traumatic extra-axial hemorrhage	NEUROLOGICAL RESEARCH			English	Article						computed tomography; extra-axial hemorrhage; traumatic brain injury	HEMATOMAS; CT	Computed tomography (CT) mixed density of traumatic extra-axial hemorrhages (TEN) or the 'swirl sign' has been reported to correlate with active bleeding found at craniotomy and poor outcome. This study was done to test the hypothesis that mixed density of TEH detected by third or fourth generation CT correlated with the type of bleeding or clinical outcome. All cases of TEH operated at Detroit Receiving Hospital from 1991-1997 were reviewed for type of bleeding (active vs. not active; arterial vs. venous); Glasgow Coma Scale (severe 1-8, not severe 9-15); and Glasgow Outcome Score (1-3 poor; 4,5 good). CT density (CTD) of 51 cases with specific written documentation of bleeding type were then independently reviewed (SKS and MHR) and classified into TEH with mixed or high density. Data was analyzed using corrected Chi Square analysis, Fischer's Exact Test and Pearson's Correlation (SPSS 6.0). The Pearson Chi Square probability for correlation follows: CTD vs. active bleeding, 0.21; CTD vs. arterial, 0.41; CTD vs. severity, 0.57; and CTD vs. outcome, 0.81. No other statistical analysis identified a significant correlation, thus the null hypothesis could not be rejected. CT mixed density was not found to be correlated by more than chance with bleeding type, injury severity or outcome. Surgeon inaccuracy in documentation of bleeding type and use of later generation CT may account for the discrepancy between this and previous studies. Nevertheless, we conclude clinical exam and other published CT criteria are better indicators of injury severity and outcome.	Detroit Receiving Hosp & Univ Hlth Ctr, Dept Neurol Surg, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI 48202 USA; Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48202 USA; Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48202 USA		Michael, DB (corresponding author), Detroit Receiving Hosp & Univ Hlth Ctr, Dept Neurol Surg, 4201 St Antoine, Detroit, MI 48201 USA.						BERGSTROM M, 1977, J COMPUT ASSIST TOMO, V1, P449, DOI 10.1097/00004728-197710000-00011; CHEE CP, 1991, NEURORADIOLOGY, V33, P152, DOI 10.1007/BF00588255; GREENBERG J, 1985, NEUROSURGERY, V17, P48, DOI 10.1227/00006123-198507000-00008; GREENBERG MS, 1997, HDB NEUROSURGERY, V1, P426; GREENBERG MS, 1997, HDB NEUROSURGERY, V2, P553; HAMILTON M, 1992, AM J NEURORADIOL, V13, P853; HELMER FA, 1968, J NEUROSURG, V29, P652, DOI 10.3171/jns.1968.29.6.0652; KAUFMAN HH, 1980, J COMPUT ASSIST TOMO, V4, P557, DOI 10.1097/00004728-198008000-00034; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; REED D, 1986, AM J NEURORADIOL, V7, P417; SMITH WP, 1981, AM J ROENTGENOL, V136, P543, DOI 10.2214/ajr.136.3.543; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729	12	17	17	0	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR	2002	24	2			SI		125	128	UNSP 0161-6412/02/020125-04	10.1179/016164102101199657			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521YR	WOS:000173869400002	11877894				2022-02-06	
J	Suhr, JA				Suhr, JA			Malingering, coaching, and the serial position effect	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						malingering; head injury; memory	ALZHEIMERS-DISEASE; HEAD-INJURY; FREE RECALL; MEMORY; TESTS; PERFORMANCE; DEMENTIA	The normal pattern of performance on list-learning tasks is to recall more words from the beginning (primacy) and end (recency) of the list. This pattern is also seen in patients with closed head injury, but malingerers tend to recall less words from the beginning of word lists, leading to a suppressed primacy effect. The present study examined this pattern on both learning trials and delayed recall of the Auditory Verbal Learning Test (AVLT) in 34 persons performing with normal effort, 38 naive malingerers, 33 warned malingerers, and 29 head-injured patients. Both malingering groups had lower scores on the primacy portion of the list during learning trials, while normals and head-injured patients had normal serial position curves. During delayed recall, normals and head-injured patients did better than the two malingering groups on middle and recency portions of the list. Findings suggest that the serial position effect during learning trials may be a useful pattern of performance to watch for when suspicious of malingering. (C) 2001 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Ohio Univ, Dept Psychol, Athens, OH 45701 USA		Suhr, JA (corresponding author), Ohio Univ, Dept Psychol, Porter Hall 200, Athens, OH 45701 USA.						BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Burkart M, 1998, DEMENT GERIATR COGN, V9, P130, DOI 10.1159/000017036; Carlesimo GA, 1997, CORTEX, V33, P155, DOI 10.1016/S0010-9452(97)80011-1; Carlesimo GA, 1995, CORTEX, V31, P735, DOI 10.1016/S0010-9452(13)80024-X; CRAIK FIM, 1970, J VERB LEARN VERB BE, V9, P143, DOI 10.1016/S0022-5371(70)80042-1; GIBSON AJ, 1981, BRIT J CLIN PSYCHOL, V20, P179, DOI 10.1111/j.2044-8260.1981.tb00516.x; Hermann BP, 1996, CORTEX, V32, P323, DOI 10.1016/S0010-9452(96)80054-2; Martin RC, 1996, J CLIN EXP NEUROPSYC, V18, P265, DOI 10.1080/01688639608408281; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; MARTIN RC, 1992, FORENSIC REPORTS, V5, P393; MASSMAN PJ, 1993, DEV NEUROPSYCHOL, V9, P1, DOI 10.1080/87565649309540540; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; RUNDUS D, 1971, J EXP PSYCHOL, V89, P63, DOI 10.1037/h0031185; RUNDUS D, 1970, J VERB LEARN VERB BE, V9, P684, DOI 10.1016/S0022-5371(70)80033-0; SUHR J, 1997, J CLIN EXPT NEUROPSY, V19, P495; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3	20	17	18	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2002	17	1					69	77		10.1016/S0887-6177(00)00102-5			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	504XD	WOS:000172880700006	14589754	Bronze			2022-02-06	
J	Esmail, S; Esmail, Y; Munro, B				Esmail, S; Esmail, Y; Munro, B			Sexuality and disability: The role of health care professionals in providing options and alternatives for couples	SEXUALITY AND DISABILITY			English	Article						sexuality; disability; relationships; P-LI-SS-IT model	SPINAL-CORD INJURY; TRAUMATIC BRAIN INJURY; PARTNER EXPERIENCES; ADJUSTMENT; QUALITY; MARRIAGE; IMPACT; LIFE	Disability affects both the individual and his/her partner and, if health care professionals are to work with clients in a holistic manner they will need to include the partner. A comprehensive review of the literature was completed to examine the impact of disability on sexuality as it relates to couple relationships and to explore strategies health care providers can utilize to help couples deal with these issues. The literature describes some common intervention strategies that have been shown to be effective in helping couples affected by disability or illness address the issue of sexuality. Specific concerns and difficulties faced by couples are also identified. Finally, the various intervention strategies will be incorporated into a framework known as the P-LI-SS-IT model. With this framework, health care providers will be able to determine the client's needs, as well as assess their own level of comfort and expertise in dealing with this very important task.	Univ Alberta, Fac Rehabil Med, Dept Occupat Therapy, Edmonton, AB T6G 2G4, Canada; Univ Alberta, Capital Hlth Author, Edmonton, AB, Canada; Univ Alberta, Dept Human Ecol, Edmonton, AB, Canada		Esmail, S (corresponding author), Univ Alberta, Fac Rehabil Med, Dept Occupat Therapy, Rm 2-12 Corbett Hall, Edmonton, AB T6G 2G4, Canada.						ABRAMS KS, 1981, PARAPLEGIA, V19, P253, DOI 10.1038/sc.1981.49; Anderson L., 1992, CANADIAN J HUMAN SEX, V1, P177; Annon J. S., 1974, BEHAV TREATMENT SEXU; Annon J. S, 1976, BEHAV TREATMENT SEXU; BERNARDO ML, 1981, REHABIL LIT, V43, P213; BROWN JS, 1986, SOC SCI MED, V23, P313, DOI 10.1016/0277-9536(86)90353-9; CHIPOURAS S, 1979, SEX DISABIL, V2, P301; CHUBON RA, 1981, SEX DISABIL, V4, P3, DOI 10.1007/BF01102460; COHEN BD, 1976, ARCH PHYSICAL MED RE, V5, P473; CONINE TA, 1984, REHABILITATION PSYCH; CREWE NM, 1988, ARCH PHYS MED REHAB, V69, P435; CREWE NM, 1993, REPRODUCTIVE ISSUES FOR PERSONS WITH PHYSICAL DISABILITIES, P141; DAVID A, 1977, PARAPLEGIA, V15, P198, DOI 10.1038/sc.1977.29; De Kleijin-de Vrankrijker M. W., 1998, INTRO DISABILITY, P11; DEVIVO MJ, 1995, ARCH PHYS MED REHAB, V76, P130, DOI 10.1016/S0003-9993(95)80022-0; DeVivo MJ, 1996, REHABIL PSYCHOL, V41, P321, DOI 10.1037/h0092836; DICKERFRIEDMAN J, 1997, OT PRACTICE, P20; Feigin R, 1998, MARRIAGE FAM REV, V27, P71, DOI 10.1300/J002v27n01_06; GAMEL C, 1993, J ADV NURS, V18, P1219, DOI 10.1046/j.1365-2648.1993.18081219.x; Gill K.M, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI [DOI 10.1097/00001199-199005020-00007, 10.1097/00001199-199005020-00007]; HOCH Z, 1977, ARCH PHYS MED REHAB, V58, P413; Kennedy M., 1987, CANADIAN J OCCUPATIO, V54, P189; KESTER BL, 1988, REHABIL COUNS BULL, V32, P4; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; KREUTER M, 1994, PARAPLEGIA, V32, P225, DOI 10.1038/sc.1994.42; Kreuter M, 1996, ARCH PHYS MED REHAB, V77, P541, DOI 10.1016/S0003-9993(96)90292-0; KREUTER M, 1994, PARAPLEGIA, V32, P759, DOI 10.1038/sc.1994.122; LICHTENSTEIN J, 1991, DISS ABSTR INT A, V51, P10; McAlonan S, 1996, AM J OCCUP THER, V50, P826, DOI 10.5014/ajot.50.10.826; McNeff Elizabeth A., 1997, P595; Miller L., 1994, J COGNITIVE REHABILI, V12, P12; Milligan MS, 1998, SEX DISABIL, V16, P117, DOI 10.1023/A:1023080009783; Montagu A., 1978, TOUCHING HUMAN SIGNI; NEISTADT ME, 1986, AM J OCCUP THER, V40, P542, DOI 10.5014/ajot.40.8.542; Perlesz A, 1998, INT J REHABIL RES, V21, P339, DOI 10.1097/00004356-199812000-00001; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; RATHUS SA, 1997, HUMAN SEXUALITY WORL; Rintala DH, 1997, SEX DISABIL, V15, P219, DOI 10.1023/A:1024717313923; RODOCKER M, 1981, SEXUALITY PHYSICAL D, P277; ROLLAND JS, 1994, J MARITAL FAM THER, V20, P327, DOI 10.1111/j.1752-0606.1994.tb00125.x; SADOUGHI W, 1971, Archives of Physical Medicine and Rehabilitation, V52, P311; Sandel M. Elizabeth, 1997, P221; SCHULER M, 1982, J SEX MARITAL THER, V8, P241, DOI 10.1080/00926238208405826; Sipski Marca L., 1997, P3; THORNGRAY BE, 1983, REHABIL LIT, V44, P138; Urey J R, 1987, Rehabil Nurs, V12, P26; UREY JR, 1987, ARCH PHYS MED REHAB, V68, P69; Vargo F., 1984, J APPL REHABIL COUNS, V15, P28; Whitehead T. L., 1993, Journal of Burn Care and Rehabilitation, V14, P221, DOI 10.1097/00004630-199303000-00018; WHO, 1975, ED TREATM HUM SEX TR; WILLIAMS SE, 1993, ARCH PHYS MED REHAB, V74, P361; Wilson M E, 1988, Oncol Nurs Forum, V15, P49; Yim SY, 1998, SPINAL CORD, V36, P826, DOI 10.1038/sj.sc.3100714; YOSHIDA KK, 1994, SEX DISABIL, V12, P179, DOI 10.1007/BF02547904; [No title captured]	55	17	18	1	4	KLUWER ACADEMIC-HUMAN SCIENCES PRESS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0146-1044			SEX DISABIL	Sex. Disabil.	WIN	2001	19	4					267	282		10.1023/A:1017905425599			16	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	528ZL	WOS:000174275500004					2022-02-06	
J	Hilsabeck, RC; LeCompte, DC; Marks, AR; Grafman, J				Hilsabeck, RC; LeCompte, DC; Marks, AR; Grafman, J			The Word Completion Memory Test (WCMT): a new test to detect malingered memory deficits	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						malingering; neuropsychological; analogue; coaching; WCMT	MMPI-2 VALIDITY SCALES; HEAD-INJURY; IMPAIRMENT; FRAMEWORK	In recent years, much research has focused on developing tests to detect malingering. A drawback of existing tests is their poor ability to detect malingerers possessing more "sophisticated" knowledge of neuropsychological deficits. The current study presents preliminary validation data on a new measure, the Word Completion Memory Test (WCMT), which is the first malingering test to utilize a sophisticated coaching methodology in its development. The WCMT was administered to control participants, memory-impaired patients, and coached simulators. The coached simulators were provided with specific information about and examples of memory deficits commonly experienced following closed head injury (CHI; e.g., anterograde vs. retrograde amnesia). They also read a detailed scenario describing the lifestyle and motivations likely experienced by CHI litigants, and then practiced their roles by taking a quiz about their deficits. Results showed that 93% of coached simulators and 100% of control and memory-impaired participants were correctly classified by the WCMT. (C) 2001 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; BMC Software, Houston, TX USA; NINDS, NIH, Bethesda, MD USA		Hilsabeck, RC (corresponding author), Univ Calif San Diego, Med Ctr, 200 W Arbor Dr, San Diego, CA 92103 USA.		Hilsabeck, Robin/ABC-5093-2020	Grafman, Jordan H./0000-0001-8645-4457			BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Chouinard M J, 1997, J Int Neuropsychol Soc, V3, P545; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; Frederick R. I., 1997, VALIDITY INDICATOR P; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; GUILMETTE TJ, 1994, PERCEPT MOTOR SKILL, V78, P1179, DOI 10.2466/pms.1994.78.3c.1179; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HILSABECK RC, 1997, WORLD COMPLETION MEM; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Lamb D.G., 1994, PSYCHOL ASSESSMENT, V6, P8, DOI [https://doi.org/10.1037/1040-3590.6.1.8, DOI 10.1037/1040-3590.6.1.8]; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MARTIN RC, 1992, FORENSIC REPORTS, V5, P393; Rey A., 1964, EXAMEN CLIN PSYCHOL; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; ROGERS R, 1988, CLIN ASSESSMENT MALI; ROSE FE, 1995, CLIN NEUROPSYCHOL, V10, P163; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; WETTER MW, 1995, PROF PSYCHOL-RES PR, V26, P474, DOI 10.1037/0735-7028.26.5.474; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]	31	17	17	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	OCT	2001	16	7					669	677		10.1016/S0887-6177(00)00077-9			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	473RK	WOS:000171061700004	14589785	Bronze			2022-02-06	
J	Mueller, FO; Marshall, SW; Kirby, DP				Mueller, FO; Marshall, SW; Kirby, DP			Injuries in Little League Baseball from 1987 through 1996 - Implications for prevention	PHYSICIAN AND SPORTSMEDICINE			English	Article							COMMOTIO CORDIS; CHEST IMPACTS; SOFTBALL; RISK	BACKGROUND: Baseball is a very popular team sport in the United States, but there has been concern with the number of injuries and fatalities. OBJECTIVE: This study describes the incidence of injuries to Little League Baseball, Inc, players from 5 to 12 years old from 1987 through 1996. METHODS: Descriptive statistical analyses of injuries derived from Little League Baseball, Inc, insurance data from 17,221,210 player-years of follow-up in the 10-year study period. An average of 1,722,121 children participated every year. RESULTS: During the study, there were 29,038 injuries and an injury rate of 1.69 injuries per 1,000 participants per season. Ball-related injuries totaled 15,266, and batters had the greatest number of ball injuries. There were 12,306 facial and teeth injuries, mostly in defensive players. Sliding was associated with 60% of the injuries to base runners. Approximately 25% of the injuries were considered severe (fractures, dislocations, and concussions), and 13 players died. CONCLUSION: Based on the data, youth baseball appears to be a very safe sport, but there are areas where injury prevention is possible. Data and additional attention are needed concerning face mask use for players in the field, modified balls for minimizing contact injuries, education on sliding technique, and use of safety bases for runners.	Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Jury Prevent Res Ctr, Chapel Hill, NC 27599 USA; Little League Baseball Inc, Williamsport, PA USA		Mueller, FO (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, CB-8700,209 Fetzer Gym, Chapel Hill, NC 27599 USA.			Marshall, Stephen/0000-0002-2664-9233			*BAS SOFTB COUNC, 1996, BAS REP PART AM NAT, P1; CAVENESS LS, 1988, INT OPHTHALMOL CLIN, V28, P238, DOI 10.1097/00004397-198802830-00015; Crisco JJ, 1997, MED SCI SPORT EXER, V29, P26, DOI 10.1097/00005768-199701000-00005; Hosey RG, 2000, AM J SPORT MED, V28, P360, DOI 10.1177/03635465000280031301; Janda DH, 1998, J TRAUMA, V44, P298, DOI 10.1097/00005373-199802000-00011; Janda DH, 1993, CLIN J SPORT MED, V3, P78; Janda DH., 1992, CLIN J SPORT MED, V2, P172; KYLE SB, 1996, YOUTH BASEBALL PROTE; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; Pasternack JS, 1996, PEDIATRICS, V98, P445; RISSER WL, 1994, PEDIATRICS, V93, P690; SENDRE RA, 1994, AM J SPORT MED, V22, P450, DOI 10.1177/036354659402200403; Vincent GM, 2000, PHYSICIAN SPORTSMED, V28, P31, DOI 10.3810/psm.2000.11.1285; Vinger PF, 1999, ARCH OPHTHALMOL-CHIC, V117, P354, DOI 10.1001/archopht.117.3.354; Vinger PF, 1997, JAMA-J AM MED ASSOC, V277, P142, DOI 10.1001/jama.277.2.142; Yen KL, 2000, PEDIATR EMERG CARE, V16, P215, DOI 10.1097/00006565-200006000-00021	16	17	19	0	7	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000 USA	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	JUL	2001	29	7					41	48		10.3810/psm.2001.07.874			8	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	447XN	WOS:000169597900012	20086581				2022-02-06	
J	Schmitter-Edgecombe, M; Beglinger, L				Schmitter-Edgecombe, M; Beglinger, L			Acquisition of skilled visual search performance following severe closed-head injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						visual search; skill learning; automaticity; closed-head injury; traumatic brain injury	CONNECTIONIST CONTROL ARCHITECTURE; AUTOMATIC PROCESS-DEVELOPMENT; DIVIDED ATTENTION; MEMORY; CONSISTENT; RETENTION; CATEGORY; COMPONENTS; CAPACITY; IMPLICIT	This study used a semantic-category visual search task to investigate skill acquisition and automatic process development in a severe closed-head injured (CHI) population. Eighteen severe CHI participants (> 1 year post injury) and 18 matched controls completed over 3600 trials of training in both consistent mapping (CM) and varied mapping (VM) training situations. Transfer conditions were also used to test for development of an automatic attention response (AAR) that was independent of general, task-related learning. For both the severe CHI and control group, CM training, where individuals always responded in the same way to a specific class of stimuli, resulted in dramatic performance improvements and the development of an AAR. In the VM training condition, where individuals could not respond in the same way to a class of stimuli from one stimulus exposure to the next, there was little performance improvement and continued reliance on controlled processes. The visual search rates of the CHI participants also remained slower than those of controls following extended VM but not extended CM practice. These results indicate that skill acquisition training guidelines can be used to teach severe CHI patients to develop a new automatic skill.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 644820, Pullman, WA 99164 USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD35838] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER		ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; BOND MR, 1983, REHABILITATION HEAD, P185; COLLEN A, 1975, J EXP PSYCHOL-HUM L, V1, P629; Craik FI., 1986, HUMAN MEMORY COGNITI, V5, P409; CZERWINSKI M, 1992, AM J PSYCHOL, V105, P271, DOI 10.2307/1423030; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; FISHER DL, 1984, COGNITIVE PSYCHOL, V16, P449, DOI 10.1016/0010-0285(84)90017-3; FISHER DL, 1988, J EXP PSYCHOL HUMAN, V14, P253, DOI 10.1037/0096-1523.14.2.253; FISHER DL, 1982, PSYCHOL REV, V89, P662, DOI 10.1037/0033-295X.89.6.662; Fisk A. D., 1991, MULTIPLE TASK PERFOR, P415; FISK AD, 1994, PSYCHOL AGING, V9, P206, DOI 10.1037/0882-7974.9.2.206; FISK AD, 1992, COGNITIVE APPROACHES TO AUTOMATED INSTRUCTION, P171; FISK AD, 1992, HUM FACTORS, V34, P147, DOI 10.1177/001872089203400202; FISK AD, 1992, HUM FACTORS, V34, P693, DOI 10.1177/001872089203400604; FISK AD, 1991, HUM FACTORS, V33, P267, DOI 10.1177/001872089103300303; FISK AD, 1988, HUM FACTORS, V30, P703, DOI 10.1177/001872088803000606; FISK AD, 1995, PSYCHOL AGING, V10, P255, DOI 10.1037/0882-7974.10.2.255; FISK AD, 1983, J EXP PSYCHOL LEARN, V9, P177, DOI 10.1037/0278-7393.9.2.177; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; HAYS WL, 1988, STATISTICS; Jennett B, 1981, MANAGEMENT HEAD INJU; JONIDES J, 1980, CAN J PSYCHOL, V34, P103, DOI 10.1037/h0081031; Kaplan E., 1987, MANUAL CALIFORNIA VE; KRAMER AF, 1990, J EXP PSYCHOL HUMAN, V16, P505; KRAMER AF, 1991, PSYCHOPHYSIOLOGY, V28, P425, DOI 10.1111/j.1469-8986.1991.tb00726.x; LOGAN GD, 1985, CAN J PSYCHOL, V39, P367, DOI 10.1037/h0080066; Mattis S, 1988, DEMENTIA RATING SCAL; MILLER E, 1981, BRIT J CLIN PSYCHOL, V20, P69, DOI 10.1111/j.2044-8260.1981.tb00498.x; PLUDE DJ, 1981, J GERONTOL, V36, P588; PRINZ W, 1979, PERCEPT PSYCHOPHYS, V25, P137, DOI 10.3758/BF03198800; ROGERS WA, 1994, J EXP PSYCHOL LEARN, V20, P710, DOI 10.1037/0278-7393.20.3.710; SALTHOUSE TA, 1978, J GERONTOL, V33, P232, DOI 10.1093/geronj/33.2.232; Sattler J. M., 1988, ASSESSMENT CHILDREN; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; SCHNEIDER W, 1988, HUM FACTORS, V30, P539, DOI 10.1177/001872088803000502; SCHNEIDER W, 1987, PSYCHOL LEARN MOTIV, V21, P53; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCHNEIDER W, 1988, BEHAV RES METH INSTR, V20, P206, DOI 10.3758/BF03203833; SCHNEIDER W, 1984, J EXP PSYCHOL LEARN, V10, P1; SCHNEIDER W, 1982, PERCEPT PSYCHOPHYS, V31, P160, DOI 10.3758/BF03206216; SCHNEIDER W, 1985, ATTENTION PERFORM, V11, P475; SCHNEIDER W, 1980, 8004 U ILL HUM ATT R; SHIFFRIN RM, 1988, J EXP PSYCHOL LEARN, V14, P562, DOI 10.1037/0278-7393.14.3.562; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHIFFRIN RM, 1981, COGNITIVE SKILLS THE, P11; SHIFFRIN RM, 1988, STEVENS HDB EXPT PSY, V1, P739; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Smith A., 1991, SYMBOL DIGIT MODALIT; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; STRAYER DL, 1994, PSYCHOL AGING, V9, P589, DOI 10.1037/0882-7974.9.4.589; TEASDALE G, 1974, LANCET, V2, P81; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1981, WECHSLER ADULT INTEL; WHALEY CJ, 1993, HUM FACTORS, V35, P639	65	17	17	0	7	CAMBRIDGE UNIV PRESS	PORT CHESTER	110 MIDLAND AVE, PORT CHESTER, NY 10573-9863 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2001	7	5					615	630		10.1017/S1355617701755099			16	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	451XM	WOS:000169827900009	11459113				2022-02-06	
J	Diamond, PT; Gale, SD; Denkhaus, HK				Diamond, PT; Gale, SD; Denkhaus, HK			Head injuries in skiers: an analysis of injury severity and outcome	BRAIN INJURY			English	Article							SKIING INJURIES	To examine the incidence, injury severity, and outcomes of persons hospitalized as a result of ski-related head trauma, a cross-sectional survey was carried out from the Colorado traumatic brain injury database. This database is an ongoing population-based statewise surveillance system, compiled by the Department of Public Health and Environment. Participants were Colorado residents who sustained a head injury while skiing at Colorado ski resorts and hospitalized over three full ski seasons (1994-1997). Injury severity measures included GCS, ISS, AIS, and presence/absence of intracranial lesion, skull fracture and amnesia. Outcome measures included GOS and hospital length of stay. Mean injury severity scores were as follows: GCS 14.51 (SD = 0.99), AIS 2.98 (0.99) and ISS 13.17 (6.71). Twenty-four per cent sustained skull fracture, 39% had intracranial lesions, and 79% demonstrated amnesia. Mean length of stay was 4.31 days (10.58). Head injury incidence was 0.77 per 100 000 ski visits (age-specific range = 0.17-1.91). Males were more likely to have a skull fracture and evidence of intracranial lesion. Finally, children and older adults were at increased risk of ski-related head trauma, suggesting head injury prevention programmes geared toward these age groups should be emphasized.	Univ Virginia Hlth Syst, Dept Phys Med & Rehabil, Charlottesville, VA 22908 USA		Diamond, PT (corresponding author), Univ Virginia Hlth Syst, Dept Phys Med & Rehabil, 545 Ray C Hunt Dr,Suite 240,POB 801004, Charlottesville, VA 22908 USA.		Gale, Shawn/M-3144-2013	Gale, Shawn/0000-0002-8989-0964	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [U17/CCU811909] Funding Source: Medline		Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Chissell HR, 1996, SPORTS MED, V22, P141, DOI 10.2165/00007256-199622030-00001; FURRER M, 1995, J TRAUMA, V39, P737, DOI 10.1097/00005373-199510000-00024; Hunter RE, 1999, AM J SPORT MED, V27, P381, DOI 10.1177/03635465990270032101; JENNETT B, 1975, LANCET, V1, P480; MORROW PL, 1988, J TRAUMA, V28, P95, DOI 10.1097/00005373-198801000-00014; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Sahlin Y, 1989, Br J Sports Med, V23, P241; Shealy J, 1985, SKIING TRAUMA SAFETY, P349; Shorter NA, 1996, J TRAUMA, V40, P997, DOI 10.1097/00005373-199606000-00024; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ., 1995, GUIDELINES SURVEILLA; US Consumer Product Safety Commission, 1999, SKIING HELM EV POT R	14	17	17	0	2	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2001	15	5					429	434		10.1080/02699050010005922			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	431TW	WOS:000168648700005	11350656				2022-02-06	
J	Heath, DL; Vink, R				Heath, DL; Vink, R			Subdural hematoma following traumatic brain injury causes a secondary decline in brain free magnesium concentration	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; magnetic resonance; neurotrauma; outcome; treatment	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; RATS; STROKE; MODEL; EFFICACY; THERAPY	A number of studies have demonstrated that neurologic motor and cognitive deficits induced by traumatic brain injury (TBI) can be attenuated with administration of magnesium salts, However, many severe traumatic brain injuries have a significant hematoma that develops subsequent to the primary events, and it is unclear whether magnesium salts are effective in this situation. In the present study, an impact-acceleration rodent model of TBI was used to produce an injury that causes an extensive subdural hematoma in over 50% of injured animals. At 30 min after TBI, rats were randomly administered 250 mu moles/kg intravenous MgSO4 or equal volume saline before being monitored by magnetic resonance spectroscopy for 8 h to determine brain intracellular free magnesium concentration. Animals were then assessed for neurologic motor deficits over 1 week using a rotarod device, followed by postmortem examination for presence of subdural hematoma. Animals with subdural hematoma treated with MgSO4 showed no improvement in motor outcome when compared to nontreated controls. Animals with no visible subdural hematoma demonstrated a significant improvement (p < 0.05 by ANOVA) in rotarod scores with MgSO4 treatment, Brain free magnesium concentration in the magnesium treated/hematoma group demonstrated a biphasic decline made up of an immediate initial decline, recovery of brain magnesium levels with MgSO4 treatment, and then a significant second magnesium decline (p < 0.05). Such a secondary decline did not occur in the Mg treated/no hematoma animals. Our results suggest that development of a subdural hematoma following TBI results in a decline in brain magnesium, even after bolus administration of magnesium salts. Such effects of hematoma development will need to be considered in trials examining efficacy of magnesium salts as an intervention following TBI.	James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia		Vink, R (corresponding author), James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia.		Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P191, DOI 10.1007/BF01808958; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; Muir KW, 1998, MAGNESIUM RES, V11, P43; PANTER SS, 1992, J NEUROTRAUM, V9, P47, DOI 10.1089/neu.1992.9.47; Regan RF, 1998, J NEUROCHEM, V70, P77; Schmid-Elsaesser R, 1999, NEUROSURGERY, V44, P163, DOI 10.1097/00006123-199901000-00100; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Suzuki M, 1997, GEN PHARMACOL, V28, P119, DOI 10.1016/S0306-3623(96)00148-6; VINK R, 1989, BIOCHEM BIOPH RES CO, V165, P913, DOI 10.1016/S0006-291X(89)80053-1; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Yang Y, 2000, NEUROSCI LETT, V285, P119, DOI 10.1016/S0304-3940(00)01048-X	27	17	17	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2001	18	4					465	469		10.1089/089771501750171074			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	425TP	WOS:000168308000009	11336446				2022-02-06	
J	McFarland, K; Jackson, L; Geffen, G				McFarland, K; Jackson, L; Geffen, G			Post-traumatic amnesia: Consistency-of-recovery and duration-to-recovery following traumatic brain impairment	CLINICAL NEUROPSYCHOLOGIST			English	Article							CLOSED-HEAD-INJURY; POSTTRAUMATIC AMNESIA; MEMORY; DISORIENTATION	The aim of this research was to examine the nature and order of recovery of orientation and memory functioning during Post-Traumatic Amnesia (PTA) in relation to injury severity and PTA duration. The Westmead PTA Scale was used across consecutive testing days to assess the recovery of orientation and memory during PTA in 113 patients. Two new indices were examined: a Consistency-of-Recovery and a Duration-to-Recovery index. a predictable order of recovery was observed during PTA: orientation-to-person recovered sooner and more consistently than the following cluster; orientation-to-time, orientation-to-place, and the ability to remember a face and name. However, the type of memory functioning required for the recall face and name task recovered more consistently than that required for memorizing three pictures. An important overall finding was that the "order-of-recovery'' of orientation and memory functioning was dependent upon both the elapsed days since injury, and the consistency of recovery. The newly developed indices were shown to be a valuable means of accounting for differences between groups in the elapsed days to recovery of orientation and memory. These indices also clearly increase the clinical utility of the Westmead PTA Scale and supply an objective means of charting (and potentially predicting) patients' recovery on the different components of orientation and memory throughout their period of hospitalization.	Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia; Univ Queensland, Cognit Psychophysiol Lab, Herston, Qld, Australia		McFarland, K (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia.						DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; FORRESTER G, 1994, J FARR CTR POST TRAU; FORRESTER G, 1994, BRAIN INJURY, V8, P15; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; KREUTZER J, 1988, ARCH PHYS MED REHAB, V69, P768; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1990, J CLIN EXPT NEUROPSY, V21, P129; RICHARDSON JTE, 1984, COGN NEUROPSYCHOL, V1, P217, DOI 10.1080/02643298408252023; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; STERN JM, 1985, SCANDINAVIAN J REHAB, V4, P55; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; WITTY CWM, 1977, AMNESIA, P118; [No title captured]; [No title captured]	20	17	17	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	2001	15	1					59	68		10.1076/clin.15.1.59.1916			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	439AH	WOS:000169086300005	11778579				2022-02-06	
J	Allen, GV; Chase, T				Allen, GV; Chase, T			Induction of heat shock proteins and motor function deficits after focal cerebellar injury	NEUROSCIENCE			English	Article						cerebellum; heat shock protein; motor function; beam walking test; traumatic brain injury; Purkinje cell	TRAUMATIC BRAIN INJURY; SENSORIMOTOR CORTEX INJURY; ALPHA-B-CRYSTALLIN; GLUCOSE-REGULATED PROTEINS; RAT-BRAIN; HUMAN HSP27; MOLECULAR CHAPERONES; CEREBRAL-ISCHEMIA; RABBIT CEREBELLUM; DROSOPHILA HSP27	A weight drop model of focal cerebellar injury was used to identify heat shock protein induction and motor function deficits in the anesthetized, adult male, Sprague-Dawley rat. All animals were trained on a beam walking test prior to surgery. Groups of animals received severe, mild or sham weight drop injury to the lateral/paravermal region of the cerebellum. The mild and sham-injured animals showed no motor deficits in the beam walking test, whereas animals with severe cerebellar injury showed significant motor deficits in the beam walking test that approached recovery of motor function 20 days after injury. Following severe injury, induction of hear shock protein of 27 kDa was observed in Purkinje cells and in neurons of the deep cerebellar nuclei, as well as Bergmann glial cells, glial cells located in the granule cell layer and the underlying white matter. Following mild injury, hear shook protein of 27 kDa induction was observed in Purkinje cells and gli;ll cells, but not in neurons of the deep cerebellar nuclei. The labeled Purkinje cells were widely distributed in the ipsilateral cerebellar cortex. Many of the glial cells that were immunostained with heat shock protein of 27 kDa co-localized with tells immunoreactive for glial fibrillary acidic protein. After severe injury, heat shock protein of 72 kDa was localized mainly in granule cells at the site of the trauma and in the ipsilateral deep cerebellar nuclei whereas, after mild injury, light labeling was observed only in the granule cell layer. The results demonstrate that focal cerebellar injury has profound effects on motor behavior and induces different families of heat shock proteins in specific groups of neurons and glial cells in the cerebellum. (C) 2001 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Dalhousie Univ, Fac Med, Dept Neurobiol & Anat, Halifax, NS B3H 4H7, Canada		Allen, GV (corresponding author), Dalhousie Univ, Fac Med, Dept Neurobiol & Anat, Halifax, NS B3H 4H7, Canada.						ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Armstrong CL, 2000, J COMP NEUROL, V416, P383, DOI 10.1002/(SICI)1096-9861(20000117)416:3<383::AID-CNE9>3.0.CO;2-M; Barr CS, 1999, BRAIN RES, V847, P9, DOI 10.1016/S0006-8993(99)01988-5; Beasley TC, 1998, DEV BRAIN RES, V105, P125, DOI 10.1016/S0165-3806(97)00179-X; Bechtold DA, 2000, MOL BRAIN RES, V75, P309, DOI 10.1016/S0169-328X(99)00323-X; BOTEZ MI, 1989, REHABILITATION PATH, P179; BOYESON MG, 1993, AM J PHYS MED REHAB, V72, P286, DOI 10.1097/00002060-199310000-00007; BOYESON MG, 1992, BRAIN RES BULL, V29, P435, DOI 10.1016/0361-9230(92)90080-H; BOYESON MG, 1994, AM J PHYS MED REHAB, V73, P76, DOI 10.1097/00002060-199404000-00002; BOYESON MG, 1991, RESTOR NEUROL NEUROS, V3, P227, DOI 10.3233/RNN-1991-3501; BOYESON MG, 1992, BEHAV NEUROSCI, V106, P964, DOI 10.1037/0735-7044.106.6.964; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; BROWN IR, 1983, J NEUROCHEM, V40, P1490, DOI 10.1111/j.1471-4159.1983.tb13596.x; CHAMBERS WW, 1955, ARCH NEURO PSYCHIATR, V74, P653, DOI 10.1001/archneurpsyc.1955.02330180071008; Chen J, 1996, J CEREBR BLOOD F MET, V16, P566, DOI 10.1097/00004647-199607000-00006; CURRIE RW, 1981, SCIENCE, V214, P72, DOI 10.1126/science.7280681; D'Souza CA, 1998, J NEUROSCI RES, V52, P538, DOI 10.1002/(SICI)1097-4547(19980601)52:5<538::AID-JNR6>3.0.CO;2-D; DunnMeynell AA, 1997, J NEUROTRAUM, V14, P43, DOI 10.1089/neu.1997.14.43; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; EISENMAN LM, 1993, J COMP NEUROL, V335, P586, DOI 10.1002/cne.903350410; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; Feeney DM, 1997, ADV NEUROL, V73, P383; FEENEY DM, 1985, PHYSIOL PSYCHOL, V13, P197; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; Glickstein M, 1990, J Cogn Neurosci, V2, P69, DOI 10.1162/jocn.1990.2.2.69; GOLDSTEIN LB, 1991, RESTOR NEUROL NEUROS, V3, P41, DOI 10.3233/RNN-1991-3105; GOODMAN DC, 1963, J COMP NEUROL, V121, P51, DOI 10.1002/cne.901210106; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HAWKES R, 1987, J COMP NEUROL, V256, P29, DOI 10.1002/cne.902560104; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hillier SL, 1997, BRAIN INJURY, V11, P661; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kanayama G, 1997, PSYCHIAT CLIN NEUROS, V51, P157, DOI 10.1111/j.1440-1819.1997.tb02379.x; KATO H, 1991, BRAIN RES, V553, P238, DOI 10.1016/0006-8993(91)90831-F; Kato K, 1999, J NEUROCHEM, V73, P229, DOI 10.1046/j.1471-4159.1999.0730229.x; KENNEDY PR, 1990, TRENDS NEUROSCI, V13, P475; Kikuchi K, 2000, BRAIN RES, V860, P130, DOI 10.1016/S0006-8993(00)02034-5; KITAGAWA K, 1991, J CEREBR BLOOD F MET, V11, P449, DOI 10.1038/jcbfm.1991.86; LANDRY J, 1991, J CELL PHYSIOL, V147, P93, DOI 10.1002/jcp.1041470113; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; MANZERRA P, 1993, J NEUROSCI RES, V36, P480, DOI 10.1002/jnr.490360414; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; McIntosh TK, 1996, LAB INVEST, V74, P315; MEHLEN P, 1995, J IMMUNOL, V154, P363; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; MEHLEN P, 1996, J BIOL CHEM, V271, P1610; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MOSSER DD, 1997, MOL CELL BIOL, V17, P5217; NEEDELS DL, 1986, NEUROSCIENCE, V18, P517, DOI 10.1016/0306-4522(86)90055-2; NOWAK TS, 1985, J NEUROCHEM, V45, P1635, DOI 10.1111/j.1471-4159.1985.tb07236.x; Parsons LM, 1997, INT REV NEUROBIOL, V41, P255, DOI 10.1016/S0074-7742(08)60355-4; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; Plumier JCL, 1997, J CEREBR BLOOD F MET, V17, P781; Plumier JCL, 1997, MOL BRAIN RES, V45, P239, DOI 10.1016/S0169-328X(96)00255-0; Plumier JCL, 1996, NEUROSCIENCE, V75, P849, DOI 10.1016/0306-4522(96)00317-X; RAGHUPATHI R, 1995, BLOOD FOW METAB, V15, P467; Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Turner CP, 1999, MOL BRAIN RES, V65, P87, DOI 10.1016/S0169-328X(98)00340-4; Wagstaff MJD, 1999, J BIOL CHEM, V274, P5061, DOI 10.1074/jbc.274.8.5061	72	17	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2001	102	3					603	614		10.1016/S0306-4522(00)00519-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	400UM	WOS:000166890100010	11226697				2022-02-06	
J	Bieman-Copland, S; Dywan, J				Bieman-Copland, S; Dywan, J			Achieving rehabilitative gains in anosognosia after TBI	BRAIN AND COGNITION			English	Article								Impaired self-awareness can be a serious consequence of traumatic brain injury (TBI) and has been associated with poor therapeutic compliance and poor functional recovery. Traditional rehabilitation approaches which make use of direct feedback and education are often ineffective because they elicit more elaborated and entrenched confabulatory beliefs as individuals are forced to defend their position. Empirical case data is presented from a woman with profound anosognosia following a TBI with right frontal involvement. Targeted behaviors were decreased through behavioral interventions, bur the emphasis of treatment was on the formation of trusting, nonconfrontational therapeutic relationships. Marked reductions in inappropriate behaviors were achieved along with a return to supportive community living. (C) 2000 Academic Press.	Brock Univ, St Catharines, ON L2S 3A1, Canada		Bieman-Copland, S (corresponding author), Brock Univ, St Catharines, ON L2S 3A1, Canada.						Barco PP, 1991, COGNITIVE REHABILITA, P129; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008	2	17	17	2	6	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					1	5					5	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300001					2022-02-06	
J	Hwang, SK; Kim, SL				Hwang, SK; Kim, SL			Infantile head injury, with special reference to the development of chronic subdural hematoma	CHILDS NERVOUS SYSTEM			English	Article						infant head injury; chronic subdural hematoma		An infantile head injury has unique features in that infants are totally helpless and dependent on their parents, and biomechanical characteristics of the skull and brain are very different from those of other age groups. The authors reviewed a total of 16 infant head injury patients under 12 months of age who were treated in our hospital from 1989 to 1997. Birth head injury was excluded. The most common age group was 3-5 months. Early seizures were noted in 7 cases, and motor weakness in 6. Three patients with acute intracranial hematoma and another 3 with depressed skull fracture were operated on soon after admission. Chronic subdural hematomas (SDHs) developed in 3 infants. Initial CT scans showed a small amount of SDH that needed no emergency operation. Resolution of the acute SDH and development of subdural hygroma appeared on follow-up CT scans within 2 weeks of injury. TWO of these infants developed early seizures. Chronic SDH was diagnosed on the 68th and 111th days after the injuries were sustained, respectively. The third patient was the subject of close follow-up with special attention to the evolution of chronic SDH in view of our experience in the previous 2 cases, and was found to have developed chronic SDH on the 90th day after injury. All chronic SDH patients were successively treated by subduro-peritoneal shunting. In conclusion, the evolution of chronic SDH from acute SDH is relatively common following infantile head injury. Infants with head injuries, especially if they are associated with acute SDH and early development of subdural hygroma, should be carefully followed up with special attention to the possible development of chronic SDH.	Kyungpook Natl Univ, Sch Med, Dept Neurosurg, Chung Ku, Taegu 700721, South Korea		Hwang, SK (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Neurosurg, Chung Ku, 50 Samdukdong, Taegu 700721, South Korea.						Aoki N, 1976, No Shinkei Geka, V4, P391; AOKI N, 1990, J NEUROSURG, V73, P201, DOI 10.3171/jns.1990.73.2.0201; COLLINS WF, 1961, J PEDIATR-US, V58, P482, DOI 10.1016/S0022-3476(61)80180-7; Ingraham FD, 1944, J PEDIATR-US, V24, P1, DOI 10.1016/S0022-3476(44)80138-X; James HE, 1985, BRAIN INSULTS INFANT, P179; MATSON DD, 1969, NEUROSURGERY INFANCY; MCCORMICK MC, 1981, AM J DIS CHILD, V135, P159, DOI 10.1001/archpedi.1981.02130260051015; MCLAURIN R L, 1989, Neurosurgical Review, V12, P219, DOI 10.1007/BF01790652; MCLAURIN RL, 1971, J NEUROSURG, V34, P753, DOI 10.3171/jns.1971.34.6.0753; MCLAURIN RL, 1986, PRINCIPLES PEDIAT NE, P183; Misra M, 1996, SURG NEUROL, V46, P378, DOI 10.1016/S0090-3019(96)00188-7; MIYAGAMI M, 1979, SHONI NO NOSHINKEI, V4, P41; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; PARENT AD, 1992, PEDIATR NEUROSURG, V18, P266, DOI 10.1159/000120674; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; ROSENBLUTH PR, 1962, JAMA-J AM MED ASSOC, V179, P759, DOI 10.1001/jama.1962.03050100013003; SMITH MD, 1975, J TRAUMA, V15, P987, DOI 10.1097/00005373-197511000-00008; YAMAMOTO S, 1978, SHONI NO NOSHINKEI, V3, P162	18	17	17	1	1	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	SEP	2000	16	9					590	594		10.1007/s003810000312			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	359LH	WOS:000089612000012	11048634				2022-02-06	
J	Poggi, G; Calori, G; Mancarella, G; Colombo, E; Profice, P; Martinelli, F; Triscar, C; Castelli, E				Poggi, G; Calori, G; Mancarella, G; Colombo, E; Profice, P; Martinelli, F; Triscar, C; Castelli, E			Visual disorders after traumatic brain injury in developmental age	BRAIN INJURY			English	Article							PEDIATRIC HEAD TRAUMA; CHILDREN; INFANTS; ABNORMALITIES; DYSFUNCTION; IMPAIRMENT; SEX	Visual disorders secondary to TBI are common, often multiple, associated with complex clinical pictures; in developmental age they may particularly interfere with the development process, and compromise the rehabilitation and outcome processes. The aim of this study is to identify visual disorders in 56 post-traumatic children admitted to the Traumatic Brain Injury Unit. All patients underwent a complete clinical, neurological and neuroophthalmological assessment. Correlations were studied between visual disorders and clinical parameters of acute phase, age at trauma, neuroimaging data and outcome, in order to identify possible risk factors for their occurrence. A high incidence was found of complex visual disorders following head trauma: decreased visual acuity, together with a convergence oculo-motor deficit, is the most frequently detected deficit. Trauma severity, indicated by duration of coma, is associated with most of the visual disorders and appears to be the main risk factor conducive to their appearance.	IRCCS E Medea, I-23842 Bosisio Parini LC, Italy; IRCCS, HS Raffaele, Epidemiol Unit, Milan, Italy		Poggi, G (corresponding author), IRCCS E Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini LC, Italy.		Boneschi, Filippo Martinelli/H-8592-2012; Castelli, Enrico/J-1887-2012; Poggi, Geraldina/K-4490-2016	Poggi, Geraldina/0000-0003-0589-6347; Profice, Paolo/0000-0001-9923-9246; martinelli boneschi, filippo/0000-0002-9955-1368			ALEXANDER PK, 1990, J VISUAL IMPAIRMENT, V84, P373; ANDERSON DP, 1980, CAN J SURG, V23, P163; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; BERNEY J, 1994, CHILD NERV SYST, V10, P509, DOI 10.1007/BF00335073; BERNEY J, 1994, CHILD NERV SYST, V10, P517, DOI 10.1007/BF00335074; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; CHATRIAN GE, 1984, J CLIN NEUROPHYSIOL, V1, P3; Cohen A H, 1992, J Am Optom Assoc, V63, P530; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; DROSTE PJ, 1991, OPHTHALMOLOGY, V98, P1513; Dutton G, 1996, EYE, V10, P302, DOI 10.1038/eye.1996.64; ELISEVICH KV, 1984, SURG NEUROL, V22, P565, DOI 10.1016/0090-3019(84)90433-6; FLEISS JL, 1980, STATISTICAL METHODS, P58; Fowler MS, 1996, J NEUROL, V243, P86; GOOD WV, 1994, SURV OPHTHALMOL, V38, P351, DOI 10.1016/0039-6257(94)90073-6; HELLERSTEIN FL, 1995, J AM OPTOM ASSOC, V66, P634; JENNETT B, 1975, LANCET, V1, P480; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Lanners J, 1999, J INTELL DISABIL RES, V43, P1, DOI 10.1046/j.1365-2788.1999.43120106.x; Max JE, 1998, BRAIN INJURY, V12, P31; PADULA WV, 1988, POSTTRAUMA VISION SY, P167; PADULA WV, 1992, J OPTOM VIS DEV, V23, P4; PIPER JDA, 1992, TECTONOPHYSICS, V201, P17, DOI 10.1016/0040-1951(92)90173-4; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; SACHER P, 1987, SCHWEIZ MED WSCHR, V117, P656; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; STANWORTH A, 1974, BRIT J OPHTHALMOL, V58, P266, DOI 10.1136/bjo.58.3.266; TEASDALE G, 1974, LANCET, V2, P81; TELLER DY, 1986, DEV MED CHILD NEUROL, V28, P779; Thomsen I V, 1989, Brain Inj, V3, P157, DOI 10.3109/02699058909004547; Tierney D W, 1988, J Am Optom Assoc, V59, P614; UZZELL BP, 1988, ARCH NEUROL-CHICAGO, V45, P420, DOI 10.1001/archneur.1988.00520280066017; VOGEL MS, 1992, J AM OPTOM ASSOC, V63, P567; Webb C, 1996, BRAIN INJURY, V10, P303, DOI 10.1080/026990596124476	35	17	17	0	7	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2000	14	9					833	845		10.1080/026990500421930			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	357YT	WOS:000089530300006	11030456				2022-02-06	
J	Hayden, ME; Moreault, AM; LeBlanc, J; Plenger, PM				Hayden, ME; Moreault, AM; LeBlanc, J; Plenger, PM			Reducing level of handicap in traumatic brain injury: An environmentally based model of treatment	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; ecological validity; environmental variables; outcome; reducing handicap; treatment	REHABILITATION; PREDICTION; DOMAIN; COMA; WORK	A treatment model is described that has as its primary focus reducing the lever of handicap of individuals with traumatic brain injury (TBI) by addressing the interaction between critical environmental variables and areas of deficit. The model focuses on two primary environmental variables-degree of distraction tolerated and degree of structure required by each individual to function optimally. These variables are systematically addressed in treatment through environmental simulations within the clinic. hn outcome measurement system (Pate Environmentally Relevant Program Outcome System [PERPOS]) is presented that quantities the level of handicap throughout treatment and at discharge as a function of the interplay between deficit and environment. Data are provided that validate the PERPOS scores through comparison with qualitative descriptors of day-to-day functioning in several domains. Outcome data indicate the participants in this treatment model made significant gains with regard to reduction of handicap.	Pate Rehabil, Dallas, TX USA; Sabine Valley Ctr, Marshall Valley Ctr, Marshall, TX 75670 USA								BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; BENYISHAY Y, 1983, REHABILITATION BRAIN; BUTTERS MA, 1993, J CLIN EXP NEUROPSYC, V15, P219, DOI 10.1080/01688639308402559; Cicerone KD, 1999, J HEAD TRAUMA REHAB, V14, P316, DOI 10.1097/00001199-199906000-00011; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; GLISKY EL, 1988, J LEARN DISABIL-US, V21, P333, DOI 10.1177/002221948802100604; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; HART T, 1986, CLIN NEUROPSYCHOLOGY; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; HAYDEN ME, 1997, AM ASS OCCUP HLTH NU, V42, P635; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; HEINSSEN RK, 1996, COGNITIVE REHABILITA; Jennett B, 1981, MANAGEMENT HEAD INJU; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Levin HS., 1982, NEUROBEHAVIORAL CONS; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sherer M, 1999, BRAIN INJURY, V13, P973; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; SOHLBERG M M, 1992, Brain Injury, V6, P129, DOI 10.3109/02699059209029651; SOHLBERG M M, 1992, Brain Injury, V6, P139, DOI 10.3109/02699059209029652; TEASDALE G, 1974, LANCET, V2, P81; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; [No title captured]	32	17	17	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	2000	15	4					1000	1021		10.1097/00001199-200008000-00004			22	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	340DK	WOS:000088517700004	10876172				2022-02-06	
J	McHenry, M				McHenry, M			Acoustic characteristics of voice after severe traumatic brain injury	LARYNGOSCOPE			English	Article						voice disorders; traumatic brain injury; intelligibility	DYSARTHRIA; DISEASE	Objectives/Hypothesis: To describe the acoustic characteristics of voice in individuals with motor speech disorders after traumatic brain injury (TBI), Study Design: Prospective study of 100 individuals with TBI based on consecutive referrals for motor speech evaluations. Methods: Subjects were audio tape-recorded while producing sustained vowels and single word and sentence intelligibility tests. Laryngeal airway resistance was estimated, and voice quality was rated perceptually. Results: None of the subjects evidenced vocal parameters within normal limits. The most frequently occurring abnormal parameter across subjects was amplitude perturbation, followed by voice turbulence index. Twenty-three percent of subjects evidenced deviation in all five parameters measured. The perceptual ratings of breathiness were significantly correlated with both the amplitude perturbation quotient and the noise-to-harmonics ratio. Conclusions: Vocal quality deviation is common in motor speech disorders after TBI and mag impact intelligibility.	Transit Learning Ctr, Galveston, TX 77553 USA		McHenry, M (corresponding author), Transit Learning Ctr, 1528 PO St, Galveston, TX 77553 USA.						BARLOW S M, 1989, Journal of Voice, V3, P283, DOI 10.1016/S0892-1997(89)80050-5; BARLOW SM, 1991, J COMPUTER USERS SPE, V7, P211; COHEN J, 1993, APPL MULTIPLE REGRES; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; De Bodt M, 1996, Acta Otorhinolaryngol Belg, V50, P325; Dejonckere P H, 1998, Rev Laryngol Otol Rhinol (Bord), V119, P265; Dromey C, 1998, J SPEECH LANG HEAR R, V41, P1003, DOI 10.1044/jslhr.4105.1003; DROMEY C, 1995, J SPEECH HEAR RES, V38, P751, DOI 10.1044/jshr.3804.751; Duffy JR., 2020, MOTOR SPEECH DISORDE; Hanson HM, 1997, J ACOUST SOC AM, V101, P466, DOI 10.1121/1.417991; Kent RD, 1999, AM J SPEECH-LANG PAT, V8, P129, DOI 10.1044/1058-0360.0802.129; Kent RD, 1997, FOLIA PHONIATR LOGO, V49, P63, DOI 10.1159/000266440; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; McHenry MA, 1996, DISORDERS MOTOR SPEE, P229; MCHENRY MA, 1997, AM J SPEECH-LANG PAT, V6, P56; NETSELL R, 1991, J VOICE, V5, P1, DOI 10.1016/S0892-1997(05)80157-2; Ramig L.O., 1992, INTELLIGIBILITY SPEE, P119, DOI DOI 10.1075/SSPCL.1.05RAM; RAMIG LA, 1988, ANN OTO RHINOL LARYN, V97, P164, DOI 10.1177/000348948809700214; RAMIG LO, 1992, DISORDERS LARYNX, P163; Theodoros DG, 1996, DISORDERS MOTOR SPEE, P205; TITZE IR, 1991, J SPEECH HEAR RES, V34, P460, DOI 10.1044/jshr.3403.460; Van Lierde K, 1996, Acta Otorhinolaryngol Belg, V50, P345; Yorkston K., 1984, COMPUTERIZED ASSESSM; ZWIRNER P, 1991, J COMMUN DISORD, V24, P287, DOI 10.1016/0021-9924(91)90004-3; ZYSKI BJ, 1987, J COMMUN DISORD, V20, P367, DOI 10.1016/0021-9924(87)90025-6	26	17	17	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	JUL	2000	110	7					1157	1161		10.1097/00005537-200007000-00017			5	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	330NZ	WOS:000087969300017	10892688	Bronze			2022-02-06	
J	Switzer, JA; Nork, SE; Routt, MLC				Switzer, JA; Nork, SE; Routt, MLC			Comminuted fractures of the iliac wing	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						iliac fracture; comminuted; unstable; degloving	PELVIC RING FRACTURES; INTERNAL-FIXATION; DEGLOVING INJURIES; MULTIPLE TRAUMA; CLASSIFICATION; HEMORRHAGE; MANAGEMENT; DISRUPTIONS	Purpose: Comminuted iliac fractures are uncommon and difficult to treat. The purpose of this study is to further delineate the fractures, to present a management protocol, and to evaluate the results of treatment. Design: Retrospective clinical study. Setting: Level one trauma center at Harborview Medical Center. Patients: During a sixty-eight-month period, 695 patients with pelvic ring disruptions were treated at a level one trauma center. Thirteen (1.9%) of these patients had a severely comminuted iliac fracture. All patients were men, ranging in age from twenty to eighty years (mean, 38 years). These patients were polytraumatized and had a mean Injury Severity Score of 23. Eleven of the thirteen patients had severe iliac and flank degloving injuries. Five patients had open fractures, one with fecal contamination requiring diverting colostomy. Six patients with clinical signs of hemodynamic instability had local arterial injuries associated with their fractures. All five patients with extension of the fracture into the greater sciatic notch were found to have a local arterial injury on angiography. One patient had a lumbosacral plexopathy on the fractured side. Four patients had traumatic brain injuries. Intervention: All thirteen patients were treated operatively. Routine pelvic external fixation was not possible because of the iliac comminution. Stable internal fixation was accomplished by an anterior iliac surgical exposure using lag screw and plate combinations. The open wounds and degloving injuries were treated with irrigation, debridement, and closed suction drain age. Main Outcome Measurements: Healing and stability of fixation were assessed clinically and on pelvic radiographs. Results: Comminuted iliac fractures were divided into two patient groups, according to associated pelvic ring disruption. Follow-up evaluations were available for all patients at a mean of eighteen months after injury. There were no deaths. All of the fractures healed clinically and radiographically. In one patient, fecal contamination caused a polymicrobial wound infection, and this patient had an associated delay in union of the fracture. Another patient with an open fracture developed a deep wound infection. Both infections responded to local management and antibiotics. There were no complications associated with the degloving injuries. Conclusions: Comminuted iliac fractures occur in two distinct patterns and are associated with numerous local injuries that complicate management. Management protocols should include early open reduction and stable internal fixation. Traumatic open wounds should not be closed primarily. Primary closure with closed suction drainage is effective in the management of associated degloving injuries. Extension of the fracture into the greater sciatic notch warrants further evaluation with pelvic angiography.	Univ Washington, Harborview Med Ctr, Dept Orthopaed Surg, Seattle, WA 98104 USA		Routt, MLC (corresponding author), Univ Washington, Harborview Med Ctr, Dept Orthopaed Surg, 325 9Th Ave,Box 359798, Seattle, WA 98104 USA.			Switzer, Julie/0000-0002-4834-1643			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BIROLINI D, 1990, J TRAUMA, V30, P492, DOI 10.1097/00005373-199030040-00023; Borrelli J, 1996, J ORTHOP TRAUMA, V10, P165, DOI 10.1097/00005131-199604000-00004; BUCHANAN JR, 1980, CLIN ORTHOP RELAT R, P164; BUCHOLZ RW, 1981, J BONE JOINT SURG AM, V63, P400, DOI 10.2106/00004623-198163030-00013; BURGESS AR, 1990, J TRAUMA, V30, P848, DOI 10.1097/00005373-199007000-00015; CORMACK GC, 1985, PLAST RECONSTR SURG, V75, P342, DOI 10.1097/00006534-198503000-00008; CRYER HM, 1988, J TRAUMA, V28, P973, DOI 10.1097/00005373-198807000-00011; DALAL SA, 1989, J TRAUMA, V29, P981, DOI 10.1097/00005373-198907000-00012; DAVIDSON BS, 1993, J TRAUMA, V35, P36, DOI 10.1097/00005373-199307000-00006; Gansslen A, 1996, INJURY, V27, P13, DOI 10.1016/S0020-1383(96)90106-0; GOLDSTEIN A, 1986, J TRAUMA, V26, P325; GRUEN GS, 1994, J TRAUMA, V36, P706, DOI 10.1097/00005373-199405000-00019; Hak DJ, 1997, J TRAUMA, V42, P1046, DOI 10.1097/00005373-199706000-00010; HANSON PB, 1991, J BONE JOINT SURG BR, V73, P325, DOI 10.1302/0301-620X.73B2.2005166; Henderson R C, 1989, J Orthop Trauma, V3, P41, DOI 10.1097/00005131-198903010-00008; HUDSON DA, 1992, PLAST RECONSTR SURG, V89, P853, DOI 10.1097/00006534-199205000-00013; KLEIN SR, 1992, J CARDIOVASC SURG, V33, P349; Kottmeier SA, 1996, CLIN ORTHOP RELAT R, P46; KUDSK KA, 1981, J TRAUMA, V21, P835, DOI 10.1097/00005373-198110000-00002; LATENSER BA, 1991, J TRAUMA, V31, P28, DOI 10.1097/00005373-199101000-00006; LUNT H R W, 1970, Injury, V2, P121, DOI 10.1016/S0020-1383(70)80011-0; MATTA JM, 1989, CLIN ORTHOP RELAT R, P83; Mayo K., 1990, TECH ORTHOP, V4, P24, DOI [10.1097/00013611-199001000-00004, DOI 10.1097/00013611-199001000-00004]; MCMURTRY R, 1980, CLIN ORTHOP RELAT R, P22; MEARS DC, 1980, CLIN ORTHOP RELAT R, P65; MORENO C, 1986, J TRAUMA, V26, P987, DOI 10.1097/00005373-198611000-00005; MUCHA P, 1988, SURG CLIN N AM, V68, P757; ONEILL PA, 1996, CLIN ORHTOP, V329, P60; PENNAL GF, 1980, CLIN ORTHOP RELAT R, P12; PERRY JJ, 1980, CLIN ORTHOPAEDICS, V151, P141; RICHARDSON JD, 1982, J TRAUMA, V22, P533, DOI 10.1097/00005373-198207000-00002; ROTHENBERGER D, 1978, J TRAUMA, V18, P184, DOI 10.1097/00005373-197803000-00006; Routt MLC, 1996, J TRAUMA, V40, P784, DOI 10.1097/00005373-199605000-00018; Simonian PT, 1997, INJURY, V28, P469, DOI 10.1016/S0020-1383(97)00112-5; SLATIS P, 1972, ACTA CHIR SCAND, V138, P799; TILE M, 1980, CLIN ORTHOP RELAT R, P56; TILE M, 1988, J BONE JOINT SURG BR, V70, P1; Tile M., 1984, FRACTURES PELVIS ACE; WEBB L, 1991, ORTHOP T, V15, P801; Webb L X, 1990, J Orthop Trauma, V4, P376, DOI 10.1097/00005131-199012000-00002; WEIS EB, 1984, J TRAUMA, V24, P983, DOI 10.1097/00005373-198411000-00010	42	17	19	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	MAY	2000	14	4					270	276		10.1097/00005131-200005000-00008			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	326CC	WOS:000087713500008	10898200				2022-02-06	
J	Dean, S; Colantonio, A; Ratcliff, G; Chase, S				Dean, S; Colantonio, A; Ratcliff, G; Chase, S			Clients' perspectives on problems many years after traumatic brain injury	PSYCHOLOGICAL REPORTS			English	Article							CLOSED HEAD-INJURY; FOLLOW-UP	This study investigated the types of self-reported main problems that persons report many years following a traumatic brain injury. This preliminary study is part of a large ongoing study of disability and handicap in adults following traumatic brain injury. As part of an extensive interview, subjects were asked an open-ended question regarding their current main problems which they thought resulted from their traumatic brain injury. Responses were obtained from 166 adult subjects (119 men and 47 women) whose lime postinjury ranged from 9 to 24 pears. Categories for responses were subsequently developed. The most commonly reported categories of problems were those relating to movement (39%), cognition (36%), and sensory impairment (31%). Findings suggest that subjects' long-term concerns were related to specific impairments more than to psychosocial, emotional, or behavioral issues. Methodological issues concerning this research are discussed in relation to findings.	Univ Toronto, Grad Dept Rehabil Sci, Dept Occupat Therapy, Toronto, ON M5T 1W5, Canada; HealthS Harmarville Rehabil Hosp, Pittsburgh, PA USA		Colantonio, A (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, Dept Occupat Therapy, 256 McCaul St, Toronto, ON M5T 1W5, Canada.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34740-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034740] Funding Source: NIH RePORTER		*COUNC CLIN CLASS, 1980, INT CLASS DIS; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885	6	17	17	0	2	PSYCHOLOGICAL REPORTS	MISSOULA	P O BOX 9229, MISSOULA, MT 59807 USA	0033-2941			PSYCHOL REP	Psychol. Rep.	APR	2000	86	2					653	658		10.2466/pr0.2000.86.2.653			6	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	316AX	WOS:000087146100046	10840924				2022-02-06	
J	Stuss, DT; Binns, MA; Carruth, FG; Levine, B; Brandys, CF; Moulton, RJ; Snow, WG; Schwartz, ML				Stuss, DT; Binns, MA; Carruth, FG; Levine, B; Brandys, CF; Moulton, RJ; Snow, WG; Schwartz, ML			Prediction of recovery of continuous memory after traumatic brain injury	NEUROLOGY			English	Article						traumatic brain injury; post-traumatic amnesia; recovery; severity; confusion; prediction of recovery	SEVERE HEAD-INJURY; ALZHEIMERS-DISEASE; POSTTRAUMATIC AMNESIA; AGE; EDUCATION; IMPACT	Objective: To evaluate the ability of measures of initial severity, tests of attention, and demographic characteristics to predict recovery of continuous memory for words over a 24-hour period in patients with acute traumatic brain injury. Methods: Recovery of continuous memory was assessed prospectively in 94 patients with nonpenetrating traumatic brain injury. A classification and regression tree analysis identified a hierarchical subset of variables that may be used as a simple guideline for predicting recovery of continuous memory. Weibull regression models evaluated and compared the predictive ability of multiple variables. Results: Four groups of patients were identified based on measures of severity of injury and demographic characteristics. These four groups had recovery profiles that were more precise than could be obtained by using the Glasgow Coma Scale alone: mild, about 1 week to recovery of continuous memory; moderate, 1 to 4 weeks; severe, 2 to 6 weeks; and extremely severe, 4 to 8 weeks. Regression analysis confirmed that measures of capacity (inherent resources such as indicated by age) and compromise (general functional brain state measured neuropsychologically) improved prediction over models based only on injury severity measures, such as the Glasgow Coma Scale. Conclusions: Approaches to predicting recovery of continuous memory in the acute period after traumatic brain injury that take into account multiple measures provide a more sensitive predictive index.	Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Med Neurol Rehabil Sci, Toronto, ON, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Surg, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; St Michaels Hosp, Toronto, ON M5B 1W8, Canada		Stuss, DT (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	dstuss@rotman-baycrest.on.ca	Levine, Brian/O-2725-2019; Binns, Malcolm/AAQ-9195-2020; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Binns, Malcolm/0000-0001-9998-6612; Levine, Brian/0000-0003-4343-811X			Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; BROOKS D N, 1974, Cortex, V10, P224; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; DAVIS CS, 1988, J AM GERIATR SOC, V36, P225, DOI 10.1111/j.1532-5415.1988.tb01805.x; Evans D A, 1993, Ann Epidemiol, V3, P71; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KATZ DI, 1999, REHABILITATION ADULT, P89; KATZ DI, 1994, HDB NEUROREHABILITAT, P493; Kidron D, 1997, NEUROLOGY, V49, P1504, DOI 10.1212/WNL.49.6.1504; Lawless JF., 1982, STAT MODELS METHODS; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MORTIMER JA, 1993, NEUROLOGY, V43, pS39; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; RICHARDSON JTE, 1984, COGN NEUROPSYCHOL, V1, P217, DOI 10.1080/02643298408252023; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WILSON J T L, 1992, Brain Injury, V6, P391, DOI 10.3109/02699059209008135; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; WINOCUR G, 1990, CAN J PSYCHOL, V44, P435, DOI 10.1037/h0084270; Winocur G., 1992, HDB AGING COGNITION, P315; WONG PP, 1994, BRAIN INJURY, V8, P509, DOI 10.3109/02699059409151003; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412	35	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR 28	2000	54	6					1337	1344		10.1212/WNL.54.6.1337			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297XY	WOS:000086109300024	10746607				2022-02-06	
J	Whitfield, PC; Pickard, JD				Whitfield, PC; Pickard, JD			Expression of the immediate early genes c-Fos and c-Jun after head injury in man	NEUROLOGICAL RESEARCH			English	Article						immediate early gene; c-Fos; c-Jun; brain injury; contusion; human	PROGRAMMED CELL-DEATH; ISCHEMIC BRAIN-DAMAGE; PROTEIN; INDUCTION; NEURONS; APOPTOSIS; SEQUENCE; ENCODES; TRAUMA; NERVE	Immediate early genes (IEG) are expressed in a variety of experimental paradigms including cerebral ischemia and trauma. There is a paucity of information on whether the results of laboratory experiments can be extrapolated from animals into man. To examine this further we hypothesised that expression of c-Fos and c-Jun occurs after contusional head injury in man. We also sought to identify whether there was an association between the level of immediate early gene expression and 1. the outcome one year after head injury, 2. the timing of surgery after head injury. IEG expression was examined using in situ hybridisation and immunocytochemistry in brain tissue therapeutically removed in 14 patients with head injury 6 h to 6 days after contusional injury IEG expression was also examined in tissue removed during elective non-traumatic neurosurgery for comparative purposes. Expression of c-fos and c-jun mRNA was observed in 50% and 64% of head-injured patients respectively Protein immunoreactivity for these IEGs was evident in 67% of head injured patients. The expression of c-Fos and c-lun was associated with final outcome. Patients with poorer outcomes had higher levels of gene expression (p = 0.08 for c-Fos and p = 0.006 for c-jun). No correlation between the timing of surgery and the intensity of gene expression was evident in the trauma patients (r(2) = 0.09 and 0.10 for c-Fos and c-lun respectively). In the non-trauma patients 36% expressed c-fos and 73% expressed c-jun mRNA, with all patients studied expressing c-Fos and c-lun proteins. We conclude that differential expression of c-Fos and c-lun occurs in the patients with cerebral contusions. The difference in expression rates between mRNA and protein emphasises the need for analysis of gene products when investigating gene expression. These results support the hypothesis that IEGs may be involved in the pathogenetic mechanisms of contusional head injury. Observations of IEG expression in human brain injury are important in steering animal experimental programmes towards studies that may yield information directly applicable to human brain injury.	Addenbrookes NHS Trust, Whitfield Acad Neurosurg Unit, Dept Acad Neurosurg, MRC,Ctr Brain Repair, Cambridge CB2 2QQ, England		Whitfield, PC (corresponding author), Addenbrookes NHS Trust, Whitfield Acad Neurosurg Unit, Dept Acad Neurosurg, MRC,Ctr Brain Repair, Box 166,Hills Rd, Cambridge CB2 2QQ, England.				Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI		Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; DRAGUNOW M, 1990, BRAIN RES, V527, P41, DOI 10.1016/0006-8993(90)91058-O; DRAGUNOW M, 1993, MOL BRAIN RES, V18, P347, DOI 10.1016/0169-328X(93)90101-T; DRAGUNOW M, 1990, EXP NEUROL, V107, P236, DOI 10.1016/0014-4886(90)90141-E; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Katano H, 1998, BRAIN RES, V800, P69, DOI 10.1016/S0006-8993(98)00493-4; LUCIBELLO FC, 1989, CELL, V59, P999, DOI 10.1016/0092-8674(89)90756-3; MacManus JP, 1997, J CEREBR BLOOD F MET, V17, P815, DOI 10.1038/aj.jcbfm.9590266; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NOWAK TS, 1993, PROG BRAIN RES, V96, P195; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SCHLINGENSIEPEN KH, 1994, CELL MOL NEUROBIOL, V14, P487, DOI 10.1007/BF02088833; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; SOMMER C, 1995, BRAIN PATHOL, V5, P135, DOI 10.1111/j.1750-3639.1995.tb00587.x; Soriano MA, 1996, NEUROREPORT, V7, P425, DOI 10.1097/00001756-199601310-00012; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183; Whitfield P. C., 1997, Clinical Science (London), V93, p25P; Whitfield PC, 1999, BRAIN RES, V818, P450, DOI 10.1016/S0006-8993(98)01342-0; WHITFIELD PC, 1996, J NEUROL NEUROSUR PS, V61, P550	30	17	25	0	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR	2000	22	2					138	144		10.1080/01616412.2000.11741050			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	302VD	WOS:000086385600001	10763499				2022-02-06	
J	Hermann, DM; Mies, G; Hata, R; Hossmann, KA				Hermann, DM; Mies, G; Hata, R; Hossmann, KA			Microglial and astrocytic reactions prior to onset of thalamic cell death after traumatic lesion of the rat sensorimotor cortex	ACTA NEUROPATHOLOGICA			English	Article						complement receptor type 3b; glial fibrillary acidic protein; major histocompatibility complex class II retrograde degeneration; terminal transferase-mediated biotinylated dUTP nick end labeling (TUNEL)	EXCITOTOXIC LESION; RETROGRADE DEGENERATION; BRAIN; EXPRESSION; COMPLEX; CNS; MACROPHAGES; ISCHEMIA; AXOTOMY; NEURONS	The temporospatial relationship between microglial and astrocytic reactions and delayed thalamic cell death was examined 1-7 days following a traumatic cold lesion of the rat sensorimotor cortex using immunocytochemistry in combination with terminal deoxynucleo-tidyltransferase-mediated biotinylated dUTP nick end labeling (TUNEL) of nuclear DNA fragmentation. No or only occasional TUNEL-positive cells were found in the thalamic relay nuclei up to 3 days after trauma. After 7 days, on the other hand, a considerable number of TUNEL-positive cells were seen in the ventrobasal, the ventrolateral and posterior thalamic nuclei. Already 3 days after trauma, i.e., before cell injury was detectable, many protoplasmic astrocytes, which were reactive for glial fibrillary acidic protein, and ramified microglia, which were positive for complement receptor type 3b (CR3b) but negative for major histocompatibility complex (MHC) class II antigen, were noticed in the thalamus. The number of labeled astro- and microglia further increased after 7 days, when DNA fragmentation became evident. At this time, the morphology of microglia shifted towards bushy and rod-like cells, and microglia became also reactive for MHC class LI antigen. Clusters of CR3b- and MHC class II-positive microglia were found in the ventrobasal thalamus. The present findings demonstrate that trauma-induced microglial and astrocytic reactions appear in the thalamus prior the onset of cell damage.	Max Planck Inst Neurol Res, Dept Expt Neurol, D-50931 Cologne, Germany		Hermann, DM (corresponding author), Max Planck Inst Neurol Res, Dept Expt Neurol, Gleueler Str 50, D-50931 Cologne, Germany.		Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk M./AAT-3652-2021	Hermann, Dirk M./0000-0003-0198-3152			Acarin L, 1997, EXP NEUROL, V147, P410, DOI 10.1006/exnr.1997.6593; BANATI RB, 1993, GLIA, V7, P11; BARRON KD, 1967, J NEUROPATH EXP NEUR, V26, P300, DOI 10.1097/00005072-196704000-00007; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; deBilbao F, 1996, NEUROREPORT, V7, P3051, DOI 10.1097/00001756-199611250-00051; DONOGHUE JP, 1977, BRAIN RES, V125, P351, DOI 10.1016/0006-8993(77)90629-1; DUSART I, 1991, NEUROSCIENCE, V45, P541, DOI 10.1016/0306-4522(91)90269-T; FERRER I, 1994, BRAIN PATHOL, V4, P115, DOI 10.1111/j.1750-3639.1994.tb00821.x; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; Hermann DM, 1999, NEUROREPORT, V10, P759, DOI 10.1097/00001756-199903170-00018; Hermann DM, 1998, NEUROREPORT, V9, P1917, DOI 10.1097/00001756-199806010-00046; HERRERA DG, 1992, NEUROSCIENCE, V49, P781, DOI 10.1016/0306-4522(92)90356-7; Kermer P, 1998, J NEUROSCI, V18, P4656; KERNS JM, 1973, J COMP NEUROL, V151, P255, DOI 10.1002/cne.901510304; KOLB B, 1983, EXP NEUROL, V79, P223, DOI 10.1016/0014-4886(83)90393-X; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; MAEHLEN J, 1989, J NEUROIMMUNOL, V23, P125, DOI 10.1016/0165-5728(89)90031-3; MARTY S, 1991, NEUROSCIENCE, V45, P529, DOI 10.1016/0306-4522(91)90268-S; MATTHEWS MA, 1973, J NEUROCYTOL, V151, P255; MILLIGAN CE, 1991, J COMP NEUROL, V314, P136, DOI 10.1002/cne.903140113; PESCHANSKI M, 1987, J COMP NEUROL, V258, P185, DOI 10.1002/cne.902580203; RINK A, 1995, AM J PATHOL, V147, P1575; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Sorensen JC, 1996, EXP BRAIN RES, V112, P203; STREIT WJ, 1989, J NEUROIMMUNOL, V21, P117, DOI 10.1016/0165-5728(89)90167-7; Watanabe H, 1998, J CEREBR BLOOD F MET, V18, P686, DOI 10.1097/00004647-199806000-00011	27	17	18	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0001-6322			ACTA NEUROPATHOL	Acta Neuropathol.	FEB	2000	99	2					147	153		10.1007/PL00007418			7	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	275TA	WOS:000084835200009	10672321				2022-02-06	
J	Irazuzta, JE; Olson, J; Kiefaber, MP; Wong, H				Irazuzta, JE; Olson, J; Kiefaber, MP; Wong, H			Hypothermia decreases excitatory neurotransmitter release in bacterial meningitis in rabbits	BRAIN RESEARCH			English	Article						hypothermia; meningitis; glutamate; aspartate; neurotransmitter; heat shock protein	EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; HEAT-SHOCK-PROTEIN; TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; RAT-BRAIN; MODERATE HYPOTHERMIA; NEURONAL INJURY; NITRIC-OXIDE; AMINO-ACIDS	The excitatory neurotransmitters glutamate (GLU) and aspartate (ASP) are involved in the pathogenesis of neuronal injury in meningitis. Based on past findings that the induction of moderate hypothermia (32-34 degrees C) attenuates the release of GLU in ischemic brain injury, this study was designed to detect if the application of moderate hypothermia decreases the release of excitatory amino acids (EAA) from brain tissue of animals with bacterial meningitis. Also examined was whether meningitis induces the expression of 72-kDa heat shock protein (HSP 70) in the cerebellum and how hypothermia affects it, for induction of HSP 70 has been used as a sensitive marker of neuronal stress in other forms of brain injury. Meningitis was induced by injecting Group B Streptococcus (GBS) into the cisterna magnae of rabbits. Antibiotic treatment began 16 h later. At this time the animals were anesthetized, instrumented, and randomized to normothermic (Nor) or hypothermic (Hy) conditions. Temperatures were strictly regimented for the following 10 h while maintaining stable cardiorespiratory parameters. Cerebrospinal fluid (CSF) samples were then withdrawn to measure concentrations of bacteria, protein, and amino acids. Meningitis causes CSF contents of GLU and ASP to increase significantly. Hypothermia treated animals demonstrated a 40-50% reduction in CSF GLU and ASP. Meningitis induced the expression of HSP 70 in the cerebellum while hypothermic animals experienced a significant decrease HSP 70 induction. These data demonstrate that hypothermia produces an attenuation of the release of excitatory neurotransmitters in meningitis and suggest that this treatment may attenuate neuronal stress. (C) 1999 Published by Elsevier Science B.V. All rights reserved.	Childrens Hosp, Med Ctr, Div Crit Care, Cincinnati, OH 45229 USA; Childrens Med Ctr, Dayton, OH 45404 USA; Wright State Univ, Dept Emergency Med, Dayton, OH 45435 USA; MSI Ohio State Univ, Columbus, OH USA		Irazuzta, JE (corresponding author), Childrens Hosp, Med Ctr, Div Crit Care, Cincinnati, OH 45229 USA.			Wong, Hector/0000-0001-7989-1173	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K08HL03725] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K08HL003725] Funding Source: NIH RePORTER		Arditi M, 1998, PEDIATRICS, V102, P1087, DOI 10.1542/peds.102.5.1087; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; BARONE FC, 1995, MOL CHEM NEUROPATHOL, V24, P13, DOI 10.1007/BF03160109; BARSARSKY TA, 1999, J NEUROSCI, V19, P6439; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BERING EA, 1961, AM J PHYSIOL, V200, P417; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; BURYAKOVA AV, 1975, ARCH NEUROL-CHICAGO, V32, P28, DOI 10.1001/archneur.1975.00490430050007; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Darakchiev BJ, 1997, ACT NEUR S, V70, P98; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; GUERRAROMERO L, 1993, PEDIATR RES, V33, P510, DOI 10.1203/00006450-199305000-00018; HILGIER W, 1994, J NEUROCHEM, V62, P197; KIM YS, 1995, J NEUROPATH EXP NEUR, V54, P531, DOI 10.1097/00005072-199507000-00007; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; KOEDEL U, 1995, ANN NEUROL, V37, P313, DOI 10.1002/ana.410370307; Lahrtz F, 1998, J NEUROIMMUNOL, V85, P33, DOI 10.1016/S0165-5728(97)00267-1; Leib SL, 1996, J INFECT DIS, V173, P166, DOI 10.1093/infdis/173.1.166; LOCKWOOD AH, 1980, BRAIN RES, V200, P216, DOI 10.1016/0006-8993(80)91112-9; LOWENSTEIN DH, 1990, BRAIN RES, V531, P173, DOI 10.1016/0006-8993(90)90771-3; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MCALLISTER CK, 1975, J INFECT DIS, V132, P355, DOI 10.1093/infdis/132.4.355; MINAMISAWA H, 1990, J CEREBR BLOOD F MET, V10, P365, DOI 10.1038/jcbfm.1990.66; OLDENDORF WH, 1976, AM J PHYSIOL, V230, P940; Olney J W, 1986, Adv Neurol, V44, P857; Planas AM, 1997, PROG NEUROBIOL, V51, P607, DOI 10.1016/S0301-0082(97)00004-X; Qureshi GA, 1998, NEUROCHEM INT, V32, P197, DOI 10.1016/S0197-0186(97)00061-2; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; ROSOMOFF HL, 1959, J NEUROSURG, V16, P177, DOI 10.3171/jns.1959.16.2.0177; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; SAEZLLORENS X, 1990, J PEDIATR-US, V116, P671, DOI 10.1016/S0022-3476(05)82647-2; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SHAVER EG, 1995, STROKE, V26, P1273, DOI 10.1161/01.STR.26.7.1273; SHIMADA N, 1993, J NEUROCHEM, V60, P66, DOI 10.1111/j.1471-4159.1993.tb05823.x; SIMON RP, 1991, J NEUROSCI, V11, P881; SLOVITER RS, 1992, J NEUROSCI, V12, P3004, DOI 10.1523/JNEUROSCI.12-08-03004.1992; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; STERNS RH, 1993, AM J PHYSIOL, V264, P833; Stringaris AK, 1997, ACTA NEUROPATHOL, V93, P215, DOI 10.1007/s004010050606; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/0361-9230(96)00159-1; Tanaka K, 1996, BRAIN RES, V737, P59, DOI 10.1016/0006-8993(96)00658-0; TAUBER MG, 1992, AM J PATHOL, V141, P53; TUCCI S, 1998, CLIN BIOCHEM, P31; TUOMANEN EI, 1989, J EXP MED, V170, P959, DOI 10.1084/jem.170.3.959; Yu ACH, 1995, PROG BRAIN RES, V105, P245	51	17	17	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	NOV 13	1999	847	1					143	148		10.1016/S0006-8993(99)02120-4			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256UU	WOS:000083745500020	10564748				2022-02-06	
J	Schlund, MW; Pace, G				Schlund, MW; Pace, G			Relations between traumatic brain injury and the environment: feedback reduces maladaptive behaviour exhibited by three persons with traumatic brain injury	BRAIN INJURY			English	Article							NEUROLOGICAL REHABILITATION; INVOLVEMENT	Feedback is a commonly used technique in neurorehabilitation. It functions cu strengthen or weaken select relations between individuals' behaviour and their environment. The study of behaviour-environment relations is a locus of operant psychology, commonly referred to as behaviour analysis. Central to behaviour analysis is die analysis of interrelations among stimuli, behaviour, and consequences. The focus on behaviour-environment relations may have considerable benefits for designing clinical treatment and accounting for successful and unsuccessful treatments, especially psychological interventions for maladaptive behaviour. In the present investigation, three persons with traumatic brain injuries, diagnosed with depression and presenting mild cognitive impairments, received feedback about their maladaptive behaviour. Weekly feedback resulted in general reductions in the variability and frequency of maladaptive behaviour. The results support the utility of giving equal consideration to relations between persons with traumatic brain inury and their environment, despite existing psychological or cognitive impairments. Future research on variables that influence the development and maintenance of behaviour-environment relations, and more generally operant behaviour, may provide a unique perspective on the effect of traumatic brain injury.	Kennedy Krieger Inst, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA		Schlund, MW (corresponding author), Kennedy Krieger Inst, 333 Cassell Dr,Triad Technol Bldg Suite 4200, Baltimore, MD 21224 USA.						Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; BAER DM, 1968, J APPL BEHAV ANAL, V1, P91, DOI 10.1901/jaba.1968.1-91; Damasio A.R., 1993, CLIN NEUROPSYCHOLOGY, P409; DUBBERT PM, 1984, BEHAV RES THER, V22, P227, DOI 10.1016/0005-7967(84)90003-2; FISHER JE, 1988, 41 ANN SCI M GER SOC; HARRELL M, 1992, COGNITIVE REHABILITA; Lane SD, 1998, DRUG ALCOHOL DEPEN, V51, P239, DOI 10.1016/S0376-8716(98)00045-3; LATTAL KA, 1995, BEHAV ANALYST, V18, P209, DOI 10.1007/BF03392709; MCGLYNN SM, 1990, PSYCHOL BULL, V108, P420, DOI 10.1037/0033-2909.108.3.420; Morris E K, 1982, Behav Anal, V5, P109; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; Pace GM, 1999, BRAIN INJURY, V13, P535; Pace GM, 1996, J HEAD TRAUMA REHAB, V11, P18, DOI 10.1097/00001199-199602000-00004; PACE GM, 1993, STAFF DEV CLIN INTER, P105; PERONE M, 1982, J GERONTOL, V37, P443, DOI 10.1093/geronj/37.4.443; PETERS MD, 1995, BRAIN INJURY, V9, P543, DOI 10.3109/02699059509008213; SALZINGER K, 1988, BEHAV THEORY BEHAV T, P98; SCHLUND M, 1998, J REHABILITATION OUT, V2, P2; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; SCHLUND MW, IN PRESS BEHAV MODIF; SLIFER KJ, 1993, ARCH PHYS MED REHAB, V74, P810, DOI 10.1016/0003-9993(93)90006-V; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; WOOD R, 1988, J HEAD TRAUMA REHAB, V3, P53	24	17	19	0	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	1999	13	11					889	897					9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	253FZ	WOS:000083547000005	10579660				2022-02-06	
J	Lubillo, S; Bolanos, J; Carreira, L; Cardenosa, J; Arroyo, J; Manzano, J				Lubillo, S; Bolanos, J; Carreira, L; Cardenosa, J; Arroyo, J; Manzano, J			Prognostic value of early computerized tomography scanning following craniotomy for traumatic hematoma	JOURNAL OF NEUROSURGERY			English	Article						head injury; intracranial hematoma; computerized tomography scanning; intracranial pressure; cerebral perfusion pressure; outcome	SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; COMA DATA-BANK; CT SCAN; SUBARACHNOID HEMORRHAGE; PREDICTION; EXPERIENCE	Object. Patients with head injuries traditionally were categorized on the basis of whether their lesions appeared to be diffuse, focal, or mass lesions on admission computerized tomography (CT) scanning. In the classification of Marshall, et al., the presence of a hematoma (evacuated or not evacuated) is more significant than any diffuse injury (DI). The CT scan appearance after evacuation of a mass lesion has not been analyzed previously in relation to outcome. The authors have investigated the importance of: 1) neurological assessment at hospital admission; 2) the status of the basal cisterns and associated intracranial lesions on the admission CT scan; and 3) the degree of DI on the early CT scan obtained after craniotomy to identify patients at risk for development of raised intracranial pressure (ICP) and lowered cerebral perfusion pressure (CPP) and to discover the influence of the postoperative CT appearance of the lesion on patient outcome. Methods. The authors prospectively studied 82 patients with isolated, severe closed head injury (Glasgow Coma Scale [GCS] score < 8), all of whom had intracranial hematoma. Both ICP and CPP were continuously monitored, and a CT scan was obtained within 2 to 12 hours after craniotomy. The CT images were categorized according to the classification of Marshall, et al. The mortality rate during the hospital stay was 37%, and 50% of the patients achieved a favorable outcome. Compression of the basal cistern on the admission (preoperative) CT scan was associated with raised ICP and a CPP of less than 70 mm Hg but not with any other features or with poor patient outcome. In 53 patients the postoperative CT scan revealed DIs III or IV and 29 patients had DIs I or II. The percentages of time during the hospital stay in which ICP was higher than 20 mm Hg and CPP was lower than 70 mm Hg as well as unfavorable outcome were higher in the group of patients in whom DI III or IV was present (p < 0.001). Raised ICP, CPP lower than 70 mm Hg, DI III or IV, and unfavorable outcome were more frequently observed in patients who presented with a motor (m)GCS score of 3 or less, bilateral unreactive pupils: associated intracranial injuries, and hypotension (p < 0.001). When logistic regression analysis was performed, an mGCS score of 3 or less (p = 0.0013, odds ratio [OR] 10.8), bilateral unreactive pupils (p = 0.0047, OR 31.8), and DI In or IV observed on CT scanning after surgery (p = 0.015, OR 8.9) were independently associated with poor outcome. Conclusions. Features on CT scans obtained shortly after craniotomy constitute an independent predictor of outcome in patients with traumatic hematoma. Patients in whom DI III or IV appears on postoperative CT scanning, who often present with an mGCS score of 3 or less and nonreactive pupils, are at high risk for the development of raised ICP and lowered CPP.	Hosp Univ Pino, Intens Care Unit, Las Palmas Gran Canaria, Canary Isl, Spain; Hosp Univ Pino, Dept Neurosurg, Las Palmas Gran Canaria, Canary Isl, Spain		Lubillo, S (corresponding author), Care of Olivares C, 26-17A2, Las Palmas Gran Canaria 350011, Canary Isl, Spain.	cendrero@idecnet.com					BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENTLEMAN D, 1990, LANCET, V335, P330, DOI 10.1016/0140-6736(90)90615-C; GENTLEMAN D, 1981, LANCET, V2, P853; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MURPHY A, 1983, INTRACRANIAL PRESSUR, V5, P562; MURRAY LS, 1993, J NEUROTRAUMA, V10, pS101; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237	32	17	19	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	1999	91	4					581	587		10.3171/jns.1999.91.4.0581			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	239HV	WOS:000082763400008	10507378				2022-02-06	
J	Hawkins, KA				Hawkins, KA			Memory deficits in patients with schizophrenia: preliminary data from the Wechsler Memory Scale Third Edition support earlier findings	JOURNAL OF PSYCHIATRY & NEUROSCIENCE			English	Article						Alzheimer disease; intelligence; intelligence tests; Korsakoff syndrome; learning; memory; schizophrenia; Wechsler Scales		Objective: To determine whether memory data presented for a schizophrenia sample in the Technical Manual of the Wechsler Memory Scale-Third Edition support trends identified in a previously published review of studies employing an earlier version of the instrument, the Wechsler Memory Scale-Revised. Design: Archival: reformulation of published data. Patients: Patients with schizophrenia, Alzheimer's disease, Korsakoffs syndrome or traumatic brain injury (TBI) for whom intelligence and memory data were reported in the Technical Manual of the Wechsler Adult Intelligence Scale-Third Edition Wechsler Memory Scale-Third Edition (WAIS-III WMS-III). Outcome measures: Mean Full Scale, Verbal, and Performance Intelligence Quotients of the WAIS-III and mean WMS-III Immediate and General Memory Indexes. Single-trial learning and learning slope data were also culled from the WAIS-III WMS-III Technical Manual. Results: Memory indexes for patients with Alzheimer's disease or Korsakoffs syndrome were substantially lower than those for patients with schizophrenia or TBI. In tests of learning processes, patients with schizophrenia had an inferior ability to repeat material presented just once, in comparison with the standardization sample. However, they did relatively better with repeated presentations than patients with Alzheimer's disease or Korsakoffs syndrome. The learning slope for patients with schizophrenia demonstrated an ability to absorb and consolidate increasing amounts of material with repeated exposure that is inconsistent with pronounced memory impairment. Conclusions: Although patients with schizophrenia exhibit new learning deficiencies, their memory capabilities are-not substantially weaker than their general intellectual abilities, and do not approach the memory impairment exhibited by patients with Alzheimer's disease or Korsakoffs syndrome.	Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06519 USA		Hawkins, KA (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 34 Pk St, New Haven, CT 06519 USA.	Keith.Hawkins@Yale.edu		Hawkins, Keith/0000-0003-3494-2103			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; GOLDBERG TE, 1991, REV PSYCHIATRY, V10, P60; Hawkins KA, 1997, J PSYCHIATR NEUROSCI, V22, P169; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hawkins KA, 1997, J NEUROPSYCH CLIN N, V9, P81; LEVIN S, 1989, J ABNORM PSYCHOL, V98, P341, DOI 10.1037/0021-843X.98.4.341; NESTOR PG, 1993, AM J PSYCHIAT, V150, P1849; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; SEIDMAN LJ, 1994, BIOL PSYCHIAT, V35, P235, DOI 10.1016/0006-3223(94)91254-8; Sharma T, 1998, J CLIN PSYCHOPHARM, V18, p12S, DOI 10.1097/00004714-199804001-00004; Squire LR., 1987, MEMORY BRAIN; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL	14	17	18	0	3	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	1180-4882	1488-2434		J PSYCHIATR NEUROSCI	J. Psychiatry Neurosci.	SEP	1999	24	4					341	347					7	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	241KH	WOS:000082881800008	10516802				2022-02-06	
J	Katano, H; Fujita, K; Kato, T; Asai, K; Kawamura, Y; Masago, A; Yamada, K				Katano, H; Fujita, K; Kato, T; Asai, K; Kawamura, Y; Masago, A; Yamada, K			Traumatic injury in vitro induces IEG mRNAs in cultured glial cells, suppressed by co-culture with neurons	NEUROREPORT			English	Article						c-fos; c-jun; glia; immediate early gene; in situ hybridization; mechanical injury; mRNA; neuron; zif/268	MESSENGER-RNA EXPRESSION; IMMEDIATE EARLY GENES; REACTIVE ASTROCYTES; NERVOUS-SYSTEM; GROWTH-FACTOR; BRAIN INJURY; INVITRO; FOS; MODEL; RAT	GLIAL changes following traumatic injury to glial monolayers as well as to neuronal-glial co-culture systems in vitro were examined with a focus on the expression of mRNAs coding for the immediate early genes (IEG) c-fos, c-jun and zif/268, demonstrated using in situ hybridization. Glial cells along scratch wound lines extended cytoplasmic processes as early as 10 min post-injury and the whole wound was covered with gliosis by 24 h. For complete restoration in the case of glial cells co-cultured with neurons, this required 48h. Induction of the three IEG mRNAs was eminent along the edges of scratch wound, peaking at 30-60 min postinjury and subsiding by 3 h. The peak expression of IEG mRNAs was delayed to 1-3h post-injury and became undetectable at 6h in neuronal-glial co-cultures. The data suggest that mechanical injury to glial cells causes gliosis and the expression of IEG mRNAs, which are suppressed by co culture with neurons, indicating some influence of neuronal-glial interactions. NeuroReport 10:2439-2448 (C) 1999 Lippincott Williams & Wilkins.	Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Nagoya City Univ, Sch Med, Dept Bioregulat Res, Mizuho Ku, Nagoya, Aichi 4678601, Japan		Katano, H (corresponding author), Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.		Asai, Kiyofumi/H-2356-2014	Asai, Kiyofumi/0000-0001-7015-2251			Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; CONDORELLI DF, 1993, J NEUROCHEM, V60, P877, DOI 10.1111/j.1471-4159.1993.tb03232.x; CURRAN T, 1987, ONCOGENE, V2, P79; GASSER UE, 1990, J NEUROSCI, V10, P1276; Harada S, 1997, NEUROREPORT, V8, P3399, DOI 10.1097/00001756-199710200-00041; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Iwata A, 1997, J NEUROTRAUM, V14, P201, DOI 10.1089/neu.1997.14.201; Katano H, 1998, BRAIN RES, V800, P69, DOI 10.1016/S0006-8993(98)00493-4; MacFarlane SN, 1997, J NEUROSCI, V17, P7316; Masago A, 1996, NEUROREPORT, V7, P2565, DOI 10.1097/00001756-199611040-00032; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NAKANISHI K, 1994, BRAIN RES, V659, P169, DOI 10.1016/0006-8993(94)90876-1; PENDE M, 1994, P NATL ACAD SCI USA, V91, P3215, DOI 10.1073/pnas.91.8.3215; Pennypacker KR, 1996, MOL BRAIN RES, V37, P224, DOI 10.1016/0169-328X(95)00318-M; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; VIGE X, 1992, BRAIN RES, V591, P345, DOI 10.1016/0006-8993(92)91718-T; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306	24	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	AUG 20	1999	10	12					2439	2448		10.1097/00001756-199908200-00002			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	228BN	WOS:000082116100003	10574349				2022-02-06	
J	Brown, M; Gordon, WA				Brown, M; Gordon, WA			Quality of life as a construct in health and disability research	MOUNT SINAI JOURNAL OF MEDICINE			English	Article						quality of life; disability; chronic illness; research methodology	TRAUMATIC BRAIN INJURY; COMMUNITY INTEGRATION QUESTIONNAIRE; CLOSED-HEAD-INJURY; OF-LIFE; REHABILITATION OUTCOMES; FUNCTIONAL ASSESSMENT; MULTIPLE-SCLEROSIS; IMPACT PROFILE; SATISFACTION; HANDICAP	Definitional issues that affect the measurement of quality of life (QOL) in health care research are discussed. In reviewing a broad sample of health- and disability-related QOL studies, the authors note several characteristics in which respective approaches to measurement differ: (a) In various measurement tools, QOL has been located either within the insider's (i.e., the person being measured) judgment of the "goodness" of his or her life or outside this judgment. (b) The insider's and/or outsider's values may hold sway in deciding the elements of life that are relevant to QOL within the measurement process, and in rating the degree of "goodness" of these life domains. (c) QOL models incorporate domains of items varying in breadth and specificity; and they take either a negative or neutral view of functioning. (d) QOL models vary in their complexity, type of linkage between components, and inclusion (or not) of both the insider's judgment and external predictors of QOL. These distinctions are used by the authors in recommending approaches to QOL measurement suitable for health care research aimed at outcome assessment and description of populations.	Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA		Gordon, WA (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, Box 1240,1 E 100th St, New York, NY 10029 USA.						ALEXANDER JL, 1981, ARCH PHYS MED REHAB, V62, P261; Aller L J, 1995, J Gerontol Nurs, V21, P20; Allison PJ, 1997, SOC SCI MED, V45, P221, DOI 10.1016/S0277-9536(96)00339-5; Andrews F. M., 1976, SOCIAL INDICATORS WE; Aronson KJ, 1997, NEUROLOGY, V48, P74, DOI 10.1212/WNL.48.1.74; Bach C A, 1993, Rehabil Nurs, V18, P364; BADLEY EM, 1995, DISABIL REHABIL, V17, P53, DOI 10.3109/09638289509166628; Batterham RW, 1996, ARCH PHYS MED REHAB, V77, P1219, DOI 10.1016/S0003-9993(96)90183-5; Bauer R. A., 1966, SOCIAL INDICATORS; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Berzon RA, 1995, QUAL LIFE RES, V4, P547, DOI 10.1007/BF00634750; BOWLING A, 1995, SOC SCI MED, V41, P1447, DOI 10.1016/0277-9536(95)00113-L; Brazil L, 1997, J NEURO-ONCOL, V34, P187, DOI 10.1023/A:1005710729748; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brown M, 1980, REHABILITATION CLIEN, P102; BURCKHARDT CS, 1989, RES NURS HEALTH, V12, P347, DOI 10.1002/nur.4770120604; Campbell A.-Ph. E. Converse-W. L., 1976, QUALITY AM LIFE PERC; Carr AJ, 1996, BRIT J RHEUMATOL, V35, P275; Carr AJ, 1996, BRIT J RHEUMATOL, V35, P921; CHUBON RA, 1987, EVAL HEALTH PROF, V10, P186, DOI 10.1177/016327878701000203; CLAYTON KS, 1994, ARCH PHYS MED REHAB, V75, P633, DOI 10.1016/0003-9993(94)90184-8; CONDELUCI A, 1992, Brain Injury, V6, P543, DOI 10.3109/02699059209008151; DECKER SD, 1985, AM J OCCUP THER, V39, P740, DOI 10.5014/ajot.39.11.740; DENNIS RE, 1993, EXCEPT CHILDREN, V59, P499, DOI 10.1177/001440299305900603; Duncan O. D., 1969, SOCIAL REPORTING NEX; EBRAHIM S, 1995, SOC SCI MED, V41, P1383, DOI 10.1016/0277-9536(95)00116-O; Edgerton R.B., 1990, QUALITY LIFE PERSPEC, P149; FADEN R, 1992, MED CARE, V30, pMS166, DOI 10.1097/00005650-199205001-00014; FARQUHAR M, 1995, SOC SCI MED, V41, P1439, DOI 10.1016/0277-9536(95)00117-P; Felce D, 1997, J INTELL DISABIL RES, V41, P126, DOI 10.1111/j.1365-2788.1997.tb00689.x; FLANAGAN JC, 1978, AM PSYCHOL, V33, P138, DOI 10.1037/0003-066X.33.2.138; FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; FUHRER MJ, 1994, AM J PHYS MED REHAB, V73, P358, DOI 10.1097/00002060-199409000-00010; FUHRER MJ, 1997, ASSESSING MED REHABI; Gill TM, 1995, J ROY SOC MED, V88, P680; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; GORDON WA, 1999, REHABILITATION ADULT, P372; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; HALPERN AS, 1984, FUNCTIONAL ASSESSMEN; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hobart JC, 1996, CURR OPIN NEUROL, V9, P441, DOI 10.1097/00019052-199612000-00008; HORLEY J, 1984, GERONTOLOGIST, V24, P124, DOI 10.1093/geront/24.2.124; IRWIN PH, 1982, SOC INDIC RES, V10, P187, DOI 10.1007/BF00302510; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; LAMAN H, 1994, DISABIL REHABIL, V16, P198, DOI 10.3109/09638289409166613; Lankhorst GJ, 1996, J NEUROL, V243, P469, DOI 10.1007/BF00900502; LEHMAN AF, 1995, HEALTH AFFAIR, V14, P90, DOI 10.1377/hlthaff.14.3.90; Leplege A, 1997, JAMA-J AM MED ASSOC, V278, P47, DOI 10.1001/jama.278.1.47; LINDSTROM B, 1991, Pediatrician, V18, P121; MCGEE HM, 1991, PSYCHOL MED, V21, P749, DOI 10.1017/S0033291700022388; MINAIRE P, 1993, VITAL HLTH STAT, V5, P9; Montgomery H, 1996, SCAND J REHABIL MED, V28, P233; Ormel J, 1997, SOC SCI MED, V45, P1051, DOI 10.1016/S0277-9536(97)00032-4; PETERSON RA, 1995, J COUNTRY MUSIC, V17, P3; Raphael D, 1997, INT J NURS STUD, V34, P231, DOI 10.1016/S0020-7489(97)00010-2; Robinson J. P, 1977, AM USE TIME SOCIAL P; ROGERSON RJ, 1995, SOC SCI MED, V41, P1373, DOI 10.1016/0277-9536(95)00122-N; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; SIOSTEEN A, 1990, PARAPLEGIA, V28, P476, DOI 10.1038/sc.1990.64; SPILKER B, 1990, QUALITY LIFE PHARMAC; STENSMAN R, 1985, SCAND J REHABIL MED, V17, P87; TENNANT A, 1995, ANN RHEUM DIS, V54, P439, DOI 10.1136/ard.54.6.439; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITENECK GG, 1994, ARCH PHYS MED REHAB, V75, P1073, DOI 10.1016/0003-9993(94)90080-9; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization, 1997, ICIDH 2 INT CLASS IM; WRIGHT B, 1960, PHYSICAL DISABILITY; ZIEBLAND S, 1993, SOC SCI MED, V37, P69, DOI 10.1016/0277-9536(93)90319-Y; 1995, MMWR MORB MORTAL WKL, V44, P195; [No title captured]	80	17	18	0	4	MOUNT SINAI HOSPITAL	NEW YORK	BOX 1094 ONE GUSTAVE L LEVY PLACE ATTN: CIRCULATION ASST, NEW YORK, NY 10029-6574 USA	0027-2507			MT SINAI J MED	Mt. Sinai J. Med.	MAY	1999	66	3					160	169					10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199UN	WOS:000080502600005	10377547				2022-02-06	
J	Adelson, PD				Adelson, PD			Animal models of traumatic brain injury in the immature: A review	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	IIIrd International Congress of Pathophysiology	JUN 28-JUL 03, 1998	LAHTI, FINLAND			brain injury; traumatic; Immature; brain injury; traumatic brain injury	CEREBRAL BLOOD-FLOW; FREELY MOVING RATS; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; CHILDREN; RESPONSES; METABOLISM; NEWBORN; PIGLETS; EDEMA		Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA		Adelson, PD (corresponding author), Childrens Hosp Pittsburgh, 3705 5th Ave, Pittsburgh, PA 15213 USA.	david_adelson@poplar.chp.edu	Adelson, David/W-2083-2019				ADAMS JH, 1984, RECENT ADV HISTOPATH, P241; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Adelson PD, 1996, J NEUROSURG, V84, P804; ADELSON PD, 1997, J NEUROTRAUM, V14, P787; ADELSON PD, 1995, J NEUROTRAUM, V12, P984; ADELSON PD, 1997, J NEUROTRAUM, V14, P781; ADELSON PD, 1998, IN PRESS J NEUROTRAU, V15; ADELSON PD, 1998, IN PRESS ACTA NEUR S, V71; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BOKSA P, 1995, PEDIATR RES, V37, P489, DOI 10.1203/00006450-199504000-00018; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DUHAIME AC, 1997, J NEUROTRAUM, V14, P777; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; FRITZ H, 1998, PATHOPHYSIOLOGY S1, V5, P237; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KRAUS JF, 1987, PEDIATRICS, V79, P501; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marmarou A, 1997, ACT NEUR S, V70, P68; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; NEHLIG A, 1989, J CEREBR BLOOD F MET, V9, P579, DOI 10.1038/jcbfm.1989.83; NEHLIG A, 1988, J NEUROSCI, V8, P2321; OI YO, 1995, NEUR ABSTR, V21; PRINS MI, 1997, J NEUROTRAUM, V14, P780; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; SMITH ML, 1995, J NEUROTRAUM, V12, P143; Walter B, 1997, BASIC RES CARDIOL, V92, P191, DOI 10.1007/s003950050037	44	17	17	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	FEB	1999	51	2					130	136					7	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pathology; Toxicology	177NZ	WOS:000079218000004	10192581				2022-02-06	
J	Zasler, ND				Zasler, ND			Posttraumatic headache: Caveats and controversies	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; headache; head trauma trauma; whiplash	INJURY; SEVERITY	Posttraumatic headache (PTHA) although quite common, is still poorly understood in many ways. This article arm provide opinions, insights, and analysis of some of the ongoing controversies and issues in PTHA assessment and treatment. Topics germane to nomenclature problems, classification criteria, paradoxes regarding headache incidence relative to injury severity, lack of identified medical specialty for referral of patients with PTHA, medicolegal issues, PTHA perpetuating factors, impairment and disability assessment, and research needs are addressed. Recommendations for addressing some of the concerns brought up in this commentary will be focused on in the article's concluding comments. These caveats and controversies will hopefully serve to familiarize readers with some of the inherent difficulties in PTHA management and treatment.	Concuss Care Ctr Virginia LTD, Glen Allen, VA 23060 USA; Tree Life, Glen Allen, VA USA		Zasler, ND (corresponding author), Concuss Care Ctr Virginia LTD, 10120 W Broad St,Suite G, Glen Allen, VA 23060 USA.						American Medical Association, 1993, GUID EV PERM IMP; APPENZELLER O, 1993, WOLFFS HEADACHE OTHE; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; FREEMAN MD, 1997, WHIPLASH INJURIES; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; *INT HEAD SOC HEAD, 1988, CEPHALALGIA, V8; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; NICK J, 1969, RES CLIN STUDIES HEA, V2; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; PACKARD RC, 1993, HEADACHE, V33, P359, DOI 10.1111/j.1526-4610.1993.hed3307359.x; Penfield W, 1936, ARCH NEURO PSYCHIATR, V36, P75, DOI 10.1001/archneurpsyc.1936.02260070083007; RADANOV BP, 1993, BRIT MED J, V307, P652, DOI 10.1136/bmj.307.6905.652; RUSSELL WR, 1933, T MED CHJIR SOC ENDB, V113, P129; SIEGMUND GP, P 41 STAPP CAR CRASH; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Warner JS, 1996, NEUROLOGY, V46, P915, DOI 10.1212/WNL.46.4.915; *WHO, 1997, CEPHALALGIA, V17; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x	19	17	17	0	3	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1999	14	1					1	8		10.1097/00001199-199902000-00003			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	165LT	WOS:000078523100003	9949242				2022-02-06	
J	Satish, U; Streufert, S; Eslinger, PJ				Satish, U; Streufert, S; Eslinger, PJ			Complex decision making after orbitofrontal damage: Neuropsychological and strategic management simulation assessment	NEUROCASE			English	Article						orbitofrontal damage; executive function; computer simulation assessment	MINOR HEAD-INJURY; TRAUMATIC BRAIN INJURY; FRONTAL-LOBE; BEHAVIORAL COMPLEXITY; PREFRONTAL CORTEX; MILD CONCUSSION; SEQUELAE; SYMPTOMS; RECOVERY; CONSEQUENCES	Neuropsychological tests have considerable value in identifying deficits following brain injury, but may not adequately measure certain residual problems which limit adaptive functioning after recovery. This paper reports the case of a 48-year-old woman who suffered right orbitofrontal damage after traumatic brain injury and experienced marked difficulties handling real-world (e.g, work-related) challenges despite very good recovery. Neuropsychological measurement indicated mild difficulties in select measures of executive functions, but no severe deficiencies were encountered. Therefore, further study was undertaken with a validated, computer-scored Strategic Management Simulation technique to assess how multiple, interactive aspects of executive competency might have been affected. Results revealed significantly impaired scores on several decision-making parameters, including initiative, information utilization, breadth of strategy, opportunistic actions and aspects of emergency handling which we attributed to the effects of orbitofrontal damage. Contextual or single-task problems were handled considerably better. The data suggest that the Strategic Management Simulation may provide a particularly valuable paradigm for assessing executive function deficits as a complement to neuropsychological measurement, although further studies are needed to establish its reliability and validity in relationship to neuropsychological impairments. Refined analysis of altered decision-making competencies after orbitofrontal damage may suggest new avenues for rehabilitative intervention.	Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Behav Sci, Hershey, PA 17033 USA; Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Med,Sect Neurol, Hershey, PA 17033 USA			usxs4@psu.edu					ALEXANDER G, 1990, PROGR BRAIN RES, V85; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BARBAS H, 1995, NEUROSCI BIOBEHAV R, V19, P499, DOI 10.1016/0149-7634(94)00053-4; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BIJUR PE, 1990, PEDIATRICS, V86, P337; BLEIBERG J, 1991, P MILD HEAD INJ C CO; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; BREUER K, 1996, CORPORATE TRAINING E; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CLARK E, 1992, CURR PSYCHOL RES REV, V11, P21, DOI 10.1007/BF02686825; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DAMASIO AR, 1990, FRONTAL LOBE FUNCTIO, P217; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Denker P., 1944, NY STATE J MED, V44, P379; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1989, MILD HEAD INJURY, P229; Eslinger Paul J., 1996, P415; ESLINGER PJ, 1993, NEUROPSYCHOLOGIA, V31, P17, DOI 10.1016/0028-3932(93)90077-D; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; ESLINGER PJ, 1991, NEUROLOGY, V41, P450, DOI 10.1212/WNL.41.3.450; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; GENTILINI M, 1989, MILD HEAD INJURY, P163; Goldstein F. C., 1995, CLIN NEUROPSYCHOLOGI, P49, DOI [10.1007/978-1-4757-9709-1_3, DOI 10.1007/978-1-4757-9709-1_3]; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; GRAFMAN J, 1986, BRAIN, V109, P1127, DOI 10.1093/brain/109.6.1127; GRONWALL D, 1974, LANCET, V2, P605; HARLOW JM, 1868, RECOVERY SEVERE INJU; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Jones R. D., 1996, P375; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; LEININGER B, 1992, REHABILITATION POST, P169; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1993, CURR OPIN NEUROL, V6, P841, DOI 10.1097/00019052-199312000-00003; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; NEAFSEY EJ, 1990, PROG BRAIN RES, V85, P147; PACKARD RC, 1993, HEADACHE, V33, P365, DOI 10.1111/j.1526-4610.1993.hed3307365.x; Price JL, 1996, PROG BRAIN RES, V107, P523; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Satish U, 1997, J APPL SOC PSYCHOL, V27, P2047, DOI 10.1111/j.1559-1816.1997.tb01640.x; Satish U, 1997, J APPL SOC PSYCHOL, V27, P2117, DOI 10.1111/j.1559-1816.1997.tb01643.x; Streufert S, 1997, J APPL SOC PSYCHOL, V27, P2068, DOI 10.1111/j.1559-1816.1997.tb01641.x; Streufert S, 1997, J APPL SOC PSYCHOL, V27, P2122, DOI 10.1111/j.1559-1816.1997.tb01644.x; Streufert S., 1988, Computers in Human Behaviour, V4, P77, DOI 10.1016/0747-5632(88)90034-9; Streufert S., 1985, ADV ENVIRON PSYCHOL, V5, P99; Streufert S, 1978, BEHAV COMPLEX ENV; STUSS DT, 1995, NEUROLOGY, V45, P1251, DOI 10.1212/WNL.45.7.1251; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; Tiller SG, 1998, PERCEPT MOTOR SKILL, V86, P1240, DOI 10.2466/pms.1998.86.3c.1240; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437	60	17	17	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		1999	5	4					355	364		10.1093/neucas/5.4.355			10	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	232XQ	WOS:000082395600009					2022-02-06	
J	Fiser, SM; Johnson, SB; Fortun, JB				Fiser, SM; Johnson, SB; Fortun, JB			Resource utilization in traumatic brain injury: The Role of magnetic resonance imaging	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Meeting of the Southeastern-Surgical-Congress	FEB 01-05, 1997	NASHVILLE, TENNESSEE	SE Surg Congress			CLOSED-HEAD-INJURY; MR; CHILDREN; CT	Cerebral CT scanning is routine in the acute evaluation of traumatic brain injury (TBI) patients. MRI has been reported to identify cerebral lesions better than CT scan. The purpose of this study was to determine whether MRI influenced the acute diagnosis and management of TBI patients. A retrospective medical records review was performed on all TBI patients undergoing cerebral CT scan and MRI admitted to a regional trauma center during a 2-year period. Patient data collected included demography, extent of TBI, CT scan and MRT use, and therapeutic interventions. Forty TBI patients (initial Glascow Coma Scale, 8.8 +/- 0.7) underwent 79 CT scans and 40 MRIs. Time to initial CT scan was 6.3 +/- 4.3 hours and time to MRI was 2.9 +/- 3.1 days. Nine patients (22.5%) had injuries on CT scan but not on MRI, most commonly skull fractures or small subarachnoid hemorrhages. Twenty-four patients (60%) had injuries on MRI but not on CT scan, most commonly corpus callosum shear injuries. There were two cases of child abuse and both had injuries of varying ages identified by MRI, but not CT. All injuries requiring a therapeutic intervention or change in management were identified by CT scan. Magnetic resonance angiography identified one patient with a traumatic internal carotid artery thrombosis. The performance of MRI resulted in additional charges of $75,640 or $3,152/patient identified with a new lesion. Although MRI identifies lesions not evident on CT scan, MRI does not alter management plans and is of limited value in the acute management: of TBI, MRI may be of medicolegal benefit in cases of child abuse.	Univ Arizona, Hlth Sci Ctr, Dept Surg, Sect Gen Surg & Trauma, Tucson, AZ 85724 USA		Johnson, SB (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Surg, Sect Gen Surg & Trauma, 1501 N Campbell Ave, Tucson, AZ 85724 USA.		Fortun, Jesus/H-1816-2017	Fortun, Jesus/0000-0002-6959-5263			AICHNER F, 1992, ANN NEUROL, V32, P507, DOI 10.1002/ana.410320405; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; GODERSKY JC, 1990, ACT NEUR S, V51, P311; HADLEY DM, 1988, CLIN RADIOL, V39, P131; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; LEVIN HS, 1989, NEUROSURGERY, V24, P223, DOI 10.1227/00006123-198902000-00011; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; National Board of Health and Welfare, 1996, ANN PLAN FISC YEAR 1, P2; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; Olshaker Jonathan S., 1993, Emergency Medicine Clinics of North America, V11, P165; Romano Valerie A., 1994, Journal of Emergency Medicine, V12, P369, DOI 10.1016/0736-4679(94)90280-1; SKLAR EML, 1992, RADIOL CLIN N AM, V30, P353; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; YEALY D M, 1991, Emergency Medicine Clinics of North America, V9, P707; YOKATA H, 1991, J TRAUMA, V31, P351	19	17	17	0	6	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	NOV	1998	64	11					1088	1093					6	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	131XU	WOS:000076601200017	9798776				2022-02-06	
J	Constantoyannis, C; Tzortzidis, F; Papadakis, N				Constantoyannis, C; Tzortzidis, F; Papadakis, N			Internuclear ophthalmoplegia following minor head injury: a case report	BRITISH JOURNAL OF NEUROSURGERY			English	Article						head injury; internuclear opthalmoplegia; multiple sclerosis		Internuclear ophthalmoplegia (INO) is a common sign of multiple sclerosis in young patients and of vascular diseases in older people. Traumatic bilateral internuclear ophthalmoplegia following severe head injuries may occur. We present the unusual case of a young patient suffered from bilateral INO as an isolated finding after a minor head injury, without other signs of brain stem or cortical injury. The ophthalmoplegia has persisted for 22 months.	Univ Hosp Patras, Sch Med, Dept Neurosurg, Patras, Greece		Constantoyannis, C (corresponding author), Univ Patras, Sch Med, Dept Neurosurg, Rion Patras 26500, Greece.			Constantoyannis, Constantine/0000-0003-3030-8439			BAKER RS, 1979, J NEUROSURG, V51, P552, DOI 10.3171/jns.1979.51.4.0552; BIELSCHOWSKY A, 1903, BER DTSCH OPHTHALMOL, V30, P164; COGAN DG, 1970, ARCH OPHTHALMOL-CHIC, V84, P583; Cooper PR, 1993, HEAD INJURY; DEVEREAUX MW, 1979, NEUROLOGY, V29, P251, DOI 10.1212/WNL.29.2.251; JAENSCH PA, 1924, KLIN MONATSBL AUGENH, V73, P471; MCALPINE D, 1972, MULTIPLE SCLEROSIS R, P101; RICH JR, 1974, ARCH OPHTHALMOL-CHIC, V92, P66; SATO O, 1974, NEUROCHIRURGIA, V17, P141; SMITH JL, 1959, ARCH OPHTHALMOL-CHIC, V61, P687, DOI 10.1001/archopht.1959.00940090689003; VANVLIET AGM, 1976, HDB CLIN NEUROLOGY, V24, P75; WALSH FB, 1969, CLIN NEUROOPHTHALMOL, V1, P985; ZAUEL D, 1979, ANN NEUROL, V1, P308; [No title captured]	14	17	17	0	1	CARFAX PUBL CO	ABINGDON	PO BOX 25, ABINGDON, OXFORDSHIRE, ENGLAND OX14 3UE	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	AUG	1998	12	4					377	379		10.1080/02688699844943			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	115AC	WOS:000075640500017	10070436				2022-02-06	
J	Katano, H; Masago, A; Harada, S; Iwata, A; Yamada, K				Katano, H; Masago, A; Harada, S; Iwata, A; Yamada, K			Differential induction of immediate early gene mRNAs following cryogenic and impact trauma with/without craniotomy in rats	BRAIN RESEARCH			English	Article						Immediate early gene; c-fos; c-jun; traumatic brain injury; messenger RNA; in situ hybridization	FOS MESSENGER-RNA; NERVE-CELL DEATH; C-FOS; BRAIN INJURY; TRANSCRIPTION FACTORS; INCREASED EXPRESSION; NMDA RECEPTOR; JUN; FOREBRAIN; CORTEX	Expression of immediate early gene (IEG) mRNAs following traumatic brain injury in 3 different models-cryogenic injury, impact injury with craniotomy and impact injury without craniotomy-was investigated using in situ hybridization. Cryogenic brain injury resulted in c-fos and c-jun mRNA expression throughout the ipsilateral cortex, piriform cortex and dentate gyrus on the injured side, with peak at 30 min to 1 h post-injury. Impact injury with craniotomy was associated with hybridization signals in the same areas and also in the subcortical white matter or ependyma underlying the impact site at 30 min post-injury. The expression was rather more prolonged than with cryogenic injury. Impact injury without craniotomy induced the expression of both mRNAs throughout the ipsilateral cortex, piriform cortex and dentate gyrus at 30 min post-injury, but this was promptly attenuated by 1 h post-injury, except for bilateral elevation in the dentate gyrus. The present study, thus, demonstrated that regional and temporal expression of IEG mRNAs is influenced by the intensity, quality and manner of application of the insult. Differences in the expression of IEGs may alter the late response gene expression and affect the succeeding events. (C) 1998 Elsevier Science B.V. All rights reserved.	Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, Nagoya, Aichi 467, Japan		Katano, H (corresponding author), Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 467, Japan.						Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; Amaral D.G., 1994, RAT NERVOUS SYSTEM, P443; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BELLUARDO N, 1995, NEUROCHEM INT, V26, P443, DOI 10.1016/0197-0186(94)00155-N; Campeau S, 1997, NEUROSCIENCE, V78, P1087, DOI 10.1016/S0306-4522(96)00632-X; CURRAN T, 1987, ONCOGENE, V2, P79; DRAGUNOW M, 1995, BRAIN RES REV, V21, P1, DOI 10.1016/0165-0173(95)00003-L; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; DRAGUNOW M, 1993, MOL BRAIN RES, V18, P347, DOI 10.1016/0169-328X(93)90101-T; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FUKUHARA T, 1995, NEUROSCI LETT, V193, P133, DOI 10.1016/0304-3940(95)11687-R; Gass P, 1997, MOL BRAIN RES, V46, P177, DOI 10.1016/S0169-328X(96)00300-2; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Honkaniemi J, 1997, J CEREBR BLOOD F MET, V17, P636; Iwata A, 1997, J NEUROTRAUM, V14, P201, DOI 10.1089/neu.1997.14.201; Katano H, 1997, RESTOR NEUROL NEUROS, V11, P153, DOI 10.3233/RNN-1997-11305; KINOUCHI H, 1994, J CEREBR BLOOD F MET, V14, P808, DOI 10.1038/jcbfm.1994.101; KOHMURA E, 1995, MOL BRAIN RES, V28, P117, DOI 10.1016/0169-328X(94)00198-N; Lindsberg PJ, 1996, J CEREBR BLOOD F MET, V16, P82, DOI 10.1097/00004647-199601000-00010; Masago A, 1996, NEUROREPORT, V7, P2565, DOI 10.1097/00001756-199611040-00032; MORGAN JI, 1991, TRENDS PHARMACOL SCI, V12, P343, DOI 10.1016/0165-6147(91)90594-I; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MUDO G, 1993, NEUROSCIENCE, V57, P901, DOI 10.1016/0306-4522(93)90036-F; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHARP FR, 1989, NEUROSCI LETT, V100, P117, DOI 10.1016/0304-3940(89)90670-8; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X	37	17	19	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 27	1998	800	1					69	77		10.1016/S0006-8993(98)00493-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	107YE	WOS:000075237900008	9685588				2022-02-06	
J	Oberg, L; Turkstra, LS				Oberg, L; Turkstra, LS			Use of elaborative encoding to facilitate verbal learning after adolescent traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CLOSED-HEAD-INJURY; MEMORY; CHILDREN; PERFORMANCE	Objective: To investigate the effectiveness of elaborative encoding in learning and remembering word definitions after traumatic brain injury (TBI). Design: Two case studies. Setting: University outpatient clinic. Participants: Two adolescents with severe memory impairments after TBI who needed specific vocabulary for school. Interventions: A series of individual speech-language therapy sessions incorperating clinician-and subject-generated strategies to facilitate elaborative encoding. Target words were based on school requirements and pretreatment test results and were assigned randomly to treatment or control groups. Main Outcome Measure: Accuracy of free recalled definitions at the conclusion of therapy and after 1 month with no therapy. Results: Significant improvement in expressed word knowledge at the conclusion of therapy, with improvement on treated words maintained at 1 month for both subjects. Conclusions: Elaborative encoding was an effective tool for teaching specific information required for school. Patterns of response differed substantially from those of normally developing children. Generalization to classroom use was planned for and should be measured in future research.	Univ Arizona, Dept Speech & Hearing Sci, Tucson, AZ 85721 USA; Univ Arizona, Dept Neurol, Tucson, AZ 85721 USA		Turkstra, LS (corresponding author), Case Western Reserve Univ, Dept Commun Sci, 11206 Euclid Ave,LC 7154, Cleveland, OH 44106 USA.		Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC-01409] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P60DC001409] Funding Source: NIH RePORTER		ANSHEL J, 1990, HEALTHY EYES BETTER; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; CHORAZY AJL, 1985, HEAD INJURY REHABILI; CORDES AK, 1994, J SPEECH HEAR RES, V37, P264, DOI 10.1044/jshr.3702.264; CROSSON B, 1993, CLIN NEUROPSYCHOL, V7, P250, DOI 10.1080/13854049308401897; CURTIS ME, 1987, NATURE VOCABULARY AC; DELIS D, 1987, CALIFORNIA VERBAL LE; DEMPSTER FN, 1987, J EDUC PSYCHOL, V79, P162, DOI 10.1037/0022-0663.79.2.162; DILLER L, 1987, NEUROBEHAVIORAL RECO; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; GOLDSTEIN G, 1988, CLIN NEUROPSYCHOL, V2, P251; GOODGLASS H, 1993, CORTEX, V29, P377, DOI 10.1016/S0010-9452(13)80250-X; HAMMILL D, 1991, DETROIT TESTS LEARNI; Hammill D. D., 1994, TEST ADOLESCENT ADUL; HOBBS DJ, 1987, PROGRAM LEARN EDUC T, V24, P145; JOHNSON CJ, 1995, J SPEECH HEAR RES, V38, P612, DOI 10.1044/jshr.3803.612; LEE CP, 1994, J LEARN DISABIL, V27, P454, DOI 10.1177/002221949402700705; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LLOYD LF, 1994, BRAIN INJURY, V8, P529, DOI 10.3109/02699059409151005; Mateer Catherine A., 1992, Seminars in Speech and Language, V13, P280, DOI 10.1055/s-2008-1064203; MCKEOWN MG, 1987, NATURE VOCABULARY AC; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Nippold M. A., 1988, LATER LANGUAGE DEV; PRESSLEY M, 1984, J VERB LEARN VERB BE, V23, P270, DOI 10.1016/S0022-5371(84)90181-6; Raven, 1938, PROGR MATRICES PERCE; Savage RC, 1987, J HEAD TRAUMA REHAB, V2, P1; SEMEL W, 1995, CLIN EVALUATION LANG; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SWANSON HL, 1989, J EXP CHILD PSYCHOL, V47, P370, DOI 10.1016/0022-0965(89)90020-9; TURKSTRA LS, 1995, BRAIN INJURY, V9, P61, DOI 10.3109/02699059509004573; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WESSELLS MG, 1982, COGNITIVE PSYCHOL; WIIG EH, 1988, TEST LANGUAGE COMPET; ZACHMAN I, 1989, ADOLESCENT WORD TEST; ZURIF E, 1994, J PSYCHOLINGUIST RES, V23, P487, DOI 10.1007/BF02146687; [No title captured]	39	17	18	0	10	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1998	13	3					44	62		10.1097/00001199-199806000-00005			19	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ZT046	WOS:000074042200005	9582178				2022-02-06	
J	Zhao, SR; Pang, Y; Beuerman, RW; Thompson, HW; Kline, DG				Zhao, SR; Pang, Y; Beuerman, RW; Thompson, HW; Kline, DG			Expression of c-fos protein in the spinal cord after brachial plexus injury: Comparison of root avulsion and distal nerve transection	NEUROSURGERY			English	Article						brachial plexus injury; c-fos; immediate-early gene; nerve root avulsion; nerve transection; spinal cord injury	PROGRAMMED CELL-DEATH; PERSISTENT EXPRESSION; RAT-BRAIN; INDUCTION; NEURONS; IMMUNOREACTIVITY; STIMULATION; APOPTOSIS; NOCICEPTION; PATTERNS	OBJECTIVE: Clinical reports indicate poor outcomes for avulsion injuries, compared with more peripheral nerve damage. These two different injuries may both affect gene expression in spinal neurons, and the changes in gene expression may be related to the types of injuries. METHODS: The brachial plexus of 48 adult male rats was lesioned by either root avulsion close to the spinal cord or distal nerve transection. The rats were quickly revived and remained awake until death at 30, 60, or 120 min after surgery. In rats with avulsive injuries, traumatic sites on the dorsal and ventral horns of the spinal cord were microscopically detected. Immunocytochemical analysis of the c-fos product was performed for the two experimental groups and for sham-treated control animals at the same survival times. RESULTS: An increase in Fos-like immunoreactivity (FLI) in cells of the spinal cord, at levels C4-T1, was detected at 30 min after nerve transection or root avulsion. The number of FLI-positive cells continued to increase at 60 and 120 min after the nerve injury (P = 0.001). FLI-positive cells were compared at the C7 level, in laminae 1 and 2, 3 and 4, and 5 to 10, after the two injuries and were found to be more abundant after the avulsive injury (P = 0.0001); furthermore, the number of FLI-positive cells increased with time (P = 0.001). In a comparison of ail levels, both experimental groups demonstrated significantly greater numbers of FLI-positive cells than did controls, and the group with nerve root avulsion showed significantly (P = 0.0001) more FLI-positive cells than did the group with distal nerve transection. CONCLUSION: These results suggest that nerve root avulsion from the spinal cord leads to increased and prolonged expression of c-fos and, potentially, greatly increased transcription of new messages for recovery, survival, or cell death.	Louisiana State Univ, Med Ctr, Dept Neurosurg, Ctr Eye, New Orleans, LA 70112 USA; Louisiana State Univ, Ctr Eye, Dept Neurol, New Orleans, LA 70112 USA; Louisiana State Univ, Sch Med, Lions Eye Res Ctr, New Orleans, LA 70112 USA		Kline, DG (corresponding author), Louisiana State Univ, Med Ctr, Dept Neurosurg, Ctr Eye, 1542 Tulane Ave, New Orleans, LA 70112 USA.				NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY004074, P30EY002377] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY02377, EY04074] Funding Source: Medline		ABBADIE C, 1992, BRAIN RES, V578, P17, DOI 10.1016/0006-8993(92)90224-W; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; BULLITT E, 1992, BRAIN RES, V580, P172, DOI 10.1016/0006-8993(92)90941-2; BULLITT E, 1989, BRAIN RES, V493, P391, DOI 10.1016/0006-8993(89)91177-3; CHI SI, 1993, BRAIN RES, V617, P225, DOI 10.1016/0006-8993(93)91090-F; CHI SI, 1993, BRAIN RES, V617, P220, DOI 10.1016/0006-8993(93)91089-B; COLOTTA F, 1992, J BIOL CHEM, V267, P18278; DELEO JA, 1991, MOL BRAIN RES, V11, P167, DOI 10.1016/0169-328X(91)90118-H; DRAGUNOW M, 1990, BRAIN RES, V533, P324, DOI 10.1016/0006-8993(90)91357-M; DRAISCI G, 1989, MOL BRAIN RES, V6, P31, DOI 10.1016/0169-328X(89)90025-9; Ducker T B, 1977, Clin Neurosurg, V24, P406; EDSTROM JE, 1959, J NEUROCHEM, V5, P43, DOI 10.1111/j.1471-4159.1959.tb13331.x; EMERY DG, 1987, EXP BRAIN RES, V67, P41, DOI 10.1007/BF00269451; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; GEHRMANN J, 1995, J NEUROPATH EXP NEUR, V54, P680, DOI 10.1097/00005072-199509000-00010; Grafstein B, 1978, NEURONAL PLASTICITY, P155; Gu ZZ, 1997, NEUROCHEM INT, V30, P417, DOI 10.1016/S0197-0186(96)00077-0; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; JONSE KJ, 1991, J NEUROSCI RES, V28, P291; KLINE DG, 1995, NERVE INJURIES OPERA, P397; LEE JH, 1992, BRAIN RES, V577, P80, DOI 10.1016/0006-8993(92)90540-P; LO AC, 1995, EXP NEUROL, V134, P49, DOI 10.1006/exnr.1995.1035; LUCAS J H, 1990, Journal of Neurotrauma, V7, P169, DOI 10.1089/neu.1990.7.169; LUCAS JH, 1992, J NEUROTRAUM, V9, P117, DOI 10.1089/neu.1992.9.117; MENETREY D, 1989, J COMP NEUROL, V285, P177, DOI 10.1002/cne.902850203; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MUNGLANI R, 1995, BRIT J ANAESTH, V75, P186, DOI 10.1093/bja/75.2.186; PANG Y, 1993, MOL BRAIN RES, V20, P162, DOI 10.1016/0169-328X(93)90122-6; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; PLANTINGA LC, 1994, INT J DEV NEUROSCI, V12, P117, DOI 10.1016/0736-5748(94)90004-3; PRESLEY RW, 1990, J NEUROSCI, V10, P323; Preston GA, 1996, MOL CELL BIOL, V16, P211; Sandkuhler J, 1996, NEUROSCIENCE, V73, P657, DOI 10.1016/0306-4522(96)00073-5; SEARLE J, 1982, PATHOL ANNU, V17, P229; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; SMITH MA, 1992, BRAIN RES, V578, P135, DOI 10.1016/0006-8993(92)90240-A; SZENTAGOTHAI J, 1949, ARCH NEURO PSYCHIATR, V62, P734, DOI 10.1001/archneurpsyc.1949.02310180035005; WILLIAMS S, 1990, NEUROSCIENCE, V36, P73, DOI 10.1016/0306-4522(90)90352-5; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; ZORUB DS, 1974, SURG NEUROL, V2, P347	42	17	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUN	1998	42	6					1357	1362		10.1097/00006123-199806000-00099			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ZR050	WOS:000073930700091	9632196				2022-02-06	
J	Coplin, WM; O'Keefe, GE; Grady, MS; Grant, GA; March, KS; Winn, HR; Lam, AM				Coplin, WM; O'Keefe, GE; Grady, MS; Grant, GA; March, KS; Winn, HR; Lam, AM			Accuracy of continuous jugular bulb oximetry in the intensive care unit	NEUROSURGERY			English	Article						arteriovenous difference of oxygen; continuous in vivo oximetry; head injury; intensive care unit; jugular bulb oxygen saturation; monitoring	HEAD-INJURED PATIENTS; VENOUS OXYGEN-SATURATION; CEREBRAL BLOOD-FLOW; CONTINUOUS MONITOR; SURGERY	OBJECTIVE: To address the accuracy of a bedside jugular bulb oxygen saturation (SjO2) catheter monitor (Baxter-Edwards, Santa Ana, CA) versus in vitro co-oximetry measurements in the intensive care unit (ICU). METHODS: By prospective protocol, we compared blood gas measurements with simultaneously recorded continuous bedside oximetric monitor values for 31 ICU patients with traumatic brain injury undergoing jugular bulb catheter monitoring. For suboptimal fiberoptic light signal quality indices, the catheter was repositioned, flushed, or both before drawing the sample for in vitro measurement. Laboratory and bedside monitor data were examined for association using the chi(2) and paired t tests and a linear regression model. RESULTS: We assessed 195 samples (median, 5 per patient; range, 1-14) who were monitored an average of 3.4 (range, 1-6) days. The in vivo monitor (range, 32-94%) and in vitro co-oximetry (range, 38-93%) values had acceptable correlation (y = 0.94x + 4.4, r(2) = 0.80). For bedside monitor detection of jugular bulb desaturation (SjO2 < 50% for 10 min), the kappa statistic was 0.35, the sensitivity was 45 to 50%, and the specificity was 98 to 100%. CONCLUSION: Continuous ICU SjO2 monitoring correlates significantly with in vitro values, but less so than previously described during intracranial surgery. Although sensitivity of the bedside monitor to detect confirmed desaturations remains an issue, the high specificity indicates that it is less of a concern that patients may be misdiagnosed as having desaturations resulting in unnecessary interventions. Nonetheless, suspected jugular bulb desaturation should be verified before taking therapeutic actions.	Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Dept Neurol, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Dept Nursing Educ, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98104 USA		Grady, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 9Th Ave,Box 359766, Seattle, WA 98104 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030305] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30305] Funding Source: Medline		ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; Cruz J, 1988, Acta Neurochir Suppl (Wien), V42, P35; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; GARLICK R, 1987, SCAND J CLIN LAB INV, V47, P47; GIBBS EL, 1945, AM J PSYCHIAT, V102, P184, DOI 10.1176/ajp.102.2.184; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GUNN HC, 1995, J NEUROSURG ANESTH, V7, P174, DOI 10.1097/00008506-199507000-00003; JAKOBSEN M, 1989, J CEREBR BLOOD F MET, V9, P717, DOI 10.1038/jcbfm.1989.101; MATTA BF, 1994, ANESTH ANALG, V79, P745; NAKAJIMA T, 1992, ANESTH ANALG, V74, P630; NAKAJIMA T, 1993, ANESTH ANALG, V77, P1111; REICH DL, 1993, 15 ANN M SOC CARD AN; Ritter AM, 1996, J CLIN MONITOR, V12, P285, DOI 10.1007/BF02221748; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; ROBERTSON CS, 1992, J NEUROSURG, V77, P163; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; TEASDALE G, 1974, LANCET, V2, P81; Trubiano P, 1996, ANESTH ANALG, V82, P964, DOI 10.1097/00000539-199605000-00013	20	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAR	1998	42	3					533	539		10.1097/00006123-199803000-00020			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ZC008	WOS:000072530300069	9526988				2022-02-06	
J	Schmitter-Edgecombe, M; Kibby, MK				Schmitter-Edgecombe, M; Kibby, MK			Visual selective attention after severe closed head injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						closed head injury; traumatic brain injury; attention; selective attention; focused attention; divided attention; visual search	FEATURE-INTEGRATION; FOCUSED ATTENTION; REACTION-TIME; SEARCH; PARALLEL	This study investigated the nature of selective attention deficits after severe closed head injury (CHI). Twenty participants with severe CHI (greater than 1 year postinjury) and 20 matched controls completed search and nonsearch visual selective attention tasks under conditions of low (Experiment 1) and high (Experiment 2) target-distracter similarity. In the search situations, participants searched visual displays that contained 1, 4, or 8 items for the targets. In the nonsearch situations, the location of the targets was visually cued with a peripheral arrow. The results revealed that in both the low and high target-distracter similarity search conditions, CHI participants required a longer time than controls to locate and identify the target. In contrast, in the nonsearch condition, CHI participants were able to successfully ignore irrelevant task information when target-distractor similarity was low. However, when target-distracter similarity was high, CHI participants had more difficulty than controls ignoring the irrelevant information. These results suggest that, in comparison to controls, CHI participants may be at a disadvantage in selective attention situations when visual search is required and when the discriminability between targets and distracters is difficult.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA; Univ Memphis, Memphis, TN 38152 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-e@wsu.edu	Kibby, Michelle/A-9671-2009	Kibby, Michelle/0000-0002-2161-2108			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BARBER P, 1981, PSYCHOL BULL, V89, P176, DOI 10.1037/0033-2909.89.1.176; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; CATTELL RB, 1973, HDB INDIVIDUAL GROUP; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; COLEGATE RL, 1973, PERCEPT PSYCHOPHYS, V14, P217, DOI 10.3758/BF03212380; Davies D. R., 1984, VARIETIES ATTENTION, P395; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCAN J, 1992, J EXP PSYCHOL HUMAN, V18, P578, DOI 10.1037/0096-1523.18.2.578; Ekstrom RB., 1976, MANUAL KIT FACTOR RE; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; ERIKSEN CW, 1972, PERCEPT PSYCHOPHYS, V12, P201, DOI 10.3758/BF03212870; Hasher L, 1988, PSYCHOL LEARNING MOT, P193, DOI DOI 10.1016/S0079-7421(08)60041-9; Heaton RK, 1981, MANUAL WISCONSIN CAR; JOHNSTON WA, 1986, ANNU REV PSYCHOL, V37, P43, DOI 10.1146/annurev.ps.37.020186.000355; JONIDES J, 1980, CAN J PSYCHOL, V34, P103, DOI 10.1037/h0081031; KAHNEMAN D, 1973, ATTENTION MEMORY; Kaplan E., 1987, MANUAL CALIFORNIA VE; MCGHIE A, 1969, PATHOLOGY ATTENTION; MILLER E, 1981, BRIT J CLIN PSYCHOL, V20, P69, DOI 10.1111/j.2044-8260.1981.tb00498.x; Miller E, 1970, Cortex, V6, P121; NEISSER U, 1963, AM J PSYCHOL, V76, P376, DOI 10.2307/1419778; Plude D., 1985, AGING HUMAN PERFORMA, P47; PLUDE D, 1986, PSYCHOL AGING, V1, P1; PLUDE DJ, 1989, PSYCHOL AGING, V4, P98, DOI 10.1037/0882-7974.4.1.98; PRINZMETAL W, 1986, J EXP PSYCHOL HUMAN, V12, P361, DOI 10.1037/0096-1523.12.3.361; SANDSON J, 1988, COGNITIVE APPROACHES, P45; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCIALFA CT, 1994, J GERONTOL B-PSYCHOL, V49, P173; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TOWNSEND JT, 1971, PERCEPT PSYCHOPHYS, V10, P161, DOI 10.3758/BF03205778; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; Wechsler D, 1981, WECHSLER ADULT INTEL; Wickens CD, 1984, VARIETIES ATTENTION, P395; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P135, DOI 10.1037/0096-1523.16.1.135; [No title captured]	42	17	17	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	1998	4	2					144	159		10.1017/S1355617798001441			16	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	103EY	WOS:000075146200006	9529824				2022-02-06	
J	Papagno, C				Papagno, C			Transient retrograde amnesia associated with impaired naming of living categories	CORTEX			English	Article						retrograde amnesia; living/non-living dissociation	CLOSED-HEAD-INJURY; MEMORY; ENCEPHALITIS; CORTEX	A ease of pure retrograde amnesia following mild head injury is reported. The patient, who also showed a deficit in verbal fluency and a living/non-living dissociation in naming during the amnesic period, recovered progressively in about ten days post-trauma. Both a psychogenic and an organic origin could be taken into account. A mechanism (no matter if psychogenic or organic) can be hypothesized, which produces a functional inhibition also involving performances that are unlikely to be affected by psychological factors.	Univ Milan, Osped San Paolo, Clin Neurol 3, I-20142 Milan, Italy		Papagno, C (corresponding author), Univ Milan, Osped San Paolo, Clin Neurol 3, Via Rudini 8, I-20142 Milan, Italy.	costanza.p@iol.it	papagno, costanza/K-8460-2012	papagno, costanza/0000-0002-3659-6294			Barbarotto R, 1996, NEUROPSYCHOLOGIA, V34, P575, DOI 10.1016/0028-3932(95)00141-7; Barbarotto R, 1996, ACTA NEUROL SCAND, V93, P272; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BORRINI G, 1989, PSYCHOL MED, V19, P215, DOI 10.1017/S0033291700011181; Calabrese P, 1996, J NEUROL NEUROSUR PS, V61, P304, DOI 10.1136/jnnp.61.3.304; Campodonico J R, 1996, J Int Neuropsychol Soc, V2, P146; CAPITANI E, 1991, ITAL J NEUROL SCI, V12, P461, DOI 10.1007/BF02335507; CAPITANI E, 1994, NEUROPSYCHOLOGIA, V16, P491; Capitani Erminio, 1993, Archivio di Psicologia Neurologia e Psichiatria, V54, P457; DeRenzi E, 1997, NEUROPSYCHOLOGIA, V35, P781, DOI 10.1016/S0028-3932(97)00018-3; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; FAGLIONI P, 1991, Archivio di Psicologia Neurologia e Psichiatria, V52, P339; GLOOR P, 1990, BRAIN, V113, P1673, DOI 10.1093/brain/113.6.1673; HODGES JR, 1994, J NEUROL NEUROSUR PS, V57, P605, DOI 10.1136/jnnp.57.5.605; HOKKANEN L, 1995, PSYCHOL MED, V25, P203, DOI 10.1017/S0033291700028245; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; Kapur N, 1996, Cogn Neuropsychiatry, V1, P247, DOI 10.1080/135468096396541; KAPUR N, 1991, BRIT J PSYCHIAT, V159, P872, DOI 10.1192/bjp.159.6.872; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; KOPELMAN MD, 1994, NEUROPSYCHOLOGIA, V32, P675, DOI 10.1016/0028-3932(94)90028-0; KOPELMAN MD, 1992, NATO ADV SCI INST SE, V65, P427; KOPELMAN MD, 1987, BRIT J PSYCHIAT, V150, P428, DOI 10.1192/bjp.150.4.428; LUCCHELLI F, 1995, BRAIN, V118, P167, DOI 10.1093/brain/118.1.167; MALLOY P, 1994, HANDB NEUR, V9, P203; Markowitsch HJ, 1996, NEUROCASE, V2, P357; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; NOVELLI C, 1986, ARCH NEUROLOGIA PSIC, V47, P278; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; PAPAGNO C, 1990, MOLTE FACCE MEMORIA, P107; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SCHACTER DL, 1989, HDB NEUROPSYCHOLOGY, V3, P209; Spinnler H, 1996, BRAIN, V119, P1403, DOI 10.1093/brain/119.4.1403; SPINNLER H, 1987, ITALIAN J NEUROLOG S, V8	35	17	18	0	2	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	FEB	1998	34	1					111	121		10.1016/S0010-9452(08)70740-8			11	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	ZA672	WOS:000072389500007	9533997				2022-02-06	
J	Shiina, G; Onuma, T; Kameyama, M; Shimosegawa, Y; Ishii, K; Shirane, R; Yoshimoto, T				Shiina, G; Onuma, T; Kameyama, M; Shimosegawa, Y; Ishii, K; Shirane, R; Yoshimoto, T			Sequential assessment of cerebral blood flow in diffuse brain injury by I-123-iodoamphetamine single-photon emission CT	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							CLOSED-HEAD-INJURY; COMPUTED-TOMOGRAPHY; TECHNETIUM-99M-HMPAO SPECT; METABOLISM; PERFUSION; ISCHEMIA; LESIONS; HUMANS	PURPOSE: Our goal was to elucidate the temporal profile of cerebral circulation and its relationship to prognosis in patients with diffuse brain injury by using single-photon emission CT (SPECT) and I-123-iodoamphetamine (IMP). METHODS: A total of 67 assessments were made in 26 patients with diffuse brain injury (Glasgow Coma Scale score less than or equal to 8). The microsphere method was used for quantifying cerebral blood flow (CBF). The hemispheric CBF was defined as a mean regional CBF (rCBF), and the total cerebral hemispheric CBF (tCBF) as a mean of the bilateral hemispheric CBF, The relationship between patient outcome and tCBF was investigated. RESULTS: The rCBF in patients with diffuse brain injury showed dynamic and global changes with little regional differences. The tCBF values increased in 1 to 3 days, and they were higher in the poor-outcome group than in the good-outcome group. During the period of 14 to 42 days, the tCBF values stayed within normal range in the good-outcome group, whereas they were below normal range in the poor-outcome group. CONCLUSION: Our results revealed a good correlation between patient outcome and CBF values. Quantitative and sequential CBF studies with IMP SPECT are promising for helping to determine the prognosis for patients with diffuse brain injury.	Sendai City Hosp, Dept Neurosurg, Wakabayashi Ku, Sendai, Miyagi 984, Japan; Sendai City Hosp, Dept Radiol, Sendai, Miyagi, Japan; Tohoku Univ, Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan		Shiina, G (corresponding author), Sendai City Hosp, Dept Neurosurg, Wakabayashi Ku, 3-1 Shimizu Kohji, Sendai, Miyagi 984, Japan.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; DONALD WM, 1991, J NEUROSURG, V74, P407; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Goncalves J M, 1992, Acta Neurochir Suppl (Wien), V55, P11; Graham D I, 1983, Acta Neurochir Suppl (Wien), V32, P65; GRAY BG, 1992, J NUCL MED, V33, P52; GREENBERG JH, 1990, J NUCL MED, V31, P1364; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1975, LANCET, V1, P480; KUHL DE, 1982, J NUCL MED, V23, P196; KUHL DE, 1975, CIRC RES, V36, P610, DOI 10.1161/01.RES.36.5.610; LEVEILLE J, 1989, J NUCL MED, V30, P1902; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; Matsuda H, 1986, Am J Physiol Imaging, V1, P186; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MURASE K, 1990, MED PHYS, V17, P79, DOI 10.1118/1.596531; NEIRINCKX RD, 1988, J CEREBR BLOOD F MET, V8, pS4, DOI 10.1038/jcbfm.1988.27; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Odano Ikuo, 1994, Japanese Journal of Nuclear Medicine, V31, P223; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; OGAWA A, 1989, Brain and Nerve (Tokyo), V41, P843; OSTERHOLM JL, 1972, J NEUROSURG, V36, P395, DOI 10.3171/jns.1972.36.4.0395; ROPER SN, 1991, J NUCL MED, V32, P1684; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SHEPP LA, 1974, IEEE T NUCL SCI, VNS21, P21, DOI 10.1109/TNS.1974.6499235; Sorenson J. A., 1974, INSTRUM NUCL, P311; TEASDALE G, 1974, LANCET, V2, P81; TRAUPE H, 1982, STROKE, V13, P615, DOI 10.1161/01.STR.13.5.615; WINCHELL HS, 1980, J NUCL MED, V21, P947; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	37	17	17	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	FEB	1998	19	2					297	302					6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	YX191	WOS:000072015500018	9504482				2022-02-06	
J	Vaz, R; Sarmento, A; Borges, N; Cruz, C; Azevedo, T				Vaz, R; Sarmento, A; Borges, N; Cruz, C; Azevedo, T			Experimental traumatic cerebral contusion: Morphological study of brain microvessels and characterization of the oedema	ACTA NEUROCHIRURGICA			English	Article						brain oedema; head injury; blood-brain barrier; morphology	FLUID-PERCUSSION MODEL; DIFFUSE AXONAL INJURY; CLOSED-HEAD-INJURY; RAT; EDEMA; CONCUSSION	Several experimental brain oedema models are currently available, but most of them are very different from what happens in clinical practice. As it is simple and seems to replicate the range of injuries seen in man we decided to evaluate Marmarou's model of head injury in order to test physiopathogenic and therapeutic hypotheses. Three groups of Wistar rats weighting 360-400 gr, anaesthetized with sodium pentobarbitone and breathing spontaneously, without tracheal intubation, were studied. In the first group six animals were killed two hours after injury and the brain's water content compared with that of nine controls. In another group Evans blue (100 mg/kg) was injected one hour before trauma and dye's extraction ratio determined at various times after injury: five animals at 15 minutes, six at 30 minutes, five at 60 minutes and nine at 120 minutes. A total of twenty-eight animals served as controls. In the last group morphological studies with light and electron microscopy were performed in the traumatized brain tissue from rats killed 5 and 120 minutes after injury and in brain tissue from control rats. Results showed that Marmarou's brain trauma model induced perivascular brain oedema, already visible at the ultrastructural level 5 minutes after the injury. Endothelial cells themselves were "oedematiated", rich in pinocytotic vesicles and membrane blebs, and presented intact tight junctions. Two hours after trauma the perivascular oedema was more marked. At this time the brain water content was significantly higher than that in controls. Evans blue extraction ratio increased linearly with time, being significantly higher than in controls 120 minutes after injury. We conclude that Marmarou's model is a suitable model for the study of brain oedema induced by trauma, and that this oedema, assessed by three different methodologies, was statistically significant two hours after injury.	Hosp Sao Joao, Dept Neurosurg, Mes Fac, P-4200 Porto, Portugal; Hosp Sao Joao, Inst Pharmacol & Therapeut, Porto, Portugal		Vaz, R (corresponding author), Hosp Sao Joao, Dept Neurosurg, Mes Fac, Alameda Prof Hernani Monteiro, P-4200 Porto, Portugal.		Sarmento, Antonio/M-5235-2013; Borges, Nuno/K-7051-2013	Sarmento, Antonio/0000-0001-5269-7231; Borges, Nuno/0000-0001-6357-0615; Vaz, Rui/0000-0001-7527-8187			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KITA H, 1994, ACTA NEUROCHIR, P452; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1944, ACTA NEUROCHIR WIE S, V60, P3; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NAVARRO JC, 1991, J NEUROL SCI, V103, pS3; PENN RD, 1982, HEAD INJURY, P233; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; STEWART PA, 1987, J NEUROSURG, V67, P697, DOI 10.3171/jns.1987.67.5.0697; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TORNHEIM PA, 1983, J NEUROSURG, V59, P431, DOI 10.3171/jns.1983.59.3.0431; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; VANDENBRINK WA, 1994, ACTA NEUROCHIR WIE S, V60, P455; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2	31	17	17	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1998	140	1					76	81		10.1007/s007010050061			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YV305	WOS:000071809900026	9522912				2022-02-06	
J	OBrien, D; ODell, MW; Eversol, A				OBrien, D; ODell, MW; Eversol, A			Delayed traumatic cerebral aneurysm after brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							INTRACRANIAL ANEURYSMS; CHILDHOOD	Traumatic aneurysms (TAs) are an unusual etiology for late neurological deterioration after traumatic brain injury (TBI) and represent less than 1% of all cerebral aneurysms. TAs most often are diagnosed acutely but may be delayed in presentation. To increase awareness of this serious but treatable condition when diagnosed early, we report a delayed TA after a motor vehicle accident. The patient experienced a seizure on day 46 postinjury while in rehabilitation and demonstrated persistent lethargy and hemiparesis. Neuroimaging revealed a large, ruptured left pericallosal artery TA, which was surgically clipped. The patient completed his rehabilitation course and was eventually discharged home with family. Among TBIs, TAs are associated with penetrating injuries and skull base or anterior cranial fossa fractures. Associated mortality is high, especially if rupture has occurred. Although TAs are rare, the clinician should be vigilant in the at-risk patient. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	UNIV CINCINNATI,COLL MED,DEPT PHYS MED & REHABIL,CINCINNATI,OH; DRAKECTR INC,BRAIN INJURY REHABIL PROGRAMS,CINCINNATI,OH								ALMEIDA GM, 1977, CHILD BRAIN, V3, P193; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BECKER DP, 1990, NEUROLOGICAL SURG, P2105; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; FLEISHER AS, 1975, SURG NEUROL, V4, P223; Fox, 1983, INTRACRANIAL ANEURYS; FOX JL, 1983, INTRACRANIAL ANEURYS, V3; HADDAD FS, 1991, NEUROSURGERY, V28, P1; JUNGUEIRA LC, 1986, BASIC HISTOLOGY; LAUN A, 1979, CEREBRAL ANEURYSMS A, P364; LAURENT JP, 1981, NEUROSURGERY, V9, P303, DOI 10.1227/00006123-198109000-00015; MAURER JJ, 1961, J NEUROSURG, V18, P837, DOI 10.3171/jns.1961.18.6.0837; PATEL AN, 1971, J NEUROSURG, V35, P571, DOI 10.3171/jns.1971.35.5.0571; SMITH KR, 1968, J NEUROSURG, V29, P551, DOI 10.3171/jns.1968.29.5.0551; STEINMETZ H, 1988, SURG NEUROL, V30, P305, DOI 10.1016/0090-3019(88)90304-7; Takakura K, 1990, NEUROLOGICAL SURG, P1864; YOKOTA H, 1983, Neurological Surgery, V11, P521	19	17	18	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1997	78	8					883	885		10.1016/S0003-9993(97)90205-7			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XQ791	WOS:A1997XQ79100018	9344311				2022-02-06	
J	Bogan, AM; Livingston, MG; ParryJones, WL; Buston, KM; Wood, SF				Bogan, AM; Livingston, MG; ParryJones, WL; Buston, KM; Wood, SF			The experiential impact of head injury on adolescents: Individual perspectives on longterm outcome	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; FOLLOW-UP; RELATIVES; WORK	Thirty-one young people, who were experiencing chronic sequelae of a head injury sustained at least 1 year previously, were interviewed in-depth about the impact head injury had had on their lives. Their functioning was also assessed using the Offer Self-image Questionnaire (OSIQ-R). The main theme raised by subjects was that they had not received adequate explanation of the emotional problems associated with head injury and relevant support in coming to terms with their condition. Head injury had had a devastating effect on their lives, causing limitations in day-to-day activities, employment, education and relationships, and they scored significantly below norms on the OSIQ-R scale of self-confidence. However, these young people had a predominantly positive attitude towards life, which appeared to be related to their appreciation of how fortunate they had been to survive. They scored significantly above norms on the OSIQ-R scale of Social Functioning. Markers of poor functioning were identified and, in clinical practice, could be used as a method of highlighting those head-injured young people who potentially are most in need of support. The findings have implications for future research directions, service delivery and planning, in that particular weaknesses of current provision are demonstrated and recommendations made for improvements.	UNIV GLASGOW,GLASGOW,LANARK,SCOTLAND								BRENNAN MA, 1981, IRISH MED J, V74, P5; BROOKS D N, 1986, Health Bulletin (Edinburgh), V44, P110; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; FORD B, 1976, MED J AUSTRALIA, V1, P603, DOI 10.5694/j.1326-5377.1976.tb140904.x; GREENWOOD RJ, 1994, BRIT MED J, V308, P1199, DOI 10.1136/bmj.308.6938.1199; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KIRKWOOD BR, 1990, ESSENTIALS MED STAT, P133; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; LISHMAN WA, 1978, ORGANIC PSYCHIATRY P, P23; LIVINGSTON M G, 1990, Pediatrician, V17, P255; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1986, BRIT MED J, V293, P742, DOI 10.1136/bmj.293.6549.742; MCMILLAN T, 1993, NEUROLOGICAL REHABIL, P437; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Offer D, 1992, OFFER SELF IMAGE QUE; Office of Population Censuses and Surveys (OPCS), 1991, STAND OCC CLASS; *QUAL SOL RES, 1994, NUD REV 3 0 WIND; RUSSELL WR, 1971, TRAUMATIC AMNESIA; SPSS Inc, 1988, SPSS X US GUID; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE G, 1985, BRIT J HOSP MED  FEB, P67; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WRIGHTSON P, 1989, MILD HEAD INJURY, P245; [No title captured], DOI DOI 10.1097/00001199-198812000-00004	30	17	17	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1997	11	6					431	443					13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	WZ726	WOS:A1997WZ72600004	9171928				2022-02-06	
J	Zafonte, RD; Lee, CY				Zafonte, RD; Lee, CY			Kernohan-Woltman notch phenomenon: An unusual cause of ipsilateral motor deficit	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SEVERE HEAD-INJURY	Posttraumatic ipsilateral motor deficits are rare and raise etiologic and prognostic concerns for the rehabilitation team. We present two cases with an unusual central neurologic cause of ipsilateral weakness. The first patient was assaulted, with a resultant severe traumatic brain injury. Initial computed tomography showed a large right subdural hematoma (SDH) with significant mass effect. Following a craniotomy for evacuation of the SDH, the patient was noted to have paradoxical right-sided (ipsilateral) motor deficits. Postoperative magnetic resonance imaging (MRI) showed compression of the contralateral (left) cerebral peduncle against the tentorium, thus resulting in ipsilateral (right-sided) motor weakness (the Kernohan-Woltman notch phenomenon). Prior limited reports carried a grave prognosis for these patients. On discharge from inpatient rehabilitation, the patient was functioning at a Rancho Los Amigos Scale VI. The second patient was involved in a motor vehicle accident and was found to have a large left frontotemporal subdural hematoma with shift. A dense left hemiplegia was noted after hematoma evacuation. MRI also showed a right cerebral peduncle hypointensity. At discharge, the patient was rated a Rancho Los Amigos Scale VI, Physiatrists need to be aware of the causes of ipsilateral motor weakness as well as the limitations of prognostic data. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.			Zafonte, RD (corresponding author), WAYNE STATE UNIV,SCH MED,DETROIT MED CTR,REHABIL INST MICHIGAN,DEPT PHYS MED & REHABIL,DETROIT,MI 48201, USA.						ADAMS RD, 1991, PRINCIPLES NEUROLOGY, P42; Davis RL, 1991, TXB NEUROPATHOLOGY; Diaz-Marchan PG, 1996, NEUROTRAUMA, V1st, P137; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JONES KM, 1991, AM J NEURORADIOL, V12, P1238; KERNOHAN JW, 1928, ARCH NEUROL-CHICAGO, P274; MARSHALL SB, 1990, NEUROSCIENCE CRITICA; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	13	17	17	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	1997	78	5					543	545		10.1016/S0003-9993(97)90174-X			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WY386	WOS:A1997WY38600020	9161379				2022-02-06	
J	DellaCorte, F; Giordano, A; Pennisi, MA; Barelli, A; Caricato, A; Campioni, P; Galli, G				DellaCorte, F; Giordano, A; Pennisi, MA; Barelli, A; Caricato, A; Campioni, P; Galli, G			Quantitative cerebral blood flow and metabolism determination in the first 48 hours after severe head injury with a new dynamic SPECT device	ACTA NEUROCHIRURGICA			English	Article						head trauma; cerebral blood flow; cerebral metabolism; jugular vein oxygen saturation; intracranial pressure	EMISSION COMPUTED-TOMOGRAPHY; INERT-GAS CONCENTRATIONS; INTRACRANIAL HYPERTENSION; BRAIN-FUNCTION; CIRCULATION; RECOVERY; COMA; ICP	Objective: To determine cerebral blood flow (CBF) and metabolism in the acute phase after severe head injury by a new dynamic SPECT device using (133)Xenon and to evaluate a possible role of CBF and metabolism in the determination of prognosis. Design: Prospective study Setting: General intensive carl unit in a universitary teaching hospital Subjects: 23 severely head injured patients having CT scan and CBF determination. intracranial pressure (ICP) and jugular bulb oxygen saturation monitoring in the first 35 hours. Measurements and main results: CBF varied from 18.0 to 60.0 ml/100 g/min. No correlation was found between early CBF and severity of trauma evaluated with the Glasgow Coma Score (GCS) (F = 2.151, p = 0.142) and between CBF and prognosis at 6 months evaluated with Glasgow outcome score (GOS) (F = 0.491, p = 0.622; r(s) = 0.251, p = 0.246). CMRO2 was depressed in relation to the severity of injury, specifically ranging from 0.9 +/- 0.5 ml 100 g/min in patients with GCS 3 to 1.7 +/- 0.8 ml/100 g/min in patients with GCS 6-7. In no patient with a CMRO2 less than 0.8 ml/100 g/min was a good outcome observed. PI significant cor; relation was found between GCS and GOS (r(s) = 0.699, p = 0.0002). between CMRO2 and GOS (F = 4.303, p = 0.031: r(s) = 0.525, p = 0.013) and between AJDO(2) and GOS (F = 3.602, p=0.046; r(s) = 0.491, p = 0.017. Fronto-occipital ratio (F/O) of CBF distribution was significantly lower than normal values (chi(2) = 18.658, p = 0.001) but did not correlate either with prognosis (chi(2) = 1.626. p = 0.443) of with severity (chi(2) = 1.913, p = 0.384). Conclusions: CBF ill the First 48 hours after trauma varies within a large range of values and is nor correlated with severity and prognosis. Clinical evaluation with GCS and CMRO2 are much more reliable indicators of severity of head trauma and have a sig nificant role in the determination of prognosis. F/O ration is significantly altered from normal values confirming ''post-traumatic hypofrontalism'' but does not correlate with severly sind prognosis.	UNIV CATTOLICA SACRO CUORE, DEPT NUCL MED, I-00168 ROME, ITALY; UNIV CATTOLICA SACRO CUORE, DEPT RADIOL, I-00168 ROME, ITALY		DellaCorte, F (corresponding author), UNIV CATTOLICA SACRO CUORE, IST ANESTESIOL & RIANIMAZ, DEPT ANAESTHESIOL & INTENS CARE, I-00168 ROME, ITALY.		Della Corte, Francesco/ABI-7646-2020; Campioni, Paolo/AAI-3729-2020; Campioni, Paolo/ABB-5437-2020	Della Corte, Francesco/0000-0003-1736-2318; Campioni, Paolo/0000-0002-7275-7358; PENNISI, Mariano Alberto/0000-0001-8761-5144; Giordano, Alessandro/0000-0002-6978-0880			BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CELSIS P, 1981, J COMPUT ASSIST TOMO, V5, P641, DOI 10.1097/00004728-198110000-00006; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1981, CIRCULATING CATECHOL, P228; Cold G E, 1990, Acta Neurochir Suppl (Wien), V49, P1; DAJEM HMA, 1987, RADIOLOGY, V165, P221; DEROSSI G, 1992, RADIOL DIAGN, V33, P236; DEUTSCH G, 1987, J CEREBR BLOOD F MET, V7, P29, DOI 10.1038/jcbfm.1987.5; EISENBERG HM, 1983, INTRACRANIAL PRESSUR, V5, P549; FELDMAN Z, 1992, Contemporary Neurosurgery, V14, P1; GIORDANO A, 1991, NUCLEAR MED NUCLEAR, P6; HEMMER M, 1988, UPDATE INTENSIVE CAR, V5, P537; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; KANNO I, 1979, J COMPUT ASSIST TOMO, V3, P71, DOI 10.1097/00004728-197902000-00012; Langfitt T W, 1981, Prog Neurol Surg, V10, P14, DOI 10.1159/000384767; LASSEN NA, 1978, SCI AM, V239, P62, DOI 10.1038/scientificamerican1078-62; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1975, J NEUROL NEUROSUR PS, V38, P657, DOI 10.1136/jnnp.38.7.657; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, TXB HEAD INJURY; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; OMMAYA AK, 1975, P 2 CHIC S NEUR TRAU; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PFENNINGER EG, 1991, ACTA ANAESTH SCAND, V35, P148, DOI 10.1111/j.1399-6576.1991.tb03263.x; ROBERTSON CS, 1983, J NEUROSURG, V59, P455, DOI 10.3171/jns.1983.59.3.0455; ROINE RO, 1991, ARCH NEUROL-CHICAGO, V48, P625, DOI 10.1001/archneur.1991.00530180081021; ROPER SN, 1991, J NUCL MED, V32, P1684; Sato M, 1989, Neurol Med Chir (Tokyo), V29, P389, DOI 10.2176/nmc.29.389; TEASDALE G, 1974, LANCET, V2, P81; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830	38	17	17	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1997	139	7					636	642					7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XL118	WOS:A1997XL11800013	9265957				2022-02-06	
J	Hoots, WK				Hoots, WK			Experience with antithrombin concentrates in neurotrauma patients	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						antithrombin (AT); neurotrauma; disseminated intravascular coagulation (DIC); inflammation; clinical trial	DISSEMINATED INTRAVASCULAR COAGULATION; INJURY; BRAIN	Plasma coagulation results from 2,100 injured patients were sequentially and systematically evaluated in a large natural history study of neurotrauma. A significant correlation became apparent between the severity of and morbidity from head injury and the degree of abnormality in coagulation results, especially for young injured victims. Subsequent studies in the United States, Europe, and Japan have supported the significant correlation between final clinical outcome and these measurements of plasma coagulation, as well as inflammatory proteins, performed soon after injury. This discussion reviews the data from many published reports that support this conclusion, especially data that corroborate the strong clinical association between head trauma and disseminated intravascular coagulation (DIC), The data that demonstrate a high predisposition for head-injured individuals to develop DIC serve as a the rationale for therapeutic intervention with coagulation protease inhibitors, especially antithrombin (AT), A large, double-blind, placebo-controlled trial that evaluates the therapeutic use of AT concentrate for DIC in such patients has yet to be completed. Described here is the design for such a clinical trial that examined the impact of mortality as an outcome, However, this trial was terminated for nonscientific reasons soon after it began. Very truncated data collected from this aborted study support both the scientific rationale for and the feasibility of such a study in the future. Data from such a clinical trial are needed to support the use of AT concentrate to treat DIC in this and other morbid diseases.	Gulf States Hemophilia Diagnost & Treatment Ctr, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, MD Anderson Cancer Ctr, Houston, TX USA		Hoots, WK (corresponding author), Gulf States Hemophilia Diagnost & Treatment Ctr, 6410 Fannin,Suite 416 PHB, Houston, TX 77030 USA.						BLAUHUT B, 1985, THROMB RES, V39, P81, DOI 10.1016/0049-3848(85)90123-9; BREDBACKA S, 1992, J NEUROSURG ANESTH, V4, P128, DOI 10.1097/00008506-199204000-00008; CUNNINGHAM DD, 1993, THROMB HAEMOSTASIS, V70, P168; EDWARDS RL, 1992, SEMIN HEMATOL, V29, P202; FAULK WP, 1994, SEMIN HEMATOL, V31, P26; HOOTS K, 1996, NEUROTRAUMA, P673; HOOTS WK, 1983, BLOOD S1, V652, pA275; HOOTS WK, 1985, PEDIAT RES 2 S, V19, pA142; KAUFMAN HH, 1985, CENTRAL NERVOUS SYST, P187; MARBET GA, 1986, THROM HEMOSTAS, V55, P28; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1983, J NEUROSURG, V59, P283; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Owings JT, 1996, J TRAUMA, V41, P396, DOI 10.1097/00005373-199609000-00004; ROSENZWEIG SM, 1989, COMMENTARY, V87, P2; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; WADA H, 1993, AM J HEMATOL, V43, P190, DOI 10.1002/ajh.2830430306	17	17	17	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176			SEMIN THROMB HEMOST	Semin. Thromb. Hemost.		1997	23			1			3	16					14	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	172RN	WOS:000078938200002	9156417				2022-02-06	
J	Markowitsch, HJ; Ewald, K				Markowitsch, HJ; Ewald, K			Right-hemispheric fronto-temporal injury leading to severe autobiographical retrograde and moderate anterograde episodic amnesia - implications for the anatomy of memory	NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH			English	Article						prefrontal cortex; temporal cortex; amnesia; memory; hemispheric specialization; head trauma; ecphory	RETRIEVAL; CORTEX; DEFICITS; RECALL; PET	Neuropsychological and neuroradiological data are reported for a 56 year old patient, DD, with traumatic brain injury. Prior to injury the patient had been a top specialist in his professional field and had obtained a doctor's degree. Hit by a bus. DD received major right sided damage to his frontal skull. resulting in loss of right eye vision, and extensive right prefrontal and anterior temporal damage. In addition the anterior right basal ganglia and the inferior anterior left frontal lobe were damaged together with the genu of the corpus callosum. The patient was repeatedly tested neuropsychologically 2 to 3 years post-injury. He was depressed and manifested moderate anterograde and severe autobiographical retrograde amnesia. His anterograde memory problems seem to be a consequence of reduced cognitive flexibility and inefficient structuring and active self-organization abilities, caused by his prefrontal damage. His retrograde amnesia is interpreted as related to the combined temporo-frontal damage in the right hemisphere which has been shown to result in precisely this deficit pattern in other patients with the same pattern of brain damage. It is concluded that fronto-temporal brain damage, largely restricted to the right hemisphere, results in an inability to retrieve or ecphorize autobiographical old memories.	Univ Bielefeld, D-33501 Bielefeld, Germany								Baddeley A. D., 1990, AUTOBIOGRAPHICAL MEM; Calabrese P, 1996, J NEUROL NEUROSUR PS, V61, P304, DOI 10.1136/jnnp.61.3.304; Damasio A., 1994, DESCARTES ERROR EMOT; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Fink GR, 1996, J NEUROSCI, V16, P4275; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Fuster JM, 1989, PREFRONTAL CORTEX, V2nd; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; HODGES JR, 1993, BRAIN, V116, P921, DOI 10.1093/brain/116.4.921; JOKEIT H, 1997, IN PRESS BRAIN; Kapur N, 1997, MEMORY, V5, P115, DOI 10.1080/741941152; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; Kapur N, 1996, J COGNITIVE NEUROSCI, V8, P416, DOI 10.1162/jocn.1996.8.5.416; KAPUR N, 1992, BRAIN, V115, P73, DOI 10.1093/brain/115.1.73; Kopelman M.D., 1993, HDB NEUROPSYCHOLOGY, P215; Kroll NEA, 1997, BRAIN, V120, P1377, DOI 10.1093/brain/120.8.1377; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Markowitsch H J, 1997, Cogn Neuropsychiatry, V2, P135, DOI 10.1080/135468097396379; Markowitsch H. J., 1995, COGNITIVE NEUROSCIEN, P665; Markowitsch HJ, 1997, EUR J NEUROL, V4, P178, DOI 10.1111/j.1468-1331.1997.tb00324.x; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P627, DOI 10.1080/01688639308402586; Markowitsch HJ, 1996, NEUROCASE, V2, P357; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; Markowitsch HJ, 1996, BEHAV NEUROL, V9, P45, DOI 10.3233/BEN-1996-9201; Markowitsch HJ, 1997, PSYCHIAT RES-NEUROIM, V74, P119, DOI 10.1016/S0925-4927(97)03041-2; MARKOWITSCH HJ, IN PRESS TRENDS NEUR; Mayes AR, 1997, CORTEX, V33, P197, DOI 10.1016/S0010-9452(08)70001-7; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; PRIBRAM KH, 1967, SCIENCE, V156, P1765, DOI 10.1126/science.156.3783.1765; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Schmidtke K, 1997, NEUROPSYCHOLOGIA, V35, P505, DOI 10.1016/S0028-3932(96)00109-1; SHALLICE T, 1992, ATTENTION SELECTION, P195; Swick D, 1996, NEUROPSYCHOLOGIA, V34, P1019, DOI 10.1016/0028-3932(96)00011-5; Tulving E, 1997, CURR OPIN NEUROBIOL, V7, P209, DOI 10.1016/S0959-4388(97)80009-8; Tulving E., 1983, ELEMENTS EPISODIC ME; Tulving Endel, 1995, P839; [No title captured]	40	17	17	0	5	UNIVERSITATSVERLAG ULM GMBH	ULM	BAHNHOFSTRASSE 20, D-89073 ULM, GERMANY	0941-9500			NEUROL PSYCHIAT BR	Neurol. Psychiatr. Brain Res.		1997	5	2					71	78					8	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	117PF	WOS:000075790400002					2022-02-06	
J	LordMaes, J; Obrzut, JE				LordMaes, J; Obrzut, JE			Neuropsychological consequences of traumatic brain injury in children and adolescents	JOURNAL OF LEARNING DISABILITIES			English	Article							CLOSED-HEAD-INJURY; LEARNING-DISABLED CHILDREN; DAMAGE PATTERN; WISC-R; DISABILITIES; ATTENTION; DISORDERS; SEQUELAE; HYPERACTIVITY; COLLABORATION	The study of the relationship between neuroscientific information and cognitive function and dysfunction is clearly a widely expanding field. In particular, there has been a growing body of research on traumatic brain injury (TBI) in children and adolescents. This article conveys recent findings concerning cognitive outcomes, with a particular focus on age differences with TBI, suggests a relationship between specific learning disorders and brain dysfunction, addresses differential hemisphere functioning with TBI, and alludes to recent developments in assessment of TBI.			LordMaes, J (corresponding author), UNIV ARIZONA,COLL EDUC,DEPT SPECIAL EDUC & REHABIL,SCH PSYCHOL DOCTORAL PROGRAM,TUCSON,AZ 85721, USA.						ARAM DM, 1994, NEUROPSYCHOLOGIA, V32, P85, DOI 10.1016/0028-3932(94)90071-X; ARFFA S, 1989, J LEARN DISABIL, V22, P635, DOI 10.1177/002221948902201009; BANICH MT, 1990, NEUROPSYCHOLOGIA, V28, P35, DOI 10.1016/0028-3932(90)90084-2; BIGLER ED, 1992, J LEARN DISABIL, V25, P488, DOI 10.1177/002221949202500803; BIGLER ED, 1988, J LEARN DISABIL, V21, P476, DOI 10.1177/002221948802100805; BRADSHAW JL, 1981, BEHAV BRAIN SCI, V4, P51, DOI 10.1017/S0140525X00007548; BRAZZELLI M, 1994, CORTEX, V30, P27, DOI 10.1016/S0010-9452(13)80323-1; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DOBBINS C, 1990, J CLIN PSYCHOL, V46, P863, DOI 10.1002/1097-4679(199011)46:6<863::AID-JCLP2270460628>3.0.CO;2-M; DONDERS J, 1993, J CLIN PSYCHOL, V49, P255, DOI 10.1002/1097-4679(199303)49:2<255::AID-JCLP2270490220>3.0.CO;2-Q; EISELE JA, 1993, APHASIOLOGY, V7, P513, DOI 10.1080/02687039308248627; Ewing-Cobbs L, 1990, TRAUMATIC BRAIN INJU, P107; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1986, J HEAD TRAUMA REHAB, V1, P57; FARMER JE, 1995, SCHOOL PSYCHOL REV, V24, P230; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; FUERST DR, 1989, J CONSULT CLIN PSYCH, V57, P275, DOI 10.1037/0022-006X.57.2.275; Gaddes W.H., 1994, LEARNING DISABILITIE; GESCHWIND N, 1979, SCI AM, V24, P180; GOLDSTEIN FC, 1991, BRAIN COGNITION, V17, P23, DOI 10.1016/0278-2626(91)90063-E; GOODYEAR P, 1992, J CLIN CHILD PSYCHOL, V21, P273, DOI 10.1207/s15374424jccp2103_9; HEBB DO, 1949, ORG BEHAVIOR; HOM J, 1982, Journal of Clinical Neuropsychology, V4, P249, DOI 10.1080/01688638208401133; HOOPER SR, 1993, PSYCHOL REP, V72, P371, DOI 10.2466/pr0.1993.72.2.371; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; JAFFE CC, 1982, AM SCI, V70, P576; JOHN ER, 1983, PROG NEUROBIOL, V21, P239, DOI 10.1016/0301-0082(83)90014-X; JOHN ER, 1986, INTERNAL MED SPECIAL, V7, P155; JOHNSON DA, 1992, BRIT J EDUC PSYCHOL, V62, P404, DOI 10.1111/j.2044-8279.1992.tb01033.x; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; KATZ L, 1993, J LEARN DISABIL, V26, P65, DOI 10.1177/002221949302600108; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KELLY MS, 1989, BRAIN COGNITION, V11, P275, DOI 10.1016/0278-2626(89)90022-5; KUPFERMANN I, 1985, PRINCIPLES NEURAL SC, P806; Lehr E, 1990, PSYCHOL MANAGEMENT T; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LEVIN HS, 1991, J CLIN EXP NEUROPSYC, V13, P133, DOI 10.1080/01688639108407213; LEVIN HS, 1994, J CHILD NEUROL, V9, P811; LEWIN W, 1968, BRIT MED J, V1, P5; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P351, DOI 10.1080/01688638808400871; MARTIN DA, 1988, J LEARN DISABIL, V21, P464, DOI 10.1177/002221948802100803; MARTIN JH, 1985, PRINCIPLES NEURAL SC, P260; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MATTSON AJ, 1994, J NEUROL NEUROSUR PS, V57, P818, DOI 10.1136/jnnp.57.7.818; MEYERS CA, 1992, NEUROPSY NEUROPSY BE, V5, P28; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; NASS R, 1987, DEV NEUROPSYCHOL, V3, P93, DOI 10.1080/87565648709540367; OBRZUT JE, 1987, J LEARN DISABIL, V20, P596, DOI 10.1177/002221948702001005; OBRZUT JE, 1981, DEV PSYCHOL, V17, P118, DOI 10.1037/0012-1649.17.1.118; OBRZUT JE, 1987, J LEARN DISABIL, V20, P170; OBRZUT JE, 1983, J LEARN DISABIL, V16, P532, DOI 10.1177/002221948301600907; PAPANICOLAOU AC, 1990, ARCH NEUROL-CHICAGO, V47, P562, DOI 10.1001/archneur.1990.00530050086016; REEDER KP, 1994, ARCH CLIN NEUROPSYCH, V9, P491, DOI 10.1016/0887-6177(94)90040-X; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; REITAN RM, 1992, J CLIN PSYCHOL, V48, P760, DOI 10.1002/1097-4679(199211)48:6<760::AID-JCLP2270480610>3.0.CO;2-8; Reitan RM, 1985, HALSTEADREITAN NEURO; RUSSELL EW, 1993, J CLIN PSYCHOL, V49, P241, DOI 10.1002/1097-4679(199303)49:2<241::AID-JCLP2270490218>3.0.CO;2-G; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; SELZ M, 1979, J NERV MENT DIS, V167, P298, DOI 10.1097/00005053-197905000-00006; SHERER M, 1994, ARCH CLIN NEUROPSYCH, V9, P427, DOI 10.1016/0887-6177(94)90005-1; SHERER M, 1991, J CLIN EXP NEUROPSYC, V13, P741, DOI 10.1080/01688639108401087; SHUE KL, 1992, BRAIN COGNITION, V20, P104, DOI 10.1016/0278-2626(92)90064-S; SPREEN O, 1989, J CLIN EXP NEUROPSYC, V11, P117, DOI 10.1080/01688638908400880; STILES J, 1991, BRAIN COGNITION, V15, P201, DOI 10.1016/0278-2626(91)90026-5; SZEKERES SF, 1994, TOP LANG DISORD, V15, P21, DOI 10.1097/00011363-199411000-00004; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; VIKKI J, 1989, CORTEX, V25, P363; VILLA G, 1990, CORTEX, V26, P399, DOI 10.1016/S0010-9452(13)80089-5; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D., 1981, WECHSLER INTELLIGENC, V3rd; WILLIAMS DL, 1992, J LEARN DISABIL, V25, P290, DOI 10.1177/002221949202500504; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; WOOD RL, 1989, J LEARN DISABIL, V21, P327; YLVISAKER M, 1994, TOP LANG DISORD, V15, P1, DOI 10.1097/00011363-199411000-00003; YLVISAKER M, 1994, TOP LANG DISORD, V15, P37, DOI 10.1097/00011363-199411000-00005; [No title captured]; [No title captured], DOI DOI 10.1080/13854048708520056	85	17	17	0	4	PRO-ED INC	AUSTIN	8700 SHOAL CREEK BLVD, AUSTIN, TX 78757-6897	0022-2194			J LEARN DISABIL	J. Learn. Disabil.	NOV	1996	29	6					609	617		10.1177/002221949602900605			9	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	VU234	WOS:A1996VU23400005	8942305				2022-02-06	
J	Mathew, P; Bullock, R; Graham, DI; Maxwell, WL; Teasdale, GM; McCulloch, J				Mathew, P; Bullock, R; Graham, DI; Maxwell, WL; Teasdale, GM; McCulloch, J			A new experimental model of contusion in the rat - Histopathological analysis and temporal patterns of cerebral blood flow disturbances	JOURNAL OF NEUROSURGERY			English	Article						focal injury; inflammation; ischemia; rat	TRAUMATIC BRAIN INJURY; PHORBOL-MYRISTATE ACETATE; FLUID-PERCUSSION MODEL; DIFFUSE AXONAL INJURY; ACUTE HEAD-INJURY; GLUTAMATE NEUROTOXICITY; VASCULAR DISRUPTION; ISCHEMIC DAMAGE; CORTICAL INJURY; OXYGEN RADICALS	The authors have derived a simple reproducible rodent of focal injury that uses a mechanical suction force applied through intact dura. The time course and pattern of changes in neurons, glia, and microvasculature were investigated using this model. Early traumatic disruption of the blood-brain barrier and hemorrhage do not occur in this model; however, many of the features of human contusion seen with light and electron microscopy are closely reproduced. At the site of injury, early swelling adn lucency of neural dendritic processes have been shown to precede an astrocyte response. In the absence of perivascular hemorrhage, delayed perivascular protein leakage and polymorphonuclear infiltration of the damaged cortex occurs, which is suggestive of an acute inflammatory response. Cerebral blood flow (CBF) has been measured using C-14-iodoantipyrine autoradiography at 30 minutes, 4 hours, and 24 hours after induction of negative-pressure injury in rats anesthetized with halothane and in time-matched sham-operated controls. A significant reduction in blood flow in the sensorimotor cortex at the site of the injury was present at 30 minutes, 4 hours, and 24 hours after induction of the lesion, compared to the contralateral cortex (superficial lamina, ipsilateral 50 +/- 7 ml/100 g/minute, contralateral 112 +/- 26 ml/100 g/minute). The CBF was significantly reduced at the ipsilateral entorhinal cortex at 30 minutes postinjury but no significant reduction was demonstrated at later time points. Although marked alternations in CBF occurred in this cortical injury model, the magnitude and duration of the reduction in CBF are not consistent with those necessary for production of ischemic cell damage. These data indicate that this model of cortical injury can be used to examine biomechanical aspects of confusion without domination by ischemic pathophysiology.	SO GEN HOSP, INST NEUROL SCI, DEPT NEUROSURG, GLASGOW G51 4TF, LANARK, SCOTLAND; SO GEN HOSP, INST NEUROL SCI, DEPT NEUROPATHOL, GLASGOW G51 4TF, LANARK, SCOTLAND; WELLCOME SURG INST, GLASGOW, LANARK, SCOTLAND; UNIV GLASGOW, DEPT ANAT, GLASGOW G12 8QQ, LANARK, SCOTLAND						Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 1982, RECENT ADV NEUROPATH, P165; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CAO W, 1988, NEUROSCI LETT, V88, P233, DOI 10.1016/0304-3940(88)90132-2; CHEUNG JY, 1986, NEW ENGL J MED, V314, P1670; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; CROOKS DA, 1991, NEUROPATH APPL NEURO, V17, P407, DOI 10.1111/j.1365-2990.1991.tb00740.x; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FINEMAN I, 1990, Society for Neuroscience Abstracts, V16, P778; FUJISAWA H, 1994, ACT NEUR S, V60, P193; FUMEYA H, 1990, ACT NEUR S, V51, P283; GENNARELLI TA, P 15 STAPP CAR CRASH, P296; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; GRAHAM DI, 1971, LANCET, V1, P265; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; HEISS WD, 1992, STROKE, V23, P1668, DOI 10.1161/01.STR.23.11.1668; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; HESSELINK JR, 1988, AM J ROENTGENOL, V150, P1133; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATAYAMA Y, 1989, INTRACRANIAL PRESSUR, V7, P584; KAWAI K, 1989, ACTA NEUROPATHOL, V77, P449, DOI 10.1007/BF00687245; KIMELBERG HK, 1989, J NEUROSCI, V9, P1141; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; KOCHANEK PM, 1990, LIPID MEDIATORS ISCH, P220; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDENBERG R, 1957, ARCH PATHOL, V63, P23; LITTLE JR, 1976, STROKE, V7, P25, DOI 10.1161/01.STR.7.1.25; MATHEW P, 1994, ACTA NEUROCHIR, P428; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; MAXWELL WL, 1981, J ANAT, V164, P249; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; MENDELOW AD, 1991, J CEREB BLOOD FLOW M, V11, pS867; MIES G, 1991, J CEREB BLOOD FLOW M, V11, P735; NICHOLLS D, TRENDS; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; ORRENIUS S, 1988, ISI ATLAS-PHARMACOL, V2, P319; RIPPERGER EA, 1975, HDB CLIN NEUROLOGY, V23, P91; ROPER SN, 1991, J NUCL MED, V32, P1684; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SCHURER L, 1990, ACT NEUR S, V51, P49; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHASBY DM, 1982, AM REV RESPIR DIS, V125, P443; SHASBY DM, 1983, AM REV RESPIR DIS, V127, P72, DOI 10.1164/arrd.1983.127.1.72; SHIMADA N, 1989, J CEREBR BLOOD F MET, V9, P603, DOI 10.1038/jcbfm.1989.86; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; SIESJO BK, 1992, NEURODEGENER DIS, P35; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TEASDALE E, 1990, HDB CLIN NEUROLOGY, V13, P143; THOMAS MJ, 1990, SOC NEUR ABSTR, V16, P77; TORNHEIM PA, 1984, J NEUROSURG, V60, P473, DOI 10.3171/jns.1984.60.3.0473; TYSON GW, 1984, ANN NEUROL, V15, P559, DOI 10.1002/ana.410150608; UHL M W, 1990, Critical Care Medicine, V18, pS274; UNTERHARNSCHEID.FJ, 1970, DYNAMIC RESPONSE BIO; VANEZIS P, 1987, FORENSIC SCI INT, V35, P1, DOI 10.1016/0379-0738(87)90018-1; VORNOV JJ, 1991, J NEUROCHEM, V56, P996, DOI 10.1111/j.1471-4159.1991.tb02020.x; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WEISSMANN G, 1980, NEW ENGL J MED, V303, P27; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117	73	17	19	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	1996	85	5					860	870		10.3171/jns.1996.85.5.0860			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	VP489	WOS:A1996VP48900017	8893725				2022-02-06	
J	Jordan, FM; CremonaMeteyard, S; King, A				Jordan, FM; CremonaMeteyard, S; King, A			High-level linguistic disturbances subsequent to childhood closed head injury	BRAIN INJURY			English	Article							INTELLECTUAL ABILITY; ADOLESCENTS; CHILDREN; RECOVERY	High-level language functioning was assessed in a group of 11 children with severe closed head injury (CHI). Performance was examined on measures of figurative language, oral expression, inferencing, and interpretation of ambiguous sentences, and was compared with that of a control group matched for age, gender, and handedness. The children with CHI demonstrated inferior performance on the oral expression, ambiguous sentences, and figurative language tests; however, performance on the inferencing task appeared intact. These findings are discussed with respect to the underlying nature of the observed impairments. Both linguistic and cognitive factors are considered. It is concluded that a complex interaction of cognitive and linguistic impairments experienced by children with CHI may underlie the performance deficits identified in the current study.			Jordan, FM (corresponding author), UNIV QUEENSLAND,DEPT SPEECH PATHOL & AUDIOL,ST LUCIA,QLD 4072,AUSTRALIA.						BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Bloom L., 1978, LANGUAGE DEV LANGUAG; BOCK JK, 1982, PSYCHOL REV, V89, P1, DOI 10.1037/0033-295X.89.1.1; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Ewing-Cobbs L., 1985, SPEECH LANGUAGE EVAL, P97; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Fisher J. P., 1992, 100 PICTURES NAMING; FULD PA, 1977, DEV MED CHILD NEUROL, V19, P495; Guilford J. P., 1967, NATURE HUMAN INTELLI; HELIMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265; IMES C, 1983, COGNITIVE REHABILITA, V1, P11; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; JORDAN FM, 1995, J INT NEUROPSYCHOLOG, V1, P328; JORDAN FM, 1996, IN PRESS APHASIOLOGY; Kaplan E, 1983, BOSTON NAMING TEST; KENNEDY MRT, 1991, COMMUNICATION DISORD, P123; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kolb B., 1990, FUNDAMENTALS HUMAN N; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1979, CHILD BRAIN, V5, P281; MALKMUS D, 1982, MOD TECHN COGN REH I, V2; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; SCHULTZ TR, 1973, CHILD DEV, V44, P728; Spreen O., 1969, NEUROSENSORY CTR COM; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; TEASDALE G, 1974, LANCET, V2, P81; Towne R.L., 1993, LANG SPEECH HEAR SER, V24, P100; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; WARD K, 1995, THESIS U QUEENSLAND; Wiig E. H., 1989, TEST LANGUAGE COMPET; Wiig E. H., 1988, NEUROPSYCHOLOGICAL S, P186	34	17	17	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1996	10	10					729	738		10.1080/026990596123990			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VH730	WOS:A1996VH73000003	8879663				2022-02-06	
J	Fattori, B; Borsari, C; Vannucci, G; Casani, A; Cristofani, R; Bonuccelli, L; Ghilardi, PL				Fattori, B; Borsari, C; Vannucci, G; Casani, A; Cristofani, R; Bonuccelli, L; Ghilardi, PL			Acupuncture treatment for balance disorders following whiplash injury	ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH			English	Article						acupuncture; whiplash injury; posturography; cervical vertigo	MACULAR VESTIBULAR INPUTS; NECK; NEURONS; RESPONSES	In this study, by means of computerized static posturography, we evaluated the postural changes after acupuncture treatment in a group of 15 patients with balance disorders caused by cervical torsion due to Whiplash Injury (WI). The acupuncture treatment consisted of 3 sessions (one weekly session for 3 weeks) during which the acupuncture points Bladder 10 (B1.10) and Gall Bladder 20 (G.B.20). VB were stimulated by means of piercing with needles, and manipulating the needles for 20 seconds. Each patient underwent posturographic evaluations before and just after each session of acupuncture. The posturographic tests were performed with open eyes (OE), closed eyes (CE) and closed eyes with retroflexed head (CER). As a control group, we used 17 patients complaining of the same symptoms as the study group due to WT, but treated with drugs (FANS and myorelaxing) and physiotherapy only. The patients of the control group also underwent posturographic tests once a week for three weeks. We observed a significant difference between the two groups regarding the reduction of the CER Length of the statokinesigram just before each session of acupuncture and reduction of the frequency oscillations (FFT) of the patients on the sagittal plane in the study group, in CER, whereas in the control group we observed a progressive increase in these values. The high percentage of positive results in our WI patients leads us to advocate the therapeutic efficacy of acupuncture for balance disorders due to cervical pathology, where it can be associated with or be a valid alternative to pharmacological treatment.			Fattori, B (corresponding author), UNIV PISA, ENT CLIN, 10 VIA SAVI, I-56100 PISA, ITALY.		salimi, mehdi/D-1192-2009				ABRAHAMS VC, 1988, PROG BRAIN RES, V76, P125; BAOHIAN P, 1993, WORLD J ACUPUNTURE M, V3, P43; BONUCCELLI L, 1991, GIORNALE ITALIANO RI, V3, P2; BOYLE R, 1981, J NEUROPHYSIOL, V45, P852, DOI 10.1152/jn.1981.45.5.852; CHAN SHH, 1975, EXP NEUROL, V48, P336, DOI 10.1016/0014-4886(75)90161-2; COAN RM, 1982, AM J CLIN MED, V9, P327; CORVAJA N, 1979, NEUROSCIENCE, V4, P507, DOI 10.1016/0306-4522(79)90127-1; COULTER JD, 1976, J NEUROPHYSIOL, V39, P45, DOI 10.1152/jn.1976.39.1.45; DENOTH F, 1980, J NEUROPHYSIOL, V43, P46, DOI 10.1152/jn.1980.43.1.46; GURFINKEL E V, 1973, Agressologie, V14, P9; HAN J, 1988, SCI BASES ACUPUNCTUR, P7; HINOKI M, 1975, ACTA OTO-LARYNGOL, P185; Ito M., 1984, CEREBELLUM NEURAL CO; Karlberg M, 1996, J VESTIBUL RES-EQUIL, V6, P37; KUBIN L, 1981, J NEUROPHYSIOL, V46, P48, DOI 10.1152/jn.1981.46.1.48; MARCHAND AR, 1987, PFLUG ARCH EUR J PHY, V409, P13, DOI 10.1007/BF00584745; NORRE M E, 1987, Acta Oto-Rhino-Laryngologica Belgica, V41, P574; Norre M E, 1985, Ann Otolaryngol Chir Cervicofac, V102, P503; NORRE ME, 1988, CAHIERS ORL, V23, P11; NORRE ME, 1985, CAHIERS ORL, V20, P255; OMURA Y, 1982, ACUPUNCTURE ELECTRO, V7, P209, DOI 10.3727/036012982816952026; OMURA Y, 1983, ACUPUNCTURE ELECTRO, V8, P177; Omura Y., 1985, ACUPUNCTURE ELECTRO, V10, P1; Omura Y., 1975, ACUPUNCTURE ELECTRO, V1, P51; OMURA Y, 1996, ACUPUNCTURE MED ITS; POMERANZ B, 1988, SCI BASES ACUPUNCTUR; POMPEIANO O, 1995, ACTA OTO-LARYNGOL, P82; Pompeiano O, 1957, ARCH ITAL BIOL, V95, P166; QIU CZ, 1993, WORD J ACUPUNCTURE M, V3, P46; SENELAR R, 1979, NOUVEAU TRAITE ACUPU, P249; Zhang S, 1991, J Tradit Chin Med, V11, P26; ZIZZO A, 1990, 4 C AG NEUR, P29; [No title captured]	33	17	17	0	9	COGNIZANT COMMUNICATION CORP	PUTNAM VALLEY	18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA	0360-1293	2167-9010		ACUPUNCTURE ELECTRO	Acupunct. Electro-Ther. Res.	JUL-DEC	1996	21	3-4					207	217		10.3727/036012996816356861			11	Integrative & Complementary Medicine; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine; Neurosciences & Neurology	WJ613	WOS:A1996WJ61300004	9051168				2022-02-06	
J	Little, AJ; Templer, DI; Persel, CS; Ashley, MJ				Little, AJ; Templer, DI; Persel, CS; Ashley, MJ			Feasibility of the neuropsychological spectrum in prediction of outcome following head injury	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article								This study provided further substantiation of the neuropsychological spectrum conceptualization (Templer, Campodonico, Trent, Spencer, & Hartlage, to appear; Templer, Spencer, & Hartlage, 1993; Templer, Campodonico, Trent, & Spencer, 1991). Two hundred and two traumatic brain injury patients were administered the Wechsler Adult Intelligence Scale-Revised, the Luria-Nebraska Neuropsychological Battery, the Wisconsin Card Sorting Test, the Booklet Category Test, and Trails A and B. The correlations between neuropsychological and intellectual tests were significantly lower than the correlations within intelligence tests and within neuropsychological tests. Neuropsychological tests predicted outcome better than intelligence tests. This was interpreted in terms of outcome for severely brain-damaged patients being more dependent upon basic neuropsychological functioning than on abstract thinking ability. (C) 1996 John Wiley & Sons, Inc.	CTR NEURO SKILLS,BAKERSFIELD,CA		Little, AJ (corresponding author), CALIF SCH PROFESS PSYCHOL,FRESNO,CA 93721, USA.						Ashley M. J., 1993, J HEAD TRAUMA REHAB, V8, P30; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Golden CJ., 1980, LURIA NEBRASKA NEURO; Heaton R.K., 1981, WISCONSIN CARD SORTI; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Reitan RM, 1955, J GEN PSYCHOL, V53, P97, DOI 10.1080/00221309.1955.9710140; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; TEMPLER D, IN PRESS INT J CLIN; TEMPLER D, 1991, NEUROPSYCHOLOGICAL S; Templer D. I., 1993, BIOSOCIAL PSYCHOPATH; Wechsler, 1997, WECHSLER ADULT INTEL	14	17	17	0	1	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	JUL	1996	52	4					455	460		10.1002/(SICI)1097-4679(199607)52:4<455::AID-JCLP11>3.0.CO;2-F			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UZ761	WOS:A1996UZ76100011	8842883				2022-02-06	
J	Tsur, A; Sazbon, L; Lotem, M				Tsur, A; Sazbon, L; Lotem, M			Relationship between muscular tone, movement and periarticular new bone formation in postcoma-unaware (PC-U) patients	BRAIN INJURY			English	Article								Forty-eight post-traumatic brain-injured patients in postcoma-unawareness (PC-U) state, are included in this study. All recovered consciousness at least 1 month after the accident. The muscular tone and movement of all limbs was examined. At least two X-rays of the big joints were taken. Periarticular new bone formation appeared in 26 patients. This heterotopic ossification occurs in severely injured patients, primarily in proximal joints of the upper and lower extremities. Their aetiology in brain injury is unknown. Risk factors include prolonged coma, tone and movements in the involved extremity, and associated fractures. We found that the appearance of periarticular new bone formation had a close correlation with pathological movement (paresis or plegia), a borderline correlation with hypertonus, and no correlation with hypotonus or with associated fractures.	TEL AVIV UNIV,SACKLER SCH MED,IL-69978 TEL AVIV,ISRAEL; LOEWENSTEIN HOSP & REHABIL CTR,COMA INTENS CARE UNIT,RAANANA,ISRAEL; MEIR HOSP,DEPT ORTHOPAED SURG,KEFAR SAVA,ISRAEL		Tsur, A (corresponding author), WESTERN GALILEE HOSP NAHARIYA,DEPT GERIATR,REHABIL UNIT,POB 21,IL-22100 NAHARIYYA,ISRAEL.						BAGLEY SL, 1979, ORTHOPEDIC REV, V8, P113; BARRY DT, 1990, KRUSENS HDB PHYSICAL, P61; CHANTRAINE A, 1989, J TRAUMATOLOGY SPORT, V3, P128; DEJERINE, 1919, REV NEUROL, V26, P399; DEJERINE MME, 1918, ANN MED, V5, P497; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1989, CLIN ORTHOP RELAT R, V245, P303; GROSSWASSER Z, 1986, HAREFUAH, V7, P323; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Sazbon L, 1989, Brain Inj, V3, P57, DOI 10.3109/02699058909008074; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; SAZBON L, 1980, HAREFUAH, V10, P317; TSUR A, 1992, HAREFUAH, V3, P86	14	17	17	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1996	10	4					259	262		10.1080/026990596124430			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UJ541	WOS:A1996UJ54100003	9044691				2022-02-06	
J	Shohami, E; Bass, R; Trembovler, V; Weidenfeld, J				Shohami, E; Bass, R; Trembovler, V; Weidenfeld, J			The effect of the adrenocortical axis upon recovery from closed head injury	JOURNAL OF NEUROTRAUMA			English	Article						ACTH; adrenalectomy; closed-head injury; edema; hypophysectomy	TRAUMATIC BRAIN INJURY; FUNCTIONAL RECOVERY; NUCLEUS ACCUMBENS; DOPAMINE SYSTEMS; II RECEPTORS; RAT; DESTRUCTION; GLUCOCORTICOIDS	Fragments and analogs of the hormone ACTH were previously shown to have beneficial effect on the outcome of head injury, while elevated levels of corticosterone (CS) exacerbate it, In the present study we investigated the role of the hypothalamo-pituitary-adrenal (HPA) axis in the pathophysiology of closed head injury (CHI), CHI was produced in ether-anesthetized rats by a calibrated weight-drop device, After evaluating the functional status according to a set of criteria, at 1 and 24 h, the rats were sacrificed and cortical tissue was removed to determine its water content, CHI was also produced in rats that underwent surgical procedures to remove their adrenal gland (ADEX) or the pituitary (HypoX), thus altering the levels of their circulating HPA hormones, Given after CHI, to rats with intact HPA axis, ACTH reduced edema and improved recovery, ADEX rats (6 days postsurgery) had 10-fold higher levels of plasma ACTH, ADEX rats subjected to CHI showed improved functional outcome (p = 0.008) and reduced edema (p = 0.02), We then produced CHI in three groups of rats: HypoX (15 days postsurgery), HypoX treated with ACTH, and controls, In HypoX rats, CHI resulted in increased mortality (35% vs 0) and edema in the surviving rats, and a slower recovery, as compared with the control, Mortality was prevented, edema slightly reduced, and recovery significantly improved after administration of 1-24-ACTH to HypoX rats with CHI, Our results suggest that ACTH has a cerebroprotective effect on the outcome of CHI.	HADASSAH MED CTR,SCH PHARM,DEPT PHARMACOL,IL-91120 JERUSALEM,ISRAEL; HADASSAH MED CTR,DEPT NEUROL,IL-91120 JERUSALEM,ISRAEL								ATTELLA MJ, 1992, BEHAV NEURAL BIOL, V53, P157; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; DEKOSKY ST, 1984, NEUROENDOCRINOLOGY, V38, P33, DOI 10.1159/000123862; DUNN AJ, 1994, BRAIN RES, V645, P103, DOI 10.1016/0006-8993(94)91643-8; FERTIG A, 1971, EXP NEUROL, V33, P372, DOI 10.1016/0014-4886(71)90029-X; GOLDMAN H, 1993, J NEUROTRAUM, V10, P386; MCDANIEL WF, 1993, BEHAV BRAIN RES, V56, P11, DOI 10.1016/0166-4328(93)90018-L; MCMASTERS RE, 1962, J COMP NEUROL, V119, P251; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MORSE JK, 1990, EXP NEUROL, V110, P86, DOI 10.1016/0014-4886(90)90053-U; NAVARRA P, 1991, ENDOCRINOLOGY, V128, P37, DOI 10.1210/endo-128-1-37; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; RATKA A, 1989, NEUROENDOCRINOLOGY, V50, P117, DOI 10.1159/000125210; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1228; SCHEFF SW, 1980, EXP NEUROL, V68, P195, DOI 10.1016/0014-4886(80)90077-1; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; SHARP BM, 1993, ENDOCRINOLOGY, V132, P269, DOI 10.1210/en.132.1.269; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; SPRUIJT BM, 1992, PSYCHONEUROENDOCRINO, V17, P315, DOI 10.1016/0306-4530(92)90037-8; WEIDENFELD J, 1993, NEUROENDOCRINOLOGY, V58, P49, DOI 10.1159/000126511; WEIDENFELD J, 1993, ENDOCRINOLOGY, V132, P941, DOI 10.1210/en.132.3.941; WEIDENFELD J, 1989, NEUROENDOCRINOLOGY, V50, P132, DOI 10.1159/000125212; WEXLER BC, 1957, ENDOCRINOLOGY, V61, P488, DOI 10.1210/endo-61-5-488; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; WOLTERINK G, 1990, BRAIN RES, V507, P101, DOI 10.1016/0006-8993(90)90527-I; WOLTERINK G, 1990, BRAIN RES, V507, P109, DOI 10.1016/0006-8993(90)90528-J; WOLTERINK G, 1990, BRAIN RES, V507, P92, DOI 10.1016/0006-8993(90)90526-H	35	17	18	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	1995	12	6					1069	1077		10.1089/neu.1995.12.1069			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TU518	WOS:A1995TU51800007	8742135				2022-02-06	
J	CONSTANTINIDOU, F; NEILS, J				CONSTANTINIDOU, F; NEILS, J			STIMULUS MODALITY AND VERBAL-LEARNING AFTER MODERATE TO SEVERE CLOSED-HEAD INJURY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	American-Speech-Language-Hearing-Association Annual Convention	NOV, 1993	ANAHEIM, CA	Amer Speech Language Hearing Assoc			MEMORY	Objective: To determine the effects of stimulus modality on the verbal learning of patients with closed head injury (CHI) and to compare the performance of the patients with CHI to matched normal subjects. Patients: Twenty-four randomly selected subjects with moderate to severe CHI were matched In age, sex, education, and handedness to 16 normal volunteers. Main outcome measure: A multitrial free recall paradigm incorporating three modalities (auditory, visual, and auditory plus visual) was used to measure the number of words learned per trial. Results: Subjects with CHI learned new information at a significantly slower rate compared with normal subjects. Patients with CHI learned more words presented visually (with or without auditory presentation of names) during free recall and recognition. Conclusions: Visual therapy methods that incorporate pictures may enhance verbal learning in patients with moderate to severe CHI.	UNIV CINCINNATI,DEPT COMMUN SCI & DISORDERS,CINCINNATI,OH		CONSTANTINIDOU, F (corresponding author), MIAMI UNIV,DEPT COMMUN,OXFORD,OH 45056, USA.			Constantinidou, Fofi/0000-0002-7928-8363			AGRESTI AA, 1987, DISS ABSTR INT, V47, P3097; ARNETT JA, 1986, PSYCHOL REP, V59, P315, DOI 10.2466/pr0.1986.59.1.315; BROOKS D N, 1975, Cortex, V11, P329; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CONSTANTINIDOU F, 1989, THESIS SO ILLINOIS U; DARLEY F, 1972, CLIN APHASIOLOGY C P; DELIS D, 1987, CALIFORNIA VERBAL LE; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; ELBERT M, 1980, CONTRASTS PICTURE FI; Gentilini M., 1989, MILD HEAD INJURY; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; Hagen C., 1972, REHABILITATION HEAD; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1992, SCANDINAVIAN J REHAB, V26, P14; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCCAFFREY RJ, 1987, INT J CLIN NEUROPSYC, V9, P171; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; ODONNELL JP, 1988, J GEN PSYCHOL, V115, P355, DOI 10.1080/00221309.1988.9710572; Paivio A., 1971, IMAGERY VERBAL PROCE; Paivio A., 1976, RECALL RECOGNITION; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; SPSS, 1988, SPSS X US GUID; STEVENS J, 1992, APPLIED MULTIVARIATE; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Thorndike E. L., 1944, TEACHERS BOOK 30000; VENTRY IM, 1986, EVALUATING RES SPEEC; VINYARD A, 1988, COMP PERFORMANCE NOR; Wechsler, 1997, WECHSLER ADULT INTEL; Zechmeister E. B., 1982, HUMAN MEMORY INTRO R	30	17	17	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1995	10	4					90	100		10.1097/00001199-199508000-00009			11	Clinical Neurology; Rehabilitation	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RN010	WOS:A1995RN01000009					2022-02-06	
J	NILSSON, F; AKESON, J; MESSETER, K; RYDING, E; ROSEN, I; NORDSTROM, CH				NILSSON, F; AKESON, J; MESSETER, K; RYDING, E; ROSEN, I; NORDSTROM, CH			A PORCINE MODEL FOR EVALUATION OF CEREBRAL HEMODYNAMICS AND METABOLISM DURING INCREASED INTRACRANIAL-PRESSURE	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						INTRACRANIAL HYPERTENSION; CEREBRAL BLOOD FLOW; EXTRADURAL MASS; EEG; PIG	TRAUMATIC BRAIN-LESIONS; BLOOD-FLOW; HEAD-INJURY; VASOREACTIVITY	In patients with severe head injuries raised intracranial pressure (ICP) constitutes the most important cause of mortality. Several new therapies for increased ICP have recently been suggested and it is of importance to study the physiological effects of these treatments in animal experiments during steady state conditions. A porcine model for evaluation of cerebral haemodynamics and metabolism during increased ICP is presented. Intracranial hypertension was induced by inflation of two tonometric gastric balloons placed extradurally covering a major part of the parietooccipital region bilaterally The distribution of the blood flow supplied by the carotid artery used for the cerebral blood flow (CBF) measurements was studied by intraarterial (i.a.) injection of Tc-99np-HMPAO. The measurements showed that following ligation of the external carotid and the occipital artery no accumulation of tracer substance occurred in extracranial tissues during normal or increased ICP. Cerebral physiological variabies (CBF, Cavo(2), and ICP) were measured 5, 20 and 60 min after induction of intracranial hypertension. The results confirm that the experimental situation gives a reproducible increase in ICP (25-28 mm Hg) and that the physiologial variables remain stable during the period of intracranial hypertension. We conclude chat the model simulates the effects of an acute intracranial focal mass and is well suited for the evaluation of different pharmacological therapies of increased ICP.			NILSSON, F (corresponding author), LUND UNIV,MALMO GEN HOSP 04266,DEPT ANAESTHESIA & INTENS CARE,S-21401 MALMO,SWEDEN.						AKESON J, 1993, ACTA ANAESTH SCAND, V37, P525, DOI 10.1111/j.1399-6576.1993.tb03759.x; AKESON J, 1992, ACTA ANAESTH SCAND, V36, P419, DOI 10.1111/j.1399-6576.1992.tb03491.x; AKESON J, 1992, ACTA ANAESTH SCAND, V37, P85; AKESON J, 1992, ACTA ANAESTH SCAND, V37, P211; BJORKMAN S, 1993, J PHARM BIOPHARM Q, V2, P637; CARLSSON C, 1977, BRAIN RES, V119, P223, DOI 10.1016/0006-8993(77)90102-0; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P359, DOI 10.1111/j.1399-6576.1977.tb01232.x; CUMMINGS MF, 1983, BRIT J ANAESTH, V55, P619, DOI 10.1093/bja/55.7.619; DOMENECH J S, 1976, British Journal of Anaesthesia, V48, P1143, DOI 10.1093/bja/48.12.1143; HAGGENDAL E, 1970, ACTA PHYSIOL SCAND, V79, P262, DOI 10.1111/j.1748-1716.1970.tb04725.x; IVANKOVICH AD, 1975, J PHARM PHARMACOL, V27, P837, DOI 10.1111/j.2042-7158.1975.tb10226.x; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NEIRINCKX RD, 1987, J NUCL MED, V18, P191; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; SCARBOUGH FW, 1973, STROKE, V4, P674; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SUNDBARG G, 1987, J NEUROSURG, V67, P841, DOI 10.3171/jns.1987.67.6.0841	22	17	17	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	AUG	1995	39	6					827	834		10.1111/j.1399-6576.1995.tb04179.x			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	RL987	WOS:A1995RL98700022	7484043				2022-02-06	
J	KIHARA, T; SAKATA, S; IKEDA, M				KIHARA, T; SAKATA, S; IKEDA, M			DIRECT-DETECTION OF ASCORBYL RADICAL IN EXPERIMENTAL BRAIN INJURY - MICRODIALYSIS AND AN ELECTRON-SPIN-RESONANCE SPECTROSCOPIC STUDY	JOURNAL OF NEUROCHEMISTRY			English	Article						ASCORBYL RADICAL; ELECTRON SPIN RESONANCE; COLD INJURY; MICRODIALYSIS	ENTRAPPED SUPEROXIDE-DISMUTASE; EDEMA; REPERFUSION; ISCHEMIA; GENERATION; OXIDATION; SYSTEM	To examine the role played by free radicals in brain injury, we performed experiments to detect radicals in the frontal cortex of rats, using electron spin resonance (ESR) and microdialysis. A dialysis probe was inserted into the frontal cortex, and spin adducts in perfusates were immediately detected by ESR. We obtained a relatively stable doublet signal, with parameters of g = 2.0057 and aH = 0.17 mT. This signal corresponded with that of the ascorbyl radical. Ascorbyl radical in the perfusate collected from the frontal cortex was augmented by microinjection of H2O2 and FeCl2 adjacent to the dialysis probe. When the rats were challenged with cold-induced brain injury, ascorbyl radical and lactate dehydrogenase (LDH) level in the perfusate increased significantly. Pretreatment with superoxide dismutase and catalase attenuated the increase in ascorbyl radical and LDH level induced by the cold injury. Infusion of FeCl2 dissolved in perfusate caused a pronounced increase in ascorbyl radical and LDH level after the cold injury. We conclude that the direct detection of free radical formation further supports the hypothesis that free radicals play an important role in traumatic brain injury. Our findings also indicate that combined microdialysis with ESR spectroscopy is a useful in vivo method for monitoring free radical production in the brain.			KIHARA, T (corresponding author), SHIONOGI & CO LTD,SHIONOGI RES LABS,KANZAKIGAWA LAB,3-1-1 FUTABA CHO,TOYONAKA,OSAKA 561,JAPAN.						ANDO Y, 1989, BRAIN RES, V477, P286, DOI 10.1016/0006-8993(89)91416-9; ASANO T, 1989, MOL CHEM NEUROPATHOL, V10, P101, DOI 10.1007/BF03159717; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; IKEDA Y, 1990, NEUROSURGERY, V27, P1; IKEDA Y, 1989, NEUROSURGERY, V24, P820, DOI 10.1227/00006123-198906000-00006; IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; LIU TH, 1989, AM J PHYSIOL, V259, pH589; MINETTI M, 1992, BIOCHEM J, V282, P459, DOI 10.1042/bj2820459; NISHIKIMI M, 1975, BIOCHEM BIOPH RES CO, V63, P463, DOI 10.1016/0006-291X(75)90710-X; Pellegrino L.J., 1979, STEREOTAXIC ATLAS RA; PIETRI S, 1990, EUR J BIOCHEM, V193, P845, DOI 10.1111/j.1432-1033.1990.tb19408.x; SADRZADEH SMH, 1987, J CLIN INVEST, V79, P662, DOI 10.1172/JCI112865; SAKAMOTO A, 1991, BRAIN RES, V554, P186, DOI 10.1016/0006-8993(91)90187-Z; WANG XY, 1992, FREE RADICAL BIO MED, V12, P121, DOI 10.1016/0891-5849(92)90005-2; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; ZETTERSTROM T, 1983, J NEUROCHEM, V41, P1769, DOI 10.1111/j.1471-4159.1983.tb00893.x; ZINI I, 1992, NEUROSCI LETT, V138, P279, DOI 10.1016/0304-3940(92)90933-X; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404; [No title captured]	21	17	17	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0022-3042			J NEUROCHEM	J. Neurochem.	JUL	1995	65	1					282	286					5	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	RX166	WOS:A1995RX16600035	7790872				2022-02-06	
J	MUIR, JK; LYETH, BG; HAMM, RJ; ELLIS, EF				MUIR, JK; LYETH, BG; HAMM, RJ; ELLIS, EF			THE EFFECT OF ACUTE COCAINE OR LIDOCAINE ON BEHAVIORAL FUNCTION FOLLOWING FLUID PERCUSSION BRAIN INJURY IN RATS	JOURNAL OF NEUROTRAUMA			English	Article							CEREBRAL BLOOD-FLOW; RADICAL SCAVENGER; RECOVERY; NOREPINEPHRINE; DEFICITS; ISCHEMIA; RELEASE; MOTOR; MODEL	One of the goals of our laboratory is to examine how the presence of drugs of abuse will influence traumatic brain injury. Previous studies in our laboratory have shown that cocaine or lidocaine treatment before experimental fluid percussion brain injury in rats seduces the cortical hypoperfusion normally found in the early posttraumatic period. The purpose of the current study was to determine if pretreatment with cocaine or lidocaine is also associated with changes in trauma-induced suppression of reflexes and motor and cognitive dysfunction that occurs following traumatic brain injury (TBI). Twenty-four hours after surgical preparation, rats were randomly assigned to a saline or drug pretreatment group, cocaine (0.5, 2, or 5 mg/kg) car lidocaine (2 mg/kg), which was injected via the tail vein. None of the drug pretreatments worsened injury. Lidocaine and cocaine decreased the duration of suppression of some neurological reflexes and reduced posttraumatic body weight losses. Lidocaine and cocaine both decreased postinjury motor deficits. Lidocaine and cocaine did not affect cognitive function on days 11-15 postinjury. The mechanism by which lidocaine improves acute neurological and motor function following brain injury is unknown, but may involve improved posttraumatic cortical blood now, as seen in our previous study. Our results, along with other studies showing lidocaine to be neuroprotective in animal models of ischemia, suggest that studies of the effect of posttraumatic administration of lidocaine are warranted.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,DIV NEUROSURG,RICHMOND,VA 23298					Lyeth, Bruce/0000-0003-4811-1474	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [29995, 05274, 27214] Funding Source: Medline		BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; DAS KC, 1992, MOL CELL BIOCHEM, V115, P179; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUTKA AJ, 1992, STROKE, V23, P1515, DOI 10.1161/01.STR.23.10.1515; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hamm RJ, 1993, BRAIN RES COGN BRAIN, V1, P223, DOI [10.1016/0926-6410(93)90006-Q, DOI 10.1016/0926-6410(93)90006-Q]; HAMM RJ, 1994, BEHAV BRAIN RES, V59, P169; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; IMPERATO A, 1993, EUR J PHARMACOL, V238, P377, DOI 10.1016/0014-2999(93)90869-J; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; MUIR JK, 1992, J NEUROTRAUM, V9, P394; MUIR JK, 1995, AM J PHYSIOL, V268, P468; MUIR JK, 1993, 11TH ANN NEUR S; NAGAO S, 1988, J TRAUMA, V28, P1650, DOI 10.1097/00005373-198812000-00006; PORRINO LJ, 1988, NEUROPSYCHOPHARMACOL, V1, P109, DOI 10.1016/0893-133X(88)90002-4; RASOOL N, 1990, STROKE, V21, P929, DOI 10.1161/01.STR.21.6.929; SHOKUNBI MT, 1990, STROKE, V21, P107, DOI 10.1161/01.STR.21.1.107; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	32	17	17	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	1995	12	1					87	97		10.1089/neu.1995.12.87			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QN638	WOS:A1995QN63800007	7783235				2022-02-06	
J	FORMISANO, R; SALTUARI, L; GERSTENBRAND, F				FORMISANO, R; SALTUARI, L; GERSTENBRAND, F			PRESENCE OF KLUVER-BUCY SYNDROME AS A POSITIVE PROGNOSTIC FEATURE FOR THE REMISSION OF TRAUMATIC PROLONGED DISTURBANCES OF CONSCIOUSNESS	ACTA NEUROLOGICA SCANDINAVICA			English	Article						BRAIN INJURY; TRAUMATIC APALLIC SYNDROME; KLUVER-BUCY SYNDROME; SOCIAL INTEGRATION	VEGETATIVE-STATE; INJURY	After severe brain injury a prolonged disturbance of consciousness may occur, sometimes with transient apallic syndrome (awakening without awareness of self and surroundings). Kluver-Bucy is described in the literature as a typical post-traumatic remission phase, in which the patients show an increase of oral automatisms and/or of sexual drive. The study describes Kluver-Bucy syndrome as a sign associated with favourable prognosis in the outcome of traumatic disturbances of consciousness in survivors of head trauma. Seventy-seven patients who had suffered severe brain injury due to traffic accidents entered into the study. All had experienced a relatively benign clinical course since they recovered full awareness, that is were able to communicate with their relatives. The occurrence of prolonged coma, of apallic syndrome and of Kluver-Bucy syndrome are related to outcome date in regards to the patient's work and family function at a mean of 32 months later. In particular, the duration of the apallic syndrome (duration of unconsciousness) was significantly correlated with the global outcome of the patients (p < 0.001).	UNIV INNSBRUCK, INST NEUROL, INNSBRUCK, AUSTRIA		FORMISANO, R (corresponding author), IRCCS, CLIN S LUCIA, CTR REHABIL, V VIGNOLA 75, I-00196 ROME, ITALY.						BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; DOUGHERTY JH, 1981, NEUROLOGY, V31, P991, DOI 10.1212/WNL.31.8.991; GERSTENBRAND F, 1983, NEUROSCI BIOBEHAV R, V7, P413, DOI 10.1016/0149-7634(83)90047-7; Gerstenbrand F., 1967, TRAUMATISCHE APALLIS; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; Levy D E, 1978, Ann N Y Acad Sci, V315, P293, DOI 10.1111/j.1749-6632.1978.tb50347.x; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; [No title captured]; [No title captured]	11	17	17	0	2	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	JAN	1995	91	1					54	57					4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QQ446	WOS:A1995QQ44600010	7732775				2022-02-06	
J	CASSIDY, JW				CASSIDY, JW			NEUROPHARMACOLOGICAL MANAGEMENT OF DESTRUCTIVE BEHAVIOR AFTER TRAUMATIC BRAIN INJURY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						AGGRESSION; AGITATION; DESTRUCTIVE BEHAVIOR; PHARMACOLOGY		Destructive behavior following traumatic brain injury can occur during every phase of recovery. It is a symptom of many neuropsychiatric syndromes. To date, there have been few adequately controlled studies to guide clinicians in the neuropharmacologic management of this problem. However, there are emerging strategies that have been helpful for some patients. This article develops a syndromic approach to understanding these behavioral disorders and summarizes the available data and clinical experience in their management.			CASSIDY, JW (corresponding author), DEL ORO INST REHABIL, NEUROBEHAV PROGRAMS, HOUSTON, TX USA.						ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; ADAMS F, 1984, CANCER B, V36, P156; ANDEN N, 1973, J PHARM PHARMACOL, V25, P346, DOI 10.1111/j.2042-7158.1973.tb10025.x; BALLENGER JC, 1980, AM J PSYCHIAT, V137, P782; BLUMER D, 1975, J NERV MENT DIS, V160, P127, DOI 10.1097/00005053-197502000-00007; BOND WS, 1986, J CLIN PSYCHOPHARM, V6, P81; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CARDENAS DD, 1992, PHYS MED REH CLIN N, V3, P273; CASSIDY JW, 1989, J HEAD TRAUMA REHAB, V4, P67; CASSIDY JW, 1994, NEUROPSYCHIATRY TRAU; CASSIDY JW, 1990, J HEAD TRAUMA REHAB, V5, P83; Chandler M C, 1988, Brain Inj, V2, P309; COLENDA CC, 1988, LANCET, V1, P1169; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; DEBERDT R, 1978, ACTA PSYCHIAT SCAND, P104; DONALDSON SR, 1983, SCHIZOPHR B, P504; EAMES P, 1989, MODELS BRAIN INJURY; EAMES P, 1990, REHABILITATION ADULT; Eichelman B, 1990, J Neuropsychiatry Clin Neurosci, V2, P288; EISON AS, 1986, AM J MED, V80, P1, DOI 10.1016/0002-9343(86)90325-6; ELLIOTT FA, 1977, ANN NEUROL, V1, P489, DOI 10.1002/ana.410010516; ERWIN CW, 1973, ARCH GEN PSYCHIAT, V28, P646; EVANS RW, 1985, CLIN NEUROPHARMACOL, V8, P221, DOI 10.1097/00002826-198509000-00003; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FERNANDEZ F, 1988, J CLIN PSYCHIAT, V49, P239; Flor-Henry P., 1983, CEREBRAL BASIS PSYCH; FOLKS DG, 1982, AM J PSYCHIAT, V139, P115; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FREEMAN TW, 1992, AM J PSYCHIAT, V149, P108; GARBUTT JC, 1983, AM J PSYCHIAT, V140, P1363; GARDOS G, 1977, AM J PSYCHIAT, V134, P302; Gilman A.G., 1985, PHARM BASIS THERAPEU; GLENN MB, 1989, AM J PHYS MED REHAB, V68, P221, DOI 10.1097/00002060-198910000-00004; GRANT I, 1987, NEUROBEHAVIORAL RECO; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; GREENDYKE RM, 1986, J CLIN PSYCHIAT, V47, P423; HAAS JF, 1985, ARCH PHYS MED REHAB, V66, P472; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; HUMPHRIES SR, 1988, BRIT J PSYCHIAT, V152, P571, DOI 10.1192/S0007125000219739; JACKSON RD, 1985, ARCH PHYS MED REHAB, V66, P180; JACOBS HE, 1993, BEHAVIOR ANAL GUIDEL; Janicak PG, 1993, PRINCIPLES PRACTICE; Levine A M, 1988, Brain Inj, V2, P165, DOI 10.3109/02699058809150940; LIPOWSKI ZJ, 1980, COMPR PSYCHIAT, V21, P190, DOI 10.1016/0010-440X(80)90002-4; Lipowski ZJ., 1990, DELIRIUM ACUTE CONFU; LIPPER S, 1976, J NERV MENT DIS, V162, P366, DOI 10.1097/00005053-197605000-00008; LUCHINS DJ, 1984, PSYCHOPHARMACOL BULL, V20, P569; MATTES JA, 1984, PSYCHOPHARMACOL BULL, V20, P98; MCALLISTER TW, 1985, J CLIN PSYCHIAT, V46, P393; MCELROY SL, 1989, J CLIN PSYCHIAT, V50, P23; MCELROY SL, 1987, J CLIN PSYCHOPHARM, V7, P16; MCELROY SL, 1988, USE ANTICONVULSANTS; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MENZA MA, 1987, J CLIN PSYCHIAT, V48, P278; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; MORRISON SD, 1973, DIS NERV SYST, V34, P186; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; NEPPE VM, 1983, J CLIN PSYCHIAT, V44, P326; ONEIL M, 1986, LANCET, V2, P859; PATTERSON JF, 1988, J CLIN PSYCHOPHARM, V8, P296, DOI 10.1097/00004714-198808000-00026; POLAKOFF SA, 1986, J CLIN PSYCHOPHARM, V6, P125; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; RABINS PV, 1982, BRIT J PSYCHIAT, V140, P149, DOI 10.1192/bjp.140.2.149; RALL TW, 1985, PHARM BASIS THERAPEU; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; RATEY JJ, 1992, J CLIN PSYCHOPHARM, V12, P362; RIBLET LA, 1982, J CLIN PSYCHIAT, V43, P11; ROSENTHAL M, 1990, REHABILITATION ADULT; RUDD P, 1985, PHARM BASIS THERAPEU; SALZMAN C, 1987, PSYCHOPHARMACOLOGY 3; SCHATZBERG AF, 1986, MANUAL CLIN PSYCHOPH; SCHOU M, 1988, JAMA-J AM MED ASSOC, V259, P1834, DOI 10.1001/jama.259.12.1834; SHAPIRO LB, 1939, IMJ, V10, P150; SHEARD MH, 1975, J NERV MENT DIS, V160, P108, DOI 10.1097/00005053-197502000-00005; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; SILVER JM, 1987, TXB NEUROPSYCHIATRY; SOS J, 1980, DRUG THER, V10, P103; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; SPIKER DG, 1985, AM J PSYCHIAT, V142, P430; STERN JM, 1978, SCAND J REHABIL MED, V10, P7; STRUB RL, 1988, NEUROBEHAVIORAL DISO; Taylor M. A., 1981, NEUROPSYCHIATRIC MEN; TESAR GE, 1985, J CLIN PSYCHOPHARM, V5, P344, DOI 10.1097/00004714-198505060-00009; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; VOLAVKA J, 1988, POSTGRAD MED, P163; WATSON AJS, 1986, LANCET, V2, P1462; WEINSTEIN GS, 1981, J CLIN PSYCHIAT, V42, P120; WILCOCK GK, 1987, LANCET, V1, P929; WILLIAMS KH, 1979, AM J PSYCHIAT, V136, P800; WISE MG, 1987, TXB NEUROPSYCHIATRY; Wood R. L., 1987, BRAIN INJURY REHABIL; YUDOFSKY S, 1981, AM J PSYCHIAT, V138, P218; YUDOFSKY SC, 1990, J CLIN PSYCHIAT, V51, P22	96	17	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP	1994	9	3					43	60		10.1097/00001199-199409000-00005			18	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QD376	WOS:A1994QD37600005					2022-02-06	
J	COPE, DN				COPE, DN			AN INTEGRATION OF PSYCHOPHARMACOLOGICAL AND REHABILITATION APPROACHES TO TRAUMATIC BRAIN INJURY REHABILITATION	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						BRAIN INJURY; INTEGRATION; METHODOLOGY; PSYCHOPHARMACOLOGY	MANAGEMENT	Although significant advances have been made in the application of psychopharmacological treatment methodologies to the survivors of traumatic brain injury, to date little has been published regarding the integration of these new therapeutic options within the context of traditional rehabilitation approaches. This article describes a conceptual approach to such an integration and discusses aspects of current clinical, fiscal, and legal environments that affect implementation of such an integration.			COPE, DN (corresponding author), PARADIGM HLTH CORP,MED AFFAIRS,CONCORD,CA, USA.						ABELOFF MD, 1992, JAMA-J AM MED ASSOC, V267, P2473, DOI 10.1001/jama.267.18.2473; AYD FJ, 1991, NEUROPSYCHOPHARMACOL, V5, P71; BLEIBERG J, 1989, PHYSICAL MED REHABIL, V3; Block S H, 1987, Brain Inj, V1, P203, DOI 10.3109/02699058709034459; CASSIDY JW, 1990, NEUROBEHAVIORAL SEQU; COPE DN, 1990, NEUROBEHAVIORAL SEQU; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA; Hayes R L, 1987, Brain Inj, V1, P1, DOI 10.3109/02699058709034437; JOHNSTON A, 1991, J CLIN PSYCHIAT, V52, P450; LAETZ T, 1991, JAMA-J AM MED ASSOC, V266, P2996, DOI 10.1001/jama.266.21.2996; LEININGER BE, 1992, PHYS MED REHABIL STA, V6, P180; ODDEY M, 1985, J NEUROL NEUROSUR PS, V48, P564; *PHARM MAN ASS, 1991, DRUGS DEV DEB DIS AL; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; SABEL BA, 1986, NATURE, V323, P493, DOI 10.1038/323493a0; SHARFSTEIN SS, 1989, AM J PSYCHIAT, V146, P345; Silver J M, 1991, J Neuropsychiatry Clin Neurosci, V3, pS22; SILVER JM, 1992, AM PSYCHIATRIC PRESS; SILVER JM, 1992, J NEUROPSYCHIAT, V4, P103; SKERRETT PJ, 1990, SCIENCE, V250, P1504; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TISCHLER GL, 1990, AM J PSYCHIAT, V147, P967; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; WOOD RL, 1989, PHYSICAL MED REHABIL, V3; YARNELL PR, 1990, J NEUROREHABIL, V4, P9; ZASLER N D, 1992, Brain Injury, V6, P1, DOI 10.3109/02699059209008117	28	17	17	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP	1994	9	3					1	18		10.1097/00001199-199409000-00003			18	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QD376	WOS:A1994QD37600003					2022-02-06	
J	SHUM, DHK; MCFARLAND, K; BAIN, JD				SHUM, DHK; MCFARLAND, K; BAIN, JD			EFFECTS OF CLOSED-HEAD INJURY ON ATTENTIONAL PROCESSES - GENERALITY OF STERNBERG ADDITIVE FACTOR METHOD	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article								The present study examined the generality of Shum, McFarland, Bain, and Humphreys' (1990) findings that closed-head injury (CHI) selectively impairs different processes of attention (operationalized in terms of stages of information processing) depending on the severity of, and the time since, injury. The procedure of Shum et al. was based on Sternberg's additive factor method (AFM), with the mode of information processing involved being a physical-directional matching of visual stimuli. The present study followed a similar procedure except that a name-matching task was used. This task was administered to 16 first-year psychology students and two groups of CHI patients (viz., severe short-term (SS) and severe long-term (SL)) with matched control groups. The results obtained replicated the study by Shum in that the SS group was found to be impaired on the identification and response-selection stages of information processing whereas the SL group was found to be impaired only on the response-selection stage. The present study confirms that the AFM is not limited to one specific mode of information process and strengthens the validity of the conclusions made by Shum et al. regarding the effects of CHI on attention.	UNIV QUEENSLAND,DEPT PSYCHOL,ST LUCIA,QLD 4072,AUSTRALIA; GRIFFITH UNIV,NEUROPSYCHOL UNIT,NATHAN,QLD 4111,AUSTRALIA; GRIFFITH UNIV,FAC EDUC,NATHAN,QLD 4111,AUSTRALIA				Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262			BLOUGH DS, 1985, J EXP PSYCHOL ANIM B, V11, P261, DOI 10.1037/0097-7403.11.2.261; BOND MR, 1983, REHABILITATION HEAD, P97; DODD DH, 1973, PSYCHOL BULL, V79, P391, DOI 10.1037/h0034347; Fidell L.S., 1983, USING MULTIVARIATE S; FROWEIN HW, 1981, BIOL PSYCHOL, V13, P239, DOI 10.1016/0301-0511(81)90039-9; FROWEIN HW, 1981, ACTA PSYCHOL, V47, P105, DOI 10.1016/0001-6918(81)90002-0; GILMORE GC, 1979, PERCEPT PSYCHOPHYS, V25, P425, DOI 10.3758/BF03199852; Gronwall D, 1989, MILD HEAD INJURY, P153; Gronwall D, 1974, PSYCHOL EFFECTS CONC; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; HUNT EB, 1982, ADV PSYCHOL HUMAN IN, P201; KEEPEL G, 1982, DESIGN ANAL RES HDB; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MANNING SK, 1977, BEHAV RES METH INSTR, V9, P495, DOI 10.3758/BF03213982; Mirsky A. F., 1989, INTEGRATING THEORY P, P75; PARSONS OA, 1978, J CONSULT CLIN PSYCH, V46, P608, DOI 10.1037/0022-006X.46.4.608; POSNER MI, 1969, J EXP PSYCHOL, V79, P1, DOI 10.1037/h0026947; Sanders A. F., 1980, TUTORIALS MOTOR BEHA, P331, DOI DOI 10.1016/S0166-4115(08)61955-X; SANDERS AF, 1982, ACTA PSYCHOL, V51, P41, DOI 10.1016/0001-6918(82)90018-X; SANDERS AF, 1990, ACTA PSYCHOL, V51, P41; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SHWARTZ SP, 1977, J EXP PSYCHOL HUMAN, V3, P402, DOI 10.1037/0096-1523.3.3.402; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; TEASDALE G, 1974, LANCET, V2, P81; Van Zomeren A. H., 1981, REACTION TIME ATTENT; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANDERMEERE J, 1989, J ABNORM CHILD PSYCH, V17, P409, DOI 10.1007/BF00915035; [No title captured]	30	17	17	0	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	1994	16	4					547	555		10.1080/01688639408402666			9	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	NW682	WOS:A1994NW68200007	7818694				2022-02-06	
J	GEFFEN, GM; BUTTERWORTH, P; FORRESTER, GM; GEFFEN, LB				GEFFEN, GM; BUTTERWORTH, P; FORRESTER, GM; GEFFEN, LB			AUDITORY VERBAL-LEARNING TEST COMPONENTS AS MEASURES OF THE SEVERITY OF CLOSED-HEAD INJURY	BRAIN INJURY			English	Article							MEMORY	Auditory verbal learning and memory was assessed in 18 patients with moderate-severe closed-head injury (CHI). Compared to a matched control group, performance of the CHI subjects on all measures of the Auditory Verbal Learning Test (AVLT) was significantly worse. Discriminant function analysis correctly classified 90% of subjects as CHI or control using the three most reliable measures of the AVLT. Retention of the learning list following the distractor trial varied with severity of injury as indexed by duration of post-traumatic amnesia (PTA). The more severe the injury (longer PTA), the fewer words were recalled after interference (r = -0.72). Susceptibility of verbal memory to retroactive interference is sensitive to the presence and severity of CHI.	UNIV QUEENSLAND & QUEENSLAND HLTH,BRISBANE,AUSTRALIA; JULIA FARR CTR,BEDFORD PK,SA,AUSTRALIA; FLINDERS UNIV S AUSTRALIA,BEDFORD PK,SA 5042,AUSTRALIA					Butterworth, Peter/0000-0002-1531-3881			BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; BROOKS DN, 1983, REHABILITATION HEAD, P185; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; DELLIS DC, 1988, CLIN NEUROPSYCHOLOGI, V2, P188; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; GEFFEN GM, IN PRESS ARCH CLIN N; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; HANNAY HJ, 1988, J CLIN EXPT NEUROPSY, V11, P444; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MAYES AR, 1986, NEUROPSYCHOLOGIA, V24, P25, DOI 10.1016/0028-3932(86)90041-2; Nelson H. E, 1982, NATIONAL ADULT READI; NORUSIS MJ, 1985, SPSS X ADV STATISTIC; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ryan J J, 1986, Arch Clin Neuropsychol, V1, P209; SCHONELL R, 1955, SCHONELL GRADED WORD; VANZOMEREN AH, 1981, REACTION ATTENTION C; Wechsler D., 1974, WECHSLER INTELLIGENC; WECHSLER D, 1967, WECHSLER MEMORY SCAL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WILSON R S, 1979, Journal of Clinical Neuropsychology, V1, P49, DOI 10.1080/01688637908401097	23	17	17	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1994	8	5					405	411		10.3109/02699059409150992			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NW122	WOS:A1994NW12200002	7951203				2022-02-06	
J	GOLDSTEIN, P; ZIEGLER, W; VOGEL, M; HOOLE, P				GOLDSTEIN, P; ZIEGLER, W; VOGEL, M; HOOLE, P			COMBINED PALATAL-LIFT AND EPG-FEEDBACK THERAPY IN DYSARTHRIA - A CASE-STUDY	CLINICAL LINGUISTICS & PHONETICS			English	Article						DYSARTHRIA; THERAPY; PALATAL LIFT; EPG INTELLIGIBILITY	CLEFT-PALATE; SPEECH; ELECTROPALATOGRAPHY; BIOFEEDBACK; PROSTHESES; DYSPHONIA; DISORDERS; PATIENT; VOICE	A therapeutic intervention in a case of severe dysarthria after closed-head injury is described. The patient, whose articulation was characterized by a severe velopharyngeal incompetence, was supplied with a palatal lift prosthesis. In order to help the patient improve his remaining deficit of lingual motor control he was further treated with an EPG feedback device. The clinically relevant details of this intervention are described and the treatment effects are documented on the basis of EPG, acoustic, and perceptual data.	CITY HOSP BOGENHAUSEN,ENTWICKLUNGSGRP KLIN NEUROPSYCHOL,MUNICH,GERMANY		GOLDSTEIN, P (corresponding author), UNIV MUNICH,INST PHOENET & SPRACHLICHE KOMMUN,W-8000 MUNICH 2,GERMANY.						ANDREWS S, 1986, BRIT J DISORD COMMUN, V21, P353; BARLOW SM, 1990, J SPEECH HEAR RES, V33, P660, DOI 10.1044/jshr.3304.660; BARRY RM, 1989, CLIN LINGUIST PHONET, V3, P81, DOI 10.3109/02699208908985273; BASTIAN RW, 1987, J VOICE, V1, P279; BEDWINEK AP, 1985, J COMMUN DISORD, V18, P169, DOI 10.1016/0021-9924(85)90019-X; BRIN MF, 1989, MOVEMENT DISORD, V4, P287, DOI 10.1002/mds.870040401; DANIEL B, 1982, J PROSTHET DENT, V48, P565, DOI 10.1016/0022-3913(82)90364-X; DAVIS SM, 1980, BIOFEEDBACK SELF-REG, V5, P159, DOI 10.1007/BF00998593; DEDO HH, 1991, ANN OTOLOGY RHINOLOG, V3100, P274; EDWARDS S, 1989, CLIN LINGUIST PHONET, V3, P111, DOI 10.3109/02699208908985275; FINSTERWALD M, 1990, THESIS U BUNDESWEHR; FURUSAWA K, 1992, BRAIN RES BULL, V29, P69, DOI 10.1016/0361-9230(92)90010-U; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; Gonzalez JB, 1970, CLEFT PALATE J, V7, P91; HARDCASTLE W, 1989, CLIN LINGUIST PHONET, V3, P1, DOI 10.3109/02699208908985268; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HIRSCHBERG J, 1986, FOLIA PHONIATR, V38, P221, DOI 10.1159/000265828; Huber W., 1983, AACHENER APHASIE TES; KUNZEL HJ, 1982, FOLIA PHONIATR, V34, P92; LAVELLE WE, 1979, J PROSTHET DENT, V42, P308, DOI 10.1016/0022-3913(79)90222-1; MCLEAN MD, 1987, J SPEECH HEAR RES, V30, P276; MICHI K, 1986, J SPEECH HEAR DISORD, V51, P226, DOI 10.1044/jshd.5103.226; MORR KE, 1988, FOLIA PHONIATR, V40, P284, DOI 10.1159/000265921; NETSELL R, 1973, J SPEECH HEAR RES, V38, P131, DOI 10.1044/jshd.3801.131; NETSELL R, 1985, SPEECH LANGUAGE EVAL; PHILIPS BJ, 1984, SPEECH LANGUAGE ADV, V11; ROSENBEK JC, 1984, SEMINARS SPEECH LANG, V5, P359; RUBOW R, 1984, DYSARTHRIAS PHYSL AC; SIMPSON MB, 1988, J SPEECH HEAR DISORD, V53, P433, DOI 10.1044/jshd.5304.433; SUZUKI N, 1989, CLIN LINGUIST PHONET, V3, P127, DOI 10.3109/02699208908985276; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; TILL JA, 1988, J SPEECH HEAR DISORD, V53, P449, DOI 10.1044/jshd.5304.449; TOMODA H, 1987, NEUROLOGY, V37, P117, DOI 10.1212/WNL.37.1.117; VOGEL M, 1992, 11TH C INT ASS DENT; VOLIN RA, 1991, TOP LANG DISORD, V11, P65, DOI 10.1097/00011363-199111020-00007; Weismer Gary, 1992, INTELLIGIBILITY SPEE; WOLF SL, 1987, BIOFEEDBACK STUDIES; YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P398, DOI 10.1044/jshd.4604.398; ZIEGLER W, 1988, BRIT J DISORD COMMUN, V23, P215; ZIEGLER W, 1993, J SPEECH HEAR RES, V36, P683, DOI 10.1044/jshr.3604.683; ZIEGLER W, 1992, NERVENARZT, V63, P602; ZIEGLER W, 1988, CLIN LINGUIST PHONET, V2, P291, DOI 10.3109/02699208808985261; ZIEGLER W, 1993, NERVENARZT, V654, P653; ZIEGLER W, 1994, IN PRESS 1ST P C ICP	44	17	17	0	6	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9206			CLIN LINGUIST PHONET	Clin. Linguist. Phon.	JUL-SEP	1994	8	3					201	218		10.3109/02699209408985307			18	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	NP452	WOS:A1994NP45200002					2022-02-06	
J	PARKER, RS				PARKER, RS			NEUROBEHAVIORAL OUTCOME OF CHILDRENS MILD TRAUMATIC BRAIN INJURY	SEMINARS IN NEUROLOGY			English	Article							HEAD-INJURY; CHILDHOOD; SEQUELAE; INFANT; ADOLESCENCE; ATTENTION; EPILEPSY; LANGUAGE; LESIONS; APHASIA	This article offers an overview of children's and adolescents' neuropsychologic dysfunctions after mild brain injury, organized according to a taxonomy of neurobehavioral systems. Neurobehavioral outcome of children's brain injury differs from adults' because of developmental implications and substantial anatomic differences between the neonate and adult, but not in range of dysfunctions. It is a disturbance of adaptation-that is, integrated coping with one's environment.1 Mild head injury (MHI) implies minimal loss of consciousness (LOC) and lack of focal neurologic findings (although soft signs may exist) after an acceleration or impact injury, or both. MHI may be established by neuropsychologic study of higher processes,2 deviation from baseline functioning, and impaired development. Without wide range and precise study of neuropsychologic outcome, cases may be described as ''asymptomatic.''3 Traumatic brain injury (TBI) is a process that is primary: Mechanical forces causing injury; secondary: Mass effects that may be initiated by the initial injury; tertiary: Late-developing neurobehavioral symptoms; quaternary: Late developing symptoms due to a damaged hypothalamic-pituitary-endocrine axis. Relatively, MHI is the most common injury sustained by children.4 Occult brain damage is common: parents may be unaware of an accident; physicians may not recognize it in their office or the emergency room; children may conceal or be unable to report it; there may be no LOC; deficits appear years later. Therefore it is difficult to attribute symptoms to a particular incident. Even ''trivial'' head trauma alerts the physician to the need for monitoring later development.5-7 Undocumented injuries as high as 89% have been reported.8			PARKER, RS (corresponding author), NYU MED CTR,DEPT NEUROL,550 1ST AVE,NEW YORK,NY 10016, USA.						AICARDI J, 1992, DIS NERV SYST, P736; ARAM DM, 1988, NEUROPSYCHOLOGIA, V26, P903, DOI 10.1016/0028-3932(88)90058-9; ASARNOW RB, 1991, J PEDIATR NEUROL, V5, P543; Bailey B. N., 1989, TXB HEAD INJURY, P308; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BEERS S, 1993, NEUROPSYCHOL REV, V3, P281; Begali V., 1987, HEAD INJURY CHILDREN; Benson D.F., 1986, FRONTAL LOBES; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; BERG RA, 1986, CHILD NEUROPSYCHOL, V2, P113; BERGLAND MM, 1991, REHABIL COUNS BULL, V35, P5; Bigler E. D., 1988, ASSESSMENT ISSUES CH, P67; BIJUR PE, 1990, PEDIATRICS, V86, P337; BOYCE WT, 1992, PEDIATRICS, V90, P483; BROWN ER, 1991, SEMIN NEUROL, V11, P167, DOI 10.1055/s-2008-1041218; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bruce D., 1990, REHABILITATION ADULT, P521; CAFFEY J, 1974, PEDIATRICS, V54, P396; CHELUNE GJ, 1981, J CONSULT CLIN PSYCH, P777; CHRISTOFFEL KK, 1991, JAMA-J AM MED ASSOC, V266, P1146; CRANBERG LD, 1987, NEUROLOGY, V37, P1165, DOI 10.1212/WNL.37.7.1165; CROWLEY JA, 1991, J PEDIATR PSYCHOL, V16, P611, DOI 10.1093/jpepsy/16.5.611; Dalmady-Israel Christina, 1993, Brain Injury, V7, P263, DOI 10.3109/02699059309029679; DEAN RS, 1986, CHILD NEUROPSYCHOL, V2, P83; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DENNIS M, 1985, J CLIN EXP NEUROPSYC, V7, P526, DOI 10.1080/01688638508401283; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; DEUEL RK, 1987, SOFT NEUROLOGICAL SI, P95; DIAMOND A, 1991, BRAIN MATURATION COG; DIEKEMA DS, 1993, PEDIATRICS, V91, P612; DREIFUSS JE, 1989, PEDIATR NEUROL, V1, P393; EPSTEIN FM, 1987, MED COMPLICATIONS HE, P390; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FENICHEL G, 1993, CLIN PEDIATRIC NEURO, P260; Fletcher JM, 1987, NEUROBEHAVIORAL RECO, P279; FUTAGI Y, 1992, BRAIN DEV-JPN, V14, P294, DOI 10.1016/S0387-7604(12)80146-X; GODANO U, 1992, CHILD NERV SYST, V8, P136, DOI 10.1007/BF00298269; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; Grumbach MM, 1992, WILLIAMS TXB ENDOCRI, P1139; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; JORDAN FM, 1990, ACQUIRED NEUROLOGICA, P124; Kaiser G., 1986, HEAD INJURIES NEWBOR, P263; KLONOFF H, 1984, ADV CLIN NEUROPSYCHO, V2, P139; KUYPERS HGM, 1989, ENCY NEUROSCIENCE S, V1, P107; Lantz J. A., 1990, PSYCHOL MANAGEMENT T, P133; LEHR E, 1990, PSYCHOL MANAGEMENT T, P6; LESCOHIER I, 1993, PEDIATRICS, V91, P721; Levin H. S., 1991, ACQUIRED APHASIA, P455; LIEDERMAN J, 1989, BRAIN LATERALIZATION, P375; MCLAURIN RL, 1989, NEUROLOGICAL SURGERY, V1, P2148; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; MILLER WL, 1980, NEW ENGL J MED, V302, P724, DOI 10.1056/NEJM198003273021305; NASS R, 1985, NEUROLOGY, V35, P1059, DOI 10.1212/WNL.35.7.1059; Ozanne AE, 1990, ACQUIRED NEUROLOGICA, P1; PARKER RS, 1990, TRAUMATIC BRAIN INJU, P76; Passler MA, 1985, DEV NEUROPSYCHOL, V1, P349, DOI 10.1080/87565648509540320; Peacock W. J., 1986, HEAD INJURIES NEWBOR, P53; PELCO L, 1992, Brain Injury, V6, P29, DOI 10.3109/02699059209008119; PESCOVITZ O H, 1992, P473; Raimondi J. R., 1986, HEAD INJURIES NEWBOR, P141; REYNOLDS CR, 1985, HDB INTELLIGENCE, P60; ROSMAN NP, 1989, PEDIATRIC NEUROLOGY, V2; ROSS ED, 1993, NEUROL CLIN, V11, P9, DOI 10.1016/S0733-8619(18)30168-3; RUDEL R, 1979, ED BRAIN, P269; SATTLER JM, 1988, ASSESSMENT CHILDREN, P127; SHAPIRO K, 1987, HEAD INJURY, P367; STYNE DM, 1991, BASIC CLIN ENDOCRINO, P519; TAKAHASHI H, 1980, CHILD BRAIN, V7, P124; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; Tramontana M. G., 1989, HDB CLIN CHILD NEURO, P87; Tupper D, 1986, CHILD NEUROPSYCHOL, V2, P139; VARGHAKHADEM F, 1985, BRAIN, V108, P677, DOI 10.1093/brain/108.3.677; Ward J. D., 1989, TXB HEAD INJURY, P319; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; WINOGRAD P, 1988, TOP LANG DISORD, V8, P38, DOI 10.1097/00011363-198806000-00006; Witelson SF, 1988, BRAIN LATERALIZATION, P35; [No title captured]	80	17	17	0	6	THIEME MEDICAL PUBL INC	NEW YORK	381 PARK AVE SOUTH, NEW YORK, NY 10016	0271-8235			SEMIN NEUROL	Semin. Neurol.	MAR	1994	14	1					67	73		10.1055/s-2008-1041061			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NE151	WOS:A1994NE15100012	8029562				2022-02-06	
J	MOORE, D; GREER, BG; LI, L				MOORE, D; GREER, BG; LI, L			ALCOHOL AND OTHER SUBSTANCE USE ABUSE AMONG PEOPLE WITH DISABILITIES	JOURNAL OF SOCIAL BEHAVIOR AND PERSONALITY			English	Article							SPINAL-CORD INJURY	This paper reports findings of a multi-state survey on substance use/abuse among 916 people with disabilities. Self-report data suggest that respondents used alcohol at least as much as the general population, with a high incidence of substance abuse symptoms reported by some disability groups. People with quadriplegia, traumatic brain injury, and mental illness were significantly more likely to abuse alcohol than were people with other disabilities. Additional disability-related factors (e.g., acquired versus congenital, early versus late onset of disability, and attitude toward disability) were also significantly related to alcohol abuse. This study yielded some indications that disability-related factors, such as belief in entitlement to use due to the disability, and age of disability onset are culpable factors in the development of substance abuse among this population.	UNIV MEMPHIS,DEPT COUNSELING EDUC PSYCHOL & RES,MEMPHIS,TN 38163		MOORE, D (corresponding author), WRIGHT STATE UNIV,DEPT COMMUNITY HLTH,DAYTON,OH 45401, USA.						BUSS A, 1989, INCIDENCE ALCOHOL US; Cahalan D., 1969, AM DRINKING PRACTICE; DELOACH C, 1981, ADJUSTMENT SEVERE PH; DULL RT, 1983, J DRUG EDUC, V13, P49, DOI 10.2190/9HTX-V0BQ-JU5A-7UHB; GLASS EJ, 1980, ALCOHOL HLTH RES WOR, V8, P20; GREER BG, 1994, UNPUB ISSUES APPROAC; GREER BG, 1990, REHABIL ED, V4, P33; GREER BG, 1986, J REHABIL, V14, P34; HEINEMANN AW, 1989, REHABIL PSYCHOL, V34, P191, DOI 10.1037//0090-5550.34.3.191; HINDMAN MH, 1980, ALCOHOL HLTH RES WOR, V5, P5; JOHNSTON LD, 1986, PSYCHOTHERAPEUTIC LI; KAPLAN H, 1980, NIDA MONOGRAPH, V56; Merton RK, 1938, AM SOCIOL REV, V3, P672, DOI 10.2307/2084686; MOORE D, 1991, INT J ADDICT, V26, P65, DOI 10.3109/10826089109056240; MOORE D, 1991, RES DRUG ALCOHOL ABU; Moore D, 1989, ALCOHOL HEALTH RES W, V13, P118; PRENDERGAST M, 1990, PREVENTION RES UPDAT; ROHE DE, 1989, REHABIL PSYCHOL, V34, P25; SCHASCHL S, 1989, ALCOHOL HEALTH RES W, V13, P150; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010	21	17	17	0	0	SELECT PRESS	CORTE MADERA	PO BOX 37, CORTE MADERA, CA 94976	0886-1641			J SOC BEHAV PERS	J. Soc. Behav. Pers.		1994	9	5			SI		369	382					14	Psychology, Social	Social Science Citation Index (SSCI)	Psychology	PH940	WOS:A1994PH94000023					2022-02-06	
J	LEAF, LE				LEAF, LE			TRAUMATIC BRAIN INJURY - AFFECTING FAMILY RECOVERY	BRAIN INJURY			English	Article								Ongoing interest in how families adjust to traumatic events has enouraged much research, with varying results. Viewing the family process of adjustment from a systems perspective provides a workable model. The current article explores basic system tenets and provides data on varying adjustment issues for families. Results are consistent with current research trends and family data.			LEAF, LE (corresponding author), MEADOWBROOK CHICAGO,444 N NW HIGHWAY,SUITE 145,PK RIDGE,IL 60068, USA.						Bowen M., 1978, FAMILY THERAPY CLIN; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROOKS N, 1991, Brain Injury, V5, P103, DOI 10.3109/02699059109008082; Goldenberg I, 1980, FAMILY THERAPY OVERV; LIVINGSTON MG, 1990, REHABILITATION ADULT, V2, P225; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42	6	17	17	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV-DEC	1993	7	6					543	546		10.3109/02699059309008182			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	MA173	WOS:A1993MA17300009	8260958				2022-02-06	
J	MEYER, S; GIBB, T; JURKOVICH, GJ				MEYER, S; GIBB, T; JURKOVICH, GJ			EVALUATION AND SIGNIFICANCE OF THE PUPILLARY LIGHT REFLEX IN TRAUMA PATIENTS	ANNALS OF EMERGENCY MEDICINE			English	Article						NEUROTRAUMA		The pupillary light reflex is an important component of the neurologic examination of the trauma victim. Although the normal reflex can be predictably altered by specific head injuries, a variety of other factors common to trauma patients such as alcohol, illicit drugs, narcotics, paralyzing agents, hypothermia, and orbital or ophthalmic injury can confound the evaluation of the pupillary light reflex. This report reviews the anatomy and neurophysiology of the pupillary light reflex and discusses the impact these confounding variables may have on this key component of the initial trauma evaluation.	UNIV WASHINGTON,HARBORVIEW MED CTR,DEPT SURG,SEATTLE,WA 98104									0	17	17	1	6	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JUN	1993	22	6					1052	1057		10.1016/S0196-0644(05)82750-7			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LE338	WOS:A1993LE33800016	8503525				2022-02-06	
J	OMALLEY, MB; MACLEISH, PR				OMALLEY, MB; MACLEISH, PR			INDUCTION OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ON ADULT PRIMATE RETINAL NEURONS	JOURNAL OF NEUROIMMUNOLOGY			English	Article						PRIMATE RETINA; TRAUMATIC INJURY; CNS REGENERATION; MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN	CENTRAL NERVOUS-SYSTEM; RAT MOTOR NEURONS; HLA-A; MONOCLONAL-ANTIBODIES; ALZHEIMERS-DISEASE; HUMAN ORGANS; CELL-LINES; EXPRESSION; BRAIN; RECEPTORS	The expression of class I major histocompatibility complex (MHC) antigens was examined on adult monkey and human retinal cells following injury caused by dissociation. In a panning assay, neurons and glia demonstrated a rapid induction of class I MHC antigens following enzymatic dissociation, and expression was sustained on regenerating neurons as well as on glia in culture. Class I MHC antigen expression was also enhanced following optic nerve crush of monkey eyes in vivo. These results suggest that the functions of class I MHC antigens may be relevant to primate CNS neurons and glia following injury.	ROCKEFELLER UNIV,NEUROBIOL LAB,NEW YORK,NY 10021						NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY-05201] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM07739-10] Funding Source: Medline		AKIYAMA H, 1988, J NEUROSCI RES, V20, P147, DOI 10.1002/jnr.490200202; BACKES MG, 1990, J COMP NEUROL, V295, P428, DOI 10.1002/cne.902950307; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BARTLETT PF, 1978, J CELL BIOL, V77, P377, DOI 10.1083/jcb.77.2.377; BERAH M, 1970, TRANSPLANTATION, V9, P185, DOI 10.1097/00007890-197003000-00001; BRODSKY FM, 1982, J IMMUNOL, V128, P129; BURROUS M R, 1989, Society for Neuroscience Abstracts, V15, P334; BURROUS M R, 1988, Society for Neuroscience Abstracts, V14, P497; CURTIS ASG, 1979, NATURE, V281, P222, DOI 10.1038/281222a0; DAAR AS, 1984, TRANSPLANTATION, V38, P287, DOI 10.1097/00007890-198409000-00018; DRAGER UC, 1984, J NEUROSCI, V4, P2025; DUE C, 1986, P NATL ACAD SCI USA, V83, P6007, DOI 10.1073/pnas.83.16.6007; FEHLMANN M, 1985, P NATL ACAD SCI USA, V82, P8634, DOI 10.1073/pnas.82.24.8634; HOGLUND P, 1991, P NATL ACAD SCI USA, V88, P10332, DOI 10.1073/pnas.88.22.10332; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; KIYONO H, 1982, P NATL ACAD SCI-BIOL, V79, P596, DOI 10.1073/pnas.79.2.596; LAMPSON LA, 1983, J IMMUNOL, V130, P2471; LAMPSON LA, 1986, J IMMUNOL, V136, P4054; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LAMPSON LA, 1986, J INTERFERON RES, V6, P257, DOI 10.1089/jir.1986.6.257; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; MACLEISH PR, 1983, P NATL ACAD SCI-BIOL, V80, P7014, DOI 10.1073/pnas.80.22.7014; MAEHLEN J, 1989, BRAIN RES, V481, P368, DOI 10.1016/0006-8993(89)90816-0; MAEHLEN J, 1988, NEUROSCI LETT, V92, P8, DOI 10.1016/0304-3940(88)90733-1; MAGE MG, 1977, J IMMUNOL METHODS, V15, P47, DOI 10.1016/0022-1759(77)90016-3; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; MARION DW, 1990, BRAIN RES, V519, P133, DOI 10.1016/0006-8993(90)90071-I; MCQUARRIE IG, 1973, ARCH NEUROL-CHICAGO, V29, P53, DOI 10.1001/archneur.1973.00490250071008; MUCKE L, 1992, J NEUROIMMUNOL, V36, P193, DOI 10.1016/0165-5728(92)90050-U; OLSSON T, 1989, J NEUROSCI, V9, P3870; OMALLEY MB, 1993, IN PRESS J NEUROSCI; PARHAM P, 1977, J BIOL CHEM, V252, P7555; RICHMAN LK, 1981, CELL IMMUNOL, V62, P110, DOI 10.1016/0008-8749(81)90304-X; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; SCHREIBER AB, 1984, J CELL BIOL, V98, P725, DOI 10.1083/jcb.98.2.725; SCHULTZBERG M, 1989, J NEUROIMMUNOL, V24, P105, DOI 10.1016/0165-5728(89)90104-5; SKIAS DD, 1987, J IMMUNOL, V138, P3254; SOBEL RA, 1988, J NEUROPATH EXP NEUR, V47, P19, DOI 10.1097/00005072-198801000-00003; SOLANO AR, 1988, P NATL ACAD SCI USA, V85, P5087, DOI 10.1073/pnas.85.14.5087; STREIT WJ, 1989, J NEUROIMMUNOL, V21, P117, DOI 10.1016/0165-5728(89)90167-7; TOOYAMA I, 1990, BRAIN RES, V523, P273, DOI 10.1016/0006-8993(90)91496-4; TRAUGOTT U, 1985, J NEUROL SCI, V69, P365, DOI 10.1016/0022-510X(85)90147-9; WHELAN JP, 1986, J IMMUNOL, V137, P2561; WILLIAMS KA, 1980, TRANSPLANTATION, V29, P274, DOI 10.1097/00007890-198004000-00002; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0	46	17	17	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728			J NEUROIMMUNOL	J. Neuroimmunol.	MAR	1993	43	1-2					45	57		10.1016/0165-5728(93)90074-9			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	KV485	WOS:A1993KV48500007	8458987				2022-02-06	
J	MEGUID, MM; MUSCARITOLI, M				MEGUID, MM; MUSCARITOLI, M			CURRENT USES OF TOTAL PARENTERAL-NUTRITION	AMERICAN FAMILY PHYSICIAN			English	Article								Total parenteral nutrition has become a well-established intervention for the following indications: to sustain life in patients with short-bowel syndrome; for perioperative use in nutritionally deprived patients; to improve quality of life for patients with inflammatory bowel diseases; to assist the healing of enterocutaneous and pancreatic fistulas; for supportive care in patients with acute pancreatitis; as an adjunct to therapy in patients with acute renal or hepatic failure; for hypermetabolic states such as sepsis, trauma, burns and acquired immunodeficiency syndrome; in neonatal and pediatric patients; in transplantation recipients, including bone marrow, renal, cardiac and liver transplants; for precoronary artery bypass graft myocardial glycogen loading; in the field of obstetrics; to enhance survival in patients with closed head injuries; to treat life-threatening anorexia nervosa; in patients with cystic fibrosis and for nutritional support in home use			MEGUID, MM (corresponding author), SUNY SYRACUSE,HLTH SCI CTR,SYRACUSE,NY 13210, USA.							0	17	17	0	1	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797	0002-838X			AM FAM PHYSICIAN	Am. Fam. Physician	FEB 1	1993	47	2					383	394					12	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KL872	WOS:A1993KL87200010	8430592				2022-02-06	
J	DELIAC, P; RICHER, E; BERTHOMIEU, J; PATY, J; COHADON, F; BENSCH, C				DELIAC, P; RICHER, E; BERTHOMIEU, J; PATY, J; COHADON, F; BENSCH, C			ELECTROPHYSIOLOGY UNDER THALAMIC-STIMULATION OF POST TRAUMATIC VEGETATIVE STATES	NEUROCHIRURGIE			French	Article						QUANTITATIVE EEG; EVOKED POTENTIALS; PERSISTENT VEGETATIVE STATE; THALAMIC STIMULATION	MULTIMODALITY EVOKED-POTENTIALS; HEAD-INJURY; BRAIN; COMA; COMPONENT; ADULTS	We have studied the electrophysiological evolution, with the aid of long-term, quantitative E.E.G. (Holter method) and sensory evoked potentials (visual, auditory and somatosensory) on 25 severe traumatic head injury patients (initial Glasgow scale - between 3 and 5) aged from 5 to 42 years having evolved towards a persistent vegetative state and being object of a protocol of thalamic stimulation. Electrophysiological exploration was practised before placement of the stimulation, then at 2 weeks, 1 month, 2 months and finally 3 months after. The electrophysiological parameters appear to have no predictive value on the clinical evolution after stimulation. However, changes such as long-term quantitative EEG as well as evoked potentials mostly precede-clinical progress when present. Cortical evoked potentials are the first to change significantly (J15) followed by long-term quantitative EEG and brain stem evoked potentials (J30); the latter improving more completely. Also the consideration of the chronobiological aspects of the recordings of the long term EEG allow the proposal of <<waking targeted>> stimulations at the most favorable moments of the nyctohemeral period.	HOP PELLEGRIN TRIPODE,SERV NEUROCHIRURG,F-33076 BORDEAUX,FRANCE		DELIAC, P (corresponding author), HOP PELLEGRIN TRIPODE,EXPLORAT FONCTIONELLES SYST NERVEUX LAB,F-33076 BORDEAUX,FRANCE.						BERGAMASCO B, 1968, ACTA NEUROL SCAND, V44, P495, DOI 10.1111/j.1600-0404.1968.tb05588.x; BRICOLO A, 1978, REANIMATION MED URGE, P174; CANT BR, 1984, NEUROLOGY, V34, P35, DOI 10.1212/WNL.34.1.35; CELESIA GG, 1985, EVOKED POTENTIAL TES, P1; DANZE F, 1989, Neurosurgical Review, V12, P477, DOI 10.1007/BF01790694; DANZE F, 1991, NEUROPSY, V6, P455; Davis H, 1985, EVOKED POTENTIAL TES, P55; DELIAC P, 1987, CONCILIA MED, V1, P40; DESMEDT JE, 1985, ELECTROMYOGRAPHY EVO; FACCO E, 1991, Brain Topography, V3, P447, DOI 10.1007/BF01129004; GARMA L, 1991, NEUROPSY, V6, P657; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GUERIT JM, 1990, NEUROLOGY EUROPE, P383; HANSOTIA PL, 1985, ARCH NEUROL-CHICAGO, V42, P1048, DOI 10.1001/archneur.1985.04060100030015; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 1981, MANAGEMENT HEAD INJU; KANNO T, 1989, PACE, V12, P733, DOI 10.1111/j.1540-8159.1989.tb02724.x; KATAYAMA Y, 1991, PACE, V14, P116, DOI 10.1111/j.1540-8159.1991.tb04055.x; KEREN O, 1991, Brain Injury, V5, P233, DOI 10.3109/02699059109008094; KURTZ D, 1989, REV PRAT; MAUGUIERE F, 1983, ELECTROEN CLIN NEURO, V56, P283, DOI 10.1016/0013-4694(83)90253-5; MAX J, 1981, METHODES TECHNIQUES; Momose T, 1989, Radiat Med, V7, P243; NAU HE, 1987, INTENS CARE MED, V13, P249, DOI 10.1007/BF00265113; PASSOUANT P, 1964, REV NEUROL, P111; PERONNET F, 1984, ELECTROEN CLIN NEURO, V59, P67, DOI 10.1016/0168-5597(84)90021-2; Rechtschaffen A., 1968, MANUAL STANDARDIZED; RICHER E, REV FR DOMMAGE CORP, V14, P205; RIFFEL B, 1989, ANAESTHESIST, V38, P51; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; SCHERG M, 1985, ELECTROEN CLIN NEURO, V62, P32, DOI 10.1016/0168-5597(85)90033-4; SCHWARZ G, 1990, EEG-EMG-Z ELEK ELEKT, V21, P35; SHUCARD DW, 1987, ELECTROEN CLIN NEURO, V68, P303, DOI 10.1016/0168-5597(87)90051-7; STURM V, 1979, ACTA NEUROCHIR, V47, P235, DOI 10.1007/BF01406406; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; TSUBOKAWA T, 1990, Brain Injury, V4, P315, DOI 10.3109/02699059009026185; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113; [No title captured]	40	17	20	0	2	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0028-3770			NEUROCHIRURGIE	Neurochirurgie		1993	39	5					293	303					11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MP793	WOS:A1993MP79300003	8065487				2022-02-06	
J	RESNICK, PJ				RESNICK, PJ			DEFROCKING THE FRAUD - THE DETECTION OF MALINGERING	ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES			English	Article							COMMAND HALLUCINATIONS; CLINICAL-SIGNIFICANCE	The purpose of this paper is to provide psychiatrists with practical advice on how to detect malingered mental illness. Various types of malingering are defined and the five major purposes of malingering are specified. The research literature on malingering is reviewed. Clinicians must be thoroughly grounded in the phenomenology of true mental disease to detect malingering. Detailed information about hallucinations is reviewed so that faked hallucinations that do not follow typical patterns can be more easily identified. Strategies for approaching persons suspected of malingering are suggested. Features of malingered mutism, mania, depression and mental retardation are described. The differential diagnosis of malingering, post-traumatic stress disorder, conversion disorder, and post-concussion syndromes after trauma is discussed. Clues to malingered psychoses and post-traumatic stress disorders are delineated. Finally, specific indicators of malingered insanity defenses are identified.	CASE WESTERN RESERVE UNIV, SCH MED, CLEVELAND, OH 44106 USA								ALBERT S, 1980, J PERS ASSESS, V44, P115, DOI 10.1207/s15327752jpa4402_1; ALTSHULER LL, 1986, AM J PSYCHIAT, V143, P1409; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ANDERSON EW, 1959, ACTA PSYCHIAT NEUROL, V34, P132; ASAAD G, 1986, AM J PSYCHIAT, V143, P1088; BASH IY, 1980, ANN NY ACAD SCI, V347, P86, DOI 10.1111/j.1749-6632.1980.tb21257.x; BEABER RJ, 1985, AM J PSYCHIAT, V142, P1478; Braverman M, 1978, Occup Health Saf, V47, P36; CHANEY HS, 1984, J CLIN PSYCHOL, V40, P1450; COLE ES, 1970, MED J AUSTRALIA, V1, P93, DOI 10.5694/j.1326-5377.1970.tb77752.x; Daniel A E, 1987, Bull Am Acad Psychiatry Law, V15, P301; DAVIDSON HA, 1965, FORENSIC PSYCHIATRY; Davidson HA, 1950, B MENNINGER CLIN, V14, P157; East N, 1927, INTRO FORENSIC PSYCH; ENGEL GL, 1970, SIGNS SYMPTOMS; FALLOON IRH, 1981, PSYCHOL MED, V11, P329, DOI 10.1017/S0033291700052144; GARFIELD P, 1987, PSYCHIAT J U OTTAWA, V12, P93; GOODWIN DW, 1971, ARCH GEN PSYCHIAT, V24, P76; GOUGH HG, 1950, J CONSULT CLIN PSYCH, V46, P900; HALL HV, 1982, CRIM JUSTICE BEHAV, V9, P3, DOI 10.1177/0093854882009001001; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HELLERSTEIN D, 1987, AM J PSYCHIAT, V144, P219; HOFLING C K, 1965, GP, V31, P115; HUDDLESTON JH, 1932, ACCIDENTS NEUROSES C; INBAU FE, 1967, CRIMINAL INTERROGATI; Jones A. B., 1917, MALINGERING, P80; JUNGINGER J, 1990, AM J PSYCHIAT, V147, P245; KANAS N, 1984, ARCH GEN PSYCHIAT, V41, P919; LAYDEN M, 1966, PSYCHIATRIC PROGR, V1, P7; Lewinsohn P. M., 1970, ORIGIN MECHANISMS HA, P401; Lipman F. D., 1962, TEMPLE LAW Q, V35, P141; MACDONALD J, 1976, PSYCHIATRY CRIMINAL, P425; MOTT RH, 1965, ARCH GEN PSYCHIAT, V12, P595; OSSIPOV VP, 1944, B MENNINGER CLIN, V8, P31; Resnick PJ, 1984, BEHAV SCI LAW, V2, DOI [10.1002/bsl.2370020104, DOI 10.1002/bsl.2370020104]; RITSON B, 1970, BRIT J MED PSYCHOL, V43, P31, DOI 10.1111/j.2044-8341.1970.tb02099.x; ROGERS R, 1987, LAW MENTAL HLTH INT, V3; Rogers Richard, 1990, BEHAVIORAL SCI LAW, V8, P85, DOI DOI 10.1002/BSL.2370080110; ROSANOFF AJ, 1920, MANUAL PSYCHIATRY, P310; ROSENHAN D, 1973, SCIENCE, V172, P250; SADOFF RL, 1978, WEEKLY PSYCHIATRIC U; SCHRETLEN DJ, 1988, CLIN PSYCHOL REV, V8, P451, DOI 10.1016/0272-7358(88)90074-8; SHERMAN M, 1975, J CONSULT CLIN PSYCH, V43, P867; SMALL IF, 1966, DIS NERV SYST, V27, P349; SONIAT T L, 1960, South Med J, V53, P365; Trimble M.R., 1981, POSTTRAUMATIC NEUROS; VANDERKOLK B, 1984, AM J PSYCHIAT, V141, P2; Wachspress M, 1953, PSYCHIAT QUART, V27, P463, DOI 10.1007/BF01562502; ZISKIN J, 1988, COPING PSYCHIATRIC P, V2; ZISKIN J, 1988, COPING PSYCHIATRIC P, V1; [No title captured]; [No title captured]; [No title captured]	53	17	17	1	6	GEFEN PUBL HOUSE LTD	JERUSALEM	PO BOX 6056, JERUSALEM 91060, ISRAEL	0333-7308			ISRAEL J PSYCHIAT	Isr. J. Psychiatr. Relat. Sci.		1993	30	2					93	101					9	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	LM659	WOS:A1993LM65900005	8270391				2022-02-06	
J	SANDEL, ME; OLIVE, DA; RADER, MA				SANDEL, ME; OLIVE, DA; RADER, MA			CHLORPROMAZINE-INDUCED PSYCHOSIS AFTER BRAIN INJURY	BRAIN INJURY			English	Article							HEAD-INJURY; HALOPERIDOL; DELUSIONS; DRUGS	Antipsychotic agents, most often used for treatment of schizophrenia, are sometimes prescribed for the agitated patient with an organic brain disorder. We report the case of a brain-injured patient who was prescribed chlorpromazine for agitation and who developed a delusional state while taking this antipsychotic agent. The emergence of this delusional state coincided with the exacerbation of certain cognitive deficits. Possible mechanisms for this phenomenon are discussed. Caution is advised when prescribing neuroleptics for patients with traumatic brain injury, especially those agents with significant cognitive side-effects or with a significant potential to precipitate seizures.	MAGEE MEM REHABILITAT CTR,PHILADELPHIA,PA 19102; MEDIPLEX REHAB CAMDEN,CAMDEN,NJ 08103								ADAMS JH, 1982, NEUROPATHOLOGY APPLI, V11, P299; ALEXANDER MP, 1979, NEUROLOGY, V29, P334, DOI 10.1212/WNL.29.3.334; BENSON DF, 1976, NEUROLOGY, V26, P147, DOI 10.1212/WNL.26.2.147; BRIMER A, 1964, BRIT J PSYCHIAT, V110, P723, DOI 10.1192/bjp.110.468.723; CARDENAS DD, 1987, J HEAD TRAUMA REHAB, V2, P43; COPE DN, 1987, J HEAD TRAUMA REHAB, V2, P1; COVINGTON JS, 1975, SOUTHERN MED J, V68, P719, DOI 10.1097/00007611-197506000-00015; CUMMINGS JL, 1985, BRIT J PSYCHIAT, V146, P184, DOI 10.1192/bjp.146.2.184; Davis J.M., 1969, DIAGNOSIS DRUG TREAT; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; HAAS JF, 1985, ARCH PHYS MED REHAB, V66, P472; Hillbom E., 1960, ACTA PSYCHIATRICA S, VS142, P1; JOHNSON FN, 1969, PSYCHOPHARMACOLOGIA, V16, P105, DOI 10.1007/BF00403613; LEVINE DN, 1984, NEUROLOGY, V34, P577, DOI 10.1212/WNL.34.5.577; LEVINE DN, 1982, NEUROLOGY, V32, P267, DOI 10.1212/WNL.32.3.267; LONGO VG, 1966, PHARMACOL REV, V18, P965; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; SNYDER S, 1974, ARCH GEN PSYCHIAT, V31, P58; TUNE LE, 1982, AM J PSYCHIAT, V139, P1460; [No title captured]	22	17	17	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN-FEB	1993	7	1					77	83		10.3109/02699059309008159			7	Neurosciences; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KZ724	WOS:A1993KZ72400008	8425119				2022-02-06	
J	THEODOROS, D; MURDOCH, BE; STOKES, PD; CHENERY, HJ				THEODOROS, D; MURDOCH, BE; STOKES, PD; CHENERY, HJ			HYPERNASALITY IN DYSARTHRIC SPEAKERS FOLLOWING SEVERE CLOSED HEAD-INJURY - A PERCEPTUAL AND INSTRUMENTAL ANALYSIS	BRAIN INJURY			English	Article								Hypernasality in the dysarthric speech of 20 severely closed-head- injured (CHI) subjects was investigated using both perceptual and instrumental techniques. A perceptual analysis of the speech of the CHI subjects was performed using a four-point rating scale for hypernasality. Instrumental assessment was carried out using a computerized accelerometric technique yielding a nasal coupling index. Results revealed a high incidence of perceived hypernasality (95%) in the speech of subjects in the CHI group. More than half of these subjects exhibited hypernasality of speech to a moderate to severe degree. When compared with a control group matched for age and sex the severely CHI subjects were perceived as being significantly more hypernasal. Instrumental assessment revealed that the functioning of the velopharyngeal valve in the group of CHI subjects was significantly impaired compared to the control group. The study highlighted the need to evaluate the perceptual and instrumental assessment results for the severely CHI subjects on an individual basis. The clinical implications of these findings are discussed.	UNIV QUEENSLAND,DEPT SPEECH & HEARING,BRISBANE,QLD 4072,AUSTRALIA				Murdoch, Bruce E/C-1397-2012; Chenery, Helen J/F-5194-2010; Theodoros, Deborah/F-1362-2010				Brown J.R., 1975, MOTOR SPEECH DISORDE; HOLM S, 1979, SCAND J STAT, V6, P65; HORII Y, 1981, CLEFT PALATE J, V18, P279; HORII Y, 1983, J SPEECH HEAR RES, V26, P472, DOI 10.1044/jshr.2603.472; HORII Y, 1980, CLEFT PALATE J, V18, P279; KEARNS KP, 1988, J SPEECH HEAR RES, V31, P131, DOI 10.1044/jshr.3101.131; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; LIPPMANN RP, 1981, J SPEECH HEAR RES, V24, P314; Ludlow C., 1983, CLIN DYSARTHRIA, P121; Murdoch Bruce E., 1990, AUSTR J HUMAN COMMUN, V18, P83; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; Rosenbek, 1984, DYSARTHRIAS PHYSL AC, P101; Sarno M, 1985, SPEECH LANGUAGE EVAL, P323; [No title captured]	14	17	18	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN-FEB	1993	7	1					59	69		10.3109/02699059309008157			11	Neurosciences; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KZ724	WOS:A1993KZ72400006	8425117				2022-02-06	
J	BULLOCK, R				BULLOCK, R			INTRODUCING NMDA ANTAGONISTS INTO CLINICAL-PRACTICE - WHY HEAD-INJURY TRIALS	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						HEAD INJURY; COMPETITIVE NMDA ANTAGONISTS; SUBDURAL HEMATOMA; ISCHEMIC BRAIN DAMAGE	TRAUMATIC BRAIN INJURY; ISCHEMIC NEURONAL DAMAGE; ACUTE SUBDURAL-HEMATOMA; GLUTAMATE; RAT; COMMON	1 Head injury is the major cause of death and severe disability in young adults. Evidence from clinical studies shows ischaemic brain damage to be the major determinant of bad outcome, and that a proportion of this (perhaps up to 40%) is delayed, thus offering an opportunity for 'prophylactic' therapy. 2 Laboratory studies in several relevant animal models of human head injury (fluid percussion, subdural haematoma, and focal ischaemia by middle cerebral occlusion) indicate that excitatory amino acids are important mediators of brain damage. Pretreatment with NMDA antagonists has shown that the extent of ischaemic damage may be dramatically reduced in these models (68% reduction in the cat MCA occlusion model, 54% in the rat subdural haematoma model). 3 Trials of NMDA antagonists in human head injury are therefore strongly indicated.			BULLOCK, R (corresponding author), UNIV GLASGOW,SO GEN HOSP,INST NEUROL SCI,DEPT NEUROSURG,GLASGOW G51 4TF,SCOTLAND.						Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; BECKER DP, 1989, J CEREB BLOOD FLO S1, V9, pS302; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; BULLOCK R, 1991, J CEREB BLOOD FLO S2, V11, pS109; BULLOCK R, 1990, STROKE S3, V21; BULLOCK R, 1990, VINKEN BRUYNS HDB CL, V24, P249; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; INGLIS FM, 1991, J CEREB BLOOD FLO S2, V11, pS307; INGLIS FM, 1991, J CEREB BLOOD FLO S2, V11, pS225; INGLIS FM, 1990, 8TH P INT S BRAIN OE, P277; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, IN PRESS J CEREB BLO; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; KURODA Y, 1991, J CBF METABOL S2, V11, pS74; KURODA Y, 1992, IN PRESS 8TH P INT S; LINDENBERG R, 1957, ARCH PATHOL, V63, P23; MCCULLOCH J, 1991, EXCITATORY AMINO ACI, P287; MELDRUM B, 1990, CEREBROVAS BRAIN MET, V2, P27; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; WYPER DJ, 1991, J CEREB BLOOD FLOW M, V11, pS831	31	17	18	0	1	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0306-5251			BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	NOV	1992	34	5					396	401		10.1111/j.1365-2125.1992.tb05648.x			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	JX835	WOS:A1992JX83500003	1467133	Bronze, Green Published			2022-02-06	
J	CRISP, R				CRISP, R			RETURN TO WORK AFTER TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION			English	Article							SEVERE HEAD-INJURY; SOCIAL-ADJUSTMENT; FOLLOW-UP; SUPPORTED EMPLOYMENT; REHABILITATION; OUTCOMES; RECOVERY; PERSONALITY; DISABILITY; RELATIVES	Twenty-nine studies that identified variables related to vocational resettlement after onset of traumatic brain injury were reviewed. Although these studies have been characterized by varying standards of clinical severity of impairment and social/vocational outcome, they do provide an indication of critical factors associated with vocational outcome, i.e., severity of injury, cognitive deficits, personality change, psychosocial adaptation, physical impairment, age, pre-injury work/education history, and access to intensive rehabilitation.	COMMONWEALTH REHABIL SERV AUSTRALIA,CROYDON 3136,AUSTRALIA								AINSLEY J, 1989, COGNITIVE REHAB, V7, P28; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BLAIR JR, 1989, J REHABIL, V55, P46; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROWN JC, 1975, PSYCHOL MED, V5, P239, DOI 10.1017/S0033291700056592; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; COHEN J, 1985, J APPLIED REHABILITA, V16, P25; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HAFFEY WJ, 1989, REHABIL PSYCHOL, V34, P147, DOI 10.1037//0090-5550.34.2.147; HEATON RK, 1978, J NERV MENT DIS, V166, P408, DOI 10.1097/00005053-197806000-00004; HUMPHREY M, 1980, INJURY, V12, P107, DOI 10.1016/0020-1383(80)90133-3; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P87; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson R, 1987, Int Disabil Stud, V9, P49; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; KAY T, 1989, REHABIL PSYCHOL, V34, P159, DOI 10.1037/h0091781; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LONG CJ, 1984, J REHABIL, V50, P39; LONG CJ, 1984, J REHABIL, V50, P70; MATHESON JM, 1982, AUSTR APPROACHES REH, P32; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; Moore R.L., 1990, J APPL REHABILITATIO, V21, P3; Mysiw W J, 1989, Brain Inj, V3, P27, DOI 10.3109/02699058909008070; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; NEWCOMBE F, 1982, INJURY, V14, P111, DOI 10.1016/0020-1383(82)90046-8; NEWNAN OS, 1978, PERCEPT MOTOR SKILL, V46, P635, DOI 10.2466/pms.1978.46.2.635; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; OAKESHOTT RJ, 1982, AUSTR APPROACHES REH, P41; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OSTWALD SW, 1989, J APPL REHABILITATIO, V20, P22; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RANSEN J, 1990, COGNITIVE REHABILITA, V8, P8; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; STAPLETON M, 1989, COGNITIVE REHABILITA, V7, P18; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TATE RL, 1982, BRAIN IMPAIRMENT; Thomsen I V, 1989, Brain Inj, V3, P157, DOI 10.3109/02699058909004547; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WEHMAN P, 1989, ARCH PHYS MED REHAB, V70, P109; Wehman P., 1989, J HEAD TRAUMA REHAB, V4, P66, DOI [10.1097/00001199-198909000-00010, DOI 10.1097/00001199-198909000-00010]; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	60	17	18	0	5	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109	0022-4154			J REHABIL	J. Rehabil.	OCT-DEC	1992	58	4					27	33					7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	LN424	WOS:A1992LN42400005					2022-02-06	
J	EIDE, PK; TYSNES, OB				EIDE, PK; TYSNES, OB			EARLY AND LATE OUTCOME IN HEAD-INJURY PATIENTS WITH RADIOLOGICAL EVIDENCE OF BRAIN-DAMAGE	ACTA NEUROLOGICA SCANDINAVICA			English	Article						HEAD INJURY; BRAIN CONTUSION; BRAIN CONCUSSION; COMPUTERIZED TOMOGRAPHY; OUTCOME	COMPUTERIZED-TOMOGRAPHY; SOCIAL-ADJUSTMENT; DISABILITY; LESION	This study examined the early and late outcome in head injury patients with focal or multifocal (unilateral or bilateral) brain contusions revealed by computerized tomography (CT) scanning. The outcome was also evaluated in patients hospitalized due to brain concussion. Three months after the injury (the early outcome) 43 % of the 86 cases with multifocal contusions on the CT scan were dead. As evaluated by the Glasgow Outcome Scale, all the 57 patients with a focal brain contusion, as well as the 117 cases with brain concussion, made a good recovery or were moderately disabled. The late outcome (1 to 5 years after injury) was evaluated in 78 cases with brain contusion and in 85 cases with brain concussion, and revealed that complaints and impaired adaptive functioning were frequent in both the contusion and concussion group. The occurrence of headache, dizziness and sleep problems did not significantly differ among the various head injury groups. However, focal or multifocal brain contusions on the CT scan increased the frequency of impaired memory, impaired concentration, speech problems, weakness in arms or legs and seizures with loss of consciousness. Cognitive deficits and speech problems were particularly common in patients with a focal contusion in the temporal lobe. The late adaptive and social functioning were most markedly impaired in cases with multifocal bilateral contusions.	HAUKELAND HOSP,DEPT NEUROSURG,N-5016 BERGEN,NORWAY; HAUKELAND HOSP,DEPT NEUROL,N-5016 BERGEN,NORWAY					Tysnes, Ole-Bjorn/0000-0002-7230-6426			ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; EDNA TH, 1987, ACTA NEUROCHIR, V85, P40, DOI 10.1007/BF01402368; FORMISANO R, 1991, ACTA NEUROCHIR, V109, P1, DOI 10.1007/BF01405688; GANDY SE, 1984, ANN NEUROL, V16, P254, DOI 10.1002/ana.410160217; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P129; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; SNOEK J, 1979, J NEUROL NEUROSUR PS, V42, P215, DOI 10.1136/jnnp.42.3.215; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WELLER MPI, 1985, MED SCI LAW, V25, P11, DOI 10.1177/002580248502500103; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	23	17	18	0	5	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	AUG	1992	86	2					194	198		10.1111/j.1600-0404.1992.tb05065.x			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JL205	WOS:A1992JL20500016	1414231				2022-02-06	
J	MASANA, Y; TANEDA, M				MASANA, Y; TANEDA, M			DIRECT APPROACH TO A TRAUMATIC GIANT INTERNAL CAROTID-ARTERY ANEURYSM ASSOCIATED WITH A CAROTID-CAVERNOUS FISTULA - CASE-REPORT	JOURNAL OF NEUROSURGERY			English	Article						TRAUMATIC CEREBRAL ANEURYSM; INTERNAL CAROTID ARTERY; CAROTID-CAVERNOUS FISTULA	CEREBRAL-ARTERY; INJURY	The case is reported of a giant intracranial internal carotid artery aneurysm associated with a carotid-cavernous fistula following a closed head injury. The aneurysm and the fistula disappeared after only the neck of the aneurysm was clipped. This is the first case in which a direct surgical approach was successful in sparing the internal carotid flow. Reports of similar cases are reviewed.	HANWA MEM HOSP,DEPT NEUROSURG,OSAKA,JAPAN								ACOSTA C, 1972, J NEUROSURG, V36, P531, DOI 10.3171/jns.1972.36.5.0531; AJIR F, 1981, NEUROSURGERY, V9, P173, DOI 10.1227/00006123-198108000-00012; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BOUSQUET C, 1989, SURG NEUROL, V31, P319, DOI 10.1016/0090-3019(89)90059-1; BRIHAYE J, 1954, Acta Neurol Psychiatr Belg, V54, P411; DAY AL, 1990, J NEUROSURG, V72, P677, DOI 10.3171/jns.1990.72.5.0677; DOLENC VV, 1985, J NEUROSURG, V62, P667, DOI 10.3171/jns.1985.62.5.0667; ENOMOTO H, 1984, NEUROSURGERY, V15, P700, DOI 10.1227/00006123-198411000-00011; FIERSTIEN SB, 1978, SURG NEUROL, V9, P277; Giannotta SL, 1985, NEUROSURGERY, V2, P1678; HANDA J., 1967, ACTA NEURO CHIR, V17, P161; HAYAKAWA I, 1972, ACTA NEUROCHIR, V27, P45, DOI 10.1007/BF01402172; LAURENT JP, 1981, NEUROSURGERY, V9, P303, DOI 10.1227/00006123-198109000-00015; LIU MY, 1985, NEUROSURGERY, V17, P569, DOI 10.1227/00006123-198510000-00006; Nakao S, 1987, Neurol Med Chir (Tokyo), V27, P456, DOI 10.2176/nmc.27.456; NOTERMAN J, 1985, NEUROSURGERY, V17, P807, DOI 10.1097/00006123-198511000-00014; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; REDDY SVR, 1981, J NEUROSURG, V55, P813, DOI 10.3171/jns.1981.55.5.0813; SALCMAN M, 1985, NEUROSURGERY, V16, P218; SALMON JH, 1968, J THORAC CARDIOV SUR, V56, P28, DOI 10.1016/S0022-5223(19)42868-7; SARWAR M, 1976, NEURORADIOLOGY, V12, P79, DOI 10.1007/BF00333123; SHAW CM, 1972, J NEUROL NEUROSUR PS, V35, P247, DOI 10.1136/jnnp.35.2.247; STEINMETZ H, 1988, SURG NEUROL, V30, P305, DOI 10.1016/0090-3019(88)90304-7; TERAO H, 1972, J NEUROSURG, V37, P352, DOI 10.3171/jns.1972.37.3.0352; WAGA S, 1978, SURG NEUROL, V9, P367; Waga S, 1979, No Shinkei Geka, V7, P933; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	28	17	18	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	1992	76	3					524	527		10.3171/jns.1992.76.3.0524			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HF274	WOS:A1992HF27400021	1738034				2022-02-06	
J	LEVESQUE, MF; MARKHAM, CH				LEVESQUE, MF; MARKHAM, CH			VENTRAL INTERMEDIATE THALAMOTOMY FOR POSTTRAUMATIC HEMIBALLISMUS	STEREOTACTIC AND FUNCTIONAL NEUROSURGERY			English	Article; Proceedings Paper	MEETING ON STEREOTACTIC AND FUNCTIONAL NEUROSURGERY	JUN 16-19, 1991	PITTSBURGH, PA	AMER SOC STEREOTACT & FUNCT NEUROSURG		HEMIBALLISMUS; HEAD INJURY; STEREOTAXIC THALAMOTOMY; SUBTHALAMIC NUCLEUS		An unusual case of hemiballismus following closed head injury is presented. The abnormal movement persisted for 16 years despite medical treatment. Preoperative studies did not reveal a specific lesion within the subthalamic nucleus or within the basal ganglia. A stereotactic ventral intermediate thalamotomy was performed producing a complete resolution of the ballistic movement which persisted for the length of our 12-month follow-up.	UNIV CALIF LOS ANGELES,SCH MED,DIV NEUROSURG,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT NEUROL,LOS ANGELES,CA 90024								JAKOB A, 1923, EXTRAPYRAMIDALEN ERK, P183; LOWNIE SP, 1990, CLIN NEUROPATHOL, V9, P46; MARTIN JP, 1959, BRAIN, V82, P104, DOI 10.1093/brain/82.1.104; SHANNON KM, 1990, CLIN NEUROPHARMACOL, V13, P413, DOI 10.1097/00002826-199010000-00003	4	17	17	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1011-6125			STEREOT FUNCT NEUROS	Stereotact. Funct. Neurosurg.		1992	58	1-4					26	29		10.1159/000098967			4	Neurosciences; Neuroimaging; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JQ014	WOS:A1992JQ01400005	1439343				2022-02-06	
J	KUMAR, R; WEST, CGH; QUIRKE, C; HALL, L; TAYLOR, R				KUMAR, R; WEST, CGH; QUIRKE, C; HALL, L; TAYLOR, R			DO CHILDREN WITH SEVERE HEAD-INJURY BENEFIT FROM INTENSIVE-CARE	CHILDS NERVOUS SYSTEM			English	Article						SEVERE HEAD INJURY; CHILDREN; INTENSIVE MANAGEMENT; OUTCOME; COGNITIVE RECOVERY		Intensive management of severe closed head injury is pursued in most neurosurgical units, as it no doubt reduces mortality. However, the fate of those salvaged from death is less clearly defined. The impact of aggressive management on the psychological recovery is even less clear. This retrospective study of children admitted to a regional paediatric neurosurgical service attempts to address these issues. Eighty-four children between the ages of 3 to 16 years with severe head injuries were studied and categorized according to conservative or intensive treatment groups. The availability of intensive management led to a greater number of such children referred. The mortality in those children sustaining more severe injury, i.e. Glasgow Coma Score (GCS) 3 or 4, was halved (44%) with intensive management from 80% in the conservative group. For those with less severe injury (GCS 5-8), it was unchanged at about 23 %. The reduced mortality is at the expense of increased morbidity. Psychological testing showed that the cognitive recovery was comparable.	ROYAL MANCHESTER CHILDRENS HOSP, DEPT NEUROL SURG, MANCHESTER M27 1HA, LANCS, ENGLAND; ROYAL MANCHESTER CHILDRENS HOSP, DEPT CLIN PSYCHOL, MANCHESTER M27 1HA, LANCS, ENGLAND; ROYAL MANCHESTER CHILDRENS HOSP, DEPT MED PHYS, MANCHESTER M27 1HA, LANCS, ENGLAND								BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BECKER DP, 1982, NEUROLOGICAL SURGERY, V4, P1938; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; HAHN YS, 1988, CHILD NERV SYST, V4, P34; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, ARCH NEUROL-CHICAGO, V33, P595, DOI 10.1001/archneur.1976.00500090001001; JOHNSON DA, 1988, J CHILD PSYCHOL PSYC, V29, P199, DOI 10.1111/j.1469-7610.1988.tb00704.x; LEVIN HS, 1979, CHILD BRAIN, V5, P281; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MIDDLETON J, 1989, J CHILD PSYCHOL PSYC, V30, P663, DOI 10.1111/j.1469-7610.1989.tb00780.x; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; TEASDALE G, 1974, LANCET, V2, P81	19	17	17	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	1991	7	6					299	304		10.1007/BF00304824			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	GT109	WOS:A1991GT10900001	1764703				2022-02-06	
J	CHESLER, M; SAKATANI, K; HASSAN, AZ				CHESLER, M; SAKATANI, K; HASSAN, AZ			ELEVATION AND CLEARANCE OF EXTRACELLULAR K+ FOLLOWING CONTUSION OF THE RAT SPINAL-CORD	BRAIN RESEARCH			English	Article						CONTUSION; EXTRACELLULAR SPACE; ION-SELECTIVE MICROELECTRODE; POTASSIUM; SPINAL CORD INJURY; VALINOMYCIN	MAGNETIC-RESONANCE SPECTROSCOPY; SPREADING DEPRESSION; TRAUMATIC INJURY; VOLUME FRACTION; IONIC ACTIVITY; BRAIN-TISSUE; BLOOD-FLOW; POTASSIUM; CALCIUM; METABOLISM	The elevation and clearance of extracellular potassium following a standard contusion injury was studied in the thoracic spinal cord of rats. Animals were anesthetized, paralyzed, laminectomized at T9-T11, then artificially ventilated. A 10-g rod was released 5.0 cm above the cord with the dura intact. After impact, the dura-arachnoid and pial membranes were incised to allow penetration of K+-selective microelectrodes. Electrodes utilized a valinomycin ionophore and were double-barreled, with tip diameters of 3-5-mu-m. Extracellular potassium activity ([K+]o) increased with the depth of penetration. The maximum values of [K+]o occurred at depths greater than 500-mu-m, and remained so with time after injury. These data indicate that a dorsal-ventral gradient of [K+]o develops in spinal cords contused from the dorsal surface, with the greatest elevation of [K+]o in the gray matter. In 8 preparations, the maximum [K+]o was 65 +/- 8 mM (mean +/- S.E.M.) at 5 +/- 1 min after injury. The [K+]o peak values decayed with a half-time of 11.0 +/- 3.4 min. Compared with data available for the injured cat spinal cord, the peak [K+]o recovered relatively rapidly. Although a simple diffusion model could account for the rapid clearance of [K+]o, the persistance of dorsal-ventral [K+]o gradients could not be explained by such a model. It is postulated that secondary injury processes contributed to the persistent [K+]o gradients.			CHESLER, M (corresponding author), NYU MED CTR,DEPT NEUROSURG,550 1ST AVE,NEW YORK,NY 10016, USA.			Sakatani, Kaoru/0000-0001-8656-2132; Chesler, Mitchell/0000-0002-3189-8234	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS10164, NS27011] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS010164, R29NS027011] Funding Source: NIH RePORTER		Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; ANDERSON DK, 1980, J NEUROSURG, V53, P375, DOI 10.3171/jns.1980.53.3.0375; ARIAS MJ, 1987, SURG NEUROL, V23, P440; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; BRAUGHLER JM, 1983, J NEUROSURG, V59, P256, DOI 10.3171/jns.1983.59.2.0256; CHESLER M, 1988, NEUROSCIENCE, V27, P941, DOI 10.1016/0306-4522(88)90197-2; CHESLER M, 1990, PROG NEUROBIOL, V34, P401, DOI 10.1016/0301-0082(90)90034-E; CHESLER M, 1990, Society for Neuroscience Abstracts, V16, P1338; CORDINGLEY GE, 1978, BRAIN RES, V151, P291, DOI 10.1016/0006-8993(78)90886-7; Crank J., 1975, MATH DIFFUSION, P60; CZEH G, 1989, Society for Neuroscience Abstracts, V15, P357; Eidelberg E, 1975, Surg Neurol, V3, P317; FADEN AI, 1987, J NEUROCHEM, V48, P1809, DOI 10.1111/j.1471-4159.1987.tb05740.x; FADEN AI, 1985, ANN NEUROL, V17, P386, DOI 10.1002/ana.410170414; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P375, DOI 10.1113/jphysiol.1983.sp014540; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V108, P355, DOI 10.1111/j.1748-1716.1980.tb06544.x; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; KIMELBERG HK, 1986, ASTROCYTES, V3, P129; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; LEMKE M, 1987, BIOCHEM BIOPH RES CO, V147, P1170, DOI 10.1016/S0006-291X(87)80192-4; LEWIN MG, 1974, J NEUROSURG, V40, P65, DOI 10.3171/jns.1974.40.1.0065; MARTINEZ LJ, 1981, NEUROSURGERY, V8, P450, DOI 10.1227/00006123-198104000-00008; NICHOLSON C, 1985, BRAIN RES, V333, P325, DOI 10.1016/0006-8993(85)91586-0; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; PHILLIPS JM, 1979, BRAIN RES, V173, P567, DOI 10.1016/0006-8993(79)90254-3; SOMJEN GG, 1989, J NEUROSCI METH, V28, P35, DOI 10.1016/0165-0270(89)90007-1; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; SYKOVA E, 1983, NEUROSCI LETT, V43, P293, DOI 10.1016/0304-3940(83)90203-3; SYKOVA E, 1987, CAN J PHYSIOL PHARM, V65, P1058, DOI 10.1139/y87-167; VINK R, 1987, MAGNET RESON MED, V5, P390, DOI 10.1002/mrm.1910050413; VINK R, 1989, ANN NEUROL, V25, P26, DOI 10.1002/ana.410250105; WALZ W, 1989, PROG NEUROBIOL, V33, P309, DOI 10.1016/0301-0082(89)90005-1; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1; YOUNG W, 1982, J NEUROSURG, V57, P667, DOI 10.3171/jns.1982.57.5.0667; YOUNG W, 1982, BRAIN RES, V253, P115, DOI 10.1016/0006-8993(82)90678-3; YOUNG W, 1985, CENTRAL NERVOUS SYST, P463	40	17	17	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	AUG 9	1991	556	1					71	77		10.1016/0006-8993(91)90548-A			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GD897	WOS:A1991GD89700009	1933355				2022-02-06	
J	GLASSMAN, LR				GLASSMAN, LR			MUSIC-THERAPY AND BIBLIOTHERAPY IN THE REHABILITATION OF TRAUMATIC BRAIN INJURY - A CASE-STUDY	ARTS IN PSYCHOTHERAPY			English	Article																	BERNSTEIN L, 1957, SOMEWHERE; CHARNIN M, 1977, TOMORROW; DAVIS M, 1970, I BELIEVE IN MUSIC; FEKARIS D, 1978, I WILL SURVIVE; FRANCOIS C, 1969, MY WAY; JOEL B, 1973, I ONLY HAD WORDS TEL; JOEL B, 1977, MOVIN OUT; JOEL B, 1978, MY LIFE; JOEL B, 1977, SHES ALWAYS WOMAN; JOEL B, 1986, GETTING CLOSER; KING C, 1971, YOUVE GOT FRIEND; LENNON J, 1965, YESTERDAY; PAGE R, 1985, BROKEN WINGS; RESWICK P, 1987, I LIVE YOUR LOVE; RICHARDS K, 1965, SATISFACTION; WEBBER AL, 1981, MEMORY	16	17	17	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0197-4556			ART PSYCHOTHER	Arts Psychother.		1991	18	2					149	156		10.1016/0197-4556(91)90022-3			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FL385	WOS:A1991FL38500007					2022-02-06	
J	RUIJS, MBM; KEYSER, A; GABREELS, FJM				RUIJS, MBM; KEYSER, A; GABREELS, FJM			LONG-TERM SEQUELAE OF BRAIN-DAMAGE FROM CLOSED HEAD-INJURY IN CHILDREN AND ADOLESCENTS	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						CLOSED HEAD INJURY; PSYCHOLOGICAL SEQUELAE; POST-ACCIDENTAL SCHOOL PROBLEMS; POST-ACCIDENTAL BEHAVIORAL CHANGES	CHILDHOOD	A study was made of the sequelae of brain damage in young patients. Seventy patients between 4 and 18 years, admitted under the diagnosis "diffuse brain contusion", have been followed at least two years after head injury. The degree of function impairment in the fields of motor skills, cognition and behaviour was recorded. It was found that many patients with neurologically little or no function loss, nevertheless after the accident did suffer from psychosocial problems in the realm of family life, school or profession. Based on these findings, the authors recommend a consequent and systematic follow up of patients if they have been in coma for more than 1 hour, the objective being the early assessment of such dysfunctions, followed by adequate assistance.	CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DEPT NEUROL,NIJMEGEN,NETHERLANDS; CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DEPT CHILD NEUROL,NIJMEGEN,NETHERLANDS								BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; Deelman B, 1980, NEUROPSYCHOLOGIE NED; GOLDSTEIN K, 1942, AFTER EFFECTS BRAIN; Kleinpeter U, 1980, Psychiatr Neurol Med Psychol (Leipz), V32, P641; KLEINPETER U, 1975, ACTA PAEDOPSYCHIATR, V32, P68; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; LANSER JBK, 1985, THESIS LEIDEN; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1983, PAEDIATRIC HEAD TRAU; LEVINE DN, 1981, NEUROLOGY, V31, P257, DOI 10.1212/WNL.31.3.257; MINDERHOUD JM, 1982, CLIN NEUROL NEUROSUR, V1, P15; MINDERHOUD JM, 1984, TRAUMATISCHE HERSENL; OSSON D, 1979, NEUROPSYCHIAT ENFAN, V27, P401; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SCHAAPHUMMEL IJT, 1985, MED CONTACT, V3, P74; SHARLI AF, 1981, Z KINDER CHIR, V33, P212; [No title captured]; [No title captured]	20	17	17	0	5	VAN GORCUM CO BV	ASSEN	PO BOX 43, 9400 AA ASSEN, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.		1990	92	4					323	328		10.1016/0303-8467(90)90058-D			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ER892	WOS:A1990ER89200004	1963822				2022-02-06	
J	KLINGBEIL, GEG				KLINGBEIL, GEG			AIRWAY PROBLEMS IN PATIENTS WITH TRAUMATIC BRAIN INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article											KLINGBEIL, GEG (corresponding author), MED COLL WISCONSIN,MILWAUKEE CTY MED COMPLEX,DEPT PHYS MED & REHABIL,8700 W WISCONSIN AVE,MILWAUKEE,WI 53226, USA.						BLANC VF, 1974, ANESTH ANALG, V53, P202; DUNHAM CM, 1984, J TRAUMA, V24, P120, DOI 10.1097/00005373-198402000-00005; FRIMAN L, 1976, ANAESTHESIA, V31, P479, DOI 10.1111/j.1365-2044.1976.tb12353.x; GOODPASTURE HC, 1977, J NEUROSURG, V47, P228, DOI 10.3171/jns.1977.47.2.0228; KLOSE R, 1978, PRAKT ANASTH WIED IN, V13, P249; MACKENZIE CF, 1984, CRITICAL CARE MONITO, V4, P1; MYERS EN, 1985, TRACHEOTOMY; STAUFFER JL, 1981, AM J MED, V70, P65, DOI 10.1016/0002-9343(81)90413-7; WEICKER VW, 1982, ZBL CHIRURG, V107, P945; WHITED RE, 1984, LARYNGOSCOPE, V94, P367	10	17	18	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	1988	69	7					493	495					3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	P2181	WOS:A1988P218100003	3389987				2022-02-06	
J	LEVIN, HS; HIGH, WM; GOLDSTEIN, FC; WILLIAMS, DH				LEVIN, HS; HIGH, WM; GOLDSTEIN, FC; WILLIAMS, DH			SUSTAINED ATTENTION AND INFORMATION-PROCESSING SPEED IN CHRONIC SURVIVORS OF SEVERE CLOSED HEAD-INJURY	SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE			English	Article											LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,DIV NEUROSURG,GALVESTON,TX 77550, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 21889, NS 07377] Funding Source: Medline			0	17	17	0	0	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0036-5505			SCAND J REHABIL MED	Scand. J. Rehabil. Med.		1988				17			33	40					8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	P5160	WOS:A1988P516000006	3165209				2022-02-06	
J	SHAH, KR; WEST, M				SHAH, KR; WEST, M			THE EFFECT OF CONCUSSION ON CEREBRAL UPTAKE OF 2-DEOXY-D-GLUCOSE IN RAT	NEUROSCIENCE LETTERS			English	Article											SHAH, KR (corresponding author), UNIV MANITOBA,DEPT PHYSIOL,WINNIPEG R3E 0W3,MANITOBA,CANADA.						[Anonymous], 1966, CLIN NEUROSURG, V12, P386; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; CHASON JL, 1966, J TRAUM, V6, P767, DOI 10.1097/00005373-196611000-00008; DELANOY RL, 1978, PHARMACOL BIOCHEM BE, V9, P21, DOI 10.1016/0091-3057(78)90007-2; GINSBERG MD, 1977, NEUROLOGY, V27, P1042, DOI 10.1212/WNL.27.11.1042; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; GROAT R, 1950, J NEUROPATH EXP NEUR, V9, P150, DOI 10.1097/00005072-195004000-00003; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P112; JANE JA, 1982, HEAD INJURY BASIC CL, P229; JOSEPH PD, 1971, BRAIN RES, V26, P15; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; MARSHALL WH, 1959, PHYSIOL REV, V39, P239, DOI 10.1152/physrev.1959.39.2.239; MEIBACH RC, 1980, BRAIN RES, V195, P167, DOI 10.1016/0006-8993(80)90874-4; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; ROSS DA, 1982, DEV BRAIN RES, V3, P341, DOI 10.1016/0165-3806(82)90002-5; SELLIER K, 1966, 3RD P INT C NEUR SUR, P87; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P27; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; TOWER DB, 1966, HEAD INJURY C P; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210	25	17	17	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.		1983	40	3					287	291		10.1016/0304-3940(83)90053-8			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RP493	WOS:A1983RP49300013	6646501				2022-02-06	
J	SMITH, E				SMITH, E			INFLUENCE OF SITE OF IMPACT ON COGNITIVE IMPAIRMENT PERSISTING LONG AFTER SEVERE CLOSED HEAD-INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article									NATL HOSP NERVOUS DIS,DEPT PSYCHOL MED,MAIDA VALE,LONDON,ENGLAND								Anderson C, 1942, LANCET, V2, P1; BAUGHAN B, 1973, PROGRAM GUMMA; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; DARLEY FL, 1967, BRAIN MECHANISMS UND; DENCKER SJ, 1958, ACTA PSYCHIATRI S122, V33; DENCKER SJ, 1958, ACTA PSYCHIATRI S123, V33; ELITHORN A, 1963, AM J PSYCHOL, V76, P506, DOI 10.2307/1419799; FAHY TJ, 1967, LANCET, V2, P475; Gurdjian ES, 1943, SURGERY, V13, P333; HEILBRUN AB, 1956, J COMP PHYSIOL PSYCH, V49, P10, DOI 10.1037/h0040140; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; Holbourn AHS, 1943, LANCET, V2, P438; KIMURA D, 1963, ARCH NEUROL-CHICAGO, V8, P264, DOI 10.1001/archneur.1963.00460030048004; LEWIN W, 1967, P ROY SOC MED, V60, P1208, DOI 10.1177/003591576706011P204; LEWIN W, 1965, BIOCHEMICAL ASPECTS; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LONDON P S, 1967, Annals of the Royal College of Surgeons of England, V41, P460; LURIA AR, 1971, 19 P INT C PSYCH LON, P37; MILLER H, 1965, LANCET, V1, P225; MILNER B, 1969, LATE EFFECTS HEAD IN; MILNER B, ANALYSIS BEHAVIORAL; Newcombe F., 1969, MISSILE WOUNDS BRAIN; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; OLDFIELD RC, 1965, Q J EXP PSYCHOL, V17, P273, DOI 10.1080/17470216508416445; REUSCH J, 1944, AM J PSYCHIAT, V100, P480; RICHARDSON F, 1963, DEV MED CHILD NEUROL, V5, P471; ROBERTSON RCL, 1955, J NEUROSURG, V12, P13, DOI 10.3171/jns.1955.12.1.0013; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; STRICH SJ, 1961, LANCET, V2, P443; Symonds CP, 1943, LANCET, V1, P7; TEUBER HL, 1969, LATE EFFECTS HEAD IN; Thorndike E. L., 1944, TEACHERS WORD BOOK 3; TOW PM, 1955, PERSONALITY CHANGES; VIGNOLO LA, 1968, J LEARN DISABIL, V1, P230, DOI 10.1177/002221946800100402; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Zangwill O.L., 1960, CEREBRAL DOMINANCE I; [No title captured]	39	17	18	1	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry		1974	37	6					719	726		10.1136/jnnp.37.6.719			8	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	T5214	WOS:A1974T521400018	4844139	Green Published, Bronze			2022-02-06	
J	HEILBRUN, MP; RATCHESO.RA				HEILBRUN, MP; RATCHESO.RA			MULTIPLE EXTRACRANIAL VESSEL INJURIES FOLLOWING CLOSED HEAD AND NECK TRAUMA - CASE REPORT	JOURNAL OF NEUROSURGERY			English	Article																	CALDWELL HW, 1948, ANN INTERN MED, V28, P1132, DOI 10.7326/0003-4819-28-6-1132; CARPENTER S, 1961, J NEUROSURG, V18, P849, DOI 10.3171/jns.1961.18.6.0849; DAVIS DO, 1972, PERSONAL COMMUNICATI; GURDJIAN ES, 1963, J NEUROSURG, V20, P418, DOI 10.3171/jns.1963.20.5.0418; HOLLIN SA, 1966, J NEUROSURG, V25, P526, DOI 10.3171/jns.1966.25.5.0526; HOUCK WS, 1964, ANN SURG, V159, P219, DOI 10.1097/00000658-196402000-00006; MURRAY DS, 1957, BRIT J SURG, V44, P556, DOI 10.1002/bjs.18004418803; SCHNEIDER RC, 1952, J NEUROSURG, V9, P495, DOI 10.3171/jns.1952.9.5.0495; SIMEONE FA, 1968, J NEUROSURG, V29, P540, DOI 10.3171/jns.1968.29.5.0540; TAVERAS J, 1972, PERSONAL COMMUNICATI; THOMSON JLG, 1963, BRIT J RADIOL, V36, P840, DOI 10.1259/0007-1285-36-431-840	11	17	17	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1972	37	2					219	&		10.3171/jns.1972.37.2.0219			0	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	N2351	WOS:A1972N235100015	4558254				2022-02-06	
J	HALLERVORDEN, J; QUADBECK, G				HALLERVORDEN, J; QUADBECK, G			BRAIN CONCUSSION AND ITS EFFECTS ON THE BRAIN	DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT			English	Article																	ALLEGRANZA A, 1950, BIOL LAT, V3, P454; BAY E, 1953, HDB INN MED        3, V5, P373; Bergmann L., 1954, ULTRASCHALL; Bochnik HJ, 1952, FORTSCHR NEUROL P I, V20, P291; BONHOFFER, 1915, ARCH PSYCHIATR, V59, P330; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; BRAUN, 1912, HDB NEUROLOGIE, V3, P46; BROCK, 1949, INJURIES BRAIN SPINA; CAIRNS H, 1952, BRAIN, V75, P109, DOI 10.1093/brain/75.2.109; DEGE, 1920, NEUE DTSCH CHIRURG 1, V18; DEMORSIER G, 1941, SCHWEIZ ARCH NEUROL, V50, P162; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN, 1950, MED PHYS, V2, P127; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; DOW RS, 1945, J NEUROPHYSIOL, V8, P161; DOW RS, 1945, J NEUROSURG, V2, P154, DOI 10.3171/jns.1945.2.2.0154; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; Eck H, 1940, BEITR PATHOL ANAT AL, V104, P390; Freundlich H, 1928, KOLLOID Z, V46, P289, DOI 10.1007/BF01422714; FREUNDLICH H, 1935, THIXOTROPY ACTUALITE; FREUNDLICH H, 1928, Z PHYS CHEM, V131, P284; Frey-Wyssling A., 1948, SUBMICROSCOPIC MORPH; FRIEDE R, 1955, Zentralbl Neurochir, V15, P73; GAMA, 1837, TRAITE PLAIES TETE; GAMPER, 1938, MSCHR PSYCHIATR, V99, P552; GERLACH J, 1953, Z NATURFORSCH B, V8, P578, DOI 10.1515/znb-1953-1006; GROAT R, 1950, J NEUROPATH EXP NEUR, V9, P150, DOI 10.1097/00005072-195004000-00003; Grunthal E, 1930, HDB GEISTESKRANKHEIT, V11, P638; GRUNTHAL E, 1930, HDB GEISTESKRANKH BU, V11, P654; HALLERVORDEN J, 1941, ZBL NEUROCHIR, P37; HELLENTHAL, 1933, DTSCH ZSCHR GERICHTL, V21, P231; HEYCK H, 1952, MSCHR PSYCHIATR, V123, P43; HUG O, 1954, Strahlentherapie, V94, P79; Janzen R, 1949, NERVENARZT, V20, P416; Jung R., 1953, HDB INNEREN MED, P1206, DOI [10.1007/978-3-642-94610-3_11, DOI 10.1007/978-3-642-94610-3_11]; KALBFLEISCH W, 1940, MUNCH MED WSCHR, P769; KATZENSTEIN E, 1950, DTSCH ZSCHR NERVENHK, V164, P259; KNAUER, 1922, J PSYCHOL, V29, P1; KOBCKE H, 1944, SCHADEL HIRN TRAUMA; KOCHER, 1907, HIRNERSCHUTTERUNG HI; KOCHERFERRARI, 1882, CHIRURGISCHE BEITRAG; Larsson LE, 1954, ACTA PSYCH NEUROL SC, V95, P7; LEONHARDT, 1949, MED KLIN; LOEW F, 1950, ZBL NEUROCHIR, P132; Lynn JG, 1944, AM J PATHOL, V20, P637; MARBURG O, 1936, HDB NEUROLOGIE, V11, P1; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; MEYER SJ, 1955, ELECTROENCEPHALOGR C, V7, P511; MEYERMICKELEIT RW, 1953, DEUT MED WOCHENSCHR, P480; MITTELBACH, 1929, BEITR PATH ANAT, V83, P445; NEUBURGER K, 1930, HDB GEISTESKRANKH BU, V11, P321; ORTHNER H, 1955, HDB SPEZ PATHOL ANAT, V13, P543; PETERFI, 1927, ARCH ENTWMECH ORGAN, V112, P660; PETERFI, 1927, ARCH EXPT ZELLFORSCH, V4, P419; Peters G, 1943, ARCH PSYCHIAT NERVEN, V116, P531, DOI 10.1007/BF01873678; PETERS G, 1955, HDB SPEZIELLEN PATHO, V13, P363; PETERS G, 1943, ZBL NEUROCHIR, V8, P112; PETERS G, 1949, STRAHLENTHERAPIE, V79, P653; Peters G, 1949, FORTSCHR NEUROL P I, V17, P85; PRYCEJONES J, 1952, KOLLOID Z Z POLYM, V129, P96, DOI 10.1007/BF01519693; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; QUADBECK G, 1955, Z NATURFORSCH PT B, V10, P328, DOI 10.1515/znb-1955-0608; QUADBECK G, 1955, Z NATURFORSCH PT B, V10, P168, DOI 10.1515/znb-1955-0310; Richards AG, 1943, J CELL COMPAR PHYSL, V21, P129, DOI 10.1002/jcp.1030210206; RIEDERERVONPAAR, 1936, ARCH PSYCHIATR, V106, P71; RUSSELL LB, 1954, J CELL COMPAR PHYSL, V43, pA103, DOI 10.1002/jcp.1030430407; RUSSELL LB, 1952, RADIOLOGY, V58, P369, DOI 10.1148/58.3.369; SCHALTENBRAND, 1934, MED KLIN, V30, P1381; SCHILLER F, 1952, AMA ARCH NEUROL PSY, V67, P199, DOI 10.1001/archneurpsyc.1952.02320140067006; SCHNEIDER J, 1948, KLIN WOCHENSCHR, P43; Shelden CH, 1944, J NEUROSURG, V1, P67, DOI 10.3171/jns.1944.1.1.0067; SPATZ H, 1941, ZBL NEUROCHIR, V6; SPIEGEL EA, 1946, AM J PHYSIOL, V146, P12, DOI 10.1152/ajplegacy.1946.146.1.12; STEINMANN, 1950, ZBL NEUROCHIR, V10, P149; STOECKENIUS W, 1956, Ergeb Anat Entwicklungsgesch, V35, P420; Tonnis W, 1948, NERVENARZT, V19, P201; TONNIS, 1950, LANGENBECKS ARCH DTS, V264, P368; Uber Krauland W., 1950, DTSCH Z NERVENHEILK, V163, P265; von Braunmuhl A, 1932, Z GESAMTE NEUROL PSY, V142, P1; Voss R, 1953, NERVENARZT, V24, P155; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WANKE, 1948, PATHOLOGISCHE PHYSL; WCHNEIDER J, 1951, ARCH PSYCHIATR, V187, P253; WELTE E, 1948, ARCH PSYCHIATR, V79, P243; WELTE E, 1951, ZBL NEUR, V113; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; Witter H, 1952, FORTSCHR NEUROL P I, V20, P270; Zeh W, 1950, FORTSCHR NEUROL P I, V18, P1; [No title captured]; [No title captured]; [No title captured]; [No title captured]	93	17	17	1	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0012-0472	1439-4413		DEUT MED WOCHENSCHR	Dtsch. Med. Wochenschr.		1957	82	4					129	+		10.1055/s-0028-1114649			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WN599	WOS:A1957WN59900001	13404846				2022-02-06	
J	WINDLE, WF; RAMBACH, WA; DEARELLANO, MIRD; GROAT, RA; BECKER, RF				WINDLE, WF; RAMBACH, WA; DEARELLANO, MIRD; GROAT, RA; BECKER, RF			WATER CONTENT OF THE BRAIN AFTER CONCUSSION AND ITS NONCONTRIBUTORY RELATION TO THE HISTOPATHOLOGY OF CONCUSSION	JOURNAL OF NEUROSURGERY			English	Article																	DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; Ferraro A, 1930, J NERV MENT DIS, V71, P129, DOI 10.1097/00005053-193002000-00001; GROAT RA, 1945, SURG GYNECOL OBSTET, V81, P63; KOENIG H, 1945, STAIN TECHNOL, V20, P13, DOI 10.3109/10520294509107124; Paterson JH, 1943, J NEUROL PSYCHIATRY, V6, P87, DOI 10.1136/jnnp.6.3-4.87; Pilcher C, 1937, ARCH SURG-CHICAGO, V35, P512, DOI 10.1001/archsurg.1937.01190150095009; PILCHER C, 1941, SURG GYNECOL OBSTET, V72, P755; Rowntree LG, 1926, J PHARMACOL EXP THER, V29, P135; SNEDECOR GW, 1938, STATISTICAL METHODS, V13; WHITE JC, 1943, ANN SURG, V118, P619; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210; Windle WF, 1943, STAIN TECHNOL, V18, P77, DOI 10.3109/10520294309105794	13	17	17	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1946	3	2					157	164		10.3171/jns.1946.3.2.0157			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YD512	WOS:A1946YD51200006	21018505				2022-02-06	
J	GROAT, RA; RAMBACH, WA; WINDLE, WF				GROAT, RA; RAMBACH, WA; WINDLE, WF			CONCUSSION OF THE SPINAL CORD - AN EXPERIMENTAL STUDY AND A CRITIQUE OF THE USE OF THE TERM	SURGERY GYNECOLOGY & OBSTETRICS			English	Article																	Baldwin RS, 1934, ARCH NEURO PSYCHIATR, V32, P493, DOI 10.1001/archneurpsyc.1934.02250090028002; Brock S., 1943, INJURIES SKULL BRAIN; CASAMAJOR L, 1921, N YORK STATE J M, V21, P99; CLARK FL, 1892, LANCET, V1, P1078; CLAUDE H, 1916, REV MED-PARIS, V35, P535; CLAUDE H, 1915, J ANN MED PAR, V2, P479; CLUTTON, 1891, LANCET, V2, P928; Davison C, 1933, ARCH NEURO PSYCHIATR, V30, P326, DOI 10.1001/archneurpsyc.1933.02240140090004; de Barenne JGD, 1941, J NEUROPHYSIOL, V4, P287, DOI 10.1152/jn.1941.4.4.287; ERICHSEN JE, 1886, CONCUSSION SPINE; Ferraro A, 1927, ARCH NEURO PSYCHIATR, V18, P357, DOI 10.1001/archneurpsyc.1927.02210030037003; FERRARO A, 1922, CERVELLO ANNO, V1, P361; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; Groat RA, 1944, AM J PHYSIOL, V141, P0117, DOI 10.1152/ajplegacy.1944.141.1.117; HARTMANN F, 1900, JB PSYCHIAT NEUROL, V19, P380; Hassin GB, 1925, ARCH NEURO PSYCHIATR, V13, P369, DOI 10.1001/archneurpsyc.1925.02200090083003; Hassin GB, 1923, ARCH NEURO PSYCHIATR, V10, P194, DOI 10.1001/archneurpsyc.1923.02190260055004; Holmes G, 1915, Br Med J, V2, P769; JAKOB A, 1913, HISTOLOGISCHE HISTOP, V5, P182; Kirchgasser G., 1898, DEUT Z NERVENHEILKD, V13, P422; Kirchgasser G., 1897, DTSCH Z NERVENH, V11, P406; KNIGHT G, 1940, WAR WOUNDS INJURIES, P174; KOCH W, 1874, ARCH KLIN CHIR, V17, P190; KOENIG H, 1945, STAIN TECHNOL, V20, P13, DOI 10.3109/10520294509107124; KREMS A. D., 1942, PROC SOC EXP BIOL AND MED, V49, P73; LHERMITTE MJ, 1917, ANN MED PAR, V4, P295; Lloyd DPC, 1941, J NEUROPHYSIOL, V4, P525; MACDOUGALL JA, 1892, LANCET, V1, P863; Mairet A, 1919, REV NEUROL-FRANCE, V35, P97; MARBURG O, 1918, ARCH KLIN CHIR, V111, P71; MARBURG O, 1919, ARBEITEN NEUROL I, V22, P498; Marinesco G., 1918, REV NEUROL, V34, P329; MOTT FW, 1916, T MED SOC LONDON, V39, P157; OBERSTEINER H, 1879, MED JB, V4; OBERSTEINER H, 1879, MED JB, V3, P531; PAGE H, 1885, INJURIES SPINE SPINA; ROUSSY G, 1920, ANN MED, V8, P335; SCHEINKER IM, 1942, J NEUROPATH EXP NEUR, V1, P181; SCHMAUS H, 1890, ARCH PATH ANAT PHYSL, V122, P470; SCHMAUSS H, 1890, ARCH PATH ANAT, V122, P326; SPILLER WG, 1899, AM J M SC, V118, P190; SPILLER WG, 1903, U PENNSYLVANIA M B, V15, P483; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561	44	17	17	0	0	FRANKLIN H MARTIN FOUNDATION	CHICAGO	55 E ERIE ST, CHICAGO, IL 60611	0039-6087			SURG GYNECOL OBSTET	Surg. Gynecol. Obstet.		1945	81	1					63	74					12	Obstetrics & Gynecology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Surgery	UP125	WOS:A1945UP12500007					2022-02-06	
J	DiMaggio, CJ; Bukur, M; Wall, SP; Frangos, SG; Wen, AY				DiMaggio, Charles J.; Bukur, Marko; Wall, Stephen P.; Frangos, Spiros G.; Wen, Andy Y.			Injuries associated with electric-powered bikes and scooters: analysis of US consumer product data	INJURY PREVENTION			English	Article						Bicycle; Descriptive Epidemiology; Epidemiology; Surveys		Background Powered, two-wheeled transportation devices like electric bicycles (E-bikes) and scooters are increasingly popular, but little is known about their relative injury risk compared to pedal operated bicycles. Methods Descriptive and comparative analysis of injury patterns and trends associated with E-bikes, powered scooters and pedal bicycles from 2000 to 2017 using the US National Electronic Injury Surveillance System. Results While persons injured using E-bikes were more likely to suffer internal injuries (17.1%; 95% CI 5.6 to 28.6) and require hospital admission (OR=2.8, 95% CI 1.3 to 6.1), powered scooter injuries were nearly three times more likely to result in a diagnosis of concussion (3% of scooter injuries vs 0.5% of E-bike injuries). E-bike-related injuries were also more than three times more likely to involve a collision with a pedestrian than either pedal bicycles (OR=3.3, 95% CI 0.5 to 23.6) or powered scooters (OR=3.3, 95% CI 0.3 to 32.9), but there was no evidence that powered scooters were more likely than bicycles to be involved in a collision with a pedestrian (OR=1.0, 95% CI 0.3 to 3.1). While population-based rates of pedal bicycle-related injuries have been decreasing, particularly among children, reported E-bike injuries have been increasing dramatically particularly among older persons. Conclusions E-bike and powered scooter use and injury patterns differ from more traditional pedal operated bicycles. Efforts to address injury prevention and control are warranted, and further studies examining demographics and hospital resource utilisation are necessary.	[DiMaggio, Charles J.; Bukur, Marko; Frangos, Spiros G.] NYU Sch Med, NYU Langone Hlth, Dept Surg, New York, NY USA; [DiMaggio, Charles J.; Bukur, Marko; Frangos, Spiros G.] Bellevue Hosptial Ctr, Div Trauma Emergency Gen Surg & Surg Crit Care, New York, NY USA; [Wall, Stephen P.] NYU Sch Med, NYU Langone Hlth, Ronald O Perelman Dept Emergency Med, New York, NY USA; [Wen, Andy Y.] NYU Sch Med, NYU Langone Hlth, Div Crit Care, Dept Pediat, New York, NY USA		DiMaggio, CJ (corresponding author), NYU, Langone Med Ctr, Surg & Populat Hlth, New York, NY 10003 USA.	charles.dimaggio@nyumc.org		DiMaggio, Charles/0000-0003-2356-6659; Frangos, Spiros/0000-0003-2860-8969; Bukur, Marko/0000-0002-1850-7147; Wall, Stephen/0000-0003-3965-5074	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01--HD087460]	This study was funded by National Institute of Child Health and Human Development (Grant number: R01--HD087460).	ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; Ashurst J, 2015, WEST J EMERG MED, V16, P693, DOI 10.5811/westjem.2015.7.26549; Barkho Gabriela, 2019, OBSERVER; Consumer Product Safety Commission, 2001, MOT SCOTT US INCR IN; Consumer Product Safety Commission, 2001, MOT SCOOT US INCR IN; Donnally CJ, 2017, PEDIATR EMERG CARE, V33, P325, DOI 10.1097/PEC.0000000000001120; Dowling R, P 2015 AUSTR ROAD SA; Du W, 2014, INJURY PREV, V20, P128, DOI 10.1136/injuryprev-2012-040618; Epidemiology and Disease Surveillance Unit Epidemiology and Public Health Preparedness Division Austin Public Health, 2019, DOCKL EL SCOTT REL I; Fishman E, 2016, TRANSPORT REV, V36, P92, DOI 10.1080/01441647.2015.1033036; Gojanovic B, 2011, MED SCI SPORT EXER, V43, P2204, DOI 10.1249/MSS.0b013e31821cbdc8; Gristock J, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5192; Heyer JH, 2015, AM J PUBLIC HEALTH, V105, P2131, DOI 10.2105/AJPH.2015.302738; HOPKINS RS, 1989, AM J PREV MED, V5, P104, DOI 10.1016/S0749-3797(18)31112-7; Jimenez D, 2018, STUD HEALTH TECHNOL, V256, P357, DOI 10.3233/978-1-61499-923-2-357; Katcher ML, 1998, PEDIATRICS, V101, P720, DOI 10.1542/peds.101.4.720; Korioth T, AAP NEWS; MacArthur J, 2014, TRANSPORT RES REC, P123, DOI 10.3141/2468-14; Rogers K, HOVERBOARD SAFETY FE; Siman-Tov M, 2017, TRAFFIC INJ PREV, V18, P318, DOI 10.1080/15389588.2016.1246723; Tan AL, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7210-6; United States Consumer Product Safety Commission, NAT EL INJ SURV SYST; United States Consumer Product Safety Commission, NAT EL SURV SYST HIG; Weinert J, 2007, TRANSPORTATION, V34, P301, DOI 10.1007/s11116-007-9118-8; Zhang XJ, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1819, DOI 10.1177/1010539513496840	25	16	16	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	DEC	2020	26	6					524	528		10.1136/injuryprev-2019-043418			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	OY4IN	WOS:000594212000004	31712276				2022-02-06	
J	Manning, V; Garfield, JBB; Staiger, PK; Lubman, DI; Lum, JAG; Reynolds, J; Hall, K; Bonomo, Y; Lloyd-Jones, M; Wiers, RW; Piercy, H; Jacka, D; Verdejo-Garcia, A				Manning, Victoria; Garfield, Joshua B. B.; Staiger, Petra K.; Lubman, Dan I.; Lum, Jarrad A. G.; Reynolds, John; Hall, Kate; Bonomo, Yvonne; Lloyd-Jones, Martyn; Wiers, Reinout W.; Piercy, Hugh; Jacka, David; Verdejo-Garcia, Antonio			Effect of Cognitive Bias Modification on Early Relapse Among Adults Undergoing Inpatient Alcohol Withdrawal Treatment A Randomized Clinical Trial	JAMA PSYCHIATRY			English	Article							ABSTINENT ALCOHOLICS; ACTION-TENDENCIES; DEPENDENCE; IMPAIRMENT; DIAGNOSIS; RECOVERY	IMPORTANCE More than half of patients with alcohol use disorder who receive inpatient withdrawal treatment relapse within weeks of discharge, hampering subsequent uptake and effectiveness of psychological and pharmacologic interventions. Cognitive bias modification (CBM) improves outcomes after alcohol rehabilitation, but the efficacy of delivering CBM during withdrawal treatment has not yet been established. OBJECTIVE To test the hypothesis that CBM would increase the likelihood of abstaining from alcohol during the 2 weeks following discharge from inpatient withdrawal treatment. DESIGN, SETTING, AND PARTICIPANTS In a randomized clinical trial, 950 patients in 4 inpatient withdrawal units in Melbourne, Australia, were screened for eligibility between June 4, 2017, and July 14, 2019, to receive CBM or sham treatment. Patients with moderate or severe alcohol use disorder aged 18 to 65 years who had no neurologic illness or traumatic brain injury were eligible. Two-week follow-up, conducted by researchers blinded to the participant's condition, was the primary end point. Both per-protocol and intention-to-treat analysis were conducted. INTERVENTIONS Randomized to 4 consecutive daily sessions of CBM designed to reduce alcohol approach bias or sham training not designed to modify approach bias. MAIN OUTCOMES AND MEASURES Primary outcome was abstinence assessed using a timeline followback interview. Participants were classified as abstinent (no alcohol use in the first 14 days following discharge) or relapsed (any alcohol use during the first 14 days following discharge or lost to follow-up). RESULTS Of the 950 patients screened for eligibility, 338 did not meet inclusion criteria, 108 were discharged before being approached, and 192 refused. Of the 312 patients who consented (referred sample), 12 withdrew before being randomized. In the final population of 300 randomized patients (CBM, n = 147; sham, n = 153), 248 completed the intervention and 272 completed the follow-up. Of the 300 participants (173 [57.7%] men; mean [SD] age, 43.47 [10.43] years), 7 patients (3 controls, 4 CBM) withdrew after finding the training uncomfortable. Abstinence rates were 42.5% (95% CI, 34.3%-50.6%) in controls and 54.4% (95% CI, 46.0%-62.8%) in CBM participants, yielding an 11.9% (95% CI, 0.04%-23.8%; P = .04) difference in abstinence rates. In a per-protocol analysis including only those who completed 4 sessions of training and the follow-up, the difference in abstinence rate between groups was 17.0% (95% CI, 3.8%-30.2%; P = .008). CONCLUSIONS AND RELEVANCE The findings of this clinical trial support the efficacy of CBM for treatment of alcohol use disorder. Being safe and easy to implement, requiring only a computer and joystick, and needing no specialist staff/training, CBM could be routinely offered as an adjunctive intervention during withdrawal treatment to optimize outcomes.	[Manning, Victoria; Garfield, Joshua B. B.; Lubman, Dan I.; Piercy, Hugh] Monash Univ, Eastern Hlth Clin Sch, Monash Addict Res Ctr, Melbourne, Vic, Australia; [Manning, Victoria; Garfield, Joshua B. B.; Lubman, Dan I.; Piercy, Hugh; Verdejo-Garcia, Antonio] Eastern Hlth, Turning Point, Melbourne, Vic, Australia; [Staiger, Petra K.; Lum, Jarrad A. G.; Hall, Kate] Deakin Univ, Sch Psychol, Geelong, Vic, Australia; [Staiger, Petra K.; Hall, Kate] Deakin Univ, Ctr Drug Use Addict & Antisocial Behav Res, Geelong, Vic, Australia; [Reynolds, John] Monash Univ, Alfred Hlth & Fac Med, Nursing & Hlth Sci, Melbourne, Vic, Australia; [Bonomo, Yvonne; Lloyd-Jones, Martyn] St Vincents Hosp Melbourne, Dept Addict Med, Melbourne, Vic, Australia; [Bonomo, Yvonne] Univ Melbourne, Div Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Wiers, Reinout W.] Univ Amsterdam, Dept Psychol, Addict Dev & Psychopathol Lab, Ctr Urban Mental Hlth, Amsterdam, Netherlands; [Jacka, David] Monash Hlth, Monash Hlth Drug & Alcohol Serv, Melbourne, Vic, Australia; [Verdejo-Garcia, Antonio] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia		Manning, V (corresponding author), Eastern Hlth, Turning Point, 110 Church St, Richmond, Vic 3121, Australia.	victoria.manning@monash.edu	Reynolds, John/D-2591-2013; Garfield, Joshua/P-2436-2019; Wiers, Reinout/AAB-4008-2021; Verdejo-Garcia, Antonio/AAV-1147-2021	Reynolds, John/0000-0002-8825-8625; Garfield, Joshua/0000-0002-5076-6499; Wiers, Reinout/0000-0002-4312-9766; Verdejo-Garcia, Antonio/0000-0001-8874-9339; Piercy, Hugh/0000-0002-0631-9114; Lubman, Dan/0000-0002-6747-1937	NHMRCNational Health and Medical Research Council of Australia [1124604]	This study was funded by grant 1124604 from the NHMRC.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Batra A, 2016, DTSCH ARZTEBL INT, V113, P301, DOI 10.3238/arztebl.2016.0301; Blackwell SE, 2020, LANCET PSYCHIAT, V7, P465, DOI 10.1016/S2215-0366(20)30170-X; Bonomo Y, 2019, J PSYCHOPHARMACOL, V33, P759, DOI 10.1177/0269881119841569; Collins SE, 2009, DRUG ALCOHOL DEPEN, V105, P164, DOI 10.1016/j.drugalcdep.2009.05.023; Connor JP, 2016, LANCET, V387, P988, DOI 10.1016/S0140-6736(15)00122-1; Duka T, 2003, ALCOHOL CLIN EXP RES, V27, P1563, DOI 10.1097/01.ALC.0000090142.11260.D7; Eberl C, 2013, DEV COGN NEUROS-NETH, V4, P38, DOI 10.1016/j.dcn.2012.11.002; First MB., 2015, USERS GUIDE STRUCTUR; Hogarth L, 2020, BEHAV BRAIN RES, V394, DOI 10.1016/j.bbr.2020.112815; Jonas DE, 2014, JAMA-J AM MED ASSOC, V311, P1889, DOI 10.1001/jama.2014.3628; LaPlante DA, 2019, INT GAMBL STUD, V19, P362, DOI 10.1080/14459795.2019.1672768; Loeber S, 2010, ALCOHOL ALCOHOLISM, V45, P541, DOI 10.1093/alcalc/agq065; Loeber S, 2009, ALCOHOL ALCOHOLISM, V44, P372, DOI 10.1093/alcalc/agp030; Lubman DI, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0956-9; Magill M, 2019, J CONSULT CLIN PSYCH, V87, P1093, DOI 10.1037/ccp0000447; Mann K, 1999, ALCOHOL ALCOHOLISM, V34, P567, DOI 10.1093/alcalc/34.4.567; Mann K, 2017, EUR ADDICT RES, V23, P45, DOI 10.1159/000455841; Manning V, 2008, EUR ADDICT RES, V14, P226, DOI 10.1159/000156479; Manning V, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2999-3; Manning V, 2016, ALCOHOL CLIN EXP RES, V40, DOI 10.1111/acer.13163; Napper LE, 2010, ADDICT BEHAV, V35, P350, DOI 10.1016/j.addbeh.2009.12.006; Rinck M, 2018, J CONSULT CLIN PSYCH, V86, P1005, DOI 10.1037/ccp0000321; Simons JS, 2015, ADDICT BEHAV, V50, P205, DOI 10.1016/j.addbeh.2015.06.042; Singh A, 2017, CLIN PSYCHOPHARM NEU, V15, P210, DOI 10.9758/cpn.2017.15.3.210; Slade T, 2016, ALCOHOL CLIN EXP RES, V40, P1728, DOI 10.1111/acer.13134; Smedslund G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008063.pub2; Sobell M. B., 1996, TIMELINE FOLLOWBACK; Stahl SM, 2013, STAHLS ESSENTIAL PSY; STOCKWELL T, 1994, ADDICTION, V89, P167, DOI 10.1111/j.1360-0443.1994.tb00875.x; Verdejo-Garcia A, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00877; Wiers RW, 2009, GENES BRAIN BEHAV, V8, P101, DOI 10.1111/j.1601-183X.2008.00454.x; Wiers RW, 2021, ADDICT BEHAV, V112, DOI 10.1016/j.addbeh.2020.106602; Wiers RW, 2013, CLIN PSYCHOL SCI, V1, P192, DOI 10.1177/2167702612466547; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; World Health Organization, 2018, GLOB STAT REP ALC HL; Yahn SL, 2013, SUBST ABUS-RES TREAT, V7, P1, DOI 10.4137/SART.S9345	37	16	16	3	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-622X	2168-6238		JAMA PSYCHIAT	JAMA Psychiatry	FEB	2021	78	2					133	140		10.1001/jamapsychiatry.2020.3446		NOV 2020	8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	QC6JQ	WOS:000590796900005	33146693	Green Published			2022-02-06	
J	Kieffer, EE; Begonia, MT; Tyson, AM; Rowson, S				Kieffer, Emily E.; Begonia, Mark T.; Tyson, Abigail M.; Rowson, Steve			A Two-Phased Approach to Quantifying Head Impact Sensor Accuracy: In-Laboratory and On-Field Assessments	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Biomechanics; Accelerometer; Wearable devices; Helmet; Data; Linear; Rotational	NATIONAL OPERATING COMMITTEE; HYBRID III; EXPOSURE; ACCELERATIONS; MOUTHGUARD; VALIDATION; KINEMATICS; STANDARDS; CONTACT; DEVICES	Measuring head impacts in sports can further our understanding of brain injury biomechanics and, hopefully, advance concussion diagnostics and prevention. Although there are many head impact sensors available, skepticism on their utility exists over concerns related to measurement error. Previous studies report mixed reliability in head impact sensor measurements, but there is no uniform approach to assessing accuracy, making comparisons between sensors and studies difficult. The objective of this paper is to introduce a two-phased approach to evaluating head impact sensor accuracy. The first phase consists of in-lab impact testing on a dummy headform at varying impact severities under loading conditions representative of each sensor's intended use. We quantify in-lab accuracy by calculating the concordance correlation coefficient (CCC) between a sensor's kinematic measurements and headform reference measurements. For sensors that performed reasonably well in the lab (CCC >= 0.80), we completed a second phase of evaluation on-field. Through video validation of impacts measured by sensors on athletes, we classified each sensor measurement as either true-positive and false-positive impact events and computed positive predictive value (PPV) to summarize real-world accuracy. Eight sensors were tested in phase one, but only four sensors were assessed in phase two. Sensor accuracy varied greatly. CCC from phase one ranged from 0.13 to 0.97, with an average value of 0.72. Overall, the four devices that were implemented on-field had PPV that ranged from 16.3 to 91.2%, with an average value of 60.8%. Performance in-lab was not always indicative of the device's performance on-field. The methods proposed in this paper aim to establish a comprehensive approach to the evaluation of sensors so that users can better interpret data collected from athletes.	[Kieffer, Emily E.; Begonia, Mark T.; Tyson, Abigail M.; Rowson, Steve] Virginia Tech, Biomed Engn & Mech, Blacksburg, VA 24061 USA		Kieffer, EE (corresponding author), Virginia Tech, Biomed Engn & Mech, Blacksburg, VA 24061 USA.	kieffere@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	Lewis Family Foundation	The authors thank the Lewis Family Foundation for funding this work. The authors have no conflicts of interest to disclose.	Bartsch A., 2014, VALIDATION INTELLIGE; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Cecchi NJ, 2020, J SCI MED SPORT, V23, P927, DOI 10.1016/j.jsams.2020.03.008; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2018, AM J SPORT MED, V46, P2253, DOI 10.1177/0363546518777244; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Greenwald R. M, 2003, P AM SOC BIOM ANN M; Hecimovich M, 2018, J SPORTS MED; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kieffer E.E., 2020, USING IN MOUTH SENSO; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Miller LE, 2020, RES SPORTS MED, V28, P55, DOI 10.1080/15438627.2019.1590833; Nevins D, 2018, P I MECH ENG P-J SPO, V232, P242, DOI 10.1177/1754337117739458; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Patton DA, 2020, AM J SPORT MED, V48, P1246, DOI 10.1177/0363546520906406; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rowson S, 2019, ANN BIOMED ENG, V47, P2048, DOI 10.1007/s10439-019-02329-7; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson Steven, 2009, Biomed Sci Instrum, V45, P113; Savino AK, 2020, ANN BIOMED ENG, V48, P2763, DOI 10.1007/s10439-020-02548-3; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Tiernan S, 2019, P I MECH ENG H, V233, P735, DOI 10.1177/0954411919850961; Tierney GJ, 2020, J BIOMECH, V110, DOI 10.1016/j.jbiomech.2020.109969; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Urban J. E, 2013, ANN BIOMED ENG; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhou YJ, 2015, MATER DESIGN, V88, P162, DOI 10.1016/j.matdes.2015.08.120	44	16	16	3	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2613	2625		10.1007/s10439-020-02647-1		OCT 2020	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000577544100001	33051745				2022-02-06	
J	Baugh, CM; Kroshus, E; Lanser, BL; Lindley, TR; Meehan, WP				Baugh, Christine M.; Kroshus, Emily; Lanser, Bailey L.; Lindley, Tory R.; Meehan, William P.			Sports Medicine Staffing Across National Collegiate Athletic Association Division I, II, and III Schools: Evidence for the Medical Model	JOURNAL OF ATHLETIC TRAINING			English	Article						health policy; medical coverage; full-time equivalent; work-life balance; medical autonomy	ORGANIZATIONAL INFRASTRUCTURE; CONCUSSION-MANAGEMENT; PART I; CARE; CONTINUITY; TRAINERS; QUALITY; WORK; ANTECEDENTS; OUTCOMES	Context: The ratio of clinicians to patients has been associated with health outcomes in many medical contexts but has not been explored in collegiate sports medicine. The relationship between administrative and financial oversight models and staffing is also unknown. Objective: To (1) evaluate staffing patterns in National Collegiate Athletic Association sports medicine programs and (2) investigate whether staffing was associated with the division of competition, Power 5 conference status, administrative reporting structure (medical or athletic department), or financial structure (medical or athletic department). Design: Cross-sectional study. Setting: Collegiate sports medicine programs. Patients or Other Participants: Representatives of 325 universities. Main Outcome Measure(s): A telephone survey was conducted during June and July 2015. Participants were asked questions regarding the presence and full-time equivalence of the health care providers on their sports medicine staff. The number of athletes per athletic trainer was determined. Results: Responding sports medicine programs had 0.5 to 20 full-time equivalent staff athletic trainers (median = 4). Staff athletic trainers at participating schools cared for 21 to 525 athletes per clinician (median = 100). Both administrative and financial oversight from a medical department versus the athletics department was associated with improved staffing across multiple metrics. Staffing levels were associated with the division of competition; athletic trainers at Division I schools cared for fewer athletes than athletic trainers at Division II or III schools, on average. The support of graduate assistant and certified intern athletic trainers varied across the sample as did the contributions of nonphysician, nonathletic trainer health care providers. Conclusions: In many health care settings, clinician : patient ratios are associated with patient health outcomes. We found systematic variations in clinician : patient ratios across National Collegiate Athletic Association divisions of competition and across medical versus athletics organizational models, raising the possibility that athletes' health outcomes vary across these contexts. Future researchers should evaluate the relationships between clinician : patient ratios and athletes' access to care, care provision, health care costs, health outcomes, and clinician job satisfaction.	[Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Boston, MA 02115 USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Lanser, Bailey L.] Cleveland Clin Rehabil & Sports Therapy, Cleveland, OH USA; [Lindley, Tory R.] Northwestern Univ, Intercoll Sports Med, Evanston, IL USA; [Meehan, William P.] Boston Childrens Hosp, Sports Concuss Clin, Div Sports Med, Boston, MA USA; [Meehan, William P.] Univ Colorado, Ctr Bioeth & Humanities, Sch Med, Dept Med,Div Gen Internal Med, Aurora, CO 80045 USA		Baugh, CM (corresponding author), Univ Colorado, 13080 East 19th Ave,CB B137, Aurora, CO 80045 USA.	christine.baugh@cuanschutz.edu			National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]	This work was supported by the National Institute of Mental Health Award Number T32MH019733. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We would like to thank the many athletic trainers who volunteered their time to participate in this research project.	Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; [Anonymous], RECOMMENDATIONS AND; Aparicio S, 2015, J ATHL TRAINING, V50, P1277, DOI 10.4085/1062-6050-50.12.04; Ayanian JZ, 2016, NEW ENGL J MED, V375, P205, DOI 10.1056/NEJMp1605101; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Blegen MA, 1998, NURS RES, V47, P43, DOI 10.1097/00006199-199801000-00008; Bradley R, 2015, SPORT J, V18, P14; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Cameron A.C., 2010, MICROECONOMETRICS US, VVolume 2; Christakis DA, 1999, PEDIATRICS, V103, P738, DOI 10.1542/peds.103.4.738; Clarke SP, 2002, AM J PUBLIC HEALTH, V92, P1115, DOI 10.2105/AJPH.92.7.1115; Committee on Competitive Safeguards and Medical Aspects of Sports National Collegiate Athletic Association Sport Science Institute, 2017, INDEPENDENT MEDICAL; Dearinger AT, 2008, J GEN INTERN MED, V23, P937, DOI 10.1007/s11606-008-0654-5; DeFreese JD, 2016, J ATHL TRAINING, V51, P28, DOI 10.4085/1062-6050-51.2.05; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Eason CM, 2017, J ATHL TRAINING, V52, P35, DOI 10.4085/1062-6050-51.12.25; Gallucci AR, 2017, J ATHL TRAINING, V52, P785, DOI 10.4085/1062-6050-52.3.16; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Laursen RM, 2010, ATHLET THER TODAY, V15, P1; Mazerolle SM, 2008, J ATHL TRAINING, V43, P505, DOI 10.4085/1062-6050-43.5.505; Mazerolle SM, 2017, J ATHL TRAINING, V52, P12, DOI 10.4085/1062-6050-51.12.19; Mazerolle SM, 2012, J ATHL TRAINING, V47, P320, DOI 10.4085/1062-6050-47.3.02; Mazerolle SM, 2011, J ATHL TRAINING, V46, P194, DOI 10.4085/1062-6050-46.2.194; Mazerolle SM, 2010, ATHLET THER TODAY, V15, P34, DOI 10.1123/att.15.3.34; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Pierpoint Lauren A, 2018, Inj Epidemiol, V5, P29, DOI 10.1186/s40621-018-0159-6; Rankin J M, 1992, J Athl Train, V27, P344; Rapp GC, 2019, J ATHL TRAINING, V54, P1237, DOI 10.4085/1062-6050-83-19; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285	30	16	16	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUN	2020	55	6					573	579		10.4085/1062-6050-0463-19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	NK4ZE	WOS:000566740300003	32364760	Green Published, gold			2022-02-06	
J	Wade, SL; Gies, LM; Fisher, AP; Moscato, EL; Adlam, AR; Bardoni, A; Corti, C; Limond, J; Modi, AC; Williams, T				Wade, Shari L.; Gies, Lisa M.; Fisher, Allison P.; Moscato, Emily L.; Adlam, Anna R.; Bardoni, Alessandra; Corti, Claudia; Limond, Jennifer; Modi, Avani C.; Williams, Tricia			Telepsychotherapy With Children and Families: Lessons Gleaned From Two Decades of Translational Research	JOURNAL OF PSYCHOTHERAPY INTEGRATION			English	Article						telepsychotherapy; brain injury; problem-solving psychotherapy; parent training interventions; epilepsy	PROBLEM-SOLVING INTERVENTION; PARENTING SKILLS PROGRAM; PRELIMINARY EFFICACY; PSYCHOTHERAPY; ADOLESCENTS; INJURY; TRIAL	The novel coronavirus, COVID-19, has led to sweeping changes in psychological practice and the concomitant rapid uptake of telepsychotherapy. Although telepsychotherapy is new to many clinical psychologists, there is considerable research on telepsychotherapy treatments. Nearly 2 decades of clinical research on telepsychotherapy treatments with children with neurological conditions has the potential to inform emerging clinical practice in the age of COVID-19. Toward that end, we synthesized findings from 14 clinical trials of telepsychotherapy problem-solving and parent-training interventions involving more than 800 children and families with diverse diagnoses, including traumatic brain injury, epilepsy, brain tumors, congenital heart disease, and perinatal stroke. We summarize efficacy across studies and clinical populations and report feasibility and acceptability data from the perspectives of parents, children, and psychotherapists. We describe adaptation for international contexts and strategies for troubleshooting technological challenges and working with families of varying socioeconomic strata. The extensive research literature reviewed and synthesized provides considerable support for the utility of telepsychotherapy with children with neurological conditions and their families and underscores its high level of acceptability with both diverse clinical populations and providers. During this period of heightened vulnerability and stress and reduced access to usual supports and services, telepsychotherapy approaches such as online family problem-solving treatment and online parenting skills training may allow psychologists to deliver traditional evidence-based treatments virtually while preserving fidelity and efficacy.	[Wade, Shari L.; Gies, Lisa M.; Fisher, Allison P.; Moscato, Emily L.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Dept Psychol, Coll Med, Cincinnati, OH 45221 USA; [Wade, Shari L.; Modi, Avani C.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Gies, Lisa M.; Fisher, Allison P.; Moscato, Emily L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Adlam, Anna R.] Univ Exeter, Psychol, Exeter, Devon, England; [Bardoni, Alessandra; Corti, Claudia] Sci Inst IRCCS Eugenio Medea, Neurooncol & Neuropsychol Rehabil Unit, Bosisio Parini, Lecco, Italy; [Limond, Jennifer] Univ Exeter, Dept Psychol, Exeter, Devon, England; [Modi, Avani C.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Williams, Tricia] Hosp Sick Children, Psychol Dept, Toronto, ON, Canada		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Corti, Claudia/AAH-7222-2019	Corti, Claudia/0000-0003-1466-3182; Adlam, Anna/0000-0001-7212-4051; Moscato, Emily/0000-0002-0207-0251; Gies, Lisa/0000-0002-8996-4281; Limond, Jenny/0000-0002-1263-6562; Modi, Avani/0000-0002-7580-3751	Patient Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [DI-2018C3-14566]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HD083335]; National Institute on Disability and Rehabilitation Research Grant [H133B090010]; National Institute for Health Research under Research for Patient Benefit Programme [PB-PG-0614-34081]; Italian Ministry of HealthMinistry of Health, Italy; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HD083335]; Hospital for Sick Children Psychiatry Endowment Fund; Centre for Brain and Mental Health	The contributions of Shari L. Wade to the current article were supported by Patient Centered Outcomes Research Institute Grant DI-2018C3-14566, National Institutes of Health (NIH) Grant R21HD083335, and National Institute on Disability and Rehabilitation Research Grant H133B090010. The contributions of Anna R. Adlam, Jennifer Limond, and Shari L. Wade to the TOPS-UK feasibility study were funded by the National Institute for Health Research under Research for Patient Benefit Programme Grant PB-PG-0614-34081. The contributions of Alessandra Bardoni and Claudia Corti to this work were supported by the Italian Ministry of Health (Ricerca Corrente, 2020). The contributions of Avani C. Modi to the Epilepsy Journey intervention were funded by NIH Grant R21HD083335. The contribution of Tricia Williams was supported by the Hospital for Sick Children Psychiatry Endowment Fund and Centre for Brain and Mental Health. The views presented in this publication are solely the responsibility of the authors and do not necessarily represent the views of the National Institute on Disability and Rehabilitation Research (now NIDILRR), the NIH.	Aguilar JM, 2019, J HEAD TRAUMA REHAB, V34, P65, DOI 10.1097/HTR.0000000000000443; Anderson M, 2019, 10 AM DONT USE INTER; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Backhaus A, 2012, PSYCHOL SERV, V9, P111, DOI 10.1037/a0027924; Corti C, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/1346987; Eyberg S., 1988, CHILD FAMILY BEHAV T, V10, P33, DOI [10.1300/J019v10n01_04, DOI 10.1300/J019V10N01_04]; Fox S, 2013, HLTH ONLINE 2013; Gioia, 2004, BRIEF SR BEHAV RATIN; Gioia GA IP, 2000, BEHAV RATING INVENTO; Jenkins-Guarnieri MA, 2015, TELEMED E-HEALTH, V21, P652, DOI 10.1089/tmj.2014.0165; Joint Task Force Dev Telepsycholog, 2013, AM PSYCHOL, V68, P791, DOI 10.1037/a0035001; Laatsch L, 2020, NEUROPSYCHOL REHABIL, V30, P130, DOI 10.1080/09602011.2019.1678490; Lantagne A, 2018, J PEDIATR PSYCHOL, V43, P703, DOI 10.1093/jpepsy/jsy020; Ledochowski J, 2020, CHILD NEUROPSYCHOL, V26, P691, DOI 10.1080/09297049.2020.1721453; McHutchison C., 2013, THESIS; Modi A. C., 2020, EPILEPSY BEHAV; Modi AC, 2019, EPILEPSIA, V60, P1895, DOI 10.1111/epi.16317; Modi AC, 2017, EPILEPSY BEHAV, V72, P114, DOI 10.1016/j.yebeh.2017.04.009; Moscato EL, 2019, CLIN PRACT PEDIAT PS, V7, P68, DOI 10.1037/cpp0000265; Nelson EL, 2011, CHILD ADOL PSYCH CL, V20, P67, DOI 10.1016/j.chc.2010.08.005; Nelson EL, 2010, J CLIN PSYCHOL, V66, P490, DOI 10.1002/jclp.20682; Nezu A. M., 2006, SOLVING LIFES PROBLE; Osenbach JE, 2013, DEPRESS ANXIETY, V30, P1058, DOI 10.1002/da.22165; Palermo TM, 2016, PAIN, V157, P174, DOI 10.1097/j.pain.0000000000000348; Penate W, 2016, J TELEMED TELECARE, V22, P3, DOI 10.1177/1357633X15586491; RABASCA L, 2000, APA MONITOR PSYCHOL, V31, P28; Raj SP, 2018, J ADOLESC YOUNG ADUL, V7, P187, DOI 10.1089/jayao.2017.0084; Ritterband LM, 2003, PROF PSYCHOL-RES PR, V34, P527, DOI 10.1037/0735-7028.34.5.527; Sloan Denise M., 2011, Cognitive Behaviour Therapy, V40, P111, DOI 10.1080/16506073.2010.550058; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Wade SL, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28043; Wade SL, 2019, J INT NEUROPSYCH SOC, V25, P941, DOI 10.1017/S1355617719000778; Wade SL, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000487; Wade SL, 2019, REHABIL PSYCHOL, V64, P298, DOI 10.1037/rep0000268; Wade SL, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0422; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wade SL, 2011, PROF PSYCHOL-RES PR, V42, P487, DOI 10.1037/a0025222; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Zhang NH, 2019, J NEUROTRAUM, V36, P1147, DOI 10.1089/neu.2018.5885	42	16	17	2	18	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1053-0479			J PSYCHOTHER INTEGR	J. Psychother. Integr.	JUN	2020	30	2			SI		332	347		10.1037/int0000215			16	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	LV6XE	WOS:000538578500013	34295136	Green Accepted, Green Published, Bronze			2022-02-06	
J	Zhang, YL; Zhang, Y; Chopp, M; Zhang, ZG; Mahmood, A; Xiong, Y				Zhang, Yanlu; Zhang, Yi; Chopp, Michael; Zhang, Zheng Gang; Mahmood, Asim; Xiong, Ye			Mesenchymal Stem Cell-Derived Exosomes Improve Functional Recovery in Rats After Traumatic Brain Injury: A Dose-Response and Therapeutic Window Study	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						cell therapy; exosomes; functional outcome; neuroinflammation; neurovascular remodeling; rat; traumatic brain injury	MARROW STROMAL CELLS; NEUROVASCULAR PLASTICITY; STROKE; NEUROGENESIS; BENEFIT; ANGIOGENESIS; IMPAIRMENTS; IMPACT; MODEL	Background. Mesenchymal stem cell (MSC)-derived exosomes play a critical role in regenerative medicine. Objective. To determine the dose- and time-dependent efficacy of exosomes for treatment of traumatic brain injury (TBI). Methods. Male rats were subjected to a unilateral moderate cortical contusion. In the dose-response study, animals received a single intravenous injection of exosomes (50, 100, 200 mu g per rat) or vehicle, with treatment initiated at 1 day after injury. In the therapeutic window study, animals received a single intravenous injection of 100 mu g exosomes or vehicle starting at 1, 4, or 7 days after injury. Neurological functional tests were performed weekly after TBI for 5 weeks. Spatial learning was measured on days 31 to 35 after TBI using the Morris water maze test. Results. Compared with the vehicle, regardless of the dose and delay in treatment, exosome treatment significantly improved sensorimotor and cognitive function, reduced hippocampal neuronal cell loss, promoted angiogenesis and neurogenesis, and reduced neuroinflammation. Exosome treatment at 100 mu g per rat exhibited a significant therapeutic effect compared with the 50- or 200-mu g exosome groups. The time-dependent exosome treatment data demonstrated that exosome treatment starting at 1 day post-TBI provided a significantly greater improvement in functional and histological outcomes than exosome treatments at the other 2 delayed treatments. Conclusions. These results indicate that exosomes have a wide range of effective doses for treatment of TBI with a therapeutic window of at least 7 days postinjury. Exosomes may provide a novel therapeutic intervention in TBI.	[Zhang, Yanlu; Zhang, Yi; Chopp, Michael; Zhang, Zheng Gang; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Detroit, MI USA; [Chopp, Michael] Oakland Univ, Rochester, MI 48063 USA		Xiong, Y (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, E&R Bldg,Room 3096,2799 West Grand Blvd, Detroit, MI 48202 USA.	yxiong1@hfhs.org		Xiong, Ye/0000-0001-9770-6031	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS100710-01A1]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by National Institutes of Health Grant 1R01NS100710-01A1 to YX.	Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Farel Paul B., 2002, Anatomical Record, V269, P157, DOI 10.1002/ar.10111; Gutierrez-Fernandez M, 2018, STROKE, V49; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Kooijmans SAA, 2012, INT J NANOMED, V7, P1525, DOI 10.2147/IJN.S29661; Lai RC, 2013, REGEN MED, V8, P197, DOI [10.2217/RME.13.4, 10.2217/rme.13.4]; Lakshmipathy U, 2008, STEM CELLS, V26, P356, DOI 10.1634/stemcells.2007-0625; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2013, J NEUROSURG, V118, P381, DOI 10.3171/2012.11.JNS12753; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Moore TL, 2019, RESTOR NEUROL NEUROS, V37, P347, DOI 10.3233/RNN-190910; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Singh S, 2011, INT J NEUROSCI, V121, P589, DOI 10.3109/00207454.2011.598981; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Taupin P, 2006, CURR OPIN MOL THER, V8, P225; Tsai MJ, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-5; von Bartheld CS, 2002, HISTOL HISTOPATHOL, V17, P639, DOI 10.14670/HH-17.639; Williams AM, 2020, J TRAUMA ACUTE CARE, V88, P207, DOI [10.109711-A.0000000000002563, 10.1097/TA.0000000000002563]; Williams AM, 2019, J NEUROTRAUM, V36, P54, DOI 10.1089/neu.2018.5711; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xin HQ, 2013, NEUROSCI LETT, V542, P81, DOI 10.1016/j.neulet.2013.02.046; Xin HQ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00377; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang YL, 2013, J NEUROSURG, V118, P1343, DOI 10.3171/2013.3.JNS122061; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015; Zhang ZG, 2019, NAT REV NEUROL, V15, P193, DOI 10.1038/s41582-018-0126-4	54	16	16	3	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUL	2020	34	7					616	626	1545968320926164	10.1177/1545968320926164		MAY 2020	11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ME5FL	WOS:000536642500001	32462980	Bronze, Green Accepted			2022-02-06	
J	Stormann, P; Klug, A; Nau, C; Verboket, RD; Leiblein, M; Muller, D; Schweigkofler, U; Hoffmann, R; Marzi, I; Lustenberger, T				Stoermann, Philipp; Klug, Alexander; Nau, Christoph; Verboket, Rene D.; Leiblein, Max; Mueller, Daniel; Schweigkofler, Uwe; Hoffmann, Reinhard; Marzi, Ingo; Lustenberger, Thomas			Characteristics and Injury Patterns in Electric-Scooter Related Accidents-A Prospective Two-Center Report from Germany	JOURNAL OF CLINICAL MEDICINE			English	Article						electric scooter; e-scooter; dislocation; traffic accident; fracture; traumatic brain injury; transportation		Since the introduction of rental E-scooters in Germany in mid-June 2019, the safety of this new means of transport has been the subject of extensive public debate. However, valid data on injuries and usage habits are not yet available. This retrospective two-center study included a total of 76 patients who presented to the emergency department following E-scooter-related accidents. The mean age was 34.3 +/- 12.4 years and 69.7% of the patients were male. About half of the patients were admitted by ambulance (42.1%). Fractures were found in 48.6% of patients, and 27.6% required surgical treatment due to a fracture. The upper extremities were the most commonly affected body region, followed by injuries to the lower extremity and to the head and face. Only one patient had worn a helmet. In-hospital treatment was necessary for 26.3% of the cases. Patients presented to the emergency department mainly during the weekend and on-call times. This is the first report on E-scooter-related injuries in Germany. Accidents with E-scooters can cause serious injuries and, therefore, represent a further burden to emergency departments. The use of E-scooters appears to be mostly recreational, and the rate of use of protective gear is low.	[Stoermann, Philipp; Nau, Christoph; Verboket, Rene D.; Leiblein, Max; Mueller, Daniel; Marzi, Ingo; Lustenberger, Thomas] Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60590 Frankfurt, Germany; [Klug, Alexander; Schweigkofler, Uwe; Hoffmann, Reinhard] Berufsgenossenschaftl Unfallklin Frankfurt, D-60389 Frankfurt, Germany		Stormann, P (corresponding author), Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60590 Frankfurt, Germany.	philipp.stoermann@kgu.de; alexander.klug@bgu-frankfurt.de; christoph.nau@kgu.de; rene.verboket@kgu.de; maximilian.leiblein@kgu.de; daniel.mueller2@kgu.de; uwe.schweigkofler@bgu-frankfurt.de; aerztlicher.direktor@bgu-frankfurt.de; marzi@trauma.uni-frankfurt.de; tom.lustenberg@gmail.com	Verboket, Rene Danilo/ABA-3870-2020	Verboket, Rene Danilo/0000-0003-1086-4016; Stormann, Philipp/0000-0003-3584-2518; Klug, Alexander/0000-0002-2085-1545			Allem JP, 2019, PREV MED REP, V13, P62, DOI 10.1016/j.pmedr.2018.11.013; Badeau A, 2019, AM J EMERG MED, V37, P1531, DOI 10.1016/j.ajem.2019.05.003; Choron RL, 2019, AM J PUBLIC HEALTH, V109, P555, DOI 10.2105/AJPH.2019.304955; Dhillon N.K., 2020, J AM COLL SURG; Haworth NL, 2019, MED J AUSTRALIA, V211, P412, DOI 10.5694/mja2.50275; Ishmael CR, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.19.00390; Lustenberger T, 2010, J TRAUMA, V69, P924, DOI 10.1097/TA.0b013e3181b9a05a; Mayhew LJ, 2019, J MED IMAG RADIAT ON, V63, P461, DOI 10.1111/1754-9485.12889; Ogawa H, 2011, INJURY, V42, P1241, DOI 10.1016/j.injury.2010.12.004; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Page P.S., 2020, BRIT J NEUROSURG, V46, P1; Schnetzke M, 2018, OBERE EXTREMITAET-SC, V13, P204, DOI 10.1007/s11678-018-0466-0; Scott LR, 2019, BRAIN INJURY, V33, P1597, DOI 10.1080/02699052.2019.1650201; Siracuse BL, 2017, INJURY, V48, P1110, DOI 10.1016/j.injury.2017.03.028; Tominaga GT, 2015, BRAIN INJURY, V29, P1044, DOI 10.3109/02699052.2014.989404; Trivedi B, 2019, J ORAL MAXIL SURG, V77, P2292, DOI 10.1016/j.joms.2019.07.014; Trivedi TK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7381; Zinger ND, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029801	18	16	16	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	MAY	2020	9	5							1569	10.3390/jcm9051569			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY0OO	WOS:000540223800326	32455862	Green Published, gold			2022-02-06	
J	Rodgers, KR; Lin, YF; Langan, TJ; Iwakura, Y; Chou, RC				Rodgers, Kyla R.; Lin, Yufan; Langan, Thomas J.; Iwakura, Yoichiro; Chou, Richard C.			Innate Immune Functions of Astrocytes are Dependent Upon Tumor Necrosis Factor-Alpha	SCIENTIFIC REPORTS			English	Article							TOLL-LIKE RECEPTORS; MAMMALIAN-CELL CULTURES; TNF-ALPHA; SIGNALING PATHWAY; UP-REGULATION; SERUM; NEUROINFLAMMATION; SYNCHRONIZATION; ACTIVATION; ASTROGLIOSIS	Acute inflammation is a key feature of innate immunity that initiates clearance and repair in infected or damaged tissues. Alternatively, chronic inflammation is implicated in numerous disease processes. The contribution of neuroinflammation to the pathogenesis of neurological conditions, including infection, traumatic brain injury, and neurodegenerative diseases, has become increasingly evident. Potential drivers of such neuroinflammation include toll-like receptors (TLRs). TLRs confer a wide array of functions on different cell types in the central nervous system (CNS). Importantly, how TLR activation affects astrocyte functioning is unclear. In the present study, we examined the role of TLR2/4 signaling on various astrocyte functions (i.e., proliferation, pro-inflammatory mediator production, regulatory mechanisms, etc) by stimulating astrocytes with potent exogenous TLR2/4 agonist, bacterial lipopolysaccharide (LPS). Newborn astrocytes were derived from WT, Tnf alpha (-/-), Il1 alpha (-/-)/Il1 beta (-/-), and Tlr2(-/-)/Tlr4(-/-) mice as well as Sprague Dawley rats for all in vitro studies. LPS activated mRNA expression of different pro-inflammatory cytokines and chemokines in time- and concentration-dependent manners, and upregulated the proliferation of astrocytes based on increased H-3-thymidine update. Following LPS-mediated TLR2/4 activation, TNF-alpha and IL-1 beta self-regulated and modulated the expression of pro-inflammatory cytokines and chemokines. Polyclonal antibodies against TNF-alpha suppressed TLR2/4-mediated upregulation of astrocyte proliferation, supporting an autocrine/paracrine role of TNF-alpha on astrocyte proliferation. Astrocytes perform classical innate immune functions, which contradict the current paradigm that microglia are the main immune effector cells of the CNS. TNF-alpha plays a pivotal role in the LPS-upregulated astrocyte activation and proliferation, supporting their critical roles in in CNS pathogenesis.	[Rodgers, Kyla R.; Lin, Yufan; Chou, Richard C.] Dartmouth Coll, Dept Med, Geisel Sch Med Dartmouth, One Med Ctr Dr, Lebanon, NH 03756 USA; [Langan, Thomas J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Buffalo, NY 14203 USA; [Langan, Thomas J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY 14203 USA; [Langan, Thomas J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Physiol & Biophys, Buffalo, NY 14203 USA; [Langan, Thomas J.] New York State Ctr Excellence Bioinformat & Life, Hunter James Kelly Res Inst, New York, NY 14203 USA; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, 2669 Yamazaki, Chiba 2780022, Japan		Chou, RC (corresponding author), Dartmouth Coll, Dept Med, Geisel Sch Med Dartmouth, One Med Ctr Dr, Lebanon, NH 03756 USA.	richou@buffalo.edu	Rodgers, Kyla/AAR-8045-2021; iwakura, yoichiro/E-5457-2011	iwakura, yoichiro/0000-0002-9934-5775; Rodgers, Kyla/0000-0002-5844-1971			Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; Bowman CC, 2003, GLIA, V43, P281, DOI 10.1002/glia.10256; Bsibsi M, 2012, J NEUROSCI RES, V90, P388, DOI 10.1002/jnr.22767; Chou RC, 2003, BRAIN RES PROTOC, V11, P162, DOI 10.1016/S1385-299X(03)00043-6; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Costello DA, 2015, BRAIN BEHAV IMMUN, V46, P70, DOI 10.1016/j.bbi.2015.01.005; Cunningham C, 2019, NEUROSCIENTIST, V25, P455, DOI 10.1177/1073858418809941; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; Dobbs RJ, 1999, ACTA NEUROL SCAND, V100, P34, DOI 10.1111/j.1600-0404.1999.tb00721.x; Du SH, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00409; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; ESKANDARI MK, 1990, IMMUNOL INVEST, V19, P69, DOI 10.3109/08820139009042026; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; Facci L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06824; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; GLASS JD, 1993, NEUROLOGY, V43, P2230, DOI 10.1212/WNL.43.11.2230; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Habbas S, 2015, CELL, V163, P1730, DOI 10.1016/j.cell.2015.11.023; Hennessy E, 2017, BRAIN BEHAV IMMUN, V59, P233, DOI 10.1016/j.bbi.2016.09.011; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Howe CL, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1015-2; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P59, DOI 10.5607/en.2013.22.2.59; Jiang HS, 2018, CELL MOL NEUROBIOL, V38, P1009, DOI 10.1007/s10571-017-0570-5; Kang YM, 2018, ONCOL LETT, V15, P9647, DOI 10.3892/ol.2018.8586; Kery R, 2020, NEURAL REGEN RES, V15, P199, DOI 10.4103/1673-5374.265541; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; KNISS DA, 1988, BRAIN RES, V439, P281, DOI 10.1016/0006-8993(88)91485-0; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Langan TJ, 2017, METHODS MOL BIOL, V1524, P97, DOI 10.1007/978-1-4939-6603-5_6; Langan TJ, 2011, METHODS MOL BIOL, V761, P75, DOI 10.1007/978-1-61779-182-6_5; LANGAN TJ, 1992, BRAIN RES, V577, P200, DOI 10.1016/0006-8993(92)90275-E; LANGAN TJ, 1987, J NEUROCHEM, V49, P513, DOI 10.1111/j.1471-4159.1987.tb02894.x; Lee CY, 2003, NEUROL RES, V25, P767, DOI 10.1179/016164103101202156; Lee WJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19807-y; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu HY, 2013, J NEUROSCI, V33, P11479, DOI 10.1523/JNEUROSCI.5566-12.2013; Lund BT, 2004, J NEUROIMMUNOL, V155, P161, DOI 10.1016/j.jneuroim.2004.06.008; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Nicotra L, 2012, EXP NEUROL, V234, P316, DOI 10.1016/j.expneurol.2011.09.038; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Palani Chithra Devi, 2018, Oncotarget, V9, P6814, DOI 10.18632/oncotarget.23784; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; Rezai-Zadeh K, 2009, J NEUROIMMUNE PHARM, V4, P462, DOI 10.1007/s11481-009-9166-2; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Ryu JK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0339-z; Shah A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-96; Skaper SD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00072; Tarassishin L, 2014, GLIA, V62, P999, DOI 10.1002/glia.22657; Tarkowski E, 1999, J CLIN IMMUNOL, V19, P223, DOI 10.1023/A:1020568013953; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Verney Aurelie, 2018, Oncotarget, V9, P23589, DOI 10.18632/oncotarget.25283; Wang S, 2018, J MOL NEUROSCI, V64, P363, DOI 10.1007/s12031-018-1032-3; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Zhang GY, 2017, MOL MED REP, V16, P4620, DOI 10.3892/mmr.2017.7142; Zhu Yanan, 2017, Alzheimers Dement (Amst), V7, P41, DOI 10.1016/j.dadm.2017.01.001; Zwijnenburg PJG, 2006, INFECT IMMUN, V74, P1445, DOI 10.1128/IAI.74.3.1445-1451.2006	63	16	16	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 27	2020	10	1							7047	10.1038/s41598-020-63766-2			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LK2ZT	WOS:000530731300021	32341377	Green Published, gold			2022-02-06	
J	Gruen, DS; Brown, JB; Guyette, FX; Vodovotz, Y; Johansson, PI; Stensballe, J; Barclay, DA; Yin, JL; Daley, BJ; Miller, RS; Harbrecht, BG; Claridge, JA; Phelan, HA; Neal, MD; Zuckerbraun, BS; Billiar, TR; Sperry, JL				Gruen, Danielle S.; Brown, Joshua B.; Guyette, Francis X.; Vodovotz, Yoram; Johansson, Par, I; Stensballe, Jakob; Barclay, Derek A.; Yin, Jinling; Daley, Brian J.; Miller, Richard S.; Harbrecht, Brian G.; Claridge, Jeffrey A.; Phelan, Herb A.; Neal, Matthew D.; Zuckerbraun, Brian S.; Billiar, Timothy R.; Sperry, Jason L.			Prehospital plasma is associated with distinct biomarker expression following injury	JCI INSIGHT			English	Article							ORGAN DYSFUNCTION; SYMPATHOADRENAL ACTIVATION; ENDOTHELIAL DAMAGE; HEMORRHAGIC-SHOCK; TRAUMA; TRANSFUSION; COAGULOPATHY; MORTALITY; BARRIER; RESTORATION	BACKGROUND. Prehospital plasma improves survival in severely injured patients transported by air ambulance. We hypothesized that prehospital plasma would be associated with a reduction in immune imbalance and endothelial damage. METHODS. We sampled blood from 405 trauma patients enrolled in the Prehospital Air Medical Plasma (PAMPer) trial upon hospital admission (0 hours) and 24 hours post admission across 6 U.S. sites. We assayed samples for 21 inflammatory mediators and 7 markers associated with endothelial function and damage. We performed hierarchical clustering analysis (MCA) of these biomarkers of the immune response and endothelial injury. Regression analysis was used to control for differences across study and to assess any association with prehospital plasma resuscitation. RESULTS. FICA distinguished two patient clusters with different injury patterns and outcomes. Patients in cluster A had greater injury severity and incidence of blunt trauma, traumatic brain injury, and mortality. Cluster A patients that received prehospital plasma showed improved 30-day survival. Prehospital plasma did not improve survival in cluster B patients. In an adjusted analysis of the most seriously injured patients, prehospital plasma was associated with an increase in adiponectin, IL-1 beta, IL-17A, IL-23, and IL-17E upon admission, and a reduction in syndecan-1, TM, VEGF, IL-6, IP-10, MCP-1, and TNF-alpha, and an increase in IL-33, IL-21,IL-23, and IL-17E 24 hours later. CONCLUSION. Prehospital plasma may ameliorate immune dysfunction and the endotheliopathy of trauma. These effects of plasma may contribute to improved survival in injured patients.	[Gruen, Danielle S.; Brown, Joshua B.; Vodovotz, Yoram; Barclay, Derek A.; Yin, Jinling; Neal, Matthew D.; Zuckerbraun, Brian S.; Billiar, Timothy R.; Sperry, Jason L.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Gruen, Danielle S.; Brown, Joshua B.; Vodovotz, Yoram; Barclay, Derek A.; Yin, Jinling; Neal, Matthew D.; Zuckerbraun, Brian S.; Billiar, Timothy R.; Sperry, Jason L.] Pittsburgh Trauma Res Ctr, Div Trauma & Acute Care Surg, Pittsburgh, PA USA; [Guyette, Francis X.] Univ Pittsburgh, McGowan Inst Regenerat Med, Dept Emergency Med, Pittsburgh, PA USA; [Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA USA; [Johansson, Par, I] Copenhagen Univ Hosp, Rigshosp, Capital Reg Blood Bank, Copenhagen, Denmark; [Stensballe, Jakob] Copenhagen Univ Hosp, Rigshosp, Sect Transfus Med, Capital Reg Blood Bank, Copenhagen, Denmark; [Stensballe, Jakob] Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Dept Anesthesia, Copenhagen, Denmark; [Stensballe, Jakob] Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Trauma Ctr, Copenhagen, Denmark; [Stensballe, Jakob] Capital Reg Denmark, Emergency Med Serv, Hillerod, Denmark; [Daley, Brian J.] Univ Tennessee, Dept Surg, Hlth Sci Ctr, Knoxville, TN USA; [Miller, Richard S.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA; [Harbrecht, Brian G.] Univ Louisville, Dept Surg, Louisville, KY 40292 USA; [Claridge, Jeffrey A.] Case Western Reserve Univ, MetroHlth Med Ctr, Cleveland, OH USA; [Phelan, Herb A.] Univ Texas Southwestern, Dept Surg, Dallas, TX USA; [Sperry, Jason L.] Univ Pittsburgh, Dept Crit Care, Pittsburgh, PA USA		Sperry, JL (corresponding author), UPMC Presbyterian, Suite F-1268,200 Lothrop St, Pittsburgh, PA 15213 USA.	sperryjl@upmc.edu		Daley, Brian/0000-0002-4996-1502; Brown, Joshua/0000-0002-6936-035X; Gruen, Danielle/0000-0003-1019-4390; Johansson, Par Ingemar/0000-0001-9778-5964	NIH T32 Ruth L. Kirschstein Service FellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-2-0023]; NIH R35; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R35GM119526-01]; Office of the Assistant Secretary of Defense for Health Affairs, through the Defense Medical Research and Development Program [W81XWH-18-2-0051, W81XWH-15-PRORP-OCRCA]; Department of DefenseUnited States Department of Defense; University of PittsburghUniversity of Pittsburgh	DSG was supported by a NIH T32 Ruth L. Kirschstein Service Fellowship. The PAMPer study was supported by a grant (W81XWH-12-2-0023) from the US Army Medical Research and Materiel Command. YV and TRB are cofounders of and stakeholders in Immunetrics Inc. TRB was funded by a grant from the NIH R35. MDN is supported by 1R35GM119526-01 from the NIH. This work was also supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Defense Medical Research and Development Program under Award No. W81XWH-18-2-0051 and W81XWH-15-PRORP-OCRCA to TRB and YV. Opinions, interpretations, conclusions, and recommendations are those of the authors and not necessarily endorsed by the Department of Defense. The authors acknowledge all PAMPer study collaborators, prehospital providers, site personnel, and research staff (including MACRO) for enabling the collection of this data. JLS reports grants from Department of Defense. DSG reports grants from NIH. YV reports grants from the Department of Defense. BGH reports grants from Department of Defense and from University of Pittsburgh. MDN reports grants from NIH 1R35GM119526-01. See Supplemental Acknowledgments for consortium details.	Abboud A, 2016, CRIT CARE MED, V44, pE1074, DOI 10.1097/CCM.0000000000001951; Barelli S, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00091; Billiar IM, 2019, J SURG RES, V244, P23, DOI 10.1016/j.jss.2019.05.057; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brown JB, 2015, PREHOSP EMERG CARE, V19, P343, DOI 10.3109/10903127.2014.995851; Chang R, 2018, SHOCK, V49, P53, DOI 10.1097/SHK.0000000000000918; Charrad M, 2014, J STAT SOFTW, V61, P1; Deng XY, 2016, SHOCK, V45, P50, DOI 10.1097/SHK.0000000000000458; Diebel LN, 2018, J TRAUMA ACUTE CARE, V84, P575, DOI 10.1097/TA.0000000000001791; Etchill EW, 2017, CRIT CARE MED, V45, P1311, DOI 10.1097/CCM.0000000000002498; Gaski GE, 2019, J ORTHOP TRAUMA, V33, P220, DOI 10.1097/BOT.0000000000001437; Halbgebauer R, 2018, J CRIT CARE, V44, P229, DOI 10.1016/j.jcrc.2017.11.025; Haupt TH, 2012, CRIT CARE, V16, DOI 10.1186/cc11434; Hazeldine J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002338; He WL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01310; Hippensteel JA, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2534-2; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2015, PREHOSP EMERG CARE, V19, P1, DOI 10.3109/10903127.2014.923077; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Johansson PI, 2012, J THROMB HAEMOST, V10, P207, DOI 10.1111/j.1538-7836.2011.04589.x; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; Johansson PI, 2014, J CRIT CARE, V29, P327, DOI 10.1016/j.jcrc.2013.10.028; Johansson P, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1605-5; Kassambara A., Survminer: Drawing Survival Curves Using 'ggplot2'; Kornblith LZ, 2019, J THROMB HAEMOST, V17, P852, DOI 10.1111/jth.14450; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Lamparello AJ, 2019, J AM COLL SURGEONS, V228, P148, DOI 10.1016/j.jamcollsurg.2018.10.019; Milford EM, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2369-x; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Mira JC, 2017, CRIT CARE MED, V45, P1989, DOI 10.1097/CCM.0000000000002697; Moore HB, 2018, LANCET, V392, P283, DOI 10.1016/S0140-6736(18)31553-8; Namas RA, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.72; Namas RA, 2016, J CRIT CARE, V36, P146, DOI 10.1016/j.jcrc.2016.07.002; Namas RA, 2016, ANN SURG, V263, P191, DOI 10.1097/SLA.0000000000001001; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Naumann DN, 2018, SHOCK, V49, P420, DOI 10.1097/SHK.0000000000000999; Naumann DN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189870; Pappu R, 2012, TRENDS IMMUNOL, V33, P343, DOI 10.1016/j.it.2012.02.008; Pati S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192363; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; Pusateri AE, 2019, TRANSFUSION, V59, P1587, DOI 10.1111/trf.15261; Reitz KM, 2020, J TRAUMA ACUTE CARE, V88, P33, DOI 10.1097/TA.0000000000002485; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Russell RT, 2018, SHOCK, V49, P44, DOI 10.1097/SHK.0000000000000902; Seymour CW, 2019, JAMA-J AM MED ASSOC, V321, P2003, DOI 10.1001/jama.2019.5791; Shackelford SA, 2017, JAMA-J AM MED ASSOC, V318, P1581, DOI 10.1001/jama.2017.15097; Shankar-Hari M, 2019, INTENS CARE MED, V45, P516, DOI 10.1007/s00134-018-5480-6; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Wei SY, 2018, J AM COLL SURGEONS, V227, P587, DOI 10.1016/j.jamcollsurg.2018.09.003; Xu J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002365; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang	52	16	16	0	1	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA		2379-3708		JCI INSIGHT	JCI Insight	APR 23	2020	5	8							e135350	10.1172/jci.insight.135350			17	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	LG8HZ	WOS:000528336200015	32229722	Green Published, gold			2022-02-06	
J	Zhao, W; Ji, SB				Zhao, Wei; Ji, Songbai			Displacement- and Strain-Based Discrimination of Head Injury Models across a Wide Range of Blunt Conditions	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Traumatic brain injury; Model validation; Anisotropy; Head impact; Worcester Head Injury Model	BRAIN DEFORMATION; ATLAS; PREDICTION	Successful validation of a head injury model is critical to ensure its biofidelity. However, there is an ongoing debate on what experimental data are suitable for model validation. Here, we report that CORrelation and Analysis (CORA) scores based on the commonly adopted relative brain-skull displacements or recent marker-based strains from cadaveric head impacts may not be effective in discriminating model-simulated whole-brain strains across a wide range of blunt conditions. We used three versions of the Worcester Head Injury Model (WHIM; isotropic and anisotropic WHIM V1.0, and anisotropic WHIM V1.5) to simulate 19 experiments, including eight high-rate cadaveric impacts, seven mid-rate cadaveric pure rotations simulating impacts in contact sports, and four in vivo head rotation/extension tests. All WHIMs achieved similar average CORA scores based on cadaveric displacement (similar to 0.70; 0.47-0.88) and strain (V1.0: 0.86; 0.73-0.97 vs. V1.5: 0.78; 0.62-0.96), using the recommended settings. However, WHIM V1.5 produced similar to 1.17-2.69 times strain of the two V1.0 variants with substantial differences in strain distribution as well (Pearson correlation of similar to 0.57-0.92) when comparing their whole-brain strains across the range of blunt conditions. Importantly, their strain magnitude differences were similar to that in cadaveric marker-based strain (similar to 1.32-3.79 times). This suggests that cadaveric strains are capable of discriminating head injury models for their simulated whole-brain strains (e.g., by using CORA magnitude sub-rating alone or peak strain magnitude ratio), although the aggregated CORA may not. This study may provide fresh insight into head injury model validation and the harmonization of simulation results from diverse head injury models. It may also facilitate future experimental designs to improve model validation.	[Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, 100 Inst Rd, Worcester, MA 01609 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA.	sji@wpi.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Ji, Songbai/0000-0002-2886-5781	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853]	Funding is provided by the NIH Grant R01 NS092853.	Abaqus A, 2016, ABAQUS ONLINE DOCUME; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; [Anonymous], 9790 ISOTR; Atsumi N, 2018, ANN BIOMED ENG, V46, P736, DOI 10.1007/s10439-018-1988-8; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Cai YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197992; Chan DD, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040230; Donnelly BR, 1983, STAPP CAR CRASH J, P299; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Forte AE, 2017, BIOMECH MODEL MECHAN, V16, P907, DOI 10.1007/s10237-016-0860-8; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Guettler A., 2017, QUANTIFYING RESPONSE; Guettler A. J, 2018, SAE TECHNICAL PAPER, DOI [10.4271/2018-01-0547, DOI 10.4271/2018-01-0547]; Hardy W, 2007, THESIS; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; King A. I., 2003, 2003 IRCOBI C LISB, V12; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Lu Y.-C., 2019, ANN BIOMED ENG; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Miller LE, 2017, COMPUT METHOD BIOMEC, V5842, P1; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Peden M., 2004, TECHNICAL REPORT; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Scott GG, 2016, BIOMECH MODEL MECHAN, V15, P1101, DOI 10.1007/s10237-015-0747-0; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Stemper BD, 2018, ANN BIOMED ENG; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Wu SJ, 2020, BIOMECH MODEL MECHAN, V19, P927, DOI 10.1007/s10237-019-01261-y; Wu SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53551-1; Wu T, 2019, ANN BIOMED ENG; Yang King H, 2006, Stapp Car Crash J, V50, P429; Yang KH, 2019, BIOL MED PHYS BIOMED, P97, DOI 10.1007/978-3-030-04996-6_5; Zhang L, 2011, MATH MODELING DIFFUS; Zhao W, 2019, ANN BIOMED ENG, V47, P475, DOI 10.1007/s10439-018-02159-z; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; ZHOU Z, 2018, STAPP CAR CRASH J, V62, P1; Zhou Z, 2018, BIOMECH MODEL MECHAN; Zhou Zhou, 2019, Stapp Car Crash J, V63, P1; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	62	16	16	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JUN	2020	48	6					1661	1677		10.1007/s10439-020-02496-y		APR 2020	17	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	LW4EV	WOS:000523379400002	32240424	Green Accepted			2022-02-06	
J	Emery, C; Palacios-Derflingher, L; Black, AM; Eliason, P; Krolikowski, M; Spencer, N; Kozak, S; Schneider, KJ; Babul, S; Mrazik, M; Lebrun, CM; Goulet, C; Macpherson, A; Hagel, BE				Emery, Carolyn; Palacios-Derflingher, Luz; Black, Amanda Marie; Eliason, Paul; Krolikowski, Maciek; Spencer, Nicole; Kozak, Stacy; Schneider, Kathryn J.; Babul, Shelina; Mrazik, Martin; Lebrun, Constance M.; Goulet, Claude; Macpherson, Alison; Hagel, Brent E.			Does disallowing body checking in non-elite 13-to 14-year-old ice hockey leagues reduce rates of injury and concussion? A cohort study in two Canadian provinces	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						injury; injury prevention; concussion; adolescent; ice hockey	SPORT PARTICIPATION; CONSENSUS STATEMENT; PHYSICAL-ACTIVITY; RISK-FACTORS; YOUTH; SCHOOL; EPIDEMIOLOGY; RECOVERY; POLICY	Objective To compare rates of injury and concussion among non-elite (lowest 60% by division of play) Bantam (ages 13-14 years) ice hockey leagues that disallow body checking to non-elite Bantam leagues that allow body checking. Methods In this 2-year cohort study, Bantam non-elite ice hockey players were recruited from leagues where policy allowed body checking in games (Calgary/Edmonton 2014-2015, Edmonton 2015-2016) and where policy disallowed body checking (Kelowna/Vancouver 2014-2015, Calgary 2015-2016). All ice hockey game-related injuries resulting in medical attention, inability to complete a session and/or time loss from hockey were identified using valid injury surveillance methodology. Any player suspected of having concussion was referred to a study physician for diagnosis and management. Results 49 body checking (608 players) and 33 non-body checking teams (396 players) participated. There were 129 injuries (incidence rate (IR)=7.98/1000hours) and 54 concussions (IR=3.34/1000hours) in the body checking teams in games. After policy change, there were 31 injuries (IR=3.66/1000hours) and 17 concussions (IR=2.01/1000hours) in games. Policy disallowing body checking was associated with a lower rate of all injury (adjusted incidence rate ratio (IRR)=0.44; 95% CI: 0.27 to 0.74). The point estimate showed a lower rate of concussion (adjusted IRR=0.6; 95% CI: 0.31 to 1.18), but this was not statistically significant. Conclusion Policy change disallowing body checking in non-elite Bantam ice hockey resulted in a 56% lower rate of injury. There is growing evidence that disallowing body checking in youth ice hockey is associated with fewer injuries.	[Emery, Carolyn; Palacios-Derflingher, Luz; Black, Amanda Marie; Eliason, Paul; Krolikowski, Maciek; Spencer, Nicole; Kozak, Stacy; Schneider, Kathryn J.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Emery, Carolyn; Palacios-Derflingher, Luz] Univ Calgary, Cumming Sch Med, Community Hlth Sci, Calgary, AB, Canada; [Babul, Shelina] Univ British Columbia, Fac Med, Vancouver, AB, Canada; [Mrazik, Martin] Univ Alberta, Dept Educ Psychol, Fac Educ, Edmonton, AB, Canada; [Lebrun, Constance M.] Univ Alberta, Fac Med & Dent, Dept Family Med, Edmonton, AB, Canada; [Goulet, Claude] Laval Univ, Dept Phys Educ, Quebec City, PQ, Canada; [Macpherson, Alison] York Univ, Fac Hlth, Toronto, ON, Canada; [Hagel, Brent E.] Univ Calgary, Dept Paediat, Cumming Scjhool Med, Calgary, AB, Canada		Emery, C (corresponding author), Univ Calgary, Kinesiol, Calgary, AB T2N 1N4, Canada.	caemery@ucalgary.ca	Eliason, Paul/ABC-7702-2021; Black, Amanda/O-7675-2017	Babul, Shelina/0000-0002-0227-2574; Emery, Carolyn Ann/0000-0002-9499-6691; Black, Amanda/0000-0001-5668-9706; Schneider, Kathryn/0000-0002-5951-5899	Alberta Innovates Health Solutions (Collaborative Research and Innovation Opportunities Program) [3685]; Canadian Institutes of Health Research (Institute of Neuroscience, Mental Health and Addictions)Canadian Institutes of Health Research (CIHR) [293332]; Hotchkiss Brain Institute (University of Calgary)	This study was funded by Alberta Innovates Health Solutions (Collaborative Research and Innovation Opportunities Program Grant #3685), the Canadian Institutes of Health Research (Institute of Neuroscience, Mental Health and Addictions Grant #293332) and the Hotchkiss Brain Institute (University of Calgary).	Annual Report 2015-2016, 2016, ANN REP 2015 2016; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Fox CK, 2010, J SCHOOL HEALTH, V80, P31, DOI 10.1111/j.1746-1561.2009.00454.x; Fridman L, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-30; Fuller CW, 2006, CLIN J SPORT MED, V16, P97, DOI 10.1097/00042752-200603000-00003; Hockey Canada, TEACH CHECK BOD CHEC; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Kang J, 2014, INJURY PREV, V20, P177, DOI 10.1136/injuryprev-2012-040537; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Lacny S, 2014, BRIT J SPORT MED, V48, P1299, DOI 10.1136/bjsports-2014-093493; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mckay CD, 2014, CAN J PUBLIC HEALTH, V105, pE445, DOI 10.17269/cjph.105.4653; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; R Development Core Team, 2012, R LANG ENV STAT COMP; Slutzky CB, 2009, PSYCHOL SPORT EXERC, V10, P381, DOI 10.1016/j.psychsport.2008.09.006; Stata Statistical Software (computer software) [program], 2005, STAT STAT SOFTW COMP; Taliaferro LA, 2008, J SCHOOL HEALTH, V78, P545, DOI 10.1111/j.1746-1561.2008.00342.x; Turcotte K., 2013, CONCUSSION CHILDREN	31	16	16	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	APR	2020	54	7					414	+		10.1136/bjsports-2019-101092			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	LB2ZI	WOS:000524506500009	31492676	Bronze			2022-02-06	
J	Mondello, S; Guedes, VA; Lai, C; Czeiter, E; Amrein, K; Kobeissy, F; Mechref, Y; Jeromin, A; Mithani, S; Martin, C; Wagner, CL; Czigler, A; Toth, L; Fazekas, B; Buki, A; Gill, J				Mondello, Stefania; Guedes, Vivian A.; Lai, Chen; Czeiter, Endre; Amrein, Krisztina; Kobeissy, Firas; Mechref, Yehia; Jeromin, Andreas; Mithani, Sara; Martin, Carina; Wagner, Chelsea L.; Czigler, Andras; Toth, Luca; Fazekas, Balint; Buki, Andras; Gill, Jessica			Circulating Brain Injury Exosomal Proteins following Moderate-to-Severe Traumatic Brain Injury: Temporal Profile, Outcome Prediction and Therapy Implications	CELLS			English	Article						traumatic brain injury; biomarkers; exosomes; exosomal protein; serum; GFAP; UCH-L1; t-tau; NFL	BIOMARKERS; VALIDATION; MANAGEMENT; PROGNOSIS; MORTALITY; IMPROVE; IMPACT; CARE	Brain injury exosomal proteins are promising blood biomarker candidates in traumatic brain injury (TBI). A better understanding of their role in the diagnosis, characterization, and management of TBI is essential for upcoming clinical implementation. In the current investigation, we aimed to explore longitudinal trajectories of brain injury exosomal proteins in blood of patients with moderate-to-severe TBI, and to evaluate the relation with the free-circulating counterpart and patient imaging and clinical parameters. Exosomal levels of glial (glial fibrillary acidic protein (GFAP)) and neuronal/axonal (ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), neurofilament light chain (NFL), and total-tau (t-tau)) proteins were measured in serum of 21 patients for up 5 days after injury using single molecule array (Simoa) technology. Group-based trajectory analysis was used to generate distinct temporal exosomal biomarker profiles. We found altered profiles of serum brain injury exosomal proteins following injury. The dynamics and levels of exosomal and related free-circulating markers, although correlated, showed differences. Patients with diffuse injury displayed higher acute exosomal NFL and GFAP concentrations in serum than those with focal lesions. Exosomal UCH-L1 profile characterized by acutely elevated values and a secondary steep rise was associated with early mortality (n = 2) with a sensitivity and specificity of 100%. Serum brain injury exosomal proteins yielded important diagnostic and prognostic information and represent a novel means to unveil underlying pathophysiology in patients with moderate-to-severe TBI. Our findings support their utility as potential tools to improve patient phenotyping in clinical practice and therapeutic trials.	[Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, I-98125 Messina, Italy; [Mondello, Stefania] Oasi Res Inst IRCCS, I-94018 Troina, Italy; [Guedes, Vivian A.; Lai, Chen; Mithani, Sara; Martin, Carina; Wagner, Chelsea L.; Buki, Andras; Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA; [Czeiter, Endre; Amrein, Krisztina; Czigler, Andras; Toth, Luca; Fazekas, Balint; Buki, Andras] Univ Pecs, Dept Neurosurg, H-7623 Pecs, Hungary; [Czeiter, Endre; Amrein, Krisztina; Czigler, Andras; Toth, Luca; Fazekas, Balint; Buki, Andras] Janos Szentagothai Res Ctr, H-7624 Pecs, Hungary; [Czeiter, Endre; Amrein, Krisztina; Czigler, Andras; Toth, Luca; Fazekas, Balint; Buki, Andras] Univ Pecs, H-7624 Pecs, Hungary; [Czeiter, Endre; Amrein, Krisztina; Czigler, Andras; Toth, Luca; Fazekas, Balint] MTA PTE Clin Neurosci MR Res Grp, H-7623 Pecs, Hungary; [Kobeissy, Firas] Univ Florida, McKnight Brain Inst, Dept Psychiat & Neurosci, Gainesville, FL 32606 USA; [Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut, Lebanon; [Mechref, Yehia] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Jeromin, Andreas] Cohen Vet Biosci, Cambridge, MA 02142 USA		Mondello, S (corresponding author), Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, I-98125 Messina, Italy.; Mondello, S (corresponding author), Oasi Res Inst IRCCS, I-94018 Troina, Italy.	stm_mondello@hotmail.com; gillj@mail.nih.gov	Mondello, Stefania/A-1813-2012; Czigler, Andras/AAK-8425-2021; Kobeissy, Firas/E-7042-2017; Mechref, Yehia/I-5126-2013	Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944; , Chen/0000-0002-2178-1585; Czigler, Andras/0000-0001-6751-3298; Martin, Carina/0000-0002-6239-9817; Czeiter, Endre/0000-0002-9578-6944; Toth, Luca/0000-0002-5425-1863; de Alvarenga Guedes, Vivian/0000-0001-8478-2465; Mechref, Yehia/0000-0002-6661-6073	Ministero della Salute (Italian Ministry of Health)Ministry of Health, Italy [GR-2013-02354960]	This research was funded by the Ministero della Salute (Italian Ministry of Health), grant number GR-2013-02354960.	Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Duan PP, 2019, AM J TRANSL RES, V11, P1184; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Ferreira JV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223790; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; He XM, 2004, J STAT PLAN INFER, V122, P253, DOI 10.1016/j.jspi.2003.06.002; Hellewell SC, 2018, CRIT CARE MED, V46, P554, DOI 10.1097/CCM.0000000000002938; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mondello S, 2018, EXPERT REV PROTEOMIC, V15, P451, DOI 10.1080/14789450.2018.1464914; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; National Institute for Health and Care Excellence, 2014, HEAD INJ TRIAG ASS I; Nutma E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030600; Osier N, 2018, MOL NEUROBIOL, V55, P9280, DOI 10.1007/s12035-018-1054-4; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shi M, 2019, PROG NEUROBIOL, V175, P96, DOI 10.1016/j.pneurobio.2019.01.005; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Spitz G, 2015, J NEUROTRAUM, V32, P1272, DOI 10.1089/neu.2014.3814; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wan MH, 2020, MED RES REV, V40, P385, DOI 10.1002/med.21623; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zetterberg H, 2018, NEURON, V97, P1202, DOI 10.1016/j.neuron.2018.02.030	40	16	16	2	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	APR	2020	9	4							977	10.3390/cells9040977			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	LR2XW	WOS:000535559500188	32326450	gold, Green Published			2022-02-06	
J	Elliott, JE; Opel, RA; Pleshakov, D; Rachakonda, T; Chau, AQ; Weymann, KB; Lim, MM				Elliott, Jonathan E.; Opel, Ryan A.; Pleshakov, Dennis; Rachakonda, Tara; Chau, Alexander Q.; Weymann, Kristianna B.; Lim, Miranda M.			Posttraumatic stress disorder increases the odds of REM sleep behavior disorder and other parasomnias in Veterans with and without comorbid traumatic brain injury	SLEEP			English	Article						RBD; REM sleep without atonia; PTSD; TBI; trauma-associated sleep disorder	EYE-MOVEMENT SLEEP; PARKINSONIAN DISORDER; DELAYED EMERGENCE; PROBABLE RBD; DISEASE; ASSOCIATION; DEMENTIA; ATONIA; RISK; DISTURBANCES	Study Objectives: To describe the crude prevalence of rapid eye movement (REM) sleep behavior disorder (RBD) following traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) in Veterans, given potential relationships between TBI, PTSD, RBD, and neurodegeneration. Methods: Veterans (n = 394; 94% male; 54.4 +/- 15.5 years of age) were prospectively/cross-sectionally recruited from the VA Portland Health Care System and completed in-lab video-polysomnography and questionnaires. TBI and PTSD were assessed via diagnostic screening and medical record review. Subjects were categorized into four groups after assessment of REM sleep without atonia (RSWA) and self-reported dream enactment: (1) "Normal," neither RSWA nor dream enactment, (2) "Other Parasomnia," dream enactment without RSWA, (3) "RSWA," isolated-RSWA without dream enactment, and (4) "RBD," RSWA with dream enactment. Crude prevalence, prevalence odds ratio, and prevalence rate for parasomnias across subjects with TBI and/or PTSD were assessed. Results: Overall prevalence rates were 31%, 7%, and 9% for Other Parasomnia, RSWA, and RBD, respectively. The prevalence rate of RBD increased to 15% in PTSD subjects [age adjusted POR: 2.81 (1.17-4.66)] and to 21% in TBI + PTSD subjects [age adjusted POR: 3.43 (1.20-9.35)]. No subjects met all diagnostic criteria for traumaassociated sleep disorder (TASD), and no overt dream enactment was captured on video. Conclusions: The prevalence of RBD and related parasomnias is significantly higher in Veterans compared with the general population and is associated with PTSD and TBI + PTSD. Considering the association between idiopathic-RBD and synucleinopathy, it remains unclear whether RBD (and potentially TASD) associated with PTSD or TBI + PTSD similarly increases risk for long-term neurologic sequelae.	[Elliott, Jonathan E.; Opel, Ryan A.; Pleshakov, Dennis; Rachakonda, Tara; Chau, Alexander Q.; Weymann, Kristianna B.; Lim, Miranda M.] VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mail Code P3-RD42, Portland, OR 97239 USA; [Elliott, Jonathan E.; Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Weymann, Kristianna B.] Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Med, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA		Lim, MM (corresponding author), VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mail Code P3-RD42, Portland, OR 97239 USA.	lmir@ohsu.edu		Elliott, Jonathan/0000-0002-6992-6851	U.S. Department of Veterans AffairsUS Department of Veterans Affairs [1K2 RX002947, 1K2 BX002712]; NIH EXITO Institutional CoreUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1GM118964]; Portland VA Research Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 AT002688]; VA OAA Post-doctoral Nursing Research Fellowship; VA Portland Health Care SystemUS Department of Veterans Affairs	This material is the result of work supported with resources and the use of facilities at the VA Portland Health Care System, U.S. Department of Veterans Affairs #1K2 BX002712, NIH EXITO Institutional Core, #UL1GM118964, and the Portland VA Research Foundation to M.M.L.; National Institutes of Health T32 AT002688, and U.S. Department of Veterans Affairs #1K2 RX002947 to J.E.E.; VA OAA Post-doctoral Nursing Research Fellowship to K.B.W. Dr. Lim takes full responsibility for the data, the analyses and interpretation, and the conduct of the research; has full access to all of the data; and has the right to publish any and all data separate and apart from any sponsor. Interpretations and conclusions are those of the authors and do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	Adler CH, 2011, PARKINSONISM RELAT D, V17, P456, DOI 10.1016/j.parkreldis.2011.03.007; ANISMAN H, 1980, BRAIN RES, V191, P583, DOI 10.1016/0006-8993(80)91311-6; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Barone DA, 2018, CLIN NEUROPHYSIOL, V129, P1551, DOI 10.1016/j.clinph.2018.05.003; Berry RB, 2012, AASM MANUAL SCORING; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boeve BF, 1998, NEUROLOGY, V51, P363, DOI 10.1212/WNL.51.2.363; Boeve BF, 2010, ANN NY ACAD SCI, V1184, P15, DOI 10.1111/j.1749-6632.2009.05115.x; Camacho-Soto A, 2017, ANN NEUROL, V82, P744, DOI 10.1002/ana.25074; Chan YLE, 2017, AM J GERIAT PSYCHIAT, V25, P917, DOI 10.1016/j.jagp.2017.03.012; Chiu HFK, 2000, SLEEP, V23, P513; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dauvilliers Y, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0016-5; Elliott JE, 2018, J CLIN SLEEP MED, V14, P1177, DOI 10.5664/jcsm.7220; Feemster JC, 2019, J CLIN SLEEP MED, V15, P345, DOI 10.5664/jcsm.7642; Fernandez-Arcos A, 2016, SLEEP, V39, P121, DOI 10.5665/sleep.5332; Frauscher B, 2014, NEUROLOGY, V82, P1076, DOI 10.1212/WNL.0000000000000247; Frauscher B, 2010, SLEEP MED, V11, P167, DOI 10.1016/j.sleep.2009.03.011; Gagnon JF, 2006, LANCET NEUROL, V5, P424, DOI 10.1016/S1474-4422(06)70441-0; Galbiati A, 2019, SLEEP MED REV, V43, P37, DOI 10.1016/j.smrv.2018.09.008; GarciaRill E, 1997, MED HYPOTHESES, V49, P379, DOI 10.1016/S0306-9877(97)90083-9; Haba-Rubio J, 2018, SLEEP, V41, P1, DOI [10.1093/sleep/zsx197/4690595, DOI 10.1093/SLEEP/ZSX197/4690595]; Husain AM, 2001, J CLIN NEUROPHYSIOL, V18, P148, DOI 10.1097/00004691-200103000-00005; Jennum P, 2016, NAT SCI SLEEP, V8, P107, DOI 10.2147/NSS.S99240; Ju YE, 2011, SLEEP MED, V12, P278, DOI 10.1016/j.sleep.2010.07.022; Kang SH, 2013, SLEEP, V36, P1147, DOI 10.5665/sleep.2874; Mahlknecht P, 2015, MOVEMENT DISORD, V30, P1417, DOI 10.1002/mds.26350; Marion MH, 2008, J NEUROL, V255, P192, DOI 10.1007/s00415-008-0629-9; McCarter SJ, 2013, SLEEP MED, V14, P237, DOI 10.1016/j.sleep.2012.09.018; McCarter SJ, 2012, CURR NEUROL NEUROSCI, V12, P182, DOI 10.1007/s11910-012-0253-z; Mysliwiec V, 2018, SLEEP MED REV, V37, P94, DOI 10.1016/j.smrv.2017.01.004; Mysliwiec V, 2014, J CLIN SLEEP MED, V10, P1143, DOI 10.5664/jcsm.4120; Ohayon MM, 2010, SLEEP MED, V11, P941, DOI 10.1016/j.sleep.2010.02.016; Ohayon MM, 1997, J CLIN PSYCHIAT, V58, P369; Pearce N, 2004, ENVIRON HEALTH PERSP, V112, P1047, DOI 10.1289/ehp.6927; Plazzi G, 1997, NEUROLOGY, V48, P1094, DOI 10.1212/WNL.48.4.1094; Postuma Ronald B, 2012, Mov Disord, V27, P913, DOI 10.1002/mds.25037; ROSS RJ, 1994, SLEEP, V17, P723, DOI 10.1093/sleep/17.8.723; ROSS RJ, 1994, BIOL PSYCHIAT, V35, P195, DOI 10.1016/0006-3223(94)91152-5; Schenck CH, 2013, SLEEP MED, V14, P744, DOI 10.1016/j.sleep.2012.10.009; Schenck CH, 1996, NEUROLOGY, V46, P388, DOI 10.1212/WNL.46.2.388; SCHENCK CH, 1986, SLEEP, V9, P293, DOI 10.1093/sleep/9.2.293; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; Stefani A, 2015, J CLIN SLEEP MED, V11, P1273, DOI 10.5664/jcsm.5184; Tamhane AR, 2016, STAT MED, V35, P5730, DOI 10.1002/sim.7059; Tang WK, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-88; Teutsch P, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/6037015; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Weathers FW, 2015, POSTTRAUMATIC STRESS, V5, P4; Winkelman JW, 2004, SLEEP, V27, P317, DOI 10.1093/sleep/27.2.317	50	16	16	3	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	MAR	2020	43	3							zsz237	10.1093/sleep/zsz237			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ8GG	WOS:000548325900008	31587047	hybrid, Green Published			2022-02-06	
J	Launey, Y; Fryer, TD; Hong, YT; Steiner, LA; Nortje, J; Veenith, TV; Hutchinson, PJ; Ercole, A; Gupta, AK; Aigbirhio, FI; Pickard, JD; Coles, JP; Menon, DK				Launey, Yoann; Fryer, Tim D.; Hong, Young T.; Steiner, Luzius A.; Nortje, Jurgens; Veenith, Tonny V.; Hutchinson, Peter J.; Ercole, Ari; Gupta, Arun K.; Aigbirhio, Franklin I.; Pickard, John D.; Coles, Jonathan P.; Menon, David K.			Spatial and Temporal Pattern of Ischemia and Abnormal Vascular Function Following Traumatic Brain Injury	JAMA NEUROLOGY			English	Article							CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; REGIONAL OXYGENATION; HEAD-INJURY; O-15 PET; METABOLISM; DAMAGE; HYPERVENTILATION; MODERATE; TISSUE	Question How does (15)oxygen positron emission tomography characterization of cerebral physiology after traumatic brain injury inform clinical practice? Findings In this single-center observational cohort study of 68 patients and 27 control participants, early ischemia was common in patients, but hyperemia coexisted in different brain regions. Cerebral blood volume was consistently increased, despite low cerebral blood flow. Meaning Per this analysis, pathophysiologic heterogeneity indicates that bedside physiological monitoring with devices that measure global (jugular venous saturation) or focal (tissue oximetry) brain oxygenation should be interpreted with caution. Importance Ischemia is an important pathophysiological mechanism after traumatic brain injury (TBI), but its incidence and spatiotemporal patterns are poorly characterized. Objective To comprehensively characterize the spatiotemporal changes in cerebral physiology after TBI. Design, Setting, and Participants This single-center cohort study uses (15)oxygen positron emission tomography data obtained in a neurosciences critical care unit from February 1998 through July 2014 and analyzed from April 2018 through August 2019. Patients with TBI requiring intracranial pressure monitoring and control participants were recruited. Exposures Cerebral blood flow (CBF), cerebral blood volume (CBV), cerebral oxygen metabolism (CMRO2), and oxygen extraction fraction. Main Outcomes and Measures Ratios (CBF/CMRO2 and CBF/CBV) were calculated. Ischemic brain volume was compared with jugular venous saturation and brain tissue oximetry. Results A total of 68 patients with TBI and 27 control participants were recruited. Results from 1 patient with TBI and 7 health volunteers were excluded. Sixty-eight patients with TBI (13 female [19%]; median [interquartile range (IQR)] age, 29 [22-47] years) underwent 90 studies at early (day 1 [n = 17]), intermediate (days 2-5 [n = 54]), and late points (days 6-10 [n = 19]) and were compared with 20 control participants (5 female [25%]; median [IQR] age, 43 [31-47] years). The global CBF and CMRO2 findings for patients with TBI were less than the ranges for control participants at all stages (median [IQR]: CBF, 26 [22-30] mL/100 mL/min vs 38 [29-49] mL/100 mL/min; P < .001; CMRO2, 62 [55-71] mu mol/100 mL/min vs 131 [101-167] mu mol/100 mL/min; P < .001). Early CBF reductions showed a trend of high oxygen extraction fraction (suggesting classical ischemia), but this was inconsistent at later phases. Ischemic brain volume was elevated even in the absence of intracranial hypertension and highest at less than 24 hours after TBI (median [IQR], 36 [10-82] mL), but many patients showed later increases (median [IQR] 6-10 days after TBI, 24 [4-42] mL; across all points: patients, 10 [5-39] mL vs control participants, 1 [0-3] mL; P < 001). Ischemic brain volume was a poor indicator of jugular venous saturation and brain tissue oximetry. Patients' CBF/CMRO2 ratio was higher than controls (median [IQR], 0.42 [0.35-0.49] vs 0.3 [0.28-0.33]; P < .001) and their CBF/CBV ratio lower (median [IQR], 7.1 [6.4-7.9] vs 12.3 [11.0-14.0]; P < .001), suggesting abnormal flow-metabolism coupling and vascular reactivity. Patients' CBV was higher than controls (median [IQR], 3.7 [3.4-4.1] mL/100 mL vs 3.0 [2.7-3.6] mL/100 mL; P < .001); although values were lower in patients with intracranial hypertension, these were still greater than controls (median [IQR], 3.7 [3.2-4.0] vs 3.0 [2.7-3.6] mL/100 mL; P = .002), despite more profound reductions in partial pressure of carbon dioxide (median [IQR], 4.3 [4.1-4.6] kPa vs 4.7 [4.3-4.9] kPa; P = .001). Conclusions and Relevance Ischemia is common early, detectable up to 10 days after TBI, possible without intracranial hypertension, and inconsistently detected by jugular or brain tissue oximetry. There is substantial between-patient and within-patient pathophysiological heterogeneity; ischemia and hyperemia commonly coexist, possibly reflecting abnormalities in flow-metabolism coupling. Increased CBV may contribute to intracranial hypertension but can coexist with abnormal CBF/CBV ratios. These results emphasize the need to consider cerebrovascular pathophysiological complexity when managing patients with TBI. This single-center observational cohort study aims to comprehensively characterize the spatiotemporal changes in cerebral physiology after traumatic brain injury by comparing a cohort of affected patients with healthy control participants.	[Launey, Yoann; Steiner, Luzius A.; Nortje, Jurgens; Veenith, Tonny V.; Ercole, Ari; Gupta, Arun K.; Coles, Jonathan P.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Hills Rd,POB 93, Cambridge CB2 0QQ, Cambs, England; [Launey, Yoann] Ctr Hosp Univ Rennes, Dept Anaesthesia & Crit Care Med, Rennes, France; [Fryer, Tim D.; Hong, Young T.; Aigbirhio, Franklin I.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Steiner, Luzius A.] Univ Hosp Basel, Dept Anaesthesiol, Basel, Switzerland; [Steiner, Luzius A.] Univ Basel, Dept Clin Res, Basel, Switzerland; [Nortje, Jurgens] Norfolk & Norwich Univ Hosp Natl Hlth Serv Fdn Tr, Dept Anaesthesia, Norwich, Norfolk, England; [Veenith, Tonny V.] Univ Birmingham, Queen Elizabeth Hosp, Dept Crit Care Med, Birmingham Acute Care Res Grp, Birmingham, W Midlands, England; [Hutchinson, Peter J.; Pickard, John D.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England		Coles, JP (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Hills Rd,POB 93, Cambridge CB2 0QQ, Cambs, England.	jpc44@cam.ac.uk	Ercole, Ari/B-6288-2009; Veenith, Tonny/AAI-3067-2020; Launey, Yoann/AAN-7176-2020; Veenith, Tonny V/A-9948-2010	Ercole, Ari/0000-0001-8350-8093; Veenith, Tonny/0000-0002-4125-8804; Launey, Yoann/0000-0001-9105-8862; Veenith, Tonny V/0000-0002-4125-8804; Coles, Jonathan/0000-0003-4013-679X	Royal College of Anaesthetists/British Journal of Anaesthesia; National Institute of Academic Anaesthesia; Royal College of Surgeons of England; British Brain and Spine Foundation; Academy of Medical Sciences/Health Foundation; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0600986, G0001237]; Wellcome TrustWellcome TrustEuropean Commission [093267]; Technology Foresight Award from the UK government; Cambridge University Hospitals NHS Foundation Trust; University of CambridgeUniversity of Cambridge; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390, G0900903, G0001237] Funding Source: UKRI	This work was supported by grants from the Royal College of Anaesthetists/British Journal of Anaesthesia, National Institute of Academic Anaesthesia, Royal College of Surgeons of England, British Brain and Spine Foundation, Academy of Medical Sciences/Health Foundation, Medical Research Council (grants G9439390, G0600986, and G0001237), Wellcome Trust (grant 093267), a Technology Foresight Award from the UK government, and researchers at the National Institute for Health Research Cambridge Biomedical Research Centre. Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge acted as the sponsor for this study.	Abate MG, 2008, NEUROCRIT CARE, V9, P319, DOI 10.1007/s12028-008-9119-2; BARON JC, 1989, J CEREBR BLOOD F MET, V9, P723, DOI 10.1038/jcbfm.1989.105; Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2009, J CEREBR BLOOD F MET, V29, P965, DOI 10.1038/jcbfm.2009.22; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; FRACKOWIAK RSJ, 1980, J COMPUT ASSIST TOMO, V4, P727, DOI 10.1097/00004728-198012000-00001; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; JENNETT B, 1975, LANCET, V1, P480; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kawai N, 2008, ACTA NEUROCHIR SUPPL, V102, P241, DOI 10.1007/978-3-211-85578-2_46; LAMMERTSMA AA, 1987, J CEREBR BLOOD F MET, V7, P372, DOI 10.1038/jcbfm.1987.75; Lumb AB, 2017, CONTROL BREATHING NU, P51, DOI [10.1016/B978-0-7020-6294-0.00004-6, DOI 10.1016/B978-0-7020-6294-0.00004-6]; Marino R, 2006, NEUROLOGY, V67, P1165, DOI 10.1212/01.wnl.0000238081.35281.b5; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2003, ACT NEUR S, V86, P7; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Menon DK, 2006, CURR OPIN CRIT CARE, V12, P85, DOI 10.1097/01.ccx.0000216572.19062.8f; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00114; Schumann P, 1998, BRAIN, V121, P1369, DOI 10.1093/brain/121.7.1369; Steiner LA, 2004, INTENS CARE MED, V30, P2180, DOI 10.1007/s00134-004-2463-6; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Watabe T, 2014, NEUROSCI BULL, V30, P857, DOI 10.1007/s12264-013-1458-0; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Yamaki T, 1996, J NUCL MED, V37, P1166	44	16	16	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	MAR	2020	77	3					339	349		10.1001/jamaneurol.2019.3854			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KV5DS	WOS:000520503700011	31710336	Green Published, hybrid			2022-02-06	
J	Jiang, Q; Chen, J; Long, XB; Yao, XL; Zou, X; Yang, YP; Huang, GY; Zhang, HQ				Jiang, Qian; Chen, Jun; Long, Xiaobing; Yao, Xiaolong; Zou, Xin; Yang, Yiping; Huang, Guangying; Zhang, Huaqiu			Phillyrin protects mice from traumatic brain injury by inhibiting the inflammation of microglia via PPAR gamma signaling pathway	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Microglia; Phillyrin; Inflammation; Traumatic brain injury; PPAR gamma	NF-KAPPA-B; OXIDATIVE STRESS; WHITE-MATTER; ROSIGLITAZONE; ACTIVATION; NEUROINFLAMMATION; POLARIZATION; DEGENERATION; EXPRESSION; PHENOTYPE	The neuroinflammatory response induced by microglia plays a vital role in causing secondary brain damage after traumatic brain injury (TBI). Previous studies have found that the improved regulation of activated microglia could reduce neurological damage post-TBI. Phillyrin (Phi) is one of the main active ingredients extracted from the fruits of the medicinal plant Forsythia suspensa (Thunb.) with anti-inflammatory effects. Our study attempted to investigate the effects of phillyrin on microglial activation and neuron damage after TBI. The TBI model was applied to induce brain injury in mice, and neurological scores, brain water content, hematoxylin and eosin staining and Nissl staining were employed to determine the neuroprotective effects of phillyrin. Immunofluorescent staining and western blot analysis were used to detect nuclear factor-kappa B (NF-kappa B) and peroxisome proliferator-activated receptor gamma (PPAR gamma) expression and nuclear translocation, and the inflammation-related proteins and mRNAs were assessed by western blot analysis and quantitative real-time PCR. The results revealed that phillyrin not only inhibited the proinflammatory response induced by activated microglia but also attenuated neurological impairment and brain edema in vivo in a mouse TBI model. Additionally, phillyrin suppressed the phosphorylation of NF-kappa B in microglia after TBI insult. These effects of phillyrin were mostly abolished by the antagonist of PPAR gamma. Our results reveal that phillyrin could prominently inhibit the inflammation of microglia via the PPAR gamma signaling pathway, thus leading to potential neuroprotective treatment after traumatic brain injury.	[Jiang, Qian; Chen, Jun; Long, Xiaobing; Yao, Xiaolong; Yang, Yiping; Zhang, Huaqiu] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430030, Peoples R China; [Yao, Xiaolong] Taikang Tongji Hosp, Dept Neurosurg, Wuhan 430050, Peoples R China; [Zou, Xin; Huang, Guangying] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Tradit Chinese Med, Wuhan 430030, Peoples R China		Zhang, HQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430030, Peoples R China.	gyhuang@tjh.tjmu.edu.cn; zhanghq_04@yahoo.com		zhang, huaqiu/0000-0003-3023-2040	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371381]	This study was supported by the National Natural Science Foundation of China (No. 81371381).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Ding MF, 2014, INFLAMMATION, V37, P1919, DOI 10.1007/s10753-014-9924-z; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donovan C, 2015, AM J PHYSIOL-LUNG C, V309, pL1219, DOI 10.1152/ajplung.00156.2015; Gao WW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00281; He JC, 2018, NEUROBIOL DIS, V117, P114, DOI 10.1016/j.nbd.2018.06.003; He XQ, 2012, INT J NEUROSCI, V122, P532, DOI 10.3109/00207454.2012.686544; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kuo PC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/304830; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Li LY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-72; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luo Y, 2018, BRAIN RES, V1679, P144, DOI 10.1016/j.brainres.2017.11.030; Qu HH, 2008, J PHARM PHARMACOL, V60, P261, DOI 10.1211/jpp.60.2.0016; Qu XY, 2016, ARCH PHARM RES, V39, P998, DOI 10.1007/s12272-016-0775-z; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schober ME, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112971; Simon DW, 2018, J NEUROTRAUM, V35, P130, DOI 10.1089/neu.2017.5093; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wei T, 2014, CELL MOL NEUROBIOL, V34, P1165, DOI 10.1007/s10571-014-0091-4; Wen L, 2018, J NEUROTRAUM, V35, P2330, DOI 10.1089/neu.2017.5540; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yang LL, 2017, CELL PHYSIOL BIOCHEM, V43, P2074, DOI 10.1159/000484192; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771; Zhong WT, 2013, FITOTERAPIA, V90, P132, DOI 10.1016/j.fitote.2013.06.003; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	46	16	16	5	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	FEB	2020	79								106083	10.1016/j.intimp.2019.106083			8	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	KN3PW	WOS:000514753800034	31923823				2022-02-06	
J	Lee, SS; Kim, CJ; Shin, MS; Lim, BV				Lee, Su-Shin; Kim, Chang-Ju; Shin, Mal-Soon; Lim, Baek-Vin			Treadmill exercise ameliorates memory impairment through ERK-Akt-CREB-BDNF signaling pathway in cerebral ischemia gerbils	JOURNAL OF EXERCISE REHABILITATION			English	Article						Treadmill exercise; Cerebral ischemia; Short-term memory; Extracellular signal-regulated protein kinase; Brain-derived neurotrophic factor; Apoptosis	SHORT-TERM-MEMORY; TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; UP-REGULATION; HIPPOCAMPUS; ACTIVATION; APOPTOSIS; NEUROGENESIS; INFLAMMATION; EXPRESSION	Neuronal cell death in the hippocampus by cerebral ischemia causes disability of memory function. Cerebral ischemia also alters the expressions of brain-derived neurotrophic factor (BEAR cyclic adenosine monophosphate-responsive element binding protein (CREB), extracellular signal-regulated protein kinase (ERK), and phosphatidylinositol 3-kinase/protein kinase B (Akt). In the present study, we investigated the effect of treadmill exercise on cerebral ischemia in relation with ERK-Akt-CREB-BDNF signaling pathway in the hippocampus using gerbils. Induction of cerebral ischemia deteriorated short-term memory with suppression of phosphorylation of ERK-Akt-CREB-BDNF pathway in the hippo-campus of gerbils. Enhancement of apoptosis in the hippo- campus was accompanied in the ischemia gerbils. Treadmill exercise improved short-term memory through enhancing phosphorylation of ERK-Akt-CREB-BDNF pathway with suppressing apoptosis in the hippocampus of the ischemia gerbils. The present results suggest that improvement of memory function after cerebral ischemia by treadmill exercise may be involved in the ERK-Akt-CREB-BDNF signaling pathway, resulting in inhibition of apoptosis in the hippocampus.	[Lee, Su-Shin; Kim, Chang-Ju] Kyung Hee Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Shin, Mal-Soon] Korea Univ, Sch Global Sport Studies, Sejong, South Korea; [Lim, Baek-Vin] Dongseo Univ, Dept Exercise Prescript, Div Leisure & Sports Sci, 47 Jurye Ro, Busan 47011, South Korea		Lim, BV (corresponding author), Dongseo Univ, Dept Exercise Prescript, Div Leisure & Sports Sci, 47 Jurye Ro, Busan 47011, South Korea.	todd64@naver.com			National Research Foundation of Korea Grant - Korean Government [NRF-2018S1 A5A2A01031391]	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2018S1 A5A2A01031391).	Cao YG, 2011, BRAIN RES BULL, V85, P396, DOI 10.1016/j.brainresbull.2011.05.002; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Chae CH, 2009, NEUROCHEM INT, V55, P208, DOI 10.1016/j.neuint.2009.02.024; Choi IY, 2017, EXP THER MED, V13, P107, DOI 10.3892/etm.2016.3956; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hara T, 2003, J NEUROCHEM, V86, P805, DOI 10.1046/j.1471-4159.2003.01847.x; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/S0092-8674(04)01159-6; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Kim M, 2019, INT NEUROUROL J, V23, pS102, DOI 10.5213/inj.1938216.108; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Ko IG, 2019, J EXERC REHABIL, V15, P504, DOI 10.12965/jer.1938316.158; Ko IG, 2018, J EXERC REHABIL, V14, P327, DOI 10.12965/jer.1836248.124; Koh PO, 2006, J VET MED SCI, V68, P1019, DOI 10.1292/jvms.68.1019; Lee JM, 2019, J EXERC REHABIL, V15, P370, DOI 10.12965/jer.1938274.137; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Numakawa Tadahiro, 2010, World J Biol Chem, V1, P133, DOI 10.4331/wjbc.v1.i5.133; Park JH, 2016, INT NEUROUROL J, V20, P107, DOI 10.5213/inj.1632532.266; Park SS, 2019, INT NEUROUROL J, V23, pS32, DOI 10.5213/inj.1938046.023; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Santos AR, 2010, PROG NEUROBIOL, V92, P505, DOI 10.1016/j.pneurobio.2010.08.004; Song SH, 2018, J EXERC REHABIL, V14, P911, DOI 10.12965/jer.1836508.254; Tokuyama W, 2000, NAT NEUROSCI, V3, P1134, DOI 10.1038/80655; Wang HY, 2009, BRAIN RES, V1297, P177, DOI 10.1016/j.brainres.2009.08.054; Whitfield TW, 2011, J NEUROSCI, V31, P834, DOI 10.1523/JNEUROSCI.4986-10.2011; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; Yan XB, 2007, NEUROPHARMACOLOGY, V53, P487, DOI 10.1016/j.neuropharm.2007.06.020; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zhu DY, 2004, P NATL ACAD SCI USA, V101, P9453, DOI 10.1073/pnas.0401063101	32	16	16	1	1	KOREAN SOC EXERCISE REHABILITATION	SEOUL	264 BAEKJEGOBUN-RO, SONGPA-GU, SEOUL, 138-841, SOUTH KOREA	2288-176X	2288-1778		J EXERC REHABIL	J. Exerc. Rehabil.	FEB	2020	16	1					49	57		10.12965/jer.2040014.007			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	KS3MR	WOS:000518216400007	32161734	Green Published, gold			2022-02-06	
J	Teymoori, A; Real, R; Gorbunova, A; Haghish, EF; Andelic, N; Wilson, L; Asendorf, T; Menon, D; von Steinbuchel, N				Teymoori, Ali; Real, Ruben; Gorbunova, Anastasia; Haghish, E. F.; Andelic, Nada; Wilson, Lindsay; Asendorf, Thomas; Menon, David; von Steinbuechel, Nicole			Measurement invariance of assessments of depression (PHQ-9) and anxiety (GAD-7) across sex, strata and linguistic backgrounds in a European-wide sample of patients after Traumatic Brain Injury	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Depression; Anxiety; Measurement invariance; Differential Item Functioning (DIF)	ITEM RESPONSE THEORY; GLASGOW COMA SCALE; MAJOR DEPRESSION; DISORDERS; ASSOCIATION; VALIDITY; SEQUELAE; PACKAGE; IMPACT; CARE	Background: The Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder (GAD-7) are two widely used instruments to screen patients for depression and anxiety. Comparable psychometric properties across different demographic and linguistic groups are necessary for multiple group comparison and international research on depression and anxiety. Objectives and Method: We examine measurement invariance for the PHQ-9 and GAD-7 by: (a) the sex of the participants, (b) recruitment stratum, and (c) linguistic background. This study is based on non-randomized observational data six months after Traumatic Brain Injury (TBI) that were collected in 18 countries. We used multiple methods to detect Differential Item Functioning (DIF) including Item Response Theory, logistic regression, and the Mantel-Haenszel method. Results: At the 6-month post-injury, 2137 (738 [34.5%] women) participants completed the PHQ-9 and GAD-7 questionnaires: 885 [41.4%] patients were primarily admitted to the Intensive Care Unit (ICU), 805 [37.7%] were admitted to hospital ward, and 447 [20.9%] were evaluated in the Emergency Room and discharged. Results supported the invariance of PHQ-9 and GAD-7 across sex, patient strata and linguistic background. For different strata three PHQ-9 items and one GAD-7 item and for different linguistic groups only two GAD-7 items were flagged as showing differences in two out of four DIF tests. However, the magnitude of the DIF effect was negligible. Limitation: Despite high number of participants from ICU, patients have mostly mild TBI. Conclusion: The findings demonstrate adequate psychometric properties for PHQ-9 and GAD-7, allowing direct multigroup comparison across sex, strata, and linguistic background.	[Teymoori, Ali; Real, Ruben; Gorbunova, Anastasia; Haghish, E. F.; Asendorf, Thomas; von Steinbuechel, Nicole] Georg August Univ, Univ Med Ctr, Inst Med Psychol & Med Sociol, Waldweg 37, D-37073 Gottingen, Germany; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling, Scotland; [Asendorf, Thomas] Georg August Univ Gottingen, Med Ctr, Inst Med Stat, Gottingen, Germany; [Menon, David] Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Cambridge, England		Teymoori, A (corresponding author), Georg August Univ, Univ Med Ctr, Inst Med Psychol & Med Sociol, Waldweg 37, D-37073 Gottingen, Germany.	ali.teymoori@uqconnect.edu.au	Wilson, Lindsay/A-3659-2009	Wilson, Lindsay/0000-0003-4113-2328; Teymoori, Ali/0000-0003-2227-7361; Andelic, Nada/0000-0002-3719-4406	European UnionEuropean Commission [602150]	The research leading to these results was supported by the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 602150 (CENTER-TBI).	Arthurs E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052028; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Clauser B. E., 1998, EDUC MEAS-ISSUES PRA, V17, P31, DOI [10.1111/j.1745-3992.1998.tb00619.x, DOI 10.1111/J.1745-3992.1998.TB00619.X]; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Galenkamp H, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1506-9; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Hambleton RK, 2006, MED CARE, V44, pS182, DOI 10.1097/01.mlr.0000245443.86671.c4; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Keum B.T, 2018, PSYCHOL ASSESS; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Magis D, 2010, BEHAV RES METHODS, V42, P847, DOI 10.3758/BRM.42.3.847; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Putnick DL, 2016, DEV REV, V41, P71, DOI 10.1016/j.dr.2016.06.004; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Rutter LA, 2017, J PSYCHOPATHOL BEHAV, V39, P140, DOI 10.1007/s10862-016-9571-9; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tay L, 2015, ORGAN RES METHODS, V18, P3, DOI 10.1177/1094428114553062; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zumbo B.D., 2007, LANGUAGE ASSESSMENT, V4, P223, DOI [10.1080/15434300701375832, DOI 10.1080/15434300701375832]	40	16	16	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	FEB 1	2020	262						278	285		10.1016/j.jad.2019.10.035			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	JU3RS	WOS:000501596400037	31732280	Green Accepted			2022-02-06	
J	Lv, Y; Sun, B; Lu, XX; Liu, YL; Li, M; Xu, LX; Feng, CX; Ding, X; Feng, X				Lv, Yuan; Sun, Bin; Lu, Xing-Xing; Liu, Yan-Lin; Li, Mei; Xu, Li-Xiao; Feng, Chen-Xi; Ding, Xin; Feng, Xing			The role of microglia mediated pyroptosis in neonatal hypoxic-ischemic brain damage	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						NLRP-3; Pyroptosis; Microglia; Neonatal; Hypoxic-ischemic brain damage; MCC950	INFLAMMASOMES MECHANISM; NLRP3 INFLAMMASOME; DISEASE; INJURY	Neonatal hypoxic-ischemic encephalopathy (HIE) often leads to neonatal death or severe, irreversible neurological deficits. Pathologically, the occurrence of massive cell death and subsequent inflammation suggested that pyroptosis, an inflammation associated programed cell death, might play a role in HIE. Here, by measuring changes of key molecules in pyroptosis pathway in HIE patients, we discovered that their elevation levels tightly correlate with the severity of HIE. Next, we demonstrated that application of MCC950, a small molecule to inhibit NLRP3 inflammasome and thus pyroptosis, substantially alleviated pyroptosis and the injury severity in rats with neonatal hypoxic-ischemic brain damage (HIBD). Mechanistically, we showed that NLRP-3/caspase-1/GSDMD axis is required for microglia pyroptosis and activation. Our data demonstrated that microglia mediated pyroptosis played a crucial role in neonatal HIE, which shed lights into the development of intervention avenues targeting pyroptosis to treat HIE and traumatic brain injuries. (C) 2019 Elsevier Inc. All rights reserved.	[Lv, Yuan; Sun, Bin; Ding, Xin; Feng, Xing] Soochow Univ, Dept Neonatol, Childrens Hosp, 92 Zhongnanjie Rd, Suzhou 215025, Peoples R China; [Lu, Xing-Xing; Liu, Yan-Lin] Northern Jiangsu Peoples Hosp, Dept Neonatol, Yangzhou 225000, Jiangsu, Peoples R China; [Li, Mei; Xu, Li-Xiao; Feng, Chen-Xi] Soochow Univ, Dept Pediat, Childrens Hosp, Res Inst, Suzhou 215025, Peoples R China		Ding, X; Feng, X (corresponding author), Soochow Univ, Dept Neonatol, Childrens Hosp, 92 Zhongnanjie Rd, Suzhou 215025, Peoples R China.	dingxin@suda.edu.cn; xing_feng66@suda.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771625, 81871193, 81671532]; Jiangsu Provincial Key Medical Discipline [ZDXKA2016013]; Jiangsu Provincial Medical Youth Talent [QNRC2016763]; Jiangsu Province Women and Children Health Research Project [F201750]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20180205]; Pediatric Clinical Center of Suzhou City of China [Szzx201504]; Science and Technology Project of Suzhou City of China [SS201709]; Training Program Foundation for health talents of Gusu [GSWS2019049]; National Natural Science Foundation of China for Young ScientistsNational Natural Science Foundation of China (NSFC) [81701490]	This work is funded by the National Natural Science Foundation of China (No. 81771625, 81871193, 81671532); The Jiangsu Provincial Key Medical Discipline (No.ZDXKA2016013); Jiangsu Provincial Medical Youth Talent (QNRC2016763); The Jiangsu Province Women and Children Health Research Project (No. F201750); The Natural Science Foundation of Jiangsu Province (BK20180205), The Pediatric Clinical Center of Suzhou City of China (No. Szzx201504), The Science and Technology Project of Suzhou City of China (SS201709), The Training Program Foundation for health talents of Gusu (GSWS2019049), and National Natural Science Foundation of China for Young Scientists (81701490).	Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Broderick L, 2015, ANNU REV PATHOL-MECH, V10, P395, DOI 10.1146/annurev-pathol-012414-040431; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; De Nardo D, 2014, AM J PATHOL, V184, P42, DOI 10.1016/j.ajpath.2013.09.007; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; Ding X, 2015, NEUROSCI LETT, V591, P75, DOI 10.1016/j.neulet.2015.02.026; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; He W, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1459-7; Liu FD, 2013, ACTA PHARMACOL SIN, V34, P1121, DOI 10.1038/aps.2013.89; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Navarro V, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00140; Perlman Max, 2011, J Pediatr, V158, pe51, DOI 10.1016/j.jpeds.2010.11.014; Qi YJ, 2018, NEUROBIOL DIS, V114, P24, DOI 10.1016/j.nbd.2018.02.016; Shen HH, 2018, AUTOIMMUN REV, V17, P694, DOI 10.1016/j.autrev.2018.01.020; Yang YY, 2017, BRAIN RES, V1668, P28, DOI 10.1016/j.brainres.2017.05.001; Ye XC, 2017, EXP NEUROL, V292, P46, DOI 10.1016/j.expneurol.2017.03.002	23	16	19	14	26	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JAN 22	2020	521	4					933	938		10.1016/j.bbrc.2019.11.003			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	KC9JL	WOS:000507487200018	31718799				2022-02-06	
J	Chiaravalloti, ND; Weber, E; Wylie, G; Dyson-Hudson, T; Wecht, JM				Chiaravalloti, Nancy D.; Weber, Erica; Wylie, Glenn; Dyson-Hudson, Trevor; Wecht, Jill M.			Patterns of cognitive deficits in persons with spinal cord injury as compared with both age-matched and older individuals without spinal cord injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injury; Cognitive deficits; Memory; Processing speed; Executive functioning	TRAUMATIC BRAIN-INJURY; CLOSED HEAD-INJURY; TREAT LEARNING IMPAIRMENT; MULTIPLE-SCLEROSIS; DYSFUNCTION; MEMORY; REHABILITATION; PERFORMANCE; EXPOSURE; FLUENCY	Context/Objective: Cognitive deficits can impact as many as 60% of individuals with spinal cord injury (SCI). In an effort to identify the nature of cognitive deficits in SCI, we examined neuropsychological test performance in individuals with SCI, age matched healthy controls and older healthy controls. Design: Participants completed a motor-free neuropsychological test battery assessing attention, working memory, information processing speed, new learning /memory and executive control. Setting: Outpatient rehabilitation research facility. Participants: Participants included 60 individuals with chronic spinal cord injury [SCI; 32 with paraplegia (T2-T12) and 28 with tetraplegia (C3-T1)], 30 age-matched healthy controls (AMHC; 30-40 years old) and 20 older healthy controls (OHC; 50-60 years old). Outcome Measures: Wechsler Intelligence Scale - 3(rd) edition (WAIS-III) Digit Span and Letter-Number Sequencing; Symbol Digit Modalities Test (SDMT) - oral version; California Verbal Learning Test-II; Paced Auditory Serial Addition Test (PASAT); Wechsler Abbreviated Scale of Intelligence (WASI); Delis-Kaplan Executive Function System; Verbal Fluency subtest. Results: Significant differences were noted between the SCI and AMHC groups on measures of information processing speed, new learning and memory, and verbal fluency. No significant differences were noted between the groups on tests of attention or working memory. Conclusion: The current study documented differences in specific realms of cognitive functioning between a chronic SCI sample and AMHC. Implications for cognitive rehabilitation and overall quality of life are discussed. Additional research is needed utilizing a more comprehensive battery of motor-free neuropsychological tests that avoid the confound of upper limb motor limitations on cognitive performance.	[Chiaravalloti, Nancy D.; Weber, Erica] Kessler Fdn, Traumat Brain Injury Res, W Orange, NJ USA; [Chiaravalloti, Nancy D.; Wylie, Glenn] Kessler Fdn, Neuropsychol & Neurosci Res, W Orange, NJ USA; [Chiaravalloti, Nancy D.; Weber, Erica; Wylie, Glenn; Dyson-Hudson, Trevor] Rutgers NJ, Dept Phys Med & Rehabil, Med Sch, Newark, NJ USA; [Wylie, Glenn] VA War Related Illness & Injury Study Ctr, E Orange, NJ USA; [Dyson-Hudson, Trevor] Kessler Fdn, Spinal Cord Injury Res, W Orange, NJ USA; [Wecht, Jill M.] VA RR&D Natl Ctr Med Consequences SCI, James J Peters VAMC, Bronx, NY USA; [Wecht, Jill M.] Icahn Sch Med Mt Sinai, Dept Med & Rehabil Med, New York, NY 10029 USA		Chiaravalloti, ND (corresponding author), Kessler Fdn, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA.	nchiaravalloti@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	New Jersey Commission on Spinal Cord Research [CSCR13IRG018]; Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [B9212-C]	This work was supported by New Jersey Commission on Spinal Cord Research: [Grant Number CSCR13IRG018]; Rehabilitation Research and Development Service: [Grant Number B2020-C]; Rehabilitation Research and Development Service: [Grant Number B9212-C].	[Anonymous], 2015, J SPINAL CORD MED, V38, P812; Bombardier CH, 2016, ARCH PHYS MED REHAB, V97, P1628, DOI 10.1016/j.apmr.2016.03.008; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Capitani E, 2009, NEUROPSYCHOLOGIA, V47, P423, DOI 10.1016/j.neuropsychologia.2008.09.016; Carlozzi NE, 2017, ARCH CLIN NEUROPSYCH, V32, P555, DOI 10.1093/arclin/acx020; Chiaravalloti ND, 2016, NEUROREHAB NEURAL RE, V30, P539, DOI 10.1177/1545968315604395; Chiaravalloti ND, 2015, MULT SCLER J, V21, P1575, DOI 10.1177/1352458514567726; Chiaravalloti ND, 2013, NEUROLOGY, V81, P2066, DOI 10.1212/01.wnl.0000437295.97946.a8; Chiaravalloti ND, 2005, MULT SCLER, V11, P58, DOI 10.1191/1352458505ms1118oa; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1990, ARCH PHYS MED REHAB, V71, P121; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; Delis D, 2000, DELIS KAPLAN EXECUTI; Delis DC, 1987, CALIFORNIA VERBAL LE; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; DUBO H, 1984, P AM SPINAL INJURY A, P35; EGAN V, 1988, PERS INDIV DIFFER, V9, P179, DOI 10.1016/0191-8869(88)90046-3; Engelberts NHJ, 2002, EPILEPSY BEHAV, V3, P316, DOI 10.1016/S1525-5050(02)00036-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Guggenmos M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0037-y; Handrakis JP, 2017, J NEUROTRAUM, V34, P3372, DOI 10.1089/neu.2016.4850; Handrakis JP, 2015, J NEUROTRAUM, V32, P1168, DOI 10.1089/neu.2014.3719; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091; Jegede AB, 2010, CLIN AUTON RES, V20, P3, DOI 10.1007/s10286-009-0036-z; Jones S, 2006, CORTEX, V42, P347, DOI 10.1016/S0010-9452(08)70361-7; KESSLER HR, 1992, INT J NEUROSCI, V62, P17, DOI 10.3109/00207459108999754; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Koutsouleris N, 2014, SCHIZOPHRENIA BULL, V40, P1140, DOI 10.1093/schbul/sbt142; Krch D, 2011, J INT NEUROPSYCH SOC, V17, P557, DOI 10.1017/S1355617711000336; Krebs J, 2018, SPINAL CORD, V56, P22, DOI 10.1038/sc.2017.94; Krystal JH, 2005, ARCH GEN PSYCHIAT, V62, P985, DOI 10.1001/archpsyc.62.9.985; Ladavass E, 2011, EUR J PHYS REHAB MED, V47, P91; Lu PH, 2011, J CLIN EXP NEUROPSYC, V33, P1059, DOI 10.1080/13803395.2011.595397; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; MCKINLAY W, 1999, REHABILITATION ADULT, P74; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Molina B, 2018, SPINAL CORD, V56, P796, DOI 10.1038/s41393-018-0076-0; Murray RF, 2007, SPINAL CORD, V45, P429, DOI 10.1038/sj.sc.3102022; Patton J.H., 1991, CLIN NEUROPSYCHOL, V5, P33, DOI [10.1080/13854049108401840, DOI 10.1080/13854049108401840]; Postal KS, 2013, FEEDBACK STICKS ART; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Salthouse TA, 2009, J INT NEUROPSYCH SOC, V15, P650, DOI 10.1017/S1355617709990385; Schembri R, 2017, SLEEP, V40, DOI DOI 10.1093/sleep/zsw037; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schueneman AL, 1982, SCI DIG, V4, P64; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; SILVER JR, 1980, INJURY, V12, P219, DOI 10.1016/0020-1383(80)90011-X; Smith A., 1982, SYMBOL DIGIT MODALIT; Spreen O, 1991, COMPENDIUM NEUROPSYC; Tzourio C, 2014, HYPERTENSION, V63, P894, DOI 10.1161/HYPERTENSIONAHA.113.00147; WAGNER H, 1984, INT J RADIAT ONCOL, V10, P1575, DOI 10.1016/0360-3016(84)90506-6; WEBER E, 2018, LEARNING MEMORY PROF; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wecht JM, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12683; Wecht JM, 2012, CLIN AUTON RES, V22, P25, DOI 10.1007/s10286-011-0139-1; Wecht JM, J NEUROTRAUMA UNPUB; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Wood RL, 2017, BRAIN INJURY, V31, P1270, DOI 10.1080/02699052.2017.1332387	75	16	16	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JAN 2	2020	43	1					88	97		10.1080/10790268.2018.1543103			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KD1IS	WOS:000507626000011	30508409	Green Published			2022-02-06	
J	Herr, DR; Chew, WS; Satish, RL; Ong, WY				Herr, Deron R.; Chew, Wee Siong; Satish, R. L.; Ong, Wei-Yi			Pleotropic Roles of Autotaxin in the Nervous System Present Opportunities for the Development of Novel Therapeutics for Neurological Diseases	MOLECULAR NEUROBIOLOGY			English	Article						Autotaxin; Lysophospholipase D; Inflammatory neuropathic pain; Glioblastoma multiforme; Hemorrhagic hydrocephalus; Schizophrenia; Multiple sclerosis; Alzheimer's disease; Metabolic syndrome-induced brain damage; Traumatic brain injury; Hepatic encephalopathy induced cerebral edema; Macular edema; Major depressive disorder; Stress-induced psychiatric disorder; Alcohol-induced brain damage; HIV-induced brain injury; Pruritus; Peripheral nerve injury	LYSOPHOSPHATIDIC ACID RECEPTOR; OBVIOUS PHENOTYPIC ABNORMALITY; PROTEIN-COUPLED RECEPTOR; NF-KAPPA-B; LYSOPHOSPHOLIPASE-D; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; I-ALPHA/AUTOTAXIN; NEUROPATHIC PAIN; PHARMACOLOGICAL CHARACTERIZATION	Autotaxin (ATX) is a soluble extracellular enzyme that is abundant in mammalian plasma and cerebrospinal fluid (CSF). It has two known enzymatic activities, acting as both a phosphodiesterase and a phospholipase. The majority of its biological effects have been associated with its ability to liberate lysophosphatidic acid (LPA) from its substrate, lysophosphatidylcholine (LPC). LPA has diverse pleiotropic effects in the central nervous system (CNS) and other tissues via the activation of a family of six cognate G protein-coupled receptors. These LPA receptors (LPARs) are expressed in some combination in all known cell types in the CNS where they mediate such fundamental cellular processes as proliferation, differentiation, migration, chronic inflammation, and cytoskeletal organization. As a result, dysregulation of LPA content may contribute to many CNS and PNS disorders such as chronic inflammatory or neuropathic pain, glioblastoma multiforme (GBM), hemorrhagic hydrocephalus, schizophrenia, multiple sclerosis, Alzheimer's disease, metabolic syndrome-induced brain damage, traumatic brain injury, hepatic encephalopathy-induced cerebral edema, macular edema, major depressive disorder, stress-induced psychiatric disorder, alcohol-induced brain damage, HIV-induced brain injury, pruritus, and peripheral nerve injury. ATX activity is now known to be the primary biological source of this bioactive signaling lipid, and as such, represents a potentially high-value drug target. There is currently one ATX inhibitor entering phase III clinical trials, with several additional preclinical compounds under investigation. This review discusses the physiological and pathological significance of the ATX-LPA-LPA receptor signaling axis and summarizes the evidence for targeting this pathway for the treatment of CNS diseases.	[Herr, Deron R.; Chew, Wee Siong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117600, Singapore; [Herr, Deron R.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Satish, R. L.; Ong, Wei-Yi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 119260, Singapore; [Ong, Wei-Yi] Natl Univ Singapore, Inst Life Sci, Neurobiol Programme, Singapore 119260, Singapore		Herr, DR (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117600, Singapore.; Herr, DR (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.; Ong, WY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 119260, Singapore.; Ong, WY (corresponding author), Natl Univ Singapore, Inst Life Sci, Neurobiol Programme, Singapore 119260, Singapore.	phcdrh@nus.edu.sg; wei_yi_ong@nuhs.edu.eg		Ong, Wei-Yi/0000-0001-9756-7772			Abers HMHG, 2011, J MED CHEM, V54, P4619, DOI 10.1021/jm200310q; Aikawa S, 2017, BIOCHEM BIOPH RES CO, V484, P202, DOI 10.1016/j.bbrc.2016.12.154; Annabi B, 2009, MOL CARCINOGEN, V48, P910, DOI 10.1002/mc.20541; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Awada R, 2014, J CELL BIOCHEM, V115, P2123, DOI 10.1002/jcb.24889; Awada R, 2012, FREE RADICAL BIO MED, V52, P516, DOI 10.1016/j.freeradbiomed.2011.11.014; Bachner D, 1999, MECH DEVELOP, V84, P121, DOI 10.1016/S0925-4773(99)00048-9; Benesch MGK, 2015, FASEB J, V29, P3990, DOI 10.1096/fj.15-274480; Benesch MGK, 2015, ENDOCR-RELAT CANCER, V22, P593, DOI 10.1530/ERC-15-0045; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; Beuers U, 2006, HEPATOLOGY, V44, P280, DOI 10.1002/hep.21271; Bhave SR, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00236; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; Bouchareb R, 2015, CIRCULATION, V132, P677, DOI 10.1161/CIRCULATIONAHA.115.016757; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; Castagna D, 2016, J MED CHEM, V59, P5604, DOI 10.1021/acs.jmedchem.5b01599; Chew WS, 2016, PHARMACOL RES, V113, P521, DOI 10.1016/j.phrs.2016.09.025; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Clair T, 2003, CANCER RES, V63, P5446; Clair T, 1997, J BIOL CHEM, V272, P996, DOI 10.1074/jbc.272.2.996; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; Crack PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-37; Cui QL, 2014, GLIA, V62, P1361, DOI 10.1002/glia.22688; Dacheva I, 2016, RETINA-J RET VIT DIS, V36, P2311, DOI 10.1097/IAE.0000000000001112; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Dennis J, 2008, MOL CELL NEUROSCI, V37, P412, DOI 10.1016/j.mcn.2007.10.018; Desroy N, 2017, J MED CHEM, V60, P3580, DOI 10.1021/acs.jmedchem.7b00032; Elferink RPJO, 2015, BBA-MOL CELL BIOL L, V1851, P61, DOI 10.1016/j.bbalip.2014.09.004; Elferink RPJO, 2011, CURR OPIN GASTROEN, V27, P289, DOI 10.1097/MOG.0b013e32834575e8; Fagard L, A103 IPF MORE THERAP, pA2701, DOI [10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A2701, DOI 10.1164/AJRCCM-C0NFERENCE.2016.193.1_MEETINGABSTRACTS.A2701]; Farooqui AA, 2007, GLYCEROPHOSPHOLIPIDS; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Ferry G, 2008, J PHARMACOL EXP THER, V327, P809, DOI 10.1124/jpet.108.141911; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Fox MA, 2004, MOL CELL NEUROSCI, V27, P140, DOI 10.1016/j.mcn.2004.06.002; Fox MA, 2003, MOL CELL NEUROSCI, V23, P507, DOI 10.1016/S1044-7431(03)00073-3; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; Fujita R, 2007, NEUROCHEM INT, V50, P351, DOI 10.1016/j.neuint.2006.09.003; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Garcia-Diaz B, 2015, BRAIN STRUCT FUNCT, V220, P3701, DOI 10.1007/s00429-014-0885-7; Gierse J, 2010, J PHARMACOL EXP THER, V334, P310, DOI 10.1124/jpet.110.165845; Goldshmit Y, 2012, AM J PATHOL, V181, P978, DOI 10.1016/j.ajpath.2012.06.007; Greenman R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00053; Gupte R, 2011, CHEMMEDCHEM, V6, P922, DOI 10.1002/cmdc.201000425; Hammack BN, 2004, MULT SCLER, V10, P245, DOI 10.1191/1352458504ms1023oa; Hata E, 2016, INT IMMUNOL, V28, P283, DOI 10.1093/intimm/dxv072; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Herr DR, 2018, ACS CHEM NEUROSCI, V9, P398, DOI 10.1021/acschemneuro.8b00057; Herr KJ, 2011, P NATL ACAD SCI USA, V108, P15444, DOI 10.1073/pnas.1106129108; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Hoelzinger DB, 2008, J NEURO-ONCOL, V86, P297, DOI 10.1007/s11060-007-9480-6; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; ILLINGWORTH DR, 1971, J NEUROCHEM, V18, P769, DOI 10.1111/j.1471-4159.1971.tb12006.x; Im E, 2010, MOL CELL BIOL, V30, P2401, DOI 10.1128/MCB.01275-09; Inoue M, 2008, NEUROSCIENCE, V152, P296, DOI 10.1016/j.neuroscience.2007.12.041; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Inoue M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-6; Inoue M, 2008, J NEUROCHEM, V107, P1556, DOI 10.1111/j.1471-4159.2008.05725.x; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Itagaki K, 2019, INT J NEUROPSYCHOPH, V22, P261, DOI 10.1093/ijnp/pyz005; Iyer P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042627; Jones SB, 2016, ACS MED CHEM LETT, V7, P857, DOI 10.1021/acsmedchemlett.6b00207; Jung CG, 2007, GLIA, V55, P1656, DOI 10.1002/glia.20576; Kakiuchi Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-33; Katakai T, 2014, J IMMUNOL, V193, P617, DOI 10.4049/jimmunol.1400565; Kato K, 2016, NAT STRUCT MOL BIOL, V23, P395, DOI 10.1038/nsmb.3200; Katsifa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143083; Kawagoe H, 1997, CANCER RES, V57, P2516; Kim SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171664; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Koike S, 2011, DEV DYNAM, V240, P413, DOI 10.1002/dvdy.22543; Kremer AE, 2016, J PEDIATR GASTR NUTR, V62, P530, DOI 10.1097/MPG.0000000000001044; Kremer AE, 2015, J HEPATOL, V62, P897, DOI 10.1016/j.jhep.2014.10.041; Kremer AE, 2012, HEPATOLOGY, V56, P1391, DOI 10.1002/hep.25748; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Kuwajima K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207310; Leblanc R, 2015, EXP CELL RES, V333, P183, DOI 10.1016/j.yexcr.2014.11.010; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lee Z, 2008, MOL BIOL CELL, V19, P5435, DOI 10.1091/mbc.E08-03-0316; Li HY, 2017, KIDNEY INT, V91, P1362, DOI 10.1016/j.kint.2016.11.010; Li S, 2012, FEBS LETT, V586, P792, DOI 10.1016/j.febslet.2012.01.044; Li S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-18; Li S, 2009, BIOCHEM BIOPH RES CO, V378, P264, DOI 10.1016/j.bbrc.2008.11.047; Lin ME, 2012, J BIOL CHEM, V287, P17608, DOI 10.1074/jbc.M111.330183; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Ma L, 2010, J PHARMACOL EXP THER, V333, P540, DOI 10.1124/jpet.109.164830; Ma L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-64; Maher TM, 2018, LANCET RESP MED, V6, P627, DOI 10.1016/S2213-2600(18)30181-4; Manzardo AM, 2013, GENE, V526, P356, DOI 10.1016/j.gene.2013.05.052; Manzardo AM, 2014, ALCOHOL CLIN EXP RES, V38, P1594, DOI 10.1111/acer.12429; Masago K, 2018, BIOCHEM BIOPH RES CO, V501, P1048, DOI 10.1016/j.bbrc.2018.05.106; McArthur S, 2015, J IMMUNOL, V195, P1139, DOI 10.4049/jimmunol.1500733; McLimans KE, 2017, J ALZHEIMERS DIS, V56, P403, DOI 10.3233/JAD-160891; Mirendil H, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.33; Mirzoyan K, 2017, INFLAMMATION, V40, P1707, DOI 10.1007/s10753-017-0612-7; Moolenaar WH, 2013, BBA-MOL CELL BIOL L, V1831, P13, DOI 10.1016/j.bbalip.2012.09.013; Motiejunaite R, 2014, MICROVASC RES, V93, P62, DOI 10.1016/j.mvr.2014.03.003; Mouratis MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133619; Mulder C, 2003, J NEURAL TRANSM, V110, P949, DOI 10.1007/s00702-003-0007-9; Nagai J, 2011, J NEUROCHEM, V118, P256, DOI 10.1111/j.1471-4159.2011.07297.x; Nagai J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-78; Nahum S, 2011, CLIN EXP DERMATOL, V36, P188, DOI 10.1111/j.1365-2230.2010.03944.x; Nakao A, 2014, J INVEST DERMATOL, V134, P1745, DOI 10.1038/jid.2014.24; Nakasaki T, 2008, AM J PATHOL, V173, P1566, DOI 10.2353/ajpath.2008.071153; Nam SW, 2001, CANCER RES, V61, P6938; Navab M, 2015, J LIPID RES, V56, P871, DOI 10.1194/jlr.M056614; Ng W, 2014, J CLIN NEUROSCI, V21, P893, DOI 10.1016/j.jocn.2014.02.013; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; Nogaroli L, 2009, NEUROCHEM RES, V34, P182, DOI 10.1007/s11064-008-9772-z; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Ohuchi H, 2007, DEV DYNAM, V236, P1134, DOI 10.1002/dvdy.21119; Parimisetty A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0530-x; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Park R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10329; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ramesh S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071827; Ray R, 2017, BLOOD, V129, P1177, DOI 10.1182/blood-2016-10-743757; Reeves VL, 2015, OBESITY, V23, P2371, DOI 10.1002/oby.21232; Renback K, 2000, MOL BRAIN RES, V75, P350, DOI 10.1016/S0169-328X(99)00333-2; Robering JW, 2019, GLIA, V67, P999, DOI 10.1002/glia.23585; Saga H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093230; Salous AK, 2013, J LIPID RES, V54, P2775, DOI 10.1194/jlr.M039685; Sato K, 2005, J NEUROCHEM, V92, P904, DOI 10.1111/j.1471-4159.2004.02933.x; Savaskan NE, 2007, CELL MOL LIFE SCI, V64, P230, DOI 10.1007/s00018-006-6412-0; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Schleicher SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022182; Schmitz K, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0446-4; Shi J, 2013, BBA-MOL BASIS DIS, V1832, P29, DOI 10.1016/j.bbadis.2012.09.010; Shimizu Y, 2014, AM J PATHOL, V184, P1593, DOI 10.1016/j.ajpath.2014.01.029; Shimomura Y, 2009, EXP DERMATOL, V18, P218, DOI 10.1111/j.1600-0625.2008.00788.x; Shimura T, 2019, ANN CLIN BIOCHEM, V56, P240, DOI 10.1177/0004563218818197; Shinkuma S, 2010, HUM MUTAT, V31, P602, DOI 10.1002/humu.21235; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Spohr TCDSE, 2008, J BIOL CHEM, V283, P7470, DOI 10.1074/jbc.M707758200; Srikanth M, 2018, EUR J PHARMACOL, V841, P49, DOI 10.1016/j.ejphar.2018.10.005; St-Coeur PD, 2013, ARCH PHARM, V346, P91, DOI 10.1002/ardp.201200395; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Su J, 2015, SCAND J PAIN, V8, P53, DOI [10.1016/j.sjpain.2015.04.021, DOI 10.1016/J.SJPAIN.2015.04.021]; Sun YX, 2003, DEMENT GERIATR COGN, V16, P136, DOI 10.1159/000071001; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Szepanowski F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0612-9; Tabuchi S, 2000, NEUROCHEM RES, V25, P573, DOI 10.1023/A:1007542532395; Tabuchi S, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0059-5; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Thalman C, 2018, MOL PSYCHIATR, V23, P1699, DOI 10.1038/s41380-018-0053-1; Thirunavukkarasu K, 2017, OSTEOARTHR CARTILAGE, V25, P935, DOI 10.1016/j.joca.2016.09.006; Thirunavukkarasu K, 2016, J PHARMACOL EXP THER, V359, P207, DOI 10.1124/jpet.116.234013; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tokumura A, 2002, J LIPID RES, V43, P307; Tsukahara R, 2016, J PHARMACOL SCI, V132, P162, DOI 10.1016/j.jphs.2016.07.010; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; Ueda H, 2013, BBA-MOL CELL BIOL L, V1831, P61, DOI 10.1016/j.bbalip.2012.08.014; Umemura K, 2006, NEUROSCI LETT, V400, P97, DOI 10.1016/j.neulet.2006.02.008; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200; van Meeteren LA, 2008, CANCER LETT, V266, P203, DOI 10.1016/j.canlet.2008.02.052; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Velasco M, 2017, NEUROPHARMACOLOGY, V113, P608, DOI 10.1016/j.neuropharm.2016.04.002; Venkatraman G, 2015, FASEB J, V29, P772, DOI 10.1096/fj.14-262659; Vogt J, 2016, EMBO MOL MED, V8, P25, DOI 10.15252/emmm.201505677; Wang HYJ, 2010, RAPID COMMUN MASS SP, V24, P2057, DOI 10.1002/rcm.4620; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Weiner JA, 1998, J COMP NEUROL, V398, P587; Wheeler NA, 2016, ASN NEURO, V8, DOI 10.1177/1759091416669618; Wheeler NA, 2015, J NEUROSCI, V35, P11399, DOI 10.1523/JNEUROSCI.0345-15.2015; Woodcock JM, 2015, ONCOTARGET, V6, P14522, DOI 10.18632/oncotarget.3995; Wu JM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-71; Yao MJ, 2018, CELL MOL IMMUNOL, V15, P737, DOI 10.1038/cmi.2017.159; Ye XQ, 2012, FERTIL STERIL, V97, P757, DOI 10.1016/j.fertnstert.2011.12.004; Ye XQ, 2011, FERTIL STERIL, V95, P2107, DOI 10.1016/j.fertnstert.2011.02.024; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yeo JF, 2004, PAIN, V112, P148, DOI 10.1016/j.pain.2004.08.009; Yuelling LM, 2008, BBA-MOL CELL BIOL L, V1781, P525, DOI 10.1016/j.bbalip.2008.04.009; Yuelling LW, 2012, GLIA, V60, P1605, DOI 10.1002/glia.22381; Yukiura H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126734; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Zahednasab H, 2014, J NEUROIMMUNOL, V273, P120, DOI 10.1016/j.jneuroim.2014.06.006; Zheng HY, 2017, CARCINOGENESIS, V38, P1196, DOI 10.1093/carcin/bgx100	189	16	16	2	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2020	57	1			SI		372	392		10.1007/s12035-019-01719-1			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KV1HZ	WOS:000520176200033	31364025				2022-02-06	
J	Wang, ZY; Wilson, CM; Mendelev, N; Ge, YC; Galfalvy, H; Elder, G; Ahlers, S; Yarnell, AM; LoPresti, ML; Kamimori, GH; Carr, W; Haghighi, F				Wang, Zhaoyu; Wilson, Caroline M.; Mendelev, Natalia; Ge, Yongchao; Galfalvy, Hanga; Elder, Gregory; Ahlers, Stephen; Yarnell, Angela M.; LoPresti, Matthew L.; Kamimori, Gary H.; Carr, Walter; Haghighi, Fatemeh			Acute and Chronic Molecular Signatures and Associated Symptoms of Blast Exposure in Military Breachers	JOURNAL OF NEUROTRAUMA			English	Article						blast overpressure; epigenetics; sleep; tinnitus; traumatic brain injury	TRAUMATIC BRAIN-INJURY; LOW-LEVEL BLAST; NF-KAPPA-B; FACTOR 1A EXPRESSION; SLEEP DURATION; INNER-EAR; GENE; MILD; ACTIVATION; NEUROTRAUMA	Injuries from exposure to explosions rose dramatically during the Iraq and Afghanistan wars, which motivated investigations of blast-related neurotrauma and operational breaching. In this study, military "breachers" were exposed to controlled, low-level blast during a 10-day explosive breaching course. Using an omics approach, we assessed epigenetic, transcriptional, and inflammatory profile changes in blood from operational breaching trainees, with varying levels of lifetime blast exposure, along with daily self-reported symptoms (with tinnitus, headaches, and sleep disturbances as the most frequently reported). Although acute exposure to blast did not confer epigenetic changes, specifically in DNA methylation, differentially methylated regions (DMRs) with coordinated gene expression changes associated with lifetime cumulative blast exposures were identified. The accumulative effect of blast showed increased methylation of PAX8 antisense transcript with coordinated repression of gene expression, which has been associated with sleep disturbance. DNA methylation analyses conducted in conjunction with reported symptoms of tinnitus in the low versus high blast incidents groups identified DMRS in KCNE1 and CYP2E1 genes. KCNE1 and CYP2E1 showed the expected inverse correlation between DNA methylation and gene expression, which have been previously implicated in noise-related hearing loss. Although no significant transcriptional changes were observed in samples obtained at the onset of the training course relative to chronic cumulative blast, we identified a large number of transcriptional perturbations acutely pre- versus post-blast exposure. Acutely, 67 robustly differentially expressed genes (fold change >= 1.5), including UFC1 and YOD1 ubiquitin-related proteins, were identified. Inflammatory analyses of cytokines and chemokines revealed dysregulation of MCP-1, GCSF, HGF, MCSF, and RANTES acutely after blast exposure. These data show the importance of an omics approach, revealing that transcriptional and inflammatory biomarkers capture acute low-level blast overpressure exposure, whereas DNA methylation marks encapsulate chronic long-term symptoms.	[Wilson, Caroline M.; Mendelev, Natalia; Galfalvy, Hanga; Haghighi, Fatemeh] James J Peters VA Med Ctr, Med Epigenet, Bronx, NY USA; [Elder, Gregory] James J Peters VA Med Ctr, Neurol Serv, Bronx, NY USA; [Wang, Zhaoyu; Wilson, Caroline M.; Mendelev, Natalia; Haghighi, Fatemeh] Icahn Sch Med Mt Sinai, Nash Family Dept Neurosci, 1425 Madison Ave,Room 9-20D, New York, NY 10029 USA; [Ge, Yongchao; Elder, Gregory] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Elder, Gregory] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Galfalvy, Hanga] Columbia Univ, Dept Biostat Psychiat, New York, NY USA; [Yarnell, Angela M.; LoPresti, Matthew L.; Kamimori, Gary H.; Carr, Walter] Walter Reed Army Inst Res, Silver Spring, MD USA; [Ahlers, Stephen] Naval Med Res Ctr, Silver Spring, MD USA; [Carr, Walter] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA		Haghighi, F (corresponding author), Icahn Sch Med Mt Sinai, Nash Family Dept Neurosci, 1425 Madison Ave,Room 9-20D, New York, NY 10029 USA.	fatemeh.haghighi@mssm.edu	Ge, Yongchao/AAG-9317-2021; Galfalvy, Hanga/AAI-5492-2020	Ge, Yongchao/0000-0001-6448-5703; Galfalvy, Hanga/0000-0001-7156-6106; Mendelev, Natalia/0000-0001-8596-2986	U.S. Army Medical Research and Development Command/USAMRDC; Veterans Affairs Office of Research and Development; WRAIR; NMRCNational Medical Research Council, Singapore; United States Department of Veterans AffairsUS Department of Veterans Affairs [1IK6CX002074]; Veterans Affairs Merit Grants [RX001705, CX001395, BX003794, CX001728]; Veterans AffairsUS Department of Veterans Affairs [I01RX001705] Funding Source: NIH RePORTER	This work was supported by the U.S. Army Medical Research and Development Command/USAMRDC and the Veterans Affairs Office of Research and Development. This research was supported, in part, by an appointment to the Research Participation Program at the Walter Reed Army Institute of Research (WRAIR) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and Medical Research and Development Command/USAMRDC. The WRAIR and NMRC support further derives from Joint Program Committee Five intramural awards, The Development of Blast Exposure Standards, Evaluation of the Effects of High Level Overpressure (8+ psi) on Cognitive Performance, Brain Blood Biomarkers and Symptom Reporting, and Environmental Sensors in Training (ESiT). Dr. Haghighi is the recipient of a Research Career Scientist Award (#1IK6CX002074) from the United States Department of Veterans Affairs. Dr. Haghighi's research is supported by Veterans Affairs Merit Grants RX001705, CX001395, BX003794, and CX001728.	Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Beckelman BC, 2016, J ALZHEIMERS DIS, V54, P669, DOI 10.3233/JAD-160036; Beckelman BC, 2016, NEURODEGENER DIS, V16, P39, DOI 10.1159/000438925; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bukowska-Damska A, 2017, CHRONOBIOL INT, V34, P1211, DOI 10.1080/07420528.2017.1358176; Carr W, 2017, SHOCK WAVES, V27, P829, DOI 10.1007/s00193-017-0766-0; Carr W., 2018, 25 ANN M MIL ASP BAL; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cathomas F, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.8; Cedernaes J, 2015, J CLIN ENDOCR METAB, V100, pE1255, DOI [10.1210/jc.2015-2284, 10.1210/JC.2015-2284]; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doig J, 2013, FEBS J, V280, P6528, DOI 10.1111/febs.12554; Drake C, 2010, SLEEP, V33, P745, DOI 10.1093/sleep/33.6.745; Dubash AD, 2011, CURR BIOL, V21, pR529, DOI 10.1016/j.cub.2011.04.035; Edwards DS, 2016, INJURY, V47, P646, DOI 10.1016/j.injury.2015.12.021; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Fechter LD, 2004, JARO-J ASSOC RES OTO, V5, P90, DOI 10.1007/s10162-003-4028-8; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Frederic MY, 2009, HUM MUTAT, V30, P181, DOI 10.1002/humu.20794; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Gottlieb DJ, 2015, MOL PSYCHIATR, V20, P1232, DOI 10.1038/mp.2014.133; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Groh J, 2010, HUM MOL GENET, V19, P3530, DOI 10.1093/hmg/ddq269; Himes BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099625; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jones SE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006125; Kamnaksh A., 2014, TRANSL PROTEOM, V3, P22, DOI [10.1016/j.trprot.2013.11.001, DOI 10.1016/J.TRPROT.2013.11.001]; Kim YH, 2013, J GEN PHYSIOL, V142, P207, DOI 10.1085/jgp.201311019; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Kwon MJ, 2015, J NEUROSCI, V35, P15934, DOI 10.1523/JNEUROSCI.1924-15.2015; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Mathews ZR, 2015, J EMERG MED, V49, P573, DOI 10.1016/j.jemermed.2015.03.013; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Miller GE, 2008, BIOL PSYCHIAT, V64, P266, DOI 10.1016/j.biopsych.2008.03.017; Muessel MJ, 2002, MOL BRAIN RES, V103, P12, DOI 10.1016/S0169-328X(02)00158-4; MURTHY JMK, 1979, J NEUROSURG, V50, P260, DOI 10.3171/jns.1979.50.2.0260; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Newbery HJ, 2005, J NEUROPATH EXP NEUR, V64, P295, DOI 10.1093/jnen/64.4.295; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Orman MA, 2011, CYTOKINE, V56, P494, DOI 10.1016/j.cyto.2011.07.001; Pawelczyk M, 2012, INT J OCCUP MED ENV, V25, P356, DOI 10.2478/S13382-012-0061-3; Pedersen BS, 2012, BIOINFORMATICS, V28, P2986, DOI 10.1093/bioinformatics/bts545; Peirson SN, 2018, J NEUROSCI METH, V300, P26, DOI 10.1016/j.jneumeth.2017.04.007; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; R DEVELOPMENT CORE TEAM, 2014, R LANG ENV STAT COMP; Ramakrishnan NA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375832; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Ruiz-Llorente S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-147; Sand PG, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00041; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Seddik R, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412767; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Shanker T, 2007, NY TIMES; Shen HT, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00353; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsao Jack W, 2013, Neurol Clin Pract, V3, P30, DOI 10.1212/CPJ.0b013e318283ffa2; U.S. DIST. COURT W. DIST. OF N.Y, 2019, ANN BEN REP FISC YEA, P1; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Van Laer L, 2006, HUM MUTAT, V27, P786, DOI 10.1002/humu.20360; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318	80	16	16	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2020	37	10					1221	1232		10.1089/neu.2019.6742		DEC 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LL3VP	WOS:000506163700001	31621494	Green Published, hybrid, Green Submitted			2022-02-06	
J	Schmidt, JD; Weber, ML; Suggs, DW; Bierema, L; Miller, LS; Reifsteck, F; Courson, R; Hoff, R; Dill, K; Dunham, J				Schmidt, Julianne D.; Weber, Michelle L.; Suggs, David Welch, Jr.; Bierema, Laura; Miller, L. Stephen; Reifsteck, Fred; Courson, Ron; Hoff, Russel; Dill, Karli; Dunham, John			Improving Concussion Reporting across National College Athletic Association Divisions Using a Theory-Based, Data-Driven, Multimedia Concussion Education Intervention	JOURNAL OF NEUROTRAUMA			English	Article						concussion education; concussion non-disclosure; mild traumatic brain injury; socioecological model; sport culture	SCHOOL; SPORT; IMPLEMENTATION; KNOWLEDGE	Although a base level of knowledge is needed to recognize a concussion, knowledge-focused concussion educational materials ignore multifaceted barriers to concussion reporting. We compared student-athlete concussion reporting intentions and behaviors prior to and 1 year after exposure to an intervention or control treatment. We randomly assigned 891 collegiate student-athletes from three universities (Divisions I, II, III) to either the control group (National College Athletic Association [NCAA] Concussion Fact Sheet) or intervention group (theory-based, data-driven, multimedia, simulated concussion reporting module). A final sample of 520 student-athletes (control = 253, intervention = 267, expired eligibility = 189, left university = 182) completed intentions and behaviors surveys immediately prior to and 1 year after the educational intervention, and a second survey to assess the intervention effect. We compared intentions using 2 x 2 mixed model analyses of variance (ANOVAs). Behaviors and educational intervention effect were assessed using logistic regression models (alpha = 0.05). The intervention group had significantly improved concussion reporting intentions at 1-year follow-up relative to the control group (p = 0.009), but had similar odds for behaviors. The intervention group had 2.42 times greater odds of rating the module as "very effective," rather than "not effective" relative to the control group (95% confidence interval [CI]: 1.10,5.33). Relative to the control group, the intervention group had significantly greater odds of responding that the concussion education "greatly improved" rather than "did not improve" their knowledge (odds ratio [OR]: 2.49, 95% CI:1.25,4.96), attitudes (OR: 2.22, 95% CI: 1.23,4.03), self-efficacy (OR: 1.95,95% CI: 1.05,3.60), and intentions (OR: 1.86,95% CI: 1.03,3.35). The intervention was more effective at targeting elements of the overall sport culture in a way that substantively improved concussion reporting. We recommend use of this intervention in combination with other evidence-based educational materials.	[Schmidt, Julianne D.; Weber, Michelle L.] Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA; [Suggs, David Welch, Jr.] Univ Georgia, Dept Journalism, Athens, GA 30602 USA; [Bierema, Laura] Univ Georgia, Dept Lifelong Educ Adm & Policy, Athens, GA 30602 USA; [Miller, L. Stephen] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Reifsteck, Fred] Univ Georgia, Univ Hlth Ctr, Athens, GA 30602 USA; [Courson, Ron] Univ Georgia, Athlet Assoc, Sports Med, Athens, GA 30602 USA; [Hoff, Russel] Valdosta State Univ, Coll Nursing & Hlth Sci, Valdosta, GA USA; [Dill, Karli; Dunham, John] Emory Univ Sports Med, Atlanta, GA USA		Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu		Suggs, Jr., David Welch/0000-0002-0133-9191	National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults	This project was conducted with support from the National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Caron JG, 2018, J SPORT SCI, V36, P48, DOI 10.1080/02640414.2017.1280180; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Elliott RJS, 2016, COGENT EDUC, V3, DOI 10.1080/2331186X.2016.1256141; Hunt TN., 2015, ATHLETIC TRAIN ED J, V10, P65, DOI [10.4085/100165, DOI 10.4085/100165]; Kroshus E, 2014, BRIT J SPORT MED, V48, P1, DOI [10.1136/bjsports-2013-093253, DOI 10.1136/BJSPORTS-2013-093253]; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sullivan L, 2018, HEALTH EDUC RES, V33, P492, DOI 10.1093/her/cyy034; Wallace J, 2019, HEALTH EDUC J, V78, P315, DOI 10.1177/0017896918806935; Weber ML, 2019, BRAIN INJURY, V33, P592, DOI 10.1080/02699052.2019.1568573	24	16	16	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2020	37	4					593	599		10.1089/neu.2019.6637		NOV 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	KI3UL	WOS:000496492800001	31597536				2022-02-06	
J	Sabirzhanov, B; Matyas, J; Coll-Miro, M; Yu, LL; Faden, AI; Stoica, BA; Wu, JF				Sabirzhanov, Boris; Matyas, Jessica; Coll-Miro, Marina; Yu, Laina Lijia; Faden, Alan, I; Stoica, Bogdan A.; Wu, Junfang			Inhibition of microRNA-711 limits angiopoietin-1 and Akt changes, tissue damage, and motor dysfunction after contusive spinal cord injury in mice	CELL DEATH & DISEASE			English	Article							TRAUMATIC BRAIN-INJURY; NEURONAL CELL-DEATH; FUNCTIONAL RECOVERY; DOWN-REGULATION; LOCOMOTOR FUNCTION; NEUROPATHIC PAIN; GENE-EXPRESSION; UP-REGULATION; ACTIVATION; ANGIOGENESIS	Spinal cord injury (SCI) causes neuronal cell death and vascular damage, which contribute to neurological dysfunction. Given that many biochemical changes contribute to such secondary injury, treatment approaches have increasingly focused on combined therapies or use of multi-functional drugs. MicroRNAs (miRs) are small (20-23 nucleotide), non-protein-coding RNAs and can negatively regulate target gene expression at the post-transcriptional level. As individual miRs can potentially modulate expression of multiple relevant proteins after injury, they are attractive candidates as upstream regulators of the secondary SCI progression. In the present study we examined the role of miR-711 modulation after SCI. Levels of miR-711 were increased in injured spinal cord early after SCI, accompanied by rapid downregulation of its target angiopoietin-1 (Ang-1), an endothelial growth factor. Changes of miR-711 were also associated with downregulation of the pro-survival protein Akt (protein kinase B), another target of miR-711, with sequential activation of glycogen synthase kinase 3 and the pro-apoptotic BH3-only molecule PUMA. Central administration of a miR-711 hairpin inhibitor after SCI limited decreases of Ang-1/Akt expression and attenuated apoptotic pathways. Such treatment also reduced neuronal/axonal damage, protected microvasculature and improved motor dysfunction following SCI. In vitro, miR-711 levels were rapidly elevated by neuronal insults, but not by activated microglia and astrocytes. Together, our data suggest that post-traumatic miR-711 elevation contributes to neuronal cell death after SCI, in part by inhibiting Ang-1 and Akt pathways, and may serve as a novel therapeutic target.	[Sabirzhanov, Boris; Matyas, Jessica; Coll-Miro, Marina; Yu, Laina Lijia; Faden, Alan, I; Stoica, Bogdan A.; Wu, Junfang] Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Sabirzhanov, Boris; Matyas, Jessica; Coll-Miro, Marina; Yu, Laina Lijia; Faden, Alan, I; Stoica, Bogdan A.; Wu, Junfang] Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Faden, Alan, I; Wu, Junfang] Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA		Wu, JF (corresponding author), Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.; Wu, JF (corresponding author), Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA.; Wu, JF (corresponding author), Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA.	junfang.wu@som.umaryland.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS094527, 2R01 NR013601, R01 NS110635, R01 NS110567, RF1 NS110637, R01 NS096002]; Craig H. Nielson Foundation Research [340442]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RF1NS110637, R01NS096002, R01NS110567, R01NS110635, R01NS094527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013601] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work was supported by the National Institutes of Health Grants R01 NS094527 (J.W.), 2R01 NR013601 (J.W./A.I.F.), R01 NS110635 (J.W./A.I.F.), R01 NS110567 (J.W.), RF1 NS110637 (J.W.), R01 NS096002 (B.A.S./B.S.), and Craig H. Nielson Foundation Research (340442) (A.I.F.).	Ambacher KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046885; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Caballero-Garrido E, 2015, J NEUROSCI, V35, P12446, DOI 10.1523/JNEUROSCI.1641-15.2015; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chan WM, 2013, TRANSL STROKE RES, V4, P447, DOI 10.1007/s12975-012-0249-7; Chen JL, 2007, ANN NEUROL, V62, P49, DOI 10.1002/ana.21160; Christopher Ajay Francis, 2016, Perspect Clin Res, V7, P68, DOI 10.4103/2229-3485.179431; Datto JP, 2015, J NEUROTRAUM, V32, P1146, DOI 10.1089/neu.2014.3702; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Esau CC, 2007, ADV DRUG DELIVER REV, V59, P101, DOI 10.1016/j.addr.2007.03.007; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Farooque M, 2006, SPINAL CORD, V44, P182, DOI 10.1038/sj.sc.3101816; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Griffiths-Jones S, 2007, ANNU REV GENOM HUM G, V8, P279, DOI 10.1146/annurev.genom.8.080706.092419; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; He ZG, 2010, J BIOMED RES, V24, P2, DOI 10.1016/S1674-8301(10)60002-4; Henshall DC, 2014, CURR OPIN NEUROL, V27, P199, DOI 10.1097/WCO.0000000000000079; Herrera JJ, 2010, J NEUROTRAUM, V27, P2067, DOI 10.1089/neu.2010.1403; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Hu JZ, 2015, BRAIN RES, V1608, P191, DOI 10.1016/j.brainres.2015.02.036; Hu JY, 2016, ONCOL LETT, V11, P2155, DOI 10.3892/ol.2016.4217; Hu LY, 2010, NEUROSCIENCE, V169, P1046, DOI 10.1016/j.neuroscience.2010.05.046; Jee MK, 2012, HUM GENE THER, V23, P508, DOI 10.1089/hum.2011.121; Jee MK, 2012, BRAIN, V135, P1237, DOI 10.1093/brain/aws047; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Kosacka J, 2005, CELL TISSUE RES, V320, P11, DOI 10.1007/s00441-004-1068-2; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Liao AJ, 2016, ONCOTARGET, V7, P5842, DOI 10.18632/oncotarget.6813; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Liu S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0469-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Matyas JJ, 2017, J NEUROSCI, V37, P3956, DOI 10.1523/JNEUROSCI.3353-16.2017; Mirnezami AHF, 2009, EJSO-EUR J SURG ONC, V35, P339, DOI 10.1016/j.ejso.2008.06.006; Mochizuki N, 2009, CIRC J, V73, P2183, DOI 10.1253/circj.CJ-09-0666; Mohite A, 2011, BIOCHEMISTRY-US, V50, P1691, DOI 10.1021/bi101654w; Nambu H, 2004, GENE THER, V11, P865, DOI 10.1038/sj.gt.3302230; Nawabi H, 2012, GENE DEV, V26, P1509, DOI 10.1101/gad.198150.112; Nieto-Diaz M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00053; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Ohtake Y, 2014, BIOMATERIALS, V35, P4610, DOI 10.1016/j.biomaterials.2014.02.037; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Ponomarev ED, 2013, GLIA, V61, P91, DOI 10.1002/glia.22363; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sabirzhanov B, 2018, J NEUROTRAUM, V35, P2462, DOI 10.1089/neu.2017.5572; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Sipski ML, 2004, ARCH PHYS MED REHAB, V85, P1826, DOI 10.1016/j.apmr.2004.04.031; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tranter M, 2011, J BIOL CHEM, V286, P29828, DOI 10.1074/jbc.M111.221796; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Walker Chandler L, 2013, Front Biol (Beijing), V8, DOI 10.1007/s11515-013-1255-1; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Wang C, 2016, BIOORG MED CHEM LETT, V26, P1287, DOI 10.1016/j.bmcl.2016.01.015; Weiler J, 2006, GENE THER, V13, P496, DOI 10.1038/sj.gt.3302654; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Wu JF, 2016, J NEUROTRAUM, V33, P1919, DOI 10.1089/neu.2015.4348; Wu JF, 2015, CELL CYCLE, V14, P3698, DOI 10.1080/15384101.2015.1104436; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Wu JF, 2013, J NEUROSCI, V33, P12447, DOI 10.1523/JNEUROSCI.0846-13.2013; Wu JF, 2013, NEUROTHERAPEUTICS, V10, P520, DOI 10.1007/s13311-013-0198-1; Wu JF, 2011, NEUROTHERAPEUTICS, V8, P221, DOI 10.1007/s13311-011-0028-2; Xu LJ, 2015, EXP NEUROL, V264, P1, DOI 10.1016/j.expneurol.2014.11.007; Yan T, 2012, NEUROBIOL DIS, V46, P157, DOI 10.1016/j.nbd.2012.01.001; Yu FS, 2005, NEUROBIOL DIS, V20, P491, DOI 10.1016/j.nbd.2005.04.004; Zhou LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079805; Ziu MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014724	77	16	17	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	NOV 4	2019	10								839	10.1038/s41419-019-2079-y			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	JP0OB	WOS:000497970400012	31685802	Green Published, gold			2022-02-06	
J	Kontos, AP; Elbin, RJ; Sufrinko, A; Marchetti, G; Holland, CL; Collins, MW				Kontos, Anthony P.; Elbin, R. J.; Sufrinko, Alicia; Marchetti, Gregory; Holland, Cyndi L.; Collins, Michael W.			Recovery Following Sport-Related Concussion: Integrating Pre- and Postinjury Factors Into Multidisciplinary Care	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; modifiers; mTBI; recovery; risk factors	PREDICT PROTRACTED RECOVERY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; SEX-DIFFERENCES; BASE-LINE; POSTTRAUMATIC MIGRAINE; PROLONGED RECOVERY; FOOTBALL PLAYERS; SYMPTOMS; EPIDEMIOLOGY	Objective: Update concussion recovery curves by considering pre- and postinjury modifying factors. Determine whether there is a dose-response for modifying factors on recovery. Setting: Sports medicine concussion clinic. Participants: A total of 314 athletes aged 12-23 years within 7 days of a concussion enrolled between 2015 and 2018. Design: Prospective cohort study. Main Measures: Categorical recovery time defined as days from injury to full medical clearance for return to play per established criteria. Preinjury factors included age, gender, concussion history, and migraine history. Postinjury factors included loss of consciousness, posttraumatic amnesia, posttraumatic migraine symptoms, and high symptom burden. Results: Average recovery was 27.5 25 days. Five factors were prognostic of recovery: (1) younger than 18 years, (2) female, (3) history of migraine, (4) posttraumatic migraine symptoms, and (5) high symptom burden (P < .05). Recovery percentage at 21 days after injury was 96.7% for participants with 0 factor, 65.3% for those with 1 to 2, and 31.8% for those with 3 to 5-with prognostic separation in low- to high-risk groups of 62%. Conclusions: Findings support a dose-response for combined pre- and postinjury factors on recovery. Both the type and quantity of modifying factors influence recovery and should be considered in prognosis and approaches to multidisciplinary care.	[Kontos, Anthony P.; Sufrinko, Alicia; Collins, Michael W.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Kontos, Anthony P.; Sufrinko, Alicia; Holland, Cyndi L.; Collins, Michael W.] UPMC, Sports Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sports Concuss Res, Fayetteville, AR 72701 USA; [Marchetti, Gregory] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA		Kontos, AP (corresponding author), UPMC, Sports Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu			University of Pittsburgh from the National Football League; University of Arkansas from Brain Scope	Dr Collins is a shareholder of ImPACT Applications, Inc. Drs Kontos and Collins receive royalties from APA Books and research support through the University of Pittsburgh from the National Football League. Dr Elbin receives research support through the University of Arkansas from Brain Scope. None of the other authors have any conflicts of interest to declare.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Baugh CM, 2018, SPORTS HEALTH, V10, P60, DOI 10.1177/1941738117733685; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Elbin R, 2015, PERSPECT NEUROPHYSIO, V25, P4, DOI DOI 10.1044/NNSLD25.1.4; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Putukian M, 2021, CLIN J SPORT MED, V31, P15, DOI 10.1097/JSM.0000000000000705; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Seifert T, 2018, HAND CLINIC, V158, P119, DOI 10.1016/B978-0-444-63954-7.00012-4; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Tan CK, 2003, J CLIN ONCOL, V21, P2294, DOI 10.1200/JCO.2003.03.151; Terry DP, 2019, J NEUROTRAUM, V36, P142, DOI 10.1089/neu.2017.5443; Vetvik KG, 2017, LANCET NEUROL, V16, P76, DOI 10.1016/S1474-4422(16)30293-9; Weitzel K W, 2001, J Gend Specif Med, V4, P64; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	37	16	16	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					394	401		10.1097/HTR.0000000000000536			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200009	31479086				2022-02-06	
J	Tropeano, MP; Spaggiari, R; Ileyassoff, H; Park, KB; Kolias, AG; Hutchinson, PJ; Servadei, F				Tropeano, Maria Pia; Spaggiari, Riccardo; Ileyassoff, Hernan; Park, Kee B.; Kolias, Angelos G.; Hutchinson, Peter J.; Servadei, Franco			A comparison of publication to TBI burden ratio of low- and middle-income countries versus high-income countries: how can we improve worldwide care of TBI?	NEUROSURGICAL FOCUS			English	Article						global neurosurgery; traumatic brain injury; publication; LMICs; research	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; EPIDEMIOLOGY	OBJECTIVE Traumatic brain injury (TBI) is a global public health problem and more than 70% of trauma-related deaths are estimated to occur in low- and middle-income countries (LMICs). Nevertheless, there is a consistent lack of data from these countries. The aim of this work is to estimate the capacity of different and heterogeneous areas of the world to report and publish data on TBI. In addition, we wanted to estimate the countries with the highest and lowest number of publications when taking into account the relative TBI burden. METHODS First, a bibliometric analysis of all the publications about TBI available in the PubMed database from January 1, 2008, to December 31, 2018, was performed. These data were tabulated by country and grouped according to each geographical region as indicated by the WHO: African Region (AFR), Region of the Americas (PAH), South-East Asia Region (SEAR), European Region (EUR), Eastern Mediterranean Region (EMR), and Western Pacific Region (WPR). In this analysis, PAH was further subdivided into Latin America (AMR-L) and North America (AMR-US/Can). Then a "publication to TBI volume ratio" was derived to estimate the research interest in TBI with respect to the frequency of this pathology. RESULTS Between 2008 and 2018 a total of 8144 articles were published and indexed in the PubMed database about TBI. Leading WHO regions in terms of contributions were AMR-US/Can with 4183 articles (51.36%), followed by EUR with 2003 articles (24.60%), WPR with 1507 (18.50%), AMR-L with 141 articles (1.73%), EMR with 135 (1.66%), AFR with 91 articles (1.12%), and SEAR with 84 articles (1.03%). The highest publication to TBI volume ratios were found for AMR-US/Can (90.93) and EUR (21.54), followed by WPR (8.71) and AMR-L (2.43). Almost 90 times lower than the ratio of AMR-US/Can were the ratios for AFR (1.15) and SEAR (0.46). CONCLUSIONS An important disparity currently exists between countries with a high burden of TBI and those in which most of the research is conducted. A call for improvement of data collection and research outputs along with an increase in international collaboration could quantitatively and qualitatively improve the ability of LMICs to ameliorate TBI care and develop clinical practice guidelines.	[Tropeano, Maria Pia; Spaggiari, Riccardo; Ileyassoff, Hernan; Servadei, Franco] Humanitas Clin & Res Hosp, Dept Neurosurg, Milan, Italy; [Tropeano, Maria Pia; Spaggiari, Riccardo; Ileyassoff, Hernan; Servadei, Franco] Humanitas Univ, Milan, Italy; [Park, Kee B.] Harvard Med Sch, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Global Neurosurg Initiat, Boston, MA 02115 USA; [Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Natl Inst Hlth Res, Global Hlth Res Grp Neurotrauma, Cambridge, England; [Kolias, Angelos G.; Hutchinson, Peter J.] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Cambridge, England		Spaggiari, R (corresponding author), Humanitas Clin & Res Hosp, Rozzano, Italy.; Spaggiari, R (corresponding author), Humanitas Univ, Rozzano, Italy.	rickyspaggio945@gmail.com		Spaggiari, Riccardo/0000-0001-6069-7514; Kolias, Angelos/0000-0003-3992-0587			Adeleye AO, 2016, J NEUROL SURG PART A, V77, P167, DOI 10.1055/s-0035-1566115; Al-Shahi R, 2001, BRIT MED J, V323, P1461, DOI 10.1136/bmj.323.7327.1461; Alali AS, 2019, J NEUROSURG, V131, P612, DOI 10.3171/2018.4.JNS173166; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; Cnossen MC, 2017, J REHABIL MED, V49, P395, DOI 10.2340/16501977-2216; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corley J, 2019, WORLD NEUROSURG, V123, P295, DOI 10.1016/j.wneu.2018.12.042; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; El-Menyar A, 2017, WORLD NEUROSURG, V107, P6, DOI [10.1016/J.WNEU.2017.07.070, 10.1016/j.wneu.2017.07.070]; Hauptman JS, 2011, J NEUROSURG, V115, P1262, DOI 10.3171/2011.8.JNS11857; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Li L, 2018, WORLD NEUROSURG, V113, pE82, DOI 10.1016/j.wneu.2018.01.164; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Peeters S, 2017, WORLD NEUROSURG, V97, P580, DOI 10.1016/j.wneu.2016.09.127; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Salhab Hamza A, 2018, eNeurologicalSci, V13, P40, DOI 10.1016/j.ensci.2018.11.010; Servadei F, 2019, WORLD NEUROSURG; Servadei F, 2018, WORLD NEUROSURG, V112, P315, DOI 10.1016/j.wneu.2018.01.047; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028	28	16	16	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E5	10.3171/2019.8.FOCUS19507			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900005	31675715	gold			2022-02-06	
J	Asken, BM; Brooke, ZS; Stevens, TC; Silvestri, PG; Graham, MJ; Jaffee, MS; Clugston, JR				Asken, Breton M.; Brooke, Zechariah S.; Stevens, Taylor C.; Silvestri, Paul G.; Graham, Matthew J.; Jaffee, Michael S.; Clugston, James R.			Drill-Specific Head Impacts in Collegiate Football Practice: Implications for Reducing "Friendly Fire" Exposure	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						HIT System; Subconcussive; Concussion; Repetitive head impact exposure; Football practice drills; Impact frequency	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL FOOTBALL; DIVISION-I; YOUTH; CONCUSSION; SYSTEM; ACCURACY; PLAYERS; SEASON	This study investigated drill-specific head impact biomechanics in a Division 1 collegiate football team using the Head Impact Telemetry System (HITS). A total of 32,083 impacts were recorded across 2 years of practices. Precise tracking of instrumented athletes, head impacts, and drill participation allowed quantification of hits sustained per person per minute (H/P/M) for each specific drill. We found significant H/P/M variability between 14 drills and player position, ranging from 0.02 to 0.41 H/P/M for Linemen and 0.01 to 0.15 H/P/M for Non-Linemen. Impact magnitude data are also reported for practice term (Spring, Training Camp, In-Season) and dress-type (Helmets Only, Spyders, Shells, Full Pads). Recommendations for shortening high-risk drills, based on H/P/M drill impact frequencies, suggest possible "friendly fire" reductions of 1000 impacts for Linemen and 300 impacts for Non-Linemen over their collegiate career. Over 80% of potentially avoidable head impacts were attributable to just three drills-"Team Run," "Move the Field," and "Team." Recommending drill-specific modifications based on practical considerations (the drill's impact frequency, dress-types when performing the drill, and duration) could improve acceptance from coaches and efficiently reduce head impact exposure without drastically altering overall practice structure.	[Asken, Breton M.] Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA; [Brooke, Zechariah S.; Silvestri, Paul G.; Graham, Matthew J.; Clugston, James R.] Univ Florida, Univ Athlet Assoc, Gainesville, FL 32610 USA; [Stevens, Taylor C.] Univ Florida, Appl Physiol & Kinesiol, Gainesville, FL 32610 USA; [Jaffee, Michael S.] Univ Florida, Dept Neurol, Gainesville, FL 32610 USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL 32610 USA		Asken, BM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	basken8@phhp.ufl.edu		Asken, Breton/0000-0001-8419-142X; Clugston, James/0000-0002-2103-1039			Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Duma SM, 2014, J BIOMECH, V47, P1557, DOI 10.1016/j.jbiomech.2013.08.022; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Grissom RJ, 2012, EFFECT SIZES FOR RESEARCH: UNIVARIATE AND MULTIVARIATE APPLICATIONS, 2ND EDITION, P177; Hosick M., DI COUNCIL VOTES ELI; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06	33	16	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2019	47	10			SI		2094	2108		10.1007/s10439-018-2088-5			15	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JQ0HT	WOS:000498636800006	29987539				2022-02-06	
J	Wang, DP; Yin, H; Lin, Q; Fang, SP; Shen, JH; Wu, YF; Su, SH; Hai, J				Wang, Da-Peng; Yin, Hang; Lin, Qi; Fang, Shu-Ping; Shen, Jian-Hua; Wu, Yi-Fang; Su, Shao-Hua; Hai, Jian			Andrographolide enhances hippocampal BDNF signaling and suppresses neuronal apoptosis, astroglial activation, neuroinflammation, and spatial memory deficits in a rat model of chronic cerebral hypoperfusion	NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY			English	Article						Andrographolide; Chronic cerebral hypoperfusion; Astrocyte; Cognitive impairment; BDNF signaling	COGNITIVE IMPAIRMENT; NEUROVASCULAR UNIT; BRAIN-INJURY; DYSFUNCTION; CELLS; NEURODEGENERATION; INFLAMMATION; PANICULATA; EXPRESSION; DAMAGE	Andrographolide is a medical herbal compound with documented anti-inflammatory activity and therapeutic efficacy in animal models of Alzheimer's disease, traumatic brain injury, and ischemic stroke. The present study examined the potential therapeutic effects of andrographolide on chronic cerebral hypoperfusion (CCH)-induced hippocampal neuronal damage and cognitive dysfunction. A CCH model was established in male Sprague Dawley (SD) rats using 2-vessel occlusion (2VO). After 4 weeks of CCH, spatial learning and memory were assessed in the Morris water maze and structural damage to the hippocampus by hematoxylin and eosin (HE) staining. Astrocyte activation was examined by immunohistochemical staining and Western blotting for glial fibrillary acid protein (GFAP), while expression levels of the pro-inflammatory cytokine-tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta), the apoptosis effector cysteinyl aspartate specific proteinase-3 (caspase-3), and the neuroprotectant brain-derived neurotrophic factor (BDNF) and the TrkB receptor were estimated by Western blotting. After 4 weeks of CCH, the hippocampus of 2VO rats exhibited marked neurodegeneration as well as elevated GFAP, TNF-alpha, IL-1 beta, and caspase-3 compared to Sham controls. In addition, spatial learning was impaired compared to Sham controls. Andrographolide treatment during CCH suppressed astrocyte activation as evidenced by reduced GFAP expression, enhanced expression of BDNF and TrkB, improved impaired spatial learning and memory, and reversed upregulated TNF-alpha, IL-1 beta, and caspase-3 expression. These results reveal a potential neuroprotective effect of andrographolide on hippocampal neuronal damage and cognitive impairment from CCH due to suppression of astrocyte activation and enhancement of BDNF-TrkB signaling.	[Wang, Da-Peng; Wu, Yi-Fang; Su, Shao-Hua; Hai, Jian] Tongji Univ, Tong Ji Hosp, Sch Med, Dept Neurosurg, 389 Xincun Rd, Shanghai 200065, Peoples R China; [Yin, Hang] Zao Zhuang Municipal Hosp, Dept Neurosurg, Zaozhuang 277000, Shandong, Peoples R China; [Lin, Qi] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharm, Shanghai 200025, Peoples R China; [Fang, Shu-Ping] Feng Cheng Hosp, Dept Neurosurg, Shanghai 201499, Peoples R China; [Shen, Jian-Hua] Nantong Univ, Affiliated Dongtai Hosp, Dept Neurosurg, Nantong 224200, Jiangsu, Peoples R China		Wang, DP; Hai, J (corresponding author), Tongji Univ, Tong Ji Hosp, Sch Med, Dept Neurosurg, 389 Xincun Rd, Shanghai 200065, Peoples R China.	wdpboj@126.com; haijiandoct@zoho.com.cn	Wang, Da-Peng/V-4701-2019	Wang, Da-Peng/0000-0001-5213-4949	National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771410]; Priority of Shanghai key discipline of medicine [2017ZZ02020]	This work received funding from the National Nature Science Foundation of China (81771410) and Priority of Shanghai key discipline of medicine (2017ZZ02020).	Bertoglio JC, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0595-2; Chan SJ, 2010, BRIT J PHARMACOL, V161, P668, DOI 10.1111/j.1476-5381.2010.00906.x; Chern CM, 2011, PLANTA MED, V77, P1669, DOI 10.1055/s-0030-1271019; Das S, 2017, J NEUROIMMUNOL, V313, P161, DOI 10.1016/j.jneuroim.2017.11.003; de Pins B, 2019, J NEUROSCI; Du J, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20177061, 10.1590/1414-431x20177061]; Duncombe J, 2017, CLIN SCI, V131, P2451, DOI 10.1042/CS20160727; El Hayek L, 2019, J NEUROSCI; Fletcher JL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124131; Geng J, 2018, BIOMED PHARMACOTHER, V97, P1032, DOI 10.1016/j.biopha.2017.11.039; Goncalves CA, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01035; Graverini G, 2018, COLLOID SURFACE B, V161, P302, DOI 10.1016/j.colsurfb.2017.10.062; Gu L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113324; Hancke JL, 2019, PHYTOTHER RES, V33, P1469, DOI 10.1002/ptr.6339; Hase Y, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0666-x; Huang L, 2019, INT J MOL SCI, V20; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Kim JH, 2017, GLIA, V65, P1471, DOI 10.1002/glia.23174; Lin HC, 2019, PHYTOMEDICINE, V52, P157, DOI 10.1016/j.phymed.2018.09.205; Liu WC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1396-5; Liu Y, 2018, THERANOSTICS, V8, P6355, DOI 10.7150/thno.30953; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Mansilla A, 2018, J NEUROGENET, V32, P155, DOI 10.1080/01677063.2018.1506781; Ojha CR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208543; Paemanee A, 2019, BIOMED PHARMACOTHER, V109, P322, DOI 10.1016/j.biopha.2018.10.054; Piazzini V, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10030128; Ray AK, 2017, GLIA, V65, P2051, DOI 10.1002/glia.23214; Seo EJ, 2019, PHYTOMEDICINE, V55, P80, DOI 10.1016/j.phymed.2018.10.022; Serrano FG, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-61; Siuda J, 2017, NEUROL NEUROCHIR POL, V51, P24, DOI 10.1016/j.pjnns.2016.10.001; Trias Emiliano, 2018, Clin Exp Neuroimmunol, V9, P225, DOI 10.1111/cen3.12476; Varela-Nallar L, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/935403; Wan Q, 2017, MOL NEUROBIOL, V54, P2889, DOI 10.1007/s12035-016-9868-4; Wang DP, 2018, PSYCHIAT RES, V267, P281, DOI 10.1016/j.psychres.2018.06.012; Wang DP, 2017, BIOMED PHARMACOTHER, V91, P872, DOI 10.1016/j.biopha.2017.05.021; Wang DP, 2017, NEUROSCIENCE, V344, P293, DOI 10.1016/j.neuroscience.2016.12.034; Wang H., 2018, APPL PHYS A, V124, P1, DOI DOI 10.1080/13880209.2018.1426614; Wang L, 2017, NEUROMOL MED, V19, P423, DOI 10.1007/s12017-017-8458-6; Wang TG, 2004, J PHARMACOL EXP THER, V308, P975, DOI 10.1124/jpet.103.059683; Wang YH, 2019, NEURAL REGEN RES, V14, P470, DOI 10.4103/1673-5374.245471; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Xie YC, 2018, J ALZHEIMERS DIS, V66, P1559, DOI 10.3233/JAD-180782; Xu FB, 2016, MOL MED REP, V14, P3573, DOI 10.3892/mmr.2016.5717; Yang C. H, 2017, INT J MOL SCI, V18, P8; Yen TL, 2016, TRANSL RES, V170, P57, DOI 10.1016/j.trsl.2015.12.002; Yen TL, 2013, PHARM BIOL, V51, P1150, DOI 10.3109/13880209.2013.782051	46	16	18	2	21	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-1298	1432-1912		N-S ARCH PHARMACOL	Naunyn-Schmiedebergs Arch. Pharmacol.	OCT	2019	392	10					1277	1284		10.1007/s00210-019-01672-9			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	IY3AH	WOS:000486263400007	31187188				2022-02-06	
J	Wang, Y; Nencka, AS; Meier, TB; Guskiewicz, K; Mihalik, JP; Brooks, MA; Saykin, AJ; Koch, KM; Wu, YC; Nelson, LD; McAllister, TW; Broglio, SP; McCrea, MA				Wang, Yang; Nencka, Andrew S.; Meier, Timothy B.; Guskiewicz, Kevin; Mihalik, Jason P.; Brooks, M. Alison; Saykin, Andrew J.; Koch, Kevin M.; Wu, Yu-Chien; Nelson, Lindsay D.; McAllister, Thomas W.; Broglio, Steven P.; McCrea, Michael A.			Cerebral blood flow in acute concussion: preliminary ASL findings from the NCAA-DoD CARE consortium	BRAIN IMAGING AND BEHAVIOR			English	Article						Cerebral blood flow; Concussion; Traumatic brain injury; Arterial spin labeling; Contact sport; MRI	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; PERFUSION; RECOVERY; MRI; AUTOREGULATION; STATEMENT	Sport-related concussion (SRC) has become a major health problem, affecting millions of athletes each year. Despite the increasing occurrence and prevalence of SRC, its underlying mechanism and recovery course have yet to be fully elucidated. The National Collegiate Athletic Association-Department of Defense Grand Alliance: Concussion Assessment, Research and Education (CARE) Consortium is a large-scale, multisite study of the natural history of concussion across multiple sports. The Advanced Research Core (ARC) of CARE is focused on the advanced biomarker assessment of a reduced subject cohort. This paper reports findings from two ARC sites to evaluate cerebral blood flow (CBF) changes in acute SRC, as measured using advanced arterial spin labeling (ASL) magnetic resonance imaging (MRI). We compared relative CBF maps assessed in 24 concussed contact sport athletes obtained at 24-48 h after injury to those of a control group of 24 matched contact sport players. Significantly less CBF was detected in several brain regions in concussed athletes, while clinical assessments also indicated clinical symptom and performance impairments in SRC patients. Correlations were found between decreased CBF in acute SRC and clinical assessments, including Balance Error Scoring System total score and Immediate Post-Concussion Assessment and Cognitive Test memory composite and impulse control composite scores, as well as days from injury to asymptomatic. Although using different ASL MRI sequences, our preliminary results from two sites are consistent with previous reports and suggest that advanced ASL MRI methods might be useful for detecting acute neurobiological changes in acute SRC.	[Wang, Yang; Nencka, Andrew S.; Koch, Kevin M.] Med Coll Wisconsin, Dept Radiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Meier, Timothy B.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Guskiewicz, Kevin; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, 250 East Franklin St, Chapel Hill, NC 27515 USA; [Brooks, M. Alison] Univ Wisconsin, Dept Orthoped & Rehabil, Sch Med & Publ Hlth, 750 Highland Ave, Madison, WI USA; [Saykin, Andrew J.; Wu, Yu-Chien] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, 340 West 10th St, Indianapolis, IN 46202 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, 340 West 10th St, Indianapolis, IN 46202 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA		Wang, Y (corresponding author), Med Coll Wisconsin, Dept Radiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	yangwang@mcw.edu	Koch, Kevin/AAD-6403-2021		National Collegiate Athletic Association-Department of Defense Grand Alliance; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG053993] Funding Source: NIH RePORTER	This study was funded as part of the National Collegiate Athletic Association-Department of Defense Grand Alliance.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Aslan S, 2010, MAGN RESON IMAGING, V28, P928, DOI 10.1016/j.mri.2010.03.037; Asllani I, 2009, HUM BRAIN MAPP, V30, P2927, DOI 10.1002/hbm.20719; Asllani I, 2008, MAGN RESON MED, V60, P1362, DOI 10.1002/mrm.21670; Audenaert K., 2003, MED SCI MONITOR, V9, P112; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Chen G, 2012, NEUROIMAGE, V60, P747, DOI 10.1016/j.neuroimage.2011.12.060; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Chow HM, 2013, P NATL ACAD SCI USA, V110, P10300, DOI 10.1073/pnas.1217691110; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Dijkhuizen RM, 2011, TRANSL STROKE RES, V2, P524, DOI 10.1007/s12975-011-0130-0; Donahue MJ, 2006, NMR BIOMED, V19, P1043, DOI 10.1002/nbm.1075; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2014, PROG NEUROL SURG, V28, P112, DOI 10.1159/000358769; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGoron Anthony J, 2008, BMC Med Imaging, V8, P4, DOI 10.1186/1471-2342-8-4; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; Nencka AS, 2018, BRAIN IMAGING BEHAV, V12, P1121, DOI 10.1007/s11682-017-9775-y; Okonkwo OC, 2014, CEREB CORTEX, V24, P978, DOI 10.1093/cercor/bhs381; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Vidorreta M, 2013, NEUROIMAGE, V66, P662, DOI 10.1016/j.neuroimage.2012.10.087; Wang DJJ, 2012, STROKE, V43, P1018, DOI 10.1161/STROKEAHA.111.631929; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Wu WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082679; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE	61	16	16	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	OCT	2019	13	5					1375	1385		10.1007/s11682-018-9946-5			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IW4OO	WOS:000484959700018	30159767	Green Accepted, Green Submitted			2022-02-06	
J	Anderson, MN; Womble, MN; Mohler, SA; Said, A; Stephenson-Brown, K; Kontos, AP; Elbin, RJ				Anderson, Melissa N.; Womble, Melissa N.; Mohler, Samantha A.; Said, Azkya; Stephenson-Brown, Katie; Kontos, Anthony P.; Elbin, R. J.			Preliminary Study of Fear of Re-Injury following Sport-Related Concussion in High School Athletes	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; LOW-BACK-PAIN; CHRONIC MUSCULOSKELETAL PAIN; TEST-RETEST RELIABILITY; NEUROCOGNITIVE PERFORMANCE; AVOIDANCE BELIEFS; TAMPA SCALE; RETURN; RECOVERY; IMPACT	The influence of fear of re-injury that this variable has on recovery outcomes following sports-related concussion remains unknown. We examined changes in fear of re-injury throughout concussion recovery, and compared changes in neurocognitive, symptom, vestibular/ocular motor, and recovery time outcomes between concussed adolescent athletes who endorsed high and low fear of re-injury. Individuals with high fear of re-injury were more symptomatic and more likely to exhibit vestibular/ocular motor symptoms over clinical cutoffs than those with low fear of re-injury. Recovery time was not significantly different between the groups. These findings may help explain performance on more subjective concussion assessments.	[Anderson, Melissa N.] Univ Georgia, Dept Kinesiol, Concuss Res Lab, Athens, GA 30602 USA; [Womble, Melissa N.] Inova Med Grp, Inova Sports Med Concuss Program, Dept Orthopaed & Sports Med, Fairfax, VA USA; [Mohler, Samantha A.; Said, Azkya; Stephenson-Brown, Katie; Elbin, R. J.] Univ Arkansas, Off Sport Related Concuss Res, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA; [Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA USA		Elbin, RJ (corresponding author), Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, 155 Stadium Dr, Fayetteville, AR 72701 USA.	rjelbin@uark.edu					Ardern CL, 2011, BRIT J SPORT MED, V45, P596, DOI 10.1136/bjsm.2010.076364; Bandura A., 1981, CULTIVATING COMPETEN, P13; Buer N, 2002, PAIN, V99, P485, DOI 10.1016/S0304-3959(02)00265-8; Chmielewski TL, 2008, J ORTHOP SPORT PHYS, V38, P746, DOI 10.2519/jospt.2008.2887; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; HANSON SJ, 1992, J SPORT EXERCISE PSY, V14, P262, DOI 10.1123/jsep.14.3.262; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Johnson MH, 1997, PAIN, V69, P43, DOI 10.1016/S0304-3959(96)03272-1; Johnston LH, 2000, J SPORT REHABIL, V9, P290, DOI 10.1123/jsr.9.4.290; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Korri SH, 1990, PAIN MANAG, V3, P35; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lentz TA, 2015, AM J SPORT MED, V43, P345, DOI 10.1177/0363546514559707; Mainwaring L. M., 2004, EMOTIONAL REACTION V, P17; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCullough KA, 2012, AM J SPORT MED, V40, P2523, DOI 10.1177/0363546512456836; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Podlog L, 2006, J APPL SPORT PSYCHOL, V18, P44, DOI 10.1080/10413200500471319; REESOR KA, 1988, PAIN, V32, P35, DOI 10.1016/0304-3959(88)90021-8; Roelofs J, 2007, PAIN, V131, P181, DOI 10.1016/j.pain.2007.01.008; Rusu AC, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-280; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Swinkels-Meewisse EJCM, 2003, MANUAL THER, V8, P29, DOI 10.1054/math.2002.0484; Tripp DA, 2007, REHABIL PSYCHOL, V52, P74, DOI 10.1037/0090-5550.52.1.74; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Vlaeyen JWS, 1999, MANUAL THER, V4, P187, DOI 10.1054/math.1999.0199; Wiese-Bjornstal DM, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2010.01195.x; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zur O, 2015, DISABIL REHABIL, V37, P2197, DOI 10.3109/09638288.2014.1002577	38	16	16	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	AUG 18	2019	44	6					443	451		10.1080/87565641.2019.1667995		SEP 2019	9	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	JA0RH	WOS:000487033100001	31537099				2022-02-06	
J	Rao, V; Bechtold, K; McCann, U; Roy, D; Peters, M; Vaishnavi, S; Yousem, D; Mori, S; Yan, HJ; Leoutsakos, J; Tibbs, M; Reti, I				Rao, Vani; Bechtold, Kathleen; McCann, Una; Roy, Durga; Peters, Matthew; Vaishnavi, Sandeep; Yousem, David; Mori, Susumu; Yan, Haijuan; Leoutsakos, Jeannie; Tibbs, Michael; Reti, Irving			Low-Frequency Right Repetitive Transcranial Magnetic Stimulation for the Treatment of Depression After Traumatic Brain Injury: A Randomized Sham-Controlled Pilot Study	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							MAJOR DEPRESSION; DOUBLE-BLIND; HEAD-INJURY; EFFICACY; SERTRALINE; RTMS; METAANALYSIS; PLACEBO; SAFETY; TRIAL	Objective: Major depression is the most common psychiatric sequela of traumatic brain injury (TBI), but effective treatment continues to be a challenge, with few studies providing guidance. Methods: In a pilot study, the authors evaluated the effect size of low-frequency right-sided (LFR) repetitive transcranial magnetic stimulation (rTMS), compared with sham treatment, over the right dorsolateral prefrontal cortex (DLPFC) in patients (N=30) with TBI depression and co-occurring neuropsychiatric symptoms, including suicidal thoughts, anxiety, posttraumatic stress disorder, sleep disturbance, behavioral problems, and cognitive dysfunction. Exploratory analyses of diffusion tensor imaging pre- and postintervention were performed to determine the effect size of LFR rTMS on white matter integrity. Results: Small (Hedge's g=0.19) and highly variable effects of LRF rTMS over right DLPFC in TBI depression were observed. Similarly, the effect of LFR rTMS for treatment of comorbid neuropsychiatric symptoms varied from small to moderate. Conclusions: These findings suggest that the observed effects of LFR rTMS over the right DLPFC in TBI depression and co-occurring neuropsychiatric symptoms are small, at best, and, preliminarily, that low-frequency right DLPFC stimulation has limited potential in this patient population. However, studies employing different rTMS parameters (e.g., type, location, frequency, duration) or other participant characteristics (e.g., TBI severity, chronicity, comorbidity, concurrent treatment) may potentially yield different responses	[Rao, Vani; McCann, Una; Roy, Durga; Peters, Matthew; Yan, Haijuan; Leoutsakos, Jeannie; Tibbs, Michael; Reti, Irving] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Bechtold, Kathleen] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Vaishnavi, Sandeep] Duke Univ, Sch Med, Neuropsychiat Clin, Carolina Partners, Durham, NC USA; [Vaishnavi, Sandeep] Duke Univ, Sch Med, Dept Community & Family Med, Durham, NC USA; [Vaishnavi, Sandeep] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA; [Yousem, David; Mori, Susumu] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA		Rao, V (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.	vrao@jhmi.edu			U.S. Army Medical Research Acquisition Activity [W81XWH-13-1-0469]	Supported by a grant from the U.S. Army Medical Research Acquisition Activity (grant W81XWH-13-1-0469) to Dr. Rao.	Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Baeken Chris, 2011, Dialogues Clin Neurosci, V13, P139; Bashir S, 2010, PM&R, V2, pS253, DOI 10.1016/j.pmrj.2010.10.015; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/rtnp.18.2.213.61278; Berlim MT, 2013, NEUROPSYCHOPHARMACOL, V38, P543, DOI 10.1038/npp.2012.237; Blumberger DM, 2012, WORLD J BIOL PSYCHIA, V13, P423, DOI 10.3109/15622975.2011.579163; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borckardt JJ, 2008, BRAIN STIMUL, V1, P52, DOI 10.1016/j.brs.2007.09.003; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cohen J., 2013, STAT POWER ANAL BEHA; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; Fitzgerald PB, 2003, ARCH GEN PSYCHIAT, V60, P1002, DOI 10.1001/archpsyc.60.9.1002; Fox MD, 2012, BIOL PSYCHIAT, V72, P595, DOI 10.1016/j.biopsych.2012.04.028; Gaynes BN, 2014, J CLIN PSYCHIAT, V75, P477, DOI 10.4088/JCP.13r08815; George MS, 2014, BRAIN STIMUL, V7, P421, DOI 10.1016/j.brs.2014.03.006; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; He C, 2004, CHINESE J CLIN REHAB, V8, P6044; Isenberg Keith, 2005, Ann Clin Psychiatry, V17, P153, DOI 10.1080/10401230591002110; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kant R, 1999, J NEUROPSYCH CLIN N, V11, P32, DOI 10.1176/jnp.11.1.32; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Leung A, 2017, NEUROMODULATION; Leung A, 2016, PAIN PHYSICIAN, V19, pE347; Loo CK, 2008, INT J NEUROPSYCHOPH, V11, P131, DOI 10.1017/S1461145707007717; Marcolin M. A., 2007, ADV BIOL PSYCH-KARG, V23, P204; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; McAllister TW, 2011, TXB TRAUMATIC BRAIN, P239; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Nielson DM, 2015, ARCH PHYS MED REHAB, V96, pS138, DOI 10.1016/j.apmr.2014.09.010; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Reti IM, 2015, BRAIN INJURY, V29, P789, DOI 10.3109/02699052.2015.1009168; Romero JR, 2002, CLIN NEUROPHYSIOL, V113, P101, DOI 10.1016/S1388-2457(01)00693-9; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Salter KL, 2016, J HEAD TRAUMA REHAB, V31, pE21, DOI 10.1097/HTR.0000000000000193; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Slotema CW, 2010, J CLIN PSYCHIAT, V71, P873, DOI 10.4088/JCP.08m04872gre; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Sun W, 2012, EPILEPSIA, V53, P1782, DOI 10.1111/j.1528-1167.2012.03626.x; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Tang XY, 2014, HUM BRAIN MAPP, V35, P3701, DOI 10.1002/hbm.22431; Tang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096985; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013; Zangen A, 2005, CLIN NEUROPHYSIOL, V116, P775, DOI 10.1016/j.clinph.2004.11.008	53	16	16	2	5	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2019	31	4					306	318		10.1176/appi.neuropsych.17110338			13	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	JD7SI	WOS:000490181300004	31018810	Bronze			2022-02-06	
J	Brown, J; O'Brien, K; Knollman-Porter, K; Wallace, T				Brown, Jessica; O'Brien, Katy; Knollman-Porter, Kelly; Wallace, Tracey			The Speech-Language Pathologists' Role in Mild Traumatic Brain Injury for Middle and High School-Age Children: Viewpoints on Guidelines From the Centers for Disease Control and Prevention	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							INCOG RECOMMENDATIONS; PEDIATRIC CONCUSSION; MANAGEMENT; KNOWLEDGE; ADULTS; REHABILITATION; ADOLESCENTS; CONFIDENCE; EXECUTION; STUDENTS	Purpose: The Centers for Disease Control and Prevention (CDC) recently released guidelines for rehabilitation professionals regarding the care of children with mild traumatic brain injury (mTBI). Given that mTBI impacts millions of children each year and can be particularly detrimental to children in middle and high school age groups, access to universal recommendations for management of postinjury symptoms is ideal. Method: This viewpoint article examines the CDC guidelines and applies these recommendations directly to speech-language pathology practices. In particular, education, assessment, treatment, team management, and ongoing monitoring are discussed. In addition, suggested timelines regarding implementation of services by speech-language pathologists (SLPs) are provided. Specific focus is placed on adolescents (i.e., middle and high school-age children). Results: SLPs are critical members of the rehabilitation team working with children with mTBI and should be involved in education, symptom monitoring, and assessment early in the recovery process. SLPs can also provide unique insight into the cognitive and linguistic challenges of these students and can serve to bridge the gap among rehabilitation and school-based professionals, the adolescent with brain injury, and their parents. Conclusion: The guidelines provided by the CDC, along with evidence from the field of speech pathology, can guide SLPs to advocate for involvement in the care of adolescents with mTBI. More research is needed to enhance the evidence base for direct assessment and treatment with this population; however, SLPs can use their extensive knowledge and experience working with individuals with traumatic brain injury as a starting point for post-mTBI care.	[Brown, Jessica] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA; [O'Brien, Katy] Univ Georgia, Dept Commun Sci & Special Educ, Athens, GA 30602 USA; [Knollman-Porter, Kelly] Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA; [Wallace, Tracey] Shepherd Ctr, Complex Concuss Clin, Atlanta, GA USA		Brown, J (corresponding author), Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA.	jessicabrown@email.arizona.edu		Wallace, Tracey/0000-0002-6820-4363			Alsalaheen B, 2017, J ATHL TRAINING, V52, P834, DOI 10.4085/1062-6050-52.7.05; American Speech-Language-Hearing Association, 2016, SCOP PRACT SPEEC LAN; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Benedict, 2001, HOPKINS VERBAL LEARN; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Brown J, 2018, DISABILITY REHABILIT, V0, P1, DOI DOI 10.1080/17483107; Brown J, 2017, AM J SPEECH-LANG PAT, V26, P819, DOI 10.1044/2017_AJSLP-16-0092; Brown JA, 2016, NEUROREHABILITATION, V39, P191, DOI 10.3233/NRE-161351; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Duff MC., 2009, ASHA LEADER, V14, P10, DOI [10.1044/leader.FTR1.14092009.10, DOI 10.1044/LEADER.FTR1.14092009.10]; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Hardin K., 2015, ASHA LEADER, V20, P38; Haskins E., 2011, COGNITIVE REHABILITA; Kennedy M. R. T., 2017, COACHING COLL STUDEN; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kenworthy, 2015, BEHAV RATING INVENTO; Krause M, 2015, SEMIN SPEECH LANG, V36, P60, DOI 10.1055/s-0034-1396447; Lempke L, 2019, J SPORT REHABIL, V28, P99, DOI 10.1123/jsr.2017-0217; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; MacDonald S, 2013, STUDENT VERSION FUNC; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Mann A., 2017, BRIT J SPORT MED, V51, pA53; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Meyer AND, 2013, JAMA INTERN MED, V173, P1952, DOI 10.1001/jamainternmed.2013.10081; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Nandagopal K, 2012, LEARN INDIVID DIFFER, V22, P597, DOI 10.1016/j.lindif.2011.11.018; O'Brien KH, 2018, NEUROREHABILITATION, V42, P365, DOI 10.3233/NRE-172413; Oliveira RM., 2016, PSYCHOL NEUROSCI, V9, P54, DOI [10.1037/pne0000041, DOI 10.1037/pne0000041]; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Randolph C., 2012, REPEATABLE BATTERY A; Ransom D. M., 2013, IN M SPORT NEUR SOC; Ransom DM, 2016, J INT NEUROPSYCH SOC, V22, P1038, DOI 10.1017/S1355617716000916; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Riedeman S, 2018, AM J SPEECH-LANG PAT, V27, P181, DOI 10.1044/2017_AJSLP-17-0011; Ruban LM, 2003, J LEARN DISABIL-US, V36, P270, DOI 10.1177/002221940303600306; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Scherer M.J., 2002, TECHNOL DISABIL, V14, P125, DOI [DOI 10.3233/TAD-2002-14308, 10.3233/tad-2002-14308]; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Sohlberg MM, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0128; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas RE, 2017, RESTOR NEUROL NEUROS, V35, P643, DOI 10.3233/RNN-170761; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; ZIMMERMAN BJ, 1986, AM EDUC RES J, V23, P614, DOI 10.2307/1163093	59	16	16	2	9	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	AUG	2019	28	3					1363	1370		10.1044/2019_AJSLP-18-0296			8	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	IQ0BB	WOS:000480413800035	31170352				2022-02-06	
J	Chakroun-Walha, O; Samet, A; Jerbi, M; Nasri, A; Talbi, A; Kanoun, H; Souissi, B; Chtara, K; Bouaziz, M; Ksibi, H; Rekik, N				Chakroun-Walha, Olfa; Samet, Amal; Jerbi, Mouna; Nasri, Abdennour; Talbi, Aziza; Kanoun, Hassen; Souissi, Basma; Chtara, Kamilia; Bouaziz, Mounir; Ksibi, Hichem; Rekik, Noureddine			Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Tranexamic acid; Traumatic brain injury; Management; Prognosis; Emergency department; Pulmonary embolism	VASCULAR OCCLUSIVE EVENTS; BRAIN-INJURY; HEMORRHAGE; CRASH-2; COAGULATION; TRANSFUSION; DEATH	Introduction Tranexamic acid (TXA) is one of the debated therapies in the management of traumatic brain injury (TBI). We conducted this study to evaluate the benefits of TXA in TBI on the mortality and its safety in these patients. Methods This was a prospective randomized open-label trial including all patients, aged at 18 years or older, hospitalized in the emergency room during a 13-month period, for TBI. After the realization of the body CT scan, the patients were included if they had intracranial bleeding, and were then randomized according to their medical file number to receive or not the TXA. The eligibility criteria were based on the uncertainty principle, patients with significant extracranial bleeding were excluded since there was evidence that TXA improve their outcome. Results We enrolled 180 patients aged at 42 +/- 20 years, with an 88% men-proportion. Subarachnoid haemorrhage was the most frequent lesion in the brain CT-scan (67.5%). After randomization, 96 patients were in the TXA group (53%). Demographic data, clinical, biological and radiological features were statistically comparable in the two groups of patients ('TXA' and 'noTXA'). The needs of transfusion or neurosurgery, the mortality rate, the in-hospital length of stay and the dependency at 28-post-traumatic day were similar in the two groups of patients. However, pulmonary embolism was statistically more frequent in 'TXA' group (11.5 versus 2.4%, p = 0.02). Conclusion TXA is an interesting treatment in haemorrhagic shock. Its efficiency in head trauma is still debated and controversial. Its impact on the mortality and the needs of transfusion or surgery were not demonstrated in this study. Nevertheless, its safety worth to be studied in larger samples as we found a higher rate of pulmonary embolism in the treated group.	[Chakroun-Walha, Olfa; Samet, Amal; Jerbi, Mouna; Nasri, Abdennour; Talbi, Aziza; Kanoun, Hassen; Ksibi, Hichem; Rekik, Noureddine] Univ Hosp Habib Bourguiba, Serv Urgences & SAMU04 SFAX, Emergency Dept, Route EL Ain Km 0,5, Sfax 3029, Tunisia; [Souissi, Basma] Univ Hosp Habib Bourguiba, Radiol Dept, Sfax, Tunisia; [Chtara, Kamilia; Bouaziz, Mounir] Univ Hosp Habib Bourguiba, Intens Care Unit, Sfax, Tunisia		Chakroun-Walha, O (corresponding author), Univ Hosp Habib Bourguiba, Serv Urgences & SAMU04 SFAX, Emergency Dept, Route EL Ain Km 0,5, Sfax 3029, Tunisia.	chakroun_olfa@medecinesfax.org		chakroun-walha, olfa/0000-0002-9224-7080			[Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Boudreau RM, 2017, J SURG RES, V215, P47, DOI 10.1016/j.jss.2017.03.031; Chelly H, 2017, EUR J TRAUMA EMERG S; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Fakharian E, 2018, WORLD NEUROSURG, V109, pE748, DOI 10.1016/j.wneu.2017.10.075; French KF, 2012, NEUROCRIT CARE, V17, P107, DOI 10.1007/s12028-012-9681-5; Gayet-Ageron A, 2018, LANCET, V391, P125, DOI 10.1016/S0140-6736(17)32455-8; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Jackisch J, 2015, EUROPEAN FACTS GLOBA; JENNETT B, 1975, LANCET, V1, P480; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Kageyama H, 2013, J NEUROSURG, V119, P332, DOI 10.3171/2013.3.JNS122162; KER K, 2015, COCHRANE DB SYST REV, V9; Mahmood A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2073-6; Mahmood A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4814; Majima Nozomi, 2013, Masui, V62, P410; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Napolitano LM, 2013, J TRAUMA ACUTE CARE, V74, P1575, DOI 10.1097/TA.0b013e318292cc54; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Roberts I, 2015, J THROMB HAEMOST, V13, pS195, DOI 10.1111/jth.12878; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Roberts I, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1750-1; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Schochl H, 2014, SHOCK, V41, P44, DOI 10.1097/SHK.0000000000000093; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Valle EJ, 2014, J TRAUMA ACUTE CARE, V76, P1373, DOI 10.1097/TA.0000000000000242; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023	32	16	18	2	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2019	45	4					719	726		10.1007/s00068-018-0974-z			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IQ1JQ	WOS:000480506500016	29922895				2022-02-06	
J	Hegyi, A; Lahti, J; Giacomo, JP; Gerus, P; Cronin, NJ; Morin, JB				Hegyi, Andras; Lahti, Johan; Giacomo, Jean-Patrick; Gerus, Pauline; Cronin, Neil J.; Morin, Jean-Benoit			Impact of Hip Flexion Angle on Unilateral and Bilateral Nordic Hamstring Exercise Torque and High-Density Electromyography Activity	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						biceps femoris; rehabilitation; semitendinosus; strain injury	BICEPS FEMORIS; PROFESSIONAL FOOTBALL; TISSUE STRAINS; MUSCLE; INJURIES; EMG; SEMITENDINOSUS; ACTIVATION; RISK; MECHANISMS	BACKGROUND: In the bilateral Nordic hamstring exercise (NHE). hamstrings operate at relatively short lengths, which may limit the efficacy of the NHE in hamstring injury prevention. OBJECTIVES: To examine knee flexion torque and biceps femoris long head (BFLH) and semitendinosus (ST) high-density electromyography (EMG) activity during the unilateral and bilateral NHE, performed with either neutral (NHE0) or 90 degrees-flexed (NHE90) hips. METHODS: In this laboratory study, exercises were performed on a novel device at the eccentric 1-repetition maximum load defined for 90 degrees to 15 degrees of knee range of motion. Torque and EMG signals normalized to maximal voluntary isometric activity were compared in different phases of the exercises with statistical parametric mapping. RESULTS: The EMG levels were lower in NHE90 than in NHEO, mainly in the second half of the movement. Knee flexor eccentric torque was higher in NHE90 than in NHEO from the beginning to 87% of the bilateral movement, and over the entire unilateral movement. In NHEO, ST activity compared to BFLH activity was higher during the initial movement phase and lower when the movement was close to knee extension. Torque and EMG activity were generally similar in the bilateral and unilateral modes. CONCLUSION: If performed with neutral hips. the NHE selectively activates the BFLH near full knee extension. Performing the NHE with hips flexed to 90 degrees is preferable when higher passive torque and ST selectivity are targeted at a longer muscle length. Performing these exercises unilaterally could help train each limb separately, with similar torque and EMG output to those of the bilateral conditions.	[Hegyi, Andras; Cronin, Neil J.] Univ Jyvaskyla, Fac Sport & Hlth Sci, Neuromuscular Res Ctr, Jyvaskyla, Finland; [Lahti, Johan; Gerus, Pauline; Morin, Jean-Benoit] Univ Cote dAzur, LAMHESS, Nice, France; [Giacomo, Jean-Patrick] Ctr Evaluat & Anal Performance Sport, Carros, France		Hegyi, A (corresponding author), Off LL 175,POB 35, Jyvaskyla 40014, Finland.	andras.a.hegyi@jyu.fi	Cronin, Neil/AAA-8815-2022; Cronin, Neil/B-3860-2011	Morin, Jean-Benoit/0000-0003-3808-6762; Cronin, Neil/0000-0002-5332-1188			Adler RJ., 2007, RANDOM FIELDS GEOMET; Askling C., 2011, BRIT J SPORT MED, V45, pe2, DOI DOI 10.1136/BJSM.2010.081570.15; Askling CM, 2014, BRIT J SPORT MED, V48, P532, DOI 10.1136/bjsports-2013-093214; Askling CM, 2013, BRIT J SPORT MED, V47, DOI 10.1136/bjsports-2013-092165; Bourne MN, 2016, SCAND J MED SCI SPOR, V26, P666, DOI 10.1111/sms.12494; Bourne MN, 2018, SPORTS MED, V48, P251, DOI 10.1007/s40279-017-0796-x; Bourne MN, 2017, BRIT J SPORT MED, V51, P1021, DOI 10.1136/bjsports-2015-095739; Brooks JHM, 2006, AM J SPORT MED, V34, P1297, DOI 10.1177/0363546505286022; CAROLAN B, 1992, J APPL PHYSIOL, V73, P911, DOI 10.1152/jappl.1992.73.3.911; Cohen J, 1988, STAT POWER ANAL BEHA; Connell DA, 2004, AM J ROENTGENOL, V183, P975, DOI 10.2214/ajr.183.4.1830975; De Luca CJ, 2012, J BIOMECH, V45, P555, DOI 10.1016/j.jbiomech.2011.11.010; De Smet AA, 2000, AM J ROENTGENOL, V174, P393, DOI 10.2214/ajr.174.2.1740393; Ditroilo M, 2013, J ELECTROMYOGR KINES, V23, P1111, DOI 10.1016/j.jelekin.2013.05.008; Ekstrand J, 2016, BRIT J SPORT MED, V50, P731, DOI 10.1136/bjsports-2015-095359; Fernandez-Gonzalo R, 2016, INT J SPORTS MED, V37, P559, DOI 10.1055/s-0042-100290; Fiorentino NM, 2014, J BIOMECH, V47, P3325, DOI 10.1016/j.jbiomech.2014.08.010; Fiorentino NM, 2012, J BIOMECH, V45, P647, DOI 10.1016/j.jbiomech.2011.12.015; Fousekis K, 2011, BRIT J SPORT MED, V45, P709, DOI 10.1136/bjsm.2010.077560; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Fyfe JJ, 2013, J ELECTROMYOGR KINES, V23, P523, DOI 10.1016/j.jelekin.2012.12.006; Hagglund M, 2013, BRIT J SPORT MED, V47, P738, DOI 10.1136/bjsports-2013-092215; Hegyi A, 2018, SCAND J MED SCI SPOR, V28, P992, DOI 10.1111/sms.13016; Hickey J, 2014, BRIT J SPORT MED, V48, P729, DOI 10.1136/bjsports-2013-092884; Kellis E, 2017, MLTJ-MUSCLE LIGAMENT, V7, P286, DOI 10.11138/mltj/2017.7.2.286; Koulouris G, 2007, AM J SPORT MED, V35, P1500, DOI 10.1177/0363546507301258; Le Sant G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139272; Marshall PWM, 2015, J STRENGTH COND RES, V29, P3124, DOI 10.1519/JSC.0000000000000966; McHugh MP, 1999, SPORTS MED, V27, P157, DOI 10.2165/00007256-199927030-00002; Mendiguchia J, 2013, J STRENGTH COND RES, V27, P3426, DOI 10.1519/JSC.0b013e31828fd3e7; Messer D, 2017, J SCI MED SPORT SUPP, V20, pe125, DOI [10.1016/j.jsams.2017.01.221, DOI 10.1016/J.JSAMS.2017.01.221]; Mohamed F, 2002, CLIN BIOMECH, V17, P569, DOI 10.1016/S0268-0033(02)00070-0; Morin JB, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00404; Onishi H, 2002, J ELECTROMYOGR KINES, V12, P399, DOI 10.1016/S1050-6411(02)00033-0; Roe M, 2018, J SCI MED SPORT, V21, P155, DOI 10.1016/j.jsams.2017.08.023; Saw R, 2018, SPORTS HEALTH, V10, P208, DOI 10.1177/1941738117726070; Schache AG, 2013, EUR J APPL PHYSIOL, V113, P2813, DOI 10.1007/s00421-013-2713-9; Schuermans J, 2014, BRIT J SPORT MED, V48, P1599, DOI 10.1136/bjsports-2014-094017; Severini G, 2018, SCAND J MED SCI SPOR, V28, P2536, DOI 10.1111/sms.13288; Timmins RG, 2016, BRIT J SPORT MED, V50, P1524, DOI 10.1136/bjsports-2015-095362; Tsaklis P, 2015, OPEN ACCESS J SPORTS, V6, P209, DOI 10.2147/OAJSM.S79189; Zebis MK, 2013, BRIT J SPORT MED, V47, P1192, DOI 10.1136/bjsports-2011-090281	42	16	16	2	23	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	AUG	2019	49	8					584	+		10.2519/jospt.2019.8801			20	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	IM5HI	WOS:000478024600005	30913969				2022-02-06	
J	Rafferty, J; Ranson, C; Oatley, G; Mostafa, M; Mathema, P; Crick, T; Moore, IS				Rafferty, James; Ranson, Craig; Oatley, Giles; Mostafa, Mohamed; Mathema, Prabhat; Crick, Tom; Moore, Isabel S.			On average, a professional rugby union player is more likely than not to sustain a concussion after 25 matches	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							EXTREMITY MUSCULOSKELETAL INJURY; RISK; INCREASES; EVENTS; RETURN	Objectives To investigate concussion injury rates, the likelihood of sustaining concussion relative to the number of rugby union matches and the risk of subsequent injury following concussion. Methods A four-season (2012/2013-2015/2016) prospective cohort study of injuries in professional level (club and international) rugby union. Incidence (injuries/1000 player-match-hours), severity (days lost per injury) and number of professional matches conferring a large risk of concussion were determined. The risk of injury following concussion was assessed using a survival model. Results Concussion incidence increased from 7.9 (95% CI 5.1 to 11.7) to 21.5 injuries/1000 player-match-hours (95% CI 16.4 to 27.6) over the four seasons for combined club and international rugby union. Concussion severity was unchanged over time (median: 9 days). Players were at a greater risk of sustaining a concussion than not after an exposure of 25 matches (95% CI 19 to 32). Injury risk (any injury) was 38% greater (HR 1.38; 95% CI 1.21 to 1.56) following concussion than after a non-concussive injury. Injuries to the head and neck (HR 1.34; 95% CI 1.06 to 1.70), upper limb (HR 1.59; 95% CI 1.19 to 2.12), pelvic region (HR 2.07; 95% CI 1.18 to 3.65) and the lower limb (HR 1.60; 95% CI 1.21 to 2.10) were more likely following concussion than after a non-concussive injury. Conclusion Concussion incidence increased, while severity remained unchanged, during the 4 years of this study. Playing more than 25 matches in the 2015/2016 season meant that sustaining concussion was more likely than not sustaining concussion. The 38% greater injury risk after concussive injury (compared with non-concussive injury) suggests return to play protocols warrant investigation.	[Rafferty, James] Swansea Univ, Med Sch, Swansea, W Glam, Wales; [Ranson, Craig] English Inst Sport, Manchester, Lancs, England; [Oatley, Giles] Murdoch Univ, Sch Engn & Informat Technol, Perth, WA, Australia; [Mostafa, Mohamed] Cardiff Univ, Sch Comp Sci & Informat, Social Data Sci Lab, Cardiff, S Glam, Wales; [Mathema, Prabhat] Welsh Rugby Union, Cardiff, S Glam, Wales; [Crick, Tom] Cardiff Metropolitan Univ, Dept Comp & Informat Syst, Cardiff, S Glam, Wales; [Moore, Isabel S.] Cardiff Metropolitan Univ, Cardiff Sch Sport & Hlth Sci, Cardiff CF23 6XD, S Glam, Wales		Moore, IS (corresponding author), Cardiff Metropolitan Univ, Cardiff Sch Sport & Hlth Sci, Cardiff CF23 6XD, S Glam, Wales.	imoore@cardiffmet.ac.uk	Ranson, Craig/AAQ-5452-2020; Crick, Tom/C-8481-2011	Crick, Tom/0000-0001-5196-9389; Mostafa, Mohamed/0000-0001-9870-8637; Oatley, Giles/0000-0002-5034-5213; Ranson, Craig/0000-0002-3783-0505; Rafferty, James/0000-0002-1667-7265; Moore, Isabel/0000-0002-4746-3390	World Rugby; Welsh Rugby Union	World Rugby and Welsh Rugby Union.	Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Efron B, 1982, JACKKNIFE BOOTSTRAP, V38; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gabbett TJ, 2016, BR J SPORTS MED; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Holtzhausen LJ, 2006, SAMJ S AFR MED J, V96, P1260; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Mahmood A, 2014, BRIT J SPORT MED, V48, P630; McCrory P, 2017, BRIT J SPORT MED, V2017, P51; Moore IS, 2017, BR J SPORTS MED; Moore IS, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115596194; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Ranson C, J SPORTS SCI; RFU, 2017, ENGL PROF RUGB INJ S; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Therneau T., 2015, MIXED EFFECTS COX MO; Therneau T. M., 2013, MODELING SURVIVAL DA; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Ullah S, 2014, BRIT J SPORT MED, V48, P1287, DOI 10.1136/bjsports-2011-090803; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; WorldRugby, CONC MAN REC REM	30	16	16	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	AUG	2019	53	15					969	973		10.1136/bjsports-2017-098417			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IM3ME	WOS:000477896500011	29530941	Green Published, hybrid, Green Accepted			2022-02-06	
J	Redelmeier, DA; Manzoor, F; Thiruchelvam, D				Redelmeier, Donald A.; Manzoor, Fizza; Thiruchelvam, Deva			Association Between Statin Use and Risk of Dementia After a Concussion	JAMA NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CHRONIC SUBDURAL-HEMATOMA; ALZHEIMER-DISEASE; VASCULAR-DISEASE; ATORVASTATIN; POPULATION; HEALTH; THERAPY; CARE; DEPRESSION	Key PointsQuestionIs statin use associated with an increased or decreased risk of subsequent dementia after a concussion? FindingsIn this large extended population-based double cohort study following 28815 patients after a concussion, the 5-year incidence of dementia was substantial and statin use was associated with a significantly reduced risk of subsequent dementia. MeaningConcussions are associated with an increased long-term risk of dementia, which is modestly reduced for patients receiving a statin. This large extended population-based double cohort study tests whether statin use is associated with an increased or decreased risk of subsequent dementia after a concussion among older adults. ImportanceConcussions are an acute injury that may lead to chronic disability, while statin use might improve neurologic recovery. ObjectiveTo test whether statin use is associated with an increased or decreased risk of subsequent dementia after a concussion. Design, Setting, and ParticipantsLarge extended population-based double cohort study in Ontario, Canada, from April 1, 1993, to April 1, 2013 (enrollment), and continued until March 31, 2016 (follow-up). Dates of analysis were April 28, 2014, through March 21, 2019. Participants were older adults diagnosed as having a concussion, excluding severe cases resulting in hospitalization, individuals with a prior diagnosis of dementia or delirium, and those who died within 90 days. ExposureStatin prescription within 90 days after a concussion. Main Outcome and MeasureLong-term incidence of dementia. ResultsThis study identified 28815 patients diagnosed as having a concussion (median age, 76 years; 61.3% female), of whom 7058 (24.5%) received a statin, and 21757 (75.5%) did not receive a statin. A total of 4727 patients subsequently developed dementia over a mean follow-up of 3.9 years, equal to an incidence of 1 case per 6 patients. Patients who received a statin had a 13% reduced risk of dementia compared with patients who did not receive a statin (relative risk, 0.87; 95% CI, 0.81-0.93; P<.001). The decreased risk of dementia associated with statin use applied to diverse patient groups, remained independent of other cardiovascular medication use, intensified over time, was distinct from the risk of subsequent depression, and was not observed in patients after an ankle sprain. Conclusions and RelevanceIn this study, older adults had a substantial long-term risk of dementia after a concussion, which was associated with a modest reduction among patients receiving a statin.	[Redelmeier, Donald A.; Manzoor, Fizza] Univ Toronto, Dept Med, Toronto, ON, Canada; [Redelmeier, Donald A.; Manzoor, Fizza] Sunnybrook Res Inst, Evaluat Clin Sci Program, Toronto, ON, Canada; [Redelmeier, Donald A.; Manzoor, Fizza; Thiruchelvam, Deva] Inst Clin Evaluat Sci Ontario, Toronto, ON, Canada; [Redelmeier, Donald A.] Sunnybrook Hlth Sci Ctr, Div Gen Internal Med, 2075 Bayview Ave,Ste G-151, Toronto, ON M4N 3M5, Canada; [Redelmeier, Donald A.] Ctr Leading Injury Prevent Practice Educ & Res, Toronto, ON, Canada		Redelmeier, DA (corresponding author), Sunnybrook Hlth Sci Ctr, Div Gen Internal Med, 2075 Bayview Ave,Ste G-151, Toronto, ON M4N 3M5, Canada.	dar@ices.on.ca			Canada Research Chair in Medical Decision SciencesCanada Research Chairs; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); BrightFocus FoundationBrightFocus Foundation; Comprehensive Research Experience for Medical Students at the University of Toronto	This work was supported by a Canada Research Chair in Medical Decision Sciences, the Canadian Institutes of Health Research, the BrightFocus Foundation, and the Comprehensive Research Experience for Medical Students at the University of Toronto.	Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; [Anonymous], 2016, HLTH PROMOT CHRONIC, V36, P231, DOI DOI 10.24095/hpcdp.36.10.04; Bardach NS, 2013, JAMA-J AM MED ASSOC, V310, P1051, DOI 10.1001/jama.2013.277353; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barkow K, 2003, J AFFECT DISORDERS, V76, P157, DOI 10.1016/S0165-0327(02)00081-2; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brasure M, 2018, ANN INTERN MED, V168, P30, DOI 10.7326/M17-1528; Bronskill S., 2011, HLTH SYSTEM USE FRAI; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Butterfield DA, 2011, PHARMACOL RES, V64, P180, DOI 10.1016/j.phrs.2011.04.007; Canadian Institute for Health Information, 2008, CIHI DAT QUAL STUD E; Carlsson CM, 2012, CURR ALZHEIMER RES, V9, P990; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chan DYC, 2017, BRIT J NEUROSURG, V31, P72, DOI 10.1080/02688697.2016.1208806; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Croxford R., 2006, CANADIAN I HLTH INFO; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; Davis DHJ, 2012, BRAIN, V135, P2809, DOI 10.1093/brain/aws190; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Downey A., 2017, PREVENTING COGNITIVE; Efron DT, 2008, J TRAUMA, V64, P66, DOI 10.1097/TA.0b013e31815b842a; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Farzanegan GR, 2017, J CLIN NEUROSCI, V44, P143, DOI 10.1016/j.jocn.2017.06.010; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fink HA, 2018, ANN INTERN MED, V168, P39, DOI 10.7326/M17-1529; Gardener H, 2015, NAT REV NEUROL, V11, P651, DOI 10.1038/nrneurol.2015.195; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Giannopoulos S, 2014, J ALZHEIMERS DIS, V42, pS315, DOI 10.3233/JAD-132366; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Gurwitz JH, 2016, JAMA-J AM MED ASSOC, V316, P1971, DOI 10.1001/jama.2016.15212; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iron K., 2008, LIVING DYING ONTARIO; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Khokhar B, 2018, J HEAD TRAUMA REHAB, V33, pE68, DOI 10.1097/HTR.0000000000000369; Khokhar B, 2017, J PHARM TECHNOL, V33, P225, DOI 10.1177/8755122517735656; Kinjo M, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2016-000417; Ko DT, 2013, CIRC-CARDIOVASC QUAL, V6, P315, DOI 10.1161/CIRCOUTCOMES.111.000015; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Lin FC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002143; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Macpherson AK., 2005, INJURIES ONTARIO ICE; Maegele M, 2018, LANCET NEUROL, V17, P13, DOI 10.1016/S1474-4422(17)30419-2; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Master CL, 2018, ANN INTERN MED, V169, pITC1, DOI 10.7326/AITC201807030; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McFarland AJ, 2014, INT J MOL SCI, V15, P20607, DOI 10.3390/ijms151120607; McGuinness B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003160.pub3; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mendoza-Oliva A, 2014, CURR ALZHEIMER RES, V11, P817; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Miron VE, 2009, AM J PATHOL, V174, P1880, DOI 10.2353/ajpath.2009.080947; Morrish J, 2013, CONCUSSIONS CANADA, P1; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Neilson SJ, 2016, BRAIN INJURY, V30, P993, DOI 10.3109/02699052.2016.1147599; Ng R., 2015, BRAIN DISORDERS ONTA; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Orlando A, 2017, INJURY, V48, P1040, DOI 10.1016/j.injury.2016.11.027; Orlando Alessandro, 2013, J Clin Med Res, V5, P168, DOI 10.4021/jocmr1333w; Paterson JM, 2008, J POPUL THER CLIN PH, V15, pE108; Peng WJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/261409; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Power MC, 2015, NAT REV NEUROL, V11, P220, DOI 10.1038/nrneurol.2015.35; Prince M, 2015, ALZHEIMERS DIS INT W; Proulx Jeff, 2015, Healthc Q, V18, P11; Public Health Agency of Canada, 2017, DEM CAN INCL ALZH DI; Radosevich JJ, 2013, BRAIN INJURY, V27, P1492, DOI 10.3109/02699052.2013.823658; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Redelmeier DA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002104; Redlich C, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0348-y; Reed B, 2014, JAMA NEUROL, V71, P195, DOI 10.1001/jamaneurol.2013.5390; Robertson CS, 2017, J NEUROTRAUM, V34, P1394, DOI 10.1089/neu.2016.4717; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roy Satyajeet, 2017, J Clin Med Res, V9, P638, DOI 10.14740/jocmr3066w; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Schilling JM, 2014, BEHAV BRAIN RES, V267, P6, DOI 10.1016/j.bbr.2014.03.014; Schilling S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002265; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sessions SY, 2010, JAMA-J AM MED ASSOC, V303, P2078, DOI 10.1001/jama.2010.654; Shrank WH, 2011, J GEN INTERN MED, V26, P546, DOI 10.1007/s11606-010-1609-1; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Statistics Canada, POP EST JUL 1 AG SEX; Strom BL, 2015, JAMA INTERN MED, V175, P1399, DOI 10.1001/jamainternmed.2015.2092; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Taylor WD, 2013, MOL PSYCHIATR, V18, P963, DOI 10.1038/mp.2013.20; Tuccori M, 2014, CNS DRUGS, V28, P249, DOI 10.1007/s40263-013-0135-1; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Wang D, 2014, J NEUROL SCI, V336, P237, DOI 10.1016/j.jns.2013.11.005; Wang HX, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002251; Wee HY, 2016, J CLIN PSYCHIAT, V77, P505, DOI 10.4088/JCP.14m09749; Wilchesky M, 2004, J CLIN EPIDEMIOL, V57, P131, DOI 10.1016/S0895-4356(03)00246-4; Wilkins, 2004, AUTOMATED GEOGRAPHIC; Williams JI, 1996, PATTERNS HLTH CARE O; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xie CC, 2015, BRAIN RES, V1602, P1, DOI 10.1016/j.brainres.2014.03.021; Xu M, 2016, WORLD NEUROSURG, V91, P23, DOI 10.1016/j.wneu.2016.03.067; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yusuf S, 2016, LANCET, V388, P943, DOI 10.1016/S0140-6736(16)31532-X; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	123	16	17	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	AUG	2019	76	8					887	896		10.1001/jamaneurol.2019.1148			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IS8ZF	WOS:000482437500005	31107515	Green Published, Bronze			2022-02-06	
J	Hubbard, WB; Harwood, CL; Prajapati, P; Springer, JE; Saatman, KE; Sullivan, PG				Hubbard, W. Brad; Harwood, Christopher L.; Prajapati, Paresh; Springer, Joe E.; Saatman, Kathryn E.; Sullivan, Patrick G.			Fractionated mitochondrial magnetic separation for isolation of synaptic mitochondria from brain tissue	SCIENTIFIC REPORTS			English	Article							RAT-BRAIN; MOUSE MODEL; DYSFUNCTION; INJURY; DAMAGE; PURIFICATION; MEMBRANES; NEURONS; MICE	While mitochondria maintain essential cellular functions, such as energy production, calcium homeostasis, and regulating programmed cellular death, they also play a major role in pathophysiology of many neurological disorders. Furthermore, several neurodegenerative diseases are closely linked with synaptic damage and synaptic mitochondrial dysfunction. Unfortunately, the ability to assess mitochondrial dysfunction and the efficacy of mitochondrial-targeted therapies in experimental models of neurodegenerative disease and CNS injury is limited by current mitochondrial isolation techniques. Density gradient ultracentrifugation (UC) is currently the only technique that can separate synaptic and non-synaptic mitochondrial sub-populations, though small brain regions cannot be assayed due to low mitochondrial yield. To address this limitation, we used fractionated mitochondrial magnetic separation (FMMS), employing magnetic anti-Tom22 antibodies, to develop a novel strategy for isolation of functional synaptic and non-synaptic mitochondria from mouse cortex and hippocampus without the usage of UC. We compared the yield and functionality of mitochondria derived using FMMS to those derived by UC. FMMS produced 3x more synaptic mitochondrial protein yield compared to UC from the same amount of tissue, a mouse hippocampus. FMMS also has increased sensitivity, compared to UC separation, to measure decreased mitochondrial respiration, demonstrated in a paradigm of mild closed head injury. Taken together, FMMS enables improved brain-derived mitochondrial yield for mitochondrial assessments and better detection of mitochondrial impairment in CNS injury and neurodegenerative disease.	[Hubbard, W. Brad; Harwood, Christopher L.; Prajapati, Paresh; Springer, Joe E.; Saatman, Kathryn E.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA; [Hubbard, W. Brad; Harwood, Christopher L.; Prajapati, Paresh; Springer, Joe E.; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA; [Hubbard, W. Brad; Saatman, Kathryn E.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Sullivan, Patrick G.] Lexington VAMC, Lexington, KY 40502 USA		Sullivan, PG (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA.; Sullivan, PG (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA.; Sullivan, PG (corresponding author), Lexington VAMC, Lexington, KY 40502 USA.	patsullivan@uky.edu	Prajapati, Paresh/P-1058-2019	Prajapati, Paresh/0000-0002-3734-4662	NSF EPSCoR Seed Grant (National Science Foundation Grant) [4978/111315, 1539068]; Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) [14-13 A]; VA Merit AwardUS Department of Veterans Affairs [1I01BX003405-01A1]; Veterans AffairsUS Department of Veterans Affairs [I01BX003405] Funding Source: NIH RePORTER	The authors would like to thank Malinda Spry, Binoy Joseph, Ph.D., Jennifer Gooch, and Hemendra Vekaria, Ph.D. for their technical assistance. We would also like to acknowledge the Biomedical Illustration team of Matt Hazzard and Tom Dolan in University of Kentucky Information Technology. This work was supported by NSF EPSCoR Seed Grant 4978/111315 (National Science Foundation Grant No. 1539068), Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) Grant 14-13 A, and VA Merit Award 1I01BX003405-01A1.	Afanasyeva MA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P76, DOI 10.1134/S0006297918010108; Ahier A, 2018, NAT CELL BIOL, V20, P352, DOI 10.1038/s41556-017-0023-x; Amigo I., 2016, BIO-PROTOCOL, V6, pe1810, DOI [10.21769/BioProtoc.1810, DOI 10.21769/BIOPROTOC.1810]; Banik Bhabatosh, 2017, Curr Protoc Cell Biol, V76, DOI 10.1002/cpcb.26; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Chinopoulos C, 2011, METHODS MOL BIOL, V793, P311, DOI 10.1007/978-1-61779-328-8_20; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Devall M, 2015, BIOTECHNIQUES, V59, P241, DOI 10.2144/000114343; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Franko A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082392; Hamilton J, 2016, HUM MOL GENET, V25, P2762, DOI 10.1093/hmg/ddw133; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Hornig-Do HT, 2009, ANAL BIOCHEM, V389, P1, DOI 10.1016/j.ab.2009.02.040; Hubbard WB, 2019, J NEUROTRAUM, V36, P1252, DOI 10.1089/neu.2018.5990; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Hubbard WB, 2018, ACUTE NEURONAL INJUR, P63, DOI [10.1007/978-3-319-77495-4_4, DOI 10.1007/978-3-319-77495-4_4]; Jeanneteau F, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3985063; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; Kappler L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21107; Keane PC, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/716871; Khattar NK, 2016, J NEUROSCI METH, V263, P1, DOI 10.1016/j.jneumeth.2016.01.017; Kristian Tibor, 2010, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0722s52; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; Macheiner T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35571; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Pellman JJ, 2015, J NEUROCHEM, V134, P652, DOI 10.1111/jnc.13165; Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901; RENDON A, 1985, J NEUROSCI METH, V14, P41, DOI 10.1016/0165-0270(85)90113-X; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Tang B, 2012, MOL MED REP, V5, P1271, DOI 10.3892/mmr.2012.806; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Wang WX, 2017, PROG NEURO-PSYCHOPH, V73, P104, DOI 10.1016/j.pnpbp.2016.02.011; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Zhang L, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.65	48	16	16	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 4	2019	9								9656	10.1038/s41598-019-45568-3			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IH1AL	WOS:000474223600002	31273236	gold, Green Published			2022-02-06	
J	Geraerds, AJLM; Bonsel, GJ; Janssen, MF; de Jongh, MA; Spronk, I; Polinder, S; Haagsma, JA				Geraerds, A. J. L. M.; Bonsel, Gouke J.; Janssen, Mathieu F.; de Jongh, M. A.; Spronk, Inge; Polinder, Suzanne; Haagsma, Juanita A.			The added value of the EQ-5D with a cognition dimension in injury patients with and without traumatic brain injury	QUALITY OF LIFE RESEARCH			English	Article						HRQoL; EQ-5D; Cognition; TBI	QUALITY-OF-LIFE; HEALTH-STATUS; EUROQOL; VALIDITY	Purpose This study investigated the psychometric gain, if any, from the extension of the EQ-5D with a cognition bolt-on (EQ-5D+C) in a large cohort injury patients with and without traumatic brain injury (TBI). Methods Hospitalized adult injury patients filled out a survey 1 month after initial admission. The survey included the EQ-5D-3L, the cognition bolt-on item in EQ-5D format, and the visual analogue scale (EQ-VAS). We compared ceiling and other distributional effects between EQ-5D and EQ-5D+C and TBI and non-TBI group, and assessed convergent validity using the predictive association with EQ-VAS. Also, we assessed explanatory power using regression analysis, and classification efficiency using Shannon indices. Results In total, 715 TBI patients and 1978 non-TBI patients filled out the EQ-5D+C and EQ-VAS. Perfect health was reported by 7.9% (N=214) on the EQ-5D, and 7.3% (N=197) on the EQ-5D+C. Convergent validity was highest for EQ-5D+C in the TBI group (Spearman's rank correlation coefficient = -0.736) and lowest for EQ-5D in the non-TBI group (Spearman's rank correlation coefficient = -0.652). For both TBI and non-TBI groups, the explanatory power of EQ-5D+C was slightly higher than of EQ-5D (R-2=0.56 vs. 0.53 for TBI; R-2=0.47 vs. 0.45 for non-TBI). Absolute classification efficiency was higher for EQ-5D+C than for EQ-5D in both TBI groups, whereas relative classification efficiency was similar. Conclusions Psychometric performance in general of both the EQ-5D and EQ-5D+C was better in TBI patients. Adding a cognitive bolt-on slightly improved the psychometric performance of the EQ-5D-3L.	[Geraerds, A. J. L. M.; Bonsel, Gouke J.; Spronk, Inge; Polinder, Suzanne; Haagsma, Juanita A.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Janssen, Mathieu F.] Erasmus MC, Dept Psychiat, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands; [Bonsel, Gouke J.] Univ Utrecht, Med Ctr, Div Mother & Child, Utrecht, Netherlands; [de Jongh, M. A.] ETZ Hosp, Dept Trauma TopCare, Hilvarenbeekseweg 60, NL-5022 GC Tilburg, Netherlands		Geraerds, AJLM (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.geraerds@erasmusmc.nl	Spronk, Inge/AAZ-5905-2020	Spronk, Inge/0000-0001-9571-576X			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; de Jongh MAC, 2017, INJURY PREV, V23, P59, DOI 10.1136/injuryprev-2016-042032; Finch AP, 2018, EUR J HEALTH ECON, V19, P557, DOI 10.1007/s10198-017-0902-x; Gabbe BJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002322; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Golicki D, 2015, QUAL LIFE RES, V24, P845, DOI 10.1007/s11136-014-0834-1; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Janssen MFB, 2007, QUAL LIFE RES, V16, P895, DOI 10.1007/s11136-006-9160-6; JELSMA J, 2015, ANAL DESCRIPTIVE STU, V13, P13; Johnson JA, 1998, PHARMACOECONOMICS, V13, P421, DOI 10.2165/00019053-199813040-00005; Krabbe PFM, 1999, J CLIN EPIDEMIOL, V52, P293, DOI 10.1016/S0895-4356(98)00163-2; Lin FJ, 2013, QUAL LIFE RES, V22, P853, DOI 10.1007/s11136-012-0207-6; Linde L, 2008, J RHEUMATOL, V35, P1528; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Pickard AS, 2007, MED CARE, V45, P259, DOI 10.1097/01.mlr.0000254515.63841.81; PIELOU EC, 1966, AM NAT, V100, P463, DOI 10.1086/282439; Polinder S, 2010, INJURY PREV, V16, P147, DOI 10.1136/ip.2009.022418; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shannon CE, 1997, M D COMPUT, V14, P306; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; Wolfs CAG, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-33; Yang YL, 2015, VALUE HEALTH, V18, P52, DOI 10.1016/j.jval.2014.09.004	24	16	16	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	JUL	2019	28	7					1931	1939		10.1007/s11136-019-02144-6			9	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	ID4OG	WOS:000471655600021	30820809	Green Published, hybrid			2022-02-06	
J	Rai, JK; Erdodi, LA				Rai, Jaspreet K.; Erdodi, Laszlo A.			Impact of criterion measures on the classification accuracy of TOMM-1	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Erdodi index; modality specificity; multivariate models; performance validity; Test of Memory Malingering	RECOGNITION MEMORY TEST; VERBAL-LEARNING TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; COMPLEX IDEATIONAL MATERIAL; TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TEST; WORD CHOICE TEST; PERFORMANCE VALIDITY; DIGIT SPAN; TRIAL 1	This study was designed to examine the effect of various criterion measures on the classification accuracy of Trial 1 of the Test of Memory Malingering (TOMM-1), a free-standing performance validity test (PVT). Archival data were collected from a case sequence of 91 (M-Age = 42.2 years; M-Education = 12.7) patients clinically referred for neuropsychological assessment. Trials 2 and Retention of the TOMM, the Word Choice Test, and three validity composites were used as criterion PVTs. Classification accuracy varied systematically as a function of criterion PVT. TOMM-1 <= 43 emerged as the optimal cutoff, resulting in a wide range of sensitivity (.47-1.00), with perfect overall specificity. Failing the TOMM-1 was unrelated to age, education or gender, but was associated with elevated self-reported depression. Results support the utility of TOMM-1 as an independent, free-standing, single-trial PVT. Consistent with previous reports, the choice of criterion measure influences parameter estimates of the PVT being calibrated. The methodological implications of modality specificity to PVT research and clinical/forensic practice should be considered when evaluating cutoffs or interpreting scores in the failing range.	[Rai, Jaspreet K.; Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Neuropsychol Track, Windsor, ON, Canada; [Rai, Jaspreet K.] Univ Windsor, Edmonton, AB, Canada		Erdodi, LA (corresponding author), Glenrose Rehabil Hosp, Alberta Hlth Serv, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com					An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boone, 2007, ASSESSMENT FEIGNED C, P152; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Green P., 2003, GREENS WORD MEMORY T; Green P, 2004, GREENS MED SYMPTOM V; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Heaton R. K., 2004, REVISED COMPREHENSIV; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry GK, 2018, J INT NEUROPSYCH SOC, V24, P735, DOI 10.1017/S1355617718000218; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Horner MD, 2006, INT J NEUROSCI, V116, P1181, DOI 10.1080/00207450500514029; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kalfon TBO, 2016, J PSYCHOSOM RES, V87, P30, DOI 10.1016/j.jpsychores.2016.06.004; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee G. J., 2007, FORENSIC NEUROPSYCHO; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lichtenstein J. D., 2019, PSYCHOL INJURY LAW, DOI [10.1007/s12207-019-0935, DOI 10.1007/S12207-019-0935]; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Pearson, 2009, ADV CLIN SOLUTIONS W; Persinger VC, 2018, CLIN NEUROPSYCHOL, V32, P1039, DOI 10.1080/13854046.2017.1419507; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Schroeder RW, 2013, ARCH CLIN NEUROPSYCH, V28, P21, DOI 10.1093/arclin/acs094; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Slick D., 1997, VSVT VICTORIA SYMPTO; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith K, 2014, CLIN NEUROPSYCHOL, V28, P1048, DOI 10.1080/13854046.2014.931465; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Warrington E, 1984, RECOGNITION MEMORY T, V1; Williamson DJ, 2012, CLIN NEUROPSYCHOL, V26, P588, DOI 10.1080/13854046.2012.670266; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P208, DOI 10.1093/arclin/acr107; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	90	16	16	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 4	2021	28	2					185	196		10.1080/23279095.2019.1613994		JUN 2019	12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	QJ4GT	WOS:000473643100001	31187632				2022-02-06	
J	Lutton, EM; Ramey, SK; Andrews, AM; Shuvaev, VV; Chuang, GY; Muzykantov, VR; Ramirez, SH				Lutton, Evan M.; Ramey, S. Katie; Andrews, Allison M.; Shuvaev, Vladimir V.; Chuang, Gwo-Yu; Muzykantov, Vladimir R.; Ramirez, Servio H.			Endothelial Targeted Strategies to Combat Oxidative Stress: Improving Outcomes in Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; oxidative stress; catalase; blood-brain barrier; nanomedicine	SUPEROXIDE-DISMUTASE; IN-VITRO; FUSION PROTEIN; MODEL; NANOCARRIERS; CATALASE; DELIVERY; PATHOPHYSIOLOGY; EXPRESSION; RESPONSES	The endothelium is a thin monolayer of specialized cells that lines the luminal wall of blood vessels and constitutes the critical innermost portion of the physical barrier between the blood and the brain termed the blood-brain barrier (BBB). Aberrant changes in the endothelium occur in many neuropathological states, including those with high morbidity and mortality that lack targeted therapeutic interventions, such as traumatic brain injury (TBI). Utilizing ligands of surface determinants expressed on brain endothelium to target and combat injury mechanisms at damaged endothelium offers a new approach to the study of TBI and new avenues for clinical advancement. Many factors influence the targets that are expressed on endothelium. Therefore, the optimization of binding sites and ideal design features of nanocarriers are controllable factors that permit the engineering of nanotherapeutic agents with applicability that is specific to a known disease state. Following TBI, damaged endothelial cells upregulate cell adhesion molecules, including ICAM-1, and are key sites of reactive oxygen species (ROS) generation, including hydrogen peroxide. Reactive oxygen species along with pro-inflammatory mediators are known to contribute to endothelial damage and loss of BBB integrity. The use of targeted endothelial nanomedicine, with conjugates of the antioxidant enzyme catalase linked to anti-ICAM-1 antibodies, has recently been demonstrated to minimize oxidative stress at the BBB and reduce neuropathological outcomes following TBI. Here, we discuss targeted endothelial nanomedicine and its potential to provide benefits in TBI outcomes and future directions of this approach.	[Lutton, Evan M.; Andrews, Allison M.; Ramirez, Servio H.] Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA; [Ramey, S. Katie; Chuang, Gwo-Yu] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Andrews, Allison M.; Ramirez, Servio H.] Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19122 USA; [Shuvaev, Vladimir V.; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Ramirez, Servio H.] Temple Univ, Shriners Hosp Pediat Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19122 USA		Ramirez, SH (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA.; Ramirez, SH (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19122 USA.; Ramirez, SH (corresponding author), Temple Univ, Shriners Hosp Pediat Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.	servio@tempie.edu		ramirez, servio/0000-0002-4609-5653	Intramural Research Program of the Vaccine Research Center (National Institute of Allergy and Infectious Diseases, NIH); 2015 NF-TBI-Research Grant [SAP 4100077079];  [HL125462];  [HL126874];  [HL128398];  [P30-DA13429]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL125462, R01HL128398, R01HL126874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P41GM103311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P30DA013429] Funding Source: NIH RePORTER	This study was supported, in part, by research funding by P30-DA13429 (SR), the 2015 NF-TBI-Research Grant #SAP 4100077079 (Pennsylvania Dept. of Health, SR), and the Intramural Research Program of the Vaccine Research Center (National Institute of Allergy and Infectious Diseases, NIH), and HL125462, HL126874, and HL128398 (VM).	Alexander Nathan, 2011, IEEE Int Conf Comput Adv Bio Med Sci, V2011, P13, DOI 10.1109/ICCABS.2011.5729867; Amenta PS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0191-6; Andrews AM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00043; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; Calderon AJ, 2011, J CONTROL RELEASE, V150, P37, DOI 10.1016/j.jconrel.2010.10.025; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Carlsen RW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00028; Carnemolla R, 2013, J PHARMACOL EXP THER, V347, P339, DOI 10.1124/jpet.113.205104; Chorny M, 2010, J CONTROL RELEASE, V146, P144, DOI 10.1016/j.jconrel.2010.05.003; Coelho-Santos V, 2016, CELL MOL LIFE SCI, V73, P4701, DOI 10.1007/s00018-016-2301-3; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Corvo ML, 1999, BBA-BIOMEMBRANES, V1419, P325, DOI 10.1016/S0005-2736(99)00081-4; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dolle JP, 2014, TECHNOLOGY, V2, P106, DOI 10.1142/S2339547814500095; Eum WS, 2004, FREE RADICAL BIO MED, V37, P1656, DOI 10.1016/j.freeradbiomed.2004.07.028; Felix RA, 2002, J NEUROCHEM, V80, P64, DOI 10.1046/j.0022-3042.2001.00660.x; Ferrer MCC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102329; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Greineder CF, 2016, J CONTROL RELEASE, V226, P229, DOI 10.1016/j.jconrel.2016.02.006; Greineder CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080110; Haney MJ, 2012, NANOMEDICINE-UK, V7, P815, DOI [10.2217/NNM.11.156, 10.2217/nnm.11.156]; Howard MD, 2014, J CONTROL RELEASE, V177, P34, DOI 10.1016/j.jconrel.2013.12.035; Howard MD, 2014, ANNU REV PHARMACOL, V54, P205, DOI 10.1146/annurev-pharmtox-011613-140002; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Khoshnejad M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19784-2; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kozower BD, 2003, NAT BIOTECHNOL, V21, P392, DOI 10.1038/nbt806; Lancioni GE, 2010, RES DEV DISABIL, V31, P1121, DOI 10.1016/j.ridd.2010.06.019; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lutton EM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03309-4; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Manickam DS, 2012, J CONTROL RELEASE, V162, P636, DOI 10.1016/j.jconrel.2012.07.044; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Miller AA, 2006, ANTIOXID REDOX SIGN, V8, P1113, DOI 10.1089/ars.2006.8.1113; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Muro S, 2003, AM J PHYSIOL-CELL PH, V285, pC1339, DOI 10.1152/ajpcell.00099.2003; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Pape TLB, 2012, J REHABIL RES DEV, V49, P1137, DOI 10.1682/JRRD.2011.08.0154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Salvador E, 2018, METHODS MOL BIOL, V1717, P219, DOI 10.1007/978-1-4939-7526-6_17; Shuvaev VV, 2018, BIOMATERIALS, V185, P348, DOI 10.1016/j.biomaterials.2018.09.015; Shuvaev VV, 2018, J CONTROL RELEASE, V272, P1, DOI 10.1016/j.jconrel.2017.12.025; Shuvaev VV, 2016, J CONTROL RELEASE, V234, P115, DOI 10.1016/j.jconrel.2016.05.040; Shuvaev VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077002; Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789; Shuvaev VV, 2011, J CONTROL RELEASE, V149, P236, DOI 10.1016/j.jconrel.2010.10.026; Shuvaev VV, 2009, J PHARMACOL EXP THER, V331, P404, DOI 10.1124/jpet.109.156877; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Szarka N, 2018, J NEUROTRAUM, V35, P930, DOI 10.1089/neu.2017.5056; Venegoni W, 2017, J ADV NURS, V73, P1331, DOI 10.1111/jan.13259; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wallis RA, 1996, BRAIN RES, V710, P169, DOI 10.1016/0006-8993(95)01278-8; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Zafonte R, 2009, PROG BRAIN RES, V177, P293, DOI 10.1016/S0079-6123(09)17720-8; Zagorac D, 2005, STROKE, V36, P2589, DOI 10.1161/01.STR.0000189997.84161.95	70	16	16	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 6	2019	10								582	10.3389/fneur.2019.00582			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IC8RF	WOS:000471248500001	31275220	Green Published, gold			2022-02-06	
J	Erdodi, LA; Green, P; Sirianni, CD; Abeare, CA				Erdodi, Laszlo A.; Green, Paul; Sirianni, Christina D.; Abeare, Christopher A.			The Myth of High False-Positive Rates on the Word Memory Test in Mild TBI	PSYCHOLOGICAL INJURY & LAW			English	Article						Word Memory Test; False-positive rate; Performance validity; Mild TBI	TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; CARD SORTING TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; PERFORMANCE VALIDITY TESTS; FEIGNED COGNITIVE IMPAIRMENT; TEST-SCORES; CROSS-VALIDATION; SUBOPTIMAL PERFORMANCE; TEST INDICATORS	This study was designed to replicate previous reports of elevated false-positive rates (FPR) on the Word Memory Test (WMT) in patients with mild traumatic brain injury (TBI) and to evaluate previous claims that genuine memory deficits and non-credible responding are conflated on the WMT. Data from a consecutive case sequence of 170 patients with mild TBI referred for neuropsychological assessment were collected. Failure rate on the WMT was compared to that on other performance validity tests (PVTs). The clinical characteristics and neuropsychological profiles of patients who passed and those who failed the WMT and other PVTs were compared. Base rate of failure was the highest on the WMT (44.7%), but comparable to that on other established PVTs (39.4-41.8%). The vast majority of patients (94.7%) who failed the WMT had independent evidence of invalid performance, refuting previous estimates of 20-30% FPR. Failing the WMT was associated with globally lower scores on tests measuring various cognitive domains. The neurocognitive profile of individuals with invalid performance was remarkably consistent across various PVTs. Previously reported FPR of the WMT were not replicated. Failing the WMT typically occurred in the context of failing other PVTs too. Results suggest a common factor behind non-credible responding that is invariant of the psychometric definition of invalid performance. Failure on the WMT should not be discounted based on rational arguments unsubstantiated by objective data. Inferring elevated FPR from high failure rate alone is a fundamental epistemological error.	[Erdodi, Laszlo A.; Sirianni, Christina D.; Abeare, Christopher A.] Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Green, Paul] Greens Publishing, Kelowna, BC, Canada		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Abeare, Christopher/0000-0002-7163-7434	Faculty of Arts, Humanities, and Social Sciences at the University of Windsor	This research was supported by a Collaborative Research Grant from the Faculty of Arts, Humanities, and Social Sciences at the University of Windsor.	Abeare C., 2018, J HEAD TRAUMA REHABI; Abeare C., 2019, PSYCHOL INJURY LAW, DOI [10.1007/s12207-019-09353, DOI 10.1007/S12207-019-09353]; Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Allen LM, 1999, SEVERE TBI SAMPLE PE; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boone K.B., 2013, CLIN PRACTICE FORENS; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Brockhaus R., 2003, J INT NEUROPSYCH SOC, V9, P503; Carone DA, 2014, APPL NEUROPSYCH-ADUL, V21, P155, DOI 10.1080/09084282.2012.755533; Carone DA, 2014, CLIN NEUROPSYCHOL, V28, P146, DOI 10.1080/13854046.2013.861019; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; CONDER R, 1992, COMPUTERIZED ASSESSM; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; DeFlippis N. A., 1991, PSYCHOL ASSESSMENT R; DeFlippis N. A., 1997, PSYCHOL ASSESSMENT R; DeFlippis N. A., 1979, PSYCHOL ASSESSMENT R; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Elbaum T, 2020, APPL NEUROPSYCH-ADUL, V27, P403, DOI 10.1080/23279095.2018.1555161; Erdodi, 2018, J PEDIAT NEUROPSYCHO, V4, P94, DOI [10.1007/s40817-018-0057-4, DOI 10.1007/s40817-018-0057-4, DOI 10.1007/S40817-018-0057-4]; Erdodi L. A., 2019, ASSESSMENT FEIGNED C; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi LA, 2017, APPL NEUROPSYCHOL, V6, P335, DOI [10.1080/21622965.2016.1197126, DOI 10.1080/21622965.2016.1197126]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, PSYCHOL INJ LAW, V10, P96, DOI 10.1007/s12207-017-9282-x; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fritze E, 2003, THESIS; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Gilchrist GS, 1999, THROMB HAEMOSTASIS, P97; Gligorovic M, 2013, J INTELLECT DEV DIS, V38, P134, DOI 10.3109/13668250.2013.772956; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2012, PERFORMANCE WMT MSVT; Green P., 2007, ASSESSMENT FEIGNED C, P50; Green P, 2013, MILD TRAUMATIC BRAIN; Green P, 2004, GREENS MED SYMPTOM V; Green P, 1995, MANUAL ORAL WORD MEM; Green P, 2016, APPL NEUROPSYCH-CHIL, V5, P25, DOI 10.1080/21622965.2014.935378; Green P, 2015, APPL NEUROPSYCH-ADUL, V22, P293, DOI 10.1080/23279095.2014.925903; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hall VL, 2014, J NEUROPSYCHOL, V8, P216, DOI 10.1111/jnp.12021; Heaton R. K., 2004, REVISED COMPREHENSIV; Henry GK, 2018, J INT NEUROPSYCH SOC, V24, P735, DOI 10.1017/S1355617718000218; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hurtubise JL, 2017, PSYCHOL INJ LAW, V10, P121, DOI 10.1007/s12207-017-9287-5; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; King JH, 2002, CLIN NEUROPSYCHOL, V16, P506, DOI 10.1076/clin.16.4.506.13912; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Larochette AC, 2012, APPL NEUROPSYCH-CHIL, V1, P38, DOI 10.1080/21622965.2012.665777; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Lichtenstein JD, 2019, DEV NEUROPSYCHOL, V44, P159, DOI 10.1080/87565641.2019.1565535; Lupu T, 2018, APPL NEUROPSYCH-ADUL, V25, P532, DOI 10.1080/23279095.2017.1341410; Macciocchi SN, 2017, ARCH CLIN NEUROPSYCH, V32, P339, DOI 10.1093/arclin/acw112; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Pearson, 2009, ADV CLIN SOLUTIONS W; Persinger VC, 2018, CLIN NEUROPSYCHOL, V32, P1039, DOI 10.1080/13854046.2017.1419507; Rabin LA, 2014, PROF PSYCHOL-RES PR, V45, P368, DOI 10.1037/a0037987; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Rai J., 2019, APPL NEUROPSYCHOL, DOI [10.1080/23279095.2019.161.1613994, DOI 10.1080/23279095.2019.161.1613994]; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Shelley-Tremblay JE, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9050109; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Soble, 2019, CLIN NEUROPSYCHOL, V21, P209, DOI [10.1080/13825580601025932, DOI 10.1080/13825580601025932]; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tomer E, 2020, APPL NEUROPSYCH-ADUL, V27, P49, DOI 10.1080/23279095.2018.1480483; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; TYDECKS S, 2006, INT J FORENSIC PSYCH, V0001, P00029; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Warrington E, 1984, RECOGNITION MEMORY T, V1; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Williamson DJ, 2012, CLIN NEUROPSYCHOL, V26, P588, DOI 10.1080/13854046.2012.670266; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	119	16	16	2	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2019	12	2					155	169		10.1007/s12207-019-09356-8			15	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	IF6ZK	WOS:000473231100005					2022-02-06	
J	Jain, S; Vande Vyyere, T; Terzopoulos, V; Sima, DM; Roura, E; Maas, A; Wilms, G; Verheyden, J				Jain, Saurabh; Vande Vyyere, Thijs; Terzopoulos, Vasilis; Sima, Diana Maria; Roura, Eloy; Maas, Andrew; Wilms, Guido; Verheyden, Jan			Automatic Quantification of Computed Tomography Features in Acute Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						computed tomography; deep learning; quantification; traumatic brain injury	MIDLINE SHIFT; HEAD-INJURY; CLASSIFICATION; CT; PREDICTION; SEGMENTATION; GUIDELINES; MANAGEMENT; VOLUME; SCANS	Traumatic brain injury is a complex and diverse medical condition with a high frequency of intracranial abnormalities. These can typically be visualized on a computed tomography (CT) scan, which provides important information for further patient management, such as the need for operative intervention. In order to quantify the extent of acute intracranial lesions and associated secondary injuries, such as midline shift and cisternal compression, visual assessment of CT images has limitations, including observer variability and lack of quantitative interpretation. Automated image analysis can quantify the extent of intracranial abnormalities and provide added value in routine clinical practice. In this article, we present icobrain, a fully automated method that reliably computes acute intracranial lesions volume based on deep learning, cistern volume, and midline shift on the noncontrast CT image of a patient. The accuracy of our method is evaluated on a subset of the multi-center data set from the CENTER-TBI (Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury) study for which expert annotations were used as a reference. Median volume differences between expert assessments and icobrain are 0.07 mL for acute intracranial lesions and -0.01 mL for cistern segmentation. Correlation between expert assessments and icobrain is 0.91 for volume of acute intracranial lesions and 0.94 for volume of the cisterns. For midline shift computations, median error is -0.22 mm, with a correlation of 0.93 with expert assessments.	[Jain, Saurabh; Vande Vyyere, Thijs; Terzopoulos, Vasilis; Sima, Diana Maria; Roura, Eloy; Wilms, Guido; Verheyden, Jan] Icometrix, Res & Dev, Kolonel Begaultlaan 1b-12, B-3012 Leuven, Belgium; [Vande Vyyere, Thijs] Antwerp Univ Hosp, Dept Radiol, Antwerp, Belgium; [Vande Vyyere, Thijs; Maas, Andrew] Univ Antwerp, Antwerp, Belgium; [Maas, Andrew] Antwerp Univ Hosp, Dept Neurosurg, Antwerp, Belgium; [Wilms, Guido] UZ Leuven, Dept Radiol, Leuven, Belgium		Jain, S (corresponding author), Icometrix, Res & Dev, Kolonel Begaultlaan 1b-12, B-3012 Leuven, Belgium.	saurabh.jain@icometrix.com	Maas, Andrew IR/C-5584-2013; Vande Vyvere, Thijs/AAB-5180-2022	Maas, Andrew IR/0000-0003-1612-1264; Vande Vyvere, Thijs/0000-0003-4032-5443; Sima, Diana M/0000-0002-0118-2905	European Commission 7th Framework program [602150, FP7-COOPERATION-2013-602150]; Hannelore Kohl Foundation (Germany); nonprofit organization, One Mind	Data used in preparation of this article were obtained in the context of CENTER-TBI (FP7-COOPERATION-2013-602150), a large collaborative project supported by the European Commission 7th Framework program (602150). Funding of additional elements has been provided by the Hannelore Kohl Foundation (Germany) and by the nonprofit organization, One Mind.	Bardera A, 2009, COMPUT MED IMAG GRAP, V33, P304, DOI 10.1016/j.compmedimag.2009.02.001; Bhadauria HS, 2013, COMPUT ELECTR ENG, V39, P1527, DOI 10.1016/j.compeleceng.2013.04.010; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen MY, 2015, AUSTRALAS PHYS ENG S, V38, P627, DOI 10.1007/s13246-015-0372-3; Chilamkurthy S., 2018, ARXIV180305854CSCV; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Clatterbuck RE, 1997, NEUROSURGERY, V40, P339, DOI 10.1097/00006123-199702000-00019; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Garcia-Lorenzo D, 2013, MED IMAGE ANAL, V17, P1, DOI 10.1016/j.media.2012.09.004; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; King DB, 2015, ACS SYM SER, V1214, P1; Kochendorfer-Lucius G, 2006, EQUITY DEV, P1, DOI [DOI 10.1002/0471667196.ESS1275.PUB2, 10.1596/978-0-8213-6105-4, DOI 10.1596/978-0-8213-6105-4]; Koikkalainen J, 2014, I S BIOMED IMAGING, P125, DOI 10.1109/ISBI.2014.6867825; Liao CC, 2018, INT J BIOMED IMAGING, V2018, DOI 10.1155/2018/4303161; Liao CC, 2010, COMPUT BIOL MED, V40, P331, DOI 10.1016/j.compbiomed.2010.01.004; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; PASQUALIN A, 1991, NEUROSURGERY, V28, P370, DOI 10.1227/00006123-199103000-00006; Qureshi N., 2015, INT J COMPUT APPL, V113, P1; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Reddy D, 2014, NEUROSURGERY, V75, P646; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; Roy S, 2015, PROC SPIE, V9413, DOI 10.1117/12.2082199; Stocchetti N, 2000, J NEUROL NEUROSUR PS, V68, P14, DOI 10.1136/jnnp.68.1.14; Wang H.-C., 2017, ARXIV170300797PHYSIC; Xiao FR, 2011, COMPUT BIOL MED, V41, P756, DOI 10.1016/j.compbiomed.2011.06.011; Yuh EL, 2008, J NEUROTRAUM, V25, P1163, DOI 10.1089/neu.2008.0590; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zaki WMDW, 2011, 2011 IEEE REGION 10 CONFERENCE TENCON 2011, P369, DOI 10.1109/TENCON.2011.6129127; Zeiler M. D., 2012, ARXIV12125701CSLG	41	16	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1794	1803		10.1089/neu.2018.6183			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600010	30648469	Green Submitted, Green Accepted, Green Published, hybrid			2022-02-06	
J	McDonald, S; Dalton, KI; Rushby, JA; Landin-Romero, R				McDonald, Skye; Dalton, Katie I.; Rushby, Jacqueline A.; Landin-Romero, Ramon			Loss of white matter connections after severe traumatic brain injury (TBI) and its relationship to social cognition	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic brain injury; White matter; Diffuse axonal injury; Social cognition	NEUROPSYCHOLOGICAL IMPAIRMENT; EMOTION RECOGNITION; AUDITORY-CORTEX; DEFICITS; METAANALYSIS; PERCEPTION; EMPATHY; MIND; BEHAVIOR; NEUROPATHOLOGY	Adults with severe traumatic brain injury (TBI) often suffer poor social cognition. Social cognition is complex, requiring verbal, non-verbal, auditory, visual and affective input and integration. While damage to focal temporal and frontal areas has been implicated in disorders of social cognition after TBI, the role of white matter pathology has not been examined. In this study 17 adults with chronic, severe TBI and 17 control participants underwent structural MRI scans and Diffusion Tensor Imaging. The Awareness of Social Inference Test (TASIT) was used to assess their ability to understand emotional states, thoughts, intentions and conversational meaning in everyday exchanges. Track-based spatial statistics were used to perform voxelwise analysis of Fractional Anisotropy (FA) and Mean Diffusivity (MD) of white matter tracts associated with poor social cognitive performance. FA suggested a wide range of tracts were implicated in poor TASIT performance including tracts known to mediate, auditory localisation (planum temporale) communication between nonverbal and verbal processes in general (corpus callosum) and in memory in particular (fornix) as well as tracts and structures associated with semantics and verbal recall (left temporal lobe and hippocampus), multimodal processing and integration (thalamus, external capsule, cerebellum) and with social cognition (orbitofrontal cortex, frontopolar cortex, right temporal lobe). Even when controlling for non-social cognition, the corpus callosum, fornix, bilateral thalamus, right external capsule and right temporal lobe remained significant contributors to social cognitive performance. This study highlights the importance of loss of white matter connectivity in producing complex social information processing deficits after TBI.	[McDonald, Skye; Dalton, Katie I.; Rushby, Jacqueline A.] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Landin-Romero, Ramon] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia		McDonald, S (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014; Rushby, Jacqueline/D-1820-2010	McDonald, Skye/0000-0003-0723-6094; Rushby, Jacqueline/0000-0002-5018-638X	ARCAustralian Research Council [15010026]; NHMRCNational Health and Medical Research Council of Australia [1081923]; ARC Centre of Excellence in Cognition and its Disorders Memory NodeAustralian Research Council [CE11000102]; Appenzeller Neuroscience Fellowship in Alzheimer's Disease; NHMRC Centre of Research Excellence in Brain RecoveryNational Health and Medical Research Council of Australia	KD was supported by an ARC Discovery Project 15010026. JR was supported by NHMRC Project Grant 1081923. RLR is supported by the ARC Centre of Excellence in Cognition and its Disorders Memory Node (CE11000102) and by the Appenzeller Neuroscience Fellowship in Alzheimer's Disease. Additional support was provided from the NHMRC Centre of Research Excellence in Brain Recovery and a former ARC DP 1094083.	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Alho K, 2014, HEARING RES, V307, P29, DOI 10.1016/j.heares.2013.08.001; Alink A, 2012, HUM BRAIN MAPP, V33, P969, DOI 10.1002/hbm.21263; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baggio HC, 2012, NEUROPSYCHOLOGIA, V50, P2121, DOI 10.1016/j.neuropsychologia.2012.05.020; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burgess P.W., 1997, HAYLING BRIXTON TEST; Bzdok D, 2012, BRAIN STRUCT FUNCT, V217, P783, DOI 10.1007/s00429-012-0380-y; Carrera E, 2006, NEUROLOGY, V66, P1817, DOI 10.1212/01.wnl.0000219679.95223.4c; Champagne-Lavau M, 2009, J NEUROLINGUIST, V22, P413, DOI 10.1016/j.jneuroling.2009.02.002; Charbonneau S, 2003, NEUROPSYCHOLOGIA, V41, P605, DOI 10.1016/S0028-3932(02)00202-6; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Downey LE, 2015, NEUROIMAGE-CLIN, V8, P640, DOI 10.1016/j.nicl.2015.06.005; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kumfor F, 2016, BRAIN, V139, P986, DOI 10.1093/brain/awv387; Leigh R, 2013, BRAIN, V136, P2539, DOI 10.1093/brain/awt177; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marsh AA, 2014, SOC COGN AFFECT NEUR, V9, P3, DOI 10.1093/scan/nss097; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2018, SOC NEUROSCI-UK, V13, P471, DOI 10.1080/17470919.2017.1356370; Mike A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082422; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Reitan RM, 1992, TRAIL MAKING TEST; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Rushby JA, 2016, NEUROIMAGE-CLIN, V12, P607, DOI 10.1016/j.nicl.2016.09.017; Sacchetti B, 2009, NEUROSCIENCE, V162, P756, DOI 10.1016/j.neuroscience.2009.01.064; Saldert C, 2007, CLIN LINGUIST PHONET, V21, P637, DOI 10.1080/02699200701431056; Schmahmann J., 2006, FIBRE PATHWAYS BRAIN; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Symington SH, 2010, SOC NEUROSCI-UK, V5, P296, DOI 10.1080/17470910903462419; Tate R.L., 1998, J AUSTR NZ PUBLIC HL, V22, P11; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Timmann D, 2010, CORTEX, V46, P845, DOI 10.1016/j.cortex.2009.06.009; Tsivilis D, 2008, NAT NEUROSCI, V11, P834, DOI 10.1038/nn.2149; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Zundorf IC, 2014, BRAIN, V137, P1410, DOI 10.1093/brain/awu044	73	16	16	3	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2019	13	3					819	829		10.1007/s11682-018-9906-0			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IA1VV	WOS:000469351500023	29948905				2022-02-06	
J	Santo, CCD; Fiorin, FD; Ilha, J; Duarte, MMMF; Duarte, T; Santos, ARS				do Espirito Santo, Caroline Cunha; Fiorin, Fernando da Silva; Ilha, Jocemar; Medeiros Frescura Duarte, Marta Maria; Duarte, Tiago; Soares Santos, Adair Roberto			Spinal cord injury by clip-compression induces anxiety and depression-like behaviours in female rats: The role of the inflammatory response	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Spinal cord injury; Behaviour; Anxiety; Depression; Inflammation; Cytokines	ELEVATED-PLUS-MAZE; SEX-DIFFERENCES; EXPRESSION; STRESS; CYTOKINES; MODEL; BRAIN; ELECTROACUPUNCTURE; AUTOANTIBODIES; METAANALYSIS	Traumatic spinal cord injury (SCI) promotes long-term disability that affects mobility and functional independence. The spinal cord inflammatory response after the initial mechanical insult substantially impacts locomotor impairment and development of neuropsychiatric disorders, including anxiety and depression. However, these psychiatric events are scarcely investigated in females. This study investigated the anxiety/depression-like behaviours and inflammatory responses related to the production/release of pro- and anti-inflammatory cytokines in female adult Wistar rats submitted to severe clip-compression SCI. Data showed that SCI impaired the locomotor performance assessment by the BBB scale, but did not alter exploratory activity in open-field test. Animals' locomotor impairment was associated with anxious and depressive-like behaviours characterised by a decreased amount of time in the open arms of the elevated plus-maze test, and the motivational reduction of social interaction and anhedonia assessed by social exploration and sucrose preference tests. By contrast, SCI decreased the immobility time in the forced swimming test. Moreover, SCI caused a significant increase in local and systemic proinflammatory cytokines (TNF-alpha, INF-gamma, IL-1 beta, and IL-6) and a reduction in the anti-inflammatory cytokine IL-10. Finally, there were significant negative correlations between depression-like behaviour, but not anxiety, and increased plasma concentrations of TNF-alpha, IL-1 beta, IL-6, and INF-gamma. Additionally, the laminectomy procedure provoked the inflammatory response associated with reduced sucrose intake in Sham animals, although less expressively than in the SCI group. Collectively, these results indicate that SCI by clip-compression in female rats promotes a neuropsychiatric-like profile associated with an imbalance in the production/release of pro- and anti-inflammatory cytokines.	[do Espirito Santo, Caroline Cunha; Fiorin, Fernando da Silva; Soares Santos, Adair Roberto] Univ Fed Santa Catarina, Ctr Ciencias Biol, Programa Posgrad Neurociencias, Florianopolis, SC, Brazil; [do Espirito Santo, Caroline Cunha; Fiorin, Fernando da Silva; Soares Santos, Adair Roberto] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Ciencias Fisiol, Lab Neurobiol Dor & Inflamacao, Florianopolis, SC, Brazil; [Ilha, Jocemar] Univ Estado Santa Catarina, Dept Fisioterapia Nucleo Pesquisa Lesao Medula Es, Florianopolis, SC, Brazil; [Medeiros Frescura Duarte, Marta Maria] Univ Luterana Brasil, Programa Posgrad Farmacol, Canoas, RS, Brazil; [Medeiros Frescura Duarte, Marta Maria] Univ Luterana Brasil, Ctr Ciencias Saude, Canoas, RS, Brazil; [Duarte, Tiago] Univ Fed Santa Maria, Programa Posgrad Farmacol, Santa Maria, RS, Brazil		Santo, CCD; Santos, ARS (corresponding author), Univ Fed Santa Catarina, BR-88040900 Florianopolis, SC, Brazil.	karolces@hotmail.com; adair.santos@ufsc.br	Santos, Adair/C-5565-2013; Ilha, Jocemar/I-4247-2012; da Silva Fiorin, Fernando/AAQ-9472-2021	Santos, Adair/0000-0002-6435-4698; Ilha, Jocemar/0000-0002-6300-4696; da Silva Fiorin, Fernando/0000-0002-6517-7160; do Espirito Santo, Caroline/0000-0001-8657-9532	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC)Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Programa INCT-INOVAMED [465430/2014-7]; CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	We are thankful to Angela P. Franca, Nicolas Alexsander M. M. M. Pereira, Kelly O. Coelho, Nathana T. M. Loebens, and Amabile A. Weber for their advice in experiments and assistance in animal care. This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Programa INCT-INOVAMED (465430/2014-7). Caroline Cunha do Espirito Santo, Fernando da Silva Fiorin, and Tiago Duarte are recipients of CAPES fellowships. Adair RS Santos is recipient of a productivity fellowship from CNPq.	Allison DJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0425-2; Amsen Derk, 2009, V511, P107, DOI 10.1007/978-1-59745-447-6_5; Anyan J, 2018, NEUROPSYCHOPHARMACOL, V43, P931, DOI 10.1038/npp.2017.260; Baastrup C, 2011, BRAIN RES, V1370, P129, DOI 10.1016/j.brainres.2010.11.008; BANKS WA, 1994, J PHYSIOL-LONDON, V479, P257, DOI 10.1113/jphysiol.1994.sp020293; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bateman E., 2017, THESIS; Beedie A, 2002, J CLIN PSYCHOL MED S, V9, P227, DOI 10.1023/A:1016003428370; Boadas-Vaello P, 2018, NEUROSCI LETT, V664, P98, DOI 10.1016/j.neulet.2017.11.007; Bombardier CH, 2012, ARCH PHYS MED REHAB, V93, P775, DOI 10.1016/j.apmr.2011.12.020; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Cheng ZJ, 2017, CELL TRANSPLANT, V26, P469, DOI 10.3727/096368916X693473; Cheriyan T, 2014, SPINAL CORD, V52, P588, DOI 10.1038/sc.2014.91; Christianson JP, 2008, BEHAV BRAIN RES, V193, P87, DOI 10.1016/j.bbr.2008.04.024; Chung MC, 2006, J AFFECT DISORDERS, V93, P229, DOI 10.1016/j.jad.2006.02.021; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; Derry HM, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0618-5; Ferguson SA, 2005, PHYSIOL BEHAV, V85, P621, DOI 10.1016/j.physbeh.2005.06.009; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; FUHRER MJ, 1993, ARCH PHYS MED REHAB, V74, P255; Geng X, 2015, NEURAL REGEN RES, V10, P394, DOI 10.4103/1673-5374.153687; Goldkuhl R, 2008, EUR SURG RES, V41, P272, DOI 10.1159/000142372; Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7; Haapakoski R, 2015, BRAIN BEHAV IMMUN, V49, P206, DOI 10.1016/j.bbi.2015.06.001; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Heshmati Mitra, 2015, Curr Behav Neurosci Rep, V2, P146; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Jalan D, 2017, J NEUROSURG-SPINE, V26, P62, DOI 10.3171/2016.6.SPINE16343; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Khazaeipour Zahra, 2015, Top Spinal Cord Inj Rehabil, V21, P149, DOI 10.1310/sci2102-149; Kohler CA, 2017, ACTA PSYCHIAT SCAND, V135, P373, DOI 10.1111/acps.12698; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P1099, DOI 10.1053/apmr.2000.7167; Le J, 2016, SPINAL CORD, V54, P570, DOI 10.1038/sc.2016.15; Luedtke K, 2014, J NEUROTRAUM, V31, P1107, DOI 10.1089/neu.2013.3204; Maldonado-Bouchard S, 2016, BRAIN BEHAV IMMUN, V51, P176, DOI 10.1016/j.bbi.2015.08.009; Mehta S, 2018, TOP SPINAL CORD INJ, V24, P37, DOI 10.1310/sci16-00027; Mezadri TJ, 2011, J NEUROSCI METH, V195, P200, DOI 10.1016/j.jneumeth.2010.12.015; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Mitchell MC, 2008, SPINAL CORD, V46, P547, DOI 10.1038/sj.sc.3102154; Moieni M, 2015, NEUROPSYCHOPHARMACOL, V40, P1709, DOI 10.1038/npp.2015.17; NSCISC, 2017, ANN STAT REP SPIN CO; O'Donovan A, 2010, BRAIN BEHAV IMMUN, V24, P1074, DOI 10.1016/j.bbi.2010.03.003; Otte C, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.65; Pan WH, 1997, J NEUROIMMUNOL, V76, P105, DOI 10.1016/S0165-5728(97)00034-9; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pacheco-Unguetti AP, 2010, PSYCHOL SCI, V21, P298, DOI 10.1177/0956797609359624; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Pitsavos C, 2006, ATHEROSCLEROSIS, V185, P320, DOI 10.1016/j.atherosclerosis.2005.06.001; Popovich PG, 2001, J NEUROTRAUM, V18, P957, DOI 10.1089/089771501750451866; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Pruss H, 2011, BRAIN PATHOL, V21, P652, DOI 10.1111/j.1750-3639.2011.00488.x; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Reis JSS, 2014, PHYTOMEDICINE, V21, P1466, DOI 10.1016/j.phymed.2014.06.001; Riaz MS, 2015, PHYSIOL BEHAV, V152, P128, DOI 10.1016/j.physbeh.2015.09.005; Sandi C, 2009, TRENDS NEUROSCI, V32, P312, DOI 10.1016/j.tins.2009.02.004; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Skurlova M, 2011, NEUROSCI LETT, V487, P250, DOI 10.1016/j.neulet.2010.10.032; Song C, 2009, PHARMACOPSYCHIATRY, V42, P182, DOI 10.1055/s-0029-1202263; Vinkers CH, 2008, EUR J PHARMACOL, V585, P407, DOI 10.1016/j.ejphar.2008.02.097; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Williams R, 2015, ARCH PHYS MED REHAB, V96, P133, DOI 10.1016/j.apmr.2014.08.016; World Health Organization, 2017, DEPR OTH COMM MENT D; Wu JF, 2016, J NEUROTRAUM, V33, P1919, DOI 10.1089/neu.2015.4348; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Xiang XJ, 2011, BEHAV BRAIN RES, V222, P326, DOI 10.1016/j.bbr.2011.03.068; Yee JR, 2010, BRAIN BEHAV IMMUN, V24, P942, DOI 10.1016/j.bbi.2010.03.006; Zhang C, 2014, BIOCHEM BIOPH RES CO, V444, P395, DOI 10.1016/j.bbrc.2014.01.070; 2017, NAT NEUROSCI, V20, P1549, DOI DOI 10.1038/NN.4643; 2018, NEUROCHEM RES, V43, P1258, DOI DOI 10.1007/S11064-018-2543-6; 2016, PSYCHONEUROENDOCRINO, V65, P109, DOI DOI 10.1016/J.PSYNEUEN.2015.12.004	74	16	16	1	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAY	2019	78						91	104		10.1016/j.bbi.2019.01.012			14	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	HY6RH	WOS:000468256900012	30659938				2022-02-06	
J	Dobrachinski, F; Gerbatin, RR; Sartori, G; Golombieski, RM; Antoniazzi, A; Nogueira, CW; Royes, LF; Fighera, MR; Porciuncula, LO; Cunha, RA; Soares, FAA				Dobrachinski, Fernando; Gerbatin, Rogerio R.; Sartori, Glaubia; Golombieski, Ronaldo M.; Antoniazzi, Alfredo; Nogueira, Cristina W.; Royes, Luiz F.; Fighera, Michele R.; Porciuncula, Lisiane O.; Cunha, Rodrigo A.; Soares, Felix A. A.			Guanosine Attenuates Behavioral Deficits After Traumatic Brain Injury by Modulation of Adenosinergic Receptors	MOLECULAR NEUROBIOLOGY			English	Article						Purinergic nucleoside; Fluid percussion injury; Memory; Anxiety; Adenosine A(1) receptor; Adenosine A(2A) receptor	FLUID PERCUSSION INJURY; A(2A) RECEPTORS; RAT-BRAIN; CAFFEINE; DYSFUNCTION; MECHANISMS; A(1); DEPRIVATION; PROTECTS; MEMORY	Traumatic brain injury (TBI) is a leading cause of disability worldwide, triggering chronic neurodegeneration underlying cognitive and mood disorder still without therapeutic prospects. Based on our previous observations that guanosine (GUO) attenuates short-term neurochemical alterations caused by TBI, this study investigated the effects of chronical GUO treatment in behavioral, molecular, and morphological disturbances 21days after trauma. Rats subject to TBI displayed mood (anxiety-like) and memory dysfunction. This was accompanied by a decreased expression of both synaptic (synaptophysin) and plasticity proteins (BDNF and CREB), a loss of cresyl violet-stained neurons, and increased astrogliosis and microgliosis in the hippocampus. Notably, chronic GUO treatment (7.5mg/kgi.p. daily starting 1h after TBI) prevented all these TBI-induced long-term behavioral, neurochemical, and morphological modifications. This neuroprotective effect of GUO was abrogated in the presence of the adenosine A(1) receptor antagonist DPCPX (1mg/kg) but unaltered by the adenosine A(2A) receptor antagonist SCH58261 (0.05mg/kg). These findings show that a chronic GUO treatment prevents the long-term mood and memory dysfunction triggered by TBI, which involves adenosinergic receptors.	[Dobrachinski, Fernando; Golombieski, Ronaldo M.; Fighera, Michele R.; Soares, Felix A. A.] Univ Fed Santa Maria, Dept Biochem & Mol Biol, Ctr Nat & Exact Sci, UFSM, BR-97105900 Santa Maria, RS, Brazil; [Dobrachinski, Fernando; Cunha, Rodrigo A.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004504 Coimbra, Portugal; [Gerbatin, Rogerio R.; Royes, Luiz F.] Univ Fed Santa Maria, Lab Exercise Biochem, Santa Maria, RS, Brazil; [Sartori, Glaubia; Nogueira, Cristina W.] Univ Fed Santa Maria, Dept Biochem & Mol Biol, Lab Synth React & Pharmacol Evaluating & Toxicol, Santa Maria, RS, Brazil; [Antoniazzi, Alfredo] Univ Fed Santa Maria, Lab Biotechnol & Anim Reprod, BioRep Vet Hosp, Santa Maria, RS, Brazil; [Fighera, Michele R.] Univ Fed Santa Maria, Dept Neuropsychiat, Hlth Sci Ctr, Santa Maria, RS, Brazil; [Porciuncula, Lisiane O.] Univ Fed Rio Grande do Sul, ICBS, Dept Biochem, Lab Studies Purinerg Syst, Porto Alegre, RS, Brazil; [Cunha, Rodrigo A.] Univ Coimbra, Fac Med, P-3004504 Coimbra, Portugal		Soares, FAA (corresponding author), Univ Fed Santa Maria, Dept Biochem & Mol Biol, Ctr Nat & Exact Sci, UFSM, BR-97105900 Santa Maria, RS, Brazil.	felix@ufsm.br	Cunha, Rodrigo A/E-7475-2015; Fighera, Michele R/J-9576-2014; SARTORI, GLAUBIA/J-3435-2014; Soares, Felix/AAE-6251-2020; Dobrachinski, Fernando/C-4316-2014; Golombieski, Ronaldo M/D-3342-2014	Cunha, Rodrigo A/0000-0003-2550-6422; SARTORI, GLAUBIA/0000-0002-1088-8731; Soares, Felix/0000-0002-6453-7902; Dobrachinski, Fernando/0000-0002-3948-1273; Golombieski, Ronaldo M/0000-0002-1153-4396; Fighera, Michele/0000-0002-3111-7530	INCT for excitotoxicity and neuroprotection-MCT/CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Maratona da Saude; GAI-FMUC; Banco Santander-Totta; ERDF through Centro 2020 [CENTRO-01-0145-FEDER-000008: BrainHealth 2020]; ERDF through FCT [POCI-01-0145-FEDER-007440, PTDC/NEU-NMC/4154/2016]; FAPERGS/PRONEMFundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [11/2029-1]; CNPq Brasil (Programa Ciencia sem Fronteiras)	This study was supported by INCT for excitotoxicity and neuroprotection-MCT/CNPq. C.W.N., L.F.R., M.R.F., L.O.P., and F.A.A.S. received a fellowship by CNPq; F.D., R.R.G., and G.S. received a fellowship by CAPES. RAC received funding from Maratona da Saude, GAI-FMUC and Banco Santander-Totta, ERDF, through Centro 2020 (project CENTRO-01-0145-FEDER-000008: BrainHealth 2020), and through FCT (projects POCI-01-0145-FEDER-007440 and PTDC/NEU-NMC/4154/2016). Additional support was given by FAPERGS/PRONEM 11/2029-1. F.D. received a fellowship from CNPq Brasil (Programa Ciencia sem Fronteiras).	Almeida RF, 2017, MOL NEUROBIOL, V54, P423, DOI 10.1007/s12035-015-9660-x; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Ballerini R, 2006, INT J IMMUNOPATH PH, V19, P293, DOI 10.1177/039463200601900207; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bettio LEB, 2016, PURINERG SIGNAL, V12, P411, DOI 10.1007/s11302-016-9509-4; Bettio LEB, 2016, EUR J NEUROSCI, V43, P1006, DOI 10.1111/ejn.13172; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen ZC, 2014, J NEUROSCI, V34, P9621, DOI 10.1523/JNEUROSCI.3991-13.2014; Ciccarelli R, 2000, GLIA, V29, P202, DOI 10.1002/(SICI)1098-1136(20000201)29:3<202::AID-GLIA2>3.0.CO;2-C; Ciruela F, 2006, J NEUROSCI, V26, P2080, DOI 10.1523/JNEUROSCI.3574-05.2006; Cunha GMA, 2006, NEUROSCIENCE, V141, P1775, DOI 10.1016/j.neuroscience.2006.05.024; Cunha RA, 2016, J NEUROCHEM, V139, P1019, DOI 10.1111/jnc.13724; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dal-Cim T, 2013, J NEUROCHEM, V126, P437, DOI 10.1111/jnc.12324; Dall'Igna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008; de Mendonca A, 2000, BRAIN RES REV, V33, P258, DOI 10.1016/S0165-0173(00)00033-3; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Di Liberto V, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00158; Dobrachinski F, 2017, J NEUROTRAUM, V34, P1318, DOI 10.1089/neu.2016.4563; El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170; Forner S, 2017, TRENDS NEUROSCI, V40, P347, DOI 10.1016/j.tins.2017.04.002; Ganzella M, 2012, NEUROL SCI, V33, P985, DOI 10.1007/s10072-011-0872-1; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Gerrikagoitia I, 2009, ANAT REC, V292, P1968, DOI 10.1002/ar.20999; Giuliani P, 2015, ADV EXP MED BIOL, V837, P23, DOI 10.1007/5584_2014_73; Guo D, 2014, BRIT J PHARMACOL, V171, P5295, DOI 10.1111/bph.12836; Gysbers JW, 1996, INT J DEV NEUROSCI, V14, P19, DOI 10.1016/0736-5748(95)00083-6; Halldner L, 2004, NEUROPHARMACOLOGY, V46, P1008, DOI 10.1016/j.neuropharm.2004.01.014; Hansel G, 2015, MOL NEUROBIOL, V52, P1791, DOI 10.1007/s12035-014-8978-0; Jackson EK, 2013, AM J PHYSIOL-CELL PH, V304, pC406, DOI 10.1152/ajpcell.00212.2012; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kaster MP, 2015, P NATL ACAD SCI USA, V112, P7833, DOI 10.1073/pnas.1423088112; Lanznaster D, 2017, MOL NEUROBIOL, V54, P5482, DOI 10.1007/s12035-016-0082-1; Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MASLIAH E, 1993, BRAIN PATHOL, V3, P77, DOI 10.1111/j.1750-3639.1993.tb00728.x; Matos M, 2013, J NEUROSCI, V33, P18492, DOI 10.1523/JNEUROSCI.1828-13.2013; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Muller C E, 1993, Pharm Acta Helv, V68, P77, DOI 10.1016/0031-6865(93)90012-U; Oliveira KA, 2017, PURINERG SIGNAL, V13, P305, DOI 10.1007/s11302-017-9562-7; Paniz LG, 2014, METAB BRAIN DIS, V29, P645, DOI 10.1007/s11011-014-9548-x; Petronilho F, 2012, BRAIN BEHAV IMMUN, V26, P904, DOI 10.1016/j.bbi.2012.03.007; Prediger RDS, 2005, NEUROBIOL AGING, V26, P957, DOI 10.1016/j.neurobiolaging.2004.08.012; Quincozes-Santos A, 2013, PURINERG SIGNAL, V9, P643, DOI 10.1007/s11302-013-9377-0; Rebola N, 2011, J NEUROCHEM, V117, P100, DOI 10.1111/j.1471-4159.2011.07178.x; Rial D, 2016, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00521; Rodrigues RJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00148; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmidt AP, 2010, BRIT J PHARMACOL, V159, P1247, DOI 10.1111/j.1476-5381.2009.00597.x; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Serchov T, 2015, NEURON, V87, P549, DOI 10.1016/j.neuron.2015.07.010; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Simoes AP, 2016, NEUROPSYCHOPHARMACOL, V41, P2862, DOI 10.1038/npp.2016.98; Su C, 2013, J BIOL REG HOMEOS AG, V27, P673; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Traversa U, 2003, BIOORGAN MED CHEM, V11, P5417, DOI 10.1016/j.bmc.2003.09.043; Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wu XF, 2010, BIOCHEM BIOPH RES CO, V393, P514, DOI 10.1016/j.bbrc.2010.02.038; Yoshioka K, 2001, P NATL ACAD SCI USA, V98, P7617, DOI 10.1073/pnas.121587098; Zorec R, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00056	67	16	16	0	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAY	2019	56	5					3145	3158		10.1007/s12035-018-1296-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HZ0MQ	WOS:000468535100006	30105669				2022-02-06	
J	Howell, DR; Oldham, JR; Meehan, WP; DiFabio, MS; Buckley, TA				Howell, David R.; Oldham, Jessie R.; Meehan, William P., III; DiFabio, Melissa S.; Buckley, Thomas A.			Dual-Task Tandem Gait and Average Walking Speed in Healthy Collegiate Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; dual-task; tandem gait; SCAT3; SCAT5	BALANCE CONTROL; BASE-LINE; SINGLE-TASK; CONCUSSION; SPORT; ADOLESCENTS; PERFORMANCE; RECOVERY; DEFICITS; CONSISTENCY	Objectives: To (1) examine the association between a commonly used concussion test, tandem gait, in single/dual-task conditions with single-task and dual-task average walking speed, (2) characterize the prevalence of tandem gait false positives, and (3) develop a normative reference range of dual-task tandem gait times. Design: Cross-sectional study. Setting: Two NCAA collegiate athletic facilities. Independent Variables: Athletes completed the tandem gait test and a gait evaluation in single/dual-task conditions during a preseason examination. Main Outcome Measures: Associations between tandem gait times and average walking speeds were evaluated using multiple linear regression models. Various tandem gait test time pass/fail cutoffs were calculated to examine false-positive rates. Results: Among the 171 participants (103 men, 19.8 +/- 1.2 years of age), dual-task tandem gait completion times were independently associated with dual-task average walking speed [beta = -4.018; 95% confidence interval (CI), -7.153 to -0.883], but single-task associations were not found. Male gender was associated with faster tandem gait times in both single-task (beta = -0.880, 95% CI, -1.731 to -0.029) and dual-task conditions (beta = -2.225, 95% CI, - 3.691 to -0.759). A pass/fail cutoff threshold of 14 seconds resulted in a 2% false-positive rate for single-task tandem gait, while it resulted in a 29% false-positive rate during dual-task tandem gait. Conclusions: Average walking speed and dual-task tandem gait represent objective measures that are useful in concussion management. While a single-task tandem gait cutoff of 14 seconds seems appropriate for males, adjustments may be necessary based on sex and alternate pass/fail criteria may be appropriate for dual-task tandem gait.	[Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Dept Orthopaed, Boston, MA USA; [Howell, David R.; Meehan, William P., III] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Oldham, Jessie R.; DiFabio, Melissa S.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA; [DiFabio, Melissa S.; Buckley, Thomas A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE USA		Howell, DR (corresponding author), Boston Childrens Hosp, Div Sports Med, Dept Orthopaed, Micheli Ctr Sports Injury Prevent, 9 Hope Ave, Waltham, MA 02453 USA.	David.Howell2@childrens.harvard.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150			Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Horak F, 2015, PHYS THER, V95, P461, DOI 10.2522/ptj.20140253; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Kerrigan DC, 1998, AM J PHYS MED REHAB, V77, P2, DOI 10.1097/00002060-199801000-00002; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Nelson LD, 2017, CLIN J SPORT MED, V27, P381, DOI 10.1097/JSM.0000000000000369; Oldham JR, 2017, SPORTS HEALTH, V9, P305, DOI 10.1177/1941738116680999; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06	38	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2019	29	3					238	244		10.1097/JSM.0000000000000509			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	IQ4QT	WOS:000480736100011	31033618				2022-02-06	
J	Patil, H; Gupta, R				Patil, Harshad; Gupta, Rakesh			A Comparative Study of Bolus Dose of Hypertonic Saline, Mannitol, and Mannitol Plus Glycerol Combination in Patients with Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Hypertonic saline; Mannitol; Mannitol plus glycerol combination; Raised intracranial pressure; Severe traumatic brain injury	RAISED INTRACRANIAL-PRESSURE; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; HEMORRHAGIC-SHOCK; RESUSCITATION; MANAGEMENT; DEXTRAN; HYPERVENTILATION; HYPERTENSION; TRIAL	BACKGROUND: This prospective randomized controlled study compared the efficacy of an equiosmolar and isovolumetric dose of 3% hypertonic saline, 20% mannitol, and 10% mannitol plus 10% glycerol combination in reducing the raised intracranial pressure (ICP) in patients with severe traumatic brain injury (TBI). METHODS: A total of 120 patients of severe TBI with increased ICP were randomized to receive an equiosmolar and isovolumetric dose of 3% hypertonic saline, 20% mannitol, and 10% mannitol plus 10% glycerol combination at a defined infusion rate, which was stopped when ICP was <15 mm Hg. RESULTS: A total of 120 patients with severe TBI (aged >18 years, Glasgow Coma Scale <= 8, and had sustained elevated ICP of >20 mm Hg for more than 5 minutes) were randomized during the study. All data were presented as mean (minimum-maximum). A one-way analysis of variance test was used to analyze the effect across the treatment group, and Tukey's method was used for multiple comparisons. A paired t-test was employed to analyze the effect of the medication within each group. All 3 drugs decreased ICP below 15 mm Hg (P < 0.0001). The maximum change in ICP occurred after a bolus dose of 3% hypertonic saline followed by 10% mannitol plus 10% glycerol combination and then 20% mannitol (60% vs. 57% vs. 55%, respectively). Mean arterial pressure and cerebral perfusion pressure were increased after the bolus dose of study medications. Maximum changes occurred after infusion of 3% hypertonic saline followed by 10% mannitol plus 10% glycerol combination and 20% mannitol (P < 0.0349 and < 0.0013, respectively). There was no statistically significant change in the hematocrit value noted after the bolus dose of any of the study medications. Serum sodium and osmolarity were raised significantly after the bolus dose of study medications. Maximum changes in serum sodium and osmolarity occurred after the bolus dose of 3% hypertonic saline. The mean dose required to reduce ICP below 15 mm Hg for 3% hypertonic saline: 1.4 mL/kg, for 10% mannitol plus 10% glycerine: 1.7 mL/kg, and for 20% mannitol: 2.0 mL/kg. The mean time required to reduce ICP below 15 mm Hg for 3% hypertonic saline: 16 minutes, for 10% mannitol plus 10% glycerine: 19 minutes, and for 20% mannitol: 23 minutes. The maximum change in the Glasgow Coma Scale occurred after the bolus dose of 3% hypertonic saline, followed by 10% mannitol plus 10% glycerol combination and then 20% mannitol. CONCLUSIONS: All 3 osmotic compounds exhibit comparable effectiveness in reducing ICP when a similar osmotic load is administrated, but 3% hypertonic saline appeared to be more effective followed by 10% mannitol plus 10% glycerol combination and 20% mannitol. A dose of 1.4 mL/kg can be recommended as an initial bolus dose for 3% hypertonic saline. Hypertonic saline can be recommended to treat patients with pretreatment hypovolemia, hyponatremia, or renal failure. There is no clear benefit compared with 20% mannitol in regard to neurologic outcome, even though there is a minor positive trend for 3% hypertonic saline and 10% mannitol plus 10% glycerol combination.	[Patil, Harshad] Bansal Hosp, Dept Neurosurg, Bhopal, India; [Gupta, Rakesh] Aurobindo Hosp, Dept Neurosurg, Indore, Madhya Pradesh, India		Patil, H (corresponding author), Bansal Hosp, Dept Neurosurg, Bhopal, India.	dr.harshadpatil@gmail.com					Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Chesnut R M, 1995, New Horiz, V3, P581; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Kempski O, 1996, ACT NEUR S, V66, P114; MOON PF, 1995, CRIT CARE MED, V23, P323, DOI 10.1097/00003246-199502000-00019; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Otsubo K, 1993, Nihon Ika Daigaku Zasshi, V60, P231; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; Procaccio F, 2000, J Neurosurg Sci, V44, P11; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Schwab S, 1997, NEUROLOGY, V48, P1608, DOI 10.1212/WNL.48.6.1608; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Sheikh AA, 1996, CRIT CARE MED, V24, P1226, DOI 10.1097/00003246-199607000-00027; Soni A., 2009, Trends in Medical Research, V4, P42, DOI 10.3923/tmr.2009.42.48; Soustiel JF, 2006, ACTA NEUROCHIR, V148, P845, DOI 10.1007/s00701-006-0792-7; Tamta Anupama, 2009, Int J Biomed Sci, V5, P428; Treib J, 1997, THROMB HAEMOSTASIS, V78, P974; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4	33	16	16	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2019	125						E221	E228		10.1016/j.wneu.2019.01.051			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW2CX	WOS:000466491700029	30684710				2022-02-06	
J	Iverson, GL; Reddi, PJ; Posti, JP; Kotilainen, AK; Tenovuo, O; Ohman, J; Zetterberg, H; Blennow, K; Luoto, TM				Iverson, Grant L.; Reddi, Preethi J.; Posti, Jussi P.; Kotilainen, Anna-Kerttu; Tenovuo, Olli; Ohman, Juha; Zetterberg, Henrik; Blennow, Kaj; Luoto, Teemu M.			Serum Neurofilament Light Is Elevated Differentially in Older Adults with Uncomplicated Mild Traumatic Brain Injuries	JOURNAL OF NEUROTRAUMA			English	Article						aging; biomarker; blood; neurofilament; traumatic brain injury	CEREBROSPINAL-FLUID; NEURONAL DAMAGE; NF-L; DISEASE; PROTEIN; BIOMARKER; BLOOD; FALLS; MARKER; CHAIN	Neurofilament light (NF-L) might have diagnostic and prognostic potential as a blood biomarker for mild traumatic brain injury (mTBI). However, elevated NF-L is associated with several neurological disorders associated with older age, which could confound its usefulness as a traumatic brain injury biomarker. We examined whether NF-L is elevated differentially following uncomplicated mTBI in older adults with pre-injury neurological disorders. In a case-control study, a sample of 118 adults (mean age = 62.3 years, standard deviation [SD] = 22.5, range = 18-100; 52.5% women) presenting to the emergency department (ED) with an uncomplicated mTBI were enrolled. All participants underwent head computed tomography in the ED and showed no macroscopic evidence of injury. The mean time between injury and blood sampling was 8.3 h (median [Md] = 3.5; SD = 13.5; interquartile range [IQR] = 1.9-6.0, range = 0.8-67.4, and 90% collected within 19 h). A sample of 40 orthopedically-injured trauma control subjects recruited from a second ED also were examined. Serum NF-L levels were measured and analyzed using Human Neurology 4-Plex A assay on a HD-1 Single Molecule Array (Simoa) instrument. A high correlation was found between age and NF-L levels in the total mTBI sample (r = 0.80), within the subgroups without pre-injury neurological diseases (r = 0.76) and with pre-injury neurological diseases (r = 0.68), and in the trauma control subjects (r = 0.76). Those with mTBIs and pre-injury neurological conditions had higher NF-L levels than those with no pre-injury neurological conditions (p < 0.001, Cohen's d = 1.01). Older age and pre-injury neurological diseases are associated with elevated serum NF-L levels in patients with head trauma and in orthopedically-injured control subjects.	[Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Reddi, Preethi J.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Turku, Finland; [Posti, Jussi P.; Tenovuo, Olli] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Posti, Jussi P.; Tenovuo, Olli] Univ Turku, Turku, Finland; [Kotilainen, Anna-Kerttu] Univ Tampere, Dept Med & Life Sci, Tampere, Finland; [Ohman, Juha; Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, POB 2000,Teiskontie 35, FI-33521 Tampere, Finland; [Ohman, Juha; Luoto, Teemu M.] Univ Tampere, Tampere, Finland; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England		Luoto, TM (corresponding author), Tampere Univ Hosp, Dept Neurosurg, POB 2000,Teiskontie 35, FI-33521 Tampere, Finland.	Teemu.Luoto@pshp.fi	Posti, Jussi P./Y-2908-2019; Luoto, Teemu/W-6468-2018	Posti, Jussi P./0000-0002-5925-5193; Luoto, Teemu/0000-0002-7329-3284	Finnish State Research Funding; Finnish Medical Society Duodecim; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Emil Aaltonen Foundation sr; Finnish Brain Foundation sr; Torsten Soderberg Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; European Research CouncilEuropean Research Council (ERC)European Commission; Dementia Research Institute at UCL	The study was financially supported by the Finnish State Research Funding, and the Finnish Medical Society Duodecim. Dr. Luoto and Dr. Posti have received funding from Government's Special Financial Transfer tied to academic research in Health Sciences (Finland). Dr. Posti has received funding from the Emil Aaltonen Foundation sr and the Finnish Brain Foundation sr. Dr. Blennow acknowledges funding from The Torsten Soderberg Foundation, the Swedish Research Council, and the Swedish Brain Foundation. Dr. Zetterberg is a Wallenberg Academy Fellow and acknowledges support from the Swedish and European Research Council and the Dementia Research Institute at UCL.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bacioglu M, 2016, NEURON, V91, P56, DOI 10.1016/j.neuron.2016.05.018; Brureau A, 2017, NEUROBIOL DIS, V104, P73, DOI 10.1016/j.nbd.2017.04.007; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; De Marchis GM, 2018, EUR J NEUROL, V25, P562, DOI 10.1111/ene.13554; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; Feneberg E, 2018, NEUROLOGY, V90, pE22, DOI 10.1212/WNL.0000000000004761; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; Gattringer T, 2017, NEUROLOGY, V89, P2108, DOI 10.1212/WNL.0000000000004645; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517; Helling TS, 1999, J TRAUMA, V46, P453, DOI 10.1097/00005373-199903000-00019; Hoidrup S, 2003, SCAND J PUBLIC HEALT, V31, P24, DOI 10.1080/14034940210134185; ISHIKAWA H, 1968, J CELL BIOL, V38, P538, DOI 10.1083/jcb.38.3.538; Johansen A, 2011, EMERG MED J, V28, P25, DOI 10.1136/emj.2009.086330; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kuhle J, 2017, NEUROLOGY, V88, P826, DOI 10.1212/WNL.0000000000003653; Kuhle J, 2016, MULT SCLER J, V22, P1550, DOI 10.1177/1352458515623365; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Novakova L, 2017, NEUROLOGY, V89, P2230, DOI 10.1212/WNL.0000000000004683; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Posti J.P., 2017, J NEUROTRAUMA; Poyry T, 2013, J HEAD TRAUMA REHAB, V28, P89, DOI 10.1097/HTR.0b013e318250eadd; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; SCHLAEPFER WW, 1984, J NEUROCHEM, V43, P857, DOI 10.1111/j.1471-4159.1984.tb12809.x; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Thompson AGB, 2018, J NEUROL NEUROSUR PS, V89, P955, DOI 10.1136/jnnp-2017-317793; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Weston PSJ, 2017, NEUROLOGY, V89, P2167, DOI 10.1212/WNL.0000000000004667; Wilke C, 2018, J NEUROL, V265, P1618, DOI 10.1007/s00415-018-8893-9; Yates DM, 2009, EUR J CELL BIOL, V88, P193, DOI 10.1016/j.ejcb.2008.11.004; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	42	16	17	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2019	36	16					2400	2406		10.1089/neu.2018.6341		APR 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IN3NH	WOS:000465474500001	30843469	Green Submitted			2022-02-06	
J	Muza, P; Bachmeier, C; Mouzon, B; Algamal, M; Rafi, NG; Lungmus, C; Abdullah, L; Evans, JE; Ferguson, S; Mullan, M; Crawford, F; Ojo, JO				Muza, Phillip; Bachmeier, Corbin; Mouzon, Benoit; Algamal, Moustafa; Rafi, Naomi G.; Lungmus, Carlyn; Abdullah, Laila; Evans, James E.; Ferguson, Scott; Mullan, Michael; Crawford, Fiona; Ojo, Joseph O.			APOE Genotype Specific Effects on the Early Neurodegenerative Sequelae Following Chronic Repeated Mild Traumatic Brain Injury	NEUROSCIENCE			English	Article						APOE4; astrocytes; mild TBI; microglia; phospholipid; tau	APOLIPOPROTEIN-E POLYMORPHISM; LOW-DENSITY-LIPOPROTEIN; AMYLOID-BETA PEPTIDE; ALZHEIMERS-DISEASE; MOUSE MODEL; RISK-FACTOR; OXIDIZED LDL; ENDOTHELIAL RECEPTOR; GLIAL ACTIVATION; AXONAL INJURY	Repeated mild traumatic brain injury (r-mTBI) can potentially manifest into chronic traumatic encephalopathy (CTE). The apolipoprotein E (APOE4) genotype, a well-recognized potent genetic risk factor in age-related neurodegenerative diseases such as Alzheimer's disease, has been linked to worse outcome after TBI in individuals who carry this allele. The underlying molecular modifications triggered by APOE genotype following r-mTBI remain elusive. We addressed the influence of APOE genotype on TBI dependent tau pathology in middle-aged mice. Using a previously established experimental mTBI protocol in a new repetitive injury paradigm, we report the pathological changes that occurred following one-month of repetitive injuries in APOE3/4 gene targeted mice. Firstly, pathological assessment demonstrated evidence of microgliosis and astrogliosis in the corpus callosum of injured animals, but there was no APOE dependent genotype effect on injury. However, in the parietal cortex Iba1-immunoreactivity was significantly increased in injured versus sham APOE3 mice, but not in APOE4 mice. No effects were observed in soluble amyloid levels with injury or interaction with genotype. APOE4 mice showed significant increases in the tau conformational marker MC1, neurofilament H, brain phospholipids, and endothelial specific oxidized low density lipoprotein receptor in cortical homogenates obtained from injured mice compared to sham counterparts. This pilot work suggests APOE3 and APOE4 specific effects following injury in a mouse model of r-mTBI. These changes may underlie the molecular changes that trigger the vulnerability and increased risk of developing neurodegenerative diseases in aged individuals exposed to repetitive mTBI. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Muza, Phillip; Bachmeier, Corbin; Mouzon, Benoit; Algamal, Moustafa; Rafi, Naomi G.; Lungmus, Carlyn; Abdullah, Laila; Evans, James E.; Ferguson, Scott; Crawford, Fiona; Ojo, Joseph O.] Roskamp Inst, Sarasota, FL 34324 USA; [Bachmeier, Corbin; Mouzon, Benoit; Abdullah, Laila; Ferguson, Scott; Crawford, Fiona; Ojo, Joseph O.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Bachmeier, Corbin; Mouzon, Benoit; Algamal, Moustafa; Abdullah, Laila; Ferguson, Scott; Mullan, Michael; Crawford, Fiona; Ojo, Joseph O.] Open Univ, Milton Keynes, England; [Bachmeier, Corbin] Bay Pines VA Healthcare Syst, Bay Pines, FL USA		Ojo, JO (corresponding author), Roskamp Inst, Expt Neuropathol, Sarasota, FL 34324 USA.	jojo@roskampinstitute.org		Algamal, Moustafa/0000-0002-6215-0122			Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Abdullah L, 2013, NEUROTOXICOL TERATOL, V40, P74, DOI 10.1016/j.ntt.2013.10.002; Abdullah L, 2012, NEUROMOL MED, V14, P349, DOI 10.1007/s12017-012-8192-z; Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Agosta F, 2009, P NATL ACAD SCI USA, V106, P2018, DOI 10.1073/pnas.0812697106; Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Bennett RE, 2013, J NEUROPATH EXP NEUR, V72, P396, DOI 10.1097/NEN.0b013e31828e24ab; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Calzada E, 2016, INT REV CEL MOL BIO, V321, P29, DOI 10.1016/bs.ircmb.2015.10.001; Cao J., 2017, SCI REP, V7; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Colacicco AM, 2009, NEUROBIOL AGING, V30, P1518, DOI 10.1016/j.neurobiolaging.2007.11.015; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Deming Y, 2017, ACTA NEUROPATHOL, V133, P839, DOI 10.1007/s00401-017-1685-y; Dubal DB, 2017, JAMA NEUROL, V74, P1167, DOI 10.1001/jamaneurol.2017.1470; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Ferguson S, 2010, NEUROSCIENCE, V168, P811, DOI 10.1016/j.neuroscience.2010.01.031; Fiala M, 2007, J ALZHEIMERS DIS, V11, P457; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Gupta RK, 2016, MOL NEUROBIOL, V53, P3377, DOI 10.1007/s12035-015-9287-y; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Jana A, 2010, NEUROMOL MED, V12, P351, DOI 10.1007/s12017-010-8128-4; Jiang L, 2015, NEUROSCIENCE, V301, P375, DOI 10.1016/j.neuroscience.2015.06.005; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Li DY, 2000, ARTERIOSCL THROM VAS, V20, P1116, DOI 10.1161/01.ATV.20.4.1116; Li DY, 2003, ARTERIOSCL THROM VAS, V23, P816, DOI 10.1161/01.ATV.0000066685.13434.FA; Li DY, 2000, CIRCULATION, V101, P2889, DOI 10.1161/01.CIR.101.25.2889; Liu HC, 2015, EUR REV MED PHARMACO, V19, P3459; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Maroon JC, 2015, PLOS ONE, V10; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mishra A, 2017, BRAIN, V140, P1437, DOI 10.1093/brain/awx066; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ophir G, 2003, NEUROBIOL DIS, V12, P56, DOI 10.1016/S0969-9961(02)00005-0; Parthasarathy S, 2010, METHODS MOL BIOL, V610, P403, DOI 10.1007/978-1-60327-029-8_24; Perez E, 2007, BRAIN RES, V1128, P164, DOI 10.1016/j.brainres.2006.09.109; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Rodriguez GA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-111; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Safinia Cyrus, 2016, J Vasc Interv Neurol, V9, P34; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stevens M, 1997, NEUROLOGY, V48, P1526, DOI 10.1212/WNL.48.6.1526; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Washington PM, 2016, J NEUROPATH EXP NEUR, V75, P770, DOI 10.1093/jnen/nlw049; Yang J, 2017, J ALZHEIMERS DIS, V57, P157, DOI 10.3233/JAD-160957; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009; Yousuf A, 2015, J MOL NEUROSCI, V56, P597, DOI 10.1007/s12031-015-0554-1; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289	83	16	16	1	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 15	2019	404						297	313		10.1016/j.neuroscience.2019.01.049			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HR1TG	WOS:000462917500025	30711612				2022-02-06	
J	Webster, KM; Sun, M; Crack, PJ; O'Brien, TJ; Shultz, SR; Semple, BD				Webster, Kyria M.; Sun, Mujun; Crack, Peter J.; O'Brien, Terence J.; Shultz, Sandy R.; Semple, Bridgette D.			Age-dependent release of high-mobility group box protein-1 and cellular neuroinflammation after traumatic brain injury in mice	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						age; high mobility group box protein 1; inflammation; pediatric; RRID:AB_10013382; RRID:AB_10679369; RRID:AB_11212597; RRID:AB_1141557; RRID:AB_141607; RRID:AB_141637; RRID:AB_2224402; RRID:AB_2298772; RRID:AB_2305186; RRID:AB_2534105; RRID:AB_2617143; RRID:AB_444360; RRID:AB_783595; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; INFLAMMATORY RESPONSES; MULTIPLEX ASSESSMENT; YOUNG-CHILDREN; MOUSE-BRAIN; HMGB1; MICROGLIA; BARRIER; RAT	Accumulating research suggests that children may be more vulnerable to poor long-term outcomes after traumatic brain injury (TBI) compared to adults. The neuroinflammatory response, known to contribute to neuropathology after TBI, appears to differ depending upon age-at-insult, although this response has not been well-characterized. Elevated levels of a key initiator of inflammation, high-mobility group box protein 1 (HMGB1), have been associated with worsened outcomes after TBI in young patients. This study therefore aimed to characterize the acute time course of key mediators of the inflammatory cascade, including HMGB1, after pediatric and adult TBI. Male C57Bl/6 mice were subjected to severe controlled cortical impact or a sham control surgery, at either early adulthood (8-10 weeks) or a pediatric age (3 weeks). Cortical tissue was collected for Western blot detection of astrocyte and microglial activation (GFAP and CD68) and HMGB1 at 2 hr, 6 hr, 24 hr, 3 days, and 7 days postinjury, and serum was collected for enzyme-linked immunoassays to quantify peripheral HMGB1. An additional cohort of brains was harvested at 3 day postinjury for immunofluorescence staining. Results demonstrated a temporal profile of CD68, GFAP, and HMGB1 after TBI relative to sham, which differed between the adult and pediatric cohorts. An increase in peripheral HMGB1 was found in serum from pediatric TBI mice, which was not evident in adult serum. Together, these findings demonstrate that HMGB1 and the downstream cellular inflammatory response are influenced by age-at-insult, which may be an important consideration for treatment strategies aiming to ameliorate this response after TBI.	[Webster, Kyria M.; Sun, Mujun; O'Brien, Terence J.; Shultz, Sandy R.; Semple, Bridgette D.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Crack, Peter J.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic, Australia; [O'Brien, Terence J.; Shultz, Sandy R.; Semple, Bridgette D.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia		Semple, BD (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	bridgette.semple@monash.edu	Crack, Peter/ABE-2065-2020; O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	Crack, Peter/0000-0002-5030-0330; O'Brien, Terence/0000-0002-7198-8621; Sun, Mujun/0000-0002-9923-9913	Rebecca L Cooper Medical Research Foundation; University of MelbourneUniversity of Melbourne; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	Rebecca L Cooper Medical Research Foundation; University of Melbourne; National Health and Medical Research Council of Australia	ABS, 2004, DIS AG CAR SUMM FIND; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Alcaraz C, 1990, J Vet Diagn Invest, V2, P191; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anthony D, 1998, CURR BIOL, V8, P923, DOI 10.1016/S0960-9822(07)00373-9; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Bell MJ, 1997, ACT NEUR S, V70, P96; Bennett KS, 2014, CRIT CARE MED, V42, P2308, DOI 10.1097/CCM.0000000000000563; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bilimoria PM, 2015, BRAIN RES, V1617, P7, DOI 10.1016/j.brainres.2014.11.032; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chaboub LS, 2013, SEMIN PEDIATR NEUROL, V20, P230, DOI 10.1016/j.spen.2013.10.003; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Copland IB, 2004, AM J RESP CRIT CARE, V169, P739, DOI 10.1164/rccm.200310-1417OC; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Elhofy A, 2005, J LEUKOCYTE BIOL, V77, P229, DOI 10.1189/jlb.0804465; ENG LF, 1983, PROG NEUROPATH, V5, P19; Enokido Y, 2008, BIOCHEM BIOPH RES CO, V376, P128, DOI 10.1016/j.bbrc.2008.08.108; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Feldman P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-180; Ferriero DM, 2010, J ANAT, V217, P429, DOI 10.1111/j.1469-7580.2010.01226.x; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Gong G, 2012, ACTA PHARMACOL SIN, V33, P11, DOI 10.1038/aps.2011.151; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hayakawa K, 2012, P NATL ACAD SCI USA, V109, P7505, DOI 10.1073/pnas.1121146109; Heidebrecht F, 2009, J IMMUNOL METHODS, V345, P40, DOI 10.1016/j.jim.2009.03.018; Ieong CC, 2018, J CLIN NEUROSCI, V47, P278, DOI 10.1016/j.jocn.2017.10.034; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; KARPUS WJ, 1995, J IMMUNOL, V155, P5003; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kieslich M, 2001, DISABIL REHABIL, V23, P665; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAWSON LJ, 1995, EUR J NEUROSCI, V7, P1584, DOI 10.1111/j.1460-9568.1995.tb01154.x; Lee S, 2014, NAT CHEM BIOL, V10, P1055, DOI 10.1038/nchembio.1669; LEVI L, 1991, BRIT J NEUROSURG, V5, P617, DOI 10.3109/02688699109002885; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Luo Y, 2000, J IMMUNOL, V165, P4015, DOI 10.4049/jimmunol.165.7.4015; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Ohnishi M, 2014, NEUROCHEM INT, V75, P32, DOI 10.1016/j.neuint.2014.05.007; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Passalacqua M, 1998, NEUROSCIENCE, V82, P1021; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Rasband W. S., 1997, IMAGE J; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoderboeck L, 2009, NEUROBIOL DIS, V35, P368, DOI 10.1016/j.nbd.2009.05.026; Schultz C, 2004, CLIN EXP IMMUNOL, V135, P130, DOI 10.1111/j.1365-2249.2004.02313.x; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Semple BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Simon DW, 2018, J NEUROTRAUM, V35, P130, DOI 10.1089/neu.2017.5093; Stevenson K. L., 2000, Journal of Neurotrauma, V17, P944; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; UMEHARA F, 1990, LAB INVEST, V62, P147; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Venereau E, 2013, MOL IMMUNOL, V55, P76, DOI 10.1016/j.molimm.2012.10.037; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Ziebell JM, 2015, METAB BRAIN DIS, V30, P393, DOI 10.1007/s11011-014-9539-y	99	16	16	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	APR 15	2019	527	6					1102	1117		10.1002/cne.24589			16	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	HK9GT	WOS:000458299300005	30499129	Green Published			2022-02-06	
J	Carteri, RB; Kopczynski, A; Rodolphi, MS; Strogulski, NR; Sartor, M; Feldmann, M; De Bastiani, MA; Wannmacher, CMD; de Franceschi, ID; Hansel, G; Smith, DH; Portela, LV				Carteri, Randhall B.; Kopczynski, Afonso; Rodolphi, Marcelo Salimen; Strogulski, Nathan Ryzewski; Sartor, Monia; Feldmann, Marceli; De Bastiani, Marco Antonio; Duval Wannmacher, Clovis Milton; de Franceschi, Itiane Diehl; Hansel, Gisele; Smith, Douglas H.; Portela, Luis Valmor			Testosterone Administration after Traumatic Brain Injury Reduces Mitochondrial Dysfunction and Neurodegeneration	JOURNAL OF NEUROTRAUMA			English	Article						mitochondria; neurodegeneration; neuroenergetics; testosterone; traumatic brain injury	NEURONAL CYTOSKELETAL DEGRADATION; CONTROLLED CORTICAL IMPACT; PITUITARY-FUNCTION; OXIDATIVE DAMAGE; GENE-EXPRESSION; HYPOPITUITARISM; HIPPOCAMPUS; BIOMARKERS; RECEPTOR; TARGETS	Traumatic brain injury (TBI) increases Ca2+ influx into neurons and desynchronizes mitochondrial function leading to energy depletion and apoptosis. This process may be influenced by brain testosterone (TS) levels, which are known to decrease after TBI. We hypothesized that a TS-based therapy could preserve mitochondrial neuroenergetics after TBI, thereby reducing neurodegeneration. C57BL/6J mice were submitted to sham treatment or severe parasagittal controlled cortical impact (CCI) and were subcutaneously injected with either vehicle (VEH-SHAM and VEH-CCI) or testosterone cypionate (15 mg/kg, TS-CCI) for 10 days. Cortical tissue homogenates ipsilateral to injury were used for neurochemical analysis. The VEH-CCI group displayed an increased Ca2+-induced mitochondrial swelling after the addition of metabolic substrates (pyruvate, malate, glutamate, succinate, and adenosine diphosphate [PMGSA]). The addition of Na+ stimulated mitochondrial Ca2+ extrusion through Na+/Ca2+/Li+ exchanger (NCLX) in VEH-SHAM and TS-CCI, but not in the VEH-CCI group. Reduction in Ca2+ efflux post-injury was associated with impaired mitochondrial membrane potential formation/dissipation, and decreased mitochondrial adenosine triphosphate (ATP)-synthase coupling efficiency. Corroborating evidence of mitochondrial uncoupling was observed with an increase in H2O2 production post-injury, but not in superoxide dismutase (SOD2) protein levels. TS administration significantly reduced these neuroenergetic alterations. At molecular level, TS prevented the increase in pTau(Ser396) and alpha-Spectrin fragmentation by the Ca(2+)dependent calpain-2 activation, and decreased both caspase-3 activation and Bax/BCL-2 ratio, which suggests a downregulation of mitochondrial apoptotic signals. Search Tool for the Retrieval of Interacting Genes/Proteins database provided two distinct gene/protein clusters, "upregulated and downregulated," interconnected through SOD2. Therefore, TS administration after a severe CCI improves the mitochondrial Ca(2+)extrusion through NCLX exchanger and ATP synthesis efficiency, ultimately downregulating the overexpression of molecular drivers of neurodegeneration.	[Carteri, Randhall B.; Kopczynski, Afonso; Rodolphi, Marcelo Salimen; Strogulski, Nathan Ryzewski; Sartor, Monia; Feldmann, Marceli; De Bastiani, Marco Antonio; Duval Wannmacher, Clovis Milton; de Franceschi, Itiane Diehl; Portela, Luis Valmor] Univ Fed Rio Grande do Sul, Lab Neurotrauma & Biomarkers, Porto Alegre, RS, Brazil; [Duval Wannmacher, Clovis Milton; de Franceschi, Itiane Diehl] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [Hansel, Gisele; Smith, Douglas H.] Univ Penn, Penn Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Hansel, Gisele; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Portela, LV (corresponding author), Univ Fed Rio Grande do Sul, ICBS, Dept Biochem, Rua Ramiro Barcelos,2600 Anexo, BR-90035003 Porto Alegre, RS, Brazil.	roskaportela@gmail.com	De Bastiani, Marco Antonio/AAD-8366-2019; Carteri, Randhall/A-9015-2017; de Franceschi, Itiane D/AAO-7176-2021; Carteri, Randhall/AAN-9871-2021; Hansel, Gisele/A-9150-2015	Carteri, Randhall/0000-0003-4124-9470; de Franceschi, Itiane D/0000-0003-2093-5236; Carteri, Randhall/0000-0003-4124-9470; Hansel, Gisele/0000-0001-5048-1293; Portela, Luis Valmor/0000-0001-6113-8466; De Bastiani, Marco Antonio/0000-0003-3924-5278; Strogulski, Nathan/0000-0003-2166-2137	INNT-CNPq [465346]; CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [401645/2012-6]; FAPERGS-PPSUS [03/2017]; US National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS092398, R01NS094003, R01NS038104]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094003, R01NS038104, R01NS092398] Funding Source: NIH RePORTER	The authors would like to thank the Center for Brain Injury and Repair, University of Pennsylvania (CBIR-UPENN) for the technical and scientific support, the Brazilian scientific agencies/programs INNT-CNPq #465346, CNPq #401645/2012-6, CAPES, FAPERGS-Pronex, FAPERGS-PPSUS #03/2017, and support from the US National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award numbers R01NS092398, R01NS094003, and R01NS038104.	Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Lopez-Rodriguez AB, 2016, ENDOCRINOLOGY, V157, P3983, DOI 10.1210/en.2016-1316; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Boyman L, 2013, J MOL CELL CARDIOL, V59, P205, DOI 10.1016/j.yjmcc.2013.03.012; Burtscher J, 2015, MITOCHONDRION, V25, P104, DOI 10.1016/j.mito.2015.10.007; Castro MAA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r29; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Fanaei H, 2014, BRAIN RES, V1558, P74, DOI 10.1016/j.brainres.2014.02.028; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Gardner R, 2002, FREE RADICAL BIO MED, V32, P1351, DOI 10.1016/S0891-5849(02)00861-4; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004; Gnaiger E, 2014, MITOCHONDRIAL PATHWA; Gurer B, 2015, INJURY, V46, P240, DOI 10.1016/j.injury.2014.11.002; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hatanaka Y, 2015, BRAIN RES, V1621, P121, DOI 10.1016/j.brainres.2014.12.011; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hioki T, 2014, J MOL NEUROSCI, V52, P531, DOI 10.1007/s12031-013-0108-3; Israelsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104754; Jafri MS, 2014, PROG MOL BIOL TRANSL, V123, P103, DOI 10.1016/B978-0-12-397897-4.00001-2; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kim B, 2008, J PHYSIOL-LONDON, V586, P1683, DOI 10.1113/jphysiol.2007.148726; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Luongo TS, 2017, NATURE, V545, P93, DOI 10.1038/nature22082; Marklund S., 1985, PYROGALLOL AUTOXIDAT; Martinez-Sanchis S, 1998, PSYCHONEUROENDOCRINO, V23, P275, DOI 10.1016/S0306-4530(98)00005-5; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Muller AP, 2011, HIPPOCAMPUS, V21, P1082, DOI 10.1002/hipo.20822; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; Portela LV, 2017, MOL NEUROBIOL, V54, P5807, DOI 10.1007/s12035-016-0119-5; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tolli A, 2017, J ENDOCRINOL INVEST, V40, P193, DOI 10.1007/s40618-016-0546-1; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; Vekaria HJ, 2017, NEUROCHEM INT, V109, P117, DOI 10.1016/j.neuint.2017.04.004; Wendel A, 1981, Methods Enzymol, V77, P325; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; Zhao XR, 2008, J NEUROTRAUM, V25, P1195, DOI 10.1089/neu.2008.0635	61	16	17	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2019	36	14					2246	2259		10.1089/neu.2018.6266		APR 2019	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IH1NO	WOS:000463876100001	30794079	Green Published			2022-02-06	
J	Carlozzi, NE; Ianni, PA; Lange, RT; Brickell, TA; Kallen, MA; Hahn, EA; French, LM; Cella, D; Miner, JA; Tulsky, DS				Carlozzi, Noelle E.; Ianni, Phillip A.; Lange, Rael T.; Brickell, Tracey A.; Kallen, Michael A.; Hahn, Elizabeth A.; French, Louis M.; Cella, David; Miner, Jennifer A.; Tulsky, David S.			Understanding Health-Related Quality of Life of Caregivers of Civilians and Service Members/Veterans With Traumatic Brain Injury: Establishing the Reliability and Validity of PROMIS Social Health Measures	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Caregivers; Patient reported outcome measures; Psychometrics; Rehabilitation; Self report; Social support; Surveys and questionnaires; Veterans	FAMILY; VETERANS; BURDEN; IMPACT; INDIVIDUALS; VALIDATION; PREDICTORS; EXPERIENCE; REVISION; PARTNERS	Objective: To examine the reliability and validity of the short form (SF) and computer adaptive test (CAT) versions of the Patient-Reported Outcomes Measurement Information System (PROMIS) measures of social health of caregivers of civilians and service members/veterans (SMVs) with traumatic brain injury (TBI). Design: Self-report questionnaires administered through an online data collection platform. Setting: Hospital and community-based outreach at 3 TBI Model Systems rehabilitation hospitals, an academic medical center, and a military medical treatment facility. Participants: Caregivers (N = 560) (344 civilians and 216 military) of individuals with a documented TBI. Intervention: Not applicable. Main Outcome Measures: A total of 5 PROMIS social health measures. Results: All 5 PROMIS social health measures exceeded the a priori criterion for internal consistency reliability (>0.70); most PROMIS measures met the criterion for test-retest reliability (>0.70) in the civilian sample; in the SMV sample, test-retest reliability was generally below this criterion, except for social isolation. For both samples, convergent validity was supported by moderate correlations between the 5 PROMIS social health measures and related measures, and discriminant validity was supported by low correlations between PROMIS social health measures and measures of dissimilar constructs. Most PROMIS scores indicated significantly worse social health in both samples of those caring for individuals who were low functioning. Finally, impairment rates in social health were elevated for those caring for low-functioning individuals, especially in the SMV sample. Conclusions: The PROMIS CAT and SF social health measures have potential clinical utility for use in caregivers of civilians and SMVs with TBI. (C) 2018 by the American Congress of Rehabilitation Medicine	[Carlozzi, Noelle E.; Ianni, Phillip A.; Miner, Jennifer A.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Kallen, Michael A.; Hahn, Elizabeth A.; Cella, David] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Ctr Assessment Res & Translat, Newark, DE USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604; Tulsky, David/0000-0002-4335-4509	National Institutes of Health-National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [ULITR000433]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433, UL1TR002240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by the National Institutes of Health-National Institute of Nursing Research (grant no. R01NR013658), the National Center for Advancing Translational Sciences (grant no. ULITR000433), and the Defense and Veterans Brain Injury Center.	Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; [Anonymous], DOD WORLDW NUMB TBI; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bulmer, 1979, PRINCIPLES STAT; Calhoun PS, 2002, J TRAUMA STRESS, V15, P205, DOI 10.1023/A:1015251210928; Campbell C H, 1988, Rehabil Nurs, V13, P320; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS43, DOI 10.1016/j.apmr.2018.06.025; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS13, DOI 10.1016/j.apmr.2018.05.033; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS31, DOI 10.1016/j.apmr.2018.05.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS22, DOI 10.1016/j.apmr.2018.05.027; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Castel LD, 2008, QUAL LIFE RES, V17, P737, DOI 10.1007/s11136-008-9352-3; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cramer D., 2004, SAGE DICT STAT; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DeVellis R.F., 2017, SCALE DEV THEORY APP; DeVellis RF, 2006, MED CARE, V44, pS50, DOI 10.1097/01.mlr.0000245426.10853.30; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hahn EA, 2014, HEALTH PSYCHOL, V33, P490, DOI 10.1037/hea0000055; Hahn EA, 2010, QUAL LIFE RES, V19, P1035, DOI 10.1007/s11136-010-9654-0; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hassan STS, 2011, J NEPAL MED ASSOC, V50, P53; Hassan STS, 2012, HEALTHMED, V6, P2423; Hays RD, 1995, USERS MANUAL MED OUT; Hays RD, 2018, QUAL LIFE RES, V27, P1885, DOI 10.1007/s11136-018-1842-3; Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9; Heaton R. K., 2004, REVISED COMPREHENSIV; Hoofien D, 2001, BRAIN INJURY, V15, P189; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kratz AL, 2015, NEUROPSYCHOL REHABIL, P1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; MacDonell GV, 2014, AUST PSYCHOL, V49, P305, DOI 10.1111/ap.12069; Malec J., INTRO MAYO PORTLAND; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; MILLER B, 1990, RES AGING, V12, P72, DOI 10.1177/0164027590121004; MONTGOMERY RJV, 1985, FAM RELAT, V34, P19, DOI 10.2307/583753; Musil CM, 2002, WESTERN J NURS RES, V24, P815, DOI 10.1177/019394502762477004; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; POULSHOCK SW, 1984, J GERONTOL, V39, P230, DOI 10.1093/geronj/39.2.230; Qadeer A, 2017, CUREUS, V9, DOI 10.7759/cureus.1590; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Schulz R, 2016, FAMILIES CARING FOR AN AGING AMERICA, P1, DOI 10.17226/23606; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Ware J.E., 1994, SF 36 PHYS MENTAL SU; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zarit SH., 1985, HIDDEN VICTIMS ALZHE	62	16	16	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S110	S118		10.1016/j.apmr.2018.06.026			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900013	30075148	Green Accepted			2022-02-06	
J	Chen, JG; Qu, XL; Li, ZX; Zhang, DF; Hou, L				Chen, Jigang; Qu, Xiaolin; Li, Zhenxing; Zhang, Danfeng; Hou, Lijun			Peak Neutrophil-to-Lymphocyte Ratio Correlates with Clinical Outcomes in Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Neutrophil-to-lymphocyte ratio; Peak value; Severe traumatic brain injury; Clinical outcomes	PROGNOSTIC VALUE; MORTALITY; EPIDEMIOLOGY; ASSOCIATION; MANAGEMENT; PREDICTOR; SURVIVAL	BackgroundStudies suggested that the neutrophil-to-lymphocyte ratio (NLR) was associated with unfavorable outcomes in different diseases such as intracerebral hemorrhage, cardiovascular problem, cancer, and severe traumatic brain injury (sTBI). We aimed to evaluate the relationship between peak NLR and 1-year outcomes in patients with sTBI.MethodsWe retrospectively reviewed the clinical data of patients with sTBI who were treated in our department between January 2013 and January 2017. NLRs between day 1 and day 12 after admission as well as other related indicators were collected. The relationship between peak NLR and 1-year outcomes was analyzed. Factors associated with larger peak NLR were also explored.ResultsA total of 316 patients were included, and 81.3% (257/316) experienced unfavorable outcomes. Peak NLR was identified as an independent predictor for unfavorable outcomes after sTBI in multivariable logistic regression analysis (odds ratio, 1.086; 95% confidence interval, 1.037-1.137; P<0.001). Its predictive value was confirmed by receiver operating characteristic analysis (area under curve=0.775; P<0.001). The day 1 NLR as well as admission Glasgow Coma Scale score was independently correlated with increased peak NLR.ConclusionPeak NLR was associated with the clinical prognosis after sTBI and was a promising predictor for 1-year outcomes.	[Chen, Jigang; Qu, Xiaolin; Li, Zhenxing; Zhang, Danfeng; Hou, Lijun] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China		Zhang, DF; Hou, L (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China.	dfzhangsmmu@163.com; liijunhoucz@126.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671206]	This study was funded by the National Nature Science Foundation of China (Grant No. 81671206).	Albertsmeier M, 2015, INNATE IMMUN-LONDON, V21, P55, DOI 10.1177/1753425913516659; Bambury RM, 2013, J NEURO-ONCOL, V114, P149, DOI 10.1007/s11060-013-1164-9; Barlow KM, 2013, HAND CLINIC, V112, P891, DOI 10.1016/B978-0-444-52910-7.00011-8; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/ERC.12.159, 10.1586/erc.12.159]; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Celikbilek A, 2014, J CLIN LAB ANAL, V28, P27, DOI 10.1002/jcla.21639; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Dilektasli E, 2016, J TRAUMA ACUTE CARE, V81, P882, DOI 10.1097/TA.0000000000000980; FAIST E, 1986, ARCH SURG-CHICAGO, V121, P1000; Feinberg M, 2015, SEMIN NEUROL, V35, P50, DOI 10.1055/s-0035-1544244; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Giede-Jeppe A, 2017, CEREBROVASC DIS, V44, P26, DOI 10.1159/000468996; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hilden J, 1996, STAT MED, V15, P969, DOI 10.1002/(SICI)1097-0258(19960530)15:10<969::AID-SIM211>3.0.CO;2-9; Lattanzi S, 2017, ONCOTARGET, V8, P57489, DOI 10.18632/oncotarget.15423; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lumsdaine W, 2014, INJURY, V45, P1144, DOI 10.1016/j.injury.2014.04.019; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Moore EE, 2007, J TRAUMA, V62, P1403; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Palm NW, 2007, NAT MED, V13, P1142, DOI 10.1038/nm1007-1142b; Poon WS, 2005, ACT NEUR S, V93, P207; Proctor MJ, 2012, BRIT J CANCER, V107, P695, DOI 10.1038/bjc.2012.292; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saika A, 2015, ACTA NEUROCHIR, V157, P1323, DOI 10.1007/s00701-015-2469-6; Schwartz M, 2001, J NEUROIMMUNOL, V113, P185, DOI 10.1016/S0165-5728(00)00447-1; Smajic Jasmina, 2018, Med Arch, V72, P116, DOI 10.5455/medarh.2018.72.116-119; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Xue Mengzhou, 2003, J Stroke Cerebrovasc Dis, V12, P152, DOI 10.1016/S1052-3057(03)00036-3; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yu S, 2018, J NEUROL SCI, V387, P115, DOI 10.1016/j.jns.2018.02.002; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	39	16	16	3	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2019	30	2					334	339		10.1007/s12028-018-0622-9			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HP0UB	WOS:000461380900015	30288677				2022-02-06	
J	Dewan, MC; Rattani, A; Baticulon, RE; Faruque, S; Johnson, WD; Dempsey, RJ; Haglund, MM; Alkire, BC; Park, KB; Warf, BC; Shrime, MG				Dewan, Michael C.; Rattani, Abbas; Baticulon, Ronnie E.; Faruque, Serena; Johnson, Walter D.; Dempsey, Robert J.; Haglund, Michael M.; Alkire, Blake C.; Park, Kee B.; Warf, Benjamin C.; Shrime, Mark G.			Operative and consultative proportions of neurosurgical disease worldwide: estimation from the surgeon perspective	JOURNAL OF NEUROSURGERY			English	Article						burden; global; neurosurgery; surgeon; survey	GLOBAL NEUROSURGERY; BURDEN	OBJECTIVE The global magnitude of neurosurgical disease is unknown. The authors sought to estimate the surgical and consultative proportion of diseases commonly encountered by neurosurgeons, as well as surgeon case volume and perceived workload. METHODS An electronic survey was sent to 193 neurosurgeons previously identified via a global surgeon mapping initiative. The survey consisted of three sections aimed at quantifying surgical incidence of neurological disease, consultation incidence, and surgeon demographic data. Surgeons were asked to estimate the proportion of 11 neurological disorders that, in an ideal world, would indicate either neurosurgical operation or neurosurgical consultation. Respondent surgeons indicated their confidence level in each estimate. Demographic and surgical practice characteristics-including case volume and perceived workload-were also captured. RESULTS Eighty-five neurosurgeons from 57 countries, representing all WHO regions and World Bank income levels, completed the survey. Neurological conditions estimated to warrant neurosurgical consultation with the highest frequency were brain tumors (96%), spinal tumors (95%), hydrocephalus (94%), and neural tube defects (92%), whereas stroke (54%), central nervous system infection (58%), and epilepsy (40%) carried the lowest frequency. Similarly, surgery was deemed necessary for an average of 88% cases of hydrocephalus, 82% of spinal tumors and neural tube defects, and 78% of brain tumors. Degenerative spine disease (42%), stroke (31%), and epilepsy (24%) were found to warrant surgical intervention less frequently. Confidence levels were consistently high among respondents (lower quartile > 70/100 for 90% of questions), and estimates did not vary significantly across WHO regions or among income levels. Surgeons reported performing a mean of 245 cases annually (median 190). On a 100-point scale indicating a surgeon's perceived workload (0-not busy, 100-overworked), respondents selected a mean workload of 75 (median 79). CONCLUSIONS With a high level of confidence and strong concordance, neurosurgeons estimated that the vast majority of patients with central nervous system tumors, hydrocephalus, or neural tube defects mandate neurosurgical involvement. A significant proportion of other common neurological diseases, such as traumatic brain and spinal injury, vascular anomalies, and degenerative spine disease, demand the attention of a neurosurgeon-whether via operative intervention or expert counsel. These estimates facilitate measurement of the expected annual volume of neurosurgical disease globally.	[Dewan, Michael C.; Rattani, Abbas; Alkire, Blake C.; Park, Kee B.; Warf, Benjamin C.; Shrime, Mark G.] Dept Global Hlth & Social Med, Global Neurosurg Initiat, Program Global Surg & Social Change, Boston, MA USA; [Warf, Benjamin C.] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol Surg, Boston, MA 02115 USA; [Alkire, Blake C.] Off Global Surg & Hlth, Boston, MA USA; [Shrime, Mark G.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Faruque, Serena] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Dewan, Michael C.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA; [Rattani, Abbas] Meharry Med Coll, Sch Med, Nashville, TN 37208 USA; [Baticulon, Ronnie E.] Univ Philippines, Coll Med, Philippine Gen Hosp, Manila, Philippines; [Johnson, Walter D.] World Hlth Org, Emergency & Essential Surg Care Programme Lead, Geneva, Switzerland; [Dempsey, Robert J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol Surg, Madison, WI USA; [Haglund, Michael M.] Duke Univ, Dept Neurosurg, Div Global Neurosurg & Neurol, Durham, NC USA; [Haglund, Michael M.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA		Dewan, MC (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA.	michael.dewan@vumc.org	Baticulon, Ronnie/AAW-7768-2020; Alkire, Blake/AAY-6463-2020	Baticulon, Ronnie/0000-0002-2781-1845; 	Vanderbilt Medical Scholars Program; NCATS/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445]; GE Foundation Safe Surgery 2020General Electric; Steven and Carmella Kletjian Foundation	We thank Charles Howard for his assistance in identifying potential study participants. We acknowledge the Vanderbilt Medical Scholars Program for providing Abbas Rattani with support on this project.; Grant funding support from NCATS/NIH UL1 TR000445 for Vanderbilt REDCap (M.C.D.). Grant funding support from GE Foundation Safe Surgery 2020 and the Steven and Carmella Kletjian Foundation (M.G.S.).	Alkire BC, 2015, LANCET GLOB HEALTH, V3, pE316, DOI 10.1016/S2214-109X(15)70115-4; Anderson JE, 2014, WORLD J SURG, V38, P823, DOI 10.1007/s00268-013-2366-1; Aspinall W, 2010, NATURE, V463, P294, DOI 10.1038/463294a; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Haglund MM, 2011, WORLD J SURG, V35, P1175, DOI 10.1007/s00268-011-1080-0; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Lo A, 2014, J GLOB HEALTH, V4, DOI 10.7189/jogh.04.010402; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Miranda-Filho A, 2017, NEURO-ONCOLOGY, V19, P270, DOI 10.1093/neuonc/now166; Nayar V, 2016, ANN THORAC SURG, V101, P190, DOI 10.1016/j.athoracsur.2015.07.042; Park KB, 2016, WORLD NEUROSURG, V88, P32, DOI 10.1016/j.wneu.2015.12.048; Pugely AJ, 2015, J BONE JOINT SURG AM, V97A, P1278, DOI 10.2106/JBJS.N.01260; Punchak M, 2016, NEUROSCI COLOMB, V23, P294; Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS8, DOI 10.1016/S2214-109X(14)70384-5; Warf BC, 2015, WORLD NEUROSURG, V84, P1547, DOI 10.1016/j.wneu.2015.07.052	16	16	16	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2019	130	4					1098	1106		10.3171/2017.10.JNS17347			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HR1CV	WOS:000462866700007	29749918	Bronze			2022-02-06	
J	Li, QZ; Wang, PC; Huang, CX; Chen, BZ; Liu, JB; Zhao, MM; Zhao, JN				Li, Qingzhi; Wang, Pengcheng; Huang, Chuixue; Chen, Baozhi; Liu, Jiabin; Zhao, Mingmei; Zhao, Jiannong			N-Acetyl Serotonin Protects Neural Progenitor Cells Against Oxidative Stress-Induced Apoptosis and Improves Neurogenesis in Adult Mouse Hippocampus Following Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						N-acetyl serotonin; Neural progenitor cell; Apoptosis; Oxidative stress; Hippocampal neurogenesis; Traumatic brain injury	GLYCOGEN-SYNTHASE KINASE-3; ACTIVATION	In this study, with primary mouse neural progenitor cells (NPCs), we investigated the neuroprotective effect of a tropomyosin-related kinase receptor B (TrkB) agonist, N-acetyl serotonin (NAS), against hydrogen peroxide (H2O2)-induced toxicity. We found that pre-incubation with NAS not only ameliorates H2O2-induced cell viability loss, lactate dehydrogenase (LDH) release, and proliferative and migratory capacity impairments, but counteracts H2O2-triggered production of nitric oxide (NO), reactive oxygen species (ROS), malondialdehyde (MDA), and 8-hydroxy-deoxyguanosine (8-OHdG) in a dose-dependent manner. Additionally, pre-treatment with NAS was able to attenuate H2O2-induced apoptosis in NPCs, evidenced by the decreased percentage of apoptotic cells and altered expression of apoptosis-related factors. Furthermore, in differentiated NPCs, NAS improves H2O2-induced reduction in neurite growth. Mechanistic studies revealed that the protective effects of NAS in NPCs may be mediated by the TrkB/PI3K/Akt/ cAMP response element binding protein (CREB) signaling cascades. In a mouse traumatic brain injury (TBI) model, we found that systemic administration of 30mg/kg NAS could improve hippocampal neurogenesis, manifested by the increased number of SOX-2-positive cells and increased expression of phosphorylated CREB in the dentate gyrus (DG) area. Treatment with NAS also ameliorates cognitive impairments caused by TBI, as assessed by Y-maze and contextual and cued fear conditioning tests. Taken together, these results provide valuable insights into the neuroprotective and neuroregenerative effects of NAS, suggesting it may have therapeutic potential for the treatment of TBI.	[Li, Qingzhi; Wang, Pengcheng; Huang, Chuixue; Chen, Baozhi; Zhao, Jiannong] Hainan Gen Hosp, Dept Neurosurg, 19 Xiuhua Rd, Haikou 570311, Hainan, Peoples R China; [Liu, Jiabin] Southern Med Univ, Dept Radiotherapy, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Zhao, Mingmei] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Neurosurg, Qingdao, Shandong, Peoples R China		Zhao, JN (corresponding author), Hainan Gen Hosp, Dept Neurosurg, 19 Xiuhua Rd, Haikou 570311, Hainan, Peoples R China.	md.zhaojiannong@outlook.com					Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Bergmann O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018994; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; He YB, 2014, NAT NEUROSCI, V17, P943, DOI 10.1038/nn.3732; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Katagiri D, 2013, J AM SOC NEPHROL, V24, P2034, DOI 10.1681/ASN.2013020134; Lazarov O, 2016, PROG NEUROBIOL, V138, P1, DOI 10.1016/j.pneurobio.2015.12.006; Leaden PJ, 2007, PROSTAG LEUKOTR ESS, V77, P29, DOI 10.1016/j.plefa.2007.06.001; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Ngwenya LB, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00102; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Pierini D, 2015, METHODS MOL BIOL, V1208, P63, DOI 10.1007/978-1-4939-1441-8_5; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shoji H, 2014, JOVE-J VIS EXP, DOI 10.3791/50871; Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898; Stoleru Bogdan, 2013, Maedica (Bucur), V8, P43; Tanaka K, 2001, PROG NEUROBIOL, V65, P173, DOI 10.1016/S0301-0082(01)00002-8; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Wong AW, 2013, J NEUROSCI, V33, P4947, DOI 10.1523/JNEUROSCI.3990-12.2013; Yoo JM, 2017, REDOX BIOL, V11, P592, DOI 10.1016/j.redox.2016.12.034; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765	37	16	17	0	13	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	APR	2019	67	4					574	588		10.1007/s12031-019-01263-6			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HS2OU	WOS:000463700900009	30684239				2022-02-06	
J	Sankar, SB; Pybus, AF; Liew, A; Sanders, B; Shah, KJ; Wood, LB; Buckley, EM				Sankar, Sitara B.; Pybus, Alyssa F.; Liew, Amanda; Sanders, Bharat; Shah, Kajol J.; Wood, Levi B.; Buckley, Erin M.			Low cerebral blood flow is a non-invasive biomarker of neuroinflammation after repetitive mild traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Cerebral blood flow; Cytokines; Mild traumatic brain injury; Neuroinflammation; Kinase signaling	DIFFUSE CORRELATION SPECTROSCOPY; IN-VITRO; ACTIVATION; MICROGLIA; VEGF; LIPOPOLYSACCHARIDE; EXPRESSION; PATHWAYS; RECOVERY; PLAYERS	Previous work has shown that non-invasive optical measurement of low cerebral blood flow (CBF) is an acute biomarker of poor long-term cognitive outcome after repetitive mild traumatic brain injury (rmTBI). Herein, we explore the relationship between acute cerebral blood flow and underlying neuroinflammation. Specifically, because neuroinflammation is a driver of secondary injury after TBI, we hypothesized that both glial activation and inflammatory signaling are associated with acute CBF and, by extension, with long-term cognitive outcome after rmTBI. To test this hypothesis, cortical CBF was non-invasively measured in anesthetized mice 4 h after 3 repetitive closed head injuries spaced once-daily, at which time brains were collected. Right hemispheres were fixed for immunohistochemical staining for glial activation markers Iba1 and GFAP while left hemispheres were used to quantify Iba1 and GFAP expression via Western blot as well as 32 cytokines and 21 phospho-proteins in the MAPK, PI3K/Akt, and NF-kappa B pathways using a Luminex multiplexed immunoassay. N = 8/7 injured/sham C57/black-6 adult male mice were studied. Within the injured group, CBF inversely correlated with Iba1 expression (R = -0.86, p < .01). Further, partial least squares regression analysis revealed significant correlations between CBF and expression of multiple pro-inflammatory cytokines, including RANTES and IL-17. Finally, within the injured group, phosphorylation of specific signals in the MAPK and NF-kappa B intracellular signaling pathways (e.g., p38 MAPK and NF-kappa B) were significantly positively correlated with Iba1. In total, our data indicate that acute cerebral blood flow after rmTBI is a biomarker of underlying neuroinflammatory pathology.	[Sankar, Sitara B.; Pybus, Alyssa F.; Liew, Amanda; Sanders, Bharat; Shah, Kajol J.; Wood, Levi B.; Buckley, Erin M.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Sankar, Sitara B.; Pybus, Alyssa F.; Liew, Amanda; Sanders, Bharat; Shah, Kajol J.; Wood, Levi B.; Buckley, Erin M.] Emory Univ, Atlanta, GA 30322 USA; [Sankar, Sitara B.; Pybus, Alyssa F.; Wood, Levi B.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Wood, Levi B.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Buckley, Erin M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA		Wood, LB; Buckley, EM (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Wood, LB; Buckley, EM (corresponding author), Emory Univ, Atlanta, GA 30322 USA.; Wood, LB (corresponding author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.; Wood, LB (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.; Buckley, EM (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	levi.wood@me.gatech.edu; erin.buckley@emory.edu		Liew, Amanda/0000-0001-6984-1797	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS104801]; Woodruff School of Mechanical Engineering at Georgia Tech; Coulter Department of Biomedical Engineering at Georgia Tech; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS104801] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health [grant number R21NS104801] and start-up funds from the Woodruff School of Mechanical Engineering at Georgia Tech and from the Coulter Department of Biomedical Engineering at Georgia Tech and Emory.	Ances BM, 2009, NEUROLOGY, V73, P702, DOI 10.1212/WNL.0b013e3181b59a97; Armstead WA, 2006, EUR J PHARMACOL, V529, P129, DOI 10.1016/j.ejphar.2005.08.059; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Buckley EM, 2015, J CEREBR BLOOD F MET, V35, P1995, DOI 10.1038/jcbfm.2015.161; CHAO CC, 1992, J IMMUNOL, V149, P2736; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Eriksson L., 2013, MULTI MEGAVARIATE DA; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Farley MM, 2018, ANNU REV PATHOL-MECH, V13, P93, DOI 10.1146/annurev-pathol-012414-040354; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GOODWIN JL, 1995, BRAIN RES, V692, P207, DOI 10.1016/0006-8993(95)00646-8; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 1997, J BIOL CHEM, V272, P28853, DOI 10.1074/jbc.272.46.28853; Hanisch UK, 1996, SYNAPSE, V24, P104, DOI 10.1002/(SICI)1098-2396(199610)24:2<104::AID-SYN2>3.3.CO;2-V; Ikeda-Matsuo Y, 2005, J NEUROCHEM, V94, P1546, DOI 10.1111/j.1471-4159.2005.03302.x; IOM NRC, 2014, SPORTS RELATED CONCU; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; PATTERSON MS, 1995, APPL OPTICS, V34, P22, DOI 10.1364/AO.34.000022; Rothschild D. E., 2018, J LEUKOCYTE BIOL, DOI [10.1002/JLB.3MIR0817-346RFtR, DOI 10.1002/JLB.3MIR0817-346RFTR]; Ryu JK, 2009, J NEUROSCI, V29, P3, DOI 10.1523/JNEUROSCI.2888-08.2009; Sanchez A, 2010, NEUROPEPTIDES, V44, P323, DOI 10.1016/j.npep.2010.04.002; Simmons AJ, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156282; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Waisman A, 2015, ACTA NEUROPATHOL, V129, P625, DOI 10.1007/s00401-015-1402-7; Wu LM, 2019, J CEREBR BLOOD F MET, V39, P2196, DOI 10.1177/0271678X18786633; Xia MQ, 2000, J NEUROIMMUNOL, V108, P227, DOI 10.1016/S0165-5728(00)00285-X	40	16	17	2	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	APR	2019	124						544	554		10.1016/j.nbd.2018.12.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM1NH	WOS:000459217800048	30592976	Green Accepted			2022-02-06	
J	Yu, ST; Liu, HX; Li, K; Qin, ZG; Qin, XM; Zhu, P; Li, ZY				Yu, Shuting; Liu, Haixia; Li, Kun; Qin, Zhengguo; Qin, Xuemei; Zhu, Ping; Li, Zhenyu			Rapid characterization of the absorbed constituents in rat serum after oral administration and action mechanism of Naozhenning granule using LC-MS and network pharmacology	JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS			English	Article						Naozhenning granule; UHPLC-Qexactive quadrupole-orbitrap MS; Metabolites; Prototype components; Network pharmacology	MAJOR BIOACTIVE COMPONENTS; REHMANNIA-GLUTINOSA; CEREBRAL-ISCHEMIA; MAPK PATHWAY; IDENTIFICATION; METABOLITES; INJURY; ACTIVATION; DECOCTION; DANSHEN	Naozhenning granule is a Chinese herbal formula, which is mainly used in the treatment of concussion, cerebral post-traumatic syndrome. Although its effectiveness has been certified in the clinical use, the mechanism of action and bioactive components of Naozhenning remain unknown. In this study, the ultrahigh performance liquid chromatography coupled with hybrid quadrupole-orbitrap mass spectrometry was applied to identify the absorbed constituents of Naozhenning in the rat serum. A total of 60 compounds, including 30 prototype components and 30 metabolites were identified. Then the absorbed constituents were subjected to the network pharmacology analysis. The compound-target-disease (CTD) and KEGG pathway analysis revealed that 40 absorbed constituents, 56 target genes and three key pathways such as RAS, PI3K/Akt, MAPK, TGF beta were probably related with the efficacy of Naozhenning against cerebral trauma and cerebral concussion. The results provided a scientific basis for understanding the bioactive compounds and the pharmacological mechanism of Naozhenning granule. (C) 2019 Elsevier B.V. All rights reserved.	[Yu, Shuting; Qin, Xuemei; Li, Zhenyu] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan 030006, Shanxi, Peoples R China; [Liu, Haixia; Li, Kun; Qin, Zhengguo; Zhu, Ping] Shanxi Zhendong Ante Biol Pharmaceut Co Ltd, Jinzhong 030600, Peoples R China; [Yu, Shuting] Shanxi Univ, Coll Chem & Chem Engn, Taiyuan 030006, Shanxi, Peoples R China		Li, ZY (corresponding author), Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan 030006, Shanxi, Peoples R China.; Zhu, P (corresponding author), Shanxi Zhendong Ante Biol Pharmaceut Co Ltd, Jinzhong 030600, Peoples R China.	zp8236@sohu.com; lizhenyu@sxu.edu.cn			Program of Science and Technology of Shanxi Province [201603D3113003, 2106ZD0404]; Shanxi Provincial Education Department [2018JD05]; Key Laboratory of Effective Substances Research and Utilization in TCM of Shanxi Province [201605D111004]	This study was financially supported by the Program of Science and Technology of Shanxi Province (Nos. 201603D3113003, 2106ZD0404), Shanxi Provincial Education Department (2018JD05), Key Laboratory of Effective Substances Research and Utilization in TCM of Shanxi Province (201605D111004). We also thank Scientific Instrument Center of Shanxi University for the LC-MS analysis.	Bai YJ, 2014, J PHARMACEUT BIOMED, V94, P77, DOI 10.1016/j.jpba.2014.01.036; Bi J, 2009, NEUROCHEM INT, V54, P264, DOI 10.1016/j.neuint.2008.12.003; Cekanaviciute E, 2014, GLIA, V62, P1227, DOI 10.1002/glia.22675; Comstock K., GENE EISERBERG RAPID; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Guo C, 2015, PHYTOMEDICINE, V22, P283, DOI 10.1016/j.phymed.2014.12.001; Han D. D., 2016, EVID-BASED COMPL ALT, V2016, P1; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Hong M., 2017, MOLECULES, V22, P1; Huang JH, 2017, MOL MED REP, V16, P4583, DOI 10.3892/mmr.2017.7149; Huang T., 2018, FRONT PHARMACOL, V270, P1; Kovalska M, 2012, NEUROCHEM RES, V37, P1568, DOI 10.1007/s11064-012-0752-y; Lee Y, 2018, EUR J OBSTET GYN R B, V221, P151, DOI 10.1016/j.ejogrb.2017.12.047; Li JA, 2018, NEURAL REGEN RES, V13, P298, DOI 10.4103/1673-5374.226400; Lin ZT, 2014, PHYTOCHEM ANALYSIS, V25, P485, DOI 10.1002/pca.2517; Liu CF, 2013, J ETHNOPHARMACOL, V145, P509, DOI 10.1016/j.jep.2012.11.021; Luo XQ, 2018, CHIN MED-UK, V13, DOI 10.1186/s13020-018-0173-1; Ortuno-Sahagun D, 2014, J MOL NEUROSCI, V52, P366, DOI 10.1007/s12031-013-0157-7; Pang HH, 2018, J ZHEJIANG UNIV-SC B, V19, P227, DOI 10.1631/jzus.B1700105; Qian YY, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-42; Shi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092937; Tao JH, 2017, CHIN HERB MED, V9, P147, DOI [10.1016/S1674-6384(17)60088-1, 10.1016/s1674-6384(17)60088-1]; Tao JH, 2015, J CHROMATOGR B, V1001, P98, DOI 10.1016/j.jchromb.2015.07.035; Wang X. J., 2017, CHIN J NEUROTRAUMA S, V3, P292; Wen XD, 2012, J PHARMACEUT BIOMED, V67-68, P114, DOI 10.1016/j.jpba.2012.04.026; Willems JL, 2016, ANAL CHIM ACTA, V933, P164, DOI 10.1016/j.aca.2016.05.041; Xiao S, 2005, J MOD MED HLTH, V21, P1711; Xu DD, 2016, NEUROCHEM RES, V41, P2086, DOI 10.1007/s11064-016-1921-1; Yu GH, 2017, INT J CHRONIC OBSTR, V12, P85, DOI 10.2147/COPD.S121079; Yu J, 2015, BIOL PHARM BULL, V38, P1564, DOI 10.1248/bpb.b15-00352; Yu Shu-ting, 2018, Yaoxue Xuebao, V53, P609, DOI 10.16438/j.0513-4870.2017-1190; Zhang FY, 2009, EXP BRAIN RES, V193, P109, DOI 10.1007/s00221-008-1600-9; Zhang FX, 2016, J PHARMACEUT BIOMED, V122, P59, DOI 10.1016/j.jpba.2016.01.047; Zhang JL, 2005, BIOMED CHROMATOGR, V19, P51, DOI 10.1002/bmc.415; Zhang MS, 1997, CHIN TRADIT PAT MED, V19, P33; Zhang P, 2018, CELL BIOL INT, V42, P1041, DOI 10.1002/cbin.10980; Zhang XJ, 2018, J CHROMATOGR B, V1076, P70, DOI 10.1016/j.jchromb.2018.01.023; Zhang Y, 2017, J CHROMATOGR B, V1061, P474, DOI 10.1016/j.jchromb.2017.07.021	38	16	20	3	39	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0731-7085	1873-264X		J PHARMACEUT BIOMED	J. Pharm. Biomed. Anal.	MAR 20	2019	166						281	290		10.1016/j.jpba.2019.01.020			10	Chemistry, Analytical; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	HO2AL	WOS:000460713700033	30682694				2022-02-06	
J	Donders, J; Stout, J				Donders, Jacobus; Stout, Jacob			The Influence of Cognitive Reserve on Recovery from Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Brain reserve; Protective factors; Injury severity; Processing speed; Risk factors; Sequelae	NEUROPSYCHOLOGICAL OUTCOMES; WECHSLER TEST; MILD; INDIVIDUALS; PERFORMANCE; CONCUSSION; DEPRESSION; SYMPTOMS; ASSOCIATION; VALIDITY	we sought to determine the degree to which cognitive reserve, as assessed by the Test of Premorbid Functioning in combination with demographic variables, could act as a buffer against the effect of traumatic brain injury (TBI) on cognitive test performance. retrospective analysis of a cohort of 121 persons with TBI who completed the Wechsler Adult Intelligence ScaleuFourth Edition (WAISIV) within 112 months after injury. regression analyses indicated that cognitive reserve was a statistically significant predictor of all postinjury WAISIV factor index scores, after controlling for various premorbid and comorbid confounding variables. Only for Processing Speed did injury severity make an additional statistically significant contribution to the prediction model. cognitive reserve has a protective effect with regard to the impact of TBI on cognitive test performance but this effect is imperfect and does not completely negate the effect of injury severity.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA; [Stout, Jacob] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Banos J, 2010, PRINCIPLES PRACTICE, P329; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Centers for Disease Control and Prevention, 2014, TRAUM BRAIN INJ US F; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; Gass CS, 2017, APPL NEUROPSYCH-ADUL, V24, P357, DOI 10.1080/23279095.2016.1185427; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Holdnack JA, 2013, PRACT RESOUR MENT, P1; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Leary JB, 2018, J HEAD TRAUMA REHAB, V33, pE28, DOI 10.1097/HTR.0000000000000329; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; Murphy KR, 2004, STAT POWER ANAL; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; O'Shea DM, 2015, INT J GERIATR PSYCH, V30, P614, DOI 10.1002/gps.4192; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Pearson, 2009, ADV CLIN SOLUTIONS W; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Semrud-Clikeman M, 2008, ESSENTIALS NEUROPSYC, P245; Shapiro ME, 2014, ARCH CLIN NEUROPSYCH, V29, P110, DOI 10.1093/arclin/act071; Sherman EMS, 2000, BRAIN INJURY, V14, P621; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Stucky KJ, 2014, NEUROPSYCHOLOGY STUD, P432; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D., 2008, WECHSLER ADULT INTEL	43	16	16	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2019	34	2					206	213		10.1093/arclin/acy035			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	HQ7AR	WOS:000462572200005	29659665	Bronze			2022-02-06	
J	Farell, M; Aherne, S; O'Riordan, S; O'Keeffe, E; Greene, C; Campbell, M				Farell, Michael; Aherne, Susan; O'Riordan, Sean; O'Keeffe, Eoin; Greene, Chris; Campbell, Matthew			Blood-brain barrier dysfunction in a boxer with chronic traumatic encephalopathy and schizophrenia	CLINICAL NEUROPATHOLOGY			English	Article						chronic traumatic encephalopathy (CTE); blood-brain barrier (BBB); schizophrenia; claudin-5	SERUM S100B; INJURY; DIAGNOSIS; TAUOPATHY; PATHOLOGY; IMPACT	Chronic traumatic encephalopathy (CTE) is a neurodegenerative condition characterized by the perivascular deposition of phosphorylated tau (p-tau) protein aggregates resulting from repetitive mild traumatic brain injury (rTB1). Advances in the field have revealed the significance of repetitive head trauma in the pathogenesis of CTE in contact sports as well as military veterans. In this study we provide evidence of blood-brain barrier (BBB) disruption in regions of intense perivascular p-tau deposition in a former professional boxer diagnosed with CTE and schizophrenia. P-tau deposition was associated with loss of the tight junction protein claudin-5 and enhanced extravasation of endogenous blood components such as fibrinogen and IgG. We also provide evidence of tight junction disruption in individuals with schizophrenia, with discontinuous claudin-5 immunoreactivity in the parietal cortex. This data highlights a common phenotype of a dysfunctional BBB in individuals with CTE and schizophrenia and may represent a novel correlate of neural dysfunction in individuals at risk of developing CTE and schizophrenia.	[Farell, Michael] Beaumont Hosp, Dept Neuropathol, Dublin, Ireland; [Aherne, Susan] St Columcilles Hosp, Dept Pathol, Loughlinstown, Ireland; [O'Riordan, Sean] St Vincents Univ Hosp, Dept Neurol, Dublin, Ireland; [O'Riordan, Sean] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [O'Keeffe, Eoin; Greene, Chris; Campbell, Matthew] Trinity Coll Dublin, Smurfit Inst Genet, Trinity Pl Gate, Dublin 2, Ireland		Campbell, M (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Trinity Pl Gate, Dublin 2, Ireland.	canpbem2@tcd.ie		Greene, Chris/0000-0003-4192-9433	Science Foundation Ireland (SFI)Science Foundation Ireland [12/YI/B2614, 08/IN.I/B2033]; SFIScience Foundation Ireland; Health Research Board of Ireland (HRB); Bright Focus FoundationBrightFocus Foundation; St James' Hospital Research Foundation	This work was supported by grants from Science Foundation Ireland (SFI), (12/YI/B2614; 08/IN.I/B2033), SFI funded centre FutureNeuro, The Health Research Board of Ireland (HRB), the Bright Focus Foundation and St James' Hospital Research Foundation.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Banks WA, 2017, J ALZHEIMERS DIS, V55, P411, DOI 10.3233/JAD-160542; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bechter K, 2010, J PSYCHIATR RES, V44, P321, DOI 10.1016/j.jpsychires.2009.08.008; Catafau AM, 2004, MOVEMENT DISORD, V19, P1175, DOI 10.1002/mds.20112; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Enwright JF, 2018, MOL PSYCHIATR, V23, P1606, DOI 10.1038/mp.2017.216; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greene C, 2017, MOL PSYCHIATR, DOI [10.1038/mp.2017, DOI 10.1038/MP.2017]; Lara DR, 2001, J PSYCHIATR RES, V35, P11, DOI 10.1016/S0022-3956(01)00003-6; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menard C, 2017, NAT NEUROSCI, V20, P1752, DOI 10.1038/s41593-017-0010-3; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Najjar S, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00083; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Nishiura K, 2017, ONCOTARGET, V8, P93382, DOI 10.18632/oncotarget.21850; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rothermundt M, 2001, MOL PSYCHIATR, V6, P445, DOI 10.1038/sj.mp.4000889; Schroeter ML, 2003, SCHIZOPHR RES, V62, P231, DOI 10.1016/S0920-9964(02)00383-3; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Sun ZY, 2004, EUR PSYCHIAT, V19, P354, DOI 10.1016/j.eurpsy.2004.06.007; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022	31	16	17	3	13	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.	MAR-APR	2019	38	2					51	58		10.5414/NP301130			8	Clinical Neurology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	HM0GB	WOS:000459123800003	30574863				2022-02-06	
J	Cox, CS; Juranek, J; Bedi, S				Cox, Charles S., Jr.; Juranek, Jennifer; Bedi, Supinder			Clinical trials in traumatic brain injury: cellular therapy and outcome measures	TRANSFUSION			English	Article; Proceedings Paper	CTTACC Symposium	2017	San Francisco, CA	CTTACC			ACTIVATED MICROGLIAL/MACROPHAGE RESPONSE; DIFFUSION-TENSOR; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; RESTRICTED-DIFFUSION; CELLS; ADULT; TRANSPLANTATION; NEUROINFLAMMATION; HYPOTHERMIA	Clinical trials for traumatic brain injury (TBI) have not successfully produced a new therapeutic for neuroprotection or neurorestoration, despite multiple attempts. Stem cell-based therapies and/or cellular therapies have been developed over the past 20 years such that clinical trials are now in Phase II and III stages for neurologic diseases such as TBI and stroke. Many of the vexing issues from past clinical failures still exist today, namely, preclinical data that may not translate to clinical trial because of design and injury heterogeneity that poorly stratifies enrolled patients. Recognition of these problems has led us to advocate for outcome measures that are clinically meaningful, but do not represent a global functional "score." Specifically, we seek to measure those early physiologically relevant outcomes (intracranial pressure, edema, and therapeutic intensity) and later structural outcomes in regions of interest that are linked to putative mechanisms of action of cell based therapies. Early approval of therapeutics that are successful by these metrics would then allow further access to treatments that could be further tested via patient registries and other surveillance for ultimate adoption. Continuing to do the same thing with each iterative trial will assure the same results.	[Cox, Charles S., Jr.; Bedi, Supinder] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Med Sch, Houston, TX 77030 USA; [Juranek, Jennifer] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, McGovern Med Sch, Houston, TX 77030 USA		Cox, CS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, 6431 Fannin St,MSB 5-236, Houston, TX 77030 USA.	Charles.S.Cox@uth.tmc.edu			Glassell Foundation; Department of Defense/Joint Warfighter Grant [JW150014]; State of Texas Emerging Technology Fund; Bentsen Foundation; Evelyn Griffin Stem Cell Laboratory; Mission Connect	Supported by the Glassell Foundation, Department of Defense/Joint Warfighter Grant JW150014, State of Texas Emerging Technology Fund, Bentsen Foundation, Evelyn Griffin Stem Cell Laboratory, and Mission Connect.	Al Brashdi YH, 2015, NEURORADIOL J, V28, P409, DOI 10.1177/1971400915598071; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Dupont AC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040785; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Harriman T, 2017, NEONATAL NETW, V36, P273, DOI 10.1891/0730-0832.36.5.273; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jackson M, 2017, J NEUROTRAUM, V34, pA142; Jackson ML, 2017, J SURG RES, V214, P38, DOI 10.1016/j.jss.2017.02.078; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Muccio CF, 2009, BRAIN INJURY, V23, P466, DOI 10.1080/02699050902841912; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Narayan RK, 2002, J NEUROTRAUM, V17, P695; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Sanberg PR, 2010, J CELL MOL MED, V14, P553, DOI 10.1111/j.1582-4934.2009.00903.x; Scarf AM, 2011, J NUCL MED, V52, P667, DOI 10.2967/jnumed.110.086629; Schlaug G, 1999, NEUROLOGY, V53, P1528, DOI 10.1212/WNL.53.7.1528; Selden NR, 2013, J NEUROSURG-PEDIATR, V11, P643, DOI 10.3171/2013.3.PEDS12397; Shore PM, 2006, CRIT CARE MED, V24, P75; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith HS, 2010, PAIN PHYSICIAN, V13, P295; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Thiel A, 2010, J NUCL MED, V51, P1404, DOI 10.2967/jnumed.110.076612; Toth M, 2016, BRAIN STRUCT FUNCT, V221, P1279, DOI 10.1007/s00429-014-0970-y; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Willing AE, 2007, HISTOL HISTOPATHOL, V22, P697, DOI 10.14670/HH-22.697; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	63	16	16	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	FEB	2019	59			1	SI		858	868		10.1111/trf.14834			11	Hematology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Hematology	HK9CT	WOS:000458287400006	30737818	Bronze			2022-02-06	
J	Moser, RS; Olek, L; Schatz, P				Moser, Rosemarie Scolaro; Olek, Lauren; Schatz, Philip			Gender Differences in Symptom Reporting on Baseline Sport Concussion Testing Across the Youth Age Span	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Baseline testing; Concussion symptoms; Gender differences; Youth concussion	SEX-DIFFERENCES; NEUROCOGNITIVE PERFORMANCE; BRAIN	Background Little is known regarding gender differences in concussion symptom reporting developmentally across the age span, specifically in pre-adolescent athletes. The present study asks: Do boys and girls differ in symptom reporting across the pre-adolescent to post-adolescent age span? Method This retrospective study utilized baseline assessments from 11,695 10-22 year-old athletes assigned to 3 independent groups: Pre-adolescent 10-12 year olds (n = 1,367; 12%), Adolescent 13-17 year olds (n = 2,974; 25%), and Late Adolescent 18-22 year olds (n = 7,354; 63%). Males represented 60% of the sample. Baseline ImPACT composite scores and Post-Concussion Symptom Scale scores (Total, Physical, Cognitive, Emotional, Sleep) were analyzed for the effects of age and gender. Results Statistically significant main effects were found for age and gender on all ImPACT composites, Total Symptoms, and Symptom factors. Significant interaction effects were noted between age and gender for all ImPACT composites, Total Symptoms, and Symptom factors. Total Symptoms and all Symptom factors were highest in adolescents (ages 13-17) for males and females. In the 10-12 age group, females displayed lower Total Symptoms, Physical, and Sleep factors than males. Conclusion The notion of females being more likely than males to report symptoms does not appear to apply across the developmental age span, particularly prior to adolescence. Females show greater emotional endorsement across the youth age span (10-22 years). Adolescence (13-17 years) appears to be a time of increased symptomatology that may lessen after the age of 18.	[Moser, Rosemarie Scolaro] Sports Concuss Ctr New Jersey, RSM Psychol Ctr, Princeton, NJ USA; [Olek, Lauren; Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA		Moser, RS (corresponding author), Sports Concuss Ctr New Jersey, 281 Witherspoon St,Suite 230, Princeton, NJ 08540 USA.	rmoser@sportsconcussionNJ.com					Arain M, 2013, NEUROPSYCH DIS TREAT, V9, P449, DOI 10.2147/NDT.S39776; Barth JT, 2001, J ATHL TRAINING, V36, P253; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Blakemore SJ, 2010, HUM BRAIN MAPP, V31, P926, DOI 10.1002/hbm.21052; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Cohen J., 2013, STAT POWER ANAL BEHA; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; de Courten-Myers GM, 1999, J NEUROPATH EXP NEUR, V58, P217; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Keating P., 2017, ESPN THE MAGAZINE; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell M.R., 2011, IMPACT TECHNICAL MAN, V2013; Montopoli B., 2013, ESPN DROPS INVOLVEME; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Moser RS, 2018, ARCH CLIN NEUROPSYCH, V33, P417, DOI 10.1093/arclin/acx070; Moser RS, 2017, DEV NEUROPSYCHOL, V42, P276, DOI 10.1080/87565641.2017.1334785; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Murray K. J., 2016, PINKCONCUSSIONS INT; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Ruble DN, 2007, CHILD DEV, V78, P1121, DOI 10.1111/j.1467-8624.2007.01056.x; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schwarz A, 2010, NY TIMES; SPSS, 2015, IBM SPSS MAC VERS 23; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; World Health Organization, ANT THER HIV INF INT	37	16	16	0	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2019	34	1					50	59		10.1093/arclin/acy007			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	HO0SQ	WOS:000460614800006	29420685	Bronze			2022-02-06	
J	Okuma, Y; Wake, H; Teshigawara, K; Takahashi, Y; Hishikawa, T; Yasuhara, T; Mori, S; Takahashi, HK; Date, I; Nishibori, M				Okuma, Yu; Wake, Hidenori; Teshigawara, Kiyoshi; Takahashi, Yu; Hishikawa, Tomohito; Yasuhara, Takao; Mori, Shuji; Takahashi, Hideo K.; Date, Isao; Nishibori, Masahiro			Anti-High Mobility Group Box 1 Antibody Therapy May Prevent Cognitive Dysfunction After Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Cognitive dysfunction; Electroencephalography; High mobility group box 1; Traumatic brain injury	RECEPTOR; EPIDEMIOLOGY; INFLAMMATION; ISCHEMIA; MEDIATOR; PROFILE; CORTEX; BLOOD; HMG-1; RISK	BACKGROUND: High mobility group box 1 (HMGB1) protein plays a key role in triggering inflammatory responses in many diseases. Our previous study showed that HMGB1 is found upstream of secondary damage in traumatic brain injury (TBI). We found that anti-HMGB1 monoclonal antibody (mAb) effectively decreased acute brain damage, including the disruption of the blood-brain barrier, brain edema, and neurologic dysfunction. This effect of anti-HMGB1 mAb lasts for at least 1 week. In this study, we explored subacute effects of anti-HMGB1 mAb after TBI. METHODS: TBI was induced in rats by fluid percussion. Anti-HMGB1 mAb or control mAb was given intravenously after TBI. Histochemical staining, plasma levels of HMGB1, motor activity and memory, and video electroencephalography monitoring were evaluated 2 weeks after fluid percussion injury. RESULTS: Anti-HMGB1 mAb remarkably attenuated accumulation of activated microglia in the rat cortex in the ipsilateral hemisphere after TBI. Anti-HMGB1 mAb also prevented neuronal death in the hippocampus in the ipsilateral hemisphere after TBI. Treatment of rats with anti-HMGB1 mAb inhibited HMGB1 translocation and suppressed impairment of motor function. The beneficial effects of anti-HMGB1 mAb on motor and cognitive function persisted for 14 days after injury. Treatment with anti-HMGB1 mAb also had positive effects on electroencephalography activity. CONCLUSIONS: The beneficial effects of anti-HMGB1 mAb continued during the subacute postinjury phase, suggesting that anti-HMGB1 mAb may prevent cognitive dysfunction after TBI.	[Okuma, Yu; Wake, Hidenori; Teshigawara, Kiyoshi; Takahashi, Yu; Nishibori, Masahiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pharmacol, Okayama, Japan; [Okuma, Yu; Takahashi, Yu; Hishikawa, Tomohito; Yasuhara, Takao; Date, Isao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Okayama, Japan; [Mori, Shuji] Shujitsu Univ, Sch Pharm, Dept Pharmacol, Okayama, Japan; [Takahashi, Hideo K.] Kinki Univ, Dept Pharmacol, Sch Med, Osaka, Japan; [Okuma, Yu] Hiroshima City Hiroshima Citizens Hosp, Dept Neurol Surg, Hiroshima, Japan		Nishibori, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pharmacol, Okayama, Japan.	mbori@md.okayama-u.ac.jp		Okuma, Yu/0000-0003-4769-8111	Japan Society for the Promotion of Science KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [18K08909]	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI Grants-in-Aid for Scientific Research (C), Grant Number 18K08909.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Aneja RK, NEUROTRAUMA, DOI [10.1089/neu.2018.5664, DOI 10.1089/NEU.2018.5664]; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; D'Ambrosio R, 2013, ANN NEUROL, V73, P199, DOI 10.1002/ana.23764; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Eastman CL, 2011, J PHARMACOL EXP THER, V336, P779, DOI 10.1124/jpet.110.175133; Flores-Rio de la Loza LJ, 2005, REV NEUROLOGIA, V41, P22, DOI 10.33588/rn.4101.2004442; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Haruma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37755; Hayashi K, 2011, EPILEPSIA, V52, P1010, DOI 10.1111/j.1528-1167.2011.03046.x; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kobayashi M, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1168-7; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Nishibori M, 2009, ACTA MED OKAYAMA, V63, P65; Nosaka N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0983-9; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Okuma Y, 2013, NEUROSCI LETT, V554, P156, DOI 10.1016/j.neulet.2013.08.058; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Otani N, 2002, J NEUROTRAUM, V19, P1587, DOI 10.1089/089771502762300247; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sugihara M, 2016, AM J SURG, V211, P179, DOI 10.1016/j.amjsurg.2015.06.025; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334	36	16	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2019	122						E864	E871		10.1016/j.wneu.2018.10.164			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HJ6UM	WOS:000457328100104	30391757				2022-02-06	
J	Skrifvars, MB; Moore, E; Martensson, J; Bailey, M; French, C; Presneill, J; Nichol, A; Little, L; Duranteau, J; Huet, O; Haddad, S; Arabi, Y; McArthur, C; Cooper, DJ; Bellomo, R				Skrifvars, Markus B.; Moore, Elizabeth; Martensson, Johan; Bailey, Michael; French, Craig; Presneill, Jeffrey; Nichol, Alistair; Little, Lorraine; Duranteau, Jacques; Huet, Olivier; Haddad, Samir; Arabi, Yaseen; McArthur, Colin; Cooper, David J.; Bellomo, Rinaldo		EPO-TBI Investigators Anzics Clin	Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						acute kidney injury; creatinine; critical care; erythropoietin; renal insufficiency; traumatic brain injury	THERAPEUTIC HYPOTHERMIA; RENAL-FUNCTION; EPIDEMIOLOGY; PREVENTION; HYPOXIA; COSTS; COMA; EPO	Background Acute kidney injury (AKI) in traumatic brain injury (TBI) is poorly understood and it is unknown if it can be attenuated using erythropoietin (EPO). Methods Pre-planned analysis of patients included in the EPO-TBI (ClinicalTrials.gov NCT00987454) trial who were randomized to weekly EPO (40 000 units) or placebo (0.9% sodium chloride) subcutaneously up to three doses or until intensive care unit (ICU) discharge. Creatinine levels and urinary output (up to 7 days) were categorized according to the Kidney Disease Improving Global Outcome (KDIGO) classification. Severity of TBI was categorized with the International Mission for Prognosis and Analysis of Clinical Trials in TBI. Results Of 3348 screened patients, 606 were randomized and 603 were analyzed. Of these, 82 (14%) patients developed AKI according to KDIGO (60 [10%] with KDIGO 1, 11 [2%] patients with KDIGO 2, and 11 [2%] patients with KDIGO 3). Male gender (hazard ratio [HR] 4.0 95% confidence interval [CI] 1.4-11.2, P = 0.008) and severity of TBI (HR 1.3 95% CI 1.1-1.4, P < 0.001 for each 10% increase in risk of poor 6 month outcome) predicted time to AKI. KDIGO stage 1 (HR 8.8 95% CI 4.5-17, P < 0.001), KDIGO stage 2 (HR 13.2 95% CI 3.9-45.2, P < 0.001) and KDIGO stage 3 (HR 11.7 95% CI 3.5-39.7, P < 0.005) predicted time to mortality. EPO did not influence time to AKI (HR 1.08 95% CI 0.7-1.67, P = 0.73) or creatinine levels during ICU stay (P = 0.09). Conclusions Acute kidney injury is more common in male patients and those with severe compared to moderate TBI and appears associated with worse outcome. EPO does not prevent AKI after TBI.	[Skrifvars, Markus B.; Moore, Elizabeth; Bailey, Michael; Nichol, Alistair; Little, Lorraine; Cooper, David J.; Bellomo, Rinaldo] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Skrifvars, Markus B.] Helsinki Univ Hosp, Div Intens Care, Dept Anaesthesiol Intens Care & Pain Med, Helsinki, Finland; [Skrifvars, Markus B.] Univ Helsinki, PB 340, Helsinki 00029, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Dept Emergency Med & Serv, PB 340, Helsinki 00029, Finland; [Martensson, Johan] Karolinska Inst, Dept Physiol & Pharmacol, Sect Anaesthesia & Intens Care, Stockholm, Sweden; [French, Craig] Western Hlth, Dept Intens Care, Melbourne, Vic, Australia; [Presneill, Jeffrey] Royal Melbourne Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Nichol, Alistair] St Vincents Univ Hosp, Dublin, Ireland; [Nichol, Alistair; Cooper, David J.] Alfred, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Duranteau, Jacques] Univ Paris Sud XI, Dept Anaesthesia & Intens Care, HUPS, Orsay, France; [Huet, Olivier] Univ Bretagne Occidental, Dept Anesthesie Reanimat, Hop Cavale Blanche, CHRU Brest, Blvd Tanguy Prigent, Brest, France; [Haddad, Samir; Arabi, Yaseen] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Haddad, Samir; Arabi, Yaseen] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Haddad, Samir] G&S Med Associates, Urgent Care, Paterson, NJ USA; [McArthur, Colin] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia		Skrifvars, MB (corresponding author), Univ Helsinki, PB 340, Helsinki 00029, Finland.; Skrifvars, MB (corresponding author), Helsinki Univ Hosp, Dept Emergency Med & Serv, PB 340, Helsinki 00029, Finland.	markus.skrifvars@hus.fi	Arabi, Yaseen/ABF-3316-2020; French, Craig/ABF-5087-2020; Cooper, D. James/G-7961-2013	Arabi, Yaseen/0000-0001-5735-6241; French, Craig/0000-0003-1363-9711; Cooper, D. James/0000-0002-5872-9051; Nichol, Alistair/0000-0002-4689-1238	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [545902]; Transport Accident Commission of Victoria [D162]; Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet; Svenska Kulturfonden; Health Research Board of Ireland	EPO-TBI was supported by grants from the National Health and Medical Research Council of Australia (grant 545902) and the Transport Accident Commission of Victoria (grant D162). Markus Skrifvars has received personal research funding from Medicinska Understodsforeningen Liv och Halsa, Finska Lakaresallskapet and Svenska Kulturfonden. Alistair Nichol has received support from the Health Research Board of Ireland.	Ala-Kokko T, 2006, ACTA ANAESTH SCAND, V50, P828, DOI 10.1111/j.1399-6576.2006.01082.x; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Brandt MM, 2007, J TRAUMA, V62, P1362, DOI 10.1097/TA.0b013e318047983d; BROMAN H, 1995, ACTA PHYSIOL SCAND, V153, P179; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Dardashti A, 2014, ANESTHESIOLOGY, V121, P582, DOI 10.1097/ALN.0000000000000321; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; de Seigneux S, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-132; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Elliott S, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0438-4; Eriksson M, 2015, J TRAUMA ACUTE CARE, V79, P407, DOI 10.1097/TA.0000000000000727; Figueroa YG, 2002, EXP HEMATOL, V30, P1419, DOI 10.1016/S0301-472X(02)00934-7; Gomes E, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-1; Hafer C, 2012, KIDNEY INT, V81, P314, DOI 10.1038/ki.2011.349; Kang DH, 2005, KIDNEY INT, V67, P1683, DOI 10.1111/j.1523-1755.2005.00264.x; Kim JH, 2013, CRIT CARE, V17, DOI 10.1186/cc13081; Kiris I, 2008, J SURG RES, V149, P206, DOI 10.1016/j.jss.2007.12.752; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu KD, 2017, INTENS CARE MED, V43, P898, DOI 10.1007/s00134-017-4810-4; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Matejkova S, 2013, INTENS CARE MED, V39, P497, DOI 10.1007/s00134-012-2766-y; Moore EM, 2011, ANAESTH INTENS CARE, V39, P356, DOI 10.1177/0310057X1103900306; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichol A, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0528-6; Presneill Jeffrey, 2014, Trials, V15, P501, DOI 10.1186/1745-6215-15-501; Raj R, 2018, CRIT CARE MED, V46, pE302, DOI 10.1097/CCM.0000000000002959; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Siew ED, 2017, AM J RESP CRIT CARE, V195, P1597, DOI 10.1164/rccm.201603-0476OC; Simon F, 2008, CRIT CARE MED, V36, P2143, DOI 10.1097/CCM.0b013e31817d7912; Song YR, 2009, AM J NEPHROL, V30, P253, DOI 10.1159/000223229; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Susantitaphong P, 2012, RESUSCITATION, V83, P159, DOI 10.1016/j.resuscitation.2011.09.023; VAZIRI ND, 1994, AM J PHYSIOL, V266, pF360, DOI 10.1152/ajprenal.1994.266.3.F360; Wang GM, 2012, EUR J PHARMACOL, V689, P154, DOI 10.1016/j.ejphar.2012.05.027; Zeiner A, 2004, RESUSCITATION, V60, P253, DOI 10.1016/j.resuscitation.2003.11.006; Zygun D, 2006, CRIT CARE, V10, DOI 10.1186/cc5007	37	16	16	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	FEB	2019	63	2					200	207		10.1111/aas.13244			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	HG2SP	WOS:000454814700009	30132785	Green Published			2022-02-06	
J	Zhou, N; Liu, KL; Sun, Y; Cao, Y; Yang, J				Zhou, Nan; Liu, Kaili; Sun, Yue; Cao, Ying; Yang, Jing			Transcriptional mechanism of IRF8 and PU.1 governs microglial activation in neurodegenerative condition	PROTEIN & CELL			English	Article						microglia; 3D fluorescence imaging technique; neurodegeneration; IRF8; PU.1	CENTRAL-NERVOUS-SYSTEM; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; MYELOID CELLS; BRAIN-DEVELOPMENT; INSIGHTS; ORIGIN; GENE; NEUROINFLAMMATION; INFLAMMATION	Microglial activation occurs in divergent neuropathological conditions. Such microglial event has the key involvement in the progression of CNS diseases. However, the transcriptional mechanism governing microglial activation remains poorly understood. Here, we investigate the microglial response to traumatic injury-induced neurodegeneration by the 3D fluorescence imaging technique. We show that transcription factors IRF8 and PU.1 are both indispensible for microglial activation, as their specific post-developmental deletion in microglia abolishes the process. Mechanistically, we reveal that IRF8 and PU.1 directly target the gene transcription of each other in a positive feedback to sustain their highly enhanced expression during microglial activation. Moreover, IRF8 and PU.1 dictate the microglial response by cooperatively acting through the composite IRF-ETS motifs that are specifically enriched on microglial activation-related genes. This action of cooperative transcription can be further verified biochemically by the synergetic binding of IRF8 and PU.1 proteins to the composite-motif DNA. Our study has therefore elucidated the central transcriptional mechanism of microglial activation in response to neurodegenerative condition.	[Sun, Yue; Cao, Ying; Yang, Jing] Peking Univ, State Key Lab Membrane Biol, Beijing 100871, Peoples R China; [Yang, Jing] Peking Univ, IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China; [Liu, Kaili; Cao, Ying; Yang, Jing] Peking Univ, Ctr Life Sci, Beijing 100871, Peoples R China; [Sun, Yue; Yang, Jing] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Cao, Ying] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Zhou, Nan] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China		Yang, J (corresponding author), Peking Univ, State Key Lab Membrane Biol, Beijing 100871, Peoples R China.; Yang, J (corresponding author), Peking Univ, IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China.; Yang, J (corresponding author), Peking Univ, Ctr Life Sci, Beijing 100871, Peoples R China.; Yang, J (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	jing.yang@pku.edu.cn	Yang, Jing/M-2831-2017	Yang, Jing/0000-0002-2048-735X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31522024, 31771111]; State Key Laboratory of Membrane Biology; IDG/McGovern Institute for Brain Research; Center for Life Sciences and School of Life Sciences at Peking University	This study has been supported by State Key Laboratory of Membrane Biology, IDG/McGovern Institute for Brain Research, Center for Life Sciences and School of Life Sciences at Peking University, and National Natural Science Foundation of China to J. Yang (Grant Nos. 31522024 and 31771111).	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Biber K, 2016, NAT REV DRUG DISCOV, V15, P110, DOI 10.1038/nrd.2015.14; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Finsen B, 2011, FEBS LETT, V585, P3806, DOI 10.1016/j.febslet.2011.05.030; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Herz J, 2017, IMMUNITY, V46, P943, DOI 10.1016/j.immuni.2017.06.007; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Horiuchi M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-227; Inoue K, 2018, NAT REV NEUROSCI, V19, P138, DOI 10.1038/nrn.2018.2; Kalin S, 2015, NAT REV ENDOCRINOL, V11, P339, DOI 10.1038/nrendo.2015.48; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Lall D, 2017, J CLIN INVEST, V127, P3250, DOI 10.1172/JCI90607; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045; Meyer-Luehmann M, 2015, TRENDS NEUROSCI, V38, P659, DOI 10.1016/j.tins.2015.08.011; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Minten C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049851; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Schafer DP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020545; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Soto I, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017269; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Tay TL, 2016, CURR OPIN NEUROBIOL, V39, P30, DOI 10.1016/j.conb.2016.04.003; Terry RL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-270; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; Town T, 2006, J IMMUNOL, V176, P3804, DOI 10.4049/jimmunol.176.6.3804; Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042; Valdearcos M, 2015, ANNU REV PHYSIOL, V77, P131, DOI 10.1146/annurev-physiol-021014-071656; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Yoshida Y, 2014, IMMUNITY, V40, P187, DOI 10.1016/j.immuni.2013.11.022; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304	63	16	17	3	8	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1674-800X	1674-8018		PROTEIN CELL	Protein Cell	FEB	2019	10	2					87	103		10.1007/s13238-018-0599-3			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	HK5QG	WOS:000458021200002	30484118	Green Published, gold			2022-02-06	
J	Di Battista, AP; Churchill, N; Rhind, SG; Richards, D; Hutchison, MG				Di Battista, Alex P.; Churchill, Nathan; Rhind, Shawn G.; Richards, Doug; Hutchison, Michael G.			Evidence of a distinct peripheral inflammatory profile in sport-related concussion	JOURNAL OF NEUROINFLAMMATION			English	Article						Inflammation; Concussion; Chemokines; Cytokines; Biomarkers	TRAUMATIC BRAIN-INJURY; BLOOD BIOMARKERS; SEVERITY; STRESS; IMPACT; EXPRESSION; INCREASE; EXERCISE; HISTORY; PLASMA	BackgroundInflammation is considered a hallmark of concussion pathophysiology in experimental models, yet is understudied in human injury. Despite the growing use of blood biomarkers in concussion, inflammatory biomarkers have not been well characterized. Furthermore, it is unclear if the systemic inflammatory response to concussion differs from that of musculoskeletal injury. The purpose of this paper was to characterize systemic inflammation after injury in athletes with sport-related concussion or musculoskeletal injury.MethodsA prospective, observational cohort study was conducted employing 175 interuniversity athletes (sport-related concussion, n=43; musculoskeletal injury, n=30; healthy, n=102) from 12 sports at a sports medicine clinic at an academic institution.High-sensitivity immunoassay was used to evaluate 20 inflammatory biomarkers in the peripheral blood of athletes within 7days of injury (subacute) and at medical clearance. Healthy athletes were sampled prior to the start of their competitive season. Partial least squares regression analyses were used to identify salient biomarker contributions to class separation between injured and healthy athletes, as well as to evaluate the relationship between biomarkers and days to recovery in injured athletes.ResultsIn the subacute period after injury, compared to healthy athletes, athletes with sport-related concussion had higher levels of the chemokines' monocyte chemoattractant protein-4 (p<0.001) and macrophage inflammatory protein-1 (p=0.001); athletes with musculoskeletal injury had higher levels of thymus and activation-regulated chemokine (p=0.001). No significant differences in biomarker profiles were observed at medical clearance. Furthermore, concentrations of monocyte chemoattractant protein-1 (p=0.007) and monocyte chemoattractant protein-4 (p<0.001) at the subacute time point were positively correlated with days to recovery in athletes with sport-related concussion, while thymus and activation-regulated chemokine was (p=0.001) positively correlated with days to recovery in athletes with musculoskeletal injury.ConclusionSport-related concussion is associated with perturbations to systemic inflammatory chemokines that differ from those observed in athletes with a musculoskeletal injury. These results support inflammation as an important facet of secondary injury after sport-related concussion that can be measured systemically in a human model of injury.	[Di Battista, Alex P.; Rhind, Shawn G.; Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Di Battista, Alex P.; Rhind, Shawn G.] Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON, Canada; [Churchill, Nathan] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Neurosci Program, Toronto, ON, Canada; [Hutchison, Michael G.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, David L MacIntosh Sport Med Clin, Toronto, ON, Canada		Di Battista, AP (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.; Di Battista, AP (corresponding author), Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON, Canada.	alex.dibattista@utoronto.ca		Di Battista, Alex/0000-0002-3325-6833; Rhind, Shawn/0000-0003-2300-0620	Defense Research & Development Canada (DRDC); Canadian Institutes of Military and Veterans Health (CIMVHR)	This research was funded by Defense Research & Development Canada (DRDC) and the Canadian Institutes of Military and Veterans Health (CIMVHR). This study was approved by the Canadian Forces Surgeon General's Health Research Program. In accordance with the Department of National Defense policy, the paper was reviewed and approved for submission without modification by the DRDC Publications Office.	Battista APD, 2018, BRAIN INJURY, V32, P1; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bessa AL, 2016, J STRENGTH COND RES, V30, P311, DOI 10.1519/JSC.0b013e31828f1ee9; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; Campbell SJ, 2008, J NEUROPATH EXP NEUR, V67, P223, DOI 10.1097/NEN.0b013e3181654957; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Carp S, 2008, BIOMARK MED, V2, P67, DOI 10.2217/17520363.2.1.67; Carp SJ, 2007, CLIN SCI, V112, P305, DOI 10.1042/CS20060050; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Chrousos George P., 2000, Journal of Allergy and Clinical Immunology, V106, pS275; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Di Battista AP, 2018, J NEUROIMMUNOL, V319, P1, DOI 10.1016/j.jneuroim.2018.03.002; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Doran SJ, 2018, J NEUROTRAUMA; Duchesne E, 2017, PHYS THER, V97, P807, DOI 10.1093/ptj/pzx056; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gill J, 2016, J HEAD TRAUMA REHAB, V31, P269, DOI 10.1097/HTR.0000000000000191; Giuliano S, 2017, ENDOCRINE, V58, P115, DOI 10.1007/s12020-016-1183-3; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hopp S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0815-8; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kaspar F, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5474837; Kawata K, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00239; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, NAT REV NEUROL, V9, P361, DOI 10.1038/nrneurol.2013.88; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pesic G, 2017, MOL CELL BIOCHEM, V430, P191, DOI 10.1007/s11010-017-2967-3; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Reihmane D, 2013, EUR J APPL PHYSIOL, V113, P851, DOI 10.1007/s00421-012-2491-9; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shahim P, 2015, BRAIN INJURY, V29, P872, DOI 10.3109/02699052.2015.1018324; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; van den Berg R, 2018, SPINE J, V18, P2140, DOI 10.1016/j.spinee.2018.06.349; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Zhou P, 2018, MED SCI MONITOR, V24, P4379, DOI 10.12659/MSM.908592; Zwetsloot KA, 2014, J INFLAMM RES, V7, P9, DOI 10.2147/JIR.S54721	69	16	16	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JAN 26	2019	16								17	10.1186/s12974-019-1402-y			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology; Neurosciences & Neurology	HI8ZH	WOS:000456744000001	30684956	gold, Green Published			2022-02-06	
J	Terry, DP; Brassil, M; Iverson, GL; Panenka, WJ; Silverberg, ND				Terry, Douglas P.; Brassil, Michelle; Iverson, Grant L.; Panenka, William J.; Silverberg, Noah D.			Effect of depression on cognition after mild traumatic brain injury in adults	CLINICAL NEUROPSYCHOLOGIST			English	Article						Mild traumatic brain injury; MTBI; depression; cognition; neuropsychological functioning	PATIENT HEALTH QUESTIONNAIRE-9; SYMPTOM VALIDITY TEST; NIH TOOLBOX; NEUROPSYCHOLOGICAL OUTCOMES; DIAGNOSTIC METAANALYSIS; CONCUSSION; SEVERITY; DISORDER; TESTS; PHQ-9	Objective: The current study examined the effect of depression on cognitive test performance in a sample of adults seeking treatment for a mild traumatic brain injury (MTBI). We hypothesized that patients with greater depressive symptoms would perform worse on tasks of fluid cognition compared to those without depression, after controlling for potential confounds. Method: Patients (N = 76) completed a brief cognitive test battery (NIH Toolbox Cognition Battery; NIHTB-CB) and a depression screening questionnaire (PHQ-9) at 11.7-weeks post injury (SD = 6.3 range 2-26). Cognitive scores were adjusted for age, education, gender, and race/ethnicity. Depressive symptoms were examined continuously and dichotomized as: (1) total PHQ-9 score of >= 10, the optimal cut-off for Major Depressive Disorder caseness from prior research, and (2) five or more symptoms of depression, including either depressed mood or anhedonia (i.e. DSM-5-based definition). Results: Twenty-seven patients (35.5%) met DSM-5-based criteria for depression and 42 (55.3%) met criteria based on PHQ-9 > 10. Depression symptom severity correlated with lower fluid cognition composite scores [r = -.22, p = .05] and contributed to the prediction of fluid cognition performance in a model that controlled for time since injury and crystallized cognitive abilities [F(3, 72) = 7.49, p R-2 = 20.6%]. Examining specific NIHTB-CB fluid subtests, the largest group differences were seen on processing speed (d = .40-.49), cognitive flexibility (d = .32-.36), and episodic memory (d = .20-.34). Depression severity was strongly associated with overall post-concussion symptom burden (r = .77, p < .001). Conclusion: Depression is a common comorbidity and an important factor to consider when interpreting neurocognitive test performance in adults with concussion in a clinical setting.	[Terry, Douglas P.; Brassil, Michelle; Iverson, Grant L.; Silverberg, Noah D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Terry, Douglas P.; Brassil, Michelle; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] Home Base, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] MassGen Hosp, Children Sport Concuss Program, Boston, MA USA; [Panenka, William J.] Univ British Columbia, British Columbia Neuropsychiat Program, Vancouver, BC, Canada; [Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Rehabil Res Program, Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada		Silverberg, ND (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Silverberg, ND (corresponding author), Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada.; Silverberg, ND (corresponding author), GF Strong Rehab Ctr, Rehabil Res Program, Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada.	noah.silverberg@vch.ca		Iverson, Grant/0000-0001-7348-9570	Specific Priorities Research Grant from WorkSafeBC [RS2014-SP03]; Vancouver Coastal Health Research Institute; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research	This study was funded by a Specific Priorities Research Grant from WorkSafeBC [grant number #RS2014-SP03]. Noah Silverberg receives salary support from a Clinician-Scientist Career Development Award from the Vancouver Coastal Health Research Institute and a Health Professional Investigator Award from the Michael Smith Foundation for Health Research. Grant Iverson acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, ImPACT Applications, Inc., and the Heinz Family Foundation.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Casaletto KB, 2016, J INT NEUROPSYCH SOC, V22, P364, DOI 10.1017/S135561771500137X; Cohen J., 2013, STAT POWER ANAL BEHA; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gale CR, 2009, INTELLIGENCE, V37, P592, DOI 10.1016/j.intell.2008.09.002; Gale CR, 2008, ARCH GEN PSYCHIAT, V65, P1410, DOI 10.1001/archpsyc.65.12.1410; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Green P, 2004, GREENS MED SYMPTOM V; Hammar A, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.026.2009; Henry JD, 2005, J CLIN EXP NEUROPSYC, V27, P78, DOI 10.1080/138033990513654; Holdnack JA, 2017, REHABIL PSYCHOL, V62, P474, DOI 10.1037/rep0000145; Holdnack JA, 2017, ARCH CLIN NEUROPSYCH, V32, P574, DOI 10.1093/arclin/acx032; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LandrO N. I., NEUROPSYCHIATRY NEUR, V14, P233; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Manea L, 2015, GEN HOSP PSYCHIAT, V37, P67, DOI 10.1016/j.genhosppsych.2014.09.009; McClintock SA, 2010, NEUROPSYCHOLOGY, V24, P9, DOI 10.1037/a0017336; Mitchell AJ, 2016, BJPSYCH OPEN, V2, P127, DOI 10.1192/bjpo.bp.115.001685; Panczykowski DM, 2014, PROG NEUROL SURG, V28, P195, DOI 10.1159/000358780; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Veiel HOF, 1997, J CLIN EXP NEUROPSYC, V19, P587, DOI 10.1080/01688639708403745; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE	48	16	16	1	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2019	33	1					124	136		10.1080/13854046.2018.1459853			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	HK9OC	WOS:000458320100008	29726314				2022-02-06	
J	Chrisman, SPD; Ebel, BE; Stein, E; Lowry, SJ; Rivara, FP				Chrisman, Sara P. D.; Ebel, Beth E.; Stein, Elizabeth; Lowry, Sarah J.; Rivara, Frederick P.			Head Impact Exposure in Youth Soccer and Variation by Age and Sex	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						head impact exposure; soccer; child; adolescent; concussion; heading; brain injury; football	QUALITY-OF-LIFE; SPORTS-RELATED CONCUSSION; VISUAL SCREENING TOOL; KING-DEVICK; RELIABILITY; VALIDITY; PEDSQL(TM)-4.0; EPIDEMIOLOGY; SCALES	Objective: To examine variation in head impact exposure (HIE) by age and sex in youth soccer. Design: Prospective cohort study. Setting and Participants: Youth soccer athletes (11-14 years old) in local clubs. Exposures: Age and sex. Outcome Measures: Head impact exposure measured using adhesive-mounted accelerometers during 1 month of soccer. Results: Forty-six youth athletes (54% female) participated. No athlete reported a concussion during the study. More males than females had at least 1 head impact >= 15 g (P = 0.02). Of those who sustained a head impact above the 15-g threshold (57%), females sustained HIE of greater magnitude than males (median 47.4 g vs 33.3 g, P = 0.04). Eighty-five percent of athletes on U14 teams had at least 1 head impact >= 15 g compared with 15% of athletes on U12 teams (P < 0.001). Poisson regression stratified by sex and controlling for team-suggested age effects were significant only for females (P = 0.02). There was significant variation in HIE by team. There were no decrements in concussion symptoms, health-related quality of life, or neuropsychological testing after 1 month of soccer play. Conclusions: There is significant variation in HIE in youth soccer, which seems to be influenced by age and sex. Further studies are needed to better understand potential significance for injury prevention.	[Chrisman, Sara P. D.; Stein, Elizabeth; Lowry, Sarah J.; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Chrisman, Sara P. D.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Chrisman, Sara P. D.; Ebel, Beth E.; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA		Chrisman, SPD (corresponding author), CW8-6,POB 5371, Seattle, WA 98145 USA.	sara.chrisman@seattlechildrens.org		Chrisman, Sara/0000-0001-5373-7223; Lowry, Sarah/0000-0002-0865-635X; Stein, Elizabeth/0000-0002-1820-3821			Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cobb Bryan R, 2014, Biomed Sci Instrum, V50, P285; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; FIFA Communications Division, FIFA DAT BIG COUNT 2; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Langhorst P., ENGAGE SPORTS; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; National Institutes of Health, NINDS COMM DAT EL TR; O'Kane JW, 2016, PHYSICIAN SPORTSMED, V44, P190, DOI 10.1080/00913847.2016.1149423; Oja P, 2015, BRIT J SPORT MED, V49, P434, DOI 10.1136/bjsports-2014-093885; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Putukian Margot, 2004, Curr Sports Med Rep, V3, P9; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; U. S. Soccer, IMPL GUID US SOCC PL; Varni James W, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P705, DOI 10.1586/14737167.5.6.705; Varni JW, 2009, CLIN TRIALS, V6, P185, DOI 10.1177/1740774509102309; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006	39	16	16	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2019	29	1					3	10		10.1097/JSM.0000000000000497			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	IQ4PZ	WOS:000480734000004	29064865				2022-02-06	
J	Li, XG; Sandler, H; Kleiven, S				Li, Xiaogai; Sandler, Hakan; Kleiven, Svein			Infant skull fractures: Accident or abuse? Evidences from biomechanical analysis using finite element head models	FORENSIC SCIENCE INTERNATIONAL			English	Article						Abusive Head Trauma; Multiple skull fractures; Finite element head model; Ossification centers; Impact location	TRAUMATIC BRAIN-INJURIES; IMPACT; CHILDREN; TISSUE; FALL; PREDICTION; SUTURE	Abusive Head Trauma (AHT) is considered by some authors to be a leading cause of traumatic death in children less than two years of age and skull fractures are commonly seen in cases of suspected AHT. Today, diagnosing whether the observed fractures are caused by abuse or accidental fall is still a challenge within both the medical and the legal communities and the central question is a biomechanical question: can the described history explain the observed fractures? Finite element (FE) analysis has been shown a valuable tool for biomechanical analysis accounting for detailed head geometry, advanced material modelling, and case-specific factors (e.g. head impact location, impact surface properties). Here, we reconstructed two well-documented suspected abuse cases (a 3- and a 4-month-old) using subject-specific FE head models. The models incorporate the anatomical details and age-dependent anisotropic material properties of infant cranial bones that reflect the grainy fibres radiating from ossification centres. The impact locations are determined by combining multimodality images. The results show that the skull fracture patterns in both cases of suspected abuse could be explained by the described accidental fall history, demonstrating the inherent potential of FE analysis for providing biomechanical evidence to aid forensic investigations. Increased knowledge of injury mechanisms in children may have enormous medico-legal implications world-wide. (C) 2018 Published by Elsevier B.V.	[Li, Xiaogai; Kleiven, Svein] Royal Inst Technol KTH, Sch Technol & Hlth, Div Neuron Engn, S-14152 Huddinge, Sweden; [Sandler, Hakan] Uppsala Univ, Dept Surg Sci Forens Med, Uppsala, Sweden; [Sandler, Hakan] Natl Board Forens Med, Uppsala, Sweden		Li, XG (corresponding author), Royal Inst Technol KTH, Sch Technol & Hlth, Div Neuron Engn, S-14152 Huddinge, Sweden.	xiaogai@kth.se		Li, Xiaogai/0000-0001-8522-4705	Swedish Research CouncilSwedish Research CouncilEuropean Commission [2016-04203]; Swedish National Board of Forensic Medicine [RMV 4155451]	This work was supported by the Swedish Research Council [grant number 2016-04203]; the Swedish National Board of Forensic Medicine [grant number RMV 4155451]. The funders had no role in study design, data collection, analysis and interpretation, decision to publish, or preparation of the manuscript.	American Academy of Pediatrics, 2017, STAT AB HEAD TRAUM S; Arnholz D, 1998, J TRAUMA, V45, P172, DOI 10.1097/00005373-199807000-00039; Baumer TG, 2010, J FORENSIC SCI, V55, P993, DOI 10.1111/j.1556-4029.2010.01391.x; Beillas P., 2016, 14 INT C PROT CHILDR, P19; Bilo RAC, 2010, FORENSIC ASPECTS OF PAEDIATRIC FRACTURES: DIFFERENTIATING ACCIDENTAL TRAUMA FROM CHILD ABUSE, P1, DOI 10.1007/978-3-540-78716-7; BYLSKI DI, 1986, J BIOMECH, V19, P19, DOI 10.1016/0021-9290(86)90105-3; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Colbourne M, 2015, B C MED J, V57, P331; Deland T.S., 2016, J FORENSIC SCI, V61; Ehsani JP, 2010, AM J FOREN MED PATH, V31, P287, DOI 10.1097/PAF.0b013e3181db7eb5; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Flaherty EG, 2014, PEDIATRICS, V133, pE477, DOI 10.1542/peds.2013-3793; Giordano C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187916; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Gray H., 1918, ANATOMY HUMAN BODY; Hamel A, 2013, INT J LEGAL MED, V127, P111, DOI 10.1007/s00414-011-0627-9; Haut RC, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4034430; HELFER RE, 1977, PEDIATRICS, V60, P533; Hinds T, 2015, CURR PROB PEDIATR AD, V45, P71, DOI 10.1016/j.cppeds.2015.02.002; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; HOBBS CJ, 1984, ARCH DIS CHILD, V59, P246, DOI 10.1136/adc.59.3.246; HOBBS CJ, 1989, BRIT MED J, V298, P1015, DOI 10.1136/bmj.298.6679.1015; Holck P, 2005, FORENSIC SCI INT, V151, P187, DOI 10.1016/j.forsciint.2004.12.038; Hymel KP, 2013, PEDIATR CRIT CARE ME, V14, P210, DOI 10.1097/PCC.0b013e3182712b09; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C., 2014, FORENSIC PATHOLOGY I, P435; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kleinman PK., 2015, DIAGNOSTIC IMAGING C; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; KRIEWALL TJ, 1982, AM J OBSTET GYNECOL, V143, P707, DOI 10.1016/0002-9378(82)90119-3; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; Li XG, 2016, INT J IMPACT ENG, V91, P56, DOI 10.1016/j.ijimpeng.2015.12.010; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Li XG, 2013, J CLIN NEUROSCI, V20, P509, DOI 10.1016/j.jocn.2012.04.019; Li ZG, 2015, INT J LEGAL MED, V129, P1055, DOI 10.1007/s00414-015-1190-6; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MCPHERSON GK, 1980, J BIOMECH, V13, P9, DOI 10.1016/0021-9290(80)90003-2; MESERVY CJ, 1987, AM J ROENTGENOL, V149, P173, DOI 10.2214/ajr.149.1.173; Parks S.E., 2012, PEDIAT ABUSIVE HEAD, P5; Peterson C, 2014, PEDIATRICS, V134, P91, DOI 10.1542/peds.2014-0117; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Powell B.J., 2012, 2007DNBXK196 NAT I J; Powell BJ, 2013, J FORENSIC SCI, V58, P678, DOI 10.1111/1556-4029.12094; Ross AH, 2009, FORENSIC SCI INT, V188, P99, DOI 10.1016/j.forsciint.2009.03.021; Sullivan S, 2015, ACCIDENT ANAL PREV, V82, P143, DOI 10.1016/j.aap.2015.05.020; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; Vaughan PE, 2016, J FORENSIC SCI, V61, P1190, DOI 10.1111/1556-4029.13111; von Holst H, 2013, J NEUROTRAUM, V30, P1192, DOI 10.1089/neu.2012.2730; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; WEBER W, 1985, Z RECHTSMED, V94, P93; WEBER W, 1984, Z RECHTSMED, V92, P87, DOI 10.1007/BF02116216	53	16	16	1	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	JAN	2019	294						173	182		10.1016/j.forsciint.2018.11.008			10	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	HG3GL	WOS:000454861200029	30529991				2022-02-06	
J	Pan, ZY; Zhao, YH; Huang, WH; Xiao, ZZ; Li, ZQ				Pan, Zhi-Yong; Zhao, Yu-Hang; Huang, Wen-Hong; Xiao, Zhi-Ze; Li, Zhi-Qiang			Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials	DRUG DESIGN DEVELOPMENT AND THERAPY			English	Article						progesterone; severe traumatic brain injury; neuroprotection	PREHOSPITAL INTUBATION; INFLAMMATORY RESPONSE; EXPRESSION; APOPTOSIS; RECOVERY; MODERATE; OUTCOMES; PROTECT	Purpose: The aim of this study was to assess the neuroprotective effect of progesterone administration on severe traumatic brain injury (TBI) for different follow-up periods and administration route by completing a meta-analysis of randomized clinical trials (RCTs). Methods: A systematic literature search of PubMed, Embase, and Cochrane databases and the Web of Science (from establishment of each to September 1, 2018) was performed to identify original RCTs that evaluated the associations between progesterone treatment and the prognosis of patients with severe TBI. Results: Eight RCTs enrolling 2,251 patients with severe TBI were included. Within 3 months post-injury, patients with progesterone administration had a lower mortality (risk ratio [RR=0.59; 95% CI [0.42-0.81], P=0.001) and better neurologic outcomes (RR=1.51; 95% CI [1.12-2.02], P=0.007) than those who received placebo. However, these differences did not persist at 6 months post-injury for mortality (RR=0.96; 95% CI [0.65-1.41], P=0.83) or neurologic outcomes (RR=1.09; 95% CI [0.93-1.27], P=0.31). The analysis stratified by administration route showed that beneficial effects were only observed in patients who received progesterone intramuscularly (RR=1.61, 95% CI [1.19-2.18], P=0.002); no benefit was observed with intravenous administration (RR=0.99, 95% CI [0.911.07], P=0.75). Conclusion: Progesterone administration improved the clinical outcomes of severe TBI patients within 3 months but may not have significant long-term benefits 6 months post-injury.	[Pan, Zhi-Yong; Zhao, Yu-Hang; Huang, Wen-Hong; Xiao, Zhi-Ze; Li, Zhi-Qiang] Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Donghu Rd 169, Wuhan 430071, Hubei, Peoples R China		Li, ZQ (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Donghu Rd 169, Wuhan 430071, Hubei, Peoples R China.	lizhiqiang@whu.edu.cn			Hubei Province Health and Family Planning Scientific Research Project [WJ2017H0012]; Wuhan Science and Technology Bureau Research Project [2018060401011312]	The work was supported by grants from Hubei Province Health and Family Planning Scientific Research Project (WJ2017H0012) and Wuhan Science and Technology Bureau Research Project (2018060401011312).	Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Candolfi M, 2005, ENDOCRINOLOGY, V146, P736, DOI 10.1210/en.2004-1276; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Denninghoff KR, 2017, PREHOSP EMERG CARE, V21, P539, DOI 10.1080/10903127.2017.1315201; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Guennoun R, NEUROPHARMACOLOGY; He L, 2014, NEUROCHEM RES, V39, P2251, DOI 10.1007/s11064-014-1427-7; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Lu XY, 2016, WORLD NEUROSURG, V90, P199, DOI 10.1016/j.wneu.2016.02.110; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Sayeed I, 2018, PREHOSP EMERG CARE, V22, P535, DOI 10.1080/10903127.2017.1402111; Schumacher M, 2000, J NEUROCYTOL, V29, P307, DOI 10.1023/A:1007152904926; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Sinha S, 2017, NEUROL INDIA, V65, P1304, DOI 10.4103/0028-3886.217973; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wang XY, 2013, EXP THER MED, V6, P263, DOI 10.3892/etm.2013.1116; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201; Xiao Guo-min, 2007, Zhonghua Wai Ke Za Zhi, V45, P106; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	36	16	19	1	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-8881			DRUG DES DEV THER	Drug Des. Dev. Ther.		2019	13						265	273		10.2147/DDDT.S192633			9	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HH1WQ	WOS:000455511000001	30666088	gold, Green Published			2022-02-06	
J	Liu, Z; Li, R; Jiang, C; Zhao, S; Li, WS; Tang, XB				Liu, Zhen; Li, Rui; Jiang, Cheng; Zhao, Sha; Li, Weishan; Tang, Xiaobo			The neuroprotective effect of lithium chloride on cognitive impairment through glycogen synthase kinase-3 beta inhibition in intracerebral hemorrhage rats	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Intracerebral hemorrhage; Excitotoxicity; Lithium chloride; Glycogen synthase kinase-3 beta; Collapsin response mediator protein-2; N-methyl-D-aspartate receptor 2B	NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; NEURODEGENERATIVE DISEASES; WATER MAZE; ACTIVATION; EXCITOTOXICITY; PERFORMANCE; DISORDERS; TOXICITY; SURVIVAL	To the clinical cognitive impairment following intracerebral hemorrhage, comprehensive neuropsychological assessments and efficacious interventions have rarely been conducted. Lithium chloride, a classical treatment for bipolar disorder, has shown neuroprotective effects through glycogen synthase kinase-3 beta inhibition in a variety of central nervous system diseases, including stroke. Since neurons that contain glutamate play crucial roles in psychological functions, such as learning and memory, the glutamate-mediated excitotoxicity and consequent neuronal death and cognitive impairment in hippocampus may co-determine the clinical course of intracerebral hemorrhage. However, the potential molecular mechanisms have rarely been demonstrated in intracerebral hemorrhage researches. In this study, Male Sprague-Dawley rats, subjected to intrastriatal blood infusion, were treated with lithium chloride and underwent neurobehavioral test for equivalent injury severity and neurological functional deficits, Morris water maze test for cognitive impairment, high performance liquid chromatography analysis for excitotoxic index determination, immunohistochemistry analysis for neuronal apoptosis, and Western blot analysis for glycogen synthase kinase-3 beta activity. Our results showed lithium chloride inhibited glycogen synthase kinase-3 beta activation, which on one hand, suppressed downstream CRMP-2/NR2B, thus diminishing the excitotoxic index level; and on the other, stabilized beta-catenin, thus modulating its downstream apoptosis-related factors such as NF-kappa B, Bcl-2 and Bax. Meanwhile, glycogen synthase kinase-3 beta inactivation was paralleled by decreased neuronal death, improved neurological functional deficits and ameliorated cognitive deficits in intracerebral hemorrhage animals. These findings indicate that lithium chloride improves glutamate-mediated excitotoxicity-induced cognitive deficits after intracerebral hemorrhage and that lithium chloride might be a potential therapeutic agent for brain damages caused by intracerebral hemorrhage.	[Liu, Zhen; Li, Rui; Jiang, Cheng; Zhao, Sha; Li, Weishan; Tang, Xiaobo] Harbin Med Univ, Coll Pharm, Dept Biopharmaceut Sci, State Prov Key Labs Biomed Pharmaceut China, POB 19,157 Baojian Rd, Harbin 150081, Heilongjiang, Peoples R China		Tang, XB (corresponding author), Harbin Med Univ, Coll Pharm, Dept Biopharmaceut Sci, State Prov Key Labs Biomed Pharmaceut China, POB 19,157 Baojian Rd, Harbin 150081, Heilongjiang, Peoples R China.	ty6163@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271287]	This work was supported by funding from the National Natural Science Foundation of China (grant no. 81271287, to Dr. X. Tang).	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Brand C, 2014, BRIT J NEUROSURG, V28, P68, DOI 10.3109/02688697.2013.815314; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brittain JM, 2012, CHANNELS, V6, P52, DOI 10.4161/chan.18919; Carvajal FJ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2701526; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chiu CT, 2010, PHARMACOL THERAPEUT, V128, P281, DOI 10.1016/j.pharmthera.2010.07.006; Chong ZZ, 2007, INT J MOL MED, V19, P263; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Chuang DM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00015; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; GLOBUS MYT, 1991, NEUROSCI LETT, V127, P39, DOI 10.1016/0304-3940(91)90889-2; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Khanna R, 2012, FUTUR NEUROL, V7, P749, DOI 10.2217/FNL.12.68; King MK, 2014, PHARMACOL THERAPEUT, V141, P1, DOI 10.1016/j.pharmthera.2013.07.010; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Liu L, 2015, NEUROL RES, V37, P874, DOI 10.1179/1743132815Y.0000000067; Liu SJ, 2006, J NEUROSCI, V26, P9332, DOI 10.1523/JNEUROSCI.2929-06.2006; Pereira IT, 2015, BEHAV NEUROSCI, V129, P533, DOI 10.1037/bne0000078; Perucho J, 2015, AMINO ACIDS, V47, P963, DOI 10.1007/s00726-015-1925-1; Planton M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178886; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Righy C, 2016, CURR NEUROPHARMACOL, V14, P392, DOI 10.2174/1570159X14666151230110058; Rothstein JD, 1996, NEUROLOGY, V47, pS19, DOI 10.1212/WNL.47.4_Suppl_2.19S; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Xu RB, 2017, J NEUROSURG, V127, P522, DOI 10.3171/2016.7.JNS1668; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang Hongsheng, 2016, NAT COMMUN, V7; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zheng J, 2017, J NEUROSURG, V127, P716, DOI 10.3171/2016.7.JNS152995	36	16	18	2	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	DEC 5	2018	840						50	59		10.1016/j.ejphar.2018.10.019			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GY7QJ	WOS:000448807300007	30336136				2022-02-06	
J	Lee, SA; Kim, MK				Lee, Si A.; Kim, Myoung-Kwon			Effect of Low Frequency Repetitive Transcranial Magnetic Stimulation on Depression and Cognition of Patients with Traumatic Brain Injury: A Randomized Controlled Trial	MEDICAL SCIENCE MONITOR			English	Article						Brain Injuries; Cognition; Depression; Transcranial Magnetic Stimulation	DORSOLATERAL PREFRONTAL CORTEX; PARKINSONS-DISEASE; STROKE; NEGLECT; RELIABILITY; IMPROVEMENT; SYMPTOMS; APHASIA; TRAIL; SCALE	Background: This study was conducted to investigate the effects of low frequency repetitive transcranial magnetic stimulation (rTMS) of the right dorsolateral prefrontal cortex on depression and cognition in patients with traumatic brain injury. Material/Methods: To accomplish this, 13 patients who were diagnosed with traumatic brain injury were divided into an experimental group (n=7) and a control group (n=6). The experimental group received rTMS during a 30-minute session 5 days per week for 2 weeks; the control group received sham rTMS. The patients were then evaluated for depression using the Montgomery-Asberg Depression Rating Scale (MADRS) and for cognitive function using the Trail Making Test (TMT) and the Stroop Color Word Test (SCWT). Results: A significant decrease in MADRS, TMT, and SCWT was observed after the intervention in the experimental group (P<0.01), and there was a significant difference in the change value of MADRS, TMT, and SCWT compared to the control group (P<0.01). Moreover, the effect size for gains in the experimental group and control group was very strong for MADRS, TMT, and SCWT (effect size=1.44, 1.49, and 1.24 respectively). Conclusions: The results of this study suggest that application of low frequency rTMS to the right dorsolateral prefrontal cortex of patients with traumatic brain injury has a positive effect on depression and cognition.	[Lee, Si A.] Daegu Univ, Dept Phys Therapy, Grad Sch, Gyongsan, Gyeongbuk, South Korea; [Kim, Myoung-Kwon] Daegu Univ, Dept Phys Therapy, Coll Rehabil Sci, Gyongsan, Gyeongbuk, South Korea		Kim, MK (corresponding author), Daegu Univ, Dept Phys Therapy, Coll Rehabil Sci, Gyongsan, Gyeongbuk, South Korea.	skybird-98@hanmail.net			National Research Foundation of Korea (NRF) - Korea government (MSIT, Ministry of Science and ICT) [NRF-2017R1C1B5074052]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT, Ministry of Science and ICT) (No. NRF-2017R1C1B5074052)	Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; Barwood CHS, 2011, NEUROREHABILITATION, V28, P113, DOI 10.3233/NRE-2011-0640; Boggio PS, 2005, MOVEMENT DISORD, V20, P1178, DOI 10.1002/mds.20508; Brighina F, 2003, NEUROSCI LETT, V336, P131, DOI 10.1016/S0304-3940(02)01283-1; Carneiro AM, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0235-3; Castel-Lacanal E, 2014, ANN FR ANESTH, V33, P83, DOI 10.1016/j.annfar.2013.11.006; Deblieck C, 2017, BRAIN STIMUL, V10, P428; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; George MS, 1997, AM J PSYCHIAT, V154, P1752, DOI 10.1176/ajp.154.12.1752; Herrmann N, 1998, STROKE, V29, P618, DOI 10.1161/01.STR.29.3.618; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Kizilbash A, 2000, Pediatr Rehabil, V4, P71; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Li Y, 2015, J REHABIL MED, V47, P675, DOI 10.2340/16501977-1988; Lim JY, 2010, J REHABIL MED, V42, P447, DOI 10.2340/16501977-0553; Mak ADP, 2017, BRAIN STIMUL, V10, P378, DOI DOI 10.1016/J.BRS.2017.01.121; Maruo T, 2013, BRAIN STIMUL, V6, P884, DOI 10.1016/j.brs.2013.05.002; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Nielson DM, 2015, ARCH PHYS MED REHAB, V96, pS138, DOI 10.1016/j.apmr.2014.09.010; Oliveira-Maia AJ, 2017, BRAIN STIMUL, V10, P787, DOI 10.1016/j.brs.2017.03.013; Pallanti S, 2012, NEUROPSYCHOBIOLOGY, V65, P227, DOI 10.1159/000336999; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Park IS, 2015, J PHYS THER SCI, V27, P773, DOI 10.1589/jpts.27.773; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Rektorova I, 2005, J NEUROL SCI, V229, P157, DOI 10.1016/j.jns.2004.11.021; Reti IM, 2015, BRAIN INJURY, V29, P789, DOI 10.3109/02699052.2015.1009168; Ridding MC, 2007, NAT REV NEUROSCI, V8, P559, DOI 10.1038/nrn2169; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Spreen O, 2006, COMPENDIUM NEUROPSYC; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tassinari CA, 2003, CLIN NEUROPHYSIOL, V114, P777, DOI 10.1016/S1388-2457(03)00004-X; VonLoh M, 2013, PARKINSONISM RELAT D, V19, P573, DOI 10.1016/j.parkreldis.2013.01.007; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wecker NS, 2000, NEUROPSYCHOLOGY, V14, P409, DOI 10.1037//0894-4105.14.3.409; Wobrock T, 2015, BIOL PSYCHIAT, V77, P979, DOI 10.1016/j.biopsych.2014.10.009; Yang W, 2015, J NEUROL SCI, V359, P219, DOI 10.1016/j.jns.2015.08.1541	47	16	17	0	12	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	DEC 4	2018	24						8789	8794		10.12659/MSM.911385			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	HD1FD	WOS:000452253600004	30513530	Green Published, Green Submitted			2022-02-06	
J	Hsia, RY; Markowitz, AJ; Lin, F; Guo, J; Madhok, DY; Manley, GT				Hsia, Renee Y.; Markowitz, Amy J.; Lin, Feng; Guo, Joanna; Madhok, Debbie Y.; Manley, Geoffrey T.			Ten-year trends in traumatic brain injury: a retrospective cohort study of California emergency department and hospital revisits and readmissions	BMJ OPEN			English	Article							UNITED-STATES; MILD; OUTCOMES; VISITS; CARE; POPULATION; PREDICTORS; RETURN; ASSOCIATION; PREVENTION	Objective To describe visits and visit rates of adults presenting to emergency departments (EDs) with a diagnosis of traumatic brain injury (TBI). TBI is a major cause of death and disability in the USA; yet, current literature is limited because few studies examine longer-term ED revisits and hospital readmission patterns of TBI patients across a broad spectrum of injury severity, which can help inform potential unmet healthcare needs. Design We performed a retrospective cohort study. Setting We analysed non-public patient-level data from California's Office of Statewide Health Planning and Development for years 2005 to 2014. Participants We identified 1.2 million adult patients aged >= 18 years presenting to California EDs and hospitals with an index diagnosis of TBI. Primary and secondary outcome measures Our main outcomes included revisits, readmissions and mortality over time. We also examined demographics, mechanism and severity of injury and disposition at discharge. Results We found a 57.7% increase in the number of TBI ED visits, representing a 40.5% increase in TBI visit rates over the 10-year period (346-487 per 100 000 residents). During this time, there was also a 33.8% decrease in the proportion of patients admitted to the hospital. Older, publicly insured and black populations had the highest visit rates, and falls were the most common mechanism of injury (45.5% of visits). Of all patients with an index TBI visit, 40.5% of them had a revisit during the first year, with 46.7% of them seeking care at a different hospital from their initial hospital or ED visit. Additionally, of revisits within the first year, 13.4% of them resulted in hospital readmission. Conclusions The large proportion of patients with TBI who are discharged directly from the ED, along with the high rates of revisits and readmissions, suggest a role for an established system for follow-up, treatment and care of TBI.	[Hsia, Renee Y.; Guo, Joanna; Madhok, Debbie Y.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Hsia, Renee Y.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Markowitz, Amy J.] Univ Calif San Francisco, Brain & Spinal Injury Ctr BASIC, San Francisco, CA 94143 USA; [Lin, Feng] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA		Hsia, RY (corresponding author), Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA.; Hsia, RY (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	renee.hsia@emergency.ucsf.edu		Markowitz, Amy/0000-0001-9314-2814	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U01 NS086090-01]; One Mind; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090] Funding Source: NIH RePORTER	This study was supported in part by NIH 1U01 NS086090-01 (GTM), One Mind (GTM and AJM) and a gift from the Fisher Family.	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bolorunduro OB, 2011, J SURG RES, V166, P40, DOI 10.1016/j.jss.2010.04.012; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Canner JK, 2016, BRAIN INJURY, V30, P1570, DOI 10.1080/02699052.2016.1199898; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention [CDC], 2014, WISQARS COST INJ REP; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gabayan GZ, 2013, ANN EMERG MED, V62, P136, DOI 10.1016/j.annemergmed.2013.01.017; Ganti L, 2015, WEST J EMERG MED, V16, P481, DOI 10.5811/westjem.2015.2.23546; Geiger AA, 2011, J SURG RES, V170, P133, DOI 10.1016/j.jss.2011.03.026; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hsia RY, 2014, J TRAUMA ACUTE CARE, V76, P1048, DOI 10.1097/TA.0000000000000166; Hsia RY, 2011, ARCH SURG-CHICAGO, V146, P585, DOI 10.1001/archsurg.2010.311; Kania K, 2016, J NEUROSURG-PEDIATR, V18, P224, DOI 10.3171/2016.1.PEDS15511; Karlsson MK, 2013, SCAND J PUBLIC HEALT, V41, P442, DOI 10.1177/1403494813483215; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lagbas C, 2013, BIOMED RES INT, V2013, P1; Linton KF, 2014, BRAIN INJURY, V28, P1076, DOI 10.3109/02699052.2014.901558; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Minen M, 2017, AM J EMERG MED, V35, P365, DOI 10.1016/j.ajem.2016.10.076; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Newgard CD, 2013, HEALTH AFFAIR, V32, P1591, DOI 10.1377/hlthaff.2012.1142; Nikpay S, 2017, ANN EMERG MED, V70, P215, DOI 10.1016/j.annemergmed.2017.03.023; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pfortmueller CA, 2014, MINERVA MED, V105, P275; Rising KL, 2014, ACAD EMERG MED, V21, P864, DOI 10.1111/acem.12442; Sabbatini AK, 2016, JAMA-J AM MED ASSOC, V315, P663, DOI 10.1001/jama.2016.0649; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Southerland LT, 2016, J AM GERIATR SOC, V64, P870, DOI 10.1111/jgs.14041; Staudenmayer K, 2016, J TRAUMA ACUTE CARE, V80, P412, DOI 10.1097/TA.0000000000000956; Staudenmayer KL, 2013, J AM COLL SURGEONS, V217, P569, DOI 10.1016/j.jamcollsurg.2013.06.017; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; The Henry J. Kaiser Family Foundation, 2013, HLTH COV RAC ETHN PO; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vashi AA, 2013, JAMA-J AM MED ASSOC, V309, P364, DOI 10.1001/jama.2012.216219; Wei WH, 2005, ARCH PHYS MED REHAB, V86, P905, DOI 10.1016/j.apmr.2004.09.026; Yue JK, 2017, BRAIN INJURY, V31, P1820, DOI 10.1080/02699052.2017.1351000; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	54	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	DEC	2018	8	12							e022297	10.1136/bmjopen-2018-022297			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HG9EM	WOS:000455309300044	30552250	Green Published, gold			2022-02-06	
J	LoBue, C; Cullum, CM; Didehbani, N; Yeatman, K; Jones, B; Kraut, MA; Hart, J				LoBue, Christian; Cullum, C. Munro; Didehbani, Nyaz; Yeatman, Kylee; Jones, Bruce; Kraut, Michael A.; Hart, John, Jr.			Neurodegenerative Dementias After Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							ENVIRONMENTAL RISK-FACTORS; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; LEWY BODIES; EARLIER AGE; HEAD-INJURY; ENCEPHALOPATHY; DIAGNOSIS; PROGRESSION	Traumatic brain injury (TBI) is often considered to be a risk factor for the later development of neurodegenerative conditions, but some findings do not support a link. Differences in research methods, clinical samples, and limitations encountered when assessing and documenting TBI details likely contribute to the mixed reports in the literature. Despite some variability in findings, a review of the literature does provide support for the notion that TBI appears to be associated with earlier onset of some neurodegenerative disorders, although clearly not everyone with a TBI appears to be at an increased risk. Whereas a mechanistic link remains unknown, TBI has been found to initiate an accumulation of pathological processes related to several neurodegenerative disorders. The authors propose a hypothetical model that relates TBI to the development of pathological burden overlapping with some neurodegenerative conditions, in which onset of cognitive/behavioral impairments is hastened in some individuals, but pathological processes stabilize afterward, resulting in a similar course of decline to individuals with dementia who do not have a history of TBI.	[LoBue, Christian; Cullum, C. Munro; Didehbani, Nyaz; Jones, Bruce] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Kraut, Michael A.] Johns Hopkins Univ Hosp, Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA; [Yeatman, Kylee; Hart, John, Jr.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA		LoBue, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	Christian.LoBue@utsw.edu	Cullum, C. Munro/AAC-2496-2019	Cullum, C. Munro/0000-0001-9706-5465; Didehbani, Nyaz/0000-0001-6121-5759	NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P3012300-19]; Alzheimer's Disease Center Grant at the University of Texas Southwestern Medical Center; Texas Alzheimer's Research and Care Consortium; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG012300] Funding Source: NIH RePORTER	Supported by the NIH/NIA (P3012300-19) Alzheimer's Disease Center Grant at the University of Texas Southwestern Medical Center and the Texas Alzheimer's Research and Care Consortium.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Boot BP, 2013, NEUROLOGY, V81, P833, DOI 10.1212/WNL.0b013e3182a2cbd1; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gardner RC, 2014, BEHAV NEUROLOGY DEME; Gilbert M, 2014, INT PSYCHOGERIATR, V26, P1593, DOI 10.1017/S1041610214000842; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Hutchinson AD, 2007, J NEUROL NEUROSUR PS, V78, P917, DOI 10.1136/jnnp.2006.100669; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Ng ASL, 2015, ANN NY ACAD SCI, V1338, P71, DOI 10.1111/nyas.12638; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Petersen RC, 2002, ALZHEIMERS DIS ADV E; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548	43	16	16	1	79	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	2018	30	1					7	13		10.1176/appi.neuropsych.17070145			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	GM3DP	WOS:000437978600003	29061090	Green Accepted, Bronze			2022-02-06	
J	Chi, NF; Hu, HH; Wang, CY; Chan, L; Peng, CK; Novak, V; Hu, CJ				Chi, Nai-Fang; Hu, Han-Hwa; Wang, Cheng-Yen; Chan, Lung; Peng, Chung-Kang; Novak, Vera; Hu, Chaur-Jong			Dynamic Cerebral Autoregulation Is an Independent Functional Outcome Predictor of Mild Acute Ischemic Stroke	STROKE			English	Article						arterial pressure; autoregulation; blood pressure; infarction; odds ratio; stroke	SPONTANEOUS BLOOD-PRESSURE; TRAUMATIC BRAIN-INJURY; SPONTANEOUS FLUCTUATIONS; HYPERTENSIVE PATIENTS; TRANSCRANIAL DOPPLER; NONLINEAR ASSESSMENT; OCCLUSIVE DISEASE; FLOW FLUCTUATIONS; CAROTID STENOSIS; THROMBOLYSIS	Background and Purpose Cerebral autoregulation is impaired in patients with acute ischemic stroke. The purpose of this study was to investigate whether dynamic cerebral autoregulation (dCA) indices constitute an independent functional outcome predictor of acute ischemic stroke. Methods In this study, 86 patients at days 3 to 7 after acute ischemic stroke and 40 age- and sex-matched controls were enrolled for assessing their dCA indices under spontaneous hemodynamic fluctuations. The dCA indices of patients with favorable outcomes (modified Rankin Scale score 1 at 3 months, n=65), patients with unfavorable outcomes (modified Rankin Scale score 2 at 3 months, n=21), and controls were compared. Results The dCA indices, namely the phase shift at very low frequency band (phase_VLF), in the patients with unfavorable outcomes were significantly worse than those in the patients with favorable outcomes. However, the phase_VLF in the patients with favorable outcomes did not differ from those in the controls. Impaired dCA was associated with elevated mean arterial pressure and large infarction volume but was also present in patients with normal mean arterial pressure or small infarction volume. Phase_VLF was a predictor of outcomes in the receiver operating characteristic analysis (area under the curve: 0.722; P<0.001). Multivariate analysis revealed that a phase_VLF value of <61 degrees was independently associated with unfavorable outcomes (odds ratio=4.90; P=0.024). Conclusions Phase_VLF is an independent functional outcome predictor of acute ischemic stroke.	[Chi, Nai-Fang; Hu, Chaur-Jong] Taipei Med Univ, Grad Inst Clin Med, Coll Med, 250 Wuxing St, Taipei 110, Taiwan; [Chi, Nai-Fang; Chan, Lung; Hu, Chaur-Jong] Taipei Med Univ, Sch Med, Dept Neurol, Coll Med, Taipei, Taiwan; [Chi, Nai-Fang; Hu, Han-Hwa; Chan, Lung; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan; [Chi, Nai-Fang; Hu, Han-Hwa; Wang, Cheng-Yen; Chan, Lung; Hu, Chaur-Jong] Taipei Med Univ, Coll Med, Res Ctr Cerebrovasc Dis Treatment, Taipei, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Grad Inst Neural Regenerat Med, Coll Med Sci & Technol, Taipei, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Taipei Neurosci Inst, Taipei, Taiwan; [Chi, Nai-Fang] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Peng, Chung-Kang] Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Novak, Vera] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA		Hu, CJ (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, 250 Wuxing St, Taipei 110, Taiwan.	chaurjongh@tmu.edu.tw	Chan, Lung/AAM-3231-2021; Peng, Chung-Kang/N-1308-2019; Chi, Nai-Fang/G-3561-2016; Chan, Lung/AAI-6349-2020	Peng, Chung-Kang/0000-0003-3666-9833; Chi, Nai-Fang/0000-0002-2204-4923; Chan, Lung/0000-0001-5795-4460	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 106-2314-B-038-001, MOST 104-2314-B-038-021-MY3]	This study was supported by the Ministry of Science and Technology of Taiwan (MOST 106-2314-B-038-001, MOST 104-2314-B-038-021-MY3).	Ahmed N, 2009, STROKE, V40, P2442, DOI 10.1161/STROKEAHA.109.548602; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Brodie FG, 2009, CLIN SCI, V116, P513, DOI 10.1042/CS20080236; Castillo J, 2004, STROKE, V35, P520, DOI 10.1161/01.STR.0000109769.22917.B0; Castro P, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00113; Chi NF, 2017, ULTRASOUND MED BIOL, V43, P1307, DOI 10.1016/j.ultrasmedbio.2017.02.003; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; Dawson SL, 2000, CEREBROVASC DIS, V10, P126, DOI 10.1159/000016041; de Jong DLK, 2016, ICP 2016, P115; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fu CH, 2005, AM J HYPERTENS, V18, P1621, DOI 10.1016/j.amjhyper.2005.05.015; Guo ZN, 2015, SCI REP-UK, V5, DOI 10.1038/srep15269; Guo ZN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093213; Hu HH, 1999, J CEREBR BLOOD F MET, V19, P460, DOI 10.1097/00004647-199904000-00012; Hu K, 2008, CARDIOVASC ENG, V8, P60, DOI 10.1007/s10558-007-9045-5; Hu K, 2008, PHYSICA A, V387, P2279, DOI 10.1016/j.physa.2007.11.052; Immink RV, 2005, STROKE, V36, P2595, DOI 10.1161/01.STR.0000189624.06836.03; Immink RV, 2004, CIRCULATION, V110, P2241, DOI 10.1161/01.CIR.0000144472.08647.40; Ku HL, 2017, SCHIZOPHR RES, V188, P63, DOI 10.1016/j.schres.2017.01.015; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; Liu XY, 2015, J CEREBR BLOOD F MET, V35, P248, DOI 10.1038/jcbfm.2014.192; Manning LS, 2015, STROKE, V46, P1518, DOI 10.1161/STROKEAHA.115.009078; Moriwaki H, 2004, J HUM HYPERTENS, V18, P693, DOI 10.1038/sj.jhh.1001735; Novak V, 2003, NEUROLOGY, V60, P1657, DOI 10.1212/01.WNL.0000068023.14587.06; Oeinck M, 2013, STROKE, V44, P2722, DOI 10.1161/STROKEAHA.113.001913; Otite F, 2014, STROKE, V45, P677, DOI 10.1161/STROKEAHA.113.002630; Panerai RB, 1998, STROKE, V29, P2341, DOI 10.1161/01.STR.29.11.2341; Panerai RB, 2009, CLIN AUTON RES, V19, P197, DOI 10.1007/s10286-009-0011-8; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; Reinhard M, 2008, CEREBROVASC DIS, V26, P147, DOI 10.1159/000139662; Rivera-Lara L, 2017, CRIT CARE MED, V45, P695, DOI 10.1097/CCM.0000000000002251; Saura H, 2012, CEREBROVASC DIS, V33, P354, DOI 10.1159/000335836; Stead LG, 2005, NEUROLOGY, V65, P1179, DOI 10.1212/01.wnl.0000180939.24845.22; STRANDGAARD S, 1976, CIRCULATION, V53, P720, DOI 10.1161/01.CIR.53.4.720; Tang SC, 2008, J VASC SURG, V48, P88, DOI 10.1016/j.jvs.2008.02.025; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; Vemmos KN, 2004, J INTERN MED, V255, P257, DOI 10.1046/j.1365-2796.2003.01291.x; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Xiong L, 2017, J NEUROL NEUROSUR PS, V88, P520, DOI 10.1136/jnnp-2016-314385	44	16	17	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	NOV	2018	49	11					2605	2611		10.1161/STROKEAHA.118.022481			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	GX7RY	WOS:000447974800019	30355198	Bronze			2022-02-06	
J	Chou, W; Liu, YF; Lin, CH; Lin, MT; Chen, CC; Liu, WP; Chang, CP; Chio, CC				Chou, Willy; Liu, Yu-Fan; Lin, Cheng-Hsien; Lin, Mao-Tsun; Chen, Chi-Chun; Liu, Wen-Pin; Chang, Ching-Ping; Chio, Chung-Ching			Exercise Rehabilitation Attenuates Cognitive Deficits in Rats with Traumatic Brain Injury by Stimulating the Cerebral HSP20/BDNF/TrkB Signalling Axis	MOLECULAR NEUROBIOLOGY			English	Article						Physical exercise; Traumatic brain injury; Heat shock protein 20; Brain-derived neurotrophic factor	BETA-PROTEIN AGGREGATION; REDUCES INFARCT SIZE; NEUROTROPHIC FACTOR; AMYLOID-BETA; ALZHEIMERS-DISEASE; MODEL; CONCUSSION; ASSOCIATION; SEVERITY; TOXICITY	Physical exercise (PE) is an effective method for improving cognitive function among patients with traumatic brain injury (TBI). We previously demonstrated that PE with an infrared-sensing running wheel (ISRW) system provides strong neuroprotection in an experimental animal model of stroke. In this study, we used fluid percussion injury in rats to simulate mild TBI. For rats, we used both passive avoidance learning and the Y-maze tests to evaluate cognitive function. We investigated whether PE rehabilitation attenuated cognitive deficits in rats with TBI and determined the contribution of hippocampal and cortical expression of heat shock protein 20 (HSP20) to PE-mediated cognitive recovery. In addition to increasing hippocampal and cortical expression of HSP20, brain-derived neurotrophic factor (BDNF), and the tropomyosin receptor kinase B (TrkB) ratio, PE rehabilitation significantly attenuated brain contusion and improved cognitive deficits in the rat model. Furthermore, reducing hippocampal and cortical expression of HSP20 with an intracerebral injection of pSUPER hsp20 small interfering RNA significantly diminished the PE-induced overexpression of hippocampal and cortical BDNF and the TrkB ratio and also reversed the beneficial effect of PE in reducing neurotrauma and the cognitive deficits. A positive Pearson correlation was found between HSP20 and BDNF, as well as between HSP20 and TrkB, in the hippocampal and cortical tissues. We thus conclude that post-ischaemic ISRW exercise rehabilitation attenuates cognitive deficits, as well as brain contusions, in TBI rats by stimulating the cerebral HSP20/BDNF/TrkB signalling axis.	[Chou, Willy] Chi Mei Med Ctr, Dept Phys Med & Rehabil, Tainan 710, Taiwan; [Chou, Willy] Chia Nan Univ Pharm & Sci, Dept Recreat & Healthcare Management, Tainan 71710, Taiwan; [Liu, Yu-Fan; Lin, Cheng-Hsien; Lin, Mao-Tsun; Liu, Wen-Pin; Chang, Ching-Ping] Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan; [Liu, Yu-Fan] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki 3058574, Japan; [Lin, Cheng-Hsien] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan 710, Taiwan; [Chen, Chi-Chun] Natl Chin Yi Univ Technol, Dept Elect Engn, Taichung 41170, Taiwan; [Chio, Chung-Ching] Chi Mei Med Ctr, Dept Surg, Div Neurosurg, Tainan 710, Taiwan		Chang, CP (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan.; Chio, CC (corresponding author), Chi Mei Med Ctr, Dept Surg, Div Neurosurg, Tainan 710, Taiwan.	jessica.cpchang@gmail.com; chiocc@ms28.hinet.net	Liu, Yu-Fan/AAE-9949-2020	Chang, Ching-Ping/0000-0003-0890-9414	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 104-2314-B-384 -003 -MY3, MOST 106-2314-B-384-001-MY3] Funding Source: Medline; Chi Mei Medical Center [CMFHT 10504] Funding Source: Medline		Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Cameron RT, 2014, MOL CELL NEUROSCI, V61, P46, DOI 10.1016/j.mcn.2014.05.002; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Chen CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122394; d'Hemecourt P, 2011, CLIN SPORT MED, V30, P63, DOI 10.1016/j.csm.2010.08.008; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Eakin K, 2015, BRAIN NEUROTRAUMA MO; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Edwards HV, 2011, CELL SIGNAL, V23, P1447, DOI 10.1016/j.cellsig.2011.05.009; Franckeviciute Egle, 2006, Medicina (Kaunas), V42, P732; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hosseini N, 2013, INT J PREVENTIVE MED, V4, P187; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Jeronimo-Santos A, 2015, CEREB CORTEX, V25, P3107, DOI 10.1093/cercor/bhu105; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lin CM, 2015, EUR J CLIN INVEST, V45, P1297, DOI 10.1111/eci.12551; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wilhelmus MMM, 2009, NEUROBIOL AGING, V30, P229, DOI 10.1016/j.neurobiolaging.2007.06.001; Wilhelmus MMM, 2006, ACTA NEUROPATHOL, V111, P139, DOI 10.1007/s00401-005-0030-z; Yamashita K, 1997, METAB BRAIN DIS, V12, P271, DOI 10.1007/BF02674671; Zhong BW, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/606934	37	16	16	0	29	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	NOV	2018	55	11					8602	8611		10.1007/s12035-018-1011-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU7ID	WOS:000445493600029	29574629				2022-02-06	
J	Chung, DY; Sugimoto, K; Fischer, P; Bohm, M; Takizawa, T; Sadeghian, H; Morais, A; Harriott, A; Oka, F; Qin, T; Henninger, N; Yaseen, MA; Sakadzic, S; Ayata, C				Chung, David Y.; Sugimoto, Kazutaka; Fischer, Paul; Boehm, Maximilian; Takizawa, Tsubasa; Sadeghian, Homa; Morais, Andreia; Harriott, Andrea; Oka, Fumiaki; Qin, Tao; Henninger, Nils; Yaseen, Mohammad A.; Sakadzic, Sava; Ayata, Cenk			Real-time non-invasive in vivo visible light detection of cortical spreading depolarizations in mice	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Cortical spreading depression; Optical intrinsic signal imaging; Migraine; Stroke; Non-invasive	DEPRESSION	Background: Cortical spreading depolarization (CSD) is a phenomenon classically associated with migraine aura. CSDs have also been implicated in secondary injury following ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, and traumatic brain injury; however, most investigations involving these disease processes do not account for the occurrence of CSDs. A major barrier to detection of CSDs in experimental models is that currently validated methods are invasive and require specialized equipment and a high level of expertise to implement. New method: We present a low-cost, easy-to-implement approach to the detection of CSDs in the mouse through full-thickness intact skull. Our method uses the optical intrinsic signal from white light illumination (OIS-WL) and allows for real-time in vivo detection of CSDs using readily available USB cameras. Results: OIS-WL detected 100% of CSDs that were seen with simultaneous electrode recording (69 CSDs in 28 mice), laser Doppler flowmetry (82 CSDs in 10 mice), laser speckle flowmetry (68 CSDs in 25 mice), or combined electrode recording plus laser speckle flowmetry (29 CSDs in 20 mice). OIS-WL detected 1 additional CSD that was missed by laser Doppler flowmetry. Comparison with existing methods: : OIS-WL is less invasive than electrophysiological recordings and easier to implement than laser speckle flowmetry. Moreover, it provides excellent spatial and temporal resolution for dynamic imaging of CSDs in the setting of brain injury. Conclusions: Detection of CSDs with an inexpensive USB camera and white light source provides a reliable method for the in vivo and non-invasive detection of CSDs through unaltered mouse skull.	[Chung, David Y.; Sugimoto, Kazutaka; Fischer, Paul; Boehm, Maximilian; Takizawa, Tsubasa; Sadeghian, Homa; Morais, Andreia; Harriott, Andrea; Oka, Fumiaki; Qin, Tao; Ayata, Cenk] Massachusetts Gen Hosp, Dept Radiol, Neurovasc Res Lab, Charlestown, MA 02129 USA; [Chung, David Y.] Massachusetts Gen Hosp, Dept Neurol, Neurocrit Care & Emergency Neurol, Boston, MA 02114 USA; [Sugimoto, Kazutaka; Oka, Fumiaki] Yamaguchi Univ, Dept Neurosurg, Sch Med, Ube, Yamaguchi, Japan; [Fischer, Paul; Boehm, Maximilian] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Takizawa, Tsubasa] Keio Univ, Dept Neurol, Sch Med, Tokyo, Japan; [Harriott, Andrea; Ayata, Cenk] Massachusetts Gen Hosp, Dept Neurol, Stroke Serv, Boston, MA 02114 USA; [Henninger, Nils] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Henninger, Nils] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Yaseen, Mohammad A.; Sakadzic, Sava] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martins Ctr Biomed Imaging, Charlestown, MA 02129 USA		Chung, DY; Ayata, C (corresponding author), Massachusetts Gen Hosp, 149 13th St,6403, Charlestown, MA 02129 USA.	dychung@mgh.harvard.edu; cayata@mgh.harvard.edu	Chung, David/AAG-1359-2019	Chung, David/0000-0002-7149-5851; Harriott, Andrea/0000-0003-0417-7586; Sugimoto, Kazutaka/0000-0002-7666-2620; Fischer, Paul/0000-0001-7673-8552; Morais, Andreia/0000-0002-9351-2552	National Institute of Neurological Disorders and Stroke at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS065743, R00AG042026, NS091499, R01NS091230, R01MH111359, P01NS055104, R01NS102969]; American Heart AssociationAmerican Heart Association [18POST34030369]; Brain Aneurysm Foundation's Timothy P. Susco and Andrew David Heitman Foundation Chairs of Research; Aneurysm and AVM Foundation; Japanese Heart Foundation; Bayer Yakuhin Research Grant Abroad; Fondation LeducqLeducq Foundation; Heitman Foundation; Ellison FoundationLawrence Ellison Foundation; International Headache Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD051959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH111359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS091499, P01NS055104, R25NS065743, R01NS091230, R01NS102969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R00AG042026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA027097] Funding Source: NIH RePORTER	Funding was provided by the National Institute of Neurological Disorders and Stroke at the National Institutes of Health (R25NS065743 to D.Y.C., R00AG042026 to M.A.Y., NS091499 to N.H., R01NS091230 and R01MH111359 to S.S., and P01NS055104 and R01NS102969 to C.A.); the American Heart Association (18POST34030369 to D.Y.C); the Brain Aneurysm Foundation's Timothy P. Susco and Andrew David Heitman Foundation Chairs of Research to D.Y.C.; the Aneurysm and AVM Foundation to D.Y.C.; the International Headache Society to H.S.; the Japanese Heart Foundation and the Bayer Yakuhin Research Grant Abroad to F.O.; and Fondation Leducq, the Heitman Foundation, and the Ellison Foundation to C.A. We thank Saef Izzy for comments on the manuscript.	Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Ayata C, 2013, CEPHALALGIA, V33, P604, DOI 10.1177/0333102412470216; Chung D.Y., 2018, CEREB CORTEX; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Eikermann-Haerter K, 2012, CIRCULATION, V125, P335, DOI 10.1161/CIRCULATIONAHA.111.045096; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hartings JA, 2016, J CEREB BLOOD FLOW M; Houben T, 2016, J CEREB BLOOD FLOW M; Kaufmann D, 2017, J CEREBR BLOOD F MET, V37, P1748, DOI 10.1177/0271678X16659496; Ma Y, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0360; Oka F, 2016, J CEREB BLOOD FLOW M; Santos E, 2014, NEUROIMAGE, V99, P244, DOI 10.1016/j.neuroimage.2014.05.021; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Silasi G, 2016, J NEUROSCI METH, V267, P141, DOI 10.1016/j.jneumeth.2016.04.012; Yuzawa I, 2012, J CEREBR BLOOD F MET, V32, P376, DOI 10.1038/jcbfm.2011.148	15	16	16	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	NOV 1	2018	309						143	146		10.1016/j.jneumeth.2018.09.001			4	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GZ1KZ	WOS:000449128300015	30194041	Green Accepted, Bronze			2022-02-06	
J	Clifton, DR; Hertel, J; Onate, JA; Currie, DW; Pierpoint, LA; Wasserman, EB; Knowles, SB; Dompier, TP; Comstock, RD; Marshall, SW; Kerr, ZY				Clifton, Daniel R.; Hertel, Jay; Onate, James A.; Currie, Dustin W.; Pierpoint, Lauren A.; Wasserman, Erin B.; Knowles, Sarah B.; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.; Kerr, Zachary Y.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Girls' Basketball (2005-2006 Through 2013-2014) and National Collegiate Athletic Association Women's Basketball (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						injury rates; females; student-athletes	ANTERIOR CRUCIATE LIGAMENT; TRAINING-PROGRAM; FOOTBALL; SYSTEM; RISK; PREVENTION; PLAYERS; LEVEL; RATES	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided the acquisition of girls' and women's basketball injury data. Objective: To describe the epidemiology of injuries sustained in high school girls' basketball in the 2005-2006 through 2013-2014 academic years and collegiate women's basketball in the 2004-2005 through 2013-2014 academic years using Web-based sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from basketball teams in high school girls (annual average = 100) and collegiate women (annual average = 57). Patients or Other Participants: Girls' and women's basketball players who participated in practices and competitions during the 2005-2006 through 2013-2014 academic years in high school or the 2004-2005 through 2013-2014 academic years in college. Main Outcome Measure(s): Certified athletic trainers collected time-loss (>= 24 hours) injury and exposure data. Injury rates per 1000 athlete-exposures (AEs) were calculated. Injury rate ratios (IRRs) with 95% confidence intervals (CIs) were used to compare injury rates by school size or division, time in season, event type, and competition level. Results: The High School Reporting Information Online system documented 2930 time-loss injuries during 1 609 733 AEs; the National Collegiate Athletic Association Injury Surveillance Program documented 3887 time-loss injuries during 783 600 AEs. The injury rate was higher in college than in high school (4.96 versus 1.82/1000 AEs; IRR = 2.73; 95% CI = 2.60, 2.86). The injury rate was higher in competitions than in practices for both high school (IRR = 3.03; 95% CI = 2.82, 3.26) and collegiate (IRR = 1.99; 95% CI = 1.86, 2.12) players. The most common injuries at both levels were ligament sprains, concussions, and muscle/tendon strains; the majority of injuries affected the ankle, knee, and head/face. These injuries were often caused by contact with another player or a noncontact mechanism. Conclusions: Injury rates were higher in collegiate than in high school athletes and in competitions than in practices. Similarities in distributions of injuries by body parts, specific diagnoses, and mechanisms of injury suggest that both levels may benefit from similar injury-prevention strategies.	[Clifton, Daniel R.; Onate, James A.] Ohio State Univ, Wexner Med Ctr, Sch Hlth & Rehabil Sci, Div Athlet Training, Columbus, OH 43210 USA; [Hertel, Jay] Univ Virginia, Dept Kinesiol & Orthopaed Surg, Charlottesville, VA USA; [Onate, James A.] Ohio State Univ, Wexner Med Ctr, Jameson Crane Sports Med Res Inst, Columbus, OH 43210 USA; [Currie, Dustin W.; Pierpoint, Lauren A.; Comstock, R. Dawn] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Knowles, Sarah B.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Dompier, Thomas P.] Lebanon Valley Coll, Annville, PA USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Marshall, Stephen W.; Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27559 USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27559 USA.	zkerr@email.unc.edu		Clifton, Daniel/0000-0003-3857-124X; Wasserman, Erin/0000-0001-5957-5878	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD)	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention. The ISP was funded by the NCAA. Funding for HS RIO was provided in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. The authors also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many athletic trainers who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	Agel J, 2007, J ATHL TRAINING, V42, P202; [Anonymous], 2014 15 NCAA SPORTS; [Anonymous], WOM BASK RUL GAM; Beynnon BD, 2014, AM J SPORT MED, V42, P1806, DOI 10.1177/0363546514540862; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Chomiak J, 2000, AM J SPORT MED, V28, pS58; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P194; Dragoo JL, 2012, AM J SPORT MED, V40, P990, DOI 10.1177/0363546512442336; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; FURBY L, 1992, DEV REV, V12, P1, DOI 10.1016/0273-2297(92)90002-J; Giza E, 2005, BRIT J SPORT MED, V39, P212, DOI 10.1136/bjsm.2004.011973; Harmon KG, 1998, CLIN J SPORT MED, V8, P260, DOI 10.1097/00042752-199810000-00002; Holme E, 1999, SCAND J MED SCI SPOR, V9, P104; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hopper Diana M., 1995, Journal of Sports Sciences, V13, P213, DOI 10.1080/02640419508732230; Hosea TM, 2000, CLIN ORTHOP RELAT R, P45; Joseph AM, 2013, J ATHL TRAINING, V48, P810, DOI 10.4085/1062-6050-48.6.03; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kreck C, 2014, STATES ADDRESS CONCE; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Longo UG, 2012, AM J SPORT MED, V40, P996, DOI 10.1177/0363546512438761; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; McGuine TA, 2006, AM J SPORT MED, V34, P1103, DOI 10.1177/0363546505284191; McGuine TA, 2012, AM J SPORT MED, V40, P49, DOI 10.1177/0363546511422332; National Collegiate Athletic Association, STUD ATHL PART 1981; National Federation of High School Associations, 2014 15 HIGH SCH ATH; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Reeser JC, 2015, SPORTS HEALTH, V7, P504, DOI 10.1177/1941738115600143; Silvers-Granelli H, 2015, AM J SPORT MED, V43, P2628, DOI 10.1177/0363546515602009; Tolbert TA, 2011, STRENGTH COND J, V33, P82, DOI 10.1519/SSC.0b013e31821e2f93; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002	36	16	16	0	5	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2018	53	11					1037	1048		10.4085/1062-6050-150-17			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HH3VE	WOS:000455647200003	30715913	Green Published, gold			2022-02-06	
J	Jacquin, A; Kanakia, S; Oberly, D; Prichep, LS				Jacquin, Arnaud; Kanakia, Saloni; Oberly, Doug; Prichep, Leslie S.			A multimodal biomarker for concussion identification, prognosis and management	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						TBI; Brain function index; Enhanced BFI; Concussion; Sport-related concussion; Classifier algorithms; Quantitative brain activity; Electrophysiology of TBI; Neurocognitive assessments; Return to play	BRAIN ELECTRICAL-ACTIVITY; SPORT-RELATED CONCUSSION; HIGH-SCHOOL; GENETIC ALGORITHMS; MILD TBI; INJURY; CLASSIFICATION; SEVERITY; RECOVERY; PERFORMANCE	Background Prompt, accurate, objective assessment of concussion is crucial, particularly for children/adolescents and young adults. While there is currently no gold standard for the diagnosis of concussion, the importance of multidimensional/multimodal assessments has recently been emphasized. Methods: Concussed subjects (N = 177), matched controls (N = 187) and healthy volunteers (N = 204) represented a convenience sample of male and female subjects between the ages of 13 and 25 years, enrolled at 29 Colleges and 19 High Schools in the US. Subjects were tested at time of injury and at multiple time points during recovery. Assessments included EEG, neurocognitive tests and standard concussion assessment tools. Multimodal classifiers to maximally separate controls from concussed subjects with prolonged recovery (>= 14 days) were derived using quantitative EEG, neurocognitive and vestibular measures, informed feature reduction and a Genetic Algorithm methodology for classifier derivation. The methodology protected against overtraining using an internal cross-validation framework. An enhanced multimodal Brain Function Index (eBFI) was derived from the classifier output and mapped to a percentile scale which expressed the index relative to non-injured controls. Results: At time of injury eBFIs were significantly different between controls and concussed subjects with prolonged recovery, showing return to non-concussed levels at return-to-play plus 45 days. For the combined concussed population, and for the short recovery subjects, a more rapid recovery was seen. Conclusions: This multivariate, multimodal, objective index of brain function impairment can potentially be used, along with other tools, to aid in diagnosis, assessment, and tracking of recovery from concussion.	[Jacquin, Arnaud; Kanakia, Saloni; Prichep, Leslie S.] BrainScope Co Inc, Algorithm Dev, Bethesda, MD USA; [Oberly, Doug] BrainScope Co Inc, Clin Affairs, Bethesda, MD USA; [Prichep, Leslie S.] NYU, Sch Med, Dept Psychiat, New York, NY USA		Jacquin, A (corresponding author), BrainScope Co Inc, 1115 Broadway,Suite 1220, New York, NY 10010 USA.	arnaud.jacquin@brainscope.com			U.S. Navy (Naval Health Research Center) [W911QY-14-C-0098]; BrainScope Company, Inc.	The clinical study was funded in part by a contract to BrainScope Company Inc. from the U.S. Navy (Naval Health Research Center), contract #W911QY-14-C-0098. Disclaimer: The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Navy position, policy or decision unless so designated by other documentation. Also supported in part by BrainScope Company, Inc.	Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Brooks MA, 2018, J HEAD TRAUMA REHAB, V33, P1, DOI 10.1097/HTR.0000000000000328; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Duda R. O., 2004, PATTERN CLASSIFICATI; Elbin R. J., 2016, AM ACAD PED, V138; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Faul M, 2010, TRAUMATIC BRAIN INJU; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; Hanley DF, 2013, J NEUROTRAUM, V30, P2051, DOI 10.1089/neu.2013.3062; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Huff JS, 2017, AM J EMERG MED, V35, P1777, DOI 10.1016/j.ajem.2017.05.027; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; John E.R., 1987, HDB ELECTROENCEPHALO, P449; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Medicine BPGL and BA of S and E, 2013, BRIT J SPORT MED, V47, P259; Mitchell M., 1996, INTRO GENETIC ALGORI; Muth Christopher C, 2018, JAMA, V319, P840, DOI 10.1001/jama.2018.0436; Naunheim R, 2018, AM J EMERG MED, V36, P142, DOI 10.1016/j.ajem.2017.07.007; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Oh IS, 2004, IEEE T PATTERN ANAL, V26, P1424, DOI 10.1109/TPAMI.2004.105; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Prichep LS, 2005, CLIN EEG NEUROSCI, V36, P82, DOI 10.1177/155005940503600207; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Raymer ML, 2000, IEEE T EVOLUT COMPUT, V4, P164, DOI 10.1109/4235.850656; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; SIEDLECKI W, 1989, PATTERN RECOGN LETT, V10, P335, DOI 10.1016/0167-8655(89)90037-8; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Syswerda G, 1991, P 4 INT C GEN ALG, P502; TEASDALE G, 1974, LANCET, V2, P81; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; Thakor NV, 2004, ANNU REV BIOMED ENG, V6, P453, DOI 10.1146/annurev.bioeng.5.040202.121601; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Tomassini Marco, 1999, EVOLUTIONARY ALGORIT; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Wang T, 2015, APPL SPECTROSC, V69, P1257, DOI 10.1366/15-07859; Wilde E. A., J NEUROTRAUMA; Woodhouse J, 2013, CLIN NEUROPSYCHOL, V27, P376, DOI 10.1080/13854046.2012.762427; Yang JH, 1998, IEEE INTELL SYST APP, V13, P44, DOI 10.1109/5254.671091	65	16	16	1	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	NOV 1	2018	102						95	103		10.1016/j.compbiomed.2018.09.011			9	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	HA0IR	WOS:000449892200010	30261405				2022-02-06	
J	Wallace, C; Zetterberg, H; Blennow, K; van Donkelaar, P				Wallace, Colin; Zetterberg, Henrik; Blennow, Kaj; van Donkelaar, Paul			No change in plasma tau and serum neurofilament light concentrations in adolescent athletes following sport-related concussion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; STANDARDIZED ASSESSMENT; EPIDEMIOLOGY; PROTEIN; BIOMARKERS; DISEASE; PLAYERS; CHAIN; RATES	Sport-related concussion (SRC), a mild form of traumatic brain injury (TBI), is a common injury in contact sports. Health care professionals rely on subjective criteria (e.g., symptoms), as there is no objective marker for identification of athletes with SRC. Blood-based biomarkers have shown promise as diagnostic and prognostic tools following TBI and SRC. In the present study, we examined plasma tau and serum NF-L, two biomarkers for neuronal/axonal injury, concentrations at preseason and following SRC in contact sport athletes (n = 11) using ultrasensitive single molecule array (Simoa) assays. Preseason baseline samples were collected, and post-concussion samples were obtained at 6- and 14-days following injury. We found no difference between baseline, 6-day and 14-day post-concussion concentrations of tau (p = 0.14) or NF-L (p = 0.53). Further, no difference was found between preseason baseline and all post-SRC samples for tau (p = 0.22) or NF-L (p = 0.98). The total number of symptoms reported on the Standardized Assessment of Concussion-3(rd) Edition (SCAT3) and associated symptom severity scores increased from preseason to 6-days post-SRC but returned to baseline values at 14-days (p = 0.02 and p = 0.003, respectively). These results suggest that the severity of neuronal injury in this cohort of contact sport athletes with clinical uncomplicated SRC was too low to be detected by tau and NF-L measurements in blood samples obtained at 6- and 14-days post-injury.	[Wallace, Colin; van Donkelaar, Paul] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Wallace, Colin] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Psychiat & Neurochem,Inst Neurosci & Physio, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Zetterberg, Henrik] UK Dementia Res Inst UCL, London, England		Wallace, C (corresponding author), Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada.; Wallace, C (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.	colin.wallace@alumni.ubc.ca		Wallace, Colin/0000-0002-3720-6526	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [183304]; Canada Foundation for Innovation (CFI)Canada Foundation for Innovation; Mitacs Canada [H14-02996]; Mitacs Accelerate Program	The authors would also like to thank the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Torsten Soderberg Foundation, and Swedish State Support for Clinical Research (ALFGBG). This research was funded by grants to PvD from the Canadian Institutes for Health Research (CIHR) (funding number 183304), Canada Foundation for Innovation (CFI), and Mitacs Canada (funding number H14-02996). CW was supported by the Mitacs Accelerate Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Didehbani N., 2017, ANN SPORT MED RES, V4, P1115; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mannix R, 2014, J NEUROTRAUM, V31, P1072, DOI 10.1089/neu.2013.3265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Vila-Ortiz GJ, 2001, CELL MOL NEUROBIOL, V21, P535, DOI 10.1023/A:1013823524302; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	40	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206466	10.1371/journal.pone.0206466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	WOS:000448641200040	30372457	Green Published, gold, Green Submitted			2022-02-06	
J	Bharadwaj, VN; Rowe, RK; Harrison, J; Wu, C; Anderson, TR; Lifshitz, J; Adelson, PD; Kodibagkar, VD; Stabenfeldt, SE				Bharadwaj, Vimala N.; Rowe, Rachel K.; Harrison, Jordan; Wu, Chen; Anderson, Trent R.; Lifshitz, Jonathan; Adelson, P. David; Kodibagkar, Vikram D.; Stabenfeldt, Sarah E.			Blood-brainbarrier disruption dictates nanoparticle accumulation following experimental brain injury	NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE			English	Article						Nanoparticles; Traumatic brain injury; Blood-brain barrier; Mild closed head injury; Fluid percussion injury; Optimal therapeutic window; Drug delivery; Pharmacodynamics	FLUID PERCUSSION INJURY; BARRIER BREAKDOWN; SURFACE-CHARGE; MODEL; EPIDEMIOLOGY; PERMEABILITY; DIAPEDESIS; TRANSPORT; DELIVERY; MODERATE	Clinically, traumatic brain injury (TBI) results in complex heterogeneous pathology that cannot be recapitulated in single pre-clinical animal model. Therefore, we focused on evaluating utility of nanoparticle (NP)-based therapeutics following three diffuse-TBI models: mildclosed-head injury (mCHI), repetitive-mCHI and midline-fluid percussion injury (FPI). We hypothesized that NP accumulation after diffuse TBI correlates directly with blood-brainbarrier permeability. Mice received PEGylated-NP cocktail (20-500 nm) (intravenously) after single-or repetitive-(1 impact/day, 5 consecutive days) CHI (immediately) and midline-FPI (1 h, 3 h and 6 h). NPs circulated for 1 h before perfusion/brain extraction. NP accumulation was analyzed using fluorescent microscopy in brain regions vulnerable to neuropathology. Minimal/no NP accumulation after mCHI/RmCHI was observed. In contrast, midlineFPI resulted in significant peak accumulation of up to 500 nm NP at 3 h post-injury compared to sham, 1 h, and 6 h groups in the cortex. Therefore, our study provides the groundwork for feasibility of NP-delivery based on NPinjection time and NPsize after mCHI/RmCHI and midline-FPI. (c) 2018 Elsevier Inc. All rights reserved.	[Bharadwaj, Vimala N.; Kodibagkar, Vikram D.; Stabenfeldt, Sarah E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Rowe, Rachel K.; Wu, Chen; Lifshitz, Jonathan; Adelson, P. David] Univ Arizona, Dept Child Hlth, Coll Med, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan; Adelson, P. David] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ USA; [Harrison, Jordan; Lifshitz, Jonathan] Arizona State Univ, Interdisciplinary Grad Program Neurosci, Tempe, AZ USA; [Anderson, Trent R.] Univ Arizona, Coll Med, Basic Med Sci, Phoenix, AZ USA		Stabenfeldt, SE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	sarah.stabenfeldt@asu.edu	Adelson, David/W-2083-2019; Bharadwaj, Vimala/AAV-1040-2021	Bharadwaj, Vimala/0000-0002-6243-0861; Rowe, Rachel/0000-0002-9034-3159	NIH NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1DP2HD084067]; Flinn Foundation [1976]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2HD084067] Funding Source: NIH RePORTER	Authors declare no conflict of interest or disclosures. Authors would like to thank funding sources NIH NICHD (1DP2HD084067; SES), and Flinn Foundation (1976; VDK, SES, JL, PDA).	Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Ban Y, 1997, Mol Vis, V3, P18; Bharadwaj VN, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700668; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Bitner BR, 2012, ACS NANO, V6, P8007, DOI 10.1021/nn302615f; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carman CV, 2009, J CELL SCI, V122, P3025, DOI 10.1242/jcs.047522; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Clond MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061819; Cruz LJ, 2016, J CONTROL RELEASE, V223, P31, DOI 10.1016/j.jconrel.2015.12.029; Cruz LJ, 2016, NANO RES, V9, P1276, DOI 10.1007/s12274-016-1023-z; De Bock M, 2016, GLIA, V64, P1097, DOI 10.1002/glia.22960; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Gao X, 2017, NEUROTOXICITY OF NANOMATERIALS AND NANOMEDICINE, P59, DOI 10.1016/B978-0-12-804598-5.00003-9; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Jo DH, 2015, NANOMED-NANOTECHNOL, V11, P1603, DOI 10.1016/j.nano.2015.04.015; Johnson V. E., 2018, ACTA NEUROPATHOL, P1; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Khalin I, 2016, DRUG DELIV, V23, P3520, DOI 10.1080/10717544.2016.1199609; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Kwon EJ, 2016, ACS NANO, V10, P7926, DOI 10.1021/acsnano.6b03858; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levchenko TS, 2002, INT J PHARMACEUT, V240, P95, DOI 10.1016/S0378-5173(02)00129-1; Li SD, 2008, MOL PHARMACEUT, V5, P496, DOI 10.1021/mp800049w; Li XJ, 2013, NEURAL REGEN RES, V8, P338, DOI 10.3969/j.issn.1673-5374.2013.04.006; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martinelli R, 2014, J CELL SCI, V127, P3720, DOI 10.1242/jcs.148619; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Nyul-Toth A, 2016, AM J PHYSIOL-HEART C, V310, pH1702, DOI 10.1152/ajpheart.00774.2015; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Ping XJ, 2014, J NEUROTRAUM, V31, P1172, DOI 10.1089/neu.2013.3147; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Ruozi B, 2015, MOL NEUROBIOL, V52, P899, DOI 10.1007/s12035-015-9235-x; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Villasenor R, 2016, SCI REPORTER, P1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilhelm I, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1143544; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu JL, 2016, ADV FUNCT MATER, V26, P4124, DOI 10.1002/adfm.201504416; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; Yun X, 2013, J CEREBR BLOOD F MET, V33, P583, DOI 10.1038/jcbfm.2012.209; Zhang B, 2016, J NEUROTRAUM, V33, pA14	61	16	17	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1549-9634	1549-9642		NANOMED-NANOTECHNOL	Nanomed.-Nanotechnol. Biol. Med.	OCT	2018	14	7					2155	2166		10.1016/j.nano.2018.06.004			12	Nanoscience & Nanotechnology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Research & Experimental Medicine	GV9RF	WOS:000446496900017	29933022	Green Accepted			2022-02-06	
J	El-Abhar, H; Abd El Fattah, MA; Wadie, W; El-Tanbouly, DM				El-Abhar, Hanan; Abd El Fattah, Mai A.; Wadie, Walaa; El-Tanbouly, Dalia M.			Cilostazol disrupts TLR-4, Akt/GSK-3 beta/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; GLYCOGEN-SYNTHASE KINASE-3; TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; WHITE-MATTER DAMAGE; 3-NITROPROPIONIC ACID; CHROMOSOME-10 PHOSPHORYLATION; NEURODEGENERATIVE DISEASES; PI3K/AKT/GSK3-BETA PATHWAY; CYTOKINE SIGNALING-3	Countless neurodegenerative diseases are associated with perverse multiple targets of cyclic nucleotide signalling, hastening neuronal death. Cilostazol, a phosphodiesterase-III inhibitor, exerts neuroprotective effects against sundry models of neurotoxicity, however, its role against Huntington's disease (HD) has not yet been tackled. Hence, its modulatory effect on several signalling pathways using the 3-nitropropionic acid (3-NP) model was conducted. Animals were injected with 3-NP (10 mg/kg/day, i.p) for two successive weeks with or without the administration of cilostazol (100 mg/kg/day, p.o.). Contrary to the 3-NP effects, cilostazol largely preserved striatal dopaminergic neurons, improved motor coordination, and enhanced the immunohistochemical reaction of tyrosine hydroxylase enzyme. The anti-inflammatory effect of cilostazol was documented by the pronounced reduction of the toll like receptor-4 (TLR-4) protein expression and the inflammatory cytokine IL-6, but with a marked elevation in IL-10 striatal contents. As a consequence, cilostazol reduced IL-6 downstream signal, where it promoted the level of suppressor of cytokine signalling 3 (SOCS3), while abated the phosphorylation of Janus Kinase 2 (JAK-2) and Signal transducers and activators of transcription 3 (STAT-3). Phosphorylation of the protein kinase B/glycogen synthase kinase-3 beta/cAMP response element binding protein (Akt/GSK-3 beta/CREB) cue is another signalling pathway that was modulated by cilostazol to further signify its anti-inflammatory and antiapoptotic capacities. The latter was associated with a reduction in the caspase-3 expression assessed by immunohistochemical assay. In conclusion the present study provided a new insight into the possible mechanisms by which cilostazol possesses neuroprotective properties. These intersecting mechanisms involve the interference between TLR-4, IL-6-IL-10/JAK-2/STAT-3/SOCS-3, and Akt/GSK-3 beta/CREB signalling pathways.	[El-Abhar, Hanan; Abd El Fattah, Mai A.; Wadie, Walaa; El-Tanbouly, Dalia M.] Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt		El-Abhar, H (corresponding author), Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt.	Hanan.elabhar@pharma.cu.edu.eg	El-Abhar, Hanan/L-2289-2019	El-Abhar, Hanan/0000-0001-8819-9891			Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alexi T, 1998, NEUROREPORT, V9, pR57, DOI 10.1097/00001756-199808030-00001; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Antoniv TT, 2011, IMMUNOLOGY, V132, P567, DOI 10.1111/j.1365-2567.2010.03402.x; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Bollen E, 2012, IUBMB LIFE, V64, P965, DOI 10.1002/iub.1104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon JR, 2009, NEUROSCI LETT, V464, P14, DOI 10.1016/j.neulet.2009.08.023; Cha B, 2015, YONSEI MED J, V56, P862, DOI 10.3349/ymj.2015.56.3.862; Choi JM, 2002, J PHARMACOL EXP THER, V300, P787, DOI 10.1124/jpet.300.3.787; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dong Q, 2009, PLACENTA, V30, P11, DOI 10.1016/j.placenta.2008.10.008; Fleming SM, 2004, EXP NEUROL, V187, P418, DOI 10.1016/j.expneurol.2004.01.023; Gaudy AM, 2010, J BIOL CHEM, V285, P41356, DOI 10.1074/jbc.M110.159111; Glajch KE, 2012, BEHAV BRAIN RES, V230, P309, DOI 10.1016/j.bbr.2011.12.007; Gopinath K, 2016, CAN J PHYSIOL PHARM, V94, P65, DOI 10.1139/cjpp-2015-0035; Gotoh F, 2000, J Stroke Cerebrovasc Dis, V9, P147, DOI 10.1053/jscd.2000.7216; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hanna DMF, 2015, PROG NEURO-PSYCHOPH, V60, P36, DOI 10.1016/j.pnpbp.2015.02.005; Honda F, 2006, STROKE, V37, P223, DOI 10.1161/01.STR.0000196977.76702.6d; Hong KW, 2003, J PHARMACOL EXP THER, V306, P1182, DOI 10.1124/jpet.103.052365; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jang M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/237207; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Keller JN, 1998, J NEUROSCI, V18, P4439; KIMURA Y, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1144; Klein A, 2009, BEHAV BRAIN RES, V199, P317, DOI 10.1016/j.bbr.2008.12.007; Knott EP, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040696; Lee JH, 2006, BRAIN RES, V1082, P182, DOI 10.1016/j.brainres.2006.01.088; Lee JH, 2004, J PHARMACOL EXP THER, V308, P896, DOI 10.1124/jpet.103.061853; Lee JH, 2003, BRAIN RES, V994, P91, DOI 10.1016/j.brainres.2003.09.021; Leegwater-Kim Julie, 2004, NeuroRx, V1, P128, DOI 10.1602/neurorx.1.1.128; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Ma JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep23817; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Ozawa Y, 2008, J BIOL CHEM, V283, P24561, DOI 10.1074/jbc.M802238200; Park SY, 2013, BRIT J PHARMACOL, V168, P1401, DOI 10.1111/bph.12021; Park SY, 2006, J PHARMACOL EXP THER, V317, P1238, DOI 10.1124/jpet.105.098509; Park SY, 2016, PLOS ONE, V11, DOI [10.1371/journatpone.0168286, DOI 10.1371/JOURNATPONE.0168286]; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Qin HW, 2016, J NEUROSCI, V36, P5144, DOI 10.1523/JNEUROSCI.4658-15.2016; Ragab D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095313; Rangel-Barajas C, 2015, AGING DIS, V6, P349, DOI 10.14336/AD.2015.0330; Rauch F, 2010, BEHAV BRAIN RES, V210, P46, DOI 10.1016/j.bbr.2010.02.003; Rodriguez AI, 2003, NEUROTOX RES, V5, P443, DOI 10.1007/BF03033174; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Shin S, 2014, MOL METAB, V3, P803, DOI 10.1016/j.molmet.2014.08.001; Shyu KG, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-15; Soliman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015044; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Tamandl D, 2003, SHOCK, V20, P224, DOI 10.1097/00024382-200309000-00005; Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014; Tunez I, 2010, MOLECULES, V15, P878, DOI 10.3390/molecules15020878; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wadie W, 2017, EUR J PHARMACOL, V814, P187, DOI 10.1016/j.ejphar.2017.08.027; Watanabe T, 2006, STROKE, V37, P1539, DOI 10.1161/01.STR.0000221783.08037.a9; Yan ZQ, 2018, CLIN IMMUNOL, V189, P4, DOI 10.1016/j.clim.2016.09.014; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Ye YL, 2007, EUR J PHARMACOL, V557, P23, DOI 10.1016/j.ejphar.2006.11.003; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zhang W, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/9450137; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	72	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203837	10.1371/journal.pone.0203837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	WOS:000445907400017	30260985	Green Submitted, Green Published, gold			2022-02-06	
J	Li, H; Luo, Y; Xu, Y; Yang, L; Hu, CL; Chen, Q; Yang, Y; Ma, J; Zhang, JH; Xia, H; Li, YK; Yang, JQ				Li, Huan; Luo, Ying; Xu, Ying; Yang, Lu; Hu, Congli; Chen, Qi; Yang, Yang; Ma, Jie; Zhang, Jiahua; Xia, Hui; Li, Yuke; Yang, Junqing			Meloxicam Improves Cognitive Impairment of Diabetic Rats through COX2-PGE2-EPs-cAMP/pPKA Pathway	MOLECULAR PHARMACEUTICS			English	Article						diabetes; cognitive impairment; inflammation; cyclooxygenase 2; meloxicam	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; PROSTANOID RECEPTORS; GLUCOSE-METABOLISM; SIGNALING PATHWAY; PROSTAGLANDIN E-2; SPATIAL MEMORY; RISK-FACTOR; INHIBITION; MELLITUS	Diabetics often face greater risk of cognitive impairment than nondiabetics. However, how to prevent this disease is still unconfirmed. In this study, we investigated the potential protection and mechanism of meloxicam on cognitive impairment in diabetic rats. The diabetic rat model was established with a high-fat diet and a small dose of streptozotocin (40 mg/kg). The changes of spatial learning and memory, histopathology, and the protein expressions of amyloid protein precursor (APP) and beta-amyloid (A beta) indicated that diabetic rats had neuronal injury and cognitive impairment. Tumor necrosis factor alpha (TNF alpha), interleukin 6 (IL-6), C reactive protein (CRP) and prostaglandin E2 (PGE2) levels, and microglial cell number were significantly increased in the diabetic rat brain. Meanwhile, the protein expressions of APP, A beta, cyclooxygenases2 (COX2), E-type prostanoid recptors 1 (EP1) and EP2, and the level of cyclic adenosine monophosphate (cAMP) were significantly increased, while the protein expressions of EP3 and phosphorylated protein kinase A (pPKA) were significantly decreased in the diabetic rat hippocampus and cortex. However, the EP4 protein expression had no significant changes. Meloxicam significantly improved neuronal injury and cognitive impairment, and significantly decreased inflammatory cytokines levels. Meloxicam also significantly decreased the protein expressions of APP, A beta, COX2, EP1 and EP2, and the level of cAMP and significantly increased the EP3 and pPKA protein expressions in rat hippocampus and cortex. However, meloxicam did not significantly influence the levels of blood glucose, lipids, and insulin of rats. Our results suggest that meloxicam could significantly protect diabetic rats from cognitive impairment via a mechanism that may be associated with rebalancing the COX2-PGE2-EPs-cAMP/PKA pathway.	[Li, Huan; Luo, Ying; Yang, Lu; Hu, Congli; Chen, Qi; Yang, Yang; Ma, Jie; Zhang, Jiahua; Xia, Hui; Li, Yuke; Yang, Junqing] Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China; [Xu, Ying] SUNY Buffalo, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, Buffalo, NY 14214 USA		Yang, JQ (corresponding author), Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China.	cqyangjq@cqmu.edu.cn			Chongqing Science and Technology Commission Fund [cstc2015zdcy-ztzx120003]	The work was supported by research grants from Chongqing Science and Technology Commission Fund (cstc2015zdcy-ztzx120003).	Abe T, 2009, J CEREBR BLOOD F MET, V29, P66, DOI 10.1038/jcbfm.2008.88; Areosa Sastre A., 2017, COCHRANE DB SYST REV, V15; Benedict C, 2007, NEUROPSYCHOPHARMACOL, V32, P239, DOI 10.1038/sj.npp.1301193; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Brunner YF, 2015, J CLIN ENDOCR METAB, V100, P212, DOI 10.1210/jc.2014-3018; Candelario-Jalil E, 2008, CURR PHARM DESIGN, V14, P1401, DOI 10.2174/138161208784480216; Chen Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00609-7; Desikan RS, 2015, CIRCULATION, V131, P2061, DOI 10.1161/CIRCULATIONAHA.115.015489; Dong HQ, 2014, MOL NEUROBIOL, V49, P1487, DOI 10.1007/s12035-014-8697-6; Ferreira R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-90; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Galimbert D, 2003, ANN NEUROL, V53, P547, DOI 10.1002/ana.10531; Goverdhan P, 2012, INT J ALZHEIMERS DIS, V2012, P1, DOI DOI 10.1155/2012/974013; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Guo YX, 2016, CURR ALZHEIMER RES, V13, P1006, DOI 10.2174/1567205013666160401114601; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Harrison NA, 2014, BIOL PSYCHIAT, V76, P585, DOI 10.1016/j.biopsych.2014.01.005; Hendriksen E, 2017, NEUROSCI BIOBEHAV R, V79, P119, DOI 10.1016/j.neubiorev.2017.05.001; Heyer EJ, 2013, DIABETES CARE, V36, P3283, DOI 10.2337/dc12-2507; Ianiski FR, 2012, BEHAV BRAIN RES, V230, P100, DOI 10.1016/j.bbr.2012.01.055; Jahan H, 2017, CHEM-BIOL INTERACT, V273, P237, DOI 10.1016/j.cbi.2017.06.015; Johansson JU, 2015, J CLIN INVEST, V125, P350, DOI 10.1172/JCI77487; Jolliet P, 1997, PHARMACEUT RES, V14, P650, DOI 10.1023/A:1012165414610; Jun-Qing Y, 2006, EUR J PHARMACOL, V547, P52, DOI 10.1016/j.ejphar.2006.07.031; Kamer AR, 2012, EUR J ANAESTH, V29, P332, DOI 10.1097/EJA.0b013e3283534f56; Kasiewicz LN, 2016, ACTA BIOMATER, V32, P120, DOI 10.1016/j.actbio.2015.12.023; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Legler DF, 2010, INT J BIOCHEM CELL B, V42, P198, DOI 10.1016/j.biocel.2009.09.015; Li W, 2016, NEUROPSYCH DIS TREAT, V12, P2489, DOI 10.2147/NDT.S111298; Liu XJ, 2015, PHARMACOL RES, V93, P43, DOI 10.1016/j.phrs.2015.01.001; Liu YW, 2014, PHARMACOL BIOCHEM BE, V117, P128, DOI 10.1016/j.pbb.2013.11.027; Luo Y, 2017, ONCOTARGET, V8, P35558, DOI 10.18632/oncotarget.16009; Ma J, 2017, SCI REP-UK, V7, DOI 10.1038/srep46628; Matboli M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02320-z; Miller SB, 2006, SEMIN ARTHRITIS RHEU, V36, P37, DOI 10.1016/j.semarthrit.2006.03.005; Muller N, 2006, MOL PSYCHIATR, V11, P680, DOI 10.1038/sj.mp.4001805; Nakayama M, 1998, P NATL ACAD SCI USA, V95, P10954, DOI 10.1073/pnas.95.18.10954; Nemeth CL, 2016, BEHAV BRAIN RES, V303, P160, DOI 10.1016/j.bbr.2016.01.057; Nemeth CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108399; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; Pozzo L, 2016, LIFE SCI, V166, P149, DOI 10.1016/j.lfs.2016.09.022; Rawlings AM, 2017, DIABETES CARE, V40, P879, DOI 10.2337/dc16-2203; Riederer P, 2017, J NEURAL TRANSM, V124, P1431, DOI 10.1007/s00702-017-1763-2; Roberts RO, 2014, ALZHEIMERS DEMENT, V10, P18, DOI 10.1016/j.jalz.2013.01.001; Rojas A, 2016, NEUROPHARMACOLOGY, V110, P419, DOI 10.1016/j.neuropharm.2016.07.028; Roy S, 2015, N AM J MED SCI, V7, P220, DOI 10.4103/1947-2714.157627; Shi J, 2012, ANN NEUROL, V72, P788, DOI 10.1002/ana.23677; Shiow LR, 2017, GLIA, V65, P2024, DOI 10.1002/glia.23212; Soares E, 2013, NEUROSCIENCE, V250, P565, DOI 10.1016/j.neuroscience.2013.07.055; Song LL, 2017, J PROTEOME RES, V16, P3180, DOI 10.1021/acs.jproteome.7b00168; Stolk RP, 1997, DIABETES CARE, V20, P792, DOI 10.2337/diacare.20.5.792; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tian XY, 2016, ONCOTARGET, V7, P25304, DOI 10.18632/oncotarget.8284; Wang DB, 2010, EXP NEUROL, V224, P197, DOI 10.1016/j.expneurol.2010.03.011; Wang DY, 2017, INT J BIOL MACROMOL, V102, P396, DOI 10.1016/j.ijbiomac.2017.04.056; Wang P, 2014, AGING CELL, V13, P605, DOI 10.1111/acel.12209; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Yin F, 2016, FREE RADICAL BIO MED, V100, P108, DOI 10.1016/j.freeradbiomed.2016.04.200; Yu LJ, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-6; Zhang X., 2013, J NANOMATER, V2013, P1, DOI DOI 10.1155/2013/803150; Zhao XC, 2015, BRAIN BEHAV IMMUN, V46, P293, DOI 10.1016/j.bbi.2015.02.011; Zhou JY, 2016, EUR J PHARMACOL, V774, P87, DOI 10.1016/j.ejphar.2016.02.007; Zhou YP, 2013, J ALZHEIMERS DIS, V34, P937, DOI 10.3233/JAD-121762	65	16	18	0	10	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	SEP	2018	15	9					4121	4131		10.1021/acs.molpharmaceut.8b00532			11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GS7ZC	WOS:000443923800051	30109938				2022-02-06	
J	McAdams, RJ; Swidarski, K; Clark, RM; Roberts, KJ; Yang, JZ; Mckenzie, LB				McAdams, Rebecca J.; Swidarski, Katherine; Clark, Roxanne M.; Roberts, Kristin J.; Yang, Jingzhen; Mckenzie, Lara B.			Bicycle-related injuries among children treated in US emergency departments, 2006-2015	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Bicycle; Injury; NEISS; Children/adolescents; Helmet; Motor vehicle	TRAUMATIC BRAIN-INJURY; HELMET USE; HEAD-INJURIES; UNITED-STATES; ATTITUDES; PATTERNS; BARRIERS	Objective: One of the leading causes of non-fatal injury among children is bicycling. Past studies indicate that helmets are protective against bicycle-related injuries and involvement of motor vehicles is associated with severe injuries, but research utilizing a nationally representative data set for this population and focusing on these risk factors does not exist. The objective of this study was to describe the epidemiology of bicycle-related injuries among children treated in hospital emergency departments (EDs) in the United States (US). Methods: A retrospective analysis was conducted with data from the National Electronic Injury Surveillance System for children 5-17 years of age who were treated in US EDs from 2006 through 2015 for a bicycle-related injury. Helmet use and motor vehicle involvement were two variables that were created and coded using keyword searches of the case narratives. Rates of injuries over time were described. Multivariate logistic regression along with 95% confidence intervals (CIs) were used to contrast types of injuries sustained among injured helmet users with non-users. Results: An estimated 2 219 742 (95% CI: 1 871 120-2 568 363) children 5-17 years of age were treated in US EDs for bicycle-related injuries over the 10-year study period, an average of 608 injuries per day. Most injuries (45.7%) involved children 10-14 years of age. The rate of bicycle-related injuries significantly decreased from 447.4 per 100 000 children in 2006 to 321.1 per 100 000 children in 2015 (P < 0.001). Helmet use at the time of injury was significantly associated with lower likelihood of head and neck injuries (OR: 0.52 [95% CI: 0.400.59]) and hospitalizations (OR: 0.71 [95% CI: 0.54-0.94]), but there was no significant change in the rate of injury among helmet users over the study period (P = 0.224). Motor vehicle involvement increased the odds of bicycle-related traumatic brain injuries (TBIs) (OR: 1.98 [95% CI: 1.49-2.64]) as well as injury-related hospitalizations (OR: 4.04 [95% CI: 3.33-4.89]). Conclusions: Despite decreasing injury rates, bicycling remains an important source of injury for children. Helmet use has demonstrated significant protective effects for TBIs, head and neck injuries, and hospitalizations. Motor vehicle involvement increased the risk of hospitalization. More efforts are needed to promote use of helmets and to reduce the possibility of bicycle-motor vehicle collisions to prevent bicycle-related injuries among children.	[McAdams, Rebecca J.; Clark, Roxanne M.; Roberts, Kristin J.; Yang, Jingzhen; Mckenzie, Lara B.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA; [Swidarski, Katherine] Ohio State Univ, Coll Publ Hlth, Div Hlth Behav & Hlth Promot, 1841 Neil Ave, Columbus, OH 43210 USA; [Yang, Jingzhen; Mckenzie, Lara B.] Ohio State Univ, Coll Med, Dept Pediat, 700 Childrens Dr, Columbus, OH 43205 USA; [Yang, Jingzhen; Mckenzie, Lara B.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, 1841 Neil Ave, Columbus, OH 43210 USA		Mckenzie, LB (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	Rebecca.McAdams@NationwideChildrens.org; Swidarlcsi.5@osu.edu; Roxanne.Clark@nationwidechildrens.org; Kristin.Roberts@nationwidechildrens.org; Ginger.Yang@nationwidechildrens.org; Lara.McKenzie@NationwideChildrens.org		Roberts, Kristin J/0000-0001-6052-6731; McKenzie, Lara/0000-0003-2889-0001			Acton C H, 1995, Inj Prev, V1, P86, DOI 10.1136/ip.1.2.86; Administration N. H. T. S., 2016, CONT WORK HIGHW SAF, P2014; Alliance for Biking & Walking, 2016, BIC WALK US 2016 BEN, P198; [Anonymous], 2005, INJ PREV CONTR DAT S; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Bernstein JD, 2003, CLIN PEDIATR, V42, P673, DOI 10.1177/000992280304200802; Bromell R. J., 2016, J PAEDIAT CHILD HLTH; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Census Bureau U. S., 2011, NAT POP EST 2000S; Census Bureau U. S., 2011, INT ST US POP AG 200; Centers for Disease Control and Prevention, 1995, MMWR-MORBID MORTAL W, P24; Chen WS, 2013, ACAD EMERG MED, V20, P570, DOI 10.1111/acem.12146; Dellinger AM, 2010, J SAFETY RES, V41, P375, DOI 10.1016/j.jsr.2010.05.003; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Edmondson B., 2011, US BICYCLE MARKET TR, P10; Ellis J., 2014, BICYCLE SAFETY ED CH; Embree TE, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0282; Finch C F, 1996, Inj Prev, V2, P126, DOI 10.1136/ip.2.2.126; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Gerberich S G, 1994, Minn Med, V77, P27; Haileyesus T, 2007, INJURY PREV, V13, P202, DOI 10.1136/ip.2006.014019; Hamann C, 2013, J TRAUMA ACUTE CARE, V75, P870, DOI 10.1097/TA.0b013e3182a74a3f; Ji M, 2006, ACCIDENT ANAL PREV, V38, P128, DOI 10.1016/j.aap.2005.08.002; Joseph B, 2017, AM J SURG, V213, P413, DOI 10.1016/j.amjsurg.2016.05.021; Komanoff C., 1993, TRANS RES REC, V1405; Lee BHY, 2005, ACCIDENT ANAL PREV, V37, P93, DOI 10.1016/j.aap.2004.07.001; Macpherson A. L., 2002, PEDIATRICS, V110, P5; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; Meehan WP, 2013, J PEDIATR-US, V163, P726, DOI 10.1016/j.jpeds.2013.03.073; Mehan TJ, 2009, CLIN PEDIATR, V48, P166, DOI 10.1177/0009922808324952; Miller PA, 1996, ARCH PEDIAT ADOL MED, V150, P1259, DOI 10.1001/archpedi.1996.02170370037005; Mulvaney CA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010415.pub2; National Academies of Sciences Engineering and Medicine, 2016, BARR OPP 2 YEAR 4 YE, DOI [10.17226/21739, DOI 10.17226/21739]; National Bicycle Safety Network, 2016, BIC HELM LAWS; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; OROURKE NA, 1987, MED J AUSTRALIA, V146, P619, DOI 10.5694/j.1326-5377.1987.tb120439.x; OTIS J, 1992, PUBLIC HEALTH REP, V107, P283; Owen R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003985.pub3; Phillips J. L., 2016, J EPIDEMIOL PUBLIC H, V1; Pierce SR, 2014, HEALTH PROMOT PRACT, V15, P406, DOI 10.1177/1524839913512329; Rezendes Jennifer L, 2006, J Pediatr Nurs, V21, P35, DOI 10.1016/j.pedn.2005.06.005; Rivara F.P., 1997, INJURY PREV, V21, P47; Robertson DW, 2014, ACCIDENT ANAL PREV, V70, P314, DOI 10.1016/j.aap.2014.04.011; Rodgers G., 2002, INJURY PREV, P42; Rodgers GB, 1996, PEDIATRICS, V97, P166; Sanford T, 2015, JAMA-J AM MED ASSOC, V314, P947, DOI 10.1001/jama.2015.8295; Savage M. A., 2002, PROTECTING CHILDREN, Vx, P74; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Sosin DM, 1996, PEDIATRICS, V98, P868; Teisch LF, 2015, PEDIATR SURG INT, V31, P1021, DOI 10.1007/s00383-015-3756-2; Tucker M. E, 2010, COUNTERMEASURES WORK; US Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; US Department of Health and Human Services Centers for Disease Control and Prevention, 2008, CDC CHILDH INJ REP P; WEISS BD, 1994, CLIN SPORT MED, V13, P99; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034; Young Margaret B., 2012, Morbidity and Mortality Weekly Report, V61, P1	56	16	16	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	SEP	2018	118						11	17		10.1016/j.aap.2018.05.019			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	GO0YG	WOS:000439672000002	29843009				2022-02-06	
J	Brabazon, F; Bermudez, S; Shaughness, M; Khayrullina, G; Byrnes, KR				Brabazon, Fiona; Bermudez, Sara; Shaughness, Michael; Khayrullina, Guzal; Byrnes, Kimberly R.			The effects of insulin on the inflammatory activity of BV2 microglia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE DEMENTIA; MILD COGNITIVE IMPAIRMENT; NITRIC-OXIDE SYNTHASE; NADPH OXIDASE; BRAIN-INJURY; CELL-DEATH; IN-VITRO; ACTIVATION; NEUROTOXICITY; EXPRESSION	Microglia are the macrophages of the central nervous system (CNS), which function to monitor and maintain homeostasis. Microglial activation occurs after CNS injury, infection or disease. Prolonged microglial activation is detrimental to the CNS as they produce nitric oxide (NO), reactive oxygen species (ROS) and pro-inflammatory cytokines, resulting in neuronal cell dysfunction and death. Microglial activation is implicated in the neurological deficits following traumatic brain injury (TBI) and Alzheimer's disease. Intranasal insulin administration is a promising treatment of Alzheimer's disease and TBI. However, the exact effect of insulin on microglia is currently unclear. The goal of this study was therefore to examine the effect of insulin administration on activated microglia. The microglial cell line BV2 were exposed to a pro-inflammatory stimulus, lipopolysaccharide (LPS), followed by insulin administration. Outcome measures were conducted at 24 hours after treatment. In vitro assays quantified NO and ROS production. Western blot, immunocytochemistry and phagocytosis assay further examined the effect of insulin on microglial activity. Insulin treatment significantly reduced NO, ROS and TNF alpha production and increased phagocytic activity. Insulin treatment also significantly reduced iNOS expression, but had no significant effect on any other M1 or M2 macrophage polarization marker examined. These data suggest that insulin has very specific effects to reduce pro-inflammatory or chemoattractant properties of microglia, and this may be one mechanism by which insulin has beneficial effects in CNS injury or neurodegenerative conditions.	[Brabazon, Fiona; Shaughness, Michael; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA; [Bermudez, Sara; Khayrullina, Guzal; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA.; Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.; Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.	kimberly.byrnes@usuhs.edu		Brabazon, Fiona/0000-0003-1642-808X; Byrnes, Kimberly/0000-0002-7501-7734	Uniformed Services University of the Health Sciences Student Grant [T0-70-3278]; NIH/NINDS grant [1R01NS073667-01A1]	This study was funded by the Uniformed Services University of the Health Sciences Student Grant T0-70-3278 to FB and NIH/NINDS grant number 1R01NS073667-01A1 to KRB. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adzovic L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0282-z; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Chen YX, 2014, EXP NEUROL, V261, P610, DOI 10.1016/j.expneurol.2014.06.004; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Cooney SJ, 2014, FREE RADICAL RES, V48, P929, DOI 10.3109/10715762.2014.927578; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Dandona P, 2010, DIABETES CARE, V33, P2416, DOI 10.2337/dc10-0929; Engelhardt JF, 2001, ANTIOXID REDOX SIGN, V3, P341, DOI 10.1089/15230860152408997; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Kim WK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072108; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Krupa A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/124762; Kumar A, 2014, FREE RADICAL BIO MED, V73, P51, DOI 10.1016/j.freeradbiomed.2014.04.014; Licinio J, 1999, MOL MED TODAY, V5, P225, DOI 10.1016/S1357-4310(99)01453-7; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maimaiti S, 2016, J GERONTOL A-BIOL, V71, P30, DOI 10.1093/gerona/glu314; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Morris JK, 2012, CURR NEUROL NEUROSCI, V12, P520, DOI 10.1007/s11910-012-0297-0; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Neniskyte U, 2014, FEBS LETT, V588, P2952, DOI 10.1016/j.febslet.2014.05.046; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Orihuela R, 2015, BR J PHARM, DOI 10.1111/bph.13139; Pan XD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-45; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spielman LJ, 2015, CURR ALZHEIMER RES, V12, P684, DOI 10.2174/1567205012666150710104428; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stevens RB, 1997, J IMMUNOL, V159, P5329; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068	43	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0201878	10.1371/journal.pone.0201878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	WOS:000442804200003	30148836	Green Published, Green Submitted, gold			2022-02-06	
J	Akande, M; Minneci, PC; Deans, KJ; Xiang, H; Cooper, JN				Akande, Manzilat; Minneci, Peter C.; Deans, Katherine J.; Xiang, Henry; Cooper, Jennifer N.			Association of Medicaid Expansion Under the Affordable Care Act With Outcomes and Access to Rehabilitation in Young Adult Trauma Patients	JAMA SURGERY			English	Article							LOW-INCOME ADULTS; LENGTH-OF-STAY; INSURANCE STATUS; BRAIN-INJURY; ETHNIC DISPARITIES; DIAGNOSIS MATRIX; RISK-FACTORS; SAFETY NET; MORTALITY; RACE	IMPORTANCE Trauma is the leading cause of death and disability among young adults in the United States. Young adults are also the age group most likely to be uninsured. Implementation of Medicaid expansion through the Affordable Care Act (ACA) has increased insurance coverage, but its associations with trauma care and outcomes among young adults nationwide remain unknown. We examined whether Medicaid expansion, in its first year, was associated with changes in insurance coverage and improved outcomes in young adults hospitalized for traumatic injury. OBJECTIVE To assess the associations of ACA Medicaid expansion with insurance coverage, in-hospital mortality, failure to rescue, access to rehabilitation, and unplanned readmissions among hospitalized young adult trauma patients across many US states. DESIGN, SETTING, AND PARTICIPANTS We used the Healthcare Cost and Utilization Project State Inpatient Databases to examine changes in insurance coverage and risk adjusted outcomes among young adults (age 19 to 44 years) who were hospitalized for injuries before and after Medicaid expansion and open enrollment occurred (2012-2013 vs 2014) in 11 US states that expanded Medicaid through the ACA. We also performed difference-in-difference analyses to compare these changes between 3 expansion states and 3 non-expansion states within the same geographic region. RESULTS Of the 141 187 trauma patients hospitalized across 11 Medicaid expansion states, 43 871 (31.1%) were women, and the mean (SD) age was 31.4 (7.6) years. Medicaid expansion was associated with an increase in Medicaid coverage from 16 229 individuals (16.7%) to 15 358 individuals (34.9%) (difference: 18.2%[95% CI, 16.5%-20.0%]; P<.001), a decrease in lack of insurance from 27 016 individuals (27.8%) to 5589 individuals (12.7%) (difference: -15.1% [95% CI, -16.8% to -13.5%]; P<.001), and an increase in discharge to rehabilitation from 9220 individuals (11.4%) to 4736 individuals (12.6%) (difference: 1.16%[95% CI, 0.55%-1.77%]; P<.001). We found no significant reductions in in-hospital mortality, failure to rescue, or unplanned readmissions. Similar results were found when 3 of these states were compared with 3 geographically and demographically similar states that had not enacted Medicaid expansion. CONCLUSIONS AND RELEVANCE The first year of implementation of Medicaid expansion and open enrollment across 11 selected US states was associated with significant increases in Medicaid coverage, reductions in uninsured rates, and increased access to postdischarge rehabilitation among young adults hospitalized for injury. However, this study found no significant reductions in in-hospital mortality, failure to rescue, or unplanned readmissions.	[Akande, Manzilat] Nationwide Childrens Hosp, Dept Crit Care Med, Columbus, OH 43205 USA; [Minneci, Peter C.; Deans, Katherine J.; Cooper, Jennifer N.] Nationwide Childrens Hosp, Res Inst, Ctr Surg Outcomes Res, 700 Childrens Dr,FB Ste 3A-3, Columbus, OH 43205 USA; [Minneci, Peter C.; Deans, Katherine J.; Cooper, Jennifer N.] Nationwide Childrens Hosp, Res Inst, Ctr Innovat Pediat Practice, 700 Childrens Dr,FB Ste 3A-3, Columbus, OH 43205 USA; [Minneci, Peter C.; Deans, Katherine J.] Nationwide Childrens Hosp, Dept Surg, Columbus, OH 43205 USA; [Xiang, Henry; Cooper, Jennifer N.] Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, Columbus, OH 43205 USA		Cooper, JN (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Surg Outcomes Res, 700 Childrens Dr,FB Ste 3A-3, Columbus, OH 43205 USA.; Cooper, JN (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Innovat Pediat Practice, 700 Childrens Dr,FB Ste 3A-3, Columbus, OH 43205 USA.	jennifer.cooper@nationwidechildrens.org		Cooper, Jennifer/0000-0001-7590-7166	Research Institute at Nationwide Children's HospitalOhio State University	The Research Institute at Nationwide Children's Hospital contributed all financial and material support for this research.	Agency for Healthcare Research and Quality, HEALTHC COST UT PROJ; Akande M, 2018, J SURG RES, V228, P42, DOI 10.1016/j.jss.2018.02.058; American Heart Association Health Forum, AHA ANN SURV DAT; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Arthur M, 2008, MED CARE, V46, P192, DOI 10.1097/MLR.0b013e31815b9d8e; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Bekelis K, 2015, ANN SURG, V262, P9, DOI 10.1097/SLA.0000000000001239; Bell TM, 2013, J TRAUMA ACUTE CARE, V75, P728, DOI 10.1097/TA.0b013e3182a53aaa; Blavin F, 2016, JAMA-J AM MED ASSOC, V316, P1475, DOI 10.1001/jama.2016.14765; Cheslik TG, 2016, J TRAUMA ACUTE CARE, V80, P1010, DOI 10.1097/TA.0000000000001052; Clark DE., ICDPIC STATA MODULE; Decker SL, 2014, JAMA INTERN MED, V174, P988, DOI 10.1001/jamainternmed.2014.518; DeNavas-Walt C, 2010, INCOME POVERTY HLTH; Duron VP, 2012, J TRAUMA ACUTE CARE, V73, P1093, DOI 10.1097/TA.0b013e31826fc844; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076; Gerry JM, 2016, INJURY, V47, P197, DOI 10.1016/j.injury.2015.09.003; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hamilton EC, 2016, J PEDIATR SURG, V51, P2048, DOI 10.1016/j.jpedsurg.2016.09.036; Han XS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144429; Henry J, 2015, GUIDE SUPREME COURTS; Henry J., 2012, STAT STAT ACT MED EX; Henry J. Kaiser Family Foundation, 2018, TOTAL MONTHLY MED CH; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Joseph B, 2016, J TRAUMA ACUTE CARE, V81, P427, DOI 10.1097/TA.0000000000001082; Laupland KB, 2010, INJURY, V41, P69, DOI 10.1016/j.injury.2009.06.006; Leukhardt WH, 2010, AM J SURG, V199, P348, DOI 10.1016/j.amjsurg.2009.09.021; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Medicaid.gov, 2018, KEEP AM HLTH MONTHL; Moore L, 2014, ANN SURG, V259, P374, DOI 10.1097/SLA.0b013e31828b0fae; Morris DS, 2014, INJURY, V45, P56, DOI 10.1016/j.injury.2013.04.029; National Center for Health Statistics, 2009, ICD 10 EXT CAUS INJ; National Center for Health Statistics, 2016, NCHS URB RUR CLASS S; National Center for Health Statistics, 2017, TOOLS FRAM TOOLS CAT; Nehra D, 2016, J AM COLL SURGEONS, V223, P755, DOI 10.1016/j.jamcollsurg.2016.09.001; Perl VJU, 2017, AM J SURG, V213, P870, DOI 10.1016/j.amjsurg.2017.03.036; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Rosenthal MG, 2017, J TRAUMA ACUTE CARE, V83, P135, DOI 10.1097/TA.0000000000001540; Rudowitz R, 2017, MED ENROLLMENT SPEND; Rudowitz Robin, 2016, WHAT COVERAGE FINANC; Sabharwal S, 2007, J PEDIATR ORTHOPED, V27, P690, DOI 10.1097/BPO.0b013e3181425653; Salim A, 2010, J TRAUMA, V68, P211, DOI 10.1097/TA.0b013e3181a0e659; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Soberg HL, 2011, J TRAUMA, V71, P425, DOI 10.1097/TA.0b013e3181eff54f; Sommers B.D., 2013, MED MED RES REV, V3; Sommers BD, 2017, HEALTH AFFAIR, V36, P1119, DOI 10.1377/hlthaff.2017.0293; Sommers BD, 2015, JAMA-J AM MED ASSOC, V314, P366, DOI 10.1001/jama.2015.8421; Sommers BD, 2014, HEALTH AFFAIR, V33, P78, DOI 10.1377/hlthaff.2013.1087; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; Tepas JJ, 2011, J AM COLL SURGEONS, V212, P722, DOI 10.1016/j.jamcollsurg.2010.12.016; US Centers for Disease Control and Prevention, 2016, COST INJ VIOL US; US Centers for Disease Control and Prevention National Center for Health Statistics, 2016, DEATHS AND MORT; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; Zogg CK, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.3609	57	16	16	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	AUG	2018	153	8							e181630	10.1001/jamasurg.2018.1630			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GQ5US	WOS:000441758600003	29874372	Green Published			2022-02-06	
J	Jembrek, MJ; Radovanovic, V; Vlainic, J; Vukovic, L; Hanzic, N				Jembrek, Maja Jazvinscak; Radovanovic, Vedrana; Vlainic, Josipa; Vukovic, Lidija; Hanzic, Nikolina			Neuroprotective effect of zolpidem against glutamate-induced toxicity is mediated via the PI3K/Akt pathway and inhibited by PK11195	TOXICOLOGY			English	Article						Zolpidem; Excitotoxicity; Akt signalling; p53; PK11195; NR2B subunit of NMDA receptor	CELL-DEATH; PERMEABILITY TRANSITION; BENZODIAZEPINE-RECEPTOR; GABA(A) RECEPTORS; OXIDATIVE STRESS; ATP SYNTHASE; MITOCHONDRIAL; EXCITOTOXICITY; ACTIVATION; LIGANDS	Excitotoxicity is a pathological process in which neuronal dysfunction and death are induced by excessive glutamate stimulation, the major fast excitatory neurotransmitter in the mammalian brain. Excitotoxicity-induced neurodegeneration is a contributing factor in ischemia-induced brain damage, traumatic brain injury, and various neurodegenerative diseases. It is triggered by calcium overload due to prolonged over-activation of ionotropic N-methyl-D-aspartate (NMDA) receptors. Enhanced Ca2+ release results in neuronal vulnerability through several intertwined mechanisms, including activation of proteolytic enzymes, increased production of reactive oxygen species (ROS), mitochondrial dysfunction and modulation of intracellular signalling pathways. We investigated the neuroprotective effect of hypnotic zolpidem, a drug that exerts its central effects at the GABA(A) receptor complex, against glutamate-induced toxicity in P19 neurons. Zolpidem prevented death of P19 neurons exposed to glutamate, and abolished the glutamate-induced increase in ROS production, p53 and Bax expression, and caspase-3/7 activity. Zolpidem effects were mediated by marked over-activation of Akt kinase. The pro-survival effect, as well as the pAkt induction, were prevented in the presence of wortmannin, an inhibitor of phosphatidylinositol-3-kinase (PI3K) that functions upstream of Akt. The beneficial effect of zolpidem on neuronal survival was not prevented by fiumazenil, a GABA(A) receptor antagonist. PK11195, a drug that modulates the mitochondrial translocator protein 18 kDa (TSPO) and F0F1-ATPase, prevented the beneficial effect of zolpidem, indicating that the mechanism of zolpidem action involves preservation of mitochondrial function and integrity. Zolpidem effects were further mediated by prevention of glutamate-induced increase in the expression of the NR2B subunit of NMDA receptor. The obtained results suggest the promising therapeutic potential of zolpidem against excitotoxic insults and highlight the importance of mitochondria and the Akt pathway as valuable targets for therapeutic interventions in glutamate-mediated neuropathological conditions.	[Jembrek, Maja Jazvinscak; Radovanovic, Vedrana; Vlainic, Josipa; Hanzic, Nikolina] Rudjer Boskovic Inst, Div Mol Med, Bijenicka Cesta 54, Zagreb 10000, Croatia; [Jembrek, Maja Jazvinscak] Catholic Univ Croatia, Dept Psychol, Ilica 242, Zagreb, Croatia; [Vukovic, Lidija] Rudjer Boskovic Inst, Div Mol Biol, Bijenicka Cesta 54, Zagreb, Croatia		Jembrek, MJ (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Bijenicka Cesta 54, Zagreb 10000, Croatia.	jazvin@irb.hr	Jembrek, Jazvinscak/H-3558-2019		Croatian Ministry of Science, Education and SportsMinistry of Science, Education and Sports, Republic of Croatia [098-0000000-2448]; Catholic University of Croatia [HKS-2016-2]	This work was financed by the project of Croatian Ministry of Science, Education and Sports ("Stress, GABA<INF>A</INF> receptors and mechanisms of action of neuropsychoactive drugs", 098-0000000-2448) and by the project of the Catholic University of Croatia ("The mechanism of the neuroprotective effect of zolpidem against oxidative stress induced by high concentrations of glutamate", HKS-2016-2).	Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Beas-Zarate C, 2001, NEUROCHEM INT, V39, P1, DOI 10.1016/S0197-0186(01)00008-0; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Briston T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10673-8; Canzoniero LMT, 1996, J NEUROSCI RES, V45, P226; Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009; Cleary J, 2007, BIOORG MED CHEM LETT, V17, P1667, DOI 10.1016/j.bmcl.2006.12.102; Cong L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2050435; Cosentino K, 2017, TRENDS CELL BIOL, V27, P266, DOI 10.1016/j.tcb.2016.11.004; Datta S, 2016, MITOCHONDRION, V30, P177, DOI 10.1016/j.mito.2016.08.002; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Gao M, 2008, EUR J PHARMACOL, V591, P73, DOI 10.1016/j.ejphar.2008.06.071; Garcia-Santos G, 2004, FREE RADICAL RES, V38, P1289, DOI 10.1080/10715760400017343; Gatliff J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.186; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Grant ER, 2001, BIOCHEM PHARMACOL, V62, P283, DOI 10.1016/S0006-2952(01)00665-7; Greenblatt DJ, 2012, EXPERT OPIN PHARMACO, V13, P879, DOI 10.1517/14656566.2012.667074; Grobin AC, 1999, BRAIN RES, V827, P1; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Jayakumar AR, 2002, J NEUROCHEM, V83, P1226, DOI 10.1046/j.1471-4159.2002.01261.x; Jembrek MJ, 2015, CURR PHARM DESIGN, V21, P4943, DOI 10.2174/1381612821666150914121624; Jembrek MJ, 2012, J MOL NEUROSCI, V47, P286, DOI 10.1007/s12031-012-9737-1; Jorda EG, 2005, APOPTOSIS, V10, P91, DOI 10.1007/s10495-005-6064-9; King TD, 2008, NEUROTOX RES, V14, P367, DOI 10.1007/BF03033861; Kritis AA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00091; Kumar A, 2008, NEUROCHEM RES, V33, P370, DOI 10.1007/s11064-007-9431-9; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; Li XB, 2015, CLIN EXP PHARMACOL P, V42, P1068, DOI 10.1111/1440-1681.12460; MacPherson PA, 1997, NEUROSCIENCE, V80, P487, DOI 10.1016/S0306-4522(97)00102-4; Marcade M, 2008, J NEUROCHEM, V106, P392, DOI 10.1111/j.1471-4159.2008.05396.x; Mattner F, 2006, LIFE SCI, V79, P287, DOI 10.1016/j.lfs.2006.01.006; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Noormandi A, 2017, EXPERT REV CLIN PHAR, V10, P983, DOI 10.1080/17512433.2017.1347502; PAPADOPOULOS V, 1990, J BIOL CHEM, V265, P3772; Parker MA, 2002, J NEUROSCI RES, V69, P39, DOI 10.1002/jnr.10235; Prentice H, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/964518; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rivera-Cervantes MC, 2009, INT J DEV NEUROSCI, V27, P197, DOI 10.1016/j.ijdevneu.2008.09.006; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; TURETSKY DM, 1993, J NEUROBIOL, V24, P1157, DOI 10.1002/neu.480240904; Veenman L, 2012, CURR MOL MED, V12, P398; Vlainic J, 2012, ACTA PHARMACOL SIN, V33, P1469, DOI 10.1038/aps.2012.89; Vlainic J, 2012, LIFE SCI, V90, P889, DOI 10.1016/j.lfs.2012.04.021; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Xilouri M, 2006, EUR J NEUROSCI, V23, P43, DOI 10.1111/j.1460-9568.2005.04548.x; Xilouri M, 2008, NEUROTOX RES, V13, P209, DOI 10.1007/BF03033504; Yoo JM, 2017, REDOX BIOL, V11, P592, DOI 10.1016/j.redox.2016.12.034; Zhai DX, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-20; Zhong ZH, 2010, J NEUROSCI, V30, P15521, DOI 10.1523/JNEUROSCI.4437-10.2010	56	16	16	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-483X			TOXICOLOGY	Toxicology	AUG 1	2018	406						58	69		10.1016/j.tox.2018.05.014			12	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	GT6VY	WOS:000444660200006	29859204				2022-02-06	
J	Nadjar, A				Nadjar, A.			Role of metabolic programming in the modulation of microglia phagocytosis by lipids	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Microglia; Phagocytosis; Inflammation; Fatty acid; Lipid metabolism; Mitochondria; Bioenergetics; Immunometabolism; Glycolysis; Fatty acid oxidation; Fatty acid synthase; Pentose phosphate pathway	POLYUNSATURATED FATTY-ACIDS; TRAUMATIC BRAIN-INJURY; N-3 PUFAS DEFICIENCY; DOCOSAHEXAENOIC ACID; ACTIVATED MICROGLIA; LIPOPROTEIN-LIPASE; NITRIC-OXIDE; MITOCHONDRIAL DYSFUNCTION; INFLAMMATORY RESPONSE; NEUROPROTECTIN D1	Microglia phagocytosis is an essential process to maintain lifelong brain homeostasis and clear potential toxic factors from the neuropil. Microglia can engulf cells or part of cells through the expression of specific receptors at their surface and activation of downstream signaling pathways to engulf material. Microglia phagocytosis is finely regulated and is under the dependence of many factors, including environmental cues such as dietary lipids. Yet, the molecular mechanisms implicated are still largely unknown. The present publication is a 'hypothesis review', assessing the possibility that lipid-mediated modulation of phagocytosis occurs by affecting bioenergetic pathways within microglia. I assess our present knowledge and the elements that allow drawing such hypothesis. I also list some of the important gaps in the literature that need to be filled in. I also consider opportunities for future therapeutic target including nutritional interventions.	[Nadjar, A.] INRA, Nutr & Neurobiol Intagree, UMR 1286, F-33076 Bordeaux, France; [Nadjar, A.] Univ Bordeaux, Nutr & Neurobiol Integree, UMR 1286, F-33076 Bordeaux, France		Nadjar, A (corresponding author), INRA, Nutr & Neurobiol Intagree, UMR 1286, F-33076 Bordeaux, France.; Nadjar, A (corresponding author), Univ Bordeaux, Nutr & Neurobiol Integree, UMR 1286, F-33076 Bordeaux, France.	agnes.nadjar@u-bordeaux.fr		NADJAR, Agnes/0000-0002-3969-6530	"Fondation pour la Recherche Medicale" (FRM)Fondation pour la Recherche Medicale; Fondation de France (FDF)Fondation de France; Labex Brain	AN is supported by the "Fondation pour la Recherche Medicale" (FRM), Fondation de France (FDF) and Labex Brain.	Abedi E, 2014, FOOD SCI NUTR, V2, P443, DOI 10.1002/fsn3.121; Abiega O, 2016, PLOS BIOL, V14, DOI [10.1371/journal.pbio.1002466, 10.1371/journal.pbio.1002508, 10.1371/journal.pbio.1002554]; Afshordel S, 2015, PROSTAG LEUKOTR ESS, V92, P23, DOI 10.1016/j.plefa.2014.05.008; Al-Gubory KH, 2012, INT J BIOCHEM CELL B, V44, P1569, DOI 10.1016/j.biocel.2012.06.003; Andrade-Vieira R, 2013, CANCER BIOL THER, V14, P1050, DOI 10.4161/cbt.26206; Andre C, 2017, DIABETES, V66, P908, DOI 10.2337/db16-0586; Ano Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118512; Aoun M, 2012, BRIT J NUTR, V107, P647, DOI 10.1017/S000711451100331X; Argente-Arizon P, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00042; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Banati RB, 2004, J NEUROCYTOL, V33, P535, DOI 10.1007/s11068-004-0515-7; Barros LF, 2018, GLIA, V66, P1134, DOI 10.1002/glia.23316; Bazan NG, 2012, EXP NEUROL, V236, P122, DOI 10.1016/j.expneurol.2012.04.007; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Bernhart E, 2010, PROTEOMICS, V10, P141, DOI 10.1002/pmic.200900195; Bolon C, 1997, AM J PHYSIOL-CELL PH, V273, pC1732, DOI 10.1152/ajpcell.1997.273.5.C1732; Bordt EA, 2014, FREE RADICAL BIO MED, V76, P34, DOI 10.1016/j.freeradbiomed.2014.07.033; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Bradbury J, 2011, NUTRIENTS, V3, P529, DOI 10.3390/nu3050529; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Bruce KD, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00057; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Button EB, 2014, LIPIDS, V49, P305, DOI 10.1007/s11745-014-3882-y; Calignano A, 2000, Prog Brain Res, V129, P471; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; Chang CY, 2013, J NUTR BIOCHEM, V24, P2127, DOI 10.1016/j.jnutbio.2013.08.004; Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5; Chen CT, 2015, PROSTAG LEUKOTR ESS, V92, P33, DOI 10.1016/j.plefa.2014.05.007; Chen SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07458; Chen Y, 2014, PHYSIOL RES, V63, P57, DOI 10.33549/physiolres.932529; Chenais B, 2002, J NEUROCHEM, V81, P615, DOI 10.1046/j.1471-4159.2002.00864.x; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; CORRALIZA IM, 1995, BIOCHEM BIOPH RES CO, V206, P667, DOI 10.1006/bbrc.1995.1094; Cunha C, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6986175; Dabkowski ER, 2013, CARDIOVASC DRUG THER, V27, P499, DOI 10.1007/s10557-013-6487-4; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; De Smedt-Peyrusse V, 2008, J NEUROCHEM, V105, P296, DOI 10.1111/j.1471-4159.2007.05129.x; Delpech JC, 2015, NEUROPSYCHOPHARMACOL, V40, P2774, DOI 10.1038/npp.2015.127; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4; Duffy CM, 2015, NEUROSCI LETT, V606, P140, DOI 10.1016/j.neulet.2015.08.033; Dyall SC, 2008, NEUROMOL MED, V10, P219, DOI 10.1007/s12017-008-8036-z; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Ebert S, 2009, J NEUROCHEM, V110, P1863, DOI 10.1111/j.1471-4159.2009.06286.x; FACCI L, 1995, P NATL ACAD SCI USA, V92, P3376, DOI 10.1073/pnas.92.8.3376; Feingold KR, 2012, J LEUKOCYTE BIOL, V92, P829, DOI 10.1189/jlb.1111537; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Ferger AI, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-45; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Flowers A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0840-7; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Fukui M, 2013, J CELL BIOCHEM, V114, P192, DOI 10.1002/jcb.24354; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Gao YQ, 2017, CELL REP, V20, P3034, DOI 10.1016/j.celrep.2017.09.008; Gertig U, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00101; Ghosh S, 2018, GLIA, V66, P1200, DOI 10.1002/glia.23271; Gimeno-Bayon J, 2014, J NEUROSCI RES, V92, P723, DOI 10.1002/jnr.23356; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gordon S, 2016, IMMUNITY, V44, P463, DOI 10.1016/j.immuni.2016.02.026; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Guida F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00342-1; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hagopian K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012696; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Hasselbaink DM, 2002, MOL CELL BIOCHEM, V239, P101, DOI 10.1023/A:1020584808730; Herbst EAF, 2014, J PHYSIOL-LONDON, V592, P1341, DOI 10.1113/jphysiol.2013.267336; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hjorth E, 2013, J ALZHEIMERS DIS, V35, P697, DOI 10.3233/JAD-130131; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Holland R, 2018, BRAIN BEHAV IMMUN, V68, P183, DOI 10.1016/j.bbi.2017.10.017; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; Infantino V, 2013, BIOCHEM BIOPH RES CO, V440, P105, DOI 10.1016/j.bbrc.2013.09.037; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Innamorato NG, 2009, CURR OPIN NEUROL, V22, P308, DOI 10.1097/WCO.0b013e32832a3225; Jay TR, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0197-5; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jiang XY, 2016, TRANSL STROKE RES, V7, P548, DOI 10.1007/s12975-016-0502-6; Johnson RW, 2015, BRAIN BEHAV IMMUN, V43, P1, DOI 10.1016/j.bbi.2014.09.022; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Kang KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010296; Kaur C, 1999, NEUROSCI LETT, V262, P183, DOI 10.1016/S0304-3940(99)00075-0; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khairallah RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034402; Khatchadourian A, 2012, BBA-MOL CELL BIOL L, V1821, P607, DOI 10.1016/j.bbalip.2012.01.007; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kuda O, 2017, BIOCHIMIE, V136, P12, DOI 10.1016/j.biochi.2017.01.002; Lacombe R J Scott, 2018, Mol Aspects Med, V64, P109, DOI 10.1016/j.mam.2017.12.004; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Lambert DM, 1999, CURR MED CHEM, V6, P757; LANDS WEM, 1990, LIPIDS, V25, P505, DOI 10.1007/BF02537156; Larrieu T, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.77; Laye S, 2018, PHARMACOL REV, V70, P12, DOI 10.1124/pr.117.014092; Li LY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-72; Lim JJ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00191; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Lynch AM, 2007, NEUROBIOL AGING, V28, P845, DOI 10.1016/j.neurobiolaging.2006.04.006; Ma YH, 2013, MOL CELL PROTEOMICS, V12, P2833, DOI 10.1074/mcp.M112.026864; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Madore C, 2014, BRAIN BEHAV IMMUN, V41, P22, DOI 10.1016/j.bbi.2014.03.021; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Manzi L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/137097; de Morentin PBM, 2010, BBA-MOL CELL BIOL L, V1801, P350, DOI 10.1016/j.bbalip.2009.09.016; Mauerer R, 2009, METHODS MOL BIOL, V580, P187, DOI 10.1007/978-1-60761-325-1_10; McCarthy RC, 2018, J BIOL CHEM, V293, P7853, DOI 10.1074/jbc.RA118.001949; Mecha M, 2015, BRAIN BEHAV IMMUN, V49, P233, DOI 10.1016/j.bbi.2015.06.002; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Mingam R, 2008, EUR J NEUROSCI, V28, P1877, DOI 10.1111/j.1460-9568.2008.06470.x; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Moon JS, 2016, NAT MED, V22, P1002, DOI 10.1038/nm.4153; Mori MA, 2018, NUTR NEUROSCI, V21, P341, DOI 10.1080/1028415X.2017.1290928; Morselli E, 2014, CELL REP, V9, P633, DOI 10.1016/j.celrep.2014.09.025; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; Nadjar A, 2017, PROG NEURO-PSYCHOPH, V79, P19, DOI 10.1016/j.pnpbp.2016.07.004; Nagano T, 2010, BRAIN RES, V1323, P11, DOI 10.1016/j.brainres.2010.01.086; Nagy AM, 2018, BBA-BIOENERGETICS, V1859, P201, DOI 10.1016/j.bbabio.2017.12.002; Nagy C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00164; Nelson LH, 2017, BRAIN BEHAV IMMUN, V64, P11, DOI 10.1016/j.bbi.2017.03.010; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; O'Loughlin E, 2018, COLD SPRING HARB PER, V8; Ochiai Y, 2017, J NEUROCHEM, V141, P400, DOI 10.1111/jnc.13943; Olah M, 2011, CNS NEUROL DISORD-DR, V10, P108, DOI 10.2174/187152711794488575; Oliveira CPMS, 2006, BRAZ J MED BIOL RES, V39, P189, DOI 10.1590/S0100-879X2006000200004; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Orr SK, 2013, J NEUROCHEM, V127, P378, DOI 10.1111/jnc.12392; Orr SK, 2013, PROSTAG LEUKOTR ESS, V88, P97, DOI 10.1016/j.plefa.2012.05.008; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Pehowich DJ, 1999, BBA-BIOENERGETICS, V1411, P192, DOI 10.1016/S0005-2728(99)00041-9; Pepe S, 1999, AM J PHYSIOL-HEART C, V276, pH149, DOI 10.1152/ajpheart.1999.276.1.H149; Persson M, 2006, EUR J NEUROSCI, V24, P1063, DOI 10.1111/j.1460-9568.2006.04974.x; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Rapoport SI, 1995, NEW CONCEPTS OF A BLOOD-BRAIN BARRIER, P119; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Re G, 2007, VET J, V173, P21, DOI 10.1016/j.tvjl.2005.10.003; Redlich S, 2012, J NEUROIMMUNOL, V244, P32, DOI 10.1016/j.jneuroim.2011.12.013; REGAN JW, 1994, MOL PHARMACOL, V46, P213; Remmerie A, 2018, CELL IMMUNOL, V330, P27, DOI 10.1016/j.cellimm.2018.01.020; Reu P, 2017, CELL REP, V20, P779, DOI 10.1016/j.celrep.2017.07.004; Rey C, 2016, BRAIN BEHAV IMMUN, V55, P249, DOI 10.1016/j.bbi.2015.12.013; Rohrbach S, 2009, CURR PHARM DESIGN, V15, P4103, DOI 10.2174/138161209789909692; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Semba H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11635; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2004, PROSTAG OTH LIPID M, V73, P155, DOI 10.1016/j.prostaglandins.2004.03.005; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Song M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-92; SPECTOR R, 1988, J NEUROCHEM, V50, P639, DOI 10.1111/j.1471-4159.1988.tb02958.x; Stanley WC, 2012, CURR OPIN CLIN NUTR, V15, P122, DOI 10.1097/MCO.0b013e32834fdaf7; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Stillwell W, 1997, LIPIDS, V32, P497, DOI 10.1007/s11745-997-0064-6; Tang R, 2018, INT J BIOCHEM CELL B, V99, P64, DOI 10.1016/j.biocel.2018.03.017; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Thomsen MS, 2015, NEUROBIOL DIS, V81, P108, DOI 10.1016/j.nbd.2015.03.013; Tian YG, 2015, BIOCHEM BIOPH RES CO, V460, P799, DOI 10.1016/j.bbrc.2015.03.109; Tracy LM, 2013, J MOL NEUROSCI, V51, P805, DOI 10.1007/s12031-013-0068-7; Tremblay ME, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0580-0; Trepanier MO, 2016, EUR J PHARMACOL, V785, P187, DOI 10.1016/j.ejphar.2015.05.045; Tsalouhidou S, 2006, J ANIM SCI, V84, P2818, DOI 10.2527/jas.2006-031; Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Ulrich JD, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-20; Urrutia P, 2013, J NEUROCHEM, V126, P541, DOI 10.1111/jnc.12244; Valdearcos M, 2014, CELL REP, V9, P2124, DOI 10.1016/j.celrep.2014.11.018; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Van den Bossche J, 2012, J LEUKOCYTE BIOL, V91, P685, DOI 10.1189/jlb.0911453; Vauzour D, 2015, NEUROCHEM INT, V89, P63, DOI 10.1016/j.neuint.2015.08.004; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Voloboueva LA, 2013, FEBS LETT, V587, P756, DOI 10.1016/j.febslet.2013.01.067; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Wang Z, 2012, BRIT J NUTR, V107, P229, DOI 10.1017/S0007114511002868; Wei XC, 2016, NATURE, V539, P294, DOI 10.1038/nature20117; Won SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-182; Xie M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13280; Yanguas-Casas N, 2018, GLIA, V66, P522, DOI 10.1002/glia.23263; Yu LP, 2014, J BIOENERG BIOMEMBR, V46, P33, DOI 10.1007/s10863-013-9530-z; Zendedel A, 2015, J NEUROIMMUNOL, V278, P200, DOI 10.1016/j.jneuroim.2014.11.007; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhao XR, 2015, J NEUROSCI, V35, P11281, DOI 10.1523/JNEUROSCI.1685-15.2015; Zhu MQ, 2016, MOL NEUROBIOL, V53, P2733, DOI 10.1007/s12035-015-9544-0; Zhu MQ, 2015, J ALZHEIMERS DIS, V43, P1237, DOI 10.3233/JAD-141233; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	201	16	16	1	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	AUG	2018	135						63	73		10.1016/j.plefa.2018.07.006			11	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	GS4YL	WOS:000443663700011	30103935				2022-02-06	
J	Nencka, AS; Meier, TB; Wang, Y; Muftuler, LT; Wu, YC; Saykin, AJ; Harezlak, J; Brooks, MA; Giza, CC; Difiori, J; Guskiewicz, KM; Mihalik, JP; LaConte, SM; Duma, SM; Broglio, S; McAllister, T; McCrea, MA; Koch, KM				Nencka, Andrew S.; Meier, Timothy B.; Wang, Yang; Muftuler, L. Tugan; Wu, Yu-Chien; Saykin, Andrew J.; Harezlak, Jaroslaw; Brooks, M. Alison; Giza, Christopher C.; Difiori, John; Guskiewicz, Kevin M.; Mihalik, Jason P.; LaConte, Stephen M.; Duma, Stefan M.; Broglio, Steven; McAllister, Thomas; McCrea, Michael A.; Koch, Kevin M.			Stability of MRI metrics in the advanced research core of the NCAA-DoD concussion assessment, research and education (CARE) consortium	BRAIN IMAGING AND BEHAVIOR			English	Article						MRI; Stability; Reproducibility; Quantitative imaging; Concussion; mTBI	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; COLLEGIATE FOOTBALL PLAYERS; SPORT-RELATED CONCUSSION; TENSOR IMAGING FINDINGS; DIFFUSION TENSOR; INTERNATIONAL-CONFERENCE; RELAXATION-TIMES; WHITE-MATTER; RECOVERY	The NCAA-DoD Concussion Assessment, Research, and Education (CARE) consortium is performing a large-scale, comprehensive study of sport related concussions in college student-athletes and military service academy cadets. The CARE "Advanced Research Core" (ARC), is focused on executing a cutting-edge investigative protocol on a subset of the overall CARE athlete population. Here, we present the details of the CARE ARC MRI acquisition and processing protocol along with preliminary analyzes of within-subject, between-site, and between-subject stability across a variety of MRI biomarkers. Two experimental datasets were utilized for this analysis. First, two "human phantom" subjects were imaged multiple times at each of the four CARE ARC imaging sites, which utilize equipment from two imaging vendors. Additionally, a control cohort of healthy athletes participating in non-contact sports were enrolled in the study at each CARE ARC site and imaged at four time points. Multiple morphological image contrasts were acquired in each MRI exam; along with quantitative diffusion, functional, perfusion, and relaxometry imaging metrics. As expected, the imaging markers were found to have varying levels of stability throughout the brain. Importantly, between-subject variance was generally found to be greater than within-subject and between-site variance. These results lend support to the expectation that cross-site and cross-vendor advanced quantitative MRI metrics can be utilized to improve analytic power in assessing sensitive neurological variations; such as those effects hypothesized to occur in sports-related-concussion. This stability analysis provides a crucial foundation for further work utilizing this expansive dataset, which will ultimately be freely available through the Federal Interagency Traumatic Brain Injury Research Informatics System.	[Nencka, Andrew S.; Wang, Yang; Koch, Kevin M.] Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Meier, Timothy B.; Muftuler, L. Tugan; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Wu, Yu-Chien; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Harezlak, Jaroslaw] Indiana Univ, Dept Epidemiol & Biostat, Bloomington, IN USA; [Brooks, M. Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Rehabil, Madison, WI USA; [Giza, Christopher C.] Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Dept Pediat & Neurosurg, Los Angeles, CA USA; [Difiori, John] Univ Calif Los Angeles, Dept Orthoped, Los Angeles, CA USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [LaConte, Stephen M.] Virginia Tech, Carilon Res Inst, Blacksburg, VA USA; [Duma, Stefan M.] Virginia Tech, Inst Crit Technol & Appl Sci, Blacksburg, VA USA; [Broglio, Steven] Univ Michigan, Dept Kinesiol, Ann Arbor, MI 48109 USA; [McAllister, Thomas] Indiana Univ Sch Med, Dept Psychiat, Bloomington, IN USA		Nencka, AS (corresponding author), Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	anencka@mcw.edu	Muftuler, L. Tugan/AAG-7539-2021; Koch, Kevin/AAD-6403-2021; Harezlak, Jaroslaw/P-8557-2014; Saykin, Andrew/A-1318-2007	Wu, Yu-Chien/0000-0003-1084-2634; Harezlak, Jaroslaw/0000-0002-3070-7686; Saykin, Andrew/0000-0002-1376-8532; Muftuler, L. Tugan/0000-0002-6635-5678	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG053993, P30AG010133] Funding Source: NIH RePORTER	This project was funded with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense (DHP funds). The authors would like to thank Jenelle E. Fuller, Haley M. Cilliers, Martha Garcia, Sara John, Nana Asiedu, Liga Blyholder, Mike Powers, Morgan Shields, Briana Meyer, Sonal Singh, Zoey Wang, Mania Alexandria, Max Zeiger, Alma Martinez, Douglas Chan, Brennan Delattre, Jonathan Lisinski, Christopher Anzalone, Amber Leinwand, April 'Nikki' Jennings, Sharon Bryan, Victor Wright, Jennifer Franco, Issack Boru, Corey Rodrigo, Parker Traugot, Grant Cabell, Erin Grand, Aliza Nedimyer, and Tricia Combs for data acquisition and Brad Swearingen, Lezlie Espana, and Robin Karr for algorithm support.	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Friedman L, 2006, NEUROIMAGE, V32, P1656, DOI 10.1016/j.neuroimage.2006.03.062; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; JUST M, 1988, RADIOLOGY, V169, P779, DOI 10.1148/radiology.169.3.3187000; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mori S, 2005, MRI ATLAS HUMAN WHIT; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; Palacios E.M., 2016, AM J NEURORADIOLOGY; Penny W. D., 2011, STAT PARAMETRIC MAPP; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stevenson VL, 2000, J NEUROL SCI, V178, P81, DOI 10.1016/S0022-510X(00)00339-7; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Vidorreta M, 2013, NEUROIMAGE, V66, P662, DOI 10.1016/j.neuroimage.2012.10.087; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	49	16	16	2	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	AUG	2018	12	4					1121	1140		10.1007/s11682-017-9775-y			20	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GO6HY	WOS:000440141800017	29064019	Green Accepted, Green Submitted			2022-02-06	
J	Khalaf, S; Ahmad, AS; Chamara, KVDR; Dore, S				Khalaf, Saher; Ahmad, Abdullah Shafique; Chamara, K. V. D. Ranga; Dore, Sylvain			Unique Properties Associated with the Brain Penetrant Iron Chelator HBED Reveal Remarkable Beneficial Effects after Brain Trauma	JOURNAL OF NEUROTRAUMA			English	Article						blood; edema; microglia; traumatic brain injury	INTRACEREBRAL HEMORRHAGE; PROSTANOID RECEPTOR; INDUCED ATTENUATION; DEFEROXAMINE; INJURY; OVERLOAD; DELETION; OUTCOMES; EDEMA; RATS	Iron is postulated to contribute to secondary injury after brain trauma through various pathways including oxidative stress and inflammation. Therefore, one goal is to limit iron toxicity by either directly limiting iron activity, or limiting the secondary cascade mediated by iron, therefore rescuing the brain from damage after trauma. The N,N'-Di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid monohydrochloride (HBED) is a unique iron chelator that has the ability to cross the intact blood-brain barrier; it has a higher affinity to iron, and it has a longer half-life than most commonly used chelators. A controlled-cortical impact model of traumatic brain injury (TBI) was induced in mice. Mice were subcutaneously injected with HBED immediately after TBI, then at 12h after, followed by a twice-a-day regimen until an end-point of 3 days. Neurobehavioral tests were performed daily. Cortical injury volume, hemispheric enlargement, and hippocampal swelling were quantified. Perls' iron immunostaining along with markers of gliosis, oxidative stress, and aquaporin (AQP) 4 were also performed. Data revealed that HBED treatment significantly decreases motor deficits and improves recovery after TBI. It also reduces cortical injury volume by 36.6 +/- 6.8% (p<0.001), hippocampal swelling by 23.4 +/- 3.8% (p<0.05), and total hemispheric volume by 13.3 +/- 2.7% (p<0.01). These effects are related to a reduction in microgliosis and oxidiative stress markers in the impacted corpus callosum area by 39.8 +/- 7.3%, and by 80.5 +/- 0.8% (p<0.05), respectively. AQP4 staining is also attenuated in the hippocampus of HBED-treated mice. Therefore, our results suggest that HBED should be considered as a therapeutic tool to facilitate the recovery process following brain trauma.	[Khalaf, Saher; Ahmad, Abdullah Shafique; Chamara, K. V. D. Ranga; Dore, Sylvain] Univ Florida, Dept Anesthesiol, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA; [Dore, Sylvain] Univ Florida, Dept Neurol, Gainesville, FL USA; [Dore, Sylvain] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Dept Pharmaceut, Gainesville, FL USA; [Dore, Sylvain] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA		Dore, S (corresponding author), Univ Florida, Coll Med, 1275 Ctr Dr,Biomed Sci J493,PO 100159, Gainesville, FL 32610 USA.	sdore@ufl.edu	Dore, Sylvain/AAG-1470-2020	Dore, Sylvain/0000-0003-3771-5109	McKnight Brain Research Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS095166]; Brain and Spinal Cord Injury Research Trust Fund;  [AHA33450010]	This work was supported in part by grants from the McKnight Brain Research Foundation, Brain and Spinal Cord Injury Research Trust Fund, and AHA33450010, and NIH R21NS095166 (SD). The authors would also like to thank Dore Lab team members for providing their feedback on the manuscript and Corey Astrom, ELS, for her editorial expertise.	Abbruzzese G, 2011, HAEMATOL-HEMATOL J, V96, P1708, DOI 10.3324/haematol.2011.043018; Auriat AM, 2012, EXP NEUROL, V234, P136, DOI 10.1016/j.expneurol.2011.12.030; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bergeron RJ, 1998, BLOOD, V91, P1446, DOI 10.1182/blood.V91.4.1446; Bergeron RJ, 2002, BLOOD, V99, P3019, DOI 10.1182/blood.V99.8.3019; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Cui HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127256; Dragsten PR, 2000, J LAB CLIN MED, V135, P57, DOI 10.1016/S0022-2143(00)70021-7; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Frankowski JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17956; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Glushakov AV, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00034; Glushakov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113689; GRADY RW, 1994, ADV EXP MED BIOL, V356, P351; HALLAWAY PE, 1989, P NATL ACAD SCI USA, V86, P10108, DOI 10.1073/pnas.86.24.10108; Healy S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36410; Kontoghiorghes GJ, 2010, EXPERT OPIN DRUG SAF, V9, P633, DOI 10.1517/14740338.2010.497138; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LAU EH, 1983, J LAB CLIN MED, V101, P806; Leclerc JL, 2018, J CEREBR BLOOD F MET, V38, P1032, DOI 10.1177/0271678X16679170; Leclerc JL, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0182-2; Leclerc JL, 2015, EUR J NEUROSCI, V41, P1381, DOI 10.1111/ejn.12909; Leclerc JL, 2015, ASN NEURO, V7, DOI 10.1177/1759091415578713; LEE P, 1993, DRUG METAB DISPOS, V21, P640; Li Q, 2017, J CEREBR BLOOD F MET, V37, P3110, DOI 10.1177/0271678X17709186; Li YP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0740-2; Liang FY, 2015, NEUROSCI LETT, V598, P29, DOI 10.1016/j.neulet.2015.05.006; Liang LP, 2008, J NEUROSCI, V28, P11550, DOI 10.1523/JNEUROSCI.3016-08.2008; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; Portbury SD, 2016, METALLOMICS, V8, P193, DOI 10.1039/c5mt00234f; Potts Mathew B, 2006, NeuroRx, V3, P143; Qing WG, 2009, J NEUROSURG, V110, P462, DOI 10.3171/2008.4.JNS17512; Rollet-Labelle E, 1998, FREE RADICAL BIO MED, V24, P563, DOI 10.1016/S0891-5849(97)00292-X; Samuni AM, 2001, FREE RADICAL BIO MED, V30, P170, DOI 10.1016/S0891-5849(00)00459-7; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Thiele N.A., 2017, HBED PRODRUGS USE TH; Tricta F, 2016, AM J HEMATOL, V91, P1026, DOI 10.1002/ajh.24479; Wan S, 2006, ACTA NEUROCHIR SUPPL, V96, P199; Wang BF, 2015, ACTA PHARMACOL SIN, V36, P939, DOI 10.1038/aps.2015.47; Wang L, 2017, BIOSCI REP, V37; WHITTEN CF, 1965, PEDIATRICS, V36, P322; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675; Yu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122371; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1; Zhao F, 2011, STROKE, V42, P3587, DOI 10.1161/STROKEAHA.111.623926; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y	52	16	16	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					43	53		10.1089/neu.2017.5617		JUL 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000439949600001	29743006	Green Published			2022-02-06	
J	Hubbard, WB; Lashof-Sullivan, M; Greenberg, S; Norris, C; Eck, J; Lavik, E; VandeVord, P				Hubbard, W. Brad; Lashof-Sullivan, Margaret; Greenberg, Shaylen; Norris, Carly; Eck, Joseph; Lavik, Erin; VandeVord, Pamela			Hemostatic nanoparticles increase survival, mitigate neuropathology and alleviate anxiety in a rodent blast trauma model	SCIENTIFIC REPORTS			English	Article							BLOOD-BRAIN-BARRIER; POSTTRAUMATIC-STRESS-DISORDER; LUNG INJURY; PSYCHIATRIC-DISORDERS; OXIDATIVE STRESS; SPINAL-CORD; MOUSE MODEL; TIME-COURSE; OPEN-FIELD; RAT MODEL	Explosions account for 79% of combat related injuries and often lead to polytrauma, a majority of which include blast-induced traumatic brain injuries (bTBI). These injuries lead to internal bleeding in multiple organs and, in the case of bTBI, long term neurological deficits. Currently, there are no treatments for internal bleeding beyond fluid resuscitation and surgery. There is also a dearth of treatments for TBI. We have developed a novel approach using hemostatic nanoparticles that encapsulate an anti-inflammatory, dexamethasone, to stop the bleeding and reduce inflammation after injury. We hypothesize that this will improve not only survival but long term functional outcomes after blast polytrauma. Poly(lactic-co-glycolic acid) hemostatic nanoparticles encapsulating dexamethasone (hDNPs) were fabricated and tested following injury along with appropriate controls. Rats were exposed to a single blast wave using an Advanced Blast Simulator, inducing primary blast lung and bTBI. Survival was elevated in the hDNPs group compared to controls. Elevated anxiety parameters were found in the controls, compared to hDNPs. Histological analysis indicated that apoptosis and blood-brain barrier disruption in the amygdala were significantly increased in the controls compared to the hDNPs and sham groups. Immediate intervention is crucial to mitigate injury mechanisms that contribute to emotional deficits.	[Hubbard, W. Brad; Norris, Carly; Eck, Joseph; VandeVord, Pamela] Virginia Tech, Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Lashof-Sullivan, Margaret] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Greenberg, Shaylen] Virginia Tech, Translat Biol Med & Hlth, Blacksburg, VA USA; [Lavik, Erin] Univ Maryland Baltimore Cty, Dept Chem Biochem & Environm Engn, Baltimore, MD 21228 USA; [VandeVord, Pamela] Salem VAMC, Res Serv, Salem, VA 24153 USA; [Hubbard, W. Brad] Univ Kentucky, Coll Med, SCoBIRC, Lexington, KY USA		VandeVord, P (corresponding author), Virginia Tech, Biomed Engn & Mech, Blacksburg, VA 24061 USA.; Lavik, E (corresponding author), Univ Maryland Baltimore Cty, Dept Chem Biochem & Environm Engn, Baltimore, MD 21228 USA.; VandeVord, P (corresponding author), Salem VAMC, Res Serv, Salem, VA 24153 USA.	elavik@umbc.edu; pvord@vt.edu		VandeVord, Pamela/0000-0003-3422-2704; Lavik, Erin/0000-0002-0644-744X	DOD CDMRP Program [W81XWH-11-1-0014]; NIH Director's New Innovator AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP20D007338]	We would like to thank Dr. Michael Urban, Dr. Zachary Bailey, Bryce Dunn, and Ryan Brady for their technical assistance during blast testing. We would like to acknowledge funding support by the DOD CDMRP Program W81XWH-11-1-0014 and the NIH Director's New Innovator Award number DP20D007338 (EL).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Araz O, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-74; Azad A, 2013, SPINE J, V13, P588, DOI 10.1016/j.spinee.2013.02.001; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bertram JP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000397; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Epstein RS, 1994, NEUROPSYCHIATRY TRAU; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Forster C, 2007, J PHYSIOL-LONDON, V580, P937, DOI 10.1113/jphysiol.2007.129007; Fung Y. C., 1984, EXPT INVESTIGATION L; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Hubbard WB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5175249; Hubbard WB, 2015, ACS MACRO LETT, V4, P387, DOI 10.1021/acsmacrolett.5b00061; Hubbard William Brad, 2014, Biomed Sci Instrum, V50, P92; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; Knutson KM, 2013, NEUROPSYCHOLOGIA, V51, P686, DOI 10.1016/j.neuropsychologia.2013.01.003; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lashof-Sullivan MM, 2014, P NATL ACAD SCI USA, V111, P10293, DOI 10.1073/pnas.1406979111; Lee IN, 2015, J NEUROSCI RES, V93, P178, DOI 10.1002/jnr.23454; Liu MD, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00168, 10.3389/fncel.2015.00168]; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mathews ZR, 2015, J EMERG MED, V49, P573, DOI 10.1016/j.jemermed.2015.03.013; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mutafchiyski VM, 2014, MILITARY MED RES, V1, DOI 10.1186/2054-9369-1-13; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Okada S, 1998, RADIAT RES, V150, P304, DOI 10.2307/3579980; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Pelz J, 2013, EUR J HISTOCHEM, V57, P255, DOI 10.4081/ejh.2013.e38; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rajkowska G, 2013, BIOL PSYCHIAT, V73, P613, DOI 10.1016/j.biopsych.2012.09.024; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Regel G, 1997, Acta Anaesthesiol Scand Suppl, V110, P71; Ritenour AE, 2010, ANN SURG, V251, P1140, DOI 10.1097/SLA.0b013e3181e01270; Sajja VSSS, 2015, SHOCK, V44, P71, DOI 10.1097/SHK.0000000000000311; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shain W, 2003, IEEE T NEUR SYS REH, V11, P186, DOI 10.1109/TNSRE.2003.814800; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Shoffstall AJ, 2012, BIOMACROMOLECULES, V13, P3850, DOI 10.1021/bm3013023; Singleton JAG, 2013, J TRAUMA ACUTE CARE, V75, pS269, DOI 10.1097/TA.0b013e318299d93e; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Smith JE, 2011, PHILOS T R SOC B, V366, P291, DOI 10.1098/rstb.2010.0251; Speich HE, 2013, J THROMB THROMBOLYS, V36, P31, DOI 10.1007/s11239-012-0814-7; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Urbanska J, 2014, LIFE SCI, V96, P1, DOI 10.1016/j.lfs.2013.12.020; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xu LY, 2016, EXP NEUROL, V277, P268, DOI 10.1016/j.expneurol.2016.01.010; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	79	16	18	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 13	2018	8								10622	10.1038/s41598-018-28848-2			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8OB	WOS:000438489100007	30006635	Green Published, gold			2022-02-06	
J	Sabirzhanov, B; Faden, AI; Aubrecht, T; Henry, R; Glaser, E; Stoica, BA				Sabirzhanov, Boris; Faden, Alan I.; Aubrecht, Taryn; Henry, Rebecca; Glaser, Ethan; Stoica, Bogdan A.			MicroRNA-711-Induced Downregulation of Angiopoietin-1 Mediates Neuronal Cell Death	JOURNAL OF NEUROTRAUMA			English	Article						angiopoietin-1 (Ang-1); cell death; microRNA (miRNA); traumatic brain injury	TRAUMATIC BRAIN-INJURY; ALTERED EXPRESSION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; GROWTH-FACTOR; APOPTOSIS; ACTIVATION; RECEPTOR; BARRIER; TARGETS	Angiopoietin-1 (Ang-1) is a well-known endothelial growth factor, but its effects on neurons have yet to be elucidated. We show that Ang-1 is rapidly downregulated in the injured brain after controlled cortical impact (CCI), a mouse experimental traumatic brain injury (TBI) model and in etoposide-induced neuronal apoptosis in vitro. Ang-1 treatment inhibits etoposide-induced upregulation of proapoptotic B-cell lymphoma 2 (Bcl-2) family members Noxa, p53 upregulated modulator of apoptosis (Puma), Bcl-2 interacting mediator of cell death (Bim), and Bcl-2-associated X protein (Bax); reduces markers of caspase-dependent (cytochrome c release/caspase activation) and caspase-independent (apoptosis-inducing factor release) pathways; and limits neuronal cell death. Ang-1 treatment phosphorylates receptors Tunica interna endothelial cell kinase 2 (Tie2), and beta 1-integrin and limits the etoposide-induced decrease in protein kinase B (Akt) activity. Blocking Tie2 and beta 1-integrin signaling reduces Ang-1 neuroprotective effects. After both TBI and etoposide treatment microRNA (miR)-711 are upregulated, consistent with its putative role as a negative regulator of Ang-1. We show that miR-711 directly targets the Ang-1 messenger RNA (mRNA), decreasing Ang-1 expression. Increased levels of miR-711 and Ang-1 mRNA are found in the RNA-induced silencing complex complex site of miR-mediated degradation of target mRNAs after etoposide treatment and the miR-711mimic downregulates Ang-1. Administration of miR-711 inhibitor elevates Ang-1 after TBI whereas Ang-1 administration increases Akt activation; reduces Puma, Noxa, Bim, and Bax levels; and attenuates caspase-dependent and -independent neuronal apoptosis 24h after TBI. Ang-1 also attenuates neuronal degeneration, increases gene expression of molecules that maintain blood-brain barrier integrity, and reduces post-traumatic lesion volume/edema 24h after TBI. Although we only observed short-term neuroprotective effects after Ang-1 administration, miR-711-dependent downregulation of Ang-1, followed by Akt pathway inhibition, may play a role in neuronal cell death after neuronal injury in vitro and after experimental TBI.	Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA		Sabirzhanov, B; Stoica, BA (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Ctr Shock Trauma & Anesthesiol Res, Bressler Res Bldg,655 West Baltimore St,8th Floor, Baltimore, MD 21201 USA.	bsabirzhanov@som.umaryland.edu; bstoica@som.umaryland.edu	STOICA, BOGDAN/H-9782-2013	STOICA, BOGDAN/0000-0002-2501-6434; Faden, Alan I./0000-0003-0128-2348; Henry, Rebecca/0000-0001-8548-1170	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS091191, R01 NS096002]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091191, R01NS096002] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) grants R01 NS091191 to A.I.F. and R01 NS096002 to B.A.S and B.S.	Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Akhter R, 2014, J BIOL CHEM, V289, P10812, DOI 10.1074/jbc.M113.519355; Ambacher KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046885; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Gong D, 2011, J TRAUMA, V70, P1480, DOI 10.1097/TA.0b013e31821ac9e1; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Hellwig K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0161-y; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kosacka J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032881; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; LEE JH, 2013, J PRIVACY CONFIDENTI, V5, P5, DOI DOI 10.5345/JKIBC.2013.13.5.506; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lim JS, 2015, NEUROBIOL DIS, V81, P203, DOI 10.1016/j.nbd.2014.11.001; Lin TN, 2001, J CEREBR BLOOD F MET, V21, P690, DOI 10.1097/00004647-200106000-00007; Lin TN, 2000, J CEREBR BLOOD F MET, V20, P387, DOI 10.1097/00004647-200002000-00021; Lista S, 2017, EXPERT REV NEUROTHER, V17, P47, DOI 10.1080/14737175.2016.1204234; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; OCALLAGHAN JP, 1988, NEUROTOXICOL TERATOL, V10, P445, DOI 10.1016/0892-0362(88)90006-2; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Pietrzak M, 2011, J NEUROCHEM, V117, P1033, DOI 10.1111/j.1471-4159.2011.07279.x; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sabirzhanov B, 2012, J NEUROCHEM, V123, P542, DOI 10.1111/j.1471-4159.2012.07927.x; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Shin HY, 2010, J NEUROSCI RES, V88, P1052, DOI 10.1002/jnr.22274; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Wu Q, 2015, BIOMED REP, V3, P611, DOI 10.3892/br.2015.477; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yakovlev AG, 2004, J BIOL CHEM, V279, P28367, DOI 10.1074/jbc.M313526200; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhao JL, 2015, J CELL PHYSIOL, V230, P1895, DOI 10.1002/jcp.24920; Zhou LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079805	63	16	18	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2462	2481		10.1089/neu.2017.5572		JUL 2018	20	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000438198500001	29774773	Green Published			2022-02-06	
J	Hu, P; Uhlich, R; White, J; Kerby, J; Bosarge, P				Hu, Parker; Uhlich, Rindi; White, Jared; Kerby, Jeffrey; Bosarge, Patrick			Sarcopenia Measured Using Masseter Area Predicts Early Mortality following Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						geriatric trauma; sarcopenia; traumatic brain injury	FRAILTY INDEX; GERIATRIC TRAUMA; ELDERLY-PATIENTS; CHEWING ABILITY; MUSCLE TENSION; OLDER; PATTERNS; MORBIDITY; OUTCOMES; DEFINITION	Sarcopenia is strongly associated with poor outcomes and mortality following injury among the geriatric population. Diagnosis using psoas area is most common but may be unavailable given limited radiographic evaluation following low-impact injuries. Masseter area has recently been identified as an available alternative and associated with 2-year mortality following injury. We sought to validate this measure and its association with early mortality following severe traumatic brain injury (sTBI) using a retrospective analysis of all geriatric trauma patients with sTBI admitted from 2011-2016 to our trauma center. Admission Glasgow Coma Scale (GCS) score <= 8 was used to identify sTBI. Bilateral masseter area was measured 2 cm below the zygomatic arch and the mean used for analysis. Sarcopenia was defined as mean masseter area one standard deviation or less from the sex-based mean. Multivariate models with logistic regression and Cox proportional hazards test followed univariate analysis. Kaplan-Meier survival curves were generated and evaluated by log rank. The primary outcome of interest was 30-day mortality. A total of 108 patients were identified for inclusion. Twenty-five patients, 16 male and nine female, had sarcopenia with mean masseter areas of 2.81 +/- 0.45 cm(2) and 2.24 +/- 0.42 cm(2), respectively. Patients with sarcopenia had significantly increased rates of 30-day mortality (80.0% vs. 50.6%; p = 0.01). Sarcopenia (odds ratio [OR], 2.95; 95% confidence interval [CI] 1.03-8.49) and decreasing masseter area were significantly associated with 30-day mortality (OR, 0.66; 95% CI 0.46-0.95) in multivariate modeling. Masseter area is a readily available and objective measure to determine sarcopenia, which is significantly associated with in-creased 30-day mortality following sTBI.	[Hu, Parker; Uhlich, Rindi; Kerby, Jeffrey; Bosarge, Patrick] Univ Alabama Birmingham, Div Acute Care Surg, Dept Surg, 701 19th St South,LHRB 112, Birmingham, AL 35294 USA; [White, Jared] Univ Alabama Birmingham, Div Transplant Surg, Dept Surg, Birmingham, AL 35294 USA		Hu, P (corresponding author), Univ Alabama Birmingham, Div Acute Care Surg, Dept Surg, 701 19th St South,LHRB 112, Birmingham, AL 35294 USA.	phu@uabmc.edu	Hu, Parker/AAG-3095-2019	Hu, Parker/0000-0002-2491-6107			American College of Surgeons; National Trauma Data Bank, 2016, NAT TRAUM DAT BANK 2; Aschkenasy MT, 2006, EMERG MED CLIN N AM, V24, P413, DOI 10.1016/j.emc.2006.01.005; Battistella FD, 1998, J TRAUMA, V44, P618, DOI 10.1097/00005373-199804000-00010; Bhattacharya B, 2016, INJURY, V47, P1955, DOI 10.1016/j.injury.2016.06.019; Black D, 2017, ANN SURG ONCOL, V24, P2241, DOI 10.1245/s10434-017-5829-z; BROOS PLO, 1993, INJURY, V24, P365, DOI 10.1016/0020-1383(93)90096-O; BROOS PLO, 1988, INT SURG, V73, P119; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; Choi MH, 2018, J CACHEXIA SARCOPENI, V9, P53, DOI 10.1002/jcsm.12234; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Deer RR, 2015, CURR OPIN CLIN NUTR, V18, P248, DOI 10.1097/MCO.0000000000000162; Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002; Dirks RC, 2017, J SURG RES, V207, P13, DOI 10.1016/j.jss.2016.08.015; Evans D, 2015, AM J EMERG MED, V33, P1635, DOI 10.1016/j.ajem.2015.07.044; Evans WJ, 1996, GERIATRICS, V51, P46; Farhat JS, 2012, J TRAUMA ACUTE CARE, V72, P1526, DOI 10.1097/TA.0b013e3182542fab; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gaszynska E, 2014, CLIN INTERV AGING, V9, P1197, DOI 10.2147/CIA.S66672; Hewitt J, 2015, AM J SURG, V209, P254, DOI 10.1016/j.amjsurg.2014.05.022; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Jones K, 2017, WORLD J SURG, V41, P2266, DOI 10.1007/s00268-017-3999-2; Kaplan SJ, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2016.4604; Korfage JAM, 2005, J DENT RES, V84, P784, DOI 10.1177/154405910508400902; Korfage JAM, 2003, J DENT RES, V82, P481, DOI 10.1177/154405910308200615; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P805, DOI 10.1097/TA.0000000000000989; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; Mogal H, 2017, ANN SURG ONCOL, V24, P1714, DOI 10.1245/s10434-016-5715-0; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Mueller N, 2016, ANN SURG, V264, P1116, DOI 10.1097/SLA.0000000000001546; Nakanishi R, 2018, SURG TODAY, V48, P151, DOI 10.1007/s00595-017-1564-0; Ohara Y, 2013, GERIATR GERONTOL INT, V13, P372, DOI 10.1111/j.1447-0594.2012.00909.x; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; Partridge JSL, 2012, AGE AGEING, V41, P142, DOI 10.1093/ageing/afr182; Rangel EL, 2017, J TRAUMA ACUTE CARE, V83, P1179, DOI 10.1097/TA.0000000000001657; Revenig LM, 2013, J AM COLL SURGEONS, V217, P665, DOI 10.1016/j.jamcollsurg.2013.06.012; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rotondo M., 2014, RESOURCES OPTIMAL CA, P215; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Umeki K., 2017, INT J ORAL MED SCI, V15, P152, DOI [10.5466/ijoms.15.152, DOI 10.5466/IJOMS.15.152]; US Census Bureau Population Division, 2017, ANN EST RES POP SEL; van Kan GA, 2010, CLIN GERIATR MED, V26, P275, DOI 10.1016/j.cger.2010.02.002; Vermillion SA, 2017, J SURG ONCOL, V115, P997, DOI 10.1002/jso.24617; Wallace JD, 2017, J TRAUMA ACUTE CARE, V82, P65, DOI 10.1097/TA.0000000000001297; Watanabe Y, 2017, J AM GERIATR SOC, V65, P66, DOI 10.1111/jgs.14355; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009; Zhou CJ, 2017, J SURG RES, V211, P137, DOI 10.1016/j.jss.2016.12.014	47	16	16	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2400	2406		10.1089/neu.2017.5422		JUL 2018	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000438199500001	29631485				2022-02-06	
J	Ondruschka, B; Sieber, M; Kirsten, H; Franke, H; Dressler, J				Ondruschka, Benjamin; Sieber, Monique; Kirsten, Holger; Franke, Heike; Dressler, Jan			Measurement of Cerebral Biomarkers Proving Traumatic Brain Injuries in Post-Mortem Body Fluids	JOURNAL OF NEUROTRAUMA			English	Article						autopsy; cerebrospinal fluid; chemiluminescent immunoassay; fatal traumatic brain injury; post-mortem biochemistry	FIBRILLARY ACIDIC PROTEIN; SERUM CONCENTRATIONS; BIOCHEMICAL MARKERS; LIPOCALIN NGAL; ACUTE-PHASE; S100B; BDNF; SEVERITY; DEATH; BLOOD	Until now, it is impossible to identify a fatal traumatic brain injury (TBI) before post-mortem radiological investigations or an autopsy take place. It would be preferable to have an additional diagnostic tool such as post-mortem biochemistry to get greater insight into the pathological pathways and survival times after sustaining TBI. Cerebrospinal fluid (CSF) and serum samples of 84 autopsy cases were collected from forensic autopsies with post-mortem intervals (PMI) of up to 148h. The cases were categorized into a fatal TBI case group (n=42) and non-TBI controls (n=42). The values of glial fibrillary acidic protein (GFAP), brain-derived neurotrophic factor (BDNF), and neutrophil gelatinase-associated lipocalin (NGAL) were analyzed by means of quantitative chemiluminescent multiplex immunoassays. The main results indicate that the usage of liquid samples with good macroscopic quality is more relevant for meaningful biomarker analyses than the length of the PMI. All three proteins were shown to differentiate TBI fatalities from the controls in CSF. In serum, only GFAP could be shown to be able to identify TBI cases. This study is the first approach to measure the three proteins together in CSF and serum in autopsy cases. Determined threshold values may differentiate between fatal TBI and control cases. The presented results emphasize the possible use of post-mortem biochemistry as a supplemental tool in everyday forensic routine.	[Ondruschka, Benjamin; Sieber, Monique; Dressler, Jan] Univ Leipzig, Med Fac, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany; [Kirsten, Holger] Univ Leipzig, Med Fac, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Franke, Heike] Univ Leipzig, Med Fac, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany		Ondruschka, B (corresponding author), Univ Leipzig, Med Fac, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany.	benjamin.ondruschka@medizin.uni-leipzig.de	Kirsten, Holger/AAP-7250-2020	Kirsten, Holger/0000-0002-3126-7950	German Ministry of Defense	This work was partly supported by the German Ministry of Defense. BO has received reimbursement of travel costs from Randox Laboratories. The authors declare that no conflict of interest exists. The investigations were conducted in accordance with the human and ethical principles of the University of Leipzig (No. 117-12-23012012).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chacon-Fernandez P, 2016, J BIOL CHEM, V291, P9872, DOI 10.1074/jbc.M116.720029; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Das Abhishek, 2017, J Family Med Prim Care, V6, P191, DOI 10.4103/jfmpc.jfmpc_194_16; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Franke H, 2012, PURINERG SIGNAL, V8, P629, DOI 10.1007/s11302-012-9300-0; Ghoneim FM, 2015, INT J CLIN EXP PATHO, V8, P7710; Goede A, 2015, RECHTSMEDIZIN, V25, P261, DOI 10.1007/s00194-015-0040-7; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kim H.J., 2018, CURRENT STATE BIOMAR; Laske C, 2006, J NEURAL TRANSM, V113, P1217, DOI 10.1007/s00702-005-0397-y; Li Dong-Ri, 2006, Legal Medicine, V8, P71, DOI 10.1016/j.legalmed.2005.07.004; Li Dong-Ri, 2009, Leg Med (Tokyo), V11 Suppl 1, pS273, DOI 10.1016/j.legalmed.2009.02.042; Lin HC, 2018, ANAL CHEM, V90, P2708, DOI 10.1021/acs.analchem.7b04642; Maeda Hitoshi, 2009, Leg Med (Tokyo), V11 Suppl 1, pS46, DOI 10.1016/j.legalmed.2009.01.048; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mimasaka S, 2001, TOHOKU J EXP MED, V193, P319, DOI 10.1620/tjem.193.319; O'Bryant SE, 2009, J ALZHEIMERS DIS, V17, P337, DOI 10.3233/JAD-2009-1051; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Palmiere C, 2013, FORENSIC SCI INT, V226, P54, DOI 10.1016/j.forsciint.2012.12.007; Papa L, 2017, J NEUROTRAUM, V34, P2187, DOI 10.1089/neu.2017.5030; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Pardridge WM, 2002, ADV EXP MED BIOL, V513, P397; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Rosen C, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00001; SANCHEZRODRIGUEZ VF, 1995, AM J FOREN MED PATH, V16, P210, DOI 10.1097/00000433-199509000-00004; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Siuda J, 2017, NEUROL NEUROCHIR POL, V51, P24, DOI 10.1016/j.pjnns.2016.10.001; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Wong TH, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0215-6; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu Dafang, 2005, NeuroRx, V2, P120, DOI 10.1007/BF03206648; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Zetterberg H, 2009, BRAIN INJURY, V23, P723, DOI 10.1080/02699050903120399; Zhao JB, 2016, J NEUROL SCI, V368, P392, DOI 10.1016/j.jns.2016.07.060	51	16	16	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	17					2044	2055		10.1089/neu.2017.5441		JUL 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ7LU	WOS:000437806600001	29732941				2022-02-06	
J	Derakhshanrad, N; Saberi, H; Yekaninejad, MS; Joghataei, MT; Sheikhrezaei, A				Derakhshanrad, Nazi; Saberi, Hooshang; Yekaninejad, Mir Saeed; Joghataei, Mohammad Taghi; Sheikhrezaei, Abdolreza			Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial	JOURNAL OF NEUROSURGERY-SPINE			English	Article						spinal cord injury; granulocyte-colony stimulating factor; neurological improvement	INDEPENDENCE MEASURE; CEREBRAL-ISCHEMIA; ICCP PANEL; CELLS; EXPRESSION; THERAPY; RATS; TRANSPLANTATION; MOBILIZATION; GUIDELINES	OBJECTIVE Granulocyte-colony stimulating factor (G-CSF) is a major growth factor for activation and differentiation of granulocyte colonies in the bone marrow. This cytokine has been widely and safely employed in different conditions over many years. The purpose of this study was to investigate the efficacy of G-CSF administration for traumatic spinal cord injury (TSCI). METHODS This double-blind parallel randomized, placebo-controlled, clinical trial, a phase III study, was performed from June 2013 to June 2016 in the Brain and Spinal Cord Injury Research (BASIR) center at Tehran University of Medical Sciences (TUMS). It included 120 patients with incomplete chronic TSCI, American Spinal Injury Association (ASIA) Impairment Scale (AIS) B, C, or D, of at least 6 months' duration. Sixty patients were allocated into the treatment group and 60 patients into the control group. All the patients had completed an outpatient rehabilitation program in the post-acute period and were in a neurological and functional plateau. Patients were assessed with the ASIA grading system, the Spinal Cord Independence Measure (SCIM-III), and the International Association of Neurorestoratology-Spinal Cord Injury Functional Rating Scale (IANR-SCIFRS) just before intervention and at 1, 3, and 6 months after 7 subcutaneous administrations of 300 mu g/day of G-CSF in the treatment group and placebo in the control group (administered once per day over the course of 1 week). Randomization was performed with randomized block design, and the patients and evaluators were blinded regarding the treatment groups. One patient did not receive the entire allocated intervention and 5 patients were lost to follow-up. Thus data from 114 patients were included in the analysis. RESULTS One hundred twenty patients were randomized and allocated into the study groups. Among them, 56 patients (93.3%) in the G-CSF group and 58 patients (96.6%) in the placebo group completed the study protocol. After 6 months of follow-up, AIS in the placebo group remained unchanged, whereas in the G-CSF group, 1 patient improved from AIS B to C, and 4 patients improved from AIS C to D. The mean (+/- SE) improvement in ASIA motor score in the G-CSF group was 5.5 +/- 0.62, which was significantly more than in the placebo group (0.77 +/- 0.20) (p < 0.001). The mean light touch and pinprick sensory scores, respectively, increased by 6.1 +/- 1.1 and 8.7 +/- 1.5 in the G-CSF group and by 1.3 +/- 0.52 and 0.89 +/- 0.44 scores in the placebo group (p < 0.001). Evaluation of functional improvement by the IANR-SCIFRS instrument revealed significantly more improvement in the G-CSF group (3.5 +/- 0.37) than in the placebo group 0.41 +/- 0.12) (p < 0.001). Also, a significant difference was observed in functional improvement between the 2 groups as measured by SCIM-III instrument (7.5 +/- 0.95 vs 2.1 +/- 0.51, p < 0.001). CONCLUSIONS Administration of G-CSF for incomplete chronic spinal cord injuries is associated with significant motor, sensory, and functional improvement.	[Derakhshanrad, Nazi; Saberi, Hooshang] Univ Tehran Med Sci, Imam Khomeini Hosp, Neurosci Inst, Brain & Spinal Cord Injury Res Ctr BASIR, Tehran, Iran; [Saberi, Hooshang; Sheikhrezaei, Abdolreza] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Neurosurg, Tehran, Iran; [Yekaninejad, Mir Saeed] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Joghataei, Mohammad Taghi] Iran Univ Med Sci, Sch Adv Technol Med, Cellular & Mol Res Ctr, Tehran, Iran; [Joghataei, Mohammad Taghi] Iran Univ Med Sci, Sch Adv Technol Med, Neurosci Dept, Tehran, Iran; Imam Hosp, Res Ctr BASIR, Brain & Spinal Cord Injury, Tehran, Iran		Saberi, H (corresponding author), Imam Hosp, Res Ctr BASIR, Brain & Spinal Cord Injury, Tehran, Iran.	hgsaberi@yahoo.com	Yekaninejad, Mir Saeed/L-6752-2016	Yekaninejad, Mir Saeed/0000-0003-3648-5276			Ackerman P, 2010, SPINAL CORD, V48, P380, DOI 10.1038/sc.2009.140; Aidinoff E, 2011, SPINAL CORD, V49, P893, DOI 10.1038/sc.2011.32; Anderlini P, 1996, TRANSFUSION, V36, P590, DOI 10.1046/j.1537-2995.1996.36796323057.x; Becker P S, 1997, Biol Blood Marrow Transplant, V3, P45; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Bryukhovetskiy Andrey S, 2015, World J Transplant, V5, P110, DOI 10.5500/wjt.v5.i3.110; Chung J, 2014, J NEUROSURG-SPINE, V21, P966, DOI 10.3171/2014.8.SPINE131090; Derakhshanrad N, 2016, SPINAL CORD, V54, P901, DOI 10.1038/sc.2016.10; Derakhshanrad N, 2015, SPINAL CORD, V53, P860, DOI 10.1038/sc.2015.136; Derakhshanrad N, 2015, BASIC CLIN NEUROSCI, V6, P299; Derakhshanrad N, 2013, CELL TRANSPLANT, V22, pS139, DOI 10.3727/096368913X672109; Dittgen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029880; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Gibson CL, 2005, J NEUROPATH EXP NEUR, V64, P763, DOI 10.1097/01.jnen.0000179196.10032.dd; Guest J, 2012, J NEUROSURG-SPINE, V17, P94, DOI 10.3171/2012.5.AOSPINE1289; Guo XH, 2012, INT J NEUROSCI, V122, P723, DOI 10.3109/00207454.2012.716109; Guo YJ, 2014, J NEUROSCI RES, V92, P751, DOI 10.1002/jnr.23362; Harrop JS, 2012, J NEUROSURG-SPINE, V17, P230, DOI 10.3171/2012.5.AOSPINE12115; Huang HY, 2012, CELL TRANSPLANT, V21, pS23, DOI 10.3727/096368912X633734; Hyun JK, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/650857; Inada T, 2014, SPINE, V39, P213, DOI 10.1097/BRS.0000000000000121; Itzkovich M, 2007, DISABIL REHABIL, V29, P1926, DOI 10.1080/09638280601046302; Kadota R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050391; Kawabe J, 2011, J NEUROSURG-SPINE, V15, P414, DOI 10.3171/2011.5.SPINE10421; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Koda M, 2007, BRAIN RES, V1149, P223, DOI 10.1016/j.brainres.2007.02.058; NAGATA S, 1986, NATURE, V319, P415, DOI 10.1038/319415a0; NICOLA NA, 1983, J BIOL CHEM, V258, P9017; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Pitzer C, 2010, J NEUROCHEM, V113, P930, DOI 10.1111/j.1471-4159.2010.06659.x; Ringelstein EB, 2013, STROKE, V44, P2681, DOI 10.1161/STROKEAHA.113.001531; Saberi H, 2014, CELL TRANSPLANT, V23, pS19, DOI 10.3727/096368914X684943; Saberi H, 2011, J NEUROSURG-SPINE, V15, P515, DOI 10.3171/2011.6.SPINE10917; Sakuma T, 2012, SPINE, V37, P1475, DOI 10.1097/BRS.0b013e318260cc71; Sakuma T, 2012, EUR SPINE J, V21, P482, DOI 10.1007/s00586-011-2020-2; Salzberg CA, 1996, AM J PHYS MED REHAB, V75, P96, DOI 10.1097/00002060-199603000-00004; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Takahashi H, 2012, EUR SPINE J, V21, P2580, DOI 10.1007/s00586-012-2213-3; Tuszynski MH, 2007, SPINAL CORD, V45, P222, DOI 10.1038/sj.sc.3102009	40	16	16	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	JUL	2018	29	1					97	107		10.3171/2017.11.SPINE17769			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GO5CK	WOS:000440035400015	29701561	Bronze			2022-02-06	
J	Eckner, JT; O'Connor, KL; Broglio, SP; Ashton-Miller, JA				Eckner, James T.; O'Connor, Kathryn L.; Broglio, Steven P.; Ashton-Miller, James A.			Comparison of Head Impact Exposure Between Male and Female High School Ice Hockey Athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; female athletes; head impact biomechanics; ice hockey; X-Patch	TRAUMATIC BRAIN-INJURY; SEGMENT DYNAMIC STABILIZATION; COLLEGIATE FOOTBALL PLAYERS; SPORTS-RELATED CONCUSSION; GENDER-DIFFERENCES; SEX-DIFFERENCES; SOCCER PLAYERS; MUSCLE STRENGTH; UNITED-STATES; ACCELERATION	Background: Concussion incidence rates are higher among female than male athletes in sports played by both sexes. Biomechanical factors may play a role in observed sex-based differences in concussion incidence. Purpose: To compare head impact counts and magnitudes during sports participation between male and female high school ice hockey athletes. Study Design: Cohort study; Level of evidence, 2. Methods: Over 2 seasons, a total of 21 male and 19 female ice hockey athletes from a single high school were instrumented with impact-sensing adhesive skin patches worn over the mastoid process while participating in games and practices. The impact sensors recorded the number, magnitude (peak linear acceleration [PLA, g] and peak angular acceleration [PAA, rad/s(2)] of the head; Head Impact Telemetry severity profile [HITsp]), and location of impacts sustained during each instrumented session. Head impact counts, magnitudes, and locations were compared between the sexes. Results: Males experienced more head impacts than females during games (mean +/- SD: 7.7 +/- 3.0 vs 5.3 +/- 2.0, P < .001) as well as practices (4.3 +/- 1.6 vs 3.8 +/- 1.1, P = .002). Mean impact magnitudes were greater for females for PLA (18.8g +/- 1.7g vs 17.1g +/- 1.6g, P < .001) and HITsp (19.7 +/- 1.5 vs 17.7 +/- 1.4, P < .001), while mean PAA was greater for males (3057.6 +/- 2.0 rad/s(2) vs 2778.3 +/- 2.7 rad/s(2), P < .001). Female athletes experienced higher PLA, PAA, and HITsp magnitudes for the top 10%, 5%, and 1% of impacts (all P < .050). Males experienced more impacts to the front (34.3%) and back (31.7%) of the head, while females experienced more impacts to the side (43.1%) and top (4.1%) (x(2) = 295.70, df = 3, P < .001). Conclusion: While male high school ice hockey athletes experienced more head impacts than females, impact magnitudes tended to be higher for females.	[Eckner, James T.; O'Connor, Kathryn L.; Broglio, Steven P.; Ashton-Miller, James A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA; [O'Connor, Kathryn L.; Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA		Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu		Van Pelt, Kathryn/0000-0002-5494-2357	University of Michigan Sport, Health and Activity Research and Policy Center for Women and Girls; Rehabilitation Medicine Scientist Training Program [K12HD001097]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23HD078502]; Proctor GambleProcter & Gamble; Hologic; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078502, K12HD001097] Funding Source: NIH RePORTER	This research was supported by a pilot grant from the University of Michigan Sport, Health and Activity Research and Policy Center for Women and Girls. J.T.E. received effort support from the Rehabilitation Medicine Scientist Training Program (K12HD001097) and the National Institutes of Health (K23HD078502) during the study period. J.A.A.-M. and his Biomechanics Research Laboratory have partial support in the form of grants to the University of Michigan from Proctor & Gamble and Hologic for research that is unrelated to the topic of this article.	Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Jordan A, 1999, SPINE, V24, P1343, DOI 10.1097/00007632-199907010-00012; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lennon A., 2015, THESIS; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Mansell J, 2005, J ATHL TRAINING, V40, P310; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Morin S., 2009, PLAY LIKE A GIRL; Morrison M., 2015, J BIOSENS BIOELECTRO, V6, P1; National Collegiate Athletic Association, 2017, NCAA SPORTS SPONS PA; National Federation of State High School Associations, 2016, 2014 15 HIGH SCH ATH; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Siegmund G, 2015, INT RES COUNC BIOM 2; Staudte H W, 1994, Eur Spine J, V3, P155, DOI 10.1007/BF02190578; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; USA Hockey, 2017, 2015 2016 SEAS FIN R; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	65	16	16	1	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2018	46	9					2253	2262		10.1177/0363546518777244			10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	GN4BM	WOS:000438958100028	29856659				2022-02-06	
J	Wang, WH; Zinsmaier, AK; Firestone, E; Lin, RZ; Yatskievych, TA; Yang, S; Zhang, JS; Bao, SW				Wang, Weihua; Zinsmaier, Alexander K.; Firestone, Ethan; Lin, Ruizhu; Yatskievych, Tatiana A.; Yang, Sungchil; Zhang, Jinsheng; Bao, Shaowen			Blocking Tumor Necrosis Factor-Alpha Expression Prevents Blast-Induced Excitatory/Inhibitory Synaptic Imbalance and Parvalbumin-Positive Interneuron Loss in the Hippocampus	JOURNAL OF NEUROTRAUMA			English	Article						blast exposure; hippocampus; synaptic transmission; TNF-alpha; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MICROGLIAL ACTIVATION; TNF-ALPHA; COGNITIVE DYSFUNCTION; WHITE-MATTER; MICROGLIA/MACROPHAGE POLARIZATION; RECEPTOR TRAFFICKING; AMPA-RECEPTOR; INHIBITION; MODEL	Traumatic brain injury (TBI) is a major cause of neurological disorder and death in civilian and military populations. It comprises two components-direct injury from the traumatic impact and secondary injury from ensuing neural inflammatory responses. Blocking tumor necrosis factor-alpha (TNF-alpha), a central regulator of neural inflammation, has been shown to improve functional recovery after TBI. However, the mechanisms underlying those therapeutic effects are still poorly understood. Here, we examined effects of 3,6 '-dithiothalidomide (dTT), a potentially therapeutic TNF-alpha inhibitor, in mice with blast-induced TBI. We found that blast exposure resulted in elevated expression of TNF-alpha, activation of microglial cells, enhanced excitatory synaptic transmission, reduced inhibitory synaptic transmission, and a loss of parvalbumin-positive (PV+) inhibitory interneurons. Administration of dTT for 5 days after the blast exposure completely suppressed blast-induced increases in TNF-alpha transcription, largely reversed blasted-induced synaptic changes, and prevented PV+ neuron loss. However, blocking TNF-alpha expression by dTT failed to mitigate blast-induced microglial activation in the hippocampus, as evidenced by their non-ramified morphology. These results indicate that TNF-alpha plays a major role in modulating neuronal functions in blast-induced TBI and that it is a potential target for treatment of TBI-related brain disorders.	[Wang, Weihua; Zinsmaier, Alexander K.; Lin, Ruizhu; Yatskievych, Tatiana A.; Bao, Shaowen] Univ Arizona, Coll Med, Dept Physiol, Tucson, AZ 85724 USA; [Firestone, Ethan; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI USA; [Firestone, Ethan; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Commun Sci & Disorders, Detroit, MI USA; [Lin, Ruizhu] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Genet & Endocrinol, Guangzhou, Guangdong, Peoples R China; [Yang, Sungchil] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China		Bao, SW (corresponding author), Univ Arizona, Coll Med, Dept Physiol, Tucson, AZ 85724 USA.	sbao@email.arizona.edu		YANG, Sungchil/0000-0003-3408-2019	Department of DefenseUnited States Department of Defense [W81XWH-15-1-0356, W81XWH-15-1-0357]; Food and Health Bureau of Hong Kong Special Administrative Region Government [04150076]	This work was support by Department of Defense (W81XWH-15-1-0356 for SB, W81XWH-15-1-0357 for JZ) and by Food and Health Bureau of Hong Kong Special Administrative Region Government (04150076 for SY).	Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Antonucci F, 2012, J NEUROSCI, V32, P1989, DOI 10.1523/JNEUROSCI.2720-11.2012; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baune BT, 2008, AM J MED GENET B, V147B, P1056, DOI 10.1002/ajmg.b.30712; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Beattie MS, 2010, EUR J NEUROSCI, V32, P290, DOI 10.1111/j.1460-9568.2010.07343.x; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Braun M, 2017, J IMMUNOL, V198, P3615, DOI 10.4049/jimmunol.1601948; Cao R, 2006, NEUROSCI LETT, V401, P136, DOI 10.1016/j.neulet.2006.03.005; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; Dang DK, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0478-x; DeWalt GJ, 2017, J COMP NEUROL, V525, P2955, DOI 10.1002/cne.24252; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hanlon LA, 2017, EXP NEUROL, V290, P1, DOI 10.1016/j.expneurol.2016.12.010; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hovens IB, 2015, NEUROBIOL LEARN MEM, V118, P74, DOI 10.1016/j.nlm.2014.11.009; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Leonoudakis D, 2008, J NEUROSCI, V28, P2119, DOI 10.1523/JNEUROSCI.5159-07.2008; Liu S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/290182; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Management of Concussion-mTBI Working Group, 2016, VA DOD CLIN PRACT GU; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Pribiag H, 2013, J NEUROSCI, V33, P15879, DOI 10.1523/JNEUROSCI.0530-13.2013; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Steinmetz CC, 2010, J NEUROSCI, V30, P14685, DOI 10.1523/JNEUROSCI.2210-10.2010; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Su XF, 2015, NEUROCHEM RES, V40, P643, DOI 10.1007/s11064-014-1510-0; Sun YX, 2013, NEUROL SCI, V34, P345, DOI 10.1007/s10072-012-1007-z; Takaki J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-275; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yang S, 2014, CEREB CORTEX, V24, P1956, DOI 10.1093/cercor/bht053; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86; Yoon JS, 2013, J NEUROSCI RES, V91, P671, DOI 10.1002/jnr.23190; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zou LL, 2002, J CEREBR BLOOD F MET, V22, P959, DOI 10.1097/00004647-200208000-00007	91	16	16	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	19					2306	2316		10.1089/neu.2018.5688		JUN 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV3OA	WOS:000434097800001	29649942				2022-02-06	
J	Baez-Jurado, E; Hidalgo-Lanussa, O; Guio-Vega, G; Ashraf, GM; Echeverria, V; Aliev, G; Barreto, GE				Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Guio-Vega, Gina; Ashraf, Ghulam Md; Echeverria, Valentina; Aliev, Gjumrakch; Barreto, George E.			Conditioned Medium of Human Adipose Mesenchymal Stem Cells Increases Wound Closure and Protects Human Astrocytes Following Scratch Assay In Vitro	MOLECULAR NEUROBIOLOGY			English	Article						Human astrocytes; Brain injury; Conditioned medium; Mesenchymal stem cells; Migration; Scratch	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; FIBRILLARY ACIDIC PROTEIN; SPINAL-CORD-INJURY; HUMAN BONE-MARROW; REACTIVE ASTROCYTES; GLUCOSE DEPRIVATION; MORPHOLOGICAL-CHANGES; NEURITE OUTGROWTH; PARACRINE FACTORS	Astrocytes perform essential functions in the preservation of neural tissue. For this reason, these cells can respond with changes in gene expression, hypertrophy, and proliferation upon a traumatic brain injury event (TBI). Different therapeutic strategies may be focused on preserving astrocyte functions and favor a non-generalized and non-sustained protective response over time post-injury. A recent strategy has been the use of the conditioned medium of human adipose mesenchymal stem cells (CM-hMSCA) as a therapeutic strategy for the treatment of various neuropathologies. However, although there is a lot of information about its effect on neuronal protection, studies on astrocytes are scarce and its specific action in glial cells is not well explored. In the present study, the effects of CM-hMSCA on human astrocytes subjected to scratch assay were assessed. Our findings indicated that CM-hMSCA improved cell viability, reduced nuclear fragmentation, and preserved mitochondrial membrane potential. These effects were accompanied by morphological changes and an increased polarity index thus reflecting the ability of astrocytes to migrate to the wound stimulated by CM-hMSCA. In conclusion, CM-hMSCA may be considered as a promising therapeutic strategy for the protection of astrocyte function in brain pathologies.	[Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Guio-Vega, Gina; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA; [Echeverria, Valentina] Univ San Sebastian, Fac Cs Salud, Lientur 1457, Concepcion 4080871, Chile; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Moscow Region, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Univ Atlanta, Healthcare Adm, Johns Creek, GA 30097 USA; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gsampaio@javeriana.edu.co	Ashraf, Ghulam Md/H-9485-2012; Barreto, George E./AAD-7420-2020; Valentina Echeverria Moran, BCh/E-7765-2013; Aliev, Gjumrakch/AAE-7734-2020	Ashraf, Ghulam Md/0000-0002-9820-2078; Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Aliev, Gjumrakch/0000-0001-7373-3182; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X	PUJ [6260]; Vicerrectoria Academica of PUJ	The authors thank Dr. Camilo Prieto and the staff of the cosmetic surgery in Bogota, Colombia, for the adipose tissue samples. This work was supported by PUJ ID 6260 to GEB and scholarship for doctoral studies awarded by the Vicerrectoria Academica of PUJ to Baez-Jurado E.	Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Aye T, 2011, DIABETES CARE, V34, P1458, DOI 10.2337/dc10-2164; Baez E, 2017, NEUROTOX RES, V32, P163, DOI 10.1007/s12640-017-9733-x; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Beller JA, 2014, NEURAL REGEN RES, V9, P343, DOI 10.4103/1673-5374.128235; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bovolenta P, 2000, PROG NEUROBIOL, V61, P113, DOI 10.1016/S0301-0082(99)00044-1; Bozoyan L, 2012, J NEUROSCI, V32, P1687, DOI 10.1523/JNEUROSCI.5531-11.2012; Brown JIM, 1998, NEUROSURGERY, V42, P1057, DOI 10.1097/00006123-199805000-00060; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Calviello LA, 2017, MINERVA ANESTESIOL, V83, P844, DOI 10.23736/S0375-9393.17.12043-2; Cano V, 2014, NEUROREPORT, V25, P819, DOI 10.1097/WNR.0000000000000180; Chen J, 2015, CELL PHYSIOL BIOCHEM, V37, P1830, DOI 10.1159/000438545; Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063; Dennis EL, 2017, NEUROIMAGE-CLIN, V15, P125, DOI 10.1016/j.nicl.2017.03.014; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Ding S, 2014, NEURAL REGEN RES, V9, P2048, DOI 10.4103/1673-5374.147929; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Duncan T, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0567-5; Egashira Y, 2012, BRAIN RES, V1461, P87, DOI 10.1016/j.brainres.2012.04.033; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; FaberElman A, 1995, FASEB J, V9, P1605, DOI 10.1096/fasebj.9.15.8529840; Farhan H, 2016, TRENDS CELL BIOL, V26, P241, DOI 10.1016/j.tcb.2015.11.003; FEDOROFF S, 1984, J NEUROSCI RES, V12, P15, DOI 10.1002/jnr.490120103; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; FOKSEANG J, 1995, BRAIN RES, V689, P207, DOI 10.1016/0006-8993(95)00575-B; Frese L, 2016, TRANSFUS MED HEMOTH, V43, P268, DOI 10.1159/000448180; Gralinski LE, 2013, MBIO, V4, DOI 10.1128/mBio.00271-13; Gzielo K, 2017, CELL MOL NEUROBIOL, V37, P783, DOI 10.1007/s10571-016-0417-5; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hershey T, 2005, DIABETES CARE, V28, P2372, DOI 10.2337/diacare.28.10.2372; Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Huang WY, 2015, J CELL PHYSIOL, V230, P2461, DOI 10.1002/jcp.24981; Huang XQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-145; Ishii T, 2017, J BIOL CHEM, V292, P1240, DOI 10.1074/jbc.M116.748871; Jacobsen CT, 2003, DEV NEUROSCI-BASEL, V25, P207, DOI 10.1159/000072269; Jain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016135; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Johnson KM, 2015, NEUROSCI LETT, V600, P104, DOI 10.1016/j.neulet.2015.06.013; Kane CJM, 2014, ALCOHOL CLIN EXP RES, V38, P384, DOI 10.1111/acer.12244; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim WS, 2008, J DERMATOL SCI, V49, P133, DOI 10.1016/j.jdermsci.2007.08.004; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee DE, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0303-6; Li Z, 2010, INDIAN J BIOCHEM BIO, V47, P359; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meadows EA, 2017, J INT NEUROPSYCH SOC, V23, P451, DOI 10.1017/S1355617717000352; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Mytych J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304575; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI [10.1016/j.mito.2010.10.007, 10.1016/j.mito.2011.09.001]; Paco S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2623-4; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Paquet M, 2006, J COMP NEUROL, V494, P752, DOI 10.1002/cne.20854; Pawitan JA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965849; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pirici D, 2009, ROM J MORPHOL EMBRYO, V50, P381; Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qiu CX, 2014, ANN NEUROL, V75, P138, DOI 10.1002/ana.24063; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rutkowska A, 2015, GLIA, V63, P341, DOI 10.1002/glia.22757; Salgado AJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00249; Saur L, 2014, BRAIN STRUCT FUNCT, V219, P293, DOI 10.1007/s00429-012-0500-8; Seaquist ER, 2015, PSYCHOSOM MED, V77, P616, DOI 10.1097/PSY.0000000000000207; Shen CY, 2015, MOL MED REP, V12, P20, DOI 10.3892/mmr.2015.3409; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Song M, 2015, J NEUROSCI RES, V93, P973, DOI 10.1002/jnr.23569; Steele ML, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.018; Stiles MC, 2010, MINERVA MED, V101, P105; Su J, 2012, TRANSL PEDIATR, V1, P108, DOI 10.3978/j.issn.2224-4336.2012.04.06; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun H., 2013, PLOS ONE, V8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teixeira FG, 2013, CELL MOL LIFE SCI, V70, P3871, DOI 10.1007/s00018-013-1290-8; Tiryaki VM, 2015, NANOMEDICINE-UK, V10, P529, DOI 10.2217/nnm.14.33; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Vardjan N, 2014, GLIA, V62, P566, DOI 10.1002/glia.22626; Walter MNM, 2015, J STEM CELLS REGEN, V11, pP18; Wei X, 2009, NEUROSCI LETT, V462, P76, DOI 10.1016/j.neulet.2009.06.054; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Xiong J., 2006, NEW METHOD STUDYING; Xu C, 2017, INT J NEUROSCI, V127, P1124, DOI 10.1080/00207454.2017.1325884; Yalvac ME, 2013, BRAIN BEHAV IMMUN, V32, P122, DOI 10.1016/j.bbi.2013.03.007; Yamazaki H, 2015, NEUROSCI LETT, V609, P53, DOI 10.1016/j.neulet.2015.10.023; Yasen AL, 2017, MED SCI SPORT EXER, V49, P1066, DOI 10.1249/MSS.0000000000001217; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zeng Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119912; Zhang L, 2015, CELL STEM CELL, V17, P735, DOI 10.1016/j.stem.2015.09.012; Zhang L, 2015, TOXICOL LETT, V236, P43, DOI 10.1016/j.toxlet.2015.04.015; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015	116	16	16	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2018	55	6					5377	5392		10.1007/s12035-017-0771-4			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF5FI	WOS:000431991500067	28936798				2022-02-06	
J	Chen, C; Peng, J; Sribnick, EA; Zhu, MT; Xiang, H				Chen, Cheng; Peng, Jin; Sribnick, Eric A.; Zhu, Motao; Xiang, Henry			Trend of Age-Adjusted Rates of Pediatric Traumatic Brain Injury in US Emergency Departments from 2006 to 2013	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; pediatric; emergency department; annual percent change	UNITED-STATES; SURVEILLANCE; CONCUSSION; VISITS; MILD; CARE	Objective: To use the 2006-2013 Nationwide Emergency Department Sample (NEDS) database to describe trends of age-adjusted rates of pediatric traumatic brain injuries (TBI) treated in U.S. emergency departments. Methods: Time trend analysis was conducted on age-adjusted rates among children 17 years in the U.S. The annual percent change (APC) was calculated by fitting a least squares regression to the logarithm of the rates, using the calendar year as an independent variable. Results: In males, motor-vehicle-related trauma (APC -2.5%) and severe TBI (APC -3.6%) decreased over the study time period. Conversely, concussion (APC 5.1%), unspecified head injury (APC 6.6%), fall-related TBI (APC 7.1%), and mild TBI (APC 5.9%) increased. In females, severe TBI (APC -3.3%) decreased over the study time period and concussion (APC 6.5%), unspecified head injury (APC 7.2%), fall-related TBI (APC 7.6%), and mild TBI (APC 6.8%) increased. Conclusion: The overall age-adjusted rates of pediatric TBI-related emergency department (ED) visits increased from 2006 to 2013, which is largely caused by pediatric mild TBIs, especially unspecified injury to the head (ICD-9-CM code 959.01) and concussion. In comparison, age-adjusted rates of pediatric severe TBIs decreased. A major contributing factor might be a reduced number of traffic-related head trauma.	[Chen, Cheng; Peng, Jin; Sribnick, Eric A.; Xiang, Henry] Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, Columbus, OH 43215 USA; [Chen, Cheng; Peng, Jin; Zhu, Motao; Xiang, Henry] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43215 USA; [Peng, Jin; Xiang, Henry] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Sribnick, Eric A.; Zhu, Motao; Xiang, Henry] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43205 USA; [Sribnick, Eric A.] Nationwide Childrens Hosp, Dept Neurosurg, Columbus, OH 43205 USA		Xiang, H (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, Columbus, OH 43215 USA.; Xiang, H (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43215 USA.; Xiang, H (corresponding author), Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA.; Xiang, H (corresponding author), Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43205 USA.	chencheng616001@gmail.com; Jin.Peng@nationwidechildrens.org; Eric.Sribnick@nationwidechildrens.org; Motao.Zhu@nationwidechildrens.org; Henry.Xiang@nationwidechildrens.org	Sribnick, Eric/AAH-6693-2020	zhu, motao/0000-0001-5639-4801	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01/HS2426301]; Health Resources and Services Administration of the US Department of Health and Human Services [R40MC30759]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS024263] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD085122, R01HD074594] Funding Source: NIH RePORTER	This research was supported by the Agency for Healthcare Research and Quality [grant number R01/HS2426301] and the Health Resources and Services Administration of the US Department of Health and Human Services [grant number R40MC30759]. The conclusions are those of authors and should not be construed as the official position or policy of the funding agencies.	[Anonymous], 1991, IARC Sci Publ, P1; [Anonymous], 2001, RATES TBI RELATED HO; [Anonymous], 2008, 110 C US; [Anonymous], 2000, 106 C US AM; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Beck B, 2016, MED J AUSTRALIA, V204, P407, DOI 10.5694/mja15.01369; Centers for Disease Control and Prevention, BRIDG RAC POP EST 19; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Collins Christy L, 2014, Inj Epidemiol, V1, P13; Cook Alan, 2014, J Trauma Acute Care Surg, V76, P47, DOI 10.1097/TA.0b013e3182ab0d5d; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dao James, 2012, NY TIMES, P12; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Esteve J, 1994, IARC Sci Publ, P1; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Hankey BF, 2000, CANCER CAUSE CONTROL, V11, P31, DOI 10.1023/A:1008953201688; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Kohn MA, 2004, ACAD EMERG MED, V11, P1, DOI 10.1197/S1069-656(03)00578-5; LaMotte Sandee, 2015, CNN; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marr A., 2004, CENTRAL NERVOUS SYST; NIH/National Institute of Neurological Disorders and Stroke, 2017, WORS OUTC SERV MEMB; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Ries L. A. G., 1999, SEER CANC STAT REV 1; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Sosin DM, 1996, BRAIN INJURY, V10, P47; The United States Census Bureau, POP HOUS UN EST; Thompson MC, 2014, BRAIN INJURY, V28, P431, DOI 10.3109/02699052.2014.887146; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	37	16	16	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JUN	2018	15	6							1171	10.3390/ijerph15061171			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	GK8SE	WOS:000436496900122	29874782	Green Submitted, Green Published, gold			2022-02-06	
J	Santi, A; Genis, L; Aleman, IT				Santi, A.; Genis, L.; Torres Aleman, I.			A Coordinated Action of Blood-Borne and Brain Insulin-Like Growth Factor I in the Response to Traumatic Brain Injury	CEREBRAL CORTEX			English	Article						insulin-like growth factor I; sensorimotor function; traumatic brain injury; treatment of brain injury	PITUITARY DYSFUNCTION; IGF-I; MICE; MODEL; NEUROGENESIS; EXERCISE; BEHAVIOR; STROKE; MOTOR	In response to injury, the brain produces different neuroprotective molecules, such as insulin-like growth factor I (IGF-I). However, IGF-I is also taken up by the brain from the circulation in response to physiological stimuli. Herein, we analyzed in mice the relative contribution of circulating and locally produced IGF-I to increased brain IGF-I levels after insult. Traumatic brain injury (TBI) induced by a controlled impact resulted in increased IGF-I levels in the vicinity of the lesion, but mice with low serum IGF-I showed significantly lower increases. Indeed, in normal mice, peripheral IGF-I accumulated at the lesion site after injury, and at the same time serum IGF-I levels decreased. Collectively, these data suggest that serumIGF-I enter into the brain after TBI and contributes to increased brain IGF-I levels at the injury site. This connection between central and circulating IGF-I provides an amenable route for treatment, as subcutaneous administration of IGF-I to TBI mice led to functional recovery. These latter results add further support to the use of systemic IGF-I or its mimetics for treatment of brain injuries.	[Santi, A.; Genis, L.; Torres Aleman, I.] CSIC, Cajal Inst, Avda Dr Arce 37, Madrid 28002, Spain; [Santi, A.; Genis, L.; Torres Aleman, I.] Ciberned, C Valderrebollo 5, Madrid 28031, Spain		Aleman, IT (corresponding author), CSIC, Cajal Inst, Avda Dr Arce 37, Madrid 28002, Spain.	torres@cajal.csic.es	Torres-Aleman, Ignacio/A-1613-2008	Torres-Aleman, Ignacio/0000-0001-8107-7947; Santi, Andrea/0000-0001-9282-2340	Spanish Ministry of EconomySpanish Government [SAF2013-40710-R]; CIBERNEDInstituto de Salud Carlos III	The Spanish Ministry of Economy (SAF2013-40710-R) and by CIBERNED.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Beilharz EJ, 1998, MOL BRAIN RES, V59, P119, DOI 10.1016/S0169-328X(98)00122-3; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Carro E, 2000, J NEUROSCI, V20, P2926; Ciucci F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000475; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; De Smedt A, 2011, STROKE, V42, P2180, DOI 10.1161/STROKEAHA.110.600783; Fernandez AM, 1998, P NATL ACAD SCI USA, V95, P1253, DOI 10.1073/pnas.95.3.1253; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Garcia-Galloway E, 2003, MOL CELL NEUROSCI, V24, P1027, DOI 10.1016/j.mcn.2003.08.005; Gazit N, 2016, NEURON, V89, P583, DOI 10.1016/j.neuron.2015.12.034; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Guzzetta A, 2009, J NEUROSCI, V29, P6042, DOI 10.1523/JNEUROSCI.5548-08.2009; Hatton J, 1997, J NEUROSURG, V86, P779, DOI 10.3171/jns.1997.86.5.0779; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; LEE WH, 1992, MOL CELL NEUROSCI, V3, P36, DOI 10.1016/1044-7431(92)90006-N; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Mardinly AR, 2016, NATURE, V531, P371, DOI 10.1038/nature17187; Mattlage AE, 2016, J STROKE CEREBROVASC, V25, P1800, DOI 10.1016/j.jstrokecerebrovasdis.2016.03.054; Mitschelen M, 2011, NEUROSCIENCE, V185, P50, DOI 10.1016/j.neuroscience.2011.04.032; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rosario ER, 2013, J HEAD TRAUMA REHAB, V28, P390, DOI 10.1097/HTR.0b013e318250eac6; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Song Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32095; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Aleman IT, 2012, ENDOCRIN METAB CLIN, V41, P395, DOI 10.1016/j.ecl.2012.04.016; Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Trueba-Saiz A, 2016, CURR OPIN BEHAV SCI, V9, P15, DOI 10.1016/j.cobeha.2015.11.013; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	43	16	16	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	JUN	2018	28	6					2007	2014		10.1093/cercor/bhx106			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GL4XK	WOS:000437164200008	28449086	Bronze			2022-02-06	
J	Singer, W; Kasini, K; Manthey, M; Eckert, P; Armbruster, P; Vogt, MA; Jaumann, M; Dotta, M; Yamahara, K; Harasztosi, C; Zimmermann, U; Knipper, M; Ruttiger, L				Singer, Wibke; Kasini, Kamyar; Manthey, Marie; Eckert, Philipp; Armbruster, Philipp; Vogt, Miriam Annika; Jaumann, Mirko; Dotta, Michela; Yamahara, Kohei; Harasztosi, Csaba; Zimmermann, Ulrike; Knipper, Marlies; Ruettiger, Lukas			The glucocorticoid antagonist mifepristone attenuates sound-induced long-term deficits in auditory nerve response and central auditory processing in female rats	FASEB JOURNAL			English	Article						glucocorticoid receptors; mineralocorticoid receptors; hidden hearing loss; synaptic ribbon; auditory trauma	SENSORINEURAL HEARING-LOSS; TRAUMATIC BRAIN-INJURY; OUTER HAIR-CELLS; RESTRAINT STRESS; ACOUSTIC TRAUMA; GUINEA-PIG; MINERALOCORTICOID RECEPTOR; COCHLEAR SYNAPTOPATHY; INTRATYMPANIC DEXAMETHASONE; INNER-EAR	Systemic corticosteroids have been the mainstay of treatment for various hearing disorders for more than 30 yr. Accordingly, numerous studies have described glucocorticoids (GCs) and stressors to be protective in the auditory organ against damage associated with a variety of health conditions, including noise exposure. Conversely, stressors are also predictive risk factors for hearing disorders. How both of these contrasting stress actions are linked has remained elusive. Here, we demonstrate that higher corticosterone levels during acoustic trauma in female rats is highly correlated with a decline of auditory fiber responses in high-frequency cochlear regions, and that hearing thresholds and the outer hair cell functions (distortion products of otoacoustic emissions) are left unaffected. Moreover, when GC receptor (GR) or mineralocorticoid receptor (MR) activation was antagonized by mifepristone or spironolactone, respectively, GR, but not MR, inhibition significantly and permanently attenuated trauma-induced effects on auditory fiber responses, including inner hair cell ribbon loss and related reductions of early and late auditory brainstem responses. These findings strongly imply that higher corticosterone stress levels profoundly impair auditory nerve processing, which may influence central auditory acuity. These changes are likely GR mediated as they are prevented by mifepristone.	[Singer, Wibke; Kasini, Kamyar; Manthey, Marie; Eckert, Philipp; Armbruster, Philipp; Vogt, Miriam Annika; Jaumann, Mirko; Dotta, Michela; Yamahara, Kohei; Zimmermann, Ulrike; Knipper, Marlies; Ruettiger, Lukas] Univ Tubingen, Tubingen Hearing Res Ctr, Dept Otolaryngol, Mol Physiol Hearing, Tubingen, Germany; [Harasztosi, Csaba] Univ Tubingen, Tubingen Hearing Res Ctr, Dept Otolaryngol, Sect Physiol Acoust & Commun, Tubingen, Germany; [Yamahara, Kohei] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan		Knipper, M (corresponding author), Univ Tubingen, Dept Otolaryngol, Tubingen Hearing Res Ctr, Elfriede Aulhorn Str 5, D-72076 Tubingen, Germany.	marlies.knipper@uni-tuebingen.de	aa, a·a/AAC-7392-2019	aa, a·a/0000-0002-3281-7547; Vogt, Miriam Annika/0000-0002-3400-5067	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG-Kni-316-10-1, SPP 1608 RU 316/12-1, KN 316/12-1]	This work was supported by the Deutsche Forschungsgemeinschaft (Grants DFG-Kni-316-10-1, SPP 1608 RU 316/12-1, and KN 316/12-1). The authors thank Michael Paolillo (Interfaculty Institute of Biochemistry, University of Tubingen) for reading the manuscript. The authors declare no conflicts of interest.	Adamec R, 2007, BEHAV BRAIN RES, V179, P192, DOI 10.1016/j.bbr.2007.02.001; Perez MA, 2013, NEUROSCIENCE, V246, P94, DOI 10.1016/j.neuroscience.2013.04.044; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bharadwaj HM, 2015, J NEUROSCI, V35, P2161, DOI 10.1523/JNEUROSCI.3915-14.2015; Boudaba C, 2006, AM J PHYSIOL-REG I, V291, pR102, DOI 10.1152/ajpregu.00795.2005; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Burkard R. F., 2007, AUDITORY EVOKED POTE, P229; Canlon B, 2007, HEARING RES, V226, P61, DOI 10.1016/j.heares.2006.05.009; Chavez CM, 2009, NEUROBIOL LEARN MEM, V91, P382, DOI 10.1016/j.nlm.2008.10.010; Dagnino-Subiabre A, 2009, BEHAV BRAIN RES, V203, P88, DOI 10.1016/j.bbr.2009.04.024; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; de Kloet ER, 2013, EUR J PHARMACOL, V719, P53, DOI 10.1016/j.ejphar.2013.04.053; de Kloet ER, 2014, ENDOCRINOLOGY, V155, P2754, DOI 10.1210/en.2014-1048; El Sabbagh NG, 2017, LARYNGOSCOPE, V127, P1897, DOI 10.1002/lary.26394; El-Badry MM, 2007, BRAIN RES, V1134, P122, DOI 10.1016/j.brainres.2006.11.078; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Felmingham KL, 2012, BIOL PSYCHOL, V90, P224, DOI 10.1016/j.biopsycho.2012.03.011; Fetoni AR, 2016, FREE RADICAL BIO MED, V101, P211, DOI 10.1016/j.freeradbiomed.2016.10.014; Fox LC, 2016, BEHAV BRAIN RES, V312, P362, DOI 10.1016/j.bbr.2016.06.048; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Hickox AE, 2017, HEARING RES, V349, P164, DOI 10.1016/j.heares.2016.12.010; Hobson CE, 2016, CURR OPIN OTOLARYNGO, V24, P407, DOI 10.1097/MOO.0000000000000288; Howland RH, 2013, J PSYCHOSOC NURS MEN, V51, P11, DOI 10.3928/02793695-20121219-01; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Jia H, 2016, NEUROSCIENCE, V316, P261, DOI 10.1016/j.neuroscience.2015.12.031; Joels M, 2017, J ENDOCRINOL, V234, pT49, DOI 10.1530/JOE-16-0660; JOHNSON DH, 1976, BIOPHYS J, V16, P719, DOI 10.1016/S0006-3495(76)85724-4; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kil SH, 2013, HEARING RES, V299, P63, DOI 10.1016/j.heares.2013.01.020; Kobel M, 2017, HEARING RES, V349, P148, DOI 10.1016/j.heares.2016.12.008; KORTE SM, 1995, PSYCHONEUROENDOCRINO, V20, P385, DOI 10.1016/0306-4530(94)00069-7; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kurabi A, 2017, HEARING RES, V349, P129, DOI 10.1016/j.heares.2016.11.013; Kyrou I., 2000, ENDOTEXT; Lee HY, 2017, EUR ARCH OTO-RHINO-L, V274, P143, DOI 10.1007/s00405-016-4276-y; Ma LL, 2017, STRESS, V20, P312, DOI 10.1080/10253890.2017.1323861; Marcon S, 2008, HEARING RES, V237, P76, DOI 10.1016/j.heares.2007.12.011; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Melcher JR, 1996, HEARING RES, V93, P52, DOI 10.1016/0378-5955(95)00200-6; Meltser I, 2011, HEARING RES, V281, P47, DOI 10.1016/j.heares.2011.06.003; Muller M, 2017, HNO, V65, pS59, DOI 10.1007/s00106-016-0266-z; MULLER M, 1991, HEARING RES, V57, P63, DOI 10.1016/0378-5955(91)90075-K; Niedermeier K, 2012, ACTA OTO-LARYNGOL, V132, P1252, DOI 10.3109/00016489.2012.701017; O'Byrne PM, 1998, J ALLERGY CLIN IMMUN, V102, P879, DOI 10.1016/S0091-6749(98)70322-7; O'Leary SJ, 2013, HEARING RES, V298, P27, DOI 10.1016/j.heares.2013.01.012; Oitzl MS, 2010, NEUROSCI BIOBEHAV R, V34, P853, DOI 10.1016/j.neubiorev.2009.07.006; Plontke SK, 2014, OTOL NEUROTOL, V35, P1168, DOI 10.1097/MAO.0000000000000434; RAREY KE, 1995, HEARING RES, V82, P135, DOI 10.1016/0378-5955(94)00171-L; Ruttiger L, 2017, ORL J OTO-RHINO-LARY, V79, P93, DOI 10.1159/000455705; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Safieddine S, 2012, ANNU REV NEUROSCI, V35, P509, DOI 10.1146/annurev-neuro-061010-113705; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; Sha SH, 2017, EXPERT OPIN INV DRUG, V26, P85, DOI 10.1080/13543784.2017.1269171; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; Singer W, 2016, METHODS MOL BIOL, V1427, P263, DOI 10.1007/978-1-4939-3615-1_15; Singer W, 2013, MOL NEUROBIOL, V47, P261, DOI 10.1007/s12035-012-8372-8; Tahera Y, 2006, J NEUROSCI RES, V83, P1066, DOI 10.1002/jnr.20795; Tahera Y, 2007, NEUROBIOL DIS, V25, P189, DOI 10.1016/j.nbd.2006.09.004; Tahera Y, 2006, ENDOCRINOLOGY, V147, P4430, DOI 10.1210/en.2006-0260; Terakado M, 2011, HEARING RES, V280, P148, DOI 10.1016/j.heares.2011.05.006; Trune DR, 2012, ANAT REC, V295, P1928, DOI 10.1002/ar.22576; Trune DR, 2006, HEARING RES, V212, P22, DOI 10.1016/j.heares.2005.10.006; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Wang Y, 2002, HEARING RES, V165, P96, DOI 10.1016/S0378-5955(02)00289-7; Yao XF, 1996, ACTA OTO-LARYNGOL, V116, P493, DOI 10.3109/00016489609137879; Yoshida N, 2000, HEARING RES, V148, P213, DOI 10.1016/S0378-5955(00)00161-1; Yoshida N, 1999, HEARING RES, V131, P29, DOI 10.1016/S0378-5955(99)00008-8	70	16	16	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3005	3019		10.1096/fj.201701041RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	WOS:000432546000010	29401591				2022-02-06	
J	Jalloh, I; Helmy, A; Howe, DJ; Shannon, RJ; Grice, P; Mason, A; Gallagher, CN; Murphy, MP; Pickard, JD; Menon, DK; Carpenter, TA; Hutchinson, PJ; Carpenter, KLH				Jalloh, Ibrahim; Helmy, Adel; Howe, Duncan J.; Shannon, Richard J.; Grice, Peter; Mason, Andrew; Gallagher, Clare N.; Murphy, Michael P.; Pickard, John D.; Menon, David K.; Carpenter, T. Adrian; Hutchinson, Peter J.; Carpenter, Keri L. H.			A Comparison of Oxidative Lactate Metabolism in Traumatically Injured and Control Brains	JOURNAL OF NEUROTRAUMA			English	Article						brain metabolism; microdialysis; NMR; 3-C-13 lactate; traumatic brain injury (human)	INTRACRANIAL HYPERTENSIVE EPISODES; MAGNETIC-RESONANCE-SPECTROSCOPY; TRICARBOXYLIC-ACID CYCLE; IN-VIVO; ENERGY-METABOLISM; GLUTAMINE-SYNTHETASE; HYPERTONIC LACTATE; SODIUM LACTATE; BLOOD-FLOW; RAT-BRAIN	Metabolic abnormalities occur after traumatic brain injury (TBI). Glucose is conventionally regarded as the major energy substrate, although lactate can also be an energy source. We compared 3-C-13 lactate metabolism in TBI with "normal" control brain and muscle, measuring C-13-glutamine enrichment to assess tricarboxylic acid (TCA) cycle metabolism. Microdialysis catheters in brains of nine patients with severe TBI, five non-TBI brain surgical patients, and five resting muscle (non-TBI) patients were perfused (24h in brain, 8h in muscle) with 8mmol/L sodium 3-C-13 lactate. Microdialysate analysis employed ISCUS and nuclear magnetic resonance. In TBI, with 3-C-13 lactate perfusion, microdialysate glucose concentration increased nonsignificantly (mean +11.9%, p=0.463), with significant increases (p=0.028) for lactate (+174%), pyruvate (+35.8%), and lactate/pyruvate ratio (+101.8%). Microdialysate C-13-glutamine fractional enrichments (median, interquartile range) were: for C4 5.1 (0-11.1) % in TBI and 5.7 (4.6-6.8) % in control brain, for C3 0 (0-5.0) % in TBI and 0 (0-0) % in control brain, and for C2 2.9 (0-5.7) % in TBI and 1.8 (0-3.4) % in control brain. C-13-enrichments were not statistically different between TBI and control brain, showing both metabolize 3-C-13 lactate via TCA cycle, in contrast to muscle. Several patients with TBI exhibited C-13-glutamine enrichment above the non-TBI control range, suggesting lactate oxidative metabolism as a TBI "emergency option."	[Jalloh, Ibrahim; Helmy, Adel; Shannon, Richard J.; Gallagher, Clare N.; Pickard, John D.; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Howe, Duncan J.; Grice, Peter; Mason, Andrew] Univ Cambridge, Dept Chem, Cambridge, England; [Gallagher, Clare N.] Univ Calgary, Div Neurosurg, Dept Clin Neurosci, Calgary, ON, Canada; [Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England; [Pickard, John D.; Menon, David K.; Carpenter, T. Adrian; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Dept Med, Cambridge, England		Jalloh, I; Carpenter, KLH (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	ibrahim.jalloh@cantab.net; klc1000@wbic.cam.ac.uk	Helmy, Adel/AAS-3084-2020; Murphy, Michael/C-2120-2009	Helmy, Adel/0000-0002-0531-0556; Murphy, Michael/0000-0003-1115-9618; Hutchinson, Peter/0000-0002-2796-1835	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986 ID79068, G1002277 ID98489, G1002277 ID 98489]; National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); KLHC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Medical Research Council/Royal College of Surgeons of England Clinical Research Training FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802251]; Raymond and Beverly Sackler Fellowship; Royal College of Surgeons of England; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); National Institute for Health Research Senior Investigator Awards; Medical Research Council UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105663142]; Wellcome Trust Investigator awardWellcome Trust [110159/Z/15/Z]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105663142, G0001237, G0802251, G0600986, MC_UU_00015/3, G1002277, G9439390] Funding Source: UKRI	The authors thank Mr. John Harwood (Manufacturing Unit, Department of Pharmacy, Ipswich Hospital NHS Trust) for supervising the formulation of the substrate (sodium 3-<SUP>13</SUP>C lactate in CNS perfusion fluid). We thank Dr. Tamara Tajsic (Division of Neurosurgery, University of Cambridge) for assistance with demography (clinical outcomes). The author(s) gratefully acknowledge receipt of the following financial support for the research, authorship, and/or publication of this article: Medical Research Council (Grant Nos. G0600986 ID79068 and G1002277 ID98489) and National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: IJ - Medical Research Council (Grant no. G1002277 ID 98489) and National Institute for Health Research Biomedical Research Centre, Cambridge; KLHC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); CG - the Canadian Institute of Health Research; AH - Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship (Grant no. G0802251) and Raymond and Beverly Sackler Fellowship; Royal College of Surgeons of England and the NIHR Cambridge Biomedical Research Centre; DKM and JDP - National Institute for Health Research Senior Investigator Awards; MPM - Medical Research Council UK (MC_U105663142) and a Wellcome Trust Investigator award (110159/Z/15/Z). PJH - National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health Research Biomedical Research Centre, Cambridge.	Abe T, 2006, J CEREBR BLOOD F MET, V26, P153, DOI 10.1038/sj.jcbfm.9600175; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Bouzat P, 2014, INTENS CARE MED, V40, P920, DOI 10.1007/s00134-014-3312-x; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bouzier AK, 2000, J NEUROCHEM, V75, P480, DOI 10.1046/j.1471-4159.2000.0750480.x; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; BROOKS GA, 1986, FASEB J, V45, P2924; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Duarte JMN, 2015, J NEUROSCI RES, V93, P1009, DOI 10.1002/jnr.23531; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Halim ND, 2010, GLIA, V58, P1168, DOI 10.1002/glia.20996; Hassel B, 2000, MOL NEUROBIOL, V22, P21, DOI 10.1385/MN:22:1-3:021; Hassel B, 2000, J CEREBR BLOOD F MET, V20, P327, DOI 10.1097/00004647-200002000-00014; Henderson GC, 2004, J APPL PHYSIOL, V97, P317, DOI 10.1152/japplphysiol.01367.2003; Hertz L, 2004, J CEREBR BLOOD F MET, V24, P1241, DOI 10.1097/00004647-200411000-00008; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2002, J NEUROL NEUROSUR PS, V72, P99, DOI 10.1136/jnnp.72.1.99; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Jalloh I, 2017, J CEREBR BLOOD F MET, V37, P2626, DOI 10.1177/0271678X16672665; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Mintun MA, 2004, P NATL ACAD SCI USA, V101, P659, DOI 10.1073/pnas.0307457100; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Pardo Beatriz, 2013, Front Endocrinol (Lausanne), V4, P149, DOI 10.3389/fendo.2013.00149; Patet C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0638-5; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Qu H, 2000, DEV NEUROSCI-BASEL, V22, P429, DOI 10.1159/000017472; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Rosafio K, 2016, NEUROSCIENCE, V317, P108, DOI 10.1016/j.neuroscience.2015.12.052; Rose CF, 2013, BIOCHEM SOC T, V41, P1518, DOI 10.1042/BST20130237; Rothman DL, 1999, PHILOS T R SOC B, V354, P1165, DOI 10.1098/rstb.1999.0472; SCHOUSBOE A, 1993, DEV NEUROSCI-BASEL, V15, P359, DOI 10.1159/000111356; Tyson RL, 2003, BRAIN RES, V992, P43, DOI 10.1016/j.brainres.2003.08.027; VANDENBERG CJ, 1966, BIOCHEM BIOPH RES CO, V23, P479, DOI 10.1016/0006-291X(66)90753-4; VANDENBERG CJ, 1969, BIOCHEM J, V113, P281, DOI 10.1042/bj1130281; Vlassenko AG, 2006, P NATL ACAD SCI USA, V103, P1964, DOI 10.1073/pnas.0510632103; Waagepetersen HS, 1998, DEV NEUROSCI-BASEL, V20, P310, DOI 10.1159/000017326	50	16	16	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	17					2025	2035		10.1089/neu.2017.5459		MAY 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ7LU	WOS:000432676000001	29690859	Green Submitted, Green Published, Bronze			2022-02-06	
J	Beauchamp, MH; Aglipay, M; Yeates, KO; Desire, N; Keightley, M; Anderson, P; Brooks, BL; Barrowman, N; Gravel, J; Boutis, K; Gagnon, I; Dubrovsky, AS; Zemek, R				Beauchamp, Miriam H.; Aglipay, Mary; Yeates, Keith Owen; Desire, Naddley; Keightley, Michelle; Anderson, Peter; Brooks, Brian L.; Barrowman, Nick; Gravel, Jocelyn; Boutis, Kathy; Gagnon, Isabelle; Dubrovsky, Alexander Sasha; Zemek, Roger		5P PERC Concussion Team	Predictors of Neuropsychological Outcome After Pediatric Concussion	NEUROPSYCHOLOGY			English	Article						concussion; traumatic brain injury; neuropsychology; cognition; prediction	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; MILD HEAD-INJURY; NEUROCOGNITIVE OUTCOMES; POSTCONCUSSIVE SYMPTOMS; EMERGENCY-DEPARTMENT; CHILDREN; ADOLESCENTS; RECOVERY; IMPAIRMENT	Objective: Previous research suggests that neuropsychological outcome after pediatric concussion is determined by unmodifiable, preexisting factors. This study aimed to predict neuropsychological outcome after pediatric concussion by using a sufficiently large sample to explore a vast array of predictors. Method: A total of 311 children and adolescents (6-18 years old) with concussion were assessed in the emergency department to document acute symptomatology and to screen for cognitive functioning. At 4 and 12 weeks postinjury, they completed tests of intellectual functioning, attention/working memory, executive functions, verbal memory, processing speed, and fine motor abilities. Multiple hierarchical logistic and linear regressions were performed to assess the contribution of premorbid factors, acute symptoms, and acute cognitive screening (Standardized Assessment of Concussion-Child) to aspects of neuropsychological outcome: (a) cognitive inefficiency (defined using a modified Neuropsychological Impairment Rule; Beauchamp et al., 2015) and (b) neuropsychological performance (defined using principal component analysis). Results: Neuropsychological impairment was present in 10.3% and 4.5% of participants at 4 and 12 weeks postinjury, respectively. At 4 weeks postinjury, cognitive inefficiency was predicted by premorbid factors and acute cognitive screening, whereas at 12 weeks it was predicted by acute symptoms. Neuropsychological performance at 4 weeks was predicted by a combination of premorbid factors, acute symptoms, and acute cognitive screening, whereas as at 12 weeks, only acute cognitive screening predicted performance. Conclusions: Neuropsychological outcome after pediatric concussion is not attributable solely to preexisting problems but is instead associated with a combination of preexisting and injury-related variables. Acute cognitive screening appears to be particularly useful in predicting neuropsychological status after concussion.	[Beauchamp, Miriam H.; Desire, Naddley] Univ Montreal, Dept Psychol, CP Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.; Desire, Naddley; Gravel, Jocelyn] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada; [Aglipay, Mary; Barrowman, Nick; Zemek, Roger] Childrens Hosp Eastern Ontario Res Inst, Clin Res Unit, Ottawa, ON, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Dept Occupat Sci, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Dept Occupat Therapy, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario, Behav Neurosci & Consultat Liaison Program, Ottawa, ON, Canada; [Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program Brain Injury & Rehabil, Calgary, AB, Canada; [Barrowman, Nick; Zemek, Roger] Univ Ottawa, Dept Pediat, Ottawa, ON, Canada; [Barrowman, Nick; Zemek, Roger] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Boutis, Kathy] Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Boutis, Kathy] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Gagnon, Isabelle; Dubrovsky, Alexander Sasha] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Montreal, PQ, Canada; [Dubrovsky, Alexander Sasha] McGill Univ, Dept Pediat, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca	Barrowman, Nick/AAL-3166-2020; Mikrogianakis, Angelo/AAW-5929-2021; Yeates, Keith/AAJ-4223-2020; Richer, Lawrence/D-3622-2009	Barrowman, Nick/0000-0002-4704-9595; Mikrogianakis, Angelo/0000-0002-8854-0620; Richer, Lawrence/0000-0002-6897-8668; Yeates, Keith/0000-0001-7680-2892; Burns, Emma/0000-0001-8042-7124; Gagnon, Isabelle/0000-0003-2043-1644; Klassen, Terry/0000-0002-5309-7091; Osmond, Martin/0000-0001-8275-8381; Craig, William/0000-0002-4804-194X	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [126197]; Canadian Institutes of Health Research - Ontario Neurotrauma FoundationMild Traumatic Brain Injury Team [TM1: 127047]	This study was supported by operating grant 126197 from the Canadian Institutes of Health Research; grant TM1: 127047 from the Canadian Institutes of Health Research - Ontario Neurotrauma FoundationMild Traumatic Brain Injury Team. Brian Brooks receives royalties for the sales of the book, Pediatric Forensic Neuropsychology (2012, Oxford University Press), and three pediatric neuropsychological tests [Child and Adolescent Memory Profile (ChAMP; Sherman and Brooks, 2015, PAR Inc.), Memory Validity Profile (MVP, Sherman and Brooks, 2015, PAR Inc.), and Multidimensional Everyday Memory Ratings for Youth (MEMRY; Sherman and Brooks, 2017, PAR Inc.)]. We would like to acknowledge the input and contributions of the entire 5P Study team, with particular thanks to the coordinators and assistants at the neuropsychology substudy sites.	Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; [Anonymous], 2013, Br J Sports Med, V47, P263; Asarnow R, 1995, TRAUMATIC BRAIN INJU, P117; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Beauchamp MH, 2015, J INT NEUROPSYCH SOC, V21, P596, DOI 10.1017/S1355617715000636; Bigler ED, 2015, BRAIN INJURY, V29, P1062, DOI 10.3109/02699052.2015.1011234; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Conners C. K., 2000, CONNERS CONTINUOUS P; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC., 1994, CALIFORNIA VERBAL LE; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Golden C. J., 2003, STROOP COLOR WORD TE; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Lovell M.R., 2005, IMPACT IMMEDIATE POS; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; O'Neill J. A., 2015, J PEDIAT NEUROPSYCHO, V1, P14, DOI [10.1007/s40817-015-0003-7, DOI 10.1007/S40817-015-0003-7]; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Studer M, 2014, J INT NEUROPSYCH SOC, V20, P982, DOI 10.1017/S1355617714000927; Sufrinko A, 2017, J ATHL TRAINING, V52, P676, DOI 10.4085/1062-6050-52.4.01; Taylor AM, 2012, CURR OPIN PEDIATR, V24, P717, DOI 10.1097/MOP.0b013e32835a279b; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Trites R., 1977, GROOVED PEGBOARD TES; Wechsler D., 2005, ECHELLE INTELLIGENCE; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yumul JN, 2016, PM&R, V8, P1097, DOI 10.1016/j.pmrj.2016.05.005; Zasler ND, 2015, BRAIN INJURY, V29, P207, DOI 10.3109/02699052.2014.965213; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550	66	16	16	1	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2018	32	4					495	508		10.1037/neu0000419			14	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GH1GU	WOS:000433151900011	29809036				2022-02-06	
J	Jourdan, C; Azouvi, P; Genet, F; Selly, N; Josseran, L; Schnitzler, A				Jourdan, Claire; Azouvi, Philippe; Genet, Francois; Selly, Nicolas; Josseran, Loic; Schnitzler, Alexis			Disability and Health Consequences of Traumatic Brain Injury National Prevalence	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Brain Injuries; Epidemiology; Prevalence; Disability	ALZHEIMERS-DISEASE; UNITED-STATES; YOUNG-ADULTS; HEAD-INJURY; EPIDEMIOLOGY; POPULATION; TBI; REHABILITATION; DISORDERS; CHILDREN	Objective: The aim of the study was to measure the prevalence of traumatic brain injury (TBI)-related disability and health status in the general population. Design: The French National Survey, conducted in households and institutions, assessed 33,896 adults. Data included sequelae from TBI, impairments, current health conditions, and uses of health services. Analyses, adjusted for age and sex, compared subjects who declared sequelae from TBI (n = 479) with the remaining survey population (n = 33,287). Use of weighting factors ensured that results were representative of the national population. Results: Prevalence of persistent sequelae from TBI in France was 704/100,000. Median time since injury was 14 yrs. For all Core Set items of the International Classification of Functioning, subjects with TBI reported more impairments than the control population: adjusted odds ratios from 1.7 (behavioral difficulties) to 8.6 (motor difficulties). Rates of cardiovascular, respiratory, musculoskeletal, digestive, urological, neurological, and psychiatric conditions were higher in the TBI population. Use of health services was greater, and women with TBI had higher rates of unmet health needs. Conclusions: Persistent sequelae from TBI significantly affect health in the general population. Planning of post-TBI care should address the chronic needs of these persons.	[Jourdan, Claire] CHU Montpellier, Dept Med Phys & Readaptat, 371 Ave Doyen Gaston Giraud, F-34295 Montpellier 5, France; [Jourdan, Claire; Azouvi, Philippe; Selly, Nicolas; Josseran, Loic; Schnitzler, Alexis] Univ Versailles St Quentin, HANDIReSP EA 4047, Le Bretonneux, France; [Azouvi, Philippe; Genet, Francois; Josseran, Loic; Schnitzler, Alexis] APHP CHU Raymond Poincare, Serv Med Phys & Readaptat, Garches, France; [Genet, Francois] CIC IT 1429, Garches, France; [Genet, Francois] Univ Versailles St Quentin Yvelines, UFR Sci, INSERM U1179, Le Bretonneux, France; [Josseran, Loic] Hop Raymond Poincare, AP HP, Dept Informat Med, Garches, France		Jourdan, C (corresponding author), CHU Montpellier, Dept Med Phys & Readaptat, 371 Ave Doyen Gaston Giraud, F-34295 Montpellier 5, France.		josseran, loic/F-3190-2019	josseran, loic/0000-0002-9021-1818	French National Institute of Statistics (INSEE); Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry of France	The Disability and Health Survey was designed, undertaken, and financed by the French National Institute of Statistics (INSEE) and the Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry of France. These institutes did not finance the data analysis or the preparation of the article.	[Anonymous], 2010, MISS INT VUE EL PLAN; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bouvier G, 2011, ENQUETE HANDICAP SAN, V61; Cameron CM, 2005, B WORLD HEALTH ORGAN, V83, P345; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2017, J HEAD TRAUMA REHAB, V32, pE26, DOI 10.1097/HTR.0000000000000276; Knight M, 2001, J PUBLIC HEALTH MED, V23, P179, DOI 10.1093/pubmed/23.3.179; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laursen B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001521; Laxe S, 2013, BRAIN INJURY, V27, P379, DOI 10.3109/02699052.2012.750757; Li LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084336; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schnitzler A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115375; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; United Nations Department of Economic and Social Affairs Statistics Division, 2001, GUID PRINC DEV DIS S; vanBalen HGG, 1996, DISABIL REHABIL, V18, P181, DOI 10.3109/09638289609166298; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Willer B, 1996, NEUROREHABILITATION, V6, P219, DOI 10.3233/NRE-1996-6308; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	45	16	16	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY	2018	97	5					323	331		10.1097/PHM.0000000000000848			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GE4HI	WOS:000431175800010	29016402				2022-02-06	
J	Kerr, ZY; Zuckerman, SL; Wasserman, EB; Vander Vegt, CB; Yengo-Kahn, A; Buckley, TA; Solomon, GS; Sills, AK; Dompier, TP				Kerr, Zachary Y.; Zuckerman, Scott L.; Wasserman, Erin B.; Vander Vegt, Christina B.; Yengo-Kahn, Aaron; Buckley, Thomas A.; Solomon, Gary S.; Sills, Allen K.; Dompier, Thomas P.			Factors associated with post-concussion syndrome in high school student-athletes	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain injuries; Adolescent; Sports; Epidemiology	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; PROLONGED RECOVERY; PREDICTORS; TIME; EPIDEMIOLOGY; PREVALENCE; CONSENSUS; SYMPTOMS	Objectives: To identify factors associated with post-concussion syndrome (PCS) among a national sample of high school student-athletes from the 2011/12-2013/14 academic years. Design: Ambispective cohort study from sports injury surveillance data. Methods: Sport-related concussion data originated from the National Athletic Treatment, Injury and Outcomes Network (NATION) surveillance program, consisting of 27 sports from a convenience sample of 196 high schools across 26 states. All SRCs were reported by certified athletic trainers. The PCS and non-PCS groups consisted of concussed individuals with symptoms resolution time of >4 weeks and <= 2 weeks, respectively. Logistic regression estimated the association of athlete and concussion characteristics on the odds of PCS, and calculated adjusted odds ratios (OR) and 95% confidence intervals (CI). Results: Overall, 1334 concussed high school athletes met inclusion criteria: 215 in the PCS group and 1119 in the non-PCS group. In the multivariable analysis, concussion symptoms associated with increased odds of PCS included: retrograde amnesia (OR=3.01, 95%CI: 1.31-6.91), difficulty concentrating (OR=2.72, 95%CI: 1.56-4.77), disorientation (OR=1.86; 95%CI: 1.04-3.33), insomnia (OR=2.79; 95%CI: 1.62-4.80), loss of balance (OR=1.76; 95%CI: 1.00-3.10), sensitivity to noise (OR=1.80; 95%CI: 1.02-3.17), and visual disturbance (OR=2.21; 95%CI: 1.23-3.97). Sex and recurrent concussion were not associated with PCS. Conclusions: As in previous research, somatic and cognitive symptoms were associated with PCS. The identification of factors associated with PCS may assist clinicians in identifying concussed athletes at greater risk of having longer symptom resolution time.Copyright (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Wasserman, Erin B.; Vander Vegt, Christina B.] Univ N Carolina, Matthew A Gfeller Sport Related Traumat Brain Inj, Chapel Hill, NC USA; [Zuckerman, Scott L.; Yengo-Kahn, Aaron; Solomon, Gary S.; Sills, Allen K.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Med Ctr East, Nashville, TN 37212 USA; [Zuckerman, Scott L.; Yengo-Kahn, Aaron; Solomon, Gary S.; Sills, Allen K.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Vander Vegt, Christina B.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu	Solomon, Gary/K-9011-2019; Buckley, Thomas A/B-7525-2016; Yengo-Kahn, Aaron/AAV-7647-2020	Buckley, Thomas A/0000-0002-0515-0150; Yengo-Kahn, Aaron/0000-0002-5989-3064; Wasserman, Erin/0000-0001-5957-5878; Kerr, Zachary/0000-0003-1423-1259	National Athletic Trainers' Association Research and Education Foundation; BioCrossroads; Central Indiana Corporate Partnership Foundation	Funding for this study was provided by the National Athletic Trainers' Association Research and Education Foundation and BioCrossroads in partnership with the Central Indiana Corporate Partnership Foundation. The organizations that funded this study had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the study sponsors. We thank the many athletic trainers who have volunteered their time and efforts to submit data to NATION. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school student-athletes.	*AM PSCH ASS, 2000, DIAGN STAT MAN MENT; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Centers for Medicare and Medicaid Services, 2017, ICD9CM DIAGN PROC CO; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Currie DW, 2016, J HEAD TRAUMA REHAB, DOI [10.1097/htr.0000000000000240, DOI 10.1097/HTR.0000000000000240.PUBLISHED]; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lombardi NJ, 2016, ORTHOPEDICS, V39, pE944, DOI 10.3928/01477447-20160623-10; Luoto TM, 2015, BRAIN INJURY, V29, P565, DOI 10.3109/02699052.2014.1002421; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Tator Charles H, 2014, Neurosurgery, V75 Suppl 4, pS106, DOI 10.1227/NEU.0000000000000484; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Zuckerman SL, 2015, INT J SPORTS MED, V36, P419, DOI 10.1055/s-0034-1395587; Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	29	16	16	1	18	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2018	21	5					447	452		10.1016/j.jsams.2017.08.025			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GF8NY	WOS:000432230800004	28939003				2022-02-06	
J	Okur, SC; Erdogan, S; Demir, CS; Gunel, G; Karaoz, E				Okur, Sibel Caglar; Erdogan, Sinan; Demir, Cansu Subasi; Gunel, Gulsen; Karaoz, Erdal			The Effect of Umbilical Cord-derived Mesenchymal Stem Cell Transplantation in a Patient with Cerebral Palsy: A Case Report	INTERNATIONAL JOURNAL OF STEM CELLS			English	Article						Cerebral palsy; Mesenchymal stem cell; Rehabilitation	TRAUMATIC BRAIN-INJURY; STROMAL CELLS; PRECURSORS; THERAPIES	Background: Cerebral Palsy (CP) is the most common motor disability reason of childhood that occurs secondarily to non-progressive damage in the brain whose development is still ongoing. Methods: 6-year-old dystonic-spastic male CP patient received allogenic mesenchymal stem cells treatment four times as 1x10(6)/kg in intrathecal and intravenous administration of Umbilical Cord-derived mesenchymal stem cells (UC-MSCs) ways. Before and after the treatment, the patient was followed-up with FIM (Functional Independent Measurement), GMFCS (Gross Motor Function Classification System 88), Tardieu Scale, TCMS (Trunk Control Measurement Scale), MACS (Manual Ability Classification Scale), CFSS (Communication Function Classification System) for 18 months and received intensive rehabilitation. Results: Improvements were observed especially in functional scales except for the Tardieu Scale, and no adverse effects were detected aside from a slight pain in the back. Conclusion: Wider future case studies on UC-MSCs will enable us to assess the efficacy of UC-MSCs which have positive impacts especially on functional scales.	[Okur, Sibel Caglar] Hlth Sci Univ, Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Phys Therapy & Rehab, Istanbul, Turkey; [Erdogan, Sinan; Karaoz, Erdal] Istinye Univ, Fac Med, Dept Histol & Embryol, Istanbul, Turkey; [Demir, Cansu Subasi; Gunel, Gulsen; Karaoz, Erdal] Istinye Univ, Ctr Stem Cell & Tissue Engn Res & Practice, Istanbul, Turkey; [Karaoz, Erdal] Liv Hosp, Ctr Regenerat Med & Stem Cell Mfg LivMedCell, Istanbul, Turkey		Okur, SC (corresponding author), Hlth Dr Sadi Konuk Educ & Res Hosp, Dept Phys Med & Rehabil, Tevfik Saglam Cad 11, TR-34147 Istanbul, Turkey.	sibelcaglarokur@gmail.com	Karaoz, Erdal/AAO-1470-2020; Gunel, Gulsen/ABF-8146-2021; Caglar Okur, Sibel/U-3126-2017	Gunel, Gulsen/0000-0003-1574-0231; Caglar Okur, Sibel/0000-0002-4015-5977			Azari MF, 2010, CURR NEUROPHARMACOL, V8, P316, DOI 10.2174/157015910793358204; Broughton BRS, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00066; Cruz-Martinez P, 2014, REGEN MED, V9, P579, DOI [10.2217/RME.14.38, 10.2217/rme.14.38]; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Goldstein M, 2004, J PEDIATR-US, V145, pS42, DOI 10.1016/j.jpeds.2004.05.022; Han Hoon, 2011, J Med Case Rep, V5, P562, DOI 10.1186/1752-1947-5-562; Ichim Thomas E, 2010, Int Arch Med, V3, P30, DOI 10.1186/1755-7682-3-30; Kim Y, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0236-5; Koman LA, 2004, LANCET, V363, P1619, DOI 10.1016/S0140-6736(04)16207-7; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Lindvall O, 2004, STROKE, V35, P2691, DOI 10.1161/01.STR.0000143323.84008.f4; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mehta T, 2008, TRANSPL P, V40, P1145, DOI 10.1016/j.transproceed.2008.03.026; Nelson KB, 2003, NEW ENGL J MED, V349, P1765, DOI 10.1056/NEJMsb035364; Paneth N, 2006, CLIN PERINATOL, V33, P251, DOI 10.1016/j.clp.2006.03.011; Phermthai T, 2017, CYTOTHERAPY, V19, P990, DOI 10.1016/j.jcyt.2017.04.004; Purandare Chaitanya, 2012, Case Rep Transplant, V2012, P825289, DOI 10.1155/2012/825289; Rengasamy M, 2016, INDIAN J MED RES, V144, P852, DOI 10.4103/ijmr.IJMR_1842_15; Sankar V, 2003, NEUROSCIENCE, V118, P11, DOI 10.1016/S0306-4522(02)00929-6; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Vaquero J, 2017, CYTOTHERAPY, V19, P349, DOI 10.1016/j.jcyt.2016.12.002; Wang Liming, 2013, Case Rep Transplant, V2013, P146347, DOI 10.1155/2013/146347; Wei CC, 2014, CELL TRANSPLANT, V23, P505, DOI 10.3727/096368914X678328	24	16	17	0	11	KOREAN SOC STEM CELL RESEARCH	BANPO-DONG	CATHOLIC UNIV KOREA 505, INST BIOMEDICAL INDUSTRY, BANPO-DONG, SEOCHO-GU 00000, SOUTH KOREA	2005-3606	2005-5447		INT J STEM CELLS	Int J. Stem Cells	MAY	2018	11	1					141	147		10.15283/ijsc17077			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	GH4TE	WOS:000433396400015	29699386	Green Published, Green Submitted, gold			2022-02-06	
J	Woodruff, SI; Galarneau, MR; McCabe, CT; Sack, DI; Clouser, MC				Woodruff, Susan I.; Galarneau, Michael R.; McCabe, Cameron T.; Sack, Daniel I.; Clouser, Mary C.			Health-related quality of life among US military personnel injured in combat: findings from the Wounded Warrior Recovery Project	QUALITY OF LIFE RESEARCH			English	Article						Health-related quality of life; Mental health; Injury; Military	POSTTRAUMATIC-STRESS-DISORDER; WELL-BEING SCALE; TRAUMATIC BRAIN-INJURY; ADMINISTERED VERSION; SEVERITY SCORE; QWB-SA; VETERANS; DEPRESSION; IRAQ; COMORBIDITY	Little is known about the long-term, health-related quality of life (HRQOL) of those wounded in combat during Operations Enduring Freedom, Iraqi Freedom, and New Dawn. The present study described the overall HRQOL for a large group of US service members experiencing mild-to-severe combat-related injuries, and assessed the unique contribution of demographics, service- and injury-related characteristics, and mental health factors on long-term HRQOL. The Wounded Warrior Recovery Project examines patient-reported outcomes in a cohort of US military personnel wounded in combat. Participants were identified from the Expeditionary Medical Encounter Database, a US Navy-maintained deployment health database, and invited to complete a web-based survey. At the time of this study, 3245 service members consented and completed the survey. Hierarchical linear regression analyses were conducted to assess the unique contribution of each set of antecedents on HRQOL scores. HRQOL was uniquely associated with a number of demographics, and service- and injury-related characteristics. Nevertheless, screening positive for posttraumatic stress disorder (B = - .09; P < .001), depression (B = - .10; P < .001), or both as a set (B = - .19; P < .001) were the strongest predictors of lower long-term HRQOL. Postinjury HRQOL among service members wounded in combat was associated with service and injury experience, and demographic factors, but was most strongly linked with current mental health status. These findings underscore the significance of mental health issues long after injury. Further, findings reinforce that long-term mental health screening, services, and treatment are needed for those injured in combat.	[Woodruff, Susan I.; McCabe, Cameron T.; Clouser, Mary C.] Leidos Inc, San Diego, CA 92121 USA; [Galarneau, Michael R.] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support, 140 Sylvester Rd, San Diego, CA 92106 USA; [Sack, Daniel I.] Axiom, San Diego, CA USA		McCabe, CT (corresponding author), Leidos Inc, San Diego, CA 92121 USA.	cameron.t.mccabe.ctr@mail.mil		McCabe, Cameron/0000-0001-8395-9142	Bureau of Medicine and Surgery, under the Wounded, Ill, and Injured Psychological Health and Traumatic Brain Injury Program [17-XX, 60808]	Report No. 17-XX was supported by Bureau of Medicine and Surgery, under the Wounded, Ill, and Injured Psychological Health and Traumatic Brain Injury Program, under work unit No. 60808.	Andresen EM, 1998, MED CARE, V36, P1349, DOI 10.1097/00005650-199809000-00007; Asano M, 2008, PROSTHET ORTHOT INT, V32, P231, DOI 10.1080/03093640802024955; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barrett DH, 2003, MIL MED, V168, P941, DOI 10.1093/milmed/168.11.941; Bilmes L, 2007, SOLDIERS RETURNING I; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Browne T, 2007, BRIT J PSYCHIAT, V190, P484, DOI 10.1192/bjp.bp.106.030544; Chiu S, 2011, PUBLIC HEALTH REP, V126, P201, DOI 10.1177/003335491112600211; Christensen J, 2016, DISABIL REHABIL, V38, P2345, DOI 10.3109/09638288.2015.1129446; Cohen J., 2013, STAT POWER ANAL BEHA; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Daggett V, 2009, J NEUROSCI NURS, V41, P59, DOI 10.1097/JNN.0b013e31819a7133; Defense Casualty Analysis System, 2017, US MIL CAS OP NEW DA; Defense Casualty Analysis System, 2017, US MIL CAS OP END FR; Defense Casualty Analysis System, 2017, US MIL CAS OP IR FRE; Forman-Hoffman VL, 2005, QUAL LIFE RES, V14, P2303, DOI 10.1007/s11136-005-6540-2; Frosch DL, 2004, ARTHRIT RHEUM-ARTHR, V51, P28, DOI 10.1002/art.20071; Fryback DG, 2007, MED CARE, V45, P1162, DOI 10.1097/MLR.0b013e31814848f1; Fryback DG, 1997, MED DECIS MAKING, V17, P1, DOI 10.1177/0272989X9701700101; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gennarelli TA, 2005, ABBREVIATED INJURY S; Goldberg MS., 2016, DEFENCE PEACE ECON, V29, P1; Institute of Medicine of the National Academies, 2010, RET HOM IR AFGH PREL; Kaplan RM, 1997, PSYCHOL HEALTH, V12, P783, DOI 10.1080/08870449708406739; Le QA, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-59; Mancino MJ, 2006, J NERV MENT DIS, V194, P877, DOI 10.1097/01.nmd.0000244686.79689.21; McAndrew LM, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-73; Melcer T, 2013, J ORTHOP TRAUMA, V27, pE31, DOI 10.1097/BOT.0b013e3182517e1c; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Moergeli H, 2012, PSYCHOTHER PSYCHOSOM, V81, P305, DOI 10.1159/000330887; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Pyne JM, 2003, J AFFECT DISORDERS, V76, P237, DOI 10.1016/S0165-0327(03)00106-X; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richmond TS, 2011, GEN HOSP PSYCHIAT, V33, P327, DOI 10.1016/j.genhosppsych.2011.05.003; Riviere LA, 2011, J NERV MENT DIS, V199, P199, DOI 10.1097/NMD.0b013e31820caee4; Rosen PN, 2005, J CATARACT REFR SURG, V31, P369, DOI 10.1016/j.jcrs.2004.04.043; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; Schok ML, 2005, MIL PSYCHOL, V17, P89, DOI 10.1207/s15327876mp1702_2; Sieber WJ, 2000, HEADACHE, V40, P662, DOI 10.1046/j.1526-4610.2000.040008662.x; Sieber WJ., 2008, QUALITY WELL BEING S; Singh JA, 2005, J AM GERIATR SOC, V53, P108, DOI 10.1111/j.1532-5415.2005.53020.x; Smith BM, 2008, SPINAL CORD, V46, P507, DOI 10.1038/sc.2008.2; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Taft CT, 1999, J TRAUMA STRESS, V12, P3, DOI 10.1023/A:1024786030358; van Delft-Schreurs CCHM, 2014, QUAL LIFE RES, V23, P1353, DOI 10.1007/s11136-013-0546-y; van Delft-Schreurs CCHM, 2014, INJURY, V45, P320, DOI 10.1016/j.injury.2013.02.025; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Voelker MD, 2002, AM J EPIDEMIOL, V155, P899, DOI 10.1093/aje/155.10.899; Woodruff SI, 2014, MIL MED, V179, P265, DOI 10.7205/MILMED-D-13-00444	56	16	16	0	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	MAY	2018	27	5					1393	1402		10.1007/s11136-018-1806-7			10	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	GC1QK	WOS:000429556500026	29450855				2022-02-06	
J	Cai, HL; Zhou, X; Dougherty, GG; Reddy, RD; Haas, GL; Montrose, DM; Keshavan, M; Yao, JK				Cai, HuaLin; Zhou, Xiang; Dougherty, George G.; Reddy, Ravinder D.; Haas, Gretchen L.; Montrose, Debra M.; Keshavan, Matcheri; Yao, Jeffrey K.			Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naive patients with schizophrenia	PSYCHONEUROENDOCRINOLOGY			English	Article						Schizophrenia; First-episode antipsychotic-naive; Neurosteroids; Pregnenolone; Progesterone; Allopregnanolone; Cortisol dehydroepiandrosterone dehydroepiandrosterone sulfate	TRAUMATIC BRAIN-INJURY; RAT NUCLEUS-ACCUMBENS; NEUROACTIVE STEROIDS; DOPAMINE RELEASE; CEREBRAL-CORTEX; NEUROSTEROID ALLOPREGNANOLONE; MASS-SPECTROMETRY; GABA(A) RECEPTORS; NEGATIVE SYMPTOMS; FEMALE RATS	Neurosteroids are both endogenous and exogenous steroids that rapidly alter neuronal excitability through interactions with ligand-gated ion channels and other cell surface receptors. They are originated from cholesterol and have important implications for schizophrenia (SZ) pathophysiology and treatment strategies. Specifically, pregnenolone (PREG), progesterone (PROG) and allopregnanolone (ALLO) exhibit similar psychotropic properties. Using enzyme immunoassay, we compared the neurosteroids in PREG downstream pathways in plasma between healthy controls (HC, n = 43) and first-episode antipsychotic-naive patients with SZ (FEAN-SZ, n = 53) before antipsychotic drug (API)) treatment. Comparisons were also made particularly along PREG-PROG-ALLO pathway in the same FEAN-SZ patients across multiple time points following initiation of treatment for 12 months (m). Firstly, at baseline, levels of PREG were significantly higher and those of ALLO were lower in FEAN-SZ than in HC, whereas PROG, cortisol, dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) were not different. Consequently, the molar ratios of ALLO/PREG and ALLO/PROG in FEAN-SZ were significantly reduced. Secondly, in response to APD at 1 month, ALLO levels in FEAN-SZ were markedly elevated, whereas PREG and PROG levels decreased. Thirdly, among FEAN-SZ, lower levels of PROG (reflecting higher conversion to ALLO) at baseline may predict better therapeutic outcome after 1 month of APD treatment. These findings point to the perturbations of the PREG-PROG-ALLO pathway early in psychosis, and further study of this pathway may inform alternative and innovative therapeutic targets for SZ.	[Cai, HuaLin; Zhou, Xiang; Dougherty, George G.; Haas, Gretchen L.; Yao, Jeffrey K.] VA Pittsburgh Healthcare Syst, Med Res Serv, Pittsburgh, PA 15240 USA; [Cai, HuaLin; Zhou, Xiang; Yao, Jeffrey K.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15216 USA; [Cai, HuaLin] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Cai, HuaLin] Cent S Univ, Inst Clin Pharm, Changsha, Hunan, Peoples R China; [Dougherty, George G.; Haas, Gretchen L.; Montrose, Debra M.; Keshavan, Matcheri; Yao, Jeffrey K.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Reddy, Ravinder D.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Keshavan, Matcheri] Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA 02115 USA; [Keshavan, Matcheri] Harvard Med Sch, Boston, MA 02115 USA		Yao, JK (corresponding author), VA Pittsburgh Healthcare Syst, Bldg 1,Room 2E-140,Univ Dr C, Pittsburgh, PA 15240 USA.	jkyao@pitt.edu			Department of Veterans AffairsUS Department of Veterans Affairs; VA Pittsburgh Healthcare System, National Institute of Health [MH58141, MH64023, K02 MH 01180, MH45156]; NIH/NCRR/GCRCUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR00056]; Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [NSFC81401113]; Specialized Research Fund for the Doctoral Program of Higher Education of ChinaSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [SRFDP20130162120060]; Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province [2017JJ3444]; Chinese Scholarship CouncilChina Scholarship Council; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K02MH001180, R01MH064023, P50MH045156, R01MH058141] Funding Source: NIH RePORTER	This work was supported in part by Department of Veterans Affairs [Merit Reviews (JKY) and Senior Research Career Scientist Award (JKY)], the VA Pittsburgh Healthcare System, National Institute of Health [MH58141 (JKY), MH64023 (MK), K02 MH 01180 (MK), MH45156 (David Lewis, MD, Director), NIH/NCRR/GCRC M01 RR00056 (Arthur Levine, MD)], Nature Science Foundation of China [NSFC81401113 (HLC)], the Specialized Research Fund for the Doctoral Program of Higher Education of China [SRFDP20130162120060 (HLC)], Hunan Provincial Natural Science Foundation of China [2017JJ3444 (HLC)], and the Chinese Scholarship Council for oversea study program (HLC).	ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Barbaccia ML, 1997, BRIT J PHARMACOL, V120, P1582, DOI 10.1038/sj.bjp.0701046; Barbaccia ML, 2001, NEUROPSYCHOPHARMACOL, V25, P489, DOI 10.1016/S0893-133X(01)00254-8; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; BREIER A, 1992, LIFE SCI, V51, P1527, DOI 10.1016/0024-3205(92)90563-5; Broccardo CJ, 2013, J CHROMATOGR B, V934, P16, DOI 10.1016/j.jchromb.2013.06.031; Cai HL, 2010, PROG NEURO-PSYCHOPH, V34, P1273, DOI 10.1016/j.pnpbp.2010.07.006; Caruso D, 2013, PSYCHONEUROENDOCRINO, V38, P2278, DOI 10.1016/j.psyneuen.2013.04.016; CHENEY DL, 1995, J NEUROSCI, V15, P4641; Chesnoy-Marchais D, 2009, EUR J NEUROSCI, V30, P2100, DOI 10.1111/j.1460-9568.2009.07013.x; Condray R, 2011, INT J NEUROPSYCHOPH, V14, P756, DOI 10.1017/S1461145710001689; David SR, 2000, CLIN THER, V22, P1085, DOI 10.1016/S0149-2918(00)80086-7; Dazzi L, 2002, BRAIN RES, V932, P135, DOI 10.1016/S0006-8993(02)02290-4; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Dorgan JF, 2002, STEROIDS, V67, P151, DOI 10.1016/S0039-128X(01)00147-7; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; Farnbach-Pralong D, 1998, EUR J PHARMACOL, V349, pR7, DOI 10.1016/S0014-2999(98)00285-4; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Guy W., ECDEU ASSESSMENT MAN; Hatzimanikatis V, 2004, CURR OPIN STRUC BIOL, V14, P300, DOI 10.1016/j.sbi.2004.04.004; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Jaworska-Feil L, 1998, POL J PHARMACOL, V50, P449; JOHNSON RA, 1998, APPL MULTIVARIATE ST, P193; Khisti RT, 2002, PSYCHOPHARMACOLOGY, V161, P120, DOI 10.1007/s00213-002-1006-5; Kim YS, 2000, ANAL BIOCHEM, V277, P187, DOI 10.1006/abio.1999.4384; Kinon BJ, 2003, PSYCHONEUROENDOCRINO, V28, P69, DOI 10.1016/S0306-4530(02)00128-2; LAN NC, 1994, HORM BEHAV, V28, P537, DOI 10.1006/hbeh.1994.1052; Lehmann E.L, 1975, NONPARAMETRICS STAT; Lewis DA, 2004, PSYCHOPHARMACOLOGY, V174, P143, DOI 10.1007/s00213-003-1673-x; MacKenzie EM, 2007, CELL MOL NEUROBIOL, V27, P541, DOI 10.1007/s10571-006-9086-0; Marx CE, 2011, NEUROSCIENCE, V191, P78, DOI 10.1016/j.neuroscience.2011.06.076; Marx CE, 2000, BIOL PSYCHIAT, V47, P1000, DOI 10.1016/S0006-3223(99)00305-4; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P598, DOI 10.1016/j.pbb.2006.07.026; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P609, DOI 10.1016/j.pbb.2006.07.032; Marx CE, 2014, PSYCHOPHARMACOLOGY, V231, P3647, DOI 10.1007/s00213-014-3673-4; Marx CE, 2006, NEUROPSYCHOPHARMACOL, V31, P1249, DOI 10.1038/sj.npp.1300952; Marx CE, 2009, NEUROPSYCHOPHARMACOL, V34, P1885, DOI 10.1038/npp.2009.26; Mensah-Nyagan AG, 1999, PHARMACOL REV, V51, P63; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Motzo C, 1996, J PSYCHOPHARMACOL, V10, P266, DOI 10.1177/026988119601000402; Ohnuma T, 2005, PROG NEURO-PSYCHOPH, V29, P887, DOI 10.1016/j.pnpbp.2005.04.038; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Paba S, 2011, CURR PHARM DESIGN, V17, P151, DOI 10.2174/138161211795049589; Plitman E, 2014, EUR NEUROPSYCHOPHARM, V24, P1591, DOI 10.1016/j.euroneuro.2014.07.015; Ritsner M, 2007, EUR NEUROPSYCHOPHARM, V17, P358, DOI 10.1016/j.euroneuro.2006.10.001; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Rouge-Pont F, 2002, EUR J NEUROSCI, V16, P169, DOI 10.1046/j.1460-9568.2002.02084.x; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; SERAFINI P, 1986, FERTIL STERIL, V45, P41; Shirayama Y, 2002, SCHIZOPHR RES, V58, P69, DOI 10.1016/S0920-9964(01)00367-X; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Ugale RR, 2004, NEUROPSYCHOPHARMACOL, V29, P1597, DOI 10.1038/sj.npp.1300460; VanLandingham JW, 2008, J CEREBR BLOOD F MET, V28, P1786, DOI 10.1038/jcbfm.2008.73; Verma SK, 2009, J CLIN PSYCHIAT, V70, P997, DOI 10.4088/JCP.08m04508; Wadenberg MLG, 2001, NEUROPSYCHOPHARMACOL, V25, P633, DOI 10.1016/S0893-133X(01)00261-5; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Wong ML, 2005, MOL PSYCHIATR, V10, P421, DOI 10.1038/sj.mp.4001674; Xi ZX, 1998, BRAIN RES, V798, P156, DOI 10.1016/S0006-8993(98)00406-5; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046	63	16	16	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4530			PSYCHONEUROENDOCRINO	Psychoneuroendocrinology	APR	2018	90						43	51		10.1016/j.psyneuen.2018.02.004			9	Endocrinology & Metabolism; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry	GD8LV	WOS:000430764800006	29433072	Green Accepted, hybrid			2022-02-06	
J	Latifi, R; Olldashi, F; Dogjani, A; Dasho, E; Boci, A; El-Menyar, A				Latifi, Rifat; Olldashi, Fatos; Dogjani, Agron; Dasho, Erion; Boci, Arian; El-Menyar, Ayman			Telemedicine for Neurotrauma in Albania: Initial Results from Case Series of 146 Patients	WORLD NEUROSURGERY			English	Article						Albania; Low- and middle-income countries; Neurotrauma; Spinal cord injuries; Telemedicine; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DIGITAL OBSERVATION CAMERA; DEVELOPING-COUNTRIES; MEDICAL SYSTEMS; NEUROSURGERY; GUIDELINES; EXPERIENCE; MANAGEMENT; ARIZONA; CARE	BACKGROUND: Use of telemedicine for neurotrauma when performed by neurosurgeons is an innovative care option for traumatic brain injury patients, particularly in countries with limited neurosurgery expertise resources. In recent years, Albania has developed a robust telemedicine program and teleneurotrauma is the flagship of the program. We aimed to evaluate the outcomes of the first neurotrauma patients managed via telemedicine in Albania. METHODS: A retrospective analysis of prospectively collected data on all telemedicine consultations for isolated neurotrauma was performed from 2014 through 2016. Patient demographics, mechanism of injury, modes of teleneurotrauma consultation (store-and-forward vs. live video consultation), outcomes of teleconsultation (whether the patient was transferred or kept at the regional hospital), operative procedures for those transferred, length of hospital stay, and discharge status were analyzed. RESULTS: Of the 146 teleconsultations for neurotrauma, asynchronous technology (store-and-forward) accounted for the majority of teleconsultations (84%), while the live plus store-and-forward technique was employed in 15% of cases. Median time of response to teleconsultation was 20 minutes. Sixty-six percent of patients remained at the referring hospital for further observation and did not require transfer to a trauma center. Of the patients transferred to the tertiary care, 91% were treated nonoperatively, 85% percent were discharged to home, 9% were transferred to another hospital, and 6% died in the hospital. CONCLUSION: Telemedicine for neurotrauma, when structured appropriately and led by neurosurgeons, is a valuable service for the entire country, prevents unnecessary transfers to trauma center, and saves resources, particularly in low- and middle-income countries.	[Latifi, Rifat; El-Menyar, Ayman] Westchester Med Ctr Hlth Network, Dept Surg, Valhalla, NY 10595 USA; [Latifi, Rifat; El-Menyar, Ayman] New York Med Coll, Valhalla, NY 10595 USA; [Latifi, Rifat; Dogjani, Agron; Dasho, Erion; Boci, Arian] Int Virtual Hosp Fdn, Tucson, AZ USA; [Olldashi, Fatos] Univ Hosp Trauma, Dept Neurosurg, Tirana, Albania; [Dogjani, Agron] Univ Hosp Trauma, Dept Trauma Surg, Tirana, Albania; [Latifi, Rifat; Boci, Arian] Integrated Telemed & E Hlth Program Albania, Tirana, Albania		Latifi, R (corresponding author), Westchester Med Ctr Hlth Network, Dept Surg, Valhalla, NY 10595 USA.; Latifi, R (corresponding author), New York Med Coll, Valhalla, NY 10595 USA.; Latifi, R (corresponding author), Int Virtual Hosp Fdn, Tucson, AZ USA.; Latifi, R (corresponding author), Integrated Telemed & E Hlth Program Albania, Tirana, Albania.	Rifat.Latifi@wmchealth.org	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X; Latifi, Rifat/0000-0003-1091-3682	United States Agency for International Development in Albania, Integrated Telemedicine and e-Health ProjectUnited States Agency for International Development (USAID) [182-A-00-09-00101-00]	The study is part of the project funded from the United States Agency for International Development in Albania, Integrated Telemedicine and e-Health Project (Contract 182-A-00-09-00101-00).	Agha RA, 2016, INT J SURG, V36, P319, DOI 10.1016/j.ijsu.2016.10.025; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Demaerschalk BM, 2012, TELEMED E-HEALTH, V18, P230, DOI 10.1089/tmj.2011.0116; Demaerschalk BM, 2010, STROKE, V41, P1251, DOI 10.1161/STROKEAHA.109.574509; El Khamlichi Abdeslam, NEUROSURGERY AFRICA; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Kahn EN, 2016, WORLD NEUROSURG, V89, P133, DOI 10.1016/j.wneu.2016.01.075; Latifi R., TELEMEDICINE TRAUMA; Latifi R, TELEMED J E-HEALTH, DOI [10.1089/tmj.2014.0026.8, DOI 10.1089/TMJ.2014.0026.8]; Latifi R, 2006, TELEMED J E-HEALTH, V12, P332, DOI 10.1089/tmj.2006.12.332; Latifi R, 2016, TELEMED E-HEALTH, V22, P1024, DOI 10.1089/tmj.2016.0050; Latifi R, 2016, INT J EMERG MED, V9, DOI 10.1186/s12245-016-0124-5; Latifi R, 2015, TELEMED E-HEALTH, V21, P503, DOI 10.1089/tmj.2014.0138; Latifi R, 2014, WORLD J SURG, V38, P1898, DOI 10.1007/s00268-014-2538-7; Latifi Rifat, 2014, Am J Disaster Med, V9, P25, DOI 10.5055/ajdm.2014.0139; Latifi Rifat, 2009, Am J Surg, V198, P905, DOI 10.1016/j.amjsurg.2009.08.011; Lewis ER, 2012, TELEMED E-HEALTH, V18, P434, DOI 10.1089/tmj.2011.0199; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Migliaretti G, 2013, J TELEMED TELECARE, V19, P33, DOI 10.1177/1357633X12474738; Mrak G, 2009, J TELEMED TELECARE, V15, P142, DOI 10.1258/jtt.2009.003012; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206	24	16	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2018	112						E747	E753		10.1016/j.wneu.2018.01.146			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8FH	WOS:000432932700088	29410169				2022-02-06	
J	Schmidt, JD; Rizzone, K; Hoffman, NL; Weber, ML; Jones, C; Bazarian, J; Broglio, SP; McCrea, M; McAllister, TW				Schmidt, Julianne D.; Rizzone, Katherine; Hoffman, Nicole L.; Weber, Michelle L.; Jones, Courtney; Bazarian, Jeff; Broglio, Steven P.; McCrea, Michael; McAllister, Thomas W.		CARE Consortium Investigators	Age at First Concussion Influences the Number of Subsequent Concussions	PEDIATRIC NEUROLOGY			English	Article						mild traumatic brain injury; head trauma; head injury; sport; youth injury	PROFESSIONAL FOOTBALL PLAYERS; HIGH-SCHOOL; RECURRENT CONCUSSION; RISK; SPORTS; INJURY; COLLEGIATE; DEPRESSION; HISTORY; EPIDEMIOLOGY	BACKGROUND: Individuals who sustain their first concussion during childhood may be at greater risk of sustaining multiple concussions throughout their lifetime because of a longer window of vulnerability. This article aims to estimate the association between age at first concussion and number of subsequent concussions. PATIENTS AND METHODS: A total of 23,582 collegiate athletes from 26 universities and military cadets from three military academies completed a concussion history questionnaire (65% males, age 19.9 +/- 1.4 years). Participants self-reported concussions and age at time of each injury. Participants with a history of concussion (n = 3,647, 15.5%) were categorized as having sustained their first concussion during childhood (less than ten years old) or adolescence (>= 10 and years old). Poisson regression was used to model age group (childhood, adolescence) predicting the number of subsequent concussions (0, 1, 2+). A second Poisson regression was developed to determine whether age at first concussion predicted the number of subsequent concussions. RESULTS: Participants self-reporting their first concussion during childhood had an increased risk of subsequent concussions (rate ratio = 2.19, 95% confidence interval: 1.82, 2.64) compared with participants self-reporting their first concussion during adolescence. For every one-year increase in age at first concussion, we observed a 16% reduction in the risk of subsequent concussion (rate ratio = 0.84, 95% confidence interval: 0.82, 0.86). CONCLUSIONS: Individuals self-reporting a concussion at a young age sustained a higher number of concussions before age 18. Concussion prevention, recognition, and reporting strategies are of particular need at the youth level.	[Schmidt, Julianne D.; Hoffman, Nicole L.; Weber, Michelle L.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Schmidt, Julianne D.; Hoffman, Nicole L.; Weber, Michelle L.] Univ Georgia, UGA Concuss Res Lab, Athens, GA 30602 USA; [Rizzone, Katherine] Univ Rochester, Sch Med, Dept Orthoped, Rochester, NY USA; [Jones, Courtney; Bazarian, Jeff] Univ Rochester, Sch Med, Dept Emergency Med, Rochester, NY USA; [Broglio, Steven P.] Univ Michigan, Injury Ctr, Ann Arbor, MI 48109 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA.; Schmidt, JD (corresponding author), Univ Georgia, UGA Concuss Res Lab, Athens, GA 30602 USA.	schmidtj@uga.edu		Ortega, Justus/0000-0002-9931-5605; Chrisman, Sara/0000-0001-5373-7223; Clugston, James/0000-0002-2103-1039	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium funded, in part, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense (DHP funds).	Abrahams S, 2014, BRIT J SPORT MED, V48, P1; [Anonymous], 2003, Paediatr Child Health, V8, P577; [Anonymous], 2014, 2014 15 NCAA SPORTS; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kucera KL, 2005, BRIT J SPORT MED, V39, P462, DOI 10.1136/bjsm.2004.013672; Miyashita TL, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114554549; Morrongiello BA, 2006, J PEDIATR PSYCHOL, V31, P540, DOI 10.1093/jpepsy/jsj073; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; World Health Organization, 1986, YOUNG PEOPL HLTH CHA	29	16	16	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	APR	2018	81						19	24		10.1016/j.pediatrneurol.2017.12.017			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	GE1RY	WOS:000430995600005	29523494	Green Submitted			2022-02-06	
J	Khan, M; Dhammu, TS; Baarine, M; Kim, J; Paintlia, MK; Singh, I; Singh, AK				Khan, Mushfiquddin; Dhammu, Tajinder S.; Baarine, Mauhamad; Kim, Jinsu; Paintlia, Manjeet K.; Singh, Inderjit; Singh, Avtar K.			GSNO promotes functional recovery in experimental TBI by stabilizing HIF-1 alpha	BEHAVIOURAL BRAIN RESEARCH			English	Article						TBI; GSNO; HIF-1 alpha; VEGF; Neurobehavioral function; Neurorepair; S-nitrosylation	TRAUMATIC BRAIN-INJURY; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RECEPTOR AGONIST 8-OH-DPAT; S-NITROSOGLUTATHIONE; NITRIC-OXIDE; RAT MODEL; CEREBRAL-ISCHEMIA; STROKE; PROTECTS; DEFICITS	Traumatic brain injury (TBI) causes sustained disability due to compromised neurorepair mechanisms. Crucial to neurorepair and functional recovery following both TBI and stroke is hypoxia-inducible factor 1 alpha (HIF-1 alpha). Based on reports that HIF-1 alpha could be stabilized via S-nitrosylation, we tested the hypothesis that the S-nitrosylating agent S-nitrosoglutathione (GSNO) would stabilize HIF-1 alpha, thereby stimulating neurorepair mechanisms and aiding in functional recovery. TBI was induced by controlled cortical impact (CCI) in adult rats. GSNO (0.05 mg/kg) was administered at two hours after CCI. The treatment was repeated daily until the 14th day after CCI. Functional recovery was assessed by motor and cognitive functions, and the recovery was compared with the expression of HIF-1 alpha. The mechanisms of GSNO-mediated S-nitrosylation of HIF-1 alpha were determined using brain endothelial cells. While non-treated TBI animals showed sustained neurobehavioral deficits, GSNO treatment of TBI improved neurobehavioral functions. GSNO also increased the expression of HIF-1 alpha and VEGF. The beneficial effects of GSNO on neurobehavioral functions in TBI animals were blocked by treatment with the HIF-1 alpha inhibitor 2-methoxyestradiol (2-ME). The stimulatory effect of GSNO on VEGF was reversed not only by 2-ME but also by the denitrosylating agent dithiothreitol, confirming our hypothesis that GSNO's benefits are mediated by the stabilization of HIF-1 alpha via S-nitrosylation. GSNO's S-nitrosylation of HIF-1 alpha was further confirmed using a biotin switch assay in endothelial cells. The data provide evidence that GSNO treatment of TBI aids functional recovery through stabilizing HIF-1 alpha via S-nitrosylation. GSNO is a natural component of the human brain/body, and its exogenous administration has not shown adverse effects in humans. Therefore, the translational potential of GSNO therapy in TBI is high. (C) 2016 Elsevier B.V. All rights reserved.	[Khan, Mushfiquddin; Dhammu, Tajinder S.; Kim, Jinsu; Paintlia, Manjeet K.; Singh, Inderjit] Med Univ South Carolina, Dept Pediat, Charleston, SC 29425 USA; [Baarine, Mauhamad; Singh, Avtar K.] Med Univ South Carolina, Dept Pathol & Lab Med, 508 Childrens Res Inst,173 Ashley Ave, Charleston, SC 29425 USA; [Singh, Avtar K.] Ralph H Johnson VA Med Ctr, Charleston, SC USA		Khan, M (corresponding author), Med Univ South Carolina, Dept Pediat, Charleston, SC 29425 USA.; Singh, AK (corresponding author), Med Univ South Carolina, Dept Pathol & Lab Med, 508 Childrens Res Inst,173 Ashley Ave, Charleston, SC 29425 USA.	khanm@musc.edu; Dhammu@musc.edu; baarine@musc.edu; kimji@musc.edu; kaurm@musc.edu; singhi@musc.edu; singha@musc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-72511]; VA merit awardUS Department of Veterans Affairs [RX2090]; NIH from the Extramural Research Facilities Program of the National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [C06 RR018823, C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR018823, C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072511] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003401, I01RX002090] Funding Source: NIH RePORTER	This work was supported by grants from NIH (NS-72511) and VA merit award (RX2090). This work was also supported by the NIH, Grants C06 RR018823 and No C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. We thank Ms. Joyce Bryan for her technical help. We also acknowledge Dr. Tom Smith from the MUSC Writing Center for his valuable suggestions and editing of the manuscript.	Baarine M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143238; Baarine M, 2015, J NEUROCHEM, V133, P380, DOI 10.1111/jnc.12992; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Carbonaro M, 2012, J BIOL CHEM, V287, P11859, DOI 10.1074/jbc.M112.345587; Chen CH, 2007, J NEUROCHEM, V102, P1831, DOI 10.1111/j.1471-4159.2007.04652.x; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Chistiakov DA, 2016, EXP MOL PATHOL, V100, P409, DOI 10.1016/j.yexmp.2016.03.012; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dhawan J, 2011, FUTUR NEUROL, V6, P823, DOI 10.2217/FNL.11.55; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gao Y, 2016, MOL CELL BIOCHEM, V414, P77, DOI 10.1007/s11010-016-2660-y; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hornyak I, 2011, CURR PHARM BIOTECHNO, V12, P1368, DOI 10.2174/138920111798280983; Huang TN, 2014, NAT NEUROSCI, V17, P240, DOI 10.1038/nn.3626; Ke XJ, 2013, J HUAZHONG U SCI-MED, V33, P433, DOI 10.1007/s11596-013-1137-4; Khan M, 2015, DRUG DES DEV THER, V9, P2233, DOI 10.2147/DDDT.S77115; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Kimura H, 2002, BIOCHEM BIOPH RES CO, V296, P976, DOI 10.1016/S0006-291X(02)02029-6; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.E02-12-0791; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Mooberry SL, 2003, DRUG RESIST UPDATE, V6, P355, DOI 10.1016/j.drup.2003.10.001; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Privratsky JR, 2014, CELL TISSUE RES, V355, P607, DOI 10.1007/s00441-013-1779-3; Quaegebeur A, 2016, CELL METAB, V23, P280, DOI 10.1016/j.cmet.2015.12.007; RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x; Sen T, 2016, NEUROPHARMACOLOGY, V107, P79, DOI 10.1016/j.neuropharm.2016.03.009; Shunmugavel A, 2015, NEUROUROL URODYNAM, V34, P519, DOI 10.1002/nau.22619; Shunmugavel Anandakumar, 2012, Neurosci Med, V3, P294; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Thelin E. P., 2016, BRAIN INJURY FRONT N, V7, P23, DOI [10.3389/fneur.2016.0002327014178, DOI 10.3389/FNEUR.2016.0002327014178]; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang ZF, 2012, STROKE, V43, P2430, DOI 10.1161/STROKEAHA.112.652545; Wellman TL, 2003, FASEB J, V17, P379, DOI 10.1096/fj.03-0143fje; Yasinska IM, 2003, FEBS LETT, V549, P105, DOI 10.1016/S0014-5793(03)00807-X; Zhou DC, 2008, NEUROL RES, V30, P268, DOI 10.1179/016164107X229920	41	16	16	1	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		63	70		10.1016/j.bbr.2016.10.037			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400007	27780722	Green Accepted			2022-02-06	
J	Thelin, EP; Just, D; Frostell, A; Haggmark-Manberg, A; Risling, M; Svensson, M; Nilsson, P; Bellander, BM				Thelin, Eric Peter; Just, David; Frostell, Arvid; Haggmark-Manberg, Anna; Risling, Marten; Svensson, Mikael; Nilsson, Peter; Bellander, Bo-Michael			Protein profiling in serum after traumatic brain injury in rats reveals potential injury markers	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Hypoxia; Serum proteins; Biomarkers; Protein-array	ENDOTHELIAL GROWTH-FACTOR; NEURON-SPECIFIC ENOLASE; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; COMPLEMENT-SYSTEM; BIOMARKER LEVELS; HEAD-INJURY; ALZHEIMERS-DISEASE; TEMPORAL PROFILES; PROGNOSTIC VALUE	Introduction: The serum proteome following traumatic brain injury (TBI) could provide information for outcome prediction and injury monitoring. The aim with this affinity proteomic study was to identify serum proteins over time and between normoxic and hypoxic conditions in focal TBI. Material and methods: Sprague Dawley rats (n = 73) received a 3 mm deep controlled cortical impact ("severe injury"). Following injury, the rats inhaled either a normoxic (22% O-2) or hypoxic (11% O-2) air mixture for 30 min before resuscitation. The rats were sacrificed at day 1, 3, 7, 14 and 28 after trauma. A total of 204 antibodies targeting 143 unique proteins of interest in TBI research, were selected. The sample proteome was analyzed in a suspension bead array set-up. Comparative statistics and factor analysis were used to detect differences as well as variance in the data. Results: We found that complement factor 9 (C9), complement factor B (CFB) and aldolase c (ALDOC) were detected at higher levels the first days after trauma. In contrast, hypoxia inducing factor (HIF)1 alpha, amyloid precursor protein (APP) and WBSCR17 increased over the subsequent weeks. S100A9 levels were higher in hypoxic-compared to normoxic rats, together with a majority of the analyzed proteins, albeit few reached statistical significance. The principal component analysis revealed a variance in the data, highlighting clusters of proteins. Conclusions: Protein profiling of serum following TBI using an antibody based microarray revealed temporal changes of several proteins over an extended period of up to four weeks. Further studies are warranted to confirm our findings. (C) 2016 The Author(s). Published by Elsevier B.V.	[Thelin, Eric Peter; Frostell, Arvid; Svensson, Mikael; Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Just, David; Haggmark-Manberg, Anna; Nilsson, Peter] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Affin Prote, Stockholm, Sweden; [Risling, Marten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Svensson, Mikael; Bellander, Bo-Michael] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden		Thelin, EP (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	eric.thelin@ki.se; david.just@scilifelab.se; arvid.frostell@ki.se; anna.haggmark@scilifelab.se; marten.risling@ki.se; Mikael.svensson@ki.se; peter.nilsson@scilifelab.se; bo-michael.bellander@ki.se	Svensson, Mikael/F-8662-2012; Frostell, Arvid/ABG-5167-2021; Thelin, Eric Peter/K-2144-2012; Nilsson, Peter/E-4547-2010	Svensson, Mikael/0000-0003-1179-7003; Thelin, Eric Peter/0000-0002-2338-4364; Nilsson, Peter/0000-0002-4657-8532; Manberg (Haggmark), Anna/0000-0002-0056-1313	SENSUS Region Mellansverige, Stockholm County (ALF); ProNova VINN Excellence Centre for Protein Technology (VINNOVA, Swedish Governmental Agency for Innovation Systems)Vinnova; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; KTH Center for Applied Proteomics - Erling-Persson Family Foundation	This study was supported by SENSUS Region Mellansverige, Stockholm County (ALF), the ProNova VINN Excellence Centre for Protein Technology (VINNOVA, Swedish Governmental Agency for Innovation Systems), the Knut and Alice Wallenberg Foundation, KTH Center for Applied Proteomics financed through the Erling-Persson Family Foundation.	Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Boutte A.M., 2015, J NEUROTRAUMA; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Dalle Lucca Jurandir J, 2012, J Neurol Sci, V318, P146, DOI 10.1016/j.jns.2012.02.002; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; DIXON CE, 1991, J NEUROSCI METH, V39, P253; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; HAIMOTO H, 1987, LAB INVEST, V57, P489; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Helmy A., 2015, J CEREB BLOOD FLOW M; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; HURWITZ AA, 1992, J EXP MED, V176, P1631, DOI 10.1084/jem.176.6.1631; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Landegren U, 2012, ANAL CHEM, V84, P1824, DOI 10.1021/ac2032222; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Li L, 2013, J NEURAL TRANSM, V120, P1511, DOI 10.1007/s00702-013-1031-z; Liang J, 2013, ASIAN PAC J CANCER P, V14, P3851, DOI 10.7314/APJCP.2013.14.6.3851; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McMahon LW, 2009, BIOCHEM BIOPH RES CO, V381, P288, DOI 10.1016/j.bbrc.2009.02.038; Mondello S., 2015, J NEUROTRAUMA; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Mulder J., 2016, MOUSE BRAIN PROTEIN; Ottens A. K., 2010, J NEUROTRAUMA, V27; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rostami E, 2013, J NEUROTRAUM, V30, P1954, DOI 10.1089/neu.2012.2583; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Schwenk JM, 2008, J PROTEOME RES, V7, P3168, DOI 10.1021/pr700890b; Schwenk JM, 2010, MOL CELL PROTEOMICS, V9, P2497, DOI 10.1074/mcp.M110.001560; Scornavacca G, 2012, J NEUROCHEM, V122, P1219, DOI 10.1111/j.1471-4159.2012.07874.x; Shao Y, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1925424; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Siman R., 2015, J NEUROTRAUMA, V32; Sjostedt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130028; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Team R.D.C, 2008, R LANG ENV STAT COMP; Tegel H, 2010, PROTEIN EXPRES PURIF, V69, P159, DOI 10.1016/j.pep.2009.08.017; Tegel Hanna, 2009, Biotechnology Journal, V4, P51, DOI 10.1002/biot.200800183; Thelin E. P., 2013, J NEUROTRAUMA, V30; Thelin E. P., 2016, BRAIN INJURY FRONT N, V7, P23, DOI [10.3389/fneur.2016.0002327014178, DOI 10.3389/FNEUR.2016.0002327014178]; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Wang C, 2014, ACTA NEUROPATHOL, V127, P507, DOI 10.1007/s00401-013-1208-4; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woertgen C, 2002, ACT NEUR S, V81, P205; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yu CG, 2015, J NEUROSCI RES, V93, P199, DOI 10.1002/jnr.23503; Yu R, 2001, Chin J Traumatol, V4, P218; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	89	16	16	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		71	80		10.1016/j.bbr.2016.08.058			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400008	27591967	hybrid			2022-02-06	
J	Thomas, TC; Ogle, SB; Rumney, BM; May, HG; Adelson, PD; Lifshitz, J				Thomas, Theresa Currier; Ogle, Sarah B.; Rumney, Benjamin M.; May, Hazel G.; Adelson, P. David; Lifshitz, Jonathan			Does time heal all wounds? Experimental diffuse traumatic brain injury results in persisting histopathology in the thalamus	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Post-concussive symptoms; Thalamus; Whisker-circuit; Somatosensory	ONSET BEHAVIORAL MORBIDITY; TEMPORAL-LOBE EPILEPSY; SPINAL-CORD CONTUSION; CELL-CYCLE ACTIVATION; SYMPTOMS 6 MONTHS; REACTIVE ASTROCYTES; EPILEPTOGENIC NEOCORTEX; POSTCONCUSSION SYNDROME; NEURONAL HYPERTROPHY; SYNAPSE FORMATION	Background: Thalamic dysfunction has been implicated in overall chronic neurological dysfunction after traumatic brain injury (TBI), however little is known about the underlying histopathology. In experimental diffuse TBI (dTBI), we hypothesize that persisting histopathological changes in the ventral posteromedial (VPM) nucleus of the thalamus is indicative of progressive circuit reorganization. Since circuit reorganization in the VPM impacts the whisker sensory system, the histopathology could explain the development of hypersensitivity to whisker stimulation by 28 days post-injury; similar to light and sound hypersensitivity in human TBI survivors. Methods: Adult, male Sprague-Dawley rats underwent craniotomy and midline fluid percussion injury (FPI) (moderate severity; 1.8-2.0 atm) or sham surgery. At I d, 7d, and 28 days post-FPI (d FPI) separate experiments confirmed the cytoarchitecture (Giemsa stain) and evaluated neuropathology (silver stain), activated astrocytes (GFAP), neuron morphology (Golgi stain) and microglial morphology (Iba-1) in the VPM. Results: Cytoarchitecture was unchanged throughout the time course, similar to previously published data; however, neuropathology and astrocyte activation were significantly increased at 7d and 28d and activated microglia were present at all time points. Neuron morphology was dynamic over the time course with decreased dendritic complexity (fewer branch points; decreased length of processes) at 7d FPI and return to sham values by 28d FPI. Conclusions: These data indicate that dTBI results in persisting thalamic histopathology out to a chronic time point. While these changes can be indicative of either adaptive (recovery) or maladaptive (neurological dysfunction) circuit reorganization, they also provide a potential mechanism by which maladaptive circuit reorganization could contribute to the development of chronic neurological dysfunction. Understanding the processes that mediate circuit reorganization is critical to the development of future therapies for TBI patients. (C) 2017 Elsevier B.V. All rights reserved.	[Thomas, Theresa Currier; Ogle, Sarah B.; Adelson, P. David; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Thomas, Theresa Currier; Ogle, Sarah B.; Adelson, P. David; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Thomas, Theresa Currier; Lifshitz, Jonathan] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Rumney, Benjamin M.; May, Hazel G.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Adelson, P. David; Lifshitz, Jonathan] Arizona State Univ, Neurosci Program, Tempe, AZ USA; [Adelson, P. David] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA; [Ogle, Sarah B.] Banner Univ, Med Ctr, Phoenix Integrated Surg Residency, Phoenix, AZ USA; [Ogle, Sarah B.] Banner Univ, Med Ctr, Dept Surg, Phoenix, AZ USA		Thomas, TC (corresponding author), Univ Arizona, Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Child Hlth,Translat Neurotrauma Res Program, 425 N 5th St ABC-1 Bldg 320, Phoenix, AZ 85004 USA.	theresathomas@email.arizona.edu; sogle@emaiLarizona.edu; ben-rumney@ntlworld.com; Hazelmay094@gmail.com; dadelson@phoenixchildrens.com; jlifshitz@email.arizona.edu	Adelson, David/W-2083-2019; Thomas, Theresa Currier/K-1979-2019	Thomas, Theresa Currier/0000-0002-9619-7666; Ogle, Sarah/0000-0003-0160-5311	Arizona Biomedical Research Commission through the Arizona Department of Health Services [ADHS14-00003606]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-065052]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH R03 NS-077098]; Phoenix Children's Hospital Leadership Circle; Phoenix Children's Hospital Mission Support Funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052, R03NS077098] Funding Source: NIH RePORTER	Supported by the Arizona Biomedical Research Commission through the Arizona Department of Health Services (ADHS14-00003606), National Institute of Neurological Disorders and Stroke of the National Institutes of Health (R01 NS-065052), National Institutes of Health (NIH R03 NS-077098), Phoenix Children's Hospital Leadership Circle and Phoenix Children's Hospital Mission Support Funds.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Allen NJ, 2013, CURR OPIN NEUROBIOL, V23, P1027, DOI 10.1016/j.conb.2013.06.004; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Andresen L, 2014, NEUROBIOL DIS, V71, P305, DOI 10.1016/j.nbd.2014.08.022; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barker AJ, 2010, NEUROSCIENTIST, V16, P40, DOI 10.1177/1073858409339215; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beltramino C A, 1993, NIDA Res Monogr, V136, P101; Beltramino CA, 1993, NIDA RES MONOGR, V136, P126; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; Bothwell S, 2001, J NEUROSCI, V21, P4789, DOI 10.1523/JNEUROSCI.21-13-04789.2001; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; CHIAIA NL, 1991, J COMP NEUROL, V314, P217, DOI 10.1002/cne.903140203; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Control NCfIPa, 2003, REP C MILD TRAUM BRA; Cuello J. I., 1985, TRES PONENCIAS POLIT; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; FINCH CE, 1993, TRENDS NEUROSCI, V16, P104, DOI 10.1016/0166-2236(93)90134-8; Galvin J, 2009, AM J OCCUP THER, V63, P701, DOI 10.5014/ajot.63.6.701; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Henderson T. A., 1995, CEREBRAL CORTEX BARR, P123; Hillary E. G., 2011, INT J PSYCHOPHYSIOL; Hoffman A. N., 2016, J NEUROTRAUMA; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Hwabejire JO, 2013, SURGERY, V154, P234, DOI 10.1016/j.surg.2013.04.008; Iacono D, 2008, J NEUROPATH EXP NEUR, V67, P578, DOI 10.1097/NEN.0b013e3181772794; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kulkarni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125748; LAND PW, 1995, J COMP NEUROL, V355, P573, DOI 10.1002/cne.903550407; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Learoyd A, 2011, J NEUROTRAUM, V28, pA88; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Maxwell W. L., BRAIN NEUROTRAUMA MO; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Miremami JD, 2014, SOMATOSENS MOT RES, V31, P127, DOI 10.3109/08990220.2014.897602; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Moraga-Amaro R, 2014, J PHYSIOL-PARIS, V108, P240, DOI 10.1016/j.jphysparis.2014.08.005; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; RADULOVIC LL, 1995, DRUG METAB DISPOS, V23, P441; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Risher ML, 2015, ALCOHOL CLIN EXP RES, V39, P2403, DOI 10.1111/acer.12913; Robertson CL, 2001, J NEUROTRAUM, V18, P861, DOI 10.1089/089771501750451785; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Sa MJ, 2000, ACTA NEUROPATHOL, V99, P643, DOI 10.1007/s004010051175; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Slezak M, 2003, TRENDS NEUROSCI, V26, P531, DOI 10.1016/j.tins.2003.08.005; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Taylor SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097096; Thomas TC, 2012, J NEUROTRAUM, V29, pA13; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; van der Horn H. J., 2015, BRAIN IMAGING BEHAV; Verkhratsky A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0595; Wang GX, 2008, J NEUROSCI, V28, P11959, DOI 10.1523/JNEUROSCI.3296-08.2008; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wu JF, 2016, PAIN, V157, P488, DOI 10.1097/j.pain.0000000000000393; Wu JF, 2014, CELL CYCLE, V13, P2446, DOI 10.4161/cc.29420; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Wu JF, 2013, NEUROTHERAPEUTICS, V10, P520, DOI 10.1007/s13311-013-0198-1; Ziebell JM, 2015, METAB BRAIN DIS, V30, P393, DOI 10.1007/s11011-014-9539-y; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	108	16	16	1	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		137	146		10.1016/j.bbr.2016.12.038			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400016	28042008	Green Accepted			2022-02-06	
J	Adler, CM; DelBello, MP; Weber, W; Williams, M; Duran, LRP; Fleck, D; Boespflug, E; Eliassen, J; Strakowski, SM; Divine, J				Adler, Caleb M.; DelBello, Melissa P.; Weber, Wade; Williams, Miranda; Patino Duran, Luis Rodrigo; Fleck, David; Boespflug, Erin; Eliassen, James; Strakowski, Stephen M.; Divine, Jon			MRI Evidence of Neuropathic Changes in Former College Football Players	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						college football; concussion; brain injury; magnetic resonance imaging; diffusion tensor imaging	CHRONIC TRAUMATIC ENCEPHALOPATHY; SELF-REPORTED CONCUSSIONS; SUPERIOR TEMPORAL SULCUS; SURFACE-BASED ANALYSIS; HIGH-SCHOOL; NEUROPSYCHOLOGICAL PERFORMANCE; MULTIPLE CONCUSSIONS; SOCIAL COGNITION; BRAIN-INJURY; ATTENTION	Objective: To examine effects of participating in collegiate football on neural health several years after retirement. We hypothesized that relative cortical thinning and loss of white matter integrity would be observed in former players. Design: Former NCAA Division I football players were compared with demographically similar track-and-field athletes with regard to cortical thickness and white matter integrity. Setting: Participants participated in MRI scans at the Center for Imaging Research at the University of Cincinnati. Participants: Eleven former football players and 10 demographically similar track-and-field athletes, Main Outcome Measures: Normalized cortical thickness was compared between groups using 2-tailed Student t test. As a secondary analysis, Spearman correlation coefficient was calculated between cortical thickness and number of concussions. Fractional anisotropy for regions-of-interest placed in frontal white matter tracts and internal capsule were compared between groups using 2-tailed Student t test. Results: Football players showed significantly lower cortical thickness within portions of both the frontal and temporal cortex. Affected frontal regions included left frontal pole and right superior frontal gyrus. Affected temporal regions included portions of the superior temporal gyrus, left inferior temporal gyrus, and right middle and superior temporal gyri. Cortical thickness inversely correlated with number of reported concussions over most of these regions. In addition, fractional anisotropy was lower in the right internal capsule of tamer football players, relative to controls. Conclusions: These findings suggest that at least some consequences of high-level collegiate football play persist even after the cessation of regular head blows. Longer-term studies are warranted to examine potential cognitive and functional implications of sustained cortical atrophy.	[Adler, Caleb M.; DelBello, Melissa P.; Weber, Wade; Williams, Miranda; Patino Duran, Luis Rodrigo; Fleck, David; Boespflug, Erin; Eliassen, James; Strakowski, Stephen M.] Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA; [Adler, Caleb M.; Fleck, David; Boespflug, Erin; Eliassen, James; Strakowski, Stephen M.] Univ Cincinnati, Coll Med, Ctr Imaging Res, Cincinnati, OH USA; [Adler, Caleb M.; DelBello, Melissa P.; Fleck, David; Strakowski, Stephen M.] Univ Cincinnati, Mood Disorders Ctr, UC Hlth, Neurosci Inst, Cincinnati, OH USA; [Divine, Jon] Univ Cincinnati, Coll Med, Dept Orthoped & Sports Med, Cincinnati, OH USA		Adler, CM (corresponding author), Dept Psychiat & Behav Neurosci, 260 Stetson St,Suite 3200, Cincinnati, OH 45219 USA.	adlercb@ucmail.uc.edu			University of Cincinnati Neuroscience Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER	Supported by the University of Cincinnati Neuroscience Institute.	Adams J, 2007, CLIN J SPORT MED, V17, P304, DOI 10.1097/JSM.0b013e31803202c8; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; [Anonymous], 2011, AN FUNCT NEUR COMP P; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Boespflug EL, 2014, BRAIN STRUCT FUNCT, V219, P367, DOI 10.1007/s00429-013-0506-x; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Coutlee CG, 2012, BRAIN RES, V1428, P3, DOI 10.1016/j.brainres.2011.05.053; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dick R, 2007, J ATHL TRAINING, V42, P221; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; First M., 1997, STRUCTURED CLIN INTE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gladsjo JA, 1999, J INT NEUROPSYCH SOC, V5, P247, DOI 10.1017/S1355617799533079; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; National Collegiate Athletic Association, 2014, CONC GUID DIAGN MAN; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Onnink AMH, 2015, PROG NEURO-PSYCHOPH, V63, P14, DOI 10.1016/j.pnpbp.2015.04.008; Pedersen HA, 2014, AM J ALZHEIMERS DIS, V29, P201, DOI 10.1177/1533317513517036; Pfeifer JH, 2012, DEV COGN NEUROS-NETH, V2, P55, DOI 10.1016/j.dcn.2011.07.012; Podberesky DJ, 2009, PEDIATR RADIOL, V39, P1264; Pontifex MB, 2012, RES Q EXERCISE SPORT, V83, P553; Rosen Howard J, 2008, Handb Clin Neurol, V88, P41, DOI 10.1016/S0072-9752(07)88003-1; Saitovitch A, 2012, REV NEUROL-FRANCE, V168, P762, DOI 10.1016/j.neurol.2012.07.017; Schmithorst VJ, 2001, IEEE T MED IMAGING, V20, P535, DOI 10.1109/42.929619; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Soliva JC, 2009, ANN NY ACAD SCI, V1167, P212, DOI 10.1111/j.1749-6632.2009.04604.x; Strawn JR, 2014, J ANXIETY DISORD, V28, P717, DOI 10.1016/j.janxdis.2014.07.012; Sundman MH, 2014, J ALZHEIMERS PARKINS, V4, P137; Terry DP, 2015, ARCH CLIN NEUROPSYCH, V30, P341, DOI 10.1093/arclin/acv020; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Xiao J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09738	59	16	17	3	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2018	28	2					100	105		10.1097/JSM.0000000000000391			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	GP1HC	WOS:000440564900003	27755011				2022-02-06	
J	Brackhan, M; Bascunana, P; Ross, TL; Bengel, FM; Bankstahl, JP; Bankstahl, M				Brackhan, Mirjam; Bascunana, Pablo; Ross, Tobias L.; Bengel, Frank M.; Bankstahl, Jens P.; Bankstahl, Marion			[F-18]GE180 positron emission tomographic imaging indicates a potential double-hit insult in the intrahippocampal kainate mouse model of temporal lobe epilepsy	EPILEPSIA			English	Article						activated microglia; neuroinflammation; positron emission tomography biomarker; translocator protein	TRAUMATIC BRAIN-INJURY; TRANSLOCATOR PROTEIN; MICROGLIAL ACTIVATION; PLASMINOGEN-ACTIVATOR; HIPPOCAMPAL SCLEROSIS; ANTIEPILEPTIC DRUGS; RECURRENT SEIZURES; GLUCOSE-METABOLISM; RAT MODEL; WILD-TYPE	ObjectiveAccumulating evidence suggests that brain inflammation, elicited by epileptogenic insults, is involved in epilepsy development. Noninvasive nuclear imaging of brain inflammation in animal models of epileptogenesis represents a diagnostic invivo approach with potential for direct translation into the clinic. Here, we investigated up-regulation of the translocator protein (TSPO) indicative of microglial activation by serial [F-18]GE180 positron emission tomographic (PET) imaging in a mouse model of temporal lobe epilepsy. MethodsAs epileptogenic insult, a status epilepticus (SE) was induced in mice by intrahippocampal injection of kainate. Post-SE mice injected with kainate and sham-injected mice were subjected to [F-18]GE180 PET scans before SE and at 2days, 5-7days, 2weeks, 3weeks, 7weeks, and 14weeks postinsult. For data evaluation, brain regions ipsilateral and contralateral to the injection site were outlined by coregistration with a standard mouse brain atlas, and percentage of injected dose per cubic centimeter was calculated. In addition, a statistical parametric mapping analysis, comparing post-SE mice to baseline, sham mice to baseline, and post-SE to sham mice was performed. ResultsFollowing SE, elevations in [F-18]GE180 uptake were most prominent in the ipsilateral hippocampus, occurring between 2days and at least 7weeks after SE, with a peak at 5-7days after SE. In the contralateral hippocampus and other epilepsy-associated brain regions, increased tracer uptake was observed with a similar time profile but to a lesser extent. Moderate enhancement of tracer uptake was also evident in mice after sham surgery. SignificanceTSPO invivo imaging reliably detects brain inflammation during epileptogenesis. These inflammatory processes most prominently affect the hippocampus ipsilateral to the injection site. Inflammation induced by the traumatic insult associated with surgery synergistically contributes to total brain inflammation and may also contribute to epileptogenesis. The revealed time course of neuroinflammation will help to identify appropriate time points for anti-inflammatory, potentially antiepileptogenic treatment.	[Brackhan, Mirjam; Bascunana, Pablo; Ross, Tobias L.; Bengel, Frank M.; Bankstahl, Jens P.] Hannover Med Sch, Dept Nucl Med, Hannover, Germany; [Brackhan, Mirjam; Bankstahl, Marion] Univ Vet Med, Dept Pharmacol Toxicol & Pharm, Hannover, Germany; [Brackhan, Mirjam] Univ Oslo, Sect Neuropathol, Dept Pathol, Oslo, Norway; [Brackhan, Mirjam] Oslo Univ Hosp, Oslo, Norway		Bankstahl, M (corresponding author), Univ Vet Med, Dept Pharmacol Toxicol & Pharm, Hannover, Germany.	marion.bankstahl@tiho-hannover.de	BascuAana, Pablo/AAA-4126-2019; Bengel, Frank/AAR-7353-2020; Brackhan, Mirjam/AAF-7886-2021; Ross, Tobias/K-8628-2013	BascuAana, Pablo/0000-0003-2186-8899; Ross, Tobias/0000-0002-0101-2463; Bengel, Frank/0000-0003-4529-7963; Bankstahl, Marion/0000-0002-5775-188X; Brackhan, Mirjam/0000-0002-0753-6292	European Seventh's Framework Program [602102]	European Seventh's Framework Program (FP7/2007-2013), Grant/Award Number: 602102	Amhaoul H, 2014, NEUROSCIENCE, V279, P238, DOI 10.1016/j.neuroscience.2014.08.044; Amhaoul H, 2015, NEUROBIOL DIS, V82, P526, DOI 10.1016/j.nbd.2015.09.004; Arabadzisz D, 2005, EXP NEUROL, V194, P76, DOI 10.1016/j.expneurol.2005.01.029; Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Bertoglio D, 2017, BRAIN BEHAV IMMUN, V61, P69, DOI 10.1016/j.bbi.2016.12.015; Bertram EH, 2008, EPILEPSIA, V49, P256, DOI 10.1111/j.1528-1167.2007.01408.x; Bogdanovic RM, 2014, NEUROPHARMACOLOGY, V85, P104, DOI 10.1016/j.neuropharm.2014.05.002; Bouilleret V, 2000, EPILEPSIA, V41, P642, DOI 10.1111/j.1528-1157.2000.tb00223.x; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Brackhan M, 2016, J NUCL MED, V57, P1302, DOI 10.2967/jnumed.116.172494; Brendel M, 2017, J NUCL MED, V58, P1984, DOI 10.2967/jnumed.117.195107; Brendel M, 2016, J NUCL MED, V57, P954, DOI 10.2967/jnumed.115.167858; Breuer H, 2017, J CEREBR BLOOD F MET, V37, P2049, DOI 10.1177/0271678X16659672; Dedeurwaerdere S, 2014, EPILEPSIA, V55, P819, DOI 10.1111/epi.12642; Dedeurwaerdere S, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-60; Deleye S, 2014, NEUROIMAGE, V96, P276, DOI 10.1016/j.neuroimage.2014.04.004; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Duveau V, 2016, CNS NEUROSCI THER, V22, P497, DOI 10.1111/cns.12523; Friedman A, 2012, Jasper's Basic Mechanisms of the Epilepsies, V4th, P513; Gershen LD, 2015, JAMA NEUROL, V72, P882, DOI 10.1001/jamaneurol.2015.0941; Gouder N, 2003, EPILEPSIA, V44, P877, DOI 10.1046/j.1528-1157.2003.03603.x; Groticke I, 2008, EXP NEUROL, V213, P71, DOI 10.1016/j.expneurol.2008.04.036; Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001; James ML, 2017, THERANOSTICS, V7, P1422, DOI 10.7150/thno.17666; Kadam SD, 2017, EPILEPSIA, V58, P10, DOI 10.1111/epi.13903; Klein S, 2015, NEUROPHARMACOLOGY, V90, P53, DOI 10.1016/j.neuropharm.2014.11.008; Klein S, 2015, EXP NEUROL, V263, P263, DOI 10.1016/j.expneurol.2014.09.004; Liu B, 2015, J NEUROSCI, V35, P15716, DOI 10.1523/JNEUROSCI.0996-15.2015; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Maroso M, 2011, NEUROTHERAPEUTICS, V8, P304, DOI 10.1007/s13311-011-0039-z; Mirrione MM, 2007, NEUROIMAGE, V38, P34, DOI 10.1016/j.neuroimage.2007.06.032; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Ory D, 2015, NUCL MED BIOL, V42, P753, DOI 10.1016/j.nucmedbio.2015.06.010; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Russmann V, 2017, NEUROIMAGE-CLIN, V15, P35, DOI 10.1016/j.nicl.2017.04.003; Salazar Andres M, 2015, Handb Clin Neurol, V128, P525, DOI 10.1016/B978-0-444-63521-1.00033-9; Sridharan S, 2017, MOL IMAGING BIOL, V19, P77, DOI 10.1007/s11307-016-0984-3; Twele Friederike, 2017, Epilepsia Open, V2, P180, DOI 10.1002/epi4.12044; Twele F, 2016, EPILEPSY BEHAV, V55, P47, DOI 10.1016/j.yebeh.2015.11.027; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2014, NEUROBIOL DIS, V63, P74, DOI 10.1016/j.nbd.2013.11.019; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Wadsworth H, 2012, BIOORG MED CHEM LETT, V22, P1308, DOI 10.1016/j.bmcl.2011.12.084; Yankam Njiwa J, 2017, J CEREB BLOOD FLOW M, V37, P1251; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zattoni M, 2011, J NEUROSCI, V31, P4037, DOI 10.1523/JNEUROSCI.6210-10.2011	50	16	17	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	MAR	2018	59	3					617	626		10.1111/epi.14009			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY6YJ	WOS:000427008500013	29364511				2022-02-06	
J	Capo-Aponte, JE; Beltran, TA; Walsh, DV; Cole, WR; Dumayas, JY				Capo-Aponte, Jose E.; Beltran, Thomas A.; Walsh, David V.; Cole, Wesley R.; Dumayas, Joseph Y.			Validation of Visual Objective Biomarkers for Acute Concussion	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium (MHSRS)	2016	FL				TRAUMATIC BRAIN-INJURY; CONVERGENCE INSUFFICIENCY; DYSFUNCTIONS; RELIABILITY; RECOVERY; VISION; SIZE	Objective: Despite an increase in the awareness and diagnosis of mild traumatic brain injury (mTBI), there remains a paucity of data examining the comparative efficacy of available assessments. This study aims to validate visual functions as potential biomarkers for mTBI. Methods: This case-control correlational design utilizes military personnel diagnosed with acute (<= 72 h post-injury) mTBI (n = 100) and age-matched controls (n = 100) to examine the relative effectiveness of the pupillary light reflex (PLR), near point of convergence (NPC) break, King-Devick (KD) test time, and Convergence Insufficiency Symptom Survey (CISS) score to discriminate between participants with mTBI. Results: Three of the eight PLR parameters (i.e., average constriction velocity (ACV), average dilation velocity (ADV), and 75% re-dilation time; all p < 0.001) were affected in mTBI participants. Similarly, NPC break, KD test time, and CISS scores showed a statistically significant difference between groups (all p < 0.001). Area under the curve showed that ADV (0.82) and NPC (0.74) have the higher predictive values of all objective parameters. Conclusions: ADV, ACV, and NPC break are objective visual functions markedly affected in the acute mTBI group compared with controls; therefore, we proposed that they could be used as biomarkers for acute mTBI.	[Capo-Aponte, Jose E.; Dumayas, Joseph Y.] Womack Army Med Ctr, Dept Optometry, 2817 Reilly Rd,Stop A, Ft Bragg, NC 28310 USA; [Beltran, Thomas A.] Womack Army Med Ctr, Dept Clin Invest, 2817 Reilly Rd,Stop A, Ft Bragg, NC 28310 USA; [Walsh, David V.] US Army, Vis Protect & Performance Div, Aeromed Res Lab, 6901 Farrel Rd, Ft Rucker, AL 36362 USA; [Cole, Wesley R.] Womack Army Med Ctr, Dept Brain Injury Med, Def & Vet Brain Injury Ctr, 2817 Reilly Rd,Stop A, Ft Bragg, NC 28310 USA		Capo-Aponte, JE (corresponding author), Womack Army Med Ctr, Dept Optometry, 2817 Reilly Rd,Stop A, Ft Bragg, NC 28310 USA.			Beltran, Thomas/0000-0001-8971-1201	Military Operational Medicine Research Program of the US Army Medical Research and Materiel Command; FY13 Department of Defense Army Rapid Innovation Fund Research Program of the Office of the Congressionally Directed Medical Research Programs [W81XWH-14-C-0048]	This research was funded by the Military Operational Medicine Research Program of the US Army Medical Research and Materiel Command and FY13 Department of Defense Army Rapid Innovation Fund Research Program of the Office of the Congressionally Directed Medical Research Programs under contract no. W81XWH-14-C-0048.	Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Cap?-Aponte JE., 2013, SPINE, V4, P1; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; CDC, INJ PREV CONTR TRAUM; Centers for Disease Control and Prevention, C MILD TRAUM BRAIN I; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fountas KN, 2006, NEUROCRIT CARE, V5, P55, DOI 10.1385/NCC:5:1:55; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Hults Kathryn N, 2006, J Neurosci Nurs, V38, P447; Kasthurirangan S, 2006, VISION RES, V46, P1393, DOI 10.1016/j.visres.2005.07.004; KROHEL GB, 1986, ANN OPHTHALMOL, V18, P101; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Loewenfeld I. E., 1979, TOPICS NEURO OPHTHAL, P124; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Papa L., 2015, BRAIN NEUROTRAUMA MO; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Schmid KE, 2012, FRONT NEUROL, V3, P1; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Walsh DV, 2016, J NEUROL SCI, V370, P305, DOI 10.1016/j.jns.2016.09.014; White OB, 2012, J NEURO-OPHTHALMOL, V32, P266, DOI 10.1097/WNO.0b013e3182688230; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	33	16	16	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183			S			9	17		10.1093/milmed/usx166			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	GC0JM	WOS:000429463600003	29635572	Bronze			2022-02-06	
J	Li, L; Yang, RL; Li, PJ; Lu, HL; Hao, JB; Li, LY; Tucker, D; Zhang, QG				Li, Lei; Yang, Rongli; Li, Pingjing; Lu, Hailong; Hao, Jingbo; Li, Liyan; Tucker, Donovan; Zhang, Quanguang			Combination Treatment with Methylene Blue and Hypothermia in Global Cerebral Ischemia	MOLECULAR NEUROBIOLOGY			English	Article						Methylene blue; Hypothermia; Combination treatment; Global cerebral ischemia; Neuroprotection; Learning and memory	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; RAT HIPPOCAMPUS; FALCIPARUM-MALARIA; ENERGY-METABOLISM; MILD HYPOTHERMIA	Therapeutic hypothermia (TH) is the most potent therapeutic strategy for global cerebral ischemia (GCI), usually induced by cardiac arrest. TH has been shown both to suppress the delayed neuronal cell death in the vulnerable hippocampal CA1 subregion and to improve neurological outcomes in experimental animals after GCI. However, given the multiple adverse effects resulting from TH, application of such a therapy is typically limited. In recent years, methylene blue (MB) has emerged as a potential therapeutic drug for the treatment of neurodegenerative diseases. In this study, we investigated the beneficial effects of mild TH combined with MB treatment after GCI. We report that both the neuronal survival in the hippocampal CA1 region and the hippocampus-dependent spatial learning and memory in the combined treatment animals were enhanced compared to those in the single treatment animals. Mechanistic studies revealed that combined TH and MB treatment significantly attenuated mitochondrial dysfunction induced by GCI in the hippocampus CA1 region. The combined treatment also markedly suppressed GCI-induced reactive gliosis and inflammation and reduced oxidative stress while enhancing the antioxidant capacity of hippocampal CA1 neurons. Finally, combining TH and MB synergistically attenuated the intrinsic cytochrome c/caspase-3 apoptotic pathway induced by GCI. Our results suggest that TH and MB act synergistically to protect the ischemic brain and suppress cognitive impairment caused by GCI.	[Li, Lei; Yang, Rongli; Li, Pingjing; Lu, Hailong; Hao, Jingbo; Li, Liyan] Xuzhou Med Univ, Affiliated Hosp, Dept Geriatr, Xuzhou 221002, Jiangsu, Peoples R China; [Tucker, Donovan; Zhang, Quanguang] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, 1120 15th St, Augusta, GA 30912 USA		Zhang, QG (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, 1120 15th St, Augusta, GA 30912 USA.	qzhang@augusta.edu			American Heart AssociationAmerican Heart Association [15GRNT25240004]; science and technology project of Xuzhou city, Jiangsu [KC15SH093]; National Institute of Neurological Disorders and Stroke, National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS086929]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS086929] Funding Source: NIH RePORTER	This study was supported by Research Grant NS086929 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA; an American Heart Association Grant-in-Aid 15GRNT25240004; and a science and technology project of Xuzhou city, Jiangsu (KC15SH093).	ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; Ahmed ME, 2016, NEUROSCIENCE, V336, P39, DOI 10.1016/j.neuroscience.2016.08.036; Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Briyal S, 2010, EUR J PHARMACOL, V644, P73, DOI 10.1016/j.ejphar.2010.06.071; CAFE C, 1994, NEUROCHEM RES, V19, P1551, DOI 10.1007/BF00969005; Cai LP, 2016, J NEUROSCI RES, V94, P749, DOI 10.1002/jnr.23740; Coulibaly B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005318; D'Amico F, 2005, BIOTECH HISTOCHEM, V80, P207, DOI 10.1080/10520290600560897; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dave KR, 2001, J CEREBR BLOOD F MET, V21, P1401, DOI 10.1097/00004647-200112000-00004; Deng G, 2014, J NEUROSCI METH, V222, P34, DOI 10.1016/j.jneumeth.2013.10.015; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dormoi J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-127; Fang Q, 2016, ACTA NEUROCHIR SUPPL, V121, P227, DOI 10.1007/978-3-319-18497-5_41; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; Gillman PK, 2006, ANAESTHESIA, V61, P1013, DOI 10.1111/j.1365-2044.2006.04808.x; Ginimuge Prashant R, 2010, J Anaesthesiol Clin Pharmacol, V26, P517; Gong P, 2013, J CEREBR BLOOD F MET, V33, P928, DOI 10.1038/jcbfm.2013.33; Green SP, 2001, J CEREBR BLOOD F MET, V21, P374, DOI 10.1097/00004647-200104000-00006; Guerra-Wallace MM, 2013, PEDIATR CRIT CARE ME, V14, pE143, DOI 10.1097/PCC.0b013e3182720440; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Ji XM, 2007, FRONT BIOSCI, V12, P1737, DOI 10.2741/2185; Jiang Zhao, 2016, Brain Circ, V2, P48; KARIBE H, 1994, BRAIN RES, V649, P12, DOI 10.1016/0006-8993(94)91043-X; KENNEDY C, 1957, J CLIN INVEST, V36, P1130, DOI 10.1172/JCI103509; Kim YM, 2012, RESUSCITATION, V83, P188, DOI 10.1016/j.resuscitation.2011.07.031; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lu Q, 2016, MOL NEUROBIOL, V53, P5344, DOI 10.1007/s12035-015-9455-0; Lu YJ, 2017, NEUROBIOL AGING, V49, P165, DOI 10.1016/j.neurobiolaging.2016.10.003; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nielsen N, 2011, INT J CARDIOL, V151, P333, DOI 10.1016/j.ijcard.2010.06.008; Nielsen N, 2011, CRIT CARE MED, V39, P57, DOI 10.1097/CCM.0b013e3181fa4301; Nolan Jerry P, 2010, Int Emerg Nurs, V18, P8, DOI 10.1016/j.ienj.2009.07.001; Oh JS, 2013, AM J EMERG MED, V31, P154, DOI 10.1016/j.ajem.2012.06.033; Ostadal P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-124; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Perbet S, 2011, AM J RESP CRIT CARE, V184, P1048, DOI 10.1164/rccm.201102-0331OC; Racay P, 2009, NEUROCHEM RES, V34, P1469, DOI 10.1007/s11064-009-9934-7; Ramirez Rivera Jose, 2006, Bol Asoc Med P R, V98, P118; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Rodriguez P, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.478; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; Shankaran S, 2012, CURR TREAT OPTION NE, V14, P608, DOI [10.1007/s11940-012-0200-y, 10.1097/MOP.0000000000000199]; SIMS NR, 1992, NEUROCHEM RES, V17, P923, DOI 10.1007/BF00993269; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sunde K, 2013, REV ESP CARDIOL, V66, P346, DOI 10.1016/j.rec.2012.10.004; Tardivo JP, 2005, PHOTODIAGN PHOTODYN, V2, P175, DOI 10.1016/S1572-1000(05)00097-9; Toader Alina-Mihaela, 2013, Clujul Med, V86, P203; Urrutia PJ, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00038; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; VINCER MJ, 1987, CAN MED ASSOC J, V136, P503; Weitzdoerfer R, 2004, SEMIN PERINATOL, V28, P249, DOI 10.1053/j.semperi.2004.08.001; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Witte ME, 2010, MITOCHONDRION, V10, P411, DOI 10.1016/j.mito.2010.05.014; Wolman RL, 1999, STROKE, V30, P514, DOI 10.1161/01.STR.30.3.514; Xu CH, 2016, MOL CLIN ONCOL, V5, P279, DOI 10.3892/mco.2016.913; Yang SH, 2017, PROG NEUROBIOL, V157, P273, DOI 10.1016/j.pneurobio.2015.10.005; Zhang H, 2008, NEUROL RES, V30, P332, DOI 10.1179/174313208X300279; Zhang H, 2011, CHINESE MED J-PEKING, V124, P2764, DOI 10.3760/cma.j.issn.0366-6999.2011.17.035; Zhang QG, 2013, BRAIN, V136, P1432, DOI 10.1093/brain/awt046; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhao MY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122078; Zoungrana A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001630	69	16	17	2	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2018	55	3					2042	2055		10.1007/s12035-017-0470-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY5TG	WOS:000426897800019	28271403				2022-02-06	
J	Rojas-Carvajal, M; Fornaguera, J; Mora-Gallegos, A; Brenes, JC				Rojas-Carvajal, Mijail; Fornaguera, Jaime; Mora-Gallegos, Andrea; Brenes, Juan C.			Testing experience and environmental enrichment potentiated open-field habituation and grooming behaviour in rats	ANIMAL BEHAVIOUR			English	Article						animal model; arousal; environmental enrichment; grooming; nonassociative learning; stress	TRAUMATIC BRAIN-INJURY; FORCED SWIMMING TEST; SPRAGUE-DAWLEY RATS; SPATIAL MEMORY; DEFENSIVE BEHAVIORS; DENTATE GYRUS; TIME-COURSE; ADULT RATS; STRESS; ANXIETY	In laboratory rats, one of the most used paradigms to assess habituation to novelty is the open-field test. Environmental enrichment has proved to be a reliable way to enhance open-field test habituation. Experiment 1, therefore, was designed to test whether grooming behaviour in the open-field test increases concomitantly with the habituation of exploratory behaviours (locomotion and rearing behaviour, an alert upright posture). To this aim, after a baseline measure, rats were raised in environmentally enriched and standard housing conditions and then tested 30 and 60 days later. As some grooming subtypes are differentially displayed in the open-field test, we hypothesized that only the grooming subtype that included longer and more complex sequences (e.g. body licking) would increase with habituation. We found that environmental enrichment enhanced short-term (within days) and long-term (between days) open-field test habituation, and increased grooming, particularly body licking. To provide evidence that grooming in the open-field test is part of the habituation process and not a by-product of environmental enrichment, habituation was promoted by exposing a different group of rats that had been reared in standard housing to four consecutive open-field tests in experiment 2. We supposed that the diminution of exploratory open-field test behaviours would be accompanied by an increase in body licking. We found that as locomotion and rearing behaviour decreased, body licking increased gradually both within and between days, suggesting that the appearance of more complex and longer grooming sequences are part of a de-arousal inhibition system subserving novelty habituation. A detailed analysis of grooming, therefore, may provide information about the emotional state of the rat that cannot otherwise be obtained from assessing exploratory activity. (C) 2018 The Association for the Study of Animal Behaviour. Published by Elsevier Ltd. All rights reserved.	[Rojas-Carvajal, Mijail; Fornaguera, Jaime; Mora-Gallegos, Andrea; Brenes, Juan C.] Univ Costa Rica, Neurosci Res Ctr, San Jose 115012060, Costa Rica; [Fornaguera, Jaime] Univ Costa Rica, Sch Med, Biochem Dept, San Jose, Costa Rica; [Brenes, Juan C.] Univ Costa Rica, Inst Psychol Res, San Jose, Costa Rica		Rojas-Carvajal, M (corresponding author), Univ Costa Rica, Neurosci Res Ctr, San Jose 115012060, Costa Rica.	mijail.rojas.ca@gmail.com		Rojas-Carvajal, Mijail/0000-0002-6077-7829	University of Costa Rica [837-B7-603, 837-B5-184, 837-B5-185, 723-B4-192]; Support Found for Final Graduation Work, Vice-Rectory of Research, University of Costa Rica; grant Young Researcher in Psychology, Institute for Psychological Research, University of Costa Rica	This research was partially supported by the projects 837-B7-603, 837-B5-184, 837-B5-185 and 723-B4-192, Vice-Rectory of Research, University of Costa Rica. This work was awarded with the Support Found for Final Graduation Work, Vice-Rectory of Research, University of Costa Rica, and also with the grant Young Researcher in Psychology, Institute for Psychological Research, University of Costa Rica.	Almeida Maria Camila, 2015, Temperature (Austin), V2, P483, DOI 10.1080/23328940.2015.1095270; Amador GJ, 2015, J EXP BIOL, V218, P3164, DOI 10.1242/jeb.103937; Barbelivien A, 2006, BEHAV BRAIN RES, V169, P231, DOI 10.1016/j.bbr.2006.01.012; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Bengston SE, 2014, ANIM BEHAV, V93, P105, DOI 10.1016/j.anbehav.2014.04.022; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; Bennett JC, 2006, NEUROBIOL LEARN MEM, V85, P139, DOI 10.1016/j.nlm.2005.09.003; BERRIDGE KC, 1992, EXP BRAIN RES, V90, P275; Blanchard DC, 2008, HBK BEHAV NEUROSCI, V17, P63, DOI 10.1016/S1569-7339(07)00005-7; Blanchard RJ, 2001, NEUROSCI BIOBEHAV R, V25, P587, DOI 10.1016/S0149-7634(01)00043-4; BOWLING SL, 1993, NEUROPHARMACOLOGY, V32, P885, DOI 10.1016/0028-3908(93)90144-R; Brenes JC, 2008, NEUROSCI LETT, V436, P278, DOI 10.1016/j.neulet.2008.03.045; Brenes JC, 2016, J COMP NEUROL, V524, P1586, DOI 10.1002/cne.23842; Brenes JC, 2009, BEHAV BRAIN RES, V197, P125, DOI 10.1016/j.bbr.2008.08.014; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Carter GG, 2015, HORM BEHAV, V75, P150, DOI 10.1016/j.yhbeh.2015.10.006; Collymore C, 2015, J AM ASSOC LAB ANIM, V54, P280; DELIUS JD, 1967, NATURE, V214, P1259, DOI 10.1038/2141259a0; DIAMOND MC, 1976, J NEUROBIOL, V7, P75, DOI 10.1002/neu.480070108; Diaz-Moran S., 2014, WORLD J NEUROSCI, V4, P1, DOI DOI 10.4236/WJNS.2014.410; DOYLE G., 1959, ANIMAL BEHAVIOR, V7, P18, DOI 10.1016/0003-3472(59)90025-9; Elliott BM, 2005, BEHAV BRAIN RES, V165, P187, DOI 10.1016/j.bbr.2005.06.025; EWER RF, 1967, NATURE, V216, P686, DOI 10.1038/216686a0; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; FENTRESS JC, 1968, ANIM BEHAV, V16, P135, DOI 10.1016/0003-3472(68)90124-3; Fernandez-Teruel A, 2002, PHARMACOL BIOCHEM BE, V73, P225, DOI 10.1016/S0091-3057(02)00784-0; Fernandez-Teruel A, 2016, NAT REV NEUROSCI, V17, P591, DOI 10.1038/nrn.2016.102; Fuzesi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11937; Gagliano H, 2014, HORM BEHAV, V66, P793, DOI 10.1016/j.yhbeh.2014.11.002; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Hong WZ, 2014, CELL, V158, P1348, DOI 10.1016/j.cell.2014.07.049; Hughes RN, 2010, PHARMACOL BIOCHEM BE, V94, P534, DOI 10.1016/j.pbb.2009.11.008; ISAACSON RL, 1983, BRAIN RES BULL, V11, P289, DOI 10.1016/0361-9230(83)90162-4; JOLLES J, 1979, BEHAV NEURAL BIOL, V25, P563, DOI 10.1016/S0163-1047(79)90362-5; Kalueff AV, 2016, NAT REV NEUROSCI, V17, P45, DOI 10.1038/nrn.2015.8; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; KAMETANI H, 1988, ANN NY ACAD SCI, V525, P101, DOI 10.1111/j.1749-6632.1988.tb38599.x; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kruk MR, 1998, NEUROSCI BIOBEHAV R, V23, P163, DOI 10.1016/S0149-7634(98)00018-9; Kuzumaki N, 2011, HIPPOCAMPUS, V21, P127, DOI 10.1002/hipo.20775; LAMMERS JHCM, 1987, BRAIN RES, V418, P1, DOI 10.1016/0006-8993(87)90956-5; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Maegele M, 2015, PHYSIOL RES, V64, P129, DOI 10.33549/physiolres.932664; Marques MR, 2014, BEHAV BRAIN RES, V263, P149, DOI 10.1016/j.bbr.2014.01.007; Martin JGA, 2008, ANIM BEHAV, V75, P309, DOI 10.1016/j.anbehav.2007.05.026; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Molesti S, 2013, ANIM BEHAV, V86, P169, DOI 10.1016/j.anbehav.2013.05.008; Mora-Gallegos A, 2015, NEUROBIOL LEARN MEM, V118, P96, DOI 10.1016/j.nlm.2014.11.012; Moritz KE, 2014, RESTOR NEUROL NEUROS, V32, P701, DOI 10.3233/RNN-140414; MOYAHO A, 1995, ANIM BEHAV, V50, P61, DOI 10.1006/anbe.1995.0221; Neugebauer NM, 2004, DEV BRAIN RES, V153, P213, DOI 10.1016/j.devbrainres.2004.09.001; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Pena Y, 2006, BEHAV BRAIN RES, V174, P181, DOI 10.1016/j.bbr.2006.07.007; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Poon Chi-Sang, 2006, Behav Brain Funct, V2, P29, DOI 10.1186/1744-9081-2-29; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rau V, 2009, STRESS, V12, P125, DOI 10.1080/10253890802137320; RENNER MJ, 1986, DEV PSYCHOBIOL, V19, P303, DOI 10.1002/dev.420190403; ROBERTS WW, 1988, ANN NY ACAD SCI, V525, P363, DOI 10.1111/j.1749-6632.1988.tb38620.x; Rojas-Carvajal M., 2016, 2 FALAN C; Rojas-Carvajal M., 2016, 46 ANN M SOC NEUR; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; ROTH KA, 1979, NEUROSCI BIOBEHAV R, V3, P247, DOI 10.1016/0149-7634(79)90012-5; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Saenz JCB, 2006, BEHAV BRAIN RES, V169, P57, DOI 10.1016/j.bbr.2005.12.001; Sampedro-Piquero P, 2014, PHYSIOL BEHAV, V129, P118, DOI 10.1016/j.physbeh.2014.02.048; Schrijver NCA, 2002, PHARMACOL BIOCHEM BE, V73, P209, DOI 10.1016/S0091-3057(02)00790-6; Schuch CP, 2016, BEHAV BRAIN RES, V304, P42, DOI 10.1016/j.bbr.2016.02.010; Sequeira-Cordero A, 2014, NEUROSCIENCE, V265, P95, DOI 10.1016/j.neuroscience.2014.01.047; SEYFARTH RM, 1980, ANIM BEHAV, V28, P798, DOI 10.1016/S0003-3472(80)80140-0; Solinas M, 2010, PROG NEUROBIOL, V92, P572, DOI 10.1016/j.pneurobio.2010.08.002; Song C, 2016, NAT REV NEUROSCI, V17, DOI 10.1038/nrn.2016.103; Spradley JM, 2012, ACTA DERM-VENEREOL, V92, P515, DOI 10.2340/00015555-1364; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; THIESSEN DD, 1988, ANN NY ACAD SCI, V525, P27, DOI 10.1111/j.1749-6632.1988.tb38593.x; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; Turner KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093411; Valles A, 2000, AM J PHYSIOL-REG I, V279, pR1138, DOI 10.1152/ajpregu.2000.279.3.R1138; VANERP AMM, 1994, BEHAV BRAIN RES, V65, P47, DOI 10.1016/0166-4328(94)90072-8; Varty GB, 2000, BIOL PSYCHIAT, V47, P864, DOI 10.1016/S0006-3223(99)00269-3; Veloso A. W. N., 2016, PSYCHOL NEUROSCI, V9, P91, DOI [10.1037/pne0000038, DOI 10.1037/PNE0000038]; WELKER WI, 1959, J COMP PHYSIOL PSYCH, V52, P106, DOI 10.1037/h0042241; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982; Zimmermann A, 2001, BEHAV BRAIN RES, V121, P11, DOI 10.1016/S0166-4328(00)00377-6	86	16	18	1	18	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0003-3472	1095-8282		ANIM BEHAV	Anim. Behav.	MAR	2018	137						225	235		10.1016/j.anbehav.2018.01.018			11	Behavioral Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Zoology	FZ2TQ	WOS:000427436600024					2022-02-06	
J	Sauvigny, T; Gotsche, J; Czorlich, P; Vettorazzi, E; Westphal, M; Regelsberger, J				Sauvigny, Thomas; Goetsche, Jennifer; Czorlich, Patrick; Vettorazzi, Eik; Westphal, Manfred; Regelsberger, Jan			Intracranial pressure in patients undergoing decompressive craniectomy: new perspective on thresholds	JOURNAL OF NEUROSURGERY			English	Article						intracranial pressure; decompressive craniectomy; stroke; traumatic brain injury; neurocritical care; diagnostic technique	TRAUMATIC BRAIN-INJURY; MIDDLE-CEREBRAL-ARTERY; AGITATION-SEDATION SCALE; GLASGOW COMA SCALE; CARE-UNIT PATIENTS; SEVERE HEAD-INJURY; MALIGNANT INFARCTION; CLINICAL ARTICLE; TRIAL; HEMICRANIECTOMY	OBJECTIVE Decompressive craniectomy (DC) is an established part of treatment in patients suffering from malignant infarction of the middle cerebral artery (MCA) or traumatic brain injury (TBI). However, no clear evidence for intracranial pressure (ICP)-guided therapy after DC exists. The lack of this evidence might be due to the frequently used, but simplified threshold for ICP of 20 mm Hg, which determines further therapy. Therefore, the objective of this study was to evaluate this threshold's accuracy and to investigate the course of ICP values with respect to neurological outcome. METHODS Data on clinical characteristics and parameters of the ICP course on the intensive care unit were collected retrospectively in 102 patients who underwent DC between December 2007 and April 2014 at the authors' institution. The postoperative ICP course in the first 168 hours was recorded and analyzed. From these findings, ICP thresholds discriminating favorable from unfavorable outcome were calculated using conditional inference tree analysis. Additionally, survival analysis was performed using the Kaplan-Meier method. Prognostic factors were assessed via univariate analysis and multivariate logistic regression. Favorable outcome was defined as a score of 0-4 on the modified Rankin Scale. RESULTS Multivariate logistic regression revealed that anisocoria, diagnosis, and ICP values differed significantly between the outcome groups. ICP values in the favorable and unfavorable outcome groups differed significantly (p < 0.001), while the mean ICP of both groups lay below the limit of 20 mm Hg (17.5 and 11.5 mm Hg, respectively). These findings were reproduced when analyzing the underlying pathologies of TBI and MCA infarction separately. Based on these findings, optimized time-dependent threshold values were calculated and found to be between 10 and 17 mm Hg. These values significantly distinguished favorable from unfavorable outcome and predicted 30-day mortality (p < 0.001). CONCLUSIONS This study systematically evaluated ICP levels in a long-term analysis after DC and provides new, surprisingly low, time-dependent ICP thresholds for these patients. Future trials investigating the benefit of ICP-guided therapy should take these thresholds into consideration and validate them in further patient cohorts.	[Sauvigny, Thomas; Goetsche, Jennifer; Czorlich, Patrick; Westphal, Manfred; Regelsberger, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-20246 Hamburg, Germany; [Vettorazzi, Eik] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany		Sauvigny, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-20246 Hamburg, Germany.	t.sauvigny@uke.de	Vettorazzi, Eik/B-8130-2019; Czorlich, Patrick/H-8934-2019	Vettorazzi, Eik/0000-0002-3737-6402; 			Al-Tamimi YZ, 2009, NEUROSURGERY, V64, P94, DOI 10.1227/01.NEU.0000328392.98602.5A; Poca MA, 2010, J NEUROSURG, V112, P648, DOI 10.3171/2009.7.JNS081677; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Firsching R, 2015, AWMF LEITLINIE SCHAD; Handschu R, 2005, J NEUROL, V252, P1249, DOI 10.1007/s00415-005-0853-5; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Huttner HB, 2009, LANCET NEUROL, V8, P949, DOI 10.1016/S1474-4422(09)70224-8; Johnson RD, 2011, J CLIN NEUROSCI, V18, P1023, DOI 10.1016/j.jocn.2010.12.025; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2012, AWMF LEITLINIE INTRA; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kocher E, 1901, HIRNERSCHUTTERUNG HI, P255; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Marion DW, 2006, NEUROSURGERY, V58, P655; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Paldor I, 2015, J CLIN NEUROSCI, V22, P79, DOI 10.1016/j.jocn.2014.07.006; Potts MB, 2008, ACTA NEUROCHIR SUPPL, V102, P109, DOI 10.1007/978-3-211-85578-2_22; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sakr Y, 2012, J EVAL CLIN PRACT, V18, P231, DOI 10.1111/j.1365-2753.2010.01559.x; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sharda Priya, 2014, Asian J Neurosurg, V9, P203, DOI 10.4103/1793-5482.146605; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Suistomaa M, 2002, INTENS CARE MED, V28, P479, DOI 10.1007/s00134-002-1214-9; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9	41	16	19	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2018	128	3					819	827		10.3171/2016.11.JNS162263			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FX7WD	WOS:000426301400020	28409728	Bronze			2022-02-06	
J	Ren, HL; Lv, CN; Xing, Y; Geng, Y; Zhang, F; Bu, W; Wang, MW				Ren, Hui Ling; Lv, Chao Nan; Xing, Ying; Geng, Yuan; Zhang, Feng; Bu, Wei; Wang, Ming Wei			Downregulated Nuclear Factor E2-Related Factor 2 (Nrf2) Aggravates Cognitive Impairments via Neuroinflammation and Synaptic Plasticity in the Senescence-Accelerated Mouse Prone 8 (SAMP8) Mouse: A Model of Accelerated Senescence	MEDICAL SCIENCE MONITOR			English	Article						Aging; Inflammation; Mild Cognitive Impairment	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; SIGNALING PATHWAY; MEMORY FORMATION; MICE; INVOLVEMENT; DYSFUNCTION; ACTIVATION; MECHANISM; PATHOLOGY	Background: We observed the effects of nuclear factor E2-related factor 2 (Nrf2) downregulation via intrahippocampal injection of a lentiviral vector on cognition in senescence-accelerated mouse prone 8 (SAMP8) to investigate the role of the (Nrf2)/antioxidant response element (ARE) pathway in age-related changes. Material/Methods: Control lentivirus and Nrf2-shRNA-lentivirus were separately injected into the hippocampus of 4-month-old SAMR1 and SAMP8 mice and then successfully downregulated Nrf2 expression in this brain region. Five months later, cognitive function tests, including the novel object test, the Morris water maze test, and the passive avoidance task were conducted. Glial fibrillary acidic protein (GFAP) and ionized calcium-binding adapter molecule 1 (Iba1) immunohistochemistry was performed to observe an inflammatory response. Presynaptic synapsin (SYN) were observed by immunofluorescence. We then determined the Nrf2-regulated, heme oxygenase-1 (HO-1), P65, postsynaptic density protein (PSD), and SYN protein levels. The ultrastructure of neurons and synapses in the hippocampal CA1 region was observed by transmission electron microscopy. Results: Aging led to a decline in cognitive function compared with SAMR1 mice and the Nrf2-shRNA-lentivirus further exacerbated the cognitive impairment in SAMP8 mice. Nrf2, HO-1, PSD, and SYN levels were significantly reduced (all P<0.05) but high levels of inflammation were detected in SAMP8 mice with low expression of Nrf2. Furthermore, neurons were vacuolated, the number of organelles decreased, and the number of synapses decreased. Conclusions: Downregulation of Nrf2 suppressed the Nrf2/ARE pathway, activated oxidative stress and neuroinflammation, and accelerated cognitive impairment in SAMP8 mice. Downregulation of Nrf2 accelerates the aging process through neuroinflammation and synaptic plasticity.	[Ren, Hui Ling; Lv, Chao Nan; Geng, Yuan; Wang, Ming Wei] Hebei Med Univ, Hosp 3, Dept Neurol, Shijiazhuang, Hebei, Peoples R China; [Lv, Chao Nan; Geng, Yuan; Wang, Ming Wei] Brain Aging & Cognit Neurosci Key Lab Hebei, Shijiazhuang, Hebei, Peoples R China; [Xing, Ying; Zhang, Feng] Hebei Med Univ, Hosp 3, Dept Rehabil Med, Shijiazhuang, Hebei, Peoples R China; [Bu, Wei] Hebei Med Univ, Hosp 3, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China		Wang, MW (corresponding author), Hebei Med Univ, Hosp 3, Dept Neurol, Shijiazhuang, Hebei, Peoples R China.; Wang, MW (corresponding author), Brain Aging & Cognit Neurosci Key Lab Hebei, Shijiazhuang, Hebei, Peoples R China.	drwangmingwei@126.com	zhang, feng/AAD-1724-2019	zhang, feng/0000-0002-7845-7970	Provincial Major Medical Programs [ZD2013077, ZD2013079]; Hebei Health and Family Planning Commission Directive Program [ZL20140184]	This work was supported by Provincial Major Medical Programs (ZD2013077, ZD2013079) and the Hebei Health and Family Planning Commission Directive Program (ZL20140184)	Akiguchi I, 2017, NEUROPATHOLOGY, V37, P293, DOI 10.1111/neup.12373; Baltanas A, 2013, J PHYSIOL BIOCHEM, V69, P927, DOI 10.1007/s13105-013-0271-6; Branca C, 2017, HUM MOL GENET, V26, P4823, DOI 10.1093/hmg/ddx361; Brodziak A, 2014, MED SCI MONITOR, V20, P2733, DOI 10.12659/MSM.891056; Buendia I, 2016, PHARMACOL THERAPEUT, V157, P84, DOI 10.1016/j.pharmthera.2015.11.003; Cao HM, 2016, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00244; Chakrabarty P, 2015, NEURON, V85, P519, DOI 10.1016/j.neuron.2014.11.020; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; d'Isa R, 2014, METHODS MOL BIOL, V1120, P131, DOI 10.1007/978-1-62703-791-4_9; Deshmukh Prashant, 2017, Biophys Rev, V9, P41, DOI 10.1007/s12551-016-0244-4; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dinkova-Kostova A. T., 2018, FEBS J; Farr SA, 2014, FREE RADICAL BIO MED, V67, P387, DOI 10.1016/j.freeradbiomed.2013.11.014; Flood JF, 1998, NEUROSCI BIOBEHAV R, V22, P1; Gan L, 2012, J NEUROSCI, V32, P17775, DOI 10.1523/JNEUROSCI.3049-12.2012; Grinan-Ferre C, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00241; Grinan-Ferre C, 2016, EXP GERONTOL, V80, P57, DOI 10.1016/j.exger.2016.03.014; Heidari MH, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/290414; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Joshi G, 2015, NEUROBIOL AGING, V36, P664, DOI 10.1016/j.neurobiolaging.2014.09.004; Kandimalla R, 2016, HUM MOL GENET, V25, P4881, DOI 10.1093/hmg/ddw312; Kanninen K, 2009, P NATL ACAD SCI USA, V106, P16505, DOI 10.1073/pnas.0908397106; Karkkainen V, 2014, STEM CELLS, V32, P1904, DOI 10.1002/stem.1666; Kwon SH, 2015, NEUROSCIENCE, V304, P14, DOI 10.1016/j.neuroscience.2015.07.030; Liddell JR, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0515-9; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu YG, 2016, PHARMACOL BIOCHEM BE, V150, P207, DOI 10.1016/j.pbb.2016.11.002; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Mottahedin A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00190; Pajares M, 2016, AUTOPHAGY, V12, P1902, DOI 10.1080/15548627.2016.1208889; Pan WS, 2016, EXP THER MED, V12, P1455, DOI 10.3892/etm.2016.3470; Qiang M, 2014, J ALZHEIMERS DIS, V40, P1039, DOI 10.3233/JAD-131595; Rice RA, 2015, J NEUROSCI, V35, P9977, DOI 10.1523/JNEUROSCI.0336-15.2015; Rojo AI, 2017, REDOX BIOL, V13, P444, DOI 10.1016/j.redox.2017.07.006; Sardari M, 2015, BRAIN RES, V1625, P54, DOI 10.1016/j.brainres.2015.08.015; Tabassum S, 2017, PAK J PHARM SCI, V30, P1013; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang JH, 2016, CELL PHYSIOL BIOCHEM, V39, P1078, DOI 10.1159/000447816; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Wu G, 2016, MED SCI MONITOR, V22, P2161, DOI 10.12659/MSM.896568; Yanai S, 2016, BEHAV BRAIN RES, V308, P187, DOI 10.1016/j.bbr.2016.04.026; Ye F, 2015, SCI REP-UK, V5, DOI 10.1038/srep18636; Zhao MY, 2017, FOOD CHEM TOXICOL, V106, P25, DOI 10.1016/j.fct.2017.05.007; Zhao XJ, 2013, EXP GERONTOL, V48, P869, DOI 10.1016/j.exger.2013.05.063; Zou CY, 2016, ACTA NEUROPATHOL, V131, P235, DOI 10.1007/s00401-015-1527-8	45	16	19	3	15	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	FEB 23	2018	24						1132	1144		10.12659/MSM.908954			13	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FX6QU	WOS:000426211500002	29474348	Green Published, Green Submitted			2022-02-06	
J	Zhang, HM; Liu, P; Jiang, C; Jin, XQ; Liu, RN; Li, SQ; Zhao, Y				Zhang, Hong-Mei; Liu, Pei; Jiang, Cheng; Jin, Xiao-Qing; Liu, Rui-Ning; Li, Shun-Qing; Zhao, Yan			Notch signaling inhibitor DAPT provides protection against acute craniocerebral injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GAMMA-SECRETASE; NEUROGENESIS; APOPTOSIS; AUTOPHAGY; ISCHEMIA; MOUSE; DEATH	Notch signaling pathway is involved in many physiological and pathological processes. The gamma-secretase inhibitor DAPT inhibits Notch signaling pathway and promotes nerve regeneration after cerebral ischemia. However, neuroprotective effects of DAPT against acute craniocerebral injury remain unclear. In this study, we established rat model of acute craniocerebral injury, and found that with the increase of damage grade, the expression of Notch and downstream protein Hes1 and Hes5 expression gradually increased. After the administration of DAPT, the expression of Notch, Hes1 and Hes5 was inhibited, apoptosis and oxidative stress decreased, neurological function and cognitive function improved. These results suggest that Notch signaling can be used as an indicator to assess the severity of post-traumatic brain injury. Notch inhibitor DAPT can reduce oxidative stress and apoptosis after acute craniocerebral injury, and is a potential drug for the treatment of acute craniocerebral injury.	[Zhang, Hong-Mei; Jiang, Cheng; Jin, Xiao-Qing; Liu, Rui-Ning; Li, Shun-Qing; Zhao, Yan] Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan, Hubei, Peoples R China; [Liu, Pei] Hubei Univ Med, Taihe Hosp, Dept Intens Care Unit, Wuhan, Hubei, Peoples R China		Zhao, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan, Hubei, Peoples R China.	doctoryanzhao@163.com			Emergency Diagnostic & Therapeutic Center of Central China	This study was financially supported by the "Emergency Diagnostic & Therapeutic Center of Central China." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Xian-Long Zhou for reviewing the manuscript. This study was financially supported by the "Emergency Diagnostic & Therapeutic Center of Central China".	Altmann C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0132-1; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Evin G, 2006, CNS DRUGS, V20, P351, DOI 10.2165/00023210-200620050-00002; Fazio C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.408; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Huang M, 2014, CHINESE MED J-PEKING, V127, P924, DOI 10.3760/cma.j.issn.0366-6999.20132366; Li SY, 2012, NEUROL SCI, V33, P1257, DOI 10.1007/s10072-012-0948-6; Li ZX, 2016, TRANSL STROKE RES, V7, P132, DOI 10.1007/s12975-015-0441-7; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Pazos MC, 2017, MOL CELL ENDOCRINOL, V440, P125, DOI 10.1016/j.mce.2016.11.025; Pei HF, 2015, FREE RADICAL BIO MED, V82, P114, DOI 10.1016/j.freeradbiomed.2015.02.002; RINK A, 1995, AM J PATHOL, V147, P1575; Salottolo K, 2017, J CRIT CARE, V38, P197, DOI 10.1016/j.jcrc.2016.11.034; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wang ZX, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-56; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhang GS, 2013, CNS NEUROSCI THER, V19, P53, DOI 10.1111/cns.12032; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhang Z, 2014, BRAIN RES, V1583, P65, DOI 10.1016/j.brainres.2014.07.037	25	16	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193037	10.1371/journal.pone.0193037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	WOS:000425283900100	29447233	Green Published, Green Submitted, gold			2022-02-06	
J	Boer, C; Bossers, SM; Koning, NJ				Boer, C.; Bossers, S. M.; Koning, N. J.			Choice of fluid type: physiological concepts and perioperative indications	BRITISH JOURNAL OF ANAESTHESIA			English	Article						colloids; fluid therapy; surgical procedures	RANDOMIZED-CONTROLLED-TRIAL; HYDROXYETHYL STARCH 130/0.4; LACTATED RINGERS SOLUTION; TRAUMATIC BRAIN-INJURY; VOLUME REPLACEMENT THERAPY; ACUTE KIDNEY INJURY; ACID-BASE-BALANCE; DONOR LIVER-TRANSPLANTATION; CARDIAC-SURGERY PATIENTS; CRITICALLY-ILL PATIENTS	The consensus that i.v. resuscitation fluids should be considered as drugs with specific dose recommendations, contraindications, and side-effects has led to an increased attention for the choice of fluid during perioperative care. In particular, the debate concerning possible adverse effects of unbalanced fluids and hydroxyethyl starches resulted in a re-evaluation of the roles of different fluid types in the perioperative setting. This review provides a concise overview of the current knowledge regarding the efficacy and safety of distinct fluid types for perioperative use. First, basic physiological aspects and possible side-effects are explained. Second, we focus on considerations regarding fluid choice for specific perioperative indications based on an analysis of available randomized controlled trials.	[Boer, C.; Bossers, S. M.; Koning, N. J.] Vrije Univ Amsterdam Med Ctr, Amsterdam Cardiovasc Sci, Dept Anaesthesiol, Amsterdam, Netherlands		Boer, C (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam Cardiovasc Sci, Dept Anaesthesiol, Amsterdam, Netherlands.	c.boer@vumc.nl	Bossers, Sebastiaan/AAE-1085-2020	Bossers, Sebastiaan/0000-0002-2396-2777; Boer, Christa/0000-0002-7781-6951	Department of Anaesthesiology, VU University Medical Center	Department of Anaesthesiology, VU University Medical Center.	Abdallah E, 2014, INT UROL NEPHROL, V46, P2221, DOI 10.1007/s11255-014-0785-z; Ahn HJ, 2008, ANAESTHESIA, V63, P235, DOI 10.1111/j.1365-2044.2007.05345.x; Ando Y, 2008, J ANESTH, V22, P391, DOI 10.1007/s00540-008-0659-6; Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Atasever B, 2012, TRANSFUSION, V52, P2452, DOI 10.1111/j.1537-2995.2012.03802.x; Awad S, 2008, CLIN NUTR, V27, P179, DOI 10.1016/j.clnu.2008.01.008; Base EM, 2011, J CARDIOTHOR VASC AN, V25, P407, DOI 10.1053/j.jvca.2010.12.005; Becker BF, 2015, BRIT J CLIN PHARMACO, V80, P389, DOI 10.1111/bcp.12629; Bethlehem Irene, 2014, J Extra Corpor Technol, V46, P293; Bouwman RA, 2012, BRIT J ANAESTH, V109, P299, DOI 10.1093/bja/aes277; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Cabrales P, 2005, SHOCK, V24, P66, DOI 10.1097/01.shk.0000167111.80753.ef; Cabrales P, 2004, AM J PHYSIOL-HEART C, V287, pH363, DOI 10.1152/ajpheart.01039.2003; Cabrales P, 2008, RESUSCITATION, V77, P379, DOI 10.1016/j.resuscitation.2008.01.008; Chappell D, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0538-5; Chappell D, 2014, BEST PRACT RES-CLIN, V28, P227, DOI 10.1016/j.bpa.2014.06.003; Chen G, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0088-6; Cho JE, 2014, YONSEI MED J, V55, P625, DOI 10.3349/ymj.2014.55.3.625; Cortes DO, 2014, BRIT J ANAESTH, V112, P968, DOI 10.1093/bja/aeu047; de Crescenzo C, 2017, J TRAUMA ACUTE CARE, V82, P956, DOI 10.1097/TA.0000000000001409; Delano MJ, 2015, SHOCK, V44, P25, DOI 10.1097/SHK.0000000000000368; Demir A, 2015, TRANSPL P, V47, P1883, DOI 10.1016/j.transproceed.2015.05.015; Disma N, 2014, PEDIATR ANESTH, V24, P980, DOI 10.1111/pan.12439; Doherty M, 2012, BRIT J ANAESTH, V109, P69, DOI 10.1093/bja/aes171; Ertmer C, 2014, CRIT CARE, V18, DOI 10.1186/cc13764; Feldheiser A, 2013, BRIT J ANAESTH, V110, P231, DOI 10.1093/bja/aes377; Fenger-Eriksen C, 2009, J THROMB HAEMOST, V7, P1099, DOI 10.1111/j.1538-7836.2009.03460.x; Futier E, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1085-3; Gan TJ, 1999, ANESTH ANALG, V88, P992, DOI 10.1097/00000539-199905000-00005; Gandhi SD, 2007, ANESTHESIOLOGY, V106, P1120, DOI 10.1097/01.anes.0000265422.07864.37; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Gillies MA, 2014, BRIT J ANAESTH, V112, P25, DOI 10.1093/bja/aet303; Godet G, 2008, EUR J ANAESTH, V25, P986, DOI 10.1017/S026502150800447X; Hadimioglu N, 2008, ANESTH ANALG, V107, P264, DOI 10.1213/ane.0b013e3181732d64; Hafizah M, 2017, J NEUROSURG SCI, V61, P263, DOI 10.23736/S0390-5616.16.03221-5; Hanart C, 2009, CRIT CARE MED, V37, P696, DOI 10.1097/CCM.0b013e3181958c81; Hartmann AF, 1932, J CLIN INVEST, V11, P327, DOI 10.1172/JCI100414; Helmy A, 2016, J CLIN ANESTH, V32, P267, DOI 10.1016/j.jclinane.2016.01.025; Iriz E, 2005, ANN THORAC SURG, V79, P666, DOI 10.1016/j.athoracsur.2004.08.002; Jacob M, 2003, ANAESTHESIST, V52, P896, DOI 10.1007/s00101-003-0557-0; Jacob M, 2006, ANESTHESIOLOGY, V104, P1223, DOI 10.1097/00000542-200606000-00018; Jacob M, 2012, CRIT CARE, V16, DOI 10.1186/cc11344; Kammerer T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0866-z; Kancir ASP, 2015, ANESTH ANALG, V120, P608, DOI 10.1213/ANE.0000000000000596; Kancir ASP, 2014, ANESTHESIOLOGY, V121, P948, DOI 10.1097/ALN.0000000000000413; Kasper SM, 2003, ANESTHESIOLOGY, V99, P42, DOI 10.1097/00000542-200307000-00010; Khajavi MR, 2008, RENAL FAILURE, V30, P535, DOI 10.1080/08860220802064770; Kim SY, 2013, TRANSPL P, V45, P2191, DOI 10.1016/j.transproceed.2013.02.124; Kim TK, 2017, ANAESTHESIA, V72, P204, DOI 10.1111/anae.13642; Kimenai DM, 2013, PERFUSION-UK, V28, P512, DOI 10.1177/0267659113491446; Krajewski ML, 2015, BRIT J SURG, V102, P24, DOI 10.1002/bjs.9651; Kuitunen AH, 2004, ANESTH ANALG, V98, P291, DOI 10.1213/01.ANE.0000096006.60716.F6; Lancaster TS, 2016, ANN THORAC SURG, V102, pE77, DOI 10.1016/j.athoracsur.2016.02.070; Lavu H, 2014, ANN SURG, V260, P445, DOI 10.1097/SLA.0000000000000872; Lee JS, 2011, CIRC J, V75, P2397, DOI 10.1253/circj.CJ-11-0404; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Lindroos ACB, 2013, ACTA ANAESTH SCAND, V57, P729, DOI 10.1111/aas.12105; Lindroos AC, 2014, J ANESTH, V28, P189, DOI 10.1007/s00540-013-1711-8; Loffel LM, 2016, ANESTHESIOLOGY, V125, P678, DOI 10.1097/ALN.0000000000001238; Mahmood A, 2007, BRIT J SURG, V94, P427, DOI 10.1002/bjs.5726; Martin G, 2002, J CARDIOTHOR VASC AN, V16, P441, DOI 10.1053/jcan.2002.125146; McCluskey SA, 2013, ANESTH ANALG, V117, P412, DOI 10.1213/ANE.0b013e318293d81e; McLean DJ, 2018, BRIT J ANAESTH, V120, P397, DOI 10.1016/j.bja.2017.11.090; Mercier FJ, 2014, BRIT J ANAESTH, V113, P459, DOI 10.1093/bja/aeu103; Meybohm P, 2013, CRIT CARE, V17, DOI 10.1186/cc12845; Miao N, 2014, PERFUSION-UK, V29, P462, DOI 10.1177/0267659114528267; Mukhtar A, 2009, ANESTH ANALG, V109, P924, DOI 10.1213/ane.0b013e3181aed54f; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myles PS, 2017, WORLD J SURG, V41, P2457, DOI 10.1007/s00268-017-4055-y; Naumann DN, 2016, SHOCK, V46, P609, DOI 10.1097/SHK.0000000000000687; Nelson Axel, 2016, Intensive Care Med Exp, V4, P6, DOI 10.1186/s40635-016-0080-7; Niemi TT, 2005, ACTA ANAESTH SCAND, V49, P373, DOI 10.1111/j.1399-6576.2005.00619.x; O'Malley CMN, 2005, ANESTH ANALG, V100, P1518, DOI 10.1213/01.ANE.0000150939.28904.81; Paul M, 2003, PAEDIATR ANAESTH, V13, P603, DOI 10.1046/j.1460-9592.2003.01113.x; Paut O, 2002, BRIT J ANAESTH, V88, P277, DOI 10.1093/bja/88.2.277; Pearse RM, 2014, JAMA-J AM MED ASSOC, V311, P2181, DOI 10.1001/jama.2014.5305; Potura E, 2015, ANESTH ANALG, V120, P123, DOI 10.1213/ANE.0000000000000419; Powell M, 2014, INT J OBSTET ANESTH, V23, P330, DOI 10.1016/j.ijoa.2014.06.001; RACKOW EC, 1977, CHEST, V72, P709, DOI 10.1378/chest.72.6.709; Raiman M, 2016, EUR J ANAESTH, V33, P42, DOI 10.1097/EJA.0000000000000328; Rasmussen KC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002720; Rasmussen KC, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0162-1; Rasmussen KC, 2014, ANN SURG, V259, P249, DOI 10.1097/SLA.0000000000000267; Reddy S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1217-5; Rehm M, 2000, ANESTHESIOLOGY, V92, P657, DOI 10.1097/00000542-200003000-00008; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rex S, 2006, EUR J ANAESTH, V23, P1, DOI 10.1017/S0265021505001687; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Riddez L, 1997, CRIT CARE MED, V25, P635, DOI 10.1097/00003246-199704000-00013; Ringer S., 1882, J PHYSL, V3, p[195, 6]; Ross SW, 2015, J TRAUMA ACUTE CARE, V79, P732, DOI 10.1097/TA.0000000000000833; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Sadan O, 2017, CRIT CARE MED, V45, P1382, DOI 10.1097/CCM.0000000000002497; Schramko A, 2015, PERFUSION-UK, V30, P224, DOI 10.1177/0267659114540022; Schramko A, 2010, BRIT J ANAESTH, V104, P691, DOI 10.1093/bja/aeq084; Shao LJZ, 2013, CLINICS, V68, P323, DOI 10.6061/clinics/2013(03)OA07; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Sirvinskas E, 2007, PERFUSION-UK, V22, P121, DOI 10.1177/0267659107078484; Skhirtladze K, 2014, BRIT J ANAESTH, V112, P255, DOI 10.1093/bja/aet348; Standl T, 2008, EUR J ANAESTH, V25, P437, DOI 10.1017/S0265021508003888; Starling E H, 1896, J Physiol, V19, P312; Tamayo E, 2008, ACTA ANAESTH SCAND, V52, P1204, DOI 10.1111/j.1399-6576.2008.01758.x; Terkawi AS, 2016, J ANESTH, V30, P796, DOI 10.1007/s00540-016-2208-z; Tiryakioglu O, 2008, J CARDIOTHORAC SURG, V3, DOI 10.1186/1749-8090-3-45; Torres IP, 2016, AM J PHYSIOL-HEART C, V310, pH1468, DOI 10.1152/ajpheart.00006.2016; Van Aken HK, 2012, CURR OPIN ANESTHESIO, V25, P563, DOI 10.1097/ACO.0b013e3283572274; Van der Linden P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0830-z; Van der Linden P, 2013, ANESTHESIOLOGY, V119, P1296, DOI 10.1097/ALN.0b013e3182a6b387; Van der Linden PJ, 2005, ANESTH ANALG, V101, P629, DOI 10.1213/01.ANE.0000175216.53374.27; Van Regenmortel N, 2017, BRIT J ANAESTH, V118, P892, DOI 10.1093/bja/aex118; Villela NR, 2009, CURR OPIN ANESTHESIO, V22, P163, DOI 10.1097/ACO.0b013e328328d304; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Weinberg L, 2017, BRIT J ANAESTH, V119, P606, DOI 10.1093/bja/aex163; Weinberg L, 2015, MINERVA ANESTESIOL, V81, P1288; Wettstein R, 2003, CRIT CARE MED, V31, P1824, DOI 10.1097/01.CCM.0000069340.16319.F2; Witt L, 2008, PEDIATR ANESTH, V18, P934, DOI 10.1111/j.1460-9592.2008.02756.x; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515; Yates DRA, 2014, BRIT J ANAESTH, V112, P281, DOI 10.1093/bja/aet307; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Zausig YA, 2013, CRIT CARE, V17, DOI 10.1186/cc12898; Zazzeron L, 2016, CURR OPIN CRIT CARE, V22, P428, DOI 10.1097/MCC.0000000000000341	122	16	20	2	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	FEB	2018	120	2					384	396		10.1016/j.bja.2017.10.022			13	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GM5OI	WOS:000438189100022	29406187	Bronze			2022-02-06	
J	de la Tremblaye, PB; O'Neil, DA; LaPorte, MJ; Cheng, JP; Beitchman, JA; Thomas, TC; Bondi, CO; Kline, AE				de la Tremblaye, Patricia B.; O'Neil, Darik A.; LaPorte, Megan J.; Cheng, Jeffrey P.; Beitchman, Joshua A.; Thomas, Theresa Currier; Bondi, Corina O.; Kline, Anthony E.			Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Article; Proceedings Paper	Meeting of the International-Behavioral-Neuroscience-Society (IBNS)	JUN 07-12, 2016	Budapest, HUNGARY	Int Behav Neuroscience Soc		Antiepileptic drugs (AEDs); Antipsychotic drugs (APDs); Controlled cortical impact (CCI); Endocannabinoids; Executive function; Fluid percussion (FP) injury; Morris water maze (MWM); Rehabilitation; Stress; Traumatic brain injury (TBI)	CONTROLLED CORTICAL IMPACT; CLOSED-HEAD-INJURY; CORTICOTROPIN-RELEASING HORMONE; COGNITIVE-BEHAVIORAL PREVENTION; DEPRESSIVE-LIKE BEHAVIOR; GATED SODIUM-CHANNELS; OF-THE-LITERATURE; ENVIRONMENTAL ENRICHMENT; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR	The aim of this review is to discuss the research presented in a symposium entitled "Current Progress in characterizing therapeutic strategies and challenges in experimental CNS injury" which was presented at the 2016 International Behavioral Neuroscience Society annual meeting. Herein we discuss diffuse and focal traumatic brain injury (TBI) and ensuing chronic behavioral deficits as well as potential rehabilitative approaches. We also discuss the effects of stress on executive function after TBI as well as the response of the endocrine system and regulatory feedback mechanisms. The role of the endocannabinoids after CNS injury is also discussed. Finally, we conclude with a discussion of antipsychotic and antiepileptic drugs, which are provided to control TBI-induced agitation and seizures, respectively. The review consists predominantly of published data.	[de la Tremblaye, Patricia B.; O'Neil, Darik A.; LaPorte, Megan J.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15224 USA; [de la Tremblaye, Patricia B.; O'Neil, Darik A.; LaPorte, Megan J.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15224 USA; [Bondi, Corina O.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15224 USA; [Beitchman, Joshua A.; Thomas, Theresa Currier] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Beitchman, Joshua A.; Thomas, Theresa Currier] Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ USA; [Thomas, Theresa Currier] Phoenix VA Healthcare Syst, Phoenix, AZ USA; [Beitchman, Joshua A.] Midwestern Univ, Glendale, AZ USA		Kline, AE (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Sch Med,Phys Med & Rehabil, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Sch Med,Safar Ctr Resuscitat Res, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu	Thomas, Theresa Currier/K-1979-2019	Thomas, Theresa Currier/0000-0002-9619-7666; O'Neil, Darik/0000-0002-2475-438X; O'Neil, Darik/0000-0002-8222-7617	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, HD069620-S1, NS060005, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; Arizona Biomedical Research Commission through Arizona Department of Health Services [ADHS14-00003606]; Valley Research Partnership Awards [P2201607, P1201607]; Phoenix Children's Hospital Mission Support Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060005, R03NS094950, R01NS084967, R21NS099674, T32NS086749, R21NS099683] Funding Source: NIH RePORTER	This work was supported, in part, by National Institutes of Health grants HD069620, HD069620-S1, NS060005, NS084967 (AEK), NS094950, NS099683 (COB), the University of Pittsburgh Physicians/UPMC Academic Foundation (COB), the Arizona Biomedical Research Commission through the Arizona Department of Health Services (ADHS14-00003606), the Valley Research Partnership Awards (P2201607 and P1201607), and Phoenix Children's Hospital Mission Support Funds (TCT).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; Alves OL, 2003, ANN NY ACAD SCI, V993, P25, DOI 10.1111/j.1749-6632.2003.tb07508.x; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Alwis DS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00156; Angehagen M, 2003, EPILEPSY RES, V54, P63, DOI 10.1016/S0920-1211(03)00039-1; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Aso E, 2008, J NEUROCHEM, V105, P565, DOI 10.1111/j.1471-4159.2007.05149.x; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Baratz-Goldstein R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157064; Batty R, 2015, J CLIN EXP NEUROPSYC, V37, P917, DOI 10.1080/13803395.2015.1068279; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beaumont A, 1998, ACT NEUR S, V71, P149; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Beom J, 2016, JOVE-J VIS EXP, DOI 10.3791/54217; Berardi A, 2016, PHARMACOL RES, V111, P668, DOI 10.1016/j.phrs.2016.07.024; Beyer CE, 2010, NEUROBIOL DIS, V39, P148, DOI 10.1016/j.nbd.2010.03.020; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bondi CO, 2008, NEUROPSYCHOPHARMACOL, V33, P320, DOI 10.1038/sj.npp.1301410; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Butovsky E, 2005, J NEUROCHEM, V93, P802, DOI 10.1111/j.1471-4159.2005.03074.x; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cetnak I., 2005, NEURORX, V2, P410; Chen J, 2012, J NEUROENDOCRINOL, V24, P1055, DOI 10.1111/j.1365-2826.2012.02306.x; Chen MF, 2013, J PHYSIOL-LONDON, V591, P985, DOI 10.1113/jphysiol.2012.241125; Chen S, 2014, NEUROCHEM RES, V39, P1621, DOI 10.1007/s11064-014-1241-2; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Chou A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151418; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cimolin V, 2012, J HEAD TRAUMA REHAB, V27, P177, DOI 10.1097/HTR.0b013e3182172276; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cohen-Yeshurun A, 2013, J CEREBR BLOOD F MET, V33, P1242, DOI 10.1038/jcbfm.2013.75; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Cope EC, 2016, EXP NEUROL, V279, P96, DOI 10.1016/j.expneurol.2016.02.017; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; de Diego C, 2013, RESTOR NEUROL NEUROS, V31, P361, DOI 10.3233/RNN-120250; de In Tremblaye P. B., 2016, J NEUROTRAUM, V34, P1610; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Dittmar C, 1997, Appl Neuropsychol, V4, P50, DOI 10.1207/s15324826an0401_6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dzhala V, 2015, CNS NEUROSCI THER, V21, P173, DOI 10.1111/cns.12369; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farber NB, 2002, MOL PSYCHIATR, V7, P726, DOI 10.1038/sj.mp.4001087; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fatouros I, 2010, STRESS, V13, P461, DOI 10.3109/10253891003743432; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Firsching R, 2012, J NEUROL SURG PART A, V73, P204, DOI 10.1055/s-0032-1304815; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gertler P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009871.pub2; Goldstein LB, 2002, NEUROREHAB NEURAL RE, V16, P321, DOI 10.1177/154596830201600402; Gomez-Pinilla F, 2008, AGEING RES REV, V7, P49, DOI 10.1016/j.arr.2007.04.003; Gorzalka BB, 2008, NEUROSCI BIOBEHAV R, V32, P1152, DOI 10.1016/j.neubiorev.2008.03.004; Grace AA, 1997, TRENDS NEUROSCI, V20, P31, DOI 10.1016/S0166-2236(96)10064-3; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Heffernan ME, 2013, J NEUROTRAUM, V30, P1007, DOI 10.1089/neu.2012.2366; Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hernandez T D, 1990, Restor Neurol Neurosci, V1, P323, DOI 10.3233/RNN-1990-1503; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Higashi Y, 2014, J NEUROTRAUM, V31, P1689, DOI 10.1089/neu.2014.3331; Hill MN, 2010, J NEUROSCI, V30, P14980, DOI 10.1523/JNEUROSCI.4283-10.2010; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; HOVDA DA, 1985, P W PHARMACOL SOC, V28, P209; Hwabejire JO, 2013, SURGERY, V154, P234, DOI 10.1016/j.surg.2013.04.008; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Javed Zeeshan, 2015, Indian J Endocrinol Metab, V19, P753, DOI 10.4103/2230-8210.167561; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Kapur S, 2000, J PSYCHIATR NEUROSCI, V25, P161; Kapur S, 2001, AM J PSYCHIAT, V158, P360, DOI 10.1176/appi.ajp.158.3.360; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Keck CA, 2007, RESTOR NEUROL NEUROS, V25, P77; Khan NR, 2016, NEUROSURGERY, V79, P775, DOI 10.1227/NEU.0000000000001445; Khaspekov LG, 2004, EUR J NEUROSCI, V19, P1691, DOI 10.1111/j.1460-9568.2004.03285.x; Khodadad A, 2015, BEHAV BRAIN RES, V284, P249, DOI 10.1016/j.bbr.2015.01.032; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2001, HEAD TRAUMA, P65; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kosaki Y, 2012, BEHAV BRAIN RES, V227, P81, DOI 10.1016/j.bbr.2011.10.039; Kouzounias K, 2011, NEUROSCIENCE, V183, P171, DOI 10.1016/j.neuroscience.2011.03.069; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Krahulik D., 2016, BIOMED PAP, V161, P80; Kreber LA, 2016, BRAIN RES, V1640, P152, DOI 10.1016/j.brainres.2016.01.016; Kumlien E, 2010, SEIZURE-EUR J EPILEP, V19, P69, DOI 10.1016/j.seizure.2009.11.005; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; LAND PW, 1995, J COMP NEUROL, V355, P573, DOI 10.1002/cne.903550407; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; Leary JB, 2017, J NEUROTRAUM, V34, P444, DOI 10.1089/neu.2016.4438; Lesemann FHP, 2015, NEUROSCI BIOBEHAV R, V51, P126, DOI 10.1016/j.neubiorev.2015.01.005; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Lin LF, 2015, BRAIN INJURY, V29, P41, DOI 10.3109/02699052.2014.955881; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Lippert-Gruner M, 2011, PHYSIOL RES, V60, P367, DOI 10.33549/physiolres.931816; Lisboa SF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00005; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Mahesh R, 2010, INDIAN J EXP BIOL, V48, P466; Majdan M, 2013, J NEUROTRAUM, V30, P23, DOI 10.1089/neu.2012.2554; Mala H, 2015, BRAIN RES BULL, V116, P34, DOI 10.1016/j.brainresbull.2015.05.006; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Mead GE, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004366.pub6, 10.1002/14651858.CD004366.pub4]; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Montanez S, 2000, BRAIN RES, V860, P29, DOI 10.1016/S0006-8993(00)01951-X; Montanez S, 2001, J NEUROTRAUM, V18, P1255, DOI 10.1089/089771501317095296; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; O'Dell DM, 2000, RESTOR NEUROL NEUROS, V16, P127; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Pelicao R, 2016, NEUROSCI LETT, V624, P17, DOI 10.1016/j.neulet.2016.04.068; Perez-Garcia G., 2016, BEHAV BRAIN RES; Perez-Garcia G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00176; Phelps TI, 2017, NEUROREHAB NEURAL RE, V31, P25, DOI 10.1177/1545968316650281; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Pitkanen A, 2014, EPILEPSY RES, V108, P653, DOI 10.1016/j.eplepsyres.2014.02.001; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Purohit MP, 2013, PM&R, V5, P24, DOI 10.1016/j.pmrj.2012.06.012; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Radhakrishnan R, 2016, LANCET PSYCHIAT, V3, P1166, DOI 10.1016/S2215-0366(16)30266-8; RADULOVIC LL, 1995, DRUG METAB DISPOS, V23, P441; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Ragsdale DS, 1998, BRAIN RES REV, V26, P16, DOI 10.1016/S0165-0173(97)00054-4; RAGSDALE DS, 1991, MOL PHARMACOL, V40, P756; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rawas R., 2011, BRAIN RES, V1390, P80; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Renner CIE, 2015, J CLIN MED, V4, P1815, DOI 10.3390/jcm4091815; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Sahlholm K, 2016, EUR NEUROPSYCHOPHARM, V26, P467, DOI 10.1016/j.euroneuro.2016.01.001; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schaaf M.J., 2000, IMPLICATIONS MEMORY, V3, P201; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Sitges M, 2016, NEUROCHEM RES, V41, P758, DOI 10.1007/s11064-015-1749-0; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Steiner MA, 2008, PHARMACOGENOMICS J, V8, P196, DOI 10.1038/sj.tpj.6500466; Tait DS, 2014, CURR PHARM DESIGN, V20, P5046; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thomas TC, 2016, BEHAV BRAIN RES; Thomas TC, 2015, BRAIN NEUROTRAUMA MO; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tyagi IF, 2013, PLOS ONE, V8; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Valenti O, 2011, J NEUROSCI, V31, P12330, DOI 10.1523/JNEUROSCI.2808-11.2011; Vallez Garcia D, 2016, J NEUROTRAUM, V33, P1855, DOI 10.1089/neu.2015.4230; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Vender Haar G., 2014, BRAIN INJURY, V28, P235; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Wallace AE, 1999, RESTOR NEUROL NEUROS, V14, P35; Wang AT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091399, 10.1371/journal.pone.0110985]; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Weeks J. J., 2016, BEHAV BRAIN RES; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; Wogensen E, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/830871; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041; Wu AG, 2014, NEUROREHAB NEURAL RE, V28, P75, DOI 10.1177/1545968313498650; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu X., 2013, SPRINGER SERIES ADV, P1, DOI DOI 10.1007/S10845-013-0731-4; Yen HL, 2007, ANN ACAD MED SINGAP, V36, P62; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Yunus FW, 2015, J AUTISM DEV DISORD, V45, P3565, DOI 10.1007/s10803-015-2503-9; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36; Zou H., 2015, BRAIN INJURY, V29, P78; Zou IL, 2013, NEUROREHAB NEURAL RE, V27, P878; Zumbrun EE, 2015, J NEUROIMMUNE PHARM, V10, P245, DOI 10.1007/s11481-015-9586-0	305	16	16	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	FEB	2018	85						160	175		10.1016/j.neubiorev.2017.05.022			16	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Behavioral Sciences; Neurosciences & Neurology	FR9UO	WOS:000419418800013	28576511	Bronze, Green Published, Green Accepted			2022-02-06	
J	Friedman, BW; Babbush, K; Irizarry, E; White, D; Gallagher, EJ				Friedman, Benjamin W.; Babbush, Kayla; Irizarry, Eddie; White, Deborah; Gallagher, E. John			An exploratory study of IV metoclopramide plus diphenhydramine for acute post-traumatic headache	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Post-traumatic headache; Emergency department; Metoclopramide; Diphenhydramine	EMERGENCY-DEPARTMENT; MIGRAINE; MANAGEMENT	Background: Headache is a frequent complaint among the 1.4million patients who present to US emergency departments (ED) annually following trauma to the head. There are no evidence-based treatments of acute post-traumatic headache. Methods: This was an ED-based, prospective study of intravenous (IV) metoclopramide 20 mg + diphenhydramine 25 mg for acute post-traumatic headache. Patients who presented to our EDs with a moderate or severe headache meeting international criteria were enrolled and followed by telephone 2 and 7 days later. The primary outcome was "sustained headache relief" (headache level less than "moderate" in the ED, no additional headache medication, and no relapse to headacheworse than "mild"). We also gathered data on associated symptomotology using the validated Post Concussion Symptom Scale (PCSS). Results: 21 patients were enrolled. Twelve of 20 (60%) patients with available follow-up data reported sustained headache relief. All but one of the 21 enrolled patients (95%) reported improvement of headache to noworse than mild. Seven of 19 (37%) patients with available data reported moderate or severe headache during the 48 h after ED discharge. Oneweek later, 5/19 patients reported experiencing headaches "frequently" or "always". The mean Post Concussion Symptom Score improved from 47.5 (SD 29.4) before treatment to 10.9 (SD 14.8) at the time of ED discharge and 11.4 (SD 21.4) at one week after treatment. Conclusion: IV metoclopramide 20 mg + diphenhydramine 25 mg is an effective and well-tolerated medication regimen for patients presenting to the ED with acute post-traumatic headache, though 1/3 of patients report headache relapse after ED discharge and 1/4 of patients report persistent headaches one week later. (C) 2017 Elsevier Inc. All rights reserved.	[Friedman, Benjamin W.; Irizarry, Eddie; White, Deborah; Gallagher, E. John] Montefiore Hlth Syst, Albert Einstein Coll Med, Dept Emergency Med, Bronx, NY USA; [Babbush, Kayla] Albert Einstein Coll Med, Med Coll, Bronx, NY 10467 USA		Friedman, BW (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Emergency Med, 111 East 210th St, Bronx, NY 10467 USA.	befriedm@montefiore.org			Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore grant [UL1TR001073]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001073] Funding Source: NIH RePORTER	This publication was supported in part by the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore grant support (UL1TR001073).	Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Campbell C., 2013, ANN EMERG MED; Chan S, 2015, AM J EMERG MED, V33, P635, DOI 10.1016/j.ajem.2015.01.053; Friedman BW, 2015, CEPHALALGIA, V35, P301, DOI 10.1177/0333102414539055; Friedman BW, 2009, ANN EMERG MED, V53, P379, DOI 10.1016/j.annemergmed.2008.08.003; Olesen J, 2013, CEPHALALGIA, V33, P627, DOI 10.1177/0333102413487610; Orr SL, 2016, HEADACHE, V56, P911, DOI 10.1111/head.12835; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Zamani M, 2015, EMERGENCY, V3, P137	9	16	16	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	FEB	2018	36	2					285	289		10.1016/j.ajem.2017.10.034			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FX1YB	WOS:000425850900021	29074068	Green Accepted, Bronze			2022-02-06	
J	Kuo, C; Wu, L; Zhao, W; Fanton, M; Ji, SB; Camarillo, DB				Kuo, Calvin; Wu, Lyndia; Zhao, Wei; Fanton, Michael; Ji, Songbai; Camarillo, David B.			Propagation of errors from skull kinematic measurements to finite element tissue responses	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Brain tissue response; Finite element; Wearable head impact sensors; Mild traumatic brain injury	HEAD IMPACT SEVERITY; BRAIN-TISSUE; INJURY; MOUTHGUARD; ACCELERATION; FREQUENCY; BEHAVIOR; SYSTEM; DEVICE	Real-time quantification of head impacts using wearable sensors is an appealing approach to assess concussion risk. Traditionally, sensors were evaluated for accurately measuring peak resultant skull accelerations and velocities. With growing interest in utilizing model-estimated tissue responses for injury prediction, it is important to evaluate sensor accuracy in estimating tissue response as well. Here, we quantify how sensor kinematic measurement errors can propagate into tissue response errors. Using previous instrumented mouthguard validation datasets, we found that skull kinematic measurement errors in both magnitude and direction lead to errors in tissue response magnitude and distribution. For molar design instrumented mouthguards susceptible to mandible disturbances, 150-400% error in skull kinematic measurements resulted in 100% error in regional peak tissue response. With an improved incisor design mitigating mandible disturbances, errors in skull kinematics were reduced to < 50%, and several tissue response errors were reduced to < 10%. Applying 30 rotations to reference kinematic signals to emulate sensor transformation errors yielded below 10% error in regional peak tissue response; however, up to 20% error was observed in peak tissue response for individual finite elements. These findings demonstrate that kinematic resultant errors result in regional peak tissue response errors, while kinematic directionality errors result in tissue response distribution errors. This highlights the need to account for both kinematic magnitude and direction errors and accurately determine transformations between sensors and the skull.	[Kuo, Calvin; Fanton, Michael; Camarillo, David B.] Stanford Univ, Dept Mech Engn, 443 Via Ortega,Shriram Ctr Room 202, Stanford, CA 94305 USA; [Wu, Lyndia; Camarillo, David B.] Stanford Univ, Dept Bioengn, 443 Via Ortega,Shriram Ctr Room 202, Stanford, CA 94305 USA; [Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St,Gateway Pk 4004, Worcester, MA 01605 USA		Kuo, C (corresponding author), Stanford Univ, Dept Mech Engn, 443 Via Ortega,Shriram Ctr Room 202, Stanford, CA 94305 USA.	calvink@stanford.edu	Wu, Lyndia/AAQ-1106-2020; Kuo, Calvin/AAH-1933-2019	Wu, Lyndia/0000-0002-8236-032X; Kuo, Calvin/0000-0001-8401-9136	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Biomedical Imaging and Bioengineering (NIBIB)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [3R21EB01761101S1]; Stanford Child Health Research Institute Transdisciplinary Initiatives Program; Stanford Bio-X Graduate Research Fellowship Program; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, R21 NS088781]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21EB017611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092853, R21NS088781] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering (NIBIB) 3R21EB01761101S1, the Stanford Child Health Research Institute Transdisciplinary Initiatives Program, and the Stanford Bio-X Graduate Research Fellowship Program. Additional funding was provided by the NIH Grants R01 NS092853 and R21 NS088781.	Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Forte AE, 2017, BIOMECH MODEL MECHAN, V16, P907, DOI 10.1007/s10237-016-0860-8; Forte AE, 2016, MATER DESIGN, V112, P227, DOI 10.1016/j.matdes.2016.09.063; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hrapko M, 2008, BIORHEOLOGY, V45, P663, DOI 10.3233/BIR-2008-0512; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Ji S, 2015, J NEUROTRAUM, V14, P1, DOI [10.1089/neu.2013.3268, DOI 10.1089/NEU.2013.3268]; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Patton DA, 2015, BIOMECHANICAL DETERM, P264, DOI [10.1123/jab.2014-0223, DOI 10.1123/JAB.2014-0223]; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; SAE, 1995, ELECT INSTRUM, V552, P25, DOI [10.1520/G0154-12A, DOI 10.1520/G0154-12A]; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts EG, 2010, ENHANCED SAFETY VEHI, P1; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhao WG, 2018, ADV SCI, V5, DOI 10.1002/advs.201700131; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239	47	16	16	0	9	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	FEB	2018	17	1					235	247		10.1007/s10237-017-0957-8			13	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering	FV5VX	WOS:000424651600017	28856485	Green Accepted			2022-02-06	
J	Riedeman, S; Turkstra, L				Riedeman, Sarah; Turkstra, Lyn			Knowledge, Confidence, and Practice Patterns of Speech-Language Pathologists Working With Adults With Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							REHABILITATION; PERCEPTIONS	Purpose: Although speech-language pathologists (SLPs) are important members of the health care team serving adults with traumatic brain injury (TBI) with cognitive-communication disorders, little is known about services SLPs deliver and how they rate their own knowledge and skills. The aims of this study were to identify practice patterns, knowledge, and confidence levels of SLPs working with adults with TBI with cognitive-communication disorders. Method: We surveyed 100 SLPs from rural and urban hospitals, skilled nursing facilities, and outpatient clinics in Wisconsin and analyzed data descriptively. Results: SLPs in this sample had a combination of accurate and inaccurate knowledge related to TBI. Although all participants reported working with individuals with TBI, many participants rated themselves as lacking confidence or knowledge in this practice area. SLPs reported variable use of evidence-based procedures and training related to TBI. Conclusion: Results confirmed the high prevalence of TBI-related practice among SLPs in medical settings, but there was variable knowledge, confidence, and use of current evidence in practice. SLP graduate training programs, individual providers, health care administrators, and the American Speech-Language-Hearing Association can use results from this study to advance and improve SLP clinical services for adults with TBI.	[Riedeman, Sarah; Turkstra, Lyn] Univ Wisconsin, Madison, WI 53706 USA; [Riedeman, Sarah] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada		Riedeman, S (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.; Riedeman, S (corresponding author), McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada.	sriedeman@gmail.com	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921			American Speech-Language-Hearing Association, 2005, ROL SPEECH LANG PATH; American Speech-Language-Hearing Association, 2005, KNOWL SKILLS NEED SP; American Speech-Language-Hearing Association, 2007, SCOP PRACT SPEECH LA; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96, pS222, DOI 10.1016/j.apmr.2014.10.028; Benigas J., 2016, SPACED RETRIEVAL STE; Campbell SM, 2002, QUAL SAF HEALTH CARE, V11, P358, DOI 10.1136/qhc.11.4.358; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Constantinidou F, 2012, BRAIN INJURY, V26, P1549, DOI 10.3109/02699052.2012.698786; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Matarazzo BB, 2016, COMMUNITY MENT HLT J, V52, P158, DOI 10.1007/s10597-015-9926-9; Mateer Catherine A., 1992, Seminars in Speech and Language, V13, P280, DOI 10.1055/s-2008-1064203; McGrane SA, 2000, BRAIN INJURY, V14, P975; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Oyesanya TO, 2016, WESTERN J NURS RES, V38, P1114, DOI 10.1177/0193945916636629; Short J, 2014, INT J SPEECH-LANG PA, V16, P219, DOI 10.3109/17549507.2014.882413; Sohlberg M. M., 2011, ATTENTION PROCESS TR; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra LS, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-15-0060; United States Census Bureau, 2010, 2010 CENS URB RUR CL; United States Department of Agriculture, 2013, DOCUMENTATION; Watter K., 2014, J CLIN PRACTICE SPEE, V16, P7	32	16	16	0	10	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	FEB	2018	27	1					181	191		10.1044/2017_AJSLP-17-0011			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	FX1XA	WOS:000425847000015	29387881				2022-02-06	
J	Yang, NR; Song, J; Yoon, KW; Seo, EK				Yang, Na Rae; Song, Jihye; Yoon, Kyeong-Wook; Seo, Eui Kyo			How Early Can We Perform Cranioplasty for Traumatic Brain injury After Decompressive Craniectomy? A Retrospective Multicenter Study	WORLD NEUROSURGERY			English	Article						Cranioplasty; Complications; Decompressive craniectomy; Glasgow Coma Scale; Glasgow Outcome Scale; Hematomas; Hydrocephalus; Intracranial hypertension; Retrospective studies; Traumatic brain injury	BONE FLAP RESORPTION; SEVERE HEAD-INJURY; CLINICAL ARTICLE; RISK-FACTORS; CEREBROSPINAL-FLUID; AUTOLOGOUS BONE; CRANIAL DEFECT; COMPLICATIONS; STROKE; PREDICTION	OBJECTIVE: Decompressive craniectomy (DC) is used to treat intractable intracranial hypertension after severe traumatic brain injury (TBI). Cranioplasty (CP) is typically performed weeks or months later. However, the optimal timing for CP is unknown. We aimed to determine the earliest possible time point for CP. METHODS: We retrospectively reviewed brain computed tomography images from 159 patients who underwent CP after DC for TBI at 3 hospitals. We determined the earliest possible day for CP by reviewing the resolution of intracranial pressure in serial brain computed tomography images between DC and CP. The early CP group was defined as the group within the earliest possible timing of CP; other cases constituted the late CP group. We compared complications and the Glasgow Outcome Scale scores at 6 months between groups. RESULTS: The mean initial Glasgow Coma Scale score was 8.33 +/- 3.46. The time interval between DC and CP was 94.75 +/- 143.98 days. The earliest possible timing for CP was determined to be 34.60 +/- 34.36 days after DC. The incidence of complications did not differ significantly between groups, except for ventriculomegaly, which occurred more frequently in the late CP group (P = 0.026). Predictors of good outcome were revision because of infection, preoperative epidural hematoma, early cranioplasty, and no ventriculomegaly after DC. CONCLUSIONS: CP can be performed at around 34 days after DC for TBI. Ventriculomegaly occurred less frequently and the 6-month Glasgow Outcome Scale score was better in the early CP group than in the late CP group.	[Yang, Na Rae; Seo, Eui Kyo] Ewha Womans Univ, Coll Med, Med Ctr, Dept Neurosurg, Seoul, South Korea; [Song, Jihye] Konyang Univ, Konyang Univ Hosp, Coll Med, Dept Neurosurg, Daejeon, South Korea; [Yoon, Kyeong-Wook] Dankook Univ, Coll Med, Dept Neurosurg, Cheonan, Chungnam, South Korea		Seo, EK (corresponding author), Ewha Womans Univ, Coll Med, Med Ctr, Dept Neurosurg, Seoul, South Korea.	drekseo@ewha.ac.kr		Yang, Na Rae/0000-0002-3226-5631			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alperin N, 1996, MAGNET RESON MED, V35, P741, DOI 10.1002/mrm.1910350516; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Di Stefano C, 2016, BRAIN INJURY, V30, P164, DOI 10.3109/02699052.2015.1090013; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Malcolm JG, 2017, NEUROSURGERY; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Salma A, 2016, J NEUROSURG, V124, P280, DOI 10.3171/2015.6.JNS151378; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Thavarajah D, 2012, BRIT J NEUROSURG, V26, P78, DOI 10.3109/02688697.2011.603850; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Xu H, 2015, CLIN NEUROL NEUROSUR, V136, P33, DOI 10.1016/j.clineuro.2015.05.031; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	38	16	18	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2018	110						E160	E167		10.1016/j.wneu.2017.10.117			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FX1ZT	WOS:000425856900024	29101076				2022-02-06	
J	Wang, YJ; Chen, KY; Kuo, LN; Wang, WC; Hsu, YW; Wong, HSC; Lin, CM; Liao, KH; Zhang, YF; Chiang, YH; Chang, WC				Wang, Yu-Jia; Chen, Kai-Yun; Kuo, Li-Na; Wang, Wen-Chang; Hsu, Yu-Wen; Wong, Henry Sung-Ching; Lin, Chien-Min; Liao, Kuo-Hsing; Zhang, Yan-Feng; Chiang, Yung-Hsiao; Chang, Wei-Chiao			The association between BDNF Val66Met polymorphism and emotional symptoms after mild traumatic brain injury	BMC MEDICAL GENETICS			English	Article						Mild traumatic brain injury; Genetic polymorphism; Brain-derived neurotrophic factor; Anxiety; Depression	MAJOR DEPRESSIVE DISORDER; NEUROTROPHIC FACTOR GENE; PSYCHIATRIC-DISORDERS; SEX-DIFFERENCES; HUMAN-MEMORY; ANXIETY; STRESS; ALLELE; METAANALYSIS; RECOVERY	Background: Brain-derived neurotrophic factor (BDNF) is one of the most abundant neurotrophins in the adult brain, and it plays important roles in modulating synaptic plasticity and synaptogenesis. This study attempted to elucidate the role of the BDNF variant rs6265 in emotional symptoms following mild traumatic brain injury (mTBI). Methods: To investigate the association between BDNF Val66Met polymorphism (rs6265) and emotional symptoms in mTBI patients, we recruited 192 mTBI patients and evaluated their Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) scores in the first and sixth week after mTBI. Results: The patients carrying the T allele of rs6265 had significantly higher BAI scores in the first week following mTBI. In addition, the patients carrying the T allele also showed higher scores of BDI in the first week. In the gender-specific subgroup analysis, the male patients carrying the T allele of rs6265 had higher scores of both BAI and BDI in the first and sixth week. Meanwhile, female patients carrying the T allele also had significantly higher scores of BDI in the first week following mTBI. Conclusions: This study provides evidence for the association between the BDNF variant rs6265 and emotional symptoms following mTBI.	[Wang, Yu-Jia; Chen, Kai-Yun; Chiang, Yung-Hsiao; Chang, Wei-Chiao] Taipei Med Univ, Coll Med Sci & Technol, Program Neural Regenerat Med, Taipei, Taiwan; [Wang, Yu-Jia; Kuo, Li-Na; Chang, Wei-Chiao] Taipei Med Univ, Wan Fang Hosp, Dept Pharm, Taipei, Taiwan; [Wang, Wen-Chang] Taipei Med Univ, Coll Med Sci & Technol, Program Translat Med, Taipei, Taiwan; [Kuo, Li-Na; Wong, Henry Sung-Ching; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Hsu, Yu-Wen] Taipei Med Univ, Coll Med Sci & Technol, Program Translat Med, Taipei, Taiwan; [Hsu, Yu-Wen] Acad Sinica, Taipei, Taiwan; [Lin, Chien-Min] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei, Taiwan; [Liao, Kuo-Hsing] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Zhang, Yan-Feng] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan		Chiang, YH; Chang, WC (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Program Neural Regenerat Med, Taipei, Taiwan.; Chang, WC (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Pharm, Taipei, Taiwan.; Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.; Chiang, YH (corresponding author), Taipei Med Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan.; Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan.; Chang, WC (corresponding author), Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan.	ychiang@tmu.edu.tw; wcc@tmu.edu.tw	Zhang, Yanfeng/AAW-3915-2020	Zhang, Yanfeng/0000-0002-3859-3839; Chang, Wei-Chiao/0000-0002-8573-5924; Wang, Wen-Chang/0000-0003-3124-2136	Ministry of Health and WelfareMinistry of Health, Labour and Welfare, Japan [MOHW103-TDU-B-212-113001]; Ministry of Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [MOST105-2628-B-038-001-MY4]; National Health Research InstitutesNational Health Research Institutes, JapanNational Health Research Institutes - Taiwan [06D1-MMMOHW08]	This work was supported by grants from Ministry of Health and Welfare (MOHW103-TDU-B-212-113001), from Ministry of Science and Technology (MOST105-2628-B-038-001-MY4) and from National Health Research Institutes (06D1-MMMOHW08).	Advani T, 2009, INT J NEUROPSYCHOPH, V12, P583, DOI 10.1017/S1461145709000248; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007; Balaratnasingam S, 2012, PHARMACOL THERAPEUT, V134, P116, DOI 10.1016/j.pharmthera.2012.01.006; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boulle F, 2012, MOL PSYCHIATR, V17, P584, DOI 10.1038/mp.2011.107; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Caldieraro MA, 2017, WORLD J BIOL PSYCHIA; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chan CB, 2017, J NEUROSCI RES, V95, P328, DOI 10.1002/jnr.23863; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Dincheva I, 2017, AM J PSYCHIAT, V174, P1203, DOI 10.1176/appi.ajp.2017.15121592; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Elzinga BM, 2011, PSYCHOPHARMACOLOGY, V214, P319, DOI 10.1007/s00213-010-1961-1; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Hao R, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00306; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Herbert J, 2012, BRIT J PSYCHIAT, V201, P313, DOI 10.1192/bjp.bp.111.107037; Jiang R, 2017, PSYCHONEUROENDOCRINO, V79, P13, DOI 10.1016/j.psyneuen.2017.02.005; Jin HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13929-5; Kaufman J, 2006, BIOL PSYCHIAT, V59, P673, DOI 10.1016/j.biopsych.2005.10.026; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Korley FK, 2015, J HEAD TRAUMA REHABI; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Li K., 2017, NEUROSCI B; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moreno-Piovano GS, 2014, J STEROID BIOCHEM, V144, P243, DOI 10.1016/j.jsbmb.2014.08.001; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Schosser A, 2017, INT J NEUROPSYCHOPH, V20, P782, DOI 10.1093/ijnp/pyx028; Smarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556; SOHRABJI F, 1995, P NATL ACAD SCI USA, V92, P11110, DOI 10.1073/pnas.92.24.11110; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; TEASDALE G, 1974, LANCET, V2, P81; Tripp A, 2012, AM J PSYCHIAT, V169, P1194, DOI 10.1176/appi.ajp.2012.12020248; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; Webster MJ, 2002, DEV BRAIN RES, V139, P139, DOI 10.1016/S0165-3806(02)00540-0; Wei YC, 2017, J NEUROSCI RES, V95, P336, DOI 10.1002/jnr.23897; Wilson M, 2007, BRIT J ANAESTH, V99, P43, DOI 10.1093/bja/aem142; Zai CC, 2012, INT J NEUROPSYCHOPH, V15, P1037, DOI 10.1017/S1461145711001313; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	53	16	16	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2350			BMC MED GENET	BMC Med. Genet.	JAN 22	2018	19								13	10.1186/s12881-017-0518-0			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	FT4LG	WOS:000423126000001	29357818	Green Published, gold			2022-02-06	
J	Adams, C; Bazzigaluppi, P; Beckett, TL; Bishay, J; Weisspapir, I; Dorr, A; Mester, JR; Steinman, J; Hirschler, L; Warnking, JM; Barbier, EL; McLaurin, J; Sled, JG; Stefanovic, B				Adams, Conner; Bazzigaluppi, Paolo; Beckett, Tina L.; Bishay, Jossana; Weisspapir, Iliya; Dorr, Adrienne; Mester, James R.; Steinman, Joe; Hirschler, Lydiane; Warnking, Jan M.; Barbier, Emmanuel L.; McLaurin, JoAnne; Sled, John G.; Stefanovic, Bojana			Neurogliovascular dysfunction in a model of repeated traumatic brain injury	THERANOSTICS			English	Article						repeated TBI; neurovascular; optogenetics; closed head injury	MILD HEAD-INJURY; NEUROBEHAVIORAL CHANGES; ANGIOGENESIS; MEMORY; MICE; VULNERABILITY; ACTIVATION; DISEASE	Traumatic brain injury (TBI) research has focused on moderate to severe injuries as their outcomes are significantly worse than those of a mild TBI (mTBI). However, recent epidemiological evidence has indicated that a series of even mild TBIs greatly increases the risk of neurodegenerative and psychiatric disorders. Neuropathological studies of repeated TBI have identified changes in neuronal ionic concentrations, axonal injury, and cytoskeletal damage as important determinants of later life neurological and mood compromise; yet, there is a paucity of data on the contribution of neurogliovascular dysfunction to the progression of repeated TBI and alterations of brain function in the intervening period. Methods: Here, we established a mouse model of repeated TBI induced via three electromagnetically actuated impacts delivered to the intact skull at three-day intervals and determined the long-term deficits in neurogliovascular functioning in Thy1-ChR2 mice. Two weeks post the third impact, cerebral blood flow and cerebrovascular reactivity were measured with arterial spin labelling magnetic resonance imaging. Neuronal function was investigated through bilateral intracranial electrophysiological responses to optogenetic photostimulation. Vascular density of the site of impacts was measured with in vivo two photon fluorescence microscopy. Pathological analysis of neuronal survival and astrogliosis was performed via NeuN and GFAP immunofluorescence. Results: Cerebral blood flow and cerebrovascular reactivity were decreased by 50 +/- 16% and 70 +/- 20%, respectively, in the TBI cohort relative to sham-treated animals. Concomitantly, electrophysiological recordings revealed a 97 +/- 1% attenuation in peri-contusional neuronal reactivity relative to sham. Peri-contusional vascular volume was increased by 33 +/- 2% relative to sham-treated mice. Pathological analysis of the peri-contusional cortex demonstrated astrogliosis, but no changes in neuronal survival. Conclusion: This work provides the first in-situ characterization of the long-term deficits of the neurogliovascular unit following repeated TBI. The findings will help guide the development of diagnostic markers as well as therapeutics targeting neurogliovascular dysfunction.	[Adams, Conner; Bazzigaluppi, Paolo; Bishay, Jossana; Mester, James R.; Steinman, Joe; Sled, John G.; Stefanovic, Bojana] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Adams, Conner; Bazzigaluppi, Paolo; Beckett, Tina L.; Bishay, Jossana; Weisspapir, Iliya; Dorr, Adrienne; Mester, James R.; McLaurin, JoAnne; Stefanovic, Bojana] Sunnybrook Res Inst, Toronto, ON, Canada; [Bazzigaluppi, Paolo] Univ Hlth Network, Krembil Res Inst, Fundamental Neurobiol, Toronto, ON M5T 2S8, Canada; [Steinman, Joe; Sled, John G.] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON, Canada; [Hirschler, Lydiane; Warnking, Jan M.; Barbier, Emmanuel L.] Univ Grenoble Alpes, Grenoble Inst Neurosci, Grenoble, France; [Hirschler, Lydiane] Bruker Biospin MRI, Ettlingen, Germany; [Hirschler, Lydiane; Warnking, Jan M.; Barbier, Emmanuel L.] INSERM, U1216, Grenoble, France; [McLaurin, JoAnne] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada		Adams, C (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave,S636, Toronto, ON M4N 3M5, Canada.	Conner.adams@mail.utoronto.ca	Hirschler, Lydiane/AAA-4136-2020; Warnking, Jan M/M-1736-2014; Barbier, Emmanuel/E-6302-2011; Sled, John G/D-8268-2012	Hirschler, Lydiane/0000-0003-2379-0861; Warnking, Jan M/0000-0002-1683-5163; Barbier, Emmanuel/0000-0002-4952-1240; Sled, John G/0000-0002-4461-283X; Steinman, Joe/0000-0002-1354-4221; Mester, James/0000-0001-9878-092X	Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [FRN 148521]	This work was funded by the Canadian Institute of Health Research (FRN 148521).	Agoston DV, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00092; Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; [Anonymous], 2012, DOD POLICY GUIDANCE; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Baron JC, 2014, J CEREBR BLOOD F MET, V34, P2, DOI 10.1038/jcbfm.2013.188; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bey T, 2009, WEST J EMERG MED, V10, P6; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Donovan V, 2012, NEUROIMAGE-CLIN, V1, P18, DOI 10.1016/j.nicl.2012.08.001; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Ferguson SA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00416; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Hawrylycz M, 2014, SPRINGER HANDBOOK OF BIO-/NEUROINFORMATICS, P1111; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hirschler L, 2018, MAGN RESON MED, V79, P1314, DOI 10.1002/mrm.26767; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Lake EMR, 2017, J MAGN RESON IMAGING, V46, P505, DOI 10.1002/jmri.25541; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lee CY, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00082; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Parkes LM, 2002, MAGN RESON MED, V48, P27, DOI 10.1002/mrm.10180; Pries AR, 2005, HYPERTENSION, V46, P725, DOI 10.1161/01.HYP.0000184428.16429.be; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Tarantini S, 2015, J CEREBR BLOOD F MET, V35, P1871, DOI 10.1038/jcbfm.2015.162; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vazquez AL, 2014, CEREB CORTEX, V24, P2908, DOI 10.1093/cercor/bht147; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Weiller C, 2006, J MAGN RESON IMAGING, V23, P840, DOI 10.1002/jmri.20591; Wu G, 2010, TRANSL STROKE RES, V1, P31, DOI 10.1007/s12975-009-0008-6; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178	59	16	16	1	12	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1838-7640			THERANOSTICS	Theranostics		2018	8	17					4824	4836		10.7150/thno.24747			13	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GT0FX	WOS:000444107300018	30279740	Green Submitted, Green Published, gold			2022-02-06	
J	Brunner, M; Hemsley, B; Dann, S; Togher, L; Palmer, S				Brunner, Melissa; Hemsley, Bronwyn; Dann, Stephen; Togher, Leanne; Palmer, Stuart			Hashtag #TBI: A content and network data analysis of tweets about Traumatic Brain Injury	BRAIN INJURY			English	Article						Communication disorder; cognitive disorder; rehabilitation; social networks; twitter; traumatic brain injury	ALTERNATIVE COMMUNICATION AAC; FOOTBALL-LEAGUE PLAYER; SOCIAL MEDIA; COGNITIVE-COMMUNICATION; TWITTER NETWORKS; VIRTUAL WORLDS; YOUNG-PEOPLE; HEAD-INJURY; ADULTS; HEALTH	Objective: The aims of this study were to: (a) determine how Twitter is used by people with traumatic brain injury (TBI) and TBI organisations, (b) analyse the Twitter networks and content of tweets tagged with TBI-related hashtags, and (c) identify any challenges people with TBI encounter in using Twitter. Research Design: Mixed methods in a Twitter hashtag study. Methods: Mixed methods in a Twitter hashtag study. Tweets tagged with TBI-related hashtags were harvested from the Twitter website over a one-month period in 2016 and analysed qualitatively and quantitatively. Results: The sample of 29,199 tweets included tweets sent by 893 @ users, 219 of whom had a brain injury. Twitter was used to: (a) discuss health issues, (b) raise awareness of TBI, (c) talk about life after TBI, (d) talk about sport and concussion, and (e) communicate inspirational messages. Conclusions: Twitter is an important platform for research and knowledge translation on TBI, and for hearing the voices of people with TBI as they express their personal views and stories of living with TBI and become more visible and influential in Twitter communities. TBI clinicians could use these narratives of people with TBI in Twitter to develop more effective and personally meaningful rehabilitation goals.	[Brunner, Melissa; Hemsley, Bronwyn] Univ Newcastle, Fac Educ & Arts, Speech Pathol, Newcastle, NSW, Australia; [Dann, Stephen] Australian Natl Univ, Coll Business & Econ, Canberra, ACT, Australia; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Speech Pathol, Sydney, NSW, Australia; [Togher, Leanne] Univ New South Wales, NHMRC Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia; [Palmer, Stuart] Deakin Univ, Fac Sci Engn & Built Environm, Deans Off, Geelong, Vic, Australia		Hemsley, B (corresponding author), Univ Newcastle, Fac Educ & Arts, Sch Humanities & Social Sci, Level 2,Sch Off McMullin Bldg,Univ Dr, Callaghan, NSW 2308, Australia.	melissa.brunner@uon.edu.au	Togher, Leanne/AAC-7083-2019; Brunner, Melissa/AAS-5965-2020; Hemsley, Bronwyn/A-7427-2010	Togher, Leanne/0000-0002-4518-6748; Hemsley, Bronwyn/0000-0002-6255-3140	Australian Government Research Training Program scholarshipAustralian GovernmentDepartment of Industry, Innovation and Science; Discovery Early Career Research Award (Australian Research Council)	This research is funded through an Australian Government Research Training Program scholarship to the first author and a Discovery Early Career Research Award (Australian Research Council) to the second author.	Aladwani AM, 2015, INT J INFORM MANAGE, V35, P15, DOI 10.1016/j.ijinfomgt.2014.09.003; [Anonymous], 2016, BBC 2; Australian Bureau of Statistics, 2017, 2015 SURV DIS AG CAR; Australian Institute for Health and Welfare, 2016, AUSTR BURD DIS STUD; Baker-Sparr Christina, 2017, J HEAD TRAUMA REHAB, P1; Balandin S, 2015, DISABIL REHABIL, V37, P1543, DOI 10.3109/09638288.2015.1052574; Barnes Henry, 2016, GUARDIAN; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown S., 2011, ISJLP, V7, P457; Brunner M, 2017, INT COGN COMM DIS C; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Bruns A, 2016, COMMUN RES PRACT, V2, P20, DOI 10.1080/22041451.2016.1155328; Bruns A, 2013, INT J SOC RES METHOD, V16, P91, DOI 10.1080/13645579.2012.756095; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buddy Media, 2012, STRAT EFF TWEET STAT; Burns A., 2014, TWITTER SOC, P15; Chen LS, 2009, J AM STAT ASSOC, V104, P209, DOI 10.1198/jasa.2009.0111; Choo EK, 2015, MED TEACH, V37, P411, DOI 10.3109/0142159X.2014.993371; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; College of Audiologists and Speech-Language Pathologists of Ontario (CASLPO), 2015, PREF PRACT GUID COGN, V02, P08; Conneeley AL, 2012, BRAIN IMPAIR, V13, P72, DOI 10.1017/BrImp.2012.3; Dann S., 2015, MAXIMIZING COMMERCE, P313; Dann S., 2014, EVIDENCE BASED COMMU, V8, P187, DOI [10.1080/17489539.2015.1023988, DOI 10.1080/17489539.2015.1023988]; Dann S., 2015, MAXIMIZING COMMERCE, P280; DiAntonio A, 2016, HASHTAG ETIQUETTE US; Dollaghan C, 2007, HDB EVIDENCE BASED P; Donelle Lorie, 2012, Online J Issues Nurs, V17, P4; Douglas J, 2015, INT J SPEECH-LANG PA, V17, P199, DOI 10.3109/17549507.2015.1016113; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fraas MR, 2015, TOP LANG DISORD, V35, P210, DOI 10.1097/TLD.0000000000000063; Fraas MR, 2009, AM J SPEECH-LANG PAT, V18, P315, DOI 10.1044/1058-0360(2009/08-0008); FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Greenfield B, 2011, TOP STROKE REHABIL, V18, P35, DOI 10.1310/tsr1801-35; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Hanna R, 2011, BUS HORIZONS, V54, P265, DOI 10.1016/j.bushor.2011.01.007; Hemsley B., 2017, 50 HAW INT C SYST SC; Hemsley B, 2017, AUGMENT ALTERN COMM, V33, P14, DOI 10.1080/07434618.2016.1273386; Hemsley B, 2016, STUD HEALTH TECHNOL, V227, P41, DOI 10.3233/978-1-61499-666-8-41; Hemsley B, 2015, DISABIL REHABIL, V37, P1531, DOI 10.3109/09638288.2015.1045990; Hemsley B, 2014, DEV NEUROREHABIL, V17, P84, DOI 10.3109/17518423.2013.861529; Higuchi K., 2015, KH CODER VERSION VER; Ho K, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2969; Hu Xia, 2012, MINING TEXT DATA, P385, DOI 10.1007/978-1-4614-3223-4_12; Hynan A., 2013, I USE INTERNET ONLIN; Hynan A, 2015, DISABIL REHABIL, V37, P1559, DOI 10.3109/09638288.2015.1056387; Hynan A, 2014, CHILD LANG TEACH THE, V30, P175, DOI 10.1177/0265659013519258; Jacobs N, 2005, J COMPUT ASSIST LEAR, V21, P317, DOI 10.1111/j.1365-2729.2005.00142.x; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Krueger EA, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.4113; Kuipers P, 2014, NEUROREHABILITATION, V35, P475, DOI 10.3233/NRE-141139; Laskas J.M., 2015, CONCUSSION; Lee Carmen K. M., 2011, DIGITAL DISCOURSE LA, P110, DOI [DOI 10.1093/ACPROF:OSO/9780199795437.003.0006, 10.1093/acprof:oso/9780199795437.003.0006]; Lee JL, 2014, J MED INTERNET RES, V16, P251, DOI 10.2196/jmir.3765; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; Mairs K, 2013, HEALTH INFO LIBR J, V30, P261, DOI 10.1111/hir.12048; McDonald S, 2014, SOCIAL COMMUNICATION; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; McNeil K, 2012, EPILEPSY TWITTER ERA, V2; Microsoft, 2013, EXC VERS 15 0 4779 1; Mossberg W., 2016, THE VERGE; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Oyesanya TO, 2016, HEALTH CARE WOMEN IN, V37, P45, DOI 10.1080/07399332.2015.1005307; Palmer S, 2015, AUSTR ASS ENG ED C G; Palmer S, 2014, J MARK HIGH EDUC, V24, P257, DOI 10.1080/08841241.2014.907220; Park H, 2016, J HEALTH COMMUN, V21, P188, DOI 10.1080/10810730.2015.1058435; Paterson H, 2015, DISABIL REHABIL, V37, P1522, DOI 10.3109/09638288.2015.1052575; Paterson HL, 2017, AUGMENT ALTERN COMM, V33, P23, DOI 10.1080/07434618.2016.1275789; QSR International, 2011, NCAPTURE VERS 1 0 17; QSR International, 2012, NVIVO VERS 10 0 638; Ralph A, 2013, BRAIN INJURY, V27, P1475, DOI 10.3109/02699052.2013.823653; Retallack Hanna., 2016, LEARNING BODIES BODI, V2, DOI 10.1007/978-981-10-0306-6_6; Richards R., 2010, MERLOT J ONLINE LEAR, V6, P516; Ross C, 2011, J DOC, V67, P214, DOI 10.1108/00220411111109449; Saxton G., 2015, ADV SOCIAL WORK, V16, P154, DOI [10.18060/17952, DOI 10.18060/17952]; Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004; Schellinger S., 2015, PUBLIC PERCEPTIONS T; Schmidt J.-H., 2014, TWITTER AND SOC, P3; Shibasaki S, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.5987; Sony Pictures Digital Productions Inc, 2016, CONC; Stendal K, 2015, DISABIL REHABIL, V37, P1591, DOI 10.3109/09638288.2015.1052577; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; The Gephi Consortium, 2012, GEPH VERS 0 8 2 1; Theroux L., 2017, L THEROUXS BIOGRAPHY; Togher L, 2001, J COMMUN DISORD, V34, P131, DOI 10.1016/S0021-9924(00)00045-9; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Twitter, 2016, GETT START TWITT; VENTOLA E, 1979, J PRAGMATICS, V3, P267, DOI 10.1016/0378-2166(79)90034-1; Watermeyer R, 2010, JCOM-J SCI COMMUN, V9; Whiffin CJ, 2015, J ADV NURS, V71, P849, DOI 10.1111/jan.12551; Wiseman-Hakes C, 2010, NEUROREHABILITATION, V26, P355, DOI 10.3233/NRE-2010-0573; Yadron D, 2016, GUARDIAN; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Zimmer M, 2014, TWITTER AND SOC, V89, P169	110	16	16	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	1					49	63		10.1080/02699052.2017.1403047			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7VS	WOS:000427072300005	29219635				2022-02-06	
J	Dragojevic, T; Hollmann, JL; Tamborini, D; Portaluppi, D; Buttafava, M; Culver, JP; Villa, F; Durduran, T				Dragojevic, Tanja; Hollmann, Joseph L.; Tamborini, Davide; Portaluppi, Davide; Buttafava, Mauro; Culver, Joseph P.; Villa, Federica; Durduran, Turgut			Compact, multi-exposure speckle contrast optical spectroscopy (SCOS) device for measuring deep tissue blood flow	BIOMEDICAL OPTICS EXPRESS			English	Article							OBSTRUCTIVE SLEEP-APNEA; CEREBRAL METABOLIC-RATE; LASER-DOPPLER; RESOLUTION; OXYGEN	Speckle contrast optical spectroscopy (SCOS) measures absolute blood flow in deep tissue, by taking advantage of multi-distance (previously reported in the literature) or multi-exposure (reported here) approach. This method promises to use inexpensive detectors to obtain good signal-to-noise ratio, but it has not yet been implemented in a suitable manner for a mass production. Here we present a new, compact, low power consumption, 32 by 2 single photon avalanche diode (SPAD) array that has no readout noise, low dead lime and has high sensitivity in low light conditions, such as in vivo measurements. To demonstrate the capability to measure blood flow in deep tissue, healthy volunteers were measured, showing no significant differences from the diffuse correlation spectroscopy. In the future, this array can be miniaturized to a low-cost, robust, battery operated wireless device paving the way for measuring blood flow in a wide-range of applications from sport injury recovery and training to, on-field concussion detection to wearables. (c) 2017 Optical Society of America under the terms of the OSA Open Access Publishing Agreement	[Dragojevic, Tanja; Hollmann, Joseph L.; Durduran, Turgut] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Av Carl Friedrich Gauss 3, Castelldefels 08860, Barcelona, Spain; [Tamborini, Davide; Portaluppi, Davide; Buttafava, Mauro; Villa, Federica] Politecn Milan, Dipartimento Elettron Informat & Bioingn, Piazza Leonardo Da Vinci 32, I-20133 Milan, Italy; [Culver, Joseph P.] Washington Univ, Dept Radiol, Sch Med, St Louis, MO 63110 USA; [Culver, Joseph P.] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Durduran, Turgut] ICREA, Barcelona 08015, Spain		Dragojevic, T (corresponding author), Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Av Carl Friedrich Gauss 3, Castelldefels 08860, Barcelona, Spain.	tanja.dragojevic@icfo.eu	Villa, Federica A/G-9558-2014; Dragojevic, Tanja/AAA-5923-2019; Dragojevic, Tanja/G-5136-2015	Villa, Federica A/0000-0002-9840-0269; Dragojevic, Tanja/0000-0002-7643-0846	Fundacio CELLEX BarcelonaFoundation CELLEXEuropean Commission; Instituto de Salud Carlos III/FEDER (MEDPHOTAGE) [DTS16/00087]; "Severe Ochoa" Programme for Centres of Excellence in RD [SEV-2015-0522]; Obra social "la Caixa" Foundation (LlumMedBcn); LASERLAB-EUROPE IV; Marie Curie COFUND (FP7-PEOPLE-COFUND) fellowship; Ministerio de Economia y Competitividad (PHOTODEMENTIA) [DPI2015-64358-c1, DPI2015-64358-c2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078223, R01NS090874, R01NS099429] Funding Source: NIH RePORTER	Fundacio CELLEX Barcelona, Ministerio de Economia y Competitividad (PHOTODEMENTIA (DPI2015-64358-c1 and c2 (MINECO/FEDER)), Instituto de Salud Carlos III/FEDER (MEDPHOTAGE DTS16/00087), the "Severe Ochoa" Programme for Centres of Excellence in R&D (SEV-2015-0522), the Obra social "la Caixa" Foundation (LlumMedBcn), LASERLAB-EUROPE IV. J.L.Hollmann acknowledges the Marie Curie COFUND (FP7-PEOPLE-2013-COFUND) fellowship.	Atsumori H, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3115207; Bandyopadhyay R, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2037987; Bi R, 2013, OPT EXPRESS, V21, P22854, DOI 10.1364/OE.21.022854; Bi RZ, 2013, OPT LETT, V38, P1401, DOI 10.1364/OL.38.001401; Boas D. A., 1996, DIFFUSE PHOTON PROBE; BOAS DA, 1995, PHYS REV LETT, V75, P1855, DOI 10.1103/PhysRevLett.75.1855; Boas DA, 2010, J BIOMED OPT, V15; Boas DA, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031412; Boas DA, 2011, PHILOS T R SOC A, V369, P4407, DOI 10.1098/rsta.2011.0250; Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201; Bronzi D, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2014.2341562; Bronzi D, 2013, IEEE PHOTONIC TECH L, V25, P776, DOI 10.1109/LPT.2013.2251621; Bullock R., 1997, HEAD INJURY, P89; Devor A, 2012, J CEREBR BLOOD F MET, V32, P1259, DOI 10.1038/jcbfm.2011.195; Dietsche G, 2007, APPL OPTICS, V46, P8506, DOI 10.1364/AO.46.008506; Dragojevic T, 2015, BIOMED OPT EXPRESS, V6, P2865, DOI 10.1364/BOE.6.002865; Duchna HW, 2000, AM J RESP CRIT CARE, V161, P187, DOI 10.1164/ajrccm.161.1.9810062; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Dunn AK, 2012, ANN BIOMED ENG, V40, P367, DOI 10.1007/s10439-011-0469-0; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Kameyama M, 2004, NEUROIMAGE, V22, P1715, DOI 10.1016/j.neuroimage.2004.03.050; Kazmi SMS, 2013, J CEREBR BLOOD F MET, V33, P798, DOI 10.1038/jcbfm.2013.57; Parthasarathy AB, 2010, BIOMED OPT EXPRESS, V1, P246, DOI 10.1364/BOE.1.000246; Pinti P, 2015, JOVE-J VIS EXP, DOI 10.3791/53336; Piper SK, 2014, NEUROIMAGE, V85, P64, DOI 10.1016/j.neuroimage.2013.06.062; Quaresima V., 2016, ORGAN RES METH; Rajan V, 2009, LASER MED SCI, V24, P269, DOI 10.1007/s10103-007-0524-0; Rodgers ZB, 2016, J CEREBR BLOOD F MET, V36, P755, DOI 10.1177/0271678X15605855; Rodgers ZB, 2013, J CEREBR BLOOD F MET, V33, P1514, DOI 10.1038/jcbfm.2013.110; Scarcella C, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4850677; Sun S, 2015, OPT LETT, V40, P4587, DOI 10.1364/OL.40.004587; Takeuchi N, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0244-0; Tamborini D, 2016, IEEE SENS J, V16, P3827, DOI 10.1109/JSEN.2016.2535403; Valdes CP, 2014, BIOMED OPT EXPRESS, V5, P2769, DOI 10.1364/BOE.5.002769; van Beek AHEA, 2011, J NEUROIMAGING, V21, P340, DOI 10.1111/j.1552-6569.2010.00517.x; Walsh B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04357-6; Yu GQ, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1884603	38	16	16	0	9	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	JAN 1	2018	9	1					322	334		10.1364/BOE.9.000322			13	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	FQ8US	WOS:000418639300024	29359106	Green Published, gold			2022-02-06	
J	Graff, HJ; Christensen, U; Poulsen, I; Egerod, I				Graffa, Heidi J.; Christensen, Ulla; Poulsen, Ingrid; Egerod, Ingrid			Patient perspectives on navigating the field of traumatic brain injury rehabilitation: a qualitative thematic analysis	DISABILITY AND REHABILITATION			English	Article						Healthcare utilization; family caregiving; illness trajectory; rehabilitation; traumatic brain injury; qualitative research	TRANSITION; INDIVIDUALS; EXPERIENCES; MODERATE; HEALTH; HOME; RECOVERY; PEOPLE; NEEDS; TBI	Purpose: This study aimed to provide an understanding of the lived experience of rehabilitation in adults with traumatic brain injury (TBI) from hospital discharge up to four years post-injury. Materials and methods: We used a qualitative explorative design with semi-structured in-depth interviews. Twenty participants with TBI were included from a level I Trauma Center in Denmark at 1-4 years post-injury. Qualitative thematic analysis was applied for data analysis. Results: Three main themes emerged during analysis: A new life, Family involvement, and Rehabilitation impediments. These themes and their sub-themes described the patient perspective of TBI and rehabilitation post hospitalization. Participants reassessed their values and found a new life after TBI. Family care-givers negotiated rehabilitation services and helped the participant to overcome barriers to rehabilitation. Although participants were entitled to TBI rehabilitation, they had to fight for the services they were entitled to. Conclusion: Individuals with TBI found ways of coping after injury and created a meaningful life. Barriers to TBI rehabilitation were overcome with help from family caregivers rather than health care professionals. Future studies need to find ways to ease the burden on family caregivers and pave the way for more accessible rehabilitation in this vulnerable group of patients.	[Graffa, Heidi J.] Univ Copenhagen, Ctr Head & Orthopaed, Dept Anaesthesia, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Graffa, Heidi J.; Egerod, Ingrid] Univ Copenhagen, Rigshosp, Trauma Ctr & Acute Admiss, Copenhagen, Denmark; [Christensen, Ulla] Univ Copenhagen, Sect Social Med, Dept Publ Hlth, Copenhagen, Denmark; [Poulsen, Ingrid] Univ Copenhagen, TBI Unit, Clin Neurorehabil, Rigshosp, Hvidovre, Denmark		Graff, HJ (corresponding author), Univ Copenhagen, Ctr Head & Orthopaed, Dept Anaesthesia, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	heidi.jeannet.graff@regionh.dk	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X; Graff, Heidi/0000-0001-5726-6991; Christensen, Ulla/0000-0001-7797-6640; Egerod, Ingrid/0000-0002-9576-4390	Rigshospitalet Research Foundation [E-22260-03]; Helsefonden [16-B-0050]	This work was supported by the Rigshospitalet Research Foundation (E-22260-03) and Helsefonden (16-B-0050).	Abrahamson V., 2016, DISABIL REHABIL, V39, P1; Ailing Shilling C., 2008, CHANGING BODIES HABI, P104; Almeida J, 2011, J EPIDEMIOL COMMUN H, V65, P51, DOI 10.1136/jech.2009.092213; Beck, NURSING RES GENERATI; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Deri C, 2005, J HEALTH ECON, V24, P1076, DOI 10.1016/j.jhealeco.2005.03.008; Diderichsen F, 2012, SCAND J PUBLIC HEALT, V40, P10, DOI 10.1177/1403494812457732; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Duff Diane, 2002, Axone, V24, P14; Ekholm O, 2010, SCAND J PUBLIC HEALT, V38, P699, DOI 10.1177/1403494810382474; Engberg Aase Worsaae, 2007, Ugeskr Laeger, V169, P199; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Engstrom A, 2011, J NEUROSCI NURS, V43, P253, DOI 10.1097/JNN.0b013e318227ef9b; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Jumisko E, 2007, DISABIL REHABIL, V29, P1535, DOI 10.1080/09638280601055816; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Lefebvre Helene, 2012, J Trauma Nurs, V19, P197, DOI 10.1097/JTN.0b013e318275990d; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Magnussen J, 2009, NORDIC HLTH CARE SYS; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Nalder E, 2013, BRAIN INJURY, V27, P1294, DOI 10.3109/02699052.2013.823560; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; O'Reilly Kate, 2002, Aust Health Rev, V25, P46; Olejaz M, 2012, HEALT SYST TRANSIT, V14, P1; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Powell T, 2012, DISABIL REHABIL, V34, P1461, DOI 10.3109/09638288.2011.644384; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Rudkjobing A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4451; Shenton AndrewK., 2004, EDUC INFORM, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sundhedsstyrelsen (The Danish Health Authority), 2011, FORL REH REH VOKSN M; Sundhedsstyrelsen (The Danish Health Authority), 1997, BEH TRAUM HJERN TILG; Sveen U, 2016, DISABIL REHABIL, V38, P2296, DOI 10.3109/09638288.2015.1129445; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2011, NEUROPSYCHOL REHABIL, V21, P64, DOI 10.1080/09602011.2010.527747; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Ulfarsson T, 2014, BRAIN INJURY, V28, P1675, DOI 10.3109/02699052.2014.947625; van Manen M., 1997, RES LIVED EXPERIENCE, V2nd ed.	51	16	16	2	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	8					926	934		10.1080/09638288.2017.1280542			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FY5YB	WOS:000426913400008	28129694				2022-02-06	
J	Guenette, JP; Stern, RA; Tripodis, Y; Chua, AS; Schultz, V; Sydnor, VJ; Somes, N; Karmacharya, S; Lepage, C; Wrobel, P; Alosco, ML; Martin, BM; Chaisson, CE; Coleman, MJ; Lin, AP; Pasternak, O; Makris, N; Shenton, ME; Koerte, IK				Guenette, Jeffrey P.; Stern, Robert A.; Tripodis, Yorghos; Chua, Alicia S.; Schultz, Vivian; Sydnor, Valerie J.; Somes, Nathaniel; Karmacharya, Sarina; Lepage, Christian; Wrobel, Pawel; Alosco, Michael L.; Martin, Brett M.; Chaisson, Christine E.; Coleman, Michael J.; Lin, Alexander P.; Pasternak, Ofer; Makris, Nikos; Shenton, Martha E.; Koerte, Inga K.			Automated versus manual segmentation of brain region volumes in former football players	NEUROIMAGE-CLINICAL			English	Article						Magnetic resonance imaging; Neuroimaging; Head trauma; Traumatic brain injury; Chronic traumatic encephalopathy	CHRONIC TRAUMATIC ENCEPHALOPATHY; VENTRICULAR ENLARGEMENT; HIPPOCAMPUS SEGMENTATION; ALZHEIMERS-DISEASE; AMYGDALA VOLUMES; METAANALYSIS; FREESURFER; ATROPHY; SCHIZOPHRENIA; RELIABILITY	Objectives: To determine whether or not automated FreeSurfer segmentation of brain regions considered important in repetitive head trauma can be analyzed accurately without manual correction. Materials and methods: 3 T MR neuroimaging was performed with automated FreeSurfer segmentation and manual correction of 11 brain regions in former National Football League (NFL) players with neurobehavioral symptoms and in control subjects. Automated segmentation and manually-corrected volumes were compared using an intraclass correlation coefficient (ICC). Linear mixed effects regression models were also used to estimate between-group mean volume comparisons and to correlate former NFL player brain volumes with neurobehavioral factors. Results: Eighty-six former NFL players (55.2 +/- 8.0 years) and 22 control subjects (57.0 +/- 6.6 years) were evaluated. ICC was highly correlated between automated and manually-corrected corpus callosum volumes (0.911), lateral ventricular volumes (right 0.980, left 0.967), and amygdala-hippocampal complex volumes (right 0.713, left 0.731), but less correlated when amygdalae (right -0.170, left -0.090) and hippocampi (right 0.539, left 0.637) volumes were separately delineated and also less correlated for cingulate gyri volumes (right 0.639, left 0.351). Statistically significant differences between former NFL player and controls were identified in 8 of 11 regions with manual correction but in only 4 of 11 regions without such correction. Within NFL players, manually corrected brain volumes were significantly associated with 3 neurobehavioral factors, but a different set of 3 brain regions and neurobehavioral factor correlations was observed for brain region volumes segmented without manual correction. Conclusions: Automated FreeSurfer segmentation of the corpus callosum, lateral ventricles, and amygdala-hippocampus complex may be appropriate for analysis without manual correction. However, FreeSurfer segmentation of the amygdala, hippocampus, and cingulate gyrus need further manual correction prior to performing group comparisons and correlations with neurobehavioral measures.	[Guenette, Jeffrey P.; Schultz, Vivian; Sydnor, Valerie J.; Somes, Nathaniel; Karmacharya, Sarina; Lepage, Christian; Coleman, Michael J.; Lin, Alexander P.; Pasternak, Ofer; Makris, Nikos; Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA USA; [Guenette, Jeffrey P.; Lin, Alexander P.; Pasternak, Ofer; Makris, Nikos; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA; [Stern, Robert A.; Tripodis, Yorghos; Alosco, Michael L.; Chaisson, Christine E.] Boston Univ, BU Alzheimers Dis & CTE Ctr, Boston, MA 02215 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Tripodis, Yorghos; Chua, Alicia S.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Schultz, Vivian; Wrobel, Pawel; Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Martin, Brett M.; Chaisson, Christine E.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Lin, Alexander P.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Clin Spect, Boston, MA USA; [Makris, Nikos] Massachusetts Gen Hosp, Ctr Neural Syst Invest, Boston, MA 02114 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton Div, Brockton, MA USA		Koerte, IK (corresponding author), Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA.	ikoerte@bwh.harvard.edu	Shenton, Martha/V-8780-2019; , Bob/ABA-8507-2020; Chua, Alicia/AAA-3628-2019; Koerte, Inga Katharina/AAW-3031-2021	Chua, Alicia/0000-0001-6908-8539; Guenette, Jeffrey/0000-0002-4684-5469; Sydnor, Valerie/0000-0002-8640-668X; Tripodis, Yorghos/0000-0003-2190-7608	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 078337, R01 NS100952, F31 NS 081957, 1F32NS096803-01, P30 AG13846, P41 EB015902, T32GM074905]; JetBlue Airlines; National Football League; NFL Players Association; Else Kroner-Fresenius Foundation, Germany (IK); LMU Munich's Institutional Strategy LMUexcellent; VA Merit AwardUS Department of Veterans Affairs; German Academic Exchange Service PROMOS award; Canadian Institutes of Health Research Frederick Banting and Charles Best Doctoral AwardCanadian Institutes of Health Research (CIHR); medical faculty of the Ludwig-Maximillian University Munich; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM074905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078337, F31NS081957, F32NS096803, R01NS100952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	This study was supported by the NIH (R01 NS 078337 (RAS, YT, CMB, NGF, BMM, CC); R01 NS100952 (IK, APL); F31 NS 081957 (JMS); 1F32NS096803-01 (MLA), P30 AG13846 (RAS, YT, MLA, CMB, BMM, CC); P41 EB015902 (OP); T32GM074905 (IW)), and participant travel was partially funded by JetBlue Airlines, the National Football League, and the NFL Players Association. This study was also partly supported by the Else Kroner-Fresenius Foundation, Germany (IK), by LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative, and by a VA Merit Award (MES, MC). PW and VS were supported by the German Academic Exchange Service PROMOS award. PW was also supported by an international research scholarship by the medical faculty of the Ludwig-Maximillian University Munich. This work was completed in partial fulfillment of VS's dissertation. CL was supported by the Canadian Institutes of Health Research Frederick Banting and Charles Best Doctoral Award. The sponsors had no role in the design and conduct of the study, the collection, analysis, or the interpretation of the data, nor in the preparation, review, or approval of the manuscript, or the decision of submission for publication.	Ahmed-Leitao F, 2016, PSYCHIAT RES-NEUROIM, V256, P33, DOI 10.1016/j.pscychresns.2016.09.008; Akhondi-Asl A, 2011, NEUROIMAGE, V54, pS218, DOI 10.1016/j.neuroimage.2010.03.066; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; BARRON SA, 1976, NEUROLOGY, V26, P1011, DOI 10.1212/WNL.26.11.1011; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; BIGELOW LB, 1983, BRIT J PSYCHIAT, V142, P284, DOI 10.1192/bjp.142.3.284; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Busatto Geraldo F, 2008, Expert Rev Neurother, V8, P1691, DOI 10.1586/14737175.8.11.1691; Chera BS, 2009, AM J CLIN ONCOL-CANC, V32, P20, DOI 10.1097/COC.0b013e318178e4e8; Cherbuin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005265; Chua AS, 2015, NEUROIMAGE, V119, P81, DOI 10.1016/j.neuroimage.2015.06.037; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; de Flores R, 2015, HUM BRAIN MAPP, V36, P463, DOI 10.1002/hbm.22640; Dill V, 2015, NEUROINFORMATICS, V13, P133, DOI 10.1007/s12021-014-9243-4; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; FOX JH, 1976, JAMA-J AM MED ASSOC, V236, P365, DOI 10.1001/jama.236.4.365; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Gonzalez-Villa S, 2016, ARTIF INTELL MED, V73, P45, DOI 10.1016/j.artmed.2016.09.001; Grimm O, 2015, J NEUROSCI METH, V253, P254, DOI 10.1016/j.jneumeth.2015.05.024; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Haller S, 2016, RADIOLOGY, V281, P337, DOI 10.1148/radiol.2016150789; Inglese P, 2015, PHYS MEDICA, V31, P1085, DOI 10.1016/j.ejmp.2015.08.003; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; Kempton MJ, 2010, SCHIZOPHR RES, V120, P54, DOI 10.1016/j.schres.2010.03.036; Kiernan J A, 2012, Epilepsy Res Treat, V2012, P176157, DOI 10.1155/2012/176157; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Laurent S, 2010, J COMP PATHOL, V143, P75, DOI 10.1016/j.jcpa.2009.12.008; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mendrik AM, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/813696; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Milani ACC, 2017, PSYCHIAT CLIN NEUROS, V71, P154, DOI 10.1111/pcn.12473; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mu WY, 2017, J HEAD TRAUMA REHAB, V32, P55, DOI 10.1097/HTR.0000000000000213; Naess-Schmidt E, 2016, INT J COMPUT ASS RAD, V11, P1979, DOI 10.1007/s11548-016-1433-0; Nestor SM, 2008, BRAIN, V131, P2443, DOI 10.1093/brain/awn146; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Pol HEH, 2008, SCHIZOPHRENIA BULL, V34, P354, DOI 10.1093/schbul/sbm168; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; ROSENTHAL R, 1972, BRIT J PSYCHIAT, V121, P259, DOI 10.1192/bjp.121.3.259; Schoemaker D, 2016, NEUROIMAGE, V129, P1, DOI 10.1016/j.neuroimage.2016.01.038; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shenton Martha E, 2010, Dialogues Clin Neurosci, V12, P317; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Turner B, 2003, MULT SCLER, V9, P21, DOI 10.1191/1352458503ms868oa; Wenger E, 2014, HUM BRAIN MAPP, V35, P4236, DOI 10.1002/hbm.22473; Wible CG, 1997, PSYCHIAT RES-NEUROIM, V76, P29, DOI 10.1016/S0925-4927(97)00060-7	57	16	16	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						888	896		10.1016/j.nicl.2018.03.026			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH1NG	WOS:000433169000090	29876273	Green Published, gold			2022-02-06	
J	He, FP; Wu, M; Meng, FX; Hu, YF; Gao, J; Chen, ZQ; Bao, WX; Liu, KH; Luo, BY; Pan, G				He, Fangping; Wu, Min; Meng, Fanxia; Hu, Yangfan; Gao, Jian; Chen, Zhongqin; Bao, Wangxiao; Liu, Kehong; Luo, Benyan; Pan, Gang			Effects of 20Hz Repetitive Transcranial Magnetic Stimulation on Disorders of Consciousness: A Resting-State Electroencephalography Study	NEURAL PLASTICITY			English	Article							MOTOR CORTEX; BRAIN-STIMULATION; VEGETATIVE STATE; COMA; CONNECTIVITY; PLASTICITY; RECOVERY	Repetitive transcranial magnetic stimulation (rTMS) has been proposed as an experimental approach for the treatment of disorders of consciousness (DOC). To date, there has been little research into the use of rTMS in DOC and the therapeutic effects have been variously documented. This study aimed to examine the effects of 20 Hz rTMS on the electroencephalography (EEG) reactivity and clinical response in patients with DOC and to explore the neuromodulatory effects of high-frequency rTMS. In this randomized, sham-controlled, crossover study, real or sham 20 Hz rTMS was applied to the left primary motor cortex (M1) of patients with DOC for 5 consecutive days. Evaluations were blindly performed at the baseline (T0), immediately after the end of the 5 days of treatment (T1) and 1 week after the treatment (T2) using the JFK coma recovery scale-revised (CRS-R) and resting-state EEG. Only one patient, with a history of 2 months of traumatic brain injury, showed long-lasting (T1, T2) behavioral and neurophysiological modifications after the real rTMS stimulation. The 5 remaining patients presented brain reactivity localized at several electrodes, and the EEG modification was not significant. rTMS stimulation may improve awareness and arousal of DOC. Additionally, EEG represents a potential biomarker for the therapeutic efficacy of rTMS.	[He, Fangping; Wu, Min; Meng, Fanxia; Chen, Zhongqin; Bao, Wangxiao; Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [He, Fangping; Wu, Min; Meng, Fanxia; Chen, Zhongqin; Bao, Wangxiao; Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Brain Med Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Yangfan; Pan, Gang] Zhejiang Univ, Dept Comp Sci, Hangzhou 310007, Zhejiang, Peoples R China; [Gao, Jian; Liu, Kehong] Zhejiang Armed Police Corps, Hangzhou Hosp, Dept Rehabil, Hangzhou 310051, Zhejiang, Peoples R China; [Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Collaborat Innovat Ctr Brain Sci, Hangzhou 310003, Zhejiang, Peoples R China		Luo, BY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China.; Luo, BY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Brain Med Ctr, Hangzhou 310003, Zhejiang, Peoples R China.; Pan, G (corresponding author), Zhejiang Univ, Dept Comp Sci, Hangzhou 310007, Zhejiang, Peoples R China.; Luo, BY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Collaborat Innovat Ctr Brain Sci, Hangzhou 310003, Zhejiang, Peoples R China.	luobenyan@zju.edu.cn; gpan@zju.edu.cn	Pan, Gang/B-5978-2013	Pan, Gang/0000-0002-4049-6181; Wu, Min/0000-0001-8753-0327	National Key Basic Research Program of ChinaNational Basic Research Program of China [2013CB329504]; General Project Plan of Zhejiang Medical Technology [2017C03011, 2014RCA007]; Medical Science and Technology Project [2016152769]	This work was supported by grants from the National Key Basic Research Program of China (2013CB329504), the General Project Plan of Zhejiang Medical Technology (2017C03011, 2014RCA007), and the Medical Science and Technology Project cofounded by Zhejiang Province and the Ministry of Health of China (2016152769).	ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; ASHWAL S, 1995, NEW ENGL J MED, V333, P130, DOI 10.1056/NEJM199507133330216; Babiloni C, 2009, CLIN NEUROPHYSIOL, V120, P719, DOI 10.1016/j.clinph.2009.02.157; Chervyakov AV, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00303; Chou YH, 2015, JAMA NEUROL, V72, P432, DOI 10.1001/jamaneurol.2014.4380; Cincotta M, 2015, CORTEX, V71, P368, DOI 10.1016/j.cortex.2015.07.027; Ciurleo R, 2013, DRUGS, V73, P1849, DOI 10.1007/s40265-013-0138-8; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Demertzi A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00245; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Giacino J, 2012, NEUROMODULATION, V15, P339, DOI 10.1111/j.1525-1403.2012.00458.x; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gosseries O, 2011, FUNCT NEUROL, V26, P25; Guse B, 2010, J NEURAL TRANSM, V117, P105, DOI 10.1007/s00702-009-0333-7; Holler Y, 2014, CLIN NEUROPHYSIOL, V125, P1545, DOI 10.1016/j.clinph.2013.12.095; Howell K, 2013, RESUSCITATION, V84, P1409, DOI 10.1016/j.resuscitation.2013.05.015; Johnson JS, 2010, BRAIN TOPOGR, V22, P281, DOI 10.1007/s10548-009-0118-1; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; Liu P, 2016, EUR NEUROL, V76, P1, DOI 10.1159/000447325; Lord V, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00397; Machado C, 2002, NEUROLOGY, V59, P1473; Manganotti P, 2013, BRAIN STIMUL, V6, P913, DOI 10.1016/j.brs.2013.06.006; Naro A., 2014, NEUROREHABILITATION, V29, P603; Okamura H, 2001, J CLIN NEUROPHYSIOL, V18, P318, DOI 10.1097/00004691-200107000-00003; Piccione F, 2011, NEUROREHAB NEURAL RE, V25, P98, DOI 10.1177/1545968310369802; Pisani LR, 2015, CONSCIOUS COGN, V38, P1, DOI 10.1016/j.concog.2015.09.012; Rachid F., 2017, PSYCHIAT RES; Rajan TS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00457; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rossiter HE, 2014, NEUROIMAGE, V91, P360, DOI 10.1016/j.neuroimage.2014.01.012; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Simis M, 2013, NEUROREPORT, V24, P973, DOI 10.1097/WNR.0000000000000021; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Tergau F, 1999, LANCET, V353, P2209, DOI 10.1016/S0140-6736(99)01301-X; Vernieri F, 2009, CLIN NEUROPHYSIOL, V120, P1188, DOI 10.1016/j.clinph.2009.03.021; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	38	16	19	5	17	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2018	2018								5036184	10.1155/2018/5036184			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC3JY	WOS:000429681300001	29770146	gold, Green Submitted, Green Published			2022-02-06	
J	Klemish, D; Ramger, B; Vittetoe, K; Reiter, JP; Tokdar, ST; Appelbaum, LG				Klemish, David; Ramger, Benjamin; Vittetoe, Kelly; Reiter, Jerome P.; Tokdar, Surya T.; Appelbaum, Lawrence Gregory			Visual abilities distinguish pitchers from hitters in professional baseball	JOURNAL OF SPORTS SCIENCES			English	Article						Sensorimotor; vision; baseball; expertise; Bayesian modelling	EXPERT PERFORMANCE; EYE-MOVEMENTS; PLAYERS; ACQUISITION; BATTERS	This study aimed to evaluate the possibility that differences in sensorimotor abilities exist between hitters and pitchers in a large cohort of baseball players of varying levels of experience. Secondary data analysis was performed on 9 sensorimotor tasks comprising the Nike Sensory Station assessment battery. Bayesian hierarchical regression modelling was applied to test for differences between pitchers and hitters in data from 566 baseball players (112 high school, 85 college, 369 professional) collected at 20 testing centres. Explanatory variables including height, handedness, eye dominance, concussion history, and player position were modelled along with age curves using basis regression splines. Regression analyses revealed better performance for hitters relative to pitchers at the professional level in the visual clarity and depth perception tasks, but these differences did not exist at the high school or college levels. No significant differences were observed in the other 7 measures of sensorimotor capabilities included in the test battery, and no systematic biases were found between the testing centres. These findings, indicating that professional-level hitters have better visual acuity and depth perception than professional-level pitchers, affirm the notion that highly experienced athletes have differing perceptual skills. Findings are discussed in relation to deliberate practice theory.	[Klemish, David; Reiter, Jerome P.; Tokdar, Surya T.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Ramger, Benjamin; Vittetoe, Kelly; Appelbaum, Lawrence Gregory] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA		Appelbaum, LG (corresponding author), Duke Univ Hosp, 400 Trent Dr, Durham, NC 27710 USA.	greg@duke.edu		Appelbaum, Lawrence/0000-0002-3184-6725	United States Army Research Office [W911NF-15-1-0390]	This research was funded by grant support to L.G.A. through the United States Army Research Office [W911NF-15-1-0390].	ABERNETHY B, 1994, APPL COGNITIVE PSYCH, V8, P185, DOI 10.1002/acp.2350080302; Appelbaum L.G., 2016, ATHLETIC TRAIN SPORT, V8, P154, DOI [10.3928/19425864-20160314-01, DOI 10.3928/19425864-20160314-01]; Appelbaum LG, 2018, INT REV SPORT EXER P, V11, P160, DOI 10.1080/1750984X.2016.1266376; BAHILL AT, 1984, AM SCI, V72, P249; Broadbent DP, 2015, EUR J SPORT SCI, V15, P322, DOI 10.1080/17461391.2014.957727; Clark JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029109; Classe J G, 1997, J Am Optom Assoc, V68, P43; DHHS, 2015, ATT A HUM SUBJ RES I; Eccles DW, 2006, J SPORT SCI, V24, P1103, DOI 10.1080/02640410500432854; Erickson G., 2007, SPORTS VISION VISION; Erickson GB, 2011, OPTOMETRY, V82, P528, DOI 10.1016/j.optm.2011.01.012; Ericsson K. A., 2003, ADV RES SPORT EXPERT, P371; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Gelman A., 2013, BAYESIAN DATA ANAL, DOI DOI 10.1201/B16018; Gelman A., 2007, DATA ANAL USING REGR, DOI [10.1017/CBO9780511790942, DOI 10.1017/CBO9780511790942]; Gilliam S., 2010, NAT STRENGTH COND AS; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Helsen WF, 1999, APPL COGNITIVE PSYCH, V13, P1; Hoffman L G, 1984, J Am Optom Assoc, V55, P747; Kato T, 2002, PERCEPT MOTOR SKILL, V94, P380, DOI 10.2466/pms.2002.94.2.380; Khanal S., 2015, MEDCRAVE, V2, P1; Krasich K, 2016, J MOTOR BEHAV, V48, P401, DOI 10.1080/00222895.2015.1113918; Laby D. M., 2014, SPORTS VISION FOCAL, VXXXII; Laby DM, 1996, AM J OPHTHALMOL, V122, P476, DOI 10.1016/S0002-9394(14)72106-3; Molia L M, 1998, J AAPOS, V2, P86, DOI 10.1016/S1091-8531(98)90069-6; Poltavski D, 2015, J SPORT SCI, V33, P597, DOI 10.1080/02640414.2014.951952; Portal J M, 1998, Binocul Vis Strabismus Q, V13, P125; Reichow AW, 2011, EYE CONTACT LENS, V37, P123, DOI 10.1097/ICL.0b013e3182188a77; SCHALEN L, 1980, ACTA OTO-LARYNGOL, V90, P404, DOI 10.3109/00016488009131742; Spaniol F., 2015, NSCA NAT C ORL FLOR; Spaniol F., 2008, NAT STRENGTH COND; Uchida Y, 2013, MED SCI SPORT EXER, V45, P319, DOI 10.1249/MSS.0b013e31826fec97; Wahba G., 1990, PAPER PRESENTED AT T; Wang LL, 2015, ACTA PSYCHOL, V157, P74, DOI 10.1016/j.actpsy.2015.02.005; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Ward Paul, 2000, INT J SPORTS VISION, V6, P1; Williams AM, 2011, APPL COGNITIVE PSYCH, V25, P432, DOI 10.1002/acp.1710	37	16	16	1	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2018	36	2					171	179		10.1080/02640414.2017.1288296			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FY0AN	WOS:000426472400007	28282749				2022-02-06	
J	Maheras, AL; Dix, B; Carmo, OMS; Young, AE; Gill, VN; Sun, JL; Booker, AR; Thomason, HA; Ibrahim, AE; Stanislaw, L; Dallego, JC; Ngo, CN; Chen, A; Fortini, BK; Spence, RD				Maheras, Amanda L.; Dix, Brian; Carmo, Olivia M. S.; Young, Aleena E.; Gill, Vanessa N.; Sun, Julia L.; Booker, Aleah R.; Thomason, Helen A.; Ibrahim, Anastasia E.; Stanislaw, Lauren; Dallego, Jennifer C.; Ngo, Cat N.; Chen, Audrey; Fortini, Barbara K.; Spence, Rory D.			Genetic Pathways of Neuroregeneration in a Novel Mild Traumatic Brain Injury Model in Adult Zebrafish	ENEURO			English	Article						Concussion; DEG; mTBI; RNA-seq; TBI; zebrafish	ELEMENT-BINDING PROTEIN; STIMULATES NEUROGENESIS; REGENERATIVE RESPONSE; SUBVENTRICULAR ZONE; EFFECTOR DOMAIN; RADIAL GLIA; LONG-TERM; C-FOS; EXPRESSION; JUNB	[GRAPHICS] Mild traumatic brain injuries (mTBIs) are one of the most prevalent neurological disorders, and humans are severely limited in their ability to repair and regenerate central nervous system (CNS) tissue postinjury. However, zebrafish (Danio rerio) maintain the remarkable ability to undergo complete and functional neuroregeneration as an adult. We wish to extend knowledge of the known mechanisms of neuroregeneration by analyzing the differentially expressed genes (DEGs) in a novel adult zebrafish model of mTBI. In this study, a rodent weight drop model of mTBI was adapted to the adult zebrafish. A memory test showed significant deficits in spatial memory in the mTBI group. We identified DEGs at 3 and 21 days postinjury (dpi) through RNA-sequencing analysis. The resulting DEGs were categorized according to gene ontology (GO) categories. At 3 dpi, GO categories consisted of peak injury response pathways. Significantly, at 21 dpi, GO categories consisted of neuroregeneration pathways. Ultimately, these results validate a novel zebrafish model of mTBI and elucidate significant DEGs of interest in CNS injury and neuroregeneration.	[Maheras, Amanda L.; Sun, Julia L.; Booker, Aleah R.; Thomason, Helen A.; Stanislaw, Lauren] Scripps Coll, Claremont, CA 91711 USA; [Dix, Brian; Carmo, Olivia M. S.; Young, Aleena E.; Gill, Vanessa N.; Ibrahim, Anastasia E.; Dallego, Jennifer C.] Claremont McKenna Coll, Claremont, CA 91711 USA; [Maheras, Amanda L.; Dix, Brian; Carmo, Olivia M. S.; Young, Aleena E.; Gill, Vanessa N.; Sun, Julia L.; Booker, Aleah R.; Thomason, Helen A.; Ibrahim, Anastasia E.; Stanislaw, Lauren; Dallego, Jennifer C.; Ngo, Cat N.; Spence, Rory D.] Keck Sci Dept, Claremont, CA 91711 USA; [Ngo, Cat N.] Harvey Mudd Coll, Claremont, CA 91711 USA; [Chen, Audrey] Univ Calif Irvine, Ayala Sch Biol Sci, Dept Neurobiol & Behav, Irvine, CA USA; [Fortini, Barbara K.] Keck Grad Inst, Sch Pharm, Claremont, CA 91711 USA		Spence, RD (corresponding author), Keck Sci Dept, Off 124, 925 N Mills Ave, Claremont, CA 91711 USA.	rory.spence@gmail.com		Fortini, Barbara/0000-0003-3230-2604; Carmo, Olivia M. S./0000-0002-0132-3843; Maheras, Amanda/0000-0003-0027-7440	Keck Science Department; Rose Hills Foundation; Libby Faculty-Student Collaboration Fund; Libby Faculty-Student Collaboration Fund, HHMI	Our funding was provided by start-up lab funds provided by the Keck Science Department. Student research support was provided by the Rose Hills Foundation, The Libby Faculty-Student Collaboration Fund, HHMI, and the Keck Science Department.	Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Arai S, 2007, P NATL ACAD SCI USA, V104, P2289, DOI 10.1073/pnas.0611167104; Barba-Escobedo PA, 2012, GENES BRAIN BEHAV, V11, P366, DOI 10.1111/j.1601-183X.2012.00770.x; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Collymore C, 2014, J AM ASSOC LAB ANIM, V53, P198; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Than-Trong E, 2015, GLIA, V63, P1406, DOI 10.1002/glia.22856; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Hansen MR, 2003, J NEUROSCI RES, V72, P169, DOI 10.1002/jnr.10551; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Ishida T, 2010, DEV BIOL, V340, P468, DOI 10.1016/j.ydbio.2010.01.036; Iturbide A, 2015, MOL CELL, V58, P755, DOI 10.1016/j.molcel.2015.04.012; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lee JC, 2002, J CELL BIOL, V158, P1051, DOI 10.1083/jcb.200112124; Lee SW, 2000, MOL MICROBIOL, V35, P1540, DOI 10.1046/j.1365-2958.2000.01824.x; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu YQ, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-141; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu KT, 2015, PFLUG ARCH EUR J PHY, V467, P1651, DOI 10.1007/s00424-014-1588-x; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Luo Y, 2017, SCI REP, V7, P1077; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Maisel M, 2007, STEM CELLS, V25, P1231, DOI 10.1634/stemcells.2006-0617; Martin A, 2015, EMBO J, V34, P1090, DOI 10.15252/embj.201489975; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Miller N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048865; Mokalled MH, 2016, SCIENCE, V354, P630, DOI 10.1126/science.aaf2679; Monnot MJ, 1999, DEV DYNAM, V214, P207, DOI 10.1002/(SICI)1097-0177(199903)214:3<207::AID-AJA4>3.0.CO;2-5; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mychasiuk R, 2014, JOVE-J VIS EXP, V94; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Piya S, 2012, FEBS LETT, V586, P4233, DOI 10.1016/j.febslet.2012.10.031; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Puhakka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172521; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Skaggs K, 2014, GLIA, V62, P2061, DOI 10.1002/glia.22726; Stewart AM, 2014, TRENDS NEUROSCI, V37, P264, DOI 10.1016/j.tins.2014.02.011; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Veth KN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001310; Wang XM, 2009, J CEREBR BLOOD F MET, V29, P1644, DOI 10.1038/jcbfm.2009.83; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhu DY, 2004, P NATL ACAD SCI USA, V101, P9453, DOI 10.1073/pnas.0401063101	65	16	16	0	7	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	JAN-FEB	2018	5	1							0208-17.2017	10.1523/ENEURO.0208-17.2017			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FS8FF	WOS:000422645100003	29302617	Green Published, gold			2022-02-06	
J	McDonald, S; Rushby, JA; Dalton, KI; Allen, SK; Parks, N				McDonald, Skye; Rushby, Jacqueline A.; Dalton, Katie I.; Allen, Samantha K.; Parks, Nicklas			The role of abnormalities in the corpus callosum in social cognition deficits after Traumatic Brain Injury	SOCIAL NEUROSCIENCE			English	Article						Traumatic brain injury; white matter; diffuse axonal injury; social cognition	MEDIAL PREFRONTAL CORTEX; UNDERSTANDING SARCASM; NEURAL BASIS; AGENESIS; PERCEPTION; DAMAGE; ADOLESCENTS; RECOGNITION; IMPAIRMENT; AWARENESS	The corpus callosum (CC) is vulnerable to severe traumatic brain injury (TB!). Social cognition requires integration of non-verbal and verbal information in order to understand social behaviour and may be compromised if the CC is damaged. 17 adults with severe, chronic TBI and 17 control participants underwent structural MRI and Diffusion Tensor Imaging. A region of interest analysis examined fractional anisotropy (FA) and mean diffusivity (MD) across regions of the CC. Performance on The Awareness of Social Inference Test (TASIT): part 1 (emotion recognition) and parts 2 and 3 (social inference), was examined in relation to FA and MD. Across participants, higher genu FA values were related to higher TASIT part 3 scores. Increased splenium FA was associated with better performance for TASIT parts 1-3. There was no association between DTI values and TASIT in the controls alone. In the TBI group, FA of the genu and splenium was correlated with TASIT part 3. The pattern of performance was similar when controlling for nonsocial cognitive ability. In conclusion, social information is complex and multi-modal requiring inter-hemispheric connection. People with TBI, regardless of focal grey matter injury, may lose social cognitive ability due to trauma related changes to the corpus callosum.	[McDonald, Skye; Rushby, Jacqueline A.; Dalton, Katie I.; Allen, Samantha K.; Parks, Nicklas] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia		McDonald, S (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Rushby, Jacqueline/D-1820-2010; McDonald, Skye/G-4118-2014	Rushby, Jacqueline/0000-0002-5018-638X; McDonald, Skye/0000-0003-0723-6094	National Health and Medical Research Council [Centre of Research Excellence in Brain Recovery] [1023043, 1081923]; Australian Research CouncilAustralian Research Council [1094083, 15010026]	Study funded by National Health and Medical Research Council [Centre of Research Excellence in Brain Recovery 1023043, Project Grant 1081923] and by the Australian Research Council [Discovery Project 1094083., Discovery Project 15010026].	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Brown WS, 2005, NEUROPSYCHOLOGIA, V43, P906, DOI 10.1016/j.neuropsychologia.2004.09.008; Burgess P.W., 1997, HAYLING BRIXTON TEST; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Honan CA, 2016, CLIN NEUROPSYCHOL, V30, P243, DOI 10.1080/13854046.2015.1136691; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Lacuey N, 2016, BRAIN STRUCT FUNCT, V221, P2695, DOI 10.1007/s00429-015-1065-0; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., LOSS NEURAL CONNECTI; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Mitchell JP, 2005, NEUROIMAGE, V28, P757, DOI 10.1016/j.neuroimage.2005.03.011; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Murray RJ, 2015, HUM BRAIN MAPP, V36, P1304, DOI 10.1002/hbm.22703; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Paul LK, 2004, ARCH CLIN NEUROPSYCH, V19, P215, DOI 10.1016/S0887-6177(03)00024-6; Paul LK, 2003, BRAIN LANG, V85, P313, DOI 10.1016/S0093-934X(03)00062-2; Paul LK, 2014, BRAIN, V137, P1813, DOI 10.1093/brain/awu070; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Reitan RM, 1992, TRAIL MAKING TEST; Shamay SG, 2002, BRAIN COGNITION, V48, P558, DOI 10.1006/brcg.2001.1417; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Symington SH, 2010, SOC NEUROSCI-UK, V5, P296, DOI 10.1080/17470910903462419; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	62	16	16	1	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-0919	1747-0927		SOC NEUROSCI-UK	Soc. Neurosci.		2018	13	4					471	479		10.1080/17470919.2017.1356370			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GF8UF	WOS:000432248300007	28712330				2022-02-06	
J	Owens, JA; Spitz, G; Ponsford, JL; Dymowski, AR; Willmott, C				Owens, Jacqueline Anne; Spitz, Gershon; Ponsford, Jennie Louise; Dymowski, Alicia Rhian; Willmott, Catherine			An investigation of white matter integrity and attention deficits following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; attention; processing speed; diffusion tensor imaging; tract-based spatial statistics	INFORMATION-PROCESSING SPEED; MEMORY; ASSOCIATION; DYSFUNCTION; DTI	Objective: This study aimed to investigate the association between white matter tracts and multiple aspects of attention and working memory deficits in a relatively acute traumatic brain injury (TBI) sample.Method: Neuropsychological measures of attention and working memory were administered to 20 participants with complicated mild-to-very severe TBI and 20 control participants. Tract-based spatial statistics was used to assess fractional anisotropy (FA) and mean diffusivity (MD) of white matter tracts for 15 TBI participants and 20 controls.Results: When compared to controls, participants with TBI were found to have lower FA (p<0.001) and higher MD (p<0.001) values in the majority of white matter tracts. TBI participants were also slower to complete tasks including Trail Making Test, Hayling, computerized Selective Attention Task, n-back and Symbol Digit Modalities Test (p<0.001), when compared to controls. When controlling for age and estimated premorbid intelligence, slowed information processing speed following TBI was found to be associated with FA values in the corpus callosum, superior longitudinal fasciculus, cingulum, inferior fronto-occipital fasciculi, corona radiata and cerebral white matter.Conclusion: The results highlight the widespread damage associated with TBI, as well as the impact of these alterations on information processing speed.	[Owens, Jacqueline Anne; Spitz, Gershon; Ponsford, Jennie Louise; Dymowski, Alicia Rhian; Willmott, Catherine] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Owens, Jacqueline Anne; Spitz, Gershon; Ponsford, Jennie Louise; Dymowski, Alicia Rhian; Willmott, Catherine] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Owens, Jacqueline Anne; Spitz, Gershon; Ponsford, Jennie Louise; Dymowski, Alicia Rhian; Willmott, Catherine] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia		Owens, JA (corresponding author), Monash Univ, 18 Innovat Walk Bldg 17,Clayton Campus, Melbourne, Vic 3800, Australia.	Jacqueline.Owens@monash.edu	Willmott, Catherine/AAA-5105-2019; Ponsford, Jennie/H-8341-2014; Spitz, Gershon/H-7755-2014	Willmott, Catherine/0000-0001-8517-9035; Ponsford, Jennie/0000-0003-0430-125X; Spitz, Gershon/0000-0002-7810-1480			Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Arlinghaus KA, 2005, TXB TRAUMATIC BRAIN, P59; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kourtidou P, 2013, J HEAD TRAUMA REHAB, V28, P433, DOI 10.1097/HTR.0b013e3182585d06; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lewis Frank D, 2013, J Spec Oper Med, V13, P56; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Nelson H.E., 1982, NATL ADULT READING T; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford J, 2004, COGNITIVE BEHAV REHA; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Reitan R, 1985, HALSTEAD REITAN NEUR; Ruff RM., 1995, RUFF 2 7 SELECTIVE A; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith A., 1991, SYMBOL DIGIT MODALIT; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wechsler D., 2008, WECHSLER ADULT INTEL; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	48	16	17	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	6					776	783		10.1080/02699052.2018.1451656			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE9BZ	WOS:000431526200012	29565696				2022-02-06	
J	Pupillo, E; Poloni, M; Bianchi, E; Giussani, G; Logroscino, G; Zoccolella, S; Chio, A; Calvo, A; Corbo, M; Lunetta, C; Marin, B; Mitchell, D; Hardiman, O; Rooney, J; Stevic, Z; di Poggio, MB; Filosto, M; Cotelli, MS; Perini, M; Riva, N; Tremolizzo, L; Vitelli, E; Damiani, D; Beghi, E				Pupillo, Elisabetta; Poloni, Marco; Bianchi, Elisa; Giussani, Giorgia; Logroscino, Giancarlo; Zoccolella, Stefano; Chio, Adriano; Calvo, Andrea; Corbo, Massimo; Lunetta, Christian; Marin, Benoit; Mitchell, Douglas; Hardiman, Orla; Rooney, James; Stevic, Zorica; di Poggio, Monica Bandettini; Filosto, Massimiliano; Cotelli, Maria Sofia; Perini, Michele; Riva, Nilo; Tremolizzo, Lucio; Vitelli, Eugenio; Damiani, Danira; Beghi, Ettore		EURALS Consortium	Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium	AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION			English	Article						Amyotrophic lateral sclerosis; trauma; case-control; Europe; epidemiology	MOTOR-NEURON DISEASE; PHYSICAL-ACTIVITY; ITALIAN SOCCER; BRAIN-INJURY; RISK-FACTOR; ENCEPHALOPATHY; ASSOCIATION; DIAGNOSIS; ALS	Objectives: To assess the association between amyotrophic lateral sclerosis (ALS) and previous traumatic events, age of trauma, and site of injury. Methods: A population-based case-control study was performed in five European countries (Italy, Ireland, France, United Kingdom, Serbia). Newly diagnosed ALS patients and matched controls were interviewed to collect relevant demographic factors and exposures. Key clinical features at diagnosis were collected in ALS patients. Trauma was any accidental event causing an injury. Injuries were dated and classified according to cause, severity, type, site, and complications. All exposures were censored five years before symptoms onset. Risks were computed as odds ratios (OR) with 95% confidence intervals (CI) using univariate and multivariate conditional logistic regression models. Results: Five hundred and seventy-five ALS patients and 1150 controls were interviewed. Disabling traumatic events predominated in the cases (OR 1.54 (95% CI 1.24-1.92)) and maintained significance after adjustment, with a significant gradient. A history of 2+head injuries was associated with an almost three-fold increased risk of ALS. The risk was almost two-fold when trauma occurred at age 35-54 years. Site of injury was uneventful. Conclusions: Traumatic events leading to functional disability or confined to the head are risk factors for ALS. Traumatic events experienced at age 35-54 years carry the highest risk.	[Pupillo, Elisabetta; Poloni, Marco; Bianchi, Elisa; Giussani, Giorgia; Damiani, Danira; Beghi, Ettore] IRCCS Ist Mario Negri, Lab Malattie Neurol, Milan, Italy; [Logroscino, Giancarlo; Zoccolella, Stefano] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Logroscino, Giancarlo] Univ Bari Aldo Moro, Pia Fdn Cardinale G Panico, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Lecce, Italy; [Chio, Adriano; Calvo, Andrea] Univ Turin, Ctr SLA, Dipartimento Neurosci Rita Levi Montalcini, Turin, Italy; [Corbo, Massimo] CCP, Dept Neurorehabil Sci, Milan, Italy; [Lunetta, Christian] ASST Grande Osped Metropolitano Niguarda, Fdn Serena Onlus, Ctr Clin NEMO, Milan, Italy; [Marin, Benoit] INSERM, Trop Neuroepidemiol, U1094, Limoges, France; [Marin, Benoit] Univ Limoges, UMR S 1094, Inst Neuroepidemiol & Trop Neurol, Trop Neuroepidemiol,CNRS FR GEIST 3503, Limoges, France; [Hardiman, Orla; Rooney, James] Trinity Coll Dublin, Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin, Ireland; [Stevic, Zorica] Clin Ctr Serbia, Sch Med, Clin Neurol, Belgrade, Serbia; [di Poggio, Monica Bandettini] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy; [Filosto, Massimiliano] Spedali Civil Brescia, Unit Neurol, Brescia, Italy; [Cotelli, Maria Sofia] Osped Esine, Dept Neurol, Brescia, Italy; [Perini, Michele] Osped Gallarate, Div Neurol, Gallarate, Italy; [Riva, Nilo] Ist Sci San Raffaele, Inst Expt Neurol, Div Neurosci, Dept Neurol, Milan, Italy; [Tremolizzo, Lucio] Univ Milano Bicocca, ALS Unit, Monza, Italy; [Vitelli, Eugenio] Azienda Osped Prov Lodi, Dept Neurol, Lodi, Italy		Beghi, E (corresponding author), IRCCS Mario Negri Inst Pharmacol Res, Lab Neurol Disorders, Via Giuseppe La Masa 19, I-20156 Milan, Italy.	ettore.beghi@marionegri.it	Cotelli, Maria Sofia/K-4534-2017; Rooney, James/J-9190-2019; Bianchi, Elisa/ABF-8173-2020; Bandettini di Poggio, Monica/H-2995-2018; Pupillo, Elisabetta/ABD-2698-2020; CALVO, Andrea/K-4141-2016; Giussani, Giorgia/AAA-8029-2020; zoccolella, stefano/AAA-2515-2020; Hardiman, Orla/Y-3441-2019; MARIN, Benoit/E-2356-2015; Giussani, Giorgia/E-8057-2017; Pupillo, Elisabetta/AAA-7385-2020; Beghi, Ettore/AAA-7426-2020; Filosto, Massimiliano/S-9446-2019; Logroscino, Giancarlo/K-5148-2016	Cotelli, Maria Sofia/0000-0002-7010-2809; Rooney, James/0000-0001-6346-0731; Bianchi, Elisa/0000-0002-0279-0128; Bandettini di Poggio, Monica/0000-0001-8871-1103; Pupillo, Elisabetta/0000-0003-4420-8076; CALVO, Andrea/0000-0002-5122-7243; Giussani, Giorgia/0000-0003-2460-3095; Hardiman, Orla/0000-0003-2610-1291; Giussani, Giorgia/0000-0003-2460-3095; Pupillo, Elisabetta/0000-0003-4420-8076; Beghi, Ettore/0000-0003-2542-0469; Filosto, Massimiliano/0000-0002-2852-7512; Perini, Michele/0000-0003-2311-9760; Chio, Adriano/0000-0001-9579-5341; Logroscino, Giancarlo/0000-0003-0423-3242	American ALS Association (ALSA) [1524]; European Community's Health Seventh Framework Programme (FP7) [259867]	This work was supported by the American ALS Association (ALSA)(#1524) and, in part, by the European Community's Health Seventh Framework Programme (FP7) 2007-2013 grant agreement 259867).	Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Beghi Ettore, 2006, Neuromuscul Disord, V16, P46, DOI 10.1016/j.nmd.2005.10.004; Belli S, 2005, EUR J EPIDEMIOL, V20, P237, DOI 10.1007/s10654-004-6879-7; Beretta S, 2003, LANCET NEUROL, V2, P656, DOI 10.1016/S1474-4422(03)00579-9; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Chase Alex, 2015, Nat Rev Neurol, V11, P309, DOI 10.1038/nrneurol.2015.83; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Gargiulo-Monachelli GM, 2014, HORM METAB RES, V46, P433, DOI 10.1055/s-0034-1371891; Harwood CA, 2009, AMYOTROPH LATERAL SC, V10, P191, DOI 10.1080/17482960802549739; KURLAND LT, 1992, J NEUROL SCI, V113, P133, DOI 10.1016/0022-510X(92)90241-C; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Pupillo E, 2012, EUR J NEUROL, V19, P1509, DOI 10.1111/j.1468-1331.2012.03723.x; Pupillo E, 2014, ANN NEUROL, V75, P708, DOI 10.1002/ana.24150; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Seals RM, 2016, AM J EPIDEMIOL, V183, P294, DOI 10.1093/aje/kwv169; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Turner MR, 2010, J NEUROL SCI, V288, P45, DOI 10.1016/j.jns.2009.10.010; Valenti M, 2005, EUR J NEUROL, V12, P223, DOI 10.1111/j.1468-1331.2004.00978.x; Veldink JH, 2005, NEUROLOGY, V64, P241, DOI 10.1212/01.WNL.0000149513.82332.5C	26	16	16	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2167-8421	2167-9223		AMYOTROPH LAT SCL FR	Amyotroph. Lateral Scher. Frontotemp. Degenerat.		2018	19	1-2					118	125		10.1080/21678421.2017.1386687			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FW9QQ	WOS:000425671500017	29063790				2022-02-06	
J	Ferguson, SA; Mouzon, BC; Lynch, C; Lungmus, C; Morin, A; Crynen, G; Carper, B; Bieler, G; Mufson, EJ; Stewart, W; Mullan, M; Crawford, F				Ferguson, Scott A.; Mouzon, Benoit C.; Lynch, Cillian; Lungmus, Carlyn; Morin, Alexander; Crynen, Gogce; Carper, Benjamin; Bieler, Gayle; Mufson, Elliott J.; Stewart, William; Mullan, Michael; Crawford, Fiona			Negative Impact of Female Sex on Outcomes from Repetitive Mild Traumatic Brain Injury in hTau Mice Is Age Dependent: A Chronic Effects of Neurotrauma Consortium Study	FRONTIERS IN AGING NEUROSCIENCE			English	Article						TBI; hTau; tau; neurobehavior; Neuropathology	GENDER-DIFFERENCES; MALE-RATS; ENVIRONMENTAL ENRICHMENT; COGNITIVE RECOVERY; CONTUSION INJURY; CLINICAL-TRIAL; TAU PATHOLOGY; MOUSE MODEL; HEAD-INJURY; PROGESTERONE	Traumatic brain injury (TBI) is a serious public health concernwhich strikes someone every 15 s on average in the US. Even mild TBI, which comprise as many as 75% of all TBI cases, carries long termconsequences. The effects of age and sex on long termoutcome from TBI is not fully understood, but due to the increased risk for neurodegenerative diseases after TBI it is important to understand how these factors influence the outcome from TBI. This study examined the neurobehavioral and neuropathological effects of age and sex on the outcome 15 days following repetitive mild traumatic brain injury (r-mTBI) in mice transgenic for human tau (hTau). These mice express the six human isoforms of tau but do not express endogenous murine tau and they develop tau pathology and memory impairment in an age-dependentmanner. After 5mild impacts, aged femalemice showed motor impairments that were absent in aged male mice, as well as younger animals. Conversely, aged female sham mice outperformed all other groups of aged mice in a Barnes maze spatial memory test. Pathologically, increases in IBA-1 and GFAP staining typically seen in this model of r-mTBI showed the expected increases with both injury and age, but phosphorylated tau stained with CP13 in the hippocampus (reduced in female sham mice compared to males) and PHF1 in the cortex (reduced in female TBI mice compared to male TBI mice) showed the only histological signs of sex-dependent differences in these mice.	[Ferguson, Scott A.; Mouzon, Benoit C.; Lynch, Cillian; Lungmus, Carlyn; Morin, Alexander; Crynen, Gogce; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Sarasota, FL 34243 USA; [Ferguson, Scott A.; Mouzon, Benoit C.; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Carper, Benjamin; Bieler, Gayle] RTI Int, Res Triangle Pk, NC USA; [Mufson, Elliott J.] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Stewart, William] Queen Elizabeth Glasgow Univ Hosp, Glasgow, Lanark, Scotland; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland		Ferguson, SA (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.; Ferguson, SA (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.	sferguson@roskampinstitute.org	Carper, Benjamin A/L-3433-2017	Carper, Benjamin A/0000-0001-5882-2232; Stewart, William/0000-0003-2199-2582	U.S. Department of Veterans Affairs [Chronic Effects of Neurotrauma Consortium] [W81XWH-13-2-0095]; U.S. Army Medical Research Acquisition Activity, Chandler Street, Fort Detrick MD [21702-5014]; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	This material is based upon work supported by the U.S. Army Medical Research and Material Command and from the U.S. Department of Veterans Affairs [Chronic Effects of Neurotrauma Consortium] under Award No. W81XWH-13-2-0095. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the U.S. Government, or the U.S. Department of Veterans Affairs, and no official endorsement should be inferred.	Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; Evans TM, 2015, NEUROSCIENCE, V298, P410, DOI 10.1016/j.neuroscience.2015.04.041; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gizzi M, 1996, ARCH NEUROL-CHICAGO, V53, P1299, DOI 10.1001/archneur.1996.00550120111024; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lebouvier T, 2008, BBA-MOL CELL RES, V1783, P188, DOI 10.1016/j.bbamcr.2007.11.005; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Paris D, 2014, J BIOL CHEM, V289, P33927, DOI 10.1074/jbc.M114.608091; Pelligrino DA, 1998, NEUROREPORT, V9, P3285, DOI 10.1097/00001756-199810050-00026; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Shi J, 1998, BRAIN RES, V810, P87, DOI 10.1016/S0006-8993(98)00888-9; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052	50	16	16	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	DEC 22	2017	9								416	10.3389/fnagi.2017.00416			15	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	FQ8IC	WOS:000418605300001	29311903	Green Published, Green Accepted, gold			2022-02-06	
J	Fletcher-Sandersjoo, A; Thelin, EP; Bartek, J; Elmi-Terander, A; Broman, M; Bellander, BM				Fletcher-Sandersjoo, Alexander; Thelin, Eric Peter; Bartek, Jiri, Jr.; Elmi-Terander, Adrian; Broman, Mikael; Bellander, Bo-Michael			Management of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation (ECMO): An observational cohort study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; COMPLICATIONS; DIAGNOSIS; SCALE	Background Intracranial hemorrhage (ICH) is a common complication in adults treated with extracorporeal membrane oxygenation (ECMO). The aim of this study was to identify predictors of outcome and investigate intervention strategies following ICH development in ECMO-treated adult patients. Methods We conducted a retrospective review of adult patients (>= 18 years) who developed an ICH during ECMO treatment at the Karolinska University Hospital (Stockholm, Sweden) between September 2005 and May 2017. Outcome was assessed by 30-day mortality and Glasgow Outcome Scale (GOS) after 6 months. The statistical analysis was supplemented by a case series of patients who were surgically treated for an ICH. Results Sixty-five patients developed an ICH during ECMO treatment. 30-day mortality was 74% (n = 48), and was significantly associated with low level of consciousness at ICH diagnosis (p = 0.036), presence of intraparenchymal hematoma (IPH) (p = 0.049), IPH volume (p = 0.002), presence of intraventricular hemorrhage (p = 0.001), subarachnoid hemorrhage Fisher grade (p<0.001), hydrocephalus (p<0.001), midline shift (p = 0.026) and absent basal cisterns (p<0.001). Among the 30-day survivors (n = 17), 63% (n = 10) had favorable neurological outcome (GOS 4-5) after six months. Five patients were surgically treated for their ICH, some with dire hemorrhagic consequences, however one patient made a complete recovery. Conclusions ICH in adult ECMO patients is associated with a high mortality rate. Outcome predictors can help to identify patients where ICH treatment is indicated. Treating a patient with an ICH during ECMO represents an intricate balance between pro- and anticoagulatory demands. Furthermore, surgical treatment is associated with several risks but may be indicated in life-threatening lesions. Prospective studies are warranted.	[Fletcher-Sandersjoo, Alexander; Bartek, Jiri, Jr.; Elmi-Terander, Adrian; Bellander, Bo-Michael] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden; [Fletcher-Sandersjoo, Alexander; Thelin, Eric Peter; Bartek, Jiri, Jr.; Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Thelin, Eric Peter] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England; [Bartek, Jiri, Jr.] Rigshosp, Copenhagen Univ Hosp, Dept Neurosurg, Copenhagen, Denmark; [Bartek, Jiri, Jr.] Karolinska Inst, Dept Med, Stockholm, Sweden; [Broman, Mikael] Karolinska Univ Hosp, Dept Pediat Perioperat Med & Intens Care, ECMO Ctr Karolinska, Stockholm, Sweden; [Broman, Mikael] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden		Fletcher-Sandersjoo, A (corresponding author), Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden.; Fletcher-Sandersjoo, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	alexander.fletcher-sandersjoo@stud.ki.se	Elmi-Terander, Adrian/AAC-7997-2019; Fletcher-Sandersjoo, Alexander/AAH-4198-2019; Thelin, Eric Peter/K-2144-2012	Elmi-Terander, Adrian/0000-0002-3776-6136; Fletcher-Sandersjoo, Alexander/0000-0002-3558-3045; Thelin, Eric Peter/0000-0002-2338-4364; Broman, Mikael/0000-0003-4124-4581; Bartek Jr., Jiri/0000-0002-2911-1914	Svenska Lakaresallskapet (SE) [SLS-587221]	This was supported by Svenska Lakaresallskapet (SE) (SLS-587221) to EPT The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubron C, 2016, ANN INTENSIVE CARE, P6; Aubron C, 2013, CRIT CARE, V17, DOI 10.1186/cc12681; Broman LM, 2016, FRONT PEDIATR, P4; Broman LM, 2015, CRIT CARE CRITICAL C, P19; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Factora FNF, 2011, J NEUROSURG ANESTH, V23, P30, DOI 10.1097/ANA.0b013e3181eee55e; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Friesenecker BE, 2005, ACTA NEUROCHIR, V147, P993, DOI 10.1007/s00701-005-0568-5; Gerke AK, 2015, BMC RES NOTES, P8; Hampton CR, 2002, ARTIF ORGANS, V26, P902, DOI 10.1046/j.1525-1594.2002.07122.x; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; JENNETT B, 1975, LANCET, V1, P480; Kasirajan V, 1999, EUR J CARDIO-THORAC, V15, P508, DOI 10.1016/S1010-7940(99)00061-5; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kraus M, 2015, OPEN J ANESTHESIOL, V5, P251; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Lantigua H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1036-0; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; Lidegran MK, 2007, ACAD RADIOL, V14, P62, DOI 10.1016/j.acra.2006.10.004; Lockie CJA, 2017, CRIT CARE MED, V45, P1642, DOI 10.1097/CCM.0000000000002579; Luyt CE, 2016, INTENS CARE MED, V42, P897, DOI 10.1007/s00134-016-4318-3; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Makdisi G, 2015, J THORAC DIS, V7, pE166, DOI 10.3978/j.issn.2072-1439.2015.07.17; McCarthy FH, 2015, SEMIN THORAC CARDIOV, P27; Nasr DM, 2015, J CLIN NEUROL, V11, P383, DOI 10.3988/jcn.2015.11.4.383; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Omar HR, 2016, ASAIO J, V62, P634, DOI 10.1097/MAT.0000000000000368; Safatli Diaa A, 2016, Surg Neurol Int, V7, pS510, DOI 10.4103/2152-7806.187493; Sandersjoo AF, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0223-2; Sauer CM, 2015, ASAIO J, V61, P31, DOI 10.1097/MAT.0000000000000160; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368	34	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190365	10.1371/journal.pone.0190365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	WOS:000418587400115	29267368	Green Published, gold, Green Submitted			2022-02-06	
J	Caplain, S; Blancho, S; Marque, S; Montreuil, M; Aghakhani, N				Caplain, Sophie; Blancho, Sophie; Marque, Sebastien; Montreuil, Michele; Aghakhani, Nozar			Early Detection of Poor Outcome after Mild Traumatic Brain Injury: Predictive Factors Using a Multidimensional Approach a Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; assessment score; human; post-concussion syndrome; prognostic factors	POST-CONCUSSION SYMPTOMS; QUALITY-OF-LIFE; HEAD-INJURY; PERSISTENT SYMPTOMS; WORKING-MEMORY; POPULATION; DYSFUNCTION; ACTIVATION; DEPRESSION; SEQUELAE	Mild traumatic brain injury (MTBI) is a common condition within the general population, usually with good clinical outcome. However, in 10-25% of cases, a post-concussive syndrome (PCS) occurs. Identifying early prognostic factors for the development of PCS can ensure widespread clinical and economic benefits. The aim of this study was to demonstrate the potential value of a comprehensive neuropsychological evaluation to identify early prognostic factors following MTBI. We performed a multi-center open, prospective, longitudinal study that included 72 MTBI patients and 42 healthy volunteers matched for age, gender, and socioeconomic status. MTBI patients were evaluated 8-21 days after injury, and 6 months thereafter, with a full neurological and psychological examination and brain MRI. At 6 months follow-up, MTBI patients were categorized into two subgroups according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) as having either favorable or unfavorable evolution (UE), corresponding to the presence of major or mild neurocognitive disorder due to traumatic brain injury. Univariate and multivariate logistical regression analysis demonstrated the importance of patient complaints, quality of life, and cognition in the outcome of MTBI patients, but only 6/23 UE patients were detected early via the multivariate logistic regression model. Using several variables from each of these three categories of variables, we built a model that assigns a score to each patient presuming the possibility of UE. Statistical analyses showed this last model to be reliable and sensitive, allowing early identification of patients at risk of developing PCS with 95.7% sensitivity and 77.6% specificity.	[Caplain, Sophie; Montreuil, Michele] Univ Paris 08, Lab Psychopathol & Neuropsychol, St Denis, France; [Blancho, Sophie] Inst Rech Moelle Epiniere & Encephale, Paris, France; [Marque, Sebastien] Capionis Res, Bordeaux, France; [Aghakhani, Nozar] Bicetre Univ Hosp, AP HP, Dept Neurosurg, Le Kremlin Bicetre, France		Aghakhani, N (corresponding author), Bicetre Univ Hosp, AP HP, Dept Neurosurg, Le Kremlin Bicetre, France.	nozar.aghakhani@aphp.fr	aghakhani, nozar/ABF-7908-2021	aghakhani, nozar/0000-0001-8389-8167	French Garantie, "Mutuelle des Fonctionnaires" (GMF)	The authors thank all study participants. They are also grateful to the French Garantie, "Mutuelle des Fonctionnaires" (GMF), which funded the study, and to the "Institut de Recherche sur la Moelle Epiniere et l'Encephale (IRME)" which initiated it. The authors also express their sincere appreciation to the study group participants Arnaud Messe, Habib Benali, Stephane Lehericy, and Richard Levy from LIB (Laboratoire d'Imagerie Fonctionnelle, Inserm, UPMC Universite Paris 06, UMRS 678, Paris, France) and CENIR (Center for Neuroimaging Research, Paris, France). Authors are grateful to Pr Parsa, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, for english editing of the manuscript.	American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; [Anonymous], 2014, J HEAD TRAUMA REHABI; Azouvi P, 2001, REV NEUROPSYCHOL, V11, P383; Azouvi P, 2002, NEUROPSYCHOLOGIE LAT, P193; Brickenkamp R, 1994, TEST D2 AUFMERKSAMKE; Bryant RA, 2010, SLEEP, V33, P69, DOI 10.1093/sleep/33.1.69; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Hardy P, 1988, PSYCHIATRIE S, V79, P19; HART RP, 1987, J NEUROL NEUROSUR PS, V50, P1263, DOI 10.1136/jnnp.50.10.1263; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; LEMAN S, 2004, ANXIETE ANXIOLYTIQUE, P71; MACLEOD C, 1991, International Review of Psychiatry, V3, P279, DOI 10.3109/09540269109110407; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schweitzer M.B., 1990, MANUEL INVENTAIRE AN; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Steptoe A., 1991, ADAPTATION ENV, P150; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Thuillard F, 1983, Rev Med Suisse Romande, V103, P311; TRICHARD C, 1995, PSYCHOL MED, V25, P79, DOI 10.1017/S0033291700028105; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	16	16	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 12	2017	8								666	10.3389/fneur.2017.00666			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FP6HE	WOS:000417725000001	29312112	gold, Green Published			2022-02-06	
J	Karri, J; Cardenas, JC; Matijevic, N; Wang, YW; Choi, S; Zhu, L; Cotton, BA; Kitagawa, R; Holcomb, JB; Wade, CE				Karri, Jay; Cardenas, Jessica C.; Matijevic, Nena; Wang, Yao-Wei; Choi, Sangbum; Zhu, Liang; Cotton, Bryan A.; Kitagawa, Ryan; Holcomb, John B.; Wade, Charles E.			EARLY FIBRINOLYSIS ASSOCIATED WITH HEMORRHAGIC PROGRESSION FOLLOWING TRAUMATIC BRAIN INJURY	SHOCK			English	Article						Fibrinolysis; progressive hemorrhagic injury; traumatic brain injury	INTRACEREBRAL HEMORRHAGE; COAGULOPATHY; COAGULATION; MORTALITY; PLASMA; HYPERFIBRINOLYSIS; TRANSFUSION; PARAMETERS; MODERATE; PATIENT	Background: Progressive hemorrhagic injury (PHI) is common in patients with severe traumatic brain injury (TBI) and is associated with worse outcomes. PHI pathophysiology remains poorly understood and difficult to predict. We performed an exploratory analysis aimed at identifying markers in need of further investigation to establish their predictive value in PHI following TBI. Methods: We performed a retrospective chart review of prospectively collected data from 424 highest-level activation trauma patients from January 2012 through December 2013. Patients with severe TBI, defined as head acute injury scale (AIS) score >= 3 and intracranial hemorrhage (ICH) on initial CT, were included. Stable hemorrhage (SH) and PHI was determined by measuring ICH expansion on repeat CT within 6 h. Of 424 patients evaluated, 72 met inclusion criteria. Twenty-five patients had repeated samples available and were dichotomized into SH (n = 6, 24%) and PHI (n = 19, 76%). Levels of plasminogen, urokinase and tissue plasminogen activators (uPA, tPA), plasminogen activator inhibitor-1, alpha 2-antiplasmin (alpha 2AP), and D-Dimers (DD) were measured upon admission and 2, 4, and 6 h later. Results: Longitudinal models identified tPA and DD as positively associated and alpha 2AP inversely associated with PHI. High DD levels are strongly associated with developing PHI over time. Using the full TBI cohort of N = 72, receiver operating curve analysis provided a cutoff of 3.04 mu g/mL admission DD to distinguish SH from PHI patients. Conclusion: Our findings support a relationship between markers of fibrinolysis in polytrauma patients with severe TBI and PHI, warranting further investigation into the potential for novel, predictive biomarkers.	[Karri, Jay; Cardenas, Jessica C.; Matijevic, Nena; Wang, Yao-Wei; Cotton, Bryan A.; Holcomb, John B.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Ctr Translat Injury Res, McGovern Med Sch, Houston, TX 77030 USA; [Choi, Sangbum; Zhu, Liang] Univ Texas Hlth Sci Ctr Houston, Div Clin & Translat Sci, Dept Internal Med, McGovern Med Sch, Houston, TX 77030 USA; [Kitagawa, Ryan] Univ Texas Hlth Sci Ctr Houston, Vivian L Smith Dept Neurosurg, McGovern Med Sch, Houston, TX 77030 USA		Wade, CE (corresponding author), Dept Surg, 6431 Fannin,MSB 5-204, Houston, TX 77030 USA.; Wade, CE (corresponding author), Ctr Translat Injury Res CeTIR, 6431 Fannin,MSB 5-204, Houston, TX 77030 USA.	Charles.E.Wade@uth.tmc.edu		holcomb, john/0000-0001-8312-9157			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Cardenas JC, 2014, SHOCK, V41, P514, DOI 10.1097/SHK.0000000000000161; Cotton BA, 2012, J TRAUMA ACUTE CARE, V73, P365, DOI 10.1097/TA.0b013e31825c1234; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; L. S. o. H. a. T. Medicine, 2015, CLIN RAND ANT SIGN H; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Medcalf RL, 2015, BLOOD, V125, P2457, DOI 10.1182/blood-2015-02-629808; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; N. T. R. Institute, 2016, PRE HOSP ANT TRAUM C; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Sanchez CM, 2004, NEUROLOGIA, V19, P44; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Washington U. o., 2015, PREH TRAN ACID US TR; WINTER JP, 1989, ANN EMERG MED, V18, P553, DOI 10.1016/S0196-0644(89)80842-X; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	27	16	18	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	DEC	2017	48	6					644	650		10.1097/SHK.0000000000000912			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	FT6WN	WOS:000423294600007	28614144				2022-02-06	
J	Leva, G; Klein, C; Benyounes, J; Halle, F; Bihel, F; Collongues, N; De Seze, J; Mensah-Nyagan, AG; Patte-Mensah, C				Leva, Geraldine; Klein, Christian; Benyounes, Jeremie; Halle, Francois; Bihel, Frederic; Collongues, Nicolas; De Seze, Jerome; Mensah-Nyagan, Ayikoe-Guy; Patte-Mensah, Christine			The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Multiple sclerosis; Experimental autoimmune encephalomyelitis; XBD173; TSPO; Neurodegeneration; Neuroinflammation	18 KDA TSPO; PERIPHERAL BENZODIAZEPINE-RECEPTORS; TRAUMATIC BRAIN-INJURY; THERAPEUTIC TARGET; CELL-DEATH; ALLOPREGNANOLONE; PROGESTERONE; NEUROSTEROIDS; EXPRESSION; MICROGLIA	Multiple sclerosis (MS) is a severe autoimmune disease characterized by inflammatory, demyelinating and neurodegenerative components causing motor, sensory, visual and/or cognitive symptoms. The relapsing-remitting MS affecting 85% of patients is reliably mimicked by the proteolipid-protein (PLP)-induced experimental autoimmune encephalomyelitis (EAE) SJL/J-mouse model. Significant progress was made for MS treatment but the development of effective therapies devoid of severe side-effects remains a great challenge. Here, we combine clinical, behavioral, histopathological, biochemical and molecular approaches to demonstrate that low and well tolerated doses (10-20 mg/kg) of TSPO ligand XBD173 (Emapunil) efficiently ameliorate clinical signs and neuropathology of PLP-EAE mice. In addition to the conventional clinical scoring of symptoms, we applied the robust behavioral Catwalk-method to confirm that XBD173 (10 mg/kg) increases the maximum contact area parameter at EAE-disease peak, indicating an improvement/recovery of motor functions. Consistently, histopathological studies coupled with microscope-cellSens quantification and RT-qPCR analyzes showed that XBD173 prevented demyelination by restoring normal protein and mRNA levels of myelin basic protein that was significantly repressed in PLP-EAE mice spinal cord and brain. Interestingly, ELISA-based measurement revealed that XBD173 increased allopregnanolone concentrations in PLP-EAE mice spinal and brain tissues. Furthermore, flow cytometry assessment demonstrated that XBD173 therapy decreased serum level of pro-inflammatory cytokines, including interleukin-17A, Interleukin-6 and tumor-necrosis-factor alpha in PLP-EAE mice. As the optimal XBD173 dosing exerting the maximal beneficial action in EAE mice is the lower 10 mg/kg dose, the paper opens interesting perspectives for the development of efficient and safe therapies against MS with slight or no side-effects.	[Leva, Geraldine; Klein, Christian; Benyounes, Jeremie; Collongues, Nicolas; De Seze, Jerome; Mensah-Nyagan, Ayikoe-Guy; Patte-Mensah, Christine] Univ Strasbourg, FMTS, INSERM U1119,Fac Med, Biopathol Myelin Neuroprotect & Strategies Therap, Bettiment 3,11 Rue Humann, F-67000 Strasbourg, France; [Halle, Francois; Bihel, Frederic] CNRS UMR 7200, Fac Pharm Strasbourg, LIT, 74 Route Rhin,CS 60024, F-67401 Illkirch Graffenstaden, France		Mensah-Nyagan, AG; Patte-Mensah, C (corresponding author), Univ Strasbourg, FMTS, INSERM U1119,Fac Med, Biopathol Myelin Neuroprotect & Strategies Therap, Bettiment 3,11 Rue Humann, F-67000 Strasbourg, France.	gmensah@unistra.fr; cmensah@unistra.fr	BIHEL, Frederic JJ/B-2895-2008; Patte-Mensah, Christine/D-5961-2011; KLEIN, christian JP/J-9893-2016	BIHEL, Frederic JJ/0000-0002-4122-0929; Patte-Mensah, Christine/0000-0002-9970-8214; KLEIN, christian JP/0000-0002-7580-8536; Halle, Francois/0000-0002-5324-8160	Institut National de la Sante et de la Recherche Medicale (INSERM, France)Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Strasbourg (France)	This work was supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM, France) and Universite de Strasbourg (France). Authors would like to thank Dr. Laurence Meyer for the useful advises on the Catwalk test and Dr. Susana Brun for the helpful discussions on flow cytometry.	Akdis M, 2016, J ALLERGY CLIN IMMUN, V138, P984, DOI 10.1016/j.jaci.2016.06.033; Andrabi SS, 2017, DIS MODEL MECH, V10, P787, DOI 10.1242/dmm.025692; Baulieu EE, 1999, ACTA PAEDIATR, V88, P78, DOI 10.1111/j.1651-2227.1999.tb14408.x; Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Borowicz Kinga K, 2011, Front Endocrinol (Lausanne), V2, P50, DOI 10.3389/fendo.2011.00050; Brinton RD, 2013, NAT REV ENDOCRINOL, V9, P241, DOI 10.1038/nrendo.2013.31; Caruso D, 2014, J NEUROCHEM, V130, P591, DOI 10.1111/jnc.12745; Chen SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07458; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Costa B, 2016, ACS CHEM NEUROSCI, V7, P1041, DOI 10.1021/acschemneuro.6b00149; COSTA E, 1994, J STEROID BIOCHEM, V49, P385, DOI 10.1016/0960-0760(94)90284-4; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; DEBER CM, 1991, CLIN BIOCHEM, V24, P113, DOI 10.1016/0009-9120(91)90421-A; Desmond JE, 2010, BEHAV NEUROL, V23, P1, DOI 10.3233/BEN-2010-0272; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Eckstein C, 2016, SURV OPHTHALMOL, V61, P318, DOI 10.1016/j.survophthal.2015.12.001; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Frid K, 2015, ANN CLIN TRANSL NEUR, V2, P711, DOI 10.1002/acn3.207; Gandolfo P, 2000, J NEUROCHEM, V75, P701, DOI 10.1046/j.1471-4159.2000.0750701.x; Garay LI, 2012, NEUROSCIENCE, V226, P40, DOI 10.1016/j.neuroscience.2012.09.032; GARNIER M, 1994, J BIOL CHEM, V269, P22105; Giatti S, 2012, J MOL ENDOCRINOL, V49, pR125, DOI 10.1530/JME-12-0127; Haines JD, 2011, MT SINAI J MED, V78, P231, DOI 10.1002/msj.20246; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Hussain R, 2013, BRAIN, V136, P132, DOI 10.1093/brain/aws284; INOUYE H, 1991, J NEUROSCI RES, V28, P1, DOI 10.1002/jnr.490280102; Irwin RW, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00203; Kansal K, 2017, BRAIN, V140, P707, DOI 10.1093/brain/aww327; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Karout M, 2016, J NEUROCHEM, V139, P782, DOI 10.1111/jnc.13693; Kipp M, 2017, BRAIN PATHOL, V27, P123, DOI 10.1111/bpa.12454; Kita A, 2004, BRIT J PHARMACOL, V142, P1059, DOI 10.1038/sj.bjp.0705681; Kita A, 2009, PROG NEURO-PSYCHOPH, V33, P1040, DOI 10.1016/j.pnpbp.2009.05.018; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuwabara T, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3908061; Lassmann H, 2014, EXP NEUROL, V262, P2, DOI 10.1016/j.expneurol.2013.12.003; Leitner H, 2010, MED HYPOTHESES, V75, P229, DOI 10.1016/j.mehy.2010.02.028; Luchtman DW, 2014, CYTOKINE GROWTH F R, V25, P403, DOI 10.1016/j.cytogfr.2014.07.013; Massella A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-12; McNamara C, 2017, AM J NEURORADIOL, V38, P1672, DOI 10.3174/ajnr.A5148; Mensah-Nyagan AG, 1999, PHARMACOL REV, V51, P63; Messmer K, 1998, NEUROSCI LETT, V241, P53, DOI 10.1016/S0304-3940(97)00967-1; Milo R, 2010, AUTOIMMUN REV, V9, pA387, DOI 10.1016/j.autrev.2009.11.010; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; Nothdurfter C, 2012, J NEUROENDOCRINOL, V24, P82, DOI 10.1111/j.1365-2826.2011.02166.x; Panzica GC, 2012, J NEUROENDOCRINOL, V24, P1, DOI 10.1111/j.1365-2826.2011.02265.x; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Papadopoulos V, 2015, MOL CELL ENDOCRINOL, V408, P90, DOI 10.1016/j.mce.2015.03.014; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Patte-Mensah C, 2014, PROG NEUROBIOL, V113, P70, DOI 10.1016/j.pneurobio.2013.07.004; Pawlikowski M, 1993, PERIPHERAL BENZODIAZ, P125; Peterburs J, 2016, CURR OPIN NEUROBIOL, V40, P38, DOI 10.1016/j.conb.2016.06.011; Porcu P, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12351; Qi XL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/162934; Ravikumar B, 2016, NEUROPHARMACOLOGY, V108, P229, DOI 10.1016/j.neuropharm.2016.03.053; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Schaeffer V, 2010, PROG NEUROBIOL, V92, P33, DOI 10.1016/j.pneurobio.2010.04.009; Scholz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0422-5; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Shan K, 2017, CELL MOL IMMUNOL, V14, P909, DOI 10.1038/cmi.2017.12; Siddiqui Shazia Veqar, 2008, Indian J Psychiatry, V50, P202, DOI 10.4103/0019-5545.43634; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Versijpt J, 2005, MULT SCLER J, V11, P127, DOI 10.1191/1352458505ms1140oa; Vlodavsky E, 2007, J NEURO-ONCOL, V81, P1, DOI 10.1007/s11060-006-9199-9; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Yang T, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1642-2; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yasuno F, 2008, BIOL PSYCHIAT, V64, P835, DOI 10.1016/j.biopsych.2008.04.021; Yates MA, 2010, J NEUROIMMUNOL, V220, P136, DOI 10.1016/j.jneuroim.2010.01.013; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079; Zhang MR, 2007, J NUCL MED, V48, P1853, DOI 10.2967/jnumed.107.043505; Zhang YN, 2017, CLIN SCI, V131, P297, DOI 10.1042/CS20160547	78	16	16	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	DEC	2017	1863	12					3016	3027		10.1016/j.bbadis.2017.09.007			12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FN1SH	WOS:000415771000002	28899788	Bronze			2022-02-06	
J	Rajan, TS; Diomede, F; Bramanti, P; Trubiani, O; Mazzon, E				Rajan, Thangavelu Soundara; Diomede, Francesca; Bramanti, Placido; Trubiani, Oriana; Mazzon, Emanuela			Conditioned medium from human gingival mesenchymal stem cells protects motor-neuron-like NSC-34 cells against scratch-injury-induced cell death	INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY			English	Article						apoptosis; gingival mesenchymal stem cells conditioned medium; in vitro CNS injury model; inflammation; neurotrophic factors; NSC-34 cells; oxidative stress	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; IN-VITRO; PERIODONTAL-LIGAMENT; CORTICAL-NEURONS; SCIATIC-NERVE; APOPTOSIS; MODEL; REGENERATION; MYELINATION	Neuronal cell death is a normal process during central nervous system (CNS) development and is also involved in the death of motor neurons in diverse spinal motor neuron degenerative diseases. Here, we investigated the neuroprotective effect of secretory factors released from human gingival mesenchymal stem cells (hGMSCs) in mechanically injured murine motor-neuron-like NSC-34 cells. The cells were exposed to scratch injury and the markers for apoptosis and oxidative stress were examined. Immunocytochemistry results showed that proapoptotic markers cleaved caspase-3 and Bax were elevated while anti-apoptotic protein Bcl-2 was suppressed in scratch-injured NSC-34 cells. Oxidative stress markers SOD-1, inducible nitric oxide synthase (iNOS), Cox-2, and proinflammatory cytokine tumor necrosis factor alpha (TNF-) were activated. Conditioned medium (CM) derived from hGMSCs (hGMSC-CM) significantly blocked the cell death by suppressing SOD-1, iNOS, TNF-, cleaved caspase-3, and Bax. Bcl-2 and anti-inflammatory cytokine anti-interleukin 10 (IL-10) were increased in hGMSC-CM-treated injured cells. Moreover, hGMSC-CM treatment upregulated neurotrophins anti-brain-derived neurotrophic factor (BDNF) and NT3. Western blot data of hGMSC-CM revealed the presence of neurotrophins nerve growth factor (NGF), NT3, anti-inflammatory cytokines IL-10, and transforming growth factor beta (TGF-), suggesting their positive role to elicit neuroprotection. Our results propose that hGMSC-CM may serve as a simple and potential autologous therapeutic tool to treat motor neuron injury.	[Rajan, Thangavelu Soundara; Bramanti, Placido; Mazzon, Emanuela] IRCCS Ctr Neurolesi Bonino Pulejo, Via Prov Palermo, I-98124 Messina, Italy; [Diomede, Francesca; Trubiani, Oriana] G dAnnnzio Univ Chieti Pescara, Dept Med Oral & Biotechnol Sci, Stem Cells & Regenerat Med Lab, Chieti, Italy		Mazzon, E (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Via Prov Palermo, I-98124 Messina, Italy.	emazzon.irccs@gmail.com	Rajan, Thangavelu Soundara/J-9840-2016; Bramanti, Placido/K-5117-2016; Diomede, Francesca/AAL-6840-2020; Mazzon, Emanuela/AAL-4334-2020; Gao, Jing/M-8264-2018	Rajan, Thangavelu Soundara/0000-0001-8728-6176; Diomede, Francesca/0000-0002-0384-6509; mazzon, emanuela/0000-0002-5073-717X	IRCCS Centro Neurolesi "Bonino-Pulejo," Messina, Italy	This study has been supported by current research funds 2016 of IRCCS Centro Neurolesi "Bonino-Pulejo," Messina, Italy.	Ahmed NEB, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8102478; Aly LAA, 2015, WORLD J STEM CELLS, V7, P1047, DOI 10.4252/wjsc.v7.i7.1047; Bansal Ramta, 2015, J Nat Sci Biol Med, V6, P29, DOI 10.4103/0976-9668.149074; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen H, 2001, INVEST OPHTH VIS SCI, V42, P966; Citron BA, 1997, NEUROSCI LETT, V230, P25, DOI 10.1016/S0304-3940(97)00468-0; Dasari Venkata Ramesh, 2014, World J Stem Cells, V6, P120, DOI 10.4252/wjsc.v6.i2.120; Diomede F, 2017, STEM CELLS INT, V2017, DOI DOI 10.1155/2017/5651287; Ernfors P, 1996, NAT MED, V2, P463, DOI 10.1038/nm0496-463; Fawzy El-Sayed KM, 2016, GEM STEM CELLS INT, V2016, DOI DOI 10.1155/2016/7154327; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Giacoppo S, 2017, EUROPEAN J HISTOCHEM, V61; Giacoppo S, 2017, FASEB J, V31, P5592, DOI 10.1096/fj.201700524R; Hajivalili M, 2016, CURR STEM CELL RES T, V11, P41, DOI 10.2174/1574888X10666150902095031; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Konala VBR, 2016, CYTOTHERAPY, V18, P13, DOI 10.1016/j.jcyt.2015.10.008; Libro R, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00559; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Ma J, 2016, AM J TRANSL RES, V8, P1895; Ma YH, 2012, NEUROSCI LETT, V510, P14, DOI 10.1016/j.neulet.2011.12.061; Maier O, 2013, NEUROCHEM INT, V62, P1029, DOI 10.1016/j.neuint.2013.03.008; Matusica D, 2008, J NEUROSCI RES, V86, P553, DOI 10.1002/jnr.21507; McCombe PA, 2011, CURR MOL MED, V11, P246; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mekhemar MK, 2018, CELL IMMUNOL, V326, P60, DOI 10.1016/j.cellimm.2017.01.007; Park YJ, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9305986; Payette DJ, 2008, INT J CLIN EXP PATHO, V1, P44; Rajan TS, 2017, J CELL BIOCHEM, V118, P819, DOI 10.1002/jcb.25757; Rajan TS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38743; Rajan TS, 2016, EXP CELL RES, V349, P152, DOI 10.1016/j.yexcr.2016.10.008; Sathasivam S, 2005, LANCET NEUROL, V4, P500, DOI 10.1016/S1474-4422(05)70142-3; Sharpe PT, 2016, DEVELOPMENT, V143, P2273, DOI 10.1242/dev.134189; Soler-Botija C, 2002, BRAIN, V125, P1624, DOI 10.1093/brain/awf155; Trubiani O, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0253-4; Trubiani O, 2015, TISSUE ENG PART C-ME, V21, P52, DOI [10.1089/ten.tec.2014.0024, 10.1089/ten.TEC.2014.0024]; Ulusoy C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0451-0; Villanova M, 2015, AM J PHYS MED REHAB, V94, P410, DOI 10.1097/PHM.0000000000000309; Xu X, 2013, J DENT RES, V92, P825, DOI 10.1177/0022034513497961; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1111/j.1460-9568.2000.01312.x; Zhang N, 2012, INDIAN J MED RES, V135, P287; Zhang QZ, 2017, STEM CELL TRANSL MED, V6, P458, DOI 10.5966/sctm.2016-0177; Zhang QZ, 2012, STEM CELLS DEV, V21, P937, DOI 10.1089/scd.2011.0252; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004	45	16	17	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0394-6320	2058-7384		INT J IMMUNOPATH PH	Int. J. Immunopathol. Pharmacol.	DEC	2017	30	4					383	394		10.1177/0394632017740976			12	Immunology; Pathology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pathology; Pharmacology & Pharmacy	FQ8ZC	WOS:000418650800006	29140156	gold, Green Published			2022-02-06	
J	Zhang, D; Han, S; Wang, SZ; Luo, YL; Zhao, L; Li, JF				Zhang, Dan; Han, Song; Wang, Shizun; Luo, Yanlin; Zhao, Li; Li, Junfa			cPKC gamma-mediated down-regulation of UCHL1 alleviates ischaemic neuronal injuries by decreasing autophagy via ERK-mTOR pathway	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						ischaemic stroke; conventional protein kinase C (cPKC)gamma; ubiquitin C-terminal hydrolase L1; autophagy; mammalian target of rapamycin; extracellular signal-regulated kinase	PROTEIN-KINASE-C; NF-KAPPA-B; CARBOXYL-TERMINAL HYDROLASE; OXYGEN-GLUCOSE DEPRIVATION; TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; PARKINSONS-DISEASE; INDUCED NEUROPROTECTION; CELL INJURY; MEMBRANE TRANSLOCATION	Stroke is one of the leading causes of death in the world, but its underlying mechanisms remain unclear. Both conventional protein kinase C (cPKC)gamma and ubiquitin C-terminal hydrolase L1 (UCHL1) are neuron-specific proteins. In the models of 1-hr middle cerebral artery occlusion (MCAO)/24-hr reperfusion in mice and 1-hr oxygen-glucose deprivation (OGD)/24-hr reoxygenation in cortical neurons, we found that cPKC gamma gene knockout remarkably aggravated ischaemic injuries and simultaneously increased the levels of cleaved (Cl)-caspase-3 and LC3-I proteolysis product LC3-II, and the ratio of TUNEL-positive cells to total neurons. Moreover, cPKC gene knockout could increase UCHL1 protein expression via elevating its mRNA level regulated by the nuclear factor B inhibitor alpha (I kappa B-alpha)/nuclear factor kappa B (NF-kappa B) pathway in cortical neurons. Both inhibitor and shRNA of UCHL1 significantly reduced the ratio of LC3-II/total LC3, which contributed to neuronal survival after ischaemic stroke, but did not alter the level of Cl-caspase-3. In addition, UCHL1 shRNA reversed the effect of cPKC gamma on the phosphorylation levels of mTOR and ERK rather than that of AMPK and GSK-3 beta. In conclusion, our results suggest that cPKC gamma activation alleviates ischaemic injuries of mice and cortical neurons through inhibiting UCHL1 expression, which may negatively regulate autophagy through ERK-mTOR pathway.	[Zhao, Li; Li, Junfa] Capital Med Univ, Beijing Inst Brain Disorders, Dept Neurobiol, Beijing, Peoples R China; Capital Med Univ, Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China		Zhao, L; Li, JF (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Dept Neurobiol, Beijing, Peoples R China.	zhaoli@ccmu.edu.cn; junfali@ccmu.edu.cn	; Li, Junfa/H-8707-2013	Zhao, Li/0000-0002-2578-9533; Li, Junfa/0000-0002-1930-9724	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400948, 31471142, 31671205]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7141001]; Scientific Research Common Program of Beijing Municipal Commission of EducationBeijing Municipal Commission of Education [KM201410025004]	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: National Natural Science Foundation of China (Grant No. 81400948, 31471142 and 31671205), Beijing Natural Science Foundation (Grant No. 7141001) and Scientific Research Common Program of Beijing Municipal Commission of Education (KM201410025004).	Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Avila A, 2002, MOL CELL BIOL, V22, P8787, DOI 10.1128/MCB.22.24.8787-8795.2002; Balkaya M, 2013, J NEUROSCI METH, V213, P179, DOI 10.1016/j.jneumeth.2012.12.021; Bu XN, 2011, J NEUROCHEM, V117, P346, DOI 10.1111/j.1471-4159.2011.07209.x; Carrieri C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00114; Cartier AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034713; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Du Ping, 2014, Shengli Xuebao, V66, P528; Goncharova EA, 2013, FASEB J, V27, P1796, DOI 10.1096/fj.12-222224; Gong X, 2016, AM J TRANSL RES, V8, P2127; Gordon R, 2016, NEUROBIOL DIS, V93, P96, DOI 10.1016/j.nbd.2016.04.008; Guglielmotto M, 2012, AGING CELL, V11, P834, DOI 10.1111/j.1474-9726.2012.00854.x; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Hamabe W, 2005, J PHARMACOL EXP THER, V313, P1027, DOI 10.1124/jpet.104.082735; Hassanian SM, 2016, J THROMB HAEMOST, V14, P2261, DOI 10.1111/jth.13477; Hayashi S, 2005, J NEUROCHEM, V93, P883, DOI 10.1111/j.1471-4159.2005.03080.x; Huang XP, 2015, J INTEGR MED-JIM, V13, P289, DOI 10.1016/S2095-4964(15)60187-X; Huang X, 2009, J IMMUNOL, V182, P5810, DOI 10.4049/jimmunol.0804073; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Kim HJ, 2015, ONCOTARGET, V6, P16287, DOI 10.18632/oncotarget.3843; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krupinski J, 1998, ACTA NEUROBIOL EXP, V58, P13; Li JF, 2005, BRAIN RES, V1060, P62, DOI 10.1016/j.brainres.2005.08.047; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Liu RJ, 2013, NEUROPSYCHOPHARMACOL, V38, P2268, DOI 10.1038/npp.2013.128; Liu Y, 2008, NEUROSCI LETT, V444, P87, DOI 10.1016/j.neulet.2008.08.014; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubjuhn J, 2009, J NEUROSCI METH, V184, P95, DOI 10.1016/j.jneumeth.2009.07.029; Matsumoto S, 2004, J CEREBR BLOOD F MET, V24, P54, DOI 10.1097/01.WCB.0000095920.70924.F5; Matsumoto S, 2008, NEUROCHEM RES, V33, P2302, DOI 10.1007/s11064-008-9727-4; Mincheva-Tasheva S, 2013, NEUROSCIENTIST, V19, P175, DOI 10.1177/1073858412444007; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Niu CC, 2005, NEUROSCI LETT, V384, P1, DOI 10.1016/j.neulet.2005.03.071; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Ren CH, 2013, BRAIN RES, V1540, P84, DOI 10.1016/j.brainres.2013.09.051; Rodriguez R, 2005, J NEUROSCI METH, V147, P22, DOI 10.1016/j.jneumeth.2005.02.013; Saito N, 2002, J BIOCHEM, V132, P683, DOI 10.1093/oxfordjournals.jbchem.a003274; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Spalenza V, 2011, VET J, V189, P278, DOI 10.1016/j.tvjl.2010.11.017; Tennant KA, 2009, J NEUROSCI METH, V181, P18, DOI 10.1016/j.jneumeth.2009.04.009; Tramutola A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2756068; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wang G, 2015, J CELL MOL MED, V19, P1637, DOI 10.1111/jcmm.12538; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang RT, 2011, J NEUROCHEM, V116, P1160, DOI 10.1111/j.1471-4159.2011.07172.x; Wang Y, 2016, NEUROREPORT, V27, P1072, DOI 10.1097/WNR.0000000000000659; Wang YX, 2013, J BIOL CHEM, V288, P12852, DOI 10.1074/jbc.M112.410357; Wei HP, 2016, TRANSL STROKE RES, V7, P497, DOI 10.1007/s12975-016-0484-4; Wexler EJ, 2002, J NEUROSCI METH, V113, P51, DOI 10.1016/S0165-0270(01)00476-9; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; WILSON POG, 1988, BRIT J EXP PATHOL, V69, P91; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Xiang TX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029783; Xu EH, 2009, J CLIN NEUROSCI, V16, P1473, DOI 10.1016/j.jocn.2009.03.027; Zhang LS, 2017, ENVIRON POLLUT, V220, P843, DOI 10.1016/j.envpol.2016.10.067; Zhang N, 2011, NEUROCHEM INT, V58, P684, DOI 10.1016/j.neuint.2011.02.007; Zhao L, 2013, NEUROSCIENCE, V255, P203, DOI 10.1016/j.neuroscience.2013.10.001; Zhao YQ, 2016, J NUTR BIOCHEM, V38, P41, DOI 10.1016/j.jnutbio.2016.08.009; Zhao YQ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081196	64	16	16	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	DEC	2017	21	12					3641	3657		10.1111/jcmm.13275			17	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	FQ7WP	WOS:000418574500045	28726275	Green Published, gold			2022-02-06	
J	Rau, CS; Wu, SC; Chien, PC; Kuo, PJ; Chen, YC; Hsieh, HY; Hsieh, CH				Rau, Cheng-Shyuan; Wu, Shao-Chun; Chien, Peng-Chen; Kuo, Pao-Jen; Chen, Yi-Chun; Hsieh, Hsiao-Yun; Hsieh, Ching-Hua			Prediction of Mortality in Patients with Isolated Traumatic Subarachnoid Hemorrhage Using a Decision Tree Classifier: A Retrospective Analysis Based on a Trauma Registry System	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; subarachnoid hemorrhage; traumatic subarachnoid hemorrhage; mortality; decision tree	BRAIN-INJURY; EXTERNAL VALIDATION; PROGNOSTIC MODELS; HEAD-INJURY; CLINICAL-SIGNIFICANCE; HYPERNATREMIA; IMPACT; RISK; SEVERITY; LEVEL	Background: In contrast to patients with traumatic subarachnoid hemorrhage (tSAH) in the presence of other types of intracranial hemorrhage, the prognosis of patients with isolated tSAH is good. The incidence of mortality in these patients ranges from 0-2.5%. However, few data or predictive models are available for the identification of patients with a high mortality risk. In this study, we aimed to construct a model for mortality prediction using a decision tree (DT) algorithm, along with data obtained from a population-based trauma registry, in a Level 1 trauma center. Methods: Five hundred and forty-five patients with isolated tSAH, including 533 patients who survived and 12 who died, between January 2009 and December 2016, were allocated to training (n = 377) or test (n = 168) sets. Using the data on demographics and injury characteristics, as well as laboratory data of the patients, classification and regression tree (CART) analysis was performed based on the Gini impurity index, using the rpart function in the rpart package in R. Results: In this established DT model, three nodes (head Abbreviated Injury Scale (AIS) score <= 4, creatinine (Cr) <1.4 mg/dL, and age <76 years) were identified as important determinative variables in the prediction of mortality. Of the patients with isolated tSAH, 60% of those with a head AIS >4 died, as did the 57% of those with an AIS score <= 4, but Cr >= 1.4 and age >= 76 years. All patients who did not meet the above-mentioned criteria survived. With all the variables in the model, the DT achieved an accuracy of 97.9% (sensitivity of 90.9% and specificity of 98.1%) and 97.7% (sensitivity of 100% and specificity of 97.7%), for the training set and test set, respectively. Conclusions: The study established a DT model with three nodes (head AIS score <= 4, Cr <1.4, and age <76 years) to predict fatal outcomes in patients with isolated tSAH. The proposed decision-making algorithm may help identify patients with a high risk of mortality.	[Rau, Cheng-Shyuan] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan; [Wu, Shao-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung 83301, Taiwan; [Chien, Peng-Chen; Kuo, Pao-Jen; Chen, Yi-Chun; Hsieh, Hsiao-Yun; Hsieh, Ching-Hua] Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan		Hsieh, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan.	ersh2127@cloud.cgmh.org.tw; shaochunwu@gmail.com; venu_chien@hotmail.com; bow110470@gmail.com; libe320@yahoo.com.tw; sylvia19870714@hotmail.com; m93chinghua@gmail.com		Hsieh, Ching-Hua/0000-0002-0945-2746; WU, Shaochun/0000-0002-0984-6921	 [CMRPG8F0801]	This research was supported by a grant from CMRPG8F0801. We appreciate the help extended by the Biostatistics Center, Kaohsiung Chang Gung Memorial Hospital, with the statistical analysis.	Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Association for the Advancement of Automotive Medicine, 1998, ABBR INJ SCAL 1998 R; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Carter EL, 2016, BRIT J NEUROSURG, V30, P227, DOI 10.3109/02688697.2016.1139048; Chang LY, 2006, ACCIDENT ANAL PREV, V38, P1019, DOI 10.1016/j.aap.2006.04.009; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Farion K, 2010, J MED SYST, V34, P551, DOI 10.1007/s10916-009-9268-7; Fisher LA, 2006, NEUROCRIT CARE, V5, P180, DOI 10.1385/NCC:5:3:180; Gates M, 2017, WORLD NEUROSURG, V100, P417, DOI 10.1016/j.wneu.2017.01.046; Guilbault RWR, 2017, J INTENSIVE CARE MED, V32, P333, DOI 10.1177/0885066616686924; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hayashi T, 2016, WORLD NEUROSURG, V86, DOI 10.1016/j.wneu.2015.09.108; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Hsieh CH, 2017, BIOMED J, V40, P113, DOI 10.1016/j.bj.2016.10.005; Hsieh CH, 2017, BIOMED J, V40, P121, DOI 10.1016/j.bj.2016.10.006; Kasbekar PU, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00025; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lee JJ, 2014, J NEUROTRAUM, V31, P595, DOI 10.1089/neu.2013.3152; Lin TK, 2012, J TRAUMA ACUTE CARE, V73, P131, DOI 10.1097/TA.0b013e31824aff74; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; Neil-Dwyer G, 1990, Acta Neurochir Suppl (Wien), V47, P102; Parchani A, 2014, WORLD NEUROSURG, V82, pE639, DOI 10.1016/j.wneu.2014.06.022; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Qureshi AI, 2002, NEUROSURGERY, V50, P749, DOI 10.1097/00006123-200204000-00012; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Shi KQ, 2017, J VIRAL HEPATITIS, V24, P132, DOI 10.1111/jvh.12617; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Stitzel Joel D, 2008, Ann Adv Automot Med, V52, P235; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; TAKEUCHI J, 1960, JAP HEART J, V1, P288, DOI DOI 10.1536/IHJ.1.288; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Wu C, 2012, J TRAUMA ACUTE CARE, V73, P1247, DOI 10.1097/TA.0b013e318265d24e; Zimmerman RK, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1839-x; Zintzaras E, 2007, COMPUT BIOL MED, V37, P637, DOI 10.1016/j.compbiomed.2006.06.001	43	16	16	0	3	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2017	14	11							1420	10.3390/ijerph14111420			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	FO1SQ	WOS:000416545200136	29165330	Green Published, gold, Green Submitted			2022-02-06	
J	Wang, C; Costanzo, ME; Rapp, PE; Darmon, D; Nathan, DE; Bashirelahi, K; Pham, DL; Roy, MJ; Keyser, DO				Wang, Chao; Costanzo, Michelle E.; Rapp, Paul E.; Darmon, David; Nathan, Dominic E.; Bashirelahi, Kylee; Pham, Dzung L.; Roy, Michael J.; Keyser, David O.			Disrupted gamma synchrony after Mild Traumatic Brain injury and its correlation with White Matter abnormality	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; EEG; neural synchronization; functional connectivity; white matter integrity	FUNCTIONAL CONNECTIVITY; PHASE-SYNCHRONIZATION; CONSCIOUS PERCEPTION; CEREBELLAR CIRCUITRY; COGNITIVE DYSMETRIA; NEURONAL COHERENCE; VOLUME-CONDUCTION; NEURAL ACTIVITY; AXONAL INJURY; ACUTE STAGE	Mild traumatic brain injury (mTBI) has been firmly associated with disrupted white matter integrity due to induced white matter damage and degeneration. However, comparatively less is known about the changes of the intrinsic functional connectivity mediated via neural synchronization in the brain after mTBI. Moreover, despite the presumed link between structural and functional connectivity, no existing studies in mTBI have demonstrated clear association between the structural abnormality of white matter axons and the disruption of neural synchronization. To investigate these questions, we recorded resting state EEG and diffusion tensor imaging (DTI) from a cohort of military service members. A newly developed synchronization measure, the weighted phase lag index was applied on the EEG data for estimating neural synchronization. Fractional anisotropy was computed from the DTI data for estimating white matter integrity. Fifteen service members with a history of mTBI within the past 3 years were compared to 22 demographically similar controls who reported no history of head injury. We observed that synchronization at low-gamma frequency band (25-40 Hz) across scalp regions was significantly decreased in mTBI cases compared with controls. The synchronization in theta (4-7 Hz), alpha (8-13 Hz), and beta (15-23 Hz) frequency bands were not significantly different between the two groups. In addition, we found that across mTBI cases, the disrupted synchronization at low-gamma frequency was significantly correlated with the white matter integrity of the inferior cerebellar peduncle, which was also significantly reduced in the mTBI group. These findings demonstrate an initial correlation between the impairment of white matter integrity and alterations in EEG synchronization in the brain after mTBI. The results also suggest that disruption of intrinsic neural synchronization at low-gamma frequency may be a characteristic functional pathology following mTBI and may prove useful for developing better methods of diagnosis and treatment.	[Wang, Chao; Rapp, Paul E.; Darmon, David; Nathan, Dominic E.; Bashirelahi, Kylee; Keyser, David O.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Traumat Injury Res Program, Bethesda, MD 20814 USA; [Wang, Chao; Costanzo, Michelle E.; Darmon, David; Nathan, Dominic E.; Bashirelahi, Kylee] Mil Med Inc, Henry M Jackson Fdn Adv, Bethesda, MD 20889 USA; [Costanzo, Michelle E.; Roy, Michael J.] Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA; [Nathan, Dominic E.] Uniformed Serv Univ Hlth Sci, Grad Sch Nursing, Bethesda, MD 20814 USA; [Pham, Dzung L.] Mil Med Inc, Henry M Jackson Fdn Adv, Ctr Neurosci & Regenerat Med, Bethesda, MD USA		Wang, C (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Traumat Injury Res Program, Bethesda, MD 20814 USA.; Wang, C (corresponding author), Mil Med Inc, Henry M Jackson Fdn Adv, Bethesda, MD 20889 USA.	chaowang.ufl@gmail.com	Pham, Dzung/AAR-8263-2020; Wang, Chao/M-3165-2016	Wang, Chao/0000-0002-1313-2569	Department of Defense Center for Neuroscience and Regenerative Medicine [3006018.0160855510005]; Non-Invasive Neuro-Assessment Device (NINAD) Test and Evaluation Support Group from US Army Medical Research and Materiel Command [MEM-91-2714]; Development of Predictive Models and Analytic Strategies,from the US Army medical Research and Materiel Command [MEM-91-3097]	Funds for this effort came from the Department of Defense Center for Neuroscience and Regenerative Medicine 3006018.0160855510005, the Non-Invasive Neuro-Assessment Device (NINAD) Test and Evaluation Support Group MEM-91-2714 from US Army Medical Research and Materiel Command, and Development of Predictive Models and Analytic Strategies, MEM-91-3097 from the US Army medical Research and Materiel Command. Any opinions or assertions expressed are those of the authors and do not necessarily reflect the official policy or position of Uniformed Services University, the US Army, US Navy, Department of Defense, or the US Government.	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazin PL, 2011, NEUROIMAGE, V58, P458, DOI 10.1016/j.neuroimage.2011.06.020; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Croft RJ, 1998, ELECTROEN CLIN NEURO, V107, P387, DOI 10.1016/S0013-4694(98)00086-8; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; HOUK JC, 2003, FUNDAMENTAL NEUROSCI, P841; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Landman BA, 2013, NEUROINFORMATICS, V11, P91, DOI 10.1007/s12021-012-9159-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee KH, 2003, BRAIN RES REV, V41, P57, DOI 10.1016/S0165-0173(02)00220-5; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Mori S, 2005, MRI ATLAS HUMAN WHIT; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Popa D, 2013, J NEUROSCI, V33, P6552, DOI 10.1523/JNEUROSCI.5521-12.2013; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Srinivasan R, 1999, J NEUROSCI, V19, P5435; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Veraart J, 2011, MAGN RESON MED, V65, P138, DOI 10.1002/mrm.22603; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wang C, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00071; Wang C, 2016, J NEUROSCI, V36, P3919, DOI 10.1523/JNEUROSCI.3652-15.2016; Wang C, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00015; Wang ZQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151489; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Womelsdorf T, 2006, J PHYSIOL-PARIS, V100, P182, DOI 10.1016/j.jphysparis.2007.01.005; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	74	16	16	1	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 30	2017	8								571	10.3389/fneur.2017.00571			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL1EU	WOS:000413958100004	29163337	Green Published, gold			2022-02-06	
J	Bennett, JL; Piatt, JA; Van Puymbroeck, M				Bennett, Jessie L.; Piatt, Jennifer A.; Van Puymbroeck, Marieke			Outcomes of a Therapeutic Fly-Fishing Program for Veterans with Combat-Related Disabilities: A Community-Based Rehabilitation Initiative	COMMUNITY MENTAL HEALTH JOURNAL			English	Article						Fly-fishing; Mental health; Therapeutic recreation; Veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; LEISURE SATISFACTION; AFGHANISTAN VETERANS; SELF-DETERMINATION; SERVICE MEMBERS; SOCIAL SUPPORT; PTSD; PARTICIPATION; HEALTH	The purpose of this study was to examine the outcomes of a therapeutic fly-fishing program for veterans with combat-related disabilities. A total of 40 veterans participated in the 4-day therapeutic fly-fishing program and this study. The outcomes examined included reducing symptoms of posttraumatic stress (PTS), depression, perceived stress, functional impairment (i.e., work, relationships, physical, and everyday life), increasing self-determination, and leisure satisfaction. Each research participant completed pretest, posttest, and 3-month follow-up questionnaires. Repeated measures MANOVA and ANOVA were conducted to examine the differences between the three time points on each outcomes. The results indicated significant decreases from the pretest to posttest for symptoms of PTS, depression, perceived stress, and functional impairment, and an increase in leisure satisfaction from pretest to 3-month follow-up. These results highlight the use of therapeutic recreation programming for veterans with disabilities as a holistic approach to treatment and recovery.	[Bennett, Jessie L.] Univ New Hampshire, 4 Lib Way, Durham, NH 03824 USA; [Piatt, Jennifer A.] Indiana Univ, HPER Bldg 133,1025 E Seventh St, Bloomington, IN 47405 USA; [Van Puymbroeck, Marieke] Clemson Univ, 128 McGinty Court,283 Lehotsky Hall, Clemson, SC 29634 USA		Bennett, JL (corresponding author), Univ New Hampshire, 4 Lib Way, Durham, NH 03824 USA.	Jessie.bennett@unh.edu		Van Puymbroeck, Marieke/0000-0002-5881-8409			Adshead G, 2000, BRIT J PSYCHIAT, V177, P144, DOI 10.1192/bjp.177.2.144; Agate JR, 2009, J LEISURE RES, V41, P205, DOI 10.1080/00222216.2009.11950166; Alger D., 2016, THIS LAND IS YOUR LA, P111; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; American Therapeutic Recreation Association, 2009, BEN THER RECR; Aronson R., 2005, FRONTLINE; Baumeister RF., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, 10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; BEARD JG, 1980, J LEISURE RES, V12, P20, DOI 10.1080/00222216.1980.11969416; Beck JG, 2009, J ANXIETY DISORD, V23, P443, DOI 10.1016/j.janxdis.2008.09.001; Bennett JL, 2014, THER RECREAT J, V48, P74; Bennett JL, 2014, THER RECREAT J, V48, P169; Bowling UB, 2008, PROF PSYCHOL-RES PR, V39, P451, DOI 10.1037/0735-7028.39.4.451; Brooks K. N., 2010, IDENTITY, V6, P16; Caldwell LL, 2005, BRIT J GUID COUNS, V33, P7, DOI 10.1080/03069880412331335939; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COLEMAN D, 1993, J LEISURE RES, V25, P111, DOI 10.1080/00222216.1993.11969913; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Deci E.L., 1985, INTRINSIC MOTIVATION; Deci E.L., 2008, SELF DETERMINATION T; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Donovan B, 2001, J TRAUMA STRESS, V14, P757, DOI 10.1023/A:1013094206154; Dustin D, 2011, THER RECREAT J, V45, P326; Fischer H., 2010, US MILITARY CAUSUALT; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gagne M, 2003, MOTIV EMOTION, V27, P199, DOI 10.1023/A:1025007614869; Hawkins B. L., 2011, THERAPEUTIC RECREATI, V45; Hawkins BL, 2016, THER RECREAT J, V50, P55, DOI 10.18666/TRJ-2016-V50-I1-6793; Hawn R., 2008, PARKS RECREATION, V43, P34; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Hyer L, 1996, J CLIN PSYCHOL, V52, P263, DOI 10.1002/(SICI)1097-4679(199605)52:3<263::AID-JCLP3>3.0.CO;2-T; Johnson HA, 2006, MARRIAGE FAM REV, V40, P69, DOI 10.1300/J002v40n01_05; Kelly J, 1996, LEISURE, P16; Kleiber DA, 2002, LEISURE SCI, V24, P219, DOI 10.1080/01490400252900167; Kleiber DA, 2008, NEUROREHABILITATION, V23, P321; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurtz M. E., 1991, Leisure Studies, V10, P69, DOI 10.1080/02614369100390071; Laffaye C, 2008, J TRAUMA STRESS, V21, P394, DOI 10.1002/jts.20348; LePage JP, 2008, AM J DRUG ALCOHOL AB, V34, P171, DOI 10.1080/00952990701877060; Longmore RJ, 2007, CLIN PSYCHOL REV, V27, P173, DOI 10.1016/j.cpr.2006.08.001; Lundberg N.R., 2007, PARKS RECREATION, V42, P22; Lundberg N, 2011, THER RECREAT J, V45, P105; Marx B. P., 2009, DEP DEF MIL HLTH RES; Meagher I., 2007, WAR LIST OEF OIF STA; Miller MW, 2008, J REHABIL RES DEV, V45, P359, DOI 10.1682/JRRD.2007.06.0085; Mowatt RA, 2011, THER RECREAT J, V45, P286; Neulinger, 1974, PSYCHOL LEISURE; Price WD, 2015, J LEISURE RES, V47, P185, DOI 10.1080/00222216.2015.11950356; RAGHEB MG, 1980, J LEISURE RES, V12, P138, DOI 10.1080/00222216.1980.11969433; RAGHEB MG, 1982, J LEISURE RES, V14, P295, DOI 10.1080/00222216.1982.11969527; Ragsdale KG, 1996, J TRAUMA STRESS, V9, P269, DOI 10.1007/BF02110660; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schiraldi GR, 2009, POSTTRAUMATIC STRESS, Vsecond; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Seppala EM, 2014, J TRAUMA STRESS, V27, P397, DOI 10.1002/jts.21936; Sigford BJ, 2010, J REHABIL RES DEV, V47, pXV, DOI 10.1682/JRRD.2009.02.0020; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tarrier N, 2010, CLIN PSYCHOL-SCI PR, V17, P134, DOI 10.1111/j.1468-2850.2010.01203.x; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167; U.S. Census Bureau, 2015, AM FACTFINDER; Uomoto JM, 2009, REHABIL PSYCHOL, V54, P259, DOI 10.1037/a0016907; Vaira D, 2009, PARKS RECREATION, V44, P32; Van Puymbroeck M, 2011, THER RECREAT J, V45, P265; Vella EJ, 2013, MIL MED, V178, P254, DOI 10.7205/MILMED-D-12-00308; Vermeulen J, 2009, SPORT SOC, V12, P1206, DOI 10.1080/17430430903137886; Vieweg W Victor R, 2006, Prim Care Companion J Clin Psychiatry, V8, P25; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilcox S, 2010, PSYCHOL TRAUMA-US, V2, P175, DOI 10.1037/a0019062; Wilder A, 2011, THER RECREAT J, V45, P268	75	16	16	0	13	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0010-3853	1573-2789		COMMUNITY MENT HLT J	Community Ment. Health J.	OCT	2017	53	7					756	765		10.1007/s10597-017-0124-9			10	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	FG9LK	WOS:000410760300002	28303444				2022-02-06	
J	Cabraser, EJ; Issacharoff, S				Cabraser, Elizabeth J.; Issacharoff, Samuel			THE PARTICIPATORY CLASS ACTION	NEW YORK UNIVERSITY LAW REVIEW			English	Article							PRECLUSION; LITIGATION; OPT	The class action has emerged as the settlement instrument of choice in mass harm cases such as the Volkswagen emissions scandal or the Deepwater Horizon after-math. But the class action has also reemerged in the mass tort context, most notably in the NFL Concussion litigation. After seemingly collapsing following the Amchem and Ortiz Supreme Court decisions of the 1990s, the class action device is getting an important second life in courts today.& para;& para;This Article argues that the new class action has a feature that should increase its doctrinal acceptability: forms of active class member participation. What we term the "participatory class action" emerges from two developments. The first is the technological transformation in the means of communication with class members, and among the class members themselves. The second is that the current class action almost invariably arises from the initial aggregation and centralization of large numbers of individual suits and putative class actions in the Multidistrict Litigation (MDL) process. As a result, classes are comprised not simply of lawyers and absent class members, but of hundreds or even thousands of individual claims, with individuals capable of monitoring the class and represented by independent counsel.& para;& para;With over forty percent of the actively litigated civil cases in federal courts now in the MDL dockets, the transformation in mass resolution is well underway. In these new consolidations, the assumptions of older law about absent class member passivity break down. In the popular typology in academic examination of class actions, class action law should insist on the loyalty of agents and the importance of individual ability to exit as guarantors of systemic legitimacy. In the participatory class action, voice emerges as a critical element, with the capacity of the normally silent class members to assert their interests and their views. As with the need for class action law to move from first-class mail to Twitter, so too must the law embrace the implications of real participation by those represented in the assessment of representational propriety.	[Cabraser, Elizabeth J.] Lieff Cabraser Heiman & Bernstein, San Francisco, CA 94111 USA; [Issacharoff, Samuel] NYU, Sch Law, Constitut Law, New York, NY 10003 USA		Cabraser, EJ (corresponding author), Lieff Cabraser Heiman & Bernstein, San Francisco, CA 94111 USA.						ADVISORY COMM, 2016, REP ADV COMM CIV RUL, P2; Alexandra Bursak Note, 2016, NEW YORK U LAW REV, V91, P1670; [Anonymous], 2017, AN FEBR 8 STAT C; [Anonymous], 2017, E COMMUNICATION; [Anonymous], 2016, COST ISS CHECKS; Baker Lynn A., 1998, VA LAW REV, V84, P1496; Barnard Thomas H., 2014, HOFSTRA LAB EMP L J, V31, P387; BARRETT WP, 1993, FORBES          1011, P52; BrownGreer PLC, 2017, NFL CONC SETTL UNPUB; Brummer C, 2004, COLUMBIA LAW REV, V104, P1042, DOI 10.2307/4099367; Brush Pete, 2015, LAW360; Burch EC, 2015, NEW YORK U LAW REV, V90, P71; Burch Elizabeth Chamblee, 2015, NEW YORK U LAW REV, V90, P73; Bursak A, 2016, NEW YORK U LAW REV, V91, P1651; Cabraser EJ, 2005, STANFORD LAW REV, V57, P1475; Cabraser Elizabeth J., 2005, STANFORD LAW REV, V57, P1476; Cabraser Elizabeth J., 2014, G WASH L REV ARGUEND, V82, P85; Cabraser Elizabeth J., 2014, G WASH L REV ARGUEND, V82, P88; Cabraser Elizabeth J., 2015, AKRON L REV, V48, P800; Cabraser Elizabeth J., 2015, AKRON L REV, V48, P760; Chris Brummer Note, 2004, COLUMBIA LAW REV, V104, P1060; COFFEE JC, 1995, COLUMBIA LAW REV, V95, P1343, DOI 10.2307/1123132; COFFEE JC, 1986, COLUMBIA LAW REV, V86, P669, DOI 10.2307/1122577; Coffee JC, 2000, COLUMBIA LAW REV, V100, P370, DOI 10.2307/1123472; Coffee Jr John C., 1986, COLUMBIA LAW REV, V86, P671; Collignon Cassie, 2012, CLASS ACTIONS 101 NE; DUKE LAW CTR, 2014, STAND BEST PRACT LAR, px; Eisenberg T, 2004, VANDERBILT LAW REV, V57, P1529; Erichson HM, 2014, GEORGE WASH LAW REV, V82, P951; Erichson HM, 2011, CORNELL LAW REV, V96, P265; Gershman Jacob, 2017, WALL ST J L BLOG; GRIMES EA, 1980, STANFORD LAW REV, V32, P743, DOI 10.2307/1228461; Grimes Elizabeth A., 1980, STANFORD LAW REV, V32, P747; Hao William, 2016, NORTON ANN SURV BANK, V524, P605; Hao William, 2016, NORTON ANN SURV BANK, V606; Hirschman A.O., 1970, EXIT VOICE LOYALTY R; Issacharoff S, 2002, NOTRE DAME LAW REV, V77, P1057; Issacharoff S, 2006, UCLA LAW REV, V53, P1353; Issacharoff S, 2013, FORDHAM LAW REV, V81, P3165; Issacharoff S, 2009, FORDHAM LAW REV, V78, P1177; Issacharoff Samuel, 2006, UCLA LAW REV, V53, P1415; Issacharoff Samuel, 1999, SUP CT REV, P337, DOI DOI 10.1016/J.JFINECO.2008.08.006; Issacharoff Samuel, 2014, LA LAW REV, V74, P397; Issacharoff Samuel, 1999, SUP CT REV, V1999, P341; Issacharoff Samuel, 2014, LA LAW REV, V74, P413; Judicial Business, 2015, JUD BUS 2015 JUD PAN; Klonoff Robert H., 2016, EMORY LJ, V65, P1589; Koniak Susan P., 2001, HOFSTRA L REV, V30, P129; Koniak Susan P., 2001, HOFSTRA L REV, V30, P132; LLP SEYFARTH SHAW, 2016, 12 ANN WORKPLACE CLA, P14; McKenzie TA, 2012, NEW YORK U LAW REV, V87, P960; McKenzie Troy A., 2012, NEW YORK U LAW REV, V87, P963; MILLER AR, 1979, HARVARD LAW REV, V92, P664, DOI 10.2307/1340397; Miller Arthur R., 1979, HARVARD LAW REV, V92, P665; Nagareda RA, 2002, HARVARD LAW REV, V115, P747, DOI 10.2307/1342662; NAGAREDA RICHARD A., 2007, MASS TORTS WORLD SET, V237-41, P250; Nagareda Richard A., 2002, HARVARD LAW REV, V115, P786; Randazzo Sara, 2016, WALL ST J, pB3; Ratner Morris A., WASH L REV, V92, P785; Ratner Morris A., WASH L REV, V92, P845; Robert H, 2016, EMORY LJ, V65, P1569; RUBENSTEIN WILLIAM B., 2011, NEWBERG CLASS ACTION, P133; Savage ZB, 2013, NEW YORK U LAW REV, V88, P439; Savage Zachary B., 2013, NEW YORK U LAW REV, V88, P465; Shapiro DL, 1998, NOTRE DAME LAW REV, V73, P913; Silver C, 1998, VA LAW REV, V84, P1465, DOI 10.2307/1073789; Wajert Sean, 2010, MASS TORT DEF B 0604; WEISS EJ, 1995, YALE LAW J, V104, P2053, DOI 10.2307/796992; WRIGHT CHARLES ALAN, 2017, FEDERAL PRACTICE PRO, P1710; [No title captured]	70	16	16	0	2	NEW YORK UNIV SCHOOL LAW	NEW YORK	110 WEST THIRD ST, NEW YORK, NY 10012 USA	0028-7881			NEW YORK U LAW REV	N. Y. Univ. Law Rev.	OCT	2017	92	4					846	877					32	Law	Social Science Citation Index (SSCI)	Government & Law	FM4WV	WOS:000415030400002					2022-02-06	
J	Yu, P; Li, SJ; Zhang, ZF; Wen, XL; Quan, W; Tian, QL; Gao, C; Su, WQ; Zhang, JN; Jiang, RC				Yu, Peng; Li, Shengjie; Zhang, Zhifei; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Gao, Chuang; Su, Wanqiang; Zhang, Jianning; Jiang, Rongcai			Progesterone-mediated angiogenic activity of endothelial progenitor cell and angiogenesis in traumatic brain injury rats were antagonized by progesterone receptor antagonist	CELL PROLIFERATION			English	Article							ENHANCES NEUROGENESIS; CLINICAL-TRIAL; GROWTH-FACTOR; IN-VIVO; EXPRESSION; PROLIFERATION; MECHANISM; NEUROPROTECTION; TRANSPLANTATION; VASCULOGENESIS	ObjectivesProgesterone (P4) has the potential therapeutic effects for traumatic brain injury (TBI) whose recovery depended on the enhanced angiogenesis. Endothelial progenitor cell (EPC) plays an essential role in vascular biology. We previously demonstrated that P4 administration improved circulating EPC level and neurological recovery of rat with TBI. Here, we hypothesized that P4 augmented angiogenic potential of EPC and the angiogenesis-related neurorestoration after TBI through classical progesterone receptor (PR). Materials and methodsEPC derived from rats were stimulated with graded concentrations (0, 10(-10), 10(-9), 5x10(-9), 10(-8), 10(-7)mol/L) of P4 or 10(-6)mol/L ulipristal acetate (UPA, a PR antagonist). Male rats were subjected to cortical impact injury and treated with (i) DMSO (dimethyl sulfoxide), (ii) P4 and (iii) P4 and UPA. ResultsIt showed that P4 improved the angiogenic potential of EPC, including tube formation, adhesion, migration and vascular endothelial growth factor secretion, in a dose-dependent fashion with the maximal effect achieved at 10(-9)mol/L P4. High concentration (10(-7)mol/L) of P4 impaired the angiogenic potential of EPC. Notably, 10(-6)mol/L UPA antagonized the stimulatory effects of 10(-9)mol/L P4. After administrating P4, a significant improvement of neurological function and the restoration of the leaked blood-brain barrier were observed as well as a reduction of the brain water content. Both vessel density and expression of occludin of vessels were increased. When UPA was administered with P4, the neural restoration and angiogenesis were all reversed. Western blot showed that 10(-9)mol/L P4 increased the content of PRA and PRB of EPC, while 10(-7)mol/L P4 reduced the content of both PR isoforms, but there was no change found in the TBI rats. ConclusionsIt may suggest that P4-mediated angiogenic activity of EPC and angiogenesis in TBI rats were antagonized by PR antagonist.	[Yu, Peng; Li, Shengjie; Zhang, Zhifei; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Gao, Chuang; Su, Wanqiang; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China; [Yu, Peng; Li, Shengjie; Zhang, Zhifei; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Gao, Chuang; Su, Wanqiang; Zhang, Jianning; Jiang, Rongcai] Tianjin Neurol Inst, Tianjin, Peoples R China; [Yu, Peng; Li, Shengjie; Zhang, Zhifei; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Gao, Chuang; Su, Wanqiang; Zhang, Jianning; Jiang, Rongcai] Minist Educ & Tianjin City, Key Lab Postneurotrauma Neurorepair & Regenerat C, Tianjin, Peoples R China		Zhang, JN; Jiang, RC (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China.	jianningzhang@hotmail.com; jiang116216@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100920, 81200907, 81301629, 81271359]; Tianjin Research Program of Application Foundation and Advanced Technology [11JCZDJC18100]; Ontario-China Research and Innovation Fund [2011DFG33430]; Tianjin colleges and universities of science and technology development fund [2010013]	National Natural Science Foundation of China, Grant/Award Number: 81100920, 81200907, 81301629 and 81271359; Tianjin Research Program of Application Foundation and Advanced Technology, Grant/Award Number: 11JCZDJC18100; Ontario-China Research and Innovation Fund, Grant/Award Number: 2011DFG33430; Tianjin colleges and universities of science and technology development fund, Grant/Award Number: 2010013	Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bharti JN, 2015, J CLIN DIAGN RES, V9, pEC5, DOI 10.7860/JCDR/2015/10591.5447; Botelho MC, 2015, SM J REPROD HLTH INF, V1, P1; Candolfi M, 2005, ENDOCRINOLOGY, V146, P736, DOI 10.1210/en.2004-1276; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Conneely OM, 2002, RECENT PROG HORM RES, V57, P339, DOI 10.1210/rp.57.1.339; Cooke PS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00108; Dai D, 2002, CANCER RES, V62, P881; ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122, DOI 10.1152/ajplegacy.1949.157.1.122; Esber N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140795; Frontczak-Baniewicz M, 2003, ACTA NEUROBIOL EXP, V63, P65; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Girling JE, 2007, ENDOCRINOLOGY, V148, P5433, DOI 10.1210/en.2007-0856; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; He L, 2014, NEUROCHEM RES, V39, P2251, DOI 10.1007/s11064-014-1427-7; Herbrig K, 2006, ANN RHEUM DIS, V65, P157, DOI 10.1136/ard.2005.035378; Hsu SP, 2008, CELL MOL LIFE SCI, V65, P3839, DOI 10.1007/s00018-008-8441-3; Hsu SP, 2011, MOL ENDOCRINOL, V25, P421, DOI 10.1210/me.2010-0424; Ichioka M, 2015, J STEROID BIOCHEM, V147, P103, DOI 10.1016/j.jsbmb.2014.12.008; Inoue T, 2002, J CLIN ENDOCR METAB, V87, P5325, DOI 10.1210/jc.2002-012096; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kempisty B, 2015, J BIOL REG HOMEOS AG, V29, P39; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Lee O, 2016, CANCER LETT, V376, P310, DOI 10.1016/j.canlet.2016.04.010; Lee TS, 2015, J CELL BIOCHEM, V116, P1411, DOI 10.1002/jcb.25101; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Leo JCL, 2008, INT J CANCER, V122, P230, DOI 10.1002/ijc.23081; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Matsubara Y, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-2; Nallasamy S, 2013, REPROD SCI, V20, P371, DOI 10.1177/1933719112459239; Neubauer Nikki L., 2011, Hormones & Cancer, V2, P170, DOI 10.1007/s12672-011-0065-7; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Okada H, 2011, FERTIL STERIL, V96, P786, DOI 10.1016/j.fertnstert.2011.06.048; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Selvaraj V, 2014, INT J NANOMED, V9, P1379, DOI 10.2147/IJN.S52625; Semenza GL, 2007, J CELL BIOCHEM, V102, P840, DOI 10.1002/jcb.21523; Shao RJ, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.381; Shimizu T, 2007, ANIM REPROD SCI, V102, P228, DOI 10.1016/j.anireprosci.2006.11.012; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Talaulikar VS, 2012, EUR J OBSTET GYN R B, V165, P135, DOI 10.1016/j.ejogrb.2012.07.023; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Thomas P, 2013, STEROIDS, V78, P583, DOI 10.1016/j.steroids.2013.01.003; Tsukada S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt168; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Walter LM, 2005, REPRODUCTION, V129, P765, DOI 10.1530/rep.1.00625; Wang XY, 2013, EXP THER MED, V6, P263, DOI 10.3892/etm.2013.1116; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756; Wassmann S, 2006, CIRC RES, V99, pE74, DOI 10.1161/01.RES.0000246095.90247.d4; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Westin SN, 2012, CANCER BIOL THER, V13, P1, DOI 10.4161/cbt.13.1.18438; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu FF, 2014, BRAIN INJURY, V28, P1594, DOI 10.3109/02699052.2014.943289; Yeh CH, 1998, BLOOD, V92, P3268, DOI 10.1182/blood.V92.9.3268.421k41_3268_3276; Yu P, 2016, CELL PROLIFERAT, V49, P48, DOI 10.1111/cpr.12231; Yuan JJ, 2015, REPROD SCI, V22, P1516, DOI 10.1177/1933719115589409; Zhang RL, 2006, J NEUROSCI RES, V83, P1213, DOI 10.1002/jnr.20813; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	70	16	19	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7722	1365-2184		CELL PROLIFERAT	Cell Prolif.	OCT	2017	50	5							e12362	10.1111/cpr.12362			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FF7LQ	WOS:000409197900009	28752929	Green Published			2022-02-06	
J	Nagendran, T; Larsen, RS; Bigler, RL; Frost, SB; Philpot, BD; Nudo, RJ; Taylor, AM				Nagendran, Tharkika; Larsen, Rylan S.; Bigler, Rebecca L.; Frost, Shawn B.; Philpot, Benjamin D.; Nudo, Randolph J.; Taylor, Anne Marion			Distal axotomy enhances retrograde presynaptic excitability onto injured pyramidal neurons via trans-synaptic signaling	NATURE COMMUNICATIONS			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; PRIMARY MOTOR CORTEX; CORTICAL-NEURONS; GABAERGIC INHIBITION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; AXONAL INJURY; NITRIC-OXIDE	Injury of CNS nerve tracts remodels circuitry through dendritic spine loss and hyper-excitability, thus influencing recovery. Due to the complexity of the CNS, a mechanistic understanding of injury-induced synaptic remodeling remains unclear. Using microfluidic chambers to separate and injure distal axons, we show that axotomy causes retrograde dendritic spine loss at directly injured pyramidal neurons followed by retrograde presynaptic hyper-excitability. These remodeling events require activity at the site of injury, axon-to-soma signaling, and transcription. Similarly, directly injured corticospinal neurons in vivo also exhibit a specific increase in spiking following axon injury. Axotomy-induced hyperexcitability of cultured neurons coincides with elimination of inhibitory inputs onto injured neurons, including those formed onto dendritic spines. Netrin-1 downregulation occurs following axon injury and exogenous netrin-1 applied after injury normalizes spine density, presynaptic excitability, and inhibitory inputs at injured neurons. Our findings show that intrinsic signaling within damaged neurons regulates synaptic remodeling and involves netrin-1 signaling.	[Nagendran, Tharkika; Taylor, Anne Marion] Univ N Carolina, UNC NCSU Joint Dept Biomed Engn, Campus Box 7575, Chapel Hill, NC 27599 USA; [Nagendran, Tharkika; Larsen, Rylan S.; Philpot, Benjamin D.; Taylor, Anne Marion] Univ N Carolina, UNC Neurosci Ctr, Campus Box 7250, Chapel Hill, NC 27599 USA; [Larsen, Rylan S.; Philpot, Benjamin D.] Univ N Carolina, Dept Cell Biol & Physiol, Campus Box 7545, Chapel Hill, NC 27599 USA; [Bigler, Rebecca L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Frost, Shawn B.; Nudo, Randolph J.] Univ Kansas, Med Ctr, Landon Ctr Aging, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Frost, Shawn B.; Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Rehabil Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Philpot, Benjamin D.; Taylor, Anne Marion] Carolina Inst Dev Disabil, Campus Box 7255, Chapel Hill, NC 27599 USA; [Larsen, Rylan S.] Allen Inst Brain Sci, 615 Westlake Ave North, Seattle, WA 98109 USA		Taylor, AM (corresponding author), Univ N Carolina, UNC NCSU Joint Dept Biomed Engn, Campus Box 7575, Chapel Hill, NC 27599 USA.; Taylor, AM (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Campus Box 7250, Chapel Hill, NC 27599 USA.; Taylor, AM (corresponding author), Carolina Inst Dev Disabil, Campus Box 7255, Chapel Hill, NC 27599 USA.	anne.marion.taylor@gmail.com	Taylor, Anne Marion/F-4454-2012; Nagendran, Tharkika/N-2335-2019	Taylor, Anne Marion/0000-0003-0998-087X; Larsen, Rylan/0000-0002-7136-1175	American Heart AssociationAmerican Heart Association [17GRNT33700108]; Eunice Kennedy Shriver NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD073945]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R42 MH097377]; Alfred P. Sloan Research FellowshipAlfred P. Sloan Foundation; NIH-NINDS Neuroscience Center Support Grant [P30 NS045892]; NIH- NICHD Intellectual and Developmental Disabilities Research Center Support Grant [U54 D079124]; NRSA predoctoral fellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 MH091817]; UNC Department of Cell Biology and Physiology's Dr Susan Fellner fellowship; NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5T32 GM007092]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS085093, R01 NS30853]; Ronald D. Deffenbaugh Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD073945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R42MH097377, F31MH091817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS045892, R01NS085093, R01NS030853] Funding Source: NIH RePORTER	We thank Stephanie Gupton for netrin-1, Kelly Carstens for preliminary gene expression work, Cassie Meeker for technical support, and Fabio Urbina for assistance in statistical analysis. We thank Richard Segal (MUSC), Julius Dewald (RIC), and Taylor lab members for their advice and discussions. A.M.T. acknowledges support from the American Heart Association (17GRNT33700108), Eunice Kennedy Shriver NICHD (K12 HD073945), NIMH (R42 MH097377), and an Alfred P. Sloan Research Fellowship. Imaging was partially performed at the Neuroscience Center Microscopy Core Facility, supported, in part, by funding from the NIH-NINDS Neuroscience Center Support Grant P30 NS045892 and the NIH- NICHD Intellectual and Developmental Disabilities Research Center Support Grant U54 D079124. R.S.L was supported by NRSA predoctoral fellowship F31 MH091817 and the UNC Department of Cell Biology and Physiology's Dr Susan Fellner fellowship. R.L.B. was supported in part by NIGMS grant 5T32 GM007092. B.D.P was supported by NINDS grant R01 NS085093. R.J.N. was supported by NINDS grant R01 NS30853 and the Ronald D. Deffenbaugh Family Foundation.	Ahn KJ, 2007, NEUROSCI LETT, V419, P43, DOI 10.1016/j.neulet.2007.03.068; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARRON KD, 1988, J NEUROPATH EXP NEUR, V47, P62, DOI 10.1097/00005072-198801000-00008; BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Canty AJ, 2013, J NEUROSCI, V33, P10374, DOI 10.1523/JNEUROSCI.0254-13.2013; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Du GH, 2011, RADIAT RES, V176, P706, DOI 10.1667/RR2592.1; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Frost SB, 2015, J NEUROTRAUM, V32, P1666, DOI 10.1089/neu.2015.3961; Fu MM, 2014, AUTOPHAGY, V10, P2079, DOI 10.4161/auto.34451; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Ghosh A, 2012, CEREB CORTEX, V22, P1309, DOI 10.1093/cercor/bhr191; Goldman JS, 2013, J NEUROSCI, V33, P17278, DOI 10.1523/JNEUROSCI.1085-13.2013; Gonzalez-Forero D, 2014, NEUROSCIENCE, V283, P138, DOI 10.1016/j.neuroscience.2014.08.021; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Han XF, 2017, MOL NEUROBIOL, V54, P1684, DOI 10.1007/s12035-016-9723-7; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Henry FE, 2012, J NEUROSCI, V32, P17128, DOI 10.1523/JNEUROSCI.2149-12.2012; Higley MJ, 2014, NAT REV NEUROSCI, V15, P567, DOI 10.1038/nrn3803; Horn KE, 2013, CELL REP, V3, P173, DOI 10.1016/j.celrep.2012.12.005; Ikeda S, 1998, BRAIN RES, V792, P164, DOI 10.1016/S0006-8993(98)00213-3; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jaerve A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049812; Kim BG, 2006, EXP NEUROL, V198, P401, DOI 10.1016/j.expneurol.2005.12.010; Larsen RS, 2014, NEURON, V83, P879, DOI 10.1016/j.neuron.2014.07.039; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lu Haiyan, 2011, Front Med, V5, P86, DOI 10.1007/s11684-011-0118-x; Manitt C, 2006, J NEUROSCI RES, V84, P1808, DOI 10.1002/jnr.21070; Manitt C, 2009, J NEUROSCI, V29, P11065, DOI 10.1523/JNEUROSCI.0947-09.2009; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McIlwain DL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-19; MCKINLEY PA, 1990, J NEUROSCI, V10, P1429; Menon S, 2015, DEV CELL, V35, P698, DOI 10.1016/j.devcel.2015.11.022; Nagendran T, 2011, NEUROSCIENCE, V199, P548, DOI 10.1016/j.neuroscience.2011.09.048; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Neto E, 2016, J NEUROSCI, V36, P11573, DOI 10.1523/JNEUROSCI.1748-16.2016; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; NUDO RJ, 1995, J COMP NEUROL, V358, P181, DOI 10.1002/cne.903580203; Oudega M, 2012, J PHYSIOL-LONDON, V590, P3647, DOI 10.1113/jphysiol.2012.233189; Persson AK, 2013, J NEUROSCI, V33, P19250, DOI 10.1523/JNEUROSCI.2148-13.2013; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Stavoe AKH, 2012, J CELL BIOL, V197, P75, DOI 10.1083/jcb.201110127; Sun H, 2011, NEUROBIOL DIS, V44, P73, DOI 10.1016/j.nbd.2011.06.006; Sunico CR, 2005, J NEUROSCI, V25, P1448, DOI 10.1523/JNEUROSCI.4600-04.2005; Takechi U, 2014, CLIN NEUROPHYSIOL, V125, P2055, DOI 10.1016/j.clinph.2014.01.034; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Taylor AM, 2013, J NEUROSCI, V33, P5584, DOI 10.1523/JNEUROSCI.2944-12.2013; Tu HJ, 2015, NEURON, V86, P1407, DOI 10.1016/j.neuron.2015.05.013; Urban ETR, 2012, MOL CELL BIOCHEM, V369, P267, DOI 10.1007/s11010-012-1390-z; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014; Xu K, 2014, SCIENCE, V344, P1275, DOI 10.1126/science.1255149; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	65	16	16	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	SEP 20	2017	8								625	10.1038/s41467-017-00652-y			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6VJ	WOS:000411317800001	28931811	Green Submitted, Green Published, gold			2022-02-06	
J	Lee, BE; Choi, BY; Hong, DK; Kim, JH; Lee, SH; Kho, AR; Kim, H; Choi, HC; Suh, SW				Lee, Bo Eun; Choi, Bo Young; Hong, Dae Kee; Kim, Jin Hee; Lee, Song Hee; Kho, A. Ra; Kim, Haesung; Choi, Hui Chul; Suh, Sang Won			The cancer chemotherapeutic agent paclitaxel (Taxol) reduces hippocampal neurogenesis via down-regulation of vesicular zinc	SCIENTIFIC REPORTS			English	Article							LONG-TERM POTENTIATION; RECEIVING ADJUVANT TREATMENT; TRAUMATIC BRAIN-INJURY; BREAST-CANCER; COGNITIVE DYSFUNCTION; ADULT NEUROGENESIS; DENTATE GYRUS; CELLS; WOMEN; MICE	Chemotherapy-induced cognitive impairment (CICI) is increasingly recognized as a major unwanted side effect of an otherwise highly valuable life-saving technology. In part, this awareness is a result of increased cancer survival rates following chemotherapy. Altered hippocampal neurogenesis may play a role in mediating CICI. In particular, zinc could act as a key regulator of this process. To test this hypothesis, we administered paclitaxel (Px) to male C57BL/6 mice for set time periods and then evaluated the effects of Px treatment on hippocampal neurogenesis and vesicular zinc. We found that vesicular zinc levels and expression of zinc transporter 3 (ZnT3) were reduced in Px-treated mice, compared to vehicle-treated mice. Moreover, Px-treated mice demonstrated a significant decrease in the number of neuroblasts present. However, no difference in the number of progenitor cells were observed. In addition, zinc supplementation by treatment with ZnCl2 ameliorated the Px-induced decrease in hippocampal neurogenesis and cognitive impairment. These results suggest that via disruption of vesicular zinc stores in hippocampal mossy fiber terminals, chemotherapy may impinge upon one or more of the sequential stages involved in the maturation of new neurons derived via adult neurogenesis and thereby leads to the progressive cognitive decline associated with CICI.	[Lee, Bo Eun; Choi, Bo Young; Hong, Dae Kee; Kim, Jin Hee; Lee, Song Hee; Kho, A. Ra; Suh, Sang Won] Hallym Univ, Coll Med, Dept Phys, Chunchon, South Korea; [Choi, Hui Chul] Chuncheon Sacred Heart Hosp, Coll Med, Dept Neurol, Chunchon, South Korea; [Kim, Haesung] Chuncheon Sacred Heart Hosp, Coll Med, Dept Surg, Chunchon, South Korea		Suh, SW (corresponding author), Hallym Univ, Coll Med, Dept Phys, Chunchon, South Korea.	swsuh@hallym.ac.kr		Hong, Dae Ki/0000-0002-8937-1064; Hong, Dae-Ki/0000-0003-3769-3456; Choi, Bo Young/0000-0002-9579-3503; Suh, Sang Won/0000-0002-7492-579X	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016M3C7A1913844]	This work was support by Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016M3C7A1913844) to S.W.S.	Avraham HK, 2014, J PATHOL, V232, P369, DOI 10.1002/path.4304; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Barton DL, 2013, SUPPORT CARE CANCER, V21, P1185, DOI 10.1007/s00520-012-1647-9; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Bower JE, 2008, J CLIN ONCOL, V26, P768, DOI 10.1200/JCO.2007.14.3248; Brayer SW, 2015, NEUROREHAB NEURAL RE, V29, P483, DOI 10.1177/1545968314550367; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Choi BY, 2016, NEUROSCIENCE, V339, P634, DOI 10.1016/j.neuroscience.2016.10.035; Choi BY, 2014, J TRACE ELEM MED BIO, V28, P474, DOI 10.1016/j.jtemb.2014.07.007; Choi BY, 2014, METALLOMICS, V6, P1513, DOI 10.1039/c4mt00067f; Davis J, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-153; Dietrich J, 2008, ONCOLOGIST, V13, P1285, DOI 10.1634/theoncologist.2008-0130; Fan HGM, 2008, SUPPORT CARE CANCER, V16, P577, DOI 10.1007/s00520-007-0341-9; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Gangloff A, 2005, J NUCL MED, V46, P1866; Ganguly A, 2010, MOL CANCER THER, V9, P2914, DOI 10.1158/1535-7163.MCT-10-0552; GOLUB MS, 1994, AM J CLIN NUTR, V60, P238, DOI 10.1093/ajcn/60.2.238; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Huang YS, 2015, BIOCHEM J, V466, P499, DOI 10.1042/BJ20141143; Janelsins MC, 2010, CANCER INVEST, V28, P544, DOI 10.3109/07357900903405942; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kampan NC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/413076; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048543; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Linkous DH, 2008, J HISTOCHEM CYTOCHEM, V56, P3, DOI 10.1369/jhc.6A7035.2007; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Mennenga SE, 2015, PHYSIOL BEHAV, V138, P260, DOI 10.1016/j.physbeh.2014.09.001; Monje M, 2012, BEHAV BRAIN RES, V227, P376, DOI 10.1016/j.bbr.2011.05.012; Moore HCF, 2014, ONCOLOGY-NY, V28, P797; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nabholtz J M, 2000, Expert Opin Pharmacother, V1, P187, DOI 10.1517/14656566.1.2.187; Nokia MS, 2012, EUR J NEUROSCI, V36, P3521, DOI 10.1111/ejn.12007; PerezClausell J, 1996, J CHEM NEUROANAT, V11, P99, DOI 10.1016/0891-0618(96)00131-7; Qian AQ, 2006, J NEUROSCI, V26, P10899, DOI 10.1523/JNEUROSCI.3453-06.2006; Qian J, 2005, J PHYSIOL-LONDON, V566, P747, DOI 10.1113/jphysiol.2005.089276; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rodriguez PL, 2014, INT J CANCER, V134, P1034, DOI 10.1002/ijc.28433; Shemesh OA, 2010, ACTA NEUROPATHOL, V119, P235, DOI 10.1007/s00401-009-0586-0; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Suzuki M, 2015, NEUROCHEM INT, V87, P60, DOI 10.1016/j.neuint.2015.05.006; Takeda A, 2008, NEUROCHEM INT, V52, P241, DOI 10.1016/j.neuint.2007.06.021; Tanimukai H, 2013, BIOCHEM BIOPH RES CO, V437, P151, DOI 10.1016/j.bbrc.2013.06.057; van Dam FSAM, 1998, J NATL CANCER I, V90, P210, DOI 10.1093/jnci/90.3.210; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vardy J, 2007, CRIT REV ONCOL HEMAT, V63, P183, DOI 10.1016/j.critrevonc.2007.06.001; Vardy J, 2007, J CLIN ONCOL, V25, P2455, DOI 10.1200/JCO.2006.08.1604; Wefel JS, 2004, CANCER-AM CANCER SOC, V100, P2292, DOI 10.1002/cncr.20272; WEISS JH, 1989, NATURE, V338, P212, DOI 10.1038/338212b0; You L, 2015, BIOCHEM BIOPH RES CO, V456, P598, DOI 10.1016/j.bbrc.2014.11.120	57	16	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 15	2017	7								11667	10.1038/s41598-017-12054-7			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VQ	WOS:000410859100005	28916767	gold, Green Published			2022-02-06	
J	Bailly, N; Llari, M; Donnadieu, T; Masson, C; Arnoux, PJ				Bailly, N.; Llari, M.; Donnadieu, T.; Masson, C.; Arnoux, P. J.			Head impact in a snowboarding accident	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						Snowboard; ski; head injury; helmet; biomechanics	INJURIES; CONCUSSION; HELMETS; SKIERS; RISK	To effectively prevent sport traumatic brain injury (TBI), means of protection need to be designed and tested in relation to the reality of head impact. This study quantifies head impacts during a typical snowboarding accident to evaluate helmet standards. A snowboarder numerical model was proposed, validated against experimental data, and used to quantify the influence of accident conditions (speed, snow stiffness, morphology, and position) on head impacts (locations, velocities, and accelerations) and injury risk during snowboarding backward falls. Three hundred twenty-four scenarios were simulated: 70% presented a high risk of mild TBI (head peak acceleration >80g) and 15% presented a high risk of severe TBI (head injury criterion >1000). Snow stiffness, speed, and snowboarder morphology were the main factors influencing head impact metrics. Mean normal head impact speed (28 +/- 6km/h) was higher than equivalent impact speed used in American standard helmet test (ASTM F2040), and mean tangential impact speed, not included in standard tests, was 13.8 (+/- 7km/h). In 97% of simulated impacts, the peak head acceleration was below 300g, which is the pass/fail criteria used in standard tests. Results suggest that initial speed, impacted surface, and pass/fail criteria used in helmet standard performance tests do not fully reflect magnitude and variability of snowboarding backward-fall impacts.	[Bailly, N.; Llari, M.; Masson, C.; Arnoux, P. J.] Univ Mediterranee, IFSTTAR UMRT24, Lab Biomecan Appl, Marseille 20, France; [Bailly, N.; Donnadieu, T.] Salomon SAS, Annecy 9, France		Bailly, N (corresponding author), Univ Mediterranee, IFSTTAR UMRT24, Lab Biomecan Appl, Fac Med Sect Nord, Bd P Dramard, F-13916 Marseille 20, France.	nicolas.bailly@ifsttar.fr	ARNOUX, Pierre Jean/AAK-6652-2021	ARNOUX, Pierre Jean/0000-0002-0311-560X			Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Association des Medecin de Montagne, 2013, DOSS PRESS ACC SPORT; Beusenberg MC., 2000, P INT RES C BIOM IMP; Bourdet N, 2014, INT J CRASHWORTHINES, V19, P222, DOI 10.1080/13588265.2013.805293; Cavallero C, 1983, IMPROVEMENT PEDESTRI; Di Landro L, 2002, POLYM TEST, V21, P217, DOI 10.1016/S0142-9418(01)00073-3; Domaines skiables de France, 2013, IND AN 2013; Dressler D, 2012, AM SOC TEST MATER, V1553, P235, DOI 10.1520/STP104525; European Committee for Standardization, 2007, 10772007 EUR COMM ST; European Committee for Standardization, 2006, 9602006 BS EN, V960; F08 Committee, 2011, F 2040 SPEC HELM US; Fierz C, 2009, J ECOL, V12, P111; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Funk James R, 2008, Biomed Sci Instrum, V44, P207; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Glasson E, 2000, IMECHE CONF TRANS, V2000, P79; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; King A. I., 2003, IRCOBI C LISB PORT; Kleinberger M, 1998, DEV IMPROVED INJURY; Koyama S, 2011, AM J SPORT MED, V39, P2656, DOI 10.1177/0363546511422331; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; Meyers MC, 2007, SPORTS MED, V37, P485, DOI 10.2165/00007256-200737060-00003; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; Nakaguchi H, 2002, J NEUROSURG, V97, P542, DOI 10.3171/jns.2002.97.3.0542; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Richards Darrin, 2008, Journal of ASTM International, V5, DOI 10.1520/JAI101406; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Ruedl G, 2013, WILD ENVIRON MED, V24, P118, DOI 10.1016/j.wem.2012.11.021; Scher I., 2006, Journal of ASTM International (JAI), V3, pJAI14203, DOI 10.1520/JAI14203; Serre T, 2007, INT J CRASHWORTHINES, V12, P227, DOI 10.1080/13588260701441050; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Van Hooijdonk, 2012, IRCOBI C SEPT 12 14, P622; Xiang HY, 2005, J TRAUMA, V58, P112, DOI 10.1097/01.TA.0000151270.26634.DD; Yang J.K., 2000, J CRASH PREVENTION I, V2, P131, DOI [10.1080/10286580008902559, DOI 10.1080/10286580008902559]; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	40	16	16	2	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	SEP	2017	27	9					964	974		10.1111/sms.12699			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FC8DJ	WOS:000407071700007	27185578				2022-02-06	
J	Cadena, R; Shoykhet, M; Ratcliff, JJ				Cadena, Rhonda; Shoykhet, Michael; Ratcliff, Jonathan J.			Emergency Neurological Life Support: Intracranial Hypertension and Herniation	NEUROCRITICAL CARE			English	Article						Intracranial pressure; Emergency Neurological Life Support; Neurocritical care; Intracranial hypertension	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; DECOMPRESSIVE CRANIECTOMY; PERFUSION-PRESSURE; HYPERTONIC SALINE; RANDOMIZED-TRIAL; TRANSTENTORIAL HERNIATION; INTRACEREBRAL HEMORRHAGE; DIABETIC-KETOACIDOSIS	Sustained intracranial hypertension and acute brain herniation are "brain codes,'' signifying catastrophic neurological events that require immediate recognition and treatment to prevent irreversible injury and death. As in cardiac arrest, a brain code mandates the organized implementation of a stepwise management algorithm. The goal of this Emergency Neurological Life Support protocol is to implement an evidence-based, standardized approach to the evaluation and management of patients with intracranial hypertension and/or herniation.	[Cadena, Rhonda] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27599 USA; [Cadena, Rhonda] Univ N Carolina, Sch Med, Dept Neurosurg, Chapel Hill, NC 27599 USA; [Cadena, Rhonda] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC 27599 USA; [Shoykhet, Michael] Washington Univ, Sch Med, Dept Pediat, Pediat Crit Care Med, St Louis, MO 63110 USA; [Ratcliff, Jonathan J.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Ratcliff, Jonathan J.] Emory Univ, Dept Neurol, Atlanta, GA USA		Cadena, R (corresponding author), Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27599 USA.; Cadena, R (corresponding author), Univ N Carolina, Sch Med, Dept Neurosurg, Chapel Hill, NC 27599 USA.; Cadena, R (corresponding author), Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC 27599 USA.	rhonda.cadena@unc.edu; jonathan.ratcliff@emoryhealthcare.org		Shoykhet, Michael/0000-0001-5031-2377			Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; Brain Trauma F American Association of Neurological S Congress of Neurological S, 2016, GUID MAN SERV TRAUM; Brain Trauma Foundation, 2016, GUID MAN SERV TRAUM; Bulger EM, 2012, JAMA-J AM MED ASSOC, V304, P1455; Bullock MR, 1996, J NEUROTRAUM, V13, P711; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cushing H, 1901, B J HOPKINS HOSP, V126, P289; DUBICK MA, 1994, J TRAUMA, V36, P323, DOI 10.1097/00005373-199403000-00007; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Edge JA, 2001, ARCH DIS CHILD, V85, P16, DOI 10.1136/adc.85.1.16; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Fong JJ, 2008, CRIT CARE MED, V36, P2281, DOI 10.1097/CCM.0b013e318180c1eb; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; GALICICH JH, 1961, J LANCET, V81, P46; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Johnson RD, 2011, J CLIN NEUROSCI, V18, P1018, DOI 10.1016/j.jocn.2010.12.021; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; Kerr ME, 2000, J NEUROSURG ANESTH, V12, P324, DOI 10.1097/00008506-200010000-00005; Khoshyomn Sami, 2004, Semin Pediatr Surg, V13, P80, DOI 10.1053/j.sempedsurg.2004.01.003; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Mendelow AD, 2005, LANCET, V365, P387; Meyer A, 1920, ARCH NEURO PSYCHIATR, V4, P387, DOI 10.1001/archneurpsyc.1920.02180220036003; Monro A., 1783, OBSERVATIONS STRUCTU; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Perez-Barcena J, 2008, CRIT CARE, V12, DOI 10.1186/cc6999; Pfefferkorn T, 2009, STROKE, V40, P3045, DOI 10.1161/STROKEAHA.109.550871; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; QUARTEY GRC, 1976, J NEUROSURG, V45, P301, DOI 10.3171/jns.1976.45.3.0301; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Raco A, 2003, NEUROSURGERY, V53, P1061, DOI 10.1227/01.NEU.0000088766.34559.3E; Roberts RJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8145; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; Sperling, 2014, PEDIAT ENDOCRINOLOGY; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012	59	16	16	1	11	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	SEP	2017	27			1			S82	S88		10.1007/s12028-017-0454-z			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FU8HO	WOS:000424094100006	28913634	Green Submitted			2022-02-06	
J	Hurstak, E; Johnson, JK; Tieu, L; Guzman, D; Ponath, C; Lee, CT; Jamora, CW; Kushel, M				Hurstak, Emily; Johnson, Julene K.; Tieu, Lina; Guzman, David; Ponath, Claudia; Lee, Christopher T.; Jamora, Christina Weyer; Kushel, Margot			Factors associated with cognitive impairment in a cohort of older homeless adults: Results from the HOPE HOME study	DRUG AND ALCOHOL DEPENDENCE			English	Article						Cognitive impairment; Homeless persons; Alcohol misuse	TRAUMATIC BRAIN-INJURY; ALCOHOL-USE DISORDERS; EXECUTIVE FUNCTION; GERIATRIC SYNDROMES; GENERAL-POPULATION; RISK DRINKING; HEALTH; MEMORY; PERFORMANCE; VALIDATION	Background: We evaluated cognitive function and factors associated with cognitive impairment in a cohort of older homeless adults. We hypothesized that substance use and a history of traumatic brain injury would be associated with cognitive impairment. Methods: We recruited 350 homeless individuals aged >= 50 years using population-based sampling and conducted structured interviews and neuropsychological testing. We evaluated alcohol use with the Alcohol Use Disorder Identification Test, defining high-severity alcohol use as a total score >= 16 or >= 4 on the alcohol dependency sub-scale. We assessed global cognition with the Modified Mini-Mental State Test (3MS) and processing speed and executive function with the Trail Making Test (TMTB), defining impairment as performing 1.5 standard deviations below the standardized mean. We used multivariable logistic regression to examine the association between alcohol use and cognition. Results: Participants had a median age of 58 years [IQR 54-61], 76.7% were men, and 79.9% were African American. A quarter (25.1%) of participants met criteria for impairment on the 3MS; 32.9% met criteria for impairment on TMTB. In models adjusted for sociodemographic variables and health conditions, high-severity alcohol use was associated with global cognitive impairment (AOR 2.39, CI 1.19-4.79) and executive dysfunction (AOR 3.09, CI 1.61-5.92). Conclusions: Older homeless adults displayed a prevalence of cognitive impairment 3-4 times higher than has been observed in general population adults aged 70 and older. Impaired cognition in older homeless adults could impact access to housing programs and the treatment of health conditions, including the treatment of alcohol use disorders.	[Hurstak, Emily; Tieu, Lina; Guzman, David; Ponath, Claudia; Lee, Christopher T.; Kushel, Margot] Univ Calif San Francisco, Div Gen Internal Med, Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA 94143 USA; [Johnson, Julene K.] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA USA; [Johnson, Julene K.; Jamora, Christina Weyer] Univ Calif San Francisco, Ctr Aging Diverse Communities, San Francisco, CA 94143 USA; [Tieu, Lina; Guzman, David; Lee, Christopher T.; Kushel, Margot] Univ Calif San Francisco, Ctr Vulnerable Populat, Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA 94143 USA; [Jamora, Christina Weyer] Univ Calif San Francisco, Dept Psychiat, Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA 94143 USA		Hurstak, E; Kushel, M (corresponding author), UCSF ZSFG, Box 1364, San Francisco, CA 94143 USA.	Emily.hurstak@ucsf.edu; Margot.kushel@ucsf.edu		Lee, Christopher/0000-0001-7957-1524; Tieu, Lina/0000-0002-9980-0774; Kushel, Margot/0000-0002-1361-6889	National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG041860, K24AG046372, P30AG15272, P30AG044281]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HP19025]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG041860, K24AG046372, P30AG044281, P30AG015272] Funding Source: NIH RePORTER	This study was funded by grants from the National Institute on Aging (NIA): R01AG041860 [Kushel, Ponath, Guzman], K24AG046372 [Kushel, Guzman and Tieu], P30AG15272 [Johnson], and P30AG044281 [Kushel]. These funding sources had no role in the preparation, review, or approval of the manuscript and do not necessarily represent the official views of the NIH or AHRQ.; Dr. Hurstak receives fellowship support from National Institute of HealthT32HP19025.	Al Hazzouri AZ, 2017, AM J PREV MED, V52, P1, DOI 10.1016/j.amepre.2016.08.009; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Andersen J, 2014, DISABIL REHABIL, V36, P2210, DOI 10.3109/09638288.2014.895870; Arias F, 2016, ADDICT BEHAV, V60, P137, DOI 10.1016/j.addbeh.2016.03.018; Babor T.F., 2001, AUDIT THE ALCOHOL US; Backer Thomas Earl, 2007, J Prim Prev, V28, P375, DOI 10.1007/s10935-007-0100-1; Bates ME, 2005, ALCOHOL CLIN EXP RES, V29, P367, DOI 10.1097/01.ALC.0000156131.88125.2A; Bland RC, 2001, CAN J PSYCHIAT, V46, P506, DOI 10.1177/070674370104600604; Bommersbach TJ, 2015, MAYO CLIN PROC, V90, P659, DOI 10.1016/j.mayocp.2015.03.012; Bousman CA, 2010, J NERV MENT DIS, V198, P790, DOI 10.1097/NMD.0b013e3181f97dff; BRANDT J, 1983, ARCH GEN PSYCHIAT, V40, P435; Bravo G, 1997, INT J GERIATR PSYCH, V12, P1008, DOI 10.1002/(SICI)1099-1166(199710)12:10<1008::AID-GPS676>3.0.CO;2-A; Brown R.T., 2016, GERONTOLOGIST; Brown RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155065; Brown RT, 2013, J HEALTH CARE POOR U, V24, P456, DOI 10.1353/hpu.2013.0077; Brown RT, 2012, J GEN INTERN MED, V27, P16, DOI 10.1007/s11606-011-1848-9; Buhrich N, 2000, PSYCHIATR SERV, V51, P520, DOI 10.1176/appi.ps.51.4.520; BURNAM MA, 1988, EVALUATION REV, V12, P117, DOI 10.1177/0193841X8801200202; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; Burt M.R., 1999, HOMELESSNESS PROGRAM; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Carpenter WT, 2000, ARCH GEN PSYCHIAT, V57, P533, DOI 10.1001/archpsyc.57.6.533; Chen YJ, 2017, ALZHEIMERS DEMENT, V13, P399, DOI 10.1016/j.jalz.2016.07.151; Cimino T, 2015, JAMA INTERN MED, V175, P1237, DOI 10.1001/jamainternmed.2015.1562; CONIGRAVE KM, 1995, ADDICTION, V90, P1479, DOI 10.1111/j.1360-0443.1995.tb02810.x; Connelly R., 2016, METHOD INNOV, V9; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Crews FT, 2005, ALCOHOL CLIN EXP RES, V29, P1504, DOI 10.1097/01.alc.0000175013.50644.61; Culhane Dennis P., 2013, ANAL SOCIAL ISSUES P, V13, P1; Darke S, 2000, ADDICTION, V95, P687, DOI 10.1046/j.1360-0443.2000.9556874.x; Department of Housing and Urban Development, 2011, HOM EM ASS RAP TRANS; Depp CA, 2015, J NERV MENT DIS, V203, P126, DOI 10.1097/NMD.0000000000000248; Ennis N., 2014, MEMORY, P1; Ersche KD, 2006, NEUROPSYCHOPHARMACOL, V31, P1036, DOI 10.1038/sj.npp.1300889; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; Gabrielian S, 2015, J CLIN PSYCHIAT, V76, pE469, DOI 10.4088/JCP.14m09229; Gardner RC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002246; Garibaldi B, 2005, J GEN INTERN MED, V20, P726, DOI 10.1111/j.1525-1497.2005.0142.x; GELBERG L, 1990, J AM GERIATR SOC, V38, P1220, DOI 10.1111/j.1532-5415.1990.tb01503.x; Gonzalez EA, 2001, J NERV MENT DIS, V189, P176, DOI 10.1097/00005053-200103000-00006; Hagen E, 2016, J SUBST ABUSE TREAT, V66, P1, DOI 10.1016/j.jsat.2016.02.010; Heaton R. K., 2004, REVISED COMPREHENSIV; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Inozemtseva O., 2016, SUBST USE MISUSE, P1; Johnson JK, 2007, J GERONTOL A-BIOL, V62, P1134, DOI 10.1093/gerona/62.10.1134; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Koedam ELGE, 2008, DEMENT GERIATR COGN, V26, P147, DOI 10.1159/000149585; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Lee CT, 2016, SOC SCI MED, V153, P131, DOI 10.1016/j.socscimed.2016.02.004; Lee CM, 2017, AM J GERIAT PSYCHIAT, V25, P107, DOI 10.1016/j.jagp.2016.07.019; Lundin A, 2015, ALCOHOL CLIN EXP RES, V39, P158, DOI 10.1111/acer.12593; Lundqvist T, 2005, PHARMACOL BIOCHEM BE, V81, P319, DOI 10.1016/j.pbb.2005.02.017; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; McTeague L.M., 2017, AM J PSYCHIAT; Monteiro, 2010, ALCOHOL SMOKING SUBS; Montgomery AE, 2015, PSYCHIAT SERV, V66, P317, DOI 10.1176/appi.ps.201400014; Nishio A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138052; Pluck G, 2011, BRIT J CLIN PSYCHOL, V50, P33, DOI 10.1348/014466510X490253; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RITCHEY FJ, 1990, AM J PUBLIC HEALTH, V80, P1384, DOI 10.2105/AJPH.80.11.1384; Rumpf HJ, 2002, ALCOHOL ALCOHOLISM, V37, P261, DOI 10.1093/alcalc/37.3.261; Sabia S, 2014, NEUROLOGY, V82, P332, DOI 10.1212/WNL.0000000000000063; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Seidman LJ, 2003, PSYCHIAT SERV, V54, P905, DOI 10.1176/appi.ps.54.6.905; Seidman LJ, 1997, J NERV MENT DIS, V185, P3, DOI 10.1097/00005053-199701000-00002; Shih RA, 2011, AM J PUBLIC HEALTH, V101, P1721, DOI 10.2105/AJPH.2011.300169; SOLARZ A, 1990, J COMMUNITY PSYCHOL, V18, P79, DOI 10.1002/1520-6629(199001)18:1<79::AID-JCOP2290180112>3.0.CO;2-B; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; Stergiopoulos V, 2015, ACTA PSYCHIAT SCAND, V131, P256, DOI 10.1111/acps.12391; Sullivan G, 2001, PSYCHIATR SERV, V52, P1097, DOI 10.1176/appi.ps.52.8.1097; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Tsemberis S, 2007, J COMMUNITY PSYCHOL, V35, P29, DOI 10.1002/jcop.20132; Verdejo-Garcia A, 2007, PSYCHOPHARMACOLOGY, V190, P517, DOI 10.1007/s00213-006-0632-8; Virag M, 2015, EXP BRAIN RES, V233, P2081, DOI 10.1007/s00221-015-4279-8; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Wilcox CE, 2014, REV NEUROSCIENCE, V25, P1, DOI 10.1515/revneuro-2013-0054; Wong S, 2016, J ALZHEIMERS DIS, V51, P889, DOI 10.3233/JAD-151016; Wong YLI, 2000, PSYCHOL ASSESSMENT, V12, P69, DOI 10.1037/1040-3590.12.1.69; Woods AJ, 2016, ALCOHOL CLIN EXP RES, V40, P2435, DOI 10.1111/acer.13211; Yarborough BJH, 2016, DRUG ALCOHOL DEPEN, V167, P49, DOI 10.1016/j.drugalcdep.2016.07.024	86	16	16	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0376-8716	1879-0046		DRUG ALCOHOL DEPEN	Drug Alcohol Depend.	SEP 1	2017	178						562	570		10.1016/j.drugalcdep.2017.06.002			9	Substance Abuse; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry	FF6UK	WOS:000409152300077	28738314	Green Accepted			2022-02-06	
J	Perez-Urrutia, N; Mendoza, C; Alvarez-Ricartes, N; Oliveros-Matus, P; Echeverria, F; Grizzell, JA; Barreto, GE; Iarkov, A; Echeverria, V				Perez-Urrutia, Nelson; Mendoza, Cristhian; Alvarez-Ricartes, Nathalie; Oliveros-Matus, Patricia; Echeverria, Florencia; Alex Grizzell, J.; Barreto, George E.; Iarkov, Alexandre; Echeverria, Valentina			Intranasal cotinine improves memory, and reduces depressive-like behavior, and GFAP plus cells loss induced by restraint stress in mice	EXPERIMENTAL NEUROLOGY			English	Article						Astrocytes; Stress; Cotinine; Depression; Memory	FIBRILLARY ACIDIC PROTEIN; NICOTINIC ACETYLCHOLINE-RECEPTORS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; AMYOTROPHIC-LATERAL-SCLEROSIS; COMBAT-RELATED PTSD; ALZHEIMERS-DISEASE; MOUSE MODEL; FLUOXETINE TREATMENT; HUNTINGTONS-DISEASE	Posttraumatic stress disorder (PTSD), chronic psychological stress, and major depressive disorder have been found to be associated with a significant decrease in glial fibrillary acidic protein (GFAP) immunoreactivity in the hippocampus of rodents. Cotinine is an alkaloid that prevents memory impairment, depressive-like behavior and synaptic loss when co-administered during restraint stress, a model of PTSD and stress-induced depression, in mice. Here, we investigated the effects of post-treatment with intranasal cotinine on depressive- and anxiety like behaviors, visual recognition memory as well as the number and morphology of GFAP+ immunoreactive cells, in the hippocampus and frontal cortex of mice subjected to prolonged restraint stress. The results revealed that in addition to the mood and cognitive impairments, restraint stress induced a significant decrease in the number and arborization of GFAP+ cells in the brain of mice. Intranasal cotinine prevented these stress-derived symptoms and the morphological abnormalities GFAP+ cells in both of these brain regions which are critical to resilience to stress. The significance of these findings for the therapy of PTSD and depression is discussed. (C) 2017 Elsevier Inc. All rights reserved.	[Perez-Urrutia, Nelson; Mendoza, Cristhian; Alvarez-Ricartes, Nathalie; Oliveros-Matus, Patricia; Echeverria, Florencia; Iarkov, Alexandre; Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile; [Alex Grizzell, J.] Univ Tennessee, NeuroNET Res Ctr, Dept Psychol, Knoxville, TN 37996 USA; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.; Echeverria, Valentina] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst Res & Dev, Bay Pines, FL 33744 USA		Iarkov, A; Echeverria, V (corresponding author), Fac Cs Salud, Lientur 1457, Concepcion 4080871, Chile.; Echeverria, V (corresponding author), 10,000 Bay Pines Blvd, Bay Pines, FL 33744 USA.	Alexandre.larkov@uss.cl; valentina.echeverria@uss.cl	Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./AAD-7420-2020; Grizzell, J. Alex/AAF-3845-2019	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Perez Urrutia, Nelson/0000-0001-9009-671X; Mendoza, Cristhian/0000-0002-5038-0991	Fondo de Ciencia y Tecnologia (FONDECYT) de Chile [1150149]	This material is the result of work supported with resources and the use of facilities at the Bay Pines VA Healthcare System. The contents do not necessarily represent the views of the Department of Veterans Affairs or the United States Government. Also, we thank Dr. William Fray and Dr. Leha Hanson from the Alzheimer's Research Center at Regions Hospital, HealthPartners Research Foundation for providing training and guidance with the implementation of intranasal delivery of drugs to mice. We would also like to thank Drs. Lowell Gaertner and Matthew Cooper from the University of Tennessee for advice on statistical analyses. Funding: This work was supported by the Fondo de Ciencia y Tecnologia (FONDECYT) de Chile, grant 1150149.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Babb T L, 1996, Epilepsy Res Suppl, V12, P343; Balsera B, 2014, EUR J MED CHEM, V86, P724, DOI 10.1016/j.ejmech.2014.09.039; Barreto GE, 2015, CURR PHARM DESIGN, V21, P3589, DOI 10.2174/1381612821666150710145250; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Bencherif M, 2014, CNS NEUROL DISORD-DR, V13, P836, DOI 10.2174/1871527313666140711094525; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Cobb JA, 2016, NEUROSCIENCE, V316, P209, DOI 10.1016/j.neuroscience.2015.12.044; Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1; Colvonen PJ, 2017, NEUROSCI BIOBEHAV R, V75, P140, DOI 10.1016/j.neubiorev.2017.01.027; Crotti A, 2015, TRENDS IMMUNOL, V36, P364, DOI 10.1016/j.it.2015.04.007; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; d'Incamps BL, 2014, J PHYSIOL-LONDON, V592, P4131, DOI 10.1113/jphysiol.2014.273128; Day JR, 1998, J APPL PHYSIOL, V85, P716, DOI 10.1152/jappl.1998.85.2.716; de Aguiar RB, 2013, NEUROPHARMACOLOGY, V71, P292, DOI 10.1016/j.neuropharm.2013.03.032; Dienel GA, 2017, NEUROSCI LETT, V637, P18, DOI 10.1016/j.neulet.2015.02.052; Diniz DG, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0111-2; Echeverria V, 2017, CURR MED CHEM, V24, P411, DOI 10.2174/0929867323666161101140908; Echeverria V, 2016, PROG NEUROBIOL, V144, P142, DOI 10.1016/j.pneurobio.2016.01.002; Echeverria V, 2016, CURR PHARM DESIGN, V22, P1324, DOI 10.2174/138161282210160304112511; Exley R, 2008, BRIT J PHARMACOL, V153, pS283, DOI 10.1038/sj.bjp.0707510; Feng DY, 2015, EUR NEUROPSYCHOPHARM, V25, P1287, DOI 10.1016/j.euroneuro.2015.04.020; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; Forster D, 2016, NEUROCHEM INT, V94, P57, DOI 10.1016/j.neuint.2016.02.006; Franklin KBJ, 2001, MOUSE BRAIN STEREOTA; Fuchs E, 2006, FRONT BIOSCI-LANDMRK, V11, P2746, DOI 10.2741/2004; Fuller S, 2010, MUTAT RES-FUND MOL M, V690, P40, DOI 10.1016/j.mrfmmm.2009.08.016; Gao J, 2014, BIOORG MED CHEM LETT, V24, P1472, DOI 10.1016/j.bmcl.2014.02.008; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Grayson B, 2015, BEHAV BRAIN RES, V285, P176, DOI 10.1016/j.bbr.2014.10.025; Grizzell JA, 2017, PROG NEURO-PSYCHOPH, V78, P75, DOI 10.1016/j.pnpbp.2017.05.010; Grizzell JA, 2015, NEUROCHEM RES, V40, P2032, DOI 10.1007/s11064-014-1359-2; Grizzell JA, 2014, BEHAV NEUROSCI, V128, P713, DOI 10.1037/bne0000021; Grizzell JA, 2014, BEHAV BRAIN RES, V268, P55, DOI 10.1016/j.bbr.2014.03.047; Grizzell JA, 2014, NEUROCHEM RES; Guo-Ross SX, 1999, J NEUROCHEM, V73, P1609, DOI 10.1046/j.1471-4159.1999.0731609.x; Hanson LR, 2007, J NEUROIMMUNE PHARM, V2, P81, DOI 10.1007/s11481-006-9039-x; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Heinrichs SC, 2013, NEUROSCI LETT, V552, P108, DOI 10.1016/j.neulet.2013.07.035; Hennessy E, 2015, J NEUROSCI, V35, P8411, DOI 10.1523/JNEUROSCI.2745-14.2015; Iarkov A, 2016, CANCER CHEMOTH PHARM, V78, P1033, DOI 10.1007/s00280-016-3161-0; Imbe H, 2012, NEUROSCIENCE, V223, P209, DOI 10.1016/j.neuroscience.2012.08.007; Jak A.J, 2016, CURR TOP BEHAV NEURO; Javidi H, 2012, INT J OCCUP ENV MED, V3, P2; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Karperien AL, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00051; Kim J, 2015, J NEUROCHEM, V134, P927, DOI 10.1111/jnc.13178; KRETZSCHMAR HA, 1985, J NEUROPATH EXP NEUR, V44, P459, DOI 10.1097/00005072-198509000-00002; Laughame J., 2016, J NEUROPSYCHIATR CLI; Lee HS, 2014, P NATL ACAD SCI USA, V111, pE3343, DOI 10.1073/pnas.1410893111; Lee J. D., 2017, BR J PHARM; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Liu Y, 2015, NEUROPHARMACOLOGY, V91, P87, DOI 10.1016/j.neuropharm.2014.11.028; Lucassen Paul J., 2006, CNS & Neurological Disorders-Drug Targets, V5, P531, DOI 10.2174/187152706778559273; McHugh T, 2012, CLIN PSYCHOL REV, V32, P93, DOI 10.1016/j.cpr.2011.07.013; Meng LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33748; Moller HJ, 2015, WORLD J BIOL PSYCHIA, V16, P483, DOI 10.3109/15622975.2014.989261; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Naitoh H, 1992, Yakubutsu Seishin Kodo, V12, P105; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Niranjan R, 2014, MOL NEUROBIOL, V49, P28, DOI 10.1007/s12035-013-8483-x; North CS, 2016, ANN CLIN PSYCHIATRY, V28, P197; Orlovsky MA, 2014, BRAIN RES, V1593, P83, DOI 10.1016/j.brainres.2014.09.059; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Patel S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00162; Perrine SA, 2016, BEHAV BRAIN RES, V303, P228, DOI 10.1016/j.bbr.2016.01.056; Pichon Y, 2004, EUR BIOPHYS J BIOPHY, V33, P211, DOI 10.1007/s00249-003-0373-0; Radford RA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00414; Rehani K, 2008, BBA-MOL CELL RES, V1783, P375, DOI 10.1016/j.bbamcr.2007.12.003; Rotaru TS, 2016, INT J CLIN EXP HYP, V64, P116, DOI 10.1080/00207144.2015.1099406; Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032; Santha P, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00088; Saur L, 2016, NEUROCHEM RES, V41, P892, DOI 10.1007/s11064-015-1770-3; Schaaf KPW, 2013, RESUSCITATION, V84, P873, DOI 10.1016/j.resuscitation.2012.11.021; Schaffner AE, 2001, METHODS, V24, P323, DOI 10.1006/meth.2001.1202; Sheynin J, 2016, NEUROSCI LETT; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; Stander VA, 2014, CLIN PSYCHOL REV, V34, P87, DOI 10.1016/j.cpr.2013.12.002; Stobart JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00038; Szczepanik J, 2016, PSYCHIAT RES-NEUROIM, V254, P67, DOI 10.1016/j.pscychresns.2016.06.005; Terry AV, 2015, J PHARMACOL EXP THER, V352, P405, DOI 10.1124/jpet.114.219881; Trevizol Alisson Paulino, 2016, Trends Psychiatry Psychother., V38, P50, DOI 10.1590/2237-6089-2015-0072; Ugbode C, 2017, BIOCHEM J, V474, P333, DOI 10.1042/BCJ20160505; Verkhratsky A, 2013, FUTUR NEUROL, V8, P149, DOI 10.2217/fnl.12.90; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wang L, 2015, PSYCHOPHARMACOLOGY, V232, P4303, DOI 10.1007/s00213-015-4058-z; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Webster MJ, 2005, NEUROSCIENCE, V133, P453, DOI 10.1016/j.neuroscience.2005.02.037; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; Wildeboer-Andrud KM, 2014, PHARMACOL BIOCHEM BE, V117, P144, DOI 10.1016/j.pbb.2013.12.005; Williams SG, 2015, SLEEP BREATH, V19, P175, DOI 10.1007/s11325-014-0984-y; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Xia L, 2013, BEHAV BRAIN RES, V256, P472, DOI 10.1016/j.bbr.2013.08.048; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yang SS, 2015, PROG NEURO-PSYCHOPH, V61, P30, DOI 10.1016/j.pnpbp.2015.03.007; Yoon S, 2017, NEUROPSYCHOPHARMACOL, V42, P454, DOI 10.1038/npp.2016.136; Zeitlin R, 2012, BEHAV BRAIN RES, V228, P284, DOI 10.1016/j.bbr.2011.11.023; Zhu X., 2016, DEPRESS ANXIETY	102	16	16	0	25	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2017	295						211	221		10.1016/j.expneurol.2017.06.016			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC4OS	WOS:000406820900021	28625590				2022-02-06	
J	Snedden, TR; Brooks, MA; Hetzel, S; McGuine, T				Snedden, Traci R.; Brooks, Margaret Alison; Hetzel, Scott; McGuine, Tim			Normative Values of the Sport Concussion Assessment Tool 3 (SCAT3) in High School Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; cognitive; SCAT3; adolescent; sports; high school	PERFORMANCE; STATEMENT; SYMPTOMS; CHILDREN	Objective: Establish sex, age, and concussion history-specific normative baseline sport concussion assessment tool 3 (SCAT3) values in adolescent athletes. Design: Prospective cohort. Setting: Seven Wisconsin high schools. Participants: Seven hundred fifty-eight high school athletes participating in 19 sports. Independent Variables: Sex, age, and concussion history. Main Outcome Measures: Sport Concussion Assessment Tool 3 (SCAT3): total number of symptoms; symptom severity; total Standardized Assessment of Concussion (SAC); and each SAC component (orientation, immediate memory, concentration, delayed recall); Balance Error Scoring System (BESS) total errors (BESS, floor and foam pad). Results: Males reported a higher total number of symptoms [median (interquartile range): 0 (0-2) vs 0 (0-1), P = 0.001] and severity of symptoms [0 (0-3) vs 0 (0-2), P = 0.001] and a lower mean (SD) total SAC [26.0 (2.3) vs 26.4 (2.0), P = 0.026], and orientation [5 (4-5) vs 5 (5-5), P = 0.021]. There was no difference in baseline scores between sex for immediate memory, concentration, delayed recall or BESS total errors. No differences were found for any test domain based on age. Previously, concussed athletes reported a higher total number of symptoms [1 (0-4) vs 0 (0-2), P = 0.001] and symptom severity [2 (0-5) vs 0 (0-2), P = 0.001]. BESS total scores did not differ by concussion history. Conclusion: This study represents the first published normative baseline SCAT3 values in high school athletes. Results varied by sex and history of previous concussion but not by age. The normative baseline values generated from this study will help clinicians better evaluate and interpret SCAT3 results of concussed adolescent athletes.	[Snedden, Traci R.] Univ Wisconsin, Sch Nursing, 701 Highland Ave, Madison, WI 53705 USA; [Brooks, Margaret Alison; McGuine, Tim] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped, Madison, WI 53705 USA; [Brooks, Margaret Alison] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Hetzel, Scott] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53705 USA		Snedden, TR (corresponding author), Univ Wisconsin, Sch Nursing, 701 Highland Ave, Madison, WI 53705 USA.	tsnedden@wisc.edu		Snedden, Traci/0000-0002-1550-2340			Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bay RC, 2012, AM J SPORTS MED, V40, P927; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Khanna NK, 2015, SPORTS HEALTH, V7, P341, DOI 10.1177/1941738115571508; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 1996, STANDARDIZED ASSESSM; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2002, CLIN J SPORT MED, V12, P6; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; R Core Team, 2016, R LANG ENV STAT COMP; RIO, 2016, 2014 15 SUMM REP NAT; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	19	16	16	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2017	27	5					462	467		10.1097/JSM.0000000000000389			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	FG2HS	WOS:000409915300012	27606952				2022-02-06	
J	Wada, T; Gando, S; Maekaw, K; Katabami, K; Sageshima, H; Hayakawa, M; Sawamura, A				Wada, Takeshi; Gando, Satoshi; Maekaw, Kunihiko; Katabami, Kenichi; Sageshima, Hisako; Hayakawa, Mineji; Sawamura, Atsushi			Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury	CRITICAL CARE			English	Article						Disseminated intravascular coagulation; Fibrinolysis; Fibrinogenolysis; Isolated traumatic brain injury; Outcome	HEAD-INJURY; EARLY COAGULOPATHY; HEMOSTASIS; THROMBOSIS; CRITERIA; SYSTEM	Background: There is evidence to demonstrate that the coagulopathy which occurs in patients with traumatic brain injury coincides with disseminated intravascular coagulation (DIC). We hypothesized that DIC with increased fibrinolysis during the early stage of isolated traumatic brain injury (iTBI) affects the outcome of the patients and that hypoperfusion contributes to hyperfibrinolysis in the DIC. Methods: This retrospective study included 92 patients with iTBI who were divided into DIC and non-DIC groups according to the Japanese Association Acute Medicine DIC scoring system. The DIC patients were subdivided into those with and without hyperfibrinolysis. The platelet counts and global markers of coagulation and fibrinolysis were measured. Systemic inflammatory response syndrome (SIRS), organ dysfunction (assessed by the Sequential Organ Failure Assessment score), tissue hypoperfusion (assessed by the lactate levels) and the transfusion volume were also evaluated. The outcome measure was all-cause hospital mortality. Results: DIC patients showed consumption coagulopathy, lower antithrombin levels and higher fibrin/fibrinogen degradation products (FDP) and D-dimer levels than non-DIC patients. All of the DIC patients developed SIRS accompanied by organ dysfunction and required higher blood transfusion volumes, leading to a worse outcome than non-DIC patients. These changes were more prominent in DIC with hyperfibrinolysis. A higher FDP/D-dimer ratio suggests that DIC belongs to the fibrinolytic phenotype and involves fibrin(ogen)olysis. The mean blood pressures of the patients with and without DIC on arrival were identical. Hypoperfusion and the lactate levels were not identified as independent predictors of hyperfibrinolysis. Conclusions: DIC, especially DIC with hyperfibrinolysis, affects the outcome of patients with iTBI. Low blood pressure-induced tissue hypoperfusion does not contribute to hyperfibrinolysis in this type of DIC.	[Wada, Takeshi; Gando, Satoshi; Maekaw, Kunihiko; Katabami, Kenichi; Sageshima, Hisako; Hayakawa, Mineji; Sawamura, Atsushi] Hokkaido Univ, Grad Sch Med, Div Acute & Crit Care Med, Dept Anesthesiol & Crit Care Med,Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan		Gando, S (corresponding author), Hokkaido Univ, Grad Sch Med, Div Acute & Crit Care Med, Dept Anesthesiol & Crit Care Med,Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	gando@med.hokudai.ac.jp	Gando, Satoshi/T-7407-2019; Hayakawa, Mineji/G-2263-2012	Gando, Satoshi/0000-0002-3525-0750; 	Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15K15658] Funding Source: KAKEN		[Anonymous], 2016, Nat Rev Dis Primers, V2, P16038, DOI 10.1038/nrdp.2016.38; Asakura H, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-20; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Gando S, 2008, CRIT CARE MED, V36, P145, DOI 10.1097/01.CCM.0000295317.97245.2D; Gando S, 2015, SEMIN THROMB HEMOST, V41, P26, DOI 10.1055/s-0034-1398378; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Lemarchant S, 2012, NEUROPHARMACOLOGY, V62, P749, DOI 10.1016/j.neuropharm.2011.10.020; Lin HL, 2011, J TRAUMA, V70, P765, DOI 10.1097/TA.0b013e318206d12a; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Marder VJ, 2006, HEMOSTASIS THROMBOSI, P1571; Medcalf RL, 2015, BLOOD, V125, P2457, DOI 10.1182/blood-2015-02-629808; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; TOVI D, 1973, ACTA NEUROL SCAND, V49, P152; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929	33	16	17	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	AUG 22	2017	21								219	10.1186/s13054-017-1808-9			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE2KE	WOS:000408044400001	28826407	gold, Green Published			2022-02-06	
J	Sanchez, EJ; Gabler, LF; McGhee, JS; Olszko, AV; Chancey, VC; Crandall, JR; Panzer, MB				Sanchez, Erin J.; Gabler, Lee F.; McGhee, James S.; Olszko, Ardyn V.; Chancey, V. Carol; Crandall, Jeff R.; Panzer, Matthew B.			Evaluation of Head and Brain Injury Risk Functions Using Sub-Injurious Human Volunteer Data	JOURNAL OF NEUROTRAUMA			English	Article						finite element modeling; head kinematics; human research volunteers; injury risk functions	INTRACRANIAL-PRESSURE; CEREBRAL CONCUSSION; TOLERANCE CURVES; ICE HOCKEY; IMPACT; FOOTBALL; ACCELERATION; KINEMATICS; SYSTEM; NEUROTRAUMA	Risk assessment models are developed to estimate the probability of brain injury during head impact using mechanical response variables such as head kinematics and brain tissue deformation. Existing injury risk functions have been developed using different datasets based on human volunteer and scaled animal injury responses to impact. However, many of these functions have not been independently evaluated with respect to laboratory-controlled human response data. In this study, the specificity of 14 existing brain injury risk functions was assessed by evaluating their ability to correctly predict non-injurious response using previously conducted sled tests with well-instrumented human research volunteers. Six degrees-of-freedom head kinematics data were obtained for 335 sled tests involving subjects in frontal, lateral, and oblique sled conditions up to 16 Gs peak sled acceleration. A review of the medical reports associated with each individual test indicated no clinical diagnosis of mild or moderate brain injury in any of the cases evaluated. Kinematic-based head and brain injury risk probabilities were calculated directly from the kinematic data, while strain-based risks were determined through finite element model simulation of the 335 tests. Several injury risk functions substantially over predict the likelihood of concussion and diffuse axonal injury; proposed maximum principal strain-based injury risk functions predicted nearly 80 concussions and 14 cases of severe diffuse axonal injury out of the 335 non-injurious cases. This work is an important first step in assessing the efficacy of existing brain risk functions and highlights the need for more predictive injury assessment models.	[Sanchez, Erin J.; Gabler, Lee F.; Crandall, Jeff R.; Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, Charlottesville, VA USA; [McGhee, James S.; Olszko, Ardyn V.; Chancey, V. Carol] US Army Aeromed Res Labs, Ft Rucker, AL USA		Panzer, MB (corresponding author), Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	mbp2q@virginia.edu	MPH, James S. McGhee MD/AAG-6354-2021		Partnership for Dummy Technology and Biomechanics	The authors would like to thank the Partnership for Dummy Technology and Biomechanics for their support and funding the University of Virginia for this study. Additionally, we would like to thank the Netherlands Organization for Applied Scientific Research (TNO) for providing the processed volunteer head kinematic and sled test data.	Abel J. M., 1978, 780886 SAE, DOI [10.4271/780886, DOI 10.4271/780886]; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bandak F. A., 2001, INT TECHN C ENH SAF; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Chamouard F., 1987, 872195 SAE, DOI [10.4271/872195, DOI 10.4271/872195]; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Ewing C. L., 1972, DTIC DOCUMENT; Ewing C. L., 1977, 770928 SAE, DOI [10.4271/770928, DOI 10.4271/770928]; Ewing C. L., 1975, 780888 SAE, DOI [10.4271/780888, DOI 10.4271/780888]; Ewing C. L., 1976, 760800 SAE, DOI [10.4271/760800, DOI 10.4271/760800]; Ewing C. L., 1969, 690817 SAE, DOI [10.4271/690817, DOI 10.4271/690817]; Faul M, 2010, TRAUMATIC BRAIN INJU; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gadd C. W., 1962, IMPACT ACCEL STRESS, V977, P141; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Holbourn AHS, 1943, LANCET, V2, P438; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kang HS, 1997, P 41 STAPP CAR CRASH, P329; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Laituri T. R., 2015, 2015011437 SAE, DOI [10.4271/2015-01-1437, DOI 10.4271/2015-01-1437]; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1999, COMP DIFFUSE BRAIN I; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Meaney DF, 1993, ASME CRASHWORTHINESS, V25, P169; Mertz H. J., 1996, 960099 SAE, DOI [10.4271/960099, DOI 10.4271/960099]; Mueller B., 2015, 24 INT TECHN C ENH S; Nahum A., 1993, ACCIDENTAL INJURY BI, P268; National Highway Traffic Safety Administration WebAPIs, 2015, NEW CAR ASS PROGR; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2015, STAND ATHL EQ NOCSAE; Newman J., 1986, P INT RES COUNC BIOM; Newman J, 2000, NEW BIOMECHANICAL 2; Newman J A, 2000, Stapp Car Crash J, V44, P215; NHTSA VSR, QUER BIOM TEST DAT S; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK., 1985, BIOMECHANICS TRAUMA, P245; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Pascrell WJ, 2009, CLIN NEUROPSYCHOL, V23, P1281, DOI 10.1080/13854040902939319; Patrick L. M., 1963, P 7 STAPP CAR CRASH, V7, P483; Patton DA, 2012, P I MECH ENG P-J SPO, V226, P177, DOI 10.1177/1754337112438305; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prasad P., 1985, SAE T, V94, P106; Prasad Priya, 2014, Stapp Car Crash J, V58, P175; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stalnaker RL, 1977, VALIDATION STUDIES H; Takhounts E. G., 2011, P 22 ENH SAF VEH C; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thibault L. E., 1985, 856022 SAE; Thunnissen J, 1995, P 39 STAPP CAR CRASH, P439, DOI [DOI 10.4271/952721, 10.4271/952721]; Versace J. A., 1971, 710881 SAE, DOI [10.4271/710881, DOI 10.4271/710881]; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Wismans J., 1987, 872194 SAE, DOI [10.4271/872194, DOI 10.4271/872194]; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	75	16	16	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2017	34	16					2410	2424		10.1089/neu.2016.4681			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FC6RI	WOS:000406968400004	28358277				2022-02-06	
J	Higgins, GA; Georgoff, P; Nikolian, V; Allyn-Feuer, A; Pauls, B; Higgins, R; Athey, BD; Alam, HE				Higgins, Gerald A.; Georgoff, Patrick; Nikolian, Vahagn; Allyn-Feuer, Ari; Pauls, Brian; Higgins, Richard; Athey, Brian D.; Alam, Hasan E.			Network Reconstruction Reveals that Valproic Acid Activates Neurogenic Transcriptional Programs in Adult Brain Following Traumatic Injury	PHARMACEUTICAL RESEARCH			English	Article						bioinformatics; network modeling; pharmacoepigenomics	HISTONE DEACETYLASE; FUNCTIONAL-NEURONS; CHROMATIN DOMAINS; DIRECT CONVERSION; GENE-EXPRESSION; ASSOCIATION; DATABASE; VARIANTS; GENOME; DIFFERENTIATION	To determine the mechanism of action of valproic acid (VPA) in the adult central nervous system (CNS) following traumatic brain injury (TBI) and hemorrhagic shock (HS). Data were analyzed from different sources, including experiments in a porcine model, data from postmortem human brain, published studies, public and commercial databases. The transcriptional program in the CNS following TBI, HS, and VPA treatment includes activation of regulatory pathways that enhance neurogenesis and suppress gliogenesis. Genes which encode the transcription factors (TFs) that specify neuronal cell fate, including MEF2D, MYT1L, NEUROD1, PAX6 and TBR1, and their target genes, are induced by VPA. VPA represses genes responsible for oligodendrogenesis, maintenance of white matter, T-cell activation, angiogenesis, and endothelial cell proliferation, adhesion and chemotaxis. NEUROD1 has regulatory interactions with 38% of the genes regulated by VPA in a swine model of TBI and HS in adult brain. Hi-C spatial mapping of a VPA pharmacogenomic SNP in the GRIN2B gene shows it is part of a transcriptional hub that contacts 12 genes that mediate chromatin-mediated neurogenesis and neuroplasticity. Following TBI and HS, this study shows that VPA administration acts in the adult brain through differential activation of TFs responsible for neurogenesis, genes responsible for neuroplasticity, and repression of TFs that specify oligodendrocyte cell fate, endothelial cell chemotaxis and angiogenesis. Short title: Mechanism of action of valproic acid in traumatic brain injury.	[Higgins, Gerald A.; Allyn-Feuer, Ari; Athey, Brian D.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA; [Georgoff, Patrick; Nikolian, Vahagn; Alam, Hasan E.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA; [Pauls, Brian] Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA; [Higgins, Richard] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Athey, Brian D.] Michigan Inst Data Sci MIDAS, Ann Arbor, MI USA		Higgins, GA (corresponding author), Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA.	gehiggin@med.umich.edu; georgoff@med.umich.edu; vnikolia@med.umich.edu; ariallyn@umich.edu; brianobi@med.umich.edu; richard@relh.net; bleu@med.umich.edu; alamh@med.umich.edu		Higgins, Gerry/0000-0002-0434-1465			Berto S, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00031; Bharadwaj R, 2014, NEURON, V84, P997, DOI 10.1016/j.neuron.2014.10.032; Boley N, 2014, METHODS, V68, P38, DOI 10.1016/j.ymeth.2014.03.007; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chu TC, 2015, BRAIN RES, V1596, P31, DOI 10.1016/j.brainres.2014.11.029; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Dawson HD, 2012, MINIPIG IN BIOMEDICAL RESEARCH, P323; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; di Iulio J, 2016, BIORXIV; Ghodke-Puranik Y, 2013, PHARMACOGENET GENOM, V23, P236, DOI 10.1097/FPC.0b013e32835ea0b2; Gonzalez-Sandoval A, 2016, TRENDS GENET, V32, P485, DOI 10.1016/j.tig.2016.05.004; Gopalakrishnan S, 2017, BRAIN RES, V1656, P2, DOI 10.1016/j.brainres.2015.10.012; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Guida M, 2015, EXPERT REV NEUROTHER, V15, P947, DOI 10.1586/14737175.2015.1065180; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Hadjab S, 2013, J NEUROSCI, V33, P17656, DOI 10.1523/JNEUROSCI.1090-13.2013; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halsall JA, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0021-9; He XL, 2013, EPILEPTIC DISORD, V15, P272, DOI 10.1684/epd.2013.0603; Higgins GA, 2015, PHARMACOGENOMICS, V16, P1565, DOI 10.2217/pgs.15.105; Hung CC, 2011, PHARMACOGENOMICS, V12, P1107, DOI [10.2217/PGS.11.64, 10.2217/pgs.11.64]; Jessen WJ, 2015, PEERJ, V3, pe1802; Jones B, 2015, NAT REV GENET, V16, P438, DOI 10.1038/nrg3985; Kaplun A, 2016, PHARMACOGENOMICS J, V16, P124, DOI 10.1038/tpj.2015.32; Kelkhoff D, 2016, PHYSIOL HEALTH DIS, P163, DOI 10.1007/978-1-4939-5617-3_8; Kestler HA, 2008, BIOESSAYS, V30, P1110, DOI 10.1002/bies.20834; Kim B, 2009, PSYCHIAT RES, V168, P209, DOI 10.1016/j.psychres.2008.05.010; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Kulkarni AV, 2009, JAMA-J AM MED ASSOC, V302, P1092, DOI 10.1001/jama.2009.1307; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Li H, 2016, BIORXIV; Liu XS, 2012, NEUROSCIENCE, V220, P313, DOI 10.1016/j.neuroscience.2012.06.012; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Lv L, 2011, BRAIN RES, V1396, P60, DOI 10.1016/j.brainres.2011.03.040; Manuel MN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00070; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Mihalas AB, 2017, CURR TOP DEV BIOL, V122, P279, DOI 10.1016/bs.ctdb.2016.08.001; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Ninkovic J, 2013, CELL STEM CELL, V13, P403, DOI 10.1016/j.stem.2013.07.002; Notwell JH, 2016, GENOME RES, V26, P1013, DOI 10.1101/gr.203612.115; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Phillips ML, 2014, AM J PSYCHIAT, V171, P829, DOI 10.1176/appi.ajp.2014.13081008; Rackham OJL, 2016, NAT GENET, V48, P331, DOI 10.1038/ng.3487; Ramani V, 2016, GENOM PROTEOM BIOINF, V14, P7, DOI 10.1016/j.gpb.2016.01.002; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Saint-Andre V, 2016, GENOME RES, V26, P385, DOI 10.1101/gr.197590.115; Schurr J, 2017, BRAIN PATHOL, V27, P26, DOI 10.1111/bpa.12347; Son EY, 2014, AM J MED GENET C, V166, P333, DOI 10.1002/ajmg.c.31416; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Teng L, 2015, BIOINFORMATICS, V31, P2560, DOI 10.1093/bioinformatics/btv158; Tesar Paul J., 2012, U.S. Patent Application, Patent No. [13/280,562, 13280562]; Thakurela S, 2015, GENOME RES, V25, P1309, DOI 10.1101/gr.190926.115; Vehlow C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S19-S2; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang SY, 2016, SCIENCE, V353, P598, DOI 10.1126/science.aaf8084; Yi JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054792; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	66	16	16	0	14	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741	1573-904X		PHARM RES-DORDR	Pharm. Res.	AUG	2017	34	8					1658	1672		10.1007/s11095-017-2130-6			15	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	EZ8RZ	WOS:000404996100014	28271248	Green Published, hybrid			2022-02-06	
J	Murphy, AM; Askew, KL; Sumner, KE				Murphy, Ashley M.; Askew, Kevin L.; Sumner, Kenneth E.			Parents' Intentions to Allow Youth Football Participation: Perceived Concussion Risk and the Theory of Planned Behavior	SPORT EXERCISE AND PERFORMANCE PSYCHOLOGY			English	Article						youth sports; attitude; sport psychology; athletes; decision-making	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; DEVELOPING INTERVENTIONS; EDUCATION; BELIEFS; INITIATIVES; MAGNITUDE; CHILDREN; SOCCER	Despite many benefits, participation in youth football has declined, with many blaming concussion risk. While there is risk, not participating in youth football leads to missing out on the sport's physical, social, and psychological benefits. Understanding the reasons behind the decline in football participation is important to reversing the trend. The goals of this study were to understand parents' intentions to allow their children to participate in organized football and to create a theoretical platform from which interventions may be implemented to promote participation. Based on research in related areas, we proposed and tested an augmented Theory of Planned Behavior with parents of youth-football-age children (n = 497). We found the hypothesized model accounted for over half the variance in intention to allow football participation (R-2 = .58), and that four factors predict a parent's intention to let his or her child play football: social norms, attitudes toward youth football participation, behavioral control, and the perceived risk of concussion. This study helps better explain parents' decisions regarding youth football participation. These findings provide a promising theoretical platform for new interventions that can promote continued youth football participation.	[Murphy, Ashley M.; Askew, Kevin L.; Sumner, Kenneth E.] Montclair State Univ, Psychol Dept, 1 Normal Ave,Dickson Hall 219, Montclair, NJ 07043 USA		Murphy, AM (corresponding author), Montclair State Univ, Psychol Dept, 1 Normal Ave,Dickson Hall 219, Montclair, NJ 07043 USA.	murphya5.montclair@gmail.com					Ajzen I., 2012, HDB THEORIES SOCIAL, P438, DOI DOI 10.4135/9781446249215.N22; Ajzen I., 2002, CONSTRUCTING TPB QUE; Angelopoulos PD, 2009, EUR J PUBLIC HEALTH, V19, P319, DOI 10.1093/eurpub/ckp004; Askew K, 2014, COMPUT HUM BEHAV, V36, P510, DOI 10.1016/j.chb.2014.04.006; Cantu R. C., 2012, NY TIMES; Cheung BY, 2015, PERS SOC PSYCHOL B, V41, P1723, DOI 10.1177/0146167215610520; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Deroche T, 2009, ACCIDENT ANAL PREV, V41, P1064, DOI 10.1016/j.aap.2009.06.016; Elliott MA, 2009, BRIT J PSYCHOL, V100, P111, DOI 10.1348/000712608X318626; Fainaru S., 2013, YOUTHFOOTBALL PARTIC; Findler P, 2015, J PHILOS SPORT, V42, P443, DOI 10.1080/00948705.2015.1079132; French DP, 2012, BRIT J HEALTH PSYCH, V17, P1, DOI 10.1111/j.2044-8287.2010.02010.x; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilbert F., 2011, AJOB NEUROSCIENCE, V2, P48, DOI [DOI 10.1080/21507740.2011.611125, https://doi.org/10.1080/21507740.2011.611125]; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iversen MD, 2009, SCAND J MED SCI SPOR, V19, P595, DOI 10.1111/j.1600-0838.2008.00817.x; Kanten AB, 2015, PERS SOC PSYCHOL B, V41, P1712, DOI 10.1177/0146167215609894; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; Pabian S, 2014, EUR J DEV PSYCHOL, V11, P463, DOI 10.1080/17405629.2013.858626; Pop Warner National Office, 2012, RUL CHANG REG PRACT; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rigby J, 2013, J ATHL TRAINING, V48, P636, DOI 10.4085/1062-6050-48.3.10; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; University of Pittsburg Medical Center, 2015, KNOWL AR AM CONC ASS; White KM, 2015, PREV MED, V72, P19, DOI 10.1016/j.ypmed.2014.12.025; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036	34	16	16	1	30	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	2157-3905	2157-3913		SPORT EXERC PERFORM	Sport Exerc. Perform. Psychol.	AUG	2017	6	3					230	242		10.1037/spy0000102			13	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	FD8RW	WOS:000407792800003					2022-02-06	
J	Varner, EL; Leong, CL; Jaquins-Gerstl, A; Nesbitt, KM; Boutelle, MG; Michael, AC				Varner, Erika L.; Leong, Chi Leng; Jaquins-Gerstl, Andrea; Nesbitt, Kathryn M.; Boutelle, Martyn G.; Michael, Adrian C.			Enhancing Continuous Online Microdialysis Using Dexamethasone: Measurement of Dynamic Neurometabolic Changes during Spreading Depolarization	ACS CHEMICAL NEUROSCIENCE			English	Article						Microdialysis; dexamethasone; biosensor; microfluidic; spreading depolarization	TRAUMATIC BRAIN-INJURY; STRIATAL DOPAMINE RELEASE; RAT STRIATUM; DEPRESSION; LACTATE; GLUCOSE; PROBES; IMPLANTATION; ISCHEMIA; RETRODIALYSIS	Microdialysis is well established in chemical neuroscience as a mainstay technology for real time intracranial chemical monitoring in both animal models and human patients. Evidence shows that microdialysis can be enhanced by mitigating the penetration injury caused during the insertion of microdialysis probes into brain tissue. Herein, we show that retrodialysis of dexamethasone in the rat cortex enhances the microdialysis detection of K+ and glucose transients induced by spreading depolarization. Without dexamethasone, quantification of glucose transients was unreliable by 5 days after probe insertion. With dexamethasone, robust K+ and glucose transients were readily quantified at 2 h, 5 days, and 10 days after probe insertion. The amplitudes of the K+ transients declined day-to-day following probe insertion, and the amplitudes of the glucose transients exhibited a decreasing trend that did not reach statistical significance. Immunohistochemistry and fluorescence microscopy confirm that dexamethasone is highly effective at preserving a healthy probe-brain interface for at least 10 days even though retrodialysis of dexamethasone ceased after 5 days.	[Varner, Erika L.; Jaquins-Gerstl, Andrea; Nesbitt, Kathryn M.; Michael, Adrian C.] Univ Pittsburgh, Dept Chem, 219 Parkman Ave, Pittsburgh, PA 15260 USA; [Leong, Chi Leng; Boutelle, Martyn G.] Imperial Coll London, Dept Bioengn, London SW7 2AZ, England		Michael, AC (corresponding author), Univ Pittsburgh, Dept Chem, 219 Parkman Ave, Pittsburgh, PA 15260 USA.	amichael@pitt.edu		Leong, Chi Leng/0000-0002-2654-1345; /0000-0002-0101-0249	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS092245]; NSFNational Science Foundation (NSF) [1247842]; University of Pittsburgh's Center for Biologic Imaging [1S10RR028478-01]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR028478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS092245] Funding Source: NIH RePORTER	This work was funded by the NIH (NS092245), NSF Graduate Research Fellowship Program (E.L.V., 1247842), and University of Pittsburgh's Center for Biologic Imaging (1S10RR028478-01: for the use of the Olympus FluoView 1000)	[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; Bungay PM, 2003, J NEUROCHEM, V86, P932, DOI 10.1046/j.1471-4159.2003.01904.x; Clapp-Lilly KL, 1999, J NEUROSCI METH, V90, P129, DOI 10.1016/S0165-0270(99)00064-3; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1, DOI [10.1038/jcbfm.2009.252, 10.1038/jcbfm.2010.191]; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Feuerstein D, 2009, ANAL CHEM, V81, P4987, DOI 10.1021/ac900161x; Groothuis J, 2014, BRAIN STIMUL, V7, P1, DOI 10.1016/j.brs.2013.07.001; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hascup ER, 2009, BRAIN RES, V1291, P12, DOI 10.1016/j.brainres.2009.06.084; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Holson RR, 1996, BRAIN RES, V739, P301, DOI 10.1016/S0006-8993(96)00837-2; Holson RR, 1998, BRAIN RES, V808, P182, DOI 10.1016/S0006-8993(98)00816-6; Jaquins-Gerstl A, 2011, ANAL CHEM, V83, P7662, DOI 10.1021/ac200782h; Jaquins-Gerstl A, 2009, J NEUROSCI METH, V183, P127, DOI 10.1016/j.jneumeth.2009.06.023; Jones DA, 2002, J ELECTROANAL CHEM, V538, P243, DOI 10.1016/S0022-0728(02)00839-2; Kozai TDY, 2016, BIOMATERIALS, V87, P157, DOI 10.1016/j.biomaterials.2016.02.013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Mitala CM, 2008, J NEUROSCI METH, V174, P177, DOI 10.1016/j.jneumeth.2008.06.034; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Nesbitt KM, 2015, ACS CHEM NEUROSCI, V6, P163, DOI 10.1021/cn500257x; Nesbitt KM, 2013, ANAL CHEM, V85, P8173, DOI 10.1021/ac401201x; Papadimitriou KI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00212; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; ROBINSON TE, 1991, J NEUROSCI METH, V40, P211, DOI 10.1016/0165-0270(91)90070-G; Rogers ML, 2017, J CEREBR BLOOD F MET, V37, P1883, DOI 10.1177/0271678X16674486; Rogers ML, 2013, ACS CHEM NEUROSCI, V4, P799, DOI 10.1021/cn400047x; SHARP T, 1986, PHARMACOL BIOCHEM BE, V24, P1755, DOI 10.1016/0091-3057(86)90516-2; Spataro L, 2005, EXP NEUROL, V194, P289, DOI 10.1016/j.expneurol.2004.08.037; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Varner EL, 2016, ACS CHEM NEUROSCI, V7, P728, DOI 10.1021/acschemneuro.5b00331; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Watson CJ, 2006, ANAL CHEM, V78, P1391, DOI 10.1021/ac0693722; Westerink B. H., 2007, HDB MICRODIALYSIS ME; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024; Zhou F, 2001, AM J PATHOL, V158, P2145, DOI 10.1016/S0002-9440(10)64686-X	49	16	17	0	20	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	AUG	2017	8	8					1779	1788		10.1021/acschemneuro.7b00148			10	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	FE2WK	WOS:000408077700022	28482157	Green Accepted			2022-02-06	
J	Ouyang, J; Pace, E; Lepczyk, L; Kaufman, M; Zhang, J; Perrine, SA; Zhang, JS				Ouyang, Jessica; Pace, Edward; Lepczyk, Laura; Kaufman, Michael; Zhang, Jessica; Perrine, Shane A.; Zhang, Jinsheng			Blast-Induced Tinnitus and Elevated Central Auditory and Limbic Activity in Rats: A Manganese-Enhanced MRI and Behavioral Study	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; VENTRAL COCHLEAR NUCLEUS; ENRICHED ACOUSTIC ENVIRONMENT; RESONANCE-IMAGING MEMRI; NEURAL ACTIVITY; HEARING-LOSS; PSYCHIATRIC-DISORDERS; INFERIOR COLLICULUS; EVOKED POTENTIALS	Blast-induced tinitus is the number one service-connected disability that currently affects military personnel and veterans. To elucidate its underlying mechanisms, we subjected 13 Sprague Dawley adult rats to unilateral 14 psi blast exposure to induce tinnitus and measured auditory and limbic brain activity using manganese-enhanced MRI (MEMRI). Tinnitus was evaluated with a gap detection acoustic startle reflex paradigm, while hearing status was assessed with prepulse inhibition (PPI) and auditory brainstem responses (ABRs). Both anxiety and cognitive functioning were assessed using elevated plus maze and Morris water maze, respectively. Five weeks after blast exposure, 8 of the 13 blasted rats exhibited chronic tinnitus. While acoustic PPI remained intact and ABR thresholds recovered, the ABR wave P1-N1 amplitude reduction persisted in all blast-exposed rats. No differences in spatial cognition were observed, but blasted rats as a whole exhibited increased anxiety. MEMRI data revealed a bilateral increase in activity along the auditory pathway and in certain limbic regions of rats with tinnitus compared to age-matched controls. Taken together, our data suggest that while blast-induced tinnitus may play a role in auditory and limbic hyperactivity, the non-auditory effects of blast and potential traumatic brain injury may also exert an effect.	[Ouyang, Jessica; Pace, Edward; Lepczyk, Laura; Kaufman, Michael; Zhang, Jessica; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol & Head & Neck Surg, Detroit, MI 48201 USA; [Perrine, Shane A.] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA; [Zhang, Jinsheng] Wayne State Univ, Dept Commun Sci & Disorders, Coll Liberal Arts & Sci, Detroit, MI 48201 USA		Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol & Head & Neck Surg, Detroit, MI 48201 USA.; Zhang, JS (corresponding author), Wayne State Univ, Dept Commun Sci & Disorders, Coll Liberal Arts & Sci, Detroit, MI 48201 USA.	jinzhang@med.wayne.edu			Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031]; AANA Foundation	This work was supported by a grant from the Department of Defense (grant award #W81XWH-11-2-0031) to J.S. Zhang and a grant from the AANA Foundation to J. Ouyang. We would like to thank Drs. Pamela Vande Vord and Srinivas Kallakuri for assisting with the blast procedure. We would also like to thank Drs. Bruce Berkowitz and David Bissig for their assistance in using the 7T MRI scanner and MEMRI data analysis. We would like to thank Dr. Gulrez Mahmood for his assistance during MEMRI scanning. Lastly, we would like to thank Senior Biostatistician Dr. George Divine for his assistance in power analysis and statistics.	Aldhafeeri FM, 2012, NEURORADIOLOGY, V54, P883, DOI 10.1007/s00234-012-1044-6; Andersson G, 2000, J SPEECH LANG HEAR R, V43, P1168, DOI 10.1044/jslhr.4305.1168; Andersson G, 2009, SCAND J PSYCHOL, V50, P517, DOI 10.1111/j.1467-9450.2009.00752.x; Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bauer C.A., 2008, J NEUROSCI RES; Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8; Benson RR, 2014, HEARING RES, V309, P8, DOI 10.1016/j.heares.2013.10.005; Bissig D, 2014, NEUROBIOL AGING, V35, P1453, DOI 10.1016/j.neurobiolaging.2013.12.019; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Boyen K, 2014, HEARING RES, V312, P48, DOI 10.1016/j.heares.2014.03.001; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Brozoski TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077674; Brozoski TJ, 2012, JARO-J ASSOC RES OTO, V13, P55, DOI 10.1007/s10162-011-0290-3; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; BRUNSOBECHTOLD JK, 1981, J COMP NEUROL, V197, P705, DOI 10.1002/cne.901970410; Cacace AT, 2014, HEARING RES, V311, P49, DOI 10.1016/j.heares.2014.02.003; Cacace AT, 1999, AUDIOL NEURO-OTOL, V4, P258, DOI 10.1159/000013849; Carpenter-Thompson JR, 2014, BRAIN RES, V1567, P28, DOI 10.1016/j.brainres.2014.04.024; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen GD, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/658741; Chen GD, 2012, BRAIN RES, V1485, P63, DOI 10.1016/j.brainres.2012.03.016; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Chuang KH, 2009, MAGN RESON IMAGING, V27, P594, DOI 10.1016/j.mri.2008.10.006; Crippa Alessandro, 2010, Open Neuroimag J, V4, P16, DOI 10.2174/1874440001004010016; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; Dehmel S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00042; DOBIE RA, 1993, AM J OTOL, V14, P18; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Eagle AL, 2013, NEUROSCI RES, V75, P130, DOI 10.1016/j.neures.2012.11.001; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Feng Y, 2014, CHINESE MED J-PEKING, V127, P522, DOI 10.3760/cma.j.issn.0366-6999.20132245; Fraticelli-Torres AI, 2010, ETHNIC DIS, V20; Frick KM, 2000, NEUROREPORT, V11, P3461, DOI 10.1097/00001756-200011090-00013; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gu JW, 2012, JARO-J ASSOC RES OTO, V13, P819, DOI 10.1007/s10162-012-0344-1; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; HALLBERG LRM, 1993, BRIT J AUDIOL, V27, P19, DOI 10.3109/03005369309077885; Hebert S, 2011, J SLEEP RES, V20, P38, DOI 10.1111/j.1365-2869.2010.00860.x; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Henry JA, 2009, J REHABIL RES DEV, V46, P619, DOI 10.1682/JRRD.2008.11.0157; Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; Husain FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026639; Husain FT, 2011, BRAIN RES, V1369, P74, DOI 10.1016/j.brainres.2010.10.095; Jehel L, 2003, EUR PSYCHIAT, V18, P172, DOI 10.1016/S0924-9338(03)00043-9; Jung DJ, 2014, NEUROIMAGE, V100, P642, DOI 10.1016/j.neuroimage.2014.06.055; Kallai J, 2005, BEHAV BRAIN RES, V159, P187, DOI 10.1016/j.bbr.2004.10.015; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; KERR AG, 1975, BRIT MED J, V1, P559, DOI 10.1136/bmj.1.5957.559; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kraus KS, 2011, NEUROSCIENCE, V194, P309, DOI 10.1016/j.neuroscience.2011.07.056; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kraus KS, 2012, HEARING RES, V288, P34, DOI 10.1016/j.heares.2012.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Langguth B, 2006, ACTA OTO-LARYNGOL, V126, P84, DOI 10.1080/03655230600895317; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Lanting CP, 2008, ACTA OTO-LARYNGOL, V128, P415, DOI 10.1080/00016480701793743; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lee YJ, 2007, J CLIN NEUROSCI, V14, P515, DOI 10.1016/j.jocn.2006.10.002; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Lewis J E, 2002, J Am Acad Audiol, V13, P339; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Luo H, 2017, NEUROSCIENCE, V340, P515, DOI 10.1016/j.neuroscience.2016.11.014; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; Luo H, 2012, NEUROSCI LETT, V522, P16, DOI 10.1016/j.neulet.2012.05.072; Lyche P, 2011, CLIN NEUROPSYCHOL, V25, P359, DOI 10.1080/13854046.2010.547518; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mahlke C, 2004, HEARING RES, V195, P17, DOI 10.1016/j.heares.2004.03.005; Mahmood G, 2014, NEUROSCIENCE, V269, P367, DOI 10.1016/j.neuroscience.2014.03.020; Mahoney CJ, 2011, J NEUROL NEUROSUR PS, V82, P1274, DOI 10.1136/jnnp.2010.235473; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Maudoux A, 2012, BRAIN RES, V1485, P10, DOI 10.1016/j.brainres.2012.05.006; McKenna L, 2000, TINNITUS HDB, P59; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore DR, 1998, J NEUROPHYSIOL, V80, P2229, DOI 10.1152/jn.1998.80.5.2229; Mrena R, 2004, ACTA OTO-LARYNGOL, V124, P946, DOI 10.1080/00016480310017045; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Nageris Ben I., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P185; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Norena AJ, 2006, NEUROREPORT, V17, P559, DOI 10.1097/00001756-200604240-00001; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Nowotny M, 2011, J ACOUST SOC AM, V130, P2827, DOI 10.1121/1.3646902; Oishi N, 2010, AUDIOL NEURO-OTOL, V15, P187, DOI 10.1159/000251916; Pace E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075011; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Pautler Robia G, 2006, Methods Mol Med, V124, P365; PAXINOS G, 1998, RAT BRAIN STEREOTAXI, V4; Plewnia C, 2007, J NEUROL NEUROSUR PS, V78, P152, DOI 10.1136/jnnp.2006.095612; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rizzardo R, 1998, J OTOLARYNGOL, V27, P21; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rodriguez O, 2016, J NEUROTRAUM, V33, P662, DOI 10.1089/neu.2015.4002; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Sample PL, 2012, BRAIN INJURY, V26, P1670, DOI 10.3109/02699052.2012.700090; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schmidt SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076488; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Shulman, 1995, Int Tinnitus J, V1, P13; Shussman N, 2011, J TRAUMA, V70, P1546, DOI 10.1097/TA.0b013e318202edcf; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Singer W, 2013, MOL NEUROBIOL, V47, P261, DOI 10.1007/s12035-012-8372-8; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Snow J, 2004, TINNITUS THEORY MANA, P16; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Thuen M, 2008, J MAGN RESON IMAGING, V28, P855, DOI 10.1002/jmri.21504; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Tyler Richard S., 1993, Seminars in Hearing, V14, P377, DOI 10.1055/s-0028-1085135; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Wang HT, 2001, CHINESE MED J-PEKING, V114, P848; Watts LT, 2015, J NEUROTRAUM, V32, P1001, DOI 10.1089/neu.2014.3737; Xie K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064907; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yoo Done-Sik, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1870; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z; Zhang JS, 2003, EXP BRAIN RES, V153, P655, DOI 10.1007/s00221-003-1612-4; Zheng Y, 2011, NEUROSCIENCE, V193, P143, DOI 10.1016/j.neuroscience.2011.07.026; Zheng Y, 2011, NEUROSCIENCE, V186, P48, DOI 10.1016/j.neuroscience.2011.04.052; Zheng Y, 2011, NEUROSCIENCE, V180, P75, DOI 10.1016/j.neuroscience.2011.02.040; Zoger S, 2001, AUDIOLOGY, V40, P133; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	162	16	17	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 7	2017	7								4852	10.1038/s41598-017-04941-w			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ8JI	WOS:000404970900014	28687812	Green Published, gold			2022-02-06	
J	Baricich, A; de Sire, A; Antoniono, E; Gozzerino, F; Lamberti, G; Cisari, C; Invernizzi, M				Baricich, Alessio; de Sire, Alessandro; Antoniono, Elena; Gozzerino, Francesca; Lamberti, Gianfranco; Cisari, Carlo; Invernizzi, Marco			Recovery from vegetative state of patients with a severe brain injury: a 4-year real-practice prospective cohort study	FUNCTIONAL NEUROLOGY			English	Article						brain injury; minimally conscious state; rehabilitation; vegetative state	MINIMALLY CONSCIOUS STATE; STATUS EPILEPTICUS; BEHAVIORAL-ASSESSMENT; CLINICAL-PRACTICE; NATURAL-HISTORY; DISORDERS; EMERGENCE; REHABILITATION; RECOMMENDATIONS; MANAGEMENT	Patients who have suffered severe traumatic or non-traumatic brain injuries can show a progressive recovery, transitioning through a range of clinical conditions. They may progress from coma to a vegetative state (VS) and/or a minimally conscious state (MCS). A longer duration of the VS is known to be related to a lower probability of emergence from it; furthermore, the literature seems to lack evidence of late improvements in these patients. This real-practice prospective cohort study was conducted in inpatients in a VS following a severe brain injury, consecutively admitted to a vegetative state unit (VSU). The aim of the study was to assess their recovery in order to identify variables that might increase the probability of a VS patient transitioning to MCS. Rehabilitation treatment included passive joint mobilisation and helping/placing patients into an upright sitting position on a tilt table. All the patients underwent a specific assessment protocol every month to identify any emergence, however late, from the VS. Over a 4-year period, 194 patients suffering sequelae of a severe brain injury, consecutively seen, had an initial Glasgow Coma Scale score <= 8. Of these, 63 (32.5%) were in a VS, 84 (43.3%) in a MCS, and 47 (24.2%) in a coma; of the 63 patients admitted in a VS, 49 (57.1% males and 42.9% females, mean age 25.34 +/- 19.12 years) were transferred to a specialist VSU and put on a slow-to-recover brain injury programme. Ten of these 49 patients were still in a VS after 36 months; of these 10, 3 recovered consciousness, transitioning to a MCS, 2 died, and 5 remained in a VS during the last 12 months of the observation. Univariate analysis identified male sex, youth, a shorter time from onset of the VS, diffuse brain injury, and the presence of status epilepticus as variables increasing the likelihood of transition to a MCS. Long-term monitoring of patients with chronic disorders of consciousness should be adequately implemented in order to optimise their access to rehabilitation services.	[Baricich, Alessio; Cisari, Carlo] Univ Hosp Maggiore Carita, Phys Med & Rehabil, Novara, Italy; [Baricich, Alessio; Cisari, Carlo; Invernizzi, Marco] Univ Piemonte Orientale, Dept Hlth Sci, Phys & Rehabil Med, Novara, Italy; [de Sire, Alessandro] Univ Campania Luigi Vanvitelli, Dept Med & Surg Specialties & Dent, Naples, Italy; [Antoniono, Elena; Gozzerino, Francesca; Lamberti, Gianfranco] Azienda Sanit Locale CN, Neurorehabil & Vegetat State Unit, Cuneo, Italy		de Sire, A (corresponding author), Univ Campania Luigi Vanvitelli, Dept Med & Surg Specialties & Dent, Naples, Italy.	alessandro.desire@gmail.com	Baricich, Alessio/ABG-7696-2020; Invernizzi, Marco/I-9635-2019	Invernizzi, Marco/0000-0001-5141-0681; BARICICH, Alessio/0000-0001-8440-6283			ALEXANDER E, 1982, SURG NEUROL, V17, P107, DOI 10.1016/S0090-3019(82)80031-1; Andrews K, 1993, RECOVERY PATIENTS 4, V306, P1597; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; Baricich A, 2017, AM J PHYS MED REHAB, V96, pS80, DOI 10.1097/PHM.0000000000000573; Bartolo M, 2016, EUR J PHYS REHAB MED, V52, P90; Bernat JL, 2010, NEUROLOGY, V75, P206, DOI 10.1212/WNL.0b013e3181e8e960; Bernat JL, 2009, ANNU REV MED, V60, P381, DOI 10.1146/annurev.med.60.060107.091250; Cesarini KG, 1999, J NEUROSURG, V90, P664, DOI 10.3171/jns.1999.90.4.0664; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; de Jong BM, 2012, J HEAD TRAUMA REHABI; De Tanti A, 2015, EUR J PHYS REHAB MED, V51, P89; DeFina PA, 2010, RESTOR NEUROL NEUROS, V28, P769, DOI 10.3233/RNN-2010-0548; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Faran S, 2006, J NEUROL NEUROSUR PS, V77, P998, DOI 10.1136/jnnp.2005.076554; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2007, CURR OPIN NEUROL, V20, P614, DOI 10.1097/WCO.0b013e3282f189ef; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GILLIES JD, 1980, DEV MED CHILD NEUROL, V22, P642; Hagen C, 1979, REHABILITATION HEAD; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Khot S, 2006, SEMIN NEUROL, V26, P422, DOI 10.1055/s-2006-948323; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LOWENSTEIN DH, 1992, NEUROLOGY, V42, P100, DOI 10.1212/WNL.42.1.100; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Lupi A, 2014, CURR RADIOPHARM, V7, P57, DOI 10.2174/1874471007666140411103819; Machado C, 2010, NEUROLOGY, V74, P1156, DOI 10.1212/WNL.0b013e3181d5df0d; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Picelli A, 2015, EUR J PHYS REHAB MED, V51, P849; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Taricco M, 2006, Eura Medicophys, V42, P73; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; Thibaut A, 2012, J REHABIL MED   0319; Towne A, 1998, EPILIPSIA, V39, P3; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; VUILLEUMIER P, 1995, NEUROCHIRURGIE, V41, P98; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Wilson SL, 2000, BRAIN INJURY, V14, P319	53	16	16	3	7	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264	1971-3274		FUNCT NEUROL	Funct. Neurol.	JUL-SEP	2017	32	3					131	136					6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FI4PG	WOS:000411954000004	29042001				2022-02-06	
J	Becchi, S; Buson, A; Foot, J; Jarolimek, W; Balleine, BW				Becchi, Serena; Buson, Alberto; Foot, Jonathan; Jarolimek, Wolfgang; Balleine, Bernard W.			Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							IN-VIVO; MICROGLIAL ACTIVATION; SYSTEMIC INFLAMMATION; LEUKOCYTE RECRUITMENT; CONCISE GUIDE; BRAIN; VAP-1/SSAO; OXIDASE; PHARMACOLOGY; MORPHOLOGY	BACKGROUND AND PURPOSE Neuroinflammation is initiated by a variety of stimuli including infections, sepsis, neurodegenerative diseases or traumatic brain injury and, if not adequately controlled, can lead to various degrees of neuronal damage and behavioural impairment. A critical event in the initial steps of inflammation is neutrophil extravasation. Semicarbazide-sensitive amine oxidase (SSAO, also known as vascular adhesion protein 1 or VAP-1) regulates neutrophil adhesion and extravasation. Here, we elucidate the role of SSAO/VAP-1 in the early stage inflammatory response after LPS insult in the brain. EXPERIMENTAL APPROACH PXS-4681A, a selective and irreversible SSAO/VAP-1 inhibitor, was tested in two rat models of neuroinflammation, following systemic or i.c.v. LPS. Immunohistochemical and immunofluorescence techniques were used to measure neutrophils and microglia. VAP-1 was quantitated by Western blotting. KEY RESULTS Both systemic and i.c.v. administration of LPS induced an increase in neutrophil recruitment and microglial response in various brain areas including the substantia nigra and striatum. PXS-4681A produced a significant inhibition of neutrophil recruitment and extravasation after i.c.v. LPS injection and also reversed microglial cell recruitment and morphological changes to the level of the sham controls in both LPS models. CONCLUSIONS AND IMPLICATIONS PXS-4681A acted as an effective anti-inflammatory agent after both systemic and i.c.v. LPS injections suggesting that SSAO/VAP-1 inhibition could be beneficial in the treatment of brain inflammation.	[Becchi, Serena; Balleine, Bernard W.] Univ NSW, Sch Psychol, Kensington, NSW 2052, Australia; [Becchi, Serena; Balleine, Bernard W.] Univ Sydney, Brain & Mind Ctr, Camperdown, NSW, Australia; [Buson, Alberto; Foot, Jonathan; Jarolimek, Wolfgang] Pharmaxis Ltd, Frenchs Forest, NSW, Australia		Balleine, BW (corresponding author), Univ NSW, Sch Psychol, Kensington, NSW 2052, Australia.	bernard.balleine@unsw.edu.au		Balleine, Bernard/0000-0001-8618-7950; Jarolimek, Wolfgang/0000-0002-1757-5420	Laureate Fellowship from the Australian Research CouncilAustralian Research Council [FL0992409]; Research in Business Award from the Australian Research Council; Pharmaxis Ltd	This project was supported by a Laureate Fellowship from the Australian Research Council, Grant #FL0992409, a Research in Business Award from the Australian Research Council, and with additional research funding provided by Pharmaxis Ltd supporting S.B.	Aalto K, 2011, BLOOD, V118, P3725, DOI 10.1182/blood-2010-09-311076; Abella A, 2004, DIABETOLOGIA, V47, P429, DOI 10.1007/s00125-004-1346-2; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5744, DOI 10.1111/bph.13348; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P6024, DOI 10.1111/bph.13354; Andonegui G, 2002, J IMMUNOL, V169, P2111, DOI 10.4049/jimmunol.169.4.2111; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; Castillo V, 1998, NEUROCHEM INT, V33, P415, DOI 10.1016/S0197-0186(98)00045-X; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; DALLAIRE L, 1991, BIOCHEM J, V276, P745, DOI 10.1042/bj2760745; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Ear T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-14; Fan LW, 2005, NEUROSCIENCE, V133, P159, DOI 10.1016/j.neuroscience.2005.02.016; Ferrer I, 2002, NEUROSCI LETT, V321, P21, DOI 10.1016/S0304-3940(01)02465-X; Foot JS, 2013, J PHARMACOL EXP THER, V347, P365, DOI 10.1124/jpet.113.207613; Fukushima S, 2015, J NEUROIMMUNOL, V285, P31, DOI 10.1016/j.jneuroim.2015.05.014; Garcia-Vicente S, 2005, J PHYSIOL BIOCHEM, V61, P395, DOI 10.1007/BF03167057; GIULIAN D, 1995, J NEUROSCI, V15, P7712; Hernandez-Guillamon M, 2012, CEREBROVASC DIS, V33, P55, DOI 10.1159/000333370; Hinwood M, 2013, CEREB CORTEX, V23, P1784, DOI 10.1093/cercor/bhs151; Holz O, 2010, EUR RESPIR J, V35, P564, DOI 10.1183/09031936.00048509; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Ji KA, 2008, GLIA, V56, P1039, DOI 10.1002/glia.20677; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; Korytko PJ, 1996, NEUROPHARMACOLOGY, V35, P231, DOI 10.1016/0028-3908(95)00162-X; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; Reinert KRS, 2014, BRAIN RES, V1557, P164, DOI 10.1016/j.brainres.2014.02.005; Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; Salmi M, 1996, J EXP MED, V183, P569, DOI 10.1084/jem.183.2.569; Salter-Cid LM, 2005, J PHARMACOL EXP THER, V315, P553, DOI 10.1124/jpet.105.089649; Schilter HC, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0200-z; Southan C, 2016, NUCLEIC ACIDS RES, V44, pD1054, DOI 10.1093/nar/gkv1037; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; Tohka S, 2001, FASEB J, V15, P373, DOI 10.1096/fj.00-0240com; Tsushima H, 2000, BRAIN RES, V852, P367, DOI 10.1016/S0006-8993(99)02177-0; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103; Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309; Zhou Y, 2012, J NEUROCHEM, V123, P771, DOI 10.1111/jnc.12010	50	16	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	JUL	2017	174	14					2302	2317		10.1111/bph.13832			16	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EZ0PI	WOS:000404407600013	28437839	Green Published, Bronze			2022-02-06	
J	Brooks, MA; Snedden, TR; Mixis, B; Hetzel, S; McGuine, TA				Brooks, M. Alison; Snedden, Traci R.; Mixis, Benjamin; Hetzel, Scott; McGuine, Timothy A.			Establishing Baseline Normative Values for the Child Sport Concussion Assessment Tool	JAMA PEDIATRICS			English	Article							HIGH-SCHOOL; SCAT2; ADOLESCENTS; RECOVERY; INJURY; AGE	IMPORTANCE The Child Sport Concussion Assessment Tool (SCAT3) is a postconcussion sideline assessment tool measuring symptoms, cognition, and balance in preadolescent children. Minimal normative baseline data exist to aid decision making in clinical and athletic settings. OBJECTIVE To collect normative baseline data for the Child SCAT3 in a large cohort of young athletes. DESIGN, SETTING, AND PARTICIPANTS A cross-sectional study was conducted from May 31 to August 12, 2014, at various sporting events (basketball, soccer, baseball, and swimming) in Central Wisconsin among children 5 to 13 years of age who were English-speaking and did not report a lower leg injury within the past 2 months or a concussion within the past month. Data were analyzed between October 8, 2014, and September 12, 2016. MAIN OUTCOMES AND MEASURES All Child SCAT3 components were assessed: child and parent report of symptom number and severity, cognition (Standardized Assessment of Concussion-child version [SAC-C]), and balance (modified Balance Error Scoring System [mBESS] and tandem gait). Summary statistics, mean differences, and effect sizes were calculated for each test component. RESULTS Participants included 478 children (234 girls and 241 boys; mean [SD] age, 9.9 [1.9] years]) and their parents. Age had the largest effect on all Child SCAT3 components, with children 5 to 7 years of age reporting higher mean (SD) symptom severity scores compared with those 11 to 13 years of age (18.2 [10.0] vs 11.3 [9.0]; mean difference, 6.86 [95% CI, 4.22-9.50]; effect size, 0.74) and performing more poorly on the total SAC-C (mean [SD] score, 19.5 [5.1] vs 26.1 [2.1]; mean difference, -6.59 [95% CI, -7.49 to -5.68]; effect size, -2.1), mBESS (mean [SD] score, 1.67 [1.8] vs 0.76 [1.2]; mean difference, 0.91 [95% CI, 0.53-1.29]; effect size, 0.68), and tandem gait (mean [SD] time, 22.2 [8.3] vs 14.0 [3.7] seconds; mean difference, 8.23 seconds [95% CI, 6.63-9.82]; effect size, 1.55). Sex had a small effect on the mean (SD) number and severity of symptoms reported by the child (severity: boys, 15.1 [9.8] vs girls, 11.8 [9.2]; mean difference, 3.31 [95% CI, 1.60-5.02]; effect size, 0.35), mean (SD) number and severity of symptoms reported by the parent (severity: boys, 11.1 [7.7] vs girls, 9.4 [8.1]; mean difference, 1.63 [95% CI, 0.21-3.05]; effect size, 0.21), mean (SD) total SAC-C score (boys, 23.9 [3.9] vs girls, 24.9 [3.5]; mean difference, -0.92 [95% CI, -1.61 to -0.23]; effect size, -0.25), and mean (SD) mBESS score (boys, 1.21 [1.5] vs girls, 0.71 [1.0]; mean difference, 0.50 [95% CI, 0.27-0.74]; effect size, 0.38). CONCLUSIONS AND RELEVANCE Child SCAT3 baseline normative symptom, cognitive, and balance scores were different, with a large main effect for age and a small effect for sex. These findings may assist health care professionals with interpretation of Child SCAT3 scores for young athletes with a concussion in athletic and clinical settings.	[Brooks, M. Alison; McGuine, Timothy A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Pediat, 1685 Highland Ave, Madison, WI 53705 USA; [Brooks, M. Alison; McGuine, Timothy A.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Snedden, Traci R.] Univ Wisconsin, Sch Nursing, Madison, WI USA; [Mixis, Benjamin] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Hetzel, Scott] Univ Wisconsin, Biostat & Med Informat, Madison, WI USA		Brooks, MA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Pediat, 1685 Highland Ave, Madison, WI 53705 USA.	brooks@ortho.wisc.edu		Snedden, Traci/0000-0002-1550-2340	American Medical Society for Sports Medicine	This project was funded by a research grant from the American Medical Society for Sports Medicine.	Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Bazarian JJ, 2005, BRAIN INJ, V19; Berk Laura E., 2000, CHILD DEV, Vfifth; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Nelson LD, 2016, CLIN J SPORTS MED; Porter S, 2015, BMJ OPEN SPORT EXERC, V1; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Wadsworth BJ, PIAGETS THEORY COGNI; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	27	16	16	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	JUL	2017	171	7					670	677		10.1001/jamapediatrics.2017.0592			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	EZ3IK	WOS:000404604400013	28492862	Green Published			2022-02-06	
J	Hunnicutt, G; Lundgren, K; Murray, C; Olson, L				Hunnicutt, Gwen; Lundgren, Kristine; Murray, Christine; Olson, Loreen			The Intersection of Intimate Partner Violence and Traumatic Brain Injury: A Call for Interdisciplinary Research	JOURNAL OF FAMILY VIOLENCE			English	Article						Gender; Domestic violence; Public health; Socio-ecological framework	POSTTRAUMATIC-STRESS-DISORDER; BATTERED WOMEN; DOMESTIC VIOLENCE; COGNITIVE IMPAIRMENT; HEALTH CONSEQUENCES; HEAD-INJURIES; MENTAL-HEALTH; HELP-SEEKING; VICTIMS; RISK	An emerging body of research suggests that survivors of intimate partner violence (IPV) are at a high risk for sustaining traumatic brain injury (TBI). However, most scholars and practitioners working on the problem of IPV have not examined how TBI could be related to their familiar subject of study. Concomitantly, little work in the brain injury field has been done to examine TBI in the context of IPV. In this paper, we encourage cross-collaboration among these fields. To that end, we consider the relationship between IPV and TBI; the difficulty in detecting and measuring the IPV-related TBI and ethical concerns that may arise when addressing this issue. Our work emphasizes the need to recognize the complex interplay among psycho-physiological health and socio-cultural contexts. As such, we present a socio-ecological perspective of IPV-related TBI to provide a contextual framework to guide future interdisciplinary research. Finally, we outline directions for future research.	[Hunnicutt, Gwen] Univ North Carolina Greensboro, Dept Sociol & Womens Gender Studies, 316 Graham Bldg,POB 26170, Greensboro, NC 27402 USA; [Lundgren, Kristine] Univ North Carolina Greensboro, Dept Commun Sci & Disorders, 320 Ferguson Bldg, Greensboro, NC 27402 USA; [Murray, Christine] Univ North Carolina Greensboro, Dept Counseling & Educ Dev, 221 Curry Bldg, Greensboro, NC 27402 USA; [Olson, Loreen] Univ North Carolina Greensboro, Dept Commun Studies, 102 Ferguson Bldg,POB 26170, Greensboro, NC 27402 USA		Hunnicutt, G (corresponding author), Univ North Carolina Greensboro, Dept Sociol & Womens Gender Studies, 316 Graham Bldg,POB 26170, Greensboro, NC 27402 USA.	gchunnic@uncg.edu; k_lundgr@uncg.edu; cemurray@uncg.edu; lnolson@uncg.edu	Hunnicutt, Gwen/AAS-1272-2020				Ackerman RJ, 2003, WOMEN THER, V26, P343, DOI 10.1300/J015v26n03_11; Alderman N, 2002, BRAIN INJURY, V16, P469, DOI 10.1080/02699050110118458; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Arosarena OA, 2009, ARCH FACIAL PLAST S, V11, P48, DOI 10.1001/archfacial.2008.507; Banks ME, 2002, WOMEN THER, V25, P133, DOI 10.1300/J015v25n03_10; Belson K., 2013, NY TIMES; Breiding MJ, 2008, ANN EPIDEMIOL, V18, P538, DOI 10.1016/j.annepidem.2008.02.005; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; CDC, 2014, SOC EC MOD FRAM PREV; Centers for Disease Control, 2010, OV INT PART VIOL US; Committee on Mild Traumatic Brain Injury and American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P48; Corrigan J. D., 2001, AM J OBSTET GYNECOL, V188, P571; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; Diaz-Olavarrieta C, 1999, ARCH NEUROL-CHICAGO, V56, P681, DOI 10.1001/archneur.56.6.681; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Faul M, 2010, TRAUMATIC BRAIN INJU; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Helfrich CA, 2008, J INTERPERS VIOLENCE, V23, P437, DOI 10.1177/0886260507312942; Housecamp M. J., 1991, J INTERPERS VIOLENCE, V6, P367; Hughes K, 2012, LANCET, V379, P1621, DOI 10.1016/S0140-6736(11)61851-5; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee A. C., 2012, J NEUROL, P1, DOI [10.1093/brain/aws307, DOI 10.1093/BRAIN/AWS307]; Mechanic MB, 2008, VIOLENCE AGAINST WOM, V14, P1148, DOI 10.1177/1077801208323792; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Murray CE, 2013, RESPONDING TO FAMILY VIOLENCE: A COMPREHENSIVE, RESEARCH-BASED GUIDE FOR THERAPISTS, P1; Murray C. E., PARTNER VIO IN PRESS; Olson L. G., 2004, J FAMILY COMMUNICATI, V4, P209; Overstreet NM, 2013, BASIC APPL SOC PSYCH, V35, P109, DOI 10.1080/01973533.2012.746599; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Ray B, 2014, J FORENSIC SCI, V59, P1248, DOI 10.1111/1556-4029.12466; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Reichard AA, 2007, J HEAD TRAUMA REHAB, V22, P390, DOI 10.1097/01.HTR.0000300234.36361.b1; Richard L, 2011, ANNU REV PUBL HEALTH, V32, P307, DOI 10.1146/annurev-publhealth-031210-101141; Roberts AR, 2005, J SOC SERV RES, V32, P33, DOI 10.1300/J079v32n01_03; Stern Judith M, 2004, Curr Neurol Neurosci Rep, V4, P179, DOI 10.1007/s11910-004-0034-4; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Tjaden P, 2000, NIJ PUBLICATION; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Wenner K., 2012, NY TIMES; World Health Organization, 2012, UNDERSTANDING ADDRES; Wuest J, 2009, PAIN MED, V10, P739, DOI 10.1111/j.1526-4637.2009.00624.x	49	16	16	1	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7482	1573-2851		J FAM VIOLENCE	J. Fam. Violence	JUL	2017	32	5					471	480		10.1007/s10896-016-9854-7			10	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	EW7NR	WOS:000402701400001		Green Accepted			2022-02-06	
J	Konigs, M; van Heurn, LWE; Bakx, R; Vermeulen, RJ; Goslings, JC; Poll-The, BT; van der Wees, M; Catsman-Berrevoets, CE; Oosterlaan, J; Pouwels, PJW				Konigs, Marsh; van Heurn, L. W. Ernest; Bakx, Roel; Vermeulen, R. Jeroen; Goslings, J. Carel; Poll-The, Bwee Tien; van der Wees, Marleen; Catsman-Berrevoets, Coriene E.; Oosterlaan, Jaap; Pouwels, Petra J. W.			The Structural Connectome of Children With Traumatic Brain Injury	HUMAN BRAIN MAPPING			English	Article						pediatrics; traumatic brain injury; structural connectivity; functional outcome	CONNECTIVITY; NETWORKS; OUTCOMES; IMPAIRMENT; TBI	This study aimed to investigate the impact of mild to severe pediatric TBI on the structural connectome. Children aged 8-14 years with trauma control (TC) injury (n = 27) were compared to children with mild TBI and risk factors for complicated TBI (mild(RF+), n = 20) or moderate/severe TBI (n=16) at 2.8 years post-injury. Probabilistic tractography on diffusion tensor imaging data was used in combination with graph theory to study structural connectivity. Functional outcome was measured using neurocognitive tests and parent and teacher questionnaires for behavioral functioning. The results revealed no evidence for an impact of mild(RF+) TBI on the structural connectome. In contrast, the moderate/severe TBI group showed longer characteristic path length (P=0.022, d=0.82) than the TC group. Furthermore, longer characteristic path length was related to poorer intelligence and poorer working memory in children with TBI. In conclusion, children have abnormal organization of the structural connectome moderate/severe TBI, which may be implicated in neurocognitive dysfunction associated with pediatric TBI. These findings should be interpreted in the context of our exploratory analyses, which indicate that the definition and weighting of connectivity (e.g., streamline density, fractional anisotropy) influence the properties of the reconstructed connectome and its sensitivity to the impact and outcome of pediatric TBI. (C) 2017 Wiley Periodicals, Inc.	[Konigs, Marsh; Oosterlaan, Jaap] Vrije Univ Amsterdam, Clin Neuropsychol Sect, Amsterdam, Netherlands; [Konigs, Marsh; Oosterlaan, Jaap] Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands; [van Heurn, L. W. Ernest; Bakx, Roel] Emma Childrens Hosp, Acad Med Ctr, Pediat Surg Ctr Amsterdam, Amsterdam, Netherlands; [van Heurn, L. W. Ernest; Bakx, Roel] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Vermeulen, R. Jeroen] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Neurol, Amsterdam, Netherlands; [Vermeulen, R. Jeroen] Maastricht UMC, Dept Pediat Neurol, Maastricht, Netherlands; [Goslings, J. Carel] Acad Med Ctr, Trauma Unit, Amsterdam, Netherlands; [Poll-The, Bwee Tien] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Neurol, Amsterdam, Netherlands; [van der Wees, Marleen] Blixembosch, Libra Rehabil Med & Audiol, Eindhoven, Netherlands; [Catsman-Berrevoets, Coriene E.] Sophia Childrens Univ Hosp, Erasmus Univ Hosp, Dept Pediat Neurol, Rotterdam, Netherlands; [Oosterlaan, Jaap] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands; [Pouwels, Petra J. W.] Vrije Univ Amsterdam, Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands; [Pouwels, Petra J. W.] Neurosci Campus Amsterdam, Amsterdam, Netherlands		Konigs, M (corresponding author), Vrije Univ Amsterdam, Clin Neuropsychol Sect, Amsterdam, Netherlands.	m.konigs@vu.nl		Bakx, Roel/0000-0001-5884-2997; Vermeulen, R. Jeroen/0000-0002-3503-3625; Poll-The, Bwee Tien/0000-0002-8118-5419	Netherlands' Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [022.003.010]	Contract grant sponsor: Netherlands' Organization for Scientific Research (NWO, http://www.nwo.nl); Contract grant number: 022.003.010.	American College of Surgeons, 2004, ADV TRAUM LIF SUPP P; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Cohen J., 1988, STAT POWER ANAL BEHA; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Konigs M, 2017, BRAIN IMAGING BEHAV, P1, DOI DOI 10.1007/S11682-017-9673-3; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Qi SL, 2015, J NEUROSCI METH, V253, P170, DOI 10.1016/j.jneumeth.2015.06.016; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sattler JM, 2001, ASSESSMENT CHILDREN, P774; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Statistics Netherlands, 2006, ED CAT STAND; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Van Beek L, 2015, BRAIN INJURY, V29, P1701, DOI 10.3109/02699052.2015.1075172; van den Burg W, 1999, ARCH CLIN NEUROPSYCH, V14, P545, DOI 10.1016/S0887-6177(98)00042-0; Van der Ende J, 2013, HANDLEIDING ASEBA VR; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	42	16	16	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JUL	2017	38	7					3603	3614		10.1002/hbm.23614			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EZ8GR	WOS:000404963400022	28429381	Green Published			2022-02-06	
J	Lavaur, J; Le Nogue, D; Lemaire, M; Pype, J; Farjot, G; Hirsch, EC; Michel, PP				Lavaur, Jeremie; Le Nogue, Deborah; Lemaire, Marc; Pype, Jan; Farjot, Geraldine; Hirsch, Etienne C.; Michel, Patrick P.			The noble gas xenon provides protection and trophic stimulation to midbrain dopamine neurons	JOURNAL OF NEUROCHEMISTRY			English	Article						astroglial cells; dopamine neurons; glutamate; neurodegeneration; NMDA; xenon	D-ASPARTATE RECEPTOR; MITOCHONDRIAL CALCIUM HOMEOSTASIS; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; NMDA RECEPTOR; COMPETITIVE-INHIBITION; SUBSTANTIA-NIGRA; GLYCINE SITE; SUBTHALAMIC NUCLEUS; HYPOXIA-ISCHEMIA	Despite its low chemical reactivity, the noble gas xenon possesses a remarkable spectrum of biological effects. In particular, xenon is a strong neuroprotectant in preclinical models of hypoxic-ischemic brain injury. In this study, we wished to determine whether xenon retained its neuroprotective potential in experimental settings that model the progressive loss of midbrain dopamine (DA) neurons in Parkinson's disease. Using rat midbrain cultures, we established that xenon was partially protective for DA neurons through either direct or indirect effects on these neurons. So, when DA neurons were exposed to l-trans-pyrrolidine-2,4-dicarboxylic acid so as to increase ambient glutamate levels and generate slow and sustained excitotoxicity, the effect of xenon on DA neurons was direct. The vitamin E analog Trolox also partially rescued DA neurons in this setting and enhanced neuroprotection by xenon. However, in the situation where DA cell death was spontaneous, the protection of DA neurons by xenon appeared indirect as it occurred through the repression of a mechanism mediated by proliferating glial cells, presumably astrocytes and their precursor cells. Xenon also exerted trophic effects for DA neurons in this paradigm. The effects of xenon were mimicked and improved by the N-methyl-d-aspartate glutamate receptor antagonist memantine and xenon itself appeared to work by antagonizing N-methyl-d-aspartate receptors. Note that another noble gas argon could not reproduce xenon effects. Overall, present data indicate that xenon can provide protection and trophic support to DA neurons that are vulnerable in Parkinson's disease. This suggests that xenon might have some therapeutic value for this disorder.	[Lavaur, Jeremie; Le Nogue, Deborah; Hirsch, Etienne C.; Michel, Patrick P.] UPMC Univ Paris 06, Sorbonne Univ, INSERM, Hop Pitie Salpetriere,CNRS,Inst Cerveau & Moelle, Paris, France; [Lemaire, Marc; Pype, Jan; Farjot, Geraldine] Air Liquide Sante Int, Med R&D Paris, Saclay Res Ctr, Jouy En Josas, France		Michel, PP (corresponding author), Hop La Pitie Salpetriere, ICM, 47 Bd Hop, F-75013 Paris, France.	patrick-pierre.michel@upmc.fr	Hirsch, Etienne/AAC-7655-2019; Michel, Patrick Pierre/J-5248-2019	Hirsch, Etienne/0000-0003-4823-276X; Michel, Patrick Pierre/0000-0001-5607-3119	programs 'Investissements d'Avenir'French National Research Agency (ANR) [ANR-10-IAIHU-06, ANR-11-INBS-0011-NeurATRIS]; CIFRE doctoral fellowship; Association Nationale de la Recherche et de la Technologie (ANRT)French National Research Agency (ANR) [2014/0589]; Air Liquide Sante International	This study was funded by a grant from Air Liquide Sante International. The research leading to these results also received support from the programs 'Investissements d'Avenir' ANR-10-IAIHU- 06 and ANR-11-INBS-0011-NeurATRIS: Translational Research Infrastructure for Biotherapies in Neurosciences. This work benefited from equipment and services from the CELIS cell culture facility, at ICM. More specifically, we thank David Akbar for assistance regarding automated fluorescence microscopy. ML, JP, and GF are Air Liquide employees. DLN was supported by a CIFRE doctoral fellowship co-funded by Association Nationale de la Recherche et de la Technologie (ANRT, 2014/0589) and Air Liquide Sante International. We also wish to mention the contribution of other Air Liquide staff members, Aude Milet and Matthieu Chalopin for project management and Francois Gilles for technical support with gas delivery systems. Air Liquide has filed patent applications for the use of xenon as therapeutic agent for Parkinson's disease. E. Hirsch is an editor of JNC.	Aoyama K, 2015, MOLECULES, V20, P8742, DOI 10.3390/molecules20058742; Armstrong SP, 2012, ANESTHESIOLOGY, V117, P38, DOI 10.1097/ALN.0b013e31825ada2e; Assous M, 2014, NEUROBIOL DIS, V65, P69, DOI 10.1016/j.nbd.2014.01.011; Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Bantel C, 2010, ANESTHESIOLOGY, V112, P623, DOI 10.1097/ALN.0b013e3181cf894a; Berman AE, 2011, ANN NEUROL, V69, P509, DOI 10.1002/ana.22162; Blandini F, 2001, ANN NEUROL, V49, P525, DOI 10.1002/ana.104.abs; Blitzblau R, 1996, EUR J NEUROSCI, V8, P1840, DOI 10.1111/j.1460-9568.1996.tb01328.x; Brennan-Minnella AM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.111; Brucken A, 2013, BRIT J ANAESTH, V110, P106, DOI 10.1093/bja/aes509; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Charles PD, 2008, NAT CLIN PRACT NEURO, V4, P424, DOI 10.1038/ncpneuro0848; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Coburn M, 2012, EUR J ANAESTH, V29, P549, DOI 10.1097/EJA.0b013e328357bfdd; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Deng J, 2014, PROG NEUROBIOL, V115, P210, DOI 10.1016/j.pneurobio.2014.01.001; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Gouix E, 2009, MOL CELL NEUROSCI, V40, P463, DOI 10.1016/j.mcn.2009.01.002; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Guerreiro S, 2015, MOL PHARMACOL, V87, P525, DOI 10.1124/mol.114.095703; Guerreiro S, 2009, J NEUROCHEM, V109, P1118, DOI 10.1111/j.1471-4159.2009.06040.x; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Janc OA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00056; Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jimenez-Blasco D, 2015, CELL DEATH DIFFER, V22, P1877, DOI 10.1038/cdd.2015.49; Kotermanski SE, 2009, J NEUROSCI, V29, P2774, DOI 10.1523/JNEUROSCI.3703-08.2009; Kramer ER, 2015, FEBS LETT, V589, P3760, DOI 10.1016/j.febslet.2015.11.006; Lavaur J, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.18; Lavaur J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.86; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Liu LT, 2010, J PHYS CHEM B, V114, P9010, DOI 10.1021/jp101687j; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma SY, 1997, J NEUROL SCI, V151, P83, DOI 10.1016/S0022-510X(97)00100-7; MAKI R, 1994, J NEUROSCI, V14, P6754; Michel PP, 2016, NEURON, V90, P675, DOI 10.1016/j.neuron.2016.03.038; Michel PP, 2013, FASEB J, V27, P3414, DOI 10.1096/fj.12-220418; Michel PP, 1997, J NEUROCHEM, V69, P1499; Mourlevat S, 2003, MOL PHARMACOL, V64, P578, DOI 10.1124/mol.64.3.578; Nafia I, 2008, J NEUROCHEM, V105, P484, DOI 10.1111/j.1471-4159.2007.05146.x; Petzelt C, 2003, LIFE SCI, V72, P1909, DOI 10.1016/S0024-3205(02)02439-6; Petzelt C, 1999, LIFE SCI, V65, P901, DOI 10.1016/S0024-3205(99)00320-3; Piallat B, 1999, J NEURAL TRANSM-SUPP, P71; Ramaswamy P, 2014, NEUROL SCI, V35, P823, DOI 10.1007/s10072-013-1604-5; Rasband W.S, 1997, IMAGEJ US; Rousseau E, 2013, MOL PHARMACOL, V84, P888, DOI 10.1124/mol.113.087965; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Sanders RD, 2003, BRIT J ANAESTH, V91, P709, DOI 10.1093/bja/aeg232; Sauguet L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149795; Sepulveda-Diaz JE, 2016, GLIA, V64, P1912, DOI 10.1002/glia.23032; Spaggiari S, 2013, CELL CYCLE, V12, P2636, DOI 10.4161/cc.25650; Thomas C, 2009, REDOX REP, V14, P102, DOI 10.1179/135100009X392566; Thoresen M, 2009, J CEREBR BLOOD F MET, V29, P707, DOI 10.1038/jcbfm.2008.163; Toulorge D, 2011, FASEB J, V25, P2563, DOI 10.1096/fj.11-182824; Toulorge D, 2010, J NEUROCHEM, V114, P553, DOI 10.1111/j.1471-4159.2010.06785.x; Toyomoto M, 2005, NEUROSCI LETT, V379, P185, DOI 10.1016/j.neulet.2004.12.063; Vaarmann A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.194; Verkhratsky A, 2007, NEUROSCIENTIST, V13, P28, DOI 10.1177/1073858406294270; Waagepetersen HS, 2001, NEUROCHEM RES, V26, P661, DOI 10.1023/A:1010939304104; Wallace BA, 2007, BRAIN, V130, P2129, DOI 10.1093/brain/awm137; Wu HM, 2009, NEUROPSYCHOPHARMACOL, V34, P2344, DOI 10.1038/npp.2009.64; Yamamoto Y, 2010, ACTA ANAESTH SCAND, V54, P337, DOI 10.1111/j.1399-6576.2009.02111.x; Yang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037020; ZHANG YX, 1995, AM MINERAL, V80, P670; Zhao HL, 2016, ONCOTARGET, V7, P25640, DOI 10.18632/oncotarget.8241	68	16	20	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUL	2017	142	1					14	28		10.1111/jnc.14041			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EY3UE	WOS:000403899000002	28398653	Green Published, hybrid			2022-02-06	
J	Modi, AC; Schmidt, M; Smith, AW; Turnier, L; Glaser, N; Wade, SL				Modi, Avani C.; Schmidt, Matthew; Smith, Aimee W.; Turnier, Luke; Glaser, Noah; Wade, Shari L.			Development of a web-based executive functioning intervention for adolescents with epilepsy: The Epilepsy Journey	EPILEPSY & BEHAVIOR			English	Article						Technology; Teenagers; Attention; Seizures; Treatment	TRAUMATIC BRAIN-INJURY; PROBLEM-SOLVING INTERVENTION; RANDOMIZED CLINICAL-TRIAL; SYMPTOMATIC EPILEPSY; PRELIMINARY EFFICACY; CHILDHOOD EPILEPSY; ABSENCE EPILEPSY; CHILDREN; DEFICITS; DYSFUNCTION	Introduction: Youth with epilepsy exhibit significant deficits in executive functioning (EF), yet there are few interventions to improve EF for adolescents. The aims of the current study were to develop an individuallytailored intervention, called Epilepsy Journey, to improve aspects of EF through an iterative, patient-centered process including focus groups and usability testing. Methods: Five adolescents and caregivers participated in focus groups. This input was used to develop ten learning modules based on subscales of the Behavioral Rating Inventory of Executive Functions and key issues that may impact EF in adolescents. Six adolescents participated in usability testing and a usability expert conducted a heuristic evaluation. Demographic information, chart reviews and measures of EF were also completed. Results: Focus group participants and their parents reported difficulties with memory, attention, organization, monitoring, initiation, impulsivity, emotional control, sleep, awareness in schools and managing stress. They also identified successful strategies to address memory and organizational difficulties. Usability testing of the resultant Epilepsy Journey modules revealed problems with navigation and identified features that promoted usability, including progress bars and interactivemodules. Programmodificationsweremade after each usability trial resulting in a relatively brief, interactive and readily navigable program. Perceived utility was high with all but one participant. Participants rated the content as helpful and indicated they would recommend Epilepsy Journey to others. Conclusions: Feedback from the focus group and usability testing yielded a feasible, acceptable, relevant and user-friendly web-based intervention for adolescents with epilepsy. The Epilepsy Journey program will be further tested in an open pilot with adolescents with epilepsy and associated EF deficits. (C) 2017 Elsevier Inc. All rights reserved.	[Modi, Avani C.; Smith, Aimee W.; Turnier, Luke] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Schmidt, Matthew; Glaser, Noah] Univ Cincinnati, Coll Educ Criminal Justice & Human Serv, Cincinnati, OH 45221 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA		Modi, AC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Ctr Adherence & Self Management, 3333 Burnet Ave,MLC 7039, Cincinnati, OH 45229 USA.	avani.modi@cchmc.org		Glaser, Noah/0000-0002-1966-2720; Modi, Avani/0000-0002-7580-3751; Schmidt, Matthew/0000-0002-8110-4367	National Institutes of Health-Eunice Kennedy Shriver, National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD083335-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD083335] Funding Source: NIH RePORTER	This research was funded by the National Institutes of Health-Eunice Kennedy Shriver, National Institute of Child Health and Human Development (R21HD083335-01).	Bailet LL, 2000, EPILEPSIA, V41, P426, DOI 10.1111/j.1528-1157.2000.tb00184.x; Duggan, 2013, TEENS AND TECHNOLOGY; Fuentes A, 2017, EPILEPSY BEHAV, V67, P51, DOI 10.1016/j.yebeh.2016.12.016; Gaudieri PA, 2008, DIABETES CARE, V31, P1892, DOI 10.2337/dc07-2132; Gioia G. A., 2000, PSYCHOL ASSESSMENT R; Goggins S, 2010, 43 HAW INT C SYST SC; Goggins Sean P., 2011, International Journal of Social and Organizational Dynamics in IT, V1, P30, DOI 10.4018/ijsodit.2011010103; Hermann BP, 2008, EPILEPSIA, V49, P1847, DOI 10.1111/j.1528-1167.2008.01735.x; Hijmans CT, 2011, PEDIATR BLOOD CANCER, V56, P783, DOI 10.1002/pbc.22879; Hoie B, 2008, DEV MED CHILD NEUROL, V50, P530, DOI 10.1111/j.1469-8749.2008.03015.x; Hoie B, 2005, SEIZURE-EUR J EPILEP, V14, P223, DOI 10.1016/j.seizure.2004.10.006; Jackson DC, 2013, J PEDIATR-US, V162, P1047, DOI 10.1016/j.jpeds.2012.10.046; Jones JE, 2010, EPILEPSY BEHAV, V18, P211, DOI 10.1016/j.yebeh.2010.03.015; Kerr EN, 2015, EPILEPSIA, V56, P1784, DOI 10.1111/epi.13195; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Lenhart A, 2015, TEEN SOCIAL MEDIA TE; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Macallister WS, 2014, APPL NEUROPSYCHOL CH; Masur D, 2013, NEUROLOGY, V81, P1572, DOI 10.1212/WNL.0b013e3182a9f3ca; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Pavone P, 2001, NEUROLOGY, V56, P1047, DOI 10.1212/WNL.56.8.1047; Piccinelli P, 2010, SEIZURE-EUR J EPILEP, V19, P540, DOI 10.1016/j.seizure.2010.07.014; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2013, J HEAD TRAUMA REHABI; Winter AL, 2014, J CLIN EXP NEUROPSYC, V36, P818, DOI 10.1080/13803395.2014.943695	31	16	16	1	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	JUL	2017	72						114	121		10.1016/j.yebeh.2017.04.009			8	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	FB7LE	WOS:000406321300019	28575759	Green Accepted			2022-02-06	
J	Mower, WR; Gupta, M; Rodriguez, R; Hendey, GW				Mower, William R.; Gupta, Malkeet; Rodriguez, Robert; Hendey, Gregory W.			Validation of the sensitivity of the National Emergency X-Radiography Utilization Study (NEXUS) Head computed tomographic (CT) decision instrument for selective imaging of blunt head injury patients: An observational study	PLOS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; UNITED-STATES; RULE; DEPARTMENTS; MULTICENTER; TRENDS; TRIAL	Background Clinicians, afraid of missing intracranial injuries, liberally obtain computed tomographic (CT) head imaging in blunt trauma patients. Prior work suggests that clinical criteria (National Emergency X-Radiography Utilization Study [NEXUS] Head CT decision instrument [DI]) can reliably identify patients with important injuries, while excluding injury, and the need for imaging in many patients. Validating this DI requires confirmation of the hypothesis that the lower 95% confidence limit for its sensitivity in detecting serious injury exceeds 99.0%. A secondary goal of the study was to complete an independent validation and comparison of the Canadian and NEXUS Head CT rules among the subgroup of patients meeting the inclusion and exclusion criteria. Methods and findings We conducted a prospective observational study of the NEXUS Head CT DI in 4 hospital emergency departments between April 2006 and December 2015. Implementation of the rule requires that patients satisfy 8 criteria to achieve "low-risk" classification. Patients are excluded from "low-risk" classification and assigned "high-risk" status if they fail to meet 1 or more criteria. We examined the instrument's performance in assigning "high-risk" status to patients requiring neurosurgical intervention among a cohort of 11,770 blunt head injury patients. The NEXUS Head CT DI assigned high-risk status to 420 of 420 patients requiring neurosurgical intervention (sensitivity, 100.0% [95% confidence interval [CI]: 99.1%-100.0%]). The instrument assigned low-risk status to 2,823 of 11,350 patients who did not require neurosurgical intervention (specificity, 24.9% [95% CI: 24.1%-25.7%]). None of the 2,823 low-risk patients required neurosurgical intervention (negative predictive value [NPV], 100.0% [95% CI: 99.9%-100.0%]). The DI assigned high-risk status to 759 of 767 patients with significant intracranial injuries (sensitivity, 99.0% [95% CI: 98.0%-99.6%]). The instrument assigned low-risk status to 2,815 of 11,003 patients who did not have significant injuries (specificity, 25.6% [95% CI: 24.8%-26.4%]). Significant injuries were absent in 2,815 of the 2,823 patients assigned low-risk status (NPV, 99.7% [95% CI: 99.4%-99.9%]). Of our patients, 7,759 (65.9%) met the inclusion and exclusion criteria of the Canadian Head CT rule, including 111 patients (1.43%) who required neurosurgical intervention and 306 (3.94%) who had significant intracranial injuries. In our study, the Canadian criteria for neurosurgical intervention identified 108 of 111 patients requiring neurosurgical intervention to yield a sensitivity of 97.3% (95% CI: 92.3%-99.4%) and exhibited a specificity of 58.8% (95% CI: 57.7%-59.9%). The NEXUS rule, when applied to this same cohort, identified all 111 patients requiring neurosurgical intervention, yielding a sensitivity of 100% (95% CI: 96.7%-100.0%) with a specificity of 32.6% (95% CI: 31.5%-33.6%). Our study found that the Canadian medium-risk factors identified 301 of 306 patients with significant injuries (sensitivity = 98.4%; 95% CI: 96.2%-99.5%), while the NEXUS rule identified 299 of these patients (sensitivity = 97.7%; 95% CI: 95.3%-99.1%). In our study, the Canadian medium-risk rule exhibited a specificity of 12.3% (95% CI: 11.6%-13.1%), while the NEXUS rule exhibited a specificity of 33.3% (95% CI: 32.3%-34.4%). Limitations of the study may arise from application of the rule by different clinicians in different environments. Clinicians may vary in their interpretation and application of the instrument's criteria and risk assignment and may also vary in deciding which patients require intervention. The instrument's specificity is also subject to spectrum bias and may change with variations in the proportion of "low-risk" patients seen in other centers. Conclusions The NEXUS Head CT DI reliably identifies blunt trauma patients who require head CT imaging and could significantly reduce the use of CT imaging.	[Mower, William R.; Gupta, Malkeet; Hendey, Gregory W.] Univ Calif Los Angeles, Dept Emergency Med, Ronald Reagan UCLA Med Ctr, Los Angeles, CA 90095 USA; [Gupta, Malkeet] Antelope Valley Hosp, Emergency Dept, Lancaster, CA USA; [Rodriguez, Robert] UCSF, Sch Med, Dept Emergency Med, San Francisco Gen Hosp, San Francisco, CA USA; [Hendey, Gregory W.] UCSF Fresno, Community Reg Med Ctr, Fresno, CA USA		Mower, WR (corresponding author), Univ Calif Los Angeles, Dept Emergency Med, Ronald Reagan UCLA Med Ctr, Los Angeles, CA 90095 USA.	wmower@ucla.edu		Hendey, Gregory/0000-0002-0170-8743; Mower, William/0000-0003-1468-6501	Agency for Health Care Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [HS09699]; National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [CE001589]; UC Center for Health Quality and Innovation [HL120466]	This work was funded, in part, by the following grants: Agency for Health Care Research and Quality (www.ahrq.gov) HS09699, National Center for Injury Prevention and Control (https://www.cdc.gov/injury) CE001589, UC Center for Health Quality and Innovation (health.universityotcalifornia.edu/innovation-center) HL120466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Board of Internal Medicine, CHOOS WIS IN ABIM FD; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Brenner DJ, 2010, RADIAT RES, V174, P809, DOI 10.1667/RR1859.1; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Fleiss JH., 1981, STAT METHODS RATES P; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hussein W, 2015, ACAD EMERG MED, V22, P663, DOI 10.1111/acem.12684; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Melnick ER, 2015, JT COMM J QUAL PATIE, V41, P313, DOI 10.1016/S1553-7250(15)41041-4; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; *NAT RES COUNC, 1990, HLTH EFF EXP LOW LEV; Prowse SJ, 2010, EMERG MED J, V27, P277, DOI 10.1136/emj.2008.070649; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Sierink JC, 2016, LANCET, V388, P673, DOI 10.1016/S0140-6736(16)30932-1; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	24	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1676			PLOS MED	PLos Med.	JUL	2017	14	7							e1002313	10.1371/journal.pmed.1002313			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1QA	WOS:000406611200002	28700585	Green Published, gold			2022-02-06	
J	Righy, C; do Brasil, PEA; Valles, J; Bozza, FA; Martin-Loeches, I				Righy, Cassia; Americano do Brasil, Pedro Emmanuel; Valles, Jordi; Bozza, Fernando A.; Martin-Loeches, Ignacio			Systemic antibiotics for preventing ventilator-associated pneumonia in comatose patients: a systematic review and meta-analysis	ANNALS OF INTENSIVE CARE			English	Article						Systematic review; Meta-analysis; Ventilator-associated pneumonia; Coma	TRAUMATIC BRAIN-INJURY; EARLY-ONSET PNEUMONIA; INTENSIVE-CARE-UNIT; HOSPITAL-ACQUIRED PNEUMONIA; RISK-FACTORS; PROPHYLAXIS; INFECTIONS; MORTALITY; PATHOGENS; IMPACT	Background: Early-onset ventilator-associated pneumonia (EO-VAP) is the leading cause of morbidity and mortality in comatose patients. However, VAP prevention bundles focus mainly on late-onset VAP and may be less effective in preventing EO-VAP in comatose patients. Systemic antibiotic administration at the time of intubation may have a role in preventing EO-VAP. Therefore, we evaluated the effectiveness of systemic antibiotic administration in VAP prevention in comatose patients through a systematic review and meta-analysis. Methods: We searched for studies published through December 2015 that evaluated systemic antibiotic prophylaxis in comatose patients. Two authors independently selected and evaluated full-length reports of randomized clinical trials or prospective cohorts in patients aged > 16 years that evaluated the impact of systemic antibiotics at the time of intubation on EO-VAP compared to placebo or no prophylaxis. The outcome variables were the incidence of EOVAP, the duration of mechanical ventilation, ICU length of stay, and ICU mortality. Results: We identified 10,988 citations, yielding 26 articles for further analysis; three studies with 267 patients were finally analyzed. Most patients (n = 135) were comatose due to head trauma. Systemic antibiotic administration was associated with decreased incidence of EO-VAP (RR 0.32; 95% CI 0.19-0.54) and shorter ICU LOS (standardized mean difference -0.32; 95% CI -0.56 to -0.08), but had no effect on mortality (RR 1.03; 95% CI 0.7-1.53) or duration of mechanical ventilation (standardized mean difference -0.16; 95% CI -0.41 to 0.08). Conclusions: Antibiotic prophylaxis in comatose patients reduced the incidence of EO-VAP and decreased the ICU stay slightly. Future trials are needed to confirm these results.	[Righy, Cassia; Americano do Brasil, Pedro Emmanuel; Bozza, Fernando A.] Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Infect Dis Evandro Chagas, Rio De Janeiro, Brazil; [Righy, Cassia] Paulo Niemeyer Brain Inst, ICU, Rio De Janeiro, Brazil; [Valles, Jordi; Martin-Loeches, Ignacio] CIBERES, Barcelona, Spain; [Valles, Jordi] Hosp Sabadell, Crit Care Ctr, CIBER Enfermedades Resp, Sabadell, Spain; [Bozza, Fernando A.] DOr Inst Res & Educ, IDOR, Rio De Janeiro, Brazil; [Martin-Loeches, Ignacio] St Jamess Univ Hosp Dublin, Dept Clin Med, Trinity Ctr Hlth Sci, MICRO,Wellcome Trust,HRB Clin Res, Dublin, Ireland; [Martin-Loeches, Ignacio] ICVB, Dublin, Ireland		Righy, C (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Infect Dis Evandro Chagas, Rio De Janeiro, Brazil.	cassiarighy@gmail.com	Shinotsuka, Cassia Righy/H-9181-2013; Bozza, Fernando A/A-2618-2013; Brasil, Pedro E A A/B-4357-2008; martin-loeches, Prof. Ignacio/Q-6645-2018	Shinotsuka, Cassia Righy/0000-0002-9206-9552; Bozza, Fernando A/0000-0003-4878-0256; Brasil, Pedro E A A/0000-0002-6700-2268; martin-loeches, Prof. Ignacio/0000-0002-5834-4063	Clinical Research Collaboration (CRC) by European Respiratory Society	Clinical Research Collaboration (CRC) by European Respiratory Society.	Acquarolo A, 2005, INTENS CARE MED, V31, P510, DOI 10.1007/s00134-005-2585-5; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Berrouane Y, 1998, J HOSP INFECT, V40, P275, DOI 10.1016/S0195-6701(98)90303-6; Boehme AK, 2013, J STROKE CEREBROVASC, V22, pE582, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.020; Bornstain C, 2004, CLIN INFECT DIS, V38, P1401, DOI 10.1086/386321; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Croce MA, 2013, J TRAUMA ACUTE CARE, V74, P354, DOI 10.1097/TA.0b013e31827a0c65; Depuydt PO, 2008, CRIT CARE, V12, DOI 10.1186/cc7119; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Giard M, 2008, J CRIT CARE, V23, P27, DOI 10.1016/j.jcrc.2007.08.005; Gould CV, 2006, INFECT CONT HOSP EP, V27, P920, DOI 10.1086/507280; Harbarth S, 2000, CIRCULATION, V101, P2916, DOI 10.1161/01.CIR.101.25.2916; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Imran H, 2008, EUR J CLIN MICROBIOL, V27, P53, DOI 10.1007/s10096-007-0397-y; Jovanovic B, 2016, MED PRIN PRACT, V25, P435, DOI 10.1159/000447566; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Liu Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009413.pub2; Maier IL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116836; Martin-Loeches I, 2015, LANCET RESP MED, V3, P859, DOI 10.1016/S2213-2600(15)00326-4; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Nseir S, 2014, CRIT CARE, V18, DOI 10.1186/cc13940; Pileggi C, 2011, CRIT CARE, V15, DOI 10.1186/cc10285; de Antonio LAR, 2011, NEUROLOGIA, V26, P150, DOI 10.1016/j.nrl.2010.07.030; Ruhnke AM, ONLINE SUPPLEMENTARY; Scheitz JF, 2015, INT J STROKE, V10, P61, DOI 10.1111/j.1747-4949.2012.00864.x; Schuts EC, 2016, LANCET INFECT DIS, V16, P847, DOI 10.1016/S1473-3099(16)00065-7; Seguin P, 2014, CRIT CARE MED, V42, P1, DOI 10.1097/CCM.0b013e3182a2770f; Shah SV, 2015, J STROKE CEREBROVASC, V24, P1969, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.037; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Sykora M, 2015, STROKE, V46, P1269, DOI 10.1161/STROKEAHA.114.008260; Valles J, 2007, INTENS CARE MED, V33, P1363, DOI 10.1007/s00134-007-0721-0; Valles J, 2013, CHEST, V143, P1219, DOI 10.1378/chest.12-1361; Westendorp WF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub2; Winklewski PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0213-4; Zilahi G, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0199-4	40	16	18	0	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2110-5820			ANN INTENSIVE CARE	Ann. Intensive Care	JUN 15	2017	7								67	10.1186/s13613-017-0291-4			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5QV	WOS:000404773400001	28620893	gold, Green Published			2022-02-06	
J	Wang, ZJ; Wang, Q; Wang, CJ; Xu, XZ; Yu, HM				Wang, Zhijing; Wang, Qi; Wang, Cuijie; Xu, Xiuzhen; Yu, Hongmei			Tetramethylpyrazine attenuates periorbital allodynia and neuroinflammation in a model of traumatic brain injury	JOURNAL OF INFLAMMATION-LONDON			English	Article						Traumatic brain injury; Tetramethylpyrazine; Pain; Neuroinflammation	NEUROPATHIC PAIN; RAT; RECEPTORS; STRESS	Background: Traumatic brain injury (TBI) is a public health issue. As the major complaint in 51% of TBI patients, chronic pain is an important aspect in TBI treatment. Tetramethylpyrazine (TMP) is an important compound in Ligustrazine, an analgesic drug in traditional Chinese medicine, but its potential in relieving pain symptom in TBI has not been tested. We established a TBI mouse model with controlled cortical impact (CCI), and measured periorbital hypersensitivity with von Frey monofilaments. We examined activated microglia and astrocytes and the levels of substance P (SP) and inducible isoform of nitric oxide synthase (iNOS) with immunohistochemistry, measured mRNA and protein levels of proinflammatory cytokines with qPCR and enzyme-linked immunosorbent assay, respectively. Western blot was employed to detect molecules in NF-kappa B signaling pathway. Results: TMP significantly attenuated periorbital hypersensitivity in TBI mice. Within 3 days after CCI, TMP attenuated activation of microglia and astrocytes, levels of SP, iNOS, and CGRP in trigeminal pathway, and levels of proinflammatory cytokines (including IL-6, TNF-alpha, IL-12). In isolated microglia, TMP attenuated the effects of lipopolysaccharide on the phosphorylation of cytoplasmic IKKa/beta and IKB-a, and levels of nucleic p65. Conclusion: TMP reversed periorbital hypersensitivity by limiting neuroinflammation at the primary stage of TBI, and could be a promising drug for pain treatment in TBI.	[Wang, Zhijing; Wang, Cuijie] Cangzhou Cent Hosp, Operating Theatre, Brain Branch, Cangzhou City 061000, Hebei Province, Peoples R China; [Wang, Qi; Yu, Hongmei] Cangzhou Cent Hosp, Dept Anesthesiol, Brain Branch, Cangzhou City 061000, Hebei Province, Peoples R China; [Xu, Xiuzhen] Cangzhou Cent Hosp, Dept Neurosurg 4, Brain Branch, Cangzhou City 061000, Hebei Province, Peoples R China		Wang, ZJ (corresponding author), Cangzhou Cent Hosp, Operating Theatre, Brain Branch, Cangzhou City 061000, Hebei Province, Peoples R China.	zxyywzj@126.com			The Cangzhou Central Hospital Foundation	This study was supported by The Cangzhou Central Hospital Foundation.	Carr AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037640; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Gao Y, 2008, BRAIN RES BULL, V77, P27, DOI 10.1016/j.brainresbull.2008.02.026; Gao Y, 2010, BURNS, V36, P127, DOI 10.1016/j.burns.2009.04.032; Hsieh T. H., 2016, CEREB CORTEX; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Leng YF, 2012, AM J CHINESE MED, V40, P1229, DOI 10.1142/S0192415X12500917; Liang SD, 2005, BRAIN RES, V1040, P92, DOI 10.1016/j.brainres.2005.01.076; Liang SD, 2004, BRAIN RES, V995, P247, DOI 10.1016/j.brainres.2003.09.070; Liang SD, 2010, NEUROCHEM INT, V57, P705, DOI 10.1016/j.neuint.2010.09.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nemzek JA, 2001, J IMMUNOL METHODS, V255, P149, DOI 10.1016/S0022-1759(01)00419-7; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Shao HK, 2015, MED SCI MONITOR, V21, P3704, DOI 10.12659/MSM.895362; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858	24	16	17	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1476-9255			J INFLAMM-LOND	J. Inflamm.-Lond.	JUN 8	2017	14								13	10.1186/s12950-017-0161-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EX3YZ	WOS:000403171900001	28603455	Green Published, gold			2022-02-06	
J	Chien, WC; Chung, CH; Lin, FH; Yeh, CB; Huang, SY; Lu, RB; Chang, HA; Kao, YC; Chiang, WS; Chou, YC; Tsao, CH; Wu, YF; Tzeng, NS				Chien, Wu-Chien; Chung, Chi-Hsiang; Lin, Fu-Huang; Yeh, Chin-Bin; Huang, San-Yuan; Lu, Ru-Band; Chang, Hsin-An; Kao, Yu-Chen; Chiang, Wei-Shan; Chou, Yu-Ching; Tsao, Chang-Huei; Wu, Yung-Fu; Tzeng, Nian-Sheng			The risk of injury in adults with attention-deficit hyperactivity disorder: A nationwide, matched-cohort, population-based study in Taiwan	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Adults; Attention-deficit hyperactivity disorder; Injury; National Health Insurance Database	TRAUMATIC BRAIN-INJURY; DEFICIT/HYPERACTIVITY DISORDER; UNINTENTIONAL INJURY; LIFE-SPAN; FOLLOW-UP; ADHD; CHILDREN; COMORBIDITY; EFFICACY; METHYLPHENIDATE	Background: Few studies have investigated the risk of injuries associated with adults with attention-deficit hyperactivity disorder (ADHD), even though several studies have suggested a higher risk of injury in children and adolescents with ADHD. Aims: To investigate the risk of injury in adults with ADHD. Methods and procedures: We included 665 adults with ADHD from January 1, to December 31, 2000, and 1995 sex-, age- and index day-matched controls without ADHD from the Longitudinal Health Insurance Database (LHID) subset of the National Health Insurance Research Database in Taiwan. The Cox proportional hazard models were used to analyze the associations between the relevant demographics, and the psychiatric comorbidities and the risk of injury. Outcomes and results: The patients with ADHD had a 143% increased risk of overall injuries than the controls after considering all the confounding factors. In addition, the use of methylphenidate was associated with a 22.6% decrease in the risk of injuries in the patients with ADHD. Conclusions and implications: Our findings strongly support that adults with ADHD are at an increased risk of injury, and imply that methylphenidate therapy may attenuate this risk.	[Chien, Wu-Chien; Chung, Chi-Hsiang; Tsao, Chang-Huei; Wu, Yung-Fu] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang; Lin, Fu-Huang; Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Yeh, Chin-Bin; Huang, San-Yuan; Lu, Ru-Band; Chang, Hsin-An; Kao, Yu-Chen; Chiang, Wei-Shan; Tzeng, Nian-Sheng] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, Taipei, Taiwan; [Yeh, Chin-Bin; Huang, San-Yuan; Lu, Ru-Band] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Div Clin Psychol, Tainan, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Coll Med, Dept Psychiat, Tainan, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Coll Med, Inst Behav Med, Tainan, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan, Taiwan; [Lu, Ru-Band] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Miaoli County, Taiwan; [Chang, Hsin-An; Tzeng, Nian-Sheng] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan; [Kao, Yu-Chen] Triserv Gen Hosp, Natl Def Med Ctr, Song Shan Branch, Dept Psychiat, Taipei, Taiwan; [Chiang, Wei-Shan] Tamkang Univ, Dept & Inst Math, New Taipei, Taiwan; [Tsao, Chang-Huei] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan		Tzeng, NS (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Psychiat, 325,Sect 2,Cheng Kung Rd, Taipei 11490, Taiwan.	pierrens@mail.ndmctsgh.edu.tw	Tzeng, Nian-Sheng/AAU-4945-2021; Chung, Chi-Hsiang/AAY-3386-2021	Chang, Hsin-An/0000-0001-5572-7109	Tri-Service General Hospital Research Foundation [TSGH-C105-003, TSGH-C105-130, TSGH-C106-002]	This study is funded by Tri-Service General Hospital Research Foundation (TSGH-C105-003, TSGH-C105-130, and TSGH-C106-002).	Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Cadman T, 2012, J AM ACAD CHILD PSY, V51, P879, DOI 10.1016/j.jaac.2012.06.017; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089867; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chinese Hospital Association, 2000, ICD 9 900 ENGL CHIN; Chou IC, 2014, DEV MED CHILD NEUROL, V56, P1111, DOI 10.1111/dmcn.12501; Chou IC, 2013, J DEV BEHAV PEDIATR, V34, P181, DOI 10.1097/DBP.0b013e3182829f2b; Cumyn L, 2009, CAN J PSYCHIAT, V54, P673, DOI 10.1177/070674370905401004; Dalsgaard S, 2015, LANCET PSYCHIAT, V2, P702, DOI 10.1016/S2215-0366(15)00271-0; Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6; Dalsgaard S, 2014, J CHILD ADOL PSYCHOP, V24, P253, DOI 10.1089/cap.2013.0101; Ertan C, 2012, EMERG MED J, V29, P911, DOI 10.1136/emermed-2011-200298; Faraone SV, 2010, J CLIN PSYCHIAT, V71, P754, DOI 10.4088/JCP.08m04902pur; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Groom MJ, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0566-y; Guo NW, 2016, J PEDIATR ORTHOP B, V25, P369, DOI 10.1097/BPB.0000000000000243; Hartman CA, 2016, NEUROSCI BIOBEHAV R, V71, P529, DOI 10.1016/j.neubiorev.2016.09.003; Hinshaw SP, 2012, J CONSULT CLIN PSYCH, V80, P1041, DOI 10.1037/a0029451; Hutchison SL, 2016, THER ADV PSYCHOPHARM, V6, P317, DOI 10.1177/2045125316647686; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Jensen PS, 2001, J AM ACAD CHILD PSY, V40, P147, DOI 10.1097/00004583-200102000-00009; Kang JH, 2013, ACTA PAEDIATR, V102, P640, DOI 10.1111/apa.12213; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Lam L T, 2002, J Atten Disord, V6, P77, DOI 10.1177/108705470200600204; Lam LT, 2006, ACCIDENT ANAL PREV, V38, P1176, DOI 10.1016/j.aap.2006.05.004; Lam LT, 2005, J ADOLESCENT HEALTH, V36, P19, DOI 10.1016/j.jadohealth.2003.12.010; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Liang JA, 2011, CANCER EPIDEM BIOMAR, V20, P473, DOI 10.1158/1055-9965.EPI-10-1280; Loe IM, 2007, J PEDIATR PSYCHOL, V32, P643, DOI 10.1093/jpepsy/jsl054; London AS, 2016, PREV MED, V90, P8, DOI 10.1016/j.ypmed.2016.06.021; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Marcus SC, 2008, J ATTEN DISORD, V12, P64, DOI 10.1177/1087054707305168; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Mota-Veloso I, 2016, INT J PAEDIATR DENT, V26, P471, DOI 10.1111/ipd.12222; Nag S, 1999, NEUROL INDIA, V47, P32; National Health Insurance Administration, 2013, NAT HLTH INS ADM INS; National Health Insurance Administration, 2008, REV REG MED REIMB NA, V2016; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Olazagasti M. A. Ramos, 2013, J AM ACAD CHILD ADOL, V52; Perroud N, 2014, J AFFECT DISORDERS, V168, P161, DOI 10.1016/j.jad.2014.06.053; Peterson K, 2008, PSYCHOPHARMACOLOGY, V197, P1, DOI 10.1007/s00213-007-0996-4; Santosh PJ, 2011, CNS DRUGS, V25, P737, DOI 10.2165/11593070-000000000-00000; Schwebel DC, 2002, J PEDIATR PSYCHOL, V27, P727, DOI 10.1093/jpepsy/27.8.727; Shyu YC, 2015, SCHIZOPHR RES, V168, P161, DOI 10.1016/j.schres.2015.08.033; Silva D, 2014, EUR CHILD ADOLES PSY, V23, P1043, DOI 10.1007/s00787-014-0545-8; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Sobanski E, 2006, EUR ARCH PSY CLIN N, V256, P26, DOI 10.1007/s00406-006-1004-4; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Spencer TJ, 2001, AM J PSYCHIAT, V158, P611, DOI 10.1176/appi.ajp.158.4.611; STONER HB, 1980, J ROY SOC MED, V73, P19, DOI 10.1177/014107688007300105; Swanson EN, 2014, J CHILD PSYCHOL PSYC, V55, P505, DOI 10.1111/jcpp.12193; Swensen A., 2004, J ADOLESC HLTH OFF P, V35, pe341; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; Van Patten R, 2016, J CLIN EXP NEUROPSYC, V38, P12, DOI 10.1080/13803395.2015.1091064; Walker DJ, 2015, POSTGRAD MED, V127, P686, DOI 10.1080/00325481.2015.1081046; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85	62	16	16	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	JUN	2017	65						57	73		10.1016/j.ridd.2017.04.011			17	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	EZ4PT	WOS:000404695700006	28458048				2022-02-06	
J	Combs, B; Kanaan, NM				Combs, Benjamin; Kanaan, Nicholas M.			Exposure of the Amino Terminus of Tau Is a Pathological Event in Multiple Tauopathies	AMERICAN JOURNAL OF PATHOLOGY			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; CHRONIC TRAUMATIC ENCEPHALOPATHY; DEPENDENT AXONAL-TRANSPORT; REPETITIVE HEAD-INJURY; CORTICOBASAL DEGENERATION; ALZHEIMERS-DISEASE; PICKS-DISEASE; NEUROFIBRILLARY DEGENERATION; MESSENGER-RNA; KINESIN	Pathological changes to the tau protein, including conformational changes and aggregation, are major hallmarks of a group of neurodegenerative disorders known as tauopathies. Among the conformational changes are alterations involving the extreme amino terminus of the protein, known as the phosphatase-activating domain (PAD). Aberrant PAD exposure induces a signaling cascade that leads to disruption of axonal transport, a critical function for neuronal survival. Conformational display of PAD is an early marker of pathological tau in Alzheimer disease (AD), but its role in other tauopathies has yet to be firmly established. We used a relatively novel N-terminal, conformation-sensitive antibody, TNT2, to determine whether misfolding in the amino terminus (ie, PAD exposure) occurs in non-AD tauopathies. We found that TNT2 specifically labeled pathological tau in post-mortem human brain tissue from Pick disease, progressive supranuclear palsy, corticobasal degeneration, and chronic traumatic encephalopathy, but did not Label nonpathological, parenchymal tau. Tau13, another N-terminal antibody, was not sensitive to pathological N-terminal conformations. Tau13 did not readily distinguish between normal (ie, parenchymal tau) and pathological tau species and showed a range of effectiveness at identifying tau pathologies in the non-AD tauopathies. These findings demonstrate that the conformational display of the PAD in tau represents a common pathological event in many tauopathies.	[Combs, Benjamin; Kanaan, Nicholas M.] Michigan State Univ, Dept Translat Sci & Mol Med, Coll Human Med, Grand Rapids, MI USA; [Kanaan, Nicholas M.] Michigan State Univ, Neurosci Program, Grand Rapids, MI USA; [Kanaan, Nicholas M.] Mercy Hlth St Marys, Hauenstein Neurosci Ctr, Grand Rapids, MI USA		Combs, B (corresponding author), 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	benjamin.combs@hc.msu.edu	Kanaan, Nicholas M./J-3428-2016	Kanaan, Nicholas M./0000-0002-4362-2593; Combs, Benjamin/0000-0003-3136-7545	NlH/National Institute on Aging [R01 AG044372]; NIH/National Institute of Neurological Diseases and Stroke grant [R01 NS082730]; Jean P. Schultz Biomedical Research Endowment; Secchia Family Foundation Research Fund; BrightFocus Foundation grantBrightFocus Foundation [A2013364S]; Department of Veterans Affairs, NH/National Institute of Neurological Diseases and Stroke grant [1U01NS086659-01]; National Institute of Aging Boston University Alzheimer's Disease Center grant [P30AG13846, 0572063345-5]; Northwestern Alzheimer's Disease Center grant [AG13854]; NADC Neuropathology Core Tissue Bank; Michigan Alzheimer's Disease Center grant [P30AG053760]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082730, U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013854, R01AG044372, P30AG053760, P30AG013846] Funding Source: NIH RePORTER	Supported by NlH/National Institute on Aging grant R01 AG044372 (N.M.K.), NIH/National Institute of Neurological Diseases and Stroke grant R01 NS082730 (N.M.K.), the Jean P. Schultz Biomedical Research Endowment (N.M.K.), the Secchia Family Foundation Research Fund (N.M.K.), BrightFocus Foundation grant A2013364S (N.M.K.), the Department of Veterans Affairs, NH/National Institute of Neurological Diseases and Stroke grant 1U01NS086659-01, National Institute of Aging Boston University Alzheimer's Disease Center grant P30AG13846 (supplement 0572063345-5), Northwestern Alzheimer's Disease Center grant AG13854, NADC Neuropathology Core Tissue Bank, and the Michigan Alzheimer's Disease Center grant P30AG053760.	Arai T, 2004, ANN NEUROL, V55, P72, DOI 10.1002/ana.10793; Arai T, 2001, NEUROREPORT, V12, P935, DOI 10.1097/00001756-200104170-00014; Berry RW, 2004, J NEUROCYTOL, V33, P287, DOI 10.1023/B:NEUR.0000044190.96426.b9; BONDAREFF W, 1994, J NEUROPATH EXP NEUR, V53, P158, DOI 10.1097/00005072-199403000-00007; BRAAK E, 1994, ACTA NEUROPATHOL, V87, P554, DOI 10.1007/s004010050124; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 1999, BRAIN PATHOL, V9, P681; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Coleman BM, 2015, SEMIN CELL DEV BIOL, V40, P89, DOI 10.1016/j.semcdb.2015.02.007; Combs B, 2016, NEUROBIOL DIS, V94, P18, DOI 10.1016/j.nbd.2016.05.016; Cox K, 2016, NEUROBIOL AGING, V47, P113, DOI 10.1016/j.neurobiolaging.2016.07.015; DICKSON DW, 1992, ACTA NEUROPATHOL, V84, P596; FEANY MB, 1995, ACTA NEUROPATHOL, V90, P37; Feany MB, 1996, J NEUROPATH EXP NEUR, V55, P53, DOI 10.1097/00005072-199601000-00006; FEANY MB, 1995, AM J PATHOL, V146, P1388; Ferrer I, 2014, J NEUROPATH EXP NEUR, V73, P81, DOI 10.1097/NEN.0000000000000030; Fruhbeis C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00182; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; Guillozet-Bongaarts AL, 2007, ACTA NEUROPATHOL, V113, P513, DOI 10.1007/s00401-007-0209-6; HAUW JJ, 1990, NEUROSCI LETT, V119, P182, DOI 10.1016/0304-3940(90)90829-X; HYMAN BT, 1988, ANN NEUROL, V23, P371, DOI 10.1002/ana.410230410; IWATSUBO T, 1994, ACTA NEUROPATHOL, V88, P129; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1999, J NEUROSCI RES, V55, P713, DOI 10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G; Kanaan NM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.006; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kanaan NM, 2015, J NEUROPATHOLOGY EXP, V75, P19; Komori T, 1999, BRAIN PATHOL, V9, P663; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lyons DA, 2009, NAT GENET, V41, P854, DOI 10.1038/ng.376; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Patterson KR, 2011, BIOCHEMISTRY-US, V50, P10300, DOI 10.1021/bi2009147; POLLOCK NJ, 1986, LANCET, V2, P1211; Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x; Probst A, 1996, ACTA NEUROPATHOL, V92, P588, DOI 10.1007/s004010050565; Reyes JF, 2008, NEUROBIOL DIS, V31, P198, DOI 10.1016/j.nbd.2008.04.005; Schmidt I, 2012, J NEUROSCI, V32, P7466, DOI 10.1523/JNEUROSCI.0349-12.2012; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Tiernan CT, 2016, EXP NEUROL, V283, P318, DOI 10.1016/j.expneurol.2016.06.030; YAMADA T, 1992, NEUROSCI LETT, V135, P99, DOI 10.1016/0304-3940(92)90145-W; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x	47	16	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUN	2017	187	6					1222	1229		10.1016/j.ajpath.2017.01.019			8	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	EW1AE	WOS:000402221500003	28413156	Green Published, Bronze			2022-02-06	
J	Gangolli, M; Holleran, L; Kim, JH; Stein, TD; Alvarez, V; Mckee, AC; Brody, DL				Gangolli, Mihika; Holleran, Laurena; Kim, Joong Hee; Stein, Thor D.; Alvarez, Victor; Mckee, Ann C.; Brody, David L.			Quantitative validation of a nonlinear histology-MRI coregistration method using generalized Q-sampling imaging in complex human cortical white matter	NEUROIMAGE			English	Article						Diffusion MRI; Generalized Q-sampling Imaging; Radiological-Pathological Correlations; White Matter Injury; Chronic Traumatic Encephalopathy	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; EX-VIVO MRI; HEAD-INJURY; IN-VIVO; NERVOUS-SYSTEM; MOUSE MODEL; REGISTRATION; ENCEPHALOPATHY; TRACTOGRAPHY	Advanced diffusion MRI methods have recently been proposed for detection of pathologies such as traumatic axonal injury and chronic traumatic encephalopathy which commonly affect complex cortical brain regions. However, radiological-pathological correlations in human brain tissue that detail the relationship between the multi-component diffusion signal and underlying pathology are lacking. We present a nonlinear voxel based two dimensional coregistration method that is useful for matching diffusion signals to quantitative metrics of high resolution histological images. When validated in ex vivo human cortical tissue at a 250 x 250x 500 mu m spatial resolution, the method proved robust in correlations between generalized q-sampling imaging and histologically based white matter fiber orientations, with r=0.94 for the primary fiber direction and r=0.88 for secondary fiber direction in each voxel. Importantly, however, the correlation was substantially worse with reduced spatial resolution or with fiber orientations derived using a diffusion tensor model. Furthermore, we have detailed a quantitative histological metric of white matter fiber integrity termed power coherence capable of distinguishing architecturally complex but intact white matter from disrupted white matter regions. These methods may allow for more sensitive and specific radiological-pathological correlations of neurodegenerative diseases affecting complex gray and white matter.	[Gangolli, Mihika; Brody, David L.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA; [Holleran, Laurena; Kim, Joong Hee; Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Stein, Thor D.; Alvarez, Victor; Mckee, Ann C.] Boston Univ, Sch Med, Boston Univ Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Stein, Thor D.; Alvarez, Victor; Mckee, Ann C.] VA Boston Healthcare Syst, Boston, MA USA; [Brody, David L.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA		Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA.; Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.; Brody, DL (corresponding author), Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu		Stein, Thor/0000-0001-6954-4477	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH UO1 NS086659]; Hope Center Alafi Neuroimaging Laboratory at Washington University in St. Louis [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS057105, U01NS086659] Funding Source: NIH RePORTER	This work is supported by the National Institutes of Health [NIH UO1 NS086659]; the Hope Center Alafi Neuroimaging Laboratory at Washington University in St. Louis [P30 NS057105].	Amato SP, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00031; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Behrens T.E.J., 2014, MR DIFFUSION TRACTOG, P429; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bogoslovsky T., 2016, J NEUROTRAUMA; Breen MS, 2005, ANN BIOMED ENG, V33, P1100, DOI 10.1007/s10439-005-5778-8; Breen MS, 2005, COMPUT MED IMAG GRAP, V29, P405, DOI 10.1016/j.compmedimag.2005.04.006; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budde MD, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00003; Budde MD, 2012, NEUROIMAGE, V63, P1, DOI 10.1016/j.neuroimage.2012.06.042; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Choe AS, 2011, MAGN RESON IMAGING, V29, P683, DOI 10.1016/j.mri.2011.02.022; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/NMETH.2481, 10.1038/nmeth.2481]; D'Arceuil HE, 2007, NEUROIMAGE, V35, P553, DOI 10.1016/j.neuroimage.2006.12.028; Dauguet J, 2007, J NEUROSCI METH, V164, P191, DOI 10.1016/j.jneumeth.2007.04.017; Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92; Donahue CJ, 2016, J NEUROSCI, V36, P6758, DOI 10.1523/JNEUROSCI.0493-16.2016; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Edgar J.M., 2014, DIFFUSION MRI, P127; Gangolli M., 2015, NAT NEUR S MAR ANN L, pA54; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES; GOSHTASBY A, 1988, IMAGE VISION COMPUT, V6, P255, DOI 10.1016/0262-8856(88)90016-9; Goubran M, 2015, J NEUROSCI METH, V241, P53, DOI 10.1016/j.jneumeth.2014.12.005; Goubran M, 2013, NEUROIMAGE, V83, P770, DOI 10.1016/j.neuroimage.2013.07.053; Hagmann P, 2006, NEUROIMAGE, V32, P665, DOI 10.1016/j.neuroimage.2006.02.043; Herrera J.J., 2016, J NEUROTRAUMA; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kier EL, 2004, AM J NEURORADIOL, V25, P670; Kim JH, 2007, NMR BIOMED, V20, P352, DOI 10.1002/nbm.1138; Lazebnik RS, 2003, IEEE T MED IMAGING, V22, P653, DOI 10.1109/TMI.2003.812246; LeBihan D, 1995, NMR BIOMED, V8, P375; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Nazaran A, 2016, J NEUROSCI METH, V261, P75, DOI 10.1016/j.jneumeth.2015.11.023; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Parker GJ., 2014, DIFFUSION MRI, P453, DOI DOI 10.1016/B978-0-12-396460-1.00020-2; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Prins N, 2003, J OPT SOC AM A, V20, P401, DOI 10.1364/JOSAA.20.000401; Reich D.S., 2014, J NEUROPATHOL EXP NE, V73, P780; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Savaskan NE, 2009, CELL TISSUE RES, V337, P213, DOI 10.1007/s00441-009-0815-9; Schilling K, 2016, NEUROIMAGE, V129, P185, DOI 10.1016/j.neuroimage.2016.01.022; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Suri S, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0475-3; Thelwall PE, 2006, MAGN RESON MED, V56, P282, DOI 10.1002/mrm.20962; Wang Y, 2015, BRAIN, V138, P1223, DOI 10.1093/brain/awv046; Weiss M, 2015, BRAIN STRUCT FUNCT, V220, P1695, DOI 10.1007/s00429-014-0754-4; White E, 2011, J NEUROSCI METH, V195, P78, DOI 10.1016/j.jneumeth.2010.10.023; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Zagorchev L, 2006, IEEE T IMAGE PROCESS, V15, P529, DOI 10.1109/TIP.2005.863114; Zarow C, 2004, J NEUROSCI METH, V139, P209, DOI 10.1016/j.jneumeth.2004.04.034; Zemmoura I, 2014, NEUROIMAGE, V103, P106, DOI 10.1016/j.neuroimage.2014.09.016	70	16	16	1	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JUN	2017	153						152	167		10.1016/j.neuroimage.2017.03.059			16	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EX6XD	WOS:000403384500013	28365421	Green Accepted			2022-02-06	
J	Zhong, WT; Cristofori, I; Bulbulia, J; Krueger, F; Grafman, J				Zhong, Wanting; Cristofori, Irene; Bulbulia, Joseph; Krueger, Frank; Grafman, Jordan			Biological and cognitive underpinnings of religious fundamentalism	NEUROPSYCHOLOGIA			English	Article						Traumatic brain injury; Prefrontal cortex; Religious beliefs; Fundamentalism	SOCIAL COGNITION; INTELLIGENCE; FLEXIBILITY; OPENNESS; DISTINCT; NEED; AUTHORITARIANISM; ASSOCIATIONS; IDEOLOGY; DEFICITS	Beliefs profoundly affect people's lives, but their cognitive and neural pathways are poorly understood. Although previous research has identified the ventromedial prefrontal cortex (vmPFC) as critical to representing religious beliefs, the means by which vmPFC enables religious belief is uncertain. We hypothesized that the vmPFC represents diverse religious beliefs and that a vmPFC lesion would be associated with religious fundamentalism, or the narrowing of religious beliefs. To test this prediction, we assessed religious adherence with a widely-used religious fundamentalism scale in a large sample of 119 patients with penetrating traumatic brain injury (pTBI). If the vmPFC is crucial to modulating diverse personal religious beliefs, we predicted that pTBI patients with lesions to the vmPFC would exhibit greater fundamentalism, and that this would be modulated by cognitive flexibility and trait openness. Instead, we found that participants with dorsolateral prefrontal cortex (dlPFC) lesions have fundamentalist beliefs similar to patients with vmPFC lesions and that the effect of a dlPFC lesion on fundamentalism was significantly mediated by decreased cognitive flexibility and openness. These findings indicate that cognitive flexibility and openness are necessary for flexible and adaptive religious commitment, and that such diversity of religious thought is dependent on dlPFC functionality.	[Zhong, Wanting; Cristofori, Irene; Grafman, Jordan] Shirley Ryan AbilityLab, Brain Injury Res, Cognit Neurosci Lab, Chicago, IL 60611 USA; [Zhong, Wanting; Cristofori, Irene; Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Bulbulia, Joseph] Victoria Univ New Zealand, Sch Art Hist Class & Religious Studies, Wellington 6140, New Zealand; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Psychiat, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Cognit Neurol & Alzheimers Dis, Chicago, IL 60611 USA		Grafman, J (corresponding author), Shirley Ryan AbilityLab, Cognit Neurosci Lab, Brain Injury Res Program, Think & Speak Lab, 355 E Erie St, Chicago, IL 60611 USA.	jgrafman@northwestern.edu		Bulbulia, Joseph/0000-0002-5861-2056; Zhong, Wanting/0000-0002-6025-1739; Cristofori, Irene/0000-0003-2339-1457	National Naval Medical Center; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [Z01NS002792] Funding Source: NIH RePORTER	We are grateful to our Vietnam veterans for their dedicated participation in the study. We thank J. Solomon for his assistance with ABLe, as well as V. Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for testing and evaluating participants. We would also like to thank the National Naval Medical Center and the National Institute of Neurological Disorders and Stroke for providing support and facilities. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, the Department of Defense, or the U.S. Government.	Adelstein JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027633; AFQT-7A, 1960, DEP DEF FORM 1293; Altemeyer B., 2005, FUNDAMENTALISM AUTHO; Altemeyer Bob, 1992, INT J PSYCHOL RELIG, V2, P113, DOI [10.1207/s15327582ijpr0202_5, DOI 10.1207/S15327582IJPR0202_5]; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Asp E, 2012, NEUROPSYCHOLOGY, V26, P414, DOI 10.1037/a0028526; BADER C, 2006, AM PIETY 21 CENTURY; Barbey AK, 2013, NEUROIMAGE, V82, P547, DOI 10.1016/j.neuroimage.2013.05.087; BATSON CD, 1991, J SCI STUD RELIG, V30, P416, DOI 10.2307/1387277; BATSON CD, 1991, J SCI STUD RELIG, V30, P430, DOI 10.2307/1387278; Brandt MJ, 2010, PERS SOC PSYCHOL B, V36, P715, DOI 10.1177/0146167210366306; Bulbulia J, 2013, CONT TOP COGN NEUROS, P169; Bulbulia J, 2009, BEHAV BRAIN SCI, V32, P515, DOI 10.1017/S0140525X09991403; Bulbulia Joseph, 2009, BELIEVING PRIMATE SC, P44, DOI DOI 10.1093/ACPROF:OSO/9780199557028.003.0003; Bunge SA, 2009, NEUROIMAGING IN DEVELOPMENTAL CLINICAL NEUROSCIENCE, P22, DOI 10.1017/CBO9780511757402.005; Calogero RM, 2009, PERS INDIV DIFFER, V46, P154, DOI 10.1016/j.paid.2008.09.019; Canas JJ, 2003, ERGONOMICS, V46, P482, DOI 10.1080/0014013031000061640; Chapman B, 2012, AM J GERIAT PSYCHIAT, V20, P612, DOI 10.1097/JGP.0b013e31822cc9cb; Connelly BS, 2014, J PERS ASSESS, V96, P17, DOI 10.1080/00223891.2013.809355; Costa Jr P.T., 1992, NEO PI R PROFESSIONA; Cristofori I., 2017, PROCESSES BELIEVING; Cristofori I, 2016, NEUROPSYCHOLOGIA, V80, P212, DOI 10.1016/j.neuropsychologia.2015.11.021; Cristofori I, 2015, SOC COGN AFFECT NEUR, V10, P1038, DOI 10.1093/scan/nsu155; Delis DC., 2001, DELIS KAPLAN EXECUTI; DeYoung CG, 2005, J PERS, V73, P825, DOI 10.1111/j.1467-6494.2005.00330.x; DeYoung CG, 2011, J RES PERS, V45, P364, DOI 10.1016/j.jrp.2011.04.002; DeYoung CG, 2009, J PERS SOC PSYCHOL, V97, P883, DOI 10.1037/a0016615; Duckitt J, 2001, ADV EXP SOC PSYCHOL, V33, P41, DOI 10.1016/S0065-2601(01)80004-6; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; Foster KR, 2009, P ROY SOC B-BIOL SCI, V276, P31, DOI 10.1098/rspb.2008.0981; Gervais WM, 2012, SCIENCE, V336, P493, DOI 10.1126/science.1215647; Ginges J, 2009, PSYCHOL SCI, V20, P224, DOI 10.1111/j.1467-9280.2009.02270.x; Gozzi M, 2009, NEUROPSYCHOLOGIA, V47, P2125, DOI 10.1016/j.neuropsychologia.2009.04.002; Guthrie Stewart Elliott, 1993, FACES CLOUDS NEW THE; Harris S., 2009, PLOS ONE, P4; Hayes, 2018, INTRO MEDIATION MODE; Hunsberger B, 2005, J SOC ISSUES, V61, P807, DOI 10.1111/j.1540-4560.2005.00433.x; Inzlicht M, 2011, RELIG BRAIN BEHAV, V1, P192, DOI 10.1080/2153599X.2011.647849; Inzlicht M, 2009, PSYCHOL SCI, V20, P385, DOI 10.1111/j.1467-9280.2009.02305.x; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kay AC, 2008, J PERS SOC PSYCHOL, V95, P18, DOI 10.1037/0022-3514.95.1.18; Kim C, 2011, J NEUROSCI, V31, P4771, DOI 10.1523/JNEUROSCI.5923-10.2011; Krueger F, 2013, CONT TOP COGN NEUROS, P225; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kruglanski AW, 1996, PSYCHOL REV, V103, P263, DOI 10.1037/0033-295X.103.2.263; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Larsen R.J., 2015, APA HDB PERSONALITY, V4, P369, DOI [DOI 10.1037/14343-017, 10.1037/14343-017]; Lewis GJ, 2011, INTELLIGENCE, V39, P468, DOI 10.1016/j.intell.2011.08.002; Lynn R, 2009, INTELLIGENCE, V37, P11, DOI 10.1016/j.intell.2008.03.004; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; Mayr U, 2000, J EXP PSYCHOL GEN, V129, P4, DOI 10.1037/0096-3445.129.1.4; McCrae RR, 1996, PSYCHOL BULL, V120, P323, DOI 10.1037/0033-2909.120.3.323; McCullough ME, 2009, PSYCHOL BULL, V135, P69, DOI 10.1037/a0014213; McNeil M., 1994, REVISED TOKEN TEST; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Moretti L, 2009, J COGNITIVE NEUROSCI, V21, P128, DOI 10.1162/jocn.2009.21011; Neyrinck B, 2006, MOTIV EMOTION, V30, P323, DOI 10.1007/s11031-006-9048-3; Norenzayan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036880; Passamonti L, 2015, NEUROIMAGE, V104, P301, DOI 10.1016/j.neuroimage.2014.09.017; Ravizza SM, 2008, NEUROPSYCHOLOGIA, V46, P2924, DOI 10.1016/j.neuropsychologia.2008.06.006; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Saroglou, 2002, MENTAL HLTH RELIG CU, V5, P183, DOI [DOI 10.1080/13674670210144130, 10.1080/13674670210144130]; Scheufele DA, 2009, NAT NANOTECHNOL, V4, P91, DOI [10.1038/nnano.2008.361, 10.1038/NNANO.2008.361]; Schjoedt U, 2011, SOC COGN AFFECT NEUR, V6, P119, DOI 10.1093/scan/nsq023; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Schretlen DJ, 2010, J CLIN EXP NEUROPSYC, V32, P1068, DOI 10.1080/13803391003689770; Sibley CG, 2006, POLIT PSYCHOL, V27, P755, DOI 10.1111/j.1467-9221.2006.00531.x; Toepper M, 2010, NEUROSCIENCE, V165, P1244, DOI 10.1016/j.neuroscience.2009.11.019; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Elk M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130422; Vecchione M, 2009, PERS INDIV DIFFER, V46, P487, DOI 10.1016/j.paid.2008.11.021; von Stumm S, 2013, J INDIVID DIFFER, V34, P82, DOI 10.1027/1614-0001/a000101; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Willard AK, 2013, COGNITION, V129, P379, DOI 10.1016/j.cognition.2013.07.016; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Zuckerman M, 2013, PERS SOC PSYCHOL REV, V17, P325, DOI 10.1177/1088868313497266	78	16	16	1	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JUN	2017	100						18	25		10.1016/j.neuropsychologia.2017.04.009			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	EX3GL	WOS:000403120500003	28392301	Green Accepted, Bronze			2022-02-06	
J	Osier, ND; Pham, L; Pugh, BJ; Puccio, A; Ren, DX; Conley, YP; Alexander, S; Dixon, CE				Osier, Nicole D.; Pham, Lan; Pugh, Bunny J.; Puccio, Ava; Ren, Dianxu; Conley, Yvette P.; Alexander, Sheila; Dixon, C. Edward			Brain injury results in lower levels of melatonin receptors subtypes MT1 and MT2	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury (TBI); Brain trauma; Controlled cortical impact (CCI); Rat; Melatonin; Receptors	INDUCED OXIDATIVE STRESS; FREE-RADICAL SCAVENGER; CIRCADIAN-RHYTHM; SLEEP DISORDERS; DEPENDENT RESPONSE; AGONIST; RATS; ACTIVATION; EXPRESSION; APOPTOSIS	Background: Traumatic brain injury (TBI) is a devastating and costly acquired condition that affects individuals of all ages, races, and geographies via a number of mechanisms. The effects of TBI on melatonin receptors remain unknown. Purpose: The purpose of this study is to explore whether endogenous changes in two melatonin receptor subtypes (MT1 and MT2) occur after experimental TBI. Sample: A total of 25 adult male Sprague Dawley rats were used with 6 or 7 rats per group. Methods: Rats were randomly assigned to receive either TBI modeled using controlled cortical impact or sham surgery and to be sacrificed at either 6- or 24-h post-operatively. Brains were harvested, dissected, and flash frozen until whole cell lysates were prepared, and the supernatant fluid aliquoted and used for western blotting. Primary antibodies were used to probe for melatonin receptors (MT1 and MT2), and beta actin, used for a loading control. Image) and Image Lab software were used to quantify the data which was analyzed using t-tests to compare means. Results: Melatonin receptor levels were reduced in a brain region- and time point- dependent manner. Both MT1 and MT2 were reduced in the frontal cortex at 24 h and in the hippocampus at both 6 h and 24 h. Discussion: MT1 and MT2 are less abundant after injury, which may alter response to MEL therapy. Studies characterizing MT1 and MT2 after TBI are needed, including exploration of the time course and regional patterns, replication in diverse samples, and use of additional variables, especially sleep-related outcomes. Conclusion: TBI in rats resulted in lower levels of MT1 and MT2; replication of these findings is necessary as is evaluation of the consequences of lower receptor levels. (C) 2017 Elsevier B.V. All rights reserved.	[Osier, Nicole D.; Pham, Lan; Puccio, Ava; Ren, Dianxu; Conley, Yvette P.; Alexander, Sheila] Univ Pittsburgh, Sch Nursing, Victoria Bldg,3500 Victoria St, Pittsburgh, PA 15213 USA; [Osier, Nicole D.; Pugh, Bunny J.; Dixon, C. Edward] Childrens Hosp Pittsburgh UPMC, Safar Ctr Resuscitat Res, John G Rangos Res, Ctr 6th Floor,4401 Penn Ave, Pittsburgh, PA 15224 USA; [Puccio, Ava; Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Brain Trauma Res Ctr, UPMC Presbyterian, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Human Genet, Crabtree Hall,130 De Soto St, Pittsburgh, PA 15261 USA; [Alexander, Sheila] Univ Pittsburgh, Sch Med, M240 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Dixon, C. Edward] VA Pittsburgh Healthcare Syst, 4100 Allequippa St, Pittsburgh, PA 15261 USA		Dixon, CE (corresponding author), Childrens Hosp Pittsburgh UPMC, Safar Ctr Resuscitat Res, John G Rangos Res, Ctr 6th Floor,4401 Penn Ave, Pittsburgh, PA 15224 USA.	ndo8@pitt.edu; lhp4@pitt.edu; bjp80@pitt.edu; puccam@upmc.edu; dir8@pitt.edu; yconley@pitt.edu; salexand@pitt.edu; dixoec@upmc.edu	Osier, Nicole/Q-7913-2017	Osier, Nicole/0000-0002-2903-6774; Conley, Yvette/0000-0002-1784-6067	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32NR009759, F31NR014957]; Copeland Award of The Pittsburgh Foundation; International Society of Nurses in Genetics; Neurotrauma Nursing Foundation/American Association of Neuroscience Nursing; Sigma Theta Tau International Eta Chapter; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR014957, T32NR009759] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health [T32NR009759, F31NR014957]; The Copeland Award of The Pittsburgh Foundation; the International Society of Nurses in Genetics; The Neurotrauma Nursing Foundation/American Association of Neuroscience Nursing; and Sigma Theta Tau International Eta Chapter. In addition, we would like to thank Michael Farmer for his assistance with the figures, and Marilyn Farmer for her continued editorial support.	Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Babaee A, 2015, IRAN J BASIC MED SCI, V18, P867; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Boran MS, 2007, J NEUROCHEM, V102, P216, DOI 10.1111/j.1471-4159.2007.04464.x; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; Carrillo-Vico A, 2003, CELL MOL LIFE SCI, V60, P2272, DOI 10.1007/s00018-003-3207-4; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; Cirak B, 1999, PEDIATR NEUROSURG, V31, P298, DOI 10.1159/000028879; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Coronado V., 2012, EPIDEMIOLOGY PREVENT; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Farrell-Carnahan L, 2015, BRAIN INJURY, V29, P1400, DOI 10.3109/02699052.2015.1063161; Faul M, 2010, TRAUMATIC BRAIN INJU; Fisher SP, 2009, NEUROSCI LETT, V457, P93, DOI 10.1016/j.neulet.2009.04.005; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; HARRINGTON M, 2012, LAB ANIMAL, V41, P31; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; Kelestemur T, 2016, NEUROSCI LETT, V612, P92, DOI 10.1016/j.neulet.2015.11.043; Kelso ML, 2011, NEUROSCI LETT, V488, P60, DOI 10.1016/j.neulet.2010.11.003; Kennaway DJ, 1998, J CLIN ENDOCR METAB, V83, P1013, DOI 10.1210/jc.83.3.1013; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kokkola T, 2007, J PINEAL RES, V43, P255, DOI 10.1111/j.1600-079X.2007.00470.x; LEBARS D, 1991, NUCL MED BIOL, V18, P357; Lee S, 2009, J PINEAL RES, V46, P43, DOI 10.1111/j.1600-079X.2008.00607.x; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Masana MI, 2000, J PINEAL RES, V28, P185, DOI 10.1034/j.1600-079X.2001.280309.x; Miranda-Anaya M, 2002, J BIOL RHYTHM, V17, P526, DOI 10.1177/0748730402238235; Miyamoto M, 2009, CNS NEUROSCI THER, V15, P32, DOI 10.1111/j.1755-5949.2008.00066.x; Moeller Donald R, 2014, J Spec Oper Med, V14, P64; Murakami N, 2001, BRAIN RES, V889, P220, DOI 10.1016/S0006-8993(00)03205-4; Natarajan R, 2012, J NEUROIMMUNOL, V250, P106, DOI 10.1016/j.jneuroim.2012.05.014; Nau R, 2010, CLIN MICROBIOL REV, V23, P858, DOI 10.1128/CMR.00007-10; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Ochoa-Sanchez R, 2011, J NEUROSCI, V31, P18439, DOI 10.1523/JNEUROSCI.2676-11.2011; Osier N., 2014, J NEUROTRAUM, V1882, P1; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Pandi-Perumal SR, 2006, FEBS J, V273, P2813, DOI 10.1111/j.1742-4658.2006.05322.x; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; Roth T, 2005, SLEEP, V28, P303; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Senol N, 2014, NEURAL REGEN RES, V9, P1112, DOI 10.4103/1673-5374.135312; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Solis-Chagoyan H, 2008, COMP BIOCHEM PHYS A, V149, P373, DOI 10.1016/j.cbpa.2008.01.040; Steele DL, 2005, CHRONOBIOL INT, V22, P89, DOI 10.1081/CBI-200042428; Tamura H, 2013, ENDOCR J, V60, P1; Taylor SR, 2013, J NEUROSURG-PEDIATR, V12, P545, DOI 10.3171/2013.8.PEDS13154; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Wang GS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-170; Wang SX, 2012, PAIN, V153, P2448, DOI 10.1016/j.pain.2012.08.016; WETTERBERG L, 1987, CHRONOBIOLOGIA, V14, P377; Wiechmann AF, 2008, EXP EYE RES, V86, P241, DOI 10.1016/j.exer.2007.10.015; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yanagihara M, 2014, TOHOKU J EXP MED, V234, P123, DOI 10.1620/tjem.234.123; YELLON SM, 1982, ENDOCRINOLOGY, V111, P488, DOI 10.1210/endo-111-2-488; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3	67	16	16	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 22	2017	650						18	24		10.1016/j.neulet.2017.03.053			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EW2XK	WOS:000402359100004	28377323	Green Accepted			2022-02-06	
J	Bennett, TD; DeWitt, PE; Dixon, RR; Kartchner, C; Sierra, Y; Ladell, D; Srivastava, R; Riva-Cambrin, J; Kempe, A; Runyan, DK; Keenan, HT; Dean, JM				Bennett, Tellen D.; DeWitt, Peter E.; Dixon, Rebecca R.; Kartchner, Cory; Sierra, Yamila; Ladell, Diane; Srivastava, Rajendu; Riva-Cambrin, Jay; Kempe, Allison; Runyan, Desmond K.; Keenan, Heather T.; Dean, J. Michael			Development and Prospective Validation of Tools to Accurately Identify Neurosurgical and Critical Care Events in Children With Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain injuries; craniocerebral trauma; electronic health records; pediatrics; validation studies as topic	LOGISTIC-REGRESSION ANALYSIS; ADMINISTRATIVE DATABASES; EXISTING DATA; SELECTION; MODELS; REGULARIZATION; SURVEILLANCE; VARIABILITY; INFECTIONS; RECORDS	Objective: To develop and validate case definitions (computable phenotypes) to accurately identify neurosurgical and critical care events in children with traumatic brain injury. Design: Prospective observational cohort study, May 2013 to September 2015. Setting: Two large U.S. children's hospitals with level 1 Pediatric Trauma Centers. Patients: One hundred seventy-four children less than 18 years old admitted to an ICU after traumatic brain injury. Measurements and Main Results: Prospective data were linked to database codes for each patient. The outcomes were prospectively identified acute traumatic brain injury, intracranial pressure monitor placement, craniotomy or craniectomy, vascular catheter placement, invasive mechanical ventilation, and new gastrostomy tube or tracheostomy placement. Candidate predictors were database codes present in administrative, billing, or trauma registry data. For each clinical event, we developed and validated penalized regression and Boolean classifiers (models to identify clinical events that take database codes as predictors). We externally validated the best model for each clinical event. The primary model performance measure was accuracy, the percent of test patients correctly classified. The cohort included 174 children who required ICU admission after traumatic brain injury. Simple Boolean classifiers were greater than or equal to 94% accurate for seven of nine clinical diagnoses and events. For central venous catheter placement, no classifier achieved 90% accuracy. Classifier accuracy was dependent on available data fields. Five of nine classifiers were acceptably accurate using only administrative data but three required trauma registry fields and two required billing data. Conclusions: In children with traumatic brain injury, computable phenotypes based on simple Boolean classifiers were highly accurate for most neurosurgical and critical care diagnoses and events. The computable phenotypes we developed and validated can be used in any observational study of children with traumatic brain injury and can reasonably be applied in studies of these interventions in other patient populations.	[Bennett, Tellen D.] Univ Colorado, Sch Med, Dept Pediat, Sect Pediat Crit Care, Aurora, CO 80045 USA; [Bennett, Tellen D.; Sierra, Yamila; Ladell, Diane; Kempe, Allison] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Bennett, Tellen D.; Kempe, Allison] Univ Colorado, Sch Med, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO 80045 USA; [DeWitt, Peter E.] Colorado Sch Publ Hlth, Div Pediat Crit Care, Dept Pediat, Aurora, CO USA; [Dixon, Rebecca R.; Keenan, Heather T.; Dean, J. Michael] Univ Utah, Sch Med, Pediat Crit Care, Salt Lake City, UT USA; [Kartchner, Cory] Primary Childrens Med Ctr, Dept Bioinformat & Biostat, Salt Lake City, UT USA; [Srivastava, Rajendu] Univ Utah, Sch Med, Dept Pediat, Div Pediat Inpatient Med, Salt Lake City, UT USA; [Srivastava, Rajendu] Intermt Healthcare, Off Res, Salt Lake City, UT USA; [Riva-Cambrin, Jay] Univ Calgary, Dept Clin Neurosci, Div Pediat Neurosurg, Calgary, AB, Canada; [Riva-Cambrin, Jay] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Runyan, Desmond K.] Univ Colorado, Sch Med, Dept Pediat, Kempe Ctr, Aurora, CO USA		Bennett, TD (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Sect Pediat Crit Care, Aurora, CO 80045 USA.; Bennett, TD (corresponding author), Childrens Hosp Colorado, Aurora, CO 80045 USA.; Bennett, TD (corresponding author), Univ Colorado, Sch Med, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO 80045 USA.	tell.bennett@ucdenver.edu	Runyan, Desmond/S-3974-2016	Runyan, Desmond/0000-0001-5571-9029; Bennett, Tellen/0000-0003-1483-4236; DeWitt, Peter/0000-0002-6391-0795	Eunice Kennedy Shriver National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620]; National Center for Research Resources (Colorado Clinical and Translational Sciences Institute Grant) [UL1 TR001082]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); NIH, Agency for Healthcare Research and Quality; Children's Hospital Association; NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001082] Funding Source: NIH RePORTER	Supported, in part, by the Eunice Kennedy Shriver National Institute for Child Health and Human Development (Grant K23HD074620 to Dr. Bennett) and the National Center for Research Resources (Colorado Clinical and Translational Sciences Institute Grant UL1 TR001082).; Drs. Bennett, Kempe, and Dean received support for article research from the National Institutes of Health (NIH). Dr. Bennett's institution received funding from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and National Center for Research Resources. Dr. Srivastava disclosed that he is the Past Chair of the Pediatric Hospitalist Research (PRIS) Network (http://www.prisnetwork.org) that conducts a variety of research studies funded by the NIH, Agency for Healthcare Research and Quality, and the Children's Hospital Association. Dr. Keenan's institution received funding from NIH/NICHD and from the Centers for Disease Control and Prevention. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Agarwal V, 2016, J AM MED INFORM ASSN, V23, P1166, DOI 10.1093/jamia/ocw028; Allaire J. J, 2016, RMARKDOWN DYNAMIC DO; American College of Surgeons Committee on Trauma, 2010, NAT TRAUM DAT BANK R; Arabian SS, 2015, J TRAUMA ACUTE CARE, V79, P359, DOI 10.1097/TA.0000000000000788; Bennett TD, 2015, METHOD INFORM MED, V54, P328, DOI 10.3414/ME14-01-0093; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Bennett TD, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00079; Bratton SL, 2012, PEDIATR CRIT CARE ME, V13, P407, DOI 10.1097/PCC.0b013e318238b428; Brier GW, 1950, MON WEATHER REV, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Conway PH, 2009, J PEDIATR-US, V154, P789, DOI 10.1016/j.jpeds.2009.01.010; Cooke CR, 2013, CRIT CARE MED, V41, P886, DOI 10.1097/CCM.0b013e31827bfc3c; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; De Coster C, 2008, MED CARE, V46, P627, DOI 10.1097/MLR.0b013e3181649439; Dreyer NA, 2011, EPIDEMIOLOGY, V22, P295, DOI 10.1097/EDE.0b013e3182126569; Faul M, 2010, TRAUMATIC BRAIN INJU; Friedman J., 2016, GLMNET LASSO ELASTIC; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hastie T., 2008, ELEMENTS STAT LEARNI, VSecond; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Kamkar I, 2015, J BIOMED INFORM, V53, P277, DOI 10.1016/j.jbi.2014.11.013; Kirby JC, 2016, J AM MED INFORM ASSN, V23, P1046, DOI 10.1093/jamia/ocv202; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lahiri S, 2015, NEUROCRIT CARE, V23, P28, DOI 10.1007/s12028-014-0082-9; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Patrick SW, 2013, PEDIATRICS, V131, pS75, DOI 10.1542/peds.2012-1427i; R Core Team, R LANG ENV STAT COMP; Roberts RJ, 2007, CRIT CARE MED, V35, P949, DOI 10.1097/01.CCM.0000257461.17112.89; Shivade C, 2014, J AM MED INFORM ASSN, V21, P221, DOI 10.1136/amiajnl-2013-001935; Slonim AD, 2010, PEDIATRICS, V125, P1208, DOI 10.1542/peds.2009-1451; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Weiss NS, 2011, EPIDEMIOLOGY, V22, P292, DOI 10.1097/EDE.0b013e318210aca5; Wright SB, 2003, INFECT CONT HOSP EP, V24, P946, DOI 10.1086/502164; Xie Y, 2016, KNITR GEN PURPOSE PA; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	40	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2017	18	5					442	451		10.1097/PCC.0000000000001120			10	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	EW8BF	WOS:000402742400012	28252524	Green Accepted			2022-02-06	
J	Gasenzer, ER; Kanat, A; Neugebauer, EAM				Gasenzer, Elena Romana; Kanat, Ayhan; Neugebauer, Edmund A. M.			First Report of Awake Craniotomy of a Famous Musician: Suprasellar Tumor Surgery of Pianist Clara Haskil in 1942	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						pianist; history of neurosurgery; awake craniotomy; suprasellar meningioma; traumatic brain injury	MONITORED CONSCIOUS SEDATION; LOCAL-ANESTHESIA; PITUITARY-TUMORS; ELOQUENT CORTEX; MOZART; RESECTION; ANXIETY; CRANIOPHARYNGIOMAS; INTERVENTION; AROUSAL	Clara Haskil (January 7, 1895-December 7, 1960) was one of the most famous female pianists of the 20th century. In her life and work she set new standards in piano playing. However, her career was beset by poor health and the adversities of two world wars. In her lifetime Haskil had three major disorders: juvenile scoliosis requiring treatment in her adolescence, a tumor of the sellar region requiring surgery at age 47 years, and a traumatic brain injury causing her death at the age of 65. Her medical history illustrates the development of surgical methods and rehabilitation in medicine before and after World War II. At an early age, she spent a year in a nursing home for orthopedic diseases due to scoliosis. In 1942, when she was 47 years old, she displayed the first symptoms of a suprasellar brain tumor: headache and hemianopsia. The famous surgeon Marcel David performed surgery on her without general anesthesia while Haskil mentally played a Mozart piano concerto as a neuronal representation to control her memory and mental abilities. Only 3 months after that operation she played a Mozart piano concerto at a concert that began her career as a great interpreter of Mozart. Her neurologic rehabilitation was remarkable and highlighted new methods in the field. In 1960, she traveled to Brussels for a concert. In the train station she stumbled on the stairs and hit her head on one of the steps. Skull fracture and intracranial hematoma were diagnosed. Doctors tried to operate on her but she lost consciousness and died. Haskil created new styles in piano playing, and her medical history offers indications of new concepts in neurosurgery.	[Gasenzer, Elena Romana] Univ Witten Herdecke, IFOM, Campus Koln Merheim, Cologne, Nordrhein Westf, Germany; [Kanat, Ayhan] Recep Tayyip Erdogan Univ, Fac Med, Dept Neurosurg, Riz, Turkey; [Neugebauer, Edmund A. M.] Med Sch Brandenburg Theodor Fontane, Campus Neuruppin, Neuruppin, Germany		Gasenzer, ER (corresponding author), Univ Witten Herdecke, IFOM, Campus Koln Merheim, Cologne, Nordrhein Westf, Germany.	elena-romana.gasenzer@gmx.de	Kanat, Ayhan/N-2296-2015	Gasenzer, Elena Romana/0000-0002-1221-2735; Kanat, Ayhan/0000-0002-8189-2877			Apuzzo MLJ, 2001, NEUROSURGERY, V48, P1, DOI 10.1097/00006123-200101000-00001; Attari Mohammadali, 2013, Adv Biomed Res, V2, P63, DOI 10.4103/2277-9175.115815; Baars BJ, 2010, COGNITION, BRAIN, AND CONSCIOUSNESS: INTRODUCTION TO COGNITIVE NEUROSCIENCE, 2ND EDITION, P127; Bailey P, 1951, HYPOPHYSENADENOM HIR, P77; Balik MS, 2016, J CRANIOVERTEBRAL JU, V7, P87, DOI 10.4103/0974-8237.181829; Bourgery JM, 1866, TRAITE COMPLET ANATO TRAITE COMPLET ANATO; Buchet A, 2000, ILLUSTRIERTE GESCH M, V5, P2493; Buchet A, 2000, ILLUSTRIERTE GESCH M, P2519; Buchet A, 2000, ILLUSTRIERTE GESCH M, P2507; CARMEL PW, 1982, NEUROSURGERY, V11, P382, DOI 10.1227/00006123-198209000-00008; Clara Spycket J, 1977, C HASKIL BIOGRAPHIE; Clarke R. H., 2007, CLIN ORTHOP RELAT R, V463, P1799; Cushing H, 1905, B JOHNS HOPKINS HOSP, V16, P77; Cushing H, 2005, NEUROSURGERY, V57, p6 1075; Danks RA, 2000, J NEURO-ONCOL, V49, P131, DOI 10.1023/A:1026577518902; Davis T, 2012, DIMENS CRIT CARE NUR, V31, P159, DOI 10.1097/DCC.0b013e31824dffc6; De l'Etoile S.K., 2010, MUSIC MED, V2, P78, DOI DOI 10.1177/1943862110364232; De Pue A, 2016, J HEADACHE PAIN, p17 23; Dick Jutta, 1993, JUDISCHE FRAUEN 19 2; Evans D, 2002, J ADV NURS, V37, P8, DOI 10.1046/j.1365-2648.2002.02052.x; Faber T, 2010, CLIN NUCL CARDIOLOGY, P53; Fukui H, 2008, MED HYPOTHESES, V71, P765, DOI 10.1016/j.mehy.2008.06.019; Galarza M, 2014, WORLD NEUROSURG, V81, DOI 10.1016/j.wneu.2013.09.042; Gillen E, 2008, INT J EVID-BASED HEA, V6, P24, DOI [10.1111/j.1479-6988.2007.00097.x, 10.1111/j.1744-1609.2007.00097.x]; Girad P, 2000, ILLUSTRIERTE GESCH M, V3, P1143; Hadab A, 2013, J NEUROL NEUROSCI, V4, P3, DOI [10.3823/338, DOI 10.3823/338]; Hegde S, 2014, FRONT NEUROL, p5 34; Hegde S, 2016, NEUROCASE       0701; Horsley V, 1887, Br Med J, V1, P863; Horwitz NH, 1996, NEUROSURGERY, V38, P844, DOI 10.1227/00006123-199604000-00044; Houdart R, 1988, Bull Acad Natl Med, V172, P241; Hughes JR, 2000, CLIN ELECTROENCEPHAL, V31, P94, DOI 10.1177/155005940003100208; Hughes JR, 1998, CLIN ELECTROENCEPHAL, V29, P109, DOI 10.1177/155005949802900301; Husain G, 2002, MUSIC PERCEPT, V20, P151, DOI 10.1525/mp.2002.20.2.151; Jadavji-Mithani R, 2015, CAN J NEUROL SCI, V42, P7, DOI 10.1017/cjn.2014.127; Jenkins JS, 2001, J ROY SOC MED, V94, P170, DOI 10.1177/014107680109400404; Johnson H C, 1956, HIST NEUROLOGICAL SU, P157; Joswig H, 2016, WORLD NEUROSURG, V90, P588, DOI 10.1016/j.wneu.2016.02.051; Kaiser J, 2004, GRO PIANISTEN UNSERE; Kanat A, 2010, CLIN NEUROL NEUROSUR, V112, P839, DOI 10.1016/j.clineuro.2010.07.012; Kanat A, 2010, ACTA NEUROCHIR, V152, P737, DOI 10.1007/s00701-009-0507-y; Kane, 1914, JAMA-J AM MED ASSOC, V62, P1829, DOI DOI 10.1001/JAMA.1914.02560480063031; KASE CS, 2004, STROKE PATHOPHYSIOLO, P327; Kobets Andrew Joshua, 2011, Yale Journal of Biology and Medicine, V84, P161; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Konzert Mozart W, 2001, AUSGABE 2 KLAVIERE W; Kruger J, 2005, NEUROCHIRURGIE, P808; KUHLENDAHL H, 1973, Z NEUROL, V204, P159, DOI 10.1007/BF00316358; Levy MJ, 2008, CURR PAIN HEADACHE R, V12, P74, DOI 10.1007/s11916-008-0014-5; Low D, 2007, ANN ACAD MED SINGAP, V36, P326; Meng LZ, 2016, J CLIN NEUROSCI, V24, P160, DOI 10.1016/j.jocn.2015.08.021; Moskopp D, 2005, NEUROCHIRURGIE; Mozart Kloiber R, 1983, HDB INSTRUMENTALKONZ, P193; Nilsson Ulrica, 2008, AORN J, V87, P780, DOI 10.1016/j.aorn.2007.09.013; Park S, 2016, WESTERN J NURS RES, V38, P394, DOI 10.1177/0193945915593180; Pintea B, 2013, NEUROSURGERY, V20, P80; Pittman S, 2011, INT NURS REV, V58, P157, DOI 10.1111/j.1466-7657.2011.00888.x; Pollock JR, 2003, NEUROSURGERY, V52, P914, DOI 10.1227/01.NEU.0000053148.34310.BB; Potters JW, 2015, CURR OPIN ANESTHESIO, V28, P511, DOI 10.1097/ACO.0000000000000231; Preti C., 2004, BRIT J MUSIC EDUC, V21, P329; PUSEY E, 1987, AM J ROENTGENOL, V149, P383, DOI 10.2214/ajr.149.2.383; Puttgen KB., 2013, PEDIATR DERMATOL, V4th ed, P14; Rauscher FH, 2006, EDUC PSYCHOL-US, V41, P233, DOI 10.1207/s15326985ep4104_3; Sacks O, 2013, UNWIDERSTEHLICH MUSI; Schinner K M, 1995, J Neurosci Nurs, V27, P348; Schirmer M, 1998, NEUROCHIRURGIE; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Sharma M, 2013, CLIN NEUROL NEUROSUR, V115, P1951, DOI 10.1016/j.clineuro.2013.05.020; Sihvonen Aleksi J, 2014, Duodecim, V130, P1852; Taylor MD, 1999, J NEUROSURG, V90, P35, DOI 10.3171/jns.1999.90.1.0035; Thompson WF, 2001, PSYCHOL SCI, V12, P248, DOI 10.1111/1467-9280.00345; Thorek P, 1985, ANATOMY IN SURG, P1; Van Elst E, 2000, ILLUSTRIERTE GESCH M, P1637; Verrusio W, 2015, CONSCIOUS COGN, V35, P150, DOI 10.1016/j.concog.2015.05.005; von Hartnack J, 1983, GRO GEIGER UNSERER Z, P47; von Hartnack J, 1983, GRO GEIGER UNSERER Z, P226; Wang CW, 2011, WORLD NEUROSURG, V75, P294, DOI 10.1016/j.wneu.2010.08.021; Wernhard E, 1997, C HASKIL APROPOS C H; Wolfensberger R, 1961, BEITRAGEN PIERRE FOU; Zada G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.5.FOCUS1183	81	16	16	1	18	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	MAY	2017	78	3					260	268		10.1055/s-0036-1597895			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	ES3IF	WOS:000399422600008	28219086				2022-02-06	
J	Neumann, D; Malec, JF; Hammond, FM				Neumann, Dawn; Malec, James F.; Hammond, Flora M.			The Relations of Self-Reported Aggression to Alexithymia, Depression, and Anxiety After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aggression; alexithymia; anxiety; brain injury; depression; emotion	IMPULSIVE AGGRESSION; EMOTION RECOGNITION; FACIAL EXPRESSIONS; HEAD-INJURY; ANGER; MANAGEMENT; BEHAVIOR; VALIDITY; PEOPLE; IMPACT	Objectives: To compare self-reported aggression in people with and without traumatic brain injury (TBI) and examine the relations of aggression to alexithymia (poor emotional insight), depression, and anxiety. Setting: Rehabilitation hospital. Participants: Forty-six adults with moderate to severe TBI who were at least 3 months postinjury; 49 healthy controls (HCs); groups were frequency matched for age and gender. Design: Cross-sectional study using a quasi-experimental design. Main Measures: Aggression (Buss-Perry Aggression Questionnaire); alexithymia (Toronto Alexithymia Scale-20); depression (Patient Health Questionnaire-9); and trait anxiety (State-Trait Anxiety Inventory). Results: Participants with TBI had significantly higher aggression scores than HCs. For participants with TBI, 34.2% of the adjusted variance of aggression was significantly explained by alexithymia, depression, and anxiety; alexithymia accounted for the largest unique portion of the variance in this model (16.2%). Alexithymia, depression, and anxiety explained 46% of the adjusted variance of aggression in HCs; in contrast to participants with TBI, depression was the largest unique contributor to aggression (15.9%). Conclusion: This was the first empirical study showing that poor emotional insight (alexithymia) significantly contributes to aggression after TBI. This relation, and the potential clinical implications it may have for the treatment of aggression, warrants further investigation.	[Neumann, Dawn; Malec, James F.; Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA		Neumann, D (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dmneuman@iupui.edu			National Institute on Disability, Independent Living, and Rehabilitation Research Switzer Research Fellowships Program Priority (CFDA) [84.133F-1]; Indiana Spinal Cord and Brain Injury Research Fund; Indiana University Brain Rehabilitation, Advanced Imaging, and Neuroscience Signature Center Initiative; National Institutes of Health, NICHD STTR [1R41HD077967-01A1]	This research was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research Switzer Research Fellowships Program Priority (CFDA no. 84.133F-1); the Indiana Spinal Cord and Brain Injury Research Fund; and the Indiana University Brain Rehabilitation, Advanced Imaging, and Neuroscience Signature Center Initiative.; Dr Dawn Neumann is a small business owner that currently receives federal grant funding from the National Institutes of Health, NICHD STTR (grant no. 1R41HD077967-01A1), to develop and investigate an intervention related to concepts discussed in this article.	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Bagby R.M., 1997, DISORDERS AFFECT REG, P26, DOI DOI 10.1017/CBO9780511526831.005; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Berenbaum H, 1996, PSYCHOTHER PSYCHOSOM, V65, P203, DOI 10.1159/000289076; Besharat MA, 2010, PROCD SOC BEHV, V5, P614, DOI 10.1016/j.sbspro.2010.07.152; BURKE WH, 1988, INT J REHABIL RES, V11, P235, DOI 10.1097/00004356-198809000-00003; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Eames P, 2003, NEUROPSYCHOL REHABIL, V13, P241, DOI 10.1080/09602010244000435; Einspruch BC, 1998, JAMA-J AM MED ASSOC, V279, P555; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; Fakra E, 2008, SCHIZOPHR RES, V100, P191, DOI 10.1016/j.schres.2007.11.040; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Foland-Ross LC, 2010, J NEUROSCI, V30, P16673, DOI 10.1523/JNEUROSCI.4578-09.2010; Greve KW, 2001, BRAIN INJURY, V15, P255; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Harris JA, 1997, J BUS PSYCHOL, V12, P39, DOI 10.1023/A:1025058032195; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; HOLM S, 1979, SCAND J STAT, V6, P65; Holtzworth-Munroe A, 2001, BEHAV THER, V31, P603; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Jessimer M, 1997, BRAIN COGNITION, V34, P246, DOI 10.1006/brcg.1997.0900; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kokkonen P, 2001, COMPR PSYCHIAT, V42, P471, DOI 10.1053/comp.2001.27892; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lane RD, 2000, PSYCHOSOM MED, V62, P492, DOI 10.1097/00006842-200007000-00007; Levant RF., 2009, J MENS STUD, V17, P75, DOI [10.3149/jms.1701.75, DOI 10.3149/JMS.1701.75]; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McDonald S, 2011, BRAIN IMPAIR, V12, P165; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Messina A, 2014, J PSYCHOPATHOL, V20, P38; NEMIAH JC, 1970, PSYCHOTHER PSYCHOSOM, V18, P154, DOI 10.1159/000286074; Neumann D, 2015, REHABIL PSYCHOL, V60, P155, DOI 10.1037/rep0000036; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Palmer EJ, 2005, AGGRESSIVE BEHAV, V31, P56, DOI 10.1002/ab.20072; Prince L, 2012, 9 C NEUR REH SPEC IN; Sansone RA, 2013, COMPR PSYCHIAT, V54, P70, DOI 10.1016/j.comppsych.2012.06.005; Spielberger CD., 1970, STATE TRAIT ANXIETY; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Teten AL, 2008, BEHAV SCI LAW, V26, P823, DOI 10.1002/bsl.843; Velasco C, 2006, PSICOTHEMA, V18, P89; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Williams C, 2013, J HEAD TRAUMA REHAB, V28, pE21, DOI 10.1097/HTR.0b013e318267b0ab; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013; Wood RLL, 2009, BRAIN INJURY, V23, P649, DOI 10.1080/02699050902970786; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029	69	16	16	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					205	213		10.1097/HTR.0000000000000261			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900007	28476059	Green Submitted			2022-02-06	
J	Tanveer, S; Zecavati, N; Delasobera, EB; Oyegbile, TO				Tanveer, Sarah; Zecavati, Nassim; Delasobera, Elizabeth Bronson; Oyegbile, Temitayo Oyefunmike			Gender Differences in Concussion and Postinjury Cognitive Findings in an Older and Younger Pediatric Population	PEDIATRIC NEUROLOGY			English	Article						gender; concussion; cognitive testing; pediatric	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; SEX-DIFFERENCES; NEUROPSYCHOLOGICAL FUNCTION; SYMPTOMS; MANAGEMENT; IMPACT; RECOVERY	BACKGROUND: Studies have documented gender differences associated with concussion. The purpose of this study was to determine if these gender differences are also noted within a pediatric population. METHODS: This prospective study analyzed 1971 patients who had completed preconcussion and postconcussion neuropsychological testing within the Washington, DC, area. RESULTS: Our results showed that children and adolescents with concussion exhibit gender differences with respect to risk factors, recovery, and symptomatology. Females are more likely to preent with a concussion (P < 0.001), experience more discomfort from a concussion (P < 0.001),, and seek treatment for postconcussive headaches (P < 0.001). On the other hand, males are more likely to sustain a concussion from a contact sport (P < 0.001) and experience loss of consciousness, confusion, and amnesia with a concussion more frequently than females (P < 0.001). Postconcussive cognitive function also differs by gender. Both males and females exhibit a decline in cognitive testing compared with baseline (P < 0.001); however, visual memory (P = 0.02) is more affected in females than in males. These findings remain unchanged among pediatric patients aged >= 14 years; however, no gender differences were noted in individuals aged <= 13 years. CONCLUSION: It is important for health care providers, schools, athletic trainers, and coaches to be aware of these gender differences associated with concussion in order to provide adequate surveillance and appropriate monitoring and support during the recovery period.	[Oyegbile, Temitayo Oyefunmike] MedStar Georgetown Univ Hosp, Pediat Neurol Sleep Med & Epilepsy, 4200 Wisconsin Ave NW, Washington, DC 20016 USA		Oyegbile, TO (corresponding author), MedStar Georgetown Univ Hosp, Pediat Neurol Sleep Med & Epilepsy, 4200 Wisconsin Ave NW, Washington, DC 20016 USA.	Temitayo.O.Oyegbile@gunetzeorgetown.edu	Tanveer, Sarah/F-9639-2018; Tanveer, Sarah/AAK-1470-2020	Tanveer, Sarah/0000-0002-6408-9855; Tanveer, Sarah/0000-0002-6408-9855			[Anonymous], 2007, MMWR MORB MORTAL WKL, V56, P733; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211	28	16	16	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	MAY	2017	70						44	49		10.1016/j.pediatrneurol.2017.02.001			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	EV1FW	WOS:000401493100009	28320567				2022-02-06	
J	Cnossen, MC; Polinder, S; Andriessen, TM; van der Naalt, J; Haitsma, I; Horn, J; Franschman, G; Vos, PE; Steyerberg, EW; Lingsma, H				Criossen, Maryse C.; Polinder, Suzanne; Andriessen, Teuntje M.; van der Naalt, Joukje; Haitsma, Iain; Horn, Janneke; Franschman, Gaby; Vos, Pieter E.; Steyerberg, Ewout W.; Lingsma, Hester			Causes and Consequences of Treatment Variation in Moderate and Severe Traumatic Brain Injury: A Multicenter Study	CRITICAL CARE MEDICINE			English	Article						Glasgow Outcome Scale-Extended; intracranial pressure monitoring; observational studies; traumatic brain injury; treatment variation	SEVERE HEAD-INJURY; MANAGEMENT; EPIDEMIOLOGY; CARE	Objectives: Although guidelines have been developed to standardize care in traumatic brain injury, between-center variation in treatment approach has been frequently reported. We examined variation in treatment for traumatic brain injury by assessing factors influencing treatment and the association between treatment and patient outcome. Design: Secondary analysis of prospectively collected data. Setting: Five level I trauma centers in the Netherlands (2008-2009). Patients: Five hundred three patients with moderate or severe traumatic brain injury (Glasgow Coma Scale, 3-13). Interventions: We examined variation in seven treatment parameters: direct transfer, involvement of mobile medical team, mechanical ventilation, intracranial pressure monitoring, vasopressors, acute neurosurgical intervention, and extracranial operation. Measurements and Main Results: Data were collected on patient characteristics, treatment, and 6-month Glasgow Outcome Scale-Extended. Multivariable logistic regression models were used to assess the extent to which treatment was determined by patient characteristics. To examine whether there were between-center differences in treatment, we used unadjusted and adjusted random effect models with the seven treatment parameters as dependent variables. The influence of treatment approach in a center (defined as aggressive and non aggressive based on the frequency intracranial pressure monitoring) on outcome was assessed using multivariable random effect proportional odds regression models in those patients with an indication for intracranial pressure monitoring. Sensitivity analyses were performed to test alternative definitions of aggressiveness. Treatment was modestly related to patient characteristics (Nagelkerke R-2 range, 0.12-0.52) and varied widely among centers, even after case-mix correction. Outcome was more favorable in patients treated in aggressive centers than those treated in nonaggressive centers (OR, 1.73; 95% CI, 1.05-3.15). Sensitivity analyses, however, illustrated that the aggressiveness-outcome association was dependent on the definition used. Conclusions: The considerable between-center variation in treatment for patients with brain injury can only partly be explained by differences in patient characteristics. An aggressive treatment approach may imply better outcome although further confirmation is required. (Crit Care Med 2017; 45:660-669)	[Criossen, Maryse C.; Polinder, Suzanne; Steyerberg, Ewout W.; Lingsma, Hester] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [Andriessen, Teuntje M.] RIVAS Healthcare Grp, Dept Psychol, Gorinchem, Netherlands; [van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Haitsma, Iain] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Horn, Janneke] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, Amsterdam, Netherlands; [Franschman, Gaby] VU Univ Med Ctr Amsterdam, Dept Anesthesiol, Amsterdam, Netherlands; [Vos, Pieter E.] Slingeland Hosp, Dept Neurol, Doetinchem, Netherlands		Cnossen, MC (corresponding author), Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands.	m.c.cnossen@erasmusmc.nl		van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation [Hersenstichting-HSN-07-01]; European Union FP 7th Framework program CENTER-TBI [602150]; Dutch brain foundation (Hersenstichting); University Medical Center Nijmegen, Department of Neurology; Ever Neuropharma; EU FP7 programmeEuropean Commission; European Union (FP7)European Commission	The POCON study is funded by the Dutch Brain Foundation (Hersenstichting-HSN-07-01).r Dr. Cnossen received support for article research from The European Union FP 7th Framework program (grant 602150) CENTER-TBI. Dr. Andriessen's institution received funding from Dutch brain foundation (Hersenstichting). Dr. Haitsma's institution received funding from University Medical Center Nijmegen, Department of Neurology. Dr. Vos' institution received funding from Dutch Brain Foundation (Hersenstichting), and he received funding from Ever Neuropharma (consultancy). Dr. Steyerberg's institution received funding from EU FP7 programme. Dr. Lingsma received support for article research from European Union (FP7). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Akaike H, 1973, 2 INT S INF THEOR; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bosco JLF, 2010, J CLIN EPIDEMIOL, V63, P64, DOI 10.1016/j.jclinepi.2009.03.001; Brain Trauma Foundation, 2007, J NEUROTRAUMA; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Carney N, 2016, NEUROSURGERY; Christensen RHB, ORD REGR MOD ORD DAT; Cnossen MC, 2016, J NEUROTRAUM; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Hoogmartens O, 2014, PREHOSP EMERG CARE, V18, P265, DOI 10.3109/10903127.2013.856506; Kahol K, 2011, J BIOMED INFORM, V44, P425, DOI 10.1016/j.jbi.2011.04.003; Lingsma HF, 2010, QJM-INT J MED, V103, P99, DOI 10.1093/qjmed/hcp169; Lingsma HF, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-201; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; National Institute of Neurological Disorders and Stroke (NINDS), NINDS COMM DAT EL TR; R core team and contributors worldwide, R GRAPH PACK R PACK; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Signorello Lisa B, 2002, Am J Ther, V9, P199, DOI 10.1097/00045391-200205000-00005; Skoglund K, 2013, J NEUROSCI NURS, V45, P360, DOI 10.1097/JNN.0b013e3182a3cf4f; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	30	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2017	45	4					660	669		10.1097/CCM.0000000000002263			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO6JQ	WOS:000396798700013	28169945				2022-02-06	
J	Hoffmann, M; Czorlich, P; Lehmann, W; Spiro, AS; Rueger, JM; Lefering, R				Hoffmann, Michael; Czorlich, Patrick; Lehmann, Wolfgang; Spiro, Alexander S.; Rueger, Johannes M.; Lefering, Rolf		TraumaRegister DGU German	The Impact of Prehospital Intubation With and Without Sedation on Outcome in Trauma Patients With a GCS of 8 or Less	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						Glasgow Coma Scale; intubation; ventilation; sedation; prehospital; traumatic brain injury	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; BRAIN-INJURY; ENDOTRACHEAL INTUBATION; LIFE-SUPPORT; VENTILATION; MANAGEMENT; AIRWAY; FIELD; RISK	Background: Although unconsciousness (Glasgow Coma Scale [GCS] 3 to 8) necessitates intubation according national guidelines, there is a notable lack of evidence to support this approach. This study evaluates the impact on outcome of prehospital intubation with and without sedation in trauma patients with a GCS of r8. Methods: A retrospective cohort analysis of severely injured trauma patients registered in the TraumaRegister DGU of the German Trauma Society (DGU) from 2002 to 2013 was conducted. Only directly admitted patients alive on admission and with a GCS of r8 at the scene were included. The observed outcome was matched with the expected outcome deriving from the Revised Injury Severity Classification, version II (RISC-II). Furthermore, a Standardized Mortality Ratio (SMR) was calculated for various subgroups. Early neurological outcome was classified using the Glasgow Outcome Scale. Results: A total of 21,242 patients fulfilled the study inclusion criteria. A total of 18,975 patients (89.3%) received prehospital intubation. Intubation rates were continuously increasing with decreasing GCS score values. Difference between observed and expected mortality was lower in intubated patients (42.2% [95% confidence interval (CI), 41.5%-42.9%]; RISC-II prognosis 41.4%; SMR 1.020 [95% CI, 1.003-1.037]) compared with nonintubated (30.0% [95% CI, 28.1-31.9%] RISC-II prognosis 26.6% and SMR 1.128 [95% CI, 1.057-1.199]). Patients being sedated before intubation presented significant (P<0.001) lower observed mortality (37.7% [95% CI, 36.7-38.7%], RISCII prognosis 39.0%, SMR 0.967 [95% CI, 0.951-0.983]) associated with a less poor early neurological outcome compared with those being intubated without sedation. Conclusions: Observed outcome of prehospital intubated patients with a GCS of <= 8 seems less poor than predicted compared with nonintubated patients. Sedation before intubation might potentially decrease mortality and improve early neurological outcome. Further studies are required to clarify this issue.	[Hoffmann, Michael; Lehmann, Wolfgang; Spiro, Alexander S.; Rueger, Johannes M.] Univ Med Ctr Hamburg Eppendorf, Trauma Hand & Reconstruct Surg, Hamburg, Germany; [Hoffmann, Michael; Czorlich, Patrick; Lehmann, Wolfgang; Spiro, Alexander S.; Rueger, Johannes M.] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-D20246 Hamburg, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany		Czorlich, P (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-D20246 Hamburg, Germany.		Czorlich, Patrick/H-8934-2019				Bigham BL, 2013, PREHOSP EMERG CARE, V17, P361, DOI 10.3109/10903127.2013.792890; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DP, 2008, CAN MED ASSOC J, V178, P1171, DOI 10.1503/cmaj.080234; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Garner AA, 2015, EMERG MED J, V32, P869, DOI 10.1136/emermed-2014-204390; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Hatley T, 1998, J Emerg Med, V16, P731, DOI 10.1016/S0736-4679(98)00087-0; Kim D, 2014, J TRAUMA ACUTE CARE, V76, P167, DOI 10.1097/TA.0b013e3182a92596; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Seder DB, 2015, NEUROCRIT CARE, V23, pS5, DOI 10.1007/s12028-015-0164-3; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; TEASDALE G, 1974, LANCET, V2, P81; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	22	16	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	2017	29	2					161	167		10.1097/ANA.0000000000000275			7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	EN3ZH	WOS:000395946100006	26797107				2022-02-06	
J	Hu, JJ; Yang, XL; Luo, WD; Han, S; Yin, J; Liu, WH; He, XH; Peng, BW				Hu, Jiang-Jian; Yang, Xing-Liang; Luo, Wen-Di; Han, Song; Yin, Jun; Liu, Wan-Hong; He, Xiao-Hua; Peng, Bi-Wen			Bumetanide reduce the seizure susceptibility induced by pentylenetetrazol via inhibition of aberrant hippocampal neurogenesis in neonatal rats after hypoxia-ischemia	BRAIN RESEARCH BULLETIN			English	Article						Hypoxia-ischemia brain damage; NKCC1; Bumetanide; Neurogenesis; Cognitive decline	ECTOPIC GRANULE CELLS; TEMPORAL-LOBE EPILEPSY; CATION-CHLORIDE COTRANSPORTERS; INDUCED STATUS EPILEPTICUS; TRAUMATIC BRAIN INJURY; DENTATE GYRUS; NA+-K+-2CL(-) COTRANSPORTER; BASAL DENDRITES; INTERMITTENT HYPOXIA; CORTICAL-NEURONS	Hypoxia-ischemia brain damage (HIBD) is one of prevalent causes of neonatal mortality and morbidity. Our data demonstrated that hypoxia-ischemia (HI) induced Na+-K+-Cl--co-transporter 1 (NKCC1) increasing in hippocampus. Previous studies demonstrated that NKCC1 regulates various stages of neurogenesis. In this study, we studied the role of increased NKCC1 in regulating of HI-induced neurogenesis. HIBD model was established in 7 days old Sprague-Dawley rat pup, and the expression of NKCC1 was detected by western blot and qPCR. Brain electrical activity in freely rats was monitored by electroencephalography (EEG) recordings. HI-induced neurogenesis was detected by immunofluorescence staining. Neurobehavioral test was to investigate the neuro-protective role of bumetanide, an inhibitor of NKCC1, on neonatal rats after HI. The results showed that bumetanide treatment significantly reduced brain electrical activity and the seizure stage of epilepsy induced by pentylenetetrazol (PTZ) in vivo after HI. In addition, bumetanide restored aberrant hippocampal neurogenesis and associated cognitive function. Our data demonstrated that bumetanide reduces the susceptibility of epilepsy induced by PTZ in rats suffering from HI injury during neonatal period via restoring the ectopic newborn neurons in dentate gyrus (DG) and cognitive function. (C) 2017 Elsevier Inc. All rights reserved.	[Hu, Jiang-Jian; Yang, Xing-Liang; Luo, Wen-Di; Peng, Bi-Wen] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Dev OriginatedDisorder, Dept Physiol, Wuhan, Hubei, Peoples R China; [Han, Song; Yin, Jun; He, Xiao-Hua] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Dev OriginatedDisorder, Dept Pathophysiol, Wuhan, Hubei, Peoples R China; [Liu, Wan-Hong] Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan, Hubei, Peoples R China		Peng, BW (corresponding author), Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Dev OriginatedDisorder, Dept Physiol, Wuhan, Hubei, Peoples R China.	pengbiwen@whu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81370737, 81571481, 81371422]	This work was supported by the National Natural Science Foundation of China (No. 81370737, 81571481 and 81371422), the authors confirm that they have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.	Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Austin JE, 2004, J COMP NEUROL, V476, P205, DOI 10.1002/cne.20182; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Beck J, 2003, J NEUROSCI, V23, P5061; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Cameron MC, 2011, J COMP NEUROL, V519, P2175, DOI 10.1002/cne.22623; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Castro OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046044; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Dai Y, 2005, CAN J PHYSIOL PHARM, V83, P767, DOI 10.1139/Y05-076; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; Ellender TJ, 2014, J NEUROSCI, V34, P15208, DOI 10.1523/JNEUROSCI.1747-14.2014; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Haering C, 2015, J BIOL CHEM, V290, P9767, DOI 10.1074/jbc.M115.640656; Hochman DW, 2012, EPILEPSIA, V53, P18, DOI 10.1111/j.1528-1167.2012.03471.x; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jung KH, 2006, NEUROBIOL DIS, V23, P237, DOI 10.1016/j.nbd.2006.02.016; Jung KH, 2004, EUR J NEUROSCI, V19, P3219, DOI 10.1111/j.0953-816X.2004.03412.x; Kahle KT, 2009, J CHILD NEUROL, V24, P572, DOI 10.1177/0883073809333526; Kahle KT, 2012, JASPERS BASIC MECH E; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Lee V, 2013, J NEUROPHYSIOL, V110, P2520, DOI 10.1152/jn.00047.2013; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Loscher W, 2013, NEUROPHARMACOLOGY, V69, P62, DOI 10.1016/j.neuropharm.2012.05.045; Lu K. T., 2014, PFLUGERS ARCH; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Luo J, 2008, J CEREBR BLOOD F MET, V28, P737, DOI 10.1038/sj.jcbfm.9600561; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Mejia-Gervacio S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-4; Min JW, 2015, NEUROPHARMACOLOGY, V99, P38, DOI 10.1016/j.neuropharm.2015.07.007; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Myers CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068208; Noebels JL, 2010, EPILEPSIA, V51, P1, DOI 10.1111/j.1528-1167.2010.02792.x; O'Toole KK, 2014, EPILEPSY RES, V108, P29, DOI 10.1016/j.eplepsyres.2013.10.013; Parent JM, 1997, J NEUROSCI, V17, P3727; Pun RYK, 2012, NEURON, V75, P1022, DOI 10.1016/j.neuron.2012.08.002; Puskarjov M, 2014, EPILEPSIA, V55, P806, DOI 10.1111/epi.12620; RAKIC P, 1981, J COMP NEUROL, V196, P99, DOI 10.1002/cne.901960109; Ribak C. E., 2012, JASPERS BASIC MECH E; Ribak CE, 2000, J COMP NEUROL, V428, P240, DOI 10.1002/1096-9861(20001211)428:2<240::AID-CNE4>3.0.CO;2-Q; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Sanchez M., 2012, EPILEPSIA; Scharfman H. E., 2002, NEUROSCIENCE; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Scharfman H, 2007, DEV NEUROSCI-BASEL, V29, P14, DOI 10.1159/000096208; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Sivakumaran S., 2015, EPILEPSIA; Sun DD, 1999, J NEUROPHYSIOL, V81, P1939, DOI 10.1152/jn.1999.81.4.1939; Thind KK, 2008, J COMP NEUROL, V509, P190, DOI 10.1002/cne.21745; Tollner K, 2015, EUR J PHARMACOL, V746, P78, DOI 10.1016/j.ejphar.2014.10.056; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Wang GB, 2014, INT J CLIN EXP PATHO, V7, P1487; WENZEL J, 1981, J HIRNFORSCH, V22, P629; Williams PA, 2004, EPILEPSIA, V45, P1210, DOI 10.1111/j.0013-9580.2004.60403.x; Xu W., 2016, MOL NEUROBIOL; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Ye ZY, 2012, J NEUROSCI, V32, P8560, DOI 10.1523/JNEUROSCI.1346-12.2012; Young SZ, 2012, J NEUROSCI, V32, P13630, DOI 10.1523/JNEUROSCI.2864-12.2012; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhan RZ, 2010, J NEUROPHYSIOL, V104, P3293, DOI 10.1152/jn.00663.2010; Zhu LL, 2005, BRAIN RES, V1055, P1, DOI 10.1016/j.brainres.2005.04.075	67	16	17	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	APR	2017	130						188	199		10.1016/j.brainresbull.2017.01.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU9XZ	WOS:000401394300026	28161194				2022-02-06	
J	Kroshus, E; Kerr, ZY; Lee, JGL				Kroshus, Emily; Kerr, Zachary Y.; Lee, Joseph G. L.			Community-Level Inequalities in Concussion Education of Youth Football Coaches	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; HEALTH INEQUALITIES; NEIGHBORHOOD; DISPARITIES; RATES	Introduction: USA Football has made the Heads Up Football (HUF) concussion education program available for coaches of youth football players. Existing evidence about the effectiveness of the HUF coach education program is equivocal. For HUF and other programs, there is growing concern that even effective interventions can increase inequalities if there is different uptake or impact by SES or other demographic factors. Understanding how adoption is patterned along these lines is important for understanding equity issues in youth football. This study tested the hypothesis that there will be lower adoption of HUF among coaches of youth football players in lower-SES communities. Methods: The authors conducted a cross-sectional study of the association between communitylevel characteristics and number of USA Football youth league coaches who have completed HUF. Data were collected in 2014 and analyzed in 2015-2016. Results: Implementation of the HUF program was patterned by community-level socioeconomic characteristics. Leagues located in communities with a higher percentage of families with children aged o18 years living below the poverty line and a smaller percentage of non-Hispanic white residents tended to have leagues with smaller percentages of HUF-certified coaches. Conclusions: As interventions are developed that reduce the risks of youth football, it is important to consider not just the effectiveness of these interventions, but also whether they reduce or exacerbate health inequities. These results suggest that relying on voluntary adoption of coach education may result in inequitable implementation. Further study is required to identify and remedy organizational and contextual barriers to implementation of coach education in youth sport. (C) 2017 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.	[Kroshus, Emily] Univ Washington, Dept Pediat, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Lee, Joseph G. L.] East Carolina Univ, Dept Hlth Educ & Promot, Greenville, NC USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@uw.edu		Kroshus, Emily/0000-0002-7484-2601	USA Football	As a former employee of the Datalys Center, Zack Kerr served as Principal Investigator on Datalys Center projects funded by USA Football. USA Football had no role in the design and conduct of the study; management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Findings do not reflect the official opinions of USA Football.	Aspen Institute/ espnW, PROJ PLAY SURV PAR Y; Bain-Selbo E., 2009, GAME DAY GOD FOOTBAL; Bernard P, 2007, SOC SCI MED, V65, P1839, DOI 10.1016/j.socscimed.2007.05.037; Brown JC, 2016, INT J SPORTS SCI COA, V11, P637, DOI 10.1177/1747954116667100; Drewnowski A, 2007, SOC SCI MED, V65, P2458, DOI 10.1016/j.socscimed.2007.07.001; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; ESPN, YOUTH FOOTB PART DRO; Foraker RE, 2011, ANN EPIDEMIOL, V21, P580, DOI 10.1016/j.annepidem.2011.03.004; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Grubesic T.H., 2008, SOCIOECON PLAN SCI, V42, P129, DOI [DOI 10.1016/j.seps.2006.09.001, DOI 10.1016/J.SEPS.2006.09.001]; Hill S, 2014, TOB CONTROL, V23, DOI 10.1136/tobaccocontrol-2013-051110; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; National Council of Youth Sports, 2008, REP TRENDS PART ORG; National Federation of State High School Associations, 2011 12 HIGH SCH ATH; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; U. S. Census Bureau, GEOGR TERMS CONC CEN; U. S. Census Bureau, 2009, KEY FACTS; USA Football, HEADS FOOTB NEW STAN; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7	27	16	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	APR	2017	52	4					476	482		10.1016/j.amepre.2016.12.021			7	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	EU5MZ	WOS:000401077200011	28209280				2022-02-06	
J	Nelson, LD; Furger, RE; Gikas, P; Lerner, EB; Barr, WB; Hammeke, TA; Randolph, C; Guskiewicz, K; McCrea, MA				Nelson, Lindsay D.; Furger, Robyn E.; Gikas, Peter; Lerner, E. Brooke; Barr, William B.; Hammeke, Thomas A.; Randolph, Christopher; Guskiewicz, Kevin; McCrea, Michael A.			Prospective, Head-to-Head Study of Three Computerized Neurocognitive Assessment Tools Part 2: Utility for Assessment of Mild Traumatic Brain Injury in Emergency Department Patients	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Mild traumatic brain injury; Concussion; Emergency department; Neurocognitive testing; Neuropsychological testing	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; TEST-PERFORMANCE; SYMPTOMS; RECOVERY; PREDICTORS; RELIABILITY; POPULATION; PREVALENCE; MANAGEMENT	Objectives: The aim of this study was to evaluate the reliability and validity of three computerized neurocognitive assessment tools (CNTs; i.e., ANAM, DANA, and ImPACT) for assessing mild traumatic brain injury (mTBI) in patients recruited through a level I trauma center emergency department (ED). Methods: mTBI (n = 94) and matched trauma control (n = 80) subjects recruited from a level I trauma center emergency department completed symptom and neurocognitive assessments within 72 hr of injury and at 15 and 45 days post-injury. Concussion symptoms were also assessed via phone at 8 days post-injury. Results: CNTs did not differentiate between groups at any time point (e.g., M 72-hr Cohen's d = -.16, .02, and .00 for ANAM, DANA, and ImPACT, respectively; negative values reflect greater impairment in the mTBI group). Roughly a quarter of stability coefficients were over .70 across measures and test-retest intervals in controls. In contrast, concussion symptom score differentiated mTBI vs. control groups acutely), with this effect size diminished over time (72-hr and day 8, 15, and 45 Cohen's d = -.78, -.60, -.49, and -.35, respectively). Conclusions: The CNTs evaluated, developed and widely used to assess sport-related concussion, did not yield significant differences between patients with mTBI versus other injuries. Symptom scores better differentiated groups than CNTs, with effect sizes weaker than those reported in sport-related concussion studies. Nonspecific injury factors, and other characteristics common in ED settings, likely affect CNT performance across trauma patients as a whole and thereby diminish the validity of CNTs for assessing mTBI in this patient population.	[Nelson, Lindsay D.; Furger, Robyn E.; Gikas, Peter; Lerner, E. Brooke; Hammeke, Thomas A.; McCrea, Michael A.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Barr, William B.] NYU, Sch Med, New York, NY USA; [Randolph, Christopher] Loyola Univ, Sch Med, Maywood, IL 60153 USA; [Guskiewicz, Kevin] Univ North Carolina Chapel Hill, Chapel Hill, NC USA		Nelson, LD (corresponding author), Med Coll Wisconsin, Milwaukee, WI 53226 USA.; Nelson, LD (corresponding author), Neurosci Res Ctr, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu			U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-1-0004]; National Center for Advancing Translational Sciences (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436] Funding Source: NIH RePORTER	We thank David Gray, Ashley LaRoche, and Adam Pfaller for their contributions to data collection. This work was supported by the U.S. Army Medical Research and Materiel Command (M.M., award number W81XWH-12-1-0004) and the National Center for Advancing Translational Sciences (National Institutes of Health Grant Number UL1TR001436). Opinions, interpretations, conclusions, and recommendations expressed in the manuscript are those of the authors and are not necessarily endorsed by the U.S. Army or representative of the official views of the NIH. The authors have no conflicts of interest to report.	[Anonymous], 2015, C TRAUM BRAIN INJ US; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRUERA E, 1989, PAIN, V39, P13, DOI 10.1016/0304-3959(89)90169-3; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Eastvold AD, 2012, CLIN NEUROPSYCHOL, V26, P520, DOI 10.1080/13854046.2012.663000; Faul M, 2010, TRAUMATIC BRAIN INJU; Furger R. E., 2016, CONCUSSION, V1, pCNC11; Green P., 2003, GREENS MED SYMPTOM V; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Helmick K., 2006, DEFENSE VETERANS BRA; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Weathers J. W., 1994, PTSD CHECKLIST CIVIL; WechslerD, 2001, WECHSLER TEST ADULT	43	16	16	0	5	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2017	23	4					293	303		10.1017/S1355617717000157			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	ES2YO	WOS:000399394000001	28343463	Green Accepted			2022-02-06	
J	Nyam, TTE; Ao, KH; Hung, SY; Shen, ML; Yu, TC; Kuo, JR				Nyam, Tee-Tau Eric; Ao, Kam-Hou; Hung, Shu-Yu; Shen, Mei-Li; Yu, Tzu-Chieh; Kuo, Jinn-Rung			FOUR Score Predicts Early Outcome in Patients After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						FOUR score; Glasgow Coma Scale; APACHE II; Therapeutic Interventions Scoring System; Traumatic brain injury; ROC curve	GLASGOW COMA SCALE; VALIDATION; CONSCIOUSNESS; SEVERITY	The aim of the study was to determine whether the Full Outline of UnResponsiveness (FOUR) score, which includes eyes opening (E), motor function (M), brainstem reflex (B), and respiratory pattern (R), can be used as an alternate method to the Glasgow Coma Scale (GCS) in predicting intensive care unit (ICU) mortality in traumatic brain injury (TBI) patients. From January 2015 to June 2015, patients with isolated TBI admitted to the ICU were enrolled. Three advanced practice nurses administered the FOUR score, GCS, Acute Physiology and Chronic Health Evaluation II (APACHE II), and Therapeutic Intervention Scoring System (TISS) concurrently from ICU admissions. The endpoint of observation was mortality when the patients left the ICU. Data are presented as frequency with percentages, mean with standard deviation, or median with interquartile range. Each measurement tool used area under the receiver operating characteristic curve to compare the predictive power between these four tools. In addition, the difference between survival and death was estimated using the Wilcoxon rank sum test. From 55 TBI patients, males (72.73 %) were represented more than females, the mean age was 63.1 +/- 17.9, and 19 of 55 observations (35 %) had a maximum FOUR score of 16. The overall mortality rate was 14.6 %. The area under the receiver operating characteristic curve was 74.47 % for the FOUR score, 74.73 % for the GCS, 81.78 % for the APACHE II, and 53.32 % for the TISS. The FOUR score has similar predictive power of mortality compared to the GCS and APACHE II. Each of the parameters-E, M, B, and R-of the FOUR score showed a significant difference between mortality and survival group, while the verbal and eye-opening components of the GCS did not. Having similar predictive power of mortality compared to the GCS and APACHE II, the FOUR score can be used as an alternative in the prediction of early mortality in TBI patients in the ICU.	[Nyam, Tee-Tau Eric; Ao, Kam-Hou; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan; [Hung, Shu-Yu; Shen, Mei-Li; Yu, Tzu-Chieh] Chi Mei Med Ctr, Dept Nursing, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com			 [CMHCR10401]	Research has been funded by CMHCR10401 grants.	Akavipat P, 2009, NEUROL MED-CHIR, V49, P565, DOI 10.2176/nmc.49.565; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gorji Mohammad Ali Heidari, 2015, Int J Appl Basic Med Res, V5, P92, DOI 10.4103/2229-516X.157152; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; Jalali R, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/289803; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lambert J, 2008, SAS GLOB FOR 2008; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; Padilha KG, 2007, INTENS CRIT CARE NUR, V23, P162, DOI 10.1016/j.iccn.2006.07.004; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; Stevens RD, 2006, CRIT CARE MED, V34, P31, DOI 10.1097/01.CCM.0000194534.42661.9F; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Weiss N, 2009, REV NEUROL-FRANCE, V165, P796, DOI 10.1016/j.neurol.2009.01.045; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435	23	16	16	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2017	26	2					225	231		10.1007/s12028-016-0326-y			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EN5EV	WOS:000396029300010	27873233				2022-02-06	
J	Robertson, CS; McCarthy, JJ; Miller, ER; Levin, H; McCauley, SR; Swank, PR				Robertson, Claudia S.; McCarthy, James J.; Miller, Emmy R.; Levin, Harvey; McCauley, Stephen R.; Swank, Paul R.		Mission Connect Mild TBI	Phase II Clinical Trial of Atorvastatin in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial; cognitive function; traumatic brain injury	INTRACEREBRAL HEMORRHAGE; NEURONAL SURVIVAL; SIMVASTATIN; RATS; INCREASE; STATINS; NEUROGENESIS; ANGIOGENESIS; THROMBOSIS; REDUCTION	Statins constitute a class of medications commonly used in the treatment of elevated cholesterol. However, in experimental studies, statins also have other non-cholesterol-mediated mechanisms of action, which may have neuroprotective effects. The aim of this study was to determine whether administration of atorvastatin for 7 days post-injury would improve neurological recovery in patients with mild traumatic brain injury (mTBI). The hypothesis was that atorvastatin administration would reduce post-concussion symptoms and also that atorvastatin administration for 1 week post-injury would be safe. One hundred forty patients with mTBI were planned to be enrolled and randomly assigned to receive atorvastatin 1 mg/kg (up to 80 mg/kg) per day or placebo for 7 days starting within 24 h of injury. Assessments of post-concussion syndrome, post-traumatic stress and depressive symptoms, cognition, memory, verbal fluency, functional, and work status were performed at baseline, 1 week, and 1 and 3 months. The result on the Rivermead Post-Concussion Symptoms Questionnaire at 3 months was the primary outcome. Enrollment in the trial was stopped early because of difficulty in recruiting sufficient numbers of subjects. Fifty-two patients with mTBI were enrolled; 28 patients received atorvastatin and 24 received placebo. The median Rivermead score was 2 for the atorvastatin group, compared to 3.5 for the placebo group, at 3 months post-injury (chi(2) (1) = 0.0976; p = 0.7547). The change in the Rivermead score between baseline and 3 months was also analyzed. The median decrease in score was 4 for the atorvastatin group and 10.5 for the placebo group (chi(2) (1) = 0.8750; p = 0.3496). No serious adverse events occurred, and there was no significant difference in the incidence of adverse events in the two treatment groups. Atorvastatin administration for 7 days post-injury was safe, but there were no significant differences in neurological recovery post-mTBI with atorvastatin.	[Robertson, Claudia S.; Miller, Emmy R.; Levin, Harvey; McCauley, Stephen R.] Baylor Coll Med, One Baylor Plaza, Houston, TX 77030 USA; [McCarthy, James J.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Levin, Harvey] Michael E De Bakey Vet Affairs Med Ctr, Houston, TX USA; [Swank, Paul R.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Miller, Emmy R.] Virginia Commonwealth Univ, Richmond, VA USA		Robertson, CS (corresponding author), Baylor Coll Med, One Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.edu			Department of DefenseUnited States Department of Defense [W81XWH-08-2-0132, W81XWH-08-2-0131, W81XWH-08-2-0133, W81XWH-08-2-0142]	This study was supported by the Department of Defense (grant nos. W81XWH-08-2-0132 [Robertson], W81XWH-08-2-0131 [McCarthy], W81XWH-08-2-0133 [Levin], and W81XWH-08-2-0142 [Swank]).	Amarenco P, 2006, NEW ENGL J MED, V355, P549; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Department of Defense, 2007, TRAUM BRAIN INJ DEF; Farooqui AA, 2007, BRAIN RES REV, V56, P443, DOI 10.1016/j.brainresrev.2007.09.004; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Johnson-Anuna LN, 2007, J NEUROCHEM, V101, P77, DOI 10.1111/j.1471-4159.2006.04375.x; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lu DY, 2004, J NEUROSURG, V101, P822, DOI 10.3171/jns.2004.101.5.0822; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Lynch JR, 2005, STROKE, V36, P2024, DOI 10.1161/01.STR.0000177879.11607.10; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Naval NS, 2008, NEUROCRIT CARE, V8, P6, DOI 10.1007/s12028-007-0080-2; Pan YS, 2014, CNS NEUROSCI THER, V20, P548, DOI 10.1111/cns.12274; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Stoll Lynn L, 2005, Timely Top Med Cardiovasc Dis, V9, pE1; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369	32	16	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1394	1401		10.1089/neu.2016.4717			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600009	28006970				2022-02-06	
J	Zhou, YX				Zhou, Yongxia			Abnormal structural and functional hypothalamic connectivity in mild traumatic brain injury	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						mild traumatic brain injury; hypothalamus; functional connectivity; diffusion kurtosis; functional activity; fatigue	DIFFUSE AXONAL INJURY; KURTOSIS; MRI; TENSOR; CORTEX	PurposeTo investigate whether there is imaging evidence of hypothalamic injury in patients with mild traumatic brain injury (MTBI), which is a major public health problem due to the high prevalence and difficulty in diagnosis and treatment. Materials and MethodsTwenty-four patients (mean age 34.2, range, 18-56 years) with symptomatic MTBI and 22 age-matched healthy controls (mean age 37.0, range 20-61 years) participated in the study. Diffusion kurtosis imaging was performed with diffusion-weighted images acquired along 30 gradient directions and three b-values (b=0, 1000, 2000 s/mm(2)) based on a twice-refocused spin-echo sequence with a 3T magnetic resonance imaging (MRI) scanner. Resting-state functional (f)MRI with standard echo planar imaging (EPI) were performed to localize the resting-state networks (RSN) and hypothalamic functional connectivity. ResultsThere were significantly reduced mean kurtosis (P=0.0092) and radial kurtosis (P=0.0078) in patients as compared to controls in the hypothalamus. Furthermore, there was a significant negative correlation (r=-0.675, P=0.0007) between radial kurtosis in the hypothalamus and fatigue severity scale in patients. The MTBI group also showed disrupted hypothalamic RSNs, with significantly decreased positive connectivity in medial prefrontal cortex, inferior posterior parietal, and cingulate regions but increased connectivity in the peri-hypothalamic regions and cerebellum, together with significantly decreased negative RSNs in visual and bilateral premotor areas (cluster corrected P < 0.05). ConclusionOur results show disruption of functional and structural hypothalamic connectivity in patients with MTBI, and might further the understanding of an array of clinical symptoms in MTBI such as sleep disturbance and fatigue.	[Zhou, Yongxia] NYU, Langone Med Ctr, Ctr Biomed Imaging, Dept Radiol, New York, NY 10016 USA		Zhou, YX (corresponding author), NYU, Langone Med Ctr, Ctr Biomed Imaging, Dept Radiol, New York, NY 10016 USA.	yongxiazhou@gmail.com		Zhou, Yongxia (Sharon)/0000-0002-4931-2318	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-RO1 NS039135-10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135] Funding Source: NIH RePORTER	Contract grant sponsor: National Institutes of Health (NIH); contract grant number: NIH-RO1 NS039135-10.	Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Cauda F, 2009, J NEUROL NEUROSUR PS, V80, P429, DOI 10.1136/jnnp.2007.142349; Childers MK, 1998, BRAIN INJURY, V12, P517, DOI 10.1080/026990598122476; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Haehnel S, 2015, NEUROLOGY, V84, P554, DOI 10.1212/WNL.0000000000001244; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Jensen JH, 2011, J MAGN RESON, V210, P233, DOI 10.1016/j.jmr.2011.03.012; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kolassa IT, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-56; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Nunez A, 2009, CURR NEUROPHARMACOL, V7, P50, DOI 10.2174/157015909787602797; Pang H, 2016, J MAGN RESON IMAGING, V44, P30, DOI 10.1002/jmri.25090; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Rosenkrantz AB, 2015, J MAGN RESON IMAGING, V42, P1190, DOI 10.1002/jmri.24985; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00048; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Wong PK, 2015, NEUROLOGY, V85, P921; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhou Y, 2013, P ISMRM, V21, P2688; Zhou Y, RADIOLOGY, V265, P882; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhou YX, 2013, NEUROLOGY, V80, P1822, DOI 10.1212/WNL.0b013e318292a37d	42	16	17	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	APR	2017	45	4					1105	1112		10.1002/jmri.25413			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	EP6KT	WOS:000397489100016	27467114	Green Accepted			2022-02-06	
J	Kelly, M; McDonald, S; Frith, MHJ				Kelly, Michelle; McDonald, Skye; Frith, Matthew H. J.			Assessment and Rehabilitation of Social Cognition Impairment after Brain Injury: Surveying Practices of Clinicians	BRAIN IMPAIRMENT			English	Article						Traumatic brain injury; survey; clinician; staff; social cognition; social function; assessment; assessment practices; evidence-based practice	SPEECH-LANGUAGE PATHOLOGISTS; BLUNT HEAD-INJURY; HIGH-FUNCTIONING AUTISM; EMOTION RECOGNITION; COMMUNICATION PARTNERS; INDIVIDUAL-DIFFERENCES; ASPERGER-SYNDROME; BEHAVIOR; ADULTS; VALIDITY	Objectives: This study examined the current assessment practices of clinicians working with people with social cognition impairment following traumatic brain injury. Method: Two hundred and sixty clinicians completed an on-line survey that was disseminated through professional brain injury organisations. Of respondents around 90% were allied health clinicians, with the remainder comprising medical, nursing and academia. Main outcomes: The four areas of social cognition that were routinely assessed across the disciplines were insight, disinhibition, anger and social adjustment. The least routinely assessed areas were theory of mind and alexithymia. The test suggested most likely to identify social cognition impairments was The Awareness of Social Inference Test, although only 8% of clinicians responded to this question. Clinicians preferred informal assessment methods over standardised assessment methods for identifying social cognition rehabilitation goals. Higher levels of education were associated with greater use of standardised assessment modalities. Whilst there was paucity of responses overall, TBI Express was most commonly used for social cognition rehabilitation. Conclusions: Considering the high prevalence of social cognition impairments in this population, formal assessment is extremely limited. The under-utilisation of assessment tools is problematic for the assessment and rehabilitation initiatives offered to people with TBI. These results have implications for the training of clinicians working in brain injury rehabilitation.	[Kelly, Michelle] Univ Newcastle, Sch Psychol, Univ Dr Callaghan, Newcastle, NSW 2308, Australia; [Kelly, Michelle; McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Kelly, Michelle; McDonald, Skye] Ctr Res Excellence Brain Recovery, Sydney, NSW 2052, Australia; [Kelly, Michelle; Frith, Matthew H. J.] Hunter New England Hlth, Children Young People & Families, Newcastle, NSW, Australia		Kelly, M (corresponding author), Univ Newcastle, Sch Psychol, Univ Dr Callaghan, Newcastle, NSW 2308, Australia.; Kelly, M (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.; Kelly, M (corresponding author), Ctr Res Excellence Brain Recovery, Sydney, NSW 2052, Australia.; Kelly, M (corresponding author), Hunter New England Hlth, Children Young People & Families, Newcastle, NSW, Australia.	Michelle.Kelly@newcastle.edu.au	Kelly, Michelle/J-9739-2019	Kelly, Michelle/0000-0003-0375-816X	Lifetime Care and Support Authority	This research was funded by Lifetime Care and Support Authority.	Addis ME, 2002, CLIN PSYCHOL-SCI PR, V9, P367, DOI 10.1093/clipsy/9.4.367; Agresti Alan., 2013, CATEGORICAL DATA ANA, V3rd ed; Alpern G., 2007, DEV PROFILE; Australasian Faculty of Rehabilitation Medicine, 2011, STAND PROV INP AD RE; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BaronCohen S, 1997, CHILD DEV, V68, P48; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bayley N., 2005, BAYLEY SCALES INFANT; Beidas RS, 2010, CLIN PSYCHOL-SCI PR, V17, P1, DOI 10.1111/j.1468-2850.2009.01187.x; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1017/S0021963098002832; Bornhofen C, 2009, READING SMILE OTHER; Bowers D., 1991, FLORIDA AFFECT BATTE; Braun C M, 1989, Brain Inj, V3, P5, DOI 10.3109/02699058909008068; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burgess P, 1996, BEHAV ASSESSMENT DYS; Carter AS, 2006, INFANT TODDLER SOCIA; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; D'Zurilla T., 2007, SOCIAL PROBLEM SOLVI; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Dodge KA, 2002, PSYCHOL ASSESSMENT, V14, P60, DOI 10.1037//1040-3590.14.1.60; DODGE KA, 1980, CHILD DEV, V51, P162, DOI 10.2307/1129603; DONAHOE CP, 1990, PSYCHIATRY, V53, P329; Douglas J, 2000, TROBE COMMUNICATION; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Dyck MJ, 2001, EUR CHILD ADOLES PSY, V10, P105, DOI 10.1007/s007870170033; Elliott S.N., 2008, SOCIAL SKILLS RATING; Embling S, 1995, BRIT J THERAPY REHAB, V2, P142; FARRELL AD, 1985, BEHAV ASSESS, V7, P155; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Gilliam JE, 2013, GILLIAM AUTISM RATIN, V3rd; Gioa GA, 2000, BEHAV RATING INVENTO; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; Goldstein S., 2009, AUTISM SPECTRUM RATI; Grace J, 2001, FRSBE FRONTAL SYSTEM; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greenspan SI, 2004, GREENSPAN SOCIAL EMO; Gresham F., 2008, SOCIAL SKILLS IMPROV; Gresham FM., 1990, SOCIAL SKILLS RATING; Guercio JM, 2004, BRAIN INJURY, V18, P593, DOI 10.1080/02699050310001646116; Holland A., 1999, COMMUNICATION ACTIVI; Howell D.C., 2007, STAT METHODS PSYCHOL; HUGHES JN, 1989, J ABNORM CHILD PSYCH, V17, P633, DOI 10.1007/BF00917727; Hughes JN, 2004, J CLIN CHILD ADOLESC, V33, P292, DOI 10.1207/s15374424jccp3302_11; Hynes CA, 2011, SOC NEUROSCI-UK, V6, P599, DOI 10.1080/17470919.2011.584447; Jackson H.F., 1995, BRIT J THERAPY REHAB, V2, P65; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kamphaus R. W., 2008, BEHAV EMOTIONAL SCRE; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; Kelly A, 2016, TALKABOUT SOCIAL COM; Kelly G, 2010, OVERT BEHAV SCALE; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Korkman M., 2007, NEPSY, V2nd; Linscott RJ, 2003, PROFILE PRAGMA UNPUB; Loeb, 1996, INDEPENDENT LIVING S; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; LOWE MR, 1985, BEHAV MODIF, V9, P193, DOI 10.1177/01454455850092004; MAGILLEVANS J, 1995, J NONVERBAL BEHAV, V19, P151, DOI 10.1007/BF02175502; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Matsumoto D., 1988, JAPANESE CAUCASIAN F; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S., 2013, SOCIAL COMMUNICATION, P119; McDonald S., 2008, IMPROVING 1 IMPRESSI; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2009, NEUROPSYCHOL REHABIL, V19, P321, DOI 10.1080/09602010802193989; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Mehrabian A., 2000, MANUAL BALANCED EMOT; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; MunroeBlum H, 1996, SCHIZOPHR RES, V20, P211, DOI 10.1016/0920-9964(96)88527-6; National Institute of Health, 1999, JAMA; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Newman AC, 2000, BRAIN INJURY, V14, P333; Nott MT, 2008, AUST OCCUP THER J, V55, P188, DOI 10.1111/j.1440-1630.2007.00685.x; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Osborne-Crowley K, 2016, J INT NEUROPSYCH SOC, V22, P303, DOI 10.1017/S1355617715001277; Pagan E, 2015, BRAIN IMPAIR, V16, P173, DOI 10.1017/BrImp.2015.34; PARKER JG, 1993, DEV PSYCHOL, V29, P611, DOI 10.1037/0012-1649.29.4.611; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Ratner NB, 2006, LANG SPEECH HEAR SER, V37, P257, DOI 10.1044/0161-1461(2006/029); Rust JO., 2004, J PSYCHOEDUC ASSESS, V22, P367, DOI [10.1177/073428290402200407, DOI 10.1177/073428290402200407]; Rutter M, 2003, COMMUNICATION; Rutter M., 2012, AUTISM DIAGNOSTIC OB; Rutter M., 2003, SOCIAL COMMUNICATION; Sander AM, 2009, CLIN NEUROPSYCHOL, V23, P1196, DOI 10.1080/13854040902845706; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Sharpe D., 2015, PRACT ASSESS RES EVA, V20, P2; Sherer M, 2004, AWARENESS QUESTIONNA; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Sloane S, 2002, COMMUNICATE CONFIDEN; Sparrow S.S., 2005, VINELAND SOCIAL EMOT; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Spence S., 1995, SPENCE SOCIAL SKILLS; Spikman J.M., 2016, IBIA 11 WORLD C BRA; Starkstein SE, 2014, PSYCHIAT CLIN N AM, V37, P103, DOI 10.1016/j.psc.2013.10.002; Stoiber K.C., 2004, FUNCTIONAL ASSESSMEN; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate R., 2011, MANUAL SYDNEY PSYCHO; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Togher L., 2010, AUSTR COMMUNICATION, V12, P82; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; United States Surgeon General, 1999, MENT HLTH REP SURG G; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Wechsler D., 2009, ADV CLIN SOLUTIONS W; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1; Whitehouse AJO., 2009, COMMUNICATION CHECKL; Williams KR, 2001, BRAIN INJURY, V15, P349, DOI 10.1080/026990501750111319; Winegardner J., 2015, INS ASSBI 5 PAC RIM; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; Yates D., 1999, PRACTICE STAT; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Young A, 2002, FACIAL EXPRESSION EM	128	16	16	0	17	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2017	18	1					11	35		10.1017/BrImp.2016.34			25	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	EQ3SZ	WOS:000397994400003		Bronze, Green Submitted			2022-02-06	
J	Li, G; Ma, K; Sun, J; Jin, G; Qin, MX; Feng, H				Li, Gen; Ma, Ke; Sun, Jian; Jin, Gui; Qin, Mingxin; Feng, Hua			Twenty-Four-Hour Real-Time Continuous Monitoring of Cerebral Edema in Rabbits Based on a Noninvasive and Noncontact System of Magnetic Induction	SENSORS			English	Article						cerebral edema; noncontact; magnetic induction; intracranial pressure; real-time monitoring	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; PHASE-SHIFT; HEMORRHAGE; TOMOGRAPHY; RATS; SPECTROSCOPY; ISCHEMIA; TISSUE	Cerebral edema is a common disease, secondary to craniocerebral injury, and real-time continuous monitoring of cerebral edema is crucial for treating patients after traumatic brain injury. This work established a noninvasive and noncontact system by monitoring the magnetic induction phase shift (MIPS) which is associated with brain tissue conductivity. Sixteen rabbits (experimental group n = 10, control group, n = 6) were used to perform a 24 h MIPS and intracranial pressure (ICP) simultaneously monitored experimental study. For the experimental group, after the establishment of epidural freeze-induced cerebral edema models, the MIPS presented a downward trend within 24 h, with a change magnitude of -13.1121 +/- 2.3953 degrees; the ICP presented an upward trend within 24 h, with a change magnitude of 12-41 mmHg. The ICP was negatively correlated with the MIPS. In the control group, the MIPS change amplitude was -0.87795 +/- 1.5146 without obvious changes; the ICP fluctuated only slightly at the initial value of 12 mmHg. MIPS had a more sensitive performance than ICP in the early stage of cerebral edema. These results showed that this system is basically capable of monitoring gradual increases in the cerebral edema solution volume. To some extent, the MIPS has the potential to reflect the ICP changes.	[Li, Gen; Ma, Ke; Sun, Jian; Jin, Gui; Qin, Mingxin] Third Mil Med Univ, Coll Biomed Engn, Chongqing 400038, Peoples R China; [Li, Gen] Chongqing Univ, Coll Bioengn, Chongqing 400030, Peoples R China; [Sun, Jian; Feng, Hua] Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China		Sun, J; Qin, MX (corresponding author), Third Mil Med Univ, Coll Biomed Engn, Chongqing 400038, Peoples R China.; Sun, J (corresponding author), Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China.	calvin_gen@163.com; ywqmk@sohu.com; nksunj@126.com; tjjingui@126.com; qmingxin@tmmu.edu.cn; fenghua_swh@sina.com	Feng, Hua/AAX-4121-2021	Feng, Hua/0000-0003-4489-9217; Gen, Li/0000-0002-4183-4242	973 National Key Basic Research Program of ChinaNational Basic Research Program of China [2014cb541606]; Foundation of the Third Military Medical University [2014XZH03]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61372065, 61501472, 51607181]	This work was supported by the 973 National Key Basic Research Program of China (2014cb541606), the Foundation of the Third Military Medical University (2014XZH03) and the National Natural Science Foundation of China (61372065, 61501472 and 51607181). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barai A, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/8/085501; Bigdeli MR, 2007, BRAIN RES, V1152, P228, DOI 10.1016/j.brainres.2007.03.068; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Chen S., 2008, CHIN J NEUROSURG DIS, V7, P725; Gonzalez CA, 2009, PHYSIOL MEAS, V30, P809, DOI 10.1088/0967-3334/30/8/006; Gonzalez CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063223; Griffiths H, 2001, MEAS SCI TECHNOL, V12, P1126, DOI 10.1088/0957-0233/12/8/319; Griffiths H, 1999, ANN NY ACAD SCI, V873, P335, DOI 10.1111/j.1749-6632.1999.tb09481.x; Heiss WD, 2016, CEREBROVASC DIS, V41, P1, DOI 10.1159/000441627; Horstmann S, 2009, J NEUROL SCI, V276, P75, DOI 10.1016/j.jns.2008.08.038; Huang YC, 2013, MAGN RESON IMAGING, V31, P1174, DOI 10.1016/j.mri.2013.03.026; Jin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097179; Jin G, 2014, BIOSENS BIOELECTRON, V52, P374, DOI 10.1016/j.bios.2013.09.019; Kao HP, 1999, IEEE T BIO-MED ENG, V46, P1121, DOI 10.1109/10.784144; Kawai N, 2003, J NEUROTRAUM, V20, P649, DOI 10.1089/089771503322144563; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Laufer S., 2015, PHYSIOL MEAS, V33, P997, DOI [10.1088/0967-3334/33/6/99722561199, DOI 10.1088/0967-3334/33/6/99722561199]; Liu L., 2013, NEUROL RES, V28, P31, DOI [10.1179/016164106X9184316464360, DOI 10.1179/016164106X9184316464360]; Maciel CB, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-015-0519-4; McBride DW, 2014, J NEUROTRAUM, V31, P1948, DOI 10.1089/neu.2014.3439; Melhem S., 2012, NEW ENGL J MED, V367, P2471, DOI [10.1186/cc13713, DOI 10.1186/CC13713]; O'Toole MD, 2015, MEAS SCI TECHNOL, V26, DOI 10.1088/0957-0233/26/3/035102; Pan WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128127; Park KJ, 2010, J NEUROSURG, V112, P73, DOI 10.3171/2009.4.JNS09158; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Salci K, 2004, J NEUROTRAUM, V21, P317, DOI 10.1089/089771504322972103; Scharfetter H, 2003, IEEE T BIO-MED ENG, V50, P870, DOI 10.1109/TBME.2003.813533; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Sun J, 2014, BRAZ J MED BIOL RES, V47, P144, DOI 10.1590/1414-431X20132978; Sun J, 2012, J PHYS CONF SER, V407, DOI 10.1088/1742-6596/407/1/012014; Thal SC, 2009, J NEUROSURG, V111, P988, DOI 10.3171/2009.3.JNS08412; Thrane AS, 2015, TRENDS NEUROSCI, V38, P333, DOI 10.1016/j.tins.2015.04.009; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Wykes V., 2015, SURG OXFORD, V33, P355, DOI [10.1016/j.mpsur.2015.06.001, DOI 10.1016/J.MPSUR.2015.06.001]; Yan Q., 2016, BIOMED ENG, V62, P23, DOI [10.1515/bmt-2015-012926982603, DOI 10.1515/BMT-2015-012926982603]; Zolgharni M, 2009, PHYSIOL MEAS, V30, pS187, DOI 10.1088/0967-3334/30/6/S13	36	16	17	3	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	MAR	2017	17	3							537	10.3390/s17030537			12	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	ER5CJ	WOS:000398818700110	28282851	Green Published, gold, Green Submitted			2022-02-06	
J	Dretsch, MN; Silverberg, N; Gardner, AJ; Panenka, WJ; Emmerich, T; Crynen, G; Ait-Ghezala, G; Chaytow, H; Mathura, V; Crawford, FC; Iverson, GL				Dretsch, Michael N.; Silverberg, Noah; Gardner, Andrew J.; Panenka, William J.; Emmerich, Tanja; Crynen, Gogce; Ait-Ghezala, Ghania; Chaytow, Helena; Mathura, Venkat; Crawford, Fiona C.; Iverson, Grant L.			Genetics and Other Risk Factors for Past Concussions in Active-Duty Soldiers	JOURNAL OF NEUROTRAUMA			English	Article						APOE; BDNF; concussion; DRD2; genetics; mild traumatic brain injury; military; personality	TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; APOE PROMOTER; PSYCHIATRIC-DISORDERS; AGGRESSIVE-BEHAVIOR; META-REGRESSION; SPONTANEOUS SAH; HEAD-INJURY; ALCOHOL-USE; ASSOCIATION	Risk factors for concussion in active-duty military service members are poorly understood. The present study examined the association between self-reported concussion history and genetics (apolipoprotein E [APOE], brain-derived neurotrophic factor [BDNF], and D2 dopamine receptor genes [DRD2]), trait personality measures (impulsive-sensation seeking and trait aggression-hostility), and current alcohol use. The sample included 458 soldiers who were preparing to deploy for Operation Iraqi Freedom/Operation Enduring Freedom. For those with the BDNFMet/Met genotype, 57.9% (11/19) had a history of one or more prior concussions, compared with 35.6% (154/432) of those with other BDNF genotypes (p = 0.049, odds ratio [OR] = 2.48). APOE and DRD2 genotypes were not associated with risk for past concussions. Those with the BDNF Met/Met genotype also reported greater aggression and hostility personality characteristics. When combined in a predictive model, prior military deployments, being male, and having the BDNF Met/Met genotype were independently associated with increased lifetime history of concussions in active-duty soldiers. Replication in larger independent samples is necessary to have more confidence in both the positive and negative genetic associations reported in this study.	[Dretsch, Michael N.] US Army Aeromed Res Lab, Ft Rucker, AL USA; [Dretsch, Michael N.] Headquarters Army Training & Doctrine Command HQ, Human Dimens Div, Ft Eustis, VA USA; [Silverberg, Noah] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Silverberg, Noah] GF Strong Rehabil Ctr, Vancouver, BC, Canada; [Silverberg, Noah; Emmerich, Tanja; Crynen, Gogce; Ait-Ghezala, Ghania; Chaytow, Helena; Mathura, Venkat; Crawford, Fiona C.] Roskamp Inst, Sarasota, FL USA; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Hunter New England Local Hlth Dist Sports Concuss, Newcastle, NSW, Australia; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Newcastle, NSW, Australia; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Spaulding Rehabil Hosp & Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Iverson, Grant L.] Def & Vet Brain Injury Ctr, Bethesda, MD USA		Dretsch, MN (corresponding author), Headquarters Training & Doctrine Command, Army Capabil Integrat Ctr, Human Dimens Div, 950 Jefferson Ave, Ft Eustis, VA 23604 USA.	michael.n.dretsch.mil@mail.mil		Chaytow, Helena/0000-0003-2257-7620; Emmerich, Tanja/0000-0001-5064-7150; Panenka, William/0000-0001-7143-6512; Crynen, Gogce/0000-0001-6066-9900; Ait-Ghezala, Ghania/0000-0002-9836-8617; Iverson, Grant/0000-0001-7348-9570; Gardner, Andrew/0000-0001-5031-5586	INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]; New South Wales Sporting Injuries Committee-Sports Research & Injury Prevention; Brain Foundation; Australia-Brain Injury Award; Hunter Medical Research Institute (HMRI); Australian Football League (AFL)	Grant L. Iverson acknowledges support from the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (X81XWH-07-CC-CSDoD). Andrew J. Gardner acknowledges funding from the New South Wales Sporting Injuries Committee-Sports Research & Injury Prevention Scheme, the Brain Foundation, Australia-Brain Injury Award, Hunter Medical Research Institute (HMRI) early career funding through Anne Greaves, and research fellowship funding from Jennie Thomas, Life Governor of the HMRI. Grant L. Iverson has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild TBI and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including athletes). He has received honoraria for serving on research panels that provide scientific peer review of programs. He is a co-investigator, collaborator, or consultant on grants relating to mild TBI funded by several organizations. Andrew J. Gardner has a clinical practice in neuropsychology involving the assessment and management of individuals who have sustained sport-related concussion (including current and former athletes). He received travel funding from the Australian Football League (AFL) to present at the Concussion in Football Conference in 2013. He also serves in a unremunerated capacity as a member of the Concussion Advisory Group for the Australian Rugby Union (ARU). The other authors have nothing to disclose.	Babor T.F., 2001, AUDIT THE ALCOHOL US; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bergman O, 2011, INT J NEUROPSYCHOPH, V14, P1367, DOI 10.1017/S1461145711000502; Bogner J, 2015, BRAIN INJURY, V29, P905, DOI 10.3109/02699052.2015.1005136; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cusimano MD, 2014, J HEAD TRAUMA REHAB, V29, P172, DOI 10.1097/HTR.0b013e31827c7d15; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Greenwald MK, 2013, ADDICT BIOL, V18, P836, DOI 10.1111/j.1369-1600.2011.00431.x; Harvey AR, 2015, BRAIN RES, V1619, P36, DOI 10.1016/j.brainres.2014.10.049; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Isokuortti H, 2016, J NEUROTRAUM, V33, P232, DOI 10.1089/neu.2015.3888; Ito W, 2011, GENES BRAIN BEHAV, V10, P365, DOI 10.1111/j.1601-183X.2010.00676.x; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kazemi DM, 2014, J PSYCHOSOC NURS MEN, V52, P38, DOI 10.3928/02793695-20140310-01; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lambert JC, 1998, HUM MOL GENET, V7, P1511, DOI 10.1093/hmg/7.9.1511; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lendon CL, 2003, NEUROLOGY, V61, P683, DOI 10.1212/01.WNL.0000078033.81925.80; Logrip ML, 2015, BRAIN RES, V1628, P60, DOI 10.1016/j.brainres.2015.03.025; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Neumann D, 2015, REHABIL PSYCHOL, V60, P155, DOI 10.1037/rep0000036; Popoli M, 2015, INT J NEUROPSYCHOPHA, V18; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwab KA, 2006, NEUROLOGY, V66, pA235; Su H, 2014, NEUROSCI LETT, V582, P16, DOI 10.1016/j.neulet.2014.08.030; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Terrell TR, 2012, CLIN J SPORT MED, V22, P172; Thomson CJ, 2015, J SPORT SCI, V33, P1861, DOI 10.1080/02640414.2015.1020841; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Wu HT, 2010, BRAIN RES, V1362, P112, DOI 10.1016/j.brainres.2010.09.013; Yin C, 2015, GENE, V563, P52, DOI 10.1016/j.gene.2015.03.009; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; ZUCKERMAN M, 1993, J PERS SOC PSYCHOL, V65, P757, DOI 10.1037/0022-3514.65.4.757; Zuckerman M, 2002, BIG FIVE ASSESSMENT, P377	48	16	16	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					869	875		10.1089/neu.2016.4480			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200014	27396498				2022-02-06	
J	Genc, S; Anderson, V; Ryan, NP; Malpas, CB; Catroppa, C; Beauchamp, MH; Silk, TJ				Genc, Sila; Anderson, Vicki; Ryan, Nicholas P.; Malpas, Charles B.; Catroppa, Cathy; Beauchamp, Miriam H.; Silk, Timothy J.			Recovery of White Matter following Pediatric Traumatic Brain Injury Depends on Injury Severity	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; pediatric; severity; traumatic brain injury; white matter	SPORTS-RELATED CONCUSSION; TENSOR IMAGING DETECTS; CORPUS-CALLOSUM; AXONAL INJURY; DIFFUSION; CHILDHOOD; CHILDREN; DTI; INTEGRITY; MICROSTRUCTURE	Previous studies in pediatric traumatic brain injury (TBI) have been variable in describing the effects of injury severity on white-matter development. The present study used diffusion tensor imaging to investigate prospective sub-acute and longitudinal relationships between early clinical indicators of injury severity, diffusion metrics, and neuropsychological outcomes. Pediatric patients with TBI underwent magnetic resonance imaging (MRI) (n = 78, mean [M] = 10.56, standard deviation [SD] = 2.21 years) at the sub-acute stage after injury (M = 5.55, SD = 3.05 weeks), and typically developing children were also included and imaged (n = 30, M = 10.60, SD = 2.88 years). A sub-set of the patients with TBI (n = 15) was followed up with MRI 2 years post-injury. Diffusion MRI images were acquired at sub-acute and 2-year follow-up time points and analyzed using Tract-Based Spatial Statistics. At the sub-acute stage, mean diffusivity and axial diffusivity were significantly higher in the TBI group compared with matched controls (p < 0.05). TBI severity significantly predicted diffusion profiles at the sub-acute and 2-year post-injury MRI. Patients with more severe TBI also exhibited poorer information processing speed at 6-months post-injury, which in turn correlated with their diffusion metrics. These findings highlight that the severity of the injury not only has an impact on white-matter microstructure, it also impacts its recovery over time. Moreover, findings suggest that sub-acute microstructural changes may represent a useful prognostic marker to identify children at elevated risk for longer term deficits.	[Genc, Sila; Anderson, Vicki; Ryan, Nicholas P.; Malpas, Charles B.; Catroppa, Cathy; Silk, Timothy J.] Murdoch Childrens Res Inst, Dev Imaging, Clin Sci, Melbourne, Vic, Australia; [Anderson, Vicki; Ryan, Nicholas P.; Catroppa, Cathy] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Silk, Timothy J.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia		Genc, S (corresponding author), Royal Childrens Hosp, Dev Imaging, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	sila.genc@mcri.edu.au	Silk, Tim/K-4295-2019; Malpas, Charles/L-4741-2019; Ryan, Nicholas/K-5445-2019; Catroppa, Cathy/AAX-9458-2021	Ryan, Nicholas/0000-0002-0878-8889; Catroppa, Cathy/0000-0002-9750-0436; Genc, Sila/0000-0002-4624-7071; Silk, Tim/0000-0002-7290-512X; Malpas, Charles/0000-0003-0534-3718	Victoria Neurotrauma Initiative, Australia; Murdoch Childrens Research Institute; Royal Children's Hospital; Royal Children's Hospital Foundation; Department of Paediatrics, University of Melbourne; Victorian Government's Operational Infrastructure Support Program	This work was supported by a grant from the Victoria Neurotrauma Initiative, Australia. This research was conducted within the Australian Centre for Child Neuropsychological Studies and Developmental Imaging research groups, Murdoch Childrens Research Institute and the Children's MRI Centre, Royal Children's Hospital, Melbourne, Victoria. It was supported by the Murdoch Childrens Research Institute, The Royal Children's Hospital, The Royal Children's Hospital Foundation, The Department of Paediatrics, The University of Melbourne and the Victorian Government's Operational Infrastructure Support Program.	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beauchamp MH, 2011, BRAIN INJURY, V25, P950, DOI 10.3109/02699052.2011.589791; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Bobinski M, 2000, NEUROSCIENCE, V95, P721; Bonett DG, 2008, PSYCHOL METHODS, V13, P99, DOI 10.1037/1082-989X.13.2.99; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Chaddock-Heyman L, 2013, BIOL PSYCHOL, V94, P109, DOI 10.1016/j.biopsycho.2013.05.008; Cohen J., 2013, STAT POWER ANAL BEHA; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kantarci K, 2010, NEUROLOGY, V74, P1814, DOI 10.1212/WNL.0b013e3181e0f7cf; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Sasson E, 2012, BRAIN STRUCT FUNCT, V217, P503, DOI 10.1007/s00429-011-0344-7; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; TEASDALE G, 1974, LANCET, V2, P81; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	47	16	16	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					798	806		10.1089/neu.2016.4584			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200006	27468807				2022-02-06	
J	Wang, WX; Sullivan, PG; Springer, JE				Wang, Wang-Xia; Sullivan, Patrick G.; Springer, Joe E.			Mitochondria and microRNA crosstalk in traumatic brain injury	PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY			English	Article						Traumatic brain injury; Mitochondrial function; Glutamate excitotoxicity; Oxidative damage	CENTRAL-NERVOUS-SYSTEM; NEURONAL CELL-DEATH; CORTICAL IMPACT; DOWN-REGULATION; DYSFUNCTION; EXPRESSION; APOPTOSIS; RESPONSES; RAT; HIPPOCAMPUS	Traumatic brain injury (TBI) is a leading cause of long-term impairments in higher cognitive functioning, including deficits in attention and memory. It is well known that some of these persistent deficits are related, in part, to ongoing secondary injury events characterized by pervasive biochemical and pathophysiological stressors, including a rapid and sustained phase of mitochondrial dysfunction. A loss of mitochondrial function impacts a number of important cellular events and we have begun to investigate the novel hypothesis that mitochondria play a critical role in regulating the cellular activity of specific microRNAs in response to cellular demands and stressors. In this special issue report, we summarize briefly the rationale for investigating the crosstalk between mitochondria and microRNA, and provide recent preliminary data suggesting that mitochondria-microRNA interactions are modified in response to TBI-related cellular stressors. We postulate that this interaction is critical for regulating appropriate cellular microRNA responses, which opens up opportunities for therapeutic interventions targeting both mitochondrial function and microRNA activity. (C) 2016 Elsevier Inc. All rights reserved.	[Wang, Wang-Xia] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Springer, Joe E.] Univ Kentucky, Phys Med & Rehabil, Lexington, KY 40536 USA; [Sullivan, Patrick G.; Springer, Joe E.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Sullivan, Patrick G.; Springer, Joe E.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA		Wang, WX (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Springer, JE (corresponding author), Univ Kentucky, Phys Med & Rehabil, Lexington, KY 40536 USA.	wwangc@email.uky.edu; jspring@uky.edu	Wang, Wang-Xia/AAD-6900-2019	Wang, Wang-Xia/0000-0002-8104-3779	Kentucky Spinal Cord and Head Injury Research Trust [15-12A]	Supported by grant #15-12A from the Kentucky Spinal Cord and Head Injury Research Trust.	Bandiera S, 2013, FREE RADICAL BIO MED, V64, P12, DOI 10.1016/j.freeradbiomed.2013.06.013; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Barrey E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020220; Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Colamaio M, 2015, J CLIN ENDOCR METAB, V100, pE59, DOI 10.1210/jc.2014-2280; Danger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060702; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Fordham JB, 2015, J LEUKOCYTE BIOL, V98, P195, DOI 10.1189/jlb.1A1014-519RR; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Hollander JM, 2014, AM J PHYSIOL-HEART C, V307, pH1, DOI 10.1152/ajpheart.00747.2013; Hu Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/728342; Huang L, 2011, J BIOL CHEM, V286, P24219, DOI 10.1074/jbc.M111.240259; Jagannathan R, 2015, CIRC-CARDIOVASC GENE, V8, P785, DOI 10.1161/CIRCGENETICS.115.001067; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li PF, 2012, J CELL BIOCHEM, V113, P1104, DOI 10.1002/jcb.24004; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Liu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095514; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Liu NK, 2011, PHYSIOL GENOMICS, V43, P571, DOI 10.1152/physiolgenomics.00168.2010; Marciano PG, 2004, J NEUROSCI, V24, P2866, DOI 10.1523/JNEUROSCI.5051-03.2004; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; Ouyang YB, 2015, ANTIOXID REDOX SIGN, V22, P187, DOI 10.1089/ars.2013.5757; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sripada L, 2012, MITOCHONDRION, V12, P593, DOI 10.1016/j.mito.2012.10.009; Sripada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044873; Su SC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9523; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Wang WX, 2015, NEURAL REGEN RES, V10, P1026, DOI 10.4103/1673-5374.160061; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang Wang-Xia, 2014, Genomics Proteomics & Bioinformatics, V12, P19, DOI 10.1016/j.gpb.2013.10.003; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Watson William D, 2013, Front Neuroenergetics, V5, P12, DOI 10.3389/fnene.2013.00012; Wong JJ., 2016, NUCL ACIDS RES; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218	54	16	17	0	27	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-5846	1878-4216		PROG NEURO-PSYCHOPH	Prog. Neuro-Psychopharmacol. Biol. Psychiatry	FEB 6	2017	73						104	108		10.1016/j.pnpbp.2016.02.011			5	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	ED8ZR	WOS:000389160100013	26925707				2022-02-06	
J	Dickson, TJ; Trathen, S; Terwiel, FA; Waddington, G; Adams, R				Dickson, T. J.; Trathen, S.; Terwiel, F. A.; Waddington, G.; Adams, R.			Head injury trends and helmet use in skiers and snowboarders in Western Canada, 2008-2009 to 2012-2013: an ecological study	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						Skiing; snowboarding; concussion; helmets; injury prevention	SAFETY HELMETS; RISK; NECK	This research explored associations between helmet use and head injuries in snowsports by investigating reported snowsport injuries in Western Canada from 2008-2009 to 2012-2013. The key finding was that increased helmet use (from 69% to 80%) was not associated with a reduction in reported head injuries. Over the study period, the average rate of reported head injuries was 0.2/1000 skier visits, with a statistically significant variation (P < 0.001). The line of best fit showed an non-significant upward trend (P = 0.13). Lacerations were the only subcategory of head injuries that decreased significantly with helmet use. A higher proportion of people who reported a head injury were wearing a helmet than for injuries other than to the head. Skiers were more likely to report a head injury when wearing a helmet than snowboarders (P < 0.001 cf. P = 0.22). There were significant differences in characteristics of helmet and non-helmet wearers. Helmet wearers were more likely to be: young adults (P < 0.001); beginner/novices (P = 0.004); and snowboarders (P < 0.001), but helmet wearing was not associated with gender (P = 0.191). Further research is needed to explore the possible reasons for the failure of helmets to reduce head injuries, for example, increased reporting of head injuries and increased risk-taking combined with overrating of the helmets' protection.	[Dickson, T. J.; Trathen, S.; Waddington, G.; Adams, R.] Univ Canberra, Res Inst Sport & Exercise, Univ Ave, Canberra, ACT 2601, Australia; [Terwiel, F. A.] Thompson Rivers Univ, Fac Adventure Culinary Arts & Tourism, Kamloops, BC, Canada		Dickson, TJ (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Univ Ave, Canberra, ACT 2601, Australia.	tracey.dickson@canberra.edu.au	Dickson, Tracey/Z-5352-2019	Dickson, Tracey/0000-0002-9889-1512; Waddington, Gordon/0000-0002-4306-9193; Terwiel, Anne/0000-0003-4621-201X			Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; ASTM International, 2000, F2040 ASTM INT; Bianchi G., 2011, SKIING TRAUMA SAFETY, V18, P32; Bussewitz C., 2010, US TODAY; Canadian Ski Council, 2014, 2008 9 2012 13 AD HO; Canadian Ski Council, 2010, CAN SKIER SNOWB FACT; CDC, 2014, PAR ATHL CONC INF SH; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; CWSAA, 2014, CAN W SKI AR ASS; CWSAA, 2013, CAN W SKI AR ASS NAT; Dickson TJ, 2012, RISK MANAGEMENT OUTD, P204; Dickson TJ, 2012, AM SOC TEST MATER, V1553, P184, DOI 10.1520/STP104490; Dickson TJ, 2016, APPL ERGON, V53, P79, DOI 10.1016/j.apergo.2015.08.006; European Committee for Standardization, 1996, 1077 EN EUR COMM STA; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Finch CF, 2011, SPORTS MED, V41, P59, DOI 10.2165/11537260-000000000-00000; Graves JM, 2013, INJURY PREV, V19, P399, DOI 10.1136/injuryprev-2012-040727; Hagel B, 2005, ACCIDENT ANAL PREV, V37, P103, DOI 10.1016/j.aap.2004.04.003; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Hagel BE, 2010, AM J EPIDEMIOL, V171, P1134, DOI 10.1093/aje/kwq039; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Jung CS, 2011, ACTA NEUROCHIR, V153, P101, DOI 10.1007/s00701-010-0704-8; Khan U., 2009, TELEGRAPH IN PRESS; Marshall SW, 2008, EPIDEMIOLOGY, V19, P277, DOI 10.1097/EDE.0b013e3181632700; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; McMillan K., 2013, SKI HELMET USE ISNT; Morris H., 2014, TELEGRAPH; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; National Ski Areas Association, 2014, LIDS KIDS HELM ITS S; Parry T., 2013, DAILY MIRROR; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Ruedl G, 2015, SCAND J MED SCI SPOR, V25, P125, DOI 10.1111/sms.12139; Ruedl G, 2012, SCAND J MED SCI SPOR, V22, P448, DOI 10.1111/j.1600-0838.2011.01429.x; Russell K, 2013, CLIN J SPORT MED, V23, P172, DOI 10.1097/JSM.0b013e31827bd918; SafeKids Canada, 2010, EFF STAND SKI SNOWB; Scher I., 2006, Journal of ASTM International (JAI), V3, pJAI14203, DOI 10.1520/JAI14203; Scott MD, 2007, INJURY PREV, V13, P173, DOI 10.1136/ip.2006.014142; Shealy JE., 2015, SKIING TRAUMA SAFETY, V20th Volume, P22, DOI DOI 10.1520/STP158220140079; Slobounov S, 2014, BRIT J SPORT MED, V48, P75, DOI 10.1136/bjsports-2013-092362; Snell Memorial Foundation, 1998, STAND PROT HEADG RS; Stevenson M, 2005, INJURY PREV, V11, P2, DOI 10.1136/ip.2003.003384; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Sulheim S, 2011, BRIT J SPORT MED, V45, P1303, DOI 10.1136/bjsports-2011-090407; Worksafe BC, SKI HELM AR IN PRESS	44	16	16	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	FEB	2017	27	2					236	244		10.1111/sms.12642			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EL4UQ	WOS:000394616800013	26688174				2022-02-06	
J	Ferbert, T; Child, C; Graeser, V; Swing, T; Akbar, M; Heller, R; Biglari, B; Moghaddam, A				Ferbert, Thomas; Child, Christopher; Graeser, Viola; Swing, Tyler; Akbar, Michael; Heller, Raban; Biglari, Bahram; Moghaddam, Arash			Tracking Spinal Cord Injury: Differences in Cytokine Expression of IGF-1, TGF-B1, and sCD95I Can Be Measured in Blood Samples and Correspond to Neurological Remission in a 12-Week Follow-Up	JOURNAL OF NEUROTRAUMA			English	Article						inflammation; spinal cord injury; traumatic spinal cord injury	FAS-MEDIATED APOPTOSIS; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-I; FUNCTIONAL RECOVERY; INTERNATIONAL STANDARDS; INFLAMMATORY CYTOKINES; MESSENGER-RNA; GLIAL SCAR; RAT-BRAIN; DEGENERATION	Neuroinflammation presumably has an important impact on the secondary phase of spinal cord injury and is regulated by pro-and anti-inflammatory cytokines. We analyzed serum levels of three different cytokines (insulin-like-growth-factor [IGF]-1, tumor growth factor [TGF]-beta 1, and soluble CD 95 ligand [sCD95L]), in blood samples of 23 patients admitted with acute traumatic spinal cord injury between November 2010 and July 2013 with a follow-up period of 12 weeks. Quantification was performed using Human Quantikine Immunoassays, classification of neurological impairment was performed using the American Spinal Cord Injury Impairment Scale at time of admission and after 12 weeks. After an initial drop of all three cytokine serum levels, IGF-1, TGF-beta 1, and sCD95L showed significantly increased serum levels during the acute and sub-acute phases. For IGF-1 and sCD95L, we could also observe significantly higher serum levels in patients without neurological improvement compared with patients who had improvement after 12 weeks. In this study, we were able to show differences in cytokine serum levels in patients with different neurological outcome. Measuring the serum level patterns of IGF-1, TGF-beta 1, and sCD95L might be a useful tool for prognosis in patients with neurological improvement and tracking the pathophysiology in further studies. Further, our observations might link promising therapeutic efforts in numerous animal studies and future studies in human patients.	[Ferbert, Thomas; Child, Christopher; Graeser, Viola; Swing, Tyler; Akbar, Michael; Heller, Raban; Moghaddam, Arash] Univ Heidelberg Hosp, HTRG Heidelberg Trauma Res Grp, Trauma & Reconstruct Surg, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Heidelberg, Germany; [Biglari, Bahram] Berufsgenossenschaftl Unfallklin Ludwigshaf, Dept Paraplegiol, Ludwigshafen, Germany		Ferbert, T (corresponding author), Univ Heidelberg Hosp, HTRG Heidelberg Trauma Res Grp, Trauma & Reconstruct Surg, Dept Orthoped Traumatol & Paraplegiol, Schlierbacherlandstr 200a, D-69118 Heidelberg, Germany.	thomas.ferbert@med.uni-heidelberg.de	Heller, Raban/P-4152-2019	Heller, Raban/0000-0001-8006-9742			Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Ackery A, 2006, J NEUROTRAUM, V23, P604, DOI 10.1089/neu.2006.23.604; Ashcroft GS, 1999, MICROBES INFECT, V1, P1275, DOI 10.1016/S1286-4579(99)00257-9; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bethea JR, 1998, J NEUROSCI, V18, P3251; Biglari B, 2015, SPINAL CORD, V53, P510, DOI 10.1038/sc.2015.28; Biglari B, 2013, SPINAL CORD, V51, P183, DOI 10.1038/sc.2012.139; Buss A, 2008, SPINAL CORD, V46, P364, DOI 10.1038/sj.sc.3102148; Casha S, 2005, EXP NEUROL, V196, P390, DOI 10.1016/j.expneurol.2005.08.020; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kirshblum S, 2014, PHYS MED REH CLIN N, V25, P505, DOI 10.1016/j.pmr.2014.04.001; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Kohta M, 2009, NEUROSCI RES, V65, P393, DOI 10.1016/j.neures.2009.08.017; Kurokawa R, 2011, SPINE, V36, P865, DOI 10.1097/BRS.0b013e3181e878a1; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Li GL, 2000, ACTA NEUROPATHOL, V100, P75, DOI 10.1007/s004010051195; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; Moghaddam A, 2015, INT J MOL SCI, V16, P7900, DOI 10.3390/ijms16047900; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Nakao Y, 2001, J THORAC CARDIOV SUR, V122, P136, DOI 10.1067/mtc.2001.114101; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Robins-Steele S, 2012, J NEUROTRAUM, V29, P1586, DOI 10.1089/neu.2011.2005; Russell JW, 1998, J NEUROBIOL, V36, P455, DOI 10.1002/(SICI)1097-4695(19980915)36:4<455::AID-NEU1>3.0.CO;2-V; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Stammers AT, 2012, J NEUROSCI RES, V90, P782, DOI 10.1002/jnr.22820; TAKAHASHI T, 1994, INT IMMUNOL, V6, P1567, DOI 10.1093/intimm/6.10.1567; Tan ZQ, 2001, NEUROREPORT, V12, P1979, DOI 10.1097/00001756-200107030-00040; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Tei R, 2005, NEUROL RES, V27, P403, DOI 10.1179/016164105X25180; TURNER M, 1990, Cytokine, V2, P211, DOI 10.1016/1043-4666(90)90018-O; Umemura T, 2010, TRANSL RES, V156, P292, DOI 10.1016/j.trsl.2010.08.002; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Westhauser F, 2015, ARCH ORTHOP TRAUM SU, V135, P1107, DOI 10.1007/s00402-015-2253-3; Yoshino O, 2004, SPINE, V29, P1394, DOI 10.1097/01.BRS.0000129894.34550.48; Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3; Zurita M, 2001, J NEUROSURG, V94, P257, DOI 10.3171/spi.2001.94.2.0257	54	16	17	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2017	34	3					607	614		10.1089/neu.2015.4294			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EI9GJ	WOS:000392815600008	27533262				2022-02-06	
J	Formisano, R; Longo, E; Azicnuda, E; Silvestro, D; D'Ippolito, M; Truelle, JL; von Steinbuchel, N; von Wild, K; Wilson, L; Rigon, J; Barba, C; Forcina, A; Giustini, M				Formisano, Rita; Longo, Eloise; Azicnuda, Eva; Silvestro, Daniela; D'Ippolito, Mariagrazia; Truelle, Jean-Luc; von Steinbuechel, Nicole; von Wild, Klaus; Wilson, Lindsay; Rigon, Jessica; Barba, Carmen; Forcina, Antonio; Giustini, Marco			Quality of life in persons after traumatic brain injury as self-perceived and as perceived by the caregivers	NEUROLOGICAL SCIENCES			English	Article						Caregiver; Health-related quality of life; Self-awareness; Traumatic brain injury	EXECUTIVE FUNCTION; COGNITIVE-FACTORS; SCALE; QOLIBRI; AWARENESS; EMPATHY; REHABILITATION; SATISFACTION; ADULTS; MIND	The primary aim of the study was to adopt QOLIBRI (quality of life after brain injury) questionnaire in a proxy version (Q-Pro), i.e., to use caregivers for comparison and to evaluate whether TBI patients' judgment corresponds to that of their caregivers since the possible self-awareness deficit of the persons with TBI. A preliminary sample of 19 outpatients with TBI and their proxies was first evaluated with the Patient Competency Rating Scale to assess patients' self-awareness; then they were evaluated with the QOLIBRI Patient version (Q-Pt) and a patient-centered version of the Q-Pro. Subsequently, 55 patients and their caregivers were evaluated using the patient-centered and the caregiver-centered Q-Pro versions. Q-Pt for assessing Quality of Life (QoL) after TBI, as patients' subjective perspective and Q-Pro to assess the QoL of patients as perceived by the caregivers. The majority of patients (62.2%) showed better self-perception of QoL than their proxies; however, patients with low self-awareness were less satisfied than patients with adequate self-awareness. Low self-awareness does not impair the ability of patients with TBI to report on satisfaction with QoL as self-perceived.	[Formisano, Rita; Azicnuda, Eva; Silvestro, Daniela; D'Ippolito, Mariagrazia] Rehabil Hosp Santa Lucia Fdn, IRCCS, Rome, Italy; [Longo, Eloise; Giustini, Marco] Natl Inst Hlth, Viale Regina Elena 299, I-00161 Rome, Italy; [Silvestro, Daniela; D'Ippolito, Mariagrazia] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Truelle, Jean-Luc] CHU Raymonde Poincare, Serv Med Phys & Readapt, Garches, France; [von Steinbuechel, Nicole] Georg August Univ, Dept Med Psychol & Med Sociol, Gottingen, Germany; [von Wild, Klaus] Westfalian Wilhelms Univ Munster, Clemens Hosp, Dept Neurosurg & Early Neurotraumatol Rehabil, Psychol, Munster, Germany; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling, Scotland; [Rigon, Jessica] IRCCS San Camillo Hosp Fdn, Venice, Italy; [Barba, Carmen] Univ Florence, A Meyer Childrens Hosp, Pediat Neurol Unit, Florence, Italy; [Forcina, Antonio] Univ Naples Federico II, Dept Engn, Naples, Italy		Giustini, M (corresponding author), Natl Inst Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	marco.giustini@iss.it	Giustini, Marco/Q-3166-2017; Wilson, Lindsay/A-3659-2009; barba, carmen/K-4942-2016; Barba, Carmen/AAB-7162-2022; D'Ippolito, Mariagrazia/K-4010-2016; Azicnuda, Eva/K-9010-2016	Giustini, Marco/0000-0003-2691-1956; Wilson, Lindsay/0000-0003-4113-2328; barba, carmen/0000-0001-5445-5842; D'Ippolito, Mariagrazia/0000-0001-7818-7352; 	Italian Ministry of HealthMinistry of Health, Italy [31]; G.B. Baroni Foundation	This research was partially supported by the Italian Ministry of Health (Grant RF2008, No. 31) and a Grant from the G.B. Baroni Foundation.	Altman DG, 1991, PRACTICAL STAT MED R, P610; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bivona U, 2015, RESTOR NEUROL NEUROS, V33, P335, DOI 10.3233/RNN-140484; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; BROTHERS L, 1992, J COGNITIVE NEUROSCI, V4, P107, DOI 10.1162/jocn.1992.4.2.107; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Formisano R, 2016, INT EMERG MED; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Giustini M, 2014, FUNCT NEUROL, V29, P167, DOI 10.11138/FNeur/2014.29.3.167; Heaton RK, 2000, FORMA COMPLETA REVIS, P1; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; JENNETT B, 1975, LANCET, V1, P480; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Mehrabian A, 2000, MANUAL BALANCED EMOT, V2000, P93040; Muehlan H, 2016, ASSESSMENT, V23, P124, DOI 10.1177/1073191115569844; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Orsini A., 2003, B PSICOL APPL, V239, P73; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; TEASDALE G, 1974, LANCET, V2, P81; Tramonti F, 2015, PSYCHOL HEALTH MED, V10, P1, DOI DOI 10.1080/13548506.2015.1009380; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2016, J NEUROTRAUMA; World Health Organization, 2011, INT STAT CLASS DIS R, VI-III; Zimmerman P., 1992, TEST BATTERIE AUFMER	42	16	16	1	9	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	FEB	2017	38	2					279	286		10.1007/s10072-016-2755-y			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EL1NB	WOS:000394386000010	27826793				2022-02-06	
J	Gross, BW; Edavettal, MM; Cook, AD; Rinehart, CD; Lynch, CA; Bradburn, EH; Wu, D; Rogers, FB				Gross, Brian W.; Edavettal, Mathew M.; Cook, Alan D.; Rinehart, Cole D.; Lynch, Caitlin A.; Bradburn, Eric H.; Wu, Daniel; Rogers, Frederick B.			Big children or little adults? A statewide analysis of adolescent isolated severe traumatic brain injury outcomes at pediatric versus adult trauma centers	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	29th Annual Scientific Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 09-16, 2016	San Antonio, TX	Eastern Assoc Surg Trauma		Adolescent; traumatic brain injury; mortality; pediatric trauma center; adult trauma center	SYSTEM REDUCES MORTALITY; RATES; CARE; IMPACT	BACKGROUND: The appropriate managing center for adolescent trauma patients is debated. We sought to determine whether outcome differences existed for adolescent severe traumatic brain injury (sTBI) patients treated at pediatric versus adult trauma centers. We hypothesized that no difference in mortality, functional status at discharge (FSD), or overall complication rate would be observed between center types. METHODS: All adolescent trauma patients (aged 15-17 years) presenting with isolated sTBI (head Abbreviated Injury Scale [AIS] score >= 3; all other AIS body region scores <= 2) to accredited Levels I to II trauma centers in Pennsylvania from 2003 to 2015 were extracted from the Pennsylvania Trauma Outcome Study database. Dead on arrival, transfer, and penetrating trauma patients were excluded from analysis. Adult trauma centerswere defined as non-pediatirc (PED) (n = 24), whereas standalone pediatric hospitals and adult centers with pediatric affiliation were considered Pediatric (n = 9). Multilevel mixed effects logistic regression models and a generalized linear mixed models assessed the adjusted impact of center type on mortality, overall complications, and FSD. Significance was defined as a p value less than 0.05. RESULTS: A total of 1,109 isolated sTBI patients aged 15 to 17 years presented over the 13-year study period (non-PED, 685; PED, 424). In adjusted analysis controlling for age, shock index, head AIS, Glasgow Coma Scale motor, trauma center level of managing facility, case volume of managing facility, and injury year, no significant difference in mortality (adjusted odds ratio, 0.82; 95% confidence interval [CI], 0.23-2.86; p = 0.754), FSD (coefficient, -0.85; 95% CI, -2.03 to 0.28; p = 0.136), or total complication rate (adjusted odds ratio, 1.21; 95% CI, 0.43-3.39; p = 0.714) was observed between center types. CONCLUSION: Although the optimal treatment facility for adolescent patients is frequently debated, patients aged 15 to 17 years presenting with isolated sTBI may experience similar outcomes when managed at pediatric and adult trauma centers. (Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Gross, Brian W.; Rinehart, Cole D.; Lynch, Caitlin A.; Bradburn, Eric H.; Wu, Daniel; Rogers, Frederick B.] Penn Med Lancaster Gen Hlth, Trauma Serv, Lancaster, PA USA; [Edavettal, Mathew M.; Cook, Alan D.] Chandler Reg Med Ctr, Trauma Res Program, Chandler, AZ USA		Rogers, FB (corresponding author), 555N Duke St, Lancaster, PA 17602 USA.	frogers2@lghealth.org					BENSARD DD, 1994, J PEDIATR SURG, V29, P11, DOI 10.1016/0022-3468(94)90514-2; Committee on Trauma, 2006, RESOURCES OPTIMAL CA; Faul M, 2010, TRAUMATIC BRAIN INJU; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; GUSS DA, 1989, ANN EMERG MED, V18, P1141, DOI 10.1016/S0196-0644(89)80048-4; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Matsushima K, 2013, AM SURGEON, V79, P267; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Notrica DM, 2012, J TRAUMA ACUTE CARE, V73, P566, DOI 10.1097/TA.0b013e318265ca6f; Osler TM, 2001, J TRAUMA, V50, P96, DOI 10.1097/00005373-200101000-00017; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Pracht EE, 2008, J PEDIATR SURG, V43, P212, DOI 10.1016/j.jpedsurg.2007.09.047; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; Twijnstra MJ, 2010, ANN SURG, V251, P339, DOI 10.1097/SLA.0b013e3181c0e910; Walther AE, 2014, J TRAUMA ACUTE CARE, V77, P109, DOI 10.1097/TA.0000000000000277; Wang NE, 2013, J TRAUMA ACUTE CARE, V75, P704, DOI 10.1097/TA.0b013e31829a0a65	18	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2017	82	2					368	373		10.1097/TA.0000000000001291			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	EJ8GO	WOS:000393463600024	27805998				2022-02-06	
J	Huang, SW; Wang, WT; Chou, LC; Liou, TH; Lin, HW				Huang, Shih-Wei; Wang, Wei-Te; Chou, Lin-Chuan; Liou, Tsan-Hon; Lin, Hui-Wen			Risk of Dementia in Patients with Spinal Cord Injury: A Nationwide Population-Based Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						dementia; population-based study; risk; SCI	TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; DISABILITY ASSESSMENT; FALLS; DEPRESSION; DISEASE; PEOPLE; NEUROINFLAMMATION; METAANALYSIS; DEFICITS	Spinal cord injury (SCI) can cause physical disability and psychological distress; however, whether SCI is a risk factor for dementia is unclear. This study evaluated the incidence of dementia in patients with SCI. Study participants were recruited from a nationwide cohort during 2004-2007 and categorized into SCI (patients diagnosed with SCI; n = 941) and non-SCI (age- and sex-matched controls; n = 5060) cohorts. Each participant was followed for 7 years until diagnosis of dementia or December 31, 2010, whichever occurred first. Data were subjected to Kaplan-Meier and Cox regression analyses. The incidence of dementia was significantly higher in the SCI cohort (1106 per 100,000 person-years) than in the non-SCI cohort (p <0.001). Patients with SCI had a significantly higher risk of dementia than did those without SCI (crude hazard ratio [HR] = 2.14, 95% confidence interval [CI], 1.57-2.92, p <0.001 vs. adjusted HR = 1.95, 95% CI, 1.43-2.67, p <0.001). Further analysis found that there is no statistical significance of higher risk for developing Alzheimer's disease among SCI patients, but that SCI patients were at higher risk of developing other types of dementia than the control cohort (crude HR= 1.88, 95% CI, 1.33-2.63, p <0.001 vs. adjusted HR= 1.90, 95% CI, 1.35-2.68, p <0.001). In conclusion, patients with SCI are at high risk of dementia, and effective dementia prevention strategies are recommended for comprehensive SCI care.	[Huang, Shih-Wei; Chou, Lin-Chuan; Liou, Tsan-Hon] Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Huang, Shih-Wei; Liou, Tsan-Hon] Taipei Med Univ, Dept Phys Med & Rehabil, Sch Med, Coll Med, Taipei, Taiwan; [Liou, Tsan-Hon] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Lin, Hui-Wen] Taipei Med Univ, Evidence Based Med Ctr, Wan Fang Hosp, Taipei, Taiwan; [Wang, Wei-Te] Changhua Christian Hosp, Dept Phys Med & Rehabil, Changhua, Taiwan; [Lin, Hui-Wen] Soochow Univ, Dept Math, 70 Linhsi Rd, Taipei, Taiwan; [Huang, Shih-Wei] Natl Taiwan Sport Univ, Grad Inst Sports Sci, Taoyuan, Taiwan		Lin, HW (corresponding author), Soochow Univ, Dept Math, 70 Linhsi Rd, Taipei, Taiwan.	linhw@tmu.edu.tw	Liou, Tsan-Hon/I-8808-2019; Huang, ShihWei/S-9278-2019	Liou, Tsan-Hon/0000-0002-0959-4023	National Science Council of TaiwanMinistry of Science and Technology, Taiwan [MOST 104-2118-M-031-001]	This study was based partly on data from the NHIRD, provided by the BNHI (Department of Health), managed by the Taiwan National Health Research Institutes, and supported by the National Science Council of Taiwan under grant MOST 104-2118-M-031-001. S.W.H. and H.W.L. conceptualized and designed the study, and S.W.H. drafted the manuscript; S.W.H. and H.W.L. analyzed and interpreted the data; S.W.H. critically revised the article for valuable intellectual content; T.H.L. and H.W.L. approved the article; L.C.C. provided study materials and patients; H.W.L. offered statistical expertise; and W.T.W. provided administrative, technical, and logistical support.	Adriaansen JJE, 2013, DISABIL REHABIL, V35, P1104, DOI 10.3109/09638288.2012.712196; Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; BUCHNER DM, 1987, JAMA-J AM MED ASSOC, V257, P1492, DOI 10.1001/jama.257.11.1492; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Feldman H, 2001, ALZ DIS ASSOC DIS, V15, P89, DOI 10.1097/00002093-200104000-00008; FLEMING KC, 1995, MAYO CLIN PROC, V70, P1093, DOI 10.4065/70.11.1093; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; FUHRER MJ, 1993, ARCH PHYS MED REHAB, V74, P255; Ginis KAM, 2011, SPINAL CORD, V49, P1088, DOI 10.1038/sc.2011.63; Ginis KAM, 2010, ARCH PHYS MED REHAB, V91, P722, DOI 10.1016/j.apmr.2009.12.027; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; HANCOCK KM, 1993, PARAPLEGIA, V31, P349, DOI 10.1038/sc.1993.59; Hoffman JM, 2011, ARCH PHYS MED REHAB, V92, P411, DOI 10.1016/j.apmr.2010.10.036; Jensen MP, 2007, ARCH PHYS MED REHAB, V88, P638, DOI 10.1016/j.apmr.2007.02.002; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Lazzaro I, 2013, J CLIN NEUROPHYSIOL, V30, P59, DOI 10.1097/WNP.0b013e31827edb0c; Mead GE, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004366.pub6, 10.1002/14651858.CD004366.pub4]; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; Murray RF, 2007, SPINAL CORD, V45, P429, DOI 10.1038/sj.sc.3102022; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Perry GML, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-56; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Prince M., 2009, WORLD ALZHEIMER REPO; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Ripatti S, 2000, BIOMETRICS, V56, P1016, DOI 10.1111/j.0006-341X.2000.01016.x; Rolland Y, 2008, J AM MED DIR ASSOC, V9, P390, DOI 10.1016/j.jamda.2008.02.007; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Schaller S, 2015, INT J GERIATR PSYCH, V30, P111, DOI 10.1002/gps.4198; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Strubreither W, 1997, SPINAL CORD, V35, P487, DOI 10.1038/sj.sc.3100495; Therneau T.M., 2000, STAT BIOL HEALTH; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; van Leeuwen CMC, 2012, SPINAL CORD, V50, P174, DOI 10.1038/sc.2011.120; Widerstrom-Noga EG, 1999, ARCH PHYS MED REHAB, V80, P580, DOI 10.1016/S0003-9993(99)90203-4; Wu JF, 2014, CELL CYCLE, V13, P2446, DOI 10.4161/cc.29420; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014	44	16	16	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2017	34	3					615	622		10.1089/neu.2016.4525			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EI9GJ	WOS:000392815600009	27539630				2022-02-06	
J	Matthieu, MM; Lawrence, KA; Robertson-Blackmore, E				Matthieu, Monica M.; Lawrence, Karen A.; Robertson-Blackmore, Emma			The impact of a civic service program on biopsychosocial outcomes of post 9/11 US military veterans	PSYCHIATRY RESEARCH			English	Article						Veterans; Health; Volunteer; Mental health; Depression; Brain injury; Stress disorders; Post-traumatic; Loneliness; Social support; Self-efficacy; Reintegration	MENTAL-HEALTH PROBLEMS; AFGHANISTAN VETERANS; IRAQ; PTSD; DEPRESSION; VALIDITY; ADULTS	Volunteering as a health promotion intervention, improves physical health, mental health, and social outcomes particularly in older adults, yet limited research exists for veterans. We conducted a preliminary study to explore whether volunteering impacts a variety of biopsychosocial outcomes, including symptoms of post-traumatic stress disorder (PTSD) and depression, among returning military veterans from Iraq and Afghanistan. A survey enrolling a prospective cohort of United States (U.S.) veterans who served in the military after 11 September 2001 and who participated in a national civic service program was conducted. A total of 346 veterans completed standardized health, mental health, and psychosocial self-report measures before and after the program. Statistically significant differences were detected in overall health rating, level of emotional difficulty, PTSD and depression symptoms, purpose in life, self-efficacy, social isolation, and the perceived availability of social support at program completion. Screening positive for probable PTSD predicted improved perceived self efficacy while probable depression predicted a decrease in loneliness, an increase in purpose in life, and an increase in perceived social support, at program completion. Volunteering was associated with significant improvements in health, mental health and social outcomes in returning veterans.	[Matthieu, Monica M.] St Louis Univ, Coll Publ Hlth & Social Justice, Sch Social Work, Tegeler Hall,Room 325,3500 Lindell Blvd, St Louis, MO 63103 USA; [Lawrence, Karen A.] Univ Kentucky, Sch Social Work, Lexington, KY USA; [Robertson-Blackmore, Emma] Halifax Hlth, Family Med Residency, Daytona Beach, FL USA; [Lawrence, Karen A.] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA		Matthieu, MM (corresponding author), St Louis Univ, Coll Publ Hlth & Social Justice, Sch Social Work, Tegeler Hall,Room 325,3500 Lindell Blvd, St Louis, MO 63103 USA.	mmatthie@slu.edu		Lawrence, Karen/0000-0002-7235-5594	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH019960, L30 MH108084] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019960] Funding Source: NIH RePORTER		American Psychiatric Association [APA], 2000, DIAGN STAT MAN TEXT; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; Bliese P.D., 2007, PSYCHOL SERV, V4, P141, DOI DOI 10.1037/1541-1559.4.3.141; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Cooperation for National and Community Service [CNCS], 2007, HLTH BEN VOL REV REC; Crawford EF, 2015, J TRAUMA STRESS, V28, P118, DOI 10.1002/jts.21993; Department of Defense [DoD], 2008, POSTD HLTH REASS DD; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; IBM Corp, 2016, IBM SPSS STAT WINDOW; Jenkinson CE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-773; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lum TY, 2005, RES AGING, V27, P31, DOI 10.1177/0164027504271349; Matthieu K.M., 2017, BEST PRACTICES MENTA; Matthieu M.M., 2016, J VETERAN STUDIES, V1, P205, DOI DOI 10.1097/AOG.0B013E31826AF3D1; McBride A.M., 2007, CIVIC SERVICE WORLDW; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Morrow-Howell Nancy, 2003, J Gerontol B Psychol Sci Soc Sci, V58, pS137; Musick MA, 1999, J GERONTOL B-PSYCHOL, V54, pS173, DOI 10.1093/geronb/54B.3.S173; Musick MA, 2003, SOC SCI MED, V56, P259, DOI 10.1016/S0277-9536(02)00025-4; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ramchand R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0575-z; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schnurr P P, 1999, Semin Clin Neuropsychiatry, V4, P295; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Sloan DM, 2015, J CONTEMP PSYCHOTHER, V45, P215, DOI 10.1007/s10879-014-9292-x; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thoits PA, 2001, J HEALTH SOC BEHAV, V42, P115, DOI 10.2307/3090173; Vaughan CA, 2014, PSYCHIAT SERV, V65, P833, DOI 10.1176/appi.ps.201300111; ZUBIN J, 1977, J ABNORM PSYCHOL, V86, P103, DOI 10.1037/0021-843X.86.2.103	38	16	16	0	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	FEB	2017	248						111	116		10.1016/j.psychres.2016.12.028			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EK1XO	WOS:000393721300018	28039802	Green Accepted, Green Submitted			2022-02-06	
J	Sprissler, RS; Wagnon, JL; Bunton-Stasyshyn, RK; Meisler, MH; Hammer, MF				Sprissler, Ryan S.; Wagnon, Jacy L.; Bunton-Stasyshyn, Rosie K.; Meisler, Miriam H.; Hammer, Michael F.			Altered gene expression profile in a mouse model of SCN8A encephalopathy	EXPERIMENTAL NEUROLOGY			English	Article						RNA-seq; Transcriptome; Seizure; Epileptic encephalopathy; Astrocyte; Gene expression; Sodium channel	CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN-INJURY; EPILEPTIC ENCEPHALOPATHY; REACTIVE ASTROCYTES; NEURONAL DEGENERATION; ANTIEPILEPTIC DRUGS; MEDIATED EXPRESSION; RAT HIPPOCAMPUS; PROGRESS REPORT; SEIZURES	SCN8A encephalopathy is a severe, early-onset epilepsy disorder resulting from de novo gain-of-function mutations in the voltage-gated sodium channel Na(v)1.6. To identify the effects of this disorder on mRNA expression, RNA-seq was performed on brain tissue from a knock-in mouse expressing the patient mutation p.Asn1768Asp (N1768D). RNA was isolated from forebrain, cerebellum, and brainstem both before and after seizure onset, and from age-matched wildtype littermates. Altered transcript profiles were observed only in forebrain and only after seizures. The abundance of 50 transcripts increased more than 3-fold and 15 transcripts decreased more than 3 fold after seizures. The elevated transcripts included two anti-convulsant neuropeptides and more than a dozen genes involved in reactive astrocytosis and response to neuronal damage. There was no change in the level of transcripts encoding other voltage-gated sodium, potassium or calcium channels. Reactive astrocytosis was observed in the hippocampus of mutant mice after seizures. There is considerable overlap between the genes affected in this genetic model of epilepsy and those altered by chemically induced seizures, traumatic brain injury, ischemia, and inflammation. The data support the view that gain-of-function mutations of SCN8A lead to pathogenic alterations in brain function contributing to encephalopathy. (C) 2016 Elsevier Inc. All rights reserved.	[Sprissler, Ryan S.; Hammer, Michael F.] Univ Arizona, ARL Div Biotechnol, 1657 E Helen St, Tucson, AZ 85721 USA; [Wagnon, Jacy L.; Bunton-Stasyshyn, Rosie K.; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Meisler, Miriam H.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Hammer, Michael F.] Univ Arizona, Dept Neurol, Tucson, AZ 85721 USA		Hammer, MF (corresponding author), Univ Arizona, ARL Div Biotechnol, 1657 E Helen St, Tucson, AZ 85721 USA.; Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	meislerm@umich.edu; mth@email.arizona.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS34509]; Dravet Syndrome Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034509] Funding Source: NIH RePORTER	Support is acknowledged from research grant NIH R01 NS34509 to MHM and a Postdoctoral Fellowship from the Dravet Syndrome Foundation to JLW. We would like to thank Branden Lau and Alexander Tchourbanov for excellent assistance with the RNAseq and biological pathway analyses.	Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; Barker B., 2016, EPILEPSIA IN PRESS; Beaumont TL, 2012, J NEUROSCI, V32, P14389, DOI 10.1523/JNEUROSCI.3408-12.2012; Bialer M, 2015, EPILEPSY RES, V111, P85, DOI 10.1016/j.eplepsyres.2015.01.001; Bialer M, 2013, EPILEPSY RES, V103, P2, DOI 10.1016/j.eplepsyres.2012.10.001; Blanchard MG, 2015, J MED GENET, V52, P330, DOI 10.1136/jmedgenet-2014-102813; Boer K, 2010, BRAIN PATHOL, V20, P704, DOI 10.1111/j.1750-3639.2009.00341.x; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Crunelli V, 2015, NEUROSCIENTIST, V21, P62, DOI 10.1177/1073858414523320; Deng L, 2015, BRAIN RES, V1622, P186, DOI 10.1016/j.brainres.2015.06.027; Elliott RC, 2003, J NEUROSCI, V23, P2218; Estacion M, 2014, NEUROBIOL DIS, V69, P117, DOI 10.1016/j.nbd.2014.05.017; Fan X, 2009, BRAIN RES REV, V62, P99, DOI 10.1016/j.brainresrev.2009.09.006; Green BR, 2011, ACS CHEM NEUROSCI, V2, P51, DOI 10.1021/cn1000974; Haberman RP, 2003, NAT MED, V9, P1076, DOI 10.1038/nm901; Hammer MF, 2016, GENEREVIEWS R; Henneberger C., 2016, J PHYSL; Howell KB, 2016, EPILEPSIA, V57, P343, DOI 10.1111/epi.13306; Jones JM, 2014, GENESIS, V52, P141, DOI 10.1002/dvg.22731; Kokaia M, 2001, P NATL ACAD SCI USA, V98, P14006, DOI 10.1073/pnas.231496298; Larsen J, 2015, NEUROLOGY, V84, P480, DOI 10.1212/WNL.0000000000001211; Lin EJD, 2003, EUR J NEUROSCI, V18, P2087, DOI 10.1046/j.1460-9568.2003.02926.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Santiago L. F., 2015, AM EP SOC ANN M; Makinson CD, 2014, NEUROBIOL DIS, V68, P16, DOI 10.1016/j.nbd.2014.03.014; Mazarati AM, 2002, NEUROSCI LETT, V331, P123, DOI 10.1016/S0304-3940(02)00847-9; Mazarati AM, 1998, J NEUROSCI, V18, P10070; Mazarati AM, 2000, J NEUROSCI, V20, P6276, DOI 10.1523/JNEUROSCI.20-16-06276.2000; McCown TJ, 2006, MOL THER, V14, P63, DOI 10.1016/j.ymthe.2006.04.004; Meisler MH, 2016, EPILEPSIA, V57, P1027, DOI 10.1111/epi.13422; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Rakhade SN, 2005, ANN NEUROL, V58, P736, DOI 10.1002/ana.20633; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Rubinstein M, 2001, J NEUROSCI, V21, P3756, DOI 10.1523/JNEUROSCI.21-11-03756.2001; Sakaida M, 2013, J PSYCHOPHARMACOL, V27, P1058, DOI 10.1177/0269881113497612; Samal BB, 2015, J MOL NEUROSCI, V57, P282, DOI 10.1007/s12031-015-0626-2; Schlifke I, 2006, EXP NEUROL, V200, P398, DOI 10.1016/j.expneurol.2006.02.124; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Wagnon JL, 2016, ANN CLIN TRANSL NEUR, V3, P114, DOI 10.1002/acn3.276; Wagnon JL, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00104; Wagnon JL, 2015, HUM MOL GENET, V24, P506, DOI 10.1093/hmg/ddu470; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Wilson DN, 2005, J MOL NEUROSCI, V25, P285, DOI 10.1385/JMN:25:3:285; Yang JL, 2016, GLIA, V64, P1083, DOI 10.1002/glia.22984; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	53	16	16	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2017	288						134	141		10.1016/j.expneurol.2016.11.002			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EI4JY	WOS:000392461100013	27836728	Green Accepted, Green Published			2022-02-06	
J	Steward, KA; Novack, TA; Kennedy, R; Crowe, M; Marson, DC; Triebel, KL				Steward, Kayla A.; Novack, Thomas A.; Kennedy, Richard; Crowe, Michael; Marson, Daniel C.; Triebel, Kristen L.			The Wechsler Test of Adult Reading as a Measure of Premorbid Intelligence Following Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Intelligence; Neuropsychological assessment; Rehabilitation	IQ; PERFORMANCE; VALIDITY; BATTERY; WAIS	Objective: The current study sought to determine whether the Wechsler Test of Adult Reading (WTAR) provides a stable estimate of premorbid intellectual ability in acutely injured patients recovering from traumatic brain injury (TBI). Method: A total of 135 participants (43 mild TBI [mTBI], 40 moderate/severe TBI [msevTBI], 52 healthy controls) were administered the WTAR at 1 and 12 months post-injury. Results: Despite similar demographic profiles, participants with msevTBI performed significantly worse than controls on the WTAR at both time points. Moreover, the msevTBI group had a significant improvement in WTAR performance over the 1-year period. In contrast, those participants with mTBI did not significantly differ from healthy controls and both the mTBI and control groups demonstrated stability on the WTAR over time. Conclusions: Results indicate that word-reading tests may underestimate premorbid intelligence during the immediate recovery period for patients with msevTBI. Clinicians should consider alternative estimation measures in this TBI subpopulation.	[Steward, Kayla A.; Crowe, Michael] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Kennedy, Richard] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Marson, Daniel C.; Triebel, Kristen L.] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA		Marson, DC (corresponding author), Univ Alabama Birmingham, Dept Neurol, Sparks Ctr 650, 1720 7th Ave South, Birmingham, AL 35294 USA.	dmarson@uabmc.edu	triebel, kristen/A-6569-2019; Steward, Kayla/AAS-8792-2021; Kennedy, Richard/K-1525-2018	triebel, kristen/0000-0001-9161-7847; Kennedy, Richard/0000-0003-4638-126X	National Institute on Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD053074]	This work was supported by the National Institute on Child Health and Human Development [grant no. 1R01HD053074].	Brasure M., 2012, COMP EFFECTIVENESS R, V72, pES1; Bushnik T, 2008, ARCH PHYS MED REHAB, V89, P894, DOI 10.1016/j.apmr.2008.03.001; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Dwan TM, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00056; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; McGurn B, 2004, NEUROLOGY, V62, P1184, DOI 10.1212/01.WNL.0000103169.80910.8B; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; RUSSELL EW, 1980, PERCEPT MOTOR SKILL, V51, P121, DOI 10.2466/pms.1980.51.1.121; Spreen O, 2006, COMPENDIUM NEUROPSYC; Triebel KL, 2012, NEUROLOGY, V78, P1472, DOI 10.1212/WNL.0b013e3182553c38; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; WechslerD, 2001, WECHSLER TEST ADULT; Wolfson, 1993, HALSTEAD REITAN NEUR	20	16	16	1	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2017	32	1					98	103		10.1093/arclin/acw081			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EO9KJ	WOS:000397007300012	27799224	Bronze			2022-02-06	
J	Nizamutdinov, D; DeMorrow, S; McMillin, M; Kain, J; Mukherjee, S; Zeitouni, S; Frampton, G; Bricker, PCS; Hurst, J; Shapiro, LA				Nizamutdinov, Damir; DeMorrow, Sharon; McMillin, Matthew; Kain, Jessica; Mukherjee, Sanjib; Zeitouni, Suzanne; Frampton, Gabriel; Bricker, Paul Clint S.; Hurst, Jacob; Shapiro, Lee A.			Hepatic alterations are accompanied by changes to bile acid transporter-expressing neurons in the hypothalamus after traumatic brain injury	SCIENTIFIC REPORTS			English	Article							TUMOR-NECROSIS-FACTOR; ACUTE-PHASE RESPONSE; CIRCADIAN-RHYTHMS; LIVER-INJURY; RAT MODEL; HPA AXIS; INFLAMMATION; SERUM; MECHANISMS; PROTEINS	Annually, there are over 2 million incidents of traumatic brain injury (TBI) and treatment options are non-existent. While many TBI studies have focused on the brain, peripheral contributions involving the digestive and immune systems are emerging as factors involved in the various symptomology associated with TBI. We hypothesized that TBI would alter hepatic function, including bile acid system machinery in the liver and brain. The results show activation of the hepatic acute phase response by 2 hours after TBI, hepatic inflammation by 6 hours after TBI and a decrease in hepatic transcription factors, Gli 1, Gli 2, Gli 3 at 2 and 24 hrs after TBI. Bile acid receptors and transporters were decreased as early as 2 hrs after TBI until at least 24 hrs after TBI. Quantification of bile acid transporter, ASBT-expressing neurons in the hypothalamus, revealed a significant decrease following TBI. These results are the first to show such changes following a TBI, and are compatible with previous studies of the bile acid system in stroke models. The data support the emerging idea of a systemic influence to neurological disorders and point to the need for future studies to better define specific mechanisms of action.	[Nizamutdinov, Damir; Kain, Jessica; Mukherjee, Sanjib; Zeitouni, Suzanne; Bricker, Paul Clint S.; Hurst, Jacob; Shapiro, Lee A.] Texas A&M Univ, Hlth Sci Ctr, Dept Surg, Coll Med, Temple, TX 76504 USA; [Nizamutdinov, Damir; Shapiro, Lee A.] Baylor Scott & White Hlth, Neurosci Res Inst, Dept Neurosurg, Temple, TX 76504 USA; [DeMorrow, Sharon; McMillin, Matthew; Frampton, Gabriel] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Internal Med, Temple, TX 76504 USA; [DeMorrow, Sharon; McMillin, Matthew; Frampton, Gabriel] Cent Texas Vet Hlth Care Syst, Temple, TX 76504 USA		Shapiro, LA (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Dept Surg, Coll Med, Temple, TX 76504 USA.; Shapiro, LA (corresponding author), Baylor Scott & White Hlth, Neurosci Res Inst, Dept Neurosurg, Temple, TX 76504 USA.	lshapiro@medicine.tamhsc.edu	McMillin, Matthew/I-3090-2019	McMillin, Matthew/0000-0002-5980-0921; Kain, Jessica/0000-0003-1285-5690	BLRD VA [IK2 BX003486] Funding Source: Medline		Alrefai WA, 2007, PHARM RES-DORDR, V24, P1803, DOI 10.1007/s11095-007-9289-1; Anderson GD, 2015, AAPS J, V17, P1255, DOI 10.1208/s12248-015-9792-y; Angeletti RH, 1997, P NATL ACAD SCI USA, V94, P283, DOI 10.1073/pnas.94.1.283; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Arvin B, 1995, ANN NY ACAD SCI, V765, P62, DOI 10.1111/j.1749-6632.1995.tb16561.x; Arvin B., 1995, ANN NY ACAD SCI, V765, P98; BAUMANN H, 1987, J IMMUNOL, V139, P4122; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; BEUTLER B, 1986, IMMUNOL RES, V5, P281, DOI 10.1007/BF02935501; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Brough D, 2015, EXP PHYSIOL, V100, P1488, DOI 10.1113/EP085135; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; CANNON JG, 1990, J INFECT DIS, V161, P79, DOI 10.1093/infdis/161.1.79; Chen F, 2003, J BIOL CHEM, V278, P19909, DOI 10.1074/jbc.M207903200; Chou TC, 2003, J NEUROSCI, V23, P10691; Cortez LM, 2015, J VIROL, V89, P7660, DOI 10.1128/JVI.01165-15; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; De Morrow S, 2008, AM J PHYSIOL-GASTR L, V294, pG506, DOI 10.1152/ajpgi.00304.2007; DECKER T, 1985, INFECT IMMUN, V50, P358, DOI 10.1128/IAI.50.2.358-364.1985; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Foley C, 2009, J VET EMERG CRIT CAR, V19, P269, DOI 10.1111/j.1476-4431.2009.00409.x; Fox A, 2014, J REHABIL RES DEV, V51, P869, DOI 10.1682/JRRD.2013.10.0233; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Gao P, 1999, J HISTOCHEM CYTOCHEM, V47, P1255, DOI 10.1177/002215549904701005; Gao WM, 2014, PEDIATR RES, V76, P280, DOI 10.1038/pr.2014.86; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Gorojankina T, 2016, CELL MOL LIFE SCI, V73, P1317, DOI 10.1007/s00018-015-2127-4; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Hegde GV, 2008, MOL CANCER RES, V6, P1928, DOI 10.1158/1541-7786.MCR-08-0142; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Isaksson J, 1997, ACTA NEUROPATHOL, V94, P16, DOI 10.1007/s004010050666; Jain S, 2011, J PHARM BIOALLIED SC, V3, P118, DOI 10.4103/0975-7406.76489; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2010, GLIA, V58, P1794, DOI 10.1002/glia.21049; Koniaris LG, 2001, J IMMUNOL, V167, P399, DOI 10.4049/jimmunol.167.1.399; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Lang MF, 2011, J NEUROENDOCRINOL, V23, P1194, DOI 10.1111/j.1365-2826.2011.02216.x; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; MACKIEWICZ A, 1992, J IMMUNOL, V149, P2021; Maier B, 2006, SHOCK, V26, P122, DOI 10.1097/01.shk.0000223127.41641.f4; McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007; McMillin M, 2016, AM J PATHOL, V186, P312, DOI 10.1016/j.ajpath.2015.10.005; McMillin M, 2015, MOL ENDOCRINOL, V29, P1720, DOI 10.1210/me.2015-1087; McMillin M, 2015, J NEUROCHEM, V135, P565, DOI 10.1111/jnc.13243; McNeilly AD, 2010, J HEPATOL, V52, P705, DOI 10.1016/j.jhep.2009.10.037; Miova B, 2015, J CELL BIOCHEM, V116, P2365, DOI 10.1002/jcb.25187; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Okuda H, 2016, NEUROCHEM RES, V41, P278, DOI 10.1007/s11064-015-1791-y; Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Quinn M, 2014, DIGEST LIVER DIS, V46, P527, DOI 10.1016/j.dld.2014.01.159; Quinn M, 2012, AM J PHYSIOL-GASTR L, V302, pG182, DOI 10.1152/ajpgi.00205.2011; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Rodrigues TMP, 2002, J CEREBR BLOOD F MET, V22, P463, DOI 10.1097/00004647-200204000-00010; Schubring SR, 2012, NEUROSCI LETT, V506, P322, DOI 10.1016/j.neulet.2011.11.036; SHNEIDER BL, 1995, J CLIN INVEST, V95, P745, DOI 10.1172/JCI117722; St-Pierre MV, 2001, J EXP BIOL, V204, P1673; Szymusiak R, 2008, ANN NY ACAD SCI, V1129, P275, DOI 10.1196/annals.1417.027; Tabe-Bordbar S, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00027; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Tzirogiannis KN, 2004, ARCH TOXICOL, V78, P321, DOI 10.1007/s00204-004-0549-0; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Venetsanou K, 2007, EUR CYTOKINE NETW, V18, P206, DOI 10.1684/ecn.2007.0112; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009; WILMS GE, 1986, RADIOLOGY, V160, P713, DOI 10.1148/radiology.160.3.3526406; Wittmann G, 2015, ENDOCRINOLOGY, V156, P1552, DOI 10.1210/en.2014-1830; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; Yu PP, 2017, MOL NEUROBIOL, V54, P212, DOI 10.1007/s12035-015-9639-7; ZAHEDI K, 1989, J IMMUNOL, V143, P2880; Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	77	16	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 20	2017	7								40112	10.1038/srep40112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI2TW	WOS:000392342300001	28106051	Green Published, gold			2022-02-06	
J	Leary, JB; Bondi, CO; LaPorte, MJ; Carlson, LJ; Radabaugh, HL; Cheng, JP; Kline, AE				Leary, Jacob B.; Bondi, Corina O.; LaPorte, Megan J.; Carlson, Lauren J.; Radabaugh, Hannah L.; Cheng, Jeffrey P.; Kline, Anthony E.			The Therapeutic Efficacy of Environmental Enrichment and Methylphenidate Alone and in Combination after Controlled Cortical Impact Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavioral outcome; controlled cortical impact; dopamine agonist; environmental enrichment; functional recovery; learning and memory; Morris water maze; traumatic brain injury	TRAUMATIC BRAIN-INJURY; RECEPTOR AGONIST 8-OH-DPAT; WATER MAZE PERFORMANCE; NEUROBEHAVIORAL BENEFIT; FUNCTIONAL IMPROVEMENT; MODERATE HYPOTHERMIA; VOLUNTARY EXERCISE; COGNITIVE FUNCTION; TREATMENT REGIMEN; CLINICAL-TRIALS	Environmental enrichment (EE) and methylphenidate (MPH) independently confer significant benefit to behavioral recovery after controlled cortical impact (CCI) injury. Given that combinational therapies may be more clinically translatable than monotherapies, the aim of the current study was to test the hypothesis that a combined treatment regimen of EE and MPH would provide greater therapeutic efficacy than either one alone. Anesthetized adult male rats received either a CCI of moderate severity or sham injury and were then randomly assigned to EE or standard (STD) housing where they received either intraperitoneal (ip) MPH (5 mg/kg) or vehicle (VEH; 1.0 mL/kg; ip) beginning 24 h after injury and once daily for 19 days. Motor and cognitive assessments were conducted on post-injury days 1-5 and 14-19, respectively. No differences were observed in sham controls regardless of treatments, and thus their data were pooled. The traumatic brain injury (TBI)+EE+VEH and TBI+EE+MPH groups exhibited enhanced beam balance and beam walk performance relative to the TBI+STD+VEH group (p < 0.05), but did not differ from one another (p > 0.05). No effect of MPH treatment alone was observed in either motor task. In contrast, MPH improved spatial learning and memory when presented alone and also when combined with EE relative to VEH-treated STD controls (p < 0.05). In addition, both EE groups performed significantly better than the TBI+STD+MPH group (p < 0.05), but did not differ from one another (p > 0.05). These data replicate previous findings that both EE and MPH confer cognitive benefits after TBI and extend the findings by revealing that combining EE and MPH does not produce effects greater than either treatment alone, which does not support the hypothesis. The lack of an additive effect may be because of the robustness of the EE.	[Leary, Jacob B.; Bondi, Corina O.; LaPorte, Megan J.; Carlson, Lauren J.; Radabaugh, Hannah L.; Cheng, Jeffrey P.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA USA; [Leary, Jacob B.; Bondi, Corina O.; LaPorte, Megan J.; Carlson, Lauren J.; Radabaugh, Hannah L.; Cheng, Jeffrey P.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA		Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resusciat Res, Dept Phys Med, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resusciat Res, Dept Rehabil, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resusciat Res, Dept Crit Care Med, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resusciat Res, Dept Psychol, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu		Bondi, Corina/0000-0002-5733-4912	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS060005, R01HD069620, HD069620-S1, R01NS084967]; University of Pittsburgh Physicians / UPMC Academic Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084967] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health grants R01NS060005, R01HD069620, HD069620-S1, R01NS084967 (AEK) and the University of Pittsburgh Physicians / UPMC Academic Foundation (COB).	Bales James W, 2010, Open Drug Discov J, V2, P119; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Bondi C.O., 2015, BRAIN NEUROTRAUMA MO; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Carmack SA, 2014, NEUROSCI LETT, V567, P45, DOI 10.1016/j.neulet.2014.03.029; Cheng J. P., 2015, BRAIN RES; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2007, NEUROSCI LETT, V416, P165, DOI 10.1016/j.neulet.2007.02.006; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Darna M, 2015, BRAIN RES, V1599, P115, DOI 10.1016/j.brainres.2014.12.034; de la Tremblaye Patricia B, J NEUROTRAUMA; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; Falchook AD, 2015, J CLIN EXP NEUROPSYC, V37, P1062, DOI 10.1080/13803395.2015.1077930; Faul M, 2010, TRAUMATIC BRAIN INJU; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Juarez J, 2015, BEHAV NEUROSCI, V129, P756, DOI 10.1037/bne0000109; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kokiko ON, 2007, BRAIN INJURY, V21, P259, DOI 10.1080/02699050701209964; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee MY, 2013, NEUROREHAB NEURAL RE, V27, P561, DOI 10.1177/1545968313481277; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mala Hana, 2016, RESTORATIVE NEUROLOG, P1; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Motaghinejad Majid, 2015, Adv Biomed Res, V4, P134, DOI 10.4103/2277-9175.161528; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Perry JL, 2008, BEHAV BRAIN RES, V193, P48, DOI 10.1016/j.bbr.2008.04.019; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Shin SS, 2013, J NEUROTRAUM, V30, P259, DOI 10.1089/neu.2012.2462; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weeks J. J., 2016, BEHAV BRAIN RES; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	74	16	17	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					444	+		10.1089/neu.2016.4438			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800020	26972895	Green Published			2022-02-06	
J	Maki-Marttunen, V; Kuusinen, V; Perakyla, J; Ogawa, KH; Brause, M; Brander, A; Hartikainen, KM				Maki-Marttunen, Veronica; Kuusinen, Venla; Perakyla, Jari; Ogawa, Keith H.; Brause, Maarja; Brander, Antti; Hartikainen, Kaisa M.			Greater Attention to Task-Relevant Threat Due to Orbitofrontal Lesion	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assessments; cognitive function; EEG; human studies; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX LESIONS; ANTERIOR THALAMIC NUCLEI; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; EMOTIONAL STIMULI; VISUAL-ATTENTION; NEURAL MECHANISMS; FRONTAL LOBES; HEAD-INJURY	Injury to the orbitofrontal cortex (OFC) is a frequent consequence of head injury and may lead to dysfunctional regulation of emotional and social behavior. Dysfunctional emotional behavior may partly be related to the role of the OFC in emotion-attention interaction, as reported previously. In order to better understand its role in emotion-attention and emotion-cognitive control interactions, we investigated attention allocation to task-relevant and task-irrelevant threat-related emotional stimuli during a task requiring cognitive control in patients with lesion to the OFC. We measured the behavioral performance and event-related potentials (ERP) of 13 patients with OFC lesion and 11 control subjects during a Go/NoGo visual discrimination task. In the task, line drawings of threatening (spider) and neutral (flower) figures served as either task-relevant Go or NoGo signals, or as task-irrelevant distractors. Overall performance did not differ between the groups. In contrast to the control group performance, the orbitofrontal group performance was improved by relevant threat signal in comparison with neutral signal. Further, task-relevant threat signals evoked larger frontocentral N2-P3 amplitude in the orbitofrontal group. Taken together, behavioral and electrophysiological results suggest that patients with OFC injury allocated more attentional and cognitive control resources in the context of task-relevant emotional stimuli. This study provides new evidence for the role of the OFC in emotion-attention and emotion-cognitive control interactions. Further, the OFC seems to contribute to the balance between voluntary and involuntary attention networks in context of emotional stimuli. Better understanding of alterations in emotion-attention interaction offers insight into affective dysfunction due to OFC lesion.	[Maki-Marttunen, Veronica; Kuusinen, Venla; Perakyla, Jari; Brause, Maarja; Hartikainen, Kaisa M.] Tampere Univ Hosp, Dept Neurosci & Rehabil, Behav Neurol Res Unit, Finnmedi 6,5th Floor,Biokatu 14, Tampere 33520, Finland; [Maki-Marttunen, Veronica] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Ogawa, Keith H.] St Marys Coll, John Magaddino Neurosci Lab, Moraga, CA 94575 USA; [Brander, Antti] Tampere Univ Hosp, Dept Radiol, Tampere, Finland; [Hartikainen, Kaisa M.] Tampere Univ Hosp, Dept Neurol & Rehabil, Tampere, Finland; [Kuusinen, Venla; Perakyla, Jari; Hartikainen, Kaisa M.] Univ Tampere, Sch Med, Tampere, Finland		Hartikainen, KM (corresponding author), Tampere Univ Hosp, Dept Neurosci & Rehabil, Behav Neurol Res Unit, Finnmedi 6,5th Floor,Biokatu 14, Tampere 33520, Finland.	kaisa.hartikainen@uta.fi	Maki-Marttunen, Veronica/AAA-5157-2022	Hartikainen, Kaisa/0000-0001-7278-9635	Academy of FinlandAcademy of FinlandEuropean Commission; Competitive Research Fund of Pirkanmaa Hospital District	This research was supported by the Academy of Finland and the Competitive Research Fund of Pirkanmaa Hospital District.	Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; [Anonymous], 2008, CURR CAR GUID; Bates D.M., 2010, LME4 MIXED EFFECTS M; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Bramham J, 2009, J NEUROPSYCHOL, V3, P125, DOI 10.1348/174866408X293994; Braver TS, 2010, CURR OPIN NEUROBIOL, V20, P242, DOI 10.1016/j.conb.2010.03.002; Carretie L, 2014, COGN AFFECT BEHAV NE, V14, P1228, DOI 10.3758/s13415-014-0270-2; Chen AJW, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00187; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Daffner KR, 2000, J COGNITIVE NEUROSCI, V12, P393, DOI 10.1162/089892900562219; Daffner KR, 1998, NEUROREPORT, V9, P787, DOI 10.1097/00001756-199803300-00004; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dixon P, 2008, J MEM LANG, V59, P447, DOI 10.1016/j.jml.2007.11.004; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hartikainen K., 2003, DETECTION CHANGE EVE, P99, DOI DOI 10.1007/978-1-4615-0294-4; Hartikainen KM, 2007, NEUROREPORT, V18, P1929, DOI 10.1097/WNR.0b013e3282f1ca18; Hartikainen KM, 2014, J CLIN EXP NEUROPSYC, V36, P540, DOI 10.1080/13803395.2014.913554; Hartikainen KM, 2012, J CLIN EXP NEUROPSYC, V34, P588, DOI 10.1080/13803395.2012.666231; Hartikainen KM, 2012, NEUROREPORT, V23, P447, DOI 10.1097/WNR.0b013e3283531e74; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hartikainen KM, 2010, NEUROREPORT, V21, P344, DOI 10.1097/WNR.0b013e328336eeb3; Hartikainen KM, 2000, NEUROPSYCHOLOGIA, V38, P1576, DOI 10.1016/S0028-3932(00)00072-5; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Liimatainen J., 2016, INTERACT J CARDIOVAS; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Lovstad M, 2012, J COGNITIVE NEUROSCI, V24, P378, DOI 10.1162/jocn_a_00099; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Maki-Marttunen V, 2014, NEUROREPORT, V25, P1038, DOI 10.1097/WNR.0000000000000223; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Oliveira L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00364; Padmala S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00192; Papazacharias A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00097; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; R Core Team, 2018, R LANGUAGE ENV STAT; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Sakaki M, 2012, COGN AFFECT BEHAV NE, V12, P115, DOI 10.3758/s13415-011-0062-x; Seidenberg M, 2009, FUTUR NEUROL, V4, P663, DOI 10.2217/FNL.09.32; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Solbakk AK, 2014, SCAND J PSYCHOL, V55, P233, DOI 10.1111/sjop.12106; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sun LH, 2015, NEUROPSYCHOLOGIA, V78, P88, DOI 10.1016/j.neuropsychologia.2015.10.001; Szczepanski SM, 2014, NEURON, V83, P1002, DOI 10.1016/j.neuron.2014.08.011; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Vuilleumier P, 2001, NEUROREPORT, V12, P1119, DOI 10.1097/00001756-200105080-00014; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012	70	16	17	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					400	413		10.1089/neu.2015.4390			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800016	27502875				2022-02-06	
J	Beretta, S; Cunningham, KM; Haus, DL; Gold, EM; Perez, H; Lopez-Velazquez, L; Cummings, BJ				Beretta, Stefania; Cunningham, Kelly M.; Haus, Daniel L.; Gold, Eric M.; Perez, Harvey; Lopez-Velazquez, Luci; Cummings, Brian J.			Effects of Human ES-Derived Neural Stem Cell Transplantation and Kindling in a Rat Model of Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article						traumatic brain injury (TBI); controlled cortical impact (CCI); human neural stem cell; cell transplantation; posttraumatic hyperexcitability; kindling model; spatial-hippocampal memory; emotional memory	SPINAL-CORD; POSTTRAUMATIC EPILEPSY; ELECTRICAL-STIMULATION; ANIMAL-MODELS; UNITED-STATES; SEIZURES; DISEASE; PILOCARPINE; ENGRAFTMENT; MECHANISMS	Traumatic brain injury (TBI) is one of the leading causes of death and disability in the population worldwide, with a broad spectrum of symptoms and disabilities. Posttraumatic hyperexcitability is one of the most common neurological disorders that affect people after a head injury. A reliable animal model of posttraumatic hyperexcitability induced by TBI which allows one to test effective treatment strategies is yet to be developed. To address these issues, in the present study, we tested human embryonic stem cell-derived neural stem cell (NSC) transplantation in an animal model of posttraumatic hyperexcitability in which the brain injury was produced in one hemisphere of immunodeficient athymic nude rats by controlled cortical impact, and spontaneous seizures were produced by repeated electrical stimulation (kindling) in the contralateral hemisphere. At 14 wk posttransplantation, we report human NSC (hNSC) survival and differentiation into all 3 neural lineages in both sham and injured animals. We observed twice as many surviving hNSCs in the injured versus sham brain, and worse survival on the kindled side in both groups, indicating that kindling/seizures are detrimental to survival or proliferation of hNSCs. We also replicated our previous finding that hNSCs can ameliorate deficits on the novel place recognition task, 33 but such improvements are abolished following kindling. We found no significant differences pre-or post-kindling on the elevated plus maze. No significant correlations were observed between hNSC survival and cognitive performance on either task. Together these findings suggest that Shef6-derived hNSCs may be beneficial as a therapy for TBI, but not in animals or patients with posttraumatic hyperexcitability.	[Beretta, Stefania] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Cunningham, Kelly M.; Perez, Harvey; Lopez-Velazquez, Luci; Cummings, Brian J.] Univ Calif Irvine, UCI Inst Memory Impairments & Neurol Disorders MI, Irvine, CA USA; [Haus, Daniel L.; Gold, Eric M.; Cummings, Brian J.] Univ Calif Irvine, Sue & Bill Gross Cell Ctr, Irvine, CA USA; [Haus, Daniel L.; Gold, Eric M.; Cummings, Brian J.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Cummings, Brian J.] Univ Calif Irvine, Phys & Med Rehabil, Irvine, CA USA		Cummings, BJ (corresponding author), Univ Calif Irvine, Room 2026,Gross Hall,845 Hlth Sci Rd, Irvine, CA 92697 USA.	cummings@uci.edu	Cummings, Brian J/C-9180-2012	Cummings, Brian J/0000-0003-3628-5290; beretta, stefania/0000-0003-1334-119X	Early Translation Award grant from CIRM [TR2-01767]; CIRM Bridges award [TB1-01182]; University of Milano-Bicocca	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funded by an Early Translation Award grant from CIRM (TR2-01767) to BJC, a CIRM Bridges award to L Klig at CUSLB (TB1-01182) to support KMC, and a fellowship from the University of Milano-Bicocca to SB.	Ager RR, 2015, HIPPOCAMPUS, V25, P813, DOI 10.1002/hipo.22405; Ahmed AI, 2016, J ROY ARMY MED CORPS, V162, P98, DOI 10.1136/jramc-2015-000475; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; Chang J, 2015, EXP NEUROL, V273, P225, DOI 10.1016/j.expneurol.2015.08.020; Chu K, 2004, BRAIN RES, V1023, P213, DOI 10.1016/j.brainres.2004.07.045; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Echegoyen J, 2009, EPILEPSY RES, V85, P123, DOI 10.1016/j.eplepsyres.2009.02.019; Englander Jeffrey, 2014, Arch Phys Med Rehabil, V95, P1223, DOI 10.1016/j.apmr.2013.06.002; Erkec OE, 2015, EPILEPSI, V21, P6, DOI 10.5505/epilepsi.2015.08108; Eslami M, 2016, NEUROL RES, V38, P269, DOI 10.1179/1743132815Y.0000000086; Faul M, 2010, TRAUMATIC BRAIN INJU, P11; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gerberding J, 2003, REPORT C MILD TRAUMA, P1; Ghafouri S, 2016, EPILEPSY RES, V126, P37, DOI 10.1016/j.eplepsyres.2016.06.010; Glushakov AV, 2016, METHODS MOL BIOL, V1462, P481, DOI 10.1007/978-1-4939-3816-2_27; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Haus DL, 2014, STEM CELL RES, V13, P214, DOI 10.1016/j.scr.2014.06.008; Hefferan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042614; Hooshmand MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005871; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Kirmani BF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00032; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Majores M, 2007, EPILEPSIA, V48, P4, DOI 10.1111/j.1528-1167.2007.01062.x; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morales JC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00200; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Parent JM, 1997, J NEUROSCI, V17, P3727; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Pires F, 2015, BBA-GEN SUBJECTS, V1850, P1158, DOI 10.1016/j.bbagen.2015.01.020; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Sontag CJ, 2014, STEM CELL REP, V2, P620, DOI 10.1016/j.stemcr.2014.03.005; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Watson NF, 2004, EPILEPSIA, V45, P690, DOI 10.1111/j.0013-9580.2004.59403.x; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; World Health Organization, 2006, NEUROLOGICAL DISORDE, P164; Xiang Y, 2014, NEURAL REGEN RES, V9, P243, DOI 10.4103/1673-5374.128215; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	53	16	18	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2017	26	7					1247	1261		10.1177/0963689717714107			15	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cell Biology; Research & Experimental Medicine; Transplantation	EZ4GO	WOS:000404671800012	28933218	Green Published, gold, Green Submitted			2022-02-06	
J	Brekke, E; Berger, HR; Wideroe, M; Sonnewald, U; Morken, TS				Brekke, Eva; Berger, Hester Rijkje; Wideroe, Marius; Sonnewald, Ursula; Morken, Tora Sund			Glucose and Intermediary Metabolism and Astrocyte-Neuron Interactions Following Neonatal Hypoxia-Ischemia in Rat	NEUROCHEMICAL RESEARCH			English	Article						Glucose metabolism; Astrocyte-neuron interactions; Neonatal hypoxia-ischemia; C-13 NMR; Pentose-phosphate-pathway; Glutamate-glutamine cycle; Pyruvate carboxylation	PENTOSE-PHOSPHATE PATHWAY; MAGNETIC-RESONANCE-SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; TRANSPORTER GENE-EXPRESSION; SECONDARY ENERGY FAILURE; EXCITATORY AMINO-ACIDS; CEREBRAL-BLOOD-FLOW; WHITE-MATTER INJURY; NMDA-BINDING-SITES; IMMATURE RAT	Neonatal hypoxia-ischemia (HI) and the delayed injury cascade that follows involve excitotoxicity, oxidative stress and mitochondrial failure. The susceptibility to excitotoxicity of the neonatal brain may be related to the capacity of astrocytes for glutamate uptake. Furthermore, the neonatal brain is vulnerable to oxidative stress, and the pentose phosphate pathway (PPP) may be of particular importance for limiting this kind of injury. Also, in the neonatal brain, neurons depend upon de novo synthesis of neurotransmitters via pyruvate carboxylase in astrocytes to increase neurotransmitter pools during normal brain development. Several recent publications describing intermediary brain metabolism following neonatal HI have yielded interesting results: (1) Following HI there is a prolonged depression of mitochondrial metabolism in agreement with emerging evidence of mitochondria as vulnerable targets in the delayed injury cascade. (2) Astrocytes, like neurons, are metabolically impaired following HI, and the degree of astrocytic malfunction may be an indicator of the outcome following hypoxic and hypoxic-ischemic brain injury. (3) Glutamate transfer from neurons to astrocytes is not increased following neonatal HI, which may imply that astrocytes fail to upregulate glutamate uptake in response to the massive glutamate release during HI, thus contributing to excitotoxicity. (4) In the neonatal brain, the activity of the PPP is reduced following HI, which may add to the susceptibility of the neonatal brain to oxidative stress. The present review aims to discuss the metabolic temporal alterations observed in the neonatal brain following HI.	[Brekke, Eva; Sonnewald, Ursula] Norwegian Univ Sci & Technol NTNU, Dept Neurosci, N-7489 Trondheim, Norway; [Brekke, Eva] Bodo Hosp, Dept Neurol, Bodo, Norway; [Berger, Hester Rijkje; Morken, Tora Sund] NTNU, Dept Lab Med, Childrens & Womens Hlth, N-7489 Trondheim, Norway; [Berger, Hester Rijkje] Univ Trondheim Hosp, Dept Pediat, St Olavs Hosp, N-7006 Trondheim, Norway; [Wideroe, Marius] NTNU, Dept Circulat & Med Imaging, N-7489 Trondheim, Norway; [Sonnewald, Ursula] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Morken, Tora Sund] Univ Trondheim Hosp, St Olavs Hosp, Dept Ophthalmol, N-7006 Trondheim, Norway		Morken, TS (corresponding author), NTNU, Dept Lab Med, Childrens & Womens Hlth, N-7489 Trondheim, Norway.; Morken, TS (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Ophthalmol, N-7006 Trondheim, Norway.	tora.sund.morken@stolav.no					Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Ben-Ari Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00035; BenYoseph O, 1996, NEUROCHEM RES, V21, P1005, DOI 10.1007/BF02532410; Berger HR, 2016, J NEUROCHEM, V136, P339, DOI 10.1111/jnc.13420; BONDY CA, 1992, MOL CELL NEUROSCI, V3, P305, DOI 10.1016/1044-7431(92)90027-Y; Borges K, 2012, EPILEPSY RES, V100, P239, DOI 10.1016/j.eplepsyres.2011.05.023; Brekke E, 2015, NEUROCHEM INT, V82, P33, DOI 10.1016/j.neuint.2015.02.002; Brekke EMF, 2014, J CEREBR BLOOD F MET, V34, P724, DOI 10.1038/jcbfm.2014.8; Brooks KJ, 2002, NEUROCHEM RES, V27, P1599, DOI 10.1023/A:1021622724485; Buckley EM, 2015, DEV NEUROSCI-BASEL, V37, P407, DOI 10.1159/000381704; Chowdhury GMI, 2007, J CEREBR BLOOD F MET, V27, P1895, DOI 10.1038/sj.jcbfm.9600490; Clarke DD, 1999, BASIC NEUROCHEMISTRY, V6th; Corbo ET, 2012, PEDIATR RES, V71, P85, DOI 10.1038/pr.2011.8; CREMER JE, 1982, J CEREBR BLOOD F MET, V2, P394, DOI 10.1038/jcbfm.1982.45; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dehaes M, 2014, J CEREBR BLOOD F MET, V34, P87, DOI 10.1038/jcbfm.2013.165; Demarest TG, 2016, J NEUROCHEM, V137, P714, DOI 10.1111/jnc.13590; DIETRICH WD, 1993, STROKE, V24, P111, DOI 10.1161/01.STR.24.1.111; DOMBROWSKI GJ, 1989, NEUROCHEM RES, V14, P667, DOI 10.1007/BF00964877; Drury PP, 2010, SEMIN FETAL NEONAT M, V15, P287, DOI 10.1016/j.siny.2010.05.005; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; Fullerton HJ, 1998, ANN NEUROL, V44, P357, DOI 10.1002/ana.410440311; Furuta A, 1997, J NEUROSCI, V17, P8363; Haberg A, 2001, J CEREBR BLOOD F MET, V21, P1451, DOI 10.1097/00004647-200112000-00010; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jantzie LL, 2015, CEREB CORTEX, V25, P482, DOI 10.1093/cercor/bht246; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Johnston MV, 2005, BRAIN PATHOL, V15, P234; Koehler-Stec EM, 1998, AM J PHYSIOL-ENDOC M, V275, pE516, DOI 10.1152/ajpendo.1998.275.3.E516; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; KUNNECKE B, 1993, NMR BIOMED, V6, P264, DOI 10.1002/nbm.1940060406; Kusaka T, 2004, PEDIATR RES, V55, P273, DOI 10.1203/01.PDR.0000102702.39608.82; LAPTOOK AR, 1995, PEDIATR RES, V38, P919, DOI 10.1203/00006450-199512000-00015; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Liu J, 2013, ANESTHESIOLOGY, V119, P1120, DOI 10.1097/ALN.0b013e31829c2d90; Liu J, 2013, PEDIATR RES, V74, P170, DOI 10.1038/pr.2013.88; Liu J, 2011, J CEREBR BLOOD F MET, V31, P547, DOI 10.1038/jcbfm.2010.125; Maltepe E, 2009, PEDIATR RES, V65, P261, DOI 10.1203/PDR.0b013e31818fc83f; McKenna MC, 2015, NEUROCHEM RES, V40, P2527, DOI 10.1007/s11064-015-1600-7; McKenna MC, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P200; McKenna MC, 1995, NEUROCHEM RES, V20, P1491, DOI 10.1007/BF00970599; McKenna MC, 1996, J NEUROCHEM, V66, P386; McKenna MC, 2000, NEUROCHEM INT, V36, P451, DOI 10.1016/S0197-0186(99)00148-5; McQuillen PS, 2004, PEDIATR NEUROL, V30, P227, DOI 10.1016/j.pediatrneurol.2003.10.001; MICHEVA KD, 1995, EUR J NEUROSCI, V7, P419, DOI 10.1111/j.1460-9568.1995.tb00338.x; Morken TS, 2014, STROKE, V45, P2777, DOI 10.1161/STROKEAHA.114.005341; Morken TS, 2014, NEUROCHEM RES, V39, P556, DOI 10.1007/s11064-013-1014-3; Morken TS, 2013, PEDIATR RES, V73, P171, DOI 10.1038/pr.2012.170; MUJSCE DJ, 1990, PEDIATR RES, V27, P450, DOI 10.1203/00006450-199005000-00007; Nehlig A, 2004, PROSTAG LEUKOTR ESS, V70, P265, DOI 10.1016/j.plefa.2003.07.006; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Nijboer CH, 2013, NEUROBIOL DIS, V54, P206, DOI 10.1016/j.nbd.2012.12.013; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; PALMER C, 1990, J CEREBR BLOOD F MET, V10, P227, DOI 10.1038/jcbfm.1990.39; PATEL MS, 1974, J NEUROCHEM, V22, P717, DOI 10.1111/j.1471-4159.1974.tb04285.x; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; PukaSundvall M, 1997, BRAIN RES, V750, P325, DOI 10.1016/S0006-8993(97)00024-3; PukaSundvall M, 1996, METAB BRAIN DIS, V11, P109, DOI 10.1007/BF02069499; REPRESA A, 1989, NEUROSCI LETT, V99, P61, DOI 10.1016/0304-3940(89)90265-6; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Rodriguez-Rodriguez P, 2012, CELL DEATH DIFFER, V19, P1582, DOI 10.1038/cdd.2012.33; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Schousboe A, 2000, NEUROCHEM RES, V25, P1241, DOI 10.1023/A:1007692012048; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sheldon RA, 2004, PEDIATR RES, V56, P656, DOI 10.1203/01.PDR.0000139413.27864.50; Sipila S, 2004, J NEUROSCI, V24, P5877, DOI 10.1523/JNEUROSCI.1287-04.2004; SONNEWALD U, 1994, NEUROCHEM INT, V24, P473, DOI 10.1016/0197-0186(94)90095-7; Sonnewald U, 2014, J NEUROCHEM, V131, P399, DOI 10.1111/jnc.12812; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; Taylor DL, 2002, PEDIATR RES, V51, P13, DOI 10.1203/00006450-200201000-00005; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; TREMBLAY E, 1988, BRAIN RES, V461, P393, DOI 10.1016/0006-8993(88)90275-2; Tyzio R, 1999, J NEUROSCI, V19, P10372; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P185, DOI 10.1159/000085991; Vannucci RC, 2004, J CEREBR BLOOD F MET, V24, P1090, DOI 10.1097/01.WCB.0000133250.03953.63; Vannucci RC, 1996, J CEREBR BLOOD F MET, V16, P1026, DOI 10.1097/00004647-199609000-00028; VANNUCCI RC, 1976, AM J PHYSIOL, V230, P1269, DOI 10.1152/ajplegacy.1976.230.5.1269; Vannucci RC, 1999, DEV BRAIN RES, V118, P147, DOI 10.1016/S0165-3806(99)00142-X; VANNUCCI RC, 1988, STROKE, V19, P245, DOI 10.1161/01.STR.19.2.245; VANNUCCI RC, 1994, J CEREBR BLOOD F MET, V14, P279, DOI 10.1038/jcbfm.1994.35; Vannucci SJ, 1998, DEV BRAIN RES, V107, P255, DOI 10.1016/S0165-3806(98)00021-2; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; VANNUCCI SJ, 1980, J NEUROCHEM, V34, P1100, DOI 10.1111/j.1471-4159.1980.tb09946.x; VANNUCCI SJ, 1994, MOL CELL BIOCHEM, V140, P177, DOI 10.1007/BF00926756; Vannucci SJ, 1996, J CEREBR BLOOD F MET, V16, P77, DOI 10.1097/00004647-199601000-00009; VANNUCCI SJ, 1994, J NEUROCHEM, V62, P240; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Vitellaro-Zuccarello L, 2003, CELL TISSUE RES, V313, P245, DOI 10.1007/s00441-003-0746-9; Wallin C, 2000, DEV BRAIN RES, V125, P51, DOI 10.1016/S0165-3806(00)00112-7; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; WELSH FA, 1982, J CEREBR BLOOD F MET, V2, P221, DOI 10.1038/jcbfm.1982.22; Wideroe M, 2012, EUR J NEUROSCI, V36, P2006, DOI 10.1111/j.1460-9568.2012.08114.x; Wideroe M, 2009, NEUROIMAGE, V45, P880, DOI 10.1016/j.neuroimage.2008.12.007; WILBUR DO, 1974, J NEUROCHEM, V22, P709, DOI 10.1111/j.1471-4159.1974.tb04284.x; Williams GD, 1997, PEDIATR RES, V42, P700, DOI 10.1203/00006450-199711000-00024; Wisnowski JL, 2016, J CEREBR BLOOD F MET, V36, P1075, DOI 10.1177/0271678X15607881; Xu LJ, 2001, EXP NEUROL, V169, P416, DOI 10.1006/exnr.2001.7678; Xu S, 2015, MAGN RESON MED, V74, P1530, DOI 10.1002/mrm.25537; YAGER JY, 1991, AM J PHYSIOL, V261, pH1102, DOI 10.1152/ajpheart.1991.261.4.H1102; YAN XX, 1992, DEV BRAIN RES, V65, P191, DOI 10.1016/0165-3806(92)90179-Z; YU ACH, 1983, J NEUROCHEM, V41, P1484, DOI 10.1111/j.1471-4159.1983.tb00849.x	111	16	16	0	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JAN	2017	42	1			SI		115	132		10.1007/s11064-016-2149-9			18	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EK4TD	WOS:000393918800011	28019006				2022-02-06	
J	Cusimano, MD; Zhang, S; Topolovec-Vranic, J; Hutchison, MG; Jing, R				Cusimano, Michael D.; Zhang, Stanley; Topolovec-Vranic, Jane; Hutchison, Michael G.; Jing, Rowan			Factors affecting the concussion knowledge of athletes, parents, coaches, and medical professionals	SAGE OPEN MEDICINE			English	Article						Concussion; traumatic brain injury; sports; knowledge; public health; prevention	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; FOR-DISEASE-CONTROL; HIGH-SCHOOL SPORTS; RACIAL DISPARITIES; UNITED-STATES; PREVENTION; EDUCATION; HEADS; ADOLESCENTS	Objectives: To determine the predictors of knowledge and awareness of concussion symptoms and outcomes through a survey of athletes, parents of players and coaches in sports settings in Canada. Methods: A cross-sectional survey of athletic communities in Canada was conducted. Respondents' concussion knowledge score consists of responses to questions about the symptoms, diagnosis, and treatment of a concussion and the timing of return-to-sport post-concussion. The percentage of correct responses was defined as the "identification rate." The extent to which participant factors affected the scores was examined by univariate and multivariate analyses. Results: Respondents were able to identify a mean of 80.6% of symptoms. Cognitive symptoms were most commonly known, and mental health symptoms associated with concussion were least known, and health professionals, coaches, and those with a personal history of concussion had the highest levels of overall knowledge. Language, age, educational level, annual household income, and traumatic brain injury history were good predictors of better concussion knowledge. Conclusion: Those designing and implementing interventions aimed at concussion management and prevention should ensure that younger, lower income, lower educational, non-English-speaking persons, and those without experience of traumatic brain injury or concussion be specifically accounted for in the design and implementation of interventions to prevent and treat concussion and mild traumatic brain injury.	[Cusimano, Michael D.; Zhang, Stanley; Topolovec-Vranic, Jane; Jing, Rowan] St Michaels Hosp, Injury Prevent Res Off, Div Neurosurg, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.; Zhang, Stanley; Topolovec-Vranic, Jane; Jing, Rowan] St Michaels Hosp, Trauma & Neurosurg Program, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada		Cusimano, MD (corresponding author), St Michaels Hosp, Injury Prevent Res Off, Div Neurosurg, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.; Cusimano, MD (corresponding author), St Michaels Hosp, Trauma & Neurosurg Program, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Topolovec-Vranic, Jane/A-5293-2013; Cusimano, Michael/X-4059-2019	Topolovec-Vranic, Jane/0000-0001-7695-4212; 	Public Health Agency of Canada; Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research was partially supported by the Public Health Agency of Canada (M.D.C), the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 (M.D.C), and the Ontario Neurotrauma Foundation (M.D.C).	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Asoogo C, 2015, CURATIONIS, V38, DOI [10.4102/curationisv38i1.1287, DOI 10.4102/CURATIONISV38I1.1287]; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Cao ZJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-26; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Gelaw Sifrash Meseret, 2016, Tuberc Res Treat, V2016, P6207457, DOI 10.1155/2016/6207457; Gonçalves Helen, 2013, Rev. bras. epidemiol., V16, P420, DOI 10.1590/S1415-790X2013000200017; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hutton A, 2015, PREHOSP DISASTER MED, V30, P175, DOI 10.1017/S1049023X15000187; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; Menger R, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15615; Montgomery M, 2014, QUEBEC IGNORES CONCU; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; National Coaching Certification Program, NAT COACH CERT PROGR; Nonzee NJ, 2015, J WOMENS HEALTH, V24, P506, DOI 10.1089/jwh.2014.4998; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; North Vancouver Minor Hockey Association, CONC AW TRAIN TOOL C; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Papa L, 2013, CURR TRANSL GERIATR, V1, P135; Paz-Soldan VA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00281; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Runyan CW, 2000, AM J PREV MED, V18, P116, DOI 10.1016/S0749-3797(00)00147-1; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shermer CR, 2007, J TRAUMA, V63, P1268; Statistics Canada, 2009, TYP MOST SER INJ PEO; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Theye Fred, 2004, Clin Med Res, V2, P165; Topolovec-Vranic J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141699; Tucker-Drob EM, 2012, PERS INDIV DIFFER, V53, P9, DOI 10.1016/j.paid.2012.02.004; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Weber M, 2012, ARCH CLIN NEUROPSYCH, V27, P355, DOI 10.1093/arclin/acs029; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482; Zhang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070563; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	54	16	16	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2050-3121			SAGE OPEN MED	SAGE Open Med.	JAN-DEC	2017	5									10.1177/2050312117699799			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	GS3AT	WOS:000443441700011	28540042				2022-02-06	
J	de Koning, ME; Scheenen, ME; van der Horn, HJ; Hageman, G; Roks, G; Yilmaz, T; Spikman, JM; van der Naalt, J				de Koning, M. E.; Scheenen, M. E.; van der Horn, H. J.; Hageman, G.; Roks, G.; Yilmaz, T.; Spikman, J. M.; van der Naalt, J.			Outpatient follow-up after mild traumatic brain injury: Results of the UPFRONT-study	BRAIN INJURY			English	Article						Mild traumatic brain injury; follow-up; hospital admission; outcome; guideline	HEAD-INJURY; SYMPTOMS; MODERATE; TOMOGRAPHY; COMPLAINTS; WORK; BIAS; CARE	Objective: To investigate outpatient follow-up after mild traumatic brain injury (mTBI) by various medical specialists, for both hospitalized and non-hospitalized patients, and to study guideline adherence regarding hospital admission. Methods: Patients (n = 1151) with mTBI recruited from the emergency department received questionnaires 2 weeks (n = 879), 3 months (n = 780) and 6 months (n = 668) after injury comprising outpatient follow-up by various health care providers, and outcome defined by the Glasgow Outcome Scale Extended (GOS-E) after 6 months. Results: Hospitalized patients (60%) were older (46.6 +/- 19.9 vs. 40.6 +/- 18.5 years), more severely injured (GCS <15, 50% vs. 13%) with more Computed Tomography (CT) abnormalities on admission (21% vs. 2%) compared to non-hospitalized patients (p < 0.01). Almost half of the patients visited a neurologist at the outpatient clinic within six months,(60% of the hospitalized and 25% of the non-hospitalized patients (x(2) = 67.10, p < 0.01)), and approximately ten per cent consulted a psychiatrist/psychologist. Outcome was unfavourable (GOS-E <7) in 34% of hospitalized and 21% of non-hospitalized patients (x(2) = 11.89, p <0.01). Conclusion: Two-thirds of all mTBI patients consult one or more specialists within six months after injury, with 30% having an unfavourable outcome. A quarter of non-hospitalized: patients was seen at the outpatient neurology clinic, underling the importance of regular follow-up of mTBI patients irrespective of hospital admittance.	[de Koning, M. E.; van der Horn, H. J.; van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Scheenen, M. E.; Spikman, J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands; [Hageman, G.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [Roks, G.; Yilmaz, T.] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands		van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	j.van.der.naalt@umcg.nl		Roks, Gerwin/0000-0002-1393-9848; van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [PS2012-06]	This study was funded by the Dutch Brain Foundation (Grant no. PS2012-06).The authors report no declaration of interest.	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Faul M, 2010, CTR DIS CONTROL PREY, P2; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Matuseviciene G, 2015, ORIGINAL REPORT EFFE; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Patel MB, 2015, J NEUROTRAUM, V6; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vikane E, 2014, BRAIN INJURY, V9052, P1; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	31	16	16	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	8					1102	1108		10.1080/02699052.2017.1296193			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FC3JI	WOS:000406734500010	28481634	hybrid, Green Published			2022-02-06	
J	Dennis, EL; Faskowitz, J; Rashid, F; Babikian, T; Mink, R; Babbitt, C; Johnson, J; Giza, CC; Jahanshad, N; Thompson, PM; Asarnow, RF				Dennis, Emily L.; Faskowitz, Joshua; Rashid, Faisal; Babikian, Talin; Mink, Richard; Babbitt, Christopher; Johnson, Jeffrey; Giza, Christopher C.; Jahanshad, Neda; Thompson, Paul M.; Asarnow, Robert F.			Diverging volumetric trajectories following pediatric traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Tensor-based morphometry; Pediatric; Traumatic brain injury; Longitudinal	TENSOR-BASED MORPHOMETRY; CORPUS-CALLOSUM; PITUITARY DYSFUNCTION; ALZHEIMERS-DISEASE; CHILDREN; MRI; MODERATE; OUTCOMES; GROWTH	Traumatic brain injury (TBI) is a significant public health concern, and can be especially disruptive in children, derailing on-going neuronal maturation in periods critical for cognitive development. There is considerable heterogeneity in post-injury outcomes, only partially explained by injury severity. Understanding the time course of recovery, and what factors may delay or promote recovery, will aid clinicians in decision-making and provide avenues for future mechanism-based therapeutics. We examined regional changes in brain volume in a pediatric/adolescent moderate-severe TBI (msTBI) cohort, assessed at two time points. Children were first assessed 2-5 months post-injury, and again 12 months later. We used tensor-based morphometry (TBM) to localize longitudinal volume expansion and reduction. We studied 21 msTBI patients (5 F, 8-18 years old) and 26 well-matched healthy control children, also assessed twice over the same interval. In a prior paper, we identified a subgroup of msTBI patients, based on interhemispheric transfer time (IHTT), with significant structural disruption of the white matter (WM) at 2-5 months post injury. We investigated how this subgroup (TBI-slow, N = 11) differed in longitudinal regional volume changes from msTBI patients (TBI-normal, N= 10) with normal WM structure and function. The TBI-slow group had longitudinal decreases in brain volume in several WM clusters, including the corpus callosum and hypothalamus, while the TBI-normal group showed increased volume in WM areas. Our results show prolonged atrophy of the WM over the first 18 months postinjury in the TBI-slow group. The TBI-normal group shows a different pattern that could indicate a return to a healthy trajectory.	[Dennis, Emily L.; Faskowitz, Joshua; Rashid, Faisal; Jahanshad, Neda; Thompson, Paul M.] Univ Southern Calif, Keck Sch Med, Mark & Mary Stevens Inst Neuroimaging & Informat, Imaging Genet Ctr, Marina Del Rey, CA 90292 USA; [Babikian, Talin; Asarnow, Robert F.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Mink, Richard] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Mink, Richard] Los Angeles BioMed Res Inst, Dept Pediat, Torrance, CA 90509 USA; [Babbitt, Christopher] Miller Childrens Hosp, Long Beach, CA 90806 USA; [Johnson, Jeffrey] LAC USC Med Ctr, Dept Pediat, Los Angeles, CA 90033 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Steve Tisch BrainSPORT Program, Dept Neurosurg, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Mattel Childrens Hosp, Div Pediat Neurol, Los Angeles, CA 90095 USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA 90033 USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA 90033 USA; [Thompson, Paul M.] USC, Dept Psychiat, Los Angeles, CA 90033 USA; [Thompson, Paul M.] USC, Dept Radiol, Los Angeles, CA 90033 USA; [Thompson, Paul M.] USC, Dept Engn, Los Angeles, CA 90033 USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Giza, Christopher C.; Asarnow, Robert F.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA		Dennis, EL (corresponding author), Univ Southern Calif, Keck Sch Med, 2001 N Soto St, Los Angeles, CA 90033 USA.	emily.dennis@ini.usc.edu	Faskowitz, Joshua/K-1330-2019; Thompson, Paul M/C-4194-2018; Jahanshad, Neda/ABD-5944-2021; Dennis, Emily/AAD-5223-2021	Faskowitz, Joshua/0000-0003-1814-7206; Thompson, Paul M/0000-0002-4720-8867; Dennis, Emily/0000-0001-7112-4009	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD061504]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99 NS096116]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54 EB020403, R01 EB008432, R01 AG040060, R01 NS080655]; NCAA; US Dept of DefenseUnited States Department of Defense; UCLA BIRC; UCLA Steve Tisch BrainSPORT Program; Easton Laboratories for Brain Injury; Staglin IMHRO Center for Cognitive Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB020403, P41EB015922, R01EB008432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99NS096116, R01NS080655, R01NS027544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040060] Funding Source: NIH RePORTER	This study was supported by the NICHD (R01 HD061504). ELD is supported by a grant from the NINDS (K99 NS096116). ELD, FR, JF, and PT are also supported by NIH grants to PT: U54 EB020403, R01 EB008432, R01 AG040060, and R01 NS080655. CCG is supported by grants from NINDS (R01 NS027544, SBIR), NCAA, US Dept of Defense, UCLA BIRC, UCLA Steve Tisch BrainSPORT Program, Easton Laboratories for Brain Injury. Scanning was supported by the Staglin IMHRO Center for Cognitive Neuroscience. We gratefully acknowledge the contributions of Alma Martinez and Alma Ramirez in assisting with participant recruitment and study coordination. Finally, the authors thank the participants and their families for contributing their time to this study.	Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; CROSSON B, 1985, BRAIN LANG, V25, P257, DOI 10.1016/0093-934X(85)90085-9; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC., 1994, CALIFORNIA VERBAL LE; Dennis E.L., 2017, NEUROLOGY; Dennis EL, 2016, J NEUROTRAUM, V33, P840, DOI 10.1089/neu.2015.4012; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dennis Emily L, 2013, Dialogues Clin Neurosci, V15, P359; Ellis M. U., 2015, J NEUROTRAU IN PRESS; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hua X, 2016, NEUROBIOL AGING, V37, P26, DOI 10.1016/j.neurobiolaging.2015.09.018; Hua X, 2013, NEUROIMAGE, V66, P648, DOI 10.1016/j.neuroimage.2012.10.086; Hua X, 2009, HUM BRAIN MAPP, V30, P209, DOI 10.1002/hbm.20498; Hua X, 2008, NEUROIMAGE, V43, P458, DOI 10.1016/j.neuroimage.2008.07.013; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Langers DRM, 2007, NEUROIMAGE, V38, P43, DOI 10.1016/j.neuroimage.2007.07.031; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Luders E, 2010, J NEUROSCI, V30, P10985, DOI 10.1523/JNEUROSCI.5122-09.2010; Maclaren J, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.37; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Wechsler D, 2003, WECHSLER INTELLIGENC; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	41	16	16	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	15						125	135		10.1016/j.nicl.2017.03.014			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG3MN	WOS:000410067200015	28507895	gold, Green Published			2022-02-06	
J	Gardner, AJ; Kohler, RMN; Levi, CR; Iverson, GL				Gardner, Andrew J.; Kohler, Ryan M. N.; Levi, Christopher R.; Iverson, Grant L.			Usefulness of Video Review of Possible Concussions in National Youth Rugby League	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						concussion; video analysis; injury management; return to play	INCIDENT ANALYSIS; INJURY; SPORT; POSITION; MATCH	A new concussion interchange rule (CIR) was introduced in 2014 for the National Rugby League and National Youth Competition (NYC). The CIR allows a player suspected of having sustained a concussion to be removed from play and assessed without an interchange being tallied against the player's team. Participants included all NYC players who used the CIR during the 2014 season. 2 raters completed video analysis of 131 (of a total of 156 reported) uses of the CIR, describing injury characteristics, situational factors, and concussion signs. The incidence rate was 44.9 (95 % CI: 38.5-52.3) uses of the CIR per 1 000 NYC player match hours, or approximately one CIR use every 1.3 games. Apparent loss of consciousness/unresponsiveness was observed in 13 % of cases, clutching the head in 65 %, unsteadiness of gait in 60 %, and a vacant stare in 23 %. Most incidences occurred from a hit-up (82 %). There appeared to be some instances of video evidence of injury but the athlete was cleared to return to play in the same game. Video review appears to be a useful adjunct for identifying players suffering possible concussion. Further research is required on the usefulness of video review for identifying signs of concussive injury.	[Gardner, Andrew J.] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Levi, Christopher R.] Hunter New England Local Hlth Dist, Sports Concuss Program, New Lambton Hts, Australia; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA		Gardner, AJ (corresponding author), Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia.	andrew.gardner@neurogard.com.au		Gardner, Andrew/0000-0001-5031-5586; Levi, Christopher/0000-0002-9474-796X; Iverson, Grant/0000-0001-7348-9570	Hunter Medical Research Institute; Hunter Medical Research Institute - Greaves Family Early Career Fellowship Fund; Mooney-Reed Charitable Foundation	Andrew J. Gardner and Christopher R. Levi have been funded to conduct research into concussion in rugby league through a New South Wales Sporting Injuries Committee-Sports Research & Injury Prevention Scheme Grant, and a Brain Foundation, Australia-Brain Injury Award. Andrew J. Gardner acknowledges sport concussion research fellowship funding from Jennie Thomas, Life Governor of the Hunter Medical Research Institute, and the Hunter Medical Research Institute supported by the Greaves Family Early Career Fellowship Fund. Grant L. Iverson acknowledges support from the Mooney-Reed Charitable Foundation.	Andersen TE, 2003, BRIT J SPORT MED, V37, P226, DOI 10.1136/bjsm.37.3.226; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Gabbett T, 2009, INT J SPORTS SCI COA, V4, P521, DOI 10.1260/174795409790291402; Gabbett TJ, 2005, J STRENGTH COND RES, V19, P749; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner AJ, 2015, BRAIN INJ; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Harriss DJ, 2015, INT J SPORTS MED, V36, P1121, DOI 10.1055/s-0035-1565186; Hoskins W, 2006, J SCI MED SPORT, V9, P46, DOI 10.1016/j.jsams.2006.03.013; Hutchison MG, 2013, BRIT J SPORT MED, P1; IBM Corp, IBM SPSS STAT MAC VE; King D, 2010, INT J PERF ANAL SPOR, V10, P241, DOI 10.1080/24748668.2010.11868519; King DA, 2010, SPORTS MED, V40, P163, DOI 10.2165/11319740-000000000-00000; Koh JO, 2004, BRAIN INJURY, V18, P1287, DOI 10.1080/02699050410001719907; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Miele VJ, 2007, NEUROSURGERY, V60, P307, DOI 10.1227/01.NEU.0000249247.48299.5B; Savage Jason, 2013, J Sports Med (Hindawi Publ Corp), V2013, P304576, DOI 10.1155/2013/304576	23	16	17	0	8	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	JAN	2017	38	1					71	75		10.1055/s-0042-116072			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EG9TI	WOS:000391402000008	27737484				2022-02-06	
J	Gross, BW; Gillio, M; Rinehart, CD; Lynch, CA; Rogers, FB				Gross, Brian W.; Gillio, Maria; Rinehart, Cole D.; Lynch, Caitlin A.; Rogers, Frederick B.			Omega-3 Fatty Acid Supplementation and Warfarin: A Lethal Combination in Traumatic Brain Injury	JOURNAL OF TRAUMA NURSING			English	Article						Bleeding risk; Fish oil; Omega-3 fatty acid; Warfarin		Polyunsaturated fatty acids such as omega-3 eicosapentaenoic acid and omega-6 docosahexaenoic acid, found in over-the-counter fish oil supplements, are often consumed for their beneficial, prophylactic, anti-inflammatory effects. Although the mechanisms of action are not fully known, a diet rich in polyunsaturated fats may reduce the risk of hyperlipidemia, atherosclerosis, high low-density lipoprotein cholesterol levels, hypertension, and inflammatory diseases. Masked by its many benefits, the risks of omega-3 fatty acid supplementation are often underappreciated, particularly its ability to inhibit platelet aggregation and promote bleeding in patients taking anticoagulant medications. The following details the clinical case of an elderly patient taking warfarin and fish oil supplementation whose warfarin-induced coagulopathy could not be reversed after suffering blunt head trauma.	[Gross, Brian W.; Gillio, Maria; Rinehart, Cole D.; Lynch, Caitlin A.; Rogers, Frederick B.] Penn Med Lancaster Gen Hlth, 555 N Duke St, Lancaster, PA 17602 USA		Gross, BW (corresponding author), Penn Med Lancaster Gen Hlth, 555 N Duke St, Lancaster, PA 17602 USA.	bgross2@lghealth.org					Adams RLC, 2009, NEPHROLOGY, V14, P462, DOI 10.1111/j.1440-1797.2009.01128.x; Buckley MS, 2004, ANN PHARMACOTHER, V38, P50, DOI 10.1345/aph.1D007; DYERBERG J, 1981, PHILOS T ROY SOC B, V294, P373, DOI 10.1098/rstb.1981.0113; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Jalili M, 2007, ARCH MED RES, V38, P901, DOI 10.1016/j.arcmed.2007.05.004; King M. W., 2016, INTRO BLOOD COAGULAT; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Mayo Clinic, 2013, OM 3 FATT AC FISH OI; McClaskey EM, 2007, PHARMACOTHERAPY, V27, P152, DOI 10.1592/phco.27.1.152; Stranger M. J., 2012, NUTR REV, V70, P107; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x	11	16	16	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	JAN-FEB	2017	24	1					15	18		10.1097/JTN.0000000000000256			4	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	EI2AK	WOS:000392288100004	28033135				2022-02-06	
J	Harrison, AL; Hunter, EG; Thomas, H; Bordy, P; Stokes, E; Kitzman, P				Harrison, Anne L.; Hunter, Elizabeth G.; Thomas, Heather; Bordy, Paige; Stokes, Erin; Kitzman, Patrick			Living with traumatic brain injury in a rural setting: supports and barriers across the continuum of care	DISABILITY AND REHABILITATION			English	Article						Rehabilitation; neurological injury; rural health care; caregiving	QUALITATIVE RESEARCH; CASE-MANAGEMENT; SERVICES; NEEDS; FAMILIES; PEOPLE; INDIVIDUALS; EXPERIENCE; MODEL; TBI	Purpose: Traumatic brain injury (TBI) is prevalent in Kentucky and comes with a high cost in care and quality of life for individuals and caregivers affected. Many people living with the condition of TBI have unmet needs. Research among people living with TBI in rural areas is limited. The purposes of this study were to (1) increase understanding of the lived experience of people with TBI and caregivers in rural regions of Kentucky across the continuum of their care and (2) provide their perspectives on barriers and facilitators of optimal function and well-being. Methods: A qualitative descriptive interview study was conducted by a multidisciplinary team. Content analysis was completed with data-derived coding and iterative modifications to analysis, coalescing codes into categories and themes. Results: Thirteen people with TBI and six caregivers participated in the interview. Categories that emerged in analysis included the experiences under each locus of care; themes included relationships, functional competence, and participation in meaningful activity. Conclusion: Relationships represented both barriers and facilitators of well-being. Major unmet needs persisted in terms of medical problems, support for caregivers, community linkages, and participation in meaningful activities. Recommendations are made regarding avenues for addressing unmet needs.	[Harrison, Anne L.; Kitzman, Patrick] Univ Kentucky, Dept Rehabil Sci, KARRN, Coll Hlth Sci, Lexington, KY USA; [Hunter, Elizabeth G.] Univ Kentucky, Grad Ctr Gerontol, Coll Publ Hlth, Lexington, KY USA; [Thomas, Heather] Kentucky Outpatient Rehabil Therapy, Lebanon, KY USA; [Bordy, Paige] Advocate Childrens Hosp, Pediat Rehabil & Dev Outpatient Pavil, Oak Lawn, IL USA; [Stokes, Erin] Select Med, Nicholasville, KY USA		Harrison, AL (corresponding author), Room 204J Wethington Bldg,900 S Limestone, Lexington, KY 40536 USA.	alharr01@uky.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-NCMHD-1RC4MD005760]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [RC4MD005760] Funding Source: NIH RePORTER	National Institutes of Health, 10.13039/100000002 [NIH-NCMHD-1RC4MD005760 (Principal Investigators Anne Harrison and Patrick Kitzman)]	Baptiste B, 2015, NEUROREHABILITATION, V36, P301, DOI 10.3233/NRE-151218; Beaven S., 2013, CENTRAL NERVOUS SYST; Bellon M, 2015, BRAIN IMPAIR, V16, P131, DOI 10.1017/BrImp.2015.17; Campbell JL, 2013, SOCIOL METHOD RES, V42, P294, DOI 10.1177/0049124113500475; CDC, CONC SIGNS SYMPT CHE; Cheek J, 2008, QUAL HEALTH RES, V18, P1599, DOI 10.1177/1049732308324865; Clark-Wilson J, 2015, NEUROREHABILITATION, V36, P289, DOI 10.3233/NRE-151217; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Danzl MM, 2013, J RURAL HEALTH, V29, P368, DOI 10.1111/jrh.12023; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Donaldson EA, 2012, CANCER-AM CANCER SOC, V118, P4851, DOI 10.1002/cncr.27487; Duncan PW, 2005, STROKE, V36, pE100, DOI 10.1161/01.STR.0000180861.54180.FF; Espinosa C., 2015, HOME VS I LIVING REL; Gaboda D, 2009, TRAUMATIC BRAIN INJU; Halverson JA, 2004, ANAL DISPARITIES HLT; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Kitzman PH, 2011, J RURAL COMMUNITY D, V6, P95; Lannin NA, 2014, NEUROREHABILITATION, V35, P635, DOI 10.3233/NRE-141161; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lewis FD, 2015, NEUROREHABILITATION, V36, P243, DOI 10.3233/NRE-151213; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; Martin EM, 2010, NEUROREHABILITATION, V26, P279, DOI 10.3233/NRE-2010-0563; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Pistarini C, 2011, DISABIL REHABIL, V33, P2333, DOI 10.3109/09638288.2011.570414; Poston KM, 2014, J NURS CARE QUAL, V29, P237, DOI 10.1097/NCQ.0000000000000040; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Salter K, 2011, BRAIN INJURY, V25, P1147, DOI 10.3109/02699052.2011.613088; Saman DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-108; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Sample PL, 2005, J HEAD TRAUMA REHAB, V20, P270, DOI 10.1097/00001199-200505000-00009; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Schoenberg NE, 2015, SOUTH MED J, V108, P170, DOI 10.14423/SMJ.0000000000000245; Schootman M, 1999, BRAIN INJURY, V13, P995; Solovieva TI, 2014, J REHABIL, V80, P10; Trudel TM, 2011, EXCEPTIONAL PARENT, V41, P33; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, P535; US Department of Agriculture, RUR URB CONT COD; Walker R, 2004, STUDY PREPARED KENTU; WHO, 2002, INN CAR CHRON COND; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	49	16	16	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	20					2071	2080		10.1080/09638288.2016.1217081			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FC3BI	WOS:000406712900008	27549899	Green Accepted, Green Published			2022-02-06	
J	Lau, L; Basso, MR; Estevis, E; Miller, A; Whiteside, DM; Combs, D; Arentsen, TJ				Lau, Lily; Basso, Michael R.; Estevis, Eduardo; Miller, Ashley; Whiteside, Douglas M.; Combs, Dennis; Arentsen, Timothy J.			Detecting coached neuropsychological dysfunction: a simulation experiment regarding mild traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Coaching; performance validity tests; symptom validity tests	MALINGERED SYMPTOMATOLOGY SIMS; MMPI-2-RF VALIDITY SCALES; RESPONSE BIAS; STRUCTURED INVENTORY; AMERICAN ACADEMY; BASE RATES; VALIDATION; PERFORMANCE; DISABILITY; CLAIMANTS	Objective: Performance validity tests (PVTs) and symptom validity tests (SVTs) are often administered during neuropsychological evaluations. Examinees may be coached to avoid detection by measures of response validity. Relatively little research has evaluated whether graduated levels of coaching has differential effects upon PVT and SVT performance. Accordingly, the present experiment evaluated the effect of graduated levels of coaching upon the classification accuracy of commonly used PVTs and SVTs and the currently accepted criterion of failing two or more PVTs or SVTs. Method: Participants simulated symptoms associated with mild traumatic brain injury (TBI). One group was provided superficial information concerning cognitive, emotional, and physical symptoms. Another group was provided detailed information about such symptoms. A third group was provided detailed information about symptoms and guidance how to evade detection by PVTs. These groups were compared to an honest-responding group. Extending prior experiments, stand-alone and embedded PVT measures were administered in addition to SVTs. Results: The three simulator groups were readily identified by PVTs and SVTs, but a meaningful minority of those provided test-taking strategies eluded detection. The Word Memory Test emerged as the most sensitive indicator of simulated mild TBI symptoms. PVTs achieved more sensitive detection of simulated head injury status than SVTs. Conclusions: Individuals coached to modify test-taking performance were marginally more successful in eluding detection by PVTs and SVTs than those coached with respect to TBI symptoms only. When the criterion of failing two or more PVTs or SVTs was applied, only 5% eluded detection.	[Lau, Lily; Basso, Michael R.; Estevis, Eduardo; Miller, Ashley] Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA; [Whiteside, Douglas M.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Combs, Dennis] Univ Texas Tyler, Dept Psychol, Tyler, TX 75799 USA; [Arentsen, Timothy J.] VA Med Ctr, Dept Psychol, Memphis, TN USA		Basso, MR (corresponding author), Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA.	michael-basso@utulsa.edu	Whiteside, Douglas/AAK-6396-2020; Basso, Michael/S-9587-2019	Basso, Michael/0000-0002-0217-662X; Whiteside, Douglas/0000-0002-8454-4413			Allen L., 1997, CARB 97 MANUAL COMPU; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Bender S., 2008, CLIN ASSESSMENT MALI, P69; Benton A., 1994, CONTRIBUTIONS NEUROP; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Delis D.C., 2000, CALIFORNIA VERBAL LE; DenBoer JW, 2007, CLIN NEUROPSYCHOL, V21, P943, DOI 10.1080/13854040601020783; Dennis K., 2009, ASHA ACCESS AUDIOLOG, V8; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Estevis E., 2014, M INT NEUR SOC; Faul M, 2010, TRAUMATIC BRAIN INJU; Frederick R. I., 1991, PSYCHOL ASSESSMENT J, V3, P596, DOI DOI 10.1037/1040-3590.3.4.596; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2007, ASSESSMENT FEIGNED C, P50; Green P., 2003, MANUAL WORD MEMORY T; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry GK, 2013, CLIN NEUROPSYCHOL, V27, P509, DOI 10.1080/13854046.2012.739644; Iverson G L, 2001, Appl Neuropsychol, V8, P167, DOI 10.1207/S15324826AN0803_6; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Jones A, 2011, CLIN NEUROPSYCHOL, V25, P1207, DOI 10.1080/13854046.2011.600726; LeesHaley PR, 1997, J CLIN PSYCHOL, V53, P745, DOI 10.1002/(SICI)1097-4679(199711)53:7<745::AID-JCLP13>3.3.CO;2-7; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; Martins M, 2010, APPL NEUROPSYCHOL, V17, P177, DOI 10.1080/09084281003715709; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nitch S. R., 2007, ASSESSMENT FEIGNED C, P78; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Ray C. L., 2012, OPEN ACCESS J FORENS, V4, P24; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Schenk K, 2010, J CLIN EXP NEUROPSYC, V32, P752, DOI 10.1080/13803390903512678; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Stevens J.P, 2009, APPL MULTIVARIATE ST; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Tabachnick B.G., 2013, USING MULTIVARIATE S; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tarescavage AM, 2013, CLIN NEUROPSYCHOL, V27, P313, DOI 10.1080/13854046.2012.744099; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 2008, WECHSLER ADULT INTEL; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]; Youngjohn JR, 2011, CLIN NEUROPSYCHOL, V25, P463, DOI [10.1080/13854046.2011.554444, 10.1080/13854046.2010.550635]	55	16	16	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	8					1412	1431		10.1080/13854046.2017.1318954			20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FM2JR	WOS:000414811500013	28415909				2022-02-06	
J	Laukkanen, H; Scheiman, M; Hayes, JR				Laukkanen, Hannu; Scheiman, Mitchell; Hayes, John R.			Brain Injury Vision Symptom Survey (BIVSS) Questionnaire	OPTOMETRY AND VISION SCIENCE			English	Article						mTBI (mild traumatic brain injury); symptoms; survey; questionnaire; BIVSS (Brain Injury Vision Symptom Survey); Rasch; Likert scale	EPIDEMIOLOGY	Purpose. Validation of the Brain Injury Vision Symptom Survey (BIVSS), a self-administered survey for vision symptoms related to traumatic brain injury (TBI). Methods. A 28-item vision symptom questionnaire was completed by 107 adult subjects (mean age 42.1, 16.2 SD, range 18-75) who self-reported as having sustained mild-to-moderate TBI and two groups of reference adult subjects (first-year optometry students: mean age 23.2, 2.8 SD, range 20-39; and 71 third-year optometry students: mean age 26.0, 2.9 SD, range 22-42) without TBI. Both a Likert-style method of analysis with factor analysis and a Rasch analysis were used. Logistic regression was used to determine sensitivity and specificity. Results. At least 27 of 28 questions were completed by 93.5% of TBI subjects, and all 28 items were completed by all of the 157 reference subjects. BIVSS sensitivity was 82.2% for correctly predicting TBI and 90.4% for correctly predicting the optometry students. Factor analysis identified eight latent variables; six factors were positive in their risk for TBI. Other than dry eye and double vision, the TBI patients were significantly more symptomatic than either cohort of optometry students by at least one standard deviation (p < 0.001). Twenty-five of 28 questions were within limits for creating a single-dimension Rasch scale. Conclusions. Nearly all of the adult TBI subjects were able to self-complete the BIVSS, and there was significant mean score separation between TBI and non-TBI groups. The Rasch analysis revealed a single dimension associated with TBI. Using the Likert method with the BIVSS, it may be possible to identify different vision symptom profiles with TBI patients. The BIVSS seems to be a promising tool for better understanding the complex and diverse nature of vision symptoms that are associated with brain injury.	[Laukkanen, Hannu; Hayes, John R.] Univ Pacific, Coll Optometry, 2043 Coll Way, Forest Grove, OR 97116 USA; [Scheiman, Mitchell] Salus Univ, Penn Coll Optometry, Philadelphia, PA USA		Laukkanen, H (corresponding author), Univ Pacific, Coll Optometry, 2043 Coll Way, Forest Grove, OR 97116 USA.	laukkanh@pacificu.edu		Scheiman, Mitchell/0000-0002-9274-5696			Anderson T.W., 1956, P 3 BERK S MATH STAT, V5, P111; [Anonymous], 2015, SPSS COMP PROGR VERS; Centers for Disease Control and Prevention, TRAUM BRAIN INJ US E; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Gianutsos R., 1998, J BEHAV OPTOMETRY, V9, P3; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Kapoor N, 2012, VISUAL DIAGNOSIS CAR, P95; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Likert R., 1932, ARCH PSYCHOL, V22, P5; Linacre JM, TABLE 23 1 23 11 PRI; Linacre JM., 2015, WINSTEPS RASCH MEASU; Massof RW, 2002, OPTOMETRY VISION SCI, V79, P516, DOI 10.1097/00006324-200208000-00015; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Wright B, 1994, MEASUREMENT T, V8, P370	18	16	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					43	50		10.1097/OPX.0000000000000940			8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EM5ZZ	WOS:000395393900007	28027193				2022-02-06	
J	Lopez, KC; Leary, JB; Pham, DL; Chou, YY; Dsurney, J; Chan, L				Lopez, Katherine C.; Leary, Jacob B.; Pham, Dzung L.; Chou, Yi-Yu; Dsurney, John; Chan, Leighton			Brain Volume, Connectivity, and Neuropsychological Performance in Mild Traumatic Brain Injury: The Impact of Post-Traumatic Stress Disorder Symptoms	JOURNAL OF NEUROTRAUMA			English	Article						DTI; head injury; learning; memory network; white matter integrity	MEMORY; VETERANS; PTSD; METAANALYSIS; IRAQ; TBI; MRI; US	Post-traumatic stress disorder (PTSD) is commonly associated with mild traumatic brain injury (mTBI). To better understand their relationship, we examined neuroanatomical structures and neuropsychological performance in a sample of individuals with mTBI, with and without PTSD symptoms. Thirty-nine subjects with mTBI were dichotomized into those with (n = 12) and without (n = 27) significant PTSD symptoms based on scores on the PTSD Checklist. Using a region-of-interest approach, fronto-temporal volumes, fiber bundles obtained by diffusion tensor imaging, and neuropsychological scores were compared between the two groups. After controlling for total intracranial volume and age, subjects with mTBI and PTSD symptoms exhibited volumetric differences in the entorhinal cortex, an area associated with memory networks, relative to mTBI-only patients (F = 4.28; p = 0.046). Additionally, subjects with PTSD symptoms showed reduced white matter integrity in the right cingulum bundle (axial diffusivity, F = 6.04; p = 0.020). Accompanying these structural alterations, mTBI and PTSD subjects also showed impaired performance in encoding (F = 5.98; p = 0.019) and retrieval (F = 7.32; p = 0.010) phases of list learning and in tests of processing speed (Wechsler Adult Intelligence Scale Processing Speed Index, F = 12.23; p = 0.001; Trail Making Test A, F = 5.56; p = 0.024). Increased volume and white matter disruptions in these areas, commonly associated with memory functions, may be related to functional disturbances during cognitively demanding tasks. Differences in brain volume and white matter integrity between mTBI subjects and those with mTBI and co-morbid PTSD symptoms point to neuroanatomical differences that may underlie poorer recovery of mTBI subjects who experience PTSD symptoms. These findings support theoretical models of PTSD and its relationship to learning deficits.	[Lopez, Katherine C.; Pham, Dzung L.; Chou, Yi-Yu; Dsurney, John; Chan, Leighton] NIH, Ctr Neurosci & Regenerat Med, Bldg 10, Bethesda, MD 20892 USA; [Leary, Jacob B.; Chan, Leighton] NIH, Ctr Clin, Dept Rehabil Med, Bethesda, MD 20892 USA		Dsurney, J (corresponding author), NIH, Ctr Neurosci & Regenerat Med, Dept Rehabil Med, 10 Ctr Dr,Room 1-1468,MSC1604, Bethesda, MD 20892 USA.	john.dsurney@nih.gov	Pham, Dzung/AAR-8263-2020		Department of Defense (Center for Neuroscience and Regenerative Medicine)United States Department of Defense; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	This work was supported by the Department of Defense (Center for Neuroscience and Regenerative Medicine) and the National Institutes of Health Intramural Research Program.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Anderson MC, 2014, TRENDS COGN SCI, V18, P279, DOI 10.1016/j.tics.2014.03.002; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Barlow-Ogden K, 2012, J REHABIL RES DEV, V49, P1101, DOI 10.1682/JRRD.2010.09.0188; Benoit RG, 2012, NEURON, V76, P450, DOI 10.1016/j.neuron.2012.07.025; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Carass A, 2011, NEUROIMAGE, V56, P1982, DOI 10.1016/j.neuroimage.2011.03.045; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Cristofori I., 2015, HDB CLIN NEUROLOGY, P579; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Hirni DI, 2013, NEUROPSYCHOLOGIA, V51, P930, DOI 10.1016/j.neuropsychologia.2013.01.013; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Joormann J, 2009, J ABNORM PSYCHOL, V118, P34, DOI 10.1037/a0013794; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lissek S, 2015, INT J PSYCHOPHYSIOL, V98, P594, DOI 10.1016/j.ijpsycho.2014.11.006; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Noulhiane M, 2007, BRAIN, V130, P3184, DOI 10.1093/brain/awm258; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Paz-Alonso PM, 2013, J NEUROSCI, V33, P5017, DOI 10.1523/JNEUROSCI.3459-12.2013; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Sasson E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00032; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Soble JR, 2013, J CLIN EXP NEUROPSYC, V35, P551, DOI 10.1080/13803395.2013.798398; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Takehara-Nishiuchi K, 2014, NEUROSCI RES, V84, P27, DOI 10.1016/j.neures.2014.02.012; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	42	16	16	1	21	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					16	22		10.1089/neu.2015.4323			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100003	26942337	Green Published			2022-02-06	
J	Naci, L; Graham, M; Owen, AM; Weijer, C				Naci, Lorina; Graham, Mackenzie; Owen, Adrian M.; Weijer, Charles			Covert narrative capacity: Mental life in patients thought to lack consciousness	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SPATIAL NORMALIZATION; DETECTING AWARENESS; EXECUTIVE FUNCTIONS; RESTING-STATE; FMRI; DISORDERS; CONNECTIVITY; INTELLIGENCE; ACCURACY	Despite the apparent absence of external signs of consciousness, a significant proportion of behaviorally nonresponsive patients can respond to commands by willfully modulating their brain activity. However, little is known about the mental life of these patients. We discuss a recent innovative approach, which sheds light on the preserved cognitive capacities of these patients, including executive function, theory of mind, and the experience of affective states. This research represents a fundamental shift in our understanding of these patients, and has important implications for both their continued treatment and care. Moreover, this research marks out avenues for future inquiry into the residual cognitive capacities of these patients.	[Naci, Lorina; Owen, Adrian M.] Western Univ, Brain & Mind Inst, London, ON N6A 5B7, Canada; [Graham, Mackenzie; Weijer, Charles] Western Univ, Rotman Inst Philosophy, London, ON N6A 5B8, Canada		Naci, L (corresponding author), Univ Western Ontario, Dept Psychol, Brain & Mind Inst, London, ON N6A 5B7, Canada.	lnaci@uwo.ca	Weijer, Charles/ABC-5433-2020	Weijer, Charles/0000-0002-5510-1074; Naci, Lorina/0000-0001-9630-3978	Canada Excellence Research Chairs (CERC) program; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP133705]; Tier I Canada Research ChairCanada Research Chairs	This research was supported by the Canada Excellence Research Chairs (CERC) program. This work was also supported by the Canadian Institutes of Health Research (grant number MOP133705). C. W. holds a Tier I Canada Research Chair.	Andrews K, 1996, BMJ-BRIT MED J, V313, P136; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Bardin JC, 2012, ARCH NEUROL-CHICAGO, V69, P176, DOI 10.1001/archneurol.2011.892; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Barttfeld P, 2015, P NATL ACAD SCI USA, V112, P887, DOI 10.1073/pnas.1418031112; Beisteiner R, 2010, HUM BRAIN MAPP, V31, P1951, DOI 10.1002/hbm.20990; Berkman LF., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI [10.1016/S0277-9536(00)00065-4, DOI 10.4135/9781412952576.N192]]; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Bruno MA, 2010, COGN NEUROSCI-UK, V1, P193, DOI 10.1080/17588928.2010.485677; CARROLL N, 1996, LEA COMMUN SER, P71; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Chow HM, 2008, NEUROIMAGE, V40, P940, DOI 10.1016/j.neuroimage.2007.11.044; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Comte A, 2015, NEUROSCIENCE, V300, P448, DOI 10.1016/j.neuroscience.2015.05.059; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; Crone JS, 2014, NEUROIMAGE-CLIN, V4, P240, DOI 10.1016/j.nicl.2013.12.005; Crone JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026373; Cruse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049933; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Fernandez-Espejo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095082; Fernandez-Espejo D, 2013, NAT REV NEUROSCI, V14, P801, DOI 10.1038/nrn3608; Gabriel D, 2015, NEUROSCIENCE, V290, P435, DOI 10.1016/j.neuroscience.2015.01.053; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Graham M, 2015, AJOB NEUROSCIENCE, V6, P31, DOI DOI 10.1080/21507740.2015.1014072; Guglielmo S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01637; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Kahane G, 2009, J MED PHILOS, V34, P6, DOI 10.1093/jmp/jhn038; Lehne M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124550; Lehne M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00079; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Naci L., 2015, NEUROIMAGE IN PRESS; Naci L, 2014, P NATL ACAD SCI USA, V111, P14277, DOI 10.1073/pnas.1407007111; Naci L, 2013, JAMA NEUROL, V70, P1235, DOI 10.1001/jamaneurol.2013.3686; Naci L, 2013, J NEUROSCI, V33, P9385, DOI 10.1523/JNEUROSCI.5577-12.2013; Naci L, 2012, ANN NEUROL, V72, P312, DOI 10.1002/ana.23656; Ortony A., 1998, COGNITIVE STRUCTURE; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Owen AM, 2016, FINDING CONSCIOUSNES, P100; Owen AM, 2016, BRAIN FUNCTION RESPO, P67; Peterson A, 2015, NEUROIMAGE-CLIN, V7, P588, DOI 10.1016/j.nicl.2015.02.008; Pinquart M, 2000, PSYCHOL AGING, V15, P187, DOI 10.1037//0882-7974.15.2.187; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Siedlecki KL, 2014, SOC INDIC RES, V117, P561, DOI 10.1007/s11205-013-0361-4; Sinai L, 2017, FRONT BIOSCI-LANDMRK, V22, P815, DOI 10.2741/4518; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; VORDERER P, 1996, LEA COMMUN SER, P233; Woolgar A, 2010, P NATL ACAD SCI USA, V107, P14899, DOI 10.1073/pnas.1007928107; Young GB, 2009, ANN NY ACAD SCI, V1157, P32, DOI 10.1111/j.1749-6632.2009.04471.x; Zillmann D., 1991, RESPONDING SCREEN RE, P281	63	16	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	JAN	2017	4	1					61	70		10.1002/acn3.376			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EK1CY	WOS:000393664600007	28078316	gold, Green Published			2022-02-06	
J	Rangaprakash, D; Dretsch, MN; Yan, WJ; Katz, JS; Denney, TS; Deshpande, G				Rangaprakash, D.; Dretsch, Michael N.; Yan, Wenjing; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna			Hemodynamic variability in soldiers with trauma: Implications for functional MRI connectivity studies	NEUROIMAGE-CLINICAL			English	Article						Functional magnetic resonance imaging; Hemodynamic response function variability; Functional connectivity; Posttraumatic stress disorder; Mild-traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; RESTING STATE FMRI; BRAIN-INJURY; BOLD; RESPONSES; METAANALYSIS; INHIBITION; SEROTONIN; STRIATUM; NETWORKS	Functional MRI (fMRI) is an indirect measure of neural activity as a result of the convolution of the hemodynamic response function (HRF) and latent (unmeasured) neural activity. Recent studies have shown variability of HRF across brain regions (intra-subject spatial variability) and between subjects (inter-subject variability). Ignoring this HRF variability during data analysis could impair the reliability of such fMRI results. Using whole-brain resting-state fMRI (rs-fMRI), we employed hemodynamic deconvolution to estimate voxel-wise HRF. Studying the impact of mental disorders on HRF variability, we identified HRF aberrations in soldiers (N= 87) with posttraumatic stress disorder (PTSD) and mild-traumatic brain injury (mTBI) compared to combat controls. Certain subcortical and default-mode regions were found to have significant HRF aberrations in the clinical groups. These brain regions have been previously associated with neurochemical alterations in PTSD, which are known to impact the shape of the HRF. We followed-up these findings with seed-based functional connectivity (FC) analysis using regions-of-interest (ROIs) whose HRFs differed between the groups. We found that part of the connectivity group differences reported from traditional FC analysis (no deconvolution) were attributable to HRF variability. These findings raise the question of the degree of reliability of findings from conventional rsfMRI studies (especially in psychiatric populations like PTSD and mTBI), which are corrupted by HRF variability. We also report and discus, for the first time, voxel-level HRF alterations in PTSD and mTBI. To the best of our knowledge, this is the first study to report evidence for the impact of HRF variability on connectivity group differences. Our work has implications for rs-fMRI connectivity studies. We encourage researchers to incorporate hemodynamic deconvolution during pre-processing to minimize the impact of HRF variability.	[Rangaprakash, D.; Yan, Wenjing; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Elect & Comp Engn, AU MRI Res Ctr, Auburn, AL 36849 USA; [Rangaprakash, D.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA; [Dretsch, Michael N.] HQ TRADOC, Human Dimens Div, Ft Eustis, VA USA; [Dretsch, Michael N.] US Army, Aeromed Res Lab, Ft Rucker, AL USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Alabama Adv Imaging Consortium, Birmingham, AL USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Univ Alabama Birmingham, Birmingham, AL USA		Deshpande, G (corresponding author), Auburn Univ, 560 Devall Dr,Suite 266D, Auburn, AL 36849 USA.	gopi@auburn.edu		Denney, Thomas/0000-0002-6695-4777; Rangaprakash, D/0000-0001-9553-1354	U.S. Army Medical Research and Materiel Command (MRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [00007218]	The authors acknowledge financial support for this work from the U.S. Army Medical Research and Materiel Command (MRMC) (Grant # 00007218). The views, opinions, and/or findings contained in this article are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of the U.S. Army or the Department of Defense (DoD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the personnel at the TBI clinic (Dr. Marlin Wolf) and behavioral health clinic, Fort Benning, GA, USA and the US Army Aeromedical Research Laboratory, Fort Rucker, AL, USA, and most of all, the soldiers who participated in the study. The authors thank Julie Rodiek and Wayne Duggan for facilitating data acquisition.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Amico E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100012; Arichi T, 2012, NEUROIMAGE, V63, P663, DOI 10.1016/j.neuroimage.2012.06.054; Boly M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125337; Brown GG, 2003, J CEREBR BLOOD F MET, V23, P829, DOI 10.1097/01.WCB.0000071887.63724.B2; Busija DW, 2007, BRAIN RES REV, V56, P89, DOI 10.1016/j.brainresrev.2007.05.011; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cisler JM, 2014, J PSYCHIATR RES, V48, P47, DOI 10.1016/j.jpsychires.2013.09.013; Cohen B. H., 2009, ANN M SOC AFF NEUR S; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Dickstein B.D., 2014, ASSESSMENT; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lamichhane B, 2014, BRAIN CONNECT, V4, P619, DOI 10.1089/brain.2014.0243; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Mayer AR, 2014, J NEUROTRAUM, V31, P189, DOI 10.1089/neu.2013.3069; Mifflin K, 2015, MOD TR PHARMACOPSYCH, V30, P94, DOI 10.1159/000435935; Muthukumaraswamy SD, 2012, HUM BRAIN MAPP, V33, P455, DOI 10.1002/hbm.21223; Nikolaus S, 2010, REV NEUROSCIENCE, V21, P119; POLDRACK R. A., 2011, HDB FUNCTIONAL MRI D; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Ramage A. E., 2015, SOC COGN AF IN PRESS; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Rangaprakash D., 2015, P ANN M INT SOC MAGN, V23, P4402; Rangaprakash D., 2017, DATA BRIEF IN PRESS; Rosso IM, 2014, DEPRESS ANXIETY, V31, P115, DOI 10.1002/da.22155; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Southwick S M, 1999, Semin Clin Neuropsychiatry, V4, P242; Thompson SK, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00159; Weathers F.W, 2015, PTSD CHECKLIST DSM 5; Wu GR, 2013, MED IMAGE ANAL, V17, P365, DOI 10.1016/j.media.2013.01.003; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	40	16	16	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	16						409	417		10.1016/j.nicl.2017.07.016			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FK1IU	WOS:000413235100043	28879082	Green Published, gold			2022-02-06	
J	Surmacki, JM; Ansel-Bollepalli, L; Pischiutta, F; Zanier, ER; Ercole, A; Bohndiek, SE				Surmacki, Jakub Maciej; Ansel-Bollepalli, Laura; Pischiutta, Francesca; Zanier, Elisa R.; Ercole, Ari; Bohndiek, Sarah Elizabeth			Label-free monitoring of tissue biochemistry following traumatic brain injury using Raman spectroscopy	ANALYST			English	Article							AMYLOID-BETA; MICE BRAIN; IN-VIVO; CELLS; HEMORRHAGE; PATHOLOGY	Traumatic brain injury (TBI) constitutes a major cause of death and long-term disability. At present, we lack methods to non-invasively track tissue biochemistry and hence select appropriate interventions for patients. We hypothesized that detailed label-free vibrational chemical analysis of focal TBI could provide such information. We assessed the early spatial and temporal changes in tissue biochemistry that are associated with brain injury in mice. Numerous differences were observed in the spectra of the contusion core and pericontusional tissue between 2 and 7 days. For example, a strong signal from haem was seen in the contusion core at 2 days due to haemorrhage, which subsequently resolved. More importantly, elevated cholesterol levels were demonstrated by 7 days, which may be a marker of important cell repair processes. Principal component analysis revealed an early 'acute' component dominated by haemorrhage and a delayed component reflecting changes in protein and lipid composition. Notably we demonstrated changes in Raman signature with time even in the contralateral hemisphere when compared to sham control mice. Raman spectroscopy therefore shows promise as a probe that is sensitive to important pathobiological processes in TBI and could be applied in future both in the experimental setting, as well as in the clinic.	[Surmacki, Jakub Maciej; Ansel-Bollepalli, Laura; Bohndiek, Sarah Elizabeth] Univ Cambridge, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England; [Surmacki, Jakub Maciej; Ansel-Bollepalli, Laura; Bohndiek, Sarah Elizabeth] Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England; [Pischiutta, Francesca; Zanier, Elisa R.] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Via G La Masa 19, I-20156 Milan, Italy; [Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Hills Rd, Cambridge CB2 0QQ, England		Bohndiek, SE (corresponding author), Univ Cambridge, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England.; Bohndiek, SE (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.; Zanier, ER (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Via G La Masa 19, I-20156 Milan, Italy.; Ercole, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Hills Rd, Cambridge CB2 0QQ, England.	js2238@cam.ac.uk; laura.bollepalli@cruk.cam.ac.uk; francesca.pischiutta@marionegri.it; elisa.zanier@marionegri.it; ae105@cam.ac.uk; seb53@cam.ac.uk	Ercole, Ari/B-6288-2009; Bohndiek, Sarah/S-9416-2019; Zanier, Elisa/AAA-8095-2020; Pischiutta, Francesca/AAA-7927-2020; Surmacki, Jakub M./N-1140-2016	Ercole, Ari/0000-0001-8350-8093; Zanier, Elisa/0000-0002-3011-8718; Pischiutta, Francesca/0000-0002-7151-0812; Surmacki, Jakub M./0000-0001-6654-0286; Ansel Bollepalli, Laura/0000-0003-2324-7228; Bohndiek, Sarah/0000-0003-0371-8635; Bollepalli, Laura/0000-0001-5902-059X	European Union Seventh Framework ProgrammeEuropean Commission [FP7-PEOPLE-CIG-630729]; CRUKCancer Research UK [C14303/A17197]; CRUK (Career Establishment Award) [C47594/A16267]; University of Cambridge Departments of Physics and Oncology; "Fondazione Umberto Veronesi" (FUV)Fondazione Umberto Veronesi; Cancer Research UKCancer Research UK [16267, 21142] Funding Source: researchfish	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. FP7-PEOPLE-2013-CIG-630729, CRUK (C14303/A17197 and Career Establishment Award grant no. C47594/A16267) and the University of Cambridge Departments of Physics and Oncology. FP was supported by "Fondazione Umberto Veronesi" (FUV). The authors would like to thank Prof. David K. Menon for numerous useful discussions.	Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Krafft C, 2005, SPECTROCHIM ACTA A, V61, P1529, DOI 10.1016/j.saa.2004.11.017; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lakshmi RJ, 2002, RADIAT RES, V157, P175, DOI 10.1667/0033-7587(2002)157[0175:TRSFTS]2.0.CO;2; Michael R, 2014, EXP EYE RES, V119, P44, DOI 10.1016/j.exer.2013.11.016; Mohs AM, 2010, ANAL CHEM, V82, P9058, DOI 10.1021/ac102058k; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Pischiutta F, 2014, NEUROPHARMACOLOGY, V79, P119, DOI 10.1016/j.neuropharm.2013.11.001; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Schallner N, 2015, J CLIN INVEST, V125, P2609, DOI 10.1172/JCI78443; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Stone N, 2004, FARADAY DISCUSS, V126, P141, DOI 10.1039/b304992b; Surmacki J, 2015, ANALYST, V140, P2121, DOI 10.1039/c4an01876a; Tay LL, 2011, ANALYST, V136, P1620, DOI 10.1039/c0an00897d; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Wachsmann-Hogiu S, 2009, CURR OPIN BIOTECH, V20, P63, DOI 10.1016/j.copbio.2009.02.006; Wood BR, 2007, ANAL BIOANAL CHEM, V387, P1691, DOI 10.1007/s00216-006-0881-8; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zanier Elisa R, 2015, Intensive Care Med Exp, V3, P39, DOI 10.1186/s40635-015-0039-0; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3	28	16	16	1	18	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	0003-2654	1364-5528		ANALYST	Analyst	JAN 1	2017	142	1					132	139		10.1039/c6an02238c			8	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	EH0IV	WOS:000391448300014	27905576	Green Published, Green Submitted, hybrid			2022-02-06	
J	Tripodis, Y; Alosco, ML; Zirogiannis, N; Gavett, BE; Chaisson, C; Martin, B; McClean, MD; Mez, J; Kowall, N; Stern, RA				Tripodis, Yorghos; Alosco, Michael L.; Zirogiannis, Nikolaos; Gavett, Brandon E.; Chaisson, Christine; Martin, Brett; McClean, Michael D.; Mez, Jesse; Kowall, Neil; Stern, Robert A.			The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer's Disease Dementia	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; APOE; cognitive decline; dementia; loss of consciousness; normal cognition; risk factor; traumatic brain injury	UNIFORM DATA SET; CENTER NACC DATABASE; DIFFUSION-TENSOR; HEAD-INJURY; RISK; ENCEPHALOPATHY; PATHOLOGY; MODERATE; EPIDEMIOLOGY; DISORDERS	Traumatic brain injury (TBI) is thought to be a risk factor for dementia, including dementia due to Alzheimer's disease (AD). However, the influence of TBI history on the neuropsychological course of AD is unknown and, more broadly, the effect of TBI history on age-related cognitive change is poorly understood. We examined the relationship between history of TBI with loss of consciousness (LOC) history and cognitive change in participants with normal cognition and probable AD, stratified by APOE epsilon 4 allele status. The sample included 706 participants (432 with normal cognition; 274 probable AD) from the National Alzheimer's Coordinating Center (NACC) dataset that completed the Uniform Data Set evaluation between 2005 and 2014. Normal and probable AD participants with a history of TBI were matched to an equal number of demographically and clinically similar participants without a TBI history. In this dataset, TBI with LOC was defined as brain trauma with brief or extended unconsciousness. For the normal and probable AD cohorts, there was an average of 3.2 +/- 1.9 and 1.8 +/- 1.1 years of follow-up, respectively. 30.8% of the normal cohort were APOE epsilon 4 carriers, whereas 70.8% of probable AD participants were carriers. Mixed effects regressions showed TBI with LOC history did not affect rates of cognitive change in APOE epsilon 4 carriers and non-carriers. Findings from this study suggest that TBI with LOC may not alter the course of cognitive function in older adults with and without probable AD. Future studies that better characterize TBI (e.g., severity, number of TBIs, history of subconconcussive exposure) are needed to clarify the association between TBI and long-term neurocognitive outcomes.	[Tripodis, Yorghos; Chaisson, Christine; Martin, Brett; McClean, Michael D.; Stern, Robert A.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Alosco, Michael L.; Mez, Jesse; Kowall, Neil] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Zirogiannis, Nikolaos] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN USA; [Gavett, Brandon E.; Kowall, Neil] Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA; VA Boston Healthcare Syst, Neurol Serv, Boston, MA USA		Stern, RA (corresponding author), BU ADC, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.	bobstern@bu.edu	, Bob/ABA-8507-2020; Kowall, Neil/M-5378-2019	Kowall, Neil/0000-0002-6624-0213; Tripodis, Yorghos/0000-0003-2190-7608; Gavett, Brandon/0000-0003-1938-1854	NIA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG013846]; NIA/NIH Grant [U01 AG016976]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG013846, P30 AG019610, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051, P30 AG013854, P30 AG008017, P30 AG010161, P50 AG047366, P30 AG010129, P50 AG016573];  [P50 AG016570];  [P50 AG005131];  [P50 AG023501];  [P30 AG035982];  [P30 AG028383];  [P30 AG010124];  [P50 AG005133];  [P50 AG005142];  [P30 AG012300];  [P50 AG005136];  [P50 AG033514];  [P50 AG005681];  [P50 AG047270]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG010161, P50AG005134, U01AG016976, P50AG008702, P30AG010133, P50AG047266, P30AG012300, P30AG035982, P50AG005133, P30AG013846, P50AG005146, P50AG005131, P30AG019610, P50AG016573, P50AG005142, K23AG046377, P30AG008051, P30AG010129, P50AG016570, P50AG005136, P50AG025688, P50AG047366, P30AG008017, P50AG005681, P30AG028383, P30AG010124, P50AG016574, P50AG047270, P30AG013854, P50AG005138, P50AG033514, P50AG023501] Funding Source: NIH RePORTER	The study is funded by NIA/NIH grant P30 AG013846 (PI Neil Kowall, MD). The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIA funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Steven Ferris, PhD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG016570 (PI Marie-Francoise Chesselet, MD, PhD), P50 AG005131 (PI Douglas Galasko, MD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda VanEldik, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P50 AG005136 (PI Thomas Montine, MD, PhD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), and P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Doornik J.A., 2009, OBJECT ORIENTED MATR; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tripodis Y., 2015, INT J CLIN BIOSTAT B, V1; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Zhou W, 2008, J NEUROTRAUM, V25, P279	56	16	16	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2017	59	1					251	263		10.3233/JAD-160585			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EZ7CA	WOS:000404876400022	28655133	Green Accepted			2022-02-06	
J	Vikane, E; Hellstrom, T; Roe, C; Bautz-Holter, E; Assmus, J; Skouen, S				Vikane, Eirik; Hellstrom, Torgeir; Roe, Cecilie; Bautz-Holter, Erik; Assmus, Jorg; Skouen, Sture			Multidisciplinary outpatient treatment in patients with mild traumatic brain injury: A randomised controlled intervention study	BRAIN INJURY			English	Article						Mild traumatic brain injury; post-concussion symptoms; randomised controlled trial; return-to-work; vocational rehabilitation	POST-CONCUSSION SYMPTOMS; MODERATE HEAD-INJURY; SICKNESS ABSENCE; CONTROLLED-TRIAL; FOLLOW-UP; WORK; RETURN; DISABILITY; SUPPORT; REHABILITATION	Objective: To evaluate the efficacy of a multidisciplinary outpatient follow-up programme compared to follow-up by a general practitioner for patients being at-risk or sick-listed with persistent post-concussion symptoms two months after a mild traumatic brain injury. Design: Randomised controlled trial. Patients: One hundred fifty-one patients, 16-56 years. Methods: Multidisciplinary outpatient rehabilitation with individual contacts and a psycho-educational group intervention at two outpatient rehabilitation clinics compared to follow-up by a general practitioner after the multidisciplinary examination. Primary outcome was sustainable return-to-work first year post-injury. Secondary outcomes were post-concussion symptoms, disability, the patient's impressions of change and psychological distress. Results: Days to sustainable return-to-work was 90 in the intervention and 71 in the control group (p = 0.375). The number of post-concussion symptoms were fewer in the intervention (6) compared to the control group (8) at 12 months (p = 0.041). No group differences were observed for disability (p = 0.193), patients impression of change (p = 0.285) or psychological distress (p = 0.716). Conclusion: The multidisciplinary outpatient follow-up programme focusing on better understanding and reassurance of favourable outcome for mild traumatic brain injury did not improve return-to-work, but may have reduced the development of post-concussion symptoms. Additional studies should focus on which factors exhibit a direct impact on return-to-work.	[Vikane, Eirik; Skouen, Sture] Haukeland Hosp, Dept Phys Med & Rehabil, POB 1400, N-5021 Bergen, Norway; [Vikane, Eirik; Skouen, Sture] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Hellstrom, Torgeir; Roe, Cecilie; Bautz-Holter, Erik] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Roe, Cecilie; Bautz-Holter, Erik] Univ Oslo, Fac Med, Oslo, Norway; [Assmus, Jorg] Haukeland Hosp, Ctr Clin Res, Bergen, Norway		Vikane, E (corresponding author), Haukeland Hosp, Dept Phys Med & Rehabil, POB 1400, N-5021 Bergen, Norway.	eirik.vikane@gmail.com	Hellstrom, Torgeir/AAW-4301-2021; Hellstrom, Torgeir/AAY-6043-2021	Hellstrom, Torgeir/0000-0003-0831-3274	Norwegian Extra Foundation for Health and Rehabilitation	Eirik Vikane, MD, PhD, was supported by the Norwegian Extra Foundation for Health and Rehabilitation. The authors report no other declarations of interest.	Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bonneterre V., 2013, Annals of Physical and Rehabilitation Medicine, V56, P652, DOI 10.1016/j.rehab.2013.10.001; Browne AL, 2013, DISABIL REHABIL, V35, P1149, DOI 10.3109/09638288.2012.721047; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Fadyl JK, 2015, DISABIL REHABIL, V37, P247, DOI 10.3109/09638288.2014.914586; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Hellstrom T, 2013, INT J PHYS MED REHAB, V1, P143; Hensing G, 1998, SCAND J SOC MED, V26, P133, DOI 10.1177/14034948980260020201; Heskestad B, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-10; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Krane L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-37; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Matuseviciene G, 2015, J REHABIL MED; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Paniak C, 2000, BRAIN INJURY, V14, P219; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; TEASDALE G, 1974, LANCET, V2, P81; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Houwelingen HC, 2007, SCAND J STAT, V34, P70, DOI 10.1111/j.1467-9469.2006.00529.x; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; van Velzen JM, 2015, DISABIL REHABIL, P1; Vikane E, 2014, BRAIN INJURY, V28, P1374, DOI 10.3109/02699052.2014.919532; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	16	16	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	4					475	484		10.1080/02699052.2017.1280852			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ES9TD	WOS:000399902900006	28296510	Green Submitted			2022-02-06	
J	Yue, JK; Winkler, EA; Rick, JW; Burke, JF; McAllister, TW; Oh, SS; Burchard, EG; Hu, DL; Rosand, J; Temkin, NR; Korley, FK; Sorani, MD; Ferguson, AR; Lingsma, HF; Sharma, S; Robinson, CK; Yuh, EL; Tarapore, PE; Wang, KKW; Puccio, AM; Mukherjee, P; Diaz-Arrastia, R; Gordon, WA; Valadka, AB; Okonkwo, DO; Manley, GT				Yue, John K.; Winkler, Ethan A.; Rick, Jonathan W.; Burke, John F.; McAllister, Thomas W.; Oh, Sam S.; Burchard, Esteban G.; Hu, Donglei; Rosand, Jonathan; Temkin, Nancy R.; Korley, Frederick K.; Sorani, Marco D.; Ferguson, Adam R.; Lingsma, Hester F.; Sharma, Sourabh; Robinson, Caitlin K.; Yuh, Esther L.; Tarapore, Phiroz E.; Wang, Kevin K. W.; Puccio, Ava M.; Mukherjee, Pratik; Diaz-Arrastia, Ramon; Gordon, Wayne A.; Valadka, Alex B.; Okonkwo, David O.; Manley, Geoffrey T.		TRACK-TBI Investigators	DRD2 C957T polymorphism is associated with improved 6-month verbal learning following traumatic brain injury	NEUROGENETICS			English	Article						Traumatic brain injury; Genetic factors; Cognition; Outcome measures; Human studies	COMMON DATA ELEMENTS; RECEPTOR GENE; TRANSFORMING RESEARCH; CLINICAL KNOWLEDGE; DOPAMINE-RECEPTORS; WORKING-MEMORY; BASAL GANGLIA; DRD2; D2; RECOMMENDATIONS	Traumatic brain injury (TBI) often leads to heterogeneous clinical outcomes, which may be influenced by genetic variation. A single-nucleotide polymorphism (SNP) in the dopamine D2 receptor (DRD2) may influence cognitive deficits following TBI. However, part of the association with DRD2 has been attributed to genetic variability within the adjacent ankyrin repeat and kinase domain containing 1 protein (ANKK1). Here, we utilize the Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study to investigate whether a novel DRD2 C957T polymorphism (rs6277) influences outcome on a cognitive battery at 6 months following TBI-California Verbal Learning Test (CVLT-II), Wechsler Adult Intelligence Test Processing Speed Index Composite Score (WAIS-PSI), and Trail Making Test (TMT). Results in 128 Caucasian subjects show that the rs6277 T-allele associates with better verbal learning and recall on CVLT-II Trials 1-5 (T-allele carrier 52.8 +/- 1.3 points, C/C 47.9 +/- 1.7 points; mean increase 4.9 points, 95% confidence interval [0.9 to 8.8]; p = 0.018), Short-Delay Free Recall (T-carrier 10.9 +/- 0.4 points, C/C 9.7 +/- 0.5 points; mean increase 1.2 points [0.1 to 2.5]; p = 0.046), and Long-Delay Free Recall (T-carrier 11.5 +/- 0.4 points, C/C 10.2 +/- 0.5 points; mean increase 1.3 points [0.1 to 2.5]; p = 0.041) after adjusting for age, education years, Glasgow Coma Scale, presence of acute intracranial pathology on head computed tomography scan, and genotype of the ANKK1 SNP rs1800497 using multivariable regression. No association was found between DRD2 C947T and non-verbal processing speed (WAIS-PSI) or mental flexibility (TMT) at 6 months. Hence, DRD2 C947T (rs6277) may be associated with better performance on select cognitive domains independent of ANKK1 following TBI.	[Yue, John K.; Winkler, Ethan A.; Rick, Jonathan W.; Burke, John F.; Sorani, Marco D.; Ferguson, Adam R.; Sharma, Sourabh; Robinson, Caitlin K.; Yuh, Esther L.; Tarapore, Phiroz E.; Mukherjee, Pratik; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Yue, John K.; Winkler, Ethan A.; Rick, Jonathan W.; Burke, John F.; Sorani, Marco D.; Ferguson, Adam R.; Sharma, Sourabh; Robinson, Caitlin K.; Tarapore, Phiroz E.; Manley, Geoffrey T.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Oh, Sam S.; Burchard, Esteban G.; Hu, Donglei] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Rosand, Jonathan] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Rosand, Jonathan] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Temkin, Nancy R.] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; [Korley, Frederick K.] Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD USA; [Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat & Neurosci, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Diaz-Arrastia, Ramon] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA		Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.; Manley, GT (corresponding author), San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu	; Yue, John/P-1348-2015	Diaz-Arrastia, Ramon/0000-0001-6051-3594; Ferguson, Adam/0000-0001-7102-1608; Yue, John/0000-0001-9694-7722; Burke, John/0000-0002-6190-5116; Wang, Kevin/0000-0002-9343-6473	 [NIH RC2 NS069409];  [NIH RC2 NS069409-02S1];  [NIH U01 NS086090-01];  [DOD W81XWH-13-1-0441];  [DOD W81XWH-14-2-0176]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090, RC2NS069409] Funding Source: NIH RePORTER	This work was supported by the following grants: NIH RC2 NS069409, NIH RC2 NS069409-02S1, NIH U01 NS086090-01, DOD W81XWH-13-1-0441, and DOD W81XWH-14-2-0176 (to G.T.M.)	Bolton JL, 2010, BEHAV GENET, V40, P630, DOI 10.1007/s10519-010-9372-y; Chien YL, 2013, J HUM GENET, V58, P229, DOI 10.1038/jhg.2012.157; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Davidson J., 2014, NEUROSCIENTIST; Delis D.C., 2000, CALIFORNIA VERBAL LE; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Faul M, 2010, TRAUMATIC BRAIN INJU; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Hirvonen MM, 2009, SYNAPSE, V63, P907, DOI 10.1002/syn.20672; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kane JM, 2012, SCHIZOPHRENIA BULL, V38, P1, DOI 10.1093/schbul/sbr131; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Libon DJ, 2011, J INT NEUROPSYCH SOC, V17, P905, DOI 10.1017/S1355617711000944; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ramsay H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127602; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; Swagell CD, 2012, ALCOHOL ALCOHOLISM, V47, P397, DOI 10.1093/alcalc/ags047; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Voisey J, 2012, PSYCHIAT RES, V196, P285, DOI 10.1016/j.psychres.2011.09.024; Voisey J, 2009, DEPRESS ANXIETY, V26, P28, DOI 10.1002/da.20517; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wechsler D., 2008, WECHSLER ADULT INTEL; WHITE NM, 1991, BEHAV NEURAL BIOL, V55, P255, DOI 10.1016/0163-1047(91)90609-T; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E	47	16	16	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1364-6745	1364-6753		NEUROGENETICS	Neurogenetics	JAN	2017	18	1					29	38		10.1007/s10048-016-0500-6			10	Genetics & Heredity; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity; Neurosciences & Neurology	EJ1CE	WOS:000392947100004	27826691	Green Accepted, Green Submitted			2022-02-06	
J	Zhang, HB; Cheng, SX; Tu, Y; Zhang, S; Hou, SK; Yang, Z				Zhang, Hai-Bo; Cheng, Shi-Xiang; Tu, Yue; Zhang, Sai; Hou, Shi-Ke; Yang, Zhen			Protective effect of mild-induced hypothermia against moderate traumatic brain injury in rats involved in necroptotic and apoptotic pathways	BRAIN INJURY			English	Article						Traumatic brain injury; hypothermia; RIPK-1; necroptosis; apoptosis	INDUCED CELL-DEATH; KINASE-DEPENDENT APOPTOSIS; CEREBRAL-BLOOD-FLOW; THERAPEUTIC HYPOTHERMIA; POSTTRAUMATIC HYPOTHERMIA; NEURONAL DEATH; RIP1 KINASE; EXPRESSION; CONTRIBUTES; IDENTIFICATION	Aim: To investigate the protective effect of hypothermia (HT) on brain injury in moderate traumatic brain injury (TB) rat models and the potential mechanisms, especially the involvement of RIPK1 in apoptosis and necroptosis. Methods: Adult Sprague-Dawley rats were randomized to four groups: sham+normothermia (sham+NT), sham+hypothermia (sham+HT), moderate TBI+normothermia (TBI+NT) and moderate TBI+hypotherMia.(TBI+HT). The sham+HT and TBI+HT groups were submitted to 32 degrees C for 6 hours. The regional cerebral blood flow (rCBF) was assessed 24 hours after TBI; 24 and 48 hours after TBI, the modified neurological severity score (mNSS), was assessed. Immediately after behavioural tests, rats were sacrificed to harvest the brain tissues. Results: mNSS scores were lower in the IBI+HT group compared with the TBI+NT group (p < 0.01) and cerebral, blood flow was better (p < 0.01). H&E staining of the cortex and ipsilateral hippocampus showed pyknotic and irregularly shaped neuron in TBI+NT rats, which were less frequent in TBI+HT rats. The TBI+NT and TBI+HT groups showed higher TNF-alpha, TRAIL, FasL, FADD, caspase-3, caspase-8, PARP-1, RIPK-1 and RIPK-3 levels than the sham+NT group (all p < 0.05), but the levels of these proteins were all lower in the TBI+HT group compared with the TBI+NT group (all p < 0.01). Conclusion: HT treatment significantly reduced RIPK-1 upregulation, which, may inhibit necroptosis and apoptosis pathways after moderate TBI.	[Zhang, Hai-Bo; Cheng, Shi-Xiang; Tu, Yue; Zhang, Sai; Hou, Shi-Ke; Yang, Zhen] Chinese Peoples Armed Police Forces PAP, Inst Traumat Brain Injury & Neurosci, Tianjin Key Lab Neurotrauma Repair, Neurosurg & Neurol Hosp PAP, 220 Chen Lin Rd, Tianjin 300162, Peoples R China		Zhang, S (corresponding author), Chinese Peoples Armed Police Forces PAP, Inst Traumat Brain Injury & Neurosci, Tianjin Key Lab Neurotrauma Repair, Neurosurg & Neurol Hosp PAP, 220 Chen Lin Rd, Tianjin 300162, Peoples R China.	zhangsaintmed@sina.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [31200809]; Chinese People's Armed Police Forces Grant [WJHQ2012-20]; Science and Technology Program of Tianjin [15ZXLCSY00040]; Logistics College of PAP [WHTD201306]	The authors report no conflicts of interest. This work was supported by grants by the National Natural Science Foundation of China (NSFC No. 31200809), the Chinese People's Armed Police Forces Grant (WJHQ2012-20), the Science and Technology Program of Tianjin (15ZXLCSY00040), and the Logistics College of PAP (WHTD201306).	Alanazi I, 2013, APOPTOSIS, V18, P1291, DOI 10.1007/s10495-013-0887-6; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheng SX, 2013, THER HYPOTHERMIA TEM, V3, P132, DOI 10.1089/ther.2013.0005; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dondelinger Y, 2013, CELL DEATH DIFFER, V20, P1381, DOI 10.1038/cdd.2013.94; Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032; Hayashi N, 1997, NEUROCHEMISTRY, P97; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Jia F, 2014, J NEUROTRAUM, V31, P387, DOI 10.1089/neu.2008.0814; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Lee EW, 2012, BMB REP, V45, P496, DOI 10.5483/BMBRep.2012.45.9.186; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Management of Concussion/m TBIWG, 2009, J REHABILITATION RES, V46, pCP1; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Shindo R, 2013, BIOCHEM BIOPH RES CO, V436, P212, DOI 10.1016/j.bbrc.2013.05.075; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Wallace JA, 2002, J CEREBR BLOOD F MET, V22, P1303, DOI 10.1097/01.WCB.0000040943.89393.c1; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	54	16	18	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					406	415		10.1080/02699052.2016.1225984			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900019	28140659				2022-02-06	
J	Johnson, KL; Chowdhury, S; Lawrimore, WB; Mao, Y; Mehmani, A; Prabhu, R; Rush, GA; Horstemeyer, MF				Johnson, K. L.; Chowdhury, S.; Lawrimore, W. B.; Mao, Y.; Mehmani, A.; Prabhu, R.; Rush, G. A.; Horstemeyer, M. F.			Constrained topological optimization of a football helmet facemask based on brain response	MATERIALS & DESIGN			English	Article						Traumatic brain injury; Design optimization; Football helmet; Concussion; Finite element analysis; Surrogate modeling	PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; DESIGN OPTIMIZATION; MODEL; IMPACTS; EPIDEMIOLOGY; SIMULATION; COLLEGIATE; INJURY	Surrogate model-based multi-objective design optimization was performed to reduce concussion risk during frontal football helmet impacts. In particular, a topological decomposition of the football helmet facemask was performed to formulate the design problem, and brain injury metrics were exploited as objective functions. A validated finite element model of a helmeted human head was used to recreate facemask impacts. Due to the prohibitive computational expense of the full scale simulations, a surrogate modeling approach was employed. An optimal surrogate model selection framework, called Concurrent Surrogate Model Selection, or COSMOS, was utilized to identify the surrogate models best suited to approximate each objective function. The resulting surrogate models were implemented in the Non-dominated Sorting Genetic Algorithm II (NSGA-II) optimization algorithm. Constraints were implemented to control the solid material fraction in the facemask design space, and binary variables were used to control the placement of the facemask bars. The optimized facemask designs reduced the maximum tensile pressure in the brain by 7.5% and the maximum shear strain by a remarkable 39.5%. This research represents a first-of-its-kind approach to multi-objective design optimization on a football helmet, and demonstrates the possibilities that are achievable in improving human safety by using such a simulation-based design optimization. (C) 2016 Elsevier Ltd. All rights reserved.	[Johnson, K. L.; Lawrimore, W. B.; Horstemeyer, M. F.] Mississippi State Univ, Dept Mech Engn, Mississippi State, MS 39762 USA; [Johnson, K. L.; Lawrimore, W. B.; Horstemeyer, M. F.] Mississippi State Univ, CAVS, Mississippi State, MS 39762 USA; [Chowdhury, S.] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA; [Mao, Y.] Predict Design Technol, Starkville, MS 39579 USA; [Mehmani, A.] Columbia Univ, Lenfest Ctr Sustainable Energy, New York, NY 10027 USA; [Prabhu, R.; Rush, G. A.] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA		Johnson, KL (corresponding author), Mississippi State Univ, Dept Mech Engn, Mississippi State, MS 39762 USA.	kljohnsonmsu@gmail.com	; Prabhu, Raj/M-7188-2017	Horstemeyer, Mark/0000-0003-4230-0063; Prabhu, Raj/0000-0002-6073-4802	Center for Advanced Vehicular Systems, Mississippi State University	The authors would like to thank Dr. G. "Sonny" Rush for his donation of the football helmet and computed tomography for our study. Also, support from the Center for Advanced Vehicular Systems, Mississippi State University is gratefully acknowledged.	Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4; Bedewi NE, 1997, INT J CRASHWORTHINES, V2, P239, DOI DOI 10.1533/CRAS.1997.0048; Belson K., 2014, BRAIN TRAUMA AFFECT, pThe New York Times; Boruah S., 2013, P IRCOBI C; Bouvard JL, 2010, ACTA MECH, V213, P71, DOI 10.1007/s00707-010-0349-y; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Chowdhury S., 2014, CONCURRENT SURROGATE; Craig M.J, 2007, BIOMECHANICS JAW LOA; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Fang H, 2005, COMPUT STRUCT, V83, P2121, DOI 10.1016/j.compstruc.2005.02.025; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Johnson KL, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026320; King A.I., IRCOBI C 2003, P1; Kurtaran H, 2002, COMPUT MECH, V29, P409, DOI 10.1007/s00466-002-0351-x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mehmani A, 2015, STRUCT MULTIDISCIP O, V52, P353, DOI 10.1007/s00158-015-1234-z; Messac, 2015, OPTIMIZATION PRACTIC; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Prabhu R., 2011, TRAUMATIC BRAIN INJU; Ren WX, 2010, ENG STRUCT, V32, P2455, DOI 10.1016/j.engstruct.2010.04.019; Shuaeib FM, 2007, MATER DESIGN, V28, P182, DOI 10.1016/j.matdes.2005.04.015; Simpson TW, 2001, AIAA J, V39, P2233, DOI 10.2514/2.1234; Stander N., 2004, J AM I AERONAUT ASTR; Tinard V, 2012, MATER DESIGN, V37, P79, DOI 10.1016/j.matdes.2011.12.005; Tse KM, 2015, ACCIDENT ANAL PREV, V79, P13, DOI 10.1016/j.aap.2015.03.012; Viana F.A.C., 2009, INT J NUMER METHODS; Viana FAC, 2014, AIAA J, V52, P670, DOI 10.2514/1.J052375; Viano DC, 2005, SOLID MECH APPL, V124, P121; Ward CC., 1977, INTRACRANIAL PRESSUR; Yang RJ, 2005, J MECH DESIGN, V127, P1014, DOI 10.1115/1.1906264; Ye KQ, 2000, J STAT PLAN INFER, V90, P145, DOI 10.1016/S0378-3758(00)00105-1; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	44	16	16	0	24	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-1275	1873-4197		MATER DESIGN	Mater. Des.	DEC 5	2016	111						108	118		10.1016/j.matdes.2016.08.064			11	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	EA8EY	WOS:000386869300013					2022-02-06	
J	Brady, RD; Grills, BL; Romano, T; Wark, JD; O'Brien, TJ; Shultz, SR; McDonald, SJ				Brady, R. D.; Grills, B. L.; Romano, T.; Wark, J. D.; O'Brien, T. J.; Shultz, S. R.; McDonald, S. J.			Sodium selenate treatment mitigates reduction of bone volume following traumatic brain injury in rats	JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS			English	Article						Neurotrauma; Bone Metabolism; Endochondral Ossification; Bone Growth; Osteoporosis	GROWTH-HORMONE; HYPERPHOSPHORYLATED TAU; MINERAL DENSITY; MOUSE MODEL; NEUROINFLAMMATION; SELENITE; SKELETON; DEFICITS; OUTCOMES; FEMALE	Objectives: Administration of sodium selenate to rats given traumatic brain injury (TBI) attenuates brain damage and improves long-term behavioural outcomes. We have previously provided evidence that TBI causes bone loss in rats, however the effect of sodium selenate treatment on bone quantity following TBI is unknown. Methods: Rats were randomly assigned into sham injury or fluid percussion injury (FPI) groups and administered saline or sodium selenate for 12 weeks post-injury. Femora were analysed using histomorphometry, peripheral quantitative computed tomography (pQCT) and biomechanical testing. Results: Distal metaphyseal trabecular bone volume fraction of FPI-selenate rats was higher than FPI-vehicle rats (41.8%; p<0.01), however, femora from selenate-treated groups were shorter in length (4.3%; p<0.01) and had increased growth plate width (22.1%; p<0.01), indicating that selenate impaired long bone growth. pQCT analysis demonstrated that distal metaphyseal cortical thickness was decreased in TBI rats compared to shams (11.7%; p<0.05), however selenate treatment to TBI animals offset this reduction (p<0.05). At the midshaft we observed no differences in biomechanical measures. Conclusion: These are the first findings to indicate that mitigating TBI-induced neuropathology may have the added benefit of preventing osteoporosis and associated fracture risk following TBI.	[Brady, R. D.; Grills, B. L.; Romano, T.; McDonald, S. J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia; [Wark, J. D.; O'Brien, T. J.; Shultz, S. R.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia		McDonald, SJ (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia.	stuart.mcdonald@latrobe.edu.au	O'Brien, Terence/L-8102-2013	McDonald, Stuart/0000-0001-5190-3179; O'Brien, Terence/0000-0002-7198-8621	NHMRCNational Health and Medical Research Council of Australia; CIHRCanadian Institutes of Health Research (CIHR); La Trobe University	This work was supported by grants to SRS and TJO from the NHMRC, a fellowship to SRS from CIHR, and funding from La Trobe University to BLG and SJM.	Anevska K, 2015, BONE, V74, P199, DOI 10.1016/j.bone.2015.01.018; Beaupre GS, 2006, AM J PHYS MED REHAB, V85, P464, DOI 10.1097/01.phm.0000214275.69286.7a; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brady RD, 2015, J NEUROTRAUMA; Brady RD, 2014, J ORTHOP RES, V32, P1277, DOI 10.1002/jor.22686; CAMPO RD, 1971, CALC TISS RES, V7, P318, DOI 10.1007/BF02062621; Chung YW, 2006, TOXICOL LETT, V160, P143, DOI 10.1016/j.toxlet.2005.06.019; Corcoran NM, 2010, BRIT J CANCER, V103, P462, DOI 10.1038/sj.bjc.6605798; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; Evans K D, 2008, Open Orthop J, V2, P121, DOI 10.2174/1874325000802010121; Evans KD, 2003, BONE, V32, P268, DOI 10.1016/S8756-3282(02)00974-2; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; GRONBAEK H, 1995, J ENDOCRINOL, V145, P105, DOI 10.1677/joe.0.1450105; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; HOLMES SJ, 1994, J CLIN ENDOCR METAB, V78, P669, DOI 10.1210/jc.78.3.669; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee JI, 2005, BRAIN INJURY, V19, P1207, DOI 10.1080/02699050500309338; Lee SH, 2008, BMB REP, V41, P495, DOI 10.5483/BMBRep.2008.41.7.495; Leppanen O, 2006, J BONE MINER RES, V21, P1231, DOI 10.1359/JBMR.060511; Lin HL, 2015, ACTA NEUROL SCAND, V131, P158, DOI 10.1111/ane.12301; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; McDonald SJ, 2012, ACTA ORTHOP, V83, P93, DOI 10.3109/17453674.2011.652891; MUNDY GR, 1991, J PERIODONTAL RES, V26, P213, DOI 10.1111/j.1600-0765.1991.tb01647.x; Nagao M, 2011, P NATL ACAD SCI USA, V108, P17767, DOI 10.1073/pnas.1109402108; Romano T, 2014, REPROD FERT DEVELOP, V26, P385, DOI 10.1071/RD12378; Romano T, 2010, BONE, V47, P1054, DOI 10.1016/j.bone.2010.08.020; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Smith EM, 2009, ARCH PHYS MED REHAB, V90, P1127, DOI 10.1016/j.apmr.2008.09.578; Szulc P, 2009, OSTEOPOROSIS INT, V20, P1281, DOI 10.1007/s00198-009-0994-y; THORLACIUSUSSING O, 1987, ENDOCRINOLOGY, V120, P659, DOI 10.1210/endo-120-2-659; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu H, 2013, BRAIN INJ; Zheng P, 2014, MOL NEUROBIOL, V49, P1532, DOI 10.1007/s12035-013-8601-9	39	16	17	0	2	JMNI	NAFPLION	7 SPILIADOU SQ, NAFPLION, 21 100, GREECE	1108-7161			J MUSCULOSKEL NEURON	J. Musculoskelet. Neuronal Interact.	DEC	2016	16	4					369	376					8	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	EJ1VB	WOS:000392997200011	27973389				2022-02-06	
J	Fernandez-Cabello, S; Valls-Pedret, C; Schurz, M; Vidal-Pineiro, D; Sala-Llonch, R; Bargallo, N; Ros, E; Bartres-Faz, D				Fernandez-Cabello, Sara; Valls-Pedret, Cinta; Schurz, Matthias; Vidal-Pineiro, Didac; Sala-Llonch, Roser; Bargallo, Nuria; Ros, Emilio; Bartres-Faz, David			White matter hyperintensities and cognitive reserve during a working memory task: a functional magnetic resonance imaging study in cognitively normal older adults	NEUROBIOLOGY OF AGING			English	Article						Aging; Cognitive reserve; fMRI; Compensation; Neural efficiency; White matter hyperintensities; Education; Working memory	TRAUMATIC BRAIN-INJURY; SMALL VESSEL DISEASE; BASAL GANGLIA; PREFRONTAL CORTEX; AGE-DIFFERENCES; LESIONS; COMPENSATION; PERFORMANCE; EDUCATION; MAINTENANCE	Cognitive reserve (CR) models posit that lifestyle factors such as education modulate the relationship between brain damage and cognition. However, the functional correlates of CR in healthy aging are still under investigation. White matter hyperintensities (WMHs) are a common age-associated finding that impacts cognition. In this study, we used functional magnetic resonance imaging to characterize the patterns of brain activation during a working memory task in older participants with high and low levels of education (as a proxy of CR) and high and low WMH volumes. Ninety older volunteers (aged 63-76 years) and 16 young adults (aged 21-27) completed the study. We found that older adults with higher education had better working memory performance than their less educated peers. Among the highly educated participants, those with WMH over-recruited areas engaged by young volunteers and showed activation in additional cortical and subcortical structures. However, those with low WMH differed little with respect to their younger counterparts. Our findings demonstrate that the functional mechanisms subtending the effects of education, as a proxy of CR, are modulated according to the WMH burden. (C) 2016 Elsevier Inc. All rights reserved.	[Fernandez-Cabello, Sara; Schurz, Matthias] Salzburg Univ, Dept Psychol, Salzburg, Austria; [Fernandez-Cabello, Sara; Schurz, Matthias] Salzburg Univ, Ctr Cognit Neurosci, Salzburg, Austria; [Fernandez-Cabello, Sara; Bartres-Faz, David] Univ Barcelona, Fac Med & Hlth Sci, Dept Med, Barcelona, Spain; [Valls-Pedret, Cinta; Ros, Emilio] Hosp Clin Barcelona, Endocrinol & Nutr Serv, Lipid Clin, Barcelona, Spain; [Valls-Pedret, Cinta; Bargallo, Nuria; Ros, Emilio; Bartres-Faz, David] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Valls-Pedret, Cinta; Ros, Emilio] Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain; [Vidal-Pineiro, Didac; Sala-Llonch, Roser] Univ Oslo, Dept Psychol, Res Grp Lifespan Changes Brain & Cognit, Oslo, Norway; [Bargallo, Nuria] Hosp Clin Barcelona, Ctr Diagnost Imatge, Serv Radiol, Neuroradiol Sect, Barcelona, Spain		Bartres-Faz, D (corresponding author), Univ Barcelona, Fac Med, Dept Psychiat & Clin Psychobiol, C Casanova 143, E-08036 Barcelona, Spain.	dbartres@ub.edu	cohorts, Doctoral College Imaging the Mind - all/I-4689-2018; Sala-Llonch, Roser/E-7882-2012; Bartres-Faz, David/C-8997-2011; Vidal-Pineiro, Didac/O-5012-2016; Bargallo, Nuria/G-6854-2016	Sala-Llonch, Roser/0000-0003-3576-0475; Bartres-Faz, David/0000-0001-6020-4118; Vidal-Pineiro, Didac/0000-0001-9997-9156; Fernandez Rodriguez-Cabello, Sara/0000-0002-2589-8449; Bargallo, Nuria/0000-0001-6284-5402; Ros, Emilio/0000-0002-2573-1294; Valls-Pedret, Cinta/0000-0001-5005-0653	Doctoral College "Imaging the Mind" of the Austrian Science Foundation [FWF-W1233]; Spanish Ministry of Economy and Competitiveness (MINECO) [PSI2015-64227-R]; Walnuts and Healthy Aging (WAHA) - California Walnut Commission, Sacramento, California, USA [NCT01634841]	Sara Fernandez-Cabello was supported by the Doctoral College "Imaging the Mind" (FWF-W1233) of the Austrian Science Foundation (FWF-W1233). Partially funded by a Spanish Ministry of Economy and Competitiveness (MINECO) grant to David Bartres-Faz (PSI2015-64227-R) and the Walnuts and Healthy Aging (WAHA) study (http://www.clinicaltrials.gov NCT01634841) funded by the California Walnut Commission, Sacramento, California, USA.	Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Bartres-Faz D, 2011, BRAIN TOPOGR, V24, P340, DOI 10.1007/s10548-011-0195-9; Bartres-Faz D, 2009, BIOL PSYCHOL, V80, P256, DOI 10.1016/j.biopsycho.2008.10.005; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Bennett DA, 2014, ACTA NEUROPATHOL, V127, P137, DOI 10.1007/s00401-013-1226-2; Birdsill AC, 2014, NEUROBIOL AGING, V35, P769, DOI 10.1016/j.neurobiolaging.2013.10.072; Brickman AM, 2011, NEUROBIOL AGING, V32, P1588, DOI 10.1016/j.neurobiolaging.2009.10.013; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; Carlson MC, 2008, GERONTOLOGIST, V48, P793, DOI 10.1093/geront/48.6.793; Chan AS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00050; D'Esposito M, 2015, ANNU REV PSYCHOL, V66, P115, DOI 10.1146/annurev-psych-010814-015031; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Dahlin E, 2008, PSYCHOL AGING, V23, P720, DOI 10.1037/a0014296; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Dufouil C, 2003, NEUROLOGY, V60, P831, DOI 10.1212/01.WNL.0000049456.33231.96; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Griebe M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103359; Guo LH, 2013, ALZHEIMERS DEMENT, V9, P580, DOI 10.1016/j.jalz.2012.10.002; Holtzer R, 2009, BRAIN RES, V1249, P148, DOI 10.1016/j.brainres.2008.10.009; Kim MA, 2010, SCHIZOPHR RES, V117, P42, DOI 10.1016/j.schres.2009.12.014; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Kruschke JK, 2011, PERSPECT PSYCHOL SCI, V6, P299, DOI 10.1177/1745691611406925; Lockhart SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122445; Lovden M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.013; McDonough IM, 2015, RESTOR NEUROL NEUROS, V33, P865, DOI 10.3233/RNN-150533; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Moore AB, 2013, BRAIN LANG, V125, P316, DOI 10.1016/j.bandl.2012.05.003; Nagel IE, 2011, J COGNITIVE NEUROSCI, V23, P2030, DOI 10.1162/jocn.2010.21560; Nagel IE, 2009, P NATL ACAD SCI USA, V106, P22552, DOI 10.1073/pnas.0908238106; Nebes RD, 2006, AGING NEUROPSYCHOL C, V13, P326, DOI 10.1080/138255890969294; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/jocn.2006.18.3.418; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 2014, PSYCHOL SCI, V25, P103, DOI 10.1177/0956797613499592; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; Poldrack RA, 2015, DEV COGN NEUROS-NETH, V11, P12, DOI 10.1016/j.dcn.2014.06.001; Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Sala-Llonch R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00663; Sala-Llonch R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00152; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; SEEMAN P, 1987, J PHARMACOL METHOD, V17, P347, DOI 10.1016/0160-5402(87)90048-9; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Steffener J, 2011, BRAIN IMAGING BEHAV, V5, P212, DOI 10.1007/s11682-011-9125-4; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P589, DOI 10.1076/jcen.25.5.589.14571; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Sumowski JF, 2013, NEUROLOGY, V80, P2186, DOI 10.1212/WNL.0b013e318296e98b; Sumowski JF, 2009, J CLIN EXP NEUROPSYC, V31, P913, DOI 10.1080/13803390902740643; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tuladhar AM, 2015, NEUROIMAGE-CLIN, V7, P518, DOI 10.1016/j.nicl.2015.02.003; Tullberg M, 2004, NEUROLOGY, V63, P246, DOI 10.1212/01.WNL.0000130530.55104.B5; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vemuri P, 2015, BRAIN, V138, P761, DOI 10.1093/brain/awu393; Venkatraman VK, 2010, NEUROIMAGE, V49, P3436, DOI 10.1016/j.neuroimage.2009.11.019; Vidal-Pineiro D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00256; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7	65	16	16	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	DEC	2016	48						23	33		10.1016/j.neurobiolaging.2016.08.008			11	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	EA9PW	WOS:000386977300003	27636672				2022-02-06	
J	Del Turco, D; Paul, MH; Schlaudraff, J; Hick, M; Endres, K; Muller, UC; Deller, T				Del Turco, Domenico; Paul, Mandy H.; Schlaudraff, Jessica; Hick, Meike; Endres, Kristina; Mueller, Ulrike C.; Deller, Thomas			Region-Specific Differences in Amyloid Precursor Protein Expression in the Mouse Hippocampus	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						APP; dentategyrus; CA1; immunostaining; western blotting; laser microdissection; in situ hybridization; RT-qPCR	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; GENE-EXPRESSION; MESSENGER-RNAS; APPS-ALPHA; FAMILY-MEMBERS; RAT; PLASTICITY; MICE	The physiological role of amyloid precursor protein (APP) has been extensively investigated in the rodent hippocampus. Evidence suggests that APP plays a role in synaptic plasticity, dendritic and spine morphogenesis, neuroprotection and-at the behavioral level-hippocampus-dependent forms of learning and memory. Intriguingly, however, studies focusing on the role of APP in synaptic plasticity have reported diverging results and considerable differences in effect size between the dentate gyrus (DG) and area CA1 of the mouse hippocampus. We speculated that regional differences in APP expression could underlie these discrepancies and studied the expression of APP in both regions using immunostaining, in situ hybridization (ISH), and laser microdissection (LMD) in combination with quantitative reverse transcription polymerase chain reaction (RT-qPCR) and western blotting. In sum, our results show that APP is approximately 1.7-fold higher expressed in pyramidal cells of Ammons horn than in granule cells of the DG. This regional difference in APP expression may explain why loss-of-function approaches using APP-deficient mice revealed a role for APP in Hebbian plasticity in area CA1, whereas this could not be shown in the DG of the same APP mutants.	[Del Turco, Domenico; Paul, Mandy H.; Schlaudraff, Jessica; Hick, Meike; Deller, Thomas] Goethe Univ, Ctr Neurosci, Inst Clin Neuroanat, Frankfurt, Germany; [Hick, Meike; Mueller, Ulrike C.] Heidelberg Univ, IPMB, Heidelberg, Germany; [Endres, Kristina] Univ Med Ctr Mainz, Clin Psychiat & Psychotherapy, Mainz, Germany		Del Turco, D (corresponding author), Goethe Univ, Ctr Neurosci, Inst Clin Neuroanat, Frankfurt, Germany.	delturco@em.uni-frankfurt.de	Endres, Kristina/K-4960-2015		Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [FOR 1332]	This research was funded by the Deutsche Forschungsgemeinschaft (DFG FOR 1332 to TD and UCM).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anliker B, 2006, NEURODEGENER DIS, V3, P239, DOI 10.1159/000095262; Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Burbach GJ, 2003, J NEUROSCI METH, V131, P83, DOI 10.1016/S0165-0270(03)00232-2; CLARRIS HJ, 1995, DEV BRAIN RES, V88, P87, DOI 10.1016/0165-3806(95)00083-P; Cousins SL, 2009, J NEUROCHEM, V111, P1501, DOI 10.1111/j.1471-4159.2009.06424.x; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Del Turco D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084962; Deller T, 1997, PROG NEUROBIOL, V53, P687, DOI 10.1016/S0301-0082(97)00044-0; Deller T, 2000, ANN NY ACAD SCI, V911, P207; Deller T, 2007, PROG BRAIN RES, V163, P501, DOI 10.1016/S0079-6123(07)63027-1; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; Endres K, 2012, EXP BRAIN RES, V217, P343, DOI 10.1007/s00221-011-2885-7; Fahrenholz F, 2007, CURR ALZHEIMER RES, V4, P412, DOI 10.2174/156720507781788837; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; Fol R, 2016, ACTA NEUROPATHOL, V131, P247, DOI 10.1007/s00401-015-1498-9; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; HAASS C, 1991, J NEUROSCI, V11, P3783; Heber S, 2000, J NEUROSCI, V20, P7951; Hick M, 2015, ACTA NEUROPATHOL, V129, P21, DOI 10.1007/s00401-014-1368-x; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; IZUMI R, 1992, GENE, V112, P189, DOI 10.1016/0378-1119(92)90375-Y; Jedlicka P, 2012, EXP BRAIN RES, V217, P441, DOI 10.1007/s00221-011-2911-9; Kaden D, 2012, EUR J CELL BIOL, V91, P234, DOI 10.1016/j.ejcb.2011.01.017; KANG J, 1990, BIOCHEM BIOPH RES CO, V166, P1192, DOI 10.1016/0006-291X(90)90992-V; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Lassek M., 2016, FRONT SYNAPTIC NEURO, V7, P21, DOI 10.3389/fnsyn.2015.00021; Lassek M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004832; Lassek M, 2014, CURR ALZHEIMER RES, V11, P971; Lassek M, 2013, J NEUROCHEM, V127, P48, DOI 10.1111/jnc.12358; LEBLANC AC, 1991, FEBS LETT, V292, P171, DOI 10.1016/0014-5793(91)80861-V; Li ZW, 1996, P NATL ACAD SCI USA, V93, P6158, DOI 10.1073/pnas.93.12.6158; Lynch G, 1978, Prog Brain Res, V48, P113; MONNING U, 1995, J BIOL CHEM, V270, P7104, DOI 10.1074/jbc.270.13.7104; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prinzen C, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-66; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schonrock N, 2012, EXP NEUROL, V235, P447, DOI 10.1016/j.expneurol.2011.11.013; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Stahl R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00410; Steward O., 1994, NEUROBIOLOGY CENTRAL, P266; Sun XL, 2012, J NEUROCHEM, V120, P62, DOI 10.1111/j.1471-4159.2011.07515.x; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Vincent B, 2016, BRAIN RES BULL, V126, P154, DOI 10.1016/j.brainresbull.2016.03.020; Vnencak M, 2015, J COMP NEUROL, V523, P1717, DOI 10.1002/cne.23766; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang BP, 2014, J NEUROSCI, V34, P13314, DOI 10.1523/JNEUROSCI.2848-14.2014; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x	72	16	16	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	NOV 29	2016	9								134	10.3389/fnmol.2016.00134			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED1WT	WOS:000388636300002	27965537	gold, Green Published			2022-02-06	
J	Karamzadeh, N; Amyot, F; Kenney, K; Anderson, A; Chowdhry, F; Dashtestani, H; Wassermann, EM; Chernomordik, V; Boccara, C; Wegman, E; Diaz-Arrastia, R; Gandjbakhche, AH				Karamzadeh, Nader; Amyot, Franck; Kenney, Kimbra; Anderson, Afrouz; Chowdhry, Fatima; Dashtestani, Hadis; Wassermann, Eric M.; Chernomordik, Victor; Boccara, Claude; Wegman, Edward; Diaz-Arrastia, Ramon; Gandjbakhche, Amir H.			A machine learning approach to identify functional biomarkers in human prefrontal cortex for individuals with traumatic brain injury using functional near-infrared spectroscopy	BRAIN AND BEHAVIOR			English	Article						classification; feature selection; machine learning; near-infrared spectroscopy; traumatic brain injury; time series feature extraction; wrapper method	WORKING-MEMORY; MOTOR IMAGERY; CEREBRAL HEMODYNAMICS; BLOOD-VOLUME; CLASSIFICATION; COMPLEXITY; OSCILLATIONS; FREQUENCY; FMRI; AUTOREGULATION	BackgroundWe have explored the potential prefrontal hemodynamic biomarkers to characterize subjects with Traumatic Brain Injury (TBI) by employing the multivariate machine learning approach and introducing a novel task-related hemodynamic response detection followed by a heuristic search for optimum set of hemodynamic features. To achieve this goal, the hemodynamic response from a group of 31 healthy controls and 30 chronic TBI subjects were recorded as they performed a complexity task. MethodsTo determine the optimum hemodynamic features, we considered 11 features and their combinations in characterizing TBI subjects. We investigated the significance of the features by utilizing a machine learning classification algorithm to score all the possible combinations of features according to their predictive power. Results and ConclusionsThe identified optimum feature elements resulted in classification accuracy, sensitivity, and specificity of 85%, 85%, and 84%, respectively. Classification improvement was achieved for TBI subject classification through feature combination. It signified the major advantage of the multivariate analysis over the commonly used univariate analysis suggesting that the features that are individually irrelevant in characterizing the data may become relevant when used in combination. We also conducted a spatio-temporal classification to identify regions within the prefrontal cortex (PFC) that contribute in distinguishing between TBI and healthy subjects. As expected, Brodmann areas (BA) 10 within the PFC were isolated as the region that healthy subjects (unlike subjects with TBI), showed major hemodynamic activity in response to the High Complexity task. Overall, our results indicate that identified temporal and spatio-temporal features from PFC's hemodynamic activity are promising biomarkers in classifying subjects with TBI.	[Karamzadeh, Nader; Wegman, Edward] George Mason Univ, Dept Computat & Data Sci, Fairfax, VA 22030 USA; [Karamzadeh, Nader; Anderson, Afrouz; Chowdhry, Fatima; Dashtestani, Hadis; Chernomordik, Victor; Gandjbakhche, Amir H.] NICHHD, NIH, Bethesda, MD 20892 USA; [Amyot, Franck; Kenney, Kimbra; Diaz-Arrastia, Ramon] Uniformed Serv, Dept Neurol, Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Wassermann, Eric M.] NIMH, NIH, Bethesda, MD 20892 USA; [Boccara, Claude] Inst Langevin ESPCI ParisTech, Paris, France		Gandjbakhche, AH (corresponding author), NICHHD, NIH, Bethesda, MD 20892 USA.	amir@helix.nih.gov	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210; Boccara, Claude/0000-0002-9603-0700; Diaz-Arrastia, Ramon/0000-0001-6051-3594	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Neurological Disorder and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Department of Defense in Center for Neuroscience and Regenerative MedicineUnited States Department of Defense	We acknowledge the funding of the intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Neurological Disorder and Stroke, and Department of Defense in Center for Neuroscience and Regenerative Medicine.	Ahmadlou M, 2010, J NEURAL TRANSM, V117, P1099, DOI 10.1007/s00702-010-0450-3; Amyot F, 2012, NEUROIMAGE, V60, P879, DOI 10.1016/j.neuroimage.2012.01.104; Anderson AA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00393; Bhambhani Y, 2006, J REHABIL RES DEV, V43, P845, DOI 10.1682/JRRD.2005.09.0151; Bishop CM., 2006, PATTERN RECOGN; Bosl W, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-18; Breiman L., 1984, CLASSIFICATION REGRE; Bunce Scott C., 2013, Foundations of Augmented Cognition. 7th International Conference, AC 2013. Held as Part of HCI International 2013. Proceedings, P250, DOI 10.1007/978-3-642-39454-6_26; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Chernomordikl V, 2016, BRAIN RES, V1639, P194, DOI 10.1016/j.brainres.2016.02.018; Coyle S, 2004, PHYSIOL MEAS, V25, P815, DOI 10.1088/0967-3334/25/4/003; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Domingos P, 2012, COMMUN ACM, V55, P78, DOI 10.1145/2347736.2347755; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Hibino S, 2013, NEUROL MED-CHIR, V53, P299, DOI 10.2176/nmc.53.299; Holper L, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-34; Izzetoglu M, 2005, IEEE T NEUR SYS REH, V13, P153, DOI 10.1109/TNSRE.2005.847377; Kainerstorfer JM, 2014, ACAD RADIOL, V21, P185, DOI 10.1016/j.acra.2013.10.012; Krueger F, 2009, NEUROREPORT, V20, P1093, DOI 10.1097/WNR.0b013e32832e7ea5; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Levin HS., 1982, NEUROBEHAVIORAL CONS; Liu XY, 2015, J CEREBR BLOOD F MET, V35, P248, DOI 10.1038/jcbfm.2014.192; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Luu S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016003; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Merzagora AC, 2011, J INNOV OPT HEAL SCI, V4, P251, DOI 10.1142/S1793545811001551; Merzagora ACR, 2014, BRAIN IMAGING BEHAV, V8, P446, DOI 10.1007/s11682-013-9258-8; Morchen F., 2003, TIME SERIES FEATURE; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; Naito M, 2007, IEICE T INF SYST, VE90D, P1028, DOI 10.1093/ietisy/e90-d.7.1028; Hai NT, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00516; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Plichta MM, 2006, NEUROIMAGE, V31, P116, DOI 10.1016/j.neuroimage.2005.12.008; Power SD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066004; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rizk-Jackson A, 2011, NEUROIMAGE, V56, P788, DOI 10.1016/j.neuroimage.2010.04.273; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Satyasree K., 2013, INT J EMERG TRENDS T, V2, P109; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Scholkmann F, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.105004; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Stahl D, 2012, DEV NEUROPSYCHOL, V37, P274, DOI 10.1080/87565641.2011.650808; Stangl M, 2013, J NEAR INFRARED SPEC, V21, P157, DOI 10.1255/jnirs.1048; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Tan P.-N., 2006, INTRO DATA MINING; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Welling M., 2005, FISHER LINEAR DISCRI; Woon WL, 2007, PHYSIOL MEAS, V28, P335, DOI 10.1088/0967-3334/28/4/001	59	16	16	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	NOV	2016	6	11								10.1002/brb3.541			14	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EB7RJ	WOS:000387587500004		gold, Green Published			2022-02-06	
J	Cuisinier, A; Maufrais, C; Payen, JF; Nottin, S; Walther, G; Bouzat, P				Cuisinier, Adrien; Maufrais, Claire; Payen, Jean-Francois; Nottin, Stephane; Walther, Guillaume; Bouzat, Pierre			Myocardial function at the early phase of traumatic brain injury: a prospective controlled study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; CHAMBER QUANTIFICATION; INTRACRANIAL-PRESSURE; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; ECHOCARDIOGRAPHY; DYSFUNCTION; RECOMMENDATIONS; DAMAGE	Background: The concept of brain-heart interaction has been described in several brain injuries. Traumatic brain injury (TBI) may also lead to cardiac dysfunction but evidences are mainly based upon experimental and clinical retrospective studies. Methods: We conducted a prospective case-control study in a level I trauma center. Twenty consecutive adult patients with severe TBI were matched according to age and gender with 20 control patients. The control group included adult patients undergoing a general anesthesia for a peripheral trauma surgery. Conventional and Speckle Tracking Echocardiography (STE) was performed within the first 24 post-traumatic hours in the TBI group and PRE/PER-operative in the control group. The primary endpoint was the left ventricle ejection fraction (LVEF) measured by the Simpson's method. Secondary endpoints included the diastolic function and the STE analysis. Results: We found similar LVEF between the TBI group and the PER-operative control group (61 % [56-76]) vs. 62 % [52-70]). LV morphological parameters and the systolic function were also similar between the two groups. Regarding the diastolic function, the isovolumic relaxation time was significantly higher in the TBI cohort (125 s [84-178] versus 107 s [83-141], p = 0.04), suggesting a subclinical diastolic dysfunction. Using STE parameters, we observed a trend toward higher strains in the TBI group but only the apical circumferential strain and the basal rotation reached statistical significance. STE-derived parameters of the diastolic function tended to be lower in TBI patients. Discussion: No systematic myocardial depression was found in a cohort of severe TBI patients. Conclusions: STE revealed a correct adaptation of the left systolic function, while the diastolic function slightly impaired.	[Cuisinier, Adrien; Payen, Jean-Francois; Bouzat, Pierre] Ctr Hosp Univ Grenoble, Pole Anesthesie Reanimat, Hop Albert Michallon, BP 217,CS 10217, F-38043 Grenoble, France; [Maufrais, Claire] Univ Fribourg, Lab Integrat Cardiovasc & Metab Physiol, Dept Med, Div Physiol, Fribourg, Switzerland; [Nottin, Stephane; Walther, Guillaume] Avignon Univ, LAPEC EA4278, F-84000 Avignon, France; [Payen, Jean-Francois; Bouzat, Pierre] Grenoble Inst Neurosci, INSERM, U1216, F-38043 Grenoble, France; [Payen, Jean-Francois; Bouzat, Pierre] Grenoble Alpes Univ, F-38043 Grenoble, France		Bouzat, P (corresponding author), Ctr Hosp Univ Grenoble, Pole Anesthesie Reanimat, Hop Albert Michallon, BP 217,CS 10217, F-38043 Grenoble, France.; Bouzat, P (corresponding author), Grenoble Inst Neurosci, INSERM, U1216, F-38043 Grenoble, France.	PBouzat@chu-grenoble.fr	Payen, Jean-Francois/L-6667-2014; Bouzat, Pierre/L-6881-2014; Bouzat, Pierre/AAC-4105-2019	Bouzat, Pierre/0000-0003-4667-6738	public source (Grenoble University Hospital, France)	the study was funded by public source (Grenoble University Hospital, France).	Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Bahloul M, 2006, AM J CRIT CARE, V15, P462; Blanc C, 2015, EUR NEUROL, V74, P163, DOI 10.1159/000440717; Cinotti R, 2016, INTENS CARE MED, V42, P173, DOI 10.1007/s00134-015-4106-5; Fang ZY, 2004, CLIN SCI, V106, P53, DOI 10.1042/CS20030153; Huang CC, 2012, AM J EMERG MED, V30, P732, DOI 10.1016/j.ajem.2011.05.003; KOLIN A, 1984, STROKE, V15, P990, DOI 10.1161/01.STR.15.6.990; Kopelnik A, 2005, NEUROCRIT CARE, V3, P132, DOI 10.1385/NCC:3:2:132; Kraigher-Krainer E, 2014, J AM COLL CARDIOL, V63, P447, DOI 10.1016/j.jacc.2013.09.052; Krishnamoorthy Vijay, 2015, Int J Crit Illn Inj Sci, V5, P103, DOI 10.4103/2229-5151.158409; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Le Ven F, 2011, INT J CARDIOL, V146, P475, DOI 10.1016/j.ijcard.2010.12.028; Mashaly Hazem Antar, 2008, Cleve Clin J Med, V75 Suppl 2, pS26; Mertes PM, 2012, ANN FR ANESTH, V31, P91; Moussouttas M, 2012, NEUROCRIT CARE, V16, P381, DOI 10.1007/s12028-012-9673-5; Najafipour Hamid, 2014, Iranian Biomedical Journal, V18, P225, DOI 10.6091/ibj.13222.2014; OPPENHEIMER SM, 1992, NEUROL CLIN, V10, P167, DOI 10.1016/S0733-8619(18)30239-1; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Qian R, 2015, AM J CARDIOVASC DIS, V5, P72; Riera M, 2010, J TRAUMA, V68, P13; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Schmidt EA, 2005, ACTA NEUROCHIR SUPPL, V95, P253; Shahul S, 2015, ANESTH ANALG, V121, P1547, DOI 10.1213/ANE.0000000000000943; SHANLIN RJ, 1988, J AM COLL CARDIOL, V12, P727, DOI 10.1016/S0735-1097(88)80065-2; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; Tamaki T, 2004, BRIT J NEUROSURG, V18, P158, DOI 10.1080/02688690410001681019; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Yamamoto Takeshi, 2014, Masui, V63, P954	30	16	18	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	OCT 28	2016	24								129	10.1186/s13049-016-0323-3			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EA8BL	WOS:000386860200002	27793208	Green Published, gold			2022-02-06	
J	Si, Y; Zhang, Y; Han, L; Chen, LH; Xu, YJ; Sun, F; Ji, MH; Yang, JJ; Bao, HG				Si, Yanna; Zhang, Yuan; Han, Liu; Chen, Lihai; Xu, Yajie; Sun, Fan; Ji, Muhuo; Yang, Jianjun; Bao, Hongguang			Dexmedetomidine Acts via the JAK2/STAT3 Pathway to Attenuate Isoflurane-Induced Neurocognitive Deficits in Senile Mice	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; NEUROTROPHIC FACTOR EXPRESSION; NITROUS OXIDE ANESTHESIA; TRAUMATIC BRAIN-INJURY; MEMORY IMPAIRMENT; MITOCHONDRIAL MECHANISMS; AMBULATORY ANESTHESIA; DESFLURANE ANESTHESIA; POSTNATAL MEMORY; MOUSE MODEL	Background Previous studies showed that isoflurane-induced cognitive deficits could be alleviated by dexmedetomidine in young animal subjects. In the current study, we examine whether dexmedetomidine could also alleviate isoflurane-induced cognitive deficits in senile animals. Methods Senile male C57BL/6 mice (20 months) received dexmedetomidine (50 mu g/kg, i.p.) or vehicle 30 minutes prior to isoflurane exposure (1.3% for 4 h). Cognitive function was assessed 19 days later using a 5-day testing regimen with Morris water maze. Some subjects also received pretreatment with alpha 2 adrenoreceptor antagonist atipamezole (250 mu g/kg, i.p.), JAK2 inhibitor AG490 (15 mg/kg i.p.) or STAT3 inhibitor WP1066 (40 mg/kg i.p.) 30 minutes prior to dexmedetomidine. Results Isoflurane exposure increased and reduced the time spent in the quadrant containing the target platform in training sessions. The number of crossings over the original target quadrant was also decreased. Dexmedotomidine attenuated such effects. Effects of dexmedotomidine were reduced by pretreatment with atipamezole, AG490 and WP1066. Increased phosphorylation of JAK2 and STAT3 in the hippocampus induced by isoflurane was augmented by dexmedetomidine. Effects of dexmedetomidine on JAK2/STAT3 phosphorylation were attenuated by atipamezole, AG490 and WP1066. Isoflurane promoted neuronal apoptosis and increased the expression of cleaved caspase-3 and BAD, and reduced Bcl-2 expression. Attenuation of such effects by dexmedotomidine was partially blocked by atipamezole, AG490 and WP1066. Conclusion Dexmedetomidine could protect against isoflurane-induced spatial learning and memory impairment in senile mice by stimulating the JAK2/STAT3 signaling pathway. Such findings encourage the use of dexmedetomidine in geriatric patients receiving isoflurane anesthesia.	[Si, Yanna; Zhang, Yuan; Han, Liu; Chen, Lihai; Xu, Yajie; Sun, Fan; Bao, Hongguang] Nanjing Med Univ, Nanjing Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Ji, Muhuo; Yang, Jianjun] Southeast Univ, Sch Med, Zhongda Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Ji, Muhuo; Yang, Jianjun] Xuzhou Med Coll, Coll Anesthesiol, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China		Bao, HG (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China.	hongguang_bao@hotmail.com	Yang, Jianjun/AAN-4960-2021		Medical Development Project of Nanjing Science Committee [YKK12085]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401620]; Jiangsu Provincial Special Program of Medical Science [BL2014012]	This work was supported by grants to YNS from the Medical Development Project of Nanjing Science Committee (YKK12085) and the National Natural Science Foundation of China (81401620), and grant to HGB from Jiangsu Provincial Special Program of Medical Science (BL2014012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants to YNS from the Medical Development Project of Nanjing Science Committee (YKK12085) and the National Natural Science Foundation of China (81401620), and grant to HGB from Jiangsu Provincial Special Program of Medical Science (BL2014012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R, 2013, BRIT J ANAESTH, V111, P703, DOI 10.1093/bja/aet194; Alonzi T, 2001, MOL CELL NEUROSCI, V18, P270, DOI 10.1006/mcne.2001.1018; BEDFORD PD, 1955, LANCET, V2, P259; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Callaway JK, 2015, J ALZHEIMERS DIS, V44, P995, DOI 10.3233/JAD-132444; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051431; Chen JJ, 2013, EXP THER MED, V5, P489, DOI 10.3892/etm.2012.811; Chen WJ, 2015, INT J CLIN EXP MED, V8, P4601; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Chiba T, 2009, EXPERT OPIN THER TAR, V13, P1155, DOI 10.1517/14728220903213426; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Darcet F, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00136; Engelhard K, 2003, ANESTH ANALG, V96, P524, DOI 10.1097/00000539-200302000-00041; Fiskum G, 2003, ANN NY ACAD SCI, V991, P111; Gerlai R, 2002, NEUROPHARMACOLOGY, V43, P235, DOI 10.1016/S0028-3908(02)00078-3; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; Hwang L, 2013, INT J MOL MED, V31, P1047, DOI 10.3892/ijmm.2013.1301; Izquierdo I, 1999, BEHAV BRAIN RES, V103, P1, DOI 10.1016/S0166-4328(99)00036-4; Kong FJ, 2012, BIOCHEM PHARMACOL, V84, P558, DOI 10.1016/j.bcp.2012.06.001; Kong FJ, 2011, EUR J PHARMACOL, V670, P168, DOI 10.1016/j.ejphar.2011.08.050; Lee B, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-338; Lee BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105340; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li XM, 2014, J MOL NEUROSCI, V52, P286, DOI 10.1007/s12031-013-0141-2; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Li YJ, 2013, NEUROSCI LETT, V545, P17, DOI 10.1016/j.neulet.2013.04.008; Liang G, 2008, ANESTH ANALG, V106, P492, DOI 10.1213/ane.0b013e3181605b71; Lin DW, 2012, BEHAV BRAIN RES, V228, P319, DOI 10.1016/j.bbr.2011.12.010; Lindqvist M, 2014, ACTA ANAESTH SCAND, V58, P1111, DOI 10.1111/aas.12381; Ma DQ, 2004, EUR J PHARMACOL, V502, P87, DOI 10.1016/j.ejphar.2004.08.044; Mahajan VA, 2007, EUR J ANAESTH, V24, P505, DOI 10.1017/S0265021506001980; Makkar JK, 2016, ANAESTHESIA, V71, P50, DOI 10.1111/anae.13230; Mason SE, 2010, J ALZHEIMERS DIS, V22, pS67, DOI 10.3233/JAD-2010-101086; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Negoro S, 2000, CARDIOVASC RES, V47, P797, DOI 10.1016/S0008-6363(00)00138-3; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Ren XY, 2016, J NEUROIMMUNE PHARM, V11, P238, DOI 10.1007/s11481-016-9658-9; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Sanders RD, 2009, ANESTHESIOLOGY, V110, P1077, DOI 10.1097/ALN.0b013e31819daedd; Shyu WC, 2008, J CLIN INVEST, V118, P133, DOI 10.1172/JCI32723; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Tramullas M, 2008, NEUROPHARMACOLOGY, V54, P640, DOI 10.1016/j.neuropharm.2007.11.018; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Uchimoto K, 2014, ANESTHESIOLOGY, V121, P302, DOI 10.1097/ALN.0000000000000269; Wang YJ, 2016, MOL MED REP, V14, P769, DOI 10.3892/mmr.2016.5321; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Yang H, 2008, ANESTHESIOLOGY, V109, P243, DOI 10.1097/ALN.0b013e31817f5c47; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhang F, 2014, EXP THER MED, V8, P471, DOI 10.3892/etm.2014.1769; Zhang Q, 2012, CHINESE MED J-PEKING, V125, P2455, DOI 10.3760/cma.j.issn.0366-6999.2012.14.011; Zhang Y, 2003, J NEUROCHEM, V87, P1184, DOI 10.1046/j.1471-4159.2003.02105.x; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Zhang ZH, 2014, BRAIN RES, V1563, P72, DOI 10.1016/j.brainres.2014.03.036; Zhao H, 2003, J NEUROCHEM, V85, P1026, DOI 10.1046/j.1471-4159.2003.01756.x; Zhou TF, 2013, J SURG RES, V183, P304, DOI 10.1016/j.jss.2012.11.035	58	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164763	10.1371/journal.pone.0164763			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	WOS:000386205400027	27768775	Green Published, Green Submitted, gold			2022-02-06	
J	Perez-Garcia, G; Sosa, MAG; De Gasperi, R; Lashof-Sullivan, M; Maudlin-Jeronimo, E; Stone, JR; Haghighi, F; Ahlers, ST; Elder, GA				Perez-Garcia, Georgina; Sosa, Miguel A. Gama; De Gasperi, Rita; Lashof-Sullivan, Margaret; Maudlin-Jeronimo, Eric; Stone, James R.; Haghighi, Fatemeh; Ahlers, Stephen T.; Elder, Gregory A.			Exposure to a Predator Scent Induces Chronic Behavioral Changes in Rats Previously Exposed to Low-level Blast: Implications for the Relationship of Blast-Related TBI to PTSD	FRONTIERS IN NEUROLOGY			English	Article						animal models; blast; postconcussion syndrome; post-traumatic stress disorder; rat; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; ANIMAL-MODEL; OVERPRESSURE; VETERANS; RISK; CARE	Blast-related mild traumatic brain injury (mTBI) has been unfortunately common in veterans who served in the recent conflicts in Iraq and Afghanistan. The postconcussion syndrome associated with these mTBIs has frequently appeared in combination with post-traumatic stress disorder (PTSD). The presence of PTSD has complicated diagnosis, since clinically, PTSD and the postconcussion syndrome of mTBI have many overlapping symptoms. In particular, establishing how much of the symptom complex can be attributed to the psychological trauma associated with PTSD in contrast to the physical injury of traumatic brain injury has proven difficult. Indeed, some have suggested that much of what is now being called blast-related postconcussion syndrome is better explained by PTSD. The relationship between the postconcussion syndrome of mTBI and PTSD is complex. Association of the two disorders might be viewed as additive effects of independent psychological and physical traumas suffered in a war zone. However, we previously found that rats exposed to repetitive low-level blast exposure in the absence of a psychological stressor developed a variety of anxiety and PTSD-related behavioral traits that were present months following the last blast exposure. Here, we show that a single predator scent challenge delivered 8 months after the last blast exposure induces chronic anxiety related changes in blast-exposed rats that are still present 45 days later. These observations suggest that in addition to independently inducing PTSD-related traits, blast exposure sensitizes the brain to react abnormally to a subsequent psychological stressor. These studies have implications for conceptualizing the relationship between blast-related mTBI and PTSD and suggest that blast-related mTBI in humans may predispose to the later development of PTSD in reaction to subsequent psychological stressors.	[Perez-Garcia, Georgina; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Perez-Garcia, Georgina; Sosa, Miguel A. Gama; De Gasperi, Rita; Haghighi, Fatemeh] James J Peters Dept Vet Affairs Med Ctr, Res & Dev Serv, Bronx, NY USA; [Perez-Garcia, Georgina; Sosa, Miguel A. Gama; De Gasperi, Rita; Haghighi, Fatemeh; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Sosa, Miguel A. Gama; De Gasperi, Rita; Haghighi, Fatemeh; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Lashof-Sullivan, Margaret; Maudlin-Jeronimo, Eric; Ahlers, Stephen T.] Naval Med Res Ctr, Dept Neurotrauma Operat & Undersea Med, Silver Spring, MD USA; [Stone, James R.] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA; [Stone, James R.] Univ Virginia, Dept Neurosurg, Charlottesville, VA USA; [Haghighi, Fatemeh] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Elder, Gregory A.] James J Peters Dept Vet Affairs Med Ctr, Neurol Serv, Bronx, NY 10468 USA		Elder, GA (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Elder, GA (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.; Elder, GA (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.; Elder, GA (corresponding author), James J Peters Dept Vet Affairs Med Ctr, Neurol Serv, Bronx, NY 10468 USA.	gregory.elder@va.gov			NMRCNational Medical Research Council, Singapore [0000B999.0000.000.A1503]; Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service AwardUS Department of Veterans Affairs [1I01RX000996-01]; Veterans AffairsUS Department of Veterans Affairs [I01RX001705, I01RX000996] Funding Source: NIH RePORTER	This work was supported by NMRC work unit number 0000B999.0000.000.A1503 and by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service Award 1I01RX000996-01. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. Government. ML-S, EM-J, and SA are military service members (or employees of the U.S. Government). This work was prepared as part of their official duties. Title 17 U.S.C. 105 provides that copyright protection under this title is not available for any work of the United States Government. Title 17 U.S.C. 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person's official duties.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cohen H, 2004, ANN NY ACAD SCI, V1032, P167, DOI 10.1196/annals.1314.014; Cohen H, 2014, EUR NEUROPSYCHOPHARM, V24, P1925, DOI 10.1016/j.euroneuro.2014.09.009; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Fenchel D, 2015, EUR NEUROPSYCHOPHARM, V25, P944, DOI 10.1016/j.euroneuro.2015.02.004; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Goswami S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00089; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Institute of Medicine, 2014, GULF WAR HLTH LONG T; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Saridogan GE, 2015, BEHAV BRAIN RES, V293, P227, DOI 10.1016/j.bbr.2015.07.050; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	39	16	16	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 18	2016	7								176	10.3389/fneur.2016.00176			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ2BL	WOS:000385647000001	27803688	gold, Green Published			2022-02-06	
J	Taheri, S; Tanriverdi, F; Zararsiz, G; Elbuken, G; Ulutabanca, H; Karaca, Z; Selcuklu, A; Unluhizarci, K; Tanriverdi, K; Kelestimur, F				Taheri, Serpil; Tanriverdi, Fatih; Zararsiz, Gokmen; Elbuken, Gulsah; Ulutabanca, Halil; Karaca, Zuleyha; Selcuklu, Ahmet; Unluhizarci, Kursad; Tanriverdi, Kahraman; Kelestimur, Fahrettin			Circulating MicroRNAs as Potential Biomarkers for Traumatic Brain Injury-Induced Hypopituitarism	JOURNAL OF NEUROTRAUMA			English	Article						hypopituitarism; miRNA; TBI	ANTERIOR-PITUITARY FUNCTION; ACUTE-PHASE; DYSFUNCTION	Traumatic brain injury (TBI), a worldwide public health problem, has recently been recognized as a common cause of pituitary dysfunction. Circulating microRNAs (miRNAs) present in the sera are characteristically altered in many pathological conditions and have been used as diagnostic markers for specific diseases. It is with this goal that we planned to study miRNA expression in patients with TBI-induced hypopituitarism. Thirty-eight patients (27 male, 11 female; mean age, 43 +/- 18 years) who had been admitted to the neurosurgery intensive care unit due to TBI were included in the acute phase of the study. In the chronic phase, miRNA expression profile blood samples were drawn from 25 patients who had suffered TBI 5 years ago. In the acute phase (on Days 1, 7, and 28), a substantial amount of patients (26%, 40%, and 53%; respectively) had hypopituitarism (acute adrenocorticotropic hormone deficiency). In the chronic phase eight of 25 patients (32%) had TBI-induced-hypopituitarism. Forty-seven age-gender-similar healthy controls (25 male, 22 female, mean age: 41 +/- 14 years) were included in the study. In order to identify potential candidate miRNA/miRNAs whose levels had been altered in response to TBI-induced hypopituitarism, 740 miRNA expression analyses were performed in the sera of TBI patients by high throughput real-time polymerase chain reaction. Statistical analyses showed that miRNA-126-3p (miR-126-3p) and miRNA-3610 (miR-3610) were detected in the sera of patients who developed hypopituitarism on the 1st, 7th, and 28th days, and in the 5th year following TBI. In addition, miRNA-3907 showed statistically significant and constant dynamic changes on the 1st, 7th, and 28th days, and in the 5th year in the patients with TBI. Our results indicated that altered expression of miR-126-3p and miR-3610 may play an important role in the development of TBI-induced hypopituitarism.	[Taheri, Serpil] Erciyes Univ, Betul Ziya Eren Genome & Stem Cell Ctr, Kayseri, Turkey; [Tanriverdi, Fatih; Elbuken, Gulsah; Karaca, Zuleyha; Unluhizarci, Kursad; Kelestimur, Fahrettin] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [Zararsiz, Gokmen] Erciyes Univ, Sch Med, Dept Biostat, Kayseri, Turkey; [Ulutabanca, Halil; Selcuklu, Ahmet] Erciyes Univ, Sch Med, Dept Neurosurg, Kayseri, Turkey; [Tanriverdi, Kahraman] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA		Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr	ZARARSIZ, GOKMEN/ABH-7959-2020; Taheri, Serpil/AAL-8870-2021; Zararsiz, Gokmen/E-8818-2013; Karaca, Zuleyha/ABB-7891-2021; kelestimur, f/ABE-9873-2021; Elbuken, Gulsah/ABD-5689-2020	Zararsiz, Gokmen/0000-0001-5801-1835; Elbuken, Gulsah/0000-0002-0920-6895			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Jang JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-144; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; TEASDALE G, 1974, LANCET, V2, P81; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang P, 2015, CLIN LUNG CANCER, V16, P313, DOI 10.1016/j.cllc.2014.12.006; Wang W, 2015, J ZHEJIANG UNIV-SC B, V16, P18, DOI 10.1631/jzus.B1400184	23	16	19	1	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2016	33	20					1818	1825		10.1089/neu.2015.4281			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EA6YO	WOS:000386775300002	27027233				2022-02-06	
J	Song, HL; Lu, Y; Qu, Z; Mossine, VV; Martin, MB; Hou, J; Cui, JK; Peculis, BA; Mawhinney, TP; Cheng, JL; Greenlief, CM; Fritsche, K; Schmidt, FJ; Walter, RB; Lubahn, DB; Sun, GY; Gu, ZZ				Song, Hailong; Lu, Yuan; Qu, Zhe; Mossine, Valeri V.; Martin, Matthew B.; Hou, Jie; Cui, Jiankun; Peculis, Brenda A.; Mawhinney, Thomas P.; Cheng, Jianlin; Greenlief, C. Michael; Fritsche, Kevin; Schmidt, Francis J.; Walter, Ronald B.; Lubahn, Dennis B.; Sun, Grace Y.; Gu, Zezong			Effects of aged garlic extract and FruArg on gene expression and signaling pathways in lipopolysaccharide-activated microglial cells	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; NITRIC-OXIDE; TRANSCRIPTION FACTOR; MAILLARD REACTION; ANTIOXIDANT; INFLAMMATION; MECHANISM; ARGININE; IMMUNE	Aged garlic extract (AGE) is widely used as a dietary supplement on account of its protective effects against oxidative stress and inflammation. But less is known about specific molecular targets of AGE and its bioactive components, including N-alpha-(1-deoxy-D-fructos-1-yl)-L-arginine (FruArg). Our recent study showed that both AGE and FruArg significantly attenuate lipopolysaccharide (LPS)-induced neuroinflammatory responses in BV-2 microglial cells. This study aims to unveil effects of AGE and FruArg on gene expression regulation in LPS stimulated BV-2 cells. Results showed that LPS treatment significantly altered mRNA levels from 2563 genes. AGE reversed 67% of the transcriptome alteration induced by LPS, whereas FruArg accounted for the protective effect by reversing expression levels of 55% of genes altered by LPS. Key pro-inflammatory canonical pathways induced by the LPS stimulation included toll-like receptor signaling, IL-6 signaling, and Nrf2-mediated oxidative stress pathway, along with elevated expression levels of genes, such as Il6, Cd14, Casp3, Nfkb1, Hmox1, and Tnf. These effects could be modulated by treatment with both AGE and FruArg. These findings suggests that AGE and FruArg are capable of alleviating oxidative stress and neuroinflammatory responses stimulated by LPS in BV-2 cells.	[Song, Hailong; Qu, Zhe; Cui, Jiankun; Sun, Grace Y.; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Song, Hailong; Qu, Zhe; Cui, Jiankun; Sun, Grace Y.; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO 65212 USA; [Song, Hailong; Qu, Zhe; Hou, Jie; Cui, Jiankun; Cheng, Jianlin; Greenlief, C. Michael; Fritsche, Kevin; Lubahn, Dennis B.; Sun, Grace Y.; Gu, Zezong] Univ Missouri, Ctr Bot Interact Studies, Columbia, MO 65211 USA; [Lu, Yuan; Mossine, Valeri V.; Martin, Matthew B.; Peculis, Brenda A.; Mawhinney, Thomas P.; Schmidt, Francis J.; Lubahn, Dennis B.; Sun, Grace Y.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Lu, Yuan; Walter, Ronald B.] Texas State Univ, Xiphophorus Genet Stock Ctr, San Marcos, TX 78666 USA; [Hou, Jie; Cheng, Jianlin] Univ Missouri, Inst Informat, Dept Comp Sci, Columbia, MO 65211 USA; [Greenlief, C. Michael] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Fritsche, Kevin] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA		Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA.; Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO 65212 USA.; Gu, ZZ (corresponding author), Univ Missouri, Ctr Bot Interact Studies, Columbia, MO 65211 USA.	guze@health.missouri.edu	Walter, Ronald/AAI-5522-2020; Song, Hailong/I-9418-2018; Cheng, Jianlin/N-8209-2013	Song, Hailong/0000-0002-4204-6459; Hou, Jie/0000-0002-8584-5154; Cheng, Jianlin/0000-0003-0305-2853; Mawhinney, Thomas/0000-0002-1807-2550	Department of Pathology and Anatomical Sciences research fund at the University of Missouri School of Medicine; National Center for Complementary and Integrative Health (NCCIH) [P50AT006273]; Office of Dietary Supplements (ODS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Cancer Institute (NCI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [P50AT006273] Funding Source: NIH RePORTER	This publication was made possible by funding of the Department of Pathology and Anatomical Sciences research fund at the University of Missouri School of Medicine (to Z.G.), as well as by Grant Number P50AT006273 from the National Center for Complementary and Integrative Health (NCCIH), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS, NCCIH, ODS, NCI, or the National Institutes of Health.	Amagase H, 2006, J NUTR, V136, p716S, DOI 10.1093/jn/136.3.716S; Amagase H, 1996, J NUTR, V126, P817, DOI 10.1093/jn/126.4.817; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Baune BT, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-125; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Borek C, 2001, J NUTR, V131, p1010S, DOI 10.1093/jn/131.3.1010S; Bryce PJ, 2006, INT IMMUNOL, V18, P101, DOI 10.1093/intimm/dxh354; Buchwalow I, 2013, SCI REP-UK, V3, DOI 10.1038/srep01899; Calabrese V, 2006, ANTIOXID REDOX SIGN, V8, P1975, DOI 10.1089/ars.2006.8.1975; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Chino A, 2005, INT IMMUNOPHARMACOL, V5, P871, DOI 10.1016/j.intimp.2005.01.004; Colton CA, 2008, J ALZHEIMERS DIS, V15, P571; Danielson SR, 2008, FREE RADICAL BIO MED, V44, P1787, DOI 10.1016/j.freeradbiomed.2008.03.005; Das A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121117; Dawson VL, 1998, PROG BRAIN RES, V118, P215; Di Filippo M., 2016, SCI REPORTS, V6; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Gu Z, 2005, CELL DEATH DIFFER, V12, P1202, DOI 10.1038/sj.cdd.4401705; Ide N, 1999, J NUTR BIOCHEM, V10, P372, DOI 10.1016/S0955-2863(99)00021-2; IMAI J, 1994, PLANTA MED, V60, P417, DOI 10.1055/s-2006-959522; Jiang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089748; Jung JS, 2013, BBA-MOL CELL BIOL L, V1831, P1016, DOI 10.1016/j.bbalip.2013.01.020; Kyo E, 2001, J NUTR, V131, p1075S, DOI 10.1093/jn/131.3.1075S; LEDL F, 1990, ADV LIF SCI, P19; Li JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125000; Lu Y, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0047-3; Martins SIFS, 2000, TRENDS FOOD SCI TECH, V11, P364, DOI 10.1016/S0924-2244(01)00022-X; Moriguchi T, 1997, CLIN EXP PHARMACOL P, V24, P235, DOI 10.1111/j.1440-1681.1997.tb01813.x; Morihara N, 2011, PLANT FOOD HUM NUTR, V66, P17, DOI 10.1007/s11130-011-0216-6; Mossine VV, 2010, MAILLARD REACTION: INTERFACE BETWEEN AGING, NUTRITION AND METABOLISM, P170; Mossine VV, 2008, CANCER RES, V68, P4384, DOI 10.1158/0008-5472.CAN-08-0108; Mossine VV, 2010, ADV CARBOHYD CHEM BI, V64, P291, DOI 10.1016/S0065-2318(10)64006-1; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Patwardhan B, 2005, DRUG DISCOV TODAY, V10, P495, DOI 10.1016/S1359-6446(04)03357-4; Pugh ND, 2005, INT IMMUNOPHARMACOL, V5, P637, DOI 10.1016/j.intimp.2004.12.011; Qian L, 2008, IMMUNOL RES, V41, P155, DOI 10.1007/s12026-008-8018-0; Rahman K, 2000, J NUTR, V130, P2662, DOI 10.1093/jn/130.11.2662; Rahman K, 2007, MOL NUTR FOOD RES, V51, P1335, DOI 10.1002/mnfr.200700058; Rogers J, 2007, INT REV NEUROBIOL, V82, P235, DOI 10.1016/S0074-7742(07)82012-5; Ryu K, 2001, J NUTR, V131, p972S, DOI 10.1093/jn/131.3.972S; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sethy NK, 2011, FUNCT INTEGR GENOMIC, V11, P119, DOI 10.1007/s10142-010-0195-y; Shen SM, 2005, NEUROCHEM INT, V47, P298, DOI 10.1016/j.neuint.2005.03.007; Stabler SN, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007653.pub2; Steiner M, 1996, AM J CLIN NUTR, V64, P866, DOI 10.1093/ajcn/64.6.866; Steiner M, 2001, J NUTR, V131, p980S, DOI 10.1093/jn/131.3.980S; Streit WJ, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00022; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Tsang AHK, 2009, BBA-MOL BASIS DIS, V1792, P643, DOI 10.1016/j.bbadis.2008.12.006; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wood P., 2002, NEUROINFLAMMATION ME; Yoon YD, 2003, INT IMMUNOPHARMACOL, V3, P1873, DOI 10.1016/j.intimp.2003.09.005; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhao L, 2011, NUTR REV, V69, P310, DOI 10.1111/j.1753-4887.2011.00394.x; Zhou H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113531	60	16	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 13	2016	6								35323	10.1038/srep35323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2RC	WOS:000385687900001	27734935	gold, Green Published			2022-02-06	
J	Lopez-Rodriguez, AB; Acaz-Fonseca, E; Spezzano, R; Giatti, S; Caruso, D; Viveros, MP; Melcangi, RC; Garcia-Segura, LM				Belen Lopez-Rodriguez, Ana; Acaz-Fonseca, Estefania; Spezzano, Roberto; Giatti, Silvia; Caruso, Donatella; Viveros, Maria-Paz; Melcangi, Roberto C.; Garcia-Segura, Luis M.			Profiling Neuroactive Steroid Levels After Traumatic Brain Injury in Male Mice	ENDOCRINOLOGY			English	Article							ACUTE REGULATORY PROTEIN; MALE-RATS; PITUITARY DYSFUNCTION; CEREBROSPINAL-FLUID; CEREBRAL EDEMA; D-AMPHETAMINE; HEAD-INJURY; FEMALE RATS; IN-VIVO; MODEL	The incidence of traumatic brain injuries (TBIs) in humans has rapidly increased in the last ten years. The most common causes are falls and car accidents. Approximately 80 000-90 000 persons per year will suffer some permanent disability as a result of the lesion, and one of the most common symptoms is the decline of hormone levels, also known as post-TBI hormonal deficiency syndrome. This issue has become more and more important, and many studies have focused on shedding some light on it. The hormonal decline affects not only gonadal steroid hormones but also neuroactive steroids, which play an important role in TBI recovery by neuroprotective and neurotrophic actions. The present work used an adolescent close-head murine model to analyze brain and plasma neurosteroid level changes after TBI and to establish correlations with edema and neurological impairments, 2 of the hallmarks of TBI. Our results showed changes in brain pregnenolone, testosterone, dihydrotestosterone (DHT), and 3 alpha-diol levels whereas in plasma, the changes were present in progesterone, DHT, 3 alpha-diol, and 3 beta-diol. Within them, pregnenolone, progesterone, DHT, and 3 alpha-diol levels positively correlated with edema formation and neurological score, whereas testosterone inversely correlated with these 2 variables. These findings suggest that changes in the brain levels of some neuroactive steroids may contribute to the alterations in brain function caused by the lesion and that plasma levels of some neuroactive steroids could be good candidates of blood markers to predict TBI outcome.	[Belen Lopez-Rodriguez, Ana; Acaz-Fonseca, Estefania; Garcia-Segura, Luis M.] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Belen Lopez-Rodriguez, Ana; Viveros, Maria-Paz] Univ Complutense Madrid, Fac Biol, Dept Anim Physiol Anim Physiol 2, E-28040 Madrid, Spain; [Spezzano, Roberto; Giatti, Silvia; Caruso, Donatella; Melcangi, Roberto C.] Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy		Lopez-Rodriguez, AB (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Inst Neurosci, Dublin 2, Ireland.	lopezroa@tcd.ie	Garcia-Segura, Luis M/U-3711-2017; Melcangi, Roberto Cosimo/AAA-6534-2022; Giatti, Silvia/G-9334-2016; Acaz-Fonseca, Estefania/S-5884-2016; Lopez-Rodriguez, Ana Belen/H-3631-2017; Viveros, Maria-Paz/S-6855-2016	Garcia-Segura, Luis M/0000-0002-2450-2916; Giatti, Silvia/0000-0001-7741-826X; Acaz-Fonseca, Estefania/0000-0003-2549-6420; Lopez-Rodriguez, Ana Belen/0000-0002-0747-7966; Viveros, Maria-Paz/0000-0002-4119-4636; MELCANGI, COSIMO ROBERTO/0000-0003-0861-8967	Ministerio de Economia y Competividad, Spain [BFU2014-51836-C2-1-R]; Fondazione CariploFondazione Cariplo [2012-0547]	This work was supported by the Ministerio de Economia y Competividad, Spain Grant BFU2014-51836-C2-1-R and by the Fondazione Cariplo Grant 2012-0547.	Aadal L, 2015, J NEUROSCI NURS, V47, P85, DOI 10.1097/JNN.0000000000000121; Adriani W, 2003, BEHAV NEUROSCI, V117, P695, DOI 10.1037/0735-7044.117.4.695; Adriani W, 1998, BEHAV NEUROSCI, V112, P1152, DOI 10.1037/0735-7044.112.5.1152; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Belanger M, 2005, J HEPATOL, V42, P694, DOI 10.1016/j.jhep.2004.12.029; Lopez-Rodriguez AB, 2016, EXP NEUROL, V279, P274, DOI 10.1016/j.expneurol.2016.03.018; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caruso D, 2014, J NEUROCHEM, V130, P591, DOI 10.1111/jnc.12745; Caruso D, 2013, PSYCHONEUROENDOCRINO, V38, P2278, DOI 10.1016/j.psyneuen.2013.04.016; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; CLARK JDA, 1988, CLIN ENDOCRINOL, V29, P153, DOI 10.1111/j.1365-2265.1988.tb00257.x; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FRYE CA, 1995, BRAIN RES, V696, P113, DOI 10.1016/0006-8993(95)00793-P; Frye CA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00015; Frye CA, 2009, EPILEPSY BEHAV, V16, P418, DOI 10.1016/j.yebeh.2009.09.008; Giatti S, 2010, NEUROCHEM INT, V56, P118, DOI 10.1016/j.neuint.2009.09.009; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; Lavaque E, 2006, J NEUROBIOL, V66, P308, DOI 10.1002/neu.20221; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Lorenzo Monica, 2005, Pituitary, V8, P233, DOI 10.1007/s11102-006-6046-0; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Melcangi RC, 2016, NEUROSCI BIOBEHAV R, V67, P25, DOI 10.1016/j.neubiorev.2015.09.023; Mirzatoni A, 2010, J NEUROTRAUM, V27, P1875, DOI 10.1089/neu.2010.1330; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Reddy DS, 2004, NEUROSCIENCE, V129, P195, DOI 10.1016/j.neuroscience.2004.08.002; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Sierra A, 2003, EUR J NEUROSCI, V18, P1458, DOI 10.1046/j.1460-9568.2003.02872.x; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x; WU X, 2004, J TRAUMA ACUTE CARE, V64, P1313; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhao YZ, 2015, NEURAL REGEN RES, V10, P1076, DOI 10.4103/1673-5374.160097	61	16	16	0	13	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	OCT	2016	157	10					3983	3993		10.1210/en.2016-1316			11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	DZ7QT	WOS:000386061800029	27547849	Bronze			2022-02-06	
J	Dengler, BA; Mendez-Gomez, P; Chavez, A; Avila, L; Michalek, J; Hernandez, B; Grandhi, R; Seifi, A				Dengler, Bradley A.; Mendez-Gomez, Paolo; Chavez, Amanda; Avila, Lacey; Michalek, Joel; Hernandez, Brian; Grandhi, Ramesh; Seifi, Ali			Safety of Chemical DVT Prophylaxis in Severe Traumatic Brain Injury with Invasive Monitoring Devices	NEUROCRITICAL CARE			English	Article						Deep vein thrombosis; Intracranial pressure monitor; Severe traumatic brain injury	MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM PROPHYLAXIS; PHARMACOLOGICAL THROMBOPROPHYLAXIS; INTRACRANIAL HEMORRHAGE; ENOXAPARIN PROPHYLAXIS; HEAD-INJURY; RISK; EFFICACY; COMPLICATIONS	Patients with traumatic brain injuries (TBIs) have an increased risk of developing a deep vein thrombosis (DVT), but the risk of hemorrhage expansion with intracranial monitoring devices remains unknown. We sought to determine the safety of chemical DVT prophylaxis in severe TBI patients with invasive intracranial pressure monitors. We retrospectively reviewed all patients with severe TBI admitted to the neurosurgical intensive care unit of a large tertiary care center over a three-year period. 155 patients were included with an incidence of DVT of 12 %. The median length of time to a stable head CT was 2 days, and the median time to initiation of chemical DVT prophylaxis was 3.6 days. The odds of DVT increased with intraparenchymal hemorrhage [OR 7.21, 95 % CI (1.43-36.47), p = 0.0169], non-White ethnicity [OR 7.86, 95 % CI (1.23-50.35), p = 0.0295], female gender [OR 13.93, 95 % CI (2.47-78.73), p = 0.0029], smoking [OR 4.32, 95 % CI (1.07-17.51), p = 0.0405], no anticoagulation [OR 25.39, 95 % CI (4.26-151.48), p < 0.001], and an IVC filter [OR 15.82, 95 % CI (3.14-79.76), p < 0.001]. Twenty-eight (18 %) of these subjects experienced in-hospital mortality. The risk of in-hospital death was significantly increased among those who did not receive anticoagulation. This study found no association between DVT formation, hemorrhage expansion, or increased risk from invasive monitoring devices between various doses of unfractionated heparin (UH) and low-molecular-weight heparin (LMWH). We conclude that DVT prophylaxis with either LMWH or UH is safe with intracranial pressure monitors in place.	[Dengler, Bradley A.; Grandhi, Ramesh; Seifi, Ali] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, Mail Code 7843,7703 Floyd Curl Dr MC7843, San Antonio, TX 78229 USA; [Mendez-Gomez, Paolo; Chavez, Amanda; Avila, Lacey] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, San Antonio, TX 78229 USA; [Michalek, Joel; Hernandez, Brian] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA		Seifi, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, Mail Code 7843,7703 Floyd Curl Dr MC7843, San Antonio, TX 78229 USA.	seifi@uthscsa.edu	Seifi, Ali/AAR-6163-2020; Dengler, Bradley/AAN-7688-2021				Abdel-Aziz H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0814-z; Ali SF, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000171; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Arnold JD, 2010, AM SURGEON, V76, P563; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons, 2007, J NEUROTRAUM, V24, P37; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Cothren CC, 2007, WORLD J SURG, V31, P98, DOI 10.1007/s00268-006-0304-1; Depew AJ, 2008, AM SURGEON, V74, P906; Dimitriou J, 2016, WORLD NEUROSURG, V89, P641, DOI 10.1016/j.wneu.2015.11.037; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Gardner PA, 2009, J NEUROSURG, V110, P1021, DOI 10.3171/2008.9.JNS17661; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gerlach R, 2003, NEUROSURGERY, V53, P1028, DOI 10.1227/01.NEU.0000088565.15719.22; Hamilton MG, 2011, NEUROSURGERY, V68, P571, DOI 10.1227/NEU.0b013e3182093145; Jamjoom AAB, 2013, J NEUROTRAUM, V30, P503, DOI 10.1089/neu.2012.2584; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Kleindienst A, 2003, ACTA NEUROCHIR, V145, P1085, DOI 10.1007/s00701-003-0142-y; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; MCGILL HC, 1988, AM HEART J, V115, P250, DOI 10.1016/0002-8703(88)90645-X; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Mohseni Shahin, 2012, J Emerg Trauma Shock, V5, P11, DOI 10.4103/0974-2700.93102; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Patel AP, 2013, J NEUROSURG, V118, P505, DOI 10.3171/2012.11.JNS121243; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, pS122, DOI 10.1097/TA.0b013e3182606327; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stein PD, 1998, CHEST, V113, P499, DOI 10.1378/chest.113.2.499; Valle EJ, 2014, J TRAUMA ACUTE CARE, V77, P243, DOI 10.1097/TA.0000000000000307; Wahl WL, 2011, J TRAUMA, V71, P399; Zidovetzki R, 1999, STROKE, V30, P651, DOI 10.1161/01.STR.30.3.651	38	16	17	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2016	25	2					215	223		10.1007/s12028-016-0280-8			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DY5YN	WOS:000385181000008	27350548				2022-02-06	
J	Lazaridis, C; Robertson, CS				Lazaridis, Christos; Robertson, Claudia S.			The Role of Multimodal Invasive Monitoring in Acute Traumatic Brain Injury	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Intracranial pressure; Cerebral perfusion pressure; Brain tissue oxygen; Lactate/pyruvate ratio; Pressure reactivity index; Neuromonitoring	POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; PERIINFARCT DEPOLARIZATIONS; SPREADING DEPOLARIZATIONS; COMBINED MICRODIALYSIS; TISSUE OXYGENATION; CLINICAL ARTICLE	This article reviews the role of modalities that directly monitor brain parenchyma in patients with severe traumatic brain injury. The physiology monitored involves compartmental and perfusion pressures, tissue oxygenation and metabolism, quantitative blood flow, pressure autoregulation, and electrophysiology. There are several proposed roles for this multimodality monitoring, such as to track, prevent, and treat the cascade of secondary brain injury; monitor the neurologically injured patient; integrate various data into a composite, patient-specific, and dynamic picture; apply protocolized, pathophysiology-driven intensive care; use as a prognostic marker; and understand pathophysiologic mechanisms involved in secondary brain injury to develop preventive and abortive therapies, and to inform future clinical trials.	[Lazaridis, Christos] Baylor Coll Med, Med Ctr, Dept Neurol, Div Neurocrit Care, McNair Campus,7200 Cambridge St,9th Floor, Houston, TX 77030 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, One Baylor Plaza, Houston, TX 77030 USA		Lazaridis, C (corresponding author), Baylor Coll Med, Med Ctr, Dept Neurol, Div Neurocrit Care, McNair Campus,7200 Cambridge St,9th Floor, Houston, TX 77030 USA.	lazaridi@bcm.edu					Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bragin DE, 2011, J NEUROTRAUM, V28, P775, DOI 10.1089/neu.2010.1692; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK LC, 1956, T AM SOC ART INT ORG, V2, P41; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Diringer MN, 2011, TRANSL STROKE RES, V2, P517, DOI 10.1007/s12975-011-0119-8; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Frontera J, 2015, NEUROCRIT CARE, V22, P348, DOI 10.1007/s12028-015-0133-x; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Gupta AK, 2002, J NEUROSURG, V96, P263, DOI 10.3171/jns.2002.96.2.0263; Haitsma Iain K, 2002, Curr Opin Crit Care, V8, P115, DOI 10.1097/00075198-200204000-00005; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; Lazaridis C, 2014, NEUROCRIT CARE, V21, P345, DOI 10.1007/s12028-014-0007-7; Lazaridis C, 2014, J NEUROSURG, V120, P892; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Li CY, 2016, BIOSENS BIOELECTRON, V77, P62, DOI 10.1016/j.bios.2015.09.021; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Myers RB, 2016, CRIT CARE MED; Nielsen TH, 2014, NEUROCRIT CARE, V21, P35, DOI 10.1007/s12028-013-9875-5; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Shutter L., 2014, ANN M NEUR CAR SOC S; SIGGAARDANDERSEN O, 1995, ACTA ANAESTH SCAND, V39, P137; Smielewski P, 2008, ACTA NEUROCHIR SUPPL, V102, P145, DOI 10.1007/978-3-211-85578-2_30; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wolf Stefan, 2012, Acta Neurochir Suppl, V114, P187, DOI 10.1007/978-3-7091-0956-4_36	54	16	18	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	OCT	2016	27	4					509	+		10.1016/j.nec.2016.05.010			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DY9SQ	WOS:000385475800012	27637400				2022-02-06	
J	Samson, AJ; Robertson, G; Zagnoni, M; Connolly, CN				Samson, Andrew J.; Robertson, Graham; Zagnoni, Michele; Connolly, Christopher N.			Neuronal networks provide rapid neuroprotection against spreading toxicity	SCIENTIFIC REPORTS			English	Article							OXYGEN-GLUCOSE DEPRIVATION; NMDA RECEPTORS; BRAIN-DAMAGE; CELL-DEATH; CEREBRAL-ISCHEMIA; STROKE; GLUTAMATE; RECOVERY; RATS; EXCITOTOXICITY	Acute secondary neuronal cell death, as seen in neurodegenerative disease, cerebral ischemia (stroke) and traumatic brain injury (TBI), drives spreading neurotoxicity into surrounding, undamaged, brain areas. This spreading toxicity occurs via two mechanisms, synaptic toxicity through hyperactivity, and excitotoxicity following the accumulation of extracellular glutamate. To date, there are no fast-acting therapeutic tools capable of terminating secondary spreading toxicity within a time frame relevant to the emergency treatment of stroke or TBI patients. Here, using hippocampal neurons (DIV 15-20) cultured in microfluidic devices in order to deliver a localized excitotoxic insult, we replicate secondary spreading toxicity and demonstrate that this process is driven by GluN2B receptors. In addition to the modeling of spreading toxicity, this approach has uncovered a previously unknown, fast acting, GluN2A-dependent neuroprotective signaling mechanism. This mechanism utilizes the innate capacity of surrounding neuronal networks to provide protection against both forms of spreading neuronal toxicity, synaptic hyperactivity and direct glutamate excitotoxicity. Importantly, network neuroprotection against spreading toxicity can be effectively stimulated after an excitotoxic insult has been delivered, and may identify a new therapeutic window to limit brain damage.	[Samson, Andrew J.; Connolly, Christopher N.] Univ Dundee, Sch Med, Div Neurosci, Dundee DD1 9SY, Scotland; [Robertson, Graham; Zagnoni, Michele] Univ Strathclyde, Dept Elect & Elect Engn, Ctr Microsyst & Photon, Glasgow G1 1XW, Lanark, Scotland		Connolly, CN (corresponding author), Univ Dundee, Sch Med, Div Neurosci, Dundee DD1 9SY, Scotland.	c.n.connolly@dundee.ac.uk	Robertson, Graham/Q-1414-2016	Robertson, Graham/0000-0002-3841-874X; Samson, Andrew James/0000-0002-4842-5126; Zagnoni, Michele/0000-0003-3198-9491; Connolly, Christopher/0000-0002-0445-8874	MRC doctoral scholarship at the University of DundeeUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Doctoral Training Centre (DTC) in Medical Devices at the University of Strathclyde [EP/F50036X/1]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [1314783] Funding Source: researchfish	Funding was provided by an MRC doctoral scholarship at the University of Dundee and the Doctoral Training Centre (DTC) in Medical Devices at the University of Strathclyde (EP/F50036X/1).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Aerden LAM, 2004, NEUROSCI LETT, V367, P76, DOI 10.1016/j.neulet.2004.05.083; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Chang LR, 2016, J ALZHEIMERS DIS, V51, P197, DOI 10.3233/JAD-150942; Cheng MY, 2014, P NATL ACAD SCI USA, V111, P12913, DOI 10.1073/pnas.1404109111; Chhatbar PY, 2016, BRAIN STIMUL, V9, P16, DOI 10.1016/j.brs.2015.09.002; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Fitzgerald PB, 2011, AUST NZ J PSYCHIAT, V45, P923, DOI 10.3109/00048674.2011.615294; Gouix E, 2009, MOL CELL NEUROSCI, V40, P463, DOI 10.1016/j.mcn.2009.01.002; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Kramer DR, 2016, J CLIN NEUROSCI, V24, P22, DOI 10.1016/j.jocn.2015.08.004; Lagercrantz H, 2001, ACTA PAEDIATR, V90, P707; Lin CH, 2008, EUR J PHARMACOL, V589, P85, DOI 10.1016/j.ejphar.2008.05.047; Liu AJ, 2015, AM J CHINESE MED, V43, P1541, DOI 10.1142/S0192415X15500883; Liu J., 2014, COCHRANE DB SYST REV, V6; Marshall JWB, 1999, EXP NEUROL, V156, P121, DOI 10.1006/exnr.1998.6994; Marshall JWB, 2000, BRAIN RES BULL, V52, P21, DOI 10.1016/S0361-9230(99)00275-0; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Monai H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11100; Muir JK, 1996, J CEREBR BLOOD F MET, V16, P1211, DOI 10.1097/00004647-199611000-00015; Munakata Y, 2004, DEVELOPMENTAL SCI, V7, P141, DOI 10.1111/j.1467-7687.2004.00331.x; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Narang Puneet, 2015, Innov Clin Neurosci, V12, P25; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Regenold WT, 2015, BRAIN STIMUL, V8, P855, DOI 10.1016/j.brs.2015.06.011; Robertson G, 2014, INTEGR BIOL-UK, V6, P636, DOI 10.1039/c3ib40221e; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Srejic LR, 2013, J CEREBR BLOOD F MET, V33, P1937, DOI 10.1038/jcbfm.2013.153; Stetler RA, 2014, PROG NEUROBIOL, V114, P58, DOI 10.1016/j.pneurobio.2013.11.005; SYDSERFF SG, 1995, NEURODEGENERATION, V4, P323, DOI 10.1016/1055-8330(95)90022-5; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Wang RM, 2006, LIFE SCI, V79, P1839, DOI 10.1016/j.lfs.2006.06.041; Wang X, 2014, NEUROSCIENCE, V274, P393, DOI 10.1016/j.neuroscience.2014.05.053; Ward MW, 2005, J NEUROCHEM, V92, P1081, DOI 10.1111/j.1471-4159.2004.02928.x; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Xu GP, 2002, BRAIN RES, V952, P153, DOI 10.1016/S0006-8993(02)02988-8; Zhang F, 2010, INT J MOL SCI, V11, P2658, DOI 10.3390/ijms11072658; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82	48	16	16	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 21	2016	6								33746	10.1038/srep33746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW3WN	WOS:000383573900001	27650924	Green Accepted, Green Published, gold			2022-02-06	
J	Ahmed, OH; Lee, H; Struik, LL				Ahmed, Osman H.; Lee, Hopin; Struik, Laura L.			A picture tells a thousand words: A content analysis of concussion-related images online	PHYSICAL THERAPY IN SPORT			English	Article						Concussion; Social media; Knowledge translation; Public health	KNOWLEDGE TRANSFER; SOCIAL MEDIA; INFORMATION; PINTEREST; RECALL	Background and aim: Recently image-sharing social media platforms have become a popular medium for sharing health-related images and associated information. However within the field of sports medicine, and more specifically sports related concussion, the content of images and meta-data shared through these popular platforms have not been investigated. The aim of this study was to analyse the content of concussion-related images and its accompanying meta-data on image-sharing social media platforms. Methods: We retrieved 300 images from Pinterest, Instagram and Flickr by using a standardised search strategy. All images were screened and duplicate images were removed. We excluded images if they were: non-static images; illustrations; animations; or screenshots. The content and characteristics of each image was evaluated using a customised coding scheme to determine major content themes, and images were referenced to the current international concussion management guidelines. Results: From 300 potentially relevant images, 176 images were included for analysis; 70 from Pinterest, 63 from Flickr, and 43 from Instagram. Most images were of another person or a scene (64%), with the primary content depicting injured individuals (39%). The primary purposes of the images were to share a concussion-related incident (33%) and to dispense education (19%). For those images where it could be evaluated, the majority (91%) were found to reflect the Sports Concussion Assessment Tool 3 (SCAT3) guidelines. Conclusions: The ability to rapidly disseminate rich information though photos, images, and infographics to a wide-reaching audience suggests that image-sharing social media platforms could be used as an effective communication tool for sports concussion. Public health strategies could direct educative content to targeted populations via the use of image-sharing platforms. Further research is required to understand how image-sharing platforms can be used to effectively relay evidence-based information to patients and sports medicine clinicians. (C) 2016 Elsevier Ltd. All rights reserved.	[Ahmed, Osman H.] Bournemouth Univ, Fac Hlth & Social Sci, Royal London House,Christchurch Rd, Bournemouth BH1 3LT, Dorset, England; [Ahmed, Osman H.] Poole Hosp NHS Trust, Dept Physiotherapy, Poole, Dorset, England; [Ahmed, Osman H.] FA Ctr Disabil Football Res, St Georges Pk, Burton Upon Trent, England; [Lee, Hopin] Neurosci Res Australia, Sydney, NSW, Australia; [Lee, Hopin] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Struik, Laura L.] Univ British Columbia, Okanagan Campus, Vancouver, BC V5Z 1M9, Canada		Ahmed, OH (corresponding author), Bournemouth Univ, Fac Hlth & Social Sci, Royal London House,Christchurch Rd, Bournemouth BH1 3LT, Dorset, England.	osman.hassan.ahmed@gmail.com		Lee, Hopin/0000-0001-5692-0314; Ahmed, Osman/0000-0002-1439-0076			Adams SA, 2010, INT J MED INFORM, V79, P391, DOI 10.1016/j.ijmedinf.2010.01.006; Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; [Anonymous], 2014, THE IRISH NEWS  0501; [Anonymous], 2013, BRIT J SPORT MED, V47, P259; [Anonymous], 2014, NY TIMES; [Anonymous], 2013, BBC NEWS; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Houts PS, 1998, PATIENT EDUC COUNS, V35, P83, DOI 10.1016/S0738-3991(98)00065-2; Marketing Charts, 2013, DEM INST SNAPCH US; McCrory P., 2008, BRIT J SPORT MED, V2009, pi76; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; O'Mara B, 2013, HEALTH PROMOT INT, V28, P466, DOI 10.1093/heapro/das014; Paige SR, 2015, AM J HEALTH EDUC, V46, P241, DOI 10.1080/19325037.2015.1044586; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Renner B., 2012, PLOS ONE, P7; Shellenbarger T, 2013, NURS EDUC, V38, P206, DOI 10.1097/NNE.0b013e3182a0e5e7; Smiciklas M., 2012, INFOGRAPHICS USING P; Stellrecht E, 2012, J CONS HLTH INTERNET, V16, P403, DOI 10.1080/15398285.2012.723987; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; The Pew Internet and American Life Project, 2013, PHOT VID SHAR GROW O; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853; Yom-Tov E, 2012, J MED INTERNET RES, V14, P233, DOI 10.2196/jmir.2239; Zeng XH, 2013, INFORM SYST RES, V24, P71, DOI 10.1287/isre.1120.0464	28	16	16	2	62	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	SEP	2016	21						82	86		10.1016/j.ptsp.2016.03.001			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DW0FF	WOS:000383315600013	27311926	Green Accepted, Green Published			2022-02-06	
J	Angeleri, R; Gabbatore, I; Bosco, FM; Sacco, K; Colle, L				Angeleri, Romina; Gabbatore, Ilaria; Bosco, Francesca M.; Sacco, Katiuscia; Colle, Livia			Pragmatic abilities in children and adolescents with autism spectrum disorder: a study with the ABaCo battery	MINERVA PSICHIATRICA			English	Article						Autism spectrum disorder; Linguistics; Communication	TRAUMATIC BRAIN-INJURY; EMOTION-RECOGNITION; IMPAIRMENT; GESTURES; DEFICITS; ADULTS; FACE; MIND	BACKGROUND: Pragmatic disorders are a core problem in individuals with autism spectrum disorder (ASD). Despite the clinical importance of detecting specific impairments, there are relatively few tools available to assess pragmatic abilities in these individuals. The present study aims to gain greater insight into the pragmatic skills of individuals with high -functioning ASD by using the Assessment Battery for Communication (ABaCo), a new clinical tool that assesses a wide range of communicative behaviors. METHODS: The pragmatic performance of 16 individuals with ASD and 16 control participants were compared. RESULTS: Participants with ASD had significantly poorer scores compared with healthy matched controls on all ABaCo scales, with the sole exception of paralinguistic production. CONCLUSIONS: ABaCo is an effective tool in identifying and assessing pragmatic impairments in individuals with Autism Spectrum Disorders.	[Angeleri, Romina] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Gabbatore, Ilaria] Univ Oulu, Fac Humanities, Child Language Res Ctr, Res Unit Logoped, POB 1000, Oulu 90014, Finland; [Bosco, Francesca M.; Sacco, Katiuscia; Colle, Livia] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Bosco, Francesca M.; Sacco, Katiuscia; Colle, Livia] Neurosci Inst, Turin, Italy; [Sacco, Katiuscia] Univ Turin, Dept Psychol, Imaging & Plast Res Grp, Turin, Italy		Gabbatore, I (corresponding author), Univ Oulu, Fac Humanities, Child Language Res Ctr, Res Unit Logoped, POB 1000, Oulu 90014, Finland.	ilaria.gabbatore@oulu.fi	Gabbatore, Ilaria/AAC-1925-2019; bosco, francesca marina/B-6746-2013	Gabbatore, Ilaria/0000-0002-9724-8066; bosco, francesca marina/0000-0001-6101-8587			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R., 2015, BATTERIA ASSESSMENT; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; [Anonymous], 2014, MINERVA PSICHIATRICA; ATTWOOD A, 1988, J AUTISM DEV DISORD, V18, P241, DOI 10.1007/BF02211950; Bara B. G., 2010, LINGUISTIC PHILOS IN, V9, P182; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; BATES E, 1975, MERRILL PALMER QUART, V21, P205; Bishop D.V.M., 2003, CHILDRENS COMMUNICAT; Bono MA, 2004, J AUTISM DEV DISORD, V34, P495, DOI 10.1007/s10803-004-2545-x; Bosco FM, 2016, PSYCHOL CLIN SETTING, V7, P1, DOI DOI 10.3389/FPSYG.2016.00566; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bosco FM, 2013, J CHILD LANG, V40, P741, DOI 10.1017/S0305000913000081; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Buitelaar JK, 1999, DEV PSYCHOPATHOL, V11, P39, DOI 10.1017/S0954579499001947; Colgan SE, 2006, CHILD NEUROPSYCHOL, V12, P307, DOI 10.1080/09297040600701360; Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; DAVIES S, 1994, J CHILD PSYCHOL PSYC, V35, P1033, DOI 10.1111/j.1469-7610.1994.tb01808.x; de Marchena A, 2010, AUTISM RES, V3, P311, DOI 10.1002/aur.159; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Gilliam J. E., 2006, PRAGMATIC LANGUAGE S; Golan O, 2015, MOL AUTISM, V6; Hendricks D. R., 2009, FOCUS AUTISM OTHER D; HOBSON RP, 1988, BRIT J PSYCHOL, V79, P441, DOI 10.1111/j.2044-8295.1988.tb02745.x; Jolliffe T, 2000, PSYCHOL MED, V30, P1169, DOI 10.1017/S003329179900241X; Lam YG, 2012, RES AUTISM SPECT DIS, V6, P792, DOI 10.1016/j.rasd.2011.08.004; Landa R., 2000, ASPERGER SYNDROME, P125; Le Couteur A., 2005, ADI R AUTISM DIAGNOS; Lindner JL, 2006, J AUTISM DEV DISORD, V36, P769, DOI 10.1007/s10803-006-0105-2; Lord C., 2002, AUTISM DIAGNOSTIC OB; Losh M, 2003, J AUTISM DEV DISORD, V33, P239, DOI 10.1023/A:1024446215446; Loukusa S, 2014, INT J LANG COMM DIS, V49, P498, DOI 10.1111/1460-6984.12091; Loukusa S, 2009, RES AUTISM SPECT DIS, V3, P890, DOI 10.1016/j.rasd.2009.05.002; Loveland KA, 1997, DEV PSYCHOPATHOL, V9, P579, DOI 10.1017/S0954579497001351; LOVELAND KA, 1988, J SPEECH HEAR RES, V31, P593, DOI 10.1044/jshr.3104.593; Luyster R, 2007, J CHILD LANG, V34, P623, DOI 10.1017/S0305000907008094; Mawhood L, 2000, J CHILD PSYCHOL PSYC, V41, P547, DOI 10.1111/1469-7610.00642; Morett LM, 2015, J AUTISM DEV DISORD, P1; Morgan JL, 1978, SYNTAX SEMANTICS, V9, P261; O'Hearn K, 2011, AUTISM RES, V4, P132, DOI 10.1002/aur.179; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; Phelps-Terasaki D, 2007, TEST PRAGMATIC LANGU; Sacco K, 2008, J COGN SCI, V9, P111; Sacco K, 2013, B PSICOL APPL, P55; SIGMAN MD, 1992, CHILD DEV, V63, P796, DOI 10.1111/j.1467-8624.1992.tb01662.x; Silverman LB, 2010, COGNITION, V115, P380, DOI 10.1016/j.cognition.2010.01.002; Sperry LA, 2005, AUTISM, V9, P362, DOI 10.1177/1362361305056077; Tager-Flusberg H., 2005, HDB AUTISM PERVASIVE, V3rd, P335; Volden J., 2002, J SPEECH LANGUAGE PA, V26, P138	51	16	16	0	10	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0374-9320	1827-1731		MINERVA PSICH	Minerva Psich.	SEP	2016	57	3					93	103					11	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	EQ7FY	WOS:000398251100002					2022-02-06	
J	Liu, K; Li, B; Qian, SW; Jiang, QJ; Li, L; Wang, W; Zhang, GY; Sun, YJ; Sun, G				Liu, Kai; Li, Bo; Qian, Shaowen; Jiang, Qingjun; Li, Li; Wang, Wei; Zhang, Gaiyun; Sun, Yajuan; Sun, Gang			Mental fatigue after mild traumatic brain injury: a 3D-ASL perfusion study	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury; Mental fatigue; Psychomotor vigilance test; Attention; ASL perfusion fMRI	WORKING-MEMORY; SUSTAINED ATTENTION; RESTING-STATE; ACTIVATION; MODERATE; NETWORK; FMRI; BOLD; ADOLESCENTS; PERFORMANCE	Our purpose was to evaluate mental fatigue associated with mild traumatic brain injury (MTBI) and investigate the underlying neurological mechanisms. We used a 20-min psychomotor vigilance test (PVT) related ASL-fMRI to evaluate mental fatigue in 25 MTBI patients in acute phase, 21 MTBI patients in chronic phase, and 20 healthy subjects. Mental fatigue in patients in acute phase was more severe than in chronic phase patients and healthy controls. The first 5-min-PVT increased CBF of patients in acute phase in "bottom-up" and "top-down" attention areas, and decreased CBF in default mode network (DMN) areas. Twenty-min-PVT results showed that sustained attention of patients was more fragile than in healthy subjects, while sustained attention in the acute phase was less stable than that in the chronic phase. CBF results showed that in patients in the acute phase, the second, third, and last 5-min-PVT decreased CBF in DMN areas, increased CBF of "bottom-up" and "top-down" areas; in the chronic phase, the third and last 5-min-PVT increased CBF of "bottom-up" and "top-down" cortex, while the second 5-min-PVT only increased CBF of the "top-down" cortex. Mental fatigue of MTBI patients persists for more than 12 months, and can be mitigated partly within the first year after injury. The "bottom-up" and "top-down" deficits result in mental fatigue of MTBI patients.	[Liu, Kai; Li, Bo; Qian, Shaowen; Jiang, Qingjun; Li, Li; Wang, Wei; Zhang, Gaiyun; Sun, Yajuan; Sun, Gang] Jinan Mil Gen Hosp, Dept Med Imaging, Jinan, Shandong, Peoples R China		Qian, SW; Sun, G (corresponding author), Jinan Mil Gen Hosp, Dept Med Imaging, Jinan, Shandong, Peoples R China.	qianshaowen1110@163.com; cjr.sungang@vip.163.com			China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2014M552596]; Jinan Military General Hospital President Foundation [2014MS07]	This work was supported by the China Postdoctoral Science Foundation [2014M552596] and Jinan Military General Hospital President Foundation [no. 2014MS07].	Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Foucher JR, 2004, NEUROIMAGE, V22, P688, DOI 10.1016/j.neuroimage.2004.01.048; Greenberg AS, 2010, J NEUROSCI, V30, P14330, DOI 10.1523/JNEUROSCI.4248-09.2010; Hocking C, 2001, COMP BIOCHEM PHYS A, V128, P719, DOI 10.1016/S1095-6433(01)00278-1; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kempton MJ, 2011, HUM BRAIN MAPP, V32, P71, DOI 10.1002/hbm.20999; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lange G, 2005, NEUROIMAGE, V26, P513, DOI 10.1016/j.neuroimage.2005.02.011; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Liu K, 2013, BEHAV BRAIN RES, V243, P220, DOI 10.1016/j.bbr.2013.01.013; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shomstein S, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00038; Sinclair KL, 2013, J CLIN EXP NEUROPSYC, V35, P210, DOI 10.1080/13803395.2012.762340; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; SOSIN DM, 1991, BRAIN INJURY, V10, P47, DOI DOI 10.1080/026990596124719; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tjandra T, 2005, NEUROIMAGE, V27, P393, DOI 10.1016/j.neuroimage.2005.04.021; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	48	16	16	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2016	10	3					857	868		10.1007/s11682-015-9492-3			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DU7IL	WOS:000382387300024	26781483				2022-02-06	
J	Verfaellie, M; Lee, LO; Lafleche, G; Spiro, A				Verfaellie, Mieke; Lee, Lewina O.; Lafleche, Ginette; Spiro, Avron			Self-Reported Sleep Disturbance Mediates the Relationship Between PTSD and Cognitive Outcome in Blast-Exposed OEF/OIF Veterans	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blast injuries; cognition; mediation; posttraumatic stress disorder; sleep; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL OUTCOMES; COMBAT VETERANS; PHYSICAL HEALTH; DEPRIVATION; INSOMNIA; PERFORMANCE; SYMPTOMS; MILITARY	Objectives: To examine the contribution of sleep disturbance to cognitive performance following blast exposure. Design: Correlational research evaluating self-reported sleep disturbance as a mediator of the association between the primary blast-related comorbidities of mild traumatic brain injury (mTBI) and posttraumatic stress disorder and cognitive outcome. Participants: One hundred sixty Operation Enduring Freedom/Operation Iraqi Freedom Veterans with a history of blast exposure assigned to 1 of 3 groups (no TBI, mTBI without loss of consciousness, and mTBI with loss of consciousness). Main Outcome Measures: Neuropsychological measures and self-report of sleep disturbance. Results: Increased posttraumatic stress disorder symptomatology was associated with worse performance inmultiple cognitive domains. This association was mediated in part by self-reported sleep disturbance. Traumatic brain injury with loss of consciousness was associated with lower manual dexterity, but this association was not mediated by sleep disturbance. Conclusions: Our results highlight the importance of sleep disturbance as a factor contributing to cognitive outcome in individuals with posttraumatic stress disorder symptoms. They point to the importance of considering sleep problems in the diagnosis and treatment of cognitive deficits in veterans with blast exposure.	[Verfaellie, Mieke; Lafleche, Ginette] VA Boston Healthcare Syst, Memory Disorders Res Ctr, 151-A,150 South Huntington Ave, Boston, MA 02130 USA; [Verfaellie, Mieke; Lee, Lewina O.; Lafleche, Ginette; Spiro, Avron] Boston Univ, Sch Med, Boston, MA 02118 USA; [Lee, Lewina O.; Spiro, Avron] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Lee, Lewina O.; Spiro, Avron] Boston Univ, Sch Publ Hlth, Boston, MA USA		Verfaellie, M (corresponding author), VA Boston Healthcare Syst, Memory Disorders Res Ctr, 151-A,150 South Huntington Ave, Boston, MA 02130 USA.	verf@bu.edu		/0000-0002-1652-8198; Verfaellie, Mieke/0000-0001-5535-4584; Spiro III, Avron/0000-0003-4080-8621	Merit Review grants - Clinical Science Research and Development Service and Rehabilitation Research and Development Service of the Department of Veterans AffairsUS Department of Veterans Affairs; Clinical Science Research and Development Service of the Department of Veterans Affairs; Veterans AffairsUS Department of Veterans Affairs [I01RX000216] Funding Source: NIH RePORTER	The research was supported by Merit Review grants awarded by the Clinical Science Research and Development Service and Rehabilitation Research and Development Service of the Department of Veterans Affairs to Dr Verfaellie. Drs Verfaellie and Spiro are supported by the Clinical Science Research and Development Service of the Department of Veterans Affairs. The contents do not represent the views of the U.S. Department of Veterans Affairs or the US Government.	Banks S, 2007, J CLIN SLEEP MED, V3, P519; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bentler PM, 2007, PERS INDIV DIFFER, V42, P825, DOI 10.1016/j.paid.2006.09.024; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Brownlow JA, 2014, J TRAUMA STRESS, V27, P217, DOI 10.1002/jts.21906; Burri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057826; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Clum GA, 2001, J NERV MENT DIS, V189, P618, DOI 10.1097/00005053-200109000-00008; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Couyoumdjian A, 2010, J SLEEP RES, V19, P64, DOI 10.1111/j.1365-2869.2009.00774.x; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Draganich C, 2014, J EXP PSYCHOL LEARN, V40, P857, DOI 10.1037/a0035546; Drummond SPA, 2006, J SLEEP RES, V15, P261, DOI 10.1111/j.1365-2869.2006.00535.x; Engdahl BE, 2000, BIOL PSYCHIAT, V47, P520, DOI 10.1016/S0006-3223(99)00201-2; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Fulda S, 2001, SLEEP MED REV, V5, P423, DOI 10.1053/smrv.2001.0157; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Halstead W.C., 1947, BRAIN INTELLIGENCE; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Hurwitz TD, 1998, BIOL PSYCHIAT, V44, P1066, DOI 10.1016/S0006-3223(98)00089-4; INMAN DJ, 1990, J TRAUMA STRESS, V3, P429, DOI DOI 10.1007/BF00974782; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kendall-Tackett K, 2009, PSYCHOL TRAUMA-US, V1, P35, DOI 10.1037/a0015128; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kinoshita LM, 2012, SLEEP BREATH, V16, P1201, DOI 10.1007/s11325-011-0632-8; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Kobayashi I, 2007, PSYCHOPHYSIOLOGY, V44, P660, DOI 10.1111/j.1469-8986.2007.537.x; Lamarche LJ, 2007, J CLIN PSYCHIAT, V68, P1257, DOI 10.4088/JCP.v68n0813; Landry GJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00325; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Nilsson JP, 2005, J SLEEP RES, V14, P1, DOI 10.1111/j.1365-2869.2005.00442.x; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Oudiette D, 2013, TRENDS COGN SCI, V17, P142, DOI 10.1016/j.tics.2013.01.006; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; ROSS RJ, 1989, AM J PSYCHIAT, V146, P697; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; SAMKOFF JS, 1991, ACAD MED, V66, P687, DOI 10.1097/00001888-199111000-00013; Schneider C, 2004, J SLEEP RES, V13, P373, DOI 10.1111/j.1365-2869.2004.00427.x; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Spira AP, 2014, CURR OPIN PSYCHIATR, V27, P478, DOI 10.1097/YCO.0000000000000106; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Tiffin, 1968, PURDUE PEGBOARD EXAM; Tombaugh TN, 2000, ARCH CLIN NEUROPSYCH, V15, P817; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Verfaellie M, 2012, PTSD MILD TRAUMATIC, P82; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Waters F, 2011, J INT NEUROPSYCH SOC, V17, P571, DOI 10.1017/S1355617711000610; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Yaffe K, 2014, LANCET NEUROL, V13, P1017, DOI 10.1016/S1474-4422(14)70172-3; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	93	16	16	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					309	319		10.1097/HTR.0000000000000197			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600009	26580692	Green Accepted			2022-02-06	
J	Brolliar, SM; Moore, M; Thompson, HJ; Whiteside, LK; Mink, RB; Wainwright, MS; Groner, JI; Bell, MJ; Giza, CC; Zatzick, DF; Ellenbogen, RG; Boyle, LN; Mitchell, PH; Rivara, FP; Vavilala, MS				Brolliar, Sarah M.; Moore, Megan; Thompson, Hilaire J.; Whiteside, Lauren K.; Mink, Richard B.; Wainwright, Mark S.; Groner, Jonathan I.; Bell, Michael J.; Giza, Christopher C.; Zatzick, Douglas F.; Ellenbogen, Richard G.; Boyle, Linda Ng; Mitchell, Pamela H.; Rivara, Frederick P.; Vavilala, Monica S.			A Qualitative Study Exploring Factors Associated with Provider Adherence to Severe Pediatric Traumatic Brain Injury Guidelines	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; evidence-based medicine; guideline adherence; injury; pediatrics; trauma	INTENSIVE-CARE-UNIT; CLINICAL-PRACTICE GUIDELINES; MEASURABLE OUTCOMES; IMPROVEMENT; CHILDREN; IMPLEMENTATION; MANAGEMENT; PHYSICIANS; CHECKLIST; TRIAGE	Despite demonstrated improvement in patient outcomes with use of the Pediatric Traumatic Brain Injury (TBI) Guidelines (Guidelines), there are differential rates of adherence. Provider perspectives on barriers and facilitators to adherence have not been elucidated. This study aimed to identify and explore in depth the provider perspective on factors associated with adherence to the Guidelines using 19 focus groups with nurses and physicians who provided acute management for pediatric patients with TBI at five university-affiliated Level 1 trauma centers. Data were examined using deductive and inductive content analysis. Results indicated that three inter-related domains were associated with clinical adherence: 1) perceived guideline credibility and applicability to individual patients, 2) implementation, dissemination, and enforcement strategies, and 3) provider culture, communication styles, and attitudes towards protocols. Specifically, Guideline usefulness was determined by the perceived relevance to the individual patient given age, injury etiology, and severity and the strength of the evidence. Institutional methods to formally endorse, codify, and implement the Guidelines into the local culture were important. Providers wanted local protocols developed using interdisciplinary consensus. Finally, a culture of collaboration, including consistent, respectful communication and interdisciplinary cooperation, facilitated adherence. Provider training and experience, as well as attitudes towards other standardized care protocols, mirror the use and attitudes towards the Guidelines. Adherence was determined by the interaction of each of these guideline, institutional, and provider factors acting in concert. Incorporating provider perspectives on barriers and facilitators to adherence into hospital and team protocols is an important step toward improving adherence and ultimately patient outcomes.	[Brolliar, Sarah M.; Moore, Megan; Thompson, Hilaire J.; Whiteside, Lauren K.; Zatzick, Douglas F.; Ellenbogen, Richard G.; Boyle, Linda Ng; Mitchell, Pamela H.; Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Mink, Richard B.] Harbor Univ Calif, Los Angeles, CA USA; [Mink, Richard B.] Los Angeles BioMed Res Inst, Los Angeles, CA USA; [Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Groner, Jonathan I.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Bell, Michael J.] Univ Pittsburgh, Pittsburgh, PA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, 325 Ninth Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu		Whiteside, Lauren/0000-0002-0284-5336	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002317, KL2TR000421] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000421, KL2 TR002317] Funding Source: Medline		Abrahamson KA, 2012, AM J NURS, V112, P26, DOI 10.1097/01.NAJ.0000415957.46932.bf; [Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2006.0209; [Anonymous], BRAIN INJ US EM DEP; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Byrnes MC, 2009, CRIT CARE MED, V37, P2775, DOI 10.1097/CCM.0b013e3181a96379; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cahill NE, 2010, JPEN-PARENTER ENTER, V34, P616, DOI 10.1177/0148607110361904; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Curtis JR, 2006, CRIT CARE MED, V34, P211, DOI 10.1097/01.CCM.0000190617.76104.AC; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; DuBose JJ, 2008, J TRAUMA, V64, P22, DOI 10.1097/TA.0b013e318161b0c8; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Fernandez R, 2008, ACAD EMERG MED, V15, P1025, DOI 10.1111/j.1553-2712.2008.00232.x; Fernandez R, 2008, ACAD EMERG MED, V15, P1104, DOI 10.1111/j.1553-2712.2008.00250.x; Francl LJ., 2001, PLANT HLTH INSTR, DOI [10.1094/PHIT-2001-0517-01, DOI 10.1094/PHI-T-2001-0517-01]; Freeman T, 2006, J ADV NURS, V56, P491, DOI 10.1111/j.1365-2648.2006.04043.x; Goossens A, 2008, MED DECIS MAKING, V28, P138, DOI 10.1177/0272989X07308749; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Institute for Safe Medication Practices, 2010, ISMP GUID STAND ORD; Janssen MAP, 2012, J CLIN NURS, V21, P437, DOI 10.1111/j.1365-2702.2011.03921.x; JENNETT B, 1976, LANCET, V1, P1031; Jones AE, 2007, ACAD EMERG MED, V14, P1072, DOI 10.1197/j.aem.2007.04.014; Kalpin P., 2005, CRIT CARE NURSE, V25, P80; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kernic MA, 2013, J NEUROTRAUM, V30, P1129, DOI 10.1089/neu.2012.2716; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LeBlanc JM, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.07.012; March A., 2006, FACILITATING IMPLEME; McCabe Pamela J, 2005, Crit Care Nurse, V25, P76; McCabe PJ, 2005, CRIT CARE NURSE, V25, P84; Mcilvoy L, 2001, J Neurosci Nurs, V33, P72; Mcilvoy L, 2001, J NEUROSCI NURS, V32, P72, DOI DOI 10.1097/01376517-200104000-00002; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Sinuff T, 2003, CLIN CHEST MED, V24, P739, DOI 10.1016/S0272-5231(03)00098-4; Sinuff T, 2007, CAN J ANAESTH, V54, P728, DOI 10.1007/BF03026869; Sinuff T, 2007, CRIT CARE MED, V35, P2083, DOI 10.1097/01.ccm.0000281446.15342.74; Swennen MHJ, 2013, ACAD MED, V88, P1384, DOI 10.1097/ACM.0b013e31829ed3cc; Teixeira PGR, 2013, J TRAUMA ACUTE CARE, V75, P717, DOI 10.1097/TA.0b013e31829d27b6; Thorne, 2006, INT J QUAL METH, V5, P73, DOI DOI 10.1177/160940690600500210; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507	45	16	16	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2016	33	16					1554	1560		10.1089/neu.2015.4183			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DU6ED	WOS:000382305900009	26760283	Green Published			2022-02-06	
J	Strumwasser, A; Speer, AL; Inaba, K; Branco, BC; Upperman, JS; Ford, HR; Lam, L; Talving, P; Shulman, I; Demetriades, D				Strumwasser, Aaron; Speer, Allison L.; Inaba, Kenji; Branco, Bernardino C.; Upperman, Jeffrey S.; Ford, Henri R.; Lam, Lydia; Talving, Peep; Shulman, Ira; Demetriades, Demetrios			The impact of acute coagulopathy on mortality in pediatric trauma patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Trauma; injury; coagulopathy; children; pediatric; mortality	BRAIN-INJURY; HEMOCOAGULATIVE DISORDERS; CHILDREN; PREDICTOR	BACKGROUND: Traumatic coagulopathy (TC) occurs in 24% to 38% of adults and is associated with up to a six-fold increase in mortality. This study's purpose was to determine the incidence of pediatric TC and its impact on mortality. METHODS: A retrospective review(2004-2009) of all trauma patients from our Level I trauma center was performed. Coagulopathy was defined as an international normalized ratio of 1.5 or higher or activated partial thromboplastin time of more than 36 seconds or platelets less than 100,000/mm(3). Clinical outcomes were compared between pediatric (younger than 16 years) and adult patients (>= 16 years or older). RESULTS: A total of 20,126 patients were identified (7.6% pediatric, 92.4% adult). Mean +/- SD age was 8.7 +/- 4.8 years for pediatric patients and 37.6 +/- 16.7 years for adults. The incidence of admission coagulopathy was lower in children (5.8% vs. 8.4%; p < 0.001). Pediatric patients were less likely to develop coagulopathy (8.4% vs. 12.4%; p < 0.001) and developed coagulopathy later than adults (102.3 +/- 123.2 hours vs. 59.2 +/- 1,823.9 hours; p < 0.001). Traumatic brain injury (TBI) and non-TBI-related coagulopathy increased in stepwise fashion with age (up to 19.5% in elderly). Adult and pediatric TC was associated with increased mortality (pediatric: 14.4% vs. 0.5%; p = 0.02; adult: 18.3% vs. 1.8%; p < 0.001). CONCLUSIONS: Pediatric trauma patients are less likely to present with coagulopathy, are less likely to develop coagulopathy during their admission, and tend to develop coagulopathy later than adults. If they develop coagulopathy, however, mortality increases in a stepwise fashion with age and is associated with a two-to four-fold increased risk of death. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Strumwasser, Aaron; Inaba, Kenji; Lam, Lydia; Talving, Peep; Demetriades, Demetrios] Univ Southern Calif, Div Trauma & Surg Crit Care, 1200 N State St,Room C5L100, Los Angeles, CA 90033 USA; [Speer, Allison L.; Branco, Bernardino C.] Univ Southern Calif, Keck Sch Med, Dept Surg, Los Angeles, CA USA; [Upperman, Jeffrey S.; Ford, Henri R.] Univ Southern Calif, Childrens Hosp Los Angeles, Los Angeles, CA USA; [Ford, Henri R.] Los Angeles County USC Med Ctr, Div Pediat Surg, Los Angeles, CA USA; [Shulman, Ira] Univ Southern Calif, Med Ctr, Pathol, Los Angeles, CA USA; [Shulman, Ira] Blood Bank, Los Angeles, CA USA; [Shulman, Ira] Los Angeles Cty USC Hlth Care Network, Los Angeles, CA USA		Inaba, K (corresponding author), Univ Southern Calif, Div Trauma & Surg Crit Care, 1200 N State St,Room C5L100, Los Angeles, CA 90033 USA.	kinaba@surgery.usc.edu	INABA, KENJI/AAC-8532-2020; Talving, Peep/G-8621-2015	Talving, Peep/0000-0002-9741-2073; Speer, Allison/0000-0003-4609-3778			Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Hendrickson JE, 2012, TRANSFUSION, V52, P1228, DOI 10.1111/j.1537-2995.2011.03458.x; Hendrickson JE, 2012, J PEDIATR-US, V160, P204, DOI 10.1016/j.jpeds.2011.08.019; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Karam O, 2013, VOX SANG, V104, P342, DOI 10.1111/vox.12009; Nosanov L, 2013, AM J SURG, V206, P655, DOI 10.1016/j.amjsurg.2013.07.009; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Peiniger S, 2012, PEDIATR CRIT CARE ME, V13, P455, DOI 10.1097/PCC.0b013e31823893c5; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	13	16	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2016	81	2					312	318		10.1097/TA.0000000000001060			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DS5CE	WOS:000380797300015	27032006				2022-02-06	
J	Thakkar, K; Maricich, SM; Alper, G				Thakkar, Kavita; Maricich, Stephen M.; Alper, Gulay			Acute Ataxia in Childhood: 11-Year Experience at a Major Pediatric Neurology Referral Center	JOURNAL OF CHILD NEUROLOGY			English	Article						cerebellar ataxia; case studies; case series; acute cerebellitis; postinfectious cerebellar ataxia; acute ataxia	ACUTE CEREBELLAR-ATAXIA; BARR-VIRUS-INFECTION; HEAD-INJURY; AUTOANTIBODIES; VARICELLA; CHILDREN	We categorized the causes of acute ataxia in the pediatric populationreferred to the Division of Neurologyat a large, urban pediatric medical center. Of the 120 cases identified over the past 11 years, post-infectious cerebellar ataxia was the most commonly diagnosed (59%), followed by drug intoxication, opsoclonus-myoclonus ataxia syndrome, episodic ataxia, acute cerebellitis, cerebellar stroke, ADEM, meningitis, cerebral vein thrombosis, Leigh's disease, Miller-Fisher syndrome, and concussion. Among the patients with post-infectious cerebellar ataxia, 85% were 1-6 years old and all had a history of antecedent viral illness. CSF pleocytosis was present in 40% of patients; all had normal brain MRIs. The majority (91%) recovered within 30 days. We conclude that post-infectious cerebellar ataxia remains the most common cause of acute ataxia in childhood and that it carries a good prognosis. We also differentiate acute post-infectious cerebellar ataxia from other causes with similar presentations.	[Thakkar, Kavita; Maricich, Stephen M.; Alper, Gulay] UPMC, Div Child Neurol, Dept Pediat, Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Maricich, Stephen M.] Univ Pittsburgh, Dept Pediat, Richard King Mellon Fdn Inst Pediat Res, Pittsburgh, PA 15260 USA		Thakkar, K (corresponding author), UPMC, Div Child Neurol, Dept Pediat, Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	thakkarkp@upmc.edu	Thakkar, Kavita/AAN-8599-2021				Adams C, 2000, CAN J NEUROL SCI, V27, P316, DOI 10.1017/S0317167100001074; Bakshi R, 1998, CLIN IMAG, V22, P79, DOI 10.1016/S0899-7071(97)00093-4; Chan A K, 2000, Semin Pediatr Neurol, V7, P301, DOI 10.1053/spen.2000.20075; CLEARY TG, 1980, JAMA-J AM MED ASSOC, V243, P148, DOI 10.1001/jama.243.2.148; COHEN HA, 1992, AM J DIS CHILD, V146, P930, DOI 10.1001/archpedi.1992.02160200052025; CONNOLLY AM, 1994, ANN NEUROL, V35, P673, DOI 10.1002/ana.410350607; CURNEN EC, 1961, YALE J BIOL MED, V34, P219; Daaboul Y, 1998, NEUROL RES, V20, P85; Davis DP, 2003, J EMERG MED, V24, P281, DOI 10.1016/S0736-4679(02)00746-1; De Bruecker Y, 2004, EUR RADIOL, V14, P1478, DOI 10.1007/s00330-004-2247-y; DREYFUS PM, 1974, WESTERN J MED, V120, P161; Fritzler Marvin J, 2003, BMC Pediatr, V3, P11, DOI 10.1186/1471-2431-3-11; GIERONKORTHALS MA, 1994, J CHILD NEUROL, V9, P381, DOI 10.1177/088307389400900408; Go T, 2003, ACTA PAEDIATR, V92, P504; Gohil JR, 2006, INDIAN PEDIATR, V43, P829; Hata A, 2008, J PAEDIATR CHILD H, V44, P607, DOI 10.1111/j.1440-1754.2008.01395.x; ITO H, 1994, NEUROLOGY, V44, P1506, DOI 10.1212/WNL.44.8.1506; Keller C, 1998, J CHILD NEUROL, V13, P93, DOI 10.1177/088307389801300211; KING G, 1958, PEDIATRICS, V21, P731; Martinez-Gonzalez MJ, 2006, REV NEUROLOGIA, V42, P321, DOI 10.33588/rn.4206.2006075; NAKAO T, 1970, TOHOKU J EXP MED, V101, P47, DOI 10.1620/tjem.101.47; Nussinovitch M, 2003, CLIN PEDIATR, V42, P581, DOI 10.1177/000992280304200702; Rafay MF, 2006, J CHILD NEUROL, V21, P8, DOI 10.1177/08830738060210010101; SENANAYAKE N, 1994, J NEUROL, V241, P456, DOI 10.1007/BF00900965; Shiihara T, 2007, BRAIN DEV-JPN, V29, P254, DOI 10.1016/j.braindev.2006.09.004; Shimizu Y, 1999, ARCH DIS CHILD, V80, P72, DOI 10.1136/adc.80.1.72; Spacey S., GENEREVIEWS R; Uchibori A, 2005, NEUROLOGY, V65, P1114, DOI 10.1212/01.wnl.0000178802.38268.1e; van der Maas NAT, 2009, VACCINE, V27, P1970, DOI 10.1016/j.vaccine.2009.01.019; Visudtibhan Anannit, 1998, Journal of the Medical Association of Thailand, V81, P1015; YABEK SM, 1973, PEDIATRICS, V52, P718; Yeoh HK, 2006, CHILD NERV SYST, V22, P310, DOI 10.1007/s00381-005-1154-0; Yeung W. L., 2003, Hong Kong Medical Journal, V9, P142	33	16	16	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	AUG	2016	31	9					1156	1160		10.1177/0883073816643407			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	DS7DN	WOS:000380943100009	27071467				2022-02-06	
J	Gad, SC; Sullivan, DW; Spasojevic, I; Mujer, CV; Spainhour, CB; Crapo, JD				Gad, Shayne Cox; Sullivan, Dexter W., Jr.; Spasojevic, Ivan; Mujer, Cesar V.; Spainhour, Charles B.; Crapo, James D.			Nonclinical Safety and Toxicokinetics of MnTnBuOE-2-PyP5+ (BMX-001)	INTERNATIONAL JOURNAL OF TOXICOLOGY			English	Article						BMX-001; MnTnBuOE-2-PyP5+; oncology; metalloporphyrin; anti-inflammatory; antioxidant; glioblastoma	NORMAL TISSUE-INJURY; OXIDATIVE STRESS; MANGANESE PORPHYRIN; RADIATION; TOXICITY; MITIGATION; AMIFOSTINE; FUTURE	BMX-001, a manganese porphyrin that has anti-inflammatory, antioxidant, and antitumor properties, is being developed as a potential therapeutic for high-grade glioma (HGG) and head and neck (H&N) cancer. An IND has been opened for BMX-001 in the treatment of HGG (NCT02655601) and another is in preparation for H&N. The safety of BMX-001 has been evaluated in a battery of nonclinical Good Laboratory Practice (GLP)-compliant studies. Systemic toxicity has been evaluated using the intended cGMP product administered subcutaneously for periods of up to 5 weeks in both the mouse and the monkey and included toxicokinetic evaluations to characterize systemic exposure and tissue distribution and clearance of BMX-001. In additional GLP studies, BMX-001 was not irritating to the skin or eye and caused no changes in cardiac rate or rhythm or blood pressure. Mixed results for genotoxicity were seen with the weight of evidence indicating that BMX-001 poses no genotoxic risk in humans. In systemic mouse and monkey studies, loading/maintenance dose no observed adverse effect levels were 12/2 mg/kg/dose and 6/2 mg/kg/dose, respectively, with maintenance doses administered every 3 days after the initial loading dose. Systemic data were used to determine a Food and Drug Administration-approved safe starting dose for the initial clinical study in patients with HGG. BMX-001 was detected in analyzed tissues, including the brain, persisting well past the short plasma clearance period. The highest levels of BMX-001 were seen in the liver and kidneys, with amounts in these tissues returning to close to undetectable levels after a 2-week cessation of dosing.	[Gad, Shayne Cox; Sullivan, Dexter W., Jr.] Gad Consulting Serv, 4008 Barrett Dr, Raleigh, NC 27609 USA; [Spasojevic, Ivan] Duke Univ, Med Ctr, Durham, NC USA; [Mujer, Cesar V.; Spainhour, Charles B.] Calvert Labs, Scott Township, PA USA; [Crapo, James D.] BioMimetix JV LLC, Englewood, CO USA		Gad, SC (corresponding author), Gad Consulting Serv, 4008 Barrett Dr, Raleigh, NC 27609 USA.	scgad@ix.netcom.com					[Anonymous], 2009, GUID NONCL SAF STUD; Ashcraft KA, 2015, INT J RAD ONCOL BIOL, V93, P892; Batinic-Haberle I, 2014, ANTIOXID REDOX SIGN, V20, P2372, DOI 10.1089/ars.2012.5147; Batinic-Haberle I, 2011, FREE RADICAL BIO MED, V51, P1035, DOI 10.1016/j.freeradbiomed.2011.04.046; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; Gad SC, 2013, INT J TOXICOL, V32, P274, DOI 10.1177/1091581813490203; Gridley DS, 2007, ANTICANCER RES, V27, P3101; International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Harmonised Tripartite Guideline, 2011, GUID GEN TEST DAT IN; Khan I, 2009, REDOX REP, V14, P236, DOI 10.1179/135100009X12525712409698; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lee MYK, 2010, J VASC RES, V47, P287, DOI 10.1159/000265563; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Moulder JE, 2007, SEMIN RADIAT ONCOL, V17, P141, DOI 10.1016/j.semradonc.2006.11.010; Navarro J, 1997, FREE RADICAL BIO MED, V22, P1203, DOI 10.1016/S0891-5849(96)00554-0; OECD, 2014, VIVO MAMMALIAN ALKAL, P1; Rabbani ZN, 2009, FREE RADICAL BIO MED, V47, P992, DOI 10.1016/j.freeradbiomed.2009.07.001; Rajic Z, 2012, FREE RADICAL BIO MED, V52, P1828, DOI 10.1016/j.freeradbiomed.2012.02.006; Stone HB, 2004, RADIAT RES, V162, P711, DOI 10.1667/RR3276; TAKAHASHI I, 1986, INT J RADIAT ONCOL, V12, P935, DOI 10.1016/0360-3016(86)90388-3; Tannehill SP, 1996, SEMIN ONCOL, V23, P69; Thunell S, 2000, SCAND J CLIN LAB INV, V60, P509, DOI 10.1080/003655100448310; Tovmasyan A, 2013, MED PRIN PRACT, V22, P103, DOI 10.1159/000341715; Weitzel DH, 2015, MOL CANCER THER, V14, P70, DOI 10.1158/1535-7163.MCT-14-0343; Zhao WL, 2009, CURR MED CHEM, V16, P130, DOI 10.2174/092986709787002790	24	16	16	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1091-5818	1092-874X		INT J TOXICOL	Int. J. Toxicol.	JUL-AUG	2016	35	4					438	453		10.1177/1091581816642766			16	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	DR8AU	WOS:000380121600007	27098749	Bronze			2022-02-06	
J	Kurz, JE; Poloyac, SM; Abend, NS; Fabio, A; Bell, MJ; Wainwright, MS				Kurz, Jonathan E.; Poloyac, Samuel M.; Abend, Nicholas S.; Fabio, Anthony; Bell, Michael J.; Wainwright, Mark S.		Investigators Approaches	Variation in Anticonvulsant Selection and Electroencephalographic Monitoring Following Severe Traumatic Brain Injury in Children-Understanding Resource Availability in Sites Participating in a Comparative Effectiveness Study	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						anticonvulsant; electroencephalography; neurological monitoring; pediatric neurocritical care; traumatic brain injury	CRITICALLY-ILL CHILDREN; POSTTRAUMATIC SEIZURES; ELECTROGRAPHIC SEIZURES; STATUS EPILEPTICUS; HEAD TRAUMA; LEVETIRACETAM; PROPHYLAXIS; PHENYTOIN; PREDICTORS; MANAGEMENT	Objectives: Early posttraumatic seizures may contribute to worsened outcomes after traumatic brain injury. Evidence to guide the evaluation and management of early posttraumatic seizures in children is limited. We undertook a survey of current practices of continuous electroencephalographic monitoring, seizure prophylaxis, and the management of early posttraumatic seizures to provide essential information for trial design and the development of posttraumatic seizure management pathways. Design: Surveys were sent to site principal investigators at all 43 sites participating in the Approaches and Decisions in Acute Pediatric TBI trial at the time of the survey. Surveys consisted of 12 questions addressing strategies to 1) implement continuous electroencephalographic monitoring, 2) posttraumatic seizure prophylaxis, 3) treat acute posttraumatic seizures, 4) treat status epilepticus and refractory status epilepticus, and 5) monitor antiseizure drug levels. Setting: Institutions comprised a mixture of free-standing children's hospitals and university medical centers across the United States and Europe. Subjects: Site principal investigators of the Approaches and Decisions in Acute Pediatric TBI trial. Interventions: None. Measurements and Main Results: Continuous electroencephalographic monitoring was available in the PICU in the overwhelming majority of clinical sites (98%); however, the plans to operationalize such monitoring for children varied considerably. A similar majority of sites report that administration of prophylactic antiseizure medications is anticipated in children (93%); yet, a minority reports that a specified protocol for treatment of posttraumatic seizures is in place (43%). Reported medication choices varied substantially between sites, but the majority of sites reported pentobarbital for refractory status epilepticus (81%). The presence of treatment protocols for seizure prophylaxis, early posttraumatic seizures, posttraumatic status epilepticus, and refractory status epilepticus was associated with decreased reported medications (all p < 0.05). Conclusions: This study reports the current management practices for early posttraumatic seizures in select academic centers after pediatric severe traumatic brain injury. The substantial variation in continuous electroencephalographic monitoring implementation, choice of seizure prophylaxis medications, and management of early posttraumatic seizures across institutions was reported, signifying the areas of clinical uncertainty that will help provide focused design of clinical trials. Although sites with treatment protocols reported a decreased number of medications for the scenarios described, completion of the Approaches and Decisions in Acute Pediatric TBI trial will be able to determine if these protocols lead to decreased variability in medication administration in children at the clinical sites.	[Kurz, Jonathan E.; Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Poloyac, Samuel M.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA; [Abend, Nicholas S.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Fabio, Anthony] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA		Bell, MJ (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA.	bellmj4@upmc.edu		Figaji, Anthony/0000-0002-3357-6490; Bennett, Tellen/0000-0003-1483-4236; Fabio, Anthony/0000-0002-6808-4939; Kurz, Jonathan/0000-0002-2259-4263	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 081041]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD079123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS081041] Funding Source: NIH RePORTER; Great Ormond Street Hospital Childrens Charity [V2216] Funding Source: researchfish	Dr. Bell received support for article research from the National Institutes of Health (NIH). His institution received funding from National Institute of Neurological Disorders and Stroke - NS 081041. Dr. Abend received support for article research from the NIH. Dr. Fabio received support for article research from the NIH. His institution received funding from the NIH. Dr. Wainwright received support for article research from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2016, J CHILD NEUROL, V31, P46, DOI 10.1177/0883073814562249; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Bansal S, 2014, J NEUROSURG-PEDIATR, V13, P209, DOI 10.3171/2013.10.PEDS13256; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cook AM, 2012, NEUROCRIT CARE, V17, P24, DOI 10.1007/s12028-012-9711-3; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Faul M, 2010, TRAUMATIC BRAIN INJU; Gutierrez-Colina AM, 2012, PEDIATR NEUROL, V46, P158, DOI 10.1016/j.pediatrneurol.2011.12.009; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kernic MA, 2013, J NEUROTRAUM, V30, P1129, DOI 10.1089/neu.2012.2716; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Kruessell MA, 2012, PEDIATR CRIT CARE ME, V13, pE150, DOI 10.1097/PCC.0b013e3182388a95; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Newey CR, 2013, NEUROCRIT CARE, V18, P261, DOI 10.1007/s12028-011-9650-4; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	34	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2016	17	7					649	657		10.1097/PCC.0000000000000765			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	DR0LV	WOS:000379599900011	27243415	Green Accepted			2022-02-06	
J	Marceau, EM; Lunn, J; Berry, J; Kelly, PJ; Solowij, N				Marceau, Ely M.; Lunn, Jo; Berry, Jamie; Kelly, Peter J.; Solowij, Nadia			The Montreal Cognitive Assessment (MoCA) is Sensitive to Head Injury and Cognitive Impairment in a Residential Alcohol and Other Drug Therapeutic Community	JOURNAL OF SUBSTANCE ABUSE TREATMENT			English	Article						Substance misuse; Cognitive impairment; Therapeutic community; Residential treatment; Cognitive screening; Head injury	TRAUMATIC BRAIN-INJURY; SUBSTANCE-ABUSE TREATMENT; PSYCHOLOGICAL DISTRESS; USE DISORDERS; NEUROPSYCHOLOGICAL CONSEQUENCES; EXECUTIVE FUNCTIONS; DEPENDENCE SCALE; ADDICTION; USERS; REHABILITATION	Introduction: Retaining clients in residential alcohol and other drug (AOD) treatment is difficult and cognitive impairment has been identified as a significant predictor of treatment dropout. The application of extensive screening for cognitive impairment is cost-prohibitive for most AOD treatment services. The current study aimed to explore cognitive functioning and impairment-associated factors in a typical sample of residential AOD clients using a free brief screening tool that could be utilised by front-line AOD services. Methods: Residents of an AOD therapeutic community (n = 128) and a non-substance using control group (n = 37) were administered a brief cognitive screening measure, the Montreal Cognitive Assessment (MoCA). MoCA total and domain scores were compared between these groups and within the AOD group examined in association with primary substance of misuse, severity of dependence, gender, psychological distress, and history of head injury. Results: Almost half (43.8%) of the AOD sample were identified as cognitively impaired, compared to 162% of the control group. Furthermore, 67.2% of the AOD sample had sustained head injuries and 50% of the sample required hospitalization for head injury. History of head injury was a significant determinant of cognitive impairment, and associated with greater levels of psychological distress. Conclusions: There are high rates of inter-related cognitive impairment, head injuries, and psychological distress among clients in residential AOD treatment Routine screening of clients at intake for cognitive impairment by means of a brief screening measure such as the MoCA, in combination with the assessment of history of head injuries and comorbid psychological disorders, could inform treatment modifications or adjunct interventions to increase retention and improve long-term outcomes. (C) 2016 Elsevier Inc. All rights reserved.	[Marceau, Ely M.; Kelly, Peter J.; Solowij, Nadia] Univ Wollongong, Sch Psychol, Ctr Hlth Initiat, Northfields Ave, Wollongong, NSW 2522, Australia; [Marceau, Ely M.; Kelly, Peter J.; Solowij, Nadia] Univ Wollongong, Illawarra Hlth & Med Res Inst, Northfields Ave, Wollongong, NSW 2522, Australia; [Lunn, Jo] We Help Ourselves WHOs, Bldg 128,Church St, Lilyfield, NSW 2040, Australia; [Berry, Jamie] Adv Neuropsychol Treatment Serv, POB 4070, Strathfield South, NSW 2136, Australia		Solowij, N (corresponding author), Univ Wollongong, Sch Psychol, Northfields Ave, Wollongong, NSW 2522, Australia.	nadia@uow.edu.au	Kelly, Peter J/F-5451-2012; Marceau, Ely/AAG-2399-2019	Solowij, Nadia/0000-0002-5222-5637; Marceau, Ely/0000-0003-0209-9377; Berry, Jamie/0000-0001-6560-2457; Kelly, Peter/0000-0003-0500-1865			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2010, IBM SPSS STAT WIND V; *AUSTR I HLTH WELF, 2005, NAT DRUG STRAT HOUS; Bates ME, 2013, NEUROPSYCHOL REV, V23, P27, DOI 10.1007/s11065-013-9228-3; Bernstein IH, 2011, CLIN NEUROPSYCHOL, V25, P119, DOI 10.1080/13854046.2010.533196; Brorson HH, 2013, CLIN PSYCHOL REV, V33, P1010, DOI 10.1016/j.cpr.2013.07.007; Broyd SJ, 2016, BIOL PSYCHIAT, V79, P557, DOI 10.1016/j.biopsych.2015.12.002; Caplan JP, 2007, NEUROPSYCHOL REV, V17, P363, DOI 10.1007/s11065-007-9037-7; Copersino ML, 2012, AM J DRUG ALCOHOL AB, V38, P246, DOI 10.3109/00952990.2012.670866; Copersino ML, 2009, EXP CLIN PSYCHOPHARM, V17, P337, DOI 10.1037/a0017260; Darke S, 2012, DRUG ALCOHOL REV, V31, P64, DOI 10.1111/j.1465-3362.2011.00298.x; Deane FP, 2012, J STUD ALCOHOL DRUGS, V73, P216, DOI 10.15288/jsad.2012.73.216; Duro D, 2010, J NEUROL, V257, P728, DOI 10.1007/s00415-009-5399-5; Ersche KD, 2007, NEUROPSYCHOL REV, V17, P317, DOI 10.1007/s11065-007-9033-y; Fals-Stewart W, 2010, EXP CLIN PSYCHOPHARM, V18, P87, DOI 10.1037/a0018058; FALSSTEWART W, 1992, J CLIN PSYCHOL, V48, P539, DOI 10.1002/1097-4679(199207)48:4<539::AID-JCLP2270480416>3.0.CO;2-I; FALSSTEWART W, 1994, PSYCHOL ADDICT BEHAV, V8, P179, DOI 10.1037/0893-164X.8.3.179; Freitas S, 2012, J INT NEUROPSYCH SOC, V18, P242, DOI 10.1017/S1355617711001573; George J, 2010, DRUG ALCOHOL REV, V29, P243, DOI 10.1111/j.1465-3362.2009.00159.x; Gierski F, 2013, ALCOHOL CLIN EXP RES, V37, pE356, DOI 10.1111/j.1530-0277.2012.01903.x; Goncalves PD, 2014, DRUG ALCOHOL DEPEN, V141, P79, DOI 10.1016/j.drugalcdep.2014.05.006; Gonzalez R, 2007, NEUROPSYCHOL REV, V17, P347, DOI 10.1007/s11065-007-9036-8; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; Gossop M, 1997, ADDICTION, V92, P353, DOI 10.1111/j.1360-0443.1997.tb03205.x; Gruber SA, 2007, NEUROPSYCHOL REV, V17, P299, DOI 10.1007/s11065-007-9041-y; Hester R, 2010, CURR TOP BEHAV NEURO, V3, P301, DOI 10.1007/7854_2009_28; Hides L, 2007, AUST NZ J PSYCHIAT, V41, P166, DOI 10.1080/00048670601109949; Fernandez-Serrano MJ, 2010, J PSYCHOPHARMACOL, V24, P1317, DOI 10.1177/0269881109349841; Fernandez-Serrano MJ, 2010, EUR J PHARMACOL, V626, P104, DOI 10.1016/j.ejphar.2009.10.019; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lorenzetti V, 2016, BIOL PSYCHIAT, V79, pE17, DOI 10.1016/j.biopsych.2015.11.013; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Nasreddine Z., 2015, MONTREAL COGNITIVE A; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; OLEJNIK SF, 1985, EVALUATION REV, V9, P51, DOI 10.1177/0193841X8500900104; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Perry JL, 2011, BRAIN RES REV, V65, P124, DOI 10.1016/j.brainresrev.2010.09.001; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; Rupp CI, 2012, J STUD ALCOHOL DRUGS, V73, P625, DOI 10.15288/jsad.2012.73.625; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sunderland M, 2012, J PSYCHOPATHOL BEHAV, V34, P253, DOI 10.1007/s10862-012-9276-7; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Verdejo-Garcia A., 2011, PSYCHIAT TIMES, V28, P46; Vergara-Moragues E, 2013, J STUD ALCOHOL DRUGS, V74, P452, DOI 10.15288/jsad.2013.74.452; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; Wexler BE, 2011, BIOL PSYCHIAT, V69, P197, DOI 10.1016/j.biopsych.2010.11.016; Yucel M, 2007, DRUG ALCOHOL REV, V26, P33, DOI 10.1080/09595230601036978; Yucel M, 2007, AUST NZ J PSYCHIAT, V41, P957, DOI 10.1080/00048670701689444	53	16	17	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0740-5472			J SUBST ABUSE TREAT	J. Subst. Abus. Treat.	JUL	2016	66						30	36		10.1016/j.jsat.2016.03.002			7	Psychology, Clinical; Substance Abuse	Social Science Citation Index (SSCI)	Psychology; Substance Abuse	DN1GO	WOS:000376814500005	27211994	Green Submitted			2022-02-06	
J	Moen, KG; Vik, A; Olsen, A; Skandsen, T; Haberg, AK; Evensen, KAI; Eikenes, L				Moen, Kent Goran; Vik, Anne; Olsen, Alexander; Skandsen, Toril; Haberg, Asta Kristine; Evensen, Kari Anne I.; Eikenes, Live			Traumatic Axonal Injury: Relationships Between Lesions in the Early Phase and Diffusion Tensor Imaging Parameters in the Chronic Phase of Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain injuries; magnetic resonance imaging; diffusion magnetic resonance imaging; fractional anisotropy; longitudinal studies	CLOSED-HEAD INJURY; MR-IMAGES; INTRACEREBRAL HEMORRHAGE; CORPUS-CALLOSUM; MODERATE; MILD; MICROBLEEDS; DIAGNOSIS; SEVERITY; CLASSIFICATION	This prospective study of traumatic brain injury (TBI) patients investigates fractional anisotropy (FA) from chronic diffusion tensor imaging (DTI) in areas corresponding to persistent and transient traumatic axonal injury (TAI) lesions detected in clinical MRI from the early phase. Thirty-eight patients (mean 24.7 [range 13-63] years of age) with moderate-to-severe TBI and 42 age- and sex-matched healthy controls were included. Patients underwent 1.5-T clinical MRI in the early phase (median 7 days), including fluid-attenuated inversion recovery (FLAIR) and T2*gradient echo (T2*GRE) sequences. TAI lesions from the early phase were characterized as nonhemorrhagic or microhemorrhagic. In the chronic phase (median 3 years), patients and controls were imaged at 3 T with FLAIR, T2*GRE, T1, and DTI sequences. TAI lesions were classified as transient or persistent. The FLAIR/T2*GRE images from the early phase were linearly registered to the FA images from the chronic phase and lesions manually segmented on the FA-registered FLAIR/T2*GRE images. For regions of interest (ROIs) from both nonhemorrhagic and microhemorrhagic lesion, we found a significant linear trend of lower mean FA from ROIs in healthy controls to ROIs in patients without either nonhemorrhagic or microhemorrhagic lesions and further to transient and finally persistent lesion ROIs (P < 0.001). Histogram analyses showed lower FA in persistent compared with transient nonhemorrhagic lesion ROIs (P < 0.001), but this was not found in microhemorrhagic lesion ROIs (P = 0.08-0.55). The demonstrated linear trend of lower FA values from healthy controls to persistent lesion ROIs was found in both nonhemorrhagic and microhemorrhagic lesions and indicates a gradual increasing disruption of the microstructure. Lower FA values in persistent compared with transient lesions were found only in nonhemorrhagic lesions. Thus, clinical MRI techniques are able to depict important aspects of white matter pathology across the stages of TBI. (C) 2016 Wiley Periodicals, Inc.	[Moen, Kent Goran; Vik, Anne; Skandsen, Toril; Haberg, Asta Kristine] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Moen, Kent Goran] Univ Trondheim Hosp, St Olavs Hosp, Dept Med Imaging, Trondheim, Norway; [Vik, Anne] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Olsen, Alexander; Skandsen, Toril] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Olsen, Alexander; Haberg, Asta Kristine; Eikenes, Live] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway; [Evensen, Kari Anne I.] Trondheim Municipal, Dept Physiotherapy, Trondheim, Norway; [Moen, Kent Goran] Norwegian Univ Sci & Technol, Fac Med, Post Box 8905, N-7491 Trondheim, Norway		Moen, KG (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Post Box 8905, N-7491 Trondheim, Norway.	kent.g.moen@ntnu.no	Olsen, Alexander/P-5235-2019	Olsen, Alexander/0000-0001-8691-3860; Evensen, Kari Anne I./0000-0002-0129-0164	Central Norway Regional Health Authority; Norwegian University of Science and Technology Liaison Committee; Norwegian Research Council (MI Lab); National Center of Competence Services for Functional MRI, Department of Medical Imaging, Trondheim University Hospital	Contract grant sponsor: Central Norway Regional Health Authority and Norwegian University of Science and Technology Liaison Committee (to K.G.M., T.S.); Contract grant sponsor: Norwegian Research Council (MI Lab) (to A.O.); Contract grant sponsor: National Center of Competence Services for Functional MRI, Department of Medical Imaging, Trondheim University Hospital	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Asano Y, 2012, NEUROL MED-CHIR, V52, P31, DOI 10.2176/nmc.52.31; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Castellan N. J, 1988, NONPARAMETRIC STAT B; Chung SW, 2012, J KOREAN NEUROSURG S, V52, P377, DOI 10.3340/jkns.2012.52.4.377; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Gasperini C, 2001, MULT SCLER, V7, P27, DOI 10.1191/135245801672817145; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gupta RK, 2005, EPILEPSIA, V46, P1465, DOI 10.1111/j.1528-1167.2005.01205.x; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Holland DJ, 2010, J MAGN RESON, V203, P236, DOI 10.1016/j.jmr.2010.01.001; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Scheid R, 2011, CEREBRAL MICROBLEEDS, P125; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Tatsumi S, 2008, CEREBROVASC DIS, V26, P142, DOI 10.1159/000139661; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Young VG, 2008, NEUROLOGY, V71, P804, DOI 10.1212/01.wnl.0000319691.50117.54	42	16	16	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL	2016	94	7					623	635		10.1002/jnr.23728			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DV9SC	WOS:000383280800002	26948154	Green Accepted			2022-02-06	
J	Yousuf, MA; Tan, CF; Torres-Altoro, MI; Lu, FM; Plautz, E; Zhang, SR; Takahashi, M; Hernandez, A; Kernie, SG; Plattner, F; Bibb, JA				Yousuf, Mohammad A.; Tan, Chunfeng; Torres-Altoro, Melissa I.; Lu, Fang-Min; Plautz, Erik; Zhang, Shanrong; Takahashi, Masaya; Hernandez, Adan; Kernie, Steven G.; Plattner, Florian; Bibb, James A.			Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						cyclin-dependent kinase 5; microtubule-associated protein tau; neuroinflammation; p25; retinoblastoma protein; traumatic brain injury	CONTROLLED CORTICAL IMPACT; CDK5 ACTIVATOR P35; SYNAPTIC PLASTICITY; MOUSE MODEL; HEAD-INJURY; CELL-DEATH; PHOSPHORYLATION; NEURODEGENERATION; CALPAIN; P25	Traumatic brain injury (TBI) is associated with adverse effects on brain functions, including sensation, language, emotions and/or cognition. Therapies for improving outcomes following TBI are limited. A better understanding of the pathophysiological mechanisms of TBI may suggest novel treatment strategies to facilitate recovery and improve treatment outcome. Aberrant activation of cyclin-dependent kinase 5 (Cdk5) has been implicated in neuronal injury and neurodegeneration. Cdk5 is a neuronal protein kinase activated via interaction with its cofactor p35 that regulates numerous neuronal functions, including synaptic remodeling and cognition. However, conversion of p35 to p25 via Ca2+-dependent activation of calpain results in an aberrantly active Cdk5/p25 complex that is associated with neuronal damage and cell death. Here, we show that mice subjected to controlled cortical impact (CCI), a well-established experimental TBI model, exhibit increased p25 levels and consistently elevated Cdk5-dependent phosphorylation of microtubule-associated protein tau and retinoblastoma (Rb) protein in hippocampal lysates. Moreover, CCI-induced neuroinflammation as indicated by increased astrocytic activation and number of reactive microglia. Brain-wide conditional Cdk5 knockout mice (Cdk5 cKO) subjected to CCI exhibited significantly reduced edema, ventricular dilation, and injury area. Finally, neurophysiological recordings revealed that CCI attenuated excitatory post-synaptic potential field responses in the hippocampal CA3-CA1 pathway 24h after injury. This neurophysiological deficit was attenuated in Cdk5 cKO mice. Thus, TBI induces increased levels of p25 generation and aberrant Cdk5 activity, which contributes to pathophysiological processes underlying TBI progression. Hence, selectively preventing aberrant Cdk5 activity may be an effective acute strategy to improve recovery from TBI.	[Yousuf, Mohammad A.; Tan, Chunfeng; Torres-Altoro, Melissa I.; Lu, Fang-Min; Hernandez, Adan; Plattner, Florian; Bibb, James A.] Univ Texas Southwestern Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Plautz, Erik; Bibb, James A.] Univ Texas Southwestern Med Ctr, Dept Neurol & Neurotherapeut, Dallas, TX USA; [Zhang, Shanrong; Takahashi, Masaya] Univ Texas Southwestern Med Ctr, Adv Imaging Res Ctr, Dallas, TX USA; [Kernie, Steven G.] Columbia Univ, Dept Pediat & Pathol & Cell Biol, New York, NY USA; [Bibb, James A.] Univ Texas Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA		Bibb, JA (corresponding author), Univ Texas Southwestern Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.bibb@utsouthwestern.edu	Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549; Plautz, Erik/0000-0001-8949-3064; Hernandez-Cortes, Adan/0000-0002-7098-870X; Plattner, Florian/0000-0002-3150-1866	Texas Institute for Brain Injury and Repair; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH79710, MH083711]; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [DA018343, DA033485]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS073855, NS083077]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH079710, R01MH083711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS083077, R01NS073855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P30DA018343, R01DA016672, R01DA033485] Funding Source: NIH RePORTER	We thank G. Mettlach for technical assistance, Dr P. Davis for phospho-tau antibodies, and the Beatrice Mennen Haggerty Center for Research on Brain Injury and Repair in Strokes for facilitating this research. This work was supported by a Discovery Award from the Texas Institute for Brain Injury and Repair, and National Institute of Mental Health grants (MH79710, MH083711), National Institute on Drug Abuse grants (DA018343, DA033485) and National Institute of Neurological Disorders and Stroke grants (NS073855) to J.A.B. and (NS083077) to S.G.K. The authors have no conflict of interest to declare and no competing financial interests exist.	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Angelo M, 2006, J NEUROCHEM, V99, P353, DOI 10.1111/j.1471-4159.2006.04040.x; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Faul M, 2010, TRAUMATIC BRAIN INJU; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Futatsugi A, 2012, CELL CYCLE, V11, P1603, DOI 10.4161/cc.20009; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hamdane M, 2005, J CELL SCI, V118, P1291, DOI 10.1242/jcs.01724; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Herskovits AZ, 2006, NEUROBIOL DIS, V23, P398, DOI 10.1016/j.nbd.2006.04.004; Hisanaga S, 2012, CELL CYCLE, V11, P2049, DOI 10.4161/cc.20536; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7; Lee KY, 1997, J BIOL CHEM, V272, P5622, DOI 10.1074/jbc.272.9.5622; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meyer DA, 2014, J NEUROSCI, V34, P8259, DOI 10.1523/JNEUROSCI.4368-13.2014; Meyer DA, 2008, P NATL ACAD SCI USA, V105, P18561, DOI 10.1073/pnas.0806078105; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Pozo K, 2013, CANCER CELL, V24, P499, DOI 10.1016/j.ccr.2013.08.027; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; SHAPIRA Y, 1989, Neurological Research, V11, P169; SINCLAIR RA, 1981, J CLIN PATHOL, V34, P859, DOI 10.1136/jcp.34.8.859; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Sundaram JR, 2013, J NEUROSCI, V33, P334, DOI 10.1523/JNEUROSCI.3593-12.2013; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Zheng YL, 2005, EMBO J, V24, P209, DOI 10.1038/sj.emboj.7600441; Zheng YL, 2002, EUR J BIOCHEM, V269, P4427, DOI 10.1046/j.1432-1033.2002.03133.x	63	16	17	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUL	2016	138	2					317	327		10.1111/jnc.13620			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DS0CT	WOS:000380263700010	26998748	Green Accepted			2022-02-06	
J	Baratz-Goldstein, R; Deselms, H; Heim, LR; Khomski, L; Hoffer, BJ; Atlas, D; Pick, CG				Baratz-Goldstein, Renana; Deselms, Hanna; Heim, Leore Raphael; Khomski, Lena; Hoffer, Barry J.; Atlas, Daphne; Pick, Chaim G.			Thioredoxin-Mimetic-Peptides Protect Cognitive Function after Mild Traumatic Brain Injury (mTBI)	PLOS ONE			English	Article							N-ACETYLCYSTEINE AMIDE; NECROSIS-FACTOR-ALPHA; FOCAL CEREBRAL-ISCHEMIA; ALLERGIC AIRWAY DISEASE; NEURONAL CELL-DEATH; OXIDATIVE STRESS; RAT-BRAIN; MITOCHONDRIAL BIOENERGETICS; NEURODEGENERATIVE DISEASES; DOPAMINERGIC-NEURONS	Mild traumatic brain injury (mTBI) is recognized as a common injury among children, sportsmen, and elderly population. mTBI lacks visible objective structural brain damage but patients frequently suffer from long-lasting cognitive, behavioral and emotional difficulties associated with biochemical and cellular changes. Currently there is no effective treatment for patients with mTBI. The thioredoxin reductase/thioredoxin pathway (TrxR/Trx1) has both anti-inflammatory and anti-oxidative properties. If the system is compromised, Trx1 remains oxidized and triggers cell death via an ASK1-Trx1 signal transduction mechanism. We previously showed tri and tetra peptides which were derived from the canonical -CxxC- motif of the Trx1-active site, called thioredoxin mimetic (TXM) peptides, reversed inflammatory and oxidative stress damage mimicking Trx1 activity. Here, TXM-peptides were examined for protecting cognitive function following weight drop closed-head injury in a mouse model of mTBI. TXM-CB3 (AcCys-Pro-CysNH(2)), TXM-CB13 (DY-70; AcCys-Met-Lys-CysNH(2)) or AD4 (ACysNH(2)) were administered at 50 mg/kg, 60 min after injury and cognitive performance was monitored by the novel-object-recognition and Y-maze tests. Behavioral deficits subsequent to mTBI injury were reversed by a single dose of TXM-CB3, TXM-CB13 and, to a lesser extent, by AD4. TXM-CB13 similar to TXM-CB3 and AD4 reversed oxidative stress-induced phosphorylation of mitogen-activated kinases, p38(MAPK) and c-Jun N-terminal kinase, (JNK) in human neuronal SH-SY5Y cells. We conclude that significantly improved cognitive behavior post mTBI by the TXM-peptides could result from anti-apoptotic, and/or anti-inflammatory activities. Future preclinical studies are required to establish the TXM-peptides as potential therapeutic drugs for brain injuries.	[Baratz-Goldstein, Renana; Deselms, Hanna; Heim, Leore Raphael] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Khomski, Lena; Atlas, Daphne] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel		Baratz-Goldstein, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.; Atlas, D (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	renanaba@post.tau.ac.il; daphne.atlas@mail.huji.ac.il	Meijer, Anna/K-5118-2016		Ari and Regine Aprijaskis Fund at Tel-Aviv University; H.L Lauterbach Fund (Hebrew University)	This research was supported by the Ari and Regine Aprijaskis Fund at Tel-Aviv University, and by The H.L Lauterbach Fund (Hebrew University) to DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Ari and Regine Aprijaskis Fund at Tel-Aviv University, and by The H.L Lauterbach Fund (Hebrew University).	Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Amer J, 2008, BBA-GEN SUBJECTS, V1780, P249, DOI 10.1016/j.bbagen.2007.11.009; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Bachnoff N, 2011, FREE RADICAL BIO MED, V50, P1355, DOI 10.1016/j.freeradbiomed.2011.02.026; Bahat-Stroomza M, 2005, EUR J NEUROSCI, V21, P637, DOI 10.1111/j.1460-9568.2005.03889.x; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bartov O, 2006, BRAIN RES, V1069, P198, DOI 10.1016/j.brainres.2005.10.079; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cohen-Kutner M, 2014, REDOX BIOL, V2, P447, DOI 10.1016/j.redox.2013.12.018; Cohen-Kutner M, 2013, BIOCHEM PHARMACOL, V85, P977, DOI 10.1016/j.bcp.2013.01.003; Cuzzocrea S, 2000, BRIT J PHARMACOL, V130, P1219, DOI 10.1038/sj.bjp.0703421; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FAN PY, 1995, CLIN IMMUNOL IMMUNOP, V75, P125, DOI 10.1006/clin.1995.1061; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Finme JW, 2008, VET PATHOL, V45, P307, DOI 10.1354/vp.45-3-307; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Grinberg L, 2005, FREE RADICAL BIO MED, V38, P136, DOI 10.1016/j.freeradbiomed.2004.09.025; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kim SR, 2011, AM J RESP CRIT CARE, V183, P1015, DOI 10.1164/rccm.200906-0902OC; Kronenfeld G, 2015, FREE RADICAL BIO MED, V79, P138, DOI 10.1016/j.freeradbiomed.2014.11.021; Lee KS, 2007, EXP MOL MED, V39, P756, DOI 10.1038/emm.2007.82; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nakamura T, 2016, TRENDS PHARMACOL SCI, V37, P73, DOI 10.1016/j.tips.2015.10.002; Offen D, 2004, J NEUROCHEM, V89, P1241, DOI 10.1111/j.1471-4159.2004.02428.x; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Shenk JC, 2009, J NEUROL SCI, V283, P199, DOI 10.1016/j.jns.2009.03.002; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Stelmasiak Z, 2000, Med Sci Monit, V6, P426; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Yan MS, 2008, NEOPLASIA, V10, P160, DOI 10.1593/neo.07935; Zaitone SA, 2012, PHARMACOL BIOCHEM BE, V100, P347, DOI 10.1016/j.pbb.2011.09.002; Zhang XS, 2009, BRAIN RES, V1275, P87, DOI 10.1016/j.brainres.2009.04.008; Zohar J, 2003, CNS SPECTR, V8, P634, DOI 10.1017/S1092852900008798	59	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157064	10.1371/journal.pone.0157064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	WOS:000377564000037	27285176	Green Published, Green Submitted, gold			2022-02-06	
J	Eriksson, K; Forsgren, E; Hartelius, L; Saldert, C				Eriksson, Karin; Forsgren, Emma; Hartelius, Lena; Saldert, Charlotta			Communication partner training of enrolled nurses working in nursing homes with people with communication disorders caused by stroke or Parkinson's disease	DISABILITY AND REHABILITATION			English	Article						training; nurses; Parkinson's disease; functional communication; communication; Aphasia; partner	TRAUMATIC BRAIN-INJURY; CONVERSATION PARTNERS; SUPPORTED CONVERSATION; OLDER-PEOPLE; APHASIA; ADULTS; CARE; INDIVIDUALS; VOLUNTEERS; SPOUSES	Purpose: To evaluate the effect of a communication partner training programme directed to enrolled nurses working with people with communication disorders in nursing homes, using an individualised approach. Method: Five dyads consisting of a person with stroke-induced aphasia (n = 4) or Parkinson's disease (PD) (n = 1) living in different nursing homes and his/her enrolled nurse participated in the study, which had a replicated single-subject design with multiple baselines across individuals. The main element of the intervention was supervised analysis of video-recorded natural interaction in everyday nursing situations and the formulation of individual goals to change particular communicative strategies. Results: Outcome was measured via blinded assessments of filmed natural interaction obtained at baseline, intervention and follow-up and showed an increased use of the target communicative strategies. Subjective measures of goal attainment by the enrolled nurses were consistent with these results. Measures of perceived functional communication on behalf of the persons with communication disorders were mostly positive; four of five participants with communication disorders and two of five enrolled nurses reported improved functional communication after intervention. Conclusions: The use of an individualised communication partner training programme led to significant changes in natural interaction, which contributes importantly to a growing body of knowledge regarding communication partner training. Implications for rehabilitation Communication partner training can improve the communicative environment of people with communication disorders. For people with communication disorders who live in institutions, the main conversation partner is likely to be a professional caretaker. An individualised approach for communication partner training that focussed on specific communication patterns was successful in increasing the use of supportive strategies that enrolled nurses used in natural interaction with persons with communication disorders. The training also positively affected the perceived functional communication of the persons with communication disorders.	[Eriksson, Karin; Forsgren, Emma; Hartelius, Lena; Saldert, Charlotta] Univ Gothenburg, Div Speech & Language Pathol, Inst Neurosci & Physiol, Bldg 3,POB 452, SE-40530 Gothenburg, Sweden; [Eriksson, Karin; Forsgren, Emma; Hartelius, Lena; Saldert, Charlotta] Univ Gothenburg, Ctr Person Ctr Care GPCC, SE-40530 Gothenburg, Sweden		Eriksson, K (corresponding author), Univ Gothenburg, Div Speech & Language Pathol, Inst Neurosci & Physiol, Bldg 3,POB 452, SE-40530 Gothenburg, Sweden.	karin.eriksson@neuro.gu.se	Saldert, Charlotta/ABH-1746-2020	Saldert, Charlotta/0000-0001-8808-3610; Forsgren, Emma/0000-0002-2402-0909			Apt P., 2008, TOKEN TEST; Bandura A, 1986, SOCIAL FDN THOUGHT A; Barker J, 2011, SINGLE-CASE RESEARCH METHODS IN SPORT AND EXERCISE PSYCHOLOGY, P1; Beeson PM, 2006, NEUROPSYCHOL REV, V16, P161, DOI 10.1007/s11065-006-9013-7; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bloch S, 2008, CLIN LINGUIST PHONET, V22, P974, DOI 10.1080/02699200802394831; Bryan K, 2002, AGING MENT HEALTH, V6, P248, DOI 10.1080/13607860220142495; Cardillo JE., 1994, GOAL ATTAINMENT SCAL; Carlsson E, 2014, INT J LANG COMM DIS, V49, P722, DOI 10.1111/1460-6984.12106; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Davidson B, 2003, APHASIOLOGY, V17, P243, DOI 10.1080/729255457; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Eriksson K, 2014, J INTERACT RES COM D, V5, P245, DOI 10.1558/jircd.v5i2.245; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forsgren E, 2016, INT J NURS STUD, V54, P112, DOI 10.1016/j.ijnurstu.2015.05.006; Forsgren E, 2013, LOGOP PHONIATR VOCO, V38, P82, DOI 10.3109/14015439.2012.731081; Fukkink R, 2011, EDUC PSYCHOL REV, V23, P45, DOI 10.1007/s10648-010-9144-5; Genereux S, 2004, APHASIOLOGY, V18, P1161, DOI 10.1080/02687030444000507; Gordon C, 2009, J ADV NURS, V65, P544, DOI 10.1111/j.1365-2648.2008.04917.x; Gottfries C G, 1997, Lakartidningen, V94, P1099; Hersh D, 2016, APHASIOLOGY, V30, P609, DOI 10.1080/02687038.2014.933520; Hickey EM, 2004, APHASIOLOGY, V18, P625, DOI 10.1080/02687030444000093; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hutchby I., 2008, CONVERSATION ANAL, V2nd edn.; Jensen LR, 2015, APHASIOLOGY, V29, P57, DOI 10.1080/02687038.2014.955708; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan A., 1999, THESIS U TORONTO; Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kolb DA., 1984, EXPERIENTIAL LEARNIN; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; Lock S, 2001, SUPPORTING PARTNERS; Long AF, 2008, CLIN REHABIL, V22, P1083, DOI 10.1177/0269215508090091; Long A, 2009, CLIN REHABIL, V23, P846, DOI 10.1177/0269215509336055; Lyon JG, 1997, APHASIOLOGY, V11, P693, DOI 10.1080/02687039708249416; McConachie H, 1997, EUR J DISORDER COMM, V32, P277; McGilton K, 2011, INT J OLDER PEOPLE N, V6, P13, DOI 10.1111/j.1748-3743.2010.00210.x; Nehring WM, 2009, SIMULAT GAMING, V40, P528, DOI 10.1177/1046878109332282; Purdy M, 2005, APHASIOLOGY, V19, P377, DOI 10.1080/02687030444000822; Rautakoski P, 2008, APHASIOLOGY, V22, P1269, DOI 10.1080/02687030802374788; Rayner H, 2003, INT J LANG COMM DIS, V38, P149, DOI 10.1080/1368282021000060308; RIPICH DN, 1995, GERIATR NURS, V16, P15, DOI 10.1016/S0197-4572(05)80073-4; Saldert C, 2013, APHASIOLOGY, V27, P271, DOI 10.1080/02687038.2012.710317; Schiavetti N., 1992, INTELLIGIBILITY SPEE, P11; Scruggs T. E., 2001, EXCEPTIONALITY, V9, P227, DOI DOI 10.1207/S15327035EX0904_5; SHEWAN CM, 1984, J COMMUN DISORD, V17, P175, DOI 10.1016/0021-9924(84)90010-8; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Simmons-Mackie NN, 2007, APHASIOLOGY, V21, P39, DOI 10.1080/02687030600798287; Sorin-Peters R, 2014, APHASIOLOGY, V28, P731, DOI 10.1080/02687038.2014.891094; SORINPETERS R, 1995, APHASIOLOGY, V9, P565, DOI 10.1080/02687039508248715; Sundin K, 2003, J CLIN NURS, V12, P107, DOI 10.1046/j.1365-2702.2003.00676.x; Tallberg IM, 2008, SCAND J PSYCHOL, V49, P479, DOI 10.1111/j.1467-9450.2008.00653.x; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Turner S, 2006, APHASIOLOGY, V20, P483, DOI 10.1080/02687030600589991; Wadensten B, 2009, INT J OLDER PEOPLE N, V4, P203, DOI 10.1111/j.1748-3743.2009.00170.x; Wilkinson R, 2014, RES LANG SOC INTERAC, V47, P219, DOI 10.1080/08351813.2014.925659; Wilkinson R, 2010, J INTERACT RES COM D, V1, P45, DOI 10.1558/jircd.v1i1.45; Wood M, 2012, RANDOMIZATION TEST S; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	59	16	16	0	68	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUN 4	2016	38	12					1187	1203		10.3109/09638288.2015.1089952			17	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DH5OT	WOS:000372840800008	26457882				2022-02-06	
J	Chen, P; Ward, I; Khan, U; Liu, Y; Hreha, K				Chen, Peii; Ward, Irene; Khan, Ummais; Liu, Yan; Hreha, Kimberly			Spatial Neglect Hinders Success of Inpatient Rehabilitation in Individuals With Traumatic Brain Injury: A Retrospective Study	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						hemispatial neglect; traumatic brain injury; rehabilitation outcome; length of stay	UNILATERAL NEGLECT; VISUAL DISORIENTATION; HEMISPATIAL NEGLECT; STROKE PATIENTS; CONSEQUENCES; RELIABILITY; AWARENESS; NETWORKS; WALKING; IMPACT	Background. Current knowledge about spatial neglect and its impact on rehabilitation mostly originates from stroke studies. Objective. To examine the impact of spatial neglect on rehabilitation outcome in individuals with traumatic brain injury (TBI). Methods. The retrospective study included 156 consecutive patients with TBI (73 women; median age = 69.5 years; interquartile range = 50-81 years) at an inpatient rehabilitation facility (IRF). We examined whether the presence of spatial neglect affected the Functional Independence Measure (FIM) scores, length of stay, or discharge disposition. Based on the available medical records, we also explored whether spatial neglect was associated with tactile sensation or muscle strength asymmetry in the extremities and whether specific brain injuries or lesions predicted spatial neglect. Results. In all, 30.1% (47 of 156) of the sample had spatial neglect. Sex, age, severity of TBI, or time postinjury did not differ between patients with and without spatial neglect. In comparison to patients without spatial neglect, patients with the disorder stayed in IRF 5 days longer, had lower FIM scores at discharge, improved slower in both Cognitive and Motor FIM scores, and might have less likelihood of return home. In addition, left-sided neglect was associated with asymmetric strength in the lower extremities, specifically left weaker than the right. Finally, brain injury-induced mass effect predicted left-sided neglect. Conclusions. Spatial neglect is common following TBI, impedes rehabilitation progress in both motor and cognitive domains, and prolongs length of stay. Future research is needed for linking specific traumatic injuries and lesioned networks to spatial neglect and related impairment.	[Chen, Peii] Kessler Fdn, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA; [Chen, Peii; Ward, Irene; Khan, Ummais; Liu, Yan] Rutgers State Univ, Newark, NJ 07102 USA; [Ward, Irene; Hreha, Kimberly] Kessler Inst Rehabil, W Orange, NJ USA; [Hreha, Kimberly] Columbia Univ, New York, NY USA		Chen, P (corresponding author), Kessler Fdn, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	PChen@KesslerFoundation.org		Chen, Peii/0000-0002-6724-7046	Kessler Foundation; Wallerstein Foundation for Geriatric Life Improvement	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was funded by the Kessler Foundation and the Wallerstein Foundation for Geriatric Life Improvement.	Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Appelros P, 2007, ACTA NEUROL SCAND, V116, P15, DOI 10.1111/j.1600-0404.2006.00756.x; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Azouvi P, 1996, NEUROPSYCHOL REHABIL, V6, P133, DOI 10.1080/713755501; Berti A, 2002, NEUROPSYCHOLOGY, V16, P390, DOI 10.1037//0894-4105.16.3.390; BISIACH E, 1990, NEUROLOGY, V40, P1278, DOI 10.1212/WNL.40.8.1278; Brain WR, 1941, BRAIN, V64, P244, DOI 10.1093/brain/64.4.244; Chen P, 2015, KF NAP 2015 MANUAL; Chen PI, 2015, ARCH PHYS MED REHAB, V96, P1458, DOI 10.1016/j.apmr.2015.03.019; Chen PI, 2015, ARCH PHYS MED REHAB, V96, P869, DOI 10.1016/j.apmr.2014.10.023; Chen P, 2012, TOP STROKE REHABIL, V19, P423, DOI 10.1310/tsr1905-423; Chen P, 2012, J NEUROPSYCHOL, V6, P270, DOI 10.1111/j.1748-6653.2012.02028.x; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Faul M, 2010, TRAUMATIC BRAIN INJU; Gillen R, 2005, ARCH PHYS MED REHAB, V86, P763, DOI 10.1016/j.apmr.2004.10.029; Gutschalk Alexander, 2015, Handb Clin Neurol, V129, P557, DOI 10.1016/B978-0-444-62630-1.00031-7; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; Harvey M, 2012, NEUROPSYCHOLOGIA, V50, P1018, DOI 10.1016/j.neuropsychologia.2011.09.030; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Heilman KM, 2004, FRONT BIOSCI-LANDMRK, V9, P694, DOI 10.2741/1261; Hillis AE, 2006, NEUROSCIENTIST, V12, P153, DOI 10.1177/1073858405284257; Jehkonen M, 2006, RESTOR NEUROL NEUROS, V24, P209; Karnath HO, 2009, CEREB CORTEX, V19, P2331, DOI 10.1093/cercor/bhn250; Katz N, 1999, ARCH PHYS MED REHAB, V80, P379, DOI 10.1016/S0003-9993(99)90273-3; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; LAPLANE D, 1983, J NEUROL NEUROSUR PS, V46, P152, DOI 10.1136/jnnp.46.2.152; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lindell AB, 2007, CLIN NEUROPSYCHOL, V21, P479, DOI 10.1080/13854040600630061; Lisa LP, 2013, NEUROREHABILITATION, V33, P611, DOI 10.3233/NRE-130986; McKenna K, 2006, BRAIN INJURY, V20, P507, DOI 10.1080/02699050600664368; Na DL, 1998, J NEUROL NEUROSUR PS, V64, P331, DOI 10.1136/jnnp.64.3.331; Nijboer TCW, 2014, NEUROREPORT, V25, P1381, DOI 10.1097/WNR.0000000000000277; Nijboer TCW, 2013, CORTEX, V49, P2021, DOI 10.1016/j.cortex.2012.11.006; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Paolucci S, 2001, ARCH PHYS MED REHAB, V82, P743, DOI 10.1053/apmr.2001.23191; Paternostro-Sluga T, 2008, J REHABIL MED, V40, P665, DOI 10.2340/16501977-0235; Pavlovskaya M, 2007, BRAIN COGNITION, V64, P21, DOI 10.1016/j.bandc.2006.10.003; Riddoch G, 1935, BRAIN, V58, P376, DOI 10.1093/brain/58.3.376; Ronchi R, 2012, NEUROPSYCHOLOGY, V26, P588, DOI 10.1037/a0029216; Rousseaux M, 2013, CORTEX, V49, P2607, DOI 10.1016/j.cortex.2013.07.007; Rousseaux M, 2013, NEUROLOGY, V81, P1291, DOI 10.1212/WNL.0b013e3182a823a7; Salvato G, 2014, NEUROPSYCHOLOGY, V28, P706, DOI 10.1037/neu0000062; Thiebaut de Schotten M, 2014, CEREB CORTEX, V24, P691, DOI 10.1093/cercor/bhs351; TRIGGS WJ, 1994, NEUROLOGY, V44, P1164, DOI 10.1212/WNL.44.6.1164; TROMP E, 1995, NEUROPSYCHOL REHABIL, V5, P319, DOI 10.1080/09602019508401475; Ugur C, 2000, J NEUROL NEUROSUR PS, V69, P649, DOI 10.1136/jnnp.69.5.649; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; Valenstein, 2012, CLIN NEUROPSYCHOLOGY, P296; WEBSTER JS, 1995, ARCH PHYS MED REHAB, V76, P924, DOI 10.1016/S0003-9993(95)80068-9; Wee JYM, 2008, AM J PHYS MED REHAB, V87, P910, DOI 10.1097/PHM.0b013e31818a58bd; Wilkinson D, 2012, ARCH PHYS MED REHAB, V93, P1191, DOI 10.1016/j.apmr.2012.01.010; Wilson BA, 1991, NEUROPSYCHOL REHABIL, V1, P5, DOI DOI 10.1080/09602019108401377; Yang NYH, 2013, FRONT HUM NEUROSCI, V7, P1, DOI 10.3389/fnhum.2013.00187	53	16	17	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUN	2016	30	5					451	460		10.1177/1545968315604397			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DL6BR	WOS:000375723200007	26338431	Bronze			2022-02-06	
J	de Holanda, LF; Pereira, BJA; Holanda, RR; Neto, JT; de Holanda, CVM; Giudicissi, M; de Oliveira, NRC; de Oliveira, JG				de Holanda, Luciano Ferreira; Pereira, Benedito Jamilson A.; Holanda, Rafael Rodrigues; Neto, Jose Targino; de Holanda, Carlos Vanderlei M.; Giudicissi Filho, Miguel; Cunha de Oliveira, Nathalia Ribeiro; de Oliveira, Jean G.			Neurosurgical Management of Nonmissile Penetrating Cranial Lesions	WORLD NEUROSURGERY			English	Article						Neurosurgical management; Nonmissile penetrating injury; Penetrating lesion; Trauma; Traumatic brain injury	OF-THE-LITERATURE; INTRACRANIAL WOOD; FOREIGN-BODIES; STAB WOUNDS; HEAD-INJURY; BRAIN; TOMOGRAPHY	OBJECTIVE: The objective of this study is to present a case series of nonmissile penetrating (NMP) injuries and to establish a workflow for an uncommon mechanism of traumatic head injury through the analysis of each case, classification of the type of lesion, management, and outcome score at follow-up. METHODS: From January 1991 to December 2008, 36,000 patients presenting with traumatic brain injury (TBI) were admitted in the Department of Neurosurgery, Hospital Antonio Targino, Campina Grande-PB, Brazil. From these patients, 11 presenting with lesions caused by NMP objects were selected. RESULTS: Among the 11 patients, 9 were men and 2 were women. Their ages ranged from 7 to 74 years old (mean age +/- SD, 29.1 +/- 22.99 years). All patients underwent neuro-radiologic evaluation. The entry point was classified as natural (orbit) or artificial (skull transfixation), and we also divided the patients presenting with secondary parenchymal or vascular damage from those presenting with only lesions caused by the primary penetration into the cranium and meninges. All patients were neurosurgically treated with removal of the foreign body through craniotomy, except the patient whose object (pen) was removed without craniotomy with local anesthesia. Glasgow Coma Scale (GCS) score on admission was a statistically significant factor on prognosis, and any patient who presented with a GCS score of 15 evolved satisfactorily, and there were no deaths in this group of patients (P = 0.04). CONCLUSIONS: TBIs caused by NMP objects are unusual and caused by aggression, self-inflicted harm (in the case of psychiatric patients), and accident. The foreign body may enter into the skull through a natural hole (orbit, nose, mouth, or ear) or crosses the skull, causing a fracture and creating an artificial hole. Preoperative neuro-radiologic assessment is paramount for the correct neurosurgical approach. The main prognostic factor for these patients is the GCS score at admission.	[de Holanda, Luciano Ferreira; Pereira, Benedito Jamilson A.; Holanda, Rafael Rodrigues; Neto, Jose Targino] Hosp Antonio Targino, Dept Neurosurg, Campina Grande, PB, Brazil; [de Holanda, Luciano Ferreira] Univ Fed Campina Grande, Dept Neurol & Neurosurg, Campina Grande, PB, Brazil; [Pereira, Benedito Jamilson A.; de Holanda, Carlos Vanderlei M.; Giudicissi Filho, Miguel; de Oliveira, Jean G.] Hosp Beneficencia Portuguesa, Ctr Neurol & Neurosurg Associates, Dept Neurosurg, Sao Paulo, SP, Brazil; [Cunha de Oliveira, Nathalia Ribeiro] Hosp Beneficencia Portuguesa, Ctr Neurol & Neurosurg Associates, Dept Dent, Sao Paulo, SP, Brazil		Pereira, BJA (corresponding author), Hosp Antonio Targino, Dept Neurosurg, Campina Grande, PB, Brazil.	benedito.jamilson@hotmail.com	de Oliveira, Jean G./H-2896-2012; de Oliveira, Nathalia R. C./R-7239-2016	de Oliveira, Jean G./0000-0002-7274-7715; 			Alafaci C, 2010, CLIN NEUROL NEUROSUR, V112, P813, DOI 10.1016/j.clineuro.2010.06.008; Cemil B, 2009, ULUS TRAVMA ACIL CER, V15, P624; Chibbaro S, 2006, ACTA NEUROCHIR, V148, P937, DOI 10.1007/s00701-006-0794-5; Davis GA, 2000, J CLIN NEUROSCI, V7, P545, DOI 10.1054/jocn.2000.0692; Deb S, 2000, J TRAUMA, V48, P1159, DOI 10.1097/00005373-200006000-00026; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; GLATT HJ, 1990, OPHTHALMIC PLAST REC, V6, P108, DOI 10.1097/00002341-199006000-00005; GREEN BF, 1990, OPHTHALMOLOGY, V97, P608; Gutierrez-Gonzalez R, 2008, CLIN NEUROL NEUROSUR, V110, P207, DOI 10.1016/j.clineuro.2007.09.014; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; Khoshyomn S, 2004, J TRAUMA, V56, P1131, DOI 10.1097/01.TA.0000071299.31349.D6; Large M, 2012, AM J FOREN MED PATH, V33, P13, DOI 10.1097/PAF.0b013e3181dd5b47; Lopez F, 2000, CHILD NERV SYST, V16, P117, DOI 10.1007/s003810050025; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; MILLER CF, 1977, SURG NEUROL, V7, P95; Ratiu P, 2004, J NEUROTRAUM, V21, P637, DOI 10.1089/089771504774129964; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; TEASDALE G, 1974, LANCET, V2, P81; Yamashita M, 1998, Arq Neuropsiquiatr, V56, P317, DOI 10.1590/S0004-282X1998000200026	21	16	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2016	90						420	429		10.1016/j.wneu.2016.03.015			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DS1MS	WOS:000380360500053	26987636				2022-02-06	
J	Larson, MJ; Clayson, PE; Kirwan, CB; Weissman, DH				Larson, Michael J.; Clayson, Peter E.; Kirwan, C. Brock; Weissman, Daniel H.			Event-related potential indices of congruency sequence effects without feature integration or contingency learning confounds	PSYCHOPHYSIOLOGY			English	Article						Conflict adaptation; Congruency sequence effects; Gratton effect; N450; Conflict SP; Event-related potential; ERP	ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL ADJUSTMENTS; TRAUMATIC BRAIN-INJURY; CONFLICT ADAPTATION; STROOP TASK; SIMON TASK; PROPORTION CONGRUENT; PREFRONTAL CORTEX; TIME-COURSE; INTERFERENCE	The congruency effect in Stroop-like tasks (i.e., increased response time and reduced accuracy in incongruent relative to congruent trials) is often smaller when the previous trial was incongruent as compared to congruent. This congruency sequence effect (CSE) is thought to reflect cognitive control processes that shift attention to the target and/or modulate the response engendered by the distracter differently after incongruent relative to congruent trials. The neural signatures of CSEs are therefore usually attributed to cognitive control processes that minimize distraction from irrelevant stimuli. However, CSEs in previous functional neuroimaging studies were ubiquitously confounded with feature integration and/or contingency learning processes. We therefore investigated whether a neural CSE can be observed without such confounds in a group of healthy young adults (n=56). To this end, we combined a prime-probe task that lacks such confounds with high-density ERPs to identify, for the first time, the neural time course of confound-minimized CSEs. Replicating recent behavioral findings, we observed strong CSEs in this task for mean response time and mean accuracy. Critically, conceptually replicating prior ERP results from confounded tasks, we also observed a CSE in both the parietal conflict slow potential (conflict SP) and the frontomedial N450. These findings indicate for the first time that neural CSEs as indexed by ERPs can be observed without the typical confounds. More broadly, the present study provides a confound-minimized protocol that will help future researchers to better isolate the neural bases of control processes that minimize distraction from irrelevant stimuli.	[Larson, Michael J.; Kirwan, C. Brock] Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA; [Larson, Michael J.; Kirwan, C. Brock] Brigham Young Univ, Ctr Neurosci, 244 TLRB, Provo, UT 84602 USA; [Clayson, Peter E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Weissman, Daniel H.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA		Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA.; Larson, MJ (corresponding author), Brigham Young Univ, Ctr Neurosci, 244 TLRB, Provo, UT 84602 USA.	michael_larson@byu.edu	Clayson, Peter/AAC-4028-2022; Clayson, Peter E/F-5438-2011; Larson, Michael J/C-8543-2012; Kirwan, Brock/B-1520-2014	Clayson, Peter E/0000-0003-4437-6598; Larson, Michael J/0000-0002-8199-8065; Kirwan, Brock/0000-0003-0768-1446	College of Family, Home, and Social Sciences at Brigham Young University	We gratefully acknowledge Christina Catron, Katie Slinn, Whitney Badal, Tyshae Davis, Randy Beck, Travis Johnson, Nathan Killpack, and Curtis Killpack for their assistance in data collection. This study was funded in part by the College of Family, Home, and Social Sciences at Brigham Young University.	Baldwin SA, 2015, PSYCHOPHYSIOLOGY, V52, P790, DOI 10.1111/psyp.12401; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Clawson A, 2013, PSYCHOPHYSIOLOGY, V50, P711, DOI 10.1111/psyp.12066; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P1209, DOI 10.1111/psyp.12138; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P174, DOI 10.1111/psyp.12001; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; Compton RJ, 2012, PSYCHOPHYSIOLOGY, V49, P583, DOI 10.1111/j.1469-8986.2012.01354.x; Dien J, 2010, BRAIN RES, V1355, P126, DOI 10.1016/j.brainres.2010.07.099; Donohue SE, 2012, COGN AFFECT BEHAV NE, V12, P1, DOI 10.3758/s13415-011-0060-z; Dreisbach G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00342; Duthoo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110462; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Freitas AL, 2015, PSYCHOL RES-PSYCH FO, V79, P143, DOI 10.1007/s00426-014-0540-1; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Huffmeijer R, 2014, PHYSIOL BEHAV, V130, P13, DOI 10.1016/j.physbeh.2014.03.008; Jimenez L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01042; Jimenez L, 2013, J EXP PSYCHOL HUMAN, V39, P271, DOI 10.1037/a0027734; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim S, 2014, ACTA PSYCHOL, V149, P60, DOI 10.1016/j.actpsy.2014.03.004; Larson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140770; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Larson MJ, 2013, BIOL PSYCHOL, V94, P408, DOI 10.1016/j.biopsycho.2013.08.006; Larson MJ, 2012, DEV NEUROPSYCHOL, V37, P343, DOI 10.1080/87565641.2011.650337; Larson MJ, 2012, J CHILD PSYCHOL PSYC, V53, P440, DOI 10.1111/j.1469-7610.2011.02498.x; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; LOGAN GD, 1985, ACTA PSYCHOL, V60, P193, DOI 10.1016/0001-6918(85)90055-1; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mordkoff JT, 2012, PSYCHON B REV, V19, P750, DOI 10.3758/s13423-012-0257-3; Notebaert W, 2001, PSYCHOL RES-PSYCH FO, V65, P170, DOI 10.1007/s004260000054; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; SCHIMMEL H, 1967, SCIENCE, V157, P92, DOI 10.1126/science.157.3784.92; Schmidt JR, 2008, J EXP PSYCHOL LEARN, V34, P514, DOI 10.1037/0278-7393.34.3.514; Schmidt JR, 2007, CONSCIOUS COGN, V16, P421, DOI 10.1016/j.concog.2006.06.010; Schmidt JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102337; Schmidt JR, 2013, PSYCHON B REV, V20, P615, DOI 10.3758/s13423-012-0373-0; Schmidt JR, 2011, ACTA PSYCHOL, V138, P176, DOI 10.1016/j.actpsy.2011.06.002; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Suarez-Pellicioni M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099579; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; Weissman DH, 2015, ACTA PSYCHOL, V156, P8, DOI 10.1016/j.actpsy.2015.01.003; Weissman DH, 2014, J EXP PSYCHOL HUMAN, V40, P2022, DOI 10.1037/a0037454; Wendt M, 2006, J EXP PSYCHOL HUMAN, V32, P644, DOI 10.1037/0096-1523.32.3.644; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2005, EXP BRAIN RES, V167, P38, DOI 10.1007/s00221-005-2366-y; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; West R, 2012, NEUROPSYCHOLOGIA, V50, P3450, DOI 10.1016/j.neuropsychologia.2012.10.011; West R, 2012, PSYCHOPHYSIOLOGY, V49, P1309, DOI 10.1111/j.1469-8986.2012.01464.x; Worsham W, 2015, AUTISM, V19, P897, DOI 10.1177/1362361314553280	66	16	18	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	JUN	2016	53	6					814	822		10.1111/psyp.12625			9	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	DQ1CW	WOS:000378939700006	26854028				2022-02-06	
J	Loncarevic-Vasiljkovic, N; Milanovic, D; Pesic, V; Tesic, V; Brkic, M; Lazic, D; Avramovic, V; Kanazir, S				Loncarevic-Vasiljkovic, Natasa; Milanovic, Desanka; Pesic, Vesna; Tesic, Vesna; Brkic, Marjana; Lazic, Divna; Avramovic, Vladimir; Kanazir, Selma			Dietary restriction suppresses apoptotic cell death, promotes Bcl-2 and Bcl-xl mRNA expression and increases the Bcl-2/Bax protein ratio in the rat cortex after cortical injury	NEUROCHEMISTRY INTERNATIONAL			English	Article						Dietary restriction; Cortical stab injury; Neuroapoptosis; Intrinsic apoptotic pathway	TRAUMATIC BRAIN-INJURY; FOOD RESTRICTION; GENE-EXPRESSION; TRANSGENIC MICE; BAX; OVEREXPRESSION; MECHANISMS; MEMORY; DAMAGE	Traumatic brain injury (TBI) is one of the leading causes of death and disability in humans. Subsequent pathological events occurring in the brain after TBI, referred to as secondary injury, continue to damage surrounding tissue resulting in substantial neuronal loss. Using an animal model of TBI we examined the effect of dietary restriction (DR) on the neuroapoptosis and Bcl-2 family genes as the main regulators of the intrinsic apoptotic pathway. Bcl-2, Bcl-xl and Bax mRNA and protein expression in the ipsilateral cortex of adult Wistar rats exposed to DR before TBI were studied from 2 to 28 days post injury. Our results showed that DR suppressed neuroapoptosis and promoted significant upregulation of antiapoptotic Bcl-2 and Bcl-xl mRNAs in the ipsilateral cortex following injury. Expression of the proapoptotic Bax gene increased in ad libitum (AL) fed rats but remained unchanged in rats exposed to DR. Although the expression of Bcl-2, Bcl-xl and Bax proteins was changed in a similar manner in both experimental groups, DR promoted a continuous increase in the Bcl-2:Bax protein ratio throughout the recovery period. Together with our previous finding that DR mediates inhibition of the extrinsic apoptotic pathway the present work reveals that modulation of the intrinsic pathway contributes to the beneficial effect of DR in brain injury. These findings provide new insight into the effects of DR on pro-survival signaling after injury, lending further support to its neuroprotective effect. (C) 2016 Elsevier Ltd. All rights reserved.	[Loncarevic-Vasiljkovic, Natasa; Milanovic, Desanka; Pesic, Vesna; Tesic, Vesna; Brkic, Marjana; Lazic, Divna; Avramovic, Vladimir; Kanazir, Selma] Univ Belgrade, Inst Biol Res, Dept Neurobiol, Bulevor Despota Stefana 142, Belgrade 11060, Serbia		Kanazir, S (corresponding author), Univ Belgrade, Inst Biol Res, Dept Neurobiol, Bulevor Despota Stefana 142, Belgrade 11060, Serbia.	selkan@ibiss.bg.ac.rs	; Kanazir, Selma/E-5495-2015	Loncarevic-Vasiljkovic, Natasa/0000-0002-8350-1390; Kanazir, Selma/0000-0002-7229-5296; Pesic, Vesna/0000-0002-1415-5834; Avramovic, Vladimir/0000-0002-3579-837X; Tesic, Vesna/0000-0002-7247-1034	Ministry of Education, Science and Technological Development, Republic of Serbia [ON173056]; Fogarty International Research Award, NIH [R03AG046216]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG046216] Funding Source: NIH RePORTER	We would like to thank Dr Nevena Grdovic and Dr Sanja Ivkovic for the critical reading and helpful comments regarding the manuscript. This work was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia (grant ON173056) and the Fogarty International Research Award, NIH (R03AG046216).	Bar-Am O., 2005, FASEB J, V3, P252; Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Clark RSB, 1997, J NEUROSCI, V17, P9172; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Ge Y, 2004, MOL BRAIN RES, V129, P124, DOI 10.1016/j.molbrainres.2004.06.034; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Jeong MA, 2011, J NEUROTRAUM, V28, P479, DOI 10.1089/neu.2010.1609; KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Loncarevic-Vasiljkovic N, 2009, EXP NEUROL, V220, P198, DOI 10.1016/j.expneurol.2009.08.024; Manzanero Silvia, 2011, Exp Transl Stroke Med, V3, P8, DOI 10.1186/2040-7378-3-8; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Raghupathi R., 1997, J CEREB BLOOD FLOW M, V20, P421; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Renault TT, 2013, INT J BIOCHEM CELL B, V45, P64, DOI 10.1016/j.biocel.2012.09.022; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; Roberge MC, 2008, BEHAV BRAIN RES, V187, P123, DOI 10.1016/j.bbr.2007.09.002; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sharma S, 2005, BRAIN RES BULL, V67, P482, DOI 10.1016/j.brainresbull.2005.07.015; Sharma S, 2008, NEUROCHEM RES, V33, P1178, DOI 10.1007/s11064-007-9503-x; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Stumm G, 1999, FASEB J, V13, P1065, DOI 10.1096/fasebj.13.9.1065; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wiessner C, 1999, NEUROSCI LETT, V268, P119, DOI 10.1016/S0304-3940(99)00392-4; WONG H, 1994, ANAL BIOCHEM, V223, P251, DOI 10.1006/abio.1994.1581; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Zhang X., 2005, CRIT CARE, V9	35	16	16	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN	2016	96						69	76		10.1016/j.neuint.2016.02.017			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DN1DO	WOS:000376806700008	26939764				2022-02-06	
J	Mao, WF; Yi, X; Qin, JB; Tian, ML; Jin, GH				Mao, Weifeng; Yi, Xin; Qin, Jianbing; Tian, Meiling; Jin, Guohua			CXCL12/CXCR4 Axis Improves Migration of Neuroblasts Along Corpus Callosum by Stimulating MMP-2 Secretion After Traumatic Brain Injury in Rats	NEUROCHEMICAL RESEARCH			English	Article						CXCL12; CXCR4; Migration; MMP-2; Traumatic brain injury	NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; MATRIX-METALLOPROTEINASE; ADULT NEUROGENESIS; DIRECTED MIGRATION; PROGENITOR CELLS; STROKE; PROLIFERATION; INVOLVEMENT; STRIATUM	To investigate the effect of CXCL12 on migration of neural precursor cells after traumatic brain injury (TBI). We randomly divided 48 rats into four groups: (1) the sham group, rats were performed craniotomy only, (2) the control group, saline were injected into the ipsilateral cortex after TBI, (3) the CXCL12 group, CXCL12 were injected into the ipsilateral cortex after TBI, and (4) the CXCL12 + AMD3100 group, CXCL12 and AMD3100 were mixed together and injected into the ipsilateral cortex after TBI. At 7 days after TBI, the brain tissues were subjected to immunofluorescent double-labeled staining with the antibodies of CXCR4/DCX, MMP-2/DCX, MMP-2/GFAP, MMP-2/NeuN. Western blot assay was used to measure the protein levels of MMP-2. Compared with the control group, the number of CXCR4/DCX and MMP-2 positive cells around the injured corpus callosum area were significantly increased in the CXCL12 treatment group. The area occupied by these cells expanded and the shape changed from chain distribution to radial. CXCL12 + AMD3100 treatment significantly decreased the number and distribution area of CXCR4/DCX and MMP-2 positive cells compared with the CXCL12 treatment and control group. The DCX positive cells could not form chain or radial distribution. The protein expressions of MMP-2 had the similar change trends as the results of immunofluorescent staining. MMP-2 could be secreted by DCX, GFAP and NeuN positive cells. CXCL12/CXCR4 axis can improve the migration of the neuroblasts along the corpus callosum by stimulating the MMP-2 secretion of different types of cells.	[Mao, Weifeng; Yi, Xin; Qin, Jianbing; Tian, Meiling; Jin, Guohua] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Dept Anat & Neurobiol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China		Jin, GH (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Dept Anat & Neurobiol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	jguohua@163.com					Addington CP, 2014, BIOMATERIALS, V35, P3263, DOI 10.1016/j.biomaterials.2013.12.102; Anstotz M, 2014, BRAIN STRUCT FUNCT, V219, P2119, DOI 10.1007/s00429-013-0627-2; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Belmadani A, 2015, HIPPOCAMPUS, V25, P1224, DOI 10.1002/hipo.22428; Bovetti S, 2007, EUR J NEUROSCI, V25, P2021, DOI 10.1111/j.1460-9568.2007.05441.x; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Christie KJ, 2013, NEUROSCIENCE, V247, P75, DOI 10.1016/j.neuroscience.2013.05.019; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Filippo TRM, 2013, STEM CELL RES, V11, P913, DOI 10.1016/j.scr.2013.06.003; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Merino JJ, 2015, J CELL PHYSIOL, V230, P27, DOI 10.1002/jcp.24695; Kessenbrock K, 2015, MATRIX BIOL, V44-46, P184, DOI 10.1016/j.matbio.2015.01.022; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Lee SR, 2006, J NEUROSCI, V26, P3491, DOI 10.1523/JNEUROSCI.4085-05.2006; Leong SY, 2011, NEUROCHEM INT, V59, P382, DOI 10.1016/j.neuint.2010.12.024; Lewellis SW, 2012, SEMIN CELL DEV BIOL, V23, P333, DOI 10.1016/j.semcdb.2012.03.009; Machado VM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00022; Martoncikova M, 2014, CURR NEUROVASC RES, V11, P321, DOI 10.2174/1567202611666140903121253; Ozawa PMM, 2016, INT J CANCER, V138, P10, DOI 10.1002/ijc.29333; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Reaux-Le Goazigo A, 2013, PROG NEUROBIOL, V104, P67, DOI 10.1016/j.pneurobio.2013.02.001; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Saha B, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00014; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Shen XY, 2009, J HUAZHONG U SCI-MED, V29, P363, DOI 10.1007/s11596-009-0320-0; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Turbic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025406; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; Yin W, 2013, CNS NEUROSCI THER, V19, P145, DOI 10.1111/cns.12049; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	40	16	18	1	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUN	2016	41	6					1315	1322		10.1007/s11064-016-1831-2			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DM1AB	WOS:000376076300012	26801174				2022-02-06	
J	Rowell, SE; Fair, KA; Barbosa, RR; Watters, JM; Bulger, EM; Holcomb, JB; Cohen, MJ; Rahbar, MH; Fox, EE; Schreiber, MA				Rowell, Susan E.; Fair, Kelly A.; Barbosa, Ronald R.; Watters, Jennifer M.; Bulger, Eileen M.; Holcomb, John B.; Cohen, Mitchell J.; Rahbar, Mohammad H.; Fox, Erin E.; Schreiber, Martin A.		PROMMTT Study Grp	The Impact of Pre-Hospital Administration of Lactated Ringer's Solution versus Normal Saline in Patients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; clinical management of CNS injury; head trauma; traumatic brain injury	UNCONTROLLED HEMORRHAGIC-SHOCK; HYPERTONIC SALINE; FLUID RESUSCITATION; RENAL-TRANSPLANTATION; CONTROLLED-TRIAL; DOUBLE-BLIND; SWINE MODEL; MANAGEMENT; EXPERIENCE; INFUSION	Lactated Ringer's (LR) and normal saline (NS) are both used for resuscitation of injured patients. NS has been associated with increased resuscitation volume, blood loss, acidosis, and coagulopathy compared with LR. We sought to determine if pre-hospital LR is associated with improved outcome compared with NS in patients with and without traumatic brain injury (TBI). We included patients receiving pre-hospital LR or NS from the PRospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study. Patients with TBI (Abbreviated Injury Scale [AIS] head 3) and without TBI (AIS head 2) were compared. Cox proportional hazards models including Injury Severity Score (ISS), AIS head, AIS extremity, age, fluids, intubation status, and hospital site were generated for prediction of mortality. Linear regression models were generated for prediction of red blood cell (RBC) and crystalloid requirement, and admission biochemical/physiological parameters. Seven hundred ninety-one patients received either LR (n=117) or NS (n=674). Median ISS, AIS head, AIS extremity, and pre-hospital fluid volume were higher in TBI and non-TBI patients receiving LR compared with NS (p<0.01). In patients with TBI (n=308), LR was associated with higher adjusted mortality compared with NS (hazard rate [HR]=1.78, confidence interval [CI] 1.04-3.04, p=0.035). In patients without TBI (n=483), no difference in mortality was demonstrated (HR=1.49, CI 0.757-2.95, p=0.247). Fluid type had no effect on admission biochemical or physiological parameters, 6-hour RBC, or crystalloid requirement in either group. LR was associated with increased mortality compared with NS in patients with TBI. These results underscore the need for a prospective randomized trial comparing pre-hospital LR with NS in patients with TBI.	[Rowell, Susan E.; Fair, Kelly A.; Watters, Jennifer M.; Schreiber, Martin A.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Barbosa, Ronald R.] Legacy Emanuel Hosp & Hlth Ctr, Portland, OR USA; [Bulger, Eileen M.] Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA; [Holcomb, John B.; Rahbar, Mohammad H.; Fox, Erin E.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Cohen, Mitchell J.] Univ Calif San Francisco, Med Ctr, San Francisco, CA USA		Fair, KA (corresponding author), Oregon Hlth & Sci Univ, Div Trauma Crit Care & Acute Care Surg, 3181 SW Sam Jackson Pk Rd,Mail Code L611, Portland, OR 97239 USA.	fair@ohsu.edu	Rowell, Susan/S-7480-2019	holcomb, john/0000-0001-8312-9157	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-C-0712]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 RR024148]; Haemonetics Corp.; KCI USA, Inc.; Winkenwerder Co.; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024148] Funding Source: NIH RePORTER	This work was supported by subcontract W81XWH-08-C-0712 from the U.S. Army Medical Research and Materiel Command. Infrastructure for the Data Coordinating Center was supported by Clinical and Translational Science Awards funds of grant UL1 RR024148 from the National Institutes of Health.; Dr. Holcomb has served on the board for Tenaxis, the Regional Advisory Council for Trauma, and the National Trauma Institute; has provided expert testimony for the Department of Justice; and has received grants funded by Haemonetics Corp. and KCI USA, Inc. and consultant fees from The Winkenwerder Co. No additional competing financial interests exist.	Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; American College of Surgeons Committee on Trauma, 2008, ATLS ADV TRAUM LIF S; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Coimbra R, 2006, J TRAUMA, V60, P41, DOI 10.1097/01.ta.0000197417.03460.0a; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2009, J TRAUMA, V67, P389, DOI 10.1097/TA.0b013e3181a8b26f; Deree J, 2008, J TRAUMA, V64, P1230, DOI 10.1097/TA.0b013e31816a4391; Deree J, 2007, J TRAUMA, V62, P104, DOI 10.1097/TA.0b013e31802d96cb; Didwania A, 1997, CRIT CARE MED, V25, P1851, DOI 10.1097/00003246-199711000-00024; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Fox EE, 2013, J TRAUMA ACUTE CARE, V75, pS3, DOI 10.1097/TA.0b013e31828fa3a0; Healey MA, 1998, J TRAUMA, V45, P894, DOI 10.1097/00005373-199811000-00010; KAWESKI SM, 1990, J TRAUMA, V30, P1215, DOI 10.1097/00005373-199010000-00005; Khajavi MR, 2008, RENAL FAILURE, V30, P535, DOI 10.1080/08860220802064770; Kiraly LN, 2006, J TRAUMA, V61, P57, DOI 10.1097/01.ta.0000220373.29743.69; Koustova E, 2002, J TRAUMA, V52, P872, DOI 10.1097/00005373-200205000-00009; Moore FA, 2011, J TRAUMA, V70, pS15, DOI 10.1097/TA.0b013e31821a4d6e; Nolan J, 2001, RESUSCITATION, V48, P57, DOI 10.1016/S0300-9572(00)00318-X; O'Malley CMN, 2005, ANESTH ANALG, V100, P1518, DOI 10.1213/01.ANE.0000150939.28904.81; PROUGH DS, 1985, CRIT CARE MED, V13, P407, DOI 10.1097/00003246-198505000-00008; Rahbar MH, 2012, RESUSCITATION, V83, P459, DOI 10.1016/j.resuscitation.2011.09.019; Schreiber MA, 2011, J TRAUMA, V70, pS13, DOI 10.1097/TA.0b013e31821a4ba5; Shackford SR, 2011, J TRAUMA, V70, pS32, DOI 10.1097/TA.0b013e31821a5858; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Todd SR, 2007, J TRAUMA, V62, P636, DOI 10.1097/TA.0b013e31802ee521; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Watters JM, 2004, SHOCK, V22, P283, DOI 10.1097/01.shk.0000135288.54535.8a; Williams EL, 1999, ANESTH ANALG, V88, P999, DOI 10.1097/00000539-199905000-00006	31	16	18	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					1054	1059		10.1089/neu.2014.3478			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600009	26914721	Green Published			2022-02-06	
J	Thomas, DB; Newman-Toker, DE				Thomas, Dana B.; Newman-Toker, David E.			Diagnosis is a team sport - partnering with allied health professionals to reduce diagnostic errors	DIAGNOSIS			English	Article						Diagnosis; diagnostic errors; dizziness; misdiagnosis; physical therapy specialty; vertigo	PAROXYSMAL POSITIONAL VERTIGO; VESTIBULAR REHABILITATION THERAPY; EMERGENCY PHYSICIANS; PATIENT SAFETY; DIZZINESS PRESENTATIONS; DIZZY PATIENTS; INTERNATIONAL SURVEY; CLINICAL-PRACTICE; MEDICAL-STUDENTS; SYMPTOM QUALITY	Background: Diagnostic errors are the most common, most costly, and most catastrophic of medical errors. Interdisciplinary teamwork has been shown to reduce harm from therapeutic errors, but sociocultural barriers may impact the engagement of allied health professionals (AHPs) in the diagnostic process. Methods: A qualitative case study of the experience at a single institution around involvement of an AHP in the diagnostic process for acute dizziness and vertigo. We detail five diagnostic error cases in which the input of a physical therapist was central to correct diagnosis. We further describe evolution of the sociocultural milieu at the institution as relates to AHP engagement in diagnosis. Results: Five patients with acute vestibular symptoms were initially misdiagnosed by physicians and then correctly diagnosed based on input from a vestibular physical therapist. These included missed labyrinthine concussion and post-traumatic benign paroxysmal positional vertigo (BPPV); BPPV called gastroenteritis; BPPV called stroke; stroke called BPPV; and multiple sclerosis called BPPV. As a consequence of surfacing these diagnostic errors, initial resistance to physical therapy input to aid medical diagnosis has gradually declined, creating a more collaborative environment for 'team diagnosis' of patients with dizziness and vertigo at the institution. Conclusions: Barriers to AHP engagement in 'team diagnosis' include sociocultural norms that establish medical diagnosis as something reserved only for physicians. Drawing attention to the valuable diagnostic contributions of AHPs may help facilitate cultural change. Future studies should seek to measure diagnostic safety culture and then implement proven strategies to breakdown sociocultural barriers that inhibit effective teamwork and transdisciplinary diagnosis.	[Newman-Toker, David E.] Johns Hopkins Univ, Sch Med, Dept Neurol & Otolaryngol, CRB-2,Room 2M-03 North 1550 Orleans St, Baltimore, MD 21231 USA; [Thomas, Dana B.] WakeMed Hlth & Hosp, Raleigh Campus, Raleigh, NC USA		Newman-Toker, DE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol & Otolaryngol, CRB-2,Room 2M-03 North 1550 Orleans St, Baltimore, MD 21231 USA.	toker@jhu.edu					[Anonymous], 2015, PROFESSIONAL ED C TR; [Anonymous], 2000, AUDIOLOGIC GUIDELINE; [Anonymous], 2015, **NON-TRADITIONAL**, DOI DOI 10.17226/21794; Bashir K, 2015, EMERG MED AUSTRALAS, V27, P179, DOI 10.1111/1742-6723.12362; Benbassat J, 2012, ACTA OPHTHALMOL, V90, P503, DOI 10.1111/j.1755-3768.2011.02221.x; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Bruce BB, 2011, NEW ENGL J MED, V364, P387, DOI 10.1056/NEJMc1009733; Cohen HS, 2011, J VESTIBUL RES-EQUIL, V21, P243, DOI 10.3233/VES-2011-0424; Cohen HS, 2009, J VESTIBUL RES-EQUIL, V19, P15, DOI 10.3233/VES-2009-0339; Cohen HS, 2004, OTOL NEUROTOL, V25, P130, DOI 10.1097/00129492-200403000-00008; Dixon-Woods M, 2011, MILBANK Q, V89, P167, DOI 10.1111/j.1468-0009.2011.00625.x; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Fife TD, 2008, NEUROLOGY, V70, P2067, DOI 10.1212/01.wnl.0000313378.77444.ac; Geser Rebekka, 2012, Front Neurol, V3, P169, DOI 10.3389/fneur.2012.00169; Hautz WE, 2015, JAMA-J AM MED ASSOC, V313, P303, DOI 10.1001/jama.2014.15770; HERDMAN SJ, 1990, PHYS THER, V70, P381, DOI 10.1093/ptj/70.6.381; Herdman SJ, 1997, PHYS THER, V77, P602, DOI 10.1093/ptj/77.6.602; Kattah JC, 2009, STROKE, V40, P3504, DOI 10.1161/STROKEAHA.109.551234; Kerber KA, 2006, STROKE, V37, P2484, DOI 10.1161/01.STR.0000240329.48263.0d; Kerber KA, 2015, NEUROL CLIN, V33, P565, DOI 10.1016/j.ncl.2015.04.009; Kerber KA, 2013, OTOLARYNG HEAD NECK, V148, P425, DOI 10.1177/0194599812471633; Kerber KA, 2011, ACAD EMERG MED, V18, P619, DOI 10.1111/j.1553-2712.2011.01093.x; Kreda SH., 2009, DIAGNOSIS MANAGEMENT; Manser T, 2009, ACTA ANAESTH SCAND, V53, P143, DOI 10.1111/j.1399-6576.2008.01717.x; McDonald KM, 2014, DIAGNOSIS, V1, P55, DOI 10.1515/dx-2013-0023; McDonald KM, 2013, ANN INTERN MED, V158, P381, DOI 10.7326/0003-4819-158-5-201303051-00004; Morrison R, 2006, J VASC NURS, V24, P82, DOI 10.1016/j.jvn.2006.05.002; Nemr NK, 2013, CODAS, V25, P297, DOI 10.1590/S2317-17822013000300017; Newman-Toker DE, 2008, ACTA OTO-LARYNGOL, V128, P601, DOI 10.1080/00016480701596096; Newman-Toker DE, 2007, ANN EMERG MED, V50, P204, DOI 10.1016/j.annemergmed.2007.03.037; Newman-Toker DE, 2016, ANN NEUROL, V79, P27, DOI 10.1002/ana.24532; Newman-Toker DE, 2015, SEMIN NEUROL, V35, P506, DOI 10.1055/s-0035-1564298; Newman-Toker DE, 2015, NEUROL CLIN, V33, P577, DOI 10.1016/j.ncl.2015.04.011; Newman-Toker DE, 2014, DIAGNOSIS, V1, P155, DOI 10.1515/dx-2013-0038; Newman-Toker DE, 2014, ACAD EMERG MED, V21, P348, DOI 10.1111/acem.12338; Newman-Toker DE, 2013, ACAD EMERG MED, V20, P986, DOI 10.1111/acem.12223; Newman-Toker DE, 2009, ACAD EMERG MED, V16, P970, DOI 10.1111/j.1553-2712.2009.00523.x; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Newman-Toker DE., 2015, MOD HEALTHC ANN PAT; Romig Mark, 2010, Hosp Pract (1995), V38, P114, DOI 10.3810/hp.2010.11.348; Royl G, 2011, EUR NEUROL, V66, P256, DOI 10.1159/000331046; Sakr M, 1999, LANCET, V354, P1321, DOI 10.1016/S0140-6736(99)02447-2; Savitz SI, 2007, ACAD EMERG MED, V14, P63, DOI 10.1197/j.aem.2006.06.060; Schiff GD, 2005, DIAGNOSING DIAGNOSIS, P255; Singh H, 2014, BMJ QUAL SAF, V23, P727, DOI 10.1136/bmjqs-2013-002627; SLOANE PD, 1989, J FAM PRACTICE, V29, P33; Stanton VA, 2007, MAYO CLIN PROC, V82, P1319, DOI 10.4065/82.11.1319; STEMBER M, 1991, SOC SCI J, V28, P1, DOI 10.1016/0362-3319(91)90040-B; Tarnutzer AA, 2011, CAN MED ASSOC J, V183, P1025, DOI 10.1503/cmaj.100174; Tehrani ASS, 2013, ACAD EMERG MED, V20, P689, DOI 10.1111/acem.12168; Tehrani ASS, 2013, BMJ QUAL SAF, V22, P672, DOI 10.1136/bmjqs-2012-001550; Yassa L, 2007, CANCER CYTOPATHOL, V111, P508, DOI 10.1002/cncr.23116	52	16	16	1	10	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	2194-8011	2194-802X		DIAGNOSIS	Diagnosis	JUN	2016	3	2					49	59		10.1515/dx-2016-0009			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	DN7FU	WOS:000377241500003	29536891	Green Accepted			2022-02-06	
J	Tobinick, EL				Tobinick, Edward Lewis			Perispinal Delivery of CNS Drugs	CNS DRUGS			English	Article							NECROSIS-FACTOR-ALPHA; TRANSFORAMINAL EPIDURAL ETANERCEPT; DYSFUNCTION SCIENTIFIC RATIONALE; VERTEBRAL VENOUS PLEXUS; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; TNF-ALPHA; SUBARACHNOID HEMORRHAGE; NEUROLOGICAL RECOVERY; TARGETED ETANERCEPT	Perispinal injection is a novel emerging method of drug delivery to the central nervous system (CNS). Physiological barriers prevent macromolecules from efficiently penetrating into the CNS after systemic administration. Perispinal injection is designed to use the cerebrospinal venous system (CSVS) to enhance delivery of drugs to the CNS. It delivers a substance into the anatomic area posterior to the ligamentum flavum, an anatomic region drained by the external vertebral venous plexus (EVVP), a division of the CSVS. Blood within the EVVP communicates with the deeper venous plexuses of the CSVS. The anatomical basis for this method originates in the detailed studies of the CSVS published in 1819 by the French anatomist Gilbert Breschet. By the turn of the century, Breschet's findings were nearly forgotten, until rediscovered by American anatomist Oscar Batson in 1940. Batson confirmed the unique, linear, bidirectional and retrograde flow of blood between the spinal and cerebral divisions of the CSVS, made possible by the absence of venous valves. Recently, additional supporting evidence was discovered in the publications of American neurologist Corning. Analysis suggests that Corning's famous first use of cocaine for spinal anesthesia in 1885 was in fact based on Breschet's anatomical findings, and accomplished by perispinal injection. The therapeutic potential of perispinal injection for CNS disorders is highlighted by the rapid neurological improvement in patients with otherwise intractable neuroinflammatory disorders that may ensue following perispinal etanercept administration. Perispinal delivery merits intense investigation as a new method of enhanced delivery of macromolecules to the CNS and related structures.	[Tobinick, Edward Lewis] Inst Neurol Recovery, 2300 Glades Rd,Suite 305E, Boca Raton, FL 33431 USA		Tobinick, EL (corresponding author), Inst Neurol Recovery, 2300 Glades Rd,Suite 305E, Boca Raton, FL 33431 USA.	nrimed@gmail.com		Tobinick, Edward/0000-0001-7614-499X			ANDERSON R, 1951, J NEUROSURG, V8, P411, DOI 10.3171/jns.1951.8.4.0411; Andral M, 1845, DISCOURS PRONONCES O; [Anonymous], 1886, VA MED MONTH, V12, P713; [Anonymous], 2008, NAT CLIN PRACT NEURO, V4, P181; Arango-Davila CA, 2015, INT J NEUROSCI, V125, P936, DOI 10.3109/00207454.2014.980906; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Banks WA, 2016, NAT REV DRUG DISCOV, V15, P275, DOI 10.1038/nrd.2015.21; Barami K, 2016, CHILD NERV SYST, V32, P599, DOI 10.1007/s00381-015-3010-1; Bassi E, 2010, AM J CLIN DERMATOL, V11, P44, DOI 10.2165/1153423-S0-000000000-00000; Batson OV, 1940, ANN SURG, V112, P138, DOI 10.1097/00000658-194007000-00016; BATSON OV, 1957, AMER J ROENTGENOL RA, V78, P195; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Biceroglu H, 2012, J NEUROSURG-SPINE, V16, P394, DOI 10.3171/2011.12.SPINE11108; Bier A., 1899, DTSCH ZSCH CHIR, V51, P361; Boivin N, 2013, ANTIVIR RES, V100, P649, DOI 10.1016/j.antiviral.2013.10.007; Breschet G, 1819, THESIS; Breschet G., 1829, RECHERCHES ANATOMIQU; Breschet M, 1845, LANCET, V2, P188; BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059; Brown DL, 1998, NEURAL BLOCKADE CLIN, P3; Byrod G, 2000, J PERIPHER NERV SYST, V5, P218, DOI 10.1046/j.1529-8027.2000.00023.x; Cheng X, 2014, DRUG DISCOV TODAY, V19, P1822, DOI 10.1016/j.drudis.2014.06.029; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Clark I, 2012, CNS DRUGS, V26, P1071, DOI 10.1007/s40263-012-0014-1; Clark IA, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/358263; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Clausen BH, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0203-6; Cohen SP, 2009, ANESTHESIOLOGY, V110, P1116, DOI 10.1097/ALN.0b013e3181a05aa0; Corning J.L., 1885, NY MED J, V42, P483; Corning JL, 1894, PAIN ITS NEUROPATHOL; Corning JL, 1886, BOSTON MED SURG J, V115, P541; Corning JL, 1886, LOCAL ANAESTHESIA GE; Corning JL, 1897, REFERENCE BOOK PRACT; Corning JL, 1885, NY MED J, V42, P317; Corning JL, 1888, T MED SOC STATE N Y, P260; Corning JL, 1888, MED REC, V33, P291; Corning Sr JL, 1898, RECOLLECTIONS LIFE; COUSINS MJ, 1984, ANESTHESIOLOGY, V61, P276; Cruveilhier J, 1844, ANATOMY HUMAN BODY 1; EPSTEIN HM, 1970, ANESTHESIOLOGY, V32, P332, DOI 10.1097/00000542-197004000-00007; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Feng P, 2015, BRAIN BEHAV IMMUN, V49, P32, DOI 10.1016/j.bbi.2015.04.001; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Freeman BJC, 2013, SPINE, V38, P1986, DOI 10.1097/01.brs.0000435140.61593.4c; Freud S, 1884, CENTRALBLATT GESMATE, V2, P289; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Gray H, 1878, ANATOMY DESCRIPTIVE; Gray H., 1858, ANATOMY DESCRIPTIVE; Greig NH, 1995, NEW CONCEPTS OF A BLOOD-BRAIN BARRIER, P251; Griessenauer CJ, 2015, CLIN ANAT, V28, P75, DOI 10.1002/ca.22354; Griffin WST, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-3; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; HERLIHY W F, 1947, Med J Aust, V1, P661; Huard P, 2008, COMPLETE DICT SCI BI; Ignatowski TA, 2014, CNS DRUGS, V28, P1207, DOI 10.1007/s40263-014-0212-0; Ignatowski TA, 2014, CNS DRUGS, V28, P679, DOI 10.1007/s40263-014-0174-2; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Iwata N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/189292; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Johanson CE, 2005, PHARM RES-DORDR, V22, P1011, DOI 10.1007/s11095-005-6039-0; Koller, 1884, LANCET, V124, P990, DOI 10.1016/S0140-6736(02)28859-5; KOTANI J, 1993, J NEUROSURG ANESTH, V5, P121; Lei BL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-103; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Luo C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.63; Marchand F, 2009, EUR J PAIN, V13, P673, DOI 10.1016/j.ejpain.2008.08.001; Marcus L, 1900, MED REC, V58, P561; MAX MB, 1985, CLIN PHARMACOL THER, V38, P631, DOI 10.1038/clpt.1985.237; Moes P, 1981, Arch Anat Histol Embryol, V64, P5; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Nathoo N, 2011, NEUROSURGERY, V69, P1007, DOI 10.1227/NEU.0b013e3182274865; Netter FH, 2013, NETTER COLLECTION ME, V7, P54; Ohtori S, 2012, SPINE, V37, P439, DOI 10.1097/BRS.0b013e318238af83; Parkinson D, 2000, SURG NEUROL, V54, P422, DOI 10.1016/S0090-3019(00)00342-6; Parkinson D, 2000, NEUROSURG FOCUS, V8; Perez-Polo JR, 2016, J NEUROSCI RES, V94, P27, DOI 10.1002/jnr.23617; Puri AS, 2013, J NEUROINTERV SURG; Quain J, 1878, QUAINS ELEMENTS ANAT, VII; Quain J, 1867, ELEMENTS ANATOMY; RIESELBACH RE, 1962, NEW ENGL J MED, V267, P1273, DOI 10.1056/NEJM196212202672502; Roh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040065; Rubenstein JL, 2003, BLOOD, V101, P466, DOI 10.1182/blood-2002-06-1636; Sainoh T, 2016, PAIN MED, V17, P40, DOI 10.1111/pme.12892; Shen CH, 2011, ANESTH ANALG, V112, P454, DOI 10.1213/ANE.0b013e3182025b15; Shi XL, 2013, CRIT CARE, V17, DOI 10.1186/cc13171; Siniscalchi A, 2016, CURR VASC PHARMACOL, V14, P98, DOI 10.2174/1570161113666150923111329; Siniscalchi Antonio, 2014, Journal of Basic and Clinical Physiology and Pharmacology, V25, P131, DOI 10.1515/jbcpp-2013-0121; Standring S., 2016, GRAYS ANATOMY ANATOM, V41st Edn; Stringer MD, 2012, CLIN ANAT, V25, P609, DOI 10.1002/ca.21281; Strong C, 2013, J CLIN NEUROSCI, V20, P1546, DOI 10.1016/j.jocn.2013.02.014; Tobinick E, 2004, CURR MED RES OPIN, V20, P1075, DOI 10.1185/030079903125004286; Tobinick E, 2002, US patent, Patent No. [6,419,944, 6419944]; Tobinick E, 2007, CURR ALZHEIMER RES, V4, P550, DOI 10.2174/156720507783018217; Tobinick Edward, 2006, MedGenMed, V8, P25; Tobinick Edward, 2006, MedGenMed, V8, P53; Tobinick E, 2014, CLIN DRUG INVEST, V34, P361, DOI 10.1007/s40261-014-0186-1; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tobinick E, 2012, CURR ALZHEIMER RES, V9, P99, DOI 10.2174/156720512799015073; Tobinick E, 2011, CNS DRUGS, V25, P145, DOI 10.2165/11588400-000000000-00000; Tobinick E, 2010, EXPERT REV NEUROTHER, V10, P985, DOI 10.1586/ERN.10.52; Tobinick E, 2009, CNS DRUGS, V23, P713, DOI 10.2165/11310810-000000000-00000; Tobinick Edward, 2008, Medscape J Med, V10, P135; Tobinick E, 2009, DRUG DISCOV TODAY, V14, P168, DOI 10.1016/j.drudis.2008.10.005; Tobinick EL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-27; Tobinick EL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-2; Tobinick Edward L, 2009, BMC Res Notes, V2, P28; Tobinick EL, 2003, CLIN THER, V25, P2279, DOI 10.1016/S0149-2918(03)80219-9; Tobinick EL, 2003, SWISS MED WKLY, V133, P170; Tobinick EL, 2003, CLIN THER, V25, P1211, DOI 10.1016/S0149-2918(03)80077-2; Todd RB, 1852, CYCLOPEDIA ANATOMY P; Todd RB, 1847, CYCLOPAEDIA ANATOMY; Tsutsumi S, 2015, J ANAT, V227, P297, DOI 10.1111/joa.12349; Tubbs RS, 2007, CLIN ANAT, V20, P755, DOI 10.1002/ca.20494; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Vallejo MC, 2006, ANESTH ANALG, V102, P973, DOI 10.1213/01.ANE.0000199174.30944.B4; Wallace M, 2000, REGION ANESTH PAIN M, V25, P117; Watanabe K, 2011, EUR SPINE J, V20, P1877, DOI 10.1007/s00586-011-1854-y; WEN TS, 1994, J APPL PHYSIOL, V77, P1081, DOI 10.1152/jappl.1994.77.3.1081; Winkelstein BA, 2014, INTERVERTEBRAL DISC; Wu MH, 2015, MOL NEUROBIOL, DOI [10.1007/s12035-105-9418-5, DOI 10.1007/S12035-105-9418-5]; Wulf HFW, 1998, ANESTHESIOLOGY, V89, P500, DOI 10.1097/00000542-199808000-00028; Wyeth JA, 1902, N Y STATE J MED, V2, P17; Yagi K, 2015, STROKE, V46, P2260, DOI 10.1161/STROKEAHA.114.006365; Ye J, 2014, J INFECT DIS, V210, P875, DOI 10.1093/infdis/jiu179; Zhang BF, 2015, NEUROCHEM RES, V40, P591, DOI 10.1007/s11064-014-1506-9	127	16	16	0	6	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1172-7047	1179-1934		CNS DRUGS	CNS Drugs	JUN	2016	30	6					469	480		10.1007/s40263-016-0339-2			12	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	DQ8TW	WOS:000379485000001	27120182	Green Published			2022-02-06	
J	Li, L; Sun, G; Liu, K; Li, M; Li, B; Qian, SW; Yu, LL				Li, Li; Sun, Gang; Liu, Kai; Li, Min; Li, Bo; Qian, Shao-Wen; Yu, Li-Li			White Matter Changes in Posttraumatic Stress Disorder Following Mild Traumatic Brain Injury: A Prospective Longitudinal Diffusion Tensor Imaging Study	CHINESE MEDICAL JOURNAL			English	Article						Diffusion Tensor Imaging; Mild Traumatic Brain Injury; Posttraumatic Stress Disorder; Tract-based Spatial Statistics	VOXELWISE ANALYSIS; PTSD; INTEGRITY	Background: The ability to predict posttraumatic stress disorder (PTSD) is a critical issue in the management of patients with mild traumatic brain injury (mTBI), as early medical and rehabilitative interventions may reduce the risks of long-term cognitive changes. The aim of the present study was to investigate how diffusion tensor imaging (DTI) metrics changed in the transition from acute to chronic phases in patients with mTBI and whether the alteration relates to the development of PTSD. Methods: Forty-three patients with mTBI and 22 healthy volunteers were investigated. The patients were divided into two groups: successful recovery (SR, n = 22) and poor recovery (PR, n = 21), based on neurocognitive evaluation at 1 or 6 months after injury. All patients underwent magnetic resonance imaging investigation at acute (within 3 days), subacute (10-20 days), and chronic (1-6 months) phases after injury. Group differences of fractional anisotropy (FA) and mean diffusivity (MD) were analyzed using tract-based spatial statistics (TBSS). The accuracy of DTI metrics for classifying PTSD was estimated using Bayesian discrimination analysis. Results: TBSS showed white matter (WM) abnormalities in various brain regions. In the acute phase, FA values were higher for PR and SR patients than controls (all P < 0.05). In subacute phase, PR patients have higher mean MD than SR and controls (all P < 0.05). In the chronic phase, lower FA and higher MD were observed in PR compared with both SR and control groups (all P < 0.05). PR and SR groups could be discriminated with a sensitivity of 73%, specificity of 78%, and accuracy of 75.56%, in terms of MD value in subacute phase. Conclusions: Patients with mTBI have multiple abnormalities in various WM regions. DTI metrics change over time and provide a potential indicator at subacute stage for PTSD following mTBI.	[Li, Li] Second Mil Med Univ, Inst Postgrad, Shanghai 200032, Peoples R China; [Li, Li; Sun, Gang; Liu, Kai; Li, Min; Li, Bo; Qian, Shao-Wen] Jinan Mil Gen Hosp, Dept Med Imaging, Jinan 250031, Shandong, Peoples R China; [Yu, Li-Li] Jinan Mil Gen Hosp, Dept Stat, Jinan 250031, Shandong, Peoples R China		Sun, G (corresponding author), Jinan Mil Gen Hosp, Dept Med Imaging, Jinan 250031, Shandong, Peoples R China.	cjr.sungang@vip.163.com		Li, Min/0000-0002-7649-3900	Jinan Military General Hospital [2014MS07]	This work was supported by a grant from the Jinan Military General Hospital (No. 2014MS07).	Abrams TE, 2013, RADIOLOGY, V267, P470, DOI 10.1148/radiol.13121593; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Podoll K, 2000, FORTSCHR NEUROL PSYC, V68, P458, DOI 10.1055/s-2000-7736; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Zhong Y, 2015, ACTA RADIOL, V56, P746, DOI 10.1177/0284185114537927	32	16	19	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0366-6999	2542-5641		CHINESE MED J-PEKING	Chin. Med. J.	MAY 5	2016	129	9					1091	1099		10.4103/0366-6999.180518			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK6CU	WOS:000375009800015	27098796	gold, Green Published			2022-02-06	
J	Alway, Y; Gould, KR; McKay, A; Johnston, L; Ponsford, J				Alway, Yvette; Gould, Kate Rachel; McKay, Adam; Johnston, Lisa; Ponsford, Jennie			The Evolution of Post-Traumatic Stress Disorder following Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						anxiety disorder; post-traumatic stress disorder; psychiatric disorder; traumatic brain injury	PSYCHIATRIC-DISORDERS; HEAD-INJURY; SELF-REPORT; AXIS I; PTSD; DEPRESSION; SYMPTOMS; COMORBIDITY; POPULATION; PREVALENCE	Increasing evidence indicates that post-traumatic stress disorder (PTSD) may develop following traumatic brain injury (TBI), despite most patients having no conscious memory of their accident. This prospective study examined the frequency, timing of onset, symptom profile, and trajectory of PTSD and its psychiatric comorbidities during the first 4 years following moderate-to-severe TBI. Participants were 85 individuals (78.8% male) with moderate or severe TBI recruited following admission to acute rehabilitation between 2005 and 2010. Using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Disorders (SCID-I), participants were evaluated for pre- and post-injury PTSD soon after injury and reassessed at 6 months, 12 months, 2 years, 3 years, and 4 years postinjury. Over the first 4 years post-injury, 17.6% developed injury-related PTSD, none of whom had PTSD prior to injury. PTSD onset peaked between 6 and 12 months post-injury. The majority of PTSD cases (66.7%) had a delayed-onset, which for a third was preceded by subsyndromal symptoms in the first 6 months post-injury. PTSD frequency increased over the first year post-injury, remained stable during the second year, and gradually declined thereafter. The majority of subjects with PTSD experienced a chronic symptom course and all developed one or more than one comorbid psychiatric disorder, with mood, other anxiety, and substance-use disorders being the most common. Despite event-related amnesia, post-traumatic stress symptoms, including vivid re-experiencing phenomena, may develop following moderate-to-severe TBI. Onset is typically delayed and symptoms may persist for several years post-injury.	[Alway, Yvette; Gould, Kate Rachel; McKay, Adam; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Alway, Yvette; Gould, Kate Rachel; McKay, Adam; Johnston, Lisa; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Gould, Kate Rachel; Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Alway, Y (corresponding author), Monash Univ, Sch Psychol Sci, Clayton Campus, Clayton, Vic 3800, Australia.	yvette.alway@monash.edu	Gould, Kate Rachel/AAA-5511-2020; McKay, Adam/M-6003-2017	Gould, Kate Rachel/0000-0002-3564-7408; McKay, Adam/0000-0002-0479-7681			Alway Y., 2015, ANXIETY; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Barker-Collo S, 2013, BRAIN IMPAIR, V14, P425, DOI 10.1017/BrImp.2013.27; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Breslau N, 2000, BIOL PSYCHIAT, V48, P902, DOI 10.1016/S0006-3223(00)00933-1; Breslau N, 2008, ARCH GEN PSYCHIAT, V65, P431, DOI 10.1001/archpsyc.65.4.431; Brewin CR, 2001, BEHAV RES THER, V39, P373, DOI 10.1016/S0005-7967(00)00087-5; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2002, AUST NZ J PSYCHIAT, V36, P205, DOI 10.1046/j.1440-1614.2002.01009.x; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carty J, 2006, J AFFECT DISORDERS, V90, P257, DOI 10.1016/j.jad.2005.11.011; Chalton LD, 2009, BRAIN INJURY, V23, P77, DOI 10.1080/02699050802635273; Chapman C, 2012, PSYCHOL MED, V42, P1695, DOI 10.1017/S0033291711002856; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Edmondson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066435; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Forbes D, 2010, J AFFECT DISORDERS, V127, P147, DOI 10.1016/j.jad.2010.05.005; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; Johnson SD, 2002, COMMUNITY MENT HLT J, V38, P181, DOI 10.1023/A:1015269521969; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; Mylle J, 2004, J AFFECT DISORDERS, V78, P37, DOI 10.1016/S0165-0327(02)00218-5; O'Donnell ML, 2013, PSYCHOSOM MED, V75, P68, DOI 10.1097/PSM.0b013e3182761e8b; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Pietrzak RH, 2011, J ANXIETY DISORD, V25, P456, DOI 10.1016/j.janxdis.2010.11.010; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Reid LM, 2011, J NEUROPSYCH CLIN N, V23, P454, DOI 10.1176/jnp.23.4.jnp454; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Smid GE, 2009, J CLIN PSYCHIAT, V70, P1572, DOI 10.4088/JCP.08r04484; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861	59	16	16	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					825	831		10.1089/neu.2015.3992			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800004	26176500				2022-02-06	
J	Azouvi, P; Vallat-Azouvi, C; Joseph, PA; Meulemans, T; Bertola, C; Le Gall, D; Bellmann, A; Roussel, M; Coyette, F; Krier, M; Franconie, C; Bindschadler, C; Diouf, M; Godefroy, O				Azouvi, Philippe; Vallat-Azouvi, Claire; Joseph, Pierre-Alain; Meulemans, Thierry; Bertola, Celine; Le Gall, Didier; Bellmann, Anne; Roussel, Martine; Coyette, Francoise; Krier, Marianne; Franconie, Catherine; Bindschadler, Claire; Diouf, Momar; Godefroy, Olivier		GREFEX Study Grp Grp Reflexion	Executive Functions Deficits After Severe Traumatic Brain Injury: The GREFEX Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; behavior; cognition; executive functions; rehabilitation; traumatic brain injury	CLOSED-HEAD INJURY; DYSEXECUTIVE SYNDROME; ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; DIVIDED ATTENTION; WORKING-MEMORY; NORMATIVE DATA; REHABILITATION; DYSFUNCTION; COMA	Objective: To assess the sensitivity of traditional neuropsychological tests and of a behavioral inventory of executive disorders in a large sample of patients with chronic severe traumatic brain injury. Methods: A total of 112 patients were compared with 780 healthy controls from a larger database. The GREFEX battery included 7 widely used tests and the Behavioral Dysexecutive Syndrome Inventory (proxy rating). A previously described statistical methodology was used, controlling for age, education, and gender. Summary scores were computed and performance was dichotomized on the basis of 5th percentile cutoffs from controls' z scores. Results: The frequency of cognitive impairment was high (55.4%) but lower than that of behavioral changes (81.5%). Double dissociations were observed between cognitive and behavioral assessments. Behavioral changes exhibited larger effect-sizes as compared with cognitive impairments. Logistic regression analysis showed that 3 cognitive tests (verbal fluency, Stroop reading, and Trail Making Test-B) and 3 behavior z scores (hypoactivity, anticipation, and hyperactivity) best discriminated patients from controls. Conclusion: Behavioral changes were more frequent and severe than cognitive deficits, at least as assessed with traditional testing. The present results also suggest that a shortened battery may provide a rapid screening method with reasonable sensitivity to detect deficits of executive functions in patients with severe traumatic brain injury.	[Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Azouvi, Philippe; Vallat-Azouvi, Claire] Univ Versailles St Quentin, EA HANDIReSP 4047, Garches, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, UGECAMIDF, Antenne UEROS & SAMSAH92, Garches, France; [Joseph, Pierre-Alain] Univ Bordeaux, EA 4136, Liege, Belgium; [Meulemans, Thierry] Univ Liege, Neuropsychol Unit, Liege, Belgium; [Bertola, Celine] Fdn Hopale, CRF Calve, Berck Sur Mer, France; [Le Gall, Didier] CHU, EA 4638, LPPL, Angers, France; [Le Gall, Didier] CHU, Unite Neuropsychol, Angers, France; [Le Gall, Didier] Univ Angers, Angers, France; [Bellmann, Anne] Clin Romande Readaptat, Sion, Switzerland; [Roussel, Martine; Godefroy, Olivier] Univ Hosp Amiens, Dept Neurol, Amiens, France; [Roussel, Martine; Godefroy, Olivier] Univ Hosp Amiens, Lab Funct Neurosci, EA 4559, Amiens, France; [Coyette, Francoise] St Luc Univ, Hosp Bruxelles, Brussels, Belgium; [Krier, Marianne] Inst Reg Med Phys & Readaptat, Nancy, France; [Franconie, Catherine] Univ Hosp, Nimes, France; [Bindschadler, Claire] Univ Lausanne Hosp, Lausanne, Switzerland; [Diouf, Momar] Univ Hosp Amiens, Dept Biostat, Amiens, France		Azouvi, P (corresponding author), Hop Raymond Poincare, Dept Phys Med & Rehabil, F-92380 Garches, France.	philippe.azouvi@rpc.aphp.fr		Godefroy, Olivier/0000-0001-6789-6620			Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Cazalis F, 2001, J INT NEUROPSYCH SOC, V7, P795, DOI 10.1017/S1355617701777028; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Crawford JR, 2008, CHILD NEUROPSYCHOL, V14, P99, DOI 10.1080/09297040801894709; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Glantz S, 2000, PRIMER APPL REGRESSI; Godefroy O, 2014, J ALZHEIMERS DIS, V42, P1203, DOI 10.3233/JAD-140585; Godefroy O, 2014, CORTEX, V54, P51, DOI 10.1016/j.cortex.2014.01.016; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robertson I, 1996, PHILOS T ROY SOC B, V351, P1411; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; TEASDALE G, 1974, LANCET, V2, P81; Tressoldi PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056180; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wang Y., 2014, UNDERSTANDING TRAUMA, P99; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058	65	16	16	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2016	31	3					E10	E20		10.1097/HTR.0000000000000169			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FK	WOS:000379787800002	26394296				2022-02-06	
J	Bouvier, D; Duret, T; Rouzaire, P; Jabaudon, M; Rouzaire, M; Nourrisson, C; Bourgne, C; Pereira, B; Evrard, B; Sapin, V				Bouvier, Damien; Duret, Thomas; Rouzaire, Paul; Jabaudon, Matthieu; Rouzaire, Marion; Nourrisson, Celine; Bourgne, Celine; Pereira, Bruno; Evrard, Bertrand; Sapin, Vincent			Preanalytical, analytical, gestational and pediatric aspects of the S100B immuno-assays	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						children; lymphocyte; pregnancy; reference ranges; S100B	MINOR HEAD-INJURY; REFERENCE RANGES; PROTEIN; SERUM; S-100B; BLOOD; DELIVERY	Background: Traumatic brain injury management is a tricky issue in children and pregnant women (due to adverse effects of computer tomography). To facilitate management, we report the main analytical performances and reference ranges for blood tests for the well-established S100B biomarker in under-16 children on a DiaSorin (R) Liaison XL analyzer and in pregnant women on DiaSorin (R) Liaison XL and Roche Diagnostics (R) Cobas e411 analyzers. Methods: Serum S100B concentrations were determined by chemiluminescent immunoassay on a DiaSorin (R) analyzer in a population of 409 healthy children aged 0-16 years and on DiaSorin (R)/Roche Diagnostics (R) instruments in a population of 50 pregnant women (one blood sample for each trimester). The analytical performances of both instruments and the influence of blood cells and skin pigmentation on the assay were also studied. Results: For children, four age-groups emerged, i.e. 0-3 months (mean: 0.97 mu g/L; standard deviation (SD): 0.36; 95th percentile: 1.55), 4-9 months (mean: 0.58 mu g/L; SD: 0.30; 95th: 1.18), 10-24 months (mean: 0.31 mu g/L; SD: 0.12; 95th: 0.54) and 2-16 years (mean: 0.20 mu g/L; SD: 0.07; 95th: 0.32). For pregnant women, serum S100B concentrations were similar to defined ranges for adults and not significantly different between trimesters on DiaSorin (R) (p = 0.652)/Roche Diagnostics (R) (p = 0.877) analyzers. We also found S100B expression (protein, total mRNA) in lymphocytes, an influence of skin pigmentation, and good analytical performances for both instruments. Conclusions: Data provided here is useful for interpreting serum S100B test results, in terms of preanalytical conditions, analytical performances, pediatric and pregnancy' environment.	[Sapin, Vincent] Fac Med, Lab Biochim Med, 4R3,28 Pl Henri Dunant,BP38, F-63001 Clermont Ferrand, France; [Bouvier, Damien; Duret, Thomas; Sapin, Vincent] CHU Clermont Ferrand, Biochem & Mol Biol Dept, Clermont Ferrand, France; [Bouvier, Damien; Jabaudon, Matthieu; Rouzaire, Marion; Sapin, Vincent] Univ Auvergne, Clermont Univ, EA7281, Retinoids,Reprod,Dev Dis,Fac Med, Clermont Ferrand, France; [Rouzaire, Paul; Evrard, Bertrand] CHU Clermont Ferrand, Dept Immunol, Clermont Ferrand, France; [Nourrisson, Celine] CHU Clermont Ferrand, Parasitol & Mycol Dept, Clermont Ferrand, France; [Bourgne, Celine] CHU Clermont Ferrand, Hematol Biol Dept, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Biostat Dept DRCI, Clermont Ferrand, France		Sapin, V (corresponding author), Fac Med, Lab Biochim Med, 4R3,28 Pl Henri Dunant,BP38, F-63001 Clermont Ferrand, France.; Sapin, V (corresponding author), CHU Clermont Ferrand, Biochem & Mol Biol Dept, Clermont Ferrand, France.; Sapin, V (corresponding author), Univ Auvergne, Clermont Univ, EA7281, Retinoids,Reprod,Dev Dis,Fac Med, Clermont Ferrand, France.	vincent.sapin@udamail.fr	Nourrisson, Celine/AAC-1527-2019	Nourrisson, Celine/0000-0002-4003-805X; Bouvier, Damien/0000-0002-2707-4320; Pereira, Bruno/0000-0003-3778-7161			Amer-Wahlin I, 2001, CLIN CHIM ACTA, V304, P57, DOI 10.1016/S0009-8981(00)00408-3; Beaudeux JL, 2000, CLIN CHEM, V46, P989; Beaudeux JL, 1999, ANN BIOL CLIN-PARIS, V57, P261; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Castellani C, 2008, CLIN CHEM LAB MED, V46, P1296, DOI 10.1515/CCLM.2008.262; De Santis Marco, 2007, Birth Defects Research, V81, P177, DOI 10.1002/bdrc.20099; Feriel J, 2015, CLIN CHEM LAB MED, V53, pE169, DOI 10.1515/cclm-2014-1090; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Jennen-Steinmetz C, 2014, STAT MED, V33, P1336, DOI 10.1002/sim.6024; Klajnbard A, 2010, CLIN CHEM LAB MED, V48, P237, DOI 10.1515/CCLM.2010.033; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Michetti F, 2003, CLIN CHIM ACTA, V335, P1, DOI 10.1016/S0009-8981(03)00243-2; Muller K, 2006, CLIN CHEM LAB MED, V44, P1111, DOI 10.1515/CCLM.2006.211; Ogungbenro K, 2008, EUR J CLIN PHARMACOL, V64, P705, DOI 10.1007/s00228-008-0493-7; Portela LVC, 2002, CLIN CHEM, V48, P950; Remontet L, 1999, ARCH PEDIATRIE, V6, P520, DOI 10.1016/S0929-693X(99)80558-2; Sannia A, 2011, CLIN CHIM ACTA, V412, P1337, DOI 10.1016/j.cca.2011.03.034; Schulpis KH, 2006, SCAND J CLIN LAB INV, V66, P733, DOI 10.1080/00365510600977737; Steiner J, 2011, BRAIN BEHAV IMMUN, V25, P1233, DOI 10.1016/j.bbi.2011.03.015; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vendittelli F, 2001, J Gynecol Obstet Biol Reprod (Paris), V30, P51; Zimmer DB, 2013, CELL CALCIUM, V53, P170, DOI 10.1016/j.ceca.2012.11.006	25	16	16	1	4	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	MAY	2016	54	5					833	842		10.1515/cclm-2015-0771			10	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	DK5WE	WOS:000374991000024	26479347				2022-02-06	
J	Cruz, LJ; Que, I; Aswendt, M; Chan, A; Hoehn, M; Lowik, C				Cruz, Luis Javier; Que, Ivo; Aswendt, Markus; Chan, Alan; Hoehn, Mathias; Lowik, Clemens			Targeted nanoparticles for the non-invasive detection of traumatic brain injury by optical imaging and fluorine magnetic resonance imaging	NANO RESEARCH			English	Article						imaging; nanoparticles; contrast agents; magnetic resonance imaging; brain injury; stroke	PERFLUOROOCTYL BROMIDE; CELL-DEATH; DENDRITIC CELLS; MRI; QUANTIFICATION; MICROCAPSULES; APOPTOSIS; DELIVERY; AGENTS; PET	Necrosis is a form of cell death that occurs only under pathological conditions such as ischemic diseases and traumatic brain injury (TBI). Non-invasive imaging of the affected tissue is a key component of novel therapeutic interventions and measurement of treatment responses in patients. Here, we report a bimodal approach for the detection and monitoring of TBI. PEGylated poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs), encapsulating both near infrared (NIR) fluorophores and perfluorocarbons (PFCs), were targeted to necrotic cells. We used cyanine dyes such as IRDye 800CW, for which we have previously demonstrated specific targeting to intracellular proteins of cells that have lost membrane integrity. Here, we show specific in vivo detection of necrosis by optical imaging and fluorine magnetic resonance imaging (F-19 MRI) using newly designed PLGA NP(NIR700 + PFC)-PEG-800CW. Quantitative ex vivo optical imaging and F-19 MR spectroscopy of NIR-PFC content in injured brain regions and in major organs were well correlated. Both modalities allowed the in vivo identification of necrotic brain lesions in a mouse model of TBI, with optical imaging being more sensitive than F-19 MRI. Our results confirm increased blood pool residence time of PLGA NPs coated with a PEG layer and the successful targeting of TBI-damaged tissue. A single PLGA NP containing NIR-PFC enables both rapid qualitative optical monitoring of the TBI state and quantitative 3D information from deeper tissues on the extent of the lesion by MRI. These necrosis-targeting PLGA NPs can potentially be used for clinical diagnosis of brain injuries.	[Cruz, Luis Javier; Que, Ivo; Chan, Alan; Hoehn, Mathias; Lowik, Clemens] Leiden Univ, Dept Radiol, Nanomed & Mol Imaging, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Aswendt, Markus; Hoehn, Mathias] Max Planck Inst Neurol Res, In Vivo NMR Lab, Gleueler Str 50, D-50931 Cologne, Germany; [Chan, Alan] Percuros, NL-7522 NB Enschede, Netherlands		Cruz, LJ; Lowik, C (corresponding author), Leiden Univ, Dept Radiol, Nanomed & Mol Imaging, Med Ctr, NL-2333 ZA Leiden, Netherlands.	L.J.Cruz_Ricondo@lumc.nl; c.lowik@erasmusmc.nl	Aswendt, Markus/L-2743-2019	Aswendt, Markus/0000-0003-1423-0934; Chan, Alan/0000-0001-6949-9274	EU-FP7 program TargetBraIn [HEALTH-F2-2012-279017]; EU-FP7 program BrainPath [PIAPP-GA-2013-612360]; EU-FP7 program CTMM project Cancer Vaccine Tracking [03O-302]	The authors wish to thank the technicians of the LUMC Radiology Department and Andreas Beyrau (MPI for Neurological Research in Cologne) for assistance. This work was financially supported by the EU-FP7 programs TargetBraIn (No. HEALTH-F2-2012-279017), BrainPath (No. PIAPP-GA-2013-612360), and CTMM project Cancer Vaccine Tracking (No. 03O-302).	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Aswendt M, 2012, NEUROIMAGE, V62, P1685, DOI 10.1016/j.neuroimage.2012.05.029; Blankenberg FG, 2008, CURR PHARM DESIGN, V14, P2974, DOI 10.2174/138161208786404353; Boehm-Sturm P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029040; Calvo P, 2001, PHARMACEUT RES, V18, P1157, DOI 10.1023/A:1010931127745; Caruthers SD, 2006, INVEST RADIOL, V41, P305, DOI 10.1097/01.rli.0000199281.60135.6a; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; Cruz LJ, 2011, MOL PHARMACEUT, V8, P520, DOI 10.1021/mp100356k; Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Diaz-Lopez R, 2008, J PHARMACEUT BIOMED, V48, P702, DOI 10.1016/j.jpba.2008.06.027; Diaz-Lopez R, 2010, BIOMATERIALS, V31, P1723, DOI 10.1016/j.biomaterials.2009.11.044; Diaz-Lopez R, 2009, BIOMATERIALS, V30, P1462, DOI 10.1016/j.biomaterials.2008.11.032; Ferenz KB, 2013, J MICROENCAPSUL, V30, P632, DOI 10.3109/02652048.2013.770098; Giraudeau C, 2012, NMR BIOMED, V25, P654, DOI 10.1002/nbm.1781; Gomez-Graete C, 2007, INT J PHARMACEUT, V331, P153, DOI 10.1016/j.ijpharm.2006.11.028; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Keereweer S, 2014, MOL IMAGING BIOL, V16, P10, DOI 10.1007/s11307-013-0684-1; Laufer EM, 2009, Q J NUCL MED MOL IM, V53, P26; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Marshall MV, 2010, MOL IMAGING BIOL, V12, P583, DOI 10.1007/s11307-010-0317-x; Medarova Z, 2005, DIABETES, V54, P1780, DOI 10.2337/diabetes.54.6.1780; Nobs L, 2003, INT J PHARM, V250, P327, DOI 10.1016/S0378-5173(02)00542-2; Pamula E, 2011, ANN BIOMED ENG, V39, P2114, DOI 10.1007/s10439-011-0307-4; Park J, 2009, NANOMED-NANOTECHNOL, V5, P410, DOI 10.1016/j.nano.2009.02.002; Pisani E, 2008, J COLLOID INTERF SCI, V326, P66, DOI 10.1016/j.jcis.2008.07.013; Ruiz-Cabello J, 2011, NMR BIOMED, V24, P114, DOI 10.1002/nbm.1570; Shaffer TH, 1996, EUR J PEDIATR, V155, pS30, DOI 10.1007/BF01958078; Smith BA, 2012, BIOCONJUGATE CHEM, V23, P1989, DOI 10.1021/bc3003309; Srinivas M, 2012, BIOMATERIALS, V33, P8830, DOI 10.1016/j.biomaterials.2012.08.048; Srinivas M, 2010, BIOMATERIALS, V31, P7070, DOI 10.1016/j.biomaterials.2010.05.069; Tacken PJ, 2011, BLOOD, V118, P6836, DOI 10.1182/blood-2011-07-367615; Waters EA, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-43; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Wolters SL, 2007, EUR J NUCL MED MOL I, V34, pS86, DOI 10.1007/s00259-007-0443-0; Xie BW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.207; Xie BW, 2015, ONCOTARGET, V6, P39036, DOI 10.18632/oncotarget.5498	37	16	16	8	63	TSINGHUA UNIV PRESS	BEIJING	B605D, XUE YAN BUILDING, BEIJING, 100084, PEOPLES R CHINA	1998-0124	1998-0000		NANO RES	Nano Res.	MAY	2016	9	5					1276	1289		10.1007/s12274-016-1023-z			14	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	DL4RH	WOS:000375624400006					2022-02-06	
J	Sander, AM; Maestas, KL; Pappadis, MR; Hammond, FM; Hanks, RA				Sander, Angelle M.; Maestas, Kacey Little; Pappadis, Monique R.; Hammond, Flora M.; Hanks, Robin A.		NIDILRR Traumatic Brain Injury Mod	Multicenter Study of Sexual Functioning in Spouses/Partners of Persons With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							INDEPENDENCE MEASURE; HEAD-INJURY; REHABILITATION; SATISFACTION; ADJUSTMENT; STABILITY; DISTRESS; TBI; ADENOCARCINOMA; PARTICIPATION	Objective: To investigate sexual functioning and its predictors in spouses/partners of persons with traumatic brain injury (TBI). Design: Inception cohort survey. Setting: Community. Participants: Persons (N=70) with complicated mild to severe TBI admitted to 1 of 6 participating TBI Model Systems inpatient rehabilitation units and their spouses/partners who were both living in the community and assessed 1 year after injury. Interventions: Not applicable. Main Outcome Measures: Derogatis Interview for Sexual Functioning Self-Report; Global Sexual Satisfaction Index. Results: Twenty percent of spouses/partners of persons with TBI reported sexual dysfunction, and 44% reported dissatisfaction with sexual functioning. Sixty-two percent of spouses/partners reported a decrease in sexual activity during the year postinjury, 34% reported a decrease in sexual drive or desire, and 34% indicated that sexuality was less important in comparison to preinjury. The sexual functioning of spouses/partners of persons with TBI was highly associated with the sexual functioning of the person with TBI. Age of spouses/partners and sexual functioning in persons with the TBI were significant predictors of spouses'/partners' sexual functioning, even after controlling for sex of partners and the physical, cognitive, participation, and sexual functioning of the persons with injury. Conclusions: Greater sexual dysfunction in spouses/partners was associated with older age and with poorer sexual functioning in the person with injury. Rehabilitation professionals should provide education on the potential impact of TBI on sexual functioning for both persons with TBI and their spouses/partners, and integrate the assessment of sexual functioning into their clinical assessment, making appropriate referrals for therapy. (C) 2016 by the American Congress of Rehabilitation Medicine	[Sander, Angelle M.; Maestas, Kacey Little] Baylor Coll Med, Harris Hlth Syst, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.; Maestas, Kacey Little; Pappadis, Monique R.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Pappadis, Monique R.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Hammond, Flora M.] Carolinas Hlth Care Syst, Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Hanks, Robin A.] Rehabil Inst Michigan, Detroit, MI USA		Sander, AM (corresponding author), TIRR Mem Hermann Res Ctr, 1333 Moursund St, Houston, TX 77030 USA.	asander@bcm.edu	Pappadis, Monique/Q-8639-2016	Pappadis, Monique/0000-0003-4742-4380; Ripley, David/0000-0002-5349-1830	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0028, H133A070043, 90RT5007, H133A080044, H133A070042, 90DP0036]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant nos. 90DP0028, H133A070043, 90RT5007, H133A080044, H133A070042, 90DP0036). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Aloni R, 1999, BRAIN INJURY, V13, P269, DOI 10.1080/026990599121647; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; [Anonymous], 1997, GUIDE UNIFORM DATA S; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Cameron RP, 2011, REHABIL PSYCHOL, V56, P289, DOI 10.1037/a0025513; Cohen J., 2013, STAT POWER ANAL BEHA; Derogatis L, 1987, DEROGATIS INTERVIEW; Derogatis L. R., 1975, DEROGATIS SEXUAL FUN; Derogatis LR, 1997, J SEX MARITAL THER, V23, P291; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gosling J, 1999, BRAIN INJURY, V13, P785; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee DM, 2016, ARCH SEX BEHAV, V45, P133, DOI 10.1007/s10508-014-0465-1; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Nicolosi A, 2006, J SEX MARITAL THER, V32, P331, DOI 10.1080/00926230600666469; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; TEASDALE G, 1974, LANCET, V2, P81; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P540, DOI 10.1016/j.apmr.2010.12.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; ZINREICH ES, 1990, INT J RADIAT ONCOL, V19, P729, DOI 10.1016/0360-3016(90)90503-C; ZINREICH ES, 1990, INT J RADIAT ONCOL, V19, P1001, DOI 10.1016/0360-3016(90)90025-F	44	16	16	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2016	97	5					753	759		10.1016/j.apmr.2016.01.009			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DL4UM	WOS:000375633300014	26845190				2022-02-06	
J	Silk-Eglit, GM; Lynch, JK; McCaffrey, RJ				Silk-Eglit, Graham M.; Lynch, Julie K.; McCaffrey, Robert J.			Validation of Victoria Symptom Validity Test Cutoff Scores among Mild Traumatic Brain Injury Litigants Using a Known-Groups Design	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Forensic neuropsychology; Malingering/symptom validity testing; Head injury; Traumatic brain injury	DEFINED MALINGERING GROUPS; FALSE-POSITIVE RATES; PERFORMANCE VALIDITY; NEUROPSYCHOLOGICAL TESTS; CLASSIFICATION ACCURACY; RESPONSE BIAS; TEST FAILURE; MULTIPLE PERFORMANCE; MEMORY IMPAIRMENT; INADEQUATE EFFORT	The Victoria Symptom Validity Test (VSVT) is one of the most accurate performance validity tests. Previous research has recommended several cutoffs for performance invalidity classification on the VSVT. However, only one of these studies used a known groups design and no study has investigated these cutoffs in an exclusively mild traumatic brain injury (mTBI) medico-legal sample. The current study used a known groups design to validateVSVT cutoffs among mild traumatic brain injury litigants and explored the best approach for using the multiple recommended cutoffs for this test. Cutoffs of <18 Hard items correct, <41 Total items correct, an Easy-Hard items correct difference. 6, and <5 items correct on any block yielded the strongest classification accuracy. Using multiple cutoffs in conjunction reduced classification accuracy. Given convergence across studies, a cutoff of <18 Hard items correct is the most appropriate for use with mTBI litigants.	[Silk-Eglit, Graham M.; McCaffrey, Robert J.] SUNY Albany, Dept Psychol, Albany, NY 12222 USA; [Silk-Eglit, Graham M.] Vet Adm San Diego Healthcare Syst, San Diego, CA USA; [Lynch, Julie K.; McCaffrey, Robert J.] Albany Neuropsychol Associates, Guilderland, NY USA		Silk-Eglit, GM (corresponding author), SUNY Albany, Dept Psychol, Albany, NY 12222 USA.	grahammse@gmail.com		Eglit, Graham/0000-0001-7592-9859			Babikian T., 2006, ARCH CLIN NEUROPSYCH, V26, P592; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; Brennan AM, 2006, APPL NEUROPSYCHOL, V13, P1, DOI 10.1207/s15324826an1301_1; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Committee on Mild Traumatic Brain Injury American Congress of Rehabilitation Medicine (ACRM), 1993, J HEAD TRAUMA REHAB, V8, P86; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2005, MANUAL WORD MEMORY T; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Hayden SR, 1999, ANN EMERG MED, V33, P575, DOI 10.1016/S0196-0644(99)70346-X; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1373, DOI 10.1080/13854046.2013.851740; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Keary TA, 2013, J INT NEUROPSYCH SOC, V19, P314, DOI 10.1017/S1355617712001397; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2007, ASSESSMENT MALINGERE, P44; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Randolph C., 1998, REPEATABLE BATTERY A; Rogers R., 1992, STRUCTURED INTERVIEW; Rogers R., 2008, CLIN ASSESSMENT MALI; Rogers R., 1997, CLIN ASSESSMENT MALI; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P271, DOI 10.1080/23279095.2014.921167; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Stenclik JH, 2013, APPL NEUROPSYCH-ADUL, V20, P243, DOI 10.1080/09084282.2012.704603; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wolfson, 1993, HALSTEAD REITAN NEUR	58	16	16	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2016	31	3					231	245		10.1093/arclin/acv108			15	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DL1WX	WOS:000375424900004	26795609	Bronze			2022-02-06	
J	Sohlberg, MM; Ledbetter, AK				Sohlberg, McKay Moore; Ledbetter, Alexander K.			Management of Persistent Cognitive Symptoms After Sport-Related Concussion	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CLINICAL-PRACTICE GUIDELINES; RANDOMIZED CONTROLLED-TRIAL; NEUROCOGNITIVE PERFORMANCE; ASSISTIVE TECHNOLOGY; REMEDIATION PROGRAM; REHABILITATION; CHILDHOOD; SCHOOL; RECOMMENDATIONS	Purpose: This case review examines treatments speech-language pathologists at our clinic delivered to middle school, high school, and college students for the management of persistent cognitive symptoms after sport-related concussion. The goal is to examine a range of treatment options, describe clinical rationale for selecting those treatments, and report outcomes in order to identify feasible interventions for systematic evaluation through efficacy research. Method: Review of clinic intake data identified 63 cases referred for cognitive rehabilitation over a 36-month period. Twenty-four cases (14 women and 10 men) met selection criteria, including documented sport-related concussion, postconcussion symptoms persisting at least 2 months with deleterious effect on school performance, and enrollment in secondary or postsecondary education. The authors independently coded demographics, treatment approaches, functional goal domains, and outcomes. Results: Treatment approaches fell into 4 broad categories: direct attention training, metacognitive strategy training, training assistive technology for cognition, and psychoeducational supports. Eighty-three percent of clients achieved self-selected functional goals. Conclusions: Research has focused primarily on return to play and provision of academic accommodations in the initial weeks following concussion. Findings from this case series suggest that speech-language pathologists can deliver individualized interventions that lead to positive clinical outcomes. The authors hope findings encourage efficacy research.	[Sohlberg, McKay Moore; Ledbetter, Alexander K.] Univ Oregon, Eugene, OR 97403 USA		Ledbetter, AK (corresponding author), Univ Oregon, Eugene, OR 97403 USA.	ledbette@uoregon.edu					Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; Burke Janice Posatery, 2012, Am J Occup Ther, V66, pe85, DOI 10.5014/ajot.2012.004432; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chachad S, 2006, CLIN PEDIATR, V45, P285, DOI 10.1177/000992280604500314; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Dams-O'Connor K, 2013, BRAIN IMPAIR, V14, P51, DOI 10.1017/BrImp.2013.9; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; Devineni T, 2005, BEHAV RES THER, V43, P277, DOI 10.1016/j.brat.2004.01.008; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Federici S., 2012, ASSISTIVE TECHNOLOGY; FitzGerald DB, 2011, INT J PSYCHOPHYSIOL, V82, P79, DOI 10.1016/j.ijpsycho.2011.02.011; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Glang A, 2008, NEUROREHABILITATION, V23, P477; Grant M, 2014, NEUROPSYCHOL REHABIL, V24, P661, DOI 10.1080/09602011.2014.901228; Green Robin, 2010, Neuropsychol Rehabil, V20, P471, DOI 10.1080/09602011003693298; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hux K, 1996, INTERV SCH CLIN, V31, P158, DOI 10.1177/105345129603100305; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lee Jaime, 2012, PERSPECT NEUROPHYSIO, V22, P90, DOI [10.1044/nnsld22.3.90, DOI 10.1044/NNSLD22.3.90]; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Luton LM, 2011, BRAIN INJURY, V25, P409, DOI 10.3109/02699052.2011.558044; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Marshall Cameron M, 2012, J Can Chiropr Assoc, V56, P299; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mitka M, 2010, JAMA-J AM MED ASSOC, V304, P1775, DOI 10.1001/jama.2010.1487; Nationwide Children's Hospital, ED GUID CONC CLASSR; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Scherer MJ, 2005, CRIT REV PHYS REHABI, V17, P195, DOI [DOI 10.1615/CritRevPhysRehabilMed.v17.i3.30, DOI 10.1615/CRITREVPHYSREHABILMED.V17.I3.30]; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Sohlberg MM., 2014, CLIN PRACT PEDIAT PS, V2, P263, DOI [10.1037/cpp0000072, DOI 10.1037/CPP0000072]; Turner T, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-45; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	61	16	16	1	26	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2016	25	2								10.1044/2015_AJSLP-14-0128			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	DO6AE	WOS:000377863600003	27115516				2022-02-06	
J	Teel, E; Gay, M; Johnson, B; Slobounov, S				Teel, Elizabeth; Gay, Michael; Johnson, Brian; Slobounov, Semyon			Determining Sensitivity/Specificity of Virtual Reality-Based Neuropsychological Tool for Detecting Residual Abnormalities Following Sport-Related Concussion	NEUROPSYCHOLOGY			English	Article						concussion; virtual reality; neuropsychological testing	TRAUMATIC BRAIN-INJURY; PROSPECTIVE MEMORY; COGNITIVE IMPAIRMENT; POSTURAL STABILITY; SPATIAL NAVIGATION; INITIAL VALIDATION; EXECUTIVE FUNCTION; CORTICAL ACTIVITY; HIGH-SCHOOL; SENSITIVITY	Objective: Computer-based neuropsychological (NP) evaluation is an effective clinical tool used to assess cognitive function which complements the clinical diagnosis of a concussion. However, some researchers and clinicians argue its lack of ecological validity places limitations on externalizing results to a sensory rich athletic environment. Virtual reality-based NP assessment offers clinical advantages using an immersive environment and evaluating domains not typically assessed by traditional NP assessments. The sensitivity and specificity of detecting lingering cognitive abnormalities was examined on components of a virtual reality-based NP assessment battery to cohort affiliation (concussed vs. controls). Method: Data were retrospectively gathered on 128 controls (no concussion) and 24 concussed college-age athletes on measures of spatial navigation, whole body reaction, attention, and balance in a virtual environment. Concussed athletes were tested within 10 days (M = 8.33, SD = 1.06) of concussion and were clinically asymptomatic at the time of testing. Results: A priori alpha level was set at 0.05 for all tests. Spatial navigation (sensitivity 95.8%/specificity 91.4%, d = 1.89), whole body reaction time (sensitivity 95.2%/specificity 89.1%, d = 1.50) and combined virtual reality modules (sensitivity 95.8%,/specificity 96.1%, d = 3.59) produced high sensitivity/specificity values when determining performance-based variability between groups. Conclusions: Use of a virtual reality-based NP platform can detect lingering cognitive abnormalities resulting from concussion in clinically asymptomatic participants. Virtual reality NP platforms may compliment the traditional concussion assessment battery by providing novel information.	[Teel, Elizabeth; Johnson, Brian; Slobounov, Semyon] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Gay, Michael; Johnson, Brian; Slobounov, Semyon] Penn State Univ, Penn State Ctr Sport Concuss Res & Serv, University Pk, PA 16802 USA; [Gay, Michael] Penn State Univ, Dept Intercollegiate Athlet, University Pk, PA 16802 USA; [Teel, Elizabeth] Univ N Carolina, Chapel Hill, NC USA		Slobounov, S (corresponding author), Penn State Univ, Dept Kinesiol, Coll Hlth & Human Dev, University Pk, PA 16802 USA.	sms18@psu.edu		Teel, Elizabeth/0000-0002-2846-5884			Banville F, 2010, BEHAV NEUROL, V23, P209, DOI [10.1155/2010/320707, 10.3233/BEN-2010-0297]; Barkhoudarian G., 2010, CLIN SPORTS MED, V30, pvii; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barth JT, 1989, MILD HEAD INJURY, P257; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Canovas R, 2011, EPILEPSY BEHAV, V22, P364, DOI 10.1016/j.yebeh.2011.07.021; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Curaudeau GA, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11186; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gorrindo T, 2009, ACAD PSYCHIATR, V33, P413, DOI 10.1176/appi.ap.33.5.413; Grewe P, 2014, EPILEPSY BEHAV, V31, P57, DOI 10.1016/j.yebeh.2013.11.014; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry M, 2012, J NEUROSCI METH, V210, P125, DOI 10.1016/j.jneumeth.2012.07.025; Iverson GL, 2006, CLIN NEUROPSYCHOL, V20, P695, DOI 10.1080/138540491005857; Jaiswal N, 2010, BRAIN RES, V1347, P80, DOI 10.1016/j.brainres.2010.05.086; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P207, DOI 10.1080/09084282.2011.643956; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Mihalik JP, 2008, J SPORT REHABIL, V17, P38, DOI 10.1123/jsr.17.1.38; Nolin P, 2012, BRAIN INJURY, V26, P1564, DOI 10.3109/02699052.2012.698359; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Parsons TD, 2008, CYBERPSYCHOL BEHAV, V11, P17, DOI 10.1089/cpb.2007.9934; Parsons TD, 2014, J NEUROSCI METH, V222, P15, DOI 10.1016/j.jneumeth.2013.10.006; Pollak Y, 2009, J DEV BEHAV PEDIATR, V30, P2, DOI 10.1097/DBP.0b013e3181969b22; Quatman-Yates CC, 2013, INT J SPORTS PHYS TH, V8, P741; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Slobounov S, 2006, BIOL PSYCHOL, V72, P188, DOI 10.1016/j.biopsycho.2005.10.005; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Slobounov S, 2011, IEEE ENG MED BIO, P1383, DOI 10.1109/IEMBS.2011.6090325; Slobounov SM, 2015, INT J PSYCHOPHYSIOL, V95, P254, DOI 10.1016/j.ijpsycho.2014.11.003; Slobounov SM, 2013, NEUROSCI LETT, V547, P6, DOI 10.1016/j.neulet.2013.05.001; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sweeney S, 2010, NEUROPSYCHOL REHABIL, V20, P239, DOI 10.1080/09602010903080531; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	62	16	18	0	25	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2016	30	4					474	483		10.1037/neu0000261			10	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DK2XM	WOS:000374777700008	27045961				2022-02-06	
J	Vangansewinkel, T; Geurts, N; Quanten, K; Nelissen, S; Lemmens, S; Geboes, L; Dooley, D; Vidal, PM; Pejler, G; Hendrix, S				Vangansewinkel, Tim; Geurts, Nathalie; Quanten, Kirsten; Nelissen, Sofie; Lemmens, Stefanie; Geboes, Lies; Dooley, Dearbhaile; Vidal, Pia M.; Pejler, Gunnar; Hendrix, Sven			Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6	FASEB JOURNAL			English	Article						CNS trauma; mMCP6; ECM remodeling; gene expression; improved outcome	CENTRAL-NERVOUS-SYSTEM; CHONDROITIN SULFATE PROTEOGLYCANS; AXONAL REGENERATION; GLIAL SCAR; BETA-TRYPTASE; ABC PROMOTES; MATRIX; INFLAMMATION; BRAIN; MICE	An important barrier for axon regeneration and recovery after traumatic spinal cord injury (SCI) is attributed to the scar that is formed at the lesion site. Here, we investigated the effect of mouse mast cell protease (mMCP) 6, a mast cell (MC)-specific tryptase, on scarring and functional recovery after a spinal cord hemisection injury. Functional recovery was significantly impaired in both MC-deficient and mMCP6-knockout (mMCP6(-/-)) mice after SCI compared with wild-type control mice. This decrease in locomotor performance was associated with an increased lesion size and excessive scarring at the injury site. Axon growth-inhibitory chondroitin sulfate proteoglycans and the extracellular matrix components fibronectin, laminin, and collagen IV were significantly up-regulated in MC-deficient and mMCP6(-/-) mice, with an increase in scar volume between 23 and 32%. A degradation assay revealed that mMCP6 directly cleaves fibronectin and collagen IV in vitro. In addition, gene expression levels of the scar components fibronectin, aggrecan, and collagen IV were increased up to 6.8-fold in mMCP6(-/-) mice in the subacute phase after injury. These data indicate that endogenous mMCP6 has scar-suppressing properties after SCI via indirect cleavage of axon growth-inhibitory scar components and alteration of the gene expression profile of these factors.-Vangansewinkel, T., Geurts, N., Quanten, K., Nelissen, S., Lemmens, S., Geboes, L., Dooley, D., Vidal, P. M., Pejler, G., Hendrix, S. Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6. www.fasebj.org	[Vangansewinkel, Tim; Geurts, Nathalie; Quanten, Kirsten; Nelissen, Sofie; Lemmens, Stefanie; Geboes, Lies; Dooley, Dearbhaile; Vidal, Pia M.; Hendrix, Sven] Hasselt Univ, Biomed Res Inst, Dept Morphol, Diepenbeek, Belgium; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Pejler, Gunnar] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Vidal, Pia M.] Univ Hlth Network, Div Genet & Dev, Krembil Neurosci Ctr, Toronto, ON, Canada		Hendrix, S (corresponding author), Martelarenlaan 42, B-3500 Hasselt, Belgium.	sven.hendrix@uhasselt.be	Vangansewinkel, Tim/N-4308-2017; Hendrix, Sven/F-4059-2010; Vidal, Pia M./U-8401-2019	Hendrix, Sven/0000-0003-2344-7369; Vidal, Pia M./0000-0001-9885-3076; Dooley, Dearbhaile/0000-0001-5337-1831	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SPP1394]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO)FWO [G.0389.12, G0A5813, G.0834.11N, G0A58113, 1.2.917.14N]; Agentschap voor Innovatie door Wetenschap en Technologie [101517]; COST Action Mast Cells and Basophils-Targets for Innovative Therapies [BM1007]	The authors thank Dr. David Lee (Novartis Pharma, Basel, Switzerland) and Dr. Peter Nigrovic (Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA) for providing the mMCP6<SUP>-/-</SUP> mice, and Dr. Leen Timmermans (Hasselt University) for her help with the qPCR analysis and immunohistochemistry. This study was supported in part by grants from Deutsche Forschungsgemeinschaft (SPP1394), Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO; G.0389.12, G0A5813, G.0834.11N, and G0A58113 to S.H., and 1.2.917.14N to N.G.), and from Agentschap voor Innovatie door Wetenschap en Technologie (101517 to T.V.). This work has also benefited from the support of the COST Action BM1007 Mast Cells and Basophils-Targets for Innovative Therapies.	Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Boato F, 2010, J CELL SCI, V123, P1652, DOI 10.1242/jcs.066050; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brazda N, 2009, PROG BRAIN RES, V175, P269, DOI 10.1016/S0079-6123(09)17518-0; Caughey GH, 2011, ADV EXP MED BIOL, V716, P212, DOI 10.1007/978-1-4419-9533-9_12; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Didangelos A, 2014, J NEUROSCI, V34, P16424, DOI 10.1523/JNEUROSCI.2927-14.2014; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Douaiher J, 2014, ADV IMMUNOL, V122, P211, DOI 10.1016/B978-0-12-800267-4.00006-7; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Fajardo I, 2003, J IMMUNOL, V171, P1493, DOI 10.4049/jimmunol.171.3.1493; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Galli SJ, 2008, J DERMATOL SCI, V49, P7, DOI 10.1016/j.jdermsci.2007.09.009; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hallgren J, 2000, BIOCHEMISTRY-US, V39, P13068, DOI 10.1021/bi000973b; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Hendrix S, 2013, FASEB J, V27, P920, DOI 10.1096/fj.12-204800; Hermanns S, 2006, ADV EXP MED BIOL, V557, P177; Hermanns S, 2001, RESTOR NEUROL NEUROS, V19, P139; Iddamalgoda A, 2008, ARCH DERMATOL RES, V300, pS69, DOI 10.1007/s00403-007-0806-1; Jones LL, 2003, J NEUROSCI, V23, P9276; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Lindsberg PJ, 2010, J CEREBR BLOOD F MET, V30, P689, DOI 10.1038/jcbfm.2009.282; Liu XB, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/627831; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; Loske P, 2012, J NEUROCHEM, V120, P1084, DOI 10.1111/j.1471-4159.2012.07657.x; Lundequist A, 2006, BIOL CHEM, V387, P1513, DOI 10.1515/BC.2006.189; Lundequist A, 2011, CELL MOL LIFE SCI, V68, P965, DOI 10.1007/s00018-010-0587-0; Magarinos NJ, 2013, J IMMUNOL, V191, P1404, DOI 10.4049/jimmunol.1300856; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mullan CS, 2008, AM J RESP CELL MOL, V38, P600, DOI 10.1165/rcmb.2007-0082OC; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nelissen S, 2014, NEUROBIOL DIS, V62, P260, DOI 10.1016/j.nbd.2013.09.012; Nelissen S, 2013, ACTA NEUROPATHOL, V125, P637, DOI 10.1007/s00401-013-1092-y; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Polajeva J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025222; Raposo C, 2014, GLIA, V62, P1895, DOI 10.1002/glia.22676; Ribatti D, 2015, EXP CELL RES, V332, P157, DOI 10.1016/j.yexcr.2014.11.014; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tanzola MB, 2003, J IMMUNOL, V171, P4385, DOI 10.4049/jimmunol.171.8.4385; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsai M, 2005, CHEM IMMUNOL ALLERGY, V87, P179, DOI 10.1159/000087644; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal PM, 2013, CYTOKINE GROWTH F R, V24, P1, DOI 10.1016/j.cytogfr.2012.08.008; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214; Yang XP, 2010, LEUKEMIA LYMPHOMA, V51, P1550, DOI 10.3109/10428194.2010.496013; Yasuda S, 2005, BLOOD, V105, P3893, DOI 10.1182/blood-2003-10-3501; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhu YJ, 2015, J NEUROTRAUM, V32, P1158, DOI 10.1089/neu.2014.3703	74	16	17	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2040	2057		10.1096/fj.201500114R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	WOS:000374879400030	26917739				2022-02-06	
J	Hsieh, JT; Ang, BT; Ng, YP; Allen, JC; King, NKK				Hsieh, Justin T.; Ang, Beng Ti; Ng, Yew Poh; Allen, John C.; King, Nicolas K. K.			Comparison of Gender Differences in Intracerebral Hemorrhage in a Multi-Ethnic Asian Population	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; STROKE INCIDENCE; CASE-FATALITY; INFLAMMATORY RESPONSE; CEREBRAL-ISCHEMIA; PROGESTERONE; HEART; ESTROGEN; SUBTYPES	Background Intracerebral hemorrhage (ICH) accounts for 10-15% of all first time strokes and with incidence twice as high in the Asian compared to Western population. This study aims to investigate gender differences in ICH patient outcomes in a multi-ethnic Asian population. Method Data for 1,192 patients admitted for ICH were collected over a four-year period. Multivariate logistic regression was used to identify independent predictors and odds ratios were computed for 30-day mortality and Glasgow Outcome Scale (GOS) comparing males and females. Result Males suffered ICH at a younger age than females (62.2 +/- 13.2 years vs. 66.3 +/- 15.3 years; P<0.001). The occurrence of ICH was higher among males than females at all ages until 80 years old, beyond which the trend was reversed. Females exhibited increased severity on admission as measured by Glasgow Coma Scale compared to males (10.9 +/- 4.03 vs. 11.4 +/- 4.04; P = 0.030). No difference was found in 30-day mortality between females and males (F: 30.5% [155/508] vs. M: 27.0%[186/688]), with unadjusted and adjusted odds ratio (F/M) of 1.19 (P = 0.188) and 1.21 (P = 0.300). At discharge, there was a non-statistically significant but potentially clinically relevant morbidity difference between the genders as measured by GOS (dichotomized GOS of 4-5: F: 23.7% [119/503] vs. M: 28.7% [194/677]), with unadjusted and adjusted odds ratio (F/M) of 0.77 (P = 0.055) and 0.87 (P = 0.434). Conclusion In our multi-ethnic Asian population, males developed ICH at a younger age and were more susceptible to ICH than women at all ages other than the beyond 80-year old age group. In contrast to the Western population, neurological status of female ICH patients at admission was poorer and their 30-day mortality was not reduced. Although the study was not powered to detect significance, female showed a trend toward worse 30-day morbidity at discharge.	[Hsieh, Justin T.] Duke Natl Univ Singapore Med Sch, Sch Med, Singapore, Singapore; [Ang, Beng Ti; Ng, Yew Poh; King, Nicolas K. K.] Natl Neurosci Inst, Dept Neurosurg, Singapore, Singapore; [Allen, John C.] Duke Natl Univ Singapore Med Sch, Ctr Quantitat Med, Singapore, Singapore		Hsieh, JT (corresponding author), Duke Natl Univ Singapore Med Sch, Sch Med, Singapore, Singapore.	Justin.hsieh@u.duke.nus.edu		Hsieh, Justin/0000-0002-9701-0998; Kon Kam King, Nicolas/0000-0002-6009-4411			Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Chen Z, 2011, ACTA NEUROCHIR SUPPL, V111, P289, DOI 10.1007/978-3-7091-0693-8_48; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Flaherty ML, 2005, STROKE, V36, P934, DOI 10.1161/01.STR.0000160756.72109.95; Furlan JC, 2005, J NEUROTRAUM, V22, P368, DOI 10.1089/neu.2005.22.368; Ganti L, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/219097; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Gokhale S, 2015, STROKE, V46, P886, DOI 10.1161/STROKEAHA.114.007682; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hsieh JT, 2016, NEUROENDOCRINOLOGY, V103, P518, DOI 10.1159/000440883; Inagawa T, 2003, NEUROSURGERY, V53, P1283, DOI 10.1227/01.NEU.0000093825.04365.F3; Ishikawa S, 2008, J EPIDEMIOL, V18, P144, DOI 10.2188/jea.JE2007438; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Lei BL, 2016, NEUROENDOCRINOLOGY, V103, P665, DOI 10.1159/000442204; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Morikawa Y, 2000, STROKE, V31, P1583, DOI 10.1161/01.STR.31.7.1583; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nakamura T, 2005, J NEUROSURG, V103, P97, DOI 10.3171/jns.2005.103.1.0097; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Samai AA, 2015, VASC HEALTH RISK MAN, V11, P427, DOI 10.2147/VHRM.S65886; Simon JA, 2001, CIRCULATION, V103, P638, DOI 10.1161/01.cir.103.5.638; Thrift AG, 2009, NEUROEPIDEMIOLOGY, V32, P11, DOI 10.1159/000170086; Tveiten A, 2012, EUR NEUROL, V67, P240, DOI 10.1159/000336299; Umeano O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081664; Vaartjes I, 2009, CEREBROVASC DIS, V28, P564, DOI 10.1159/000247600; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vemmos KN, 1999, STROKE, V30, P363, DOI 10.1161/01.STR.30.2.363; Wagner I, 2012, EUR J NEUROL, V19, P1477, DOI 10.1111/j.1468-1331.2011.03628.x; Wright DW, 2015, NEW ENGL J MED, V372, P1766, DOI 10.1056/NEJMc1503138; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu SH, 2012, NEUROEPIDEMIOLOGY, V38, P69, DOI 10.1159/000335040; Young AMH, 2012, CURR DRUG SAF, V7, P202, DOI 10.2174/157488612803251261; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhou JS, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0172-5; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	40	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152945	10.1371/journal.pone.0152945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	WOS:000373603500071	27050549	Green Published, Green Submitted, gold			2022-02-06	
J	Haran, FJ; Slaboda, JC; King, LA; Wright, WG; Houlihan, D; Norris, JN				Haran, F. Jay; Slaboda, Jill C.; King, Laurie A.; Wright, W. Geoff; Houlihan, Daniel; Norris, Jacob N.			Sensitivity of the Balance Error Scoring System and the Sensory Organization Test in the Combat Environment	JOURNAL OF NEUROTRAUMA			English	Article						BESS; military; mTBI; SOT	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; POSTURAL STABILITY; POSTCONCUSSIVE SYMPTOMS; RELIABLE CHANGE; CONCUSSION; PERFORMANCE; RECOVERY; CONSEQUENCES; MILITARY	This study evaluated the utility of the Balance Error Scoring System (BESS) and the Sensory Organization Test (SOT) as tools for the screening and monitoring of Service members (SMs) with mild traumatic brain injury (mTBI) in a deployed setting during the acute and subacute phases of recovery. Patient records (N = 699) were reviewed for a cohort of SMs who sustained a blast-related mTBI while deployed to Afghanistan and were treated at the Concussion Restoration Care Center (CRCC) at Camp Leatherneck. On initial intake into the CRCC, participants completed two assessments of postural control, the BESS, and SOT. SMs with mTBI performed significantly worse on the BESS and SOT when compared with comparative samples. When the SOT data were further examined using sensory ratios, the results indicated that postural instability was primarily a result of vestibular and visual integration dysfunction (r > 0.62). The main finding of this study was that the sensitivity of the SOT composite score (50-58%) during the acute phase was higher than previous sensitivities found in the sports medicine literature for impact-related trauma.	[Haran, F. Jay] Navy Expt Diving Unit, Panama City Beach, FL USA; [Slaboda, Jill C.] Geneva Fdn, Tacoma, WA USA; [King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Wright, W. Geoff] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA; [Houlihan, Daniel] Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA; [Norris, Jacob N.] Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD 20910 USA		Norris, JN (corresponding author), Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD 20910 USA.	jacob.n.norris.mil@mail.mil					Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Casscells S.W., 2007, TRAUMATIC BRAIN INJU; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Conaton E., 2012, 649011 DODI; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Denis A. M., 2007, INTENS CARE MED, P1011; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dickin DC, 2007, CLIN J SPORT MED, V17, P109, DOI 10.1097/JSM.0b013e31803bf647; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Elbin RJ, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0320-7; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2001, PSYCHOL REP, V89, P457, DOI 10.2466/pr0.2001.89.2.457; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Moritz S, 2003, APPL NEUROPSYCHOL, V10, P115, DOI 10.1207/S15324826AN1002_07; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sylvia FR, 2001, MIL MED, V166, P918, DOI 10.1093/milmed/166.10.918; Weber AF, 2013, J ATHL TRAINING, V48, P153, DOI 10.4085/1062-6050-48.1.07; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089	62	16	16	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2016	33	7					705	711		10.1089/neu.2015.4060			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DI6QK	WOS:000373624700010	26560740				2022-02-06	
J	Pan, J; Connolly, ID; Dangelmajer, S; Kintzing, J; Ho, AL; Grant, G				Pan, James; Connolly, Ian D.; Dangelmajer, Sean; Kintzing, James; Ho, Allen L.; Grant, Gerald			Sports-related brain injuries: connecting pathology to diagnosis	NEUROSURGICAL FOCUS			English	Article						traumatic brain injury; neurodegeneration; biomarkers; imaging; concussion; chronic traumatic encephalopathy; sports	CHRONIC TRAUMATIC ENCEPHALOPATHY; NEURON-SPECIFIC ENOLASE; CEREBRAL-BLOOD-FLOW; WHITE-MATTER; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; PHOSPHORYLATED TAU; SUBARACHNOID HEMORRHAGE; STANDARDIZED ASSESSMENT; SERUM BIOMARKERS	Brain injuries are becoming increasingly common in athletes and represent an important diagnostic challenge. Early detection and management of brain injuries in sports are of utmost importance in preventing chronic neurological and psychiatric decline. These types of injuries incurred during sports are referred to as mild traumatic brain injuries, which represent a heterogeneous spectrum of disease. The most dramatic manifestation of chronic mild traumatic brain injuries is termed chronic traumatic encephalopathy, which is associated with profound neuropsychiatric deficits. Because chronic traumatic encephalopathy can only be diagnosed by postmortem examination, new diagnostic methodologies are needed for early detection and amelioration of disease burden. This review examines the pathology driving changes in athletes participating in high-impact sports and how this understanding can lead to innovations in neuroimaging and biomarker discovery.	[Pan, James; Connolly, Ian D.; Ho, Allen L.; Grant, Gerald] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Dangelmajer, Sean] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Kintzing, James] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA		Grant, G (corresponding author), Stanford Univ, Med Ctr, Dept Neurosurg, 300 Pasteur Dr, Stanford, CA 94305 USA.	gerald.grant@stanford.edu					Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Azad TD, 2016, WORLD NEUROSURG, V86, DOI 10.1016/j.wneu.2015.10.032; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Blennow K, 2011, ACTA NEUROL SCAND, V123, P245, DOI 10.1111/j.1600-0404.2010.01408.x; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Borogovac A, 2012, INT J BIOMED IMAGING, V2012; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Campion S, 2013, EXPERT OPIN DRUG MET, V9, P1391, DOI 10.1517/17425255.2013.827170; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714, DOI 10.1192/bjp.105.440.714; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; Davis GA, 2015, NEUROSURGERY, V76, P643, DOI 10.1227/NEU.0000000000000722; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Drucker E, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-7; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gasparotti R, 2011, INSIGHTS IMAGING, V2, P335, DOI 10.1007/s13244-011-0086-3; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Geser F, 2011, PROG NEUROBIOL, V95, P649, DOI 10.1016/j.pneurobio.2011.08.011; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; GRONWALL D, 1975, LANCET, V2, P995; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hallen M, 2010, J TRAUMA, V69, P284, DOI 10.1097/TA.0b013e3181ca060b; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; James OG, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00038; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; MAWDSLEY C, 1963, LANCET, V2, P795; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McKee AC, 2015, ACTA NEUROPATHOL, P1; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Moseley ME, 2009, NEUROL CLIN, V27, P1, DOI 10.1016/j.ncl.2008.09.006; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nakamura K, 2013, CURR MOL MED, V13, P1098; Nakamura K, 2013, PRION, V7, P117, DOI 10.4161/pri.22849; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; National Institute of Neurological Disorders and Stroke, 1 NIH CONS C DEF NEU; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nguyen ML, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00091; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Petcharunpaisan S, 2010, WORLD J RADIOL, V2, P384, DOI 10.4329/wjr.v2.i10.384; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Romeo MJ, 2005, EXPERT REV PROTEOMIC, V2, P57, DOI 10.1586/14789450.2.1.57; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Schroeter ML, 2013, CURR DRUG TARGETS, V14, P1237; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilde EA, 2015, J NEUROTRAUMA; Wolk DA, 2012, CURR OPIN NEUROL, V25, P421, DOI 10.1097/WCO.0b013e328354ff0a; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang W, 2012, J ALZHEIMERS DIS, V31, P601, DOI 10.3233/JAD-2012-120712; Zhang ZJ, 2011, J CLIN LAB ANAL, V25, P402, DOI 10.1002/jcla.20491; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	151	16	16	2	39	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	APR	2016	40	4							E14	10.3171/2016.1.FOCUS15607			16	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI4NL	WOS:000373476500004	27032917	gold, Green Submitted			2022-02-06	
J	Serri, K; El Rayes, M; Giraldeau, G; Williamson, D; Bernard, F				Serri, Karim; El Rayes, Malak; Giraldeau, Genevieve; Williamson, David; Bernard, Francis			Traumatic brain injury is not associated with significant myocardial dysfunction: an observational pilot study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Myocardial dysfunction; Echocardiography; Left ventricular ejection fraction	NEUROCARDIOGENIC INJURY; EUROPEAN-ASSOCIATION; TROPONIN ELEVATION; AMERICAN-SOCIETY; WALL-MOTION; ECHOCARDIOGRAPHY; CLASSIFICATION; PREDICTORS; HEMORRHAGE; GUIDELINES	Background: Myocardial dysfunction has been well described with catastrophic neurological events, such as subarachnoid hemorrhage and brain death. There is very limited data describing myocardial function in the context of traumatic brain injury (TBI), as no prospective study has yet examined this association. The objective of our study was to evaluate cardiac function using echocardiography in patients with clinically important TBI. Methods: We conducted a prospective observational study of consecutive TBI patients admitted to the intensive care unit. All patients older than 16 years with moderate to severe TBI according to the Glascow Coma Scale (GCS) were eligible for the study. Only patients with a prior history of heart disease or cardiomyopathy or evidence of brain death on admission were excluded. A complete transthoracic echocardiogram was performed within 4 days of admission. Results: Forty-nine patients (67 % males, median age 34 years) were included in the study. Forty-one patients had severe TBI (84 %) with a median GCS of six, 44 patients (90 %) required mechanical ventilation and 36 (74 %) intracranial pressure monitoring. Hospital mortality was 18 %. No patients had global left ventricular dysfunction as defined by a left ventricular ejection fraction (LVEF) below 50 % (95 % CI, 0-0.07). Average LVEF was 65 +/- 4 %. Four patients (8 %) had regional wall motion abnormalities with preserved LVEF. Discussion: The main finding of this study is the absence of clinically significant myocardial dysfunction in patients with moderate or severe TBI. Although myocardial dysfunction has been well described in a variety of neurological settings, it is possible that the young age of TBI patients and the absence of cardiovascular risk factors are protective against significant myocardial injury from catecholamine excess. Conclusions: In a group of patients with clinically important TBI, we did not identify any significant cardiac dysfunction.	[Serri, Karim; El Rayes, Malak; Williamson, David; Bernard, Francis] Univ Montreal, Serv Intensifs, Hop Sacre Coeur Montreal, Dept Med, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada; [Serri, Karim; Williamson, David; Bernard, Francis] Univ Montreal, Res Ctr, Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Giraldeau, Genevieve] Univ Montreal, Inst Cardiol Montreal, Montreal, PQ, Canada		Serri, K (corresponding author), Univ Montreal, Serv Intensifs, Hop Sacre Coeur Montreal, Dept Med, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada.; Serri, K (corresponding author), Univ Montreal, Res Ctr, Hop Sacre Coeur Montreal, Montreal, PQ, Canada.	karim.serri@umontreal.ca					Banki NM, 2005, CIRCULATION, V112, P3314, DOI 10.1161/CIRCULATIONAHA.105.558239; Borbely XI, 2015, NEUROCRIT CARE, V23, P66, DOI 10.1007/s12028-014-0101-x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; DOSHI R, 1977, J NEUROL NEUROSUR PS, V40, P821, DOI 10.1136/jnnp.40.8.821; Dujardin KS, 2001, J HEART LUNG TRANSPL, V20, P350, DOI 10.1016/S1053-2498(00)00193-5; HAWKINS WE, 1971, CARDIOVASC RES, V5, P524, DOI 10.1093/cvr/5.4.524; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Huttemann E, 2002, INTENS CARE MED, V28, P1084, DOI 10.1007/s00134-002-1355-x; JACOB WA, 1972, J MOL CELL CARDIOL, V4, P287, DOI 10.1016/0022-2828(72)90076-4; KARCH SB, 1986, HUM PATHOL, V17, P9, DOI 10.1016/S0046-8177(86)80150-2; Kothavale A, 2006, NEUROCRIT CARE, V4, P199, DOI 10.1385/NCC:4:3:199; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee VH, 2006, NEUROCRIT CARE, V5, P243, DOI 10.1385/NCC:5:3:243; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MAYER SA, 1995, J NEUROSURG, V83, P889, DOI 10.3171/jns.1995.83.5.0889; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Najafipour Hamid, 2014, Iranian Biomedical Journal, V18, P225, DOI 10.6091/ibj.13222.2014; NOVITZKY D, 1986, ANN THORAC SURG, V41, P520, DOI 10.1016/S0003-4975(10)63032-9; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Salem R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0558-1; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Tung P, 2004, STROKE, V35, P548, DOI 10.1161/01.STR.0000114874.96688.54; Urbaniak K, 2007, SURG NEUROL, V67, P21, DOI 10.1016/j.surneu.2006.08.065; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	30	16	16	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 16	2016	24								31	10.1186/s13049-016-0217-4			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DH4ZT	WOS:000372795200001	26983752	Green Published, gold			2022-02-06	
J	Chou, A; Morganti, JM; Rosi, S				Chou, Austin; Morganti, Josh M.; Rosi, Susanna			Frontal Lobe Contusion in Mice Chronically Impairs Prefrontal-Dependent Behavior	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CARD SORTING TEST; SOCIAL COGNITION; ORBITOFRONTAL CORTEX; HEAD-INJURY; LESIONS; ANXIETY; DYSFUNCTION; PERFORMANCE; REVERSAL	Traumatic brain injury (TBI) is a major cause of chronic disability in the world. Moderate to severe TBI often results in damage to the frontal lobe region and leads to cognitive, emotional, and social behavioral sequelae that negatively affect quality of life. More specifically, TBI patients often develop persistent deficits in social behavior, anxiety, and executive functions such as attention, mental flexibility, and task switching. These deficits are intrinsically associated with prefrontal cortex (PFC) functionality. Currently, there is a lack of analogous, behaviorally characterized TBI models for investigating frontal lobe injuries despite the prevalence of focal contusions to the frontal lobe in TBI patients. We used the controlled cortical impact (CCI) model in mice to generate a frontal lobe contusion and studied behavioral changes associated with PFC function. We found that unilateral frontal lobe contusion in mice produced long-term impairments to social recognition and reversal learning while having only a minor effect on anxiety and completely sparing rule shifting and hippocampal-dependent behavior.	[Chou, Austin; Morganti, Josh M.; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Chou, Austin; Rosi, Susanna] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Chou, Austin; Morganti, Josh M.; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy Rehabil Sci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA		Rosi, S (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Phys Therapy Rehabil Sci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA.	rosis@ptrehab.ucsf.edu	Morganti, Josh/AAL-9727-2020	Morganti, Josh/0000-0002-4183-0049; Chou, Austin/0000-0003-4328-5811	National Institute Of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute on Aging of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21NS087458, R21AG042016]; Alzheimer's AssociationAlzheimer's Association [IIRG-11-202064]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS087458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG042016] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute Of Neurological Disorders And Stroke and National Institute on Aging of the National Institutes of Health under award numbers R21NS087458 (S.R.); R21AG042016 (S.R.); Alzheimer's Association IIRG-11-202064 (S.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsop SA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00241; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Brooks JM, 2012, NEUROPSYCHOPHARMACOL, V37, P2476, DOI 10.1038/npp.2012.106; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Cho KKA, 2015, NEURON, V85, P1332, DOI 10.1016/j.neuron.2015.02.019; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fox MT, 2003, J NEUROSCI, V23, P676, DOI 10.1523/JNEUROSCI.23-02-00676.2003; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Placek K, 2013, BEHAV BRAIN RES, V256, P405, DOI 10.1016/j.bbr.2013.08.034; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Rudebeck PH, 2014, NEURON, V84, P1143, DOI 10.1016/j.neuron.2014.10.049; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Sobota R, 2015, BEHAV NEUROSCI, V129, P389, DOI 10.1037/bne0000074; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; Wood Jacqueline N, 2003, Behav Cogn Neurosci Rev, V2, P97; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Young JW, 2010, COGN AFFECT BEHAV NE, V10, P243, DOI 10.3758/CABN.10.2.243	51	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151418	10.1371/journal.pone.0151418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	WOS:000371993000150	26964036	Green Submitted, Green Published, gold			2022-02-06	
J	Fotakopoulos, G; Tsianaka, E; Siasios, G; Vagkopoulos, K; Fountas, K				Fotakopoulos, George; Tsianaka, Eleni; Siasios, Giannis; Vagkopoulos, Konstantinos; Fountas, Kostas			Posttraumatic Hydrocephalus after Decompressive Craniectomy in 126 Patients with Severe Traumatic Brain Injury	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						posttraumatic hydrocephalus; decompressive craniectomy	SEVERE HEAD-INJURY; RISK-FACTORS; INTERHEMISPHERIC HYGROMA; INTRACRANIAL-PRESSURE; SHUNT IMPLANTATION; MANAGEMENT	Objective Severe traumatic brain injuries (TBIs) occur frequently. In some of these patients decompressive craniectomy (DC) must be performed. Posttraumatic hydrocephalus (PTH) can develop after TBI further damaging the brain. DC is considered to be one of the causes of PTH. This study defines the incidence of PTH in TBI patients who underwent DC and tries to determine associated factors. Materials and Methods We conducted a retrospective study (2009-2013) that included 126 patients with severe TBI and DC. The collected data were demographics, the craniectomy size, the presence or absence of hydrocephalus, the need for changing the opening pressure of the valve of the cerebrospinal fluid (CSF) shunt or replacing all or parts of the CSF shunt, and the interval between cranioplasty and shunt placement. We excluded patients with additional intraventricular hemorrhage and those with bilateral or bifrontal DC. Results Ten of the 126 patients (7.9%) developed PTH and were treated with a CSF shunt. There was no statistical correlation between development of PTH and age or sex, but a statistically significant correlation between development of PTH and the size of DC. Conclusion Our study suggests that PTH development is multifactorial and shows that PTH is not that rare. We showed a correlation between craniectomy size and the incidence of PTH.	[Fotakopoulos, George; Tsianaka, Eleni; Siasios, Giannis; Vagkopoulos, Konstantinos; Fountas, Kostas] Univ Hosp Thesaly, Dept Neurosurg, Larisa 41110, Thesaly, Greece		Fotakopoulos, G (corresponding author), Univ Hosp Thesaly, Dept Neurosurg, Larisa 41110, Thesaly, Greece.	gfotakop@yahoo.gr	Siasios, Ioannis/AAQ-7123-2020	Siasios, Ioannis/0000-0001-7945-9604; fotakopoulos, george/0000-0002-2491-2886			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Cho BR, 2012, KOREAN J NEUROTRAUMA, V8, P110; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Dandy WE, 1914, AM J DIS CHILD, V8, P406; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Faul M, 2010, TRAUMATIC BRAIN INJU; FOROGLOU G, 1972, Acta Radiologica Diagnosis, V13, P524; GAAB MR, 1990, ACT NEUR S, V51, P326; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Guyot LL, 2000, NEUROL RES, V22, P25; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Iencean S, 2009, ROMANIAN NEUROSURG, V16, P17; Jeon SW, 2011, J KOREAN NEUROSURG S, V49, P355, DOI 10.3340/jkns.2011.49.6.355; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Le TH, 2006, SEMIN ROENTGENOL, V41, P177, DOI 10.1053/j.ro.2006.04.003; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; Matsumoto S, 1990, ANN REV HYDROCEPHALU, V6, P147; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Osuka S, 2010, J NEUROSURG, V112, P832, DOI 10.3171/2009.7.JNS09550; Pangilinan II PH, POSTTRAUMATIC HYDROC; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Sarkari A, 2010, INDIAN J NEUROTRAUM, V7, P135, DOI 10.1016/S0973-0508(10)80028-0; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Snell RS, 2008, CLIN ANATOMY REGIONS, P450; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P281, DOI 10.1007/978-3-7091-1434-6_54; Takeuchi S, 2012, J NEUROTRAUM, V29, P1028, DOI 10.1089/neu.2010.1743; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Tribl G, 2000, BRAIN INJURY, V14, P345; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wen L, 2009, BRAIN INJURY, V23, P61, DOI 10.1080/02699050802635265; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	46	16	23	0	8	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	MAR	2016	77	2					88	92		10.1055/s-0035-1558411			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DF1CE	WOS:000371075200002	26351868				2022-02-06	
J	Maruta, J; Palacios, EM; Zimmerman, RD; Ghajar, J; Mukherjee, P				Maruta, Jun; Palacios, Eva M.; Zimmerman, Robert D.; Ghajar, Jamshid; Mukherjee, Pratik			Chronic Post-Concussion Neurocognitive Deficits. I. Relationship with White Matter Integrity	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						eye movement; diffusion tensor imaging; mild traumatic brain injury; neuroimaging; neuropsychology; post-concussion syndrome	TRAUMATIC BRAIN-INJURY; SUBJECT DIFFUSION DATA; SPATIAL STATISTICS; VOXELWISE ANALYSIS; SYMPTOMS; TRENDS; SYNCHRONIZATION; SPECIFICITY; VALIDITY; SPORTS	We previously identified visual tracking deficits and associated degradation of integrity in specific white matter tracts as characteristics of concussion. We re-explored these characteristics in adult patients with persistent post-concussive symptoms using independent new data acquired during 2009-2012. Thirty-two patients and 126 normal controls underwent cognitive assessments and MR-DTI. After data collection, a subset of control subjects was selected to be individually paired with patients based on gender and age. We identified patients' cognitive deficits through pairwise comparisons between patients and matched control subjects. Within the remaining 94 normal subjects, we identified white matter tracts whose integrity correlated with metrics that indicated performance degradation in patients. We then tested for reduced integrity in these white matter tracts in patients relative to matched controls. Most patients showed no abnormality in MR images unlike the previous study. Patients' visual tracking was generally normal. Patients' response times in an attention task were slowed, but could not be explained as reduced integrity of white matter tracts relating to normal response timing. In the present patient cohort, we did not observe behavioral or anatomical deficits that we previously identified as characteristic of concussion. The recent cohort likely represented those with milder injury compared to the earlier cohort. The discrepancy may be explained by a change in the patient recruitment pool circa 2007 associated with an increase in public awareness of concussion.	[Maruta, Jun; Ghajar, Jamshid] Brain Trauma Fdn, New York, NY USA; [Palacios, Eva M.; Mukherjee, Pratik] Univ Calif San Francisco, Sch Med, Dept Radiol & Biomed Imaging, San Francisco, CA USA; [Zimmerman, Robert D.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Ghajar, Jamshid] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA		Maruta, J (corresponding author), Brain Trauma Fdn, New York, NY USA.; Mukherjee, P (corresponding author), Univ Calif San Francisco, Sch Med, Dept Radiol & Biomed Imaging, San Francisco, CA USA.	jmaruta@braintrauma.org; pratik@radiology.ucsf.edu	Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605	U.S. Department of Defense Congressionally Directed Medical Research Programs through an Advanced Technology Award [W81XWH-08-1-0646]	We thank the staff of Brain Trauma Foundation's clinical research team and the Citigroup Biomedical Imaging Center for assistance with data collection and maintenance. Frank Ezekiel preprocessed the DTI data. This work was supported by U.S. Department of Defense Congressionally Directed Medical Research Programs through an Advanced Technology Award (W81XWH-08-1-0646) to JG.	Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; CDC, 2013, HEADS 10 YEARS ANN V; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellenbogen RG, 2010, WORLD NEUROSURG, V74, P560, DOI 10.1016/j.wneu.2010.11.016; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Ghosh SS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00004; Gong GL, 2005, NEUROREPORT, V16, P1701, DOI 10.1097/01.wnr.0000183327.98370.6a; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Inano S, 2011, AM J NEURORADIOL, V32, P2103, DOI 10.3174/ajnr.A2785; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00045; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Maruta J, 2012, PROC SPIE, V8371, DOI 10.1117/12.927790; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Niven Daniel J, 2012, Clin Epidemiol, V4, P99, DOI 10.2147/CLEP.S30816; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Temme L, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00041; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	46	16	17	3	22	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	FEB 10	2016	10								35	10.3389/fnhum.2016.00035			8	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	DD3VJ	WOS:000369850900001	26903842	Green Published, gold			2022-02-06	
J	Copeland, CT; Mahoney, JJ; Block, CK; Linck, JF; Pastorek, NJ; Miller, BI; Romesser, JM; Sim, AH				Copeland, Christopher T.; Mahoney, James J.; Block, Cady K.; Linck, John F.; Pastorek, Nicholas J.; Miller, Brian I.; Romesser, Jennifer M.; Sim, Anita H.			Relative Utility of Performance and Symptom Validity Tests	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Malingering/symptom validity testing; Assessment; Head injury, Traumatic brain injury	FAKE BAD SCALE; MMPI-2	This investigation adds to the burgeoning body of research concerned with discriminating performance and symptom validity tests (SVTs) through examination of their differential relationships with cognitive performance and symptom self-report measures. To the authors' current knowledge, prior studies have not assessed differences between participants who fail either a performance validity test (PVT) or an SVT but not both. As part of their neuropsychological evaluations at four Veterans Affairs medical centers across the United States, participants were administered a fixed, standardized battery that consisted of performance validity, symptom validity, cognitive performance, and symptom self-report measures. Compared with participants who failed a PVT and an SVT, participants who passed both and participants who only passed a PVT demonstrated better cognitive performance and self-reported fewer symptoms. Results support differential clinical utility of performance validity and SVTs when assessing cognitive performance and symptom self-report.	[Copeland, Christopher T.; Mahoney, James J.; Block, Cady K.; Linck, John F.] Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, 920 Stanton L Young Blvd, Oklahoma City, OK 73162 USA; [Linck, John F.] Vet Affairs Med Ctr, Mental Hlth & Psychol Serv, Oklahoma City, OK 73104 USA; [Pastorek, Nicholas J.; Miller, Brian I.] Michael E DeBakey VA Med Ctr, Mental Hlth Care Line, Houston, TX USA; [Romesser, Jennifer M.] George E Whalen Vet Affairs Med Ctr, Mental Hlth, Salt Lake City, UT USA; [Sim, Anita H.] Minneapolis Vet Affairs Hlth Care Syst, Dept Phys Med & Rehabil, Minneapolis, MN USA; [Mahoney, James J.] Univ Virginia, Sch Med, Neurocognit Assessment Lab, Charlottesville, VA 22908 USA; [Block, Cady K.] TIRR Mem Hermann Hosp, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Copeland, CT (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, 920 Stanton L Young Blvd, Oklahoma City, OK 73162 USA.	christopher-copeland@ouhsc.edu	Mahoney, James/ABB-9284-2021; Mahoney, James/I-2753-2014; Block, Cady/I-3078-2014	Mahoney, James/0000-0003-0824-1776; Mahoney, James/0000-0003-0824-1776; Pastorek, Nicholas/0000-0002-9290-380X; Block, Cady/0000-0001-7168-6116; Copeland, Christopher/0000-0002-8203-4436			Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Butcher J, 1989, MANUAL ADM SCORING M; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Delis D.C., 2000, CALIFORNIA VERBAL LE; Green P., 2003, GREENS WORD MEMORY T; Institute of Medicine of the National Academies, 2009, RET HOM IR AFGH PREL; Iverson G. L., 2003, CAN PSYCH ASS HAL NO; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001	19	16	16	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2016	31	1					18	22		10.1093/arclin/acv065			5	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DD8QQ	WOS:000370192400004	26537776	Bronze			2022-02-06	
J	Lemke, S; Cockerham, GC; Glynn-Milley, C; Lin, R; Cockerham, KP				Lemke, Sonne; Cockerham, Glenn C.; Glynn-Milley, Catherine; Lin, Richard; Cockerham, Kimberly P.			Automated Perimetry and Visual Dysfunction in Blast-Related Traumatic Brain Injury	OPHTHALMOLOGY			English	Article							FALSE-NEGATIVE RESPONSES; FULL THRESHOLD; SITA STANDARD; RELIABILITY INDEXES; REPRODUCIBILITY; MANIFEST; STRATEGY; SUSPECT; SYSTEM; TESTS	Purpose: To evaluate feasibility and results of automated perimetry in veterans with combat blast neurotrauma. Design: Prospective, longitudinal, observational case series. Participants: Sixty-one patients in a Veterans Affairs Polytrauma Center diagnosed with traumatic brain injury (TBI) from combat blast exposure. Methods: Study participants underwent automated perimetry at baseline (median interval, 2 months after injury) (Humphrey Field Analyzer, Carl Zeiss Meditec, Dublin, CA, Swedish Interactive Threshold Algorithm 30-2 Standard or Fast), and 36 of them were followed up (median interval, 10 months after baseline). Presence of significant mean deviation and pattern standard deviation was determined for testing with reliability indices <= 20% for fixation loss, 15% for false-positives, and 33% for false-negatives. Test-retest stability of global visual field indices was assessed for tests with these cutoffs or with elevated fixation loss. Associations between global visual field defects and predictors were examined. Main Outcome Measures: Global visual field indices (mean deviation and pattern standard deviation). Results: Among 61 study participants (109 study eyes) with baseline testing, a field that met reliability cutoffs was obtained for 48 participants (79%) and 78 eyes (72%). Fixation loss was found in 29% of eyes in initial testing. Nine study participants (15%) demonstrated hemianopia or quadrantanopia, and an additional 36% had an abnormal global visual field index. Global indices were relatively stable at follow-up testing for tests meeting fixation-loss cutoffs and tests that did not. Visual scotomas due to post-chiasmal lesions were associated with moderate to severe TBI or penetrating head injury, but other visual field deficits were prevalent across the range of mild to severe TBI. Ocular injury to the retina or choroid, poorer visual acuity, and pupillary defect were associated with visual field defects. Participants with depressed visual field sensitivity reported lower visual quality of life. Conclusions: Reliable automated perimetry can be accomplished in most patients with TBI from combat blast exposure and reveals high rates of visual field deficits, indicating that blast forces may significantly affect the eye and visual pathways. (C) 2016 Published by Elsevier on behalf of the American Academy of Ophthalmology.	[Lemke, Sonne] Vet Adm Palo Alto Hlth Care Syst, Program Evaluat & Resource Ctr, Palo Alto, CA 94304 USA; [Cockerham, Glenn C.; Glynn-Milley, Catherine; Cockerham, Kimberly P.] Vet Adm Palo Alto Hlth Care Syst, Ophthalmol, Palo Alto, CA 94304 USA; [Cockerham, Glenn C.; Cockerham, Kimberly P.] Stanford Univ, Sch Med, Ophthalmol, Stanford, CA 94305 USA; [Lin, Richard] Scripps Clin Med Grp, Ophthalmol, La Jolla, CA USA		Cockerham, GC (corresponding author), Vet Adm Palo Alto Hlth Care Syst, Ophthalmol 112 B1, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	glenn.cockerham@va.gov	Cockerham, Kimberly/AAR-5917-2021		Veterans Administration Merit Review AwardUS Department of Veterans Affairs [C5018R]; Department of Veterans AffairsUS Department of Veterans Affairs [C5018-R]	Funded by Veterans Administration Merit Review Award C5018R. The sponsor had no role in the design or conduct of this research.; This article is based on work supported by the Department of Veterans Affairs Merit Review Award Grant C5018-R. The views expressed in this article are those of the authors and do not necessarily reflect the position or policies of the Department of Veterans Affairs or the US government.	Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Anderson DR, 2011, OPHTHALMOL MANAGE; Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; Bengtsson B, 2000, ACTA OPHTHALMOL SCAN, V78, P519, DOI 10.1034/j.1600-0420.2000.078005519.x; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Bengtsson B, 1998, ACTA OPHTHALMOL SCAN, V76, P268, DOI 10.1034/j.1600-0420.1998.760303.x; Bengtsson B, 1998, ACTA OPHTHALMOL SCAN, V76, P165, DOI 10.1034/j.1600-0420.1998.760208.x; Birt CM, 1997, OPHTHALMOLOGY, V104, P1126, DOI 10.1016/S0161-6420(97)30173-0; Bosworth C F, 2000, Semin Ophthalmol, V15, P172, DOI 10.3109/08820530009037869; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Cockerham GC, 2014, OPHTHALMOLOGY, V121, P2165, DOI 10.1016/j.ophtha.2014.06.009; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Committee on Gulf War and Health, 2014, GULF WAR AND HLTH, V7, P93; Deakin JB, 2004, PSYCHOPHARMACOLOGY, V173, P88, DOI 10.1007/s00213-003-1695-4; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ishiyama Y, 2014, INVEST OPHTH VIS SCI, V55, P8149, DOI 10.1167/iovs.14-15541; JOHNSON CA, 1993, OPHTHALMOLOGY, V100, P269; Johnson CA, 2014, J GLAUCOMA, V23, P288, DOI 10.1097/IJG.0b013e31829463ab; KATZ J, 1991, OPHTHALMOLOGY, V98, P70; Kunimatsu, 2000, Jpn J Ophthalmol, V44, P190, DOI 10.1016/S0021-5155(99)00209-9; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Montolio FGJ, 2012, INVEST OPHTH VIS SCI, V53, P7010, DOI 10.1167/iovs.12-10268; Newkirk MR, 2006, INVEST OPHTH VIS SCI, V47, P4632, DOI 10.1167/iovs.05-1598; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Pieramici DJ, 1997, AM J OPHTHALMOL, V123, P820, DOI 10.1016/S0002-9394(14)71132-8; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; SANABRIA O, 1991, OPHTHALMOLOGY, V98, P76; Shao X, 2011, J CLIN EXPT OPHTHALM, V2; Snyder PJ, 2005, HUM PSYCHOPHARM CLIN, V20, P263, DOI 10.1002/hup.692; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Szatmary G, 2002, ARCH OPHTHALMOL-CHIC, V120, P1162; THOMPSON JR, 1993, BRIT J OPHTHALMOL, V77, P115, DOI 10.1136/bjo.77.2.115; Wall M, 2001, INVEST OPHTH VIS SCI, V42, P528; Wall M, 2008, J GLAUCOMA, V17, P626, DOI 10.1097/IJG.0b013e318168f03e	42	16	16	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	FEB	2016	123	2					415	424		10.1016/j.ophtha.2015.10.003			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	DB2TK	WOS:000368362200036	26581554				2022-02-06	
J	Nikolaeva, I; Crowell, B; Valenziano, J; Meaney, D; D'Arcangelo, G				Nikolaeva, Ina; Crowell, Beth; Valenziano, Julia; Meaney, David; D'Arcangelo, Gabriella			Beneficial Effects of Early mTORC1 Inhibition after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; mTOR; rapamycin	TUBEROUS SCLEROSIS COMPLEX; CONTROLLED CORTICAL IMPACT; MAMMALIAN TARGET; MOUSE MODEL; RAPAMYCIN TOXICITY; AKT; NEURONS; RECEPTORS; RECOVERY; SURVIVAL	The mammalian target of rapamycin complex 1 (mTORC1) signaling pathway mediates many aspects of cell growth and regeneration and is upregulated after moderate to severe traumatic brain injury (TBI). The significance of this increased signaling event for recovery of brain function is presently unclear. We analyzed the time course and cell specificity of mTORC1 signal activation in the mouse hippocampus after moderate controlled cortical impact (CCI) and identified an early neuronal peak of activity that occurs within a few hours after injury. We suppressed this peak activity by a single injection of the mTORC1 inhibitor rapamycin 1h after CCI and showed that this acute treatment significantly diminishes the extent of neuronal death, astrogliosis, and cognitive impairment 1-3 days after injury. Our findings suggest that the early neuronal peak of mTORC1 activity after TBI is deleterious to brain function, and that acute, early intervention with mTORC1 inhibitors after injury may represent an effective form of treatment to improve recovery in human patients.	[Nikolaeva, Ina; Crowell, Beth; D'Arcangelo, Gabriella] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Nikolaeva, Ina; D'Arcangelo, Gabriella] Rutgers State Univ, Grad Program Mol Biosci, Piscataway, NJ 08854 USA; [Valenziano, Julia; Meaney, David] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		D'Arcangelo, G (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd,B323, Piscataway, NJ 08854 USA.	darcangelo@dls.rutgers.edu		D'Arcangelo, Gabriella/0000-0003-1575-1010; Meaney, David/0000-0002-0954-4122	New Jersey Commission on Brain Injury Research [CBIR12-MIG011]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS093293] Funding Source: NIH RePORTER	This work is supported by multiprogrammatic grant CBIR12-MIG011 from the New Jersey Commission on Brain Injury Research (GD and DM).	Barlow AD, 2012, DIABETOLOGIA, V55, P1355, DOI 10.1007/s00125-012-2475-7; Barlow AD, 2013, DIABETES, V62, P2674, DOI 10.2337/db13-0106; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Das F, 2012, J BIOL CHEM, V287, P3808, DOI 10.1074/jbc.M111.246397; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Kazdoba TM, 2012, DEV NEUROSCI-BASEL, V34, P198, DOI 10.1159/000337229; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Krueger DA, 2013, ANN NEUROL, V74, P679, DOI 10.1002/ana.23960; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shein NA, 2008, J NEUROTRAUM, V25, P112, DOI 10.1089/neu.2007.0358; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Way SW, 2012, HUM MOL GENET, V21, P3226, DOI 10.1093/hmg/dds156; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	31	16	17	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2016	33	2					183	193		10.1089/neu.2015.3899			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DA7PH	WOS:000367995800004	26122481	Green Published			2022-02-06	
J	Lau, EY; Berkowitz, ML; Schwegler, E				Lau, Edmond Y.; Berkowitz, Max L.; Schwegler, Eric			Shock Wave-Induced Damage of a Protein by Void Collapse	BIOPHYSICAL JOURNAL			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; TRAUMATIC BRAIN-INJURY; GATED ION CHANNELS; FORCE-FIELD; POTASSIUM CHANNELS; CRYSTAL-STRUCTURE; DENATURED STATES; SODIUM-CHANNELS; LIPID-BILAYERS; K+ CHANNEL	In this study, we report on a series of molecular dynamics simulations that were used to examine the effects of shock waves on a membrane-bound ion channel. A planar shock wave was found to compress the ion channel upon impact, but the protein geometry resembles the crystal structure as soon as the solvent density begins to dissipate. When a void was placed in close proximity to the membrane, the shock wave proved to be more destructive to the protein due to formation of a nanojet that results from the asymmetric collapse of the void. The nanojet was able to cause significant structural changes to the protein even at low piston velocities that are not able to directly cause poration of the membrane.	[Lau, Edmond Y.; Schwegler, Eric] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Berkowitz, Max L.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA		Lau, EY (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.	lau12@llnl.gov		Lau, Edmond/0000-0003-0619-7249; Berkowitz, Max/0000-0002-9116-0362	Office of Naval ResearchOffice of Naval Research [N00014151P00020]; U.S. Department of Energy by Lawrence Livermore National LaboratoryUnited States Department of Energy (DOE) [DE-AC52-07NA27344]	This work was funded by a grant from the Office of Naval Research (N00014151P00020) and was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. Computing support for this work came from the Lawrence Livermore National Laboratory (LLNL) Institutional Computing Grand Challenge program.	ABRAHAM FF, 1977, J CHEM PHYS, V67, P2384, DOI 10.1063/1.435080; Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Anderson CAF, 2002, STRUCTURE, V10, P175, DOI 10.1016/S0969-2126(02)00700-1; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289; Brujan EA, 2005, PHYS MED BIOL, V50, P4797, DOI 10.1088/0031-9155/50/20/004; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Choubey A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3518472; CONTI F, 1982, J MEMBRANE BIOL, V69, P23, DOI 10.1007/BF01871238; Cooper EC, 1999, P NATL ACAD SCI USA, V96, P4759, DOI 10.1073/pnas.96.9.4759; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Devaraneni PK, 2011, BIOCHEMISTRY-US, V50, P10442, DOI 10.1021/bi2012965; Dima RI, 2004, J PHYS CHEM B, V108, P6564, DOI 10.1021/jp037128y; Espinosa S, 2014, MICROFLUID NANOFLUID, V16, P613, DOI 10.1007/s10404-013-1258-x; Fu HH, 2015, J PHYS CHEM LETT, V6, P413, DOI 10.1021/jz502513w; Ganzenmuller GC, 2011, SOFT MATTER, V7, P4307, DOI 10.1039/c0sm01296c; Ganzenmuller GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051989; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; HEINEMANN SH, 1987, J GEN PHYSIOL, V90, P765, DOI 10.1085/jgp.90.6.765; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarecki BW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01040; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kamatari YO, 2004, METHODS, V34, P133, DOI 10.1016/j.ymeth.2004.03.010; Karp G., 2013, CELL MOL BIOL CONCEP, P121; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koshiyama K, 2008, BBA-BIOMEMBRANES, V1778, P1423, DOI 10.1016/j.bbamem.2008.03.010; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; McAteer JA, 2008, SEMIN NEPHROL, V28, P200, DOI 10.1016/j.semnephrol.2008.01.003; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Piggot TJ, 2012, J CHEM THEORY COMPUT, V8, P4593, DOI 10.1021/ct3003157; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; RYBAKOV AP, 1995, EUR J MECH B-FLUID, V14, P323; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Santo KP, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4862987; Schiffer A, 2012, P ROY SOC A-MATH PHY, V468, P2807, DOI 10.1098/rspa.2012.0076; Schmidt M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03849; Shieh CC, 2000, PHARMACOL REV, V52, P557; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Steinhauser MO, 2014, SOFT MATTER, V10, P4778, DOI 10.1039/c4sm00407h; Tanielian T., 2008, INVISIBLE WOUNDS WAR; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; van der Spoel D., 2010, GROMACS USER MANUAL; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Zhou Y, 2012, J CONTROL RELEASE, V157, P103, DOI 10.1016/j.jconrel.2011.09.068	62	16	16	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	JAN 5	2016	110	1					147	156		10.1016/j.bpj.2015.11.030			10	Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics	DA4QD	WOS:000367783900008	26745418	Green Published, Bronze			2022-02-06	
J	Kubu, CS; Ready, RE; Festa, JR; Roper, BL; Pliskin, NH				Kubu, Cynthia S.; Ready, Rebecca E.; Festa, Joanne R.; Roper, Brad L.; Pliskin, Neil H.			The Times They Are a Changin': Neuropsychology and Integrated Care Teams	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neuropsychology; Professional Issues; Integrated Care; Health care Teams.	DEEP BRAIN-STIMULATION; CLINICAL NEUROPSYCHOLOGY; POSITION STATEMENT; CNS TUMORS; CONCUSSION; MANAGEMENT; ISSUES; SPORT	Objective: To gather illustrative data from clinical neuropsychologists who are working in integrated care settings in order to provide an initial blueprint for moving forward in this new era of health care. Method: A survey was designed to illustrate the ways in which neuropsychologists are participating in integrated care teams and distributed on major neuropsychology listservs. The survey evaluated the settings, roles, services provided, practice issues, remuneration, and impact of neuropsychologists' participation in integrated care teams with respect to patient care and health outcomes. Frequencies were used to summarize the findings as well as qualitative coding of narrative responses. Results: There were 412 respondents to the survey and 261 of those indicated that they worked in at least one integrated care setting. Neuropsychologists work in a variety of integrated care settings and provide diverse services which contribute to improved patient care and outcomes. Conclusions: Three primary themes emerge from the findings with regard to the engagement and teams: advocacy, collaboration, and communication. We argue for the need for more easily accessible outcome studies illustrating the clinical benefits and cost-savings associated with inclusion of neuropsychologists in integrated care teams. In addition, educational and training initiatives are needed to better equip current and future clinical neuropsychologists to function effectively in integrated care settings.	[Kubu, Cynthia S.] Ctr Neurol Restorat, Dept Psychiat & Psychol, Cleveland, OH USA; [Ready, Rebecca E.] Univ Massachusetts, Psychol & Brain Sci, Amherst, MA 01003 USA; [Festa, Joanne R.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Roper, Brad L.] Affairs Med Ctr, Psychol Sect, Memphis, TN USA; [Roper, Brad L.] Univ Tennessee, Coll Med, Memphis, TN USA; [Pliskin, Neil H.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA		Kubu, CS (corresponding author), Cleveland Clin Fdn, Ctr Neurol Restorat, Dept Psychiat & Psychol, P57,9500 Euclid Ave, Cleveland, OH 44195 USA.	kubuc@ccf.org					Azmi H., 2008, AM ASS STER FUNCT NE; Belar CD, 2014, TRAIN EDUC PROF PSYC, V8, P3, DOI 10.1037/tep0000027; Braun M, 2011, COGN BEHAV NEUROL, V24, P107, DOI 10.1097/WNN.0b013e3182351289; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bull KS, 2013, HAND CLINIC, V112, P967, DOI 10.1016/B978-0-444-52910-7.00017-9; Burrell JR, 2015, J NEUROL NEUROSUR PS, V86, P1216, DOI 10.1136/jnnp-2013-307483; Deuschl G, 2006, MOVEMENT DISORD, V21, pS219, DOI 10.1002/mds.20957; Dyrbye LN, 2011, JAMA-J AM MED ASSOC, V305, P2009, DOI 10.1001/jama.2011.652; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Ford PJ, 2006, J MED ETHICS, V32, P106, DOI 10.1136/jme.200X.013151; Institute of Medicine, 2001, CROSSING QUALITY CHA; Lang AE, 2006, MOVEMENT DISORD, V21, pS171, DOI 10.1002/mds.20955; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meyers CA, 2006, J CLIN ONCOL, V24, P1305, DOI 10.1200/JCO.2005.04.6086; Michels TC, 2010, AM FAM PHYSICIAN, V82, P495; Mink JW, 2006, MOVEMENT DISORD, V21, P1831, DOI 10.1002/mds.21039; Novotney A, 2010, MONITOR, V41; Nuttin B, 2014, J NEUROL NEUROSUR PS, V85, P1003, DOI 10.1136/jnnp-2013-306580; Okun MS, 2007, CLIN NEUROPSYCHOL, V21, P162, DOI 10.1080/13825580601025940; Pilitsis JG, 2005, STEREOT FUNCT NEUROS, V83, P67, DOI 10.1159/000086676; Pliskin N, 2015, NEUROBLAST; Prigatano G. P., 2003, CLIN NEUROPSYCHOLOGY; Rey-Casserly C, 2012, PROF PSYCHOL-RES PR, V43, P422, DOI 10.1037/a0028721; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Rozensky RH, 2014, TRAIN EDUC PROF PSYC, V8, P83, DOI 10.1037/tep0000021; Voon V, 2006, MOVEMENT DISORD, V21, pS305, DOI 10.1002/mds.20963; Warren AM, 2014, J TRAUMA NURS, V21, P139, DOI 10.1097/TA.0b013e3182858ab9; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Wilson SJ, 2015, EPILEPSIA, V56, P674, DOI 10.1111/epi.12962	29	16	16	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2016	30	1					51	65		10.1080/13854046.2015.1134670			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DH4CM	WOS:000372733100004	26839169				2022-02-06	
J	Armistead-Jehle, P; Cooper, DB; Vanderploeg, RD				Armistead-Jehle, Patrick; Cooper, Douglas B.; Vanderploeg, Rodney D.			The role of performance validity tests in the assessment of cognitive functioning after military concussion: A replication and extension	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Concussion; mild traumatic brain injury; military; neuropsychological testing; performance validity; symptom validity testing; testing	TRAUMATIC BRAIN-INJURY; MEMORY COMPLAINTS INVENTORY; NEUROPSYCHOLOGICAL PERFORMANCE; POSTCONCUSSIVE COMPLAINTS; REPEATABLE BATTERY; EVALUATION CONTEXT; OEF/OIF VETERANS; EFFORT INDEX; SYMPTOMS; SYMPTOMATOLOGY	The current investigation is a replication and extension of a previously published study by Cooper, Vanderploeg, Armistead-Jehle, Lewis, and Bowles (2014) demonstrating that performance validity test scores accounted for more variance in cognitive testing among service members with a history of concussion than did demographic variables, etiology of and time since injury, and symptom severity. The present study included a sample of 142 active-duty service members evaluated following a suspected or confirmed history of mild traumatic brain injury. Participants completed a battery of neuropsychological measures that included scales of performance and symptom validity (specifically the Medical Symptom Validity Test, Nonverbal Medical Symptom Validity Test, and Personality Assessment Inventory). Among the factors considered in the current study, performance validity test results accounted for the most variance in cognitive test scores, above demographic, concussion history, symptom validity, and psychological distress variables. Performance validity test results were modestly related to symptom validity as measured by the Personality Assessment Inventory Negative Impression Management scale. In sum, the current results replicated the original Cooper et al. study and highlight the importance of including performance validity tests as part of neurocognitive evaluation, even in clinical contexts, within this population.	[Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Concuss Clin, Ft Leavenworth, KS USA; [Cooper, Douglas B.] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, Ft Sam Houston, TX USA; [Vanderploeg, Rodney D.] James A Haley VAMC, Mental Hlth & Behav Sci Psychol Serv, Tampa, FL USA; [Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol & Psychiat, Tampa, FL USA		Armistead-Jehle, P (corresponding author), Munson Army Hlth Ctr, Dept Behav Hlth, 550 Pope Ave, Ft Leavenworth, KS 66027 USA.	patrick.j.armistead-jehle.civ@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P725, DOI 10.1093/arclin/acs071; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P101, DOI 10.1093/arclin/acr081; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone Dominic A, 2009, Appl Neuropsychol, V16, P309, DOI 10.1080/09084280903297883; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Edinger JD, 2003, J SLEEP RES, V12, P43, DOI 10.1046/j.1365-2869.2003.00335.x; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 2004, GREENS MED SYMPTOM V; Green P.J.E., 2008, MANUAL NONVERBAL MED; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Heaton R. K., 2004, REVISED COMPREHENSIV; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kurtz JE, 2007, J PERS ASSESS, V88, P1, DOI 10.1080/00223890709336828; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Lewis R., 1995, DIGIT VIGILANCE TEST; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Morey, 1991, PERSONALITY ASSESSME; Morey L. C., 2003, ESSENTIALS PAI ASSES; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Orff HJ, 2007, SLEEP, V30, P1205, DOI 10.1093/sleep/30.9.1205; Randolph C., 1998, REPEATABLE BATTERY A; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Wager John G, 2010, Appl Neuropsychol, V17, P305, DOI 10.1080/09084282.2010.525093; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Wolfson, 1993, HALSTEAD REITAN NEUR; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015	54	16	16	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	4					264	273		10.1080/23279095.2015.1055564			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DQ7XA	WOS:000379420300003	26569384				2022-02-06	
J	Chaput, G; Lajoie, SP; Naismith, LM; Lavigne, G				Chaput, Genevieve; Lajoie, Susanne P.; Naismith, Laura M.; Lavigne, Gilles			Pain Catastrophizing Correlates with Early Mild Traumatic Brain Injury Outcome	PAIN RESEARCH & MANAGEMENT			English	Article							POST-CONCUSSION SYMPTOMS; CENTER-TASK-FORCE; COLLABORATING-CENTER; HEAD-INJURY; PSYCHOLOGICAL DISTRESS; COPING STRATEGIES; DISABILITY; MANAGEMENT; PREVENTION; GUIDELINES	Background. Identifying which patients are most likely to be at risk of chronic pain and other postconcussion symptoms following mild traumatic brain injury (MTBI) is a difficult clinical challenge. Objectives. To examine the relationship between pain catastrophizing, defined as the exaggerated negative appraisal of a pain experience, and early MTBI outcome. Methods. This cross-sectional design included 58 patients diagnosed with a MTBI. In addition to medical chart review, postconcussion symptoms were assessed by self-report at 1 month (Time 1) and 8 weeks (Time 2) after MTBI. Pain severity, psychological distress, level of functionality, and pain catastrophizing were measured by self-report at Time 2. Results. The pain catastrophizing subscales of rumination, magnification, and helplessness were significantly correlated with pain severity (r = .31 to .44), number of postconcussion symptoms reported (r = .35 to .45), psychological distress (r = .57 to .67), and level of functionality (r = -.43 to -.29). Pain catastrophizing scores were significantly higher for patients deemed to be at high risk of postconcussion syndrome (6 or more symptoms reported at both Time 1 and Time 2). Conclusions. Higher levels of pain catastrophizing were related to adverse early MTBI outcomes. The early detection of pain catastrophizing may facilitate goal-oriented interventions to prevent or minimize the development of chronic pain and other postconcussion symptoms.	[Chaput, Genevieve] McGill Univ, Dept Canc Support & Palliat Med, Ctr Hlth, Montreal, PQ H4A 3J1, Canada; [Lajoie, Susanne P.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ H3A 1Y2, Canada; [Naismith, Laura M.] Univ Hlth Network, HoPingKong Ctr Excellence Educ & Practice, Toronto, ON M5T 2S8, Canada; [Lavigne, Gilles] Univ Montreal, Dept Dent, Montreal, PQ H3C 3J7, Canada		Chaput, G (corresponding author), McGill Univ, Dept Canc Support & Palliat Med, Ctr Hlth, Montreal, PQ H4A 3J1, Canada.	genevieve.chaput@mail.mcgill.ca		Naismith, Laura/0000-0003-3294-7090	FRSQ grant from the Quebec Pain Research Network; CIHR grantCanadian Institutes of Health Research (CIHR); Canada Research Chair in Pain, Sleep, and Trauma funds	The authors wish to thank Ms. Tabatha Chaput for her assistance with data entry and Dr. Jean Paquet for his assistance with statistical analyses. This research was supported by a FRSQ grant from the Quebec Pain Research Network and partially by the laboratory infrastructure supported by a CIHR grant, as well as a Canada Research Chair in Pain, Sleep, and Trauma funds, all awarded to Dr. Gilles Lavigne. Data collection took place within the Emergency Department of Hopital du Sacre-Coeur de Montreal.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carroll LJ, 2004, J REHABIL MED, V36, P11, DOI 10.1080/16501960410023660; Cassidy J., 2004, J REHABILITATION M S, V43, P15, DOI DOI 10.1080/16501960410023688; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Edwards RR, 2006, ARTHRIT RHEUM-ARTHR, V55, P325, DOI 10.1002/art.21865; FLOR H, 1993, BEHAV RES THER, V31, P63, DOI 10.1016/0005-7967(93)90044-U; GIL KM, 1992, J CONSULT CLIN PSYCH, V60, P267, DOI 10.1037/0022-006X.60.2.267; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hubbard CS, 2014, ENEURO, V1, DOI 10.1523/ENEURO.0006-14.2014; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jacobsen PB, 1996, J BEHAV MED, V19, P17, DOI 10.1007/BF01858172; KEEFE FJ, 1989, PAIN, V37, P51, DOI 10.1016/0304-3959(89)90152-8; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus JCL, 2005, TXB TRAUMATIC BRAIN; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Martelli M. F., 2002, PAIN MANAGEMENT PRAC, P125; Martelli MF, 2004, J HEAD TRAUMA REHAB, V19, P10, DOI 10.1097/00001199-200401000-00003; Martin MY, 1996, PAIN, V68, P45, DOI 10.1016/S0304-3959(96)03179-X; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McHugh T, 2006, BRAIN COGNITION, V60, P209; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Severeijns R, 2001, CLIN J PAIN, V17, P165, DOI 10.1097/00002508-200106000-00009; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sullivan MJL, 1998, PAIN, V77, P253, DOI 10.1016/S0304-3959(98)00097-9; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sullivan MJL, 1997, COGNITIVE THER RES, V21, P555, DOI 10.1023/A:1021809519002; Turk DC, 1996, ADV COGNITIVE BEHAV, P83; Turner JA, 2002, PAIN, V98, P127, DOI 10.1016/S0304-3959(02)00045-3; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; World Health Organization, 1978, MENT DIS GLOSS GUID; Zasler ND, 2011, TXB TRAUMATIC BRAIN, P375	51	16	16	0	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1203-6765	1918-1523		PAIN RES MANAG	Pain Res. Manag.		2016	2016								2825856	10.1155/2016/2825856			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DG6VO	WOS:000372224400001	27445604	Green Submitted, Green Published, gold			2022-02-06	
J	Currie, DW; Fields, SK; Patterson, MJ; Comstock, RD				Currie, Dustin W.; Fields, Sarah K.; Patterson, Michael J.; Comstock, R. Dawn			Cheerleading Injuries in United States High Schools	PEDIATRICS			English	Article							EPIDEMIOLOGY; PREVENTION; FREQUENCY	BACKGROUND AND OBJECTIVES: Approximately 400 000 students participate in US high school abstract cheerleading annually, including 123 386 involved in competitive spirit squads. The degree of athleticism and the difficulty of cheerleading skills have increased in recent decades, renewing safety concerns. This study describes the epidemiology of high school cheerleading injuries and compares cheerleading injury rates and patterns relative to other sports. METHODS: Data collected by the longitudinal, National High School Sports-Related Injury Surveillance Study from 2009/2010 through 2013/2014 were analyzed. RESULTS: Injury rates in cheerleading ranked 18th of 22 sports, with an overall injury rate of 0.71 per 1000 athlete-exposures (AEs). Competition (0.85) and practice (0.76) injury rates were similar, whereas performance rates were lower (0.49). Although 96.8% of injured cheerleaders were girls, the overall injury rate was higher in boys (1.33 vs 0.69, rate ratio [RR]: 1.93, 95% confidence interval [CI]: 1.30-2.88). Although concussions were the most common cheerleading injury (31.1% of injuries), concussion rates were significantly lower in cheerleading (2.21 per 10 000 athlete-exposures) than all other sports combined (3.78; RR: 0.58, 95% CI: 0.51-0.66) and all other girls' sports (2.70; RR: 0.82, 95% CI: 0.72-0.93). Over half of all injuries occurred during stunts (53.2%). CONCLUSIONS: Although safety remains a concern among cheerleaders, overall injury rates are lower than most other high school sports. Although overall injury rates are relatively low, cheerleading injuries may be more severe when they do occur. A detailed knowledge of cheerleading injury patterns relative to other sports is needed to drive targeted, evidence-based prevention efforts.	[Currie, Dustin W.; Comstock, R. Dawn] Colorado Sch Publ Hlth, Dept Epidemiol, Mail Stop B119,13001 East 17th Pl, Aurora, CO 80045 USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Fields, Sarah K.] Univ Colorado, Dept Commun, Denver, CO 80202 USA; [Patterson, Michael J.] Lemak Sports Med, Birmingham, AL USA		Currie, DW (corresponding author), Colorado Sch Publ Hlth, Dept Epidemiol, Mail Stop B119,13001 East 17th Pl, Aurora, CO 80045 USA.	dustin.currie@ucdenver.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172, R49CE000674] Funding Source: NIH RePORTER	The content of this report was supported in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01. We also acknowledge the generous research funding contributions of the National Federation of State High School Associations, the National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack.	American Association of Cheerleading Coaches and Administrators, 2006, AM ASS CHEERL COACH; American Sports Data Inc, 2004, SUP SPORTS PART, VII; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Cantu RC, 2013, 27 ANN REP FALL 1982; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Giannone L., 2006, AM ASS CHEERLEADING, P1; Hutchinson MR, 1997, PHYSICIAN SPORTSMED, V25, P83, DOI 10.3810/psm.1997.09.1508; Jacobson BH, 2005, BRIT J SPORT MED, V39, P237, DOI 10.1136/bjsm.2004.014605; Jacobson BH, 2004, J ORTHOP SPORT PHYS, V34, P261, DOI 10.2519/jospt.2004.34.5.261; LaBella CR, 2012, PEDIATRICS, V130, P966, DOI 10.1542/peds.2012-2480; Mueller FO, 2009, J ATHL TRAINING, V44, P565, DOI 10.4085/1062-6050-44.6.565; National Federation of State High School Associations, 2013 2014 HIGH SCH A; National Federation of State High School Associations, 2014, 2014 2015 SPIR RUL B; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Schulz MR., 2002, ATHLETIC INJURIES N; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Shields BJ, 2009, J ATHL TRAINING, V44, P567, DOI 10.4085/1062-6050-44.6.567	21	16	16	5	23	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JAN	2016	137	1							e20152447	10.1542/peds.2015-2447			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	DF5KJ	WOS:000371390300033	26729538				2022-02-06	
J	Eslami, M; Ghanbari, E; Sayyah, M; Etemadi, F; Choopani, S; Soleimani, M; Amiri, Z; Hadjighassem, M				Eslami, Mansoureh; Ghanbari, Elham; Sayyah, Mohammad; Etemadi, Fatemeh; Choopani, Samira; Soleimani, Mansoureh; Amiri, Zohreh; Hadjighassem, Mahmoudreza			Traumatic brain injury accelerates kindling epileptogenesis in rats	NEUROLOGICAL RESEARCH			English	Article						Controlled cortical impact; Epileptogenesis; Parieto-temporal cortex; PTZ kindling; Amygdala kindling	SEIZURES; DISEASE	Objectives: Traumatic brain injury (TBI) is a well-known cause of symptomatic epilepsy. In animal models of post-traumatic epilepsy (PTE), progression of trauma to epilepsy takes several weeks to months. Although this long process is similar to clinical PTE, it is costly and laborious. We used a combination of TBI and kindling as an accelerated animal model to develop epilepsy in much shorter period compared to that occurring in PTE. Methods: Traumatic brain injury was exerted to parieto-temporal cortex of anaesthetised rats by controlled cortical impact (CCI, 5 mm round tip, 4.5 mm/seconds velocity and 150 ms duration). Chemical kindling started 24 hours after CCI by intraperitoneal injection of 30 mg/kg pentylenetetrazole (PTZ) every other day until manifestation of three consecutive generalised seizures. Rapid electrical kindling of the amygdala began 1 week after TBI by exertion of 12 daily threshold stimuli (50 Hz mono-phasic square-wave stimulus of 1 ms per wave for 3 seconds) with 5 minutes interval between each stimulation until the rats became kindled. Results: Controlled cortical impact injury accelerated rate of both chemical and electrical kindling. Number of PTZ injections required for acquisition of generalised seizures decreased from 13.1 +/- 1.6 in sham-operated animals to 7.1 +/- 0.3 in traumatic rats (p < 0.05). The required number of stimuli to elicit electrically kindled focal and generalised seizures decreased from 24.0 +/- 3.9 and 80 +/- 6.5 in sham-operated animals to 6.6 +/- 0.9 and 53 +/- 6.5 in traumatic rats (p < 0.01), respectively. Limitations: Unlike the animal models of PTE in which recurrent seizures occur spontaneously after TBI, in our study, epilepsy is elicited by kindling stimulations. Discussion: Traumatic brain injury facilitates acquisition of epilepsy in both chemical and electrical kindling models. Combination of trauma and kindling can be considered as an inexpensive and time-saving animal model in PTE studies.	[Eslami, Mansoureh; Ghanbari, Elham; Sayyah, Mohammad; Etemadi, Fatemeh; Choopani, Samira] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran; [Eslami, Mansoureh] Shaheed Beheshti Univ Med Sci, Paramed Fac, Dept Physiol, Tehran, Iran; [Eslami, Mansoureh] Sch Adv Technol Med, Dept Neurosci, Tehran, Iran; [Soleimani, Mansoureh] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran; [Amiri, Zohreh] Shaheed Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Dept Basic Sci, Tehran, Iran; [Hadjighassem, Mahmoudreza] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Neurosci, Tehran, Iran		Sayyah, M (corresponding author), Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran.; Hadjighassem, M (corresponding author), Univ Tehran Med Sci, Sch Adv Technol Med, Dept Neurosci, Tehran, Iran.	sayyahm2@pasteur.ac.ir; mhaji63@yahoo.com	Hadjighassem, Mahmoudreza/R-7811-2019; Sayyah, Mohammad/K-4871-2017; Hadjighassem, Mahmoudreza/AAD-8498-2019	Sayyah, Mohammad/0000-0003-0603-2444; Hadjighassem, Mahmoudreza/0000-0001-9046-2767	Pasteur institute of Iran [634]; Iran University of Medical Sciences [15734]	This work is supported by the Pasteur institute of Iran [grant number 634] and the Iran University of Medical Sciences [grant number 15734].	Ahmadi A, 2013, EXP BRAIN RES, V226, P107, DOI 10.1007/s00221-013-3415-6; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Evans RW, 2014, POSTTRAUMATIC SEIZUR; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Ko DY, POSTTRAUMATIC EPILEP; LOTHMAN EW, 1993, EPILEPSY RES, V14, P209, DOI 10.1016/0920-1211(93)90045-9; LOTHMAN EW, 1991, PROG NEUROBIOL, V37, P1, DOI 10.1016/0301-0082(91)90011-O; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Shandra AA, 2005, ADV BEHAV BIOL, V55, P49; Walker MC, 2002, BRAIN, V125, P1937, DOI 10.1093/brain/awf203; Zhang F., 2012, ANIMAL MODELS ACUTE, P93, DOI DOI 10.1007/978-1-61779-782-8_9	13	16	16	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	3					269	274		10.1179/1743132815Y.0000000086			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DM4SS	WOS:000376337600011	26315855				2022-02-06	
J	Grills, CE; Armistead-Jehle, P				Grills, Chad E.; Armistead-Jehle, Patrick			Performance validity test and neuropsychological assessment battery screening module performances in an active-duty sample with a history of concussion	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Medical symptom validity test; military; neuropsychological assessment battery; symptom validity testing; word memory test	TRAUMATIC BRAIN-INJURY; EVALUATION CONTEXT; POOR EFFORT; NAB; VETERANS; SCORES; INDEX	The current retrospective investigation sought to replicate previous findings demonstrating the significant impact of performance validity test (PVT) performance and evaluation context on neuropsychological testing. We examined differences on performance validity testing between active-duty service members undergoing neurocognitive screening for concussion who were seen in a clinical context and those who were seen in a disability-seeking context, as well as the overall impact of PVT performance on a neurocognitive screening battery. Overall, 38.2% of the sample failed the Word Memory Test (WMT). Of those involved in a disability evaluation, the failure rate was 51.9%, which was significantly higher than the 36.8% failure rate among those evaluated in a clinical context. The effect size of WMT performance on a cognitive screening measure was also large. The current retrospective analysis served to replicate previous work.	[Grills, Chad E.] Brain Injury Clin, 394 Glennan Rd,Bldg 672,1st Floor, Schofield Barracks, HI 96857 USA; [Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Behav Hlth, Ft Leavenworth, KS USA		Grills, CE (corresponding author), Brain Injury Clin, 394 Glennan Rd,Bldg 672,1st Floor, Schofield Barracks, HI 96857 USA.	chad.e.grills.civ@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			American Psychological Association, 2002, ETHICAL PRINCIPLES P; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Brown LB, 2005, ARCH CLIN NEUROPSYCH, V20, P209, DOI 10.1016/j.acn.2004.06.003; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Casscells S. W., 2007, ASSISTANT SECRETARY; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Denning J., 2012, 10 AM AC CLIN NEUR A; Donders J, 2012, ARCH CLIN NEUROPSYCH, V27, P440, DOI 10.1093/arclin/acs043; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gavett BE, 2012, APPL NEUROPSYCH-ADUL, V19, P108, DOI 10.1080/09084282.2011.643947; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P, 2004, GREENS MED SYMPTOM V; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hill SW, 2012, EPILEPSY BEHAV, V24, P59, DOI 10.1016/j.yebeh.2012.02.021; Horner MD, 2014, CLIN NEUROPSYCHOL, V28, P703, DOI 10.1080/13854046.2014.925143; Iverson GL, 2007, APPL NEUROPSYCHOL, V14, P178, DOI 10.1080/09084280701508952; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Temple RO, 2009, BRAIN INJURY, V23, P45, DOI 10.1080/02699050802590361; Tombaugh T.N., 1996, TEST MEMORY MALINGER; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909; [No title captured]	46	16	16	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	4					295	301		10.1080/23279095.2015.1079713			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DQ7XA	WOS:000379420300006	26943837				2022-02-06	
J	Iraji, A; Chen, HB; Wiseman, N; Zhang, T; Welch, R; O'Neil, B; Kulek, A; Ayaz, SI; Wang, X; Zuk, C; Haacke, EM; Liu, TM; Kou, ZF				Iraji, Armin; Chen, Hanbo; Wiseman, Natalie; Zhang, Tuo; Welch, Robert; O'Neil, Brian; Kulek, Andrew; Ayaz, Syed Imran; Wang, Xiao; Zuk, Conor; Haacke, E. Mark; Liu, Tianming; Kou, Zhifeng			Connectome-scale assessment of structural and functional connectivity in mild traumatic brain injury at the acute stage	NEUROIMAGE-CLINICAL			English	Article						Brain connectivity; Brain connectome; Magnetic resonance imaging; Neuroimaging; Traumatic brain injury	AMYLOID PRECURSOR PROTEIN; RESTING-STATE NETWORKS; WHITE-MATTER INJURY; WORKING-MEMORY; AXONAL DAMAGE; LOCALIZATION; INDIVIDUALS; DISRUPTION; ACTIVATION; HEMISPHERE	Mild traumatic brain injury (mTBI) accounts for over one million emergency visits each year in the United States. The large-scale structural and functional network connectivity changes of mTBI are still unknown. This study was designed to determine the connectome-scale brain network connectivity changes in mTBI at both structural and functional levels. 40 mTBI patients at the acute stage and 50 healthy controls were recruited. A novel approach called Dense Individualized and Common Connectivity-based Cortical Landmarks (DICCCOLs) was applied for connectome-scale analysis of both diffusion tensor imaging and resting state functional MRI data. Among 358 networks identified on DICCCOL analysis, 41 networks were identified as structurally discrepant between patient and control groups. The involved major white matter tracts include the corpus callosum, and superior and inferior longitudinal fasciculi. Functional connectivity analysis identified 60 connectomic signatures that differentiate patients from controls with 93.75% sensitivity and 100% specificity. Analysis of functional domains showed decreased intra-network connectivity within the emotion network and among emotion-cognition interactions, and increased interactions among action-emotion and action-cognition as well as within perception networks. This work suggests that mTBI may result in changes of structural and functional connectivity on a connectome scale at the acute stage. (C) 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.	[Iraji, Armin; Haacke, E. Mark; Kou, Zhifeng] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA; [Chen, Hanbo; Zhang, Tuo; Liu, Tianming] Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA; [Wiseman, Natalie] Wayne State Univ, Dept Psychiat & Behav Neurosci, Detroit, MI 48207 USA; [Zhang, Tuo] Northwestern Polytech Univ, Sch Automat, Xian, Shaanxi, Peoples R China; [Welch, Robert; O'Neil, Brian; Kulek, Andrew; Ayaz, Syed Imran] Wayne State Univ, Dept Emergency Med, Detroit, MI USA; [Wang, Xiao; Zuk, Conor; Haacke, E. Mark; Kou, Zhifeng] Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA; [Wang, Xiao] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China		Kou, ZF (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA.; Liu, TM (corresponding author), Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA.; Kou, ZF (corresponding author), Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA.	tliu@cs.uga.edu; zhifeng_kou@wayne.edu	Liu, Tianming/AAA-4602-2022	Iraji, Armin/0000-0002-0605-593X; Wiseman, Natalie/0000-0003-0884-6425	International Society for Magnetic Resonance in Medicine; US Department of DefenseUnited States Department of Defense [W81XWH-11-1-0493]; National Institute of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090153]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F30HD084144]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F30HD084144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090153] Funding Source: NIH RePORTER	The authors would like to thank the following co-workers for their contribution: Mr. Zahid Latif, Mr. Yang Xuan andMr. Yashwanth Katkuri from Wayne State University MR Research Facility (MRRF) for their help of data acquisition; Ms. Anamika Chaudhary and Ms. Judith Farah from MRRF for their coordination; Detroit Receiving Hospital Emergency Medicine research team for subject screening and recruitment; and other colleagues in the Cortical Architecture Imaging and Discovery Laboratory in the University of Georgia for their assistance in image analysis. This work was supported by a Seed Grant from the International Society for Magnetic Resonance in Medicine (PI: Zhifeng Kou) and a research grant from the US Department of Defense (award number W81XWH-11-1-0493). Research reported in this publication was also partially supported by the National Institute of Neurological Disorders And Stroke of the National Institutes of Health under Award Number R21NS090153 and the Eunice Kennedy Shriver National Institute of Child Health and Human Development under Award Number F30HD084144. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACRM, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI 10.1097/00001199-199309000-00010; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P1265, DOI 10.1002/hbm.20463; CDC, 2003, REP C MILD TRAUM BRA; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen HB, 2015, LECT NOTES COMPUT SC, V9350, P194, DOI 10.1007/978-3-319-24571-3_24; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Iraji A, 2016, NEUROIMAGE, V134, P494, DOI 10.1016/j.neuroimage.2016.04.006; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Kou ZF, 2012, RSC DRUG DISCOV, V24, P19, DOI 10.1039/9781849734745-00019; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Laird Angela R, 2009, Front Neuroinform, V3, P23, DOI 10.3389/neuro.11.023.2009; Li K., 2010, ADV NEURAL INFORM PR, P1369; Li KM, 2013, HUM BRAIN MAPP, V34, P2494, DOI 10.1002/hbm.22082; Li KM, 2012, NEUROINFORMATICS, V10, P225, DOI 10.1007/s12021-012-9142-5; Li KM, 2010, I S BIOMED IMAGING, P656, DOI 10.1109/ISBI.2010.5490089; Liu TM, 2008, NEUROIMAGE, V40, P991, DOI 10.1016/j.neuroimage.2007.12.027; Liu TM, 2007, NEUROIMAGE, V38, P114, DOI 10.1016/j.neuroimage.2007.07.002; Liu TM, 2011, BRAIN IMAGING BEHAV, V5, P189, DOI 10.1007/s11682-011-9123-6; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Morgan AT, 2013, BRAIN, V136, P646, DOI 10.1093/brain/aws355; National Academy of Neuropsychology, 2002, MILD TRAUM BRAIN INJ; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Pelleg D, 2000, ICML P 17 INT C MACH, P1; Penny D.W., 2011, STAT PARAMETRIC MAPP; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shimony JS, 2009, ACAD RADIOL, V16, P578, DOI 10.1016/j.acra.2009.02.001; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tivarus ME, 2012, BRAIN LANG, V123, P1, DOI 10.1016/j.bandl.2012.06.006; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yuan YX, 2013, NEUROINFORMATICS, V11, P47, DOI 10.1007/s12021-012-9165-y; Zhang T, 2012, CEREB CORTEX, V22, P854, DOI 10.1093/cercor/bhr152; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DJ, 2014, HUM BRAIN MAPP, V35, P2911, DOI 10.1002/hbm.22373; Zhu DJ, 2013, CEREB CORTEX, V23, P786, DOI 10.1093/cercor/bhs072; Zhu DJ, 2011, LECT NOTES COMPUT SC, V6801, P97, DOI 10.1007/978-3-642-22092-0_9; Zhu DJ, 2012, NEUROIMAGE, V59, P1382, DOI 10.1016/j.neuroimage.2011.08.037; Zoroya G., 2007, US TODAY	70	16	17	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	12						100	115		10.1016/j.nicl.2016.06.012			16	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EF3AI	WOS:000390196400013	27408795	gold, Green Published			2022-02-06	
J	Keller, CJ; Chen, EC; Brodsky, K; Yoon, JH				Keller, Corey J.; Chen, Evan C.; Brodsky, Kimberly; Yoon, Jong H.			A case of butane hash oil (marijuana wax)-induced psychosis	SUBSTANCE ABUSE			English	Article						Butane hash oil; cannabis; marijuana; psychosis; THC; wax	TRAUMATIC BRAIN-INJURY; HIGH-POTENCY CANNABIS; DISORDER	Background: Marijuana is one of the most widely used controlled substances in the United States. Despite extensive research on smoked marijuana, little is known regarding the potential psychotropic effects of marijuana wax, a high-potency form of marijuana that is gaining in popularity. Case: The authors present a case of Mr. B, a 34-year-old veteran who presented with profound psychosis in the setting of recent initiation of heavy, daily marijuana wax use. He exhibited incoherent speech and odd behaviors and appeared to be in a dream-like state with perseverating thoughts about his combat experience. His condition persisted despite treatment with risperidone 4mg twice a day (BID), but improved dramatically on day 8 of hospitalization with the return of baseline mental function. Following discharge, Mr. B discontinued all marijuana use and did not exhibit the return of any psychotic symptoms. Discussion: This study highlights the need for future research regarding the potential medical and psychiatric effects of new, high-potency forms of marijuana. Could cannabis have a dose-dependent impact on psychosis? What other potential psychiatric effects could emerge heretofore unseen in lower potency formulations? Given the recent legalization of marijuana, these questions merit timely exploration.	[Keller, Corey J.; Chen, Evan C.; Brodsky, Kimberly; Yoon, Jong H.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 401 Quarry Rd, Stanford, CA 94305 USA; [Keller, Corey J.; Chen, Evan C.; Brodsky, Kimberly; Yoon, Jong H.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA		Keller, CJ (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 401 Quarry Rd, Stanford, CA 94305 USA.	coreyjkeller@gmail.com					Copeland J, 2009, INT REV PSYCHIATR, V21, P96, DOI 10.1080/09540260902782745; D'Souza DC, 2004, NEUROPSYCHOPHARMACOL, V29, P1558, DOI 10.1038/sj.npp.1300496; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Di Forti M, 2015, LANCET PSYCHIAT, V2, P233, DOI 10.1016/S2215-0366(14)00117-5; Di Forti M, 2009, BRIT J PSYCHIAT, V195, P488, DOI 10.1192/bjp.bp.109.064220; Doan C, KCRA NEWS; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Loflin M, 2014, ADDICT BEHAV, V39, P1430, DOI 10.1016/j.addbeh.2014.05.013; Mehmedic Z, 2010, J FORENSIC SCI, V55, P1209, DOI 10.1111/j.1556-4029.2010.01441.x; Morrison PD, 2009, PSYCHOL MED, V39, P1607, DOI 10.1017/S0033291709005522; Murphy CR, ABC NEWS; Paparelli A, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00001; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stogner JM, 2015, SUBST ABUS; Substance Abuse and Mental Health Services Administration, 2014, SAMHSAS CONC TRAUM G; U.S. Department of Health and Human Services, 2014, RESULTS 2013 NATL SU; What You Should Know About Marijuana Concentrates, WHAT YOU SHOULD KNOW; Zuurman L, 2010, J PSYCHOPHARMACOL, V24, P1689, DOI 10.1177/0269881109106913	18	16	16	1	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0889-7077	1547-0164		SUBST ABUS	Subst. Abus.		2016	37	3					384	386		10.1080/08897077.2016.1141153			3	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse	DV2RW	WOS:000382769800003	26820171				2022-02-06	
J	Linnstaedt, SD; Bortsov, AV; Soward, AC; Swor, R; Peak, DA; Jones, J; Rathlev, N; Lee, DC; Domeier, R; Hendry, PL; McLean, SA				Linnstaedt, Sarah D.; Bortsov, Andrey V.; Soward, April C.; Swor, Robert; Peak, David A.; Jones, Jeffrey; Rathlev, Niels; Lee, David C.; Domeier, Robert; Hendry, Phyllis L.; McLean, Samuel A.			CRHBP polymorphisms predict chronic pain development following motor vehicle collision	PAIN			English	Article						Genetic variant; CRHBP; HPA axis; Musculoskeletal pain; Stress-induced hyperalgesia; Motor vehicle collision	HPA AXIS GENES; GLUCOCORTICOID-RECEPTOR; MUSCULOSKELETAL PAIN; IMMUNOPHILIN FKBP51; STRESS; ASSOCIATION; SYMPTOMS; BRAIN; RISK; EXPRESSION	Musculoskeletal pain (MSP) is a common sequela of traumatic stress exposure. While biological factors contributing to chronic MSP after motor vehicle collision (MVC) have traditionally focused on tissue injury, increasing evidence suggests that neuro/stress/immune processes mediated by stress system activation may play a more dominant role. In a previous study, we found that genetic variants in the hypothalamic-pituitary-adrenal (HPA) axis-related gene FKBP5 influence vulnerability to persistent MSP 6 weeks after MVC. In the present cohort study (n5855), we evaluated whether genetic variants in several other important HPA axis-related genes, including the glucocorticoid receptor (NR3C1), corticotropin-releasing hormone receptor R1 (CRHR1), and corticotropin-releasing hormone-binding protein (CRHBP), influence risk of chronic MSP over time after MVC. Genetic polymorphism rs7718461 in the CRHBP gene showed significant association (P = 0.0012) with overall pain severity during the year after MVC in regression models controlling for multiple comparisons. Two additional CRHBP alleles in high linkage disequilibrium with rs7718461 also showed trend-level significance. In secondary analyses, a significant interaction between this CRHBP locus (minor allele frequency = 0.33) and time was observed (P = 0.015), with increasing effect observed over time following trauma. A significant CRHBP x FKBP5 interaction was also observed, with substantially increased MSP after MVC in those with a risk allele in both genes compared with either gene alone. The results of this study indicate that genetic variants in 2 different HPA axis genes predict chronic MSP severity following MVC and support the hypothesis that the HPA axis is involved in chronic post-MVC MSP pathogenesis.	[Linnstaedt, Sarah D.; Bortsov, Andrey V.; Soward, April C.; McLean, Samuel A.] Univ N Carolina, TRYUMPH Res Program, Chapel Hill, NC USA; [Linnstaedt, Sarah D.; Bortsov, Andrey V.; Soward, April C.; McLean, Samuel A.] Univ N Carolina, Anesthesiol, Chapel Hill, NC USA; [Swor, Robert] William Beaumont Hosp, Emergency Med, Royal Oak, MI 48072 USA; [Peak, David A.] Massachusetts Gen Hosp, Emergency Med, Boston, MA 02114 USA; [Jones, Jeffrey] Spectrum Hlth Syst, Emergency Med, Grand Rapids, MI USA; [Rathlev, Niels] Baystate Med Ctr, Emergency Med, Springfield, MA USA; [Lee, David C.] N Shore Univ Hosp, Emergency Med, Manhasset, NY USA; [Domeier, Robert] St Joseph Mercy Hlth Syst, Emergency Med, Ypsilanti, MI USA; [Hendry, Phyllis L.] Univ Florida, Coll Med, Emergency Med, Jacksonville, FL USA; [McLean, Samuel A.] Univ N Carolina, Emergency Med, Chapel Hill, NC USA		McLean, SA (corresponding author), Univ N Carolina, Sch Med, Emergency Med, Wing C CB 7010, Chapel Hill, NC 27599 USA.	smclean@aims.unc.edu			National Institute of Arthritis and Musculoskeletal and Skin diseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR056328]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR056328] Funding Source: NIH RePORTER	The project described was supported by Award Number R01AR056328 from the National Institute of Arthritis and Musculoskeletal and Skin diseases.	[Anonymous], P 12 IASP R IN PRESS; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bijur PE, 2003, ACAD EMERG MED, V10, P390, DOI 10.1197/aemj.10.4.390; Binder EB, 2010, MOL PSYCHIATR, V15, P574, DOI 10.1038/mp.2009.141; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI [10.1016/j.psyneuen.2008.08.018, 10.1016/j.psyneuen.2009.05.021]; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bortsov AV, 2014, NEUROMOL MED, V16, P83, DOI 10.1007/s12017-013-8255-9; Bortsov AV, 2013, PAIN, V154, P1419, DOI 10.1016/j.pain.2013.04.037; Bromer C, 2013, DEV PSYCHOBIOL, V55, P673, DOI 10.1002/dev.21061; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; De Luca V, 2010, J PSYCHOPHARMACOL, V24, P677, DOI 10.1177/0269881108097817; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; El-Hage W, 2013, MOL PSYCHIATR, V18, P174, DOI 10.1038/mp.2011.145; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Ferreira S H, 1993, Drugs, V46 Suppl 1, P1; FUKUOKA H, 1994, BRAIN RES, V657, P133, DOI 10.1016/0006-8993(94)90960-1; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Hartling L, 2001, SPINE, V26, P36, DOI 10.1097/00007632-200101010-00008; Holliday KL, 2010, ANN RHEUM DIS, V69, P556, DOI 10.1136/ard.2009.116137; Holm LW, 2008, SPINE, V33, pS52, DOI 10.1097/BRS.0b013e3181643ece; Khasar SG, 2008, J NEUROSCI, V28, P5721, DOI 10.1523/JNEUROSCI.0256-08.2008; Tran L, 2012, AM J PHYSIOL-GASTR L, V302, pG1301, DOI 10.1152/ajpgi.00501.2011; Levran O, 2014, ANN HUM GENET, V78, P290, DOI 10.1111/ahg.12064; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; Linnstaedt SD, 2015, J PAIN, V16, P637, DOI 10.1016/j.jpain.2015.03.011; Mahon PB, 2013, PSYCHOPHARMACOLOGY, V227, P231, DOI 10.1007/s00213-012-2956-x; MAIER SF, 1993, BRAIN RES, V623, P321, DOI 10.1016/0006-8993(93)91446-Y; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McLean SA, 2014, PAIN, V155, P309, DOI 10.1016/j.pain.2013.10.016; McLean SA, 2011, SPINE, V36, pS226, DOI 10.1097/BRS.0b013e3182387fb4; Musey PI, 2014, ACAD EMERG MED, V21, P1421, DOI 10.1111/acem.12529; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Pesole G, 1997, GENE, V205, P95, DOI 10.1016/S0378-1119(97)00407-1; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pichon X, 2012, CURR PROTEIN PEPT SC, V13, P294, DOI 10.2174/138920312801619475; Platts-Mills TF, 2011, BMC EMERG MED, V11, DOI 10.1186/1471-227X-11-14; Ribbe K, 2011, ARCH GEN PSYCHIAT, V68, P1247, DOI 10.1001/archgenpsychiatry.2011.100; Roy A, 2012, J PSYCHIATR RES, V46, P72, DOI 10.1016/j.jpsychires.2011.09.009; Scammell JG, 2001, GEN COMP ENDOCR, V124, P152, DOI 10.1006/gcen.2001.7696; Seasholtz AF, 2001, PEPTIDES, V22, P743, DOI 10.1016/S0196-9781(01)00387-4; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Suissa S, 2001, EUR SPINE J, V10, P44, DOI 10.1007/s005860000220; Ulirsch JC, 2014, PAIN; US Census Bureau, 2011, STAT ABSTR US 2012; Walton DM, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/876871; Wang SX, 2004, J NEUROSCI, V24, P8595, DOI 10.1523/JNEUROSCI.3058-04.2004; WATKINS LR, 1995, BRAIN RES, V692, P244, DOI 10.1016/0006-8993(95)00715-3; Watkins LR, 1995, PAIN, V63, P289, DOI 10.1016/0304-3959(95)00186-7; WATKINS LR, 1994, BRAIN RES, V654, P15, DOI 10.1016/0006-8993(94)91566-0; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Westphal NJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1878, DOI 10.2741/1931; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	59	16	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	JAN	2016	157	1					273	279		10.1097/j.pain.0000000000000374			7	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	DN5KD	WOS:000377104800028	26447706	Green Submitted, Green Accepted			2022-02-06	
J	Lippa, SM; Lange, RT; Bailie, JM; Kennedy, JE; Brickell, TA; French, LM				Lippa, Sara M.; Lange, Rael T.; Bailie, Jason M.; Kennedy, Jan E.; Brickell, Tracey A.; French, Louis M.			Utility of the Validity-10 scale across the recovery trajectory following traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						military; Neurobehavioral Symptom Inventory; postconcussion symptoms; symptom exaggeration; symptom report; symptom validity; TBI; time since injury; traumatic brain injury; Validity-10 scale	POSTTRAUMATIC-STRESS-DISORDER; SYMPTOM EXAGGERATION; EVALUATION CONTEXT; ENDURING FREEDOM; TEST-PERFORMANCE; RISK-FACTORS; HEAD-INJURY; VETERANS; POSTCONCUSSION; COMPENSATION	The Validity -10 scale was recently developed to screen for symptom exaggeration in patients following traumatic brain injury (TBI). However, it has only been validated on patients with TBI largely in the chronic phase of recovery. The influence of time since injury on the Validity -10 scale was investigated in 2,661 male servicemembers with TBI presenting to six U.S. Defense and Veterans Brain Injury Centers. Participants completed the Neurobehavioral Symptom Inventory (NSI). The Validity -10 scale and NSI total score were both weakly statistically significantly (1) positively correlated with time since injury, (2) negatively correlated with bodily injury severity, and (3) higher in participants undergoing medical board evaluations than in participants who returned to duty or were still hospitalized. Participants were statistically more likely to screen positive for possible symptom exaggeration on the Validity-10 scale as time since injury increased. However, the Validity-10 scale was only weakly related to time since injury, TBI severity, bodily injury severity, disposition, age, and return to duty status. That false positives are not increased in the acute phase of recovery and that the Validity -10 scale is not strongly related to clinical factors support the use of the Validity-10 scale in the acute recovery phase and across the TBI recovery trajectory.	[Lippa, Sara M.; Lange, Rael T.; Bailie, Jason M.; Kennedy, Jan E.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 19,Room 6003,8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Lippa, Sara M.; Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Bailie, Jason M.] Naval Med Ctr, San Diego, CA USA; [Kennedy, Jan E.] San Antonio Mil Med Ctr, San Antonio, TX USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Lippa, SM (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 19,Room 6003,8901 Wisconsin Ave, Bethesda, MD 20889 USA.	sara.lippa.ctr@mail.mil	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Butcher J, 1989, MANUAL ADM SCORING M; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cook J B, 1972, Scand J Rehabil Med, V4, P27; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Kaplan DA, 2014, INFORM PAPER NEUROBE; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly JP, 1997, NEUROLOGY, V48, P581; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Management of Concussion/mTBI Working Group, 2009, J REHABIL RES DEV, V46, pCP1; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea MA, 2008, INFLUENCE ACUTE INJU, P123; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; Morey LC., 1990, PERSONALITY ASSESSME; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; ROGERS R, 1992, J CLIN PSYCHOL, V48, P643; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; U.S. Air Force, 1968, FLIGHT SURG GUID; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Widows M. R., 2005, STRUCTURED INVENTORY; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	54	16	16	0	4	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	3					379	390					12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DL6EF	WOS:000375731700008	27273336	gold			2022-02-06	
J	Lozic, I; Hartz, RV; Bartlett, CA; Shaw, JA; Archer, M; Naidu, PSR; Smith, NM; Dunlop, SA; Iyer, KS; Kilburn, MR; Fitzgerald, M				Lozic, I.; Hartz, R. V.; Bartlett, C. A.; Shaw, J. A.; Archer, M.; Naidu, P. S. R.; Smith, N. M.; Dunlop, S. A.; Iyer, K. Swaminathan; Kilburn, M. R.; Fitzgerald, M.			Enabling dual cellular destinations of polymeric nanoparticles for treatment following partial injury to the central nervous system	BIOMATERIALS			English	Article						Polymer nanoparticles; Central nervous system injury; Oxidative stress and aquaporin 4; Targeted drug delivery of antioxidants; Nanoscale secondary ion mass spectroscopy (NanoSIMS); Macrophages	TRAUMATIC BRAIN-INJURY; CHRONIC SECONDARY DEGENERATION; OPTIC-NERVE; OXIDATIVE STRESS; RESVERATROL PROTECTS; CANCER-CELLS; ASTROCYTES; PROTEINS; BINDING; STROKE	Following neurotrauma, oxidative stress is spread via the astrocytic syncytium and is associated with increased aquaporin 4 (AQP4), inflammatory cell infiltration, loss of neurons and glia and functional deficits. Herein we evaluate multimodal polymeric nanoparticles functionalized with an antibody to an extracellular epitope of AQP4, for targeted delivery of an anti-oxidant as a therapeutic strategy following partial optic nerve transection. Using fluorescence microscopy, spectrophotometry, correlative nanoscale secondary ion mass spectrometry (NanoSIMS) and transmission electron microscopy, in vitro and in vivo, we demonstrate that functionalized nanoparticles are coated with serum proteins such as albumin and enter both macrophages and astrocytes when administered to the site of a partial optic nerve transection in rat. Antibody functionalized nanoparticles synthesized to deliver the antioxidant resveratrol are effective in reducing oxidative damage to DNA, AQP4 immunoreactivity and preserving visual function. Non-fiinctionalized nanoparticles evade macrophages more effectively and are found more diffusely, including in astrocytes, however they do not preserve the optic nerve from oxidative damage or functional loss following injury. Our study highlights the need to comprehensively investigate nanoparticle location, interactions and effects, both in vitro and in vivo, in order to fully understand functional outcomes. (C) 2015 Elsevier Ltd. All rights reserved.	[Lozic, I.; Naidu, P. S. R.; Smith, N. M.; Iyer, K. Swaminathan] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia; [Lozic, I.; Hartz, R. V.; Bartlett, C. A.; Archer, M.; Naidu, P. S. R.; Smith, N. M.; Dunlop, S. A.; Fitzgerald, M.] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia; [Shaw, J. A.; Kilburn, M. R.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, WA 6009, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, 35 Stirling Hwy, Crawley, WA 6009, Australia.	lindy.fitzgerald@uwa.edu.au	Shaw, Jeremy A/B-4156-2011; Smith, Nicole/L-2502-2013; Fitzgerald, Melinda/C-4235-2011; Kilburn, Matthew R/C-4515-2011	Shaw, Jeremy A/0000-0002-5140-457X; Smith, Nicole/0000-0002-5519-8152; Fitzgerald, Melinda/0000-0002-4823-8179; Kilburn, Matthew R/0000-0002-1858-8485; Dunlop, Sarah/0000-0002-1306-3962; Lozic, Ivan/0000-0001-7441-743X; Naidu, Priya/0000-0003-2241-9243	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1028681, APP1082403]; NIH/NIBIB National Resource for Imaging Mass Spectrometry [NIH/NIBIB 5P41 EB001974-10]	This work was supported by the National Health and Medical Research Council of Australia (Grant ID: APP1028681 and APP1082403). We thank Associate Professor Gabriel A. Silva at the Shiley Eye Center at the University of San Diego, CA, for gifting us a sample of rMC1 retinal Muller cells; Igor Luzinov, University of North Carolina for donating PGMA; Mr Guy Ben-Ary of Cell Central, The University of Western Australia, for assistance with fluorescence microscopy; Mr John Murphy, The University of Western Australia, for assistance with confocal microscopy; Professor Martin Saunders for assistance with TEM, Dr Paul Guagliardo and Assistant Professor Jeremy Bougoure for assistance with NanoSIMS. The authors acknowledge the facilities, scientific and technical assistance of the Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis, The University of Western Australia, a facility funded by the University, State and Commonwealth Governments. This work was made possible in part by the OpenMIMS software whose development is funded by the NIH/NIBIB National Resource for Imaging Mass Spectrometry, NIH/NIBIB 5P41 EB001974-10.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]; Bendszus M, 2003, J NEUROSCI, V23, P10892; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bonnet-Duquennoy M, 2009, INT J CANCER, V125, P708, DOI 10.1002/ijc.24413; Cao SH, 2009, J SOLUTION CHEM, V38, P1193, DOI 10.1007/s10953-009-9439-7; Clode PL, 2007, MICROSC RES TECHNIQ, V70, P220, DOI 10.1002/jemt.20409; Clode PL, 2003, BIOL BULL-US, V204, P138, DOI 10.2307/1543549; Davidson SM, 2006, CELL CALCIUM, V40, P561, DOI 10.1016/j.ceca.2006.08.017; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Evans CW, 2012, NEW J CHEM, V36, P1457, DOI 10.1039/c2nj40016b; Evans CW, 2011, ACS NANO, V5, P8640, DOI 10.1021/nn2022149; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gardette M, 2011, INVEST NEW DRUG, V29, P1253, DOI 10.1007/s10637-010-9471-x; Goldberg DA, 2003, CLIN BIOCHEM, V36, P79, DOI 10.1016/S0009-9120(02)00397-1; GROTTA J, 1995, STROKE, V26, P602, DOI 10.1161/01.STR.26.4.602; Gunnarson E, 2004, NEUROSCIENCE, V129, P947, DOI 10.1016/j.neuroscience.2004.08.022; Halonen SK, 1998, INT J PARASITOL, V28, P815, DOI 10.1016/S0020-7519(98)00035-6; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Harrison J, 2012, SMALL, V8, P1579, DOI 10.1002/smll.201102648; Ho D, 2011, NANOSCALE, V3, P907, DOI 10.1039/c0nr00666a; Hsieh Tze-chen, 2006, Med Chem, V2, P275, DOI 10.2174/157340606776930709; Huhn D, 2013, ACS NANO, V7, P3253, DOI 10.1021/nn3059295; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jannin B, 2004, BIOCHEM PHARMACOL, V68, P1113, DOI 10.1016/j.bcp.2004.04.028; Johnston APR, 2012, ACS NANO, V6, P6667, DOI 10.1021/nn3010476; Kohara A, 1998, J PHARM PHARMACOL, V50, P795, DOI 10.1111/j.2042-7158.1998.tb07142.x; Kopp C, 2015, ZOOLOGY, V118, P125, DOI 10.1016/j.zool.2014.06.006; Labarre P, 2008, NUCL MED BIOL, V35, P783, DOI 10.1016/j.nucmedbio.2008.07.003; Labiche Lise A, 2004, NeuroRx, V1, P46, DOI 10.1602/neurorx.1.1.46; Larson TA, 2012, ACS NANO, V6, P9182, DOI 10.1021/nn3035155; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lee HJ, 2013, PHARM RES-DORDR, V30, P478, DOI 10.1007/s11095-012-0893-3; Legin AA, 2014, CHEM SCI, V5, P3135, DOI 10.1039/c3sc53426j; Lesniak A, 2010, BIOMATERIALS, V31, P9511, DOI 10.1016/j.biomaterials.2010.09.049; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Liu X, 2013, J NANOMATER, V2013, DOI 10.1155/2013/938370; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lozic I, 2014, METALLOMICS, V6, P455, DOI 10.1039/c3mt00336a; Lozie I., 2015, DATA BRIEF UNPUB; Lunov O, 2011, ACS NANO, V5, P1657, DOI 10.1021/nn2000756; Meloni BP, 2015, PHARMACOL THERAPEUT, V153, P36, DOI 10.1016/j.pharmthera.2015.06.002; MORI S, 1969, J COMP NEUROL, V137, P197, DOI 10.1002/cne.901370206; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; N'soukpoe-Kossi CN, 2006, J BIOMOL STRUCT DYN, V24, P277, DOI 10.1080/07391102.2006.10507120; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Peixoto P, 2009, EUR J MED CHEM, V44, P4758, DOI 10.1016/j.ejmech.2009.06.034; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Perekatt AO, 2014, P NATL ACAD SCI USA, V111, P7695, DOI 10.1073/pnas.1400128111; Phokeo V, 2002, J COMP NEUROL, V451, P213, DOI 10.1002/cne.10330; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; Reukov V, 2011, BIOTECHNOL BIOENG, V108, P243, DOI 10.1002/bit.22958; ROBINSON JM, 1982, J CELL BIOL, V95, P933, DOI 10.1083/jcb.95.3.933; Ruge CA, 2011, NANOMED-NANOTECHNOL, V7, P690, DOI 10.1016/j.nano.2011.07.009; RUTILI G, 1977, ACTA PHYSIOL SCAND, V99, P1, DOI 10.1111/j.1748-1716.1977.tb10345.x; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Saptarshi SR, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-26; Sarfati G, 2011, BIOMATERIALS, V32, P152, DOI 10.1016/j.biomaterials.2010.09.014; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Shang L, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-5; Silva GA, 2010, ANN NY ACAD SCI, V1199, P221, DOI 10.1111/j.1749-6632.2009.05361.x; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Song CX, 1997, J CONTROL RELEASE, V43, P197, DOI 10.1016/S0168-3659(96)01484-8; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Tsai SK, 2007, J VASC SURG, V46, P346, DOI 10.1016/j.jvs.2007.04.044; Tsyalkovsky V, 2008, CHEM MATER, V20, P317, DOI 10.1021/cm0718421; Turk MJ, 2004, CANCER LETT, V213, P165, DOI 10.1016/j.canlet.2003.12.028; de Almeida LMV, 2008, ARCH BIOCHEM BIOPHYS, V480, P27, DOI 10.1016/j.abb.2008.09.006; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Xie J, 2010, ADV DRUG DELIVER REV, V62, P1064, DOI 10.1016/j.addr.2010.07.009; Yan Y, 2013, ACS NANO, V7, P10960, DOI 10.1021/nn404481f; 신진영, 2008, Clinical and Experimental Pediatrics, V51, P1102	82	16	16	1	53	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JAN	2016	74						200	216		10.1016/j.biomaterials.2015.10.001			17	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	CV9MH	WOS:000364610800018	26461115	Green Submitted			2022-02-06	
